PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Arrey, AE; Bilsen, J; Lacor, P; Deschepper, R				Arrey, Agnes Ebotabe; Bilsen, Johan; Lacor, Patrick; Deschepper, Reginald			"It's My Secret": Fear of Disclosure among Sub-Saharan African Migrant Women Living with HIV/AIDS in Belgium	PLOS ONE			English	Article							HIV-POSITIVE STATUS; PROBABILITY SAMPLE; CARIBBEAN PEOPLE; CARE SERVICES; STIGMA; HEALTH; EXPERIENCES; SEX; DISCRIMINATION; SEROSTATUS	Patients with HIV not only have to deal with the challenges of living with an incurable disease but also with the dilemma of whether or not to disclose their status to their partners, families and friends. This study explores the extent to which sub-Saharan African (SSA) migrant women in Belgium disclose their HIV positive status, reasons for disclosure/non-disclosure and how they deal with HIV disclosure. A qualitative study consisting of interviews with twenty-eight SSA women with HIV/AIDS was conducted. Thematic content analysis was employed to identify themes as they emerged. Our study reveals that these women usually only disclose their status to healthcare professionals because of the treatment and care they need. This selective disclosure is mainly due to the taboo of HIV disease in SSA culture. Stigma, notably self-stigma, greatly impedes HIV disclosure. Techniques to systematically incorporate HIV disclosure into post-test counseling and primary care services are highly recommended.	[Arrey, Agnes Ebotabe; Bilsen, Johan; Deschepper, Reginald] Vrije Univ Brussel, Fac Med & Pharm, Dept Publ Hlth, Brussels, Belgium; [Lacor, Patrick] Univ Ziekenhuis Brussel, AIDS Reference Ctr, Dept Internal Med & Infect Dis, Brussels, Belgium	Vrije Universiteit Brussel; University Hospital Brussels; Vrije Universiteit Brussel	Arrey, AE (corresponding author), Vrije Univ Brussel, Fac Med & Pharm, Dept Publ Hlth, Brussels, Belgium.	aarrey@vub.ac.be	Deschepper, Reginald/B-8103-2013	Deschepper, Reginald/0000-0002-4222-3945; Lacor, Patrick/0000-0002-7252-0924	Fonds Wetenschappelijk Onderzoek (FWO) [1901215N LV]	Fonds Wetenschappelijk Onderzoek (FWO)(FWO)	This study was funded by grant number 1901215N LV from Fonds Wetenschappelijk Onderzoek (FWO). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablon Joan, 2002, Epilepsy Behav, V3, P2, DOI 10.1016/S1525-5050(02)00543-7; Anderson M, 2010, AIDS CARE, V22, P1493, DOI 10.1080/09540121.2010.482125; Andersson N, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-274; Andersson N, 2012, AIDS BEHAV, V16, P189, DOI 10.1007/s10461-011-9912-3; Barrett HR, 2010, PSYCHOL HEALTH MED, V15, P357, DOI 10.1080/13548501003653192; Belgian Federal Government, 2013, PROTECTION DE LA VIE; Bharat S, 2011, SAHARA J-J SOC ASP H, V8, P138, DOI 10.1080/17290376.2011.9724996; Bos Arjan E R, 2009, Issues Ment Health Nurs, V30, P509, DOI 10.1080/01612840802601382; Bradley EH, 2011, HEALTH SERV RES, V46, P2019, DOI 10.1111/j.1475-6773.2011.01349.x; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Burns FM, 2007, AIDS CARE, V19, P102, DOI 10.1080/09540120600908440; Canadian HIV/AIDS Legal Network 2, 2014, CRIMINAL LAW AND HIV; Carr RL, 2004, J ASSOC NURSE AIDS C, V15, P30, DOI 10.1177/1055329003261981; Castles S, 2010, J ETHN MIGR STUD, V36, P1565, DOI 10.1080/1369183X.2010.489381; Cave J, 2012, BRIT J GEN PRACT, V62, P348, DOI 10.3399/bjgp12X652229; Chaudoir SR, 2013, BASIC APPL SOC PSYCH, V35, P75, DOI 10.1080/01973533.2012.746612; Chemaitelly H, 2014, EPIDEMICS-NETH, V6, P1, DOI 10.1016/j.epidem.2013.11.001; Ciccarone DH, 2003, AM J PUBLIC HEALTH, V93, P949, DOI 10.2105/AJPH.93.6.949; de Alencar TM, 2008, CIENC SAUDE COLETIVA, V13, P1841, DOI 10.1590/S1413-81232008000600019; Degroote S, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18643; Dinos S, 2004, BRIT J PSYCHIAT, V184, P176, DOI 10.1192/bjp.184.2.176; Dowshen N, 2009, AIDS PATIENT CARE ST, V23, P371, DOI 10.1089/apc.2008.0256; Doyal L, 2001, BRIT MED J, V323, P1061, DOI 10.1136/bmj.323.7320.1061; Drummond PD, 2011, HEALTH CARE WOMEN IN, V32, P206, DOI 10.1080/07399332.2010.529216; Duffy L, 2005, J ASSOC NURSE AIDS C, V16, P13, DOI 10.1016/j.jana.2004.11.002; Duru OK, 2006, AIDS BEHAV, V10, P495, DOI 10.1007/s10461-006-9089-3; Earnshaw VA, 2012, CHRONIC ILLN, V8, P79, DOI 10.1177/1742395311429393; European Central Bank, 2009, MET MAT TENS TEST 1, P1; European Commission, 2012, PROTECTION OF PERSON; Fakoya I, 2008, HIV MED, V9, P23, DOI 10.1111/j.1468-1293.2008.00587.x; Freund P. E. S., 1999, HEALTH ILLNESS AND T; GOFFMAN ERVING, 1963, STIGMA NOTES ON THE; GOSTIN L, 1987, AM J PUBLIC HEALTH, V77, P361, DOI 10.2105/AJPH.77.3.361; Greeff M, 2010, INT J NURS STUD, V47, P475, DOI 10.1016/j.ijnurstu.2009.09.008; Grov C, 2010, AIDS CARE, V22, P630, DOI 10.1080/09540120903280901; Hardon A, 2013, SAHARA J-J SOC ASP H, V10, pS1, DOI 10.1080/02664763.2012.755317; Hardon A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-26; Hasan MT, 2012, J HEALTH POPUL NUTR, V30, P22, DOI 10.3329/jhpn.v30i1.11272; Hatzenbuehler ML, 2013, AM J PUBLIC HEALTH, V103, P813, DOI 10.2105/AJPH.2012.301069; Hong Y, 2008, AIDS PATIENT CARE ST, V22, P823, DOI 10.1089/apc.2008.0001; Kaleeba N, 1997, AIDS CARE, V9, P13, DOI 10.1080/09540129750125307; Korner H, 2007, CULT HEALTH SEX, V9, P137, DOI 10.1080/13691050600975462; Lekas HM, 2006, QUAL HEALTH RES, V16, P1165, DOI 10.1177/1049732306292284; Likatavicius G, 2012, EURO SURVEILL, V17; Lindgren T, 2005, WOMEN HEALTH, V41, P69, DOI 10.1300/J013v41n01_05; Makoae MG, 2008, SAHARA J-J SOC ASP H, V5, P36, DOI 10.1080/17290376.2008.9724900; Mawar N, 2005, INDIAN J MED RES, V122, P471; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Monjok Emmanuel, 2009, Afr J Reprod Health, V13, P21; Monteiro SS, 2013, GLOB PUBLIC HEALTH, V8, P519, DOI 10.1080/17441692.2013.779738; Moreno CL, 2007, QUAL HEALTH RES, V17, P340, DOI 10.1177/1049732306297387; Navaza B, 2012, AIDS BEHAV, V16, P30, DOI 10.1007/s10461-010-9871-0; Ncama BP, 2007, INT NURS REV, V54, P391, DOI 10.1111/j.1466-7657.2007.00560.x; Obermeyer CM, 2011, AM J PUBLIC HEALTH, V101, P1011, DOI 10.2105/AJPH.2010.300102; Olalekan Adebimpe Wasiu, 2014, Mater Sociomed, V26, P191, DOI 10.5455/msm.2014.26.191-194; Osinde MO, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-50; Parker R, 2012, CAD SAUDE PUBLICA, V28, P164, DOI 10.1590/S0102-311X2012000100017; Parsons JT, 2004, AIDS EDUC PREV, V16, P459, DOI 10.1521/aeap.16.5.459.48741; Pettigrew SF, 2000, ADV CONSUM RES, V27, P256; Rosenthal T, 2014, J AM SOC HYPERTENS, V8, P171, DOI 10.1016/j.jash.2013.12.007; Rujumba J, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17429; Sasse A, 2013, VERBRUGGE R 2013 EPI; Serovich JM, 2003, AIDS EDUC PREV, V15, P70, DOI 10.1521/aeap.15.1.70.23846; Skinner D, 2004, SAHARA J, V1, P157; Smith RA, 2009, HEALTH COMMUN, V24, P459, DOI 10.1080/10410230903023501; Stutterheim SE, 2012, PSYCHOL HEALTH, V27, P395, DOI 10.1080/08870446.2011.585426; Stutterheim SE, 2011, AIDS CARE, V23, P195, DOI 10.1080/09540121.2010.498873; Sullivan K, 2010, WOMEN HEALTH, V50, P506, DOI 10.1080/03630242.2010.516697; Thomas F, 2010, SOC SCI MED, V70, P736, DOI 10.1016/j.socscimed.2009.10.063; Uwe EA, 2007, INT Q COMMUNITY HEAL, V27, P87, DOI 10.2190/IQ.27.1.g; van der Straten A, 1998, AIDS CARE, V10, P533, DOI 10.1080/09540129848406; Van Praag E, 1995, AIDS Asia, V2, P10; Varas-Diaz N, 2003, INCARNATING STIGMA V, V4; Visser MJ, 2009, AIDS CARE, V21, P197, DOI 10.1080/09540120801932157; Vu L, 2012, AIDS BEHAV, V16, P132, DOI 10.1007/s10461-010-9873-y; White K., 2002, AN INTRODUCTION TO T; WHO, 2011, GUIDELINE ON HIV DIS	77	34	34	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119653	10.1371/journal.pone.0119653	http://dx.doi.org/10.1371/journal.pone.0119653			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7QC	25781906	Green Submitted, Green Published, gold			2022-12-27	WOS:000351284600082
J	Aubry, S; Shin, W; Crary, JF; Lefort, R; Qureshi, YH; Lefebvre, C; Califano, A; Shelanski, ML				Aubry, Soline; Shin, William; Crary, John F.; Lefort, Roger; Qureshi, Yasir H.; Lefebvre, Celine; Califano, Andrea; Shelanski, Michael L.			Assembly and Interrogation of Alzheimer's Disease Genetic Networks Reveal Novel Regulators of Progression	PLOS ONE			English	Article							TRANSCRIPTION FACTOR YY1; LINKED MENTAL-RETARDATION; TUMOR-SUPPRESSOR; ACETYLATION; EXPRESSION; P53; PROTEIN; BRAIN; P300; PHOSPHORYLATION	Alzheimer's disease (AD) is a complex multifactorial disorder with poorly characterized pathogenesis. Our understanding of this disease would thus benefit from an approach that addresses this complexity by elucidating the regulatory networks that are dysregulated in the neural compartment of AD patients, across distinct brain regions. Here, we use a Systems Biology (SB) approach, which has been highly successful in the dissection of cancer related phenotypes, to reverse engineer the transcriptional regulation layer of human neuronal cells and interrogate it to infer candidate Master Regulators (MRs) responsible for disease progression. Analysis of gene expression profiles from laser-captured neurons from AD and controls subjects, using the Algorithm for the Reconstruction of Accurate Cellular Networks (ARACNe), yielded an interactome consisting of 488,353 transcription-factor/target interactions. Interrogation of this interactome, using the Master Regulator INference algorithm (MARINa), identified an unbiased set of candidate MRs causally responsible for regulating the transcriptional signature of AD progression. Experimental assays in autopsy-derived human brain tissue showed that three of the top candidate MRs (YY1, p300 and ZMYM3) are indeed biochemically and histopathologically dysregulated in AD brains compared to controls. Our results additionally implicate p53 and loss of acetylation homeostasis in the neurodegenerative process. This study suggests that an integrative, SB approach can be applied to AD and other neurodegenerative diseases, and provide significant novel insight on the disease progression.	[Aubry, Soline; Crary, John F.; Lefort, Roger; Qureshi, Yasir H.; Shelanski, Michael L.] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA; [Aubry, Soline; Crary, John F.; Lefort, Roger; Qureshi, Yasir H.; Shelanski, Michael L.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Shin, William; Lefebvre, Celine; Califano, Andrea] Columbia Univ, Dept Syst Biol, New York, NY 10032 USA; [Shin, William; Lefebvre, Celine; Califano, Andrea] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; [Shin, William; Califano, Andrea] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Lefebvre, Celine] Inst Gustave Roussy, INSERM, U981, F-94805 Villejuif, France	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Califano, A (corresponding author), Columbia Univ, Dept Syst Biol, New York, NY 10032 USA.	ac2248@columbia.edu; mls7@columbia.edu	Lefebvre, Celine/E-6290-2013	Qureshi, Yasir H/0000-0002-2729-2440; Califano, Andrea/0000-0003-4742-3679; Lefort, Roger/0000-0002-8885-606X	American Recovery and Reinvestment Act (ARRA) funds [P30AG036453]; Alzheimer's Association [NIRG-11-204450]; Louis V. Gerstner, Jr., Foundation; NIH [U54 CA121852, 5 T32 GM008798]; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG036453] Funding Source: NIH RePORTER	American Recovery and Reinvestment Act (ARRA) funds; Alzheimer's Association(Alzheimer's Association); Louis V. Gerstner, Jr., Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was funded in part by American Recovery and Reinvestment Act (ARRA) funds through Grant number P30AG036453 (MLS), by the Alzheimer's Association (NIRG-11-204450) and the Louis V. Gerstner, Jr., Foundation (JFC) and by the NIH (U54 CA121852; 5 T32 GM008798) (CA and WS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALL MJ, 1977, ACTA NEUROPATHOL, V37, P111, DOI 10.1007/BF00692056; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; BECKER KG, 1994, GENE, V150, P259, DOI 10.1016/0378-1119(94)90435-9; Brooks CL, 2011, PROTEIN CELL, V2, P456, DOI 10.1007/s13238-011-1063-9; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Califano A, 2012, NAT GENET, V44, P841, DOI 10.1038/ng.2355; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chan HM, 2001, J CELL SCI, V114, P2363; Cohen TJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1255; Colangelo V, 2002, J NEUROSCI RES, V70, P462, DOI 10.1002/jnr.10351; delaMonte SM, 1997, J NEUROL SCI, V152, P73, DOI 10.1016/S0022-510X(97)00131-7; Della Gatta G, 2012, NAT MED, V18, P436, DOI 10.1038/nm.2610; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Gronroos E, 2004, P NATL ACAD SCI USA, V101, P12165, DOI 10.1073/pnas.0402283101; Hakimi MA, 2003, J BIOL CHEM, V278, P7234, DOI 10.1074/jbc.M208992200; He Y, 2008, J NEUROCHEM, V106, P1493, DOI 10.1111/j.1471-4159.2008.05486.x; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Huang WC, 2005, MOL CELL BIOL, V25, P6592, DOI 10.1128/MCB.25.15.6592-6602.2005; HYMAN BT, 1984, SCIENCE, V225, P1168, DOI 10.1126/science.6474172; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Korhonen P, 2005, NEUROSCI LETT, V377, P121, DOI 10.1016/j.neulet.2004.11.085; Krippner-Heidenreich A, 2005, MOL CELL BIOL, V25, P3704, DOI 10.1128/MCB.25.9.3704-3714.2005; Lefebvre C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.31; Lefort R, 2012, J NEUROSCI, V32, P10674, DOI 10.1523/JNEUROSCI.6473-11.2012; Liang WS, 2008, PHYSIOL GENOMICS, V33, P240, DOI 10.1152/physiolgenomics.00242.2007; Liang WS, 2008, P NATL ACAD SCI USA, V105, P4441, DOI 10.1073/pnas.0709259105; Liang WS, 2010, NEUROBIOL AGING, V31, P549, DOI 10.1016/j.neurobiolaging.2008.05.013; Loring JF, 2001, DNA CELL BIOL, V20, P683, DOI 10.1089/10445490152717541; Luebben WR, 2010, P NATL ACAD SCI USA, V107, P19254, DOI 10.1073/pnas.1009650107; Miller JA, 2008, J NEUROSCI, V28, P1410, DOI 10.1523/JNEUROSCI.4098-07.2008; Min SW, 2010, NEURON, V67, P953, DOI 10.1016/j.neuron.2010.08.044; Moolman DL, 2004, J NEUROCYTOL, V33, P377, DOI 10.1023/B:NEUR.0000044197.83514.64; Noorbakhsh F, 2009, TRENDS NEUROSCI, V32, P88, DOI 10.1016/j.tins.2008.10.003; Nowak K, 2006, J NEUROCHEM, V96, P1696, DOI 10.1111/j.1471-4159.2006.03692.x; Piovan E, 2013, CANCER CELL, V24, P766, DOI 10.1016/j.ccr.2013.10.022; Pompl PN, 2003, ARCH NEUROL-CHICAGO, V60, P369, DOI 10.1001/archneur.60.3.369; Pozueta J, 2012, NEUROSCIENCE; Raz L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027039; Reifert J, 2011, J BIOL CHEM, V286, P20797, DOI 10.1074/jbc.M111.234674; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Sankar N, 2008, ONCOGENE, V27, P5717, DOI 10.1038/onc.2008.181; Scheer MP, 2000, GENOMICS, V63, P123, DOI 10.1006/geno.1999.6027; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Selvi BR, 2010, BBA-GENE REGUL MECH, V1799, P840, DOI 10.1016/j.bbagrm.2010.08.012; Selznick LA, 1999, J NEUROPATH EXP NEUR, V58, P1020, DOI 10.1097/00005072-199909000-00012; Shimohama S, 1999, BIOCHEM BIOPH RES CO, V256, P381, DOI 10.1006/bbrc.1999.0344; Small SA, 2011, NAT REV NEUROSCI, V12, P585, DOI 10.1038/nrn3085; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; vanderMaarel SM, 1996, HUM MOL GENET, V5, P887, DOI 10.1093/hmg/5.7.887; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Vonsattel JPG, 2008, ACTA NEUROPATHOL, V115, P509, DOI 10.1007/s00401-007-0311-9; Wilson CA, 1999, J NEUROPATH EXP NEUR, V58, P787, DOI 10.1097/00005072-199908000-00001; World Health Organisation, 2011, GLOBAL HEALTH AND AG; Wu Z, 2004, J AM STAT ASS, V44; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Yao YL, 2001, MOL CELL BIOL, V21, P5979, DOI 10.1128/MCB.21.17.5979-5991.2001; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030	64	62	63	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120352	10.1371/journal.pone.0120352	http://dx.doi.org/10.1371/journal.pone.0120352			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781952	Green Submitted, gold, Green Published			2022-12-27	WOS:000351284600153
J	Bergfelder-Druing, S; Grosse-Brinkhaus, C; Lind, B; Erbe, M; Schellander, K; Simianer, H; Tholen, E				Bergfelder-Drueing, Sarah; Grosse-Brinkhaus, Christine; Lind, Bianca; Erbe, Malena; Schellander, Karl; Simianer, Henner; Tholen, Ernst			A Genome-Wide Association Study in Large White and Landrace Pig Populations for Number Piglets Born Alive	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; CYTOSOLIC PHOSPHOLIPASE A(2); SINGLE-NUCLEOTIDE POLYMORPHISMS; LITTER SIZE; TYROSINE KINASE; ESTROUS-CYCLE; GENE; EXPRESSION; MODEL; DISRUPTION	The number of piglets born alive (NBA) per litter is one of the most important traits in pig breeding due to its influence on production efficiency. It is difficult to improve NBA because the heritability of the trait is low and it is governed by a high number of loci with low to moderate effects. To clarify the biological and genetic background of NBA, genome-wide association studies (GWAS) were performed using 4,012 Large White and Landrace pigs from herdbook and commercial breeding companies in Germany (3), Austria (1) and Switzerland (1). The animals were genotyped with the Illumina PorcineSNP60 BeadChip. Because of population stratifications within and between breeds, clusters were formed using the genetic distances between the populations. Five clusters for each breed were formed and analysed by GWAS approaches. In total, 17 different significant markers affecting NBA were found in regions with known effects on female reproduction. No overlapping significant chromosome areas or QTL between Large White and Landrace breed were detected.	[Bergfelder-Drueing, Sarah; Grosse-Brinkhaus, Christine; Schellander, Karl; Tholen, Ernst] Univ Bonn, Dept Anim Genet, Inst Anim Sci, Bonn, Germany; [Lind, Bianca] Biotechnol Res FBF, Bonn, Germany; [Erbe, Malena; Simianer, Henner] Univ Goettingen, Anim Breeding & Genet, Gottingen, Germany	University of Bonn; University of Gottingen	Grosse-Brinkhaus, C (corresponding author), Univ Bonn, Dept Anim Genet, Inst Anim Sci, Bonn, Germany.	cgro@itw.uni-bonn.de	Große-Brinkhaus, Christine/AAF-6712-2020; Simianer, Henner/A-6574-2015	Große-Brinkhaus, Christine/0000-0002-6190-4463; Simianer, Henner/0000-0002-7551-3797	project "pigGS" [FKZ 005-NA02-018 C]; European Union; Ministry for Economic Affairs, Energy, Building, Housing and Transport	project "pigGS"; European Union(European Commission); Ministry for Economic Affairs, Energy, Building, Housing and Transport	This study was prepared within the framework of the project "pigGS" (FKZ 005-NA02-018 C). This project was financed by the European Union and Ministry for Economic Affairs, Energy, Building, Housing and Transport. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001274; ANDERSSON L, 1994, SCIENCE, V263, P1771, DOI 10.1126/science.8134840; Archibald AL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-438; Ashworth MD, 2006, BIOL REPROD, V74, P1007, DOI 10.1095/biolreprod.105.046557; Astle W, 2009, STAT SCI, V24, P451, DOI 10.1214/09-STS307; Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Becker D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055951; BENNETT GL, 1989, J ANIM SCI, V67, P1230; Bogacka I, 2011, J PHYSIOL PHARMACOL, V62, P559; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Bouaziz M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028845; Buske B, 2006, J ANIM BREED GENET, V123, P343, DOI 10.1111/j.1439-0388.2006.00609.x; Buske B, 2006, ARCH TIERZUCHT, V49, P259, DOI 10.5194/aab-49-259-2006; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Davis BJ, 1999, ENDOCRINOLOGY, V140, P2685, DOI 10.1210/en.140.6.2685; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; DINCHUK JE, 1995, NATURE, V378, P406, DOI 10.1038/378406a0; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Ferrara N, 1999, J MOL MED, V77, P527, DOI 10.1007/s001099900019; Finlay EK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030545; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Gorlov IP, 2008, AM J HUM GENET, V82, P100, DOI 10.1016/j.ajhg.2007.09.006; Guo Liang-Yong, 2012, Yichuan, V34, P879, DOI 10.3724/SP.J.1005.2012.00879; Hirashima M, 2003, P NATL ACAD SCI USA, V100, P15637, DOI 10.1073/pnas.2635424100; Hu ZL, 2013, NUCLEIC ACIDS RES, V41, pD871, DOI 10.1093/nar/gks1150; Hyenne V, 2005, DEV BIOL, V287, P180, DOI 10.1016/j.ydbio.2005.09.004; KENNEDY BP, 1995, J BIOL CHEM, V270, P22378, DOI 10.1074/jbc.270.38.22378; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; Kishimoto K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-42; Kostka G, 2001, MOL CELL BIOL, V21, P7025, DOI 10.1128/MCB.21.20.7025-7034.2001; Kurusu S, 2012, FASEB J, V26, P3800, DOI 10.1096/fj.12-203968; LANDE R, 1990, GENETICS, V124, P743; Leutenegger AL, 2003, AM J HUM GENET, V73, P516, DOI 10.1086/378207; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; MACPHEE M, 1995, CELL, V81, P957, DOI 10.1016/0092-8674(95)90015-2; Matsumoto H, 2001, BIOL REPROD, V64, P1557, DOI 10.1095/biolreprod64.5.1557; Meszaros G, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-13; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Muller PS, 2011, DEVELOPMENT, V138, P1297, DOI 10.1242/dev.059386; Munoz M, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-23; Okita K, 2004, GENES CELLS, V9, P1083, DOI 10.1111/j.1365-2443.2004.00791.x; Omelka R, 2005, CZECH J ANIM SCI, V50, P249, DOI 10.17221/4165-CJAS; Onteru SK, 2012, ANIM GENET, V43, P18, DOI 10.1111/j.1365-2052.2011.02213.x; Pausch H, 2012, ANIM GENET, V43, P689, DOI 10.1111/j.1365-2052.2012.02340.x; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Rohrer GA, 2001, PHYSIOL GENOMICS, V6, P145, DOI 10.1152/physiolgenomics.2001.6.3.145; Rohrer GA, 1999, J ANIM SCI, V77, P1385; Rothschild M, 1996, P NATL ACAD SCI USA, V93, P201, DOI 10.1073/pnas.93.1.201; Sapirstein A, 2000, BBA-MOL CELL BIOL L, V1488, P139, DOI 10.1016/S1388-1981(00)00116-5; Sapirstein A, 2005, AM J PHYSIOL-REG I, V288, pR1774, DOI 10.1152/ajpregu.00815.2004; Serenius T, 2003, LIVEST PROD SCI, V81, P213, DOI 10.1016/S0301-6226(02)00300-7; Song G, 2010, BIOL REPROD, V82, P854, DOI 10.1095/biolreprod.109.080929; Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615; Stuart A., 2009, KENDALLS ADV THEORY, V1; Tabangin Meredith E, 2009, BMC Proc, V3 Suppl 7, pS41, DOI 10.1186/1753-6561-3-S7-S41; Tribout T, 2008, GENET SEL EVOL, V40, P61, DOI 10.1051/gse:2007035; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; Utsunomiya YT, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-52; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004	64	26	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0117468	10.1371/journal.pone.0117468	http://dx.doi.org/10.1371/journal.pone.0117468			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781935	Green Published, gold, Green Submitted			2022-12-27	WOS:000351284600013
J	Ferrero, S; Carretero-Paulet, L; Mendes, MA; Botton, A; Eccher, G; Masiero, S; Colombo, L				Ferrero, Sergio; Carretero-Paulet, Lorenzo; Mendes, Marta Adelina; Botton, Alessandro; Eccher, Giulia; Masiero, Simona; Colombo, Lucia			Transcriptomic Signatures in Seeds of Apple (Malus domestica L. Borkh) during Fruitlet Abscission	PLOS ONE			English	Article							EXPRESSION; ETHYLENE; DOMINANCE; GROWTH; ACID; GENE; BENZYLADENINE; BIOSYNTHESIS; INVOLVEMENT; RESISTANCE	Abscission is the regulated process of detachment of an organ from a plant. In apple the abscission of fruits occurs during their early development to control the fruit load depending on the nutritional state of the plant. In order to control production and obtain fruits with optimal market qualities, the horticultural procedure of thinning is performed to further reduce the number of fruitlets. In this study we have conducted a transcriptomic profiling of seeds from two different types of fruitlets, according to size and position in the fruit cluster. Transcriptomic profiles of central and lateral fruit seeds were obtained by RNAseq. Comparative analysis was performed by the functional categorization of differentially expressed genes by means of Gene Ontology (GO) annotation of the apple genome. Our results revealed the overexpression of genes involved in responses to stress, hormone biosynthesis and also the response and/or transport of auxin and ethylene. A smaller set of genes, mainly related to ion transport and homeostasis, were found to be down-regulated. The transcriptome characterization described in this manuscript contributes to unravelling the molecular mechanisms and pathways involved in the physiological abscission of apple fruits and suggests a role for seeds in this process.	[Ferrero, Sergio; Mendes, Marta Adelina; Masiero, Simona; Colombo, Lucia] Univ Milan, Dipartimento BioSci, Milan, Italy; [Carretero-Paulet, Lorenzo] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA; [Botton, Alessandro; Eccher, Giulia] Univ Padua, Dept Agron Food Nat Resources Anim & Environm, Legnaro, Italy	University of Milan; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Padua	Ferrero, S (corresponding author), Univ Milan, Dipartimento BioSci, Milan, Italy.	sergio.ferrero@unimi.it	Mendes, Marta A. M./AAL-1225-2021; Carretero-Paulet, Lorenzo/Z-2744-2019; Masiero, Simona/J-2898-2013; Botton, Alessandro/C-4164-2008	Carretero-Paulet, Lorenzo/0000-0001-6697-827X; Colombo, Lucia/0000-0001-8415-1399; Mendes, Marta Adelina/0000-0001-9223-4119; Botton, Alessandro/0000-0001-5054-1479; masiero, simona/0000-0002-7563-7634	Progetto Agroalimentare e Ricerca (AGER) [2010-2119]	Progetto Agroalimentare e Ricerca (AGER)	This work was supported by the Progetto Agroalimentare e Ricerca (AGER-Grant no. 2010-2119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	ABELES FB, 1964, PLANT PHYSIOL, V39, P169, DOI 10.1104/pp.39.6.963; Addicott F.T, 1982, ABSCISSION; Ahn IP, 2007, MOL PLANT PATHOL, V8, P747, DOI 10.1111/J.1364-3703.2007.00428.X; Baggerly KA, 2003, BIOINFORMATICS, V19, P1477, DOI 10.1093/bioinformatics/btg173; BANGERTH F, 1989, PHYSIOL PLANTARUM, V76, P608, DOI 10.1111/j.1399-3054.1989.tb05487.x; Bangerth F., 1990, Acta Horticulturae, P461; Bangerth F, 2000, PLANT GROWTH REGUL, V31, P43, DOI 10.1023/A:1006398513703; Botton A, 2011, PLANT PHYSIOL, V155, P185, DOI 10.1104/pp.110.165779; Buban T, 2000, PLANT GROWTH REGUL, V32, P381, DOI 10.1023/A:1010785604339; BURG SP, 1967, BIOCHEM BIOPH RES CO, V27, P125, DOI 10.1016/S0006-291X(67)80050-0; Callejas R., 1998, Acta Horticulturae, P271; Serrani JC, 2007, PLANT PHYSIOL, V145, P246, DOI 10.1104/pp.107.098335; Clark JI, 2005, PLANT PHYSIOL, V138, P1268, DOI 10.1104/pp.104.058529; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dal Cin V, 2005, J EXP BOT, V56, P2995, DOI 10.1093/jxb/eri296; Dal Cin V, 2007, ANN BOT-LONDON, V99, P1195, DOI 10.1093/aob/mcm062; Dal Cin V, 2007, MOL BIOTECHNOL, V36, P9, DOI 10.1007/s12033-007-0004-6; Dal Cin V, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-139; Dal Cin V, 2009, GENE, V442, P26, DOI 10.1016/j.gene.2009.04.009; Devoghalaere F, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-7; Eccher G, 2014, PLANT BIOSYST, V148, P157, DOI 10.1080/11263504.2013.870254; Eccher G, 2013, PLANT PHYSIOL, V161, P1952, DOI 10.1104/pp.112.208470; Eo J, 2009, SCI HORTIC-AMSTERDAM, V123, P224, DOI 10.1016/j.scienta.2009.08.011; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Gapper NE, 2013, AOB PLANTS, V5, DOI 10.1093/aobpla/plt021; Gonzalez-Carranza ZH, 1998, TRENDS PLANT SCI, V3, P10, DOI 10.1016/S1360-1385(97)01132-1; GREENE DW, 1992, J AM SOC HORTIC SCI, V117, P775, DOI 10.21273/JASHS.117.5.775; GRUBER J, 1990, PHYSIOL PLANTARUM, V79, P354; Hepler PK, 2005, PLANT CELL, V17, P2142, DOI 10.1105/tpc.105.032508; Hua J, 1998, CELL, V94, P261, DOI 10.1016/S0092-8674(00)81425-7; Ireland HS, 2012, POSTHARVEST BIOL TEC, V72, P42, DOI 10.1016/j.postharvbio.2012.05.003; KATSUMI M, 1991, GIBBERELLINS, P211; Kusaba S, 2001, J EXP BOT, V52, P375, DOI 10.1093/jexbot/52.355.375; Lan TY, 2013, ANAL BIOCHEM, V438, P11, DOI 10.1016/j.ab.2013.03.012; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maruyama Y, 2013, PLANT SCI, V213, P79, DOI 10.1016/j.plantsci.2013.08.008; MONSELISE S P, 1972, Hortscience, V7, P514; Pandey GK, 2005, PLANT PHYSIOL, V139, P1185, DOI 10.1104/pp.105.066324; Peiter E, 2011, CELL CALCIUM, V50, P120, DOI 10.1016/j.ceca.2011.02.002; Ranocha P, 2001, PLANT J, V25, P575, DOI 10.1046/j.1365-313x.2001.00988.x; RINNE P, 1992, J EXP BOT, V43, P975, DOI 10.1093/jxb/43.7.975; Rosti J, 2007, PLANT CELL, V19, P1565, DOI 10.1105/tpc.106.049619; Sexton R., 1985, Ethylene and plant development, P173; Sexton R, 1994, HDB PLANT CROP PHYSL; Sexton R, 1987, MODELS PLANT PHYSL B, V2, P149; STEPHENSON AG, 1988, ANN BOT-LONDON, V62, P653, DOI 10.1093/oxfordjournals.aob.a087705; STEPHENSON AG, 1981, ANNU REV ECOL SYST, V12, P253, DOI 10.1146/annurev.es.12.110181.001345; Sun Tai-Ping, 2008, Arabidopsis Book, V6, pe0103, DOI 10.1199/tab.0103; Taylor JE, 2001, NEW PHYTOL, V151, P323, DOI 10.1046/j.0028-646x.2001.00194.x; Thomas SG, 1999, P NATL ACAD SCI USA, V96, P4698, DOI 10.1073/pnas.96.8.4698; vanDoorn WG, 1997, J EXP BOT, V48, P821, DOI 10.1093/jxb/48.4.821; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Yang JC, 2003, PLANT CELL ENVIRON, V26, P1621, DOI 10.1046/j.1365-3040.2003.01081.x; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	54	12	13	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120503	10.1371/journal.pone.0120503	http://dx.doi.org/10.1371/journal.pone.0120503			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781174	Green Published, gold, Green Submitted			2022-12-27	WOS:000351284600168
J	Sambamurthy, N; Leme, AS; Oury, TD; Shapiro, SD				Sambamurthy, Nisha; Leme, Adriana S.; Oury, Tim D.; Shapiro, Steven D.			The Receptor for Advanced Glycation End Products (RAGE) Contributes to the Progression of Emphysema in Mice	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; SMOKE-INDUCED EMPHYSEMA; NORMAL LUNG; EXPRESSION; GLYCOSYLATION; MARKER; OVEREXPRESSION; PATHOGENESIS; INFLAMMATION; MECHANISM	Several recent clinical studies have implied a role for the receptor for advanced glycation end products (RAGE) and its variants in chronic obstructive pulmonary disease (COPD). In this study we have defined a role for RAGE in the pathogenesis of emphysema in mice. RAGE deficient mice (RAGE-/-) exposed to chronic cigarette smoke were significantly protected from smoke induced emphysema as determined by airspace enlargement and had no significant reduction in lung tissue elastance when compared to their air exposed controls contrary to their wild type littermates. The progression of emphysema has been largely attributed to an increased inflammatory cell-mediated elastolysis. Acute cigarette smoke exposure in RAGE-/- mice revealed an impaired early recruitment of neutrophils, approximately a 6- fold decrease compared to wild type mice. Hence, impaired neutrophil recruitment with continued cigarette smoke exposure reduces elastolysis and consequent emphysema.	[Sambamurthy, Nisha; Leme, Adriana S.; Shapiro, Steven D.] Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA; [Sambamurthy, Nisha; Oury, Tim D.] Univ Pittsburgh, Dept Pathol, Dept Med, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Shapiro, SD (corresponding author), Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA.	shapirosd@upmc.edu						Basta G, 2002, CIRCULATION, V105, P816, DOI 10.1161/hc0702.104183; Bierhaus A, 2006, CURR OPIN INVEST DR, V7, P985; Chavakis T, 2003, J EXP MED, V198, P1507, DOI 10.1084/jem.20030800; Churg A, 2008, AM J PHYSIOL-LUNG C, V294, pL612, DOI 10.1152/ajplung.00390.2007; Clynes R, 2007, CURR MOL MED, V7, P743; Constien R, 2001, GENESIS, V30, P36, DOI 10.1002/gene.1030; D'hulst AI, 2005, EUR RESPIR J, V26, P204, DOI 10.1183/09031936.05.00095204; Demling N, 2006, CELL TISSUE RES, V323, P475, DOI 10.1007/s00441-005-0069-0; DUNNILL M. S., 1962, THORAX, V17, P320, DOI 10.1136/thx.17.4.320; Englert JM, 2008, AM J PATHOL, V172, P583, DOI 10.2353/ajpath.2008.070569; Fehrenbach H, 1998, CELL MOL BIOL, V44, P1147; Fineschi S, 2013, AM J RESP CELL MOL, V48, P164, DOI 10.1165/rcmb.2012-0111OC; Hanford LE, 2003, AM J RESP CELL MOL, V29, pS77; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Katsuoka F, 1997, BIOCHEM BIOPH RES CO, V238, P512, DOI 10.1006/bbrc.1997.7263; Leclerc E, 2009, BBA-MOL CELL RES, V1793, P993, DOI 10.1016/j.bbamcr.2008.11.016; Li Y, 2014, DNA CELL BIOL, V33, P251, DOI 10.1089/dna.2013.2303; Mahadeva R, 2002, THORAX, V57, P908, DOI 10.1136/thorax.57.10.908; Milutinovic PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088259; Milutinovic PS, 2012, AM J PATHOL, V181, P1215, DOI 10.1016/j.ajpath.2012.06.031; Miniati M, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-37; Mizumoto S, 2013, FEBS J, V280, P2462, DOI 10.1111/febs.12156; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Osawa M, 2007, BBA-GEN SUBJECTS, V1770, P1468, DOI 10.1016/j.bbagen.2007.07.003; Park SJ, 2011, J BIOL CHEM, V286, P21384, DOI 10.1074/jbc.M111.241281; Ramasamy R, 2007, MOL NUTR FOOD RES, V51, P1111, DOI 10.1002/mnfr.200700008; Ramsgaard L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020132; Reynolds PR, 2008, AM J PHYSIOL-LUNG C, V294, pL1094, DOI 10.1152/ajplung.00318.2007; Reynolds PR, 2011, AM J RESP CELL MOL, V45, P1195, DOI 10.1165/rcmb.2011-0170OC; Reynolds PR, 2011, AM J RESP CELL MOL, V45, P411, DOI 10.1165/rcmb.2010-0231OC; Robinson AB, 2012, AM J PHYSIOL-LUNG C, V302, pL1192, DOI 10.1152/ajplung.00099.2012; SCHMIDT AM, 1995, J CLIN INVEST, V96, P1395, DOI 10.1172/JCI118175; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; SCHRAML P, 1994, CANCER RES, V54, P5236; Schraml P, 1997, CANCER RES, V57, P3669; Shapiro SD, 1995, P ASSOC AM PHYSICIAN, V107, P346; Shapiro SD, 2003, AM J PATHOL, V163, P2329, DOI 10.1016/S0002-9440(10)63589-4; Shapiro SD, 2005, TXB RESP MED; Sharafkhaneh Amir, 2008, Proc Am Thorac Soc, V5, P475, DOI 10.1513/pats.200708-126ET; Shifren Adrian, 2006, Proc Am Thorac Soc, V3, P428, DOI 10.1513/pats.200601-009AW; Shirasawa M, 2004, GENES CELLS, V9, P165, DOI 10.1111/j.1356-9597.2004.00712.x; Smith DJ, 2011, EUR RESPIR J, V37, P516, DOI 10.1183/09031936.00029310; SNIDER GL, 1989, ANNU REV MED, V40, P411; Stogsdill JA, 2012, AM J RESP CELL MOL, V47, P60, DOI 10.1165/rcmb.2011-0385OC; Stogsdill MP, 2013, AM J RESP CELL MOL, V49, P128, DOI 10.1165/rcmb.2013-0013OC; Su X, 2009, AM J PHYSIOL-LUNG C, V297, pL1, DOI 10.1152/ajplung.90546.2008; Sukkar MB, 2012, BRIT J PHARMACOL, V167, P1161, DOI 10.1111/j.1476-5381.2012.01984.x; Uchida T, 2006, AM J RESP CRIT CARE, V173, P1008, DOI 10.1164/rccm.200509-1477OC; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Winden DR, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-108; Wu LA, 2011, RESP MED, V105, P329, DOI 10.1016/j.rmed.2010.11.001; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82	56	41	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0118979	10.1371/journal.pone.0118979	http://dx.doi.org/10.1371/journal.pone.0118979			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781626	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000351284600041
J	Yao, M; Cai, M; Yao, DF; Xu, X; Yang, RR; Li, YT; Zhang, YY; Kido, HS; Yao, DB				Yao, Min; Cai, Min; Yao, Dengfu; Xu, Xi; Yang, Rongrong; Li, Yuting; Zhang, Yuanyuan; Kido, Hiroshi; Yao, Dengbing			Abbreviated Half-Lives and Impaired Fuel Utilization in Carnitine Palmitoyltransferase II Variant Fibroblasts	PLOS ONE			English	Article							JAPANESE PATIENTS; MALONYL-COA; DEFICIENCY; INFLUENZA; ENCEPHALOPATHY; MUTATIONS; GENE; INHIBITION; PHENOTYPE; OXIDATION	Carnitine palmitoyltransferase II (CPT II) deficiency is one of the most common causes of fatty acid oxidation metabolism disorders. However, the molecular mechanism between CPT2 gene polymorphisms and metabolic stress has not been fully clarified. We previously reported that a number of patients show a thermal instable phenotype of compound hetero/homozygous variants of CPT II. To understand the mechanism of the metabolic disorder resulting from CPT II deficiency, the present study investigated CPT II variants in patient fibroblasts, [c. 1102 G>A (p.V368I)] (heterozygous), [c. 1102 G>A (p.V368I)] (homozygous), and [c. 1055 T>G (p.F352C)] (heterozygous) + [c. 1102 G>A (p.V368I)] (homozygous) compared with fibroblasts from healthy controls. CPT II variants exerted an effect of dominant negative on the homotetrameric proteins that showed thermal instability, reduced residual enzyme activities and a short half-life. Moreover, CPT II variant fibroblasts showed a significant decrease in fatty acid beta-oxidation and adenosine triphosphate generation, combined with a reduced mitochondrial membrane potential, resulting in cellular apoptosis. Collectively, our data indicate that the CPT II deficiency induces an energy crisis of the fatty acid metabolic pathway. These findings may contribute to the elucidation of the genetic factors involved in metabolic disorder encephalopathy caused by the CPT II deficiency.	[Yao, Min; Cai, Min; Li, Yuting; Yao, Dengbing] Nantong Univ, Coinnovat Ctr Neuroregenerat, Key Lab Neuroregenerat, Sch Life Sci, Nantong, Jiangsu, Peoples R China; [Yao, Min; Yao, Dengfu; Xu, Xi; Yang, Rongrong; Zhang, Yuanyuan] Nantong Univ, Affiliated Hosp, Sch Med, Nantong, Jiangsu, Peoples R China; [Kido, Hiroshi] Univ Tokushima, Inst Enzyme Res, Div Enzyme Chem, Tokushima 770, Japan	Nantong University; Nantong University; Tokushima University	Yao, DB (corresponding author), Nantong Univ, Coinnovat Ctr Neuroregenerat, Key Lab Neuroregenerat, Sch Life Sci, Nantong, Jiangsu, Peoples R China.	yaodb@ntu.edu.cn	zhang, yuanyuan/GYA-4428-2022		National Natural Science Foundation of China [81370982, 81200634]; Scientific Research Foundation for Returned Scholars, Ministry of Education of China; Natural Science Foundation of Jiangsu Province [BK2010282]; Priority Academic Program Development of Jiangsu Higher Education Institutions, PAPD	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for Returned Scholars, Ministry of Education of China(Scientific Research Foundation for the Returned Overseas Chinese ScholarsMinistry of Education, China); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions, PAPD	This research was supported by grants from: National Natural Science Foundation of China (Grant No. 81370982, 81200634); Scientific Research Foundation for Returned Scholars, Ministry of Education of China; Natural Science Foundation of Jiangsu Province (Grant No. BK2010282) and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions, PAPD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini C, 2010, CURR OPIN PHARMACOL, V10, P338, DOI 10.1016/j.coph.2010.02.006; Anichini A, 2011, NEUROL RES, V33, P24, DOI 10.1179/016164110X12767786356390; Anwar Z, 1999, BRIT J PHARMACOL, V128, P465, DOI 10.1038/sj.bjp.0702792; BIEBER LL, 1988, ANNU REV BIOCHEM, V57, P261, DOI 10.1146/annurev.bi.57.070188.001401; Bonnefont JP, 2009, MOL ASPECTS MED, V25, P495; Chen Y, 2005, FEBS LETT, V579, P2040, DOI 10.1016/j.febslet.2005.02.050; DELORME L, 1979, AM J DIS CHILD, V133, P822, DOI 10.1001/archpedi.1979.02130080062011; DEMAUGRE F, 1991, J CLIN INVEST, V87, P859, DOI 10.1172/JCI115090; DIMAURO S, 1973, SCIENCE, V182, P929, DOI 10.1126/science.182.4115.929; Fanin M, 2012, CLIN GENET, V82, P232, DOI 10.1111/j.1399-0004.2011.01786.x; Fujimoto S, 1998, LANCET, V352, P873, DOI 10.1016/S0140-6736(98)12449-2; HUG G, 1991, NEW ENGL J MED, V325, P1862, DOI 10.1056/NEJM199112263252607; Isackson PJ, 2006, MOL GENET METAB, V89, P323, DOI 10.1016/j.ymgme.2006.08.004; Kasai T, 2000, LANCET, V355, P1558, DOI 10.1016/S0140-6736(05)74614-6; Kobayashi Y, 2013, BRAIN DEV-JPN, V35, P449, DOI 10.1016/j.braindev.2012.06.013; Lee S, 2007, J BIOL CHEM, V282, P22977, DOI 10.1074/jbc.M700679200; Lehmann D, 2014, J NEUROL SCI, V339, P183, DOI 10.1016/j.jns.2014.02.011; Manda KR, 2011, FREE RADICAL BIO MED, V50, P801, DOI 10.1016/j.freeradbiomed.2010.12.029; MCGARRY JD, 1980, NEW ENGL J MED, V303, P1413, DOI 10.1056/NEJM198012113032410; MCGARRY JD, 1983, BIOCHEM J, V214, P21, DOI 10.1042/bj2140021; MURTHY MSR, 1987, BIOCHEM J, V248, P727, DOI 10.1042/bj2480727; Olpin SE, 2003, J INHERIT METAB DIS, V26, P543, DOI 10.1023/A:1025947930752; Orngreen MC, 2005, ANN NEUROL, V57, P60, DOI 10.1002/ana.20320; Pacilli A, 2013, JNCI-J NATL CANCER I, V105, P489, DOI 10.1093/jnci/djt030; Ronnett GV, 2005, PHYSIOL BEHAV, V85, P25, DOI 10.1016/j.physbeh.2005.04.014; Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426; Rufer AC, 2006, STRUCTURE, V14, P713, DOI 10.1016/j.str.2006.01.008; SAUDUBRAY JM, 1982, PEDIATR RES, V16, P877, DOI 10.1203/00006450-198210000-00015; Sigauke E, 2003, LAB INVEST, V83, P1543, DOI 10.1097/01.LAB.0000098428.51765.83; Taggart RT, 1999, HUM MUTAT, V13, P210; Tahanian E, 2011, J INFLAMM RES, V4, P1, DOI 10.2147/JIR.S15880; Tamaoki Y, 2002, BRAIN DEV-JPN, V24, P675, DOI 10.1016/S0387-7604(02)00074-8; TARONI F, 1992, P NATL ACAD SCI USA, V89, P8429, DOI 10.1073/pnas.89.18.8429; Thuillier L, 2003, HUM MUTAT, V21, P493, DOI 10.1002/humu.10201; VERDERIO E, 1995, HUM MOL GENET, V4, P19, DOI 10.1093/hmg/4.1.19; Wataya K, 1998, HUM MUTAT, V11, P377; Weiser M, 1997, J CLIN PHARMACOL, V37, P453, DOI 10.1002/j.1552-4604.1997.tb04323.x; Wieser T., 2011, GENE REV; Yahyaoui R, 2011, MOL GENET METAB, V104, P414, DOI 10.1016/j.ymgme.2011.05.003; Yao DB, 2008, HUM MUTAT, V29, P718, DOI 10.1002/humu.20717; Yao DB, 2011, J MED INVESTIG, V58, P210, DOI 10.2152/jmi.58.210; Yao M, 2011, MOL GENET METAB, V104, P265, DOI 10.1016/j.ymgme.2011.07.009; ZIERZ S, 1994, CLIN INVESTIGATOR, V72, P957, DOI 10.1007/BF00577735	43	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119936	10.1371/journal.pone.0119936	http://dx.doi.org/10.1371/journal.pone.0119936			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781464	Green Published, gold, Green Submitted			2022-12-27	WOS:000351284600110
J	Canduela, MJ; Mendizabal-Zubiaga, J; Puente, N; Reguero, L; Elezgarai, I; Ramos-Uriarte, A; Gerrikagoitia, I; Grandes, P				Canduela, Miren-Josune; Mendizabal-Zubiaga, Juan; Puente, Nagore; Reguero, Leire; Elezgarai, Izaskun; Ramos-Uriarte, Almudena; Gerrikagoitia, Inmaculada; Grandes, Pedro			Visualization by High Resolution Immunoelectron Microscopy of the Transient Receptor Potential Vanilloid-1 at Inhibitory Synapses of the Mouse Dentate Gyrus	PLOS ONE			English	Article							LONG-TERM DEPRESSION; TRPV1 CHANNELS; IMMUNOHISTOCHEMICAL LOCALIZATION; ENDOCANNABINOID SYSTEM; CANNABINOID RECEPTOR; SYNAPTIC PLASTICITY; BRAIN; MICE; HIPPOCAMPUS; ACTIVATION	We have recently shown that the transient receptor potential vanilloid type 1 (TRPV1), a non-selective cation channel in the peripheral and central nervous system, is localized at postsynaptic sites of the excitatory perforant path synapses in the hippocampal dentate molecular layer (ML). In the present work, we have studied the distribution of TRPV1 at inhibitory synapses in the ML. With this aim, a preembedding immunogold method for high resolution electron microscopy was applied to mouse hippocampus. About 30% of the inhibitory synapses in the ML are TRPV1 immunopositive, which is mostly localized perisynaptically (similar to 60% of total immunoparticles) at postsynaptic dendritic membranes receiving symmetric synapses in the inner 1/3 of the layer. This TRPV1 pattern distribution is not observed in the ML of TRPV1 knock-out mice. These findings extend the knowledge of the subcellular localization of TRPV1 to inhibitory synapses of the dentate molecular layer where the channel, in addition to excitatory synapses, is present.	[Canduela, Miren-Josune; Mendizabal-Zubiaga, Juan; Puente, Nagore; Reguero, Leire; Elezgarai, Izaskun; Ramos-Uriarte, Almudena; Gerrikagoitia, Inmaculada; Grandes, Pedro] Univ Basque Country UPV EHU, Fac Med & Dent, Dept Neurosci, E-48940 Leioa, Spain; [Canduela, Miren-Josune; Mendizabal-Zubiaga, Juan; Puente, Nagore; Reguero, Leire; Elezgarai, Izaskun; Ramos-Uriarte, Almudena; Gerrikagoitia, Inmaculada; Grandes, Pedro] Achucarro Basque Ctr Neurosci, Zamudio, Spain	University of Basque Country	Grandes, P (corresponding author), Univ Basque Country UPV EHU, Fac Med & Dent, Dept Neurosci, E-48940 Leioa, Spain.	pedro.grandes@ehu.es	Mendizabal, Juan Luis/H-6874-2015; Elezgarai, Izaskun/H-7076-2015; Ramos-Uriarte, Almudena/H-3179-2015; Grandes, Pedro/AAA-1627-2019; Grandes, Pedro/H-7494-2015; Gerrikagoitia, Inmaculada/H-7042-2015; Ramos, Almudena/AAS-1563-2020; Puente, Nagore/H-7054-2015; Reguero, Leire/H-6865-2015	Mendizabal, Juan Luis/0000-0002-4750-4797; Elezgarai, Izaskun/0000-0003-0880-8058; Ramos-Uriarte, Almudena/0000-0002-2632-1625; Grandes, Pedro/0000-0003-3947-4230; Gerrikagoitia, Inmaculada/0000-0002-5651-9405; Ramos, Almudena/0000-0002-2632-1625; Puente, Nagore/0000-0003-0866-5747; Alonso-Alconada, Daniel/0000-0002-9874-2947; Reguero, Leire/0000-0002-0267-5568	Ministerio de Economia y Competitividad [BFU2012-33334]; Basque Government grant [IT764-13]; University of the Basque Country [UFI11/41]; Red de Trastornos Adictivos, RETICS, Instituto de Salud Carlos III [RD07/0001/2001, RD12/0028/0004]	Ministerio de Economia y Competitividad(Spanish Government); Basque Government grant(Basque Government); University of the Basque Country; Red de Trastornos Adictivos, RETICS, Instituto de Salud Carlos III(Instituto de Salud Carlos III)	P. Grandes' laboratory is provided by Ministerio de Economia y Competitividad (BFU2012-33334); Basque Government grant IT764-13; University of the Basque Country (UFI11/41) and by Red de Trastornos Adictivos, RETICS, Instituto de Salud Carlos III, grant number: RD07/0001/2001, RD12/0028/0004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Cavanaugh DJ, 2011, J NEUROSCI, V31, P5067, DOI 10.1523/JNEUROSCI.6451-10.2011; Chavez AE, 2014, J NEUROSCI, V34, P16621, DOI 10.1523/JNEUROSCI.3635-14.2014; Chavez AE, 2010, NAT NEUROSCI, V13, P1511, DOI 10.1038/nn.2684; Cristino L, 2008, NEUROSCIENCE, V151, P955, DOI 10.1016/j.neuroscience.2007.11.047; Cristino L, 2006, NEUROSCIENCE, V139, P1405, DOI 10.1016/j.neuroscience.2006.02.074; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Egertova M, 2008, J COMP NEUROL, V506, P604, DOI 10.1002/cne.21568; Gibson HE, 2008, NEURON, V57, P746, DOI 10.1016/j.neuron.2007.12.027; Grueter BA, 2010, NAT NEUROSCI, V13, P1519, DOI 10.1038/nn.2685; Huang SM, 2002, P NATL ACAD SCI USA, V99, P8400, DOI 10.1073/pnas.122196999; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Katona I, 2012, ANNU REV NEUROSCI, V35, P529, DOI 10.1146/annurev-neuro-062111-150420; Kauer JA, 2009, TRENDS NEUROSCI, V32, P215, DOI 10.1016/j.tins.2008.12.006; Kawamura Y, 2006, J NEUROSCI, V26, P2991, DOI 10.1523/JNEUROSCI.4872-05.2006; Li HB, 2008, BIOL PSYCHIAT, V64, P286, DOI 10.1016/j.biopsych.2008.02.020; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Maione S, 2009, J PHYSIOL-LONDON, V587, P2521, DOI 10.1113/jphysiol.2009.171900; Marsch R, 2007, J NEUROSCI, V27, P832, DOI 10.1523/JNEUROSCI.3303-06.2007; Micale V, 2009, NEUROPSYCHOPHARMACOL, V34, P593, DOI 10.1038/npp.2008.98; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Mori F, 2012, J NEUROSCI, V32, P873, DOI 10.1523/JNEUROSCI.2531-11.2012; Nyilas R, 2008, J NEUROSCI, V28, P1058, DOI 10.1523/JNEUROSCI.5102-07.2008; Puente N, 2015, BRAIN STRUCT FUNCT, V220, P1187, DOI 10.1007/s00429-014-0711-2; Puente N, 2011, NAT NEUROSCI, V14, P1542, DOI 10.1038/nn.2974; Roberts JC, 2004, BRAIN RES, V995, P176, DOI 10.1016/j.brainres.2003.10.001; Sanchez JF, 2001, NEUROSCIENCE, V107, P373, DOI 10.1016/S0306-4522(01)00373-6; Sasamura T, 1998, NEUROREPORT, V9, P2045, DOI 10.1097/00001756-199806220-00025; Starowicz K, 2007, PHARMACOL THERAPEUT, V114, P13, DOI 10.1016/j.pharmthera.2007.01.005; Toth A, 2005, MOL BRAIN RES, V135, P162, DOI 10.1016/j.molbrainres.2004.12.003; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	32	8	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119401	10.1371/journal.pone.0119401	http://dx.doi.org/10.1371/journal.pone.0119401			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775089	Green Published, gold, Green Submitted			2022-12-27	WOS:000351183500089
J	Chaudhry, M; Rashid, HB; Thrusfield, M; Welburn, S; Bronsvoort, BM				Chaudhry, Mamoona; Rashid, Hamad B.; Thrusfield, Michael; Welburn, Sue; Bronsvoort, Barend MdeC.			A Case-Control Study to Identify Risk Factors Associated with Avian Influenza Subtype H9N2 on Commercial Poultry Farms in Pakistan	PLOS ONE			English	Article							A VIRUS H5N1; LOW-PATHOGENICITY; CHICKEN FARMS; WILD BIRDS; OUTBREAKS; INFECTION; EPIDEMIOLOGY; SURVEILLANCE; SPREAD; KOREA	A 1:1 matched case-control study was conducted to identify risk factors for avian influenza subtype H9N2 infection on commercial poultry farms in 16 districts of Punjab, and 1 administrative unit of Pakistan. One hundred and thirty-three laboratory confirmed positive case farms were matched on the date of sample submission with 133 negative control farms. The association between a series of farm-level characteristics and the presence or absence of H9N2 was assessed by univariable analysis. Characteristics associated with H9N2 risk that passed the initial screening were included in a multivariable conditional logistic regression model. Manual and automated approaches were used, which produced similar models. Key risk factors from all approaches included selling of eggs/birds directly to live bird retail stalls, being near case/infected farms, a previous history of infectious bursal disease (IBD) on the farm and having cover on the water storage tanks. The findings of current study are in line with results of many other studies conducted in various countries to identify similar risk factors for AI subtype H9N2 infection. Enhancing protective measures and controlling risks identified in this study could reduce spread of AI subtype H9N2 and other AI viruses between poultry farms in Pakistan.	[Chaudhry, Mamoona; Welburn, Sue] Univ Edinburgh, Sch Med, Div Infect & Pathway Med, Edinburgh, Midlothian, Scotland; [Rashid, Hamad B.] Univ Vet & Anim Sci, Dept Clin Med & Surg, Lahore, Pakistan; [Thrusfield, Michael] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH9 1QH, Midlothian, Scotland; [Bronsvoort, Barend MdeC.] Univ Edinburgh, Roslin Inst RDSVS, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Veterinary & Animal Science - Pakistan; University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Chaudhry, M (corresponding author), Univ Edinburgh, Sch Med, Div Infect & Pathway Med, Edinburgh, Midlothian, Scotland.	mamoona.chaudhry@gmail.com	Chaudhry, Mamoona/D-5026-2016; Chaudhry, M/AEV-6074-2022	Chaudhry, Mamoona/0000-0002-3151-3648; Thrusfield, Michael/0000-0003-1110-4094; Bronsvoort, Mark/0000-0002-3271-8485	Higher Education Commission; Biotechnology and Biological Sciences Research Council [BBS/E/D/05191133] Funding Source: researchfish; BBSRC [BBS/E/D/05191133] Funding Source: UKRI	Higher Education Commission(Ministry of Higher Education & Scientific Research (MHESR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The study was supported by Higher Education Commission (10% Overseas Scholarship Batch-II). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamir UB, 2009, VIROLOGY, V390, P212, DOI 10.1016/j.virol.2009.05.008; Abbas MA, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-137; Abbas T, 2012, BERL MUNCH TIERARZTL, V125, P110, DOI 10.2376/0005-9366-125-110; Abramson Joseph H, 2004, Epidemiol Perspect Innov, V1, P6, DOI 10.1186/1742-5573-1-6; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; ALEXANDER DJ, 1995, J COMP PATHOL, V112, P105, DOI 10.1016/S0021-9975(05)80054-4; [Anonymous], 2004, ENV CODE PRACTICE PO; [Anonymous], 1998, GUIDELINES ESTABLISH; [Anonymous], 2001, MISSING DATA; Bano S, 2003, AVIAN DIS, V47, P817, DOI 10.1637/0005-2086-47.s3.817; Beeler E, 2009, VET CLIN N AM-SMALL, V39, P251, DOI 10.1016/j.cvsm.2008.10.011; Biswas PK, 2009, VET REC, V164, P743, DOI 10.1136/vr.164.24.743; Biswas PK, 2008, EMERG INFECT DIS, V14, P1909, DOI 10.3201/eid1412.071567; Boon ACM, 2007, EMERG INFECT DIS, V13, P1720, DOI 10.3201/eid1311.070114; Brugh M, 1987, P 2 INT S AV INFL US, P177; Buscaglia C, 2007, AVIAN DIS, V51, P467, DOI 10.1637/7542.1; Capua I, 2003, AVIAN DIS, V47, P839, DOI 10.1637/0005-2086-47.s3.839; Cohen J., 1983, APPL MULTIPLE REGRES; Desvaux S, 2011, TRANSBOUND EMERG DIS, V58, P492, DOI 10.1111/j.1865-1682.2011.01227.x; Dohoo I.R., 2003, VET EPIDEMIOLOGIC RE; DUPONT WD, 1988, BIOMETRICS, V44, P1157, DOI 10.2307/2531743; Fang LQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002268; FAO, 2004, HIGHL PATH AV INFL A; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Iqbal Munir, 2009, J Mol Genet Med, V3, P119; Kung NY, 2007, EMERG INFECT DIS, V13, P412, DOI 10.3201/eid1303.060365; Lavoie ET, 2007, DEV COMP IMMUNOL, V31, P407, DOI 10.1016/j.dci.2006.07.009; Loth L, 2010, PREV VET MED, V96, P104, DOI 10.1016/j.prevetmed.2010.05.013; Mannelli A, 2006, PREV VET MED, V73, P273, DOI 10.1016/j.prevetmed.2005.09.005; McQuiston JH, 2005, JAVMA-J AM VET MED A, V226, P767, DOI 10.2460/javma.2005.226.767; Naeem K, 2007, AVIAN DIS, V51, P189, DOI 10.1637/7617-042506R.1; Naeem K, 1999, VET REC, V145, P560, DOI 10.1136/vr.145.19.560; Nili H, 2002, AVIAN PATHOL, V31, P247, DOI 10.1080/03079450220136567; Nishiguchi A, 2007, ZOONOSES PUBLIC HLTH, V54, P337, DOI 10.1111/j.1863-2378.2007.01074.x; Pantin-Jackwood MJ, 2012, VIRUS RES, V167, P196, DOI 10.1016/j.virusres.2012.04.015; PRI, 2011, PUNJ POULTR SECT STA; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramirez-Nieto G, 2010, AVIAN DIS, V54, P513, DOI 10.1637/8902-042809-Reg.1; Si YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053362; Siddique N, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-300; Songserm T, 2006, EMERG INFECT DIS, V12, P681, DOI 10.3201/eid1204.051396; Songserm T, 2006, EMERG INFECT DIS, V12, P1744, DOI 10.3201/eid1211.060542; Susilowati S H, 2013, LIVESTOCK RES RURAL, V25; Terregino C, 2007, AVIAN PATHOL, V36, P337, DOI 10.1080/03079450701488345; Therneau T, 2011, SURVIVAL SURVIVAL AN; Tombari W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053524; Trevennec K, 2011, ACTA TROP, V120, P160, DOI 10.1016/j.actatropica.2011.07.010; Turner Elizabeth L, 2010, Epidemiol Perspect Innov, V7, P9, DOI 10.1186/1742-5573-7-9; Ward M, 2008, VET RES COMMUN, V32, P627, DOI 10.1007/s11259-008-9064-8; Wee SH, 2006, VET REC, V158, P341, DOI 10.1136/vr.158.10.341; Woo JT, 2008, J VET SCI, V9, P161, DOI 10.4142/jvs.2008.9.2.161	53	18	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119019	10.1371/journal.pone.0119019	http://dx.doi.org/10.1371/journal.pone.0119019			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774768	Green Published, gold, Green Submitted			2022-12-27	WOS:000351183500059
J	Gaston, JR; Roberts, SA; Humphreys, TL				Gaston, Jordan R.; Roberts, Sally A.; Humphreys, Tricia L.			Molecular Phylogenetic Analysis of Non-Sexually Transmitted Strains of Haemophilus ducreyi	PLOS ONE			English	Article							FIBRINOGEN-BINDING; DEFICIENT MUTANT; DSRA; INFECTION; COMPETENCE; DIVERGENCE; EVOLUTION; VIRULENCE; BACTERIA; SEQUENCE	Haemophilus ducreyi, the etiologic agent of chancroid, has been previously reported to show genetic variance in several key virulence factors, placing strains of the bacterium into two genetically distinct classes. Recent studies done in yaws-endemic areas of the South Pacific have shown that H. ducreyi is also a major cause of cutaneous limb ulcers (CLU) that are not sexually transmitted. To genetically assess CLU strains relative to the previously described class I, class II phylogenetic hierarchy, we examined nucleotide sequence diversity at 11 H. ducreyi loci, including virulence and housekeeping genes, which encompass approximately 1% of the H. ducreyi genome. Sequences for all 11 loci indicated that strains collected from leg ulcers exhibit DNA sequences homologous to class I strains of H. ducreyi. However, sequences for 3 loci, including a hemoglobin receptor (hgbA), serum resistance protein (dsrA), and a collagen adhesin (ncaA) contained informative amounts of variation. Phylogenetic analyses suggest that these non-sexually transmitted strains of H. ducreyi comprise a sub-clonal population within class I strains of H. ducreyi. Molecular dating suggests that CLU strains are the most recently developed, having diverged approximately 0.355 million years ago, fourteen times more recently than the class I/class II divergence. The CLU strains' divergence falls after the divergence of humans from chimpanzees, making it the first known H. ducreyi divergence event directly influenced by the selective pressures accompanying human hosts.	[Gaston, Jordan R.; Humphreys, Tricia L.] Allegheny Coll, Dept Biol, Meadville, PA 16335 USA; [Roberts, Sally A.] Auckland Dist Hlth Board, Dept Microbiol, Auckland, New Zealand	Allegheny College; Auckland District Health Board	Humphreys, TL (corresponding author), Allegheny Coll, Dept Biol, Meadville, PA 16335 USA.	thumphre@allegheny.edu			Allegheny College	Allegheny College	This study was funded by Allegheny College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Tawfiq JA, 2000, J INFECT DIS, V181, P1049, DOI 10.1086/315309; Al-Tawfiq JA, 1998, J INFECT DIS, V178, P1684, DOI 10.1086/314483; ALBRITTON WL, 1989, MICROBIOL REV, V53, P377, DOI 10.1128/MMBR.53.4.377-389.1989; Bauer ME, 2009, J INFECT DIS, V199, P684, DOI 10.1086/596656; Bong CTH, 2001, INFECT IMMUN, V69, P1488, DOI 10.1128/IAI.69.3.1488-1491.2001; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Fusco WG, 2013, INFECT IMMUN, V81, P4443, DOI 10.1128/IAI.00743-13; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Gioia J, 2006, J BACTERIOL, V188, P7257, DOI 10.1128/JB.00675-06; Haydock AK, 1999, J INFECT DIS, V179, P1423, DOI 10.1086/314771; Hobolth A, 2007, PLOS GENET, V3, P294, DOI 10.1371/journal.pgen.0030007; Humphrey S, 2007, J AM ACAD DERMATOL, V56, pAB121; Janowicz DM, 2009, J INFECT DIS, V199, P1671, DOI 10.1086/598966; Leduc I, 2004, INFECT IMMUN, V72, P3418, DOI 10.1128/IAI.72.6.3418-3428.2004; Leduc I, 2008, INFECT IMMUN, V76, P1608, DOI 10.1128/IAI.00994-07; MARCKMANN P, 1989, GENITOURIN MED, V65, P126; Marks M, 2014, EMERG INFECT DIS, V20, P1705, DOI 10.3201/eid2010.140573; McBride WJH, 2008, AUSTRALAS J DERMATOL, V49, P98, DOI 10.1111/j.1440-0960.2008.00439.x; Mitja O, 2014, LANCET GLOB HEALTH, V2, pE235, DOI 10.1016/S2214-109X(14)70019-1; MORAN NA, 1993, P ROY SOC B-BIOL SCI, V253, P167, DOI 10.1098/rspb.1993.0098; Obbard DJ, 2012, MOL BIOL EVOL, V29, P3459, DOI 10.1093/molbev/mss150; OCHMAN H, 1987, J MOL EVOL, V26, P74, DOI 10.1007/BF02111283; Peel TN, 2010, MED J AUSTRALIA, V192, P348, DOI 10.5694/j.1326-5377.2010.tb03537.x; Post DMB, 2007, PROTEOMICS, V7, P3131, DOI 10.1002/pmic.200600830; Redfield RJ, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-82; Ricotta EE, 2011, J BACTERIOL, V193, P2941, DOI 10.1128/JB.01400-10; SPINOLA SM, 1992, INFECT IMMUN, V60, P385, DOI 10.1128/IAI.60.2.385-391.1992; SPINOLA SM, 1994, J INFECT DIS, V169, P1146, DOI 10.1093/infdis/169.5.1146; Spinola SM, 2014, LANCET GLOB HEALTH, V2, pE387, DOI 10.1016/S2214-109X(14)70250-5; Spratt BG, 1999, CURR OPIN MICROBIOL, V2, P312, DOI 10.1016/S1369-5274(99)80054-X; Steen R, 2012, CURR OPIN INFECT DIS, V25, P100, DOI 10.1097/QCO.0b013e32834e9ad1; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Ussher JE, 2007, CLIN INFECT DIS, V44, pE85, DOI 10.1086/515404; Ward CK, 1998, J BACTERIOL, V180, P6013, DOI 10.1128/JB.180.22.6013-6022.1998; Wasserheit JN, SEXUALLY TRANSMITTED, V19, P61; White CD, 2005, INFECT IMMUN, V73, P2387, DOI 10.1128/IAI.73.4.2387-2399.2005	36	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118613	10.1371/journal.pone.0118613	http://dx.doi.org/10.1371/journal.pone.0118613			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774793	gold, Green Published, Green Submitted			2022-12-27	WOS:000351183500032
J	Gong, YF; Ericsson, KA; Moxley, JH				Gong, Yanfei; Ericsson, K. Anders; Moxley, Jerad H.			Recall of Briefly Presented Chess Positions and Its Relation to Chess Skill	PLOS ONE			English	Article							MEMORY; EXPERTISE; PERFORMANCE; PERCEPTION; KNOWLEDGE; LINHARES; CHUNKS	Individual differences in memory performance in a domain of expertise have traditionally been accounted for by previously acquired chunks of knowledge and patterns. These accounts have been examined experimentally mainly in chess. The role of chunks (clusters of chess pieces recalled in rapid succession during recall of chess positions) and their relations to chess skill are, however, under debate. By introducing an independent chunk-identification technique, namely repeated-recall technique, this study identified individual chunks for particular chess players. The study not only tested chess players with increasing chess expertise, but also tested non-chess players who should not have previously acquired any chess related chunks in memory. For recall of game positions significant differences between players and non-players were found in virtually all the characteristics of chunks recalled. Size of the largest chunks also correlates with chess skill within the group of rated chess players. Further research will help us understand how these memory encodings can explain large differences in chess skill.	[Gong, Yanfei] E China Normal Univ, Sch Psychol & Cognit Sci, Shanghai 200062, Peoples R China; [Ericsson, K. Anders; Moxley, Jerad H.] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA	East China Normal University; State University System of Florida; Florida State University	Gong, YF (corresponding author), E China Normal Univ, Sch Psychol & Cognit Sci, Shanghai 200062, Peoples R China.	fayegong_psy@yahoo.com		Moxley, Jerad/0000-0002-4362-9963	FSCW/Conradi Endowment Fund of the Florida State University Foundation (United States)	FSCW/Conradi Endowment Fund of the Florida State University Foundation (United States)	KAE was supported by the FSCW/Conradi Endowment Fund of the Florida State University Foundation (United States). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, PERCEPTION MEMORY CH; Bilalic M, 2009, COGNITIVE SCI, V33, P743, DOI 10.1111/j.1551-6709.2009.01046.x; Card S. K., 1983, PSYCHOL HUMAN COMPUT; CHARNESS N, 1981, J EXP PSYCHOL GEN, V110, P21, DOI 10.1037/0096-3445.110.1.21; CHARNESS N, 1976, J EXP PSYCHOL-HUM L, V2, P641, DOI 10.1037/0278-7393.2.6.641; CHARNESS N, 1981, J GERONTOL, V36, P615, DOI 10.1093/geronj/36.5.615; Charness N, 2012, NEW IDEAS PSYCHOL, V30, P322, DOI 10.1016/j.newideapsych.2011.12.004; Chase W.G., 1982, PSYCHOL LEARN MOTIV, V16, P1, DOI [10.1016/S0079-7421(08)60546-0, DOI 10.1016/S0079-7421(08)60546-0]; CHASE WG, 1973, COGNITIVE PSYCHOL, V4, P55, DOI 10.1016/0010-0285(73)90004-2; CHASE WG, 1981, COGNITIVE SKILLS THE, P141; Chi MTH, 1978, ADV CHILD DEV BEHAV, P91; de Groot Annette M. B., 1946, THOUGHT CHOICE CHESS; Ericsson K. Anders, 1991, GEN THEORY EXPERTISE; ERICSSON KA, 1995, PSYCHOL REV, V102, P211, DOI 10.1037/0033-295X.102.2.211; Ericsson KA, 2000, PSYCHOL REV, V107, P578, DOI 10.1037/0033-295X.107.3.578; Ericsson KA, 2004, COGNITIVE PSYCHOL, V49, P191, DOI 10.1016/j.cogpsych.2004.02.001; ERICSSON KA, 1988, J EXP PSYCHOL LEARN, V14, P305, DOI 10.1037/0278-7393.14.2.305; Ericsson KA, 1996, ANNU REV PSYCHOL, V47, P273, DOI 10.1146/annurev.psych.47.1.273; FREYHOF H, 1992, PSYCHOL RES-PSYCH FO, V54, P32, DOI 10.1007/BF01359221; Gobet F, 1996, COGNITIVE PSYCHOL, V31, P1, DOI 10.1006/cogp.1996.0011; Gobet F, 1998, MEMORY, V6, P225, DOI 10.1080/741942359; Gobet F, 2005, APPL COGNITIVE PSYCH, V19, P183, DOI 10.1002/acp.1110; Gobet F, 2004, MEMORY, V12, P732, DOI 10.1080/09658210344000530; Gobet F, 1996, MEM COGNITION, V24, P493, DOI 10.3758/BF03200937; Gobet F, 2000, COGNITIVE SCI, V24, P651, DOI 10.1207/s15516709cog2404_4; Gobet F, 2001, P 23 M COGN SCI SOC, P336; Holding D.H., 1985, PSYCHOL CHESS SKILL; Hu Y, 2012, COGNITIVE PSYCHOL, V64, P235, DOI 10.1016/j.cogpsych.2012.01.001; Hu Y, 2009, J EXP PSYCHOL LEARN, V35, P1426, DOI 10.1037/a0017395; Jastrzembski TS, 2006, PSYCHOL AGING, V21, P401, DOI 10.1037/0882-7974.21.2.401; Krampe RT, 1996, J EXP PSYCHOL GEN, V125, P331, DOI 10.1037/0096-3445.125.4.331; Lane PCR, 2011, NEW IDEAS PSYCHOL, V29, P156, DOI 10.1016/j.newideapsych.2010.08.002; Linhares A, 2012, NEW IDEAS PSYCHOL; Linhares A, 2007, COGNITIVE SCI, V31, P989, DOI 10.1080/03640210701703725; Linhares A, 2012, COGN SYST RES, V13, P72, DOI 10.1016/j.cogsys.2010.12.006; Linhares A, 2010, NEW IDEAS PSYCHOL, V28, P64, DOI 10.1016/j.newideapsych.2009.07.008; Linhares A, 2009, COGNITIVE SCI, V33, P748, DOI 10.1111/j.1551-6709.2009.01043.x; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; MILLSAP RE, 1990, EDUC PSYCHOL MEAS, V50, P297, DOI 10.1177/0013164490502008; Newell A., 1990, UNIFIED THEORIES COG; Newell A., 1972, HUMAN PROBLEM SOLVIN; Pedhazur EJ., 1997, MULTIPLE REGRESSION, V3rd ed; REITMAN JS, 1980, COGNITIVE PSYCHOL, V12, P554, DOI 10.1016/0010-0285(80)90020-1; REITMAN JS, 1976, COGNITIVE PSYCHOL, V8, P336, DOI 10.1016/0010-0285(76)90011-6; SAARILUOMA P, 1994, Q J EXP PSYCHOL-A, V47, P607, DOI 10.1080/14640749408401130; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Schneider W, 1993, EDUC PSYCHOL REV, V5, P257, DOI 10.1007/BF01323047; SIMON HA, 1973, AM SCI, V61, P394; Vicente KJ, 1998, PSYCHOL REV, V105, P33, DOI 10.1037/0033-295X.105.1.33	49	16	17	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118756	10.1371/journal.pone.0118756	http://dx.doi.org/10.1371/journal.pone.0118756			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD6EY	25774693	gold, Green Published, Green Submitted			2022-12-27	WOS:000351183500040
J	Maria, M; Ajmal, M; Azam, M; Waheed, NK; Siddiqui, SN; Mustafa, B; Ayub, H; Ali, L; Ahmad, S; Micheal, S; Hussain, A; Shah, STA; Ali, SHB; Ahmed, W; Khan, YM; den Hollander, AI; Haer-Wigman, L; Collin, RWJ; Khan, MI; Qamar, R; Cremers, FPM				Maria, Maleeha; Ajmal, Muhammad; Azam, Maleeha; Waheed, Nadia Khalida; Siddiqui, Sorath Noorani; Mustafa, Bilal; Ayub, Humaira; Ali, Liaqat; Ahmad, Shakeel; Micheal, Shazia; Hussain, Alamdar; Shah, Syed Tahir Abbas; Ali, Syeda Hafiza Benish; Ahmed, Waqas; Khan, Yar Muhammad; den Hollander, Anneke I.; Haer-Wigman, Lonneke; Collin, Rob W. J.; Khan, Muhammad Imran; Qamar, Raheel; Cremers, Frans P. M.			Homozygosity Mapping and Targeted Sanger Sequencing Reveal Genetic Defects Underlying Inherited Retinal Disease in Families from Pakistan	PLOS ONE			English	Article							LEBER CONGENITAL AMAUROSIS; RETINITIS-PIGMENTOSA; RESTORES VISION; CANINE MODEL; MUTATIONS; THERAPY; DYSTROPHY; ROD; CONSANGUINITY; TULP1	Background Homozygosity mapping has facilitated the identification of the genetic causes underlying inherited diseases, particularly in consanguineous families with multiple affected individuals. This knowledge has also resulted in a mutation dataset that can be used in a cost and time effective manner to screen frequent population-specific genetic variations associated with diseases such as inherited retinal disease (IRD). Methods We genetically screened 13 families from a cohort of 81 Pakistani IRD families diagnosed with Leber congenital amaurosis (LCA), retinitis pigmentosa (RP), congenital stationary night blindness (CSNB), or cone dystrophy (CD). We employed genome-wide single nucleotide polymorphism (SNP) array analysis to identify homozygous regions shared by affected individuals and performed Sanger sequencing of IRD-associated genes located in the sizeable homozygous regions. In addition, based on population specific mutation data we performed targeted Sanger sequencing (TSS) of frequent variants in AIPL1, CEP290, CRB1, GUCY2D, LCA5, RPGRIP1 and TULP1, in probands from 28 LCA families. Results Homozygosity mapping and Sanger sequencing of IRD-associated genes revealed the underlying mutations in 10 families. TSS revealed causative variants in three families. In these 13 families four novel mutations were identified in CNGA1, CNGB1, GUCY2D, and RPGRIP1. Conclusions Homozygosity mapping and TSS revealed the underlying genetic cause in 13 IRD families, which is useful for genetic counseling as well as therapeutic interventions that are likely to become available in the near future.	[Maria, Maleeha; Ajmal, Muhammad; Azam, Maleeha; Mustafa, Bilal; Ayub, Humaira; Ali, Liaqat; Ahmad, Shakeel; Hussain, Alamdar; Shah, Syed Tahir Abbas; Ali, Syeda Hafiza Benish; Ahmed, Waqas; Khan, Muhammad Imran; Qamar, Raheel; Cremers, Frans P. M.] Commiss Sci & Technol Sustainable Dev South, Inst Informat Technol, Dept Biosci, Islamabad, Pakistan; [Maria, Maleeha; Ajmal, Muhammad; Azam, Maleeha; Micheal, Shazia; den Hollander, Anneke I.; Haer-Wigman, Lonneke; Collin, Rob W. J.; Khan, Muhammad Imran; Cremers, Frans P. M.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Waheed, Nadia Khalida] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Siddiqui, Sorath Noorani] Al Shifa Eye Trust Hosp, Rawalpindi, Pakistan; [Micheal, Shazia; den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6525 ED Nijmegen, Netherlands; [Ali, Syeda Hafiza Benish] Bahauddin Zakariya Univ, Inst Pure & Appl Biol, Multan, Pakistan; [Ahmed, Waqas] Univ Haripur, Haripur, Pakistan; [Khan, Yar Muhammad] Univ Sci & Technol, Dept Chem, Bannu, Pakistan; [den Hollander, Anneke I.; Haer-Wigman, Lonneke; Collin, Rob W. J.; Cremers, Frans P. M.] Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Qamar, Raheel] Isra Univ, Al Nafees Med Coll & Hosp, Islamabad, Pakistan	COMSATS University Islamabad (CUI); Radboud University Nijmegen; Tufts University; Radboud University Nijmegen; Bahauddin Zakariya University; University of Science & Technology Bannu; Radboud University Nijmegen	Cremers, FPM (corresponding author), Commiss Sci & Technol Sustainable Dev South, Inst Informat Technol, Dept Biosci, Islamabad, Pakistan.	Frans.Cremers@radboudumc.nl	Siddiqui, Sorath Noorani/AAT-9861-2020; ahmed, waqas/AAD-9962-2020; Cremers, Frans/A-5625-2014; Haer-Wigman, Lonneke/P-8170-2015; Azam, Maleeha/AAD-9924-2022; Ajmal, Muhammad/G-8163-2012; Hollander, Anneke den/N-4911-2014; Collin, Rob/N-3575-2014; Shah, Syed Tahir Abbas/K-4637-2015; Azam, Maleeha/L-1721-2017	Cremers, Frans/0000-0002-4954-5592; Ajmal, Muhammad/0000-0001-5207-2469; Shah, Syed Tahir Abbas/0000-0001-9151-9374; Azam, Maleeha/0000-0003-0170-3325; Haer-Wigman, Lonneke/0000-0003-3595-0797; Mustafa, Bilal/0000-0003-0865-7974; Khan, Muhammad Imran/0000-0003-0276-5480; Maria, Maleeha/0000-0001-6526-3010	COMSATS Institute of Information Technology (CIIT); CIIT [16-64/CRGP/CIIT/IBD/12/919, 16-83/CRGP/CIIT/IBD/13/144, 16-82-CRGP-CIIT-IBD-13/145]; Stichting Nederlands Oogheelkundig Onderzoek; Nelly Reef Foundation; Stichting ter Verbetering van het Lot der Blinden; Gelderse Blinden Stichting; Rotterdamse Stichting Blindenbelangen; Stichting Blindenhulp; Stichting A.F. Deutman Researchfonds Oogheelkunde; Stichting voor Ooglijders; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid; Landelijke Stichting voor Blinden en Slechtzienden; Stichting Retina Nederland Fonds; Novartis fund; Foundation Fighting Blindness USA [C-GE-0811-0545-RAD01]; Pakistan Academy of Sciences;  [PAS/I-9/Project]	COMSATS Institute of Information Technology (CIIT); CIIT; Stichting Nederlands Oogheelkundig Onderzoek; Nelly Reef Foundation; Stichting ter Verbetering van het Lot der Blinden; Gelderse Blinden Stichting; Rotterdamse Stichting Blindenbelangen; Stichting Blindenhulp; Stichting A.F. Deutman Researchfonds Oogheelkunde; Stichting voor Ooglijders; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid; Landelijke Stichting voor Blinden en Slechtzienden; Stichting Retina Nederland Fonds; Novartis fund; Foundation Fighting Blindness USA; Pakistan Academy of Sciences; 	This work was supported by grant no. PAS/I-9/Project awarded to R.Q. and M.Az., by the Pakistan Academy of Sciences, and a core grant from the COMSATS Institute of Information Technology (CIIT) to R.Q. This work was also supported by CIIT grant No. 16-64/CRGP/CIIT/IBD/12/919 awarded to M.M., grant No. 16-83/CRGP/CIIT/IBD/13/144 awarded to M.Aj. and grant No. 16-82-CRGP-CIIT-IBD-13/145 awarded to M.Az. This work was also financially supported by the Stichting Nederlands Oogheelkundig Onderzoek, the Nelly Reef Foundation, the Stichting ter Verbetering van het Lot der Blinden (to F.P.M.C., R.W.J.C., and A.I.d.H.), the Gelderse Blinden Stichting (to F.P.M.C.), the Rotterdamse Stichting Blindenbelangen, the Stichting Blindenhulp, the Stichting A.F. Deutman Researchfonds Oogheelkunde, and the Stichting voor Ooglijders (to F.P.M.C. and M.I.K.). F.P.M.C. and M.I.K. were also supported by the following foundations: the Algemene Nederlandse Vereniging ter Voorkoming van Blindheid, the Landelijke Stichting voor Blinden en Slechtzienden, the Stichting Retina Nederland Fonds, and the Novartis fund, contributed through UitZicht. The work of L.H-W. was supported by the Foundation Fighting Blindness USA C-GE-0811-0545-RAD01 (to F.P.M.C.). The funding organizations provided unrestricted grants and had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Safieh L, 2013, GENOME RES, V23, P236, DOI 10.1101/gr.144105.112; Acland GM, 2005, MOL THER, V12, P1072, DOI 10.1016/j.ymthe.2005.08.008; Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Adhi M.I., 2002, PAK J OPHTHALMOL, V18, P106; Ajmal M, 2012, MOL VIS, V18, P1558; Ajmal M, 2012, MOL VIS, V18, P1226; Annear MJ, 2013, HUM GENE THER, V24, P883, DOI 10.1089/hum.2013.146; Ayuso C, 2010, GENOME MED, V2, DOI 10.1186/gm155; Azam M, 2011, ARCH OPHTHALMOL-CHIC, V129, P1377, DOI 10.1001/archophthalmol.2011.290; Azam M, 2010, MOL VIS, V16, P774; Azam M, 2009, MOL VIS, V15, P2526; Azam M, 2009, MOL VIS, V15, P1788; Bandah-Rozenfeld D, 2010, AM J HUM GENET, V87, P199, DOI 10.1016/j.ajhg.2010.07.004; Beltran WA, 2012, P NATL ACAD SCI USA, V109, P2132, DOI 10.1073/pnas.1118847109; Bennicelli J, 2008, MOL THER, V16, P458, DOI 10.1038/sj.mt.6300389; Bittles AH, 2001, CLIN GENET, V60, P89, DOI 10.1034/j.1399-0004.2001.600201.x; Boye SL, 2013, HUM GENE THER, V24, P189, DOI 10.1089/hum.2012.193; Collin RWJ, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.3; Collin RWJ, 2011, INVEST OPHTH VIS SCI, V52, P2227, DOI 10.1167/iovs.10-6185; Coppieters F, 2011, Bull Soc Belge Ophtalmol, P59; Damji KF, 2001, CAN J OPHTHALMOL, V36, P252, DOI 10.1016/S0008-4182(01)80018-1; den Hollander AI, 1999, NAT GENET, V23, P217, DOI 10.1038/13848; den Hollander AI, 2007, NAT GENET, V39, P889, DOI 10.1038/ng2066; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Dryja TP, 1999, INVEST OPHTH VIS SCI, V40, P1859; Estrada-Cuzcano A, 2012, HUM MOL GENET, V21, pR111, DOI 10.1093/hmg/dds298; Gerard X, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.21; Ginn SL, 2013, J GENE MED, V15, P65, DOI 10.1002/jgm.2698; Gu SM, 1998, LANCET, V351, P1103, DOI 10.1016/S0140-6736(05)79384-3; Guyon R, 2007, MOL VIS, V13, P1094; Hamamy HA, 2007, SAUDI MED J, V28, P1015; Hamel C, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-40; Iqbal M, 2011, ARCH OPHTHALMOL-CHIC, V129, P1351, DOI 10.1001/archophthalmol.2011.267; JAY M, 1982, BRIT J OPHTHALMOL, V66, P405, DOI 10.1136/bjo.66.7.405; Kelsell RE, 1997, HUM MOL GENET, V6, P597, DOI 10.1093/hmg/6.4.597; Khaliq S, 2003, EXP EYE RES, V76, P343, DOI 10.1016/S0014-4835(02)00304-4; Khan MI, 2013, CLIN GENET, V84, P290, DOI 10.1111/cge.12039; Khan MI, 2014, GENES-BASEL, V5, P176, DOI 10.3390/genes5010176; Khan MI, 2011, OPHTHALMOLOGY, V118, P1444, DOI 10.1016/j.ophtha.2010.10.047; Khan MI, 2010, MOL VIS, V16, P2753; Koenekoop RK, 2014, LANCET, V6736, P60153; Ku CA, 2011, HUM MOL GENET, V20, P4569, DOI 10.1093/hmg/ddr391; Le Meur G, 2007, GENE THER, V14, P292, DOI 10.1038/sj.gt.3302861; Lheriteau E, 2014, MOL THER, V22, P265, DOI 10.1038/mt.2013.232; Li L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019458; Littink KW, 2012, ADV EXP MED BIOL, V723, P345, DOI 10.1007/978-1-4614-0631-0_45; Mackay DS, 2013, HUM MUTAT, V34, P1537, DOI 10.1002/humu.22398; MacLaren RE, 2014, LANCET, V383, P1129, DOI 10.1016/S0140-6736(13)62117-0; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; McKibbin M, 2010, ARCH OPHTHALMOL-CHIC, V128, P107, DOI 10.1001/archophthalmol.2010.309; Mendoza-Londono R, 1999, Ophthalmic Genet, V20, P37, DOI 10.1076/opge.20.1.37.2299; Nentwich Martin M, 2013, Oman J Ophthalmol, V6, pS18, DOI 10.4103/0974-620X.122290; Nirmalan PK, 2006, OPHTHAL EPIDEMIOL, V13, P7, DOI 10.1080/09286580500473795; Perrault I, 1996, NAT GENET, V14, P461, DOI 10.1038/ng1296-461; Rivolta C, 2002, HUM MOL GENET, V11, P1219, DOI 10.1093/hmg/11.10.1219; Robson AG, 2008, DOC OPHTHALMOL, V116, P79, DOI 10.1007/s10633-007-9087-4; Roosing S, 2014, PROG RETIN EYE RES, V42, P1, DOI 10.1016/j.preteyeres.2014.05.001; Roosing S, 2013, OPHTHALMOLOGY, V120, P1239, DOI 10.1016/j.ophtha.2012.12.005; Sambrook J, 2001, MOL CLONING LAB MANU, P44; Simonelli F, 2007, INVEST OPHTH VIS SCI, V48, P4284, DOI 10.1167/iovs.07-0068; Simovich M J, 2001, Hum Mutat, V18, P164, DOI 10.1002/humu.1168; Sohocki MM, 2000, NAT GENET, V24, P79, DOI 10.1038/71732; Venselaar H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-548; Vervoort R, 2000, NAT GENET, V25, P462, DOI 10.1038/78182; Wert KJ, 2013, HUM MOL GENET, V22, P558, DOI 10.1093/hmg/dds466	65	23	23	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119806	10.1371/journal.pone.0119806	http://dx.doi.org/10.1371/journal.pone.0119806			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775262	Green Submitted, gold, Green Published			2022-12-27	WOS:000351183500126
J	Pilling, D; Cox, N; Vakil, V; Verbeek, JS; Gomer, RH				Pilling, Darrell; Cox, Nehemiah; Vakil, Varsha; Verbeek, J. Sjef; Gomer, Richard H.			The Long Pentraxin PTX3 Promotes Fibrocyte Differentiation	PLOS ONE			English	Article							SERUM AMYLOID-P; FC-GAMMA RECEPTORS; C-REACTIVE PROTEIN; PERIPHERAL-BLOOD FIBROCYTES; INDUCED PULMONARY-FIBROSIS; HUMORAL INNATE IMMUNITY; CIRCULATING FIBROCYTES; EPITHELIAL-CELLS; MOUSE MODEL; ALPHA-RI	Monocyte-derived, fibroblast-like cells called fibrocytes are associated with fibrotic lesions. The plasma protein serum amyloid P component (SAP; also known as pentraxin-2, PTX2) inhibits fibrocyte differentiation in vitro, and injections of SAP inhibit fibrosis in vivo. SAP is a member of the pentraxin family of proteins that includes C-reactive protein (CRP; PTX1) and pentraxin-3 (PTX3). All three pentraxins are associated with fibrosis, but only SAP and CRP have been studied for their effects on fibrocyte differentiation. We find that compared to SAP and CRP, PTX3 promotes human and murine fibrocyte differentiation. The effect of PTX3 is dependent on Fc gamma RI. In competition studies, the fibrocyte-inhibitory activity of SAP is dominant over PTX3. Binding competition studies indicate that SAP and PTX3 bind human Fc gamma RI at different sites. In murine models of lung fibrosis, PTX3 is present in fibrotic areas, and the PTX3 distribution is associated with collagen deposition. In lung tissue from pulmonary fibrosis patients, PTX3 has a widespread distribution, both in unaffected tissue and in fibrotic lesions, whereas SAP is restricted to areas adjacent to vessels, and absent from fibrotic areas. These data suggest that the relative levels of SAP and PTX3 present at sites of fibrosis may have a significant effect on the ability of monocytes to differentiate into fibrocytes.	[Pilling, Darrell; Cox, Nehemiah; Gomer, Richard H.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [Vakil, Varsha; Gomer, Richard H.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA; [Verbeek, J. Sjef] Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands	Texas A&M University System; Texas A&M University College Station; Rice University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Pilling, D (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	dpilling@bio.tamu.edu; rgomer@tamu.edu		Gomer, Richard/0000-0003-2361-4307; Cox, Nehemiah/0000-0002-2369-4741; Pilling, Darrell/0000-0002-7413-2773	National Institutes of Health (NIH) [R01 HL083029, R01 HL118507]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118507, R01HL083029] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) grants (www.nih.gov) R01 HL083029 and R01 HL118507. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe R, 2001, J IMMUNOL, V166, P7556, DOI 10.4049/jimmunol.166.12.7556; Aiba S, 1997, J CUTAN PATHOL, V24, P65; Andersson-Sjoland A, 2008, INT J BIOCHEM CELL B, V40, P2129, DOI 10.1016/j.biocel.2008.02.012; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Balhara J, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00127; Banerjee ER, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt112; Bharadwaj D, 2001, J IMMUNOL, V166, P6735, DOI 10.4049/jimmunol.166.11.6735; Bianchetti L, 2012, J CELL MOL MED, V16, P483, DOI 10.1111/j.1582-4934.2011.01344.x; Bonacina F, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/725102; Boonnak K, 2013, J IMMUNOL, V190, P5659, DOI 10.4049/jimmunol.1203052; Boross P, 2006, SPRINGER SEMIN IMMUN, V28, P339, DOI 10.1007/s00281-006-0049-9; Boross P, 2011, J IMMUNOL, V187, P1304, DOI 10.4049/jimmunol.1101194; Bottazzi B, 1997, J BIOL CHEM, V272, P32817, DOI 10.1074/jbc.272.52.32817; Bottazzi B, 2010, ANNU REV IMMUNOL, V28, P157, DOI 10.1146/annurev-immunol-030409-101305; Bruhns P, 2012, BLOOD, V119, P5640, DOI 10.1182/blood-2012-01-380121; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Castano AP, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000111; Cowper SE, 2003, CURR OPIN RHEUMATOL, V15, P785, DOI 10.1097/00002281-200311000-00017; Cox N, 2014, J IMMUNOL, V193, P1701, DOI 10.4049/jimmunol.1400281; Cox N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045674; Crawford JR, 2012, J LEUKOCYTE BIOL, V92, P699, DOI 10.1189/jlb.0112033; Crawford JR, 2010, J IMMUNOL METHODS, V363, P9, DOI 10.1016/j.jim.2010.09.025; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; Daigo K, 2014, PROTECTIVE EFFECT LO, pra88; Deban L, 2011, CELL TISSUE RES, V343, P237, DOI 10.1007/s00441-010-1018-0; Degryse AL, 2010, AM J PHYSIOL-LUNG C, V299, pL442, DOI 10.1152/ajplung.00026.2010; Dillingh MR, 2013, PULM PHARMACOL THER, V26, P672, DOI 10.1016/j.pupt.2013.01.008; Direkze NC, 2003, STEM CELLS, V21, P514, DOI 10.1634/stemcells.21-5-514; Doni A, 2008, J BIOL CHEM, V283, P29983, DOI 10.1074/jbc.M805631200; Doni A, 2006, J LEUKOCYTE BIOL, V79, P797, DOI 10.1189/jlb.0905493; Epperly MW, 2003, AM J RESP CELL MOL, V29, P213, DOI 10.1165/rcmb.2002-0069OC; Garlanda C, 2002, NATURE, V420, P182, DOI 10.1038/nature01195; Han B, 2005, J IMMUNOL, V175, P8303, DOI 10.4049/jimmunol.175.12.8303; Hartlapp I, 2001, FASEB J, V15, P2215, DOI 10.1096/fj.01-0049com; Hashimoto N, 2004, J CLIN INVEST, V113, P243, DOI 10.1172/JCI200418847; Haudek SB, 2008, P NATL ACAD SCI USA, V105, P10179, DOI 10.1073/pnas.0804910105; Haudek SB, 2006, P NATL ACAD SCI USA, V103, P18284, DOI 10.1073/pnas.0608799103; HAWKINS PN, 1991, CLIN EXP IMMUNOL, V84, P308; Hazenbos WLW, 1996, IMMUNITY, V5, P181, DOI 10.1016/S1074-7613(00)80494-X; He XL, 2007, AM J PHYSIOL-LUNG C, V292, pL1039, DOI 10.1152/ajplung.00490.2006; Herlihy SE, 2013, J IMMUNOL, V190, P6468, DOI 10.4049/jimmunol.1202583; Hughes AL, 1996, J MOL EVOL, V43, P4, DOI 10.1007/BF02352293; Hutchinson WL, 2000, MOL MED, V6, P482, DOI 10.1007/BF03401789; Introna M, 1996, BLOOD, V87, P1862; Ioan-Facsinay A, 2002, IMMUNITY, V16, P391, DOI 10.1016/S1074-7613(02)00294-7; Jaillon S, 2007, J EXP MED, V204, P793, DOI 10.1084/jem.20061301; Jaillon S, 2013, J IMMUNOL, V191, P1873, DOI 10.4049/jimmunol.1201642; Job ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059623; Kenakin T, 2011, J PHARMACOL EXP THER, V336, P296, DOI 10.1124/jpet.110.173948; Kisseleva T, 2006, J HEPATOL, V45, P429, DOI 10.1016/j.jhep.2006.04.014; Kitaura J, 2004, J IMMUNOL, V173, P4317, DOI 10.4049/jimmunol.173.7.4317; Kleaveland KR, 2014, EXPERT REV RESP MED, V8, P163, DOI 10.1586/17476348.2014.862154; LEE GW, 1993, J IMMUNOL, V150, P1804; Li Z, 2011, LAB INVEST, V91, P837, DOI 10.1038/labinvest.2011.42; Liu F, 2011, DIABETOLOGIA, V54, P2713, DOI 10.1007/s00125-011-2237-y; Lu JH, 2012, IMMUNOL REV, V250, P230, DOI 10.1111/j.1600-065X.2012.01162.x; Lu JH, 2011, P NATL ACAD SCI USA, V108, P4974, DOI 10.1073/pnas.1018369108; Lu JH, 2008, NATURE, V456, P989, DOI 10.1038/nature07468; Ma YJ, 2011, J BIOL CHEM, V286, P3405, DOI 10.1074/jbc.M110.190637; Maharjan AS, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-2; Maharjan AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026078; Maharjan AS, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-23; Mantovani A, 2013, ANN NY ACAD SCI, V1285, P1, DOI 10.1111/nyas.12043; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Mehrad B, 2007, BIOCHEM BIOPH RES CO, V353, P104, DOI 10.1016/j.bbrc.2006.11.149; Misharin AV, 2013, AM J RESP CELL MOL, V49, P503, DOI 10.1165/rcmb.2013-0086MA; Moalli F, 2010, BLOOD, V116, P5170, DOI 10.1182/blood-2009-12-258376; Monteiro RC, 2003, ANNU REV IMMUNOL, V21, P177, DOI 10.1146/annurev.immunol.21.120601.141011; Moore BB, 2006, AM J RESP CELL MOL, V35, P175, DOI 10.1165/rcmb.2005-0239OC; Moore BB, 2013, AM J RESP CELL MOL, V49, P167, DOI 10.1165/rcmb.2013-0094TR; Mori L, 2005, EXP CELL RES, V304, P81, DOI 10.1016/j.yexcr.2004.11.011; Murray LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009683; Nauta AJ, 2005, KIDNEY INT, V67, P543, DOI 10.1111/j.1523-1755.2005.67111.x; Nebuloni Manuela, 2011, Cardiovasc Pathol, V20, pe27, DOI 10.1016/j.carpath.2010.02.005; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Okutani D, 2007, AM J PHYSIOL-LUNG C, V292, pL144, DOI 10.1152/ajplung.00002.2006; Pauwels NS, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-134; Pegues MA, 2013, AM J PHYSIOL-RENAL, V304, pF1358, DOI 10.1152/ajprenal.00476.2012; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Pilling D, 2003, J IMMUNOL, V171, P5537, DOI 10.4049/jimmunol.171.10.5537; Pilling D, 2014, J LEUKOCYTE BIOL, V96; Pilling D, 2007, J IMMUNOL, V179, P4035, DOI 10.4049/jimmunol.179.6.4035; Pilling D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093730; Pilling D, 2009, J IMMUNOL METHODS, V351, P62, DOI 10.1016/j.jim.2009.09.011; Pilling D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007475; Pilling D, 2006, J LEUKOCYTE BIOL, V79, P1242, DOI 10.1189/jlb.0805456; Quan TE, 2004, INT J BIOCHEM CELL B, V36, P598, DOI 10.1016/j.biocel.2003.10.005; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Reilkoff RA, 2011, NAT REV IMMUNOL, V11, P427, DOI 10.1038/nri2990; Sakai N, 2008, J HYPERTENS, V26, P780, DOI 10.1097/HJH.0b013e3282f3e9e6; Sakai N, 2006, P NATL ACAD SCI USA, V103, P14098, DOI 10.1073/pnas.0511200103; Sakai N, 2010, HUM PATHOL, V41, P672, DOI 10.1016/j.humpath.2009.10.008; Schmidt M, 2003, J IMMUNOL, V171, P380, DOI 10.4049/jimmunol.171.1.380; Seiler CY, 2014, NUCLEIC ACIDS RES, V42, pD1253, DOI 10.1093/nar/gkt1060; Shao DD, 2008, J LEUKOCYTE BIOL, V83, P1323, DOI 10.1189/jlb.1107782; Singh V, 2011, EXP EYE RES, V93, P810, DOI 10.1016/j.exer.2011.09.012; Smadja DM, 2014, THROMB HAEMOSTASIS, V112, P1002, DOI 10.1160/TH13-08-0711; Sprong T, 2009, SHOCK, V31, P28, DOI 10.1097/SHK.0b013e31817fd543; Teoh H, 2008, ATHEROSCLEROSIS, V201, P318, DOI 10.1016/j.atherosclerosis.2008.02.034; van Egmond M, 1999, BLOOD, V93, P4387, DOI 10.1182/blood.V93.12.4387.412k08_4387_4394; van Rossum AP, 2004, ARTHRITIS RHEUM-US, V50, P2667, DOI 10.1002/art.20370; vanVugt MJ, 1996, BLOOD, V87, P3593, DOI 10.1182/blood.V87.9.3593.bloodjournal8793593; Varcoe RL, 2006, J THROMB HAEMOST, V4, P1125, DOI 10.1111/j.1538-7836.2006.01924.x; Verzijl D, 2011, PURINERG SIGNAL, V7, P171, DOI 10.1007/s11302-011-9232-0; Wagenaar JFP, 2009, J INFECTION, V58, P425, DOI 10.1016/j.jinf.2009.04.004; Wang JF, 2007, WOUND REPAIR REGEN, V15, P113, DOI 10.1111/j.1524-475X.2006.00192.x; White MJV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070795; Yang LJ, 2005, WOUND REPAIR REGEN, V13, P398, DOI 10.1111/j.1067-1927.2005.130407.x; Zhang JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034965	112	34	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119709	10.1371/journal.pone.0119709	http://dx.doi.org/10.1371/journal.pone.0119709			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774777	gold, Green Submitted, Green Published			2022-12-27	WOS:000351183500112
J	Li, D; Lu, WJ; Liu, YJ; Guo, HW; Xu, S; Ming, ZY; Wang, HT				Li, Dong; Lu, Wenjing; Liu, Yanjun; Guo, Hanwen; Xu, Sai; Ming, Zhongyuan; Wang, Hongtao			Analysis of Relative Concentration of Ethanol and Other Odorous Compounds (OCs) Emitted from the Working Surface at a Landfill in China	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; MUNICIPAL SOLID-WASTE; CHROMATOGRAPHY-MASS SPECTROMETRY; EMISSIONS; SITE; GAS; DEGRADATION; METHANE; VOC	Estimating odor emissions from landfill sites is a complicated task because of the various chemical and biological species that exist in landfill gases. In this study, the relative concentration of ethanol and other odorous compounds emitted from the working surface at a landfill in China was analyzed. Gas sampling was conducted at the landfill on a number of selected days from March 2012 to March 2014, which represented different periods throughout the two years. A total of 41, 59, 66, 54, 63, 54, 41, and 42 species of odorous compounds were identified and quantified in eight sampling activities, respectively; a number of 86 species of odorous compounds were identified and quantified all together in the study. The measured odorous compounds were classified into six different categories (Oxygenated compounds, Halogenated compounds, Terpenes, Sulfur compounds, Aromatics, and Hydrocarbons). The total average concentrations of the oxygenated compounds, sulfur compounds, aromatics, halogenated compounds, hydrocarbons, and terpenes were 2.450 mg/m(3), 0.246 mg/m(3), 0.203 mg/m(3), 0.319 mg/m(3), 0.530 mg/m(3), and 0.217 mg/m(3), respectively. The relative concentrations of 59 odorous compounds with respect to the concentration of ethyl alcohol (1000 ppm) were determined. The dominant contaminants that cause odor pollution around the landfill are ethyl sulfide, methyl mercaptan, acetaldehyde, and hydrogen sulfide; dimethyl disulfide and dimethyl sulfide also contribute to the pollution to a certain degree.	[Li, Dong; Lu, Wenjing; Liu, Yanjun; Guo, Hanwen; Xu, Sai; Ming, Zhongyuan; Wang, Hongtao] Tsinghua Univ, Sch Environm, Beijing 100084, Peoples R China	Tsinghua University	Wang, HT (corresponding author), Tsinghua Univ, Sch Environm, Beijing 100084, Peoples R China.	htwang@mail.tsinghua.edu.cn	刘, 严君/GZL-5764-2022; liu, yan/HCI-5542-2022; liu, yan/HGV-1365-2022; Xu, Sai/L-9259-2016	Xu, Sai/0000-0002-5395-4903	Special Fund of Environmental Protection Research for Public Welfare, Ministry of Environmental Protection, People's Republic of China [201209022]	Special Fund of Environmental Protection Research for Public Welfare, Ministry of Environmental Protection, People's Republic of China	This study was financially supported by Special Fund of Environmental Protection Research for Public Welfare, Ministry of Environmental Protection, People's Republic of China (http://www.zhb.gov.cn/; No. 201209022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MR, 1997, ENVIRON SCI TECHNOL, V31, P1054, DOI 10.1021/es9605634; Bogner JE, 2010, ENVIRON SCI TECHNOL, V44, P1197, DOI 10.1021/es901796k; Chemel C, 2012, J ENVIRON MANAGE, V93, P85, DOI 10.1016/j.jenvman.2011.08.016; Chiriac R, 2011, WASTE MANAGE, V31, P2294, DOI 10.1016/j.wasman.2011.06.009; Chu BW, 2013, FRONT ENV SCI ENG, V7, P1, DOI 10.1007/s11783-012-0476-x; Davoli E, 2010, WASTE MANAGE, V30, P1608, DOI 10.1016/j.wasman.2009.10.013; Demeestere K, 2008, J CHROMATOGR A, V1186, P348, DOI 10.1016/j.chroma.2007.11.036; Dincer F, 2006, J CHROMATOGR A, V1122, P222, DOI 10.1016/j.chroma.2006.04.075; Ding Y, 2012, WASTE MANAGE, V32, P317, DOI 10.1016/j.wasman.2011.07.016; Duan ZH, 2014, ATMOS ENVIRON, V88, P230, DOI 10.1016/j.atmosenv.2014.01.051; Durmusoglu E, 2010, J HAZARD MATER, V176, P870, DOI 10.1016/j.jhazmat.2009.11.117; Fang JJ, 2012, WASTE MANAGE, V32, P1401, DOI 10.1016/j.wasman.2012.02.013; Gallego E, 2014, SCI TOTAL ENVIRON, V470, P587, DOI 10.1016/j.scitotenv.2013.09.105; Nagata Y., 2003, ODOR MEASUREMENT REV, P118; Sadowska-Rociek A, 2009, WASTE MANAGE RES, V27, P966, DOI 10.1177/0734242X09334616; Saral A, 2009, J HAZARD MATER, V168, P338, DOI 10.1016/j.jhazmat.2009.02.043; Schuetz C, 2003, ENVIRON SCI TECHNOL, V37, P5150, DOI 10.1021/es034016b; Suffet IH, 2009, WATER ENVIRON RES, V81, P670, DOI 10.2175/106143008X390762; Tagaris E, 2003, J AIR WASTE MANAGE, V53, P629, DOI 10.1080/10473289.2003.10466198; Tassi F, 2009, SCI TOTAL ENVIRON, V407, P4513, DOI 10.1016/j.scitotenv.2009.04.022; U. S. Environmental Protection Agency (US EPA), 1998, COMP AIR POLL EM SE; United States Environmental Protection Agency (U.S. EPA), 2005, LANDF GAS EM MOD LAN; Zhang YY, 2012, WASTE MANAGE, V32, P1116, DOI 10.1016/j.wasman.2012.01.005; Zhang YY, 2012, J ENVIRON MANAGE, V101, P54, DOI 10.1016/j.jenvman.2011.10.018; Zou SC, 2003, CHEMOSPHERE, V51, P1015, DOI 10.1016/S0045-6535(03)00004-3	25	8	9	6	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119305	10.1371/journal.pone.0119305	http://dx.doi.org/10.1371/journal.pone.0119305			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25769100	Green Submitted, gold, Green Published			2022-12-27	WOS:000351277500075
J	Papler, TB; Bokal, EV; Lovrecic, L; Kopitar, AN; Maver, A				Papler, Tanja Burnik; Bokal, Eda Vrtacnik; Lovrecic, Luca; Kopitar, Andreja Natasa; Maver, Ales			No Specific Gene Expression Signature in Human Granulosa and Cumulus Cells for Prediction of Oocyte Fertilisation and Embryo Implantation	PLOS ONE			English	Article							IDENTIFICATION; BIOMARKERS; SELECTION; MARKERS; OVARY; IVF	In human IVF procedures objective and reliable biomarkers of oocyte and embryo quality are needed in order to increase the use of single embryo transfer (SET) and thus prevent multiple pregnancies. During folliculogenesis there is an intense bi-directional communication between oocyte and follicular cells. For this reason gene expression profile of follicular cells could be an important indicator and biomarker of oocyte and embryo quality. The objective of this study was to identify gene expression signature(s) in human granulosa (GC) and cumulus (CC) cells predictive of successful embryo implantation and oocyte fertilization. Forty-one patients were included in the study and individual GC and CC samples were collected; oocytes were cultivated separately, allowing a correlation with IVF outcome and elective SET was performed. Gene expression analysis was performed using microarrays, followed by a quantitative real-time PCR validation. After statistical analysis of microarray data, there were no significantly differentially expressed genes (FDR<0,05) between nonfertilized and fertilized oocytes and non-implanted and implanted embryos in either of the cell type. Furthermore, the results of quantitative real-time PCR were in consent with microarray data as there were no significant differences in gene expression of genes selected for validation. In conclusion, we did not find biomarkers for prediction of oocyte fertilization and embryo implantation in IVF procedures in the present study.	[Papler, Tanja Burnik; Bokal, Eda Vrtacnik] Univ Med Ctr Ljubljana, Div Gynaecol, Dept Human Reprod, SI-1000 Ljubljana, Slovenia; [Lovrecic, Luca; Maver, Ales] Univ Med Ctr, Div Obstet & Gynaecol, Clin Inst Med Genet, SI-1000 Ljubljana, Slovenia; [Kopitar, Andreja Natasa] Univ Ljubljana, Inst Microbiol & Immunol, Fac Med, SI-1000 Ljubljana, Slovenia	University Medical Centre Ljubljana; University of Ljubljana	Maver, A (corresponding author), Univ Med Ctr, Div Obstet & Gynaecol, Clin Inst Med Genet, Slajmerjeva 3, SI-1000 Ljubljana, Slovenia.	ales.maver@gmail.com	Lovrecic, Luca/S-8196-2018	Lovrecic, Luca/0000-0003-4119-9530	Slovenian Research Agency [P3-0326]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This study was supported by the Slovenian Research Agency (https://www.arrs.gov.si/en/novo.asp), grant number P3-0326. Tanja Burnik Papler is funded as a young researcher by the Slovenian Research Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaenssens T, 2010, HUM REPROD, V25, P1259, DOI 10.1093/humrep/deq049; Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Assou S, 2010, MOL HUM REPROD, V16, P531, DOI 10.1093/molehr/gaq032; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brison DR, 2004, HUM REPROD, V19, P2319, DOI 10.1093/humrep/deh409; BUCCIONE R, 1990, BIOL REPROD, V43, P543, DOI 10.1095/biolreprod43.4.543; Devjak R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047106; Dudoit S, 2003, STAT SCI, V18, P71, DOI 10.1214/ss/1056397487; Eppig John J., 1997, Human Reproduction (Oxford), V12, P127; Fragouli E, 2014, MOL HUM REPROD, V20, P117, DOI 10.1093/molehr/gat073; Fragouli E, 2014, HUM REPROD UPDATE, V20, P1, DOI 10.1093/humupd/dmt044; Gardner DK, 2008, REPROD FERT DEVELOP, V20, P9, DOI 10.1071/RD07160; Gardner DK, 2011, HUM REPROD, V26, P1981, DOI 10.1093/humrep/der143; Gebhardt KM, 2011, FERTIL STERIL, V96, P47, DOI 10.1016/j.fertnstert.2011.04.033; Gerris JMR, 2005, HUM REPROD UPDATE, V11, P105, DOI 10.1093/humupd/dmh049; Gilchrist RB, 2008, HUM REPROD UPDATE, V14, P159, DOI 10.1093/humupd/dmm040; Gonzalez RR, 2000, HUM REPROD UPDATE, V6, P290, DOI 10.1093/humupd/6.3.290; Grondahl ML, 2012, MOL HUM REPROD, V18, P572, DOI 10.1093/molehr/gas035; Grondahl ML, 2009, FERTIL STERIL, V91, P1820, DOI 10.1016/j.fertnstert.2008.02.137; Guerif F, 2007, HUM REPROD, V22, P1973, DOI 10.1093/humrep/dem100; Hamel M, 2008, HUM REPROD, V23, P1118, DOI 10.1093/humrep/den048; Hamel M, 2010, MOL HUM REPROD, V16, P87, DOI 10.1093/molehr/gap079; Haouzi D, 2012, HUM REPROD, V27, P3523, DOI 10.1093/humrep/des325; Iager AE, 2013, FERTIL STERIL, V99, P745, DOI 10.1016/j.fertnstert.2012.10.041; Katz-Jaffe MG, 2006, FERTIL STERIL, V85, P101, DOI 10.1016/j.fertnstert.2005.09.011; Konishi T, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S2-S6; Kovalevsky G, 2005, FERTIL STERIL, V84, P325, DOI 10.1016/j.fertnstert.2005.04.020; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matos L, 2009, MOL HUM REPROD, V15, P411, DOI 10.1093/molehr/gap034; Matzuk MM, 2002, SCIENCE, V296, P2178, DOI 10.1126/science.1071965; McKenzie LJ, 2004, HUM REPROD, V19, P2869, DOI 10.1093/humrep/deh535; Penzias AS, 2012, FERTIL STERIL, V97, P1033, DOI 10.1016/j.fertnstert.2012.03.017; Pinborg A, 2005, HUM REPROD UPDATE, V11, P575, DOI 10.1093/humupd/dmi027; Ruiz-Alonso M, 2013, FERTIL STERIL, V100, P818, DOI 10.1016/j.fertnstert.2013.05.004; Schoolcraft WB, 2001, FERTIL STERIL, V76, P863, DOI 10.1016/S0015-0282(01)02731-5; Scott L, 2003, HUM REPROD UPDATE, V9, P237, DOI 10.1093/humupd/dmg023; Scott L, 2008, REPROD BIOMED ONLINE, V17, P461, DOI 10.1016/S1472-6483(10)60232-5; Sfontouris Ioannis A, 2013, J Hum Reprod Sci, V6, P133, DOI 10.4103/0974-1208.117174; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Uyar A, 2013, FERTIL STERIL, V99, P979, DOI 10.1016/j.fertnstert.2013.01.129; van Montfoort APA, 2008, MOL HUM REPROD, V14, P157, DOI 10.1093/molehr/gam088; Wathlet S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054226; Wathlet S, 2012, FERTIL STERIL, V98, P432, DOI 10.1016/j.fertnstert.2012.05.007; Yanaihara A, 2005, FERTIL STERIL, V84, P464, DOI 10.1016/j.fertnstert.2005.02.034; Zhang SD, 2004, BIOINFORMATICS, V20, P2821, DOI 10.1093/bioinformatics/bth336	46	15	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0115865	10.1371/journal.pone.0115865	http://dx.doi.org/10.1371/journal.pone.0115865			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25769026	Green Published, Green Submitted, gold			2022-12-27	WOS:000351277500003
J	Van Den Ham, KM; Shio, MT; Rainone, A; Fournier, S; Krawczyk, CM; Olivier, M				Van Den Ham, Kristin M.; Shio, Marina Tiemi; Rainone, Anthony; Fournier, Sylvie; Krawczyk, Connie M.; Olivier, Martin			Iron Prevents the Development of Experimental Cerebral Malaria by Attenuating CXCR3-Mediated T Cell Chemotaxis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; IFN-GAMMA; DENDRITIC CELLS; PARASITE SEQUESTRATION; CUTTING EDGE; BRAIN; RECEPTOR; SUSCEPTIBILITY; EXPRESSION; CD4(+)	Cerebral malaria is a severe neurological complication of Plasmodium falciparum infection. Previous studies have suggested that iron overload can suppress the generation of a cytotoxic immune response; however, the effect of iron on experimental cerebral malaria (ECM) is yet unknown. Here we determined that the incidence of ECM was markedly reduced in mice treated with iron dextran. Protection was concomitant with a significant decrease in the sequestration of CD4(+) and CD8(+) T cells within the brain. CD4(+) T cells demonstrated markedly decreased CXCR3 expression and had reduced IFN gamma-responsiveness, as indicated by mitigated expression of IFN gamma R2 and T-bet. Additional analysis of the splenic cell populations indicated that parenteral iron supplementation was also associated with a decrease in NK cells and increase in regulatory T cells. Altogether, these results suggest that iron is able to inhibit ECM pathology by attenuating the capacity of T cells to migrate to the brain.	[Van Den Ham, Kristin M.; Shio, Marina Tiemi; Rainone, Anthony; Fournier, Sylvie; Krawczyk, Connie M.; Olivier, Martin] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Van Den Ham, Kristin M.; Shio, Marina Tiemi; Olivier, Martin] McGill Univ, Ctr Hlth, Res Inst, McGill Int TB Ctr, Montreal, PQ, Canada	McGill University; McGill University	Olivier, M (corresponding author), McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada.	martin.olivier@mcgill.ca	Shio, Marina Tiemi/E-6466-2019	Shio, Marina Tiemi/0000-0002-2494-6816	Canadian Institutes of Health Research; Natural Sciences and Engineering Council	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by grants from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) and Natural Sciences and Engineering Council (http://www.nserc-crsng.gc.ca/index_eng.asp) to MO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amani V, 2000, EUR J IMMUNOL, V30, P1646, DOI 10.1002/1521-4141(200006)30:6&lt;1646::AID-IMMU1646&gt;3.0.CO;2-0; Amante FH, 2010, J IMMUNOL, V185, P3632, DOI 10.4049/jimmunol.1000944; Angelini G, 2002, P NATL ACAD SCI USA, V99, P1491, DOI 10.1073/pnas.022630299; BACH EA, 1995, SCIENCE, V270, P1215, DOI 10.1126/science.270.5239.1215; Baptista FG, 2010, INFECT IMMUN, V78, P4033, DOI 10.1128/IAI.00079-10; Barbi J, 2007, BLOOD, V110, P2215, DOI 10.1182/blood-2007-03-081307; Belnoue E, 2002, J IMMUNOL, V169, P6369, DOI 10.4049/jimmunol.169.11.6369; Belnoue E, 2003, BLOOD, V101, P4253, DOI 10.1182/blood-2002-05-1493; Belnoue E, 2008, PARASITE IMMUNOL, V30, P544, DOI 10.1111/j.1365-3024.2008.01053.x; BURKITT MJ, 1991, P NATL ACAD SCI USA, V88, P8440, DOI 10.1073/pnas.88.19.8440; Campanella GSV, 2008, P NATL ACAD SCI USA, V105, P4814, DOI 10.1073/pnas.0801544105; CHANLING T, 1992, AM J PATHOL, V140, P1121; Claser C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018720; de Souza JB, 2002, MICROBES INFECT, V4, P291, DOI 10.1016/S1286-4579(02)01541-1; deWalick S, 2007, J IMMUNOL, V178, P6033, DOI 10.4049/jimmunol.178.10.6033; Franke-Fayard B, 2005, P NATL ACAD SCI USA, V102, P11468, DOI 10.1073/pnas.0503386102; GOOD MF, 1987, CLIN EXP IMMUNOL, V68, P375; GRAU GE, 1990, J EXP MED, V172, P1505, DOI 10.1084/jem.172.5.1505; GRAU GE, 1989, IMMUNOL REV, V112, P49, DOI 10.1111/j.1600-065X.1989.tb00552.x; GRAU GE, 1989, P NATL ACAD SCI USA, V86, P5572, DOI 10.1073/pnas.86.14.5572; GRAU GE, 1987, SCIENCE, V237, P1210, DOI 10.1126/science.3306918; GRAU GE, 1990, IMMUNOL LETT, V25, P189, DOI 10.1016/0165-2478(90)90113-5; Gwamaka M, 2012, CLIN INFECT DIS, V54, P1137, DOI 10.1093/cid/cis010; Hansen DS, 2007, J IMMUNOL, V178, P5779, DOI 10.4049/jimmunol.178.9.5779; Hansen DS, 2003, IMMUNITY, V18, P391, DOI 10.1016/S1074-7613(03)00052-9; Haque A, 2011, J IMMUNOL, V186, P6148, DOI 10.4049/jimmunol.1003955; Haque A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001221; Hearn J, 2000, INFECT IMMUN, V68, P5364, DOI 10.1128/IAI.68.9.5364-5376.2000; Hermsen CC, 1998, J INFECT DIS, V178, P1225, DOI 10.1086/515691; HERSHKO C, 1988, J EXP MED, V168, P375, DOI 10.1084/jem.168.1.375; Hunt NH, 2006, INT J PARASITOL, V36, P569, DOI 10.1016/j.ijpara.2006.02.016; Kossodo S, 1997, IMMUNOLOGY, V91, P536, DOI 10.1046/j.1365-2567.1997.00290.x; Lazarevic V, 2013, NAT REV IMMUNOL, V13, P777, DOI 10.1038/nri3536; Lord GM, 2005, BLOOD, V106, P3432, DOI 10.1182/blood-2005-04-1393; Lundie RJ, 2008, P NATL ACAD SCI USA, V105, P14509, DOI 10.1073/pnas.0806727105; Mabeza GF, 1999, PHARMACOL THERAPEUT, V81, P53, DOI 10.1016/S0163-7258(98)00037-0; Manning L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001972; Matsuzaki-Moriya C, 2011, EUR J IMMUNOL, V41, P1365, DOI 10.1002/eji.201040942; McQuillan JA, 2011, INT J PARASITOL, V41, P155, DOI 10.1016/j.ijpara.2010.08.003; Nitcheu J, 2003, J IMMUNOL, V170, P2221, DOI 10.4049/jimmunol.170.4.2221; Piva L, 2012, J IMMUNOL, V189, P1128, DOI 10.4049/jimmunol.1201171; Potter S, 2006, INT J PARASITOL, V36, P485, DOI 10.1016/j.ijpara.2005.12.005; Regis G, 2005, BLOOD, V105, P3214, DOI 10.1182/blood-2004-07-2686; Reimer T, 2010, EUR J IMMUNOL, V40, P764, DOI 10.1002/eji.200939996; Sarween N, 2004, J IMMUNOL, V173, P2942, DOI 10.4049/jimmunol.173.5.2942; SCOTT MD, 1990, BRIT J HAEMATOL, V75, P598, DOI 10.1111/j.1365-2141.1990.tb07805.x; Smith HJ, 2010, COCHRANE DB SYST REV; Spottiswoode N, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00125; Van den Steen PE, 2008, EUR J IMMUNOL, V38, P1082, DOI 10.1002/eji.200737906; Villegas-Mendez A, 2012, J IMMUNOL, V189, P968, DOI 10.4049/jimmunol.1200688; Wessling-Resnick M, 2010, ANNU REV NUTR, V30, P105, DOI 10.1146/annurev.nutr.012809.104804; Yan ZH, 2009, NAT CHEM BIOL, V5, P721, DOI 10.1038/nchembio.212; Yanez DM, 1996, J IMMUNOL, V157, P1620	53	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118451	10.1371/journal.pone.0118451	http://dx.doi.org/10.1371/journal.pone.0118451			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768944	Green Published, gold, Green Submitted			2022-12-27	WOS:000351277500026
J	Ingr, M; Lange, R; Halabalova, V; Yehya, A; Hrncirik, J; Chevalier-Lucia, D; Palmade, L; Blayo, C; Konvalinka, J; Dumay, E				Ingr, Marek; Lange, Reinhard; Halabalova, Vera; Yehya, Alaa; Hrncirik, Josef; Chevalier-Lucia, Dominique; Palmade, Laetitia; Blayo, Claire; Konvalinka, Jan; Dumay, Eliane			Inhibitor and Substrate Binding Induced Stability of HIV-1 Protease against Sequential Dissociation and Unfolding Revealed by High Pressure Spectroscopy and Kinetics	PLOS ONE			English	Article							HIGH HYDROSTATIC-PRESSURE; RIBONUCLEASE-A; RETROVIRAL PROTEASES; FIREMANS GRIP; PROTEINASE; DIMERIZATION; ASSOCIATION; MUTANTS; MONOMER; SITE	High-pressure methods have become an interesting tool of investigation of structural stability of proteins. They are used to study protein unfolding, but dissociation of oligomeric proteins can be addressed this way, too. HIV-1 protease, although an interesting object of biophysical experiments, has not been studied at high pressure yet. In this study HIV-1 protease is investigated by high pressure (up to 600 MPa) fluorescence spectroscopy of either the inherent tryptophan residues or external 8-anilino-1-naphtalenesulfonic acid at 25 degrees C. A fast concentration-dependent structural transition is detected that corresponds to the dimermonomer equilibrium. This transition is followed by a slow concentration independent transition that can be assigned to the monomer unfolding. In the presence of a tight-binding inhibitor none of these transitions are observed, which confirms the stabilizing effect of inhibitor. High-pressure enzyme kinetics (up to 350 MPa) also reveals the stabilizing effect of substrate. Unfolding of the protease can thus proceed only from the monomeric state after dimer dissociation and is unfavourable at atmospheric pressure. Dimer-destabilizing effect of high pressure is caused by negative volume change of dimer dissociation of -32.5 mL/mol. It helps us to determine the atmospheric pressure dimerization constant of 0.92 mu M. High-pressure methods thus enable the investigation of structural phenomena that are difficult or impossible to measure at atmospheric pressure.	[Ingr, Marek; Halabalova, Vera; Hrncirik, Josef] Tomas Bata Univ Zlin, Fac Technol, Dept Phys & Mat Engn, Zlin 76001, Czech Republic; [Ingr, Marek; Konvalinka, Jan] Charles Univ Prague, Dept Biochem, Prague 12843 2, Czech Republic; [Lange, Reinhard] Univ Montpellier 2, INRA UMR IATE, Biochim & Technol Alimentaires, F-34095 Montpellier 05, France; [Yehya, Alaa] Univ Montpellier 2, INSERM U710, F-34095 Montpellier 05, France; [Chevalier-Lucia, Dominique; Palmade, Laetitia; Blayo, Claire; Dumay, Eliane] Univ Montpellier 2, UMR IATE, Biochim & Technol Alimentaires, F-34095 Montpellier 05, France	Tomas Bata University Zlin; Charles University Prague; INRAE; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier	Ingr, M (corresponding author), Tomas Bata Univ Zlin, Fac Technol, Dept Phys & Mat Engn, Nam TG Masaryka 5555, Zlin 76001, Czech Republic.	ingr@ft.utb.cz	Ingr, Marek/E-2478-2015; Halabalová, Věra/H-6442-2012; PICART-PALMADE, Laetitia/B-8551-2017	Ingr, Marek/0000-0001-6741-9955; PICART-PALMADE, Laetitia/0000-0003-4229-1056; Hrncirik, Josef/0000-0002-5363-1581; Konvalinka, Jan/0000-0003-0695-9266; CHEVALIER-LUCIA, Dominique/0000-0001-6478-2994	INSERM; Grant Agency of the Czech Republic [P208-12-G016]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	RL is grateful to INSERM for supporting his emeritus status. MI and JK have been supported by Grant Agency of the Czech Republic, Grant No. P208-12-G016 (Center of Excellence). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng YS, 1999, P NATL ACAD SCI USA, V87, P9660; Cioni P, 2014, PROTEINS, V82, P1787, DOI 10.1002/prot.24532; DARKE PL, 1994, BIOCHEMISTRY-US, V33, P98, DOI 10.1021/bi00167a013; Neto DFD, 2014, VIRAL IMMUNOL, V27, P60, DOI 10.1089/vim.2013.0088; DEVILLEBONNE D, 1991, EUR J BIOCHEM, V200, P747, DOI 10.1111/j.1432-1033.1991.tb16240.x; El Moustaine D, 2008, FEBS J, V275, P2021, DOI 10.1111/j.1742-4658.2008.06356.x; Font J, 2006, BIOPHYS J, V91, P2264, DOI 10.1529/biophysj.106.082552; Font J, 2006, PROTEIN SCI, V15, P1000, DOI 10.1110/ps.052050306; Fowler Carol B, 2014, J Proteomics Bioinform, V7, P151; Gasymov OK, 2007, BBA-PROTEINS PROTEOM, V1774, P403, DOI 10.1016/j.bbapap.2007.01.002; Girard E, 2010, BIOPHYS J, V98, P2365, DOI 10.1016/j.bpj.2010.01.058; GROSS M, 1994, EUR J BIOCHEM, V221, P617, DOI 10.1111/j.1432-1033.1994.tb18774.x; HOLZMAN TF, 1991, J BIOL CHEM, V266, P19217; Ingr M, 2003, PROTEIN SCI, V12, P2173, DOI 10.1110/ps.03171903; Iranfar H, 2012, J PHYS CHEM B, V116, P1951, DOI 10.1021/jp210685q; Ishima R, 2007, J BIOL CHEM, V282, P17190, DOI 10.1074/jbc.M701304200; JORDAN SP, 1992, J BIOL CHEM, V267, P20028; Kornblatt MJ, 2004, EUR J BIOCHEM, V271, P3897, DOI 10.1111/j.1432-1033.2004.04326.x; Kozisek M, 2008, J VIROL, V82, P5869, DOI 10.1128/JVI.02325-07; Kozisek M, 2007, J MOL BIOL, V374, P1005, DOI 10.1016/j.jmb.2007.09.083; KUZMIC P, 1993, BIOCHEM BIOPH RES CO, V191, P998, DOI 10.1006/bbrc.1993.1316; Louis JM, 2009, PROTEIN SCI, V18, P2442, DOI 10.1002/pro.261; Marchal S, 2005, BRAZ J MED BIOL RES, V38, P1175, DOI 10.1590/S0100-879X2005000800004; Marchal S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050489; Meher BR, 2008, ICIT 2008: PROCEEDINGS OF THE 11TH INTERNATIONAL CONFERENCE ON INFORMATION TECHNOLOGY, P118, DOI 10.1109/ICIT.2008.39; PARGELLIS CA, 1994, BIOCHEMISTRY-US, V33, P12527, DOI 10.1021/bi00207a021; Pokorna J, 2009, VIRUSES-BASEL, V1, P1209, DOI 10.3390/v1031209; Prehoda KE, 1998, NATO ADV SCI I A-LIF, V301, P59; RUAN KC, 1988, BIOCHEMISTRY-US, V27, P3295, DOI 10.1021/bi00409a026; Ruan KC, 2000, BIOCHEM BIOPH RES CO, V269, P681, DOI 10.1006/bbrc.2000.2345; Schramm HJ, 1996, ANTIVIR RES, V30, P155, DOI 10.1016/0166-3542(96)00940-0; Silva JL, 2001, TRENDS BIOCHEM SCI, V26, P612, DOI 10.1016/S0968-0004(01)01949-1; Strisovsky K, 2000, PROTEIN SCI, V9, P1631, DOI 10.1110/ps.9.9.1631; Torrent J, 1999, BIOCHEMISTRY-US, V38, P15952, DOI 10.1021/bi991460b; Towler EM, 1998, BIOCHEMISTRY-US, V37, P17137, DOI 10.1021/bi9818927; Turner BG, 1999, J MOL BIOL, V285, P1, DOI 10.1006/jmbi.1998.2354; Uhlikova T, 1996, BIOCHEM BIOPH RES CO, V222, P38, DOI 10.1006/bbrc.1996.0694; Veverka V, 2003, J MOL BIOL, V333, P771, DOI 10.1016/j.jmb.2003.08.049; WLODAWER A, 1989, SCIENCE, V245, P616, DOI 10.1126/science.2548279; Xie D, 1999, PROTEIN SCI, V8, P1702, DOI 10.1110/ps.8.8.1702; ZHANG ZY, 1991, J BIOL CHEM, V266, P15591	41	6	6	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119099	10.1371/journal.pone.0119099	http://dx.doi.org/10.1371/journal.pone.0119099			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781460	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600050
J	Kang, ZZ; Li, Z				Kang, Zhizhong; Li, Zhen			Primitive Fitting Based on the Efficient multiBaySAC Algorithm	PLOS ONE			English	Article							RANDOM SAMPLE CONSENSUS; RANDOMIZED RANSAC; 3D; SEGMENTATION; SURFACES; MODELS; PLANES; EM	Although RANSAC is proven to be robust, the original RANSAC algorithm selects hypothesis sets at random, generating numerous iterations and high computational costs because many hypothesis sets are contaminated with outliers. This paper presents a conditional sampling method, multiBaySAC (Bayes SAmple Consensus), that fuses the BaySAC algorithm with candidate model parameters statistical testing for unorganized 3D point clouds to fit multiple primitives. This paper first presents a statistical testing algorithm for a candidate model parameter histogram to detect potential primitives. As the detected initial primitives were optimized using a parallel strategy rather than a sequential one, every data point in the multiBaySAC algorithm was assigned to multiple prior inlier probabilities for initial multiple primitives. Each prior inlier probability determined the probability that a point belongs to the corresponding primitive. We then implemented in parallel a conditional sampling method: BaySAC. With each iteration of the hypothesis testing process, hypothesis sets with the highest inlier probabilities were selected and verified for the existence of multiple primitives, revealing the fitting for multiple primitives. Moreover, the updated version of the initial probability was implemented based on a memorable form of Bayes' Theorem, which describes the relationship between prior and posterior probabilities of a data point by determining whether the hypothesis set to which a data point belongs is correct. The proposed approach was tested using real and synthetic point clouds. The results show that the proposed multiBaySAC algorithm can achieve a high computational efficiency (averaging 34% higher than the efficiency of the sequential RANSAC method) and fitting accuracy (exhibiting good performance in the intersection of two primitives), whereas the sequential RANSAC framework clearly suffers from over-and under-segmentation problems. Future work will aim at further optimizing this strategy through its application to other problems such as multiple point cloud co-registration and multiple image matching.	[Kang, Zhizhong; Li, Zhen] China Univ Geosci, Sch Land Sci & Technol, Beijing 100083, Peoples R China	China University of Geosciences	Kang, ZZ (corresponding author), China Univ Geosci, Sch Land Sci & Technol, 29 Xueyuan Rd, Beijing 100083, Peoples R China.	zzkang@cugb.edu.cn			Natural Science Foundation of China [41171358]; Fundamental Research Funds for the Central Universities [2652012103]; National High Technology Research and Development Program of China (863 Program) [2012AA12A204]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by the Natural Science Foundation of China under Grant No. 41171358, the Fundamental Research Funds for the Central Universities under Grant No. 2652012103 and the National High Technology Research and Development Program of China (863 Program) with the serial number 2012AA12A204. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, BAYESIAN STAT INTRO; Awwad TM, 2010, PHOTOGRAMM REC, V25, P5, DOI 10.1111/j.1477-9730.2009.00564.x; Bartoli A, 2007, COMPUT VIS IMAGE UND, V105, P42, DOI 10.1016/j.cviu.2006.07.011; Botterill T, 2009, P BRIT MED VIS C; Cheng CM, 2009, PATTERN RECOGN, V42, P1318, DOI 10.1016/j.patcog.2009.01.007; Chum O, 2008, IEEE T PATTERN ANAL, V30, P1472, DOI 10.1109/TPAMI.2007.70787; FISCHLER MA, 1981, COMMUN ACM, V24, P381, DOI 10.1145/358669.358692; Gallo O, 2011, PATTERN RECOGN LETT, V32, P403, DOI 10.1016/j.patrec.2010.10.009; Hahnel D, 2003, ROBOT AUTON SYST, V44, P15, DOI 10.1016/S0921-8890(03)00007-1; Lakaemper R, 2006, INT C PATT RECOG, P1077; Liu Y., 2001, P 18 INT C MACH LEAR, P329; Matas J, 2004, IMAGE VISION COMPUT, V22, P837, DOI 10.1016/j.imavis.2004.02.009; Mufti F, 2012, ROBOT AUTON SYST, V60, P16, DOI 10.1016/j.robot.2011.08.009; Overby J, 2004, INT ARCH PHOTOGRAMME, VXXXIV, P296; Papalazarou C, 2013, PATTERN RECOGN, V46, P925, DOI 10.1016/j.patcog.2012.09.013; Rottensteiner F., 2006, INT ARCH PHOTOGRAM 3, V36, P93; Schnabel R, 2007, COMPUT GRAPH FORUM, V26, P214, DOI 10.1111/j.1467-8659.2007.01016.x; Torr PHS, 2000, COMPUT VIS IMAGE UND, V78, P138, DOI 10.1006/cviu.1999.0832; Torr PHS, 2003, IEEE T PATTERN ANAL, V25, P354, DOI 10.1109/TPAMI.2003.1182098; Triebel R, 2005, IEEE INT CONF ROBOT, P4437; van den Heuvel F. A., 1999, P SOC PHOTO-OPT INS, V3641, P60; Vidal R, 2005, IEEE T PATTERN ANAL, V27, P1945, DOI 10.1109/TPAMI.2005.244; Yoon M, 2007, COMPUT AIDED DESIGN, V39, P408, DOI 10.1016/j.cad.2007.02.008	23	9	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0117341	10.1371/journal.pone.0117341	http://dx.doi.org/10.1371/journal.pone.0117341			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781620	gold, Green Published, Green Submitted			2022-12-27	WOS:000351284600011
J	Lu, N; Di, Y; Feng, XY; Qiang, JW; Zhang, JW; Wang, YG; Liu, Y				Lu, Na; Di, Yue; Feng, Xiao-Yuan; Qiang, Jin-Wei; Zhang, Jia-wen; Wang, Yong-gang; Liu, Ying			CT Perfusion with Acetazolamide Challenge in C6 Gliomas and Angiogenesis	PLOS ONE			English	Article							CEREBROVASCULAR RESERVE; CLINICAL-APPLICATIONS; MALIGNANT GLIOMAS; BRAIN-TUMORS; SPECT; EXPRESSION; CD105; PREDICTION; REACTIVITY; PROTEINS	Background This study was performed to investigate the correlation between CT perfusion with acetazolamide challenge and angiogenesis in C6 gliomas. Methods Thirty-two male Sprague-Dawley rats were evaluated. The rats were divided randomly to four groups: eight rats with orthotopically implanted C6 gliomas at 10-days old (Group A), eight rats with gliomas at 14-days old (Group B), eight rats with gliomas at 18-days old (Group C), eight rats with orthotopically injected normal saline served as controls. CT perfusion was performed before and after administration of acetazolamide. Changes in perfusion parameters due to acetazolamide administration were calculated and analyzed. Results Elevated carbon dioxide partial pressure and decreased pH were found in all 32 rats post acetazolamide challenge (P< 0.01). Cerebral blood flowpre-challenge was increased in group C (95.0 +/- 2.5 ml/100g/min), as compared to group B (80.1 +/- 11.3 ml/100g/min) and group A (63.1 +/- 2.1 ml/100g/min). Cerebral blood flow percentage changes were detected with a reduction in group C (54.2 +/- 4.8%) as compared to controls (111.3 +/- 22.2%). Cerebral blood volume(pre-challenge) was increased in group C (50.8 +/- 1.7ml/100g), as compared to group B (45.7 +/- 1.9 ml/100g) and group A (38.2 +/- 0.8 ml/100g). Cerebral blood volume percentage changes were decreased in group C (23.5 +/- 4.6%) as compared to controls (113.5 +/- 30.4%). Angiogenesis ratio = [(CD105-MVD) / (FVIII-MVD)] x100%. Positive correlations were observed between CD105-microvessel density, angiogenesis ratio, vascular endothelial growth factor, proliferation marker and cerebral blood flow(pre-challenge), cerebral blood volume (pre-challenge). Negative correlations were observed between CD105-microvessel density and cerebral blood flow percentage changes (P< 0.01, correlation coefficient r=-0.788), cerebral bloodvolume percentage changes (P< 0.01, r=-0.703). Negative correlations were observed between angiogenesis ratio, vascular endothelial growth factor, proliferation marker and cerebral blood flow percentage changes, cerebral blood volume percentage changes. Conclusion Our findings suggest that CT perfusion with challenge can provide new insight into non-invasive assessment of rat C6 glioma angiogenesis.	[Lu, Na; Qiang, Jin-Wei] Fudan Univ, Jinshan Hosp, Dept Radiol, Shanghai 200433, Peoples R China; [Di, Yue] Fudan Univ, Jinshan Hosp, Dept Ophthalmol, Shanghai 200433, Peoples R China; [Feng, Xiao-Yuan; Zhang, Jia-wen] Fudan Univ, Huashan Hosp, Dept Radiol, Shanghai 200433, Peoples R China; [Wang, Yong-gang] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Oncol, Shanghai 200030, Peoples R China; [Liu, Ying] Fudan Univ, Shanghai Med Coll, Dept Pathol, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Shanghai Jiao Tong University; Fudan University	Feng, XY (corresponding author), Fudan Univ, Huashan Hosp, Dept Radiol, Shanghai 200433, Peoples R China.	xyfeng@shmu.edu.cn; dr.jinweiqiang@163.com		Di, Yue/0000-0001-6905-7476	National Natural Science Foundations of China [30970805, 81400428]; Science and Technology Commission of Shanghai Municipality [09JC1403100]; Shanghai Municipality Commission of Health and Family Planning Projects [2011-187]; Shanghai Jinshan Municipality Health Bureau Youth Foundation [JWKJ-KTYQ-201202, JWKJ-RCYQ-201202]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Municipality Commission of Health and Family Planning Projects; Shanghai Jinshan Municipality Health Bureau Youth Foundation	This work was supported by National Natural Science Foundations of China (Grant No. 30970805, 81400428), a grant from Science and Technology Commission of Shanghai Municipality (Grant No. 09JC1403100), Shanghai Municipality Commission of Health and Family Planning Projects (Grant No. 2011-187), a grant from Shanghai Jinshan Municipality Health Bureau Youth Foundation (Grant No. JWKJ-KTYQ-201202, JWKJ-RCYQ-201202.) The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aamand R, 2011, NEUROPHARMACOLOGY, V61, P900, DOI 10.1016/j.neuropharm.2011.06.010; Andaluz N, 2010, NEUROSURG REV, V33, P225, DOI 10.1007/s10143-010-0237-x; Asdaghi N, 2011, STROKE, V42, P2191, DOI 10.1161/STROKEAHA.110.611376; Bernsen MR, 2014, EUR J NUCL MED MOL I, V41, pS36, DOI 10.1007/s00259-013-2685-3; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chamberlain MC, 2010, CANCER-AM CANCER SOC, V116, P3988, DOI 10.1002/cncr.25256; Chen A, 2006, AM J NEURORADIOL, V27, P1876; Cianfoni A, 2006, J NEURORADIOLOGY, V33, P164, DOI 10.1016/S0150-9861(06)77254-6; Duff SE, 2003, FASEB J, V17, P984, DOI 10.1096/fj.02-0634rev; Eicker S, 2011, EUR J MED RES, V16, P484, DOI 10.1186/2047-783X-16-11-484; Emblem KE, 2008, RADIOLOGY, V247, P808, DOI 10.1148/radiol.2473070571; Farid K, 2012, NUCL MED COMMUN, V33, P571, DOI 10.1097/MNM.0b013e328351d583; Folkman J, 2007, J PEDIATR SURG, V42, P1, DOI 10.1016/j.jpedsurg.2006.09.048; Fulesdi B, 2012, J CRIT CARE, V27, P337, DOI 10.1016/j.jcrc.2011.11.002; Guan LM, 2011, J NEUROSURG, V114, P1672, DOI 10.3171/2011.1.JNS101513; Hashemi M, 2014, J CANCER RES THER, V10, P107, DOI 10.4103/0973-1482.131413; Huang APH, 2014, J NEUROSURG, V120, P473, DOI 10.3171/2013.10.JNS13103; Jain R, 2011, AM J NEURORADIOL, V32, P388, DOI 10.3174/ajnr.A2280; Kozera GM, 2010, AM J HYPERTENS, V23, P1198, DOI 10.1038/ajh.2010.152; Lu N, 2012, ACAD RADIOL, V19, P159, DOI 10.1016/j.acra.2011.09.017; Lu N, 2011, ACAD RADIOL, V18, P81, DOI 10.1016/j.acra.2010.07.012; MARTUZA RL, 1991, SCIENCE, V252, P854, DOI 10.1126/science.1851332; Park SA, 2012, NEUROREHABILITATION, V30, P359, DOI 10.3233/NRE-2012-0767; Pillai JJ, 2012, TECHNOL CANCER RES T, V11, P361, DOI 10.7785/tcrt.2012.500284; Qu DW, 2014, EUR REV MED PHARMACO, V18, P516; Sasaki M, 2009, AM J NEURORADIOL, V30, P188, DOI 10.3174/ajnr.A1274; Sica G, 2011, INT J ONCOL, V38, P41, DOI 10.3892/ijo_00000822; Smith LM, 2008, J NEURORADIOLOGY, V35, P157, DOI 10.1016/j.neurad.2007.11.002; Soffietti R, 2012, CURR CANCER DRUG TAR, V12, P279, DOI 10.2174/156800912799277584; Tachezy M, 2010, HISTOL HISTOPATHOL, V25, P1239, DOI 10.14670/HH-25.1239; Uwano I, 2012, NEURORADIOLOGY, V54, P467, DOI 10.1007/s00234-011-0905-8; Vagal AS, 2009, AM J NEURORADIOL, V30, P876, DOI 10.3174/ajnr.A1538; Wang P, 2012, MOL CARCINOGEN, V51, P586, DOI 10.1002/mc.20829; WEIDNER N, 1995, AM J PATHOL, V147, P9; Wintermark M, 2008, J NEURORADIOLOGY, V35, P253, DOI 10.1016/j.neurad.2008.03.005; You SH, 2013, J KOREAN NEUROSURG S, V54, P280, DOI 10.3340/jkns.2013.54.4.280; Zhang B, 2014, BIOMATERIALS, V35, P4133, DOI 10.1016/j.biomaterials.2014.01.071	37	6	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0121631	10.1371/journal.pone.0121631	http://dx.doi.org/10.1371/journal.pone.0121631			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781321	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600209
J	Pitz, S; Kalkum, G; Arash, L; Karabul, N; Sodi, A; Larroque, S; Beck, M; Gal, A				Pitz, Susanne; Kalkum, Gisela; Arash, Laila; Karabul, Nesrin; Sodi, Andrea; Larroque, Sylvain; Beck, Michael; Gal, Andreas			Ocular Signs Correlate Well with Disease Severity and Genotype in Fabry Disease	PLOS ONE			English	Article							ENZYME REPLACEMENT THERAPY; CLINICAL MANIFESTATIONS; AGALSIDASE-ALPHA; ITALIAN PATIENTS; SCORE INDEX; COHORT; FEATURES; IMPACT	Ocular signs in Fabry disease have generally been regarded to be primarily of diagnostic value. We explored whether ocular findings, alone or in particular in combination with the alpha-galactosidase A gene mutation, have predictive value for disease severity. Data from the Fabry Outcome Survey (FOS), a large, global database sponsored by Shire, were selected for adult patients who had undergone ophthalmological examination. Three ocular signs were assessed: cornea verticillata, tortuous conjunctival and/or retinal vessels, and cataract. Fabry disease severity was measured using FOS Mainz Severity Score Index and modifications thereof. Ophthalmological data were available for 1203 (699 female, 504 male) adult patients with eye findings characteristic of Fabry disease in 55.1%. Cornea verticillata had a similar distribution in women (51.1%) and men (50.8%), whereas tortuous vessels and Fabry cataract were somewhat more frequent in men than in women. Patients with cornea verticillata, selected as the principal ocular sign for this study, had more severe disease (median score, 20.0) versus those without ocular signs (11.0; P< 0.001). This finding could be confirmed by applying age adjusted severity scores. Moreover, the prevalence of cornea verticillata was significantly higher in patients with null (male, 76.9%; female, 64.5%) and missense (male, 79.2%; female, 67.4%) mutations versus mild missense (male, 17.1%; female, 23.1%) and the p.N215S (male, 15.0%; female, 15.6%) mutations (P< 0.01). Our analyses show a correlation between the prevalence of ocular changes in Fabry disease and disease severity. Consequently, information on ocular findings and a-galactosidase A gene mutation may help assess the risk for more severe Fabry disease. These observed findings are of notable clinical importance, as Fabry disease is characterized by high clinical course variability and only weak genotype-phenotype correlation at the individual patient level. Further confirmatory studies are needed.	[Pitz, Susanne] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, D-55122 Mainz, Germany; [Kalkum, Gisela] Childrens Hosp Dr Horst Schmidt Kliniken, Wiesbaden, Germany; [Arash, Laila; Karabul, Nesrin; Beck, Michael] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Ctr Pediat & Adolescent Med, D-55122 Mainz, Germany; [Sodi, Andrea] Univ Florence, Eye Clin, Dept Surg & Translat Med, Florence, Italy; [Larroque, Sylvain] Shire, Zug, Switzerland; [Gal, Andreas] Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, Hamburg, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; University of Florence; Shire Pharmaceuticals Limited; University of Hamburg; University Medical Center Hamburg-Eppendorf	Pitz, S (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, D-55122 Mainz, Germany.	susanne.pitz@unimedizin-mainz.de			Shire	Shire	Financial support for this work was provided by Shire (http://www.shire.com/shireplc/en/home). The funder provided support in the form of a salary for author SL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Allen LE, 2010, BRIT J OPHTHALMOL, V94, P1602, DOI 10.1136/bjo.2009.176651; ARBISSER AI, 1976, AM J OPHTHALMOL, V82, P465, DOI 10.1016/0002-9394(76)90496-7; Breunig F, 2006, KIDNEY INT, V69, P1216, DOI 10.1038/sj.ki.5000208; Gal A, 2012, ANN S SOC STUD INB E; Hughes DA, 2010, MOL GENET METAB, V101, P219, DOI 10.1016/j.ymgme.2010.06.002; Lidove O, 2007, INT J CLIN PRACT, V61, P293, DOI 10.1111/j.1742-1241.2006.01237.x; Lin HY, 2010, J INHERIT METAB DIS, V33, P619, DOI 10.1007/s10545-010-9166-7; MacDermot KD, 2001, J MED GENET, V38, P750, DOI 10.1136/jmg.38.11.750; MacDermot KD, 2001, J MED GENET, V38, P769, DOI 10.1136/jmg.38.11.769; Morier AM, 2010, OPTOMETRY, V81, P437, DOI 10.1016/j.optm.2010.02.011; Morrone A, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.8.e103; Motwani M, 2012, MOL GENET METAB, V107, P197, DOI 10.1016/j.ymgme.2012.05.011; Nguyen TT, 2005, CLIN EXP OPHTHALMOL, V33, P164, DOI 10.1111/j.1442-9071.2005.00990.x; Orssaud Christophe, 2003, Ophthalmic Genet, V24, P129, DOI 10.1076/opge.24.3.129.15609; Parini R, 2008, CLIN GENET, V74, P260, DOI 10.1111/j.1399-0004.2008.01012.x; Rudich DS, 2013, JAMA OPHTHALMOL, V131, P1244, DOI 10.1001/jamaophthalmol.2013.2374; Samiy N, 2008, SURV OPHTHALMOL, V53, P416, DOI 10.1016/j.survophthal.2008.04.005; Schiffmann R, 2001, JAMA-J AM MED ASSOC, V285, P2743, DOI 10.1001/jama.285.21.2743; SHER NA, 1979, ARCH OPHTHALMOL-CHIC, V97, P671; Shrier EM, 2004, ARCH OPHTHALMOL-CHIC, V122, P1395, DOI 10.1001/archopht.122.9.1395; Sodi A IA, 2006, FABRY DIS PERSPECTIV; Sodi A, 2007, BRIT J OPHTHALMOL, V91, P210, DOI 10.1136/bjo.2006.100602; SPAETH GL, 1965, ARCH OPHTHALMOL-CHIC, V74, P760, DOI 10.1001/archopht.1965.00970040762005; TSUTSUMI A, 1984, ACTA OPHTHALMOL, V62, P923; Whybra C, 2004, CLIN GENET, V65, P299, DOI 10.1111/j.1399-0004.2004.00219.x; Whybra C, 2009, GENET MED, V11, P441, DOI 10.1097/GIM.0b013e3181a23bec	26	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120814	10.1371/journal.pone.0120814	http://dx.doi.org/10.1371/journal.pone.0120814			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781336	Green Published, gold, Green Submitted			2022-12-27	WOS:000351284600189
J	Frey, DL; Gagnon, P				Frey, Desta L.; Gagnon, Patrick			Thermal and Hydrodynamic Environments Mediate Individual and Aggregative Feeding of a Functionally Important Omnivore in Reef Communities	PLOS ONE			English	Article							GREEN SEA-URCHIN; STRONGYLOCENTROTUS-DROEBACHIENSIS; INTERSPECIFIC INTERACTIONS; GONAD GROWTH; TEMPERATURE; MARINE; KELP; DYNAMICS; ADAPTATION; STABILITY	In eastern Canada, the destruction of kelp beds by dense aggregations (fronts) of the omnivorous green sea urchin, Strongylocentrotus droebachiensis, is a key determinant of the structure and dynamics of shallow reef communities. Recent studies suggest that hydrodynamic forces, but not sea temperature, determine the strength of urchin-kelp interactions, which deviates from the tenets of the metabolic theory of ecology (MTE). We tested the hypothesis that water temperature can predict short-term kelp bed destruction by S. droebachiensis in calm hydrodynamic environments. Specifically, we experimentally determined relationships among water temperature, body size, and individual feeding in the absence of waves, as well as among wave velocity, season, and aggregative feeding. We quantified variation in kelp-bed boundary dynamics, sea temperature, and wave height over three months at one subtidal site in Newfoundland to test the validity of thermal tipping ranges and regression equations derived from laboratory results. Consistent with the MTE, individual feeding during early summer (June-July) obeyed a non-linear, size-and temperature-dependent relationship: feeding in large urchins was consistently highest and positively correlated with temperature <12 degrees C and dropped within and above the 12-15 degrees C tipping range. This relationship was more apparent in large than small urchins. Observed and expected rates of kelp loss based on sea temperature and urchin density and size structure at the front were highly correlated and differed by one order of magnitude. The present study speaks to the importance of considering body size and natural variation in sea temperature in studies of urchin-kelp interactions. It provides the first compelling evidence that sea temperature, and not only hydrodynamic forces, can predict kelp bed destruction by urchin fronts in shallow reef communities. Studying urchin-seaweed-predator interactions within the conceptual foundations of the MTE holds high potential for improving capacity to predict and manage shifts in marine food web structure and productivity.	[Frey, Desta L.; Gagnon, Patrick] Mem Univ Newfoundland, Dept Ocean Sci, Ctr Ocean Sci, St John, NF A1C 5S7, Canada	Memorial University Newfoundland	Gagnon, P (corresponding author), Mem Univ Newfoundland, Dept Ocean Sci, Ctr Ocean Sci, St John, NF A1C 5S7, Canada.	pgagnon@mun.ca		Gagnon, Patrick/0000-0001-5834-0217	Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Foundation for Innovation (CFI); Research and Development Corporation of Newfoundland and Labrador	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Research and Development Corporation of Newfoundland and Labrador	Natural Sciences and Engineering Research Council of Canada (NSERC), Canada Foundation for Innovation (CFI), and Research and Development Corporation of Newfoundland and Labrador. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blain C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098204; Blain C, 2013, J EXP MAR BIOL ECOL, V440, P176, DOI 10.1016/j.jembe.2012.12.013; BREEN PA, 1976, J FISH RES BOARD CAN, V33, P1278, DOI 10.1139/f76-164; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Bruno JF, 2001, MARINE COMMUNITY ECOLOGY, P201; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Caines S, 2012, MAR BIOL, V159, P1817, DOI 10.1007/s00227-012-1972-z; Chen Q, 2005, J WATERW PORT COAST, V131, P137, DOI 10.1061/(ASCE)0733-950X(2005)131:4(137); CONOVER W. J, 1980, PRACTICAL NONPARAMET; DAYTON PK, 1992, ECOL MONOGR, V62, P421, DOI 10.2307/2937118; Denny M. W., 1988, BIOL MECH WAVE SWEPT; Dong YW, 2009, J EXP BIOL, V212, P169, DOI 10.1242/jeb.024505; Eckman JE, 2003, MAR ECOL PROG SER, V265, P45, DOI 10.3354/meps265045; Emery W.J., 2001, DATA ANAL METHODS PH, P159, DOI DOI 10.1016/C2010-0-66362-0; Feehan C, 2012, MAR ECOL PROG SER, V444, P69, DOI 10.3354/meps09441; Gagnon P, 2003, MAR ECOL PROG SER, V258, P125, DOI 10.3354/meps258125; Gagnon P, 2005, J PHYCOL, V41, P498, DOI 10.1111/j.1529-8817.2005.00078.x; Gagnon P, 2004, MAR BIOL, V144, P1191, DOI 10.1007/s00227-003-1270-x; Gagnon P, 2006, J EXP MAR BIOL ECOL, V334, P10, DOI 10.1016/j.jembe.2006.01.012; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Gracey AY, 2008, CURR BIOL, V18, P1501, DOI 10.1016/j.cub.2008.08.049; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harley CDG, 2013, ANN NY ACAD SCI, V1297, P73, DOI 10.1111/nyas.12228; HIMMELMAN J H, 1984, Naturaliste Canadien (Quebec), V111, P337; HIMMELMAN JH, 1986, MAR ECOL PROG SER, V33, P295, DOI 10.3354/meps033295; HIMMELMAN JH, 1969, THESIS MEMORIAL U NE; Jenkins SR, 2001, J EXP MAR BIOL ECOL, V258, P123, DOI 10.1016/S0022-0981(01)00211-8; JOHNSON CR, 1988, ECOL MONOGR, V58, P129, DOI 10.2307/1942464; Kawamata S, 1998, J EXP MAR BIOL ECOL, V224, P31, DOI 10.1016/S0022-0981(97)00165-2; Kleinbaum D.G., 2008, APPL REGRESSION ANAL; Kordas RL, 2011, J EXP MAR BIOL ECOL, V400, P218, DOI 10.1016/j.jembe.2011.02.029; LARSON BR, 1980, MAR BIOL, V59, P49, DOI 10.1007/BF00396982; Lauzon-Guay JS, 2007, MAR BIOL, V151, P2109, DOI 10.1007/s00227-007-0668-2; Lauzon-Guay JS, 2007, MAR ECOL PROG SER, V329, P191, DOI 10.3354/meps329191; Lauzon-Guay JS, 2010, MAR ECOL PROG SER, V403, P29, DOI 10.3354/meps08494; Lauzon-Guay JS, 2009, MAR ECOL PROG SER, V375, P25, DOI 10.3354/meps07758; Lowe RJ, 2005, J GEOPHYS RES-OCEANS, V110, DOI [10.1029/2004JC002711, 10.1029/2004JC002788]; LUBCHENCO J, 1981, ANNU REV ECOL SYST, V12, P405, DOI 10.1146/annurev.es.12.110181.002201; Matheson K, 2012, J EXP MAR BIOL ECOL, V414, P6, DOI 10.1016/j.jembe.2012.01.006; MENGE BA, 1994, ECOL MONOGR, V64, P249, DOI 10.2307/2937163; MENGE BA, 1987, AM NAT, V130, P730, DOI 10.1086/284741; MILLER RJ, 1973, MAR BIOL, V18, P99, DOI 10.1007/BF00348685; MUNDA IM, 1977, HELGOLAND WISS MEER, V29, P311, DOI 10.1007/BF01614267; NOAA, 2001, NOAA DIV MAN DIV SCI; O'Connor MI, 2011, AM NAT, V178, P626, DOI 10.1086/662171; O'Connor MI, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000178; O'Connor MI, 2009, ECOLOGY, V90, P388, DOI 10.1890/08-0034.1; PERCY JA, 1972, PHYSIOL ZOOL, V45, P277, DOI 10.1086/physzool.45.4.30155584; Poore AGB, 2013, OECOLOGIA, V173, P1113, DOI 10.1007/s00442-013-2683-y; Rilov G, 2005, MAR BIOL, V147, P421, DOI 10.1007/s00227-005-1568-y; Robles CD, 2001, OECOLOGIA, V128, P142, DOI 10.1007/s004420100638; ROCHETTE R, 1994, MAR ECOL PROG SER, V106, P93, DOI 10.3354/meps106093; Sanford E, 2002, INTEGR COMP BIOL, V42, P881, DOI 10.1093/icb/42.4.881; Scheibling RE, 2007, DEV AQUAC FISH SCI, V37, P353, DOI 10.1016/S0167-9309(07)80082-2; Scheibling RE, 1999, CAN J FISH AQUAT SCI, V56, P2300, DOI 10.1139/cjfas-56-12-2300; SCHEINER M, 2001, DESIGN ANAL ECOLOGIC; Schiel DR, 2004, ECOLOGY, V85, P1833, DOI 10.1890/03-3107; Siddon CE, 2003, MAR ECOL PROG SER, V261, P99, DOI 10.3354/meps261099; Siikavuopio SI, 2006, AQUACULTURE, V255, P389, DOI 10.1016/j.aquaculture.2005.12.021; Siikavuopio SI, 2008, AQUACULTURE, V281, P77, DOI 10.1016/j.aquaculture.2008.05.033; Smee DL, 2010, ECOLOGY, V91, P1391, DOI 10.1890/09-0017.1; Snedecor G.W., 1989, AMES IOWA STATE U PR; Sokal R.R., 2012, BIOMETRY PRINCIPLES; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Taylor DL, 2003, MAR ECOL PROG SER, V263, P217, DOI 10.3354/meps263217; Toms JD, 2003, ECOLOGY, V84, P2034, DOI 10.1890/02-0472; VADAS RL, 1977, ECOL MONOGR, V47, P337, DOI 10.2307/1942173; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1	69	16	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118583	10.1371/journal.pone.0118583	http://dx.doi.org/10.1371/journal.pone.0118583			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774674	Green Accepted, gold, Green Published			2022-12-27	WOS:000351183500031
J	Hoylaerts, MF; Van Kerckhoven, S; Kiffer-Moreira, T; Sheen, C; Narisawa, S; Millan, JL				Hoylaerts, Marc F.; Van Kerckhoven, Soetkin; Kiffer-Moreira, Tina; Sheen, Campbell; Narisawa, Sonoko; Millan, Jose Luis			Functional Significance of Calcium Binding to Tissue-Nonspecific Alkaline Phosphatase	PLOS ONE			English	Article							STRUCTURAL EVIDENCE; MATRIX VESICLES; SWISS-MODEL; BONE; MECHANISM; PLATE; ZINC	The conserved active site of alkaline phosphatases (AP) contains catalytically important Zn2+ (M1 and M2) and Mg2+-sites (M3) and a fourth peripheral Ca2+ site (M4) of unknown significance. We have studied Ca2+ binding to M1-4 of tissue-nonspecific AP (TNAP), an enzyme crucial for skeletal mineralization, using recombinant TNAP and a series of M4 mutants. Ca2+ could substitute for Mg2+ at M3, with maximal activity for Ca2+/Zn2+-TNAP around 40% that of Mg2+/Zn2+-TNAP at pH 9.8 and 7.4. At pH 7.4, allosteric TNAP-activation at M3 by Ca2+ occurred faster than by Mg2+. Several TNAP M4 mutations eradicated TNAP activity, while others mildly influenced the affinity of Ca2+ and Mg2+ for M3 similarly, excluding a catalytic role for Ca2+ in the TNAP M4 site. At pH 9.8, Ca2+ competed with soluble Zn2+ for binding to M1 and M2 up to 1 mM and at higher concentrations, it even displaced M1- and M2-bound Zn2+, forming Ca2+/Ca2+-TNAP with a catalytic activity only 4-6% that of Mg2+/Zn2+-TNAP. At pH 7.4, competition with Zn2+ and its displacement from M1 and M2 required >10-fold higher Ca2+ concentrations, to generate weakly active Ca2+/Ca2+-TNAP. Thus, in a Ca2+-rich environment, such as during skeletal mineralization at pH 7.4, Ca2+ adequately activates Zn2+-TNAP at M3, but very high Ca2+ concentrations compete with available Zn2+ for binding to M1 and M2 and ultimately displace Zn2+ from the active site, virtually inactivating TNAP. Those ALPL mutations that substitute critical TNAP amino acids involved in coordinating Ca2+ to M4 cause hypophosphatasia because of their 3D-structural impact, but M4-bound Ca2+ is catalytically inactive. In conclusion, during skeletal mineralization, the building Ca2+ gradient first activates TNAP, but gradually inactivates it at high Ca2+ concentrations, toward completion of mineralization.	[Hoylaerts, Marc F.; Van Kerckhoven, Soetkin] Univ Leuven, Ctr Mol & Vasc Biol, Dept Cardiovasc Sci, Leuven, Belgium; [Kiffer-Moreira, Tina; Sheen, Campbell; Narisawa, Sonoko; Millan, Jose Luis] Sanford Burnham Med Res Inst, Sanford Childrens Hlth Res Ctr, La Jolla, CA 92037 USA	KU Leuven; Sanford Burnham Prebys Medical Discovery Institute	Millan, JL (corresponding author), Sanford Burnham Med Res Inst, Sanford Childrens Hlth Res Ctr, La Jolla, CA 92037 USA.	millan@sanfordburnham.org		Hoylaerts, Marc/0000-0002-6474-3933	National Institute of Dental and Craniofacial Research [R01 DE 12889]; National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health USA [R01 AR53102]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053102] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health USA; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	R01 DE 12889 from the National Institute of Dental and Craniofacial Research and R01 AR53102 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health USA.	Anderson HC, 2004, AM J PATHOL, V164, P841, DOI 10.1016/S0002-9440(10)63172-0; CATHALA G, 1975, J BIOL CHEM, V250, P6046; CATHALA G, 1975, J BIOL CHEM, V250, P6040; Ciancaglini P, 2010, J BONE MINER RES, V25, P716, DOI 10.1359/jbmr.091023; DEBERNARD B, 1986, J CELL BIOL, V103, P1615, DOI 10.1083/jcb.103.4.1615; Di Mauro S, 2002, J BONE MINER RES, V17, P1383, DOI 10.1359/jbmr.2002.17.8.1383; GENGE BR, 1988, J BIOL CHEM, V263, P18513; Gomez S, 1999, BONE, V25, P33, DOI 10.1016/S8756-3282(99)00102-7; GREENWALD I, 1945, J BIOL CHEM, V161, P697; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hoylaerts MF, 2006, BIOCHEMISTRY-US, V45, P9756, DOI 10.1021/bi052471+; HOYLAERTS MF, 1992, BIOCHEM J, V286, P23, DOI 10.1042/bj2860023; Hoylaerts MF, 1997, J BIOL CHEM, V272, P22781, DOI 10.1074/jbc.272.36.22781; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kiffer-Moreira T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089374; Le Du MH, 2001, J BIOL CHEM, V276, P9158, DOI 10.1074/jbc.M009250200; Le Du MH, 2002, J BIOL CHEM, V277, P49808, DOI 10.1074/jbc.M207394200; Leone FA, 1997, J INORG BIOCHEM, V68, P123, DOI 10.1016/S0162-0134(97)00047-0; Llinas P, 2005, J MOL BIOL, V350, P441, DOI 10.1016/j.jmb.2005.04.068; Lowe NM, 2004, J NUTR, V134, P2178, DOI 10.1093/jn/134.9.2178; Fernandez JM, 2014, BIOMETALS, V27, P601, DOI 10.1007/s10534-014-9733-8; McComb Jr RB, 1979, ALKALINE PHOSPHATASE, DOI 10.1007/978-1-4613-2970-1_4; MCLEAN FM, 1987, J BIOL CHEM, V262, P10481; Millan J.L., 2006, MAMMALIAN ALKALINE P; Millan JL, 2008, J BONE MINER RES, V23, P777, DOI 10.1359/JBMR.071213; Millan JL, 2013, CALCIFIED TISSUE INT, V93, P299, DOI 10.1007/s00223-012-9672-8; Mornet E, 2001, J BIOL CHEM, V276, P31171, DOI 10.1074/jbc.M102788200; Nakano Y, 2007, BONE, V41, P549, DOI 10.1016/j.bone.2007.06.011; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sekiya F, 1996, J BIOL CHEM, V271, P8541, DOI 10.1074/jbc.271.15.8541; Sheen CR, 2015, J BONE MINER RES, V30, P824, DOI 10.1002/jbmr.2420; Stec B, 2000, J MOL BIOL, V299, P1303, DOI 10.1006/jmbi.2000.3799; Wang Y, 2014, AM J PHYSIOL-HEART C, V307, pH933, DOI 10.1152/ajpheart.00374.2014; Whyte MP, 2010, ANN NY ACAD SCI, V1192, P190, DOI 10.1111/j.1749-6632.2010.05387.x	34	23	24	6	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119874	10.1371/journal.pone.0119874	http://dx.doi.org/10.1371/journal.pone.0119874			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775211	gold, Green Published, Green Submitted			2022-12-27	WOS:000351183500135
J	Kobus, K; Hartl, D; Ott, CE; Osswald, M; Huebner, A; von der Hagen, M; Emmerich, D; Kuhnisch, J; Morreau, H; Hes, FJ; Mautner, VF; Harder, A; Tinschert, S; Mundlos, S; Kolanczyk, M				Kobus, Karolina; Hartl, Daniela; Ott, Claus Eric; Osswald, Monika; Huebner, Angela; von der Hagen, Maja; Emmerich, Denise; Kuehnisch, Jirko; Morreau, Hans; Hes, Frederik J.; Mautner, Victor F.; Harder, Anja; Tinschert, Sigrid; Mundlos, Stefan; Kolanczyk, Mateusz			Double NF1 Inactivation Affects Adrenocortical Function in NF1Prx1 Mice and a Human Patient	PLOS ONE			English	Article							ACUTE REGULATORY PROTEIN; MITOCHONDRIAL KINASE COMPLEX; NEUROFIBROMATOSIS TYPE-1; ADRENAL-GLAND; STEROIDOGENIC ACTIVITY; PRECOCIOUS PUBERTY; BLOOD-PRESSURE; MOUSE; GROWTH; GENE	Background Neurofibromatosis type I (NF1, MIM#162200) is a relatively frequent genetic condition, which predisposes to tumor formation. Apart from tumors, individuals with NF1 often exhibit endocrine abnormalities such as precocious puberty (2,5-5% of NF1 patients) and some cases of hypertension (16% of NF1 patients). Several cases of adrenal cortex adenomas have been described in NF1 individuals supporting the notion that neurofibromin might play a role in adrenal cortex homeostasis. However, no experimental data were available to prove this hypothesis. Materials and Methods We analysed Nf1Prx1 mice and one case of adrenal cortical hyperplasia in a NF1patient. Results In Nf1Prx1 mice Nf1 is inactivated in the developing limbs, head mesenchyme as well as in the adrenal gland cortex, but not the adrenal medulla or brain. We show that adrenal gland size is increased in NF1Prx1 mice. Nf1Prx1 female mice showed corticosterone and aldosterone overproduction. Molecular analysis of Nf1 deficient adrenals revealed deregulation of multiple proteins, including steroidogenic acute regulatory protein (StAR), a vital mitochondrial factor promoting transfer of cholesterol into steroid making mitochondria. This was associated with a marked upregulation of MAPK pathway and a female specific increase of cAMP concentration in murine adrenal lysates. Complementarily, we characterized a patient with neurofibromatosis type I with macronodular adrenal hyperplasia with ACTH-independent cortisol overproduction. Comparison of normal control tissue-and adrenal hyperplasia-derived genomic DNA revealed loss of heterozygosity (LOH) of the wild type NF1 allele, showing that biallelic NF1 gene inactivation occurred in the hyperplastic adrenal gland. Conclusions Our data suggest that biallelic loss of Nf1 induces autonomous adrenal hyper-activity. We conclude that Nf1 is involved in the regulation of adrenal cortex function in mice and humans.	[Kobus, Karolina; Hartl, Daniela; Kuehnisch, Jirko; Mundlos, Stefan; Kolanczyk, Mateusz] Charite, Inst Med Genet & Human Genet, D-13353 Berlin, Germany; [Kobus, Karolina; Ott, Claus Eric; Osswald, Monika; Emmerich, Denise; Kuehnisch, Jirko; Mundlos, Stefan; Kolanczyk, Mateusz] Max Planck Inst Mol Genet, FG Dev & Dis, D-14195 Berlin, Germany; [Mundlos, Stefan] Berlin Brandenburg Ctr Regenerat Therapies BCRT, Berlin, Germany; [Morreau, Hans] Leiden Univ Ctr, Dept Pathol, NL-2333 ZA Leiden, Netherlands; [Hes, Frederik J.] Leiden Univ Ctr, Dept Clin Genet, NL-2333 ZA Leiden, Netherlands; [Mautner, Victor F.] Univ Hosp Eppendorf, Dept Maxillofacial Surg, Hamburg, Germany; [Harder, Anja] Univ Hosp Munster, Inst Neuropathol, Munster, Germany; [Tinschert, Sigrid] Med Univ Innsbruck, Dept Med Genet Mol & Clin Pharmacol, A-6020 Innsbruck, Austria; [Huebner, Angela] Tech Univ Dresden, Klin Kinder & Jugendmed, Med Fak Carl Gustav Carus, D-01062 Dresden, Germany; [von der Hagen, Maja] Tech Univ Dresden, Abt Neuropadiatrie, Med Fak Carl Gustav Carus, D-01062 Dresden, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munster; Medical University of Innsbruck; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Kobus, K (corresponding author), Charite, Inst Med Genet & Human Genet, D-13353 Berlin, Germany.	kolanshy@molgen.mpg.de; kobus@molgen.mp.de	Kühnisch, Jirko/L-7761-2013; Ott, Claus/U-8226-2019; Kühnisch, Jirko/M-3744-2019; Mundlos, Stefan/ABH-9585-2020; Ott, Claus E/G-1936-2011	Ott, Claus/0000-0003-3627-3791; Kühnisch, Jirko/0000-0003-4744-5421; Ott, Claus E/0000-0003-3627-3791; Hes, Frederik/0000-0002-3025-0882; Jahn, Denise/0000-0001-8912-5851; Mundlos, Stefan/0000-0002-9788-3166; Harder, nee Klose, Anja/0000-0002-3045-2222	Bundesministerium fur Bildung und Forschung (BMBF) [NF1-01GM0844]; Bundesverband Neurofibromatose Von Recklinghausen Gesellschaft e.V. Grant [89735103]	Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Bundesverband Neurofibromatose Von Recklinghausen Gesellschaft e.V. Grant	MK was supported by the grant from Bundesministerium fur Bildung und Forschung (BMBF), Grant NF1-01GM0844. KK was supported by the grant from Bundesverband Neurofibromatose Von Recklinghausen Gesellschaft e.V. Grant #89735103. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakane F, 1997, J BIOL CHEM, V272, P32656, DOI 10.1074/jbc.272.51.32656; Baasanjav S, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-110; Banerjee S, 2010, CANCER RES, V70, P1356, DOI 10.1158/0008-5472.CAN-09-2178; Biagi P, 1999, J INTERN MED, V246, P509, DOI 10.1046/j.1365-2796.1999.00577.x; Bielohuby M, 2007, AM J PHYSIOL-ENDOC M, V293, pE139, DOI 10.1152/ajpendo.00705.2006; Burnichon N, 2012, HUM MOL GENET, V21, P5397, DOI 10.1093/hmg/dds374; Daginakatte GC, 2008, CANCER RES, V68, P10358, DOI 10.1158/0008-5472.CAN-08-2506; Dang I, 2011, NEUROCHEM RES, V36, P1697, DOI 10.1007/s11064-011-0433-2; DASTON MM, 1992, DEV DYNAM, V195, P216, DOI 10.1002/aja.1001950307; de Joussineau C, 2012, MOL CELL ENDOCRINOL, V351, P28, DOI 10.1016/j.mce.2011.10.006; Doi M, 2010, NAT MED, V16, P67, DOI 10.1038/nm.2061; DOMALIK LJ, 1991, MOL ENDOCRINOL, V5, P1853, DOI 10.1210/mend-5-12-1853; Durland JL, 2008, J ANAT, V212, P590, DOI 10.1111/j.1469-7580.2008.00879.x; Gottfried ON, NEUROSURG FOCUS, V28, pE8, DOI [10.3171/2010.3.FOCUS09324, DOI 10.3171/2010.3.FOCUS09324]; Granot Z, 2007, MOL ENDOCRINOL, V21, P2164, DOI 10.1210/me.2005-0458; GUTMANN DH, 1994, GENE CHROMOSOME CANC, V10, P55, DOI 10.1002/gcc.2870100109; Habiby R, 1997, J PEDIATR-US, V131, P786, DOI 10.1016/S0022-3476(97)70117-3; Hartl D, 2008, PROTEOMICS, V8, P1257, DOI 10.1002/pmic.200700724; Hegedus B, 2008, HUM MOL GENET, V17, P2956, DOI 10.1093/hmg/ddn194; Hoeflich A, 2009, J MOL ENDOCRINOL, V42, P191, DOI 10.1677/JME-08-0160; Horvath A, 2008, NEW ENGL J MED, V358, P750, DOI 10.1056/NEJMc0706182; Horvath A, 2006, NAT GENET, V38, P794, DOI 10.1038/ng1809; Howe DG, 2000, J NEUROSCI, V20, P3513, DOI 10.1523/JNEUROSCI.20-10-03513.2000; Johannessen CM, 2005, P NATL ACAD SCI USA, V102, P8573, DOI 10.1073/pnas.0503224102; Kim HA, 2001, J NEUROSCI, V21, P1110; Kirschner LS, 2000, NAT GENET, V26, P89, DOI 10.1038/79238; Kolanczyk M, 2007, HUM MOL GENET, V16, P874, DOI 10.1093/hmg/ddm032; Korf BR, 2013, HAND CLINIC, V111, P333, DOI 10.1016/B978-0-444-52891-9.00039-7; Kossler N, 2011, HUM MOL GENET, V20, P2697, DOI 10.1093/hmg/ddr149; Lama G, 2004, PEDIATR NEPHROL, V19, P413, DOI 10.1007/s00467-003-1397-5; Lefrancois-Martinez AM, 2004, J CLIN ENDOCR METAB, V89, P3010, DOI 10.1210/jc.2003-031830; Lumbroso S, 2002, J PEDIATR ENDOCR MET, V15, P875; Manna PR, 2006, MOL ENDOCRINOL, V20, P362, DOI 10.1210/me.2004-0526; Martinez A, 2001, CHEM-BIOL INTERACT, V130, P903, DOI 10.1016/S0009-2797(00)00244-1; Miller WL, 1999, J STEROID BIOCHEM, V69, P131, DOI 10.1016/S0960-0760(98)00153-8; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nebrich G, 2007, ELECTROPHORESIS, V28, P1607, DOI 10.1002/elps.200600656; NOWAK KW, 1995, LIFE SCI, V57, P833, DOI 10.1016/0024-3205(95)02015-B; Ott CE, 2010, HUM MUTAT, V31, pE1587, DOI 10.1002/humu.21298; Ozawa T, 2005, J BIOL CHEM, V280, P39524, DOI 10.1074/jbc.M503707200; Paz C, 2009, METHOD ENZYMOL, V457, P169, DOI 10.1016/S0076-6879(09)05010-1; Poderoso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001443; Riccardi VM, 2010, BIRTH DEFECTS RES A, V88, P9, DOI 10.1002/bdra.20616; Roth TM, 2008, AM J MED GENET A, V146A, P1624, DOI 10.1002/ajmg.a.32301; SARTORI P, 1989, ACTA PAEDIATR SCAND, V78, P476, DOI 10.1111/j.1651-2227.1989.tb11116.x; Saruhan BG, 2005, SAUDI MED J, V26, P1705; Schneider C, 2008, J BIOL CHEM, V283, P15539, DOI 10.1074/jbc.R800001200; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Starinsky-Elbaz S, 2009, MOL CELL NEUROSCI, V42, P278, DOI 10.1016/j.mcn.2009.07.014; Tedesco MA, 2001, AM J HYPERTENS, V14, P559, DOI 10.1016/S0895-7061(00)01303-0; Tron'ko M D, 2008, Ukr Biokhim Zh (1999), V80, P65; Ueda K, 2013, AM J MED GENET A, V161A, P1154, DOI 10.1002/ajmg.a.35829; Virdis R, 2000, J PEDIATR ENDOCR MET, V13, P841; Williams JA, 2001, SCIENCE, V293, P2251, DOI 10.1126/science.1063097; Zabel C, 2009, MOL CELL PROTEOMICS, V8, P720, DOI 10.1074/mcp.M800277-MCP200; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101; ZOLLER M, 1995, ACTA DERM-VENEREOL, V75, P136	58	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119030	10.1371/journal.pone.0119030	http://dx.doi.org/10.1371/journal.pone.0119030			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775093	Green Published, gold, Green Submitted			2022-12-27	WOS:000351183500062
J	Luo, ST; Chiang, PS; Chung, WY; Chia, MY; Tsao, KC; Wang, YH; Lin, TY; Lee, MS				Luo, Shu-Ting; Chiang, Pai-Shan; Chung, Wan-Yu; Chia, Min-Yuan; Tsao, Kuo-Chien; Wang, Ying-Hsiang; Lin, Tzou-Yien; Lee, Min-Shi			Reemergence of Enterovirus 71 Epidemic in Northern Taiwan, 2012	PLOS ONE			English	Article							YOUNG-CHILDREN; MOUTH-DISEASE; INFECTIONS; COXSACKIEVIRUS; CHINA; FOOT; HAND	Background Enterovirus 71 (EV71) belongs to picornavirus family and could be classified phylogenetically into three major genogroups (A, B and C) including 11 genotypes (A, B1-B5 and C1C5). Since 1997, EV71 has caused large-scale of epidemics with neurological complications in Asian children. In Taiwan, nationwide EV71 epidemics with different predominant genotypes have occurred cyclically since 1998. A nationwide EV71 epidemic occurred again in 2012. We conducted genetic and antigenic characterizations of the 2012 epidemic. Methods Chang Gung Memorial Hospital (CGMH) is a medical center in northern Taiwan. In CGMH, specimens were collected from pediatric inpatients with suspected enterovirus infections for virus isolation. Enterovirus isolates were serotyped and genotyped and sera from EV71 inpatients were collected for measuring neutralizing antibody titers. Results There were 10, 16 and 99 EV71 inpatients identified in 2010, 2011 and 2012, respectively. There were 82 EV71 isolates genotyped, which identified 17 genotype C4a viruses and 65 genotype B5 viruses. The genotype B5 viruses were not detected until November 2011 and caused epidemics in 2012. Interestingly, the B5-2011 viruses were genetically distinguishable from the B5 viruses causing the 2008 epidemic and are likely introduced from China or Southeastern Asia. Based on antigenic analysis, minor antigenic variations were detected among the B5-2008, B5-2011, C4a-2008 and C4a-2012 viruses but these viruses antigenically differed from genotype A. Conclusions Genotype B5 and C4a viruses antigenically differ from genotype A viruses which have disappeared globally for 30 years but have been detected in China since 2008. Enterovirus surveillance should monitor genetic and antigenic variations of EV71.	[Luo, Shu-Ting; Chiang, Pai-Shan; Chung, Wan-Yu; Chia, Min-Yuan; Lee, Min-Shi] NHRI, Natl Inst Infect Dis & Vaccinol, Zhunan Town, Miaoli County, Taiwan; [Tsao, Kuo-Chien] Chang Gung Univ, Coll Med, Dept Med Biotechnol & Lab Sci, Gueishan Town, Taoyuan County, Taiwan; [Tsao, Kuo-Chien] Linkou Chang Gung Mem Hosp, Dept Lab Med, Gueishan Town, Taoyuan County, Taiwan; [Wang, Ying-Hsiang] Chiayi Chang Gung Mem Hosp, Dept Pediat, Puzi City, Chiayi County, Taiwan; [Lin, Tzou-Yien] Linkou Chang Gung Mem Hosp, Dept Pediat, Gueishan Town, Taoyuan County, Taiwan; [Lin, Tzou-Yien] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Gueishan Town, Taoyuan County, Taiwan	National Health Research Institutes - Taiwan; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Lee, MS (corresponding author), NHRI, Natl Inst Infect Dis & Vaccinol, Zhunan Town, Miaoli County, Taiwan.	minshi@nhri.org.tw	Lee, Min-Shi/E-3992-2010		National Science Council [NSC101-2811-B-400-026]; Taiwan and National Health Research Institutes	National Science Council(Ministry of Science and Technology, Taiwan); Taiwan and National Health Research Institutes	This study was funded by the National Science Council (NSC101-2811-B-400-026), Taiwan and National Health Research Institutes. The funding organization had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Chang L, 2007, NEW ENGL J MED, V356, P1226, DOI 10.1056/NEJMoa065954; Chang LY, 2004, JAMA-J AM MED ASSOC, V291, P222, DOI 10.1001/jama.291.2.222; Chia MY, 2014, PEDIATR NEONATOL, V55, P243, DOI 10.1016/j.pedneo.2013.07.007; Chua K B, 2007, Malays J Pathol, V29, P69; Fan XL, 2013, VIRUS GENES, V46, P1, DOI 10.1007/s11262-012-0814-x; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang MC, 2006, PEDIATRICS, V118, pE1785, DOI 10.1542/peds.2006-1547; Huang ML, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002067; Huang ML, 2010, J VIROL METHODS, V165, P42, DOI 10.1016/j.jviromet.2009.12.015; Huang SW, 2009, J CLIN MICROBIOL, V47, P3653, DOI 10.1128/JCM.00630-09; Huang YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080942; Huang YP, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-277; Thoa LPK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069895; Lee MS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001737; Lee MS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001476; Lee MS, 2010, PEDIATR INFECT DIS J, V29, P1030, DOI 10.1097/INF.0b013e3181e52945; Lin TL, 2008, J CLIN MICROBIOL, V46, P785, DOI 10.1128/JCM.01114-07; Luo ST, 2009, EMERG INFECT DIS, V15, P581, DOI 10.3201/eid1504.081550; Ooi MH, 2007, CLIN INFECT DIS, V44, P646, DOI 10.1086/511073; Rao CD, 2012, EMERG INFECT DIS, V18, P1833, DOI 10.3201/eid1811.111457; Seiff A, 2012, LANCET, V380, P205, DOI 10.1016/S0140-6736(12)61200-8; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Khanh TH, 2012, EMERG INFECT DIS, V18, P2002, DOI 10.3201/eid1812.120929; World Health Organization (WHO): Western Pacific Region, 2011, GUID CLIN MAN PUBL H; Wu WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083711; Yang Z, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.01112-13; Yu HY, 2010, VIRUS GENES, V41, P1, DOI 10.1007/s11262-010-0472-9; Zhu JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056318	28	17	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0116322	10.1371/journal.pone.0116322	http://dx.doi.org/10.1371/journal.pone.0116322			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774888	gold, Green Published, Green Submitted			2022-12-27	WOS:000351183500006
J	Tekari, A; Luginbuehl, R; Hofstetter, W; Egli, RJ				Tekari, Adel; Luginbuehl, Reto; Hofstetter, Willy; Egli, Rainer J.			Transforming Growth Factor Beta Signaling Is Essential for the Autonomous Formation of Cartilage-Like Tissue by Expanded Chondrocytes	PLOS ONE			English	Article							HUMAN ARTICULAR CHONDROCYTES; MESENCHYMAL STEM-CELLS; TGF-BETA; GENE-EXPRESSION; OSTEOARTHRITIC CARTILAGE; EXPANSION; DIFFERENTIATION; IMPLANTATION; PHENOTYPE; KNEE	Cartilage is a tissue with limited self-healing potential. Hence, cartilage defects require surgical attention to prevent or postpone the development of osteoarthritis. For cell-based cartilage repair strategies, in particular autologous chondrocyte implantation, articular chondrocytes are isolated from cartilage and expanded in vitro to increase the number of cells required for therapy. During expansion, the cells lose the competence to autonomously form a cartilage-like tissue, that is in the absence of exogenously added chondrogenic growth factors, such as TGF-beta s. We hypothesized that signaling elicited by autocrine and/or paracrine TGF-beta is essential for the formation of cartilage-like tissue and that alterations within the TGF-beta signaling pathway during expansion interfere with this process. Primary bovine articular chondrocytes were harvested and expanded in monolayer culture up to passage six and the formation of cartilage tissue was investigated in high density pellet cultures grown for three weeks. Chondrocytes expanded for up to three passages maintained the potential for autonomous cartilage-like tissue formation. After three passages, however, exogenous TGF-beta 1 was required to induce the formation of cartilage-like tissue. When TGF-beta signaling was blocked by inhibiting the TGF-beta receptor 1 kinase, the autonomous formation of cartilage-like tissue was abrogated. At the initiation of pellet culture, chondrocytes from passage three and later showed levels of transcripts coding for TGF-beta receptors 1 and 2 and TGF-beta 2 to be three-, five- and five-fold decreased, respectively, as compared to primary chondrocytes. In conclusion, the autonomous formation of cartilage-like tissue by expanded chondrocytes is dependent on signaling induced by autocrine and/or paracrine TGF-beta. We propose that a decrease in the expression of the chondrogenic growth factor TGF-beta 2 and of the TGF-beta receptors in expanded chondrocytes accounts for a decrease in the activity of the TGF-beta signaling pathway and hence for the loss of the potential for autonomous cartilage-like tissue formation.	[Tekari, Adel; Hofstetter, Willy; Egli, Rainer J.] Univ Bern, Dept Clin Res, Grp Bone Biol & Orthopaed Res, Bern, Switzerland; [Tekari, Adel] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland; [Luginbuehl, Reto; Egli, Rainer J.] RMS Fdn, Bettlach, Switzerland	University of Bern; University of Bern	Egli, RJ (corresponding author), Univ Bern, Dept Clin Res, Grp Bone Biol & Orthopaed Res, Bern, Switzerland.	rainer.egli@rms-foundation.ch	Tekari, Adel/E-1134-2019; Tekari, Adel/A-5101-2016	Hofstetter, Wilhelm/0000-0003-0126-8423; Tekari, Adel/0000-0003-1676-0920	RMS Foundation [E10_0007]	RMS Foundation	This study was supported by a grant of the RMS Foundation to WH (E10_0007). No individual (other than the named authors) employed or contracted by the funder was involved in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Barbero A, 2004, OSTEOARTHR CARTILAGE, V12, P476, DOI 10.1016/j.joca.2004.02.010; Barbero A, 2006, J CELL BIOCHEM, V98, P1140, DOI 10.1002/jcb.20754; Bauge C, 2013, AGE, V35, P1105, DOI 10.1007/s11357-012-9433-7; BENYA PD, 1978, CELL, V15, P1313, DOI 10.1016/0092-8674(78)90056-9; Biant LC, 2014, AM J SPORT MED, V42, P2178, DOI 10.1177/0363546514539345; BONAVENTURE J, 1994, EXP CELL RES, V212, P97, DOI 10.1006/excr.1994.1123; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Brittberg M, 2003, J BONE JOINT SURG AM, V85A, P109, DOI 10.2106/00004623-200300003-00017; Brittberg M, 2008, INJURY, V39, pS40, DOI 10.1016/j.injury.2008.01.040; Brown TD, 2006, J ORTHOP TRAUMA, V20, P739, DOI 10.1097/01.bot.0000246468.80635.ef; Cals FLJ, 2012, J TISSUE ENG REGEN M, V6, P68, DOI 10.1002/term.399; Darling EM, 2005, J ORTHOP RES, V23, P425, DOI 10.1016/j.orthres.2004.08.008; Davidson ENB, 2005, ARTHRITIS RES THER, V7, pR1338, DOI 10.1186/ar1833; Dehne T, 2010, GENE, V462, P8, DOI 10.1016/j.gene.2010.04.006; Dell'Accio F, 2001, ARTHRITIS RHEUM-US, V44, P1608, DOI 10.1002/1529-0131(200107)44:7<1608::AID-ART284>3.0.CO;2-T; Diaz-Romero J, 2005, J CELL PHYSIOL, V202, P731, DOI 10.1002/jcp.20164; Ebert JR, 2011, AM J SPORT MED, V39, P753, DOI 10.1177/0363546510390476; Egli RJ, 2008, J ORTHOP RES, V26, P977, DOI 10.1002/jor.20603; Filardo G, 2013, AM J SPORT MED, V41, P1786, DOI 10.1177/0363546513490658; Gan L, 2007, TISSUE ENG, V13, P831, DOI 10.1089/ten.2006.0231; Gelber AC, 2000, ANN INTERN MED, V133, P321, DOI 10.7326/0003-4819-133-5-200009050-00007; Giovannini S, 2010, J CELL PHYSIOL, V222, P411, DOI 10.1002/jcp.21965; Goessler UR, 2005, CELL MOL BIOL LETT, V10, P345; Goessler UR, 2005, IN VIVO, V19, P501; Goldberg AJ, 2005, J BONE JOINT SURG BR, V87B, P128, DOI 10.1302/0301-620X.87B1.14154; Hdud IM, 2012, INT J MOL SCI, V13, P4433, DOI 10.3390/ijms13044433; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hunter WVI, 1743, PHILOS T R SOC LOND, V42, P514, DOI [10.1098/rstl.1742.0079, DOI 10.1098/RSTL.1742.0079)]; Jakob M, 2001, J CELL BIOCHEM, V81, P368, DOI 10.1002/1097-4644(20010501)81:2<368::AID-JCB1051>3.0.CO;2-J; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Kizawa H, 2005, NAT GENET, V37, P138, DOI 10.1038/ng1496; KULYK WM, 1989, DEV BIOL, V135, P424, DOI 10.1016/0012-1606(89)90191-7; Lehmann M, 2013, EUR J HISTOCHEM, V57, P205, DOI 10.4081/ejh.2013.e31; LEONARD CM, 1991, DEV BIOL, V145, P99, DOI 10.1016/0012-1606(91)90216-P; Li Z, 2010, J CELL MOL MED, V14, P1338, DOI 10.1111/j.1582-4934.2009.00780.x; Lin Z, 2008, J ORTHOP RES, V26, P1230, DOI 10.1002/jor.20523; Marlovits S, 2004, J BONE JOINT SURG BR, V86B, P286, DOI 10.1302/0301-620X.86B2.14918; Minas T, 2012, OPER TECHN SPORT MED, V20, P72, DOI 10.1053/j.otsm.2012.03.009; Miura T, 2000, DEV DYNAM, V217, P241, DOI 10.1002/(SICI)1097-0177(200003)217:3<241::AID-DVDY2>3.0.CO;2-K; Narcisi R, 2012, J CELL PHYSIOL, V227, P3282, DOI 10.1002/jcp.24024; Ossendorf C, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2180; Pei M, 2012, J CELL PHYSIOL, V227, P2163, DOI 10.1002/jcp.22950; ROARK EF, 1994, DEV DYNAM, V200, P103, DOI 10.1002/aja.1002000203; Roberts S, 2003, ARTHRITIS RES THER, V5, pR60, DOI 10.1186/ar613; Schulze-Tanzil G, 2004, OSTEOARTHR CARTILAGE, V12, P448, DOI 10.1016/j.joca.2004.02.007; Serra R, 1997, J CELL BIOL, V139, P541, DOI 10.1083/jcb.139.2.541; Shen J, 2013, ARTHRITIS RHEUM-US, V65, P3107, DOI 10.1002/art.38122; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Spagnoli A, 2007, J CELL BIOL, V177, P1105, DOI 10.1083/jcb.200611031; Stokes DG, 2001, BIOCHEM J, V360, P461, DOI 10.1042/0264-6021:3600461; Tallheden T, 2004, OSTEOARTHR CARTILAGE, V12, P525, DOI 10.1016/j.joca.2004.03.004; Tchetina EV, 2006, AM J PATHOL, V168, P131, DOI 10.2353/ajpath.2006.050369; Tekari A, 2014, J ORTHOP RES, V32, P1503, DOI 10.1002/jor.22690; van Osch GJVM, 2001, PLAST RECONSTR SURG, V107, P433, DOI 10.1097/00006534-200102000-00020; Verdier MP, 2005, RHEUMATOL INT, V25, P118, DOI 10.1007/s00296-003-0409-x; VILLIGER PM, 1992, J CELL PHYSIOL, V151, P318, DOI 10.1002/jcp.1041510213; Yamaoka H, 2010, CELL PROLIFERAT, V43, P67, DOI 10.1111/j.1365-2184.2009.00655.x; Yang KGA, 2006, TISSUE ENG, V12, P2435, DOI 10.1089/ten.2006.12.2435; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35; Zeifang F, 2010, AM J SPORT MED, V38, P924, DOI 10.1177/0363546509351499; Zhang Y, 2012, BIOMATERIALS, V33, P7394, DOI 10.1016/j.biomaterials.2012.06.070	61	45	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120857	10.1371/journal.pone.0120857	http://dx.doi.org/10.1371/journal.pone.0120857			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775021	Green Published, gold, Green Submitted			2022-12-27	WOS:000351183500196
J	Wang, WJ; Hu, YL; Ma, Y; Xu, LY; Guan, JT; Kong, J				Wang, Weiji; Hu, Yulong; Ma, Yu; Xu, Liyong; Guan, Jiantao; Kong, Jie			High-Density Genetic Linkage Mapping in Turbot (Scophthalmus maximus L.) Based on SNP Markers and Major Sex- and Growth-Related Regions Detection	PLOS ONE			English	Article							GONADAL DEVELOPMENT; DIFFERENTIATION; RESOLUTION; SEQUENCE; TRAITS; LOCI	This paper describes the development of a high density consensus genetic linkage map of a turbot (Scophthalmus maximus L.) family composed of 149 mapping individuals using Single Nucleotide Polymorphisms (SNP) developed using the restriction-site associated DNA (RAD) sequencing technique with the restriction enzyme, PstI. A total of 6,647 SNPs were assigned to 22 linkage groups, which is equal to the number of chromosome pairs in turbot. For the first time, the average marker interval reached 0.3958 cM, which is equal to approximately 0.1203 Mb of the turbot genome. The observed 99.34% genome coverage indicates that the linkage map was genome-wide. A total of 220 Quantitative Traits Locus (QTLs) associated with two body length traits, two body weight traits in different growth periods and sex determination were detected with an LOD > 5.0 in 12 linkage groups (LGs), which explained the corresponding phenotypic variance (R-2), ranging from 14.4-100%. Among them, 175 overlapped with linked SNPs, and the remaining 45 were located in regions between contiguous SNPs. According to the QTLs related to growth trait distribution and the changing of LGs during different growth periods, the growth traits are likely controlled by multi-SNPs distributed on several LGs; the effect of these SNPs changed during different growth periods. Most sex-related QTLs were detected at LG 21 with a linkage span of 70.882 cM. Additionally, a small number of QTLs with high feasibility and a narrow R-2 distribution were also observed on LG7 and LG14, suggesting that multi LGs or chromosomes might be involved in sex determination. High homology was recorded between LG21 in Cynoglossus semilaevis and turbot. This high-saturated turbot RAD-Seq linkage map is undoubtedly a promising platform for marker assisted selection (MAS) and flatfish genomics research.	[Wang, Weiji; Hu, Yulong; Ma, Yu; Xu, Liyong; Kong, Jie] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Minist Agr, Key Lab Sustainable Dev Marine Fisheries, Qingdao, Shandong, Peoples R China; [Guan, Jiantao] Ocean Univ China, Qingdao, Shandong, Peoples R China	Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; Ocean University of China	Kong, J (corresponding author), Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Minist Agr, Key Lab Sustainable Dev Marine Fisheries, Qingdao, Shandong, Peoples R China.	kongjie@ysfri.ac.cn		guan, jiantao/0000-0003-1607-009X	National High Technology Research and Development Program of China [2012AA10A408-7]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by the National High Technology Research and Development Program of China (Grant No. 2012AA10A408-7). Wang is the author who received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOUZA C, 1994, MAR BIOL, V120, P609, DOI 10.1007/BF00350082; Bouza C, 2007, GENETICS, V177, P2457, DOI 10.1534/genetics.107.075416; Bouza C, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-54; Cal RM, 2006, J FISH BIOL, V68, P401, DOI 10.1111/j.0022-1112.2006.00889.x; Cal RM, 2006, AQUACULTURE, V251, P99, DOI 10.1016/j.aquaculture.2005.05.010; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Chen SL, 2012, MAR BIOTECHNOL, V14, P120, DOI 10.1007/s10126-011-9395-2; Cunado N, 2001, GENOME, V44, P1143, DOI 10.1139/gen-44-6-1143; Etter PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018561; FERNANDO RL, 1989, GENET SEL EVOL, V21, P467, DOI 10.1051/gse:19890407; Gonen S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-166; Haffray P, 2009, AQUACULTURE, V294, P30, DOI 10.1016/j.aquaculture.2009.05.004; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Howell B., 2006, SCI SERIES TECHNICAL, V32, P1; HUSEBYE H, 1994, COMP BIOCHEM PHYS B, V107, P69, DOI 10.1016/0305-0491(94)90226-7; Imsland AK, 1997, AQUAC RES, V28, P101; Jansen J, 2001, THEOR APPL GENET, V102, P1113, DOI 10.1007/s001220000489; JANSEN RC, 1994, GENETICS, V136, P1447; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; LANDE R, 1990, GENETICS, V124, P743; [雷霁霖 Lei Jilin], 2012, [渔业科学进展, Progress in Fishery Sciences], V33, P123; [栾生 LUAN Sheng], 2008, [海洋水产研究, Marine Fisheries Research], V29, P14; Martinez P, 2009, GENETICS, V183, P1443, DOI 10.1534/genetics.109.107979; Palaiokostas C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-566; Palaiokostas C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068389; Piferrer F, 2004, AQUACULTURE, V238, P403, DOI 10.1016/j.aquaculture.2004.05.009; Rodriguez-Ramilo ST, 2013, ANIM GENET, V44, P149, DOI 10.1111/j.1365-2052.2012.02385.x; Rodriguez-Ramilo ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-541; Ruan XH, 2010, AQUACULTURE, V308, P89, DOI 10.1016/j.aquaculture.2010.08.010; Sanchez-Molano E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-473; Shi CY, 2004, AQUACULTURE, V236, P11, DOI 10.1016/j.aquaculture.2003.11.007; Van Ooijen, 2004, MAPQTL SOFTWARE MAPP; Van Ooijen JW, 2011, GENET RES, V93, P343, DOI 10.1017/S0016672311000279; Van Ooijen J.W., 2006, JOINMAP4 SOFTWARE CA; Vinas A, 2012, MAR BIOTECHNOL, V14, P655, DOI 10.1007/s10126-012-9451-6; Wagner CE, 2013, MOL ECOL, V22, P787, DOI 10.1111/mec.12023; Wang WJ, 2008, I GENETIC MAPPING CH; Zhang QL, 2009, J VIROL METHODS, V158, P18, DOI 10.1016/j.jviromet.2009.01.008; [张庆文 ZHANG Qingwen], 2008, [海洋水产研究, Marine Fisheries Research], V29, P53	39	52	57	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120410	10.1371/journal.pone.0120410	http://dx.doi.org/10.1371/journal.pone.0120410			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775256	Green Submitted, gold, Green Published			2022-12-27	WOS:000351183500171
J	Yamaguchi, M; Kotani, K; Tsuzaki, K; Takagi, A; Motokubota, N; Komai, N; Sakane, N; Moritani, T; Nagai, N				Yamaguchi, Mitsue; Kotani, Kazuhiko; Tsuzaki, Kokoro; Takagi, Ayaka; Motokubota, Naoko; Komai, Naho; Sakane, Naoki; Moritani, Toshio; Nagai, Narumi			Circadian Rhythm Genes CLOCK and PER3 Polymorphisms and Morning Gastric Motility in Humans	PLOS ONE			English	Article							SLEEP-PHASE SYNDROME; LENGTH POLYMORPHISM; DIURNAL PREFERENCE; ASSOCIATION; METABOLISM; OVERWEIGHT; EXPRESSION; VARIANTS; GENETICS; HEALTH	Background Clock genes regulate circadian rhythm and are involved in various physiological processes, including digestion. We therefore investigated the association between the CLOCK 3111T/C single nucleotide polymorphism and the Period3 (PER3) variable-number tandem-repeat polymorphism (either 4 or 5 repeats 54 nt in length) with morning gastric motility. Methods Lifestyle questionnaires and anthropometric measurements were performed with 173 female volunteers (mean age, 19.4 years). Gastric motility, evaluated by electrogastrography (EGG), blood pressure, and heart rate levels were measured at 8:30 a.m. after an overnight fast. For gastric motility, the spectral powers (% normal power) and dominant frequency (DF, peak of the power spectrum) of the EGG were evaluated. The CLOCK and PER3 polymorphisms were determined by polymerase chain reaction (PCR) restriction fragment length polymorphism analysis. Results Subjects with the CLOCK C allele (T/C or C/C genotypes: n = 59) showed a significantly lower DF (mean, 2.56 cpm) than those with the T/T genotype (n = 114, 2.81 cpm, P < 0.05). Subjects with the longer PER3 allele (PER3(4/5) or PER3(5/5) genotypes: n = 65) also showed a significantly lower DF (2.55 cpm) than those with the shorter PER3(4/4) genotype (n = 108, 2.83 cpm, P < 0.05). Furthermore, subjects with both the T/C or C/C and PER3(4/5) or PER3(5/5) genotypes showed a significantly lower DF (2.43 cpm, P < 0.05) than subjects with other combinations of the alleles (T/T and PER3(4/4) genotype, T/C or C/C and PER3(4/4) genotypes, and T/T and PER3(4/5) or PER3(5/5) genotypes). Conclusions These results suggest that minor polymorphisms of the circadian rhythm genes CLOCK and PER3 may be associated with poor morning gastric motility, and may have a combinatorial effect. The present findings may offer a new viewpoint on the role of circadian rhythm genes on the peripheral circadian systems, including the time-keeping function of the gut.	[Yamaguchi, Mitsue; Takagi, Ayaka; Motokubota, Naoko; Komai, Naho; Nagai, Narumi] Univ Hyogo, Grad Sch Human Sci & Environm, Kobe, Hyogo 6500044, Japan; [Kotani, Kazuhiko] Jichi Med Univ, Dept Clin Lab Med, Shimotsuke, Tochigi, Japan; [Kotani, Kazuhiko; Tsuzaki, Kokoro; Sakane, Naoki] Kyoto Med Ctr, Natl Hosp Org, Clin Res Inst Endocrine & Metab Dis, Div Prevent Med, Kyoto, Japan; [Moritani, Toshio] Kyoto Univ, Grad Sch Human & Environm Studies, Appl Physiol Lab, Kyoto, Japan	University of Hyogo; Jichi Medical University; Kyoto University	Nagai, N (corresponding author), Univ Hyogo, Grad Sch Human Sci & Environm, Kobe, Hyogo 6500044, Japan.	nagai@shse.u-hyogo.ac.jp		Nagai, Narumi/0000-0002-2574-9371	Ministry of Education and Science of Japan [24500988]	Ministry of Education and Science of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Grant-in-Aid for Science Research from the Ministry of Education and Science of Japan (24500988). URL of funder's website: http://www.jsps.go.jp/english/e-grants/index.html. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer SN, 2003, SLEEP, V26, P413, DOI 10.1093/sleep/26.4.413; Bandin C, 2013, INT J OBESITY, V37, P1044, DOI 10.1038/ijo.2012.180; Bass J, 2011, NATURE, V469, P476, DOI 10.1038/469476a; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bray MS, 2008, AM J PHYSIOL-HEART C, V294, pH1036, DOI 10.1152/ajpheart.01291.2007; Chellappa SL, 2014, BEHAV BRAIN RES, V271, P23, DOI 10.1016/j.bbr.2014.05.050; Chellappa SL, 2012, J CLIN ENDOCR METAB, V97, pE433, DOI 10.1210/jc.2011-2391; Costa MJ, 2011, J BIOL CHEM, V286, P9063, DOI 10.1074/jbc.M110.164558; Cummings DE, 2001, DIABETES, V50, P1714, DOI 10.2337/diabetes.50.8.1714; Dallmann R, 2010, CHRONOBIOL INT, V27, P1317, DOI 10.3109/07420528.2010.489166; Dijk DJ, 2010, SLEEP MED REV, V14, P151, DOI 10.1016/j.smrv.2009.07.002; Etain B, 2011, EUR NEUROPSYCHOPHARM, V21, pS676, DOI 10.1016/j.euroneuro.2011.07.007; Garaulet M, 2010, INT J OBESITY, V34, P516, DOI 10.1038/ijo.2009.255; Garaulet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017435; Garaulet M, 2010, EUR J HUM GENET, V18, P364, DOI 10.1038/ejhg.2009.176; Goel N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005874; Hoogerwerf WA, 2007, GASTROENTEROLOGY, V133, P1250, DOI 10.1053/j.gastro.2007.07.009; Hoogerwerf WA, 2010, AM J PHYSIOL-GASTR L, V299, pG549, DOI 10.1152/ajpgi.00147.2010; Jones KHS, 2007, J SLEEP RES, V16, P12, DOI 10.1111/j.1365-2869.2007.00561.x; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; Konturek PC, 2011, J PHYSIOL PHARMACOL, V62, P139; Lazar AS, 2012, CHRONOBIOL INT, V29, P131, DOI 10.3109/07420528.2011.641193; LeSauter J, 2009, P NATL ACAD SCI USA, V106, P13582, DOI 10.1073/pnas.0906426106; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Maire M, 2014, CORTEX, V52, P47, DOI 10.1016/j.cortex.2013.11.008; Maire M, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00059; Marcheva Biliana, 2013, Handb Exp Pharmacol, P127, DOI 10.1007/978-3-642-25950-0_6; Osland TM, 2011, CHRONOBIOL INT, V28, P764, DOI 10.3109/07420528.2011.607375; Otway DT, 2011, DIABETES, V60, P1577, DOI 10.2337/db10-1098; Parkman HP, 2003, NEUROGASTROENT MOTIL, V15, P89, DOI 10.1046/j.1365-2982.2003.00396.x; Parsons MJ, 2014, J SLEEP RES, V23, P595, DOI 10.1111/jsr.12144; Pendergast JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030254; Pereira DS, 2005, SLEEP, V28, P29; Ramsey KM, 2013, METHODS MOL BIOL, V1077, P285, DOI 10.1007/978-1-62703-637-5_19; Sladek M, 2007, GASTROENTEROLOGY, V133, P1240, DOI 10.1053/j.gastro.2007.05.053; Steptoe A, 2006, ARCH INTERN MED, V166, P1689, DOI 10.1001/archinte.166.16.1689; Suzuki A, 2005, CLIN AUTON RES, V15, P368, DOI 10.1007/s10286-005-0294-3; Viola AU, 2008, AM J PHYSIOL-HEART C, V295, pH2156, DOI 10.1152/ajpheart.00662.2008; Viola AU, 2007, CURR BIOL, V17, P613, DOI 10.1016/j.cub.2007.01.073; Wakisaka S, 2012, J NUTR SCI VITAMINOL, V58, P333, DOI 10.3177/jnsv.58.333; Yamaguchi M, 2012, PHYSIOL BEHAV, V107, P87, DOI 10.1016/j.physbeh.2012.06.006; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	42	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120009	10.1371/journal.pone.0120009	http://dx.doi.org/10.1371/journal.pone.0120009			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775462	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500146
J	Huang, WJ; Arai, F; Kawahara, T				Huang, Wenjing; Arai, Fumihito; Kawahara, Tomohiro			Egg-in-Cube: Design and Fabrication of a Novel Artificial Eggshell with Functionalized Surface	PLOS ONE			English	Article							CHICK-EMBRYO; CHORIOALLANTOIC MEMBRANE; OXYGEN CONCENTRATION; ZEBRAFISH; PERMEABILITY; CULTURE; VITRO; EXPRESSION; SORPTION; GROWTH	An eggshell is a porous microstructure that regulates the passage of gases to allow respiration. The chick embryo and its circulatory system enclosed by the eggshell has become an important model for biomedical research such as the control of angiogenesis, cancer therapy, and drug delivery test, because the use of embryo is ethically acceptable and it is inexpensive and small. However, chick embryo and extra-embryonic blood vessels cannot be accessed freely and has poor observability because the eggshell is tough and cannot be seen through, which limits its application. In this study, a novel artificial eggshell with functionalized surface is proposed, which allows the total amount of oxygen to pass into the egg for the chick embryo culturing and has high observability and accessibility for embryo manipulation. First, a 40-mm enclosed cubic-shaped eggshell consisting of a membrane structure and a rigid frame structure is designed, and then the threshold of the membrane thickness suitable for the embryo survival is figured out according to the oxygen-permeability of the membrane structure. The designed artificial eggshell was actually fabricated by using polydimethylsiloxane (PDMS) and polycarbonate (PC) in the current study. Using the fabricated eggshell, chick embryo and extra-embryonic blood vessels can be observed from multiple directions. To test the effectiveness of the design, the cubic eggshells were used to culture chick embryos and survivability was confirmed when PDMS membranes with adequate oxygen permeability were used. Since the surface of the eggshell is transparent, chick embryo tissue development could be observed during the culture period. Additionally, the chick embryo tissues could be accessed and manipulated from outside the cubic eggshell, by using mechanical tools without breakage of the eggshell. The proposed "Egg-in-Cube" with functionalized surface has great potential to serve as a promising platform for biomedical research.	[Huang, Wenjing; Kawahara, Tomohiro] Kyushu Inst Technol, Dept Biol Funct Engn, Wakamatsu Ku, Kitakyushu, Fukuoka 804, Japan; [Arai, Fumihito] Nagoya Univ, Dept Micronano Syst Engn, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Kyushu Institute of Technology; Nagoya University	Kawahara, T (corresponding author), Kyushu Inst Technol, Dept Biol Funct Engn, Wakamatsu Ku, Kitakyushu, Fukuoka 804, Japan.	kawahara@lsse.kyutech.ac.jp	Huang, Wenjing/AAV-9101-2021	Huang, Wenjing/0000-0003-1406-0031	JSPS KAKENHI [23106002, 26630100]; Program to Disseminate Tenure Track System, MEXT, Japan	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Program to Disseminate Tenure Track System, MEXT, Japan	This work was partially supported by JSPS KAKENHI (23106002, 26630100), and the Program to Disseminate Tenure Track System, MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1987, LAB ANIM SCI, V37, P11; AR A, 1987, RESP PHYSIOL, V68, P377, DOI 10.1016/S0034-5687(87)80022-1; AUERBACH R, 1974, DEV BIOL, V41, P391, DOI 10.1016/0012-1606(74)90316-9; Bartlett HL, 2004, AM J PHYSIOL-HEART C, V286, pH2035, DOI 10.1152/ajpheart.00807.2003; BAUMANN R, 1992, PHYSIOL REV, V72, P941, DOI 10.1152/physrev.1992.72.4.941; BEKOFF A, 1975, P NATL ACAD SCI USA, V72, P1245, DOI 10.1073/pnas.72.4.1245; Brannen KC, 2010, BIRTH DEFECTS RES B, V89, P66, DOI 10.1002/bdrb.20223; Busch C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053970; CLARK EB, 1984, AM J CARDIOL, V53, P324, DOI 10.1016/0002-9149(84)90447-8; DAVIDSON MK, 1987, ISRAEL J MED SCI, V23, P551; De Bo I, 2003, J MEMBRANE SCI, V215, P303, DOI 10.1016/S0376-7388(03)00024-3; DeSimone Douglas W., 2004, V294, P235; Dohle Daniel S, 2009, J Vis Exp, DOI 10.3791/1620; Downing TL, 2013, NAT MATER, V12, P1154, DOI [10.1038/NMAT3777, 10.1038/nmat3777]; GALLERA J, 1961, EXPERIENTIA, V17, P134, DOI 10.1007/BF02160832; Ghatpande SK, 2008, DEV GROWTH DIFFER, V50, P437, DOI [10.1111/j.1440-169x.2008.01048.x, 10.1111/j.1440-169X.2008.01048.x]; Ghatpande SK, 2008, BIRTH DEFECTS RES A, V82, P121, DOI 10.1002/bdra.20438; GREEN CJ, 1976, P ROY SOC MED, V69, P366, DOI 10.1177/003591577606900529; Hamal KR, 2006, POULTRY SCI, V85, P1364, DOI 10.1093/ps/85.8.1364; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Harland RM, 2011, TRENDS GENET, V27, P507, DOI 10.1016/j.tig.2011.08.003; Hermsen SAB, 2012, TOXICOL SCI, V127, P303, DOI 10.1093/toxsci/kfs092; Hoper J, 1995, INT J MICROCIRC, V15, P186, DOI 10.1159/000178974; Isachenko V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032549; Kamihira M, 1998, DEV GROWTH DIFFER, V40, P449; KAMIYA Y, 1990, J POLYM SCI POL PHYS, V28, P1297, DOI 10.1002/polb.1990.090280808; Kim Byeong Jin, 2013, J Cerebrovasc Endovasc Neurosurg, V15, P20, DOI 10.7461/jcen.2013.15.1.20; KIND C, 1975, ANAT EMBRYOL, V147, P127, DOI 10.1007/BF00306727; Lange N, 2001, INVEST OPHTH VIS SCI, V42, P38; Liu M, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/3/035028; Loesberg WA, 2005, J BIOMED MATER RES A, V75A, P723, DOI 10.1002/jbm.a.30480; MacDonald JD, 2005, SKULL BASE-INTERD AP, V15, P229, DOI 10.1055/s-2005-872598; McGrath P, 2008, DRUG DISCOV TODAY, V13, P394, DOI 10.1016/j.drudis.2008.03.002; Merkel TC, 2000, J POLYM SCI POL PHYS, V38, P415, DOI 10.1002/(SICI)1099-0488(20000201)38:3<415::AID-POLB8>3.0.CO;2-Z; MEUER HJ, 1988, RESP PHYSIOL, V71, P331, DOI 10.1016/0034-5687(88)90026-6; Mitsuishi M, 2013, INT J MED ROBOT COMP, V9, P180, DOI 10.1002/rcs.1434; Molenaar R, 2010, POULTRY SCI, V89, P2010, DOI 10.3382/ps.2010-00787; Nakamura H, 2001, METHODS, V24, P43, DOI 10.1006/meth.2001.1155; NEW DAT, 1955, J EMBRYOL EXP MORPH, V3, P320; ONO T, 1991, DEV BIOL, V144, P167, DOI 10.1016/0012-1606(91)90488-O; Pink DBS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033760; Poelma C, 2010, J R SOC INTERFACE, V7, P91, DOI 10.1098/rsif.2009.0063; Rao HX, 2007, J MEMBRANE SCI, V303, P132, DOI 10.1016/j.memsci.2007.07.002; Ribatti D, 2008, INT REV CEL MOL BIO, V270, P181, DOI 10.1016/S1937-6448(08)01405-6; Saito AC, 2014, BIOTECHNOL LETT, V36, P391, DOI 10.1007/s10529-013-1368-2; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Schoeffl H, 2013, ARCH PLAST SURG-APS, V40, P104, DOI 10.5999/aps.2013.40.2.104; Seabra R, 2010, IN VIVO, V24, P457; Sedmera D, 1999, ANAT RECORD, V254, P238, DOI 10.1002/(SICI)1097-0185(19990201)254:2<238::AID-AR10>3.0.CO;2-V; Selderslaghs IWT, 2012, REPROD TOXICOL, V33, P142, DOI 10.1016/j.reprotox.2011.08.003; Shiku H, 2006, CHEM LETT, V35, P234, DOI 10.1246/cl.2006.234; Tacon A. G. J., 1982, Agricultural Wastes, V4, P335, DOI 10.1016/0141-4607(82)90030-0; Tsai WT, 2006, BIORESOURCE TECHNOL, V97, P488, DOI 10.1016/j.biortech.2005.02.050; Vargas A, 2007, ADV DRUG DELIVER REV, V59, P1162, DOI 10.1016/j.addr.2007.04.019; Wallingford JB, 2010, CURR BIOL, V20, pR263, DOI 10.1016/j.cub.2010.01.012; Yalcin Huseyin C, 2010, J Vis Exp, DOI 10.3791/2154	56	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118624	10.1371/journal.pone.0118624	http://dx.doi.org/10.1371/journal.pone.0118624			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768929	gold, Green Submitted, Green Published			2022-12-27	WOS:000351277500034
J	Semrau, J; Hentschke, C; Buchmann, J; Meng, K; Vogel, H; Faller, H; Bork, H; Pfeifer, K				Semrau, Jana; Hentschke, Christian; Buchmann, Jana; Meng, Karin; Vogel, Heiner; Faller, Hermann; Bork, Hartmut; Pfeifer, Klaus			Long-Term Effects of Interprofessional Biopsychosocial Rehabilitation for Adults with Chronic Non-Specific Low Back Pain: A Multicentre, Quasi-Experimental Study	PLOS ONE			English	Article							FEAR-AVOIDANCE MODEL; EXERCISE THERAPY; INPATIENT REHABILITATION; MEDICAL REHABILITATION; RANDOMIZED-TRIALS; PHYSICAL-ACTIVITY; CLINICAL-TRIALS; GRADED ACTIVITY; SICK LEAVE; HEALTH	Background Improvement of the long-term effectiveness of multidisciplinary ortho-paedic rehabilitation (MOR) in the management of chronic non-specific low back pain (CLBP) remains a central issue for health care in Germany. We developed an interprofessional and interdisciplinary, biopsychosocial rehabilitation concept named "PASTOR" to promote self-management in adults with CLBP and compared its effectiveness with the current model of MOR. Methods A multicentre quasi-experimental study with three measurement time points was implemented. 680 adults aged 18 to 65 with CLBP were assed for eligibil-ity in three inpatient rehabilitation centres in Germany. At first the effects of the MOR, with a total extent of 48 hours (control group), were assessed. Thereafter, PASTOR was implemented and evaluated in the same centres (intervention group). It consisted of six interprofessional modules, which were provided on 12 days in fixed groups, with a total extent of 48 hours. Participants were assessed with self-report measures at baseline, discharge, and 12 months for functional ability (primary outcome) using the Hannover Functional Ability Questionnaire (FFbH-R) and vari-ous secondary outcomes (e.g. pain, health status, physical activity, pain coping, pain-related cognitions). Results In total 536 participants were consecutively assigned to PASTOR (n=266) or MOR (n=270). At 12 months, complete data of 368 participants was available. The adjusted between-roup difference in the FFbH-R at 12 months was 6.58 (95% CI 3.38 to 9.78) using complete data and 3.56 (95% CI 0.45 to 6.67) using available da-ta, corresponding to significant small-to-medium effect sizes of d=0.42 (p<0.001) and d=0.10 (p=0.025) in favour of PASTOR. Further improvements in secondary out-comes were also observed in favour of PASTOR. Conclusion The interprofessional and interdisciplinary, biopsychosocial rehabilita-tion program PASTOR shows some improvements of the long-term effectiveness of inpatient rehabilitation in the management of adults with CLBP. Further insights into mechanisms of action of complex intervention programs are required.	[Semrau, Jana; Hentschke, Christian; Pfeifer, Klaus] Univ Erlangen Nurnberg, Inst Sport Sci & Sport, D-91054 Erlangen, Germany; [Buchmann, Jana; Meng, Karin; Vogel, Heiner; Faller, Hermann] Univ Wurzburg, Dept Med Psychol Med Sociol & Rehabil Sci, D-97070 Wurzburg, Germany; [Bork, Hartmut] Reha Zentrum Sankt Josef Stift, Sendenhorst, Germany	University of Erlangen Nuremberg; University of Wurzburg	Pfeifer, K (corresponding author), Univ Erlangen Nurnberg, Inst Sport Sci & Sport, D-91054 Erlangen, Germany.	klaus.pfeifer@fau.de	Semrau, Jana/GPX-5508-2022; Pfeifer, Klaus/V-6540-2019	Semrau, Jana/0000-0001-9408-7386; Meng, Karin/0000-0002-6940-245X; Pfeifer, Klaus/0000-0003-2418-373X	German Pension Insurance (Deutsche Rentenversicherung Bund) [0421-FSCP-0529]; Deutsche Forschungsgemeinschaft; Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)	German Pension Insurance (Deutsche Rentenversicherung Bund); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)	This project was funded in the module two of the first funding phase by the German Pension Insurance (Deutsche Rentenversicherung Bund) within the Research funding for care-oriented research "Chronic diseases and patient orientation" (http://www.forschung-patientenorientierung.de/index.php/projects/first-funding-phase/module-two-phase-1/pastor-pfeifer.html) (grant code 0421-FSCP-0529). The authors acknowledge support by Deutsche Forschungsgemeinschaft and Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi M, 2012, EUR J PAIN, V16, P1033, DOI 10.1002/j.1532-2149.2011.00097.x; Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; ALARANTA H, 1994, SPINE, V19, P1339, DOI 10.1097/00007632-199406000-00007; Angst F, 2009, J REHABIL MED, V41, P569, DOI 10.2340/16501977-0381; [Anonymous], 2008, WMA DECL HELS ETH PR; Bahrke U, 2006, Rehabilitation (Stuttg), V45, P336; Balague F, 2012, LANCET, V379, P482, DOI 10.1016/S0140-6736(11)60610-7; Bandemer-Greulich U, 2004, Rehabilitation (Stuttg), V43, P17; Biddle SJH, 2009, PSYCHOL SPORT EXERC, V10, P410, DOI 10.1016/j.psychsport.2009.02.011; BULLINGER M, 1998, SF 36 FRAGEBOGEN GES; Cassidy JD, 1998, SPINE, V23, P1860, DOI 10.1097/00007632-199809010-00012; Cohen J.E., 1988, STAT POWER ANAL BEHA; Conn VS, 2008, PATIENT EDUC COUNS, V70, P157, DOI 10.1016/j.pec.2007.10.004; Cook TD, 1979, QUASIEXPERIMENTATION, DOI [10.1007/s10899-010-9186-0, DOI 10.1007/S10899-010-9186-0]; Dean SG, 2012, INTERPROFESSIONAL RE, P45; Deck R, 1999, ERHEBUNG SOZIODEMOGR; Deutsche Rentenversicherung Bund, STAT DTSCH RENT REH; Deutsche Rentenversicherung Bund, 2009, RAHM MED REH GES REN; Deutsche Rentenversicherung Bund, 2014, REH BER UPD 2014 MED; Dibbelt S, 2006, Rehabilitation (Stuttg), V45, P324; Domenech J, 2011, PAIN, V152, P2557, DOI 10.1016/j.pain.2011.07.023; Dworkin RH, 2008, J PAIN, V9, P105, DOI 10.1016/j.jpain.2007.09.005; Dworkin RH, 2010, PAIN, V149, P177, DOI 10.1016/j.pain.2010.02.018; Ferreira PH, 2013, PHYS THER, V93, P470, DOI 10.2522/ptj.20120137; Freburger JK, 2009, ARCH INTERN MED, V169, P251, DOI 10.1001/archinternmed.2008.543; Frey I, 1999, SOZ PRAVENTIV MED, V44, P55, DOI 10.1007/BF01667127; Furlan AD, 2008, J CLIN EPIDEMIOL, V61, P209, DOI 10.1016/j.jclinepi.2007.04.019; Geidl W, 2012, REHABILITATION, V51, P259, DOI 10.1055/s-0031-1280803; Geissner E., 2001, FRAGEBOGEN ERFASSUNG; Goossens MEJB, 1998, HEALTH ECON, V7, P39, DOI 10.1002/(SICI)1099-1050(199802)7:1<39::AID-HEC323>3.3.CO;2-J; Guzman J, 2002, COCHRANE DB SYST REV, V1, DOI [DOI 10.1002/14651858.CD000963, DOI 10.1002/14651858.CD000963.PUB2]; Harman K, 2014, PHYSIOTHER CAN, V66, P82, DOI 10.3138/ptc.2012-56BC; Hartmann A, 1995, Z KLIN PSYCHOL, V4, P337; Hasenbring MI, 2010, CLIN J PAIN, V26, P747, DOI 10.1097/AJP.0b013e3181e104f2; Hasenbring MI, 2009, EUR J PAIN, V13, P620, DOI 10.1016/j.ejpain.2008.11.001; Hayden JA, 2005, ANN INTERN MED, V142, P776, DOI 10.7326/0003-4819-142-9-200505030-00014; Hellum C, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2786; Hofmann J, 2010, PHYS MED REHAB KUROR, V20, P32, DOI 10.1055/s-0029-1216370; Hofmann J, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-89; Huppe A, 2005, Rehabilitation (Stuttg), V44, P24; Jordan JL, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005956.pub2; Jordan K, 2006, J CLIN EPIDEMIOL, V59, P45, DOI 10.1016/j.jclinepi.2005.03.018; Kamper SJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000963.pub3; Kamper SJ, 2010, BEST PRACT RES CL RH, V24, P181, DOI 10.1016/j.berh.2009.11.003; Karjalainen K, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002193; Korner M, 2010, CLIN REHABIL, V24, P745, DOI 10.1177/0269215510367538; Kohlmann T, 1996, Rehabilitation (Stuttg), V35, pI; Leeuw M, 2008, PAIN, V138, P192, DOI 10.1016/j.pain.2007.12.009; Leeuw M, 2007, J BEHAV MED, V30, P77, DOI 10.1007/s10865-006-9085-0; Lewis M, 2010, EUR J PAIN, V14, P1033, DOI 10.1016/j.ejpain.2010.04.002; Lin CWC, 2011, PAIN, V152, P607, DOI 10.1016/j.pain.2010.11.034; Linton SJ, 2005, CLIN J PAIN, V21, P109, DOI 10.1097/00002508-200503000-00001; Linton SJ, 2011, PHYS THER, V91, P700, DOI 10.2522/ptj.20100330; Main CJ, 2011, PHYS THER, V91, P609, DOI 10.2522/ptj.2011.91.5.609; Mangels M, 2009, CLIN J PAIN, V25, P356, DOI 10.1097/AJP.0b013e3181925791; MARCUS R, 1976, BIOMETRIKA, V63, P655, DOI 10.1093/biomet/63.3.655; Mayer TG., 1988, FUNCTIONAL RESTORATI; Meffert C, 2012, REHABILITATION, V51, P151, DOI 10.1055/s-0032-1312660; Meng K, 2011, CLIN J PAIN, V27, P248, DOI 10.1097/AJP.0b013e3181ffbfaf; Nagel B, 2002, SCHMERZ, V16, P263, DOI 10.1007/s00482-002-0162-1; NICHOLAS MK, 1991, BEHAV RES THER, V29, P225, DOI 10.1016/0005-7967(91)90112-G; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Ostelo RWJG, 2008, SPINE, V33, P90, DOI 10.1097/BRS.0b013e31815e3a10; Ostelo RWJG, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002014.pub2; Overmeer T, 2011, PHYS THER, V91, P804, DOI 10.2522/ptj.20100079; Pincus T, 2008, ARTHRIT RHEUM-ARTHR, V59, P14, DOI 10.1002/art.23251; Pincus Tamar, 2002, Spine (Phila Pa 1976), V27, pE109, DOI 10.1097/00007632-200203010-00017; Pincus T, 2010, CLIN J PAIN, V26, P739, DOI 10.1097/AJP.0b013e3181f15d45; Schmidt CO, 2007, SPINE, V32, P2005, DOI 10.1097/BRS.0b013e318133fad8; SCHONSTEIN E, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001822; Schwarzer R, 2011, REHABIL PSYCHOL, V56, P161, DOI 10.1037/a0024509; Skouen JS, 2002, SPINE, V27, P901, DOI 10.1097/00007632-200205010-00002; Smeets RJEM, 2008, PAIN, V134, P263, DOI 10.1016/j.pain.2007.04.021; Steiger F, 2012, EUR SPINE J, V21, P575, DOI 10.1007/s00586-011-2045-6; Stirman SW, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-17; Strobl V, 2009, REHABILITATION, V48, P166, DOI 10.1055/s-0029-1220749; van den Hout JHC, 2003, CLIN J PAIN, V19, P87, DOI 10.1097/00002508-200303000-00003; van Middelkoop M, 2011, EUR SPINE J, V20, P19, DOI 10.1007/s00586-010-1518-3; van Middelkoop M, 2010, BEST PRACT RES CL RH, V24, P193, DOI 10.1016/j.berh.2010.01.002; van Tulder MW, 2006, EUR SPINE J, V15, pS64, DOI 10.1007/s00586-005-1048-6; Verbunt JA, 2010, PAIN, V149, P428, DOI 10.1016/j.pain.2010.01.020; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Waddell G., 2004, BACK PAIN REVOLUTION, V2nd, P265; Wenig CM, 2009, EUR J PAIN, V13, P280, DOI 10.1016/j.ejpain.2008.04.005; World Health Organization, 2010, Global recommendations on physical activity for health; World Health Organization, 2002, COMM LANG FUNCT DIS; World Health Organization, 2010, FRAM ACT INT ED COLL, DOI DOI 10.1111/J.1741-1130.2007.00144.X	87	33	33	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118609	10.1371/journal.pone.0118609	http://dx.doi.org/10.1371/journal.pone.0118609			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768735	Green Submitted, gold, Green Published			2022-12-27	WOS:000351277500033
J	Anderson, PG; Kainerstorfer, JM; Sassaroli, A; Krishnamurthy, N; Homer, MJ; Graham, RA; Fantini, S				Anderson, Pamela G.; Kainerstorfer, Jana M.; Sassaroli, Angelo; Krishnamurthy, Nishanth; Homer, Marc J.; Graham, Roger A.; Fantini, Sergio			Broadband Optical Mammography: Chromophore Concentration and Hemoglobin Saturation Contrast in Breast Cancer	PLOS ONE			English	Article							NEOADJUVANT CHEMOTHERAPY RESPONSE; PHOTON MIGRATION; OXYGEN-SATURATION; HUMAN-TUMORS; BLOOD-FLOW; TISSUE; SPECTROSCOPY; HYPOXIA; MICROENVIRONMENT	This study reports the optical characterization and quantitative oximetry of human breast cancer using spectrally-resolved images collected with a broadband, continuous-wave optical mammography instrument. On twenty-six cancer patients, we collected two-dimensional optical mammograms and created maps of the concentrations of hemoglobin, water, and lipids, as well as the oxygen saturation of hemoglobin. For each cancerous breast, we analyzed the difference between the tumor region (as identified by x-ray and optical mammography) and the remainder of breast tissue. With respect to the surrounding tissue, we found that cancer regions have significantly higher concentrations of total hemoglobin (+2.4 +/- 0.4 mu M) and water (+7 +/- 1% v/v), and significantly lower lipid concentration (8 +/- 2% v/v) and oxygen saturation of hemoglobin (5 +/- 1%). We also found a significant correlation between the tumor optical contrast and the grade of breast cancer as quantified by the Nottingham histologic score; this demonstrates how optical signatures may be representative of metabolic and morphological features, as well as the aggressive potential of the tumor.	[Anderson, Pamela G.; Kainerstorfer, Jana M.; Sassaroli, Angelo; Krishnamurthy, Nishanth; Fantini, Sergio] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Homer, Marc J.] Tufts Med Ctr, Dept Radiol, Boston, MA 02111 USA; [Graham, Roger A.] Tufts Med Ctr, Dept Surg, Boston, MA 02111 USA	Tufts University; Tufts Medical Center; Tufts Medical Center	Anderson, PG (corresponding author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.	pamela.anderson@tufts.edu		Anderson, Pamela/0000-0002-6602-9186	National Institutes of Health [R01 CA154774]; National Science Foundation [NSF DGE-0806676]; NATIONAL CANCER INSTITUTE [R01CA154774] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the National Institutes of Health (Grant R01 CA154774). This research was also supported by the National Science Foundation Graduate Research Fellowship (NSF DGE-0806676). Any opinion, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arridge SR, 1998, OPT LETT, V23, P882, DOI 10.1364/OL.23.000882; Boas DA, 2011, PHILOS T R SOC A, V369, P4407, DOI 10.1098/rsta.2011.0250; Cerussi A, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2337546; Cerussi AE, 2011, PHILOS T R SOC A, V369, P4512, DOI 10.1098/rsta.2011.0279; Choe R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099683; Choe R, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3103325; Contini D, 1997, APPL OPTICS, V36, P4587, DOI 10.1364/AO.36.004587; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Enfield LC, 2007, APPL OPTICS, V46, P3628, DOI 10.1364/AO.46.003628; Fantini S, 1996, MED PHYS, V23, P149, DOI 10.1118/1.597696; Fantini S, 2012, ANN BIOMED ENG, V40, P398, DOI 10.1007/s10439-011-0404-4; FENG SC, 1995, APPL OPTICS, V34, P3826, DOI 10.1364/AO.34.003826; Grosenick D, 1999, APPL OPTICS, V38, P2927, DOI 10.1364/AO.38.002927; Grosenick D, 2005, PHYS MED BIOL, V50, P2451, DOI 10.1088/0031-9155/50/11/002; Guppy M, 2002, BIOCHEM BIOPH RES CO, V299, P676, DOI 10.1016/S0006-291X(02)02710-9; Intes X, 2005, ACAD RADIOL, V12, P934, DOI 10.1016/j.acra.2005.05.006; Jiang SD, 2009, RADIOLOGY, V252, P551, DOI 10.1148/radiol.2522081202; KALLINOWSKI F, 1989, CANCER RES, V49, P3759; MUELLERKLIESER W, 1981, INT J RADIAT ONCOL, V7, P1397, DOI 10.1016/0360-3016(81)90036-5; Ntziachristos V, 2002, NEOPLASIA, V4, P347, DOI 10.1038/sj.neo.7900244; Rinneberg H, 2008, OPTO-ELECTRON REV, V16, P147, DOI 10.2478/s11772-008-0004-5; Roblyer D, 2011, P NATL ACAD SCI USA, V108, P14626, DOI 10.1073/pnas.1013103108; Sassaroli A, 2001, APPL OPTICS, V40, P185, DOI 10.1364/AO.40.000185; Semenza GL, 2002, TRENDS MOL MED, V8, pS62, DOI 10.1016/S1471-4914(02)02317-1; Soliman H, 2010, CLIN CANCER RES, V16, P2605, DOI 10.1158/1078-0432.CCR-09-1510; Sorg BS, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2003369; Spinelli L, 2005, PHYS MED BIOL, V50, P2489, DOI 10.1088/0031-9155/50/11/004; Srinivasan S, 2005, TECHNOL CANCER RES T, V4, DOI [10.1016/j.jcis.2014.12.092, DOI 10.1016/J.JCIS.2014.12.092]; Taroni P, 2009, J BIOMED OPT, V14, DOI [10.1117/1.3275480, DOI 10.1117/1.3275480]; Tingleff O., 2008, METHODS NONLINEAR LE, V2nd ed.; Tromberg BJ, 2000, NEOPLASIA, V2, P26, DOI 10.1038/sj.neo.7900082; Ueda S, 2012, CANCER RES, V72, P4318, DOI 10.1158/0008-5472.CAN-12-0056; VAUPEL P, 1991, CANCER RES, V51, P3316; VAUPEL P, 1989, CANCER RES, V49, P6449; Vaupel P, 2007, ANTIOXID REDOX SIGN, V9, P1221, DOI 10.1089/ars.2007.1628; Wang J, 2010, MED PHYS, V37, P3715, DOI 10.1118/1.3455702; Wouters BG, 2002, EUR J CANCER, V38, P240, DOI 10.1016/S0959-8049(01)00361-6; Yu Y, 2010, J INNOV OPT HEAL SCI, V3, P267, DOI 10.1142/S179354581000112X; Zhu QN, 2005, NEOPLASIA, V7, P263, DOI 10.1593/neo.04526	39	36	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0117322	10.1371/journal.pone.0117322	http://dx.doi.org/10.1371/journal.pone.0117322			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781469	Green Submitted, Green Published, gold			2022-12-27	WOS:000351284600010
J	Friebe, S; Deuquet, J; van der Goot, FG				Friebe, Sarah; Deuquet, Julie; van der Goot, F. Gisou			Differential Dependence on N-Glycosylation of Anthrax Toxin Receptors CMG2 and TEM8	PLOS ONE			English	Article							RETICULUM-ASSOCIATED DEGRADATION; LINKED PROTEIN GLYCOSYLATION; ENDOTHELIAL MARKER 8; ENDOPLASMIC-RETICULUM; PROTECTIVE ANTIGEN; GLYCOPROTEIN DEGRADATION; CAPILLARY MORPHOGENESIS; MORPHOLOGICAL EVOLUTION; TUMOR VASCULATURE; GAPO SYNDROME	ANTXR 1 and 2, also known as TEM8 and CMG2, are two type I membrane proteins, which have been extensively studied for their role as anthrax toxin receptors, but with a still elusive physiological function. Here we have analyzed the importance of N-glycosylation on folding, trafficking and ligand binding of these closely related proteins. We find that TEM8 has a stringent dependence on N-glycosylation. The presence of at least one glycan on each of its two extracellular domains, the vWA and Ig-like domains, is indeed necessary for efficient trafficking to the cell surface. In the absence of any N-linked glycans, TEM8 fails to fold correctly and is recognized by the ER quality control machinery. Expression of N-glycosylation mutants reveals that CMG2 is less vulnerable to sugar loss. The absence of N-linked glycans in one of the extracellular domains indeed has little impact on folding, trafficking or receptor function of the wild type protein expressed in tissue culture cells. N-glycans do, however, seem required in primary fibroblasts from human patients. Here, the presence of N-linked sugars increases the tolerance to mutations in cmg2 causing the rare genetic disease Hyaline Fibromatosis Syndrome. It thus appears that CMG2 glycosylation provides a buffer towards genetic variation by promoting folding of the protein in the ER lumen.	[Friebe, Sarah; Deuquet, Julie; van der Goot, F. Gisou] Ecole Polytech Fed Lausanne, Fac Life Sci, Global Hlth Inst, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	van der Goot, FG (corresponding author), Ecole Polytech Fed Lausanne, Fac Life Sci, Global Hlth Inst, Lausanne, Switzerland.	gisou.vandergoot@epfl.ch	van der Goot, Gisou/B-2279-2012	van der Goot, Gisou/0000-0002-8522-274X	Swiss National Science foundation grant	Swiss National Science foundation grant(Swiss National Science Foundation (SNSF))	GVDG received a Swiss National Science foundation grant (http://www.snf.ch). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 2006, J CELL BIOL, V172, P309, DOI 10.1083/jcb.200507067; Abrami L, 2004, J CELL BIOL, V166, P645, DOI 10.1083/jcb.200312072; Abrami L, 2013, CELL REP, V5, P986, DOI 10.1016/j.celrep.2013.10.019; Abrami L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000792; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Bayram Y, 2014, AM J MED GENET A, V164, P2328, DOI 10.1002/ajmg.a.36678; Bell SE, 2001, J CELL SCI, V114, P2755; Bernasconi R, 2008, J BIOL CHEM, V283, P16446, DOI 10.1074/jbc.M802272200; Bosques CJ, 2004, J AM CHEM SOC, V126, P8421, DOI 10.1021/ja0496266; Buck TM, 2004, AM J PHYSIOL-CELL PH, V287, pC1292, DOI 10.1152/ajpcell.00561.2003; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; Carson-Walter EB, 2001, CANCER RES, V61, P6649; Chaudhary A, 2012, CANCER CELL, V21, P212, DOI 10.1016/j.ccr.2012.01.004; Chen D, 2013, ANTXR1 A STEM CELL E; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Clerc S, 2009, J CELL BIOL, V184, P159, DOI 10.1083/jcb.200809198; Deuquet J, 2011, EMBO MOL MED, V3, P208, DOI 10.1002/emmm.201100124; Deuquet J, 2009, HUM MUTAT, V30, P583, DOI 10.1002/humu.20872; Ding ZP, 2006, PROTEIN EXPRES PURIF, V49, P121, DOI 10.1016/j.pep.2006.04.011; Ermonval M, 2001, GLYCOBIOLOGY, V11, P565, DOI 10.1093/glycob/11.7.565; Fernando S, 2009, CANCER RES, V69, P5126, DOI [10.1158/0008-5476.CAN-09-0725, 10.1158/0008-5472.CAN-09-0725]; Glozman R, 2009, J CELL BIOL, V184, P847, DOI 10.1083/jcb.200808124; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; HELENIUS A, 1994, MOL BIOL CELL, V5, P253, DOI 10.1091/mbc.5.3.253; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hirsch C, 2003, EMBO J, V22, P1036, DOI 10.1093/emboj/cdg107; Hosokawa N, 2009, J BIOL CHEM, V284, P17061, DOI 10.1074/jbc.M809725200; Hutt DM, 2009, FEBS LETT, V583, P2639, DOI 10.1016/j.febslet.2009.07.014; Jinnin M, 2008, NAT MED, V14, P1236, DOI 10.1038/nm.1877; Katiyar S, 2004, P NATL ACAD SCI USA, V101, P13774, DOI 10.1073/pnas.0405663101; Keser G, 1999, CLIN RHEUMATOL, V18, P248, DOI 10.1007/s100670050094; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Lakkaraju AKK, 2012, EMBO J, V31, P1823, DOI 10.1038/emboj.2012.15; LEPPLA SH, 1988, METHOD ENZYMOL, V165, P103; LI Y, 1993, J VIROL, V67, P584, DOI 10.1128/JVI.67.1.584-588.1993; Liu SH, 2003, J BIOL CHEM, V278, P5227, DOI 10.1074/jbc.M210321200; Liu S, 2008, J BIOL CHEM, V283, P529, DOI 10.1074/jbc.M707419200; OConnor SE, 1996, CHEM BIOL, V3, P803, DOI 10.1016/S1074-5521(96)90064-2; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Peters DE, 2012, BIOCHEM BIOPH RES CO, V422, P393, DOI 10.1016/j.bbrc.2012.04.160; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; Rainey GJA, 2005, P NATL ACAD SCI USA, V102, P13278, DOI 10.1073/pnas.0505865102; Reeves CV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034862; Rohner N, 2013, SCIENCE, V342, P1372, DOI 10.1126/science.1240276; Ruan ZH, 2009, J IMMUNOTHER, V32, P486, DOI 10.1097/CJI.0b013e3181a1d134; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Scobie HM, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000099; Scobie HM, 2005, CURR OPIN MICROBIOL, V8, P106, DOI 10.1016/j.mib.2004.12.005; St Croix B, 2000, SCIENCE, V289, P1197; Stranecky V, 2013, AM J HUM GENET, V92, P792, DOI 10.1016/j.ajhg.2013.03.023; Tannous A, 2014, N LINKED SUGAR REGUL; TARENTINO AL, 1985, BIOCHEMISTRY-US, V24, P4665, DOI 10.1021/bi00338a028; Tokuriki N, 2009, NATURE, V459, P668, DOI 10.1038/nature08009; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Vigerust DJ, 2007, TRENDS MICROBIOL, V15, P211, DOI 10.1016/j.tim.2007.03.003; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weerapana E, 2006, GLYCOBIOLOGY, V16, p91R, DOI 10.1093/glycob/cwj099	60	1	1	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119864	10.1371/journal.pone.0119864	http://dx.doi.org/10.1371/journal.pone.0119864			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781883	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600102
J	Siangcham, T; Chansela, P; Hayasaka, T; Masaki, N; Sroyraya, M; Poljaroen, J; Suwansa-ard, S; Engsusophon, A; Hanna, PJ; Sobhon, P; Setou, M				Siangcham, Tanapan; Chansela, Piyachat; Hayasaka, Takahiro; Masaki, Noritaka; Sroyraya, Morakot; Poljaroen, Jaruwan; Suwansa-ard, Saowaros; Engsusophon, Attakorn; Hanna, Peter J.; Sobhon, Prasert; Setou, Mitsutoshi			Changes of Phosphatidylcholine and Fatty Acids in Germ Cells during Testicular Maturation in Three Developmental Male Morphotypes of Macrobrachium rosenbergii Revealed by Imaging Mass Spectrometry	PLOS ONE			English	Article							FRESH-WATER PRAWN; LIPID-COMPOSITION; BIOCHEMICAL-COMPOSITION; EPIDIDYMAL MATURATION; LITOPENAEUS-VANNAMEI; REPRODUCTIVE-SYSTEM; GONADAL DEVELOPMENT; SPERM QUALITY; MOUSE TESTIS; RAT TESTIS	Testis maturation, germ cell development and function of sperm, are related to lipid composition. Phosphatidylcholines (PCs) play a key role in the structure and function of testes. As well, increases of polyunsaturated fatty acids (PUFA) and highly unsaturated fatty acids (HUFA), especially arachidonic acid (ARA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) are essential for male fertility. This study is the first report to show the composition and distribution of PCs and total fatty acids (FAs) in three groups of seminiferous tubules (STs) classified by cellular associations [i.e., A (STs with mostly early germ cells), B (STs with mostly spermatids), and C (STs with spermatozoa)], in three morpho-types of Macrobrachium rosenbergii, [i.e., small male (SM), orange claw male (OC), and blue claw male (BC)]. Thin layer chromatography exhibited levels of PCs reaching maxima in STs of group B. Imaging mass spectrometry showed remarkably high signals corresponding to PC (16:0/18:1), PC (18:0/18:2), PC (18:2/20:5), and PC (16:0/22:6) in STs of groups A and B. Moreover, most signals were detected in the early developing cells and the intertubular area, but not at the area containing spermatozoa. Finally, gas chromatography-mass spectrometry indicated that the major FAs present in the testes were composed of 14:0, 16:0, 17:0, 18:0, 16:1, 18:1, 18:2, 20:1, 20:2, 20:4, 20:5, and 22:6. The testes of OC contained the greatest amounts of these FAs while the testes of BC contained the least amounts of these FAs, and there was more EPA (20:5) in the testes of SM and OC than those in the BC. The increasing amounts of FAs in the SM and OC indicate that they are important for spermatogenesis and spermiogenesis. This knowledge will be useful in formulating diets containing PUFA and HUFA for prawn broodstocks in order to improve testis development, and lead to increased male fecundity.	[Siangcham, Tanapan; Suwansa-ard, Saowaros; Engsusophon, Attakorn; Sobhon, Prasert] Mahidol Univ, Fac Sci, Dept Anat, Bangkok 10400, Thailand; [Chansela, Piyachat] Phramongkutklao Coll Med, Dept Anat, Bangkok, Thailand; [Hayasaka, Takahiro] Hokkaido Univ, Fac Hlth Sci, Hlth Innovat & Technol Ctr, Sapporo, Hokkaido 060, Japan; [Masaki, Noritaka; Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Dept Cell Biol & Anat, Shizuoka, Japan; [Sroyraya, Morakot; Poljaroen, Jaruwan] Mahidol Univ, Nakhonsawan, Thailand; [Hanna, Peter J.] Deakin Univ, Fac Sci Engn & Built Environm, Pro Vice Chancellors Off, Geelong, Vic 3217, Australia	Mahidol University; Phramongkutklao College of Medicine; Hokkaido University; Hamamatsu University School of Medicine; Mahidol University; Deakin University	Setou, M (corresponding author), Hamamatsu Univ Sch Med, Dept Cell Biol & Anat, Shizuoka, Japan.	setou@hama-med.ac.jp	Suwansa-ard, Saowaros Mai/ABB-2227-2021	Suwansa-ard, Saowaros Mai/0000-0002-9129-2082	JSPS [25116712]; Kiban-B [25293044]; MEXT	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kiban-B; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by JSPS KAKENHI for Scientific Research on Innovative Areas "Machinery of bioactive lipids in homeostasis and diseases" (25116712) and by Kiban-B (25293044) to M.S.; and by MEXT Project for Creation of Research Platforms and Sharing of Advanced Research Infrastructure. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLUWALIA B, 1966, LIPIDS, V1, P197, DOI 10.1007/BF02531872; BECKMAN JK, 1978, BIOCHIM BIOPHYS ACTA, V530, P367, DOI 10.1016/0005-2760(78)90156-X; BIERI JG, 1965, COMP BIOCHEM PHYSIOL, V15, P275, DOI 10.1016/0010-406X(65)90131-3; Boucard CGV, 2002, J EXP MAR BIOL ECOL, V281, P63, DOI 10.1016/S0022-0981(02)00409-4; Cavalli RO, 2001, AQUACULTURE, V193, P311, DOI 10.1016/S0044-8486(00)00497-X; Chansela P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033154; Chimsung Noppawan, 2014, Songklanakarin Journal of Science and Technology, V36, P265; Clarke A, 1984, BR ANTARCT SURV B, V64, P37; CROSS NL, 1994, J ANDROL, V15, P484; DAVIS JT, 1966, BIOCHEM J, V98, P342, DOI 10.1042/bj0980342; EVANS RW, 1979, J REPROD FERTIL, V57, P197, DOI 10.1530/jrf.0.0570197; EVANS RW, 1979, J REPROD FERTIL, V57, P189, DOI 10.1530/jrf.0.0570189; EWING LL, 1966, J REPROD FERTIL, V12, P295, DOI 10.1530/jrf.0.0120295; Food and Agriculture Organization of the United Nations, 2009, FISH STAT DAT, P551; Goto-Inoue N, 2012, SURF INTERFACE ANAL, V44, P749, DOI 10.1002/sia.3869; Goto-Inoue N, 2009, GLYCOBIOLOGY, V19, P950, DOI 10.1093/glycob/cwp089; Harlioglu MM, 2013, AQUACULT INT, V21, P273, DOI 10.1007/s10499-012-9549-x; INFANTE JP, 1985, MOL CELL BIOCHEM, V69, P3; JECKEL WH, 1989, COMP BIOCHEM PHYS B, V93, P807, DOI 10.1016/0305-0491(89)90050-3; KURIS AM, 1987, J CRUSTACEAN BIOL, V7, P219, DOI 10.2307/1548603; Lenzi A, 1996, HUM REPROD UPDATE, V2, P246, DOI 10.1093/humupd/2.3.246; Lin DS, 2004, J LIPID RES, V45, P529, DOI 10.1194/jlr.M300374-JLR200; Long JA, 2012, POULTRY SCI, V91, P1990, DOI 10.3382/ps.2011-02028; Martinez P, 1996, FRONT BIOSCI, V1, P103; Meunpol O, 2005, AQUAC RES, V36, P1216, DOI 10.1111/j.1365-2109.2005.01342.x; MILLAMENA O M, 1990, Journal of the World Aquaculture Society, V21, P116, DOI 10.1111/j.1749-7345.1990.tb00531.x; Okumura T, 2004, ZOOL SCI, V21, P621, DOI 10.2108/zsj.21.621; Oresti GM, 2010, J LIPID RES, V51, P2909, DOI 10.1194/jlr.M006429; Pawlina W, 2011, HISTOLOGY TEXT ATLAS, P784; Perez-Velazquez M, 2003, J WORLD AQUACULT SOC, V34, P92, DOI 10.1111/j.1749-7345.2003.tb00043.x; Poljaroen J, 2011, AQUACULTURE, V321, P121, DOI 10.1016/j.aquaculture.2011.08.022; RAANAN Z, 1985, BIOL BULL, V169, P592, DOI 10.2307/1541301; Ranjeet K., 2002, Naga, V25, P13; Ravichandran S., 2009, Middle-East Journal of Scientific Research, V4, P175; Ravid T, 1999, J EXP BIOL, V202, P1819; Rodriguez-Gonzalez H, 2006, AQUACULTURE, V254, P637, DOI 10.1016/j.aquaculture.2005.10.020; Roqueta-Rivera M, 2010, J LIPID RES, V51, P360, DOI 10.1194/jlr.M001180; Sadler TW, 2009, LANGMANS MED EMBRYOL, P27; SAGI A, 1988, J CRUSTACEAN BIOL, V8, P43, DOI 10.2307/1548428; SAGI A, 1988, BIOL BULL, V174, P330, DOI 10.2307/1541958; Samuel MJ, 1999, AQUACULTURE, V172, P327, DOI 10.1016/S0044-8486(98)00500-6; Schwantes VS, 2009, AQUACULTURE, V287, P120, DOI 10.1016/j.aquaculture.2008.10.017; Shailender M., 2012, INT J BIOASSAYS, V1, P170; SPRANDO RL, 1987, AM J ANAT, V178, P72, DOI 10.1002/aja.1001780109; Srinivasan P, 2012, J ADV SCI RES, V3, P60; STACEY NE, 1982, CAN J FISH AQUAT SCI, V39, P92, DOI 10.1139/f82-011; Suresh Kumar S., 1998, THESIS COCHIN U SCI; WADE MG, 1994, BIOL REPROD, V51, P131, DOI 10.1095/biolreprod51.1.131; Wang DH, 2010, AQUAC RES, V41, P1140, DOI 10.1111/j.1365-2109.2009.02401.x; Wouters R, 2001, AQUACULTURE, V198, P307, DOI 10.1016/S0044-8486(01)00522-1; Wu X, 2010, AQUACULT NUTR, V16, P25, DOI 10.1111/j.1365-2095.2008.00637.x; Zaniboni L, 2006, THERIOGENOLOGY, V65, P1813, DOI 10.1016/j.theriogenology.2005.10.013	52	5	5	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120412	10.1371/journal.pone.0120412	http://dx.doi.org/10.1371/journal.pone.0120412			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781176	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600158
J	Soler-Membrives, A; Munilla, T				Soler-Membrives, Anna; Munilla, Tomas			PYCNOIB: Biodiversity and Biogeography of Iberian Pycnogonids	PLOS ONE			English	Article							ARTHROPODA PYCNOGONIDA; ABYSSAL PYCNOGONIDA; VIGO NW; ATLANTIC; GIBRALTAR; STRAIT; SEA; AFFINITIES; CRUSTACEA; KNOWLEDGE	Biodiversity and biogeographic studies comparing the distribution patterns of benthic marine organisms across the Iberian Atlantic and Mediterranean waters are scarce. The Pycnogonida (sea spiders) are a clear example of both endemicity and diversity, and are considered a key taxon to study and monitor biogeographic and biodiversity patterns. This is the first review that compiles data about abundance and diversity of Iberian pycnogonids and examines their biogeographic patterns and bathymetric constraints using GIS tools. A total of 17762 pycnogonid records from 343 localities were analyzed and were found to contain 65 species, 21 genera and 12 families. Achelia echinata and Ammothella longipes (family Acheliidae) were the most abundant comprising similar to 80% of the total records. The Acheliidae is also the most speciose in Iberian waters with 15 species. In contrast, the family Nymphonidae has 7 species but is significantly less abundant (<1% of the total records) than Acheliidae. Species accumulation curves indicate that further sampling would increase the number of Iberian species records. Current sampling effort suggests that the pycnogonid fauna of the Mediterranean region may be richer than that of the Atlantic. The Strait of Gibraltar and the Alboran Sea are recognized as species-rich areas that act as buffer zones between the Atlantic and Mediterranean boundaries. The deep waters surrounding the Iberian Peninsula are poorly surveyed, with only 15% of the sampling sites located below 1000 m. Further deep-water sampling is needed mainly on the Iberian Mediterranean side.	[Soler-Membrives, Anna; Munilla, Tomas] Univ Autonoma Barcelona, Unitat Zool BABVE, E-08193 Barcelona, Spain	Autonomous University of Barcelona	Soler-Membrives, A (corresponding author), Univ Autonoma Barcelona, Unitat Zool BABVE, E-08193 Barcelona, Spain.	Anna.Soler@uab.cat	Soler-Membrives, Anna/L-3169-2014	Soler-Membrives, Anna/0000-0002-6543-8367	Ministerio de Ciencia e Innovacion [CGD2007-66786]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was funded by the CGD2007-66786 Project: Fauna Iberica, Chelicerata, Pycnogonida (Ministerio de Ciencia e Innovacion). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANADON N, 1981, INVEST PESQ, V45, P105; ANADON R, 1975, INVEST PESQ, V39, P199; Anadon R, 1980, MEM POLICOPIADA FUND; Arango CP, 2011, DEEP-SEA RES PT II, V58, P212, DOI 10.1016/j.dsr2.2010.05.019; ARNAUD F, 1973, Tethys, V5, P147; ARNAUD F, 1987, ADV MAR BIOL, V24, P1; Arnaud F, 1988, MESOGEE B MUSEUM HIS, V47, P37; Balbin R, 2014, J MARINE SYST, V138, P70, DOI 10.1016/j.jmarsys.2013.07.004; Bamber R, 2015, PYCNOBASE WORLD PYCN; Bamber R., 2010, SYNOPSES BRIT FAUNA, V5, P1; BAMBER RN, 1995, ZOOL J LINN SOC-LOND, V115, P117, DOI 10.1111/j.1096-3642.1995.tb02325.x; Bouvier E.L., 1923, FAUNE FR, V7, P1; CANDELA J, 1991, DYNAM ATMOS OCEANS, V15, P267, DOI 10.1016/0377-0265(91)90023-9; Carballo JL, 1997, J BIOGEOGR, V24, P223, DOI 10.1046/j.1365-2699.1997.00082.x; Child C. Allan, 1995, Antarctic Research Series, V69, P69; Chimenz Gusso C., 2003, BIOGEOGRAPHIA J INTE, V24, P251, DOI [10.21426/B6110015, DOI 10.21426/B6110015, 10.21426/b6110015]; Clarke A, 2003, OCEANOGR MAR BIOL, V41, P47; Clarke KR, 2001, MAR ECOL PROG SER, V216, P265, DOI 10.3354/meps216265; Coll M, 2012, GLOBAL ECOL BIOGEOGR, V21, P465, DOI 10.1111/j.1466-8238.2011.00697.x; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; Danovaro R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011832; DEHARO A, 1978, ZOOL J LINN SOC-LOND, V63, P181, DOI 10.1111/j.1096-3642.1978.tb02097.x; Esquete P, 2013, THALASSAS, V29, P25; FERNANDEZ E, 1987, Investigacion Pesquera (Barcelona), V51, P167; Ferrer L, 2011, J MARINE SYST, V87, P133, DOI 10.1016/j.jmarsys.2011.03.008; Franganilllo P, 1918, B SOC ENTOMOLOGICA E, V1, P120; Gonzalez-Duarte MM, 2013, MAR ECOL-EVOL PERSP, V34, P33, DOI 10.1111/maec.12022; Gorley C.K., 2006, GETTING STARTED PRIM; Griffiths HJ, 2011, ECOGRAPHY, V34, P616, DOI 10.1111/j.1600-0587.2010.06612.x; Guerra-Garcia JM, 2009, J MAR BIOL ASSOC UK, V89, P387, DOI 10.1017/S0025315409002938; Hedgpeth JW, 1969, ANTARCTIC MAP FOLIO, V11, P26; Juan J., 1990, PICNOGONIDOS COSTERO, P187; Kocak C, 2010, ZOOL MIDDLE EAST, V49, P118, DOI 10.1080/09397140.2010.10638403; KRAPP F, 1973, Beaufortia, V21, P55; KRAPP F, 1983, Marine Ecology, V4, P123, DOI 10.1111/j.1439-0485.1983.tb00291.x; Krapp F, 2008, ZOOTAXA, P57; Leon TM, 2000, CAH BIOL MAR, V41, P321; Macpherson E, 2002, P ROY SOC B-BIOL SCI, V269, P1715, DOI 10.1098/rspb.2002.2091; MALDONADO M, 1995, J BIOGEOGR, V22, P89, DOI 10.2307/2846075; Munilla Leon T., 1981, Butlleti de la Institucio Catalana d'Historia Natural, V47, P77; Munilla Leon Tomas, 1997, ORSIS, V12, P65; Munilla Leon Tomas, 1994, Orsis, V9, P109; MUNILLA T, 1984, Boletin de la Asociacion Espanola de Entomologia, V8, P13; MUNILLA T, 1991, ORSIS, V6, P95; Munilla T, 1999, VIE MILIEU, V49, P155; MUNILLA T, 1987, Miscellania Zoologica (Barcelona), V11, P369; Munilla T., 1988, Butlleti de la Institucio Catalana d'Historia Natural, V55, P59; MUNILLA T, 1993, J MAR BIOL ASSOC UK, V73, P543, DOI 10.1017/S0025315400033099; Munilla T, 1982, ACTAS 2 S IBERICO ES, V3, P221; Munilla T, 1984, ELS SISTEMES NATURAL, V73, P531; Munilla T., 1978, THESIS U AUTONOMA BA; Munilla T.L, 1993, ANN MUS CIV STOR NAT, V89, P445; Munilla T, 2009, ANTARCT SCI, V21, P99, DOI 10.1017/S095410200800151X; Naranjo S, 1998, BIOL J LINN SOC, V64, P151; NOGUEIRA M, 1967, Arquivos do Museu Bocage, V1, P283; NOGUEIRA MARIA, 1956, ARQ MUS BOCAGE, V27, P65; PEREZ-RUZAFA A, 1992, Scientia Marina, V56, P21; Ros-Santaella J.L, 2004, ACTA GRANATENSE, V3, P3; Sanchez-Vidal A, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030395, 10.1371/journal.pone.0043943]; Soler-Membrives A., 2010, THESIS U AUTONOMA BA; Soler-Membrives Anna, 2014, P138; STOCK J H, 1991, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V13, P135; STOCK JH, 1978, CAH BIOL MAR, V19, P397; STOCK JH, 1987, CAH BIOL MAR, V28, P505; STOCK JH, 1978, CAH BIOL MAR, V19, P189; Stock JH, 1968, VIE MILIEU S, V19, P11; Templado J., 2012, GUIA INTERPRETATIVA; Templado J, 2011, MEM REAL SOC ESP HIS, V9, P343; Troncoso JS, 2011, J OCEANOGR MAR SCI, V2, P23; Vinogradova NG, 1997, ADV MAR BIOL, V32, P325; Woods HA, 2009, P R SOC B, V276, P1069, DOI 10.1098/rspb.2008.1489	71	12	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120818	10.1371/journal.pone.0120818	http://dx.doi.org/10.1371/journal.pone.0120818			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781483	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600190
J	Sumit, AF; Das, A; Sharmin, Z; Ahsan, N; Ohgami, N; Kato, M; Akhand, AA				Sumit, Ahmed Faisal; Das, Anindya; Sharmin, Zinat; Ahsan, Nazmul; Ohgami, Nobutaka; Kato, Masashi; Akhand, Anwarul Azim			Cigarette Smoking Causes Hearing Impairment among Bangladeshi Population	PLOS ONE			English	Article							OCCUPATIONAL NOISE EXPOSURE; AUDITORY-THRESHOLDS; WORKERS; RISK; AGE	Lifestyle including smoking, noise exposure with MP3 player and drinking alcohol are considered as risk factors for affecting hearing synergistically. However, little is known about the association of cigarette smoking with hearing impairment among subjects who carry a lifestyle without using MP3 player and drinking alcohol. We showed here the influence of smoking on hearing among Bangladeshi subjects who maintain a lifestyle devoid of using MP3 player and drinking alcohol. A total of 184 subjects (smokers: 90; non-smokers: 94) were included considering their duration and frequency of smoking for conducting this study. The mean hearing thresholds of non-smoker subjects at 1, 4, 8 and 12 kHz frequencies were 5.63 +/- 2.10, 8.56 +/- 5.75, 21.06 +/- 11.06, 40.79 +/- 20.36 decibel (dB), respectively and that of the smokers were 7 +/- 3.8, 13.27 +/- 8.4, 30.66 +/- 12.50 and 56.88 +/- 21.58 dB, respectively. The hearing thresholds of the smokers at 4, 8 and 12 kHz frequencies were significantly (p<0.05) higher than those of the non-smokers, while no significant differences were observed at 1 kHz frequency. We also observed no significant difference in auditory thresholds among smoker subgroups based on smoking frequency. In contrast, subjects smoked for longer duration (>5 years) showed higher level of auditory threshold (62.16 +/- 19.87 dB) at 12 kHz frequency compared with that (41.52 +/- 19.21 dB) of the subjects smoked for 1-5 years and the difference in auditory thresholds was statistically significant (p<0.0002). In this study, the Brinkman Index (BI) of smokers was from 6 to 440 and the adjusted odds ratio showed a positive correlation between hearing loss and smoking when adjusted for age and body mass index (BMI). In addition, age, but not BMI, also played positive role on hearing impairment at all frequencies. Thus, these findings suggested that cigarette smoking affects hearing level at all the frequencies tested but most significantly at extra higher frequencies.	[Sumit, Ahmed Faisal; Das, Anindya; Sharmin, Zinat; Ahsan, Nazmul; Akhand, Anwarul Azim] Univ Dhaka, Dept Genet Engn & Biotechnol, Dhaka 1000, Bangladesh; [Ohgami, Nobutaka] Chubu Univ, Nutr Hlth Sci Res Ctr, Kasugai, Aichi 487, Japan; [Ohgami, Nobutaka; Kato, Masashi] Nagoya Univ, Dept Occupat & Environm Hlth, Grad Sch Med, Nagoya, Aichi 4648601, Japan	University of Dhaka; Chubu University; Nagoya University	Akhand, AA (corresponding author), Univ Dhaka, Dept Genet Engn & Biotechnol, Dhaka 1000, Bangladesh.	akhand66@yahoo.com	Ahsan, Nazmul/AAE-6751-2020; Ohgami, Nobutaka/I-4572-2014; KATO, Masashi/I-7250-2014	Ahsan, Nazmul/0000-0003-1311-1589; Das, Anindya/0000-0003-4142-1517				BARTECCHI CE, 1994, NEW ENGL J MED, V330, P907, DOI 10.1056/NEJM199403313301307; Baur M, 2009, HNO, V57, P1023, DOI 10.1007/s00106-009-1900-9; Brant L J, 1996, J Am Acad Audiol, V7, P152; BRANT LJ, 1990, J ACOUST SOC AM, V88, P813, DOI 10.1121/1.399731; BRINKMAN GL, 1963, AM REV RESPIR DIS, V87, P684; Ferrite S, 2005, OCCUP MED-OXFORD, V55, P48, DOI 10.1093/occmed/kqi002; Flora MS, 2009, TOB CONTROL, V18, P445, DOI 10.1136/tc.2008.028142; Fransen E, 2008, JARO-J ASSOC RES OTO, V9, P264, DOI 10.1007/s10162-008-0123-1; Karlsmose B, 2000, BRIT J AUDIOL, V34, P47, DOI 10.3109/03005364000000117; Kim KS, 2010, J KOREAN MED SCI, V25, pS62, DOI 10.3346/jkms.2010.25.S.S62; Kim MG, 2009, YONSEI MED J, V50, P771, DOI 10.3349/ymj.2009.50.6.771; Lusk S L, 1997, AAOHN J, V45, P397; Mizoue T, 2003, OCCUP ENVIRON MED, V60, P56, DOI 10.1136/oem.60.1.56; Mohammadi S, 2010, NOISE HEALTH, V12, P187, DOI 10.4103/1463-1741.64975; Nakanishi N, 2000, J OCCUP ENVIRON MED, V42, P1045, DOI 10.1097/00043764-200011000-00001; Nasir H M, 2012, Med J Malaysia, V67, P81; Nomura K, 2005, INT ARCH OCC ENV HEA, V78, P178, DOI 10.1007/s00420-005-0604-z; Ohgami N, 2011, TOXICOL IND HEALTH, V27, P143, DOI 10.1177/0748233710382539; Oliveira Daniela Cecílio Capra Marques de, 2009, Braz. j. otorhinolaryngol., V75, P738; Palmer KT, 2004, OCCUP ENVIRON MED, V61, P340, DOI 10.1136/oem.2003.009183; Pope CA, 2011, ENVIRON HEALTH PERSP, V119, P1616, DOI 10.1289/ehp.1103639; Pouryaghoub G, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-137; Sawair FA, 2010, THER CLIN RISK MANAG, V6, P573, DOI 10.2147/TCRM.S15145; Shimada S, 2011, CIRC J, V75, P185, DOI 10.1253/circj.CJ-10-0335; Starck J, 1999, ACTA OTO-LARYNGOL, V119, P302; Szudek J, 2012, J OTOLARYNGOL-HEAD N, V41, pS78, DOI 10.2310/7070.2011.110089; Uy J, 2013, ANN INTERN MED, V158, pITC41, DOI 10.7326/0003-4819-158-7-201304020-01004; Van Tasell DJ, 2013, OTOL NEUROTOL, V34, P9, DOI 10.1097/MAO.0b013e318278c05d; Virokannas H, 1995, SCAND AUDIOL, V24, P211, DOI 10.3109/01050399509047538; Vogel I, 2009, PEDIATRICS, V123, pE953, DOI 10.1542/peds.2008-3179; Wild DC, 2005, CLIN OTOLARYNGOL, V30, P517, DOI 10.1111/j.1749-4486.2005.01105.x; Winkelmann BR, 2009, BIOMARK MED, V3, P617, DOI [10.2217/BMM.09.51, 10.2217/bmm.09.51]	32	19	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0118960	10.1371/journal.pone.0118960	http://dx.doi.org/10.1371/journal.pone.0118960			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781179	Green Published, gold, Green Submitted			2022-12-27	WOS:000351284600038
J	Aeby, GS; Work, TM; Runyon, CM; Shore-Maggio, A; Ushijima, B; Videau, P; Beurmann, S; Callahan, SM				Aeby, Greta S.; Work, Thierry M.; Runyon, Christina M.; Shore-Maggio, Amanda; Ushijima, Blake; Videau, Patrick; Beurmann, Silvia; Callahan, Sean M.			First Record of Black Band Disease in the Hawaiian Archipelago: Response, Outbreak Status, Virulence, and a Method of Treatment	PLOS ONE			English	Article							GREAT-BARRIER-REEF; WHITE SYNDROME; CORAL DISEASE; HANALEI BAY; PREVALENCE; DYNAMICS; GROWTH; IDENTIFICATION; COMMUNITIES; ANOMALIES	A high number of coral colonies, Montipora spp., with progressive tissue loss were reported from the north shore of Kaua'i by a member of the Eyes of the Reef volunteer reporting network. The disease has a distinct lesion (semi-circular pattern of tissue loss with an adjacent dark band) that was first observed in Hanalei Bay, Kaua'i in 2004. The disease, initially termed Montipora banded tissue loss, appeared grossly similar to black band disease (BBD), which affects corals worldwide. Following the initial report, a rapid response was initiated as outlined in Hawai'i's rapid response contingency plan to determine outbreak status and investigate the disease. Our study identified the three dominant bacterial constituents indicative of BBD (filamentous cyanobacteria, sulfate-reducing bacteria, sulfide-oxidizing bacteria) in coral disease lesions from Kaua'i, which provided the first evidence of BBD in the Hawaiian archipelago. A rapid survey at the alleged outbreak site found disease to affect 6-7% of the montiporids, which is higher than a prior prevalence of less than 1% measured on Kaua'i in 2004, indicative of an epizootic. Tagged colonies with BBD had an average rate of tissue loss of 5.7 cm2/day over a two-month period. Treatment of diseased colonies with a double band of marine epoxy, mixed with chlorine powder, effectively reduced colony mortality. Within two months, treated colonies lost an average of 30% less tissue compared to untreated controls.	[Aeby, Greta S.; Runyon, Christina M.; Shore-Maggio, Amanda; Ushijima, Blake; Beurmann, Silvia; Callahan, Sean M.] Hawai Inst Marine Biol, Kneohe, HI 96744 USA; [Work, Thierry M.] US Geol Survey, Natl Wildlife Hlth Ctr, Honolulu Field Stn, Honolulu, HI USA; [Aeby, Greta S.; Runyon, Christina M.; Callahan, Sean M.] Univ Hawaii, Marine Biol Grad Program, Honolulu, HI 96822 USA; [Shore-Maggio, Amanda; Ushijima, Blake; Videau, Patrick; Beurmann, Silvia; Callahan, Sean M.] Univ Hawaii, Dept Microbiol, Honolulu, HI 96822 USA	United States Department of the Interior; United States Geological Survey; University of Hawaii System; University of Hawaii System	Aeby, GS (corresponding author), Hawai Inst Marine Biol, Kneohe, HI 96744 USA.	greta@hawaii.edu	Work, Thierry M/F-1550-2015	Work, Thierry M/0000-0002-4426-9090; Ushijima, Blake/0000-0002-1053-5207; Grant, Silvia/0000-0001-5713-9212	Hawai'i Coral Reef Initiative; Hawai'i Division of Aquatic Resources; University of Hawaii	Hawai'i Coral Reef Initiative; Hawai'i Division of Aquatic Resources; University of Hawaii	Funding was provided, in part, by the Hawai'i Coral Reef Initiative and the Hawai'i Division of Aquatic Resources awarded to GSA. Further support was provided by the University of Hawaii. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebischer T, 2006, FEMS IMMUNOL MED MIC, V46, P221, DOI 10.1111/rp10.1016-j.femsim.2004.05.008; Aeby G, 2008, HAWAIIS RAPID RESPON; Aeby G, 2007, P HAN WAT WORKSH; Aeby GS, 2010, DIS AQUAT ORGAN, V91, P1, DOI 10.3354/dao02247; Aeby GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020370; Aeby Greta Smith, 2006, Atoll Research Bulletin, P471; Aeby GS, 2005, CORAL REEFS, V24, P481, DOI 10.1007/s00338-005-0493-3; Aeby GS, 2011, J MAR BIOL, V2011; Al-Moghrabi SM, 2001, CORAL REEFS, V19, P330, DOI 10.1007/s003380000127; ALLEN MM, 1968, J PHYCOL, V4, P1, DOI 10.1111/j.1529-8817.1968.tb04667.x; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Barneah O, 2007, ENVIRON MICROBIOL, V9, P1995, DOI 10.1111/j.1462-2920.2007.01315.x; Beeden R, 2012, ENVIRON MANAGE, V49, P1, DOI 10.1007/s00267-011-9770-9; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Borthakur PB, 2005, MOL MICROBIOL, V57, P111, DOI 10.1111/j.1365-2958.2005.04678.x; Bourne DG, 2011, ISME J, V5, P559, DOI 10.1038/ismej.2010.143; Bruckner AW, 1997, B MAR SCI, V61, P919; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; CARLTON RG, 1995, FEMS MICROBIOL ECOL, V18, P155, DOI 10.1016/0168-6496(95)00052-C; Cooney RP, 2002, ENVIRON MICROBIOL, V4, P401, DOI 10.1046/j.1462-2920.2002.00308.x; Dalton SJ, 2010, MAR FRESHWATER RES, V61, P342, DOI 10.1071/MF09060; Derse E, 2007, ENVIRON SCI TECHNOL, V41, P5217, DOI 10.1021/es0700449; DUCKLOW HW, 1979, MICROBIAL ECOL, V5, P215, DOI 10.1007/BF02013528; EDMUNDS PJ, 1991, CORAL REEFS, V10, P161, DOI 10.1007/BF00572175; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Frias-Lopez J, 2003, APPL ENVIRON MICROB, V69, P2409, DOI 10.1128/AEM.69.4.2409-2413.2003; Frias-Lopez J, 2002, APPL ENVIRON MICROB, V68, P2214, DOI 10.1128/AEM.68.5.2214-2228.2002; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haapkyla J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016893; Haapkyla J, 2009, DIS AQUAT ORGAN, V87, P105, DOI 10.3354/dao02160; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hudson H., 2000, DIVING SCI 21 CENTUR; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jokiel Paul L., 2004, Pacific Science, V58, P159, DOI 10.1353/psc.2004.0018; Kaczmarsky LT, 2005, CARIBB J SCI, V41, P124; Knee KL, 2008, ESTUAR COAST, V31, P607, DOI 10.1007/s12237-008-9055-6; Leloup J, 2007, ENVIRON MICROBIOL, V9, P131, DOI 10.1111/j.1462-2920.2006.01122.x; Maragos James E., 2004, Pacific Science, V58, P211, DOI 10.1353/psc.2004.0020; MESSING J, 1983, METHOD ENZYMOL, V101, P20; Miller AW, 2011, FEMS MICROBIOL ECOL, V75, P231, DOI 10.1111/j.1574-6941.2010.00991.x; Myers RL, 2009, DIS AQUAT ORGAN, V87, P97, DOI 10.3354/dao02139; NELSON DC, 1983, ARCH MICROBIOL, V136, P262, DOI 10.1007/BF00425214; Nubel U, 1997, APPL ENVIRON MICROB, V63, P3327; Page C, 2006, DIS AQUAT ORGAN, V69, P41, DOI 10.3354/dao069041; Rasoulouniriana D, 2009, DIS AQUAT ORGAN, V87, P91, DOI 10.3354/dao02089; Raymundo L.J., 2008, CORAL DIS HDB GUIDEL, V1st; Raymundo LJ, 2009, P NATL ACAD SCI USA, V106, P17067, DOI 10.1073/pnas.0900365106; Raymundo LJH, 2003, DIS AQUAT ORGAN, V56, P95, DOI 10.3354/dao056095; Richardson LL, 2009, DIS AQUAT ORGAN, V87, P79, DOI 10.3354/dao02083; Richardson LL, 1996, MICROBIAL ECOL, V32, P323; Richardson LL, 2004, CORAL HEALTH AND DISEASE, P325; Riegl B, 2002, MAR BIOL, V140, P29, DOI 10.1007/s002270100676; Ross M, 2012, P 12 INT COR REEF S, p16B; ROtzler K., 1983, PSZNI MAR ECOL, V4, P301, DOI DOI 10.1111/J.1439-0485.1983.TB00116.X; Sato Y, 2009, P R SOC B, V276, P2795, DOI 10.1098/rspb.2009.0481; Sokolow S, 2009, DIS AQUAT ORGAN, V87, P5, DOI 10.3354/dao02099; Storlazzi CD, 2009, MAR GEOL, V264, P140, DOI 10.1016/j.margeo.2009.05.002; Sussman M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002393; Sussman M, 2006, DIS AQUAT ORGAN, V69, P111, DOI 10.3354/dao069111; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Thurber RLV, 2014, GLOBAL CHANGE BIOL, V20, P544, DOI 10.1111/gcb.12450; Ushijima B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046717; Vargas-Angel B., 2009, P 11 INT COR REEF S, V1, P175; Vargas-Angel B, 2009, B MAR SCI, V84, P211; Viehman S, 2006, DIS AQUAT ORGAN, V69, P119, DOI 10.3354/dao069119; Voss JD, 2006, CORAL REEFS, V25, P569, DOI 10.1007/s00338-006-0131-8; Wagner M, 2005, METHOD ENZYMOL, V397, P469, DOI 10.1016/S0076-6879(05)97029-8; Weil E, 2012, DIS AQUAT ORGAN, V98, P163, DOI 10.3354/dao02433; Williams GJ, 2013, DIS AQUAT ORGAN, V106, P181, DOI 10.3354/dao02652; Williams GJ, 2011, DIS AQUAT ORGAN, V94, P89, DOI 10.3354/dao02323; Willis BL, 2004, CORAL HEALTH AND DISEASE, P69; Woodley CM, 2008, FIELD MANUAL FOR INV	75	31	32	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120853	10.1371/journal.pone.0120853	http://dx.doi.org/10.1371/journal.pone.0120853			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774800	Green Submitted, Green Published, gold			2022-12-27	WOS:000351183500194
J	Boerner, JL; Nechiporchik, N; Mueller, KL; Polin, L; Heilbrun, L; Boerner, SA; Zoratti, GL; Stark, K; LoRusso, PM; Burger, A				Boerner, Julie L.; Nechiporchik, Nicole; Mueller, Kelly L.; Polin, Lisa; Heilbrun, Lance; Boerner, Scott A.; Zoratti, Gina L.; Stark, Karri; LoRusso, Patricia M.; Burger, Angelika			Protein Expression of DNA Damage Repair Proteins Dictates Response to Topoisomerase and PARP Inhibitors in Triple-Negative Breast Cancer	PLOS ONE			English	Article							BRCA MUTANT-CELLS; POLY(ADP-RIBOSE) POLYMERASE; PERSPECTIVE; DEFECT; TUMORS; ERCC1	Patients with metastatic triple-negative breast cancer (TNBC) have a poor prognosis. New approaches for the treatment of TNBC are needed to improve patient survival. The concept of synthetic lethality, brought about by inactivating complementary DNA repair pathways, has been proposed as a promising therapeutic option for these tumors. The TNBC tumor type has been associated with BRCA mutations, and inhibitors of Poly (ADP-ribose) polymerase (PARP), a family of proteins that facilitates DNA repair, have been shown to effectively kill BRCA defective tumors by preventing cells from repairing DNA damage, leading to a loss of cell viability and clonogenic survival. Here we present preclinical efficacy results of combining the PARP inhibitor, ABT-888, with CPT-11, a topoisomerase I inhibitor. CPT-11 binds to topoisomerase I at the replication fork, creating a bulky adduct that is recognized as damaged DNA. When DNA damage was stimulated with CPT-11, protein expression of the nucleotide excision repair enzyme ERCC1 inversely correlated with cell viability, but not clonogenic survival. However, 4 out of the 6 TNBC cells were synergistically responsive by cell viability and 5 out of the 6 TNBC cells were synergistically responsive by clonogenic survival to the combination of ABT-888 and CPT-11. In vivo, the BRCA mutant cell line MX-1 treated with CPT-11 alone demonstrated significant decreased tumor growth; this decrease was enhanced further with the addition of ABT-888. Decrease in tumor growth correlated with an increase in double strand DNA breaks as measured by y-H2AX phosphorylation. In summary, inhibiting two arms of the DNA repair pathway simultaneously in TNBC cell lines, independent of BRCA mutation status, resulted in un-repairable DNA damage and subsequent cell death.	[Boerner, Julie L.; Nechiporchik, Nicole; Mueller, Kelly L.; Polin, Lisa; Heilbrun, Lance; Boerner, Scott A.; Zoratti, Gina L.; Stark, Karri; LoRusso, Patricia M.; Burger, Angelika] Wayne State Univ, Barbara Ann Karmanos Canc Inst, Dept Oncol, Detroit, MI 48202 USA; [Boerner, Scott A.; LoRusso, Patricia M.] Yale Univ, Dept Oncol, New Haven, CT USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Yale University	Boerner, JL (corresponding author), Wayne State Univ, Barbara Ann Karmanos Canc Inst, Dept Oncol, Detroit, MI 48202 USA.	boernerj@karmanos.org		Boerner, Scott/0000-0003-1388-9665	National Institutes of Health [U01 CA-62487, R21 CA135572-02]; NATIONAL CANCER INSTITUTE [R21CA135572, P30CA022453, U01CA062487, R01CA140314] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Institutes of Health grants U01 CA-62487 (PML) and R21 CA135572-02 (PML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Anders CK, 2011, CANCER-AM CANCER SOC, V117, P1602, DOI 10.1002/cncr.25746; Barnabas N, 2013, INT J BREAST CANCER, V2013, DOI 10.1155/2013/872743; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Chacon RD, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2574; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Ciccia A, 2008, ANNU REV BIOCHEM, V77, P259, DOI 10.1146/annurev.biochem.77.070306.102408; Corbett TH, 1998, INVEST NEW DRUG, V16, P129, DOI 10.1023/A:1006174622061; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Gossage L, 2007, CANCER TREAT REV, V33, P565, DOI 10.1016/j.ctrv.2007.07.001; Graziani G, 2005, PHARMACOL RES, V52, P109, DOI 10.1016/j.phrs.2005.02.013; Helleday T, 2011, MOL ONCOL, V5, P387, DOI 10.1016/j.molonc.2011.07.001; HOLM S, 1979, ACTA MED SCAND, V205, P587; Institute NC., PDQ GEN BREAST OV CA; Korsching E, 2008, J CLIN PATHOL, V61, P553, DOI 10.1136/jcp.2008.055475; Littell RC, 2006, STAT ANAL SYSTEM SAS; Murphy CG, 2010, CANCER J, V16, P39, DOI 10.1097/PPO.0b013e3181cf0204; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Rasheed ZA, 2003, ONCOGENE, V22, P7296, DOI 10.1038/sj.onc.1206935; Ratnam K, 2007, CLIN CANCER RES, V13, P1383, DOI 10.1158/1078-0432.CCR-06-2260; Santana-Davila R, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-42; Starita LM, 2003, CURR OPIN CELL BIOL, V15, P345, DOI 10.1016/S0955-0674(03)00042-5; Tutt ANJ, 2005, COLD SH Q B, V70, P139, DOI 10.1101/sqb.2005.70.012; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Xu J, 2012, MOL BIOL REP, V39, P3097, DOI 10.1007/s11033-011-1073-y; Zhang YW, 2011, NUCLEIC ACIDS RES, V39, P3607, DOI 10.1093/nar/gkq1304	27	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119614	10.1371/journal.pone.0119614	http://dx.doi.org/10.1371/journal.pone.0119614			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774912	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500105
J	Chappell, JM; Iqbal, A; Gunn, LJ; Abbott, D				Chappell, James M.; Iqbal, Azhar; Gunn, Lachlan J.; Abbott, Derek			Functions of Multivector Variables	PLOS ONE			English	Article								As is well known, the common elementary functions defined over the real numbers can be generalized to act not only over the complex number field but also over the skew (non-commuting) field of the quaternions. In this paper, we detail a number of elementary functions extended to act over the skew field of Clifford multivectors, in both two and three dimensions. Complex numbers, quaternions and Cartesian vectors can be described by the various components within a Clifford multivector and from our results we are able to demonstrate new inter-relationships between these algebraic systems. One key relationship that we discover is that a complex number raised to a vector power produces a quaternion thus combining these systems within a single equation. We also find a single formula that produces the square root, amplitude and inverse of a multivector over one, two and three dimensions. Finally, comparing the functions over different dimension we observe that Cl (R-3) provides a particularly versatile algebraic framework.	[Chappell, James M.; Iqbal, Azhar; Gunn, Lachlan J.; Abbott, Derek] Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia	University of Adelaide	Chappell, JM (corresponding author), Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia.	james.chappell@adelaide.edu.au	Iqbal, Azhar/E-8749-2011; Abbott, Derek/E-8352-2011	Iqbal, Azhar/0000-0002-5221-9384; Abbott, Derek/0000-0002-0945-2674; Gunn, Lachlan/0000-0003-1767-7897				Boudet R, 2009, SPRINGER SER ATOM OP, V52; Carrier G. F., 2005, FUNCTIONS COMPLEX VA, DOI [10.1137/1.9780898719116, DOI 10.1137/1.9780898719116]; Greene R. E., 2006, GRADUATE STUDIES MAT, V40; Hahn A. J., 1994, QUADRATIC ALGEBRAS C; Hestenes D., 1999, NEW FDN CLASSICAL ME, VSecond; Janovska D., 2008, MITT MATH GES HAMBUR, V27, P223; Lam T.Y., 1973, ALGEBRAIC THEORY QUA; Lounesto P., 2001, CLIFFORD ALGEBRAS SP, V2; PORTEOUS IR, 1995, CLIFFORD ALGEBRAS CL; Sangwine SJ, 2006, ADV APPL CLIFFORD AL, V16, P63, DOI 10.1007/s00006-006-0005-8	10	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0116943	10.1371/journal.pone.0116943	http://dx.doi.org/10.1371/journal.pone.0116943			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774689	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500013
J	Degen, T; Hovestadt, T; Mitesser, O; Holker, F				Degen, Tobias; Hovestadt, Thomas; Mitesser, Oliver; Hoelker, Franz			High Female Survival Promotes Evolution of Protogyny and Sexual Conflict	PLOS ONE			English	Article							MORTALITY-RATES; ARMYWORM LEPIDOPTERA; BAGWORMS LEPIDOPTERA; SIZE DIMORPHISM; MATING SUCCESS; MALES EMERGE; LIFE-SPAN; PROTANDRY; MOTH; TIME	Existing models explaining the evolution of sexual dimorphism in the timing of emergence (SDT) in Lepidoptera assume equal mortality rates for males and females. The limiting assumption of equal mortality rates has the consequence that these models are only able to explain the evolution of emergence of males before females, i.e. protandry-the more common temporal sequence of emergence in Lepidoptera. The models fail, however, in providing adaptive explanations for the evolution of protogyny, where females emerge before males, but protogyny is not rare in insects. The assumption of equal mortality rates seems too restrictive for many insects, such as butterflies. To investigate the influence of unequal mortality rates on the evolution of SDT, we present a generalised version of a previously published model where we relax this assumption. We find that longer life-expectancy of females compared to males can indeed favour the evolution of protogyny as a fitness enhancing strategy. Moreover, the encounter rate between females and males and the sex-ratio are two important factors that also influence the evolution of optimal SDT. If considered independently for females and males the predicted strategies can be shown to be evolutionarily stable (ESS). Under the assumption of equal mortality rates the difference between the females' and males' ESS remains typically very small. However, female and male ESS may be quite dissimilar if mortality rates are different. This creates the potential for an 'evolutionary conflict' between females and males. Bagworm moths (Lepidoptera: Psychidae) provide an exemplary case where life-history attributes are such that protogyny should indeed be the optimal emergence strategy from the males' and females' perspectives: (i) Female longevity is considerably larger than that of males, (ii) encounter rates between females and males are presumably low, and (iii) females mate only once. Protogyny is indeed the general mating strategy found in the bagworm family.	[Degen, Tobias; Hoelker, Franz] Leibniz Inst Freshwater Ecol & Inland Fisheries, Berlin, Germany; [Degen, Tobias] Free Univ Berlin, Inst Biol, Berlin, Germany; [Hovestadt, Thomas; Mitesser, Oliver] Univ Wurzburg, Biozentrum, Field Stn Fabrikschleichach, Dept Anim Ecol & Trop Biol, Rauhenebrach, Germany; [Hovestadt, Thomas] Univ Ghent, Dept Biol, Terr Ecol Unit, B-9000 Ghent, Belgium	Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Free University of Berlin; University of Wurzburg; Ghent University	Degen, T (corresponding author), Leibniz Inst Freshwater Ecol & Inland Fisheries, Berlin, Germany.	degen@igb-berlin.de	Hölker, Franz/A-5683-2009; Mitesser, Oliver/B-8500-2008	Hölker, Franz/0000-0001-5932-266X; Degen, Tobias/0000-0001-8001-1604; Mitesser, Oliver/0000-0002-3607-877X; Hovestadt, Thomas/0000-0001-7368-6013	"Verlust der Nacht" (Federal Ministry of Education and Research, Germany) [BMBF-033L038A]; German Research Foundation (DFG, Collaborative Research Center "Insect timing", Project C6) [SFB1047]	"Verlust der Nacht" (Federal Ministry of Education and Research, Germany); German Research Foundation (DFG, Collaborative Research Center "Insect timing", Project C6)	This work was funded by the project "Verlust der Nacht" (Federal Ministry of Education and Research, Germany, BMBF-033L038A, granted to FH) and by the German Research Foundation (DFG, Collaborative Research Center SFB 1047 "Insect timing", Project C6, granted to TH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CE, 2011, ANNU REV ENTOMOL, V56, P445, DOI 10.1146/annurev-ento-120709-144828; [Anonymous], 2014, R LANG ENV STAT COMP; Bento JMS, 2006, FLA ENTOMOL, V89, P199, DOI 10.1653/0015-4040(2006)89[199:BAMBOT]2.0.CO;2; Bonduriansky R, 2002, NATURE, V420, P377, DOI 10.1038/420377a; Boughton AJ, 2007, FLA ENTOMOL, V90, P509, DOI 10.1653/0015-4040(2007)90[509:MBOACL]2.0.CO;2; BULMER MG, 1983, THEOR POPUL BIOL, V23, P314, DOI 10.1016/0040-5809(83)90021-7; Calabrese JM, 2008, J ANIM ECOL, V77, P746, DOI 10.1111/j.1365-2656.2008.01385.x; FAGERSTROM T, 1982, OECOLOGIA, V52, P164, DOI 10.1007/BF00363830; Fox CW, 2003, FUNCT ECOL, V17, P619, DOI 10.1046/j.1365-2435.2003.00781.x; Geritz SAH, 1998, EVOL ECOL, V12, P35, DOI 10.1023/A:1006554906681; Gotthard K, 2000, OECOLOGIA, V122, P36, DOI 10.1007/PL00008833; Honek Alois, 1997, Acta Societatis Zoologicae Bohemicae, V61, P113; Kawasaki N, 2008, AM NAT, V172, P346, DOI 10.1086/589519; Kokko H, 2006, J ANIM ECOL, V75, P1293, DOI 10.1111/j.1365-2656.2006.01151.x; Larsen E, 2013, ENTOMOL EXP APPL, V146, P130, DOI 10.1111/eea.12003; Morbey YE, 2001, ECOL LETT, V4, P663, DOI 10.1046/j.1461-0248.2001.00265.x; Morbey YE, 2013, J THEOR BIOL, V339, P93, DOI 10.1016/j.jtbi.2013.05.009; Nagoshi RN, 2011, ANN ENTOMOL SOC AM, V104, P88, DOI 10.1603/AN10110; Parker G. A., 1979, SEXUAL SELECTION SEX; Parker GA, 2006, PHILOS T R SOC B, V361, P235, DOI 10.1098/rstb.2005.1785; Ramaswamy SB, 1997, ARCH INSECT BIOCHEM, V35, P539, DOI 10.1002/(SICI)1520-6327(1997)35:4<539::AID-ARCH12>3.0.CO;2-B; RHAINDS M, 1995, ENTOMOL EXP APPL, V77, P183, DOI 10.1007/BF02383032; Rhainds M, 1999, ENTOMOL EXP APPL, V91, P375, DOI 10.1023/A:1003619511525; Rhainds M, 2009, ANNU REV ENTOMOL, V54, P209, DOI 10.1146/annurev.ento.54.110807.090448; Rhainds M, 2008, ECOL ENTOMOL, V33, P663, DOI 10.1111/j.1365-2311.2008.01027.x; Rhainds M, 2010, ENTOMOL EXP APPL, V136, P211, DOI 10.1111/j.1570-7458.2010.01032.x; Robinet C, 2008, J ANIM ECOL, V77, P966, DOI 10.1111/j.1365-2656.2008.01417.x; Schtickzelle N, 2002, OIKOS, V97, P349, DOI 10.1034/j.1600-0706.2002.970305.x; Scott J.A., 1973, Journal Res Lepid, V12, P225; SIMMONS AM, 1993, FLA ENTOMOL, V76, P333, DOI 10.2307/3495733; Tammaru T, 2002, OECOLOGIA, V133, P430, DOI 10.1007/s00442-002-1057-7; TAYLOR PS, 1990, ENVIRON ENTOMOL, V19, P1422, DOI 10.1093/ee/19.5.1422; Teder T, 2014, FUNCT ECOL, V28, P479, DOI 10.1111/1365-2435.12172; Uematsu H, 1997, JPN J APPL ENTOMOL Z, V41, P217, DOI 10.1303/jjaez.41.217; WIKLUND C, 1977, OECOLOGIA, V31, P153, DOI 10.1007/BF00346917; Wiklund C, 2003, P ROY SOC B-BIOL SCI, V270, P1823, DOI 10.1098/rspb.2003.2437; Wiklund Christer, 1995, P175; ZONNEVELD C, 1991, THEOR POPUL BIOL, V40, P308, DOI 10.1016/0040-5809(91)90058-N; ZONNEVELD C, 1992, B MATH BIOL, V54, P957	39	16	17	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118354	10.1371/journal.pone.0118354	http://dx.doi.org/10.1371/journal.pone.0118354			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775473	Green Published, gold, Green Submitted			2022-12-27	WOS:000351183500029
J	Liu, SX; Zhu, WP; Li, SJ; Cui, TX; Li, ZH; Zhang, B; Li, Z; Wu, JX; Liang, XL; Lin, Z; Shi, W				Liu, Shuangxin; Zhu, Weiping; Li, Sijia; Cui, Tongxia; Li, Zhonghe; Zhang, Bin; Li, Zhuo; Wu, Jianxiong; Liang, Xinling; Lin, Zheng; Shi, Wei			The Effect of Bovine Parathyroid Hormone Withdrawal on MC3T3-E1 Cell Proliferation and Phosphorus Metabolism	PLOS ONE			English	Article							BONE-MINERAL DENSITY; HEMODIALYSIS-PATIENTS; SECONDARY HYPERPARATHYROIDISM; OSTEOBLAST DIFFERENTIATION; POSTMENOPAUSAL WOMEN; MULTIPLE MECHANISMS; DIALYSIS PATIENT; PTH; MANAGEMENT; CINACALCET	Hypocalcemia and hypophosphatemia are common complications after parathyroidectomy (PTX). Sudden removal of high circulating levels of parathyroid hormone (PTH) causes decreased osteoclastic resorption resulting in a decreased bone remodeling space. These phenomena are likely due to an increased influx of calcium and phosphorus into bone. However, there are currently no data to support this hypothesis. In this study, we found that PTX significantly reduced levels of PTH, calcium and phosphate. Compared with preoperative levels, after 1 year, postoperative PTH, calcium and phosphate levels were 295.6 +/- 173.7 pg/mL (P < 0.05), 86.62 +/- 15.98 mg/dL (P < 0.05) and 5.56 +/- 2.03 mg/dL (P < 0.05), respectively. We investigated continuous bovine PTH administration as well as withdrawal of bovine PTH stimulation in the mouse osteoblast precursor cell line MC3T3-E1. MC3T3-E1 cells were cultured with continuous bovine PTH treatment for 20 days or with transient bovine PTH treatment for 10 days. High doses of continuous bovine PTH exposure strongly reduced cell proliferation, alkaline phosphatase activity and the number of mineralized calcium nodules. However, withdrawal of bovine PTH (100 ng/mL) significantly increased the number of mineralized calcium nodules and caused a rapid decline in calcium and phosphorus content of culture medium. In conclusion, continuous exposure to bovine PTH inhibited osteoblast differentiation and reduced the formation of mineralized nodules. However, this inhibition was removed and mineralized nodule formation resumed with withdrawal of bovine PTH. According to the results of our clinical examinations and in vitro experiments, we hypothesize that the sudden removal of high levels of PTH may cause an increased influx of calcium and phosphorus into bone after PTX.	[Liu, Shuangxin; Li, Sijia; Zhang, Bin; Li, Zhuo; Wu, Jianxiong; Liang, Xinling; Lin, Zheng; Shi, Wei] Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Nephrol, Guangzhou, Guangdong, Peoples R China; [Zhu, Weiping; Cui, Tongxia; Li, Zhonghe] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Nephrol, Zhuhai, Peoples R China	Guangdong Academy of Medical Sciences & Guangdong General Hospital; Sun Yat Sen University	Shi, W (corresponding author), Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Nephrol, 106 Zhongshan 2 Rd, Guangzhou, Guangdong, Peoples R China.	shiwei@139.com	liu, shuangxin/AAS-7429-2020	Zhu, weiping/0000-0002-8856-5609	Guangdong Provincial Science and Technology Foundation [2012B031800164, 2011B031800303]; National Natural Science Foundation [81370808, 81270784, 81170683]; Guangzhou City Science and Technology Project [12A56041537, 2012J4300084, 2012Y2-00028]; National Key Technology RD Program [2011BAI10B06]; National key clinical specialist construction Programs of China; Chinese Society of Nephrology [14050400577]; Medical Scientific Research Foundation of Guangdong Province [A2014259]	Guangdong Provincial Science and Technology Foundation; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Guangzhou City Science and Technology Project; National Key Technology RD Program(National Key Technology R&D Program); National key clinical specialist construction Programs of China; Chinese Society of Nephrology; Medical Scientific Research Foundation of Guangdong Province	This work was supported by Guangdong Provincial Science and Technology Foundation (No. 2012B031800164 and 2011B031800303), the National Natural Science Foundation (No. 81370808, 81270784 and 81170683), Guangzhou City Science and Technology Project (No. 12A56041537, 2012J4300084 and 2012Y2-00028), National Key Technology R&D Program (No. 2011BAI10B06), National key clinical specialist construction Programs of China, Chinese Society of Nephrology (No. 14050400577) and Medical Scientific Research Foundation of Guangdong Province (No.A2014259). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslan D, 2012, SCAND J CLIN LAB INV, V72, P14, DOI 10.3109/00365513.2011.624631; Blair HC, 2004, HISTOL HISTOPATHOL, V19, P189, DOI 10.14670/HH-19.189; Bogazzi F, 2011, J ENDOCRINOL INVEST, V34, pE200, DOI 10.3275/7228; BRASIER AR, 1988, AM J MED, V84, P654, DOI 10.1016/0002-9343(88)90100-3; Cannata-Andia JB, 2013, J NEPHROL, V26, P73, DOI 10.5301/jn.5000212; Cooper K, 2012, NEPHRON CLIN PRACT, V121, pC124, DOI 10.1159/000345164; Cozzolino M, 2004, J NEPHROL, V17, P3; Cruz DN, 1997, AM J KIDNEY DIS, V29, P759, DOI 10.1016/S0272-6386(97)90131-1; Esbrit P, 2013, BIOCHEM PHARMACOL, V85, P1417, DOI 10.1016/j.bcp.2013.03.002; Fukuma S, 2013, KIDNEY INT SUPPL, V3, P436, DOI 10.1038/kisup.2013.91; Goldfarb M, 2012, WORLD J SURG, V36, P1314, DOI 10.1007/s00268-012-1560-x; Greenfield Edward M, 2012, Curr Mol Pharmacol, V5, P127; Horwitz MJ, 2011, J BONE MINER RES, V26, P2287, DOI 10.1002/jbmr.415; Hruska KA, 2011, ADV CHRONIC KIDNEY D, V18, P98, DOI 10.1053/j.ackd.2011.01.001; Ishizuya T, 1997, J CLIN INVEST, V99, P2961, DOI 10.1172/JCI119491; Jilka RL, 2007, BONE, V40, P1434, DOI 10.1016/j.bone.2007.03.017; Jilka RL, 2010, J BONE MINER RES, V25, P2427, DOI 10.1002/jbmr.145; Kawamura N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001058; Kerschan-Schindl K, 2012, HORM METAB RES, V44, P476, DOI 10.1055/s-0032-1308998; Kousteni Stavroula, 2008, Curr Osteoporos Rep, V6, P72, DOI 10.1007/s11914-008-0013-9; Latus J, 2013, INT J NEPHROL RENOV, V6, P131, DOI 10.2147/IJNRD.S47179; Lazar ES, 2007, SEMIN DIALYSIS, V20, P83, DOI 10.1111/j.1525-139X.2007.00248.x; Li X, 2007, J BIOL CHEM, V282, P33098, DOI 10.1074/jbc.M611781200; Norenstedt S, 2014, J BONE MINER RES, V29, P960, DOI 10.1002/jbmr.2102; Nowack R, 2006, CLIN LAB, V52, P583; PARFITT AM, 1994, J CELL BIOCHEM, V55, P273, DOI 10.1002/jcb.240550303; Qin L, 2005, J BIOL CHEM, V280, P3104, DOI 10.1074/jbc.M409846200; Rolighed L, 2013, LANGENBECK ARCH SURG, V398, P113, DOI 10.1007/s00423-012-1026-5; Sabeel A, 2000, AM J NEPHROL, V20, P421, DOI 10.1159/000013630; Sasaki Muneteru, 2013, Clin Calcium, V23, P347, DOI CliCa1303347353; Schaefer F, 2000, Novartis Found Symp, V227, P225; Schaefer F, 2000, NOVARTIS FOUND SYMP, V227, P239; Schmitt CP, 2005, PEDIATR NEPHROL, V20, P346, DOI 10.1007/s00467-004-1767-7; Schmitt CP, 2003, J AM SOC NEPHROL, V14, P407, DOI 10.1097/01.ASN.0000043905.35268.86; Shavit L, 2012, CLIN NEPHROL, V78, P399, DOI 10.5414/CN107031; Song JF, 2014, MED SCI MONITOR, V20, P2624, DOI 10.12659/MSM.892581; Sugimoto T, 2014, OSTEOPOROSIS INT, V25, P1173, DOI 10.1007/s00198-013-2516-1; Tian Y, 2011, MOL CELL BIOCHEM, V355, P211, DOI 10.1007/s11010-011-0856-8; Tsuruta Y, 2013, CLIN EXP NEPHROL, V17, P120, DOI 10.1007/s10157-012-0665-8; UDAGAWA N, 1990, P NATL ACAD SCI USA, V87, P7260, DOI 10.1073/pnas.87.18.7260; van der Horst G, 2005, J BONE MINER RES, V20, P2233, DOI 10.1359/JBMR.050821; Viaene L, 2008, NEPHRON CLIN PRACT, V110, pC80, DOI 10.1159/000151722; Wang YH, 2005, J BONE MINER RES, V20, P5, DOI 10.1359/JBMR.041016; Witteveen JE, 2013, EUR J ENDOCRINOL, V168, pR45, DOI 10.1530/EJE-12-0528; Yajima A, 2003, AM J KIDNEY DIS, V42, P729, DOI 10.1016/S0272-6386(03)00909-0; Yajima A, 2001, CLIN NEPHROL, V56, P27; Yajima A, 2008, KIDNEY INT, V74, P775, DOI 10.1038/ki.2008.242; Yamanouchi M, 2013, CLIN NEPHROL, V79, P380, DOI 10.5414/CN107661; Yano M, 2012, ENDOCR J, V59, P653, DOI 10.1507/endocrj.EJ12-0022; Yeh SM, 2009, HEMODIAL INT, V13, P163, DOI 10.1111/j.1542-4758.2009.00353.x; Zheng CM, 2012, TOHOKU J EXP MED, V226, P19, DOI 10.1620/tjem.226.19	51	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120402	10.1371/journal.pone.0120402	http://dx.doi.org/10.1371/journal.pone.0120402			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775025	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500169
J	Marini, JC; Didelija, IC				Marini, Juan C.; Didelija, Inka Cajo			Arginine Depletion by Arginine Deiminase Does Not Affect Whole Protein Metabolism or Muscle Fractional Protein Synthesis Rate in Mice	PLOS ONE			English	Article							SKELETAL-MUSCLE; CANCER-PATIENTS; CITRULLINE; CACHEXIA; GLUTAMINE; DEGRADATION; ENZYMES; BODY; MASS	Due to the absolute need for arginine that certain cancer cells have, arginine depletion is a therapy in clinical trials to treat several types of cancers. Arginine is an amino acids utilized not only as a precursor for other important molecules, but also for protein synthesis. Because arginine depletion can potentially exacerbate the progressive loss of body weight, and especially lean body mass, in cancer patients we determined the effect of arginine depletion by pegylated arginine deiminase (ADI-PEG 20) on whole body protein synthesis and fractional protein synthesis rate in multiple tissues of mice. ADI-PEG 20 successfully depleted circulating arginine (< 1 mu mol/L), and increased citrulline concentration more than tenfold. Body weight and body composition, however, were not affected by ADI-PEG 20. Despite the depletion of arginine, whole body protein synthesis and breakdown were maintained in the ADI-PEG 20 treated mice. The fractional protein synthesis rate of muscle was also not affected by arginine depletion. Most tissues (liver, kidney, spleen, heart, lungs, stomach, small and large intestine, pancreas) were able to maintain their fractional protein synthesis rate; however, the fractional protein synthesis rate of brain, thymus and testicles was reduced due to the ADI-PEG 20 treatment. Furthermore, these results were confirmed by the incorporation of ureido [C-14] citrulline, which indicate the local conversion into arginine, into protein. In conclusion, the intracellular recycling pathway of citrulline is able to provide enough arginine to maintain protein synthesis rate and prevent the loss of lean body mass and body weight.	[Marini, Juan C.] Baylor Coll Med, Dept Pediat, Sect Crit Care Med, Houston, TX 77030 USA; [Marini, Juan C.; Didelija, Inka Cajo] Baylor Coll Med, Dept Pediat, USDA ARS, Childrens Nutr Res Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; United States Department of Agriculture (USDA)	Marini, JC (corresponding author), Baylor Coll Med, Dept Pediat, Sect Crit Care Med, Houston, TX 77030 USA.	marini@bcm.edu			federal funds from the United States Department of Agriculture, Agricultural Research Service under Cooperative Agreement [58-6250-6-001]; National Institutes of Health, National Institute of General Medical Sciences [GM108940]; ARS [ARS-0426348] Funding Source: Federal RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108940] Funding Source: NIH RePORTER	federal funds from the United States Department of Agriculture, Agricultural Research Service under Cooperative Agreement; National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by federal funds from the United States Department of Agriculture, Agricultural Research Service under Cooperative Agreement Number 58-6250-6-001 (http://www.ars.usda.gov/main/main.htm) and the National Institutes of Health, National Institute of General Medical Sciences (GM108940; http://www.nigms.nih.gov/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball RO, 2007, J NUTR, V137, p1626S, DOI 10.1093/jn/137.6.1626S; Berk L, 2008, SUPPORT CARE CANCER, V16, P1179, DOI 10.1007/s00520-008-0403-7; Brosnan ME, 2004, J NUTR, V134, p2791S, DOI 10.1093/jn/134.10.2791S; COHEN PP, 1946, J BIOL CHEM, V166, P239; DEWYS WD, 1986, CLINICS ONCOL, V5, P251; Dworzak F, 1998, CANCER, V82, P42, DOI 10.1002/(SICI)1097-0142(19980101)82:1<42::AID-CNCR5>3.0.CO;2-M; Eley HL, 2007, J BIOL CHEM, V282, P7087, DOI 10.1074/jbc.M610378200; Fearon K, 2013, NAT REV CLIN ONCOL, V10, P90, DOI 10.1038/nrclinonc.2012.209; FEATHERSTON WR, 1973, AM J PHYSIOL, V224, P127, DOI 10.1152/ajplegacy.1973.224.1.127; Feun L, 2008, CURR PHARM DESIGN, V14, P1049, DOI 10.2174/138161208784246199; Jobgen WS, 2006, J NUTR BIOCHEM, V17, P571, DOI 10.1016/j.jnutbio.2005.12.001; Johns N, 2013, INT J BIOCHEM CELL B, V45, P2215, DOI 10.1016/j.biocel.2013.05.032; Marini JC, 2014, AM J PHYSIOL-RENAL, V307, pF660, DOI 10.1152/ajprenal.00289.2014; Marini JC, 2012, J NUTR, V142, P572, DOI 10.3945/jn.111.153825; Marini JC, 2011, RAPID COMMUN MASS SP, V25, P1291, DOI 10.1002/rcm.5007; Marini JC, 2010, AM J PHYSIOL-ENDOC M, V299, pE69, DOI 10.1152/ajpendo.00080.2010; Matthews DE, 2007, J NUTR, V137, p1549S, DOI 10.1093/jn/137.6.1549S; Mauldin JP, 2012, TRANSL ONCOL, V5, P26, DOI 10.1593/tlo.11262; Molfino A, 2014, CURR OPIN CLIN NUTR, V17, P471, DOI 10.1097/MCO.0000000000000075; Ott PA, 2013, INVEST NEW DRUG, V31, P425, DOI 10.1007/s10637-012-9862-2; Pasut G, 2009, ADV DRUG DELIVER REV, V61, P1177, DOI 10.1016/j.addr.2009.02.010; Phillips MM, 2013, CANCER RES TREAT, V45, P251, DOI 10.4143/crt.2013.45.4.251; RATNER S, 1973, ADV ENZYMOL RAMB, V39, P1; Roberts BM, 2013, BIOCHEM BIOPH RES CO, V435, P488, DOI 10.1016/j.bbrc.2013.05.018; Shen LJ, 2006, CURR OPIN MOL THER, V8, P240; SMITH KL, 1993, BRIT J CANCER, V67, P680, DOI 10.1038/bjc.1993.126; Synakiewicz A, 2014, EXPERT OPIN INV DRUG, V26, P1; Taskin S, 2014, J CELL MOL MED, V18, P69, DOI 10.1111/jcmm.12165; Taus M, 2014, NUTR THER METAB, V32, P10; Thomas JB, 2002, BIOCHEM J, V363, P581, DOI 10.1042/0264-6021:3630581; Tisdale MJ, 2002, NAT REV CANCER, V2, P862, DOI 10.1038/nrc927; Tsai SS, 2012, NUTR CLIN PRACT, V27, P593, DOI 10.1177/0884533612457949; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Uster A, 2013, NUTRITION, V29, P1342, DOI 10.1016/j.nut.2013.05.004; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yao K, 2008, J NUTR, V138, P867, DOI 10.1093/jn/138.5.867	36	15	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119801	10.1371/journal.pone.0119801	http://dx.doi.org/10.1371/journal.pone.0119801			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775142	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500125
J	Moratti, E; Vezzalini, M; Tomasello, L; Giavarina, D; Sorio, C				Moratti, Elisabetta; Vezzalini, Marzia; Tomasello, Luisa; Giavarina, Davide; Sorio, Claudio			Identification of Protein Tyrosine Phosphatase Receptor Gamma Extracellular Domain (sPTPRG) as a Natural Soluble Protein in Plasma	PLOS ONE			English	Article							SECRETASE-MEDIATED CLEAVAGE; MASS-SPECTROMETRY; PTP-GAMMA; IN-VITRO; EXPRESSION; GENE; LAR; CELLS; LIVER; BETA	Background PTPRG is a widely expressed protein tyrosine phosphatase present in various isoforms. Peptides from its extracellular domain have been detected in plasma by proteomic techniques. We aim at characterizing the plasmatic PTPRG (sPTPRG) form and to identify its source. Methodology/Principal Findings The expression of sPTPRG was evaluated in human plasma and murine plasma and tissues by immunoprecipitation and Western blotting. The polypeptides identified have an apparent Mr of about 120 kDa (major band) and 90 kDa (minor band) respectively. Full length PTPRG was identified in the 100.000xg pelleted plasma fraction, suggesting that it was present associated to cell-derived vesicles (exosomes). The release of sPTPRG by HepG2 human hepatocellular carcinoma cell line was induced by ethanol and sensitive to metalloproteinase and not to Furin inhibitors. Finally, increased levels of the plasmatic similar to 120 kDa isoform were associated with the occurrence of liver damage. Conclusions These results demonstrate that sPTPRG represent a novel candidate protein biomarker in plasma whose increased expression is associated to hepatocyte damage. This observation could open a new avenue of investigation in this challenging field.	[Moratti, Elisabetta; Vezzalini, Marzia; Tomasello, Luisa; Sorio, Claudio] Univ Verona, Dept Pathol & Diagnost, I-37100 Verona, Italy; [Giavarina, Davide] St Bortolo Hosp, Clin Chem & Hematol Lab, Vicenza, Italy	University of Verona; ULSS 8 Berica; Ospedale San Bortolo di Vicenza	Sorio, C (corresponding author), Univ Verona, Dept Pathol & Diagnost, I-37100 Verona, Italy.	claudio.sorio@univr.it	Giavarina, Davide/I-7331-2016; Sorio, Claudio/F-2764-2018	Giavarina, Davide/0000-0001-9589-178X; Sorio, Claudio/0000-0003-2739-4014; Vezzalini, Marzia/0000-0002-5476-0844	Associazione Italiana per la Ricerca sul Cancro [AIRC-IG 4667]; NPRP grant from the Qatar National Research Fund (Qatar Foundation) [4-157-3-052]	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); NPRP grant from the Qatar National Research Fund (Qatar Foundation)	The authors were supported by Associazione Italiana per la Ricerca sul Cancro (Investigator grant: AIRC-IG 4667 issued to CS) and and NPRP grant 4-157-3-052 from the Qatar National Research Fund (a member of the Qatar Foundation). The statements made herein are solely the responsibility of the author(s). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher B, 1997, J CELL BIOL, V138, P681, DOI 10.1083/jcb.138.3.681; Boucher CA, 2011, BBA-MOL BASIS DIS, V1812, P1225, DOI 10.1016/j.bbadis.2010.11.006; Cameron A, 2000, J BIOL CHEM, V275, P36741, DOI 10.1074/jbc.M003848200; Campan M, 1996, BIOCHEMISTRY-US, V35, P3797, DOI 10.1021/bi952552d; Cheung AKL, 2008, CANCER RES, V68, P8137, DOI 10.1158/0008-5472.CAN-08-0904; Choi D. S., 2014, MASS SPECTROM REV; Chow JPH, 2008, J BIOL CHEM, V283, P30879, DOI 10.1074/jbc.M802976200; Della Peruta M, 2010, CANCER RES, V70, P8896, DOI 10.1158/0008-5472.CAN-10-0258; Eguchi A, 2014, J HEPATOL; EHLERS MRW, 1991, BIOCHEMISTRY-US, V30, P10065, DOI 10.1021/bi00106a001; GEBBINK MFBG, 1995, J CELL BIOL, V131, P251, DOI 10.1083/jcb.131.1.251; Haapasalo A, 2007, J BIOL CHEM, V282, P9063, DOI 10.1074/jbc.M611324200; Kapp K, 2012, EUR J CELL BIOL, V91, P687, DOI 10.1016/j.ejcb.2012.04.003; Lamprianou S, 2006, MOL CELL BIOL, V26, P5106, DOI 10.1128/MCB.00101-06; Lewis JA, 2010, J PROTEOME RES, V9, P5794, DOI 10.1021/pr1005668; Liu T, 2005, J PROTEOME RES, V4, P2070, DOI 10.1021/pr0502065; Liu T, 2006, MOL CELL PROTEOMICS, V5, P1899, DOI 10.1074/mcp.M600068-MCP200; Lorenzetto E, 2013, BRAIN STRUCT FUNCT; Mafficini A, 2007, BIOMARK INSIGHTS, V2, P218; Montes de Oca BP, 2010, CENT NERV SYST AGENT, V10, P337; Pan XP, 2012, HEPATOB PANCREAT DIS, V11, P594, DOI 10.1016/S1499-3872(12)60230-6; Panagopoulos I, 1996, CANCER RES, V56, P4871; Sakurai T, 1996, J NEUROSCI RES, V43, P694, DOI 10.1002/(SICI)1097-4547(19960315)43:6<694::AID-JNR6>3.3.CO;2-9; Shintani T, 1997, BIOCHEM BIOPH RES CO, V230, P419, DOI 10.1006/bbrc.1996.5973; SORIO C, 1995, CANCER RES, V55, P4855; STREULI M, 1992, EMBO J, V11, P897, DOI 10.1002/j.1460-2075.1992.tb05128.x; Tanner S, 2007, GENOME RES, V17, P231, DOI 10.1101/gr.5646507; Vezzalini M, 2007, HISTOPATHOLOGY, V50, P615, DOI 10.1111/j.1365-2559.2007.02661.x; Wang C, 2010, J CELL BIOCHEM, V109, P113, DOI 10.1002/jcb.22387; Wang ZH, 2004, SCIENCE, V304, P1164, DOI 10.1126/science.1096096; Zhang WD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045500	31	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119110	10.1371/journal.pone.0119110	http://dx.doi.org/10.1371/journal.pone.0119110			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775014	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500070
J	Pei, JB; Li, H; Li, SY; An, TT; Farmer, J; Fu, SF; Wang, JK				Pei, Jiubo; Li, Hui; Li, Shuangyi; An, Tingting; Farmer, John; Fu, Shifeng; Wang, Jingkuan			Dynamics of Maize Carbon Contribution to Soil Organic Carbon in Association with Soil Type and Fertility Level	PLOS ONE			English	Article							RESIDUE DECOMPOSITION; FRACTIONATION; FERTILIZATION; FLUXES; RATIOS; STRAW; POOLS	Soil type and fertility level influence straw carbon dynamics in the agroecosystems. However, there is a limited understanding of the dynamic processes of straw-derived and soil-derived carbon and the influence of the addition of straw carbon on soil-derived organic carbon in different soils associated with different fertility levels. In this study, we applied the in-situ carborundum tube method and C-13-labeled maize straw (with and without maize straw) at two cropland (Phaeozem and Luvisol soils) experimental sites in northeast China to quantify the dynamics of maize-derived and soil-derived carbon in soils associated with high and low fertility, and to examine how the addition of maize carbon influences soil-derived organic carbon and the interactions of soil type and fertility level with maize-derived and soil-derived carbon. We found that, on average, the contributions of maize-derived carbon to total organic carbon in maize-soil systems during the experimental period were differentiated among low fertility Luvisol (from 62.82% to 42.90), high fertility Luvisol (from 53.15% to 30.00%), low fertility Phaeozem (from 58.69% to 36.29%) and high fertility Phaeozem (from 41.06% to 16.60%). Furthermore, the addition of maize carbon significantly decreased the remaining soil-derived organic carbon in low and high fertility Luvisols and low fertility Phaeozem before two months. However, the increasing differences in soil-derived organic carbon between both soils with and without maize straw after two months suggested that maize-derived carbon was incorporated into soil-derived organic carbon, thereby potentially offsetting the loss of soil-derived organic carbon. These results suggested that Phaeozem and high fertility level soils would fix more maize carbon over time and thus were more beneficial for protecting soil-derived organic carbon from maize carbon decomposition.	[Pei, Jiubo; Li, Hui; Li, Shuangyi; An, Tingting; Farmer, John; Fu, Shifeng; Wang, Jingkuan] Shenyang Agr Univ, Coll Land & Environm, Minist Agr, Key Lab Northeast Cultivated Land Conservat, Shenyang 110161, Liaoning Provin, Peoples R China	Ministry of Agriculture & Rural Affairs; Shenyang Agricultural University	Wang, JK (corresponding author), Shenyang Agr Univ, Coll Land & Environm, Minist Agr, Key Lab Northeast Cultivated Land Conservat, Shenyang 110161, Liaoning Provin, Peoples R China.	j-kwang@163.com	An, Tingting/V-9666-2017; An, Tingting/M-2186-2017	An, Tingting/0000-0002-5263-7375; An, Tingting/0000-0002-5263-7375	National Science Foundation of China [41171237, 31330011]; Strategic Priority Research Program of Chinese Academy of Sciences [XDA05050501]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of Chinese Academy of Sciences(Chinese Academy of Sciences)	Financial support comes from the National Science Foundation of China (41171237 and 31330011) and the Strategic Priority Research Program of Chinese Academy of Sciences (XDA05050501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam F, 1985, PLANT SOIL, V86, P15; An TT, 2015, SOIL BIOL BIOCHEM, V80, P53, DOI 10.1016/j.soilbio.2014.09.024; [Anonymous], 2010, CHINESE AGR SCI B, DOI DOI 10.1007/S11355-019-00403-9; Brady N.C, 2000, NATURE PROPERTIES SO; Bromand S, 2001, PLANT SOIL, V235, P253, DOI 10.1023/A:1011922103323; Casado-Murillo N., 2013, The Open Agriculture Journal, V7, P11, DOI 10.2174/1874331501307010011; Chen Xing-li, 2009, Yingyong Shengtai Xuebao, V20, P314; Coleman D.C., 1991, CARBON ISOTOPE TECHN; Comeau LP, 2013, BIOL FERT SOILS, V49, P1179, DOI 10.1007/s00374-013-0816-4; Conrad R, 2012, SOIL BIOL BIOCHEM, V49, P193, DOI 10.1016/j.soilbio.2012.02.030; Dijkstra FA, 2007, SOIL BIOL BIOCHEM, V39, P2264, DOI 10.1016/j.soilbio.2007.03.026; Dou Sen, 2003, Acta Pedologica Sinica, V40, P328; Follett RF, 1997, SOIL SCI SOC AM J, V61, P1068, DOI 10.2136/sssaj1997.03615995006100040012x; Han FP, 2010, GEODERMA, V154, P261, DOI 10.1016/j.geoderma.2009.10.011; IUSS Working Group WRB, 2014, WORLD SOIL RES REP, V106; Jiang Yong, 2007, Shengtaixue Zazhi, V26, P278; JMP SAS Institute Inc, 2012, JMP 10 BASIC ANAL GR, VSecond; Juarez S, 2013, EUR J SOIL BIOL, V58, P81, DOI 10.1016/j.ejsobi.2013.06.005; Kuzyakov Y, 2000, SOIL BIOL BIOCHEM, V32, P1485, DOI 10.1016/S0038-0717(00)00084-5; Lal R., 2007, Mitigation and Adaptation Strategies for Global Change, V12, P303, DOI 10.1007/s11027-006-9036-7; Leng YH., 2008, THESIS U SHENYANG AG; Liang Yao, 2011, Scientia Agricultura Sinica, V44, P3565; Lin X. X., 1981, Acta Pedologica Sinica, V18, P97; Liu Min, 2007, Yingyong Shengtai Xuebao, V18, P2503; Liu S, 2013, AFR J AGR RES, V8, P1411; Majumder B, 2008, BIOL FERT SOILS, V44, P451, DOI 10.1007/s00374-007-0226-6; Pineiro G, 2006, GLOBAL CHANGE BIOL, V12, P804, DOI 10.1111/j.1365-2486.2006.01139.x; Rochette P, 1999, SOIL SCI SOC AM J, V63, P1385, DOI 10.2136/sssaj1999.6351385x; Rui JP, 2009, APPL ENVIRON MICROB, V75, P4879, DOI 10.1128/AEM.00702-09; Shen QR, 2000, PLANT NUTR FERT SCI, V6, P98; Studdert GA, 2000, SOIL SCI SOC AM J, V64, P1496, DOI 10.2136/sssaj2000.6441496x; Sylvia D., 2005, PRINCIPLES APPL SOIL, Vsecond; Thuries L, 2001, SOIL BIOL BIOCHEM, V33, P997, DOI 10.1016/S0038-0717(01)00003-7; Vaieretti MV, 2005, PLANT SOIL, V278, P223, DOI 10.1007/s11104-005-8432-1; Wang LiLi, 2013, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V21, P1073, DOI 10.3724/SP.J.1011.2013.01073; [汪太明 Wang Taiming], 2010, [生态环境学报, Ecology and Environmental Sciences], V19, P2870; Wang XuDong, 2009, Transactions of the Chinese Society of Agricultural Engineering, V25, P252; Werth M, 2006, PLANT SOIL, V284, P319, DOI 10.1007/s11104-006-0054-8; Wingeyer AB, 2011, THESIS U NEBRASKA LI; Xu XC, 1985, CHIN J SOIL SCI, V1, P21, DOI DOI 10.19336/J.CNKI.TRTB.1985.01.007; Yu S., 2009, THESIS U SHENYANG AG	41	11	21	9	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120825	10.1371/journal.pone.0120825	http://dx.doi.org/10.1371/journal.pone.0120825			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774529	gold, Green Published, Green Submitted			2022-12-27	WOS:000351183500192
J	Qin, SS; Ricotta, V; Simon, M; Clark, RAF; Rafailovich, MH				Qin, Sisi; Ricotta, Vincent; Simon, Marcia; Clark, Richard A. F.; Rafailovich, Miriam H.			Continual Cell Deformation Induced via Attachment to Oriented Fibers Enhances Fibroblast Cell Migration	PLOS ONE			English	Article							MYOSIN-IIA; EXTRACELLULAR-MATRIX; ADHESION; NUCLEUS; ROLES	Fibroblast migration is critical to the wound healing process. In vivo, migration occurs on fibrillar substrates, and previous observations have shown that a significant time lag exists before the onset of granulation tissue. We therefore conducted a series of experiments to understand the impact of both fibrillar morphology and migration time. Substrate topography was first shown to have a profound influence. Fibroblasts preferentially attach to fibrillar surfaces, and orient their cytoplasm for maximal contact with the fiber edge. In the case of enmass cell migration out of an agarose droplet, fibroblasts on flat surfaces emerged with an enhanced velocity, v = 52 mu m/h, that decreases to the single cell value, v = 28 mu m/h within 24 hours and remained constant for at least four days. Fibroblasts emerging on fibrillar surfaces emerged with the single cell velocity, which remained constant for the first 24 hours and then increased reaching a plateau with more than twice the initial velocity within the next three days. The focal adhesions were distributed uniformly in cells on flat surfaces, while on the fibrillar surface they were clustered along the cell periphery. Furthermore, the number of focal adhesions for the cells on the flat surfaces remained constant, while it decreased on the fibrillar surface during the next three days. The deformation of the cell nuclei was found to be 50% larger on the fiber surfaces for the first 24 hours. While the mean deformation remained constant on the flat surface, it increased for the next three days by 24% in cells on fibers. On the fourth day, large actin/myosin fibers formed in cells on fibrillar surfaces only and coincided with a change from the standard migration mechanism involving extension of lamellipodia, and retraction of the rear, to one involving strong contractions oriented along the fibers and centered about the nucleus.	[Qin, Sisi; Ricotta, Vincent; Rafailovich, Miriam H.] SUNY Stony Brook, Dept Mat Sci & Engn, Stony Brook, NY 11794 USA; [Simon, Marcia] SUNY Stony Brook, Sch Dent, Stony Brook, NY 11794 USA; [Clark, Richard A. F.] SUNY Stony Brook, Dept Bioengn, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Rafailovich, MH (corresponding author), SUNY Stony Brook, Dept Mat Sci & Engn, Stony Brook, NY 11794 USA.	Miriam.rafailovich@stonybrook.edu			National Science Foundation [1344267]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation (Inspire Program Award number: 1344267). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry CC, 2004, BIOMATERIALS, V25, P5781, DOI 10.1016/j.biomaterials.2004.01.029; Cai YF, 2010, J CELL SCI, V123, P413, DOI 10.1242/jcs.058297; Chen CS, 2007, BIOPHYS J, V92, P2984, DOI 10.1529/biophysj.106.100065; Doyle AD, 2012, J CELL SCI, V125, P2244, DOI 10.1242/jcs.098806; Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041; Fomproix N, 2004, EXP CELL RES, V294, P140, DOI 10.1016/j.yexcr.2003.10.028; Friedl P, 2011, CURR OPIN CELL BIOL, V23, P55, DOI 10.1016/j.ceb.2010.10.015; Grinnell F, 2006, EXP CELL RES, V312, P86, DOI 10.1016/j.yexcr.2005.010.001; Grinnell F, 2003, TRENDS CELL BIOL, V13, P264, DOI 10.1016/S0962-8924(03)00057-6; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; Grinnell F, 2010, ANNU REV CELL DEV BI, V26, P335, DOI 10.1146/annurev.cellbio.042308.113318; Heissler SM, 2013, CELL MOL LIFE SCI, V70, P1, DOI 10.1007/s00018-012-1002-9; Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074; Jeon H, 2010, BIOMATERIALS, V31, P4286, DOI 10.1016/j.biomaterials.2010.01.103; Jorrisch MH, 2013, BIOL OPEN, V2, P368, DOI 10.1242/bio.20133707; Kaiser JP, 2006, BIOMATERIALS, V27, P5230, DOI 10.1016/j.biomaterials.2006.06.002; Kim DH, 2013, FASEB J, V27, P1351, DOI 10.1096/fj.12-220160; Liu Y, 2009, EXP CELL RES, V315, P2544, DOI 10.1016/j.yexcr.2009.05.013; Lombardi ML, 2011, J BIOL CHEM, V286, P26743, DOI 10.1074/jbc.M111.233700; McClain SA, 1996, AM J PATHOL, V149, P1257; Pan Z, 2009, BIOPHYS J, V96, P4286, DOI 10.1016/j.bpj.2009.02.039; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Rossier OM, 2010, EMBO J, V29, P1055, DOI 10.1038/emboj.2010.2; Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x; Sheets K, 2013, ACTA BIOMATER, V9, P7169, DOI 10.1016/j.actbio.2013.03.042; Shih WT, 2010, BIOPHYS J, V98, pL29, DOI 10.1016/j.bpj.2010.02.028; SINGER II, 1987, J CELL BIOL, V104, P573, DOI 10.1083/jcb.104.3.573; Swailes NT, 2006, J CELL SCI, V119, P3561, DOI 10.1242/jcs.03096; Tamada M, 2007, J CELL BIOL, V176, P27, DOI 10.1083/jcb.200609116; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wang HB, 2010, ACTA BIOMATER, V6, P2970, DOI 10.1016/j.actbio.2010.02.020; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Watterson KR, 2007, WOUND REPAIR REGEN, V15, P607, DOI 10.1111/j.1524-475X.2007.00292.x; Wolf K, 2013, J CELL BIOL, V201, P1069, DOI 10.1083/jcb.201210152	34	14	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119094	10.1371/journal.pone.0119094	http://dx.doi.org/10.1371/journal.pone.0119094			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774792	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500068
J	Tohti, M; Li, JY; Zhou, Y; Hu, YB; Yu, Z; Ma, CY				Tohti, Mamatemin; Li, Junyang; Zhou, Yuan; Hu, Yuebing; Yu, Zhuang; Ma, Chiyuan			Is Peri-Operative Steroid Replacement Therapy Necessary for the Pituitary Adenomas Treated with Surgery? A Systematic Review and Meta Analysis	PLOS ONE			English	Article							MORNING SERUM CORTISOL; GLUCOCORTICOID REPLACEMENT; ADRENAL AXIS; TRANSSPHENOIDAL SURGERY; INSULIN HYPOGLYCEMIA; ADENOMECTOMY; INSUFFICIENCY; TUMORS; TESTS	Background Patients with pituitary adenomas usually receive "stress dose" steroids in the peri-operative peroids. Though randomized controlled trials(RCT) have not been performed to assess the necessity of steroid coverage, there are several studies that explained the changes of adrenal function during peri-operative peroids. The aim of the present study is to investigate whether it is necessary to employ conventional peri-operative glucocorticoid replacement therapy to all the patients undergoing surgery. Methods We searched studies addressing peri-operative steroids coverage for pituitary adenomas in the Web of Science, Medline and the Cochrane Library. Then we extracted studies about peri-operative morning serum cortisol(MSC) levels, morbidity of early postoperative adrenal insufficiency, postoperative diabetes insipidus, relationships between MSC levels and adrenal integrity. We used RevMan Software to combine the results for meta-analysis. We used fixed-effects models for there was no significant heterogeneity existed. Findings There are 18 studies from 11 countries published between 1987 and 2013 including 1224 patients. The postoperative serum cortisol levels were significantly increased compared with the preoperative one in hypothalamic-pituitary-adrenal axis(HPAA) functions preserved patients(P<0.00001). The morbidity of early postoperative adrenal insufficiency ranged from 0.96% to 12.90%, with the overall morbidity of 5.55%(41/739). There was no significant differences of early postoperative diabetes insipidus between no supplementation patients and in supplementation patients(P=0.82). Conversely, there may be some disadvantages of high levels of cortisols such as high incidence of osteopenia and bone derangement and even the increased mortality rate. The patients with MSC levels of less than 60 nmol/l at 3 days after operation is considered as adrenal insufficient and more than 270 nmol/l as adrenal sufficient. To patients with MSC levels of 60-270 nmol/l, we need more clinical data to establish further cortisol supplementation criteria.	[Tohti, Mamatemin; Li, Junyang; Zhou, Yuan; Hu, Yuebing; Yu, Zhuang; Ma, Chiyuan] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University	Ma, CY (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing 210008, Jiangsu, Peoples R China.	machiyuan_nju@126.com		Ma, Chiyuan/0000-0002-1710-5955	National Natural Science Foundation of China [30801178]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (for CYM, NO: 30801178). The sponsor of present study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in this study and had final responsibility for the decision to submit for publication.	AUBRY RH, 1965, J CLIN ENDOCR METAB, V25, P1481, DOI 10.1210/jcem-25-11-1481; Auchus RJ, 1997, CLIN ENDOCRINOL, V46, P21, DOI 10.1046/j.1365-2265.1997.d01-1748.x; Chong JSWLV, 2001, CLIN ENDOCRINOL, V54, P267, DOI 10.1046/j.1365-2265.2001.01200.x; Ciric I, 1997, NEUROSURGERY, V40, P225, DOI 10.1097/00006123-199702000-00001; Courtney CH, 2000, CLIN ENDOCRINOL, V53, P431, DOI 10.1046/j.1365-2265.2000.01106.x; Courtney CH, 2000, CLIN ENDOCRINOL, V53, P309; Cozzi R, 2009, J ENDOCRINOL INVEST, V32, P460, DOI 10.1007/BF03346486; De Tommasi C, 2012, ACTA NEUROCHIR, V154, P1903, DOI 10.1007/s00701-012-1474-2; Filipsson H, 2006, J CLIN ENDOCR METAB, V91, P3954, DOI 10.1210/jc.2006-0524; GARCIALUNA PP, 1990, ACTA ENDOCRINOL-COP, V122, P83, DOI 10.1530/acta.0.1220083; HAGG E, 1987, CLIN ENDOCRINOL, V26, P221, DOI 10.1111/j.1365-2265.1987.tb00780.x; HOUT WM, 1988, J CLIN ENDOCR METAB, V66, P1208, DOI 10.1210/jcem-66-6-1208; Inder WJ, 2002, J CLIN ENDOCR METAB, V87, P2745, DOI 10.1210/jc.87.6.2745; Jayasena CN, 2009, CLIN CHEM, V55, P972, DOI 10.1373/clinchem.2008.117374; Karaca Z, 2010, EUR J ENDOCRINOL, V163, P377, DOI 10.1530/EJE-10-0229; Klose M, 2005, CLIN ENDOCRINOL, V63, P499, DOI 10.1111/j.1365-2265.2005.02368.x; Kristof RA, 2008, ACTA NEUROCHIR, V150, P329, DOI 10.1007/s00701-008-1517-x; Marko NF, 2010, PITUITARY, V13, P249, DOI 10.1007/s11102-010-0227-6; Marko NF, 2009, J NEUROSURG, V111, P540, DOI 10.3171/2008.12.JNS081265; McLaughlin N, 2013, WORLD NEUROSURG, V80, P569, DOI 10.1016/j.wneu.2012.07.034; Okinaga B, 2005, ENDOCR J, V52, P751, DOI 10.1507/endocrj.52.751; Page RCL, 1994, J ENDOCRINOL, V140; Peacey SR, 1997, CLIN ENDOCRINOL, V46, P255, DOI 10.1046/j.1365-2265.1997.780907.x; Rajaratnam S, 2003, BRIT J NEUROSURG, V17, P437, DOI 10.1080/02688690310001611233; Regan Jacqueline, 2013, Front Endocrinol (Lausanne), V4, P30, DOI 10.3389/fendo.2013.00030; SALEM M, 1994, ANN SURG, V219, P416, DOI 10.1097/00000658-199404000-00013; UDELSMAN R, 1986, J CLIN INVEST, V77, P1377, DOI 10.1172/JCI112443; WATTS NB, 1988, JAMA-J AM MED ASSOC, V259, P708, DOI 10.1001/jama.259.5.708; Wentworth JM, 2008, CLIN ENDOCRINOL, V68, P29, DOI 10.1111/j.1365-2265.2007.02995.x; Zueger T, 2012, J CLIN ENDOCR METAB, V97, pE1938, DOI 10.1210/jc.2012-2432	30	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119621	10.1371/journal.pone.0119621	http://dx.doi.org/10.1371/journal.pone.0119621			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775019	Green Published, gold, Green Submitted			2022-12-27	WOS:000351183500106
J	Ligthart, S; de Vries, PS; Uitterlinden, AG; Hofman, A; Franco, OH; Chasman, DI; Dehghan, A				Ligthart, Symen; de Vries, Paul S.; Uitterlinden, Andre G.; Hofman, Albert; Franco, Oscar H.; Chasman, Daniel I.; Dehghan, Abbas		CHARGE Inflammation Working Grp	Pleiotropy among Common Genetic Loci Identified for Cardiometabolic Disorders and C-Reactive Protein	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; MENDELIAN RANDOMIZATION; ASSOCIATION ANALYSES; PLASMA-CONCENTRATION; ARTERY-DISEASE; RISK; HEALTH	Pleiotropic genetic variants have independent effects on different phenotypes. C-reactive protein (CRP) is associated with several cardiometabolic phenotypes. Shared genetic backgrounds may partially underlie these associations. We conducted a genome-wide analysis to identify the shared genetic background of inflammation and cardiometabolic phenotypes using published genome-wide association studies (GWAS). We also evaluated whether the pleiotropic effects of such loci were biological or mediated in nature. First, we examined whether 283 common variants identified for 10 cardiometabolic phenotypes in GWAS are associated with CRP level. Second, we tested whether 18 variants identified for serum CRP are associated with 10 cardiometabolic phenotypes. We used a Bonferroni corrected p-value of 1.1x10(-04) (0.05/463) as a threshold of significance. We evaluated the independent pleiotropic effect on both phenotypes using individual level data from the Women Genome Health Study. Evaluating the genetic overlap between inflammation and cardiometabolic phenotypes, we found 13 pleiotropic regions. Additional analyses showed that 6 regions (APOC1, HNF1A, IL6R, PPP1R3B, HNF4A and IL1F10) appeared to have a pleiotropic effect on CRP independent of the effects on the cardiometabolic phenotypes. These included loci where individuals carrying the risk allele for CRP encounter higher lipid levels and risk of type 2 diabetes. In addition, 5 regions (GCKR, PABPC4, BCL7B, FTO and TMEM18) had an effect on CRP largely mediated through the cardiometabolic phenotypes. In conclusion, our results show genetic pleiotropy among inflammation and cardiometabolic phenotypes. In addition to reverse causation, our data suggests that pleiotropic genetic variants partially underlie the association between CRP and cardiometabolic phenotypes.	[Ligthart, Symen; de Vries, Paul S.; Uitterlinden, Andre G.; Hofman, Albert; Franco, Oscar H.; Dehghan, Abbas] Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Uitterlinden, Andre G.] Erasmus Univ, Med Ctr, Dept Internal Med, Rotterdam, Netherlands; [Chasman, Daniel I.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Harvard University; Brigham & Women's Hospital	Dehghan, A (corresponding author), Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands.	a.dehghan@erasmusmc.nl	Franco, Óscar H/ABE-2305-2020; Alizadeh, Behrooz Z Ziad/J-2921-2017; Dehghan, Abbas/ABE-7377-2020; Jamshidi, Yalda/AAL-1377-2020; Benjamin, Emelia/E-7103-2011; Ligthart, Symen/AAF-7185-2020; Ramachandran, Vasan/Y-2527-2019; Naitza, Silvia/D-5620-2017; Dehghan, Abbas/B-9896-2008; Smith, Albert Vernon/K-5150-2015; Aspelund, Thor/C-5983-2008; Sijbrands, Eric/A-1065-2009	Franco, Óscar H/0000-0002-4606-4929; Alizadeh, Behrooz Z Ziad/0000-0002-1415-8007; Jamshidi, Yalda/0000-0003-0151-6482; Benjamin, Emelia/0000-0003-4076-2336; Ramachandran, Vasan/0000-0001-7357-5970; de Vries, Paul/0000-0003-0964-0111; Koenig, Wolfgang/0000-0002-2064-9603; Soranzo, Nicole/0000-0003-1095-3852; Pramstaller, Peter P/0000-0002-9831-8302; Dehghan, Abbas/0000-0001-6403-016X; Bandinelli, Stefania/0000-0002-6491-0850; Smith, Albert Vernon/0000-0003-1942-5845; Keaney, John/0000-0002-0866-1837; Gieger, Christian/0000-0001-6986-9554; Pankow, James/0000-0001-7076-483X; Kuss, Oliver/0000-0003-3301-5869; Aspelund, Thor/0000-0002-7998-5433; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Shuldiner, Alan/0000-0001-9921-4305; Hoogeveen, Ron/0000-0003-2399-4653; Fuchsberger, Christian/0000-0002-5918-8947; Sijbrands, Eric/0000-0001-8857-7389	Nederlandse Organisatie voor Wetenschappelijk Onderzoek [916.12.154]; National Heart, Lung, and Blood Institute [HL043851, HL080467]; National Cancer Institute, the Donald W. Reynolds Foundation [CA047988]; Fondation Leducq; Amgen; National Institutes of Health (NIH) [N01-HC 25195 1, RO1 HL64753, R01 HL076784, 1 R01 AG028321]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [UM1CA182913] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076784, R01HL064753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028321] Funding Source: NIH RePORTER	Nederlandse Organisatie voor Wetenschappelijk Onderzoek(Netherlands Organization for Scientific Research (NWO)European Commission); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute, the Donald W. Reynolds Foundation; Fondation Leducq(Leducq Foundation); Amgen(Amgen); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Nederlandse Organisatie voor Wetenschappelijk Onderzoek grant [916.12.154 to A.D.]. The WGHS is supported by [HL043851] and [HL080467] from the National Heart, Lung, and Blood Institute and [CA047988] from the National Cancer Institute, the Donald W. Reynolds Foundation and the Fondation Leducq, with collaborative scientific support and funding for genotyping provided by Amgen. The CRP GWAS meta-analysis was supported by the National Institutes of Health (NIH) ([N01-HC 25195 1]; [RO1 HL64753]; [R01 HL076784]; [1 R01 AG028321]). Part of the funding for genotyping in the WGHS was provided by Amgen. Amgen has not been involved in the design, analysis and interpretation of the study. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Blake GJ, 2003, CIRCULATION, V108, P2993, DOI 10.1161/01.CIR.0000104566.10178.AF; Carter AJR, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-160; Collaboration CRPCHDG, 2011, BMJ BRITISH MEDICAL, V342; Cushman M, 2005, CIRCULATION, V112, P25, DOI 10.1161/CIRCULATIONAHA.104.504159; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Dehghan A, 2007, DIABETES, V56, P872, DOI 10.2337/db06-0922; Dehghan A, 2011, CIRCULATION, V123, P731, DOI 10.1161/CIRCULATIONAHA.110.948570; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Elliott P, 2009, JAMA-J AM MED ASSOC, V302, P37, DOI 10.1001/jama.2009.954; Hindorff LA, 2008, ATHEROSCLEROSIS, V197, P922, DOI 10.1016/j.atherosclerosis.2007.08.012; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; McIntyre LM, 2000, GENET EPIDEMIOL, V19, P18, DOI 10.1002/1098-2272(200007)19:1<18::AID-GEPI2>3.0.CO;2-Y; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; NATHAN DM, 1984, NEW ENGL J MED, V310, P341, DOI 10.1056/NEJM198402093100602; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Olden M, 2013, AM J KIDNEY DIS, V61, P889, DOI 10.1053/j.ajkd.2012.12.024; Peng G, 2010, EUR J HUM GENET, V18, P111, DOI 10.1038/ejhg.2009.115; Reiner AP, 2009, CIRC-CARDIOVASC GENE, V2, P244, DOI 10.1161/CIRCGENETICS.108.839506; Ridker PM, 2008, CLIN CHEM, V54, P249, DOI 10.1373/clinchem.2007.099366; Ridker PM, 1998, CIRCULATION, V97, P425; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Rocha VZ, 2009, NAT REV CARDIOL, V6, P399, DOI 10.1038/nrcardio.2009.55; Rost NS, 2001, STROKE, V32, P2575, DOI 10.1161/hs1101.098151; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Sesso HD, 2003, JAMA-J AM MED ASSOC, V290, P2945, DOI 10.1001/jama.290.22.2945; Smith GD, 2005, ARTERIOSCL THROM VAS, V25, P1051, DOI 10.1161/01.ATV.0000160351.95181.d0; Solovieff N, 2013, NAT REV GENET, V14, P483, DOI 10.1038/nrg3461; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Team RC, 2012, R LANG ENV STAT COMP; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Timpson NJ, 2011, INT J OBESITY, V35, P300, DOI 10.1038/ijo.2010.137; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Williams GC, 2001, SCI AGING KNOWLEDGE, V2001, pcp13	36	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118859	10.1371/journal.pone.0118859	http://dx.doi.org/10.1371/journal.pone.0118859			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768928	Green Published, Green Accepted, gold			2022-12-27	WOS:000351277500050
J	Singh, V; Kaul, SC; Wadhwa, R; Pati, PK				Singh, Varinder; Kaul, Sunil C.; Wadhwa, Renu; Pati, Pratap Kumar			Evaluation and Selection of Candidate Reference Genes for Normalization of Quantitative RT-PCR in Withania somnifera (L.) Dunal	PLOS ONE			English	Article							REAL-TIME PCR; HOUSEKEEPING GENES; INTERNAL CONTROL; LIPID-PEROXIDATION; EXPRESSION; VALIDATION; IDENTIFICATION; CANCER; MODEL; LEAF	Quantitative real-time PCR (qRT-PCR) is now globally used for accurate analysis of transcripts levels in plants. For reliable quantification of transcripts, identification of the best reference genes is a prerequisite in qRT-PCR analysis. Recently, Withania somnifera has attracted lot of attention due to its immense therapeutic potential. At present, biotechnological intervention for the improvement of this plant is being seriously pursued. In this background, it is important to have comprehensive studies on finding suitable reference genes for this high valued medicinal plant. In the present study, 11 candidate genes were evaluated for their expression stability under biotic (fungal disease), abiotic (wounding, salt, drought, heat and cold) stresses, in different plant tissues and in response to various plant growth regulators (methyl jasmonate, salicylic acid, abscisic acid). The data as analyzed by various software packages (geNorm, NormFinder, Bestkeeper and Delta Ct method) suggested that cyclophilin (CYP) is a most stable gene under wounding, heat, methyl jasmonate, different tissues and all stress conditions. T-SAND was found to be a best reference gene for salt and salicylic acid (SA) treated samples, while 26S ribosomal RNA (26S), ubiquitin (UBQ) and beta-tubulin (TUB) were the most stably expressed genes under drought, biotic and cold treatment respectively. For abscisic acid (ABA) treated samples 18S-rRNA was found to stably expressed gene. Finally, the relative expression level of the three genes involved in the withanolide biosynthetic pathway was detected to validate the selection of reliable reference genes. The present work will significantly contribute to gene analysis studies in W. somnifera and facilitate in improving the quality of gene expression data in this plant as well as and other related plant species.	[Singh, Varinder; Pati, Pratap Kumar] Guru Nanak Dev Univ, Dept Biotechnol, Amritsar 143005, Punjab, India; [Kaul, Sunil C.; Wadhwa, Renu] AIST, Natl Inst Adv Ind Sci & Technol, Cell Proliferat Res Grp, Tsukuba, Ibaraki 3058562, Japan; [Kaul, Sunil C.; Wadhwa, Renu] AIST, Natl Inst Adv Ind Sci & Technol, DBT AIST Int Lab Adv Biomed, Tsukuba, Ibaraki 3058562, Japan	Guru Nanak Dev University; National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST)	Pati, PK (corresponding author), Guru Nanak Dev Univ, Dept Biotechnol, Amritsar 143005, Punjab, India.	pkpati@yahoo.com	Wadhwa, Renu/L-8898-2018; Kaul, Sunil C/L-8671-2018	Wadhwa, Renu/0000-0001-8248-5192; Kaul, Sunil C/0000-0002-0046-3916; pati, pratap/0000-0001-9017-7608	Department of Biotechnology, Government of India; Council of Scientific and Industrial Research (CSIR), New Delhi; University Grants Commission (UGC), New Delhi, India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR), New Delhi(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission (UGC), New Delhi, India(University Grants Commission, India)	Authors thanks the Department of Biotechnology, Government of India, Council of Scientific and Industrial Research (CSIR), New Delhi and University Grants Commission (UGC), New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar N, 2013, PROTOPLASMA, V250, P613, DOI 10.1007/s00709-012-0450-2; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Barua A, 2013, AM J REPROD IMMUNOL, V70, P538, DOI 10.1111/aji.12172; Bhattacharya A, 2001, J ETHNOPHARMACOL, V74, P1, DOI 10.1016/S0378-8741(00)00309-3; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chang EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033278; CHAPPELL J, 1995, PLANT PHYSIOL, V107, P1, DOI 10.1145/224057.224059; Chatterjee S, 2010, PHYTOCHEMISTRY, V71, P1085, DOI 10.1016/j.phytochem.2010.04.001; Chaturvedi P, 2012, MOL BIOL REP, V39, P9755, DOI 10.1007/s11033-012-1841-3; Chaudhary G, 2003, CLIN EXP PHARMACOL P, V30, P399, DOI 10.1046/j.1440-1681.2003.03849.x; Chen G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067360; Cruz F, 2009, MOL BREEDING, V23, P607, DOI 10.1007/s11032-009-9259-x; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Demidenko NV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019434; Dhar N, 2014, J BIOL CHEM; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Gupta P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062714; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jarosova J, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-146; Jayaprakasam B, 2004, TETRAHEDRON, V60, P3109, DOI 10.1016/j.tet.2004.01.016; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Khazal KF, 2013, ANTICANCER RES, V33, P1519; Kim BR, 2003, BIOTECHNOL LETT, V25, P1869, DOI 10.1023/A:1026298032009; Kim OT, 2010, PLANT CELL REP, V29, P403, DOI 10.1007/s00299-010-0831-y; Kushwaha AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074777; Lee MH, 2004, PLANT CELL PHYSIOL, V45, P976, DOI 10.1093/pcp/pch126; Li RM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053006, 10.1371/journal.pone.0058597]; Mallona I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-4; Mandal C, 2008, APOPTOSIS, V13, P1450, DOI 10.1007/s10495-008-0271-0; Migocka M, 2011, MOL BREEDING, V28, P343, DOI 10.1007/s11032-010-9487-0; Mishra MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063064; Misra L, 2012, J ASIAN NAT PROD RES, V14, P39, DOI 10.1080/10286020.2011.622719; Narsai R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-56; Pati PK, 2008, INDIAN J MICROBIOL, V48, P432, DOI 10.1007/s12088-008-0053-y; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Rana S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057068; Razdan S, 2013, MOL BIOL REP, V40, P905, DOI 10.1007/s11033-012-2131-9; Reddy DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078555; Roy RV, 2013, J NAT PROD, V76, P1909, DOI 10.1021/np400441f; Sabir F, 2013, PROTOPLASMA, V250, P539, DOI 10.1007/s00709-012-0438-y; Sangwan RS, 2004, CURR SCI INDIA, V86, P461; Sharma A, 2011, PHYTOPHARMACOL, V1, P54; Sharma P, 2010, ASSAM U J SCI TECHNO, V6, P37; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Szic KSV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087850; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vicente MRS, 2011, J EXP BOT, V62, P3321, DOI 10.1093/jxb/err031; Wadhwa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077189; Widodo N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013536; Zhang K, 2013, J BIOTECHNOL, V168, P7, DOI 10.1016/j.jbiotec.2013.08.008; Zhong HY, 2011, PLANT CELL REP, V30, P641, DOI 10.1007/s00299-010-0992-8; Zhu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054411, 10.1371/journal.pone.0053196]	58	21	23	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118860	10.1371/journal.pone.0118860	http://dx.doi.org/10.1371/journal.pone.0118860			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25769035	Green Submitted, gold, Green Published			2022-12-27	WOS:000351277500051
J	Albuquerque, F; Beier, P				Albuquerque, Fabio; Beier, Paul			Rarity-Weighted Richness: A Simple and Reliable Alternative to Integer Programming and Heuristic Algorithms for Minimum Set and Maximum Coverage Problems in Conservation Planning	PLOS ONE			English	Article							SELECTION	Here we report that prioritizing sites in order of rarity-weighted richness (RWR) is a simple, reliable way to identify sites that represent all species in the fewest number of sites (minimum set problem) or to identify sites that represent the largest number of species within a given number of sites (maximum coverage problem). We compared the number of species represented in sites prioritized by RWR to numbers of species represented in sites prioritized by the Zonation software package for 11 datasets in which the size of individual planning units (sites) ranged from <1 ha to 2,500 km(2). On average, RWR solutions were more efficient than Zonation solutions. Integer programming remains the only guaranteed way find an optimal solution, and heuristic algorithms remain superior for conservation prioritizations that consider compactness and multiple near-optimal solutions in addition to species representation. But because RWR can be implemented easily and quickly in R or a spreadsheet, it is an attractive alternative to integer programming or heuristic algorithms in some conservation prioritization contexts.	[Albuquerque, Fabio; Beier, Paul] No Arizona Univ, Sch Forestry, Flagstaff, AZ 86011 USA	Northern Arizona University	Beier, P (corresponding author), No Arizona Univ, Sch Forestry, Flagstaff, AZ 86011 USA.	paul.beier@nau.edu			Northern Arizona University; postdoctoral fellowship from the Arizona Technology Research Initiative Fund	Northern Arizona University; postdoctoral fellowship from the Arizona Technology Research Initiative Fund	This work was funded by Northern Arizona University, and by a postdoctoral fellowship to FA from the Arizona Technology Research Initiative Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardron J. A., 2010, MARXAN GOOD PRACTICE; Cayuela Luis, 2012, Biodiversity Ecol, V4, P211, DOI 10.7809/b-e.00078; CDFW (California Department of Fish and Wildlife), 2003, ATL BIOD CAL; Chaplin Stephen J., 2000, P159; CORMAN T.E., 2005, ARIZONA BREEDING BIR; Csuti B, 1997, BIOL CONSERV, V80, P83, DOI 10.1016/S0006-3207(96)00068-7; Delavenne J, 2011, ICES J MARINE SCI; Hagemeijer W., 1997, EBCC ATLAS EUROPEAN; Haight R., 2009, SPATIAL CONSERVATION, P43; Inventario Nacional de Biodiversidad (INB), 2007, NAT INV TERR SPEC BR; KIRKPATRICK JB, 1983, BIOL CONSERV, V25, P127, DOI 10.1016/0006-3207(83)90056-3; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Moilanen A., 2009, SPATIAL CONSERVATION; Moilanen A., 2014, SPATIAL CONSERVATION; Moilanen A., 2009, SPATIAL CONSERVATION, P58; NatureServe, 2013, NATURESERVE HOTSP MA; Preston C, 2002, NEW ATLAS BRIT IRISH; Rodrigues ASL, 2007, ANNU REV ECOL EVOL S, V38, P713, DOI 10.1146/annurev.ecolsys.38.091206.095737; Sierra Nevada Global Change Observatory, 2013, DAT FLOR DIV SIERR N; Williams P, 1996, CONSERV BIOL, V10, P155, DOI 10.1046/j.1523-1739.1996.10010155.x	20	36	38	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119905	10.1371/journal.pone.0119905	http://dx.doi.org/10.1371/journal.pone.0119905			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25780930	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600106
J	Han, ZL; Jiang, Y; Yang, YQ; Li, XH; Yang, ZZ; Cao, KJ; Wang, DW				Han, Zhonglin; Jiang, Yu; Yang, Yuqing; Li, Xuehan; Yang, Zhongzhou; Cao, Kejiang; Wang, Dao W.			Deletion of PDK1 Causes Cardiac Sodium Current Reduction in Mice	PLOS ONE			English	Article							BRUGADA-SYNDROME; NA+ CHANNEL; IN-VITRO; SERUM; INHIBITION; MUTATIONS; SURVIVAL; DEFECTS; DISEASE	Background The AGC protein kinase family regulates multiple cellular functions. 3-phosphoinositide-dependent protein kinase-1 (PDK1) is involved in the pathogenesis of arrhythmia, and its downstream factor, Forkhead box O1 (Foxo1), negatively regulates the expression of the cardiac sodium channel, Nav1.5. Mice are known to die suddenly after PDK1 deletion within 11 weeks, but the underlying electrophysiological bases are unclear. Thus, the aim of this study was to investigate the potential mechanisms between PDK1 signaling pathway and cardiac sodium current. Methods and Results Using patch clamp and western blotting techniques, we investigated the role of the PDK1-Foxo1 pathway in PDK1 knockout mice and cultured cardiomyocytes. We found that PDK1 knockout mice undergo slower heart rate, prolonged QRS and QTc intervals and abnormal conduction within the first few weeks of birth. Furthermore, the peak sodium current is decreased by 33% in cells lacking PDK1. The phosphorylation of Akt (308T) and Foxo1 (24T) and the expression of Nav1.5 in the myocardium of PDK1-knockout mice are decreased, while the nuclear localization of Foxo1 is increased. The role of the PDK1-Foxo1 pathway in regulating Nav1.5 levels and sodium current density was verified using selective PDK1, Akt and Foxo1 inhibitors and isolated neonatal rat cardiomyocytes. Conclusion These results indicate that PDK1 participates in the dysregulation of electrophysiological basis by regulating the PDK1-Foxo1 pathway, which in turn regulates the expression of Nav1.5 and cardiac sodium channel function.				david37212@hotmail.com			National Key Basic Research Program of China (973 Program) [2013CB531105]; National Natural Science Foundation of China [81170159]	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the following grants: National Key Basic Research Program of China (973 Program), No. 2013CB531105 and National Natural Science Foundation of China, Project No. 81170159 to DWW. (http://www.973.gov.cn/English/Index.aspx). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antzelevitch C, 2005, CIRCULATION, V111, P659, DOI 10.1161/01.CIR.0000152479.54298.51; Boehmer C, 2003, CARDIOVASC RES, V57, P1079, DOI 10.1016/S0008-6363(02)00837-4; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cordes J., 2009, J PHARMACOL TOXICOL, V60, P221, DOI [10.1016/j.vascn.2009.04.059, DOI 10.1016/j.vascn.2009.04.059]; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; Di RM, 2010, CHINESE MED J-PEKING, V123, P2358, DOI 10.3760/cma.j.issn.0366-6999.2010.17.014; Diep CH, 2013, CELL CYCLE, V12, P1433, DOI 10.4161/cc.24550; Dummler B, 2007, BIOCHEM SOC T, V35, P231, DOI 10.1042/BST0350231; Farr MA, 2004, NEW ENGL J MED, V351, P185, DOI 10.1056/NEJMcibr041466; Frigo G, 2007, EUROPACE, V9, P391, DOI 10.1093/europace/eum053; Harris IS, 2014, ONCOGENE, V33, P1047, DOI 10.1038/onc.2013.24; Hashimoto N, 2006, NAT GENET, V38, P589, DOI 10.1038/ng1774; Heath BM, 2011, J PHARMACOL TOX MET, V63, P258, DOI 10.1016/j.vascn.2010.12.004; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Ito K, 2009, P NATL ACAD SCI USA, V106, P8689, DOI 10.1073/pnas.0900064106; Jiang Q, 2014, BIOCHEM BIOPH RES CO, V449, P278, DOI 10.1016/j.bbrc.2014.05.041; Kaur K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055391; Korkmaz S, 2013, J AM COLL CARDIOL, V62, P340, DOI 10.1016/j.jacc.2013.04.041; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Lang F, 2009, CURR OPIN NEPHROL HY, V18, P439, DOI 10.1097/MNH.0b013e32832f125e; London B, 1998, J PHYSIOL-LONDON, V509, P171, DOI 10.1111/j.1469-7793.1998.171bo.x; Lu ZJ, 2013, DIABETES, V62, P4257, DOI 10.2337/db13-0420; Lu ZJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003623; Mao WK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032738; Mora A, 2003, EMBO J, V22, P4666, DOI 10.1093/emboj/cdg469; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Nagashima T, 2010, MOL PHARMACOL, V78, P961, DOI 10.1124/mol.110.065714; Najafov A, 2011, BIOCHEM J, V433, P357, DOI 10.1042/BJ20101732; Nguyen TP, 2008, CIRC RES, V102, P364, DOI 10.1161/CIRCRESAHA.107.164673; Oudit GY, 2009, CARDIOVASC RES, V82, P250, DOI 10.1093/cvr/cvp014; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Pochynyuk O, 2006, J BIOL CHEM, V281, P26520, DOI 10.1074/jbc.M603716200; Pretorius L, 2009, AM J PATHOL, V175, P998, DOI 10.2353/ajpath.2009.090126; Remme CA, 2008, EUROPACE, V10, P1253, DOI 10.1093/europace/eun267; Remme CA, 2006, CIRCULATION, V114, P2584, DOI 10.1161/CIRCULATIONAHA.106.653949; Ruan YF, 2009, NAT REV CARDIOL, V6, P337, DOI 10.1038/nrcardio.2009.44; Song WH, 2012, J PHYSIOL-LONDON, V590, P5123, DOI 10.1113/jphysiol.2012.235374; Storey NM, 2002, CURR BIOL, V12, P27, DOI 10.1016/S0960-9822(01)00625-X; Wang DW, 2002, CIRCULATION, V105, P341, DOI 10.1161/hc0302.102592; Wu XQ, 2013, AM J PATHOL, V182, P2005, DOI 10.1016/j.ajpath.2013.02.012; Yang T, 2012, CIRC RES, V111, P322, DOI 10.1161/CIRCRESAHA.112.265173; Zicha S, 2004, J MOL CELL CARDIOL, V37, P91, DOI 10.1016/j.yjmcc.2004.04.003	42	6	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0122436	10.1371/journal.pone.0122436	http://dx.doi.org/10.1371/journal.pone.0122436			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781322	gold, Green Submitted, Green Published			2022-12-27	WOS:000351284600219
J	El Bcheraoui, C; Basulaiman, M; Wilson, S; Daoud, F; Tuffaha, M; AlMazroa, MA; Memish, ZA; Al Saeedi, M; Mokdad, AH				El Bcheraoui, Charbel; Basulaiman, Mohammed; Wilson, Shelley; Daoud, Farah; Tuffaha, Marwa; AlMazroa, Mohammad A.; Memish, Ziad A.; Al Saeedi, Mohammed; Mokdad, Ali H.			Breast Cancer Screening in Saudi Arabia: Free but Almost No Takers	PLOS ONE			English	Article							PROGRAM; HEALTH; BURDEN	Introduction Mammography ensures early diagnosis and a better chance for treatment and recovery from breast cancer. We conducted a national survey to investigate knowledge and practices of breast cancer screening among Saudi women aged 50 years or older in order to inform the breast cancer national health programs. Materials and Methods The Saudi Health Interview Survey is a national multistage survey of individuals aged 15 years or older. The survey included questions on socio-demographic characteristics, tobacco consumption, diet, physical activity, health-care utilization, different health-related behaviors, and self-reported chronic conditions. Female respondents were asked about knowledge and practices of self and clinical breast exams, as well as mammography. Results Between April and June 2013, a total of 10,735 participants completed the survey. Among respondents, 1,135 were women aged 50 years or older and were included in this analysis. About 89% of women reported not having a clinical breast exam in the past year, and 92% reported never having a mammogram. Women living in Al Sharqia had the highest rate of mammography use. Women who were educated, those who had received a routine medical exam within the last two years, and those who were diagnosed with hypertension were more likely to have had a mammogram in the past two years. Discussion Our results show very low rates of breast cancer screening in the Kingdom of Saudi Arabia, a country with free health services. This calls for educational campaigns to improve breast cancer screening. Addressing the barriers for breast cancer screening is a public health imperative.	[El Bcheraoui, Charbel; Wilson, Shelley; Daoud, Farah; Tuffaha, Marwa; Mokdad, Ali H.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Basulaiman, Mohammed; AlMazroa, Mohammad A.; Memish, Ziad A.; Al Saeedi, Mohammed] Minist Hlth Kingdom Saudi Arabia, Assadah, Al Murabba Riya, Saudi Arabia	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle	Mokdad, AH (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, 2301 Fifth Ave,Suite 600, Seattle, WA 98195 USA.	mokdaa@uw.edu	Mokdad, Ali H./AAD-1232-2022; Memish, Ziad Ahmed/AEJ-9424-2022	Mokdad, Ali H./0000-0002-4994-3339; Memish, Ziad Ahmed/0000-0002-5099-0714	Saudi ministry of health	Saudi ministry of health	The study was funded by the Saudi ministry of health who managed the data collection. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Aa A, 2005, ANN SAUDI MED, V26, P272; Abulkhair OA, 2010, ANN SAUDI MED, V30, P350, DOI 10.4103/0256-4947.67078; Adib S M, 2009, East Mediterr Health J, V15, P6; Akhtar S. S., 2010, Eastern Mediterranean Health Journal, V16, P1025; Alkhenizan A, 2013, J CLIN ONCOL, V31; Amin TT, 2009, ASIAN PAC J CANCER P, V10, P133; Centers for Disease Control and Prevention, BEH RISK FACT SURV S; Chouchane L, 2013, LANCET ONCOL, V14, pE417, DOI 10.1016/S1470-2045(13)70165-7; Hagi SK, 2013, AM J RES COMMUNICATI, V1; Ibrahim EM, 2008, MED ONCOL, V25, P387, DOI 10.1007/s12032-008-9051-5; King S., 2008, BREAST CANC POLITICS; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Memish ZA, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.140176; Milaat W A, 2000, East Mediterr Health J, V6, P338; Miles A, 2004, CANCER-AM CANCER SOC, V101, P1201, DOI 10.1002/cncr.20505; Mokdad AH, 2014, LANCET, V383, P309, DOI 10.1016/S0140-6736(13)62189-3; Ramady MA, 2010, SAUDI ARABIAN ECONOMY: POLICIES, ACHIEVEMENTS, AND CHALLENGES, SECOND EDITION, P1, DOI 10.1007/978-1-4419-5987-4; Sankaranarayanan R, 2001, B WORLD HEALTH ORGAN, V79, P954; Saudi arabian monetary agency (SAMA), 2013, 49 SAMA; Soni A, 2007, USE BREAST CANC DETE; TABAR L, 1985, LANCET, V1, P829, DOI 10.1016/S0140-6736(85)92204-4; VERBEEK ALM, 1984, LANCET, V1, P1222	22	73	74	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119051	10.1371/journal.pone.0119051	http://dx.doi.org/10.1371/journal.pone.0119051			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774520	gold, Green Submitted, Green Published			2022-12-27	WOS:000351183500066
J	Gupta, D; Trukova, K; Popiel, B; Lammersfeld, C; Vashi, PG				Gupta, Digant; Trukova, Kristen; Popiel, Brenten; Lammersfeld, Carolyn; Vashi, Pankaj G.			The Association between Pre-Treatment Serum 25-Hydroxyvitamin D and Survival in Newly Diagnosed Stage IV Prostate Cancer	PLOS ONE			English	Article							CELL LUNG-CANCER; BODY-MASS INDEX; VITAMIN-D; COLORECTAL-CANCER; RISK; POLYMORPHISMS; DEFICIENCY; CALCIUM; DEATH; OBESE	Background/Aims Emerging evidence in the literature suggests a positive association between serum 25-hydroxyvitamin D [25(OH)D], a standard indicator of vitamin D status, and survival in certain types of cancer. We investigated this relationship in newly diagnosed stage IV prostate cancer patients. Methods A consecutive cohort of 125 newly diagnosed stage IV prostate cancer patients underwent a baseline serum 25(OH)D evaluation prior to receiving any treatment at our institution between January 2008 and December 2011. We used the vitamin D categories of "deficient (<20 ng/ml)", "insufficient (20 to 32 ng/ml)", and "sufficient (>32 ng/ml)". Cox regression was used to evaluate the prognostic significance of serum 25(OH)D after adjusting for relevant confounders. Results Mean age at diagnosis was 60 years. Of the 125 patients, 32 (25.6%) were deficient, 49 (39.2%) were insufficient and 44 (35.2%) were sufficient in vitamin D at the time of diagnosis. The median survival in deficient, insufficient and sufficient cohorts was 47.8, 44.0 and 52.6 months respectively (p = 0.60). On univariate analysis, four variables demonstrated a statistically significant association with survival: nutritional status, bone metastasis, corrected serum calcium and serum albumin (p<0.05 for all). On multivariate analysis, five variables demonstrated statistically significant associations with survival: hospital location, age, bone metastasis, serum albumin and corrected serum calcium (p<0.05 for all). Serum vitamin D status was not significant on either univariate or multivariate analysis. Conclusion Contrary to previously published research, we found no significant association between pre-treatment serum 25(OH)D and survival in newly diagnosed stage IV prostate cancer patients. The lack of a significant association between serum vitamin D and survival in our study could perhaps be due to the fact that the disease was far too advanced in our patients for vitamin D levels to have any impact on prognosis.	[Gupta, Digant; Trukova, Kristen; Popiel, Brenten; Lammersfeld, Carolyn; Vashi, Pankaj G.] Midwestern Reg Med Ctr, CTCA, Zion, IL 60099 USA		Gupta, D (corresponding author), Midwestern Reg Med Ctr, CTCA, Zion, IL 60099 USA.	digant.gupta@ctca-hope.com	GUPTA, DIGANT/ABA-9729-2020	GUPTA, DIGANT/0000-0002-1963-8886				BELL NH, 1985, J CLIN INVEST, V76, P370, DOI 10.1172/JCI111971; Bikle D, 2009, J CLIN ENDOCR METAB, V94, P26, DOI 10.1210/jc.2008-1454; Ersfeld DL, 2004, CLIN BIOCHEM, V37, P867, DOI 10.1016/j.clinbiochem.2004.06.006; Fang F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018625; Fedirko V, 2012, CANCER EPIDEM BIOMAR, V21, P582, DOI 10.1158/1055-9965.EPI-11-1065; Fiscella K, 2011, CANCER-AM CANCER SOC, V117, P1061, DOI 10.1002/cncr.25647; Florez H, 2007, J STEROID BIOCHEM, V103, P679, DOI 10.1016/j.jsbmb.2006.12.032; Gandini S, 2011, INT J CANCER, V128, P1414, DOI 10.1002/ijc.25439; Goodwin PJ, 2009, J CLIN ONCOL, V27, P3757, DOI 10.1200/JCO.2008.20.0725; Gupta D, 2009, PROSTATE CANCER P D, V12, P215, DOI 10.1038/pcan.2009.7; Heist RS, 2008, J CLIN ONCOL, V26, P5596, DOI 10.1200/JCO.2008.18.0406; Hofmann JN, 2010, CANCER EPIDEM BIOMAR, V19, P927, DOI 10.1158/1055-9965.EPI-09-1121; Holick MF, 2009, ANN EPIDEMIOL, V19, P73, DOI 10.1016/j.annepidem.2007.12.001; Holt SK, 2013, CANCER EPIDEMIOL, V37, P666, DOI 10.1016/j.canep.2013.07.005; Lagunova Z, 2010, MOL NUTR FOOD RES, V54, P1127, DOI 10.1002/mnfr.200900512; Lee P, 2009, AM J MED, V122, P1056, DOI 10.1016/j.amjmed.2009.06.008; Mezawa H, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-347; Moan J, 2005, J PHOTOCH PHOTOBIO B, V78, P189, DOI 10.1016/j.jphotobiol.2004.11.004; Ng K, 2008, J CLIN ONCOL, V26, P2984, DOI 10.1200/JCO.2007.15.1027; Ren C, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-16; Robsahm Trude E, 2013, Cancers (Basel), V5, P1439, DOI 10.3390/cancers5041439; SAUERBREI W, 1992, STAT MED, V11, P2093, DOI 10.1002/sim.4780111607; Schwartz GG, 2012, CANCER EPIDEM BIOMAR, V21, P1768, DOI 10.1158/1055-9965.EPI-12-0585; Schwartz GG, 2009, ANN EPIDEMIOL, V19, P96, DOI 10.1016/j.annepidem.2008.03.007; Tretli S, 2009, BRIT J CANCER, V100, P450, DOI 10.1038/sj.bjc.6604865; Tucci M, 2009, PROSTATE CANCER P D, V12, P94, DOI 10.1038/pcan.2008.10; Vashi PG, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-51; Vrieling A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2920; Vuolo Laura, 2012, Front Endocrinol (Lausanne), V3, P58, DOI 10.3389/fendo.2012.00058; Welsh J, 2012, SCAND J CLIN LAB INV, V72, P103, DOI 10.3109/00365513.2012.682870; Wootton Andrew M, 2005, Clin Biochem Rev, V26, P33; Yin L, 2009, CANCER EPIDEMIOL, V33, P435, DOI 10.1016/j.canep.2009.10.014; Zhou W, 2007, J CLIN ONCOL, V25, P479, DOI 10.1200/JCO.2006.07.5358	33	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119690	10.1371/journal.pone.0119690	http://dx.doi.org/10.1371/journal.pone.0119690			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774530	gold, Green Submitted, Green Published			2022-12-27	WOS:000351183500111
J	Oliveira, TN; Possidonio, AC; Soares, CP; Ayres, R; Costa, ML; Quintas, LEM; Mermelstein, C				Oliveira, Taissa Neustadt; Possidonio, Ana Claudia; Soares, Carolina Pontes; Ayres, Rodrigo; Costa, Manoel Luis; Menezes Quintas, Luis Eduardo; Mermelstein, Claudia			The Role of Na+/K+-ATPase during Chick Skeletal Myogenesis	PLOS ONE			English	Article							PROTEIN-KINASE PATHWAY; MYOBLAST FUSION; K+-ATPASE; TERMINAL DIFFERENTIATION; CHOLESTEROL DEPLETION; MUSCLE-CELLS; EXPRESSION; OUABAIN; ALPHA-2; P38	The formation of a vertebrate skeletal muscle fiber involves a series of sequential and interdependent events that occurs during embryogenesis. One of these events is myoblast fusion which has been widely studied, yet not completely understood. It was previously shown that during myoblast fusion there is an increase in the expression of Na+/K+-ATPase. This fact prompted us to search for a role of the enzyme during chick in vitro skeletal myogenesis. Chick myogenic cells were treated with the Na+/K+-ATPase inhibitor ouabain in four different concentrations (0.01-10 mu M) and analyzed. Our results show that 0.01, 0.1 and 1 mu M ouabain did not induce changes in cell viability, whereas 10 mu M induced a 45% decrease. We also observed a reduction in the number and thickness of multinucleated myotubes and a decrease in the number of myoblasts after 10 mu M ouabain treatment. We tested the involvement of MEK-ERK and p38 signaling pathways in the ouabain-induced effects during myogenesis, since both pathways have been associated with Na+/K+-ATPase. The MEK-ERK inhibitor U0126 alone did not alter cell viability and did not change ouabain effect. The p38 inhibitor SB202190 alone or together with 10 mu M ouabain did not alter cell viability. Our results show that the 10 mu M ouabain effects in myofiber formation do not involve the MEK-ERK or the p38 signaling pathways, and therefore are probably related to the pump activity function of the Na+/K+-ATPase.	[Oliveira, Taissa Neustadt; Possidonio, Ana Claudia; Soares, Carolina Pontes; Costa, Manoel Luis; Mermelstein, Claudia] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Diferenciacao Muscular & Citoesqueleto, Rio De Janeiro, Brazil; [Ayres, Rodrigo; Menezes Quintas, Luis Eduardo] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Farmacol Bioquim & Mol, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Mermelstein, C (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Diferenciacao Muscular & Citoesqueleto, Rio De Janeiro, Brazil.	mermelstein@ufrj.br	Costa, Manoel/B-5009-2010; mermelstein, Claudia S/C-1464-2010; Quintas, Luis Eduardo M/C-3308-2009	Costa, Manoel/0000-0002-9037-0085; mermelstein, Claudia S/0000-0002-8897-8526; Quintas, Luis Eduardo M/0000-0002-0767-1240	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Fundacao do Cancer/Programa de Oncobiologia	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao do Cancer/Programa de Oncobiologia	This work was supported by Brazilian grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro (FAPERJ), and Fundacao do Cancer/Programa de Oncobiologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud-Batista FJ, 2012, AM J PHYSIOL-RENAL, V302, pF959, DOI 10.1152/ajprenal.00130.2011; Bagrov AY, 2009, PHARMACOL REV, V61, P9, DOI 10.1124/pr.108.000711; Cai T, 2008, J CELL BIOL, V182, P1153, DOI 10.1083/jcb.200712022; Chen YL, 2009, J BIOL CHEM, V284, P14881, DOI 10.1074/jbc.M109.003574; Ciuffini L, 2008, ONCOGENE, V27, P528, DOI 10.1038/sj.onc.1210665; Cuenda A, 1999, J BIOL CHEM, V274, P4341, DOI 10.1074/jbc.274.7.4341; Elia D, 2007, BBA-MOL CELL RES, V1773, P1438, DOI 10.1016/j.bbamcr.2007.06.006; EWART HS, 1995, AM J PHYSIOL-CELL PH, V269, pC295, DOI 10.1152/ajpcell.1995.269.2.C295; FAMBROUGH DM, 1983, J BIOL CHEM, V258, P3926; Gredinger E, 1998, J BIOL CHEM, V273, P10436, DOI 10.1074/jbc.273.17.10436; Hamlyn JM, 2003, ANN NY ACAD SCI, V986, P685, DOI 10.1111/j.1749-6632.2003.tb07283.x; HAMLYN JM, 1991, P NATL ACAD SCI USA, V88, P6259, DOI 10.1073/pnas.88.14.6259; He SW, 2001, AM J PHYSIOL-REG I, V281, pR917, DOI 10.1152/ajpregu.2001.281.3.R917; HIGHAM SC, 1993, J MEMBRANE BIOL, V131, P129, DOI 10.1007/BF02791321; HOLTZER H, 1991, INT CONGR SER, P187; HUNDAL HS, 1993, FEBS LETT, V328, P253, DOI 10.1016/0014-5793(93)80938-Q; Jones NC, 2001, J CELL PHYSIOL, V186, P104, DOI 10.1002/1097-4652(200101)186:1<104::AID-JCP1015>3.0.CO;2-0; Keren A, 2006, MOL CELL ENDOCRINOL, V252, P224, DOI 10.1016/j.mce.2006.03.017; Lee J, 2002, BIOCHEM BIOPH RES CO, V298, P765, DOI 10.1016/S0006-291X(02)02562-7; Li J, 2006, BIOCHEM BIOPH RES CO, V345, P1425, DOI 10.1016/j.bbrc.2006.05.051; Liang M, 2007, J BIOL CHEM, V282, P10585, DOI 10.1074/jbc.M609181200; Mermelstein CS, 2007, DIFFERENTIATION, V75, P184, DOI 10.1111/j.1432-0436.2006.00129.x; Mermelstein CS, 2005, CELL TISSUE RES, V319, P289, DOI 10.1007/s00441-004-1004-5; OBRIEN WJ, 1994, ARCH BIOCHEM BIOPHYS, V310, P32, DOI 10.1006/abbi.1994.1136; ORLOWSKI J, 1988, J BIOL CHEM, V263, P17817; Pauw PG, 2000, IN VITRO CELL DEV-AN, V36, P133; PAUW PG, 1994, IN VITRO CELL DEV-AN, V30A, P9, DOI 10.1007/BF02631408; Portilho DM, 2012, EUR J PHARMACOL, V694, P1, DOI 10.1016/j.ejphar.2012.07.035; PRIVES J, 1977, NATURE, V268, P761, DOI 10.1038/268761a0; Quintas LEM, 2000, BIOCHEM PHARMACOL, V60, P741, DOI 10.1016/S0006-2952(00)00376-2; Quintas LEM, 2010, J MOL CELL CARDIOL, V49, P525, DOI 10.1016/j.yjmcc.2010.04.015; Schwander M, 2003, DEV CELL, V4, P673, DOI 10.1016/S1534-5807(03)00118-7; SCUDIERO DA, 1988, CANCER RES, V48, P4827; Sharabani-Yosef O, 1999, J CELL PHYSIOL, V180, P236, DOI 10.1002/(SICI)1097-4652(199908)180:2<236::AID-JCP11>3.3.CO;2-N; Sharabani-Yosef O, 2001, J CELL PHYSIOL, V187, P365, DOI 10.1002/jcp.1089; SPERELAKIS N, 1972, BIOCHIM BIOPHYS ACTA, V266, P230, DOI 10.1016/0005-2736(72)90137-X; SWEADNER KJ, 1992, J BIOL CHEM, V267, P769; TAORMINO JP, 1990, J BIOL CHEM, V265, P4116; Vaudin P, 2006, DOMEST ANIM ENDOCRIN, V31, P123, DOI 10.1016/j.domaniend.2005.09.009; VIGNE P, 1982, J BIOL CHEM, V257, P5380; Volonte D, 2003, MOL BIOL CELL, V14, P4075, DOI 10.1091/mbc.E03-03-0161; Wang HJ, 2004, J BIOL CHEM, V279, P17250, DOI 10.1074/jbc.M313239200; WOLITZKY BA, 1986, J BIOL CHEM, V261, P9990; Xie Zijian, 2003, Mol Interv, V3, P157, DOI 10.1124/mi.3.3.157; ZESCHNIGK M, 1995, J CELL SCI, V108, P2973; Zetser A, 1999, J BIOL CHEM, V274, P5193, DOI 10.1074/jbc.274.8.5193	46	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120940	10.1371/journal.pone.0120940	http://dx.doi.org/10.1371/journal.pone.0120940			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775465	Green Published, gold, Green Submitted			2022-12-27	WOS:000351183500200
J	Pariona-Llanos, R; Pavani, RS; Reis, M; Noel, V; Silber, AM; Armelin, HA; Cano, MIN; Elias, MC				Pariona-Llanos, Ricardo; Pavani, Raphael Souza; Reis, Marcelo; Noel, Vincent; Silber, Ariel Mariano; Armelin, Hugo Aguirre; Cano, Maria Isabel Nogueira; Elias, Maria Carolina			Glyceraldehyde 3-Phosphate Dehydrogenase-Telomere Association Correlates with Redox Status in Trypanosoma cruzi	PLOS ONE			English	Article							PROTEIN; EXPRESSION; DIFFERENTIATION; TRANSCRIPTION; INHIBITION; PARALLEL; HOMOLOG; BINDING; CYCLE; DNA	Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) is a classical metabolic enzyme involved in energy production and plays a role in additional nuclear functions, including transcriptional control, recognition of misincorporated nucleotides in DNA and maintenance of telomere structure. Here, we show that the recombinant protein T. cruzi GAPDH (rTcGAPDH) binds single-stranded telomeric DNA. We demonstrate that the binding of GAPDH to telomeric DNA correlates with the balance between oxidized and reduced forms of nicotinamide adenine dinucleotides (NAD+/NADH). We observed that GAPDH-telomere association and NAD+/NADH balance changed throughout the T. cruzi life cycle. For example, in replicative epimastigote forms of T. cruzi, which show similar intracellular concentrations of NAD+ and NADH, GAPDH binds to telomeric DNA in vivo and this binding activity is inhibited by exogenous NAD+. In contrast, in the T. cruzi non-proliferative trypomastigote forms, which show higher NAD+ concentration, GAPDH was absent from telomeres. In addition, NAD+ abolishes physical interaction between recombinant GAPDH and synthetic telomere oligonucleotide in a cell free system, mimicking exogenous NAD+ that reduces GAPDH-telomere interaction in vivo. We propose that the balance in the NAD+/NADH ratio during T. cruzi life cycle homeostatically regulates GAPDH telomere association, suggesting that in trypanosomes redox status locally modulates GAPDH association with telomeric DNA.	[Pariona-Llanos, Ricardo; Pavani, Raphael Souza; Reis, Marcelo; Noel, Vincent; Armelin, Hugo Aguirre; Elias, Maria Carolina] Inst Butantan, Lab Especial Ciclo Celular, Sao Paulo, Brazil; [Pariona-Llanos, Ricardo; Pavani, Raphael Souza; Reis, Marcelo; Noel, Vincent; Armelin, Hugo Aguirre; Elias, Maria Carolina] Inst Butantan, Ctr Toxins Immune Response & Cell Signaling CeTIC, Sao Paulo, Brazil; [Silber, Ariel Mariano] Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, Unit Drug Discovery, BR-05508 Sao Paulo, Brazil; [Armelin, Hugo Aguirre] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [Cano, Maria Isabel Nogueira] Univ Estadual Paulista Julio de Mesquita Filho UN, Inst Biociencias, Dept Genet, Botucatu, SP, Brazil	Instituto Butantan; Instituto Butantan; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual Paulista	Elias, MC (corresponding author), Inst Butantan, Lab Especial Ciclo Celular, Sao Paulo, Brazil.	carolina.eliassabbaga@butantan.gov.br	Elias, Maria QB/AAW-9284-2021; Cano, Maria Isabel/M-7691-2019; Noël, Vincent/P-5803-2015; Instituto Butantan, Center of Toxins Immune Response and Cell Signaling CeTICS/J-5731-2015; Cano, Maria Isabel/A-4020-2008; Elias, Maria Carolina/E-9197-2015; Reis, Marcelo S./K-4075-2012; Armelin, Hugo/P-4390-2015; Silber, Ariel/O-6951-2015	Cano, Maria Isabel/0000-0001-9798-6627; Noël, Vincent/0000-0003-3448-291X; Elias, Maria Carolina/0000-0002-0501-8280; Reis, Marcelo S./0000-0002-3754-9115; Armelin, Hugo/0000-0001-9557-0804; pariona, ricardo/0000-0001-9836-6526; Silber, Ariel/0000-0003-4528-4732; Pavani, Raphael/0000-0002-7187-2995	FAPESP [05/00154-1, 2013/07467-1, 11/50631-1]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Support was provided by FAPESP Nr. 05/00154-1 to MCE, Nr. 2013/07467-1 to MCE and HAA and Nr 11/50631-1 to AMS. RPLl and RSP are FAPESP fellows (2009/50488-4 and 2011/16670-0). AMS, HAA, MINC and MCE are CNPq research fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANGS JD, 1993, J CELL SCI, V105, P1101; Benabdellah K, 2007, MOL MICROBIOL, V65, P1559, DOI 10.1111/j.1365-2958.2007.05892.x; CAMARGO E P, 1964, Rev Inst Med Trop Sao Paulo, V6, P93; da Cunha JPC, 2006, MOL BIOCHEM PARASIT, V150, P268, DOI 10.1016/j.molbiopara.2006.08.012; Chamond N, 2005, MOL MICROBIOL, V58, P46, DOI 10.1111/j.1365-2958.2005.04808.x; Chu KW, 1999, J COMPUT PHYS, V148, P646, DOI 10.1006/jcph.1998.6134; Dai RP, 2008, J BIOL CHEM, V283, P26894, DOI 10.1074/jbc.M804307200; Das A, 2004, CURR MOL MED, V4, P577, DOI 10.2174/1566524043360267; Godoy PDD, 2009, EUKARYOT CELL, V8, P1592, DOI 10.1128/EC.00161-09; Demarse NA, 2009, J MOL BIOL, V394, P789, DOI 10.1016/j.jmb.2009.09.062; Elias MCQB, 2001, MOL BIOCHEM PARASIT, V112, P79, DOI 10.1016/S0166-6851(00)00349-2; Freitas RF, 2009, BIOORGAN MED CHEM, V17, P2476, DOI 10.1016/j.bmc.2009.01.079; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Greenall A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r146; Hindmarsh AC, 2005, ACM T MATH SOFTWARE, V31, P363, DOI 10.1145/1089014.1089020; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; KARPEL RL, 1981, BIOCHIM BIOPHYS ACTA, V654, P256, DOI 10.1016/0005-2787(81)90180-5; Li B, 2005, MOL CELL BIOL, V25, P5011, DOI 10.1128/MCB.25.12.5011-5021.2005; Manning-Cela R, 2002, INFECT IMMUN, V70, P4726, DOI 10.1128/IAI.70.8.4726-4728.2002; Nazer E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019920; Silva JJN, 2010, BRIT J PHARMACOL, V160, P260, DOI 10.1111/j.1476-5381.2009.00524.x; Paes LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069419; Palenchar JB, 2006, MOL BIOCHEM PARASIT, V146, P135, DOI 10.1016/j.molbiopara.2005.12.008; Pittelli M, 2011, MOL PHARMACOL, V80, P1136, DOI 10.1124/mol.111.073916; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Silber AM, 2009, MOL BIOCHEM PARASIT, V168, P102, DOI 10.1016/j.molbiopara.2009.07.006; Silber Ariel Mariano, 2005, Current Drug Targets - Infectious Disorders, V5, P53, DOI 10.2174/1568005053174636; Neto JLS, 2007, BIOCHEM BIOPH RES CO, V358, P417, DOI 10.1016/j.bbrc.2007.04.144; Sirover MA, 2005, J CELL BIOCHEM, V95, P45, DOI 10.1002/jcb.20399; Sirover MA, 2012, J CELL BIOCHEM, V113, P2193, DOI 10.1002/jcb.24113; Stuart K, 2008, J CLIN INVEST, V118, P1301, DOI 10.1172/JCI33945; Sundararaj KP, 2004, J BIOL CHEM, V279, P6152, DOI 10.1074/jbc.M310549200; Teixeira SMR, 1998, BRAZ J MED BIOL RES, V31, P1503, DOI 10.1590/S0100-879X1998001200001; Yu FX, 2009, CELL CYCLE, V8, P773, DOI 10.4161/cc.8.5.7880; Zhang QH, 2002, SCIENCE, V295, P1895	35	17	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120896	10.1371/journal.pone.0120896	http://dx.doi.org/10.1371/journal.pone.0120896			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775131	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500197
J	Schmid, SL; Gerber, C; Farshad, M				Schmid, Samuel Luca; Gerber, Christian; Farshad, Mazda			Position of the Physician's Nametag - A Randomized, Blinded Trial	PLOS ONE			English	Article							COMMUNICATION-SKILLS; SATISFACTION	Background The patient-physician relation begins when the physician introduces himself with name and function. Most institutions request a nametag with name and function to be worn. Although nametags are consequently worn, the optimal position for the nametag is unknown. It was the purpose of this study to identify whether positioning the nametag on the right or the left chest side provides better visibility to the patient. Method and Material One hundred volunteers, blinded to the experimental setup, presented for an orthopedic consultation in a standardized manner. The nametag of the physician was randomly positioned on the left chest side and presented to 50 individuals (age 35 years (range 17 to 83)) or the right chest side and then presented to 50 other individuals (35 years (range 16 to 59)). The time of the participant noticing the nametag was documented. Subsequently, the participant was questioned concerning the relevance of a nametag and verbal self-introduction of the physician. Results 38% of the participants noticed the nametag on the right as opposed to 20% who noticed it if placed on the left upper chest (p = 0.0473). The mean time to detection was 9 (range 1-40) seconds for nametags on the right and 25.2 seconds (range 3 to 49, p = 0.006) on the left. For 87% of the participants, a nametag is expected and important and nearly all participants (96%) expected the physician to introduce himself verbally. Conclusion It is expected that a physician wears a nametag and introduce himself verbally at the first encounter. Positioning the nametag on the right chest side results in better and faster visibility.	[Schmid, Samuel Luca; Gerber, Christian; Farshad, Mazda] Univ Zurich, Dept Orthopaed, Balgrist Univ Hosp, Zurich, Switzerland	University of Zurich	Schmid, SL (corresponding author), Univ Zurich, Dept Orthopaed, Balgrist Univ Hosp, Zurich, Switzerland.	Samuel.Schmid@balgrist.ch		Gerber, Christian/0000-0002-4624-8285; Farshad, Mazda/0000-0002-7190-1127				Auerbach SM, 2002, J BEHAV MED, V25, P17, DOI 10.1023/A:1013585617303; HARDYCK C, 1977, PSYCHOL BULL, V84, P385, DOI 10.1037/0033-2909.84.3.385; Hochman O, 2008, MIL MED, V173, P878, DOI 10.7205/MILMED.173.9.878; Holder M. K, 1997, WHY ARE MORE PEOPLE; Keenum AJ, 2003, SOUTH MED J, V96, P1190, DOI 10.1097/01.SMJ.0000077011.58103.C1; Maguire P, 2002, BRIT MED J, V325, P697, DOI 10.1136/bmj.325.7366.697; Moffat Mandy, 2006, Prim Care Respir J, V15, P159, DOI 10.1016/j.pcrj.2006.02.006; Ocklenburg S, 2013, NEUROSCI BIOBEHAV R, V37, P2788, DOI 10.1016/j.neubiorev.2013.09.014; Simons Y, 2014, J HOSP MED, V9, P137, DOI 10.1002/jhm.2100; Truog RD, 2012, NEW ENGL J MED, V366, P581, DOI 10.1056/NEJMp1110848	10	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119042	10.1371/journal.pone.0119042	http://dx.doi.org/10.1371/journal.pone.0119042			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775376	Green Published, gold, Green Accepted			2022-12-27	WOS:000351183500064
J	Xu, WP; Morris, U; Aydin-Schmidt, B; Msellem, MI; Shakely, D; Petzold, M; Bjorkman, A; Martensson, A				Xu, Weiping; Morris, Ulrika; Aydin-Schmidt, Berit; Msellem, Mwinyi I.; Shakely, Deler; Petzold, Max; Bjorkman, Anders; Martensson, Andreas			SYBR Green Real-Time PCR-RFLP Assay Targeting the Plasmodium Cytochrome B Gene - A Highly Sensitive Molecular Tool for Malaria Parasite Detection and Species Determination	PLOS ONE			English	Article							DRIED BLOOD; RNA; DNA; SEQUENCES	A prerequisite for reliable detection of low-density Plasmodium infections in malaria pre-elimination settings is the availability of ultra-sensitive and high-throughput molecular tools. We developed a SYBR Green real-time PCR restriction fragment length polymorphism assay (cytb-qPCR) targeting the cytochrome b gene of the four major human Plasmodium species (P. falciparum, P. vivax, P. malariae, and P. ovale) for parasite detection and species determination with DNA extracted from dried blood spots collected on filter paper. The performance of cytb-qPCR was first compared against four reference PCR methods using serially diluted Plasmodium samples. The detection limit of the cytb-qPCR was 1 parasite/mu l (p/mu l) for P. falciparum and P. ovale, and 2 p/mu l for P. vivax and P. malariae, while the reference PCRs had detection limits of 0.5-10 p/mu l. The ability of the PCR methods to detect low-density Plasmodium infections was then assessed using 2977 filter paper samples collected during a cross-sectional survey in Zanzibar, a malaria pre-elimination setting in sub-Saharan Africa. Field samples were defined as 'final positive' if positive in at least two of the five PCR methods. Cytb-qPCR preformed equal to or better than the reference PCRs with a sensitivity of 100% (65/65; 95% CI 94.5-100%) and a specificity of 99.9%(2910/2912; 95% CI 99.7-100%) when compared against 'final positive' samples. The results indicate that the cytb-qPCR may represent an opportunity for improved molecular surveillance of low-density Plasmodium infections in malaria pre-elimination settings.	[Xu, Weiping; Morris, Ulrika; Aydin-Schmidt, Berit; Shakely, Deler; Bjorkman, Anders; Martensson, Andreas] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Div Malaria Res, Stockholm, Sweden; [Msellem, Mwinyi I.] Zanzibar Malaria Eliminat Programme, Zanzibar, Tanzania; [Petzold, Max] Univ Gothenburg, Sahlgrenska Acad, Ctr Appl Biostat, Gothenburg, Sweden; [Martensson, Andreas] Karolinska Inst, Dept Publ Hlth Sci, Div Global Hlth IHCAR, Stockholm, Sweden; [Martensson, Andreas] Uppsala Univ, Ctr Clin Res Sormland, Uppsala, Sweden	Karolinska Institutet; University of Gothenburg; Karolinska Institutet; Uppsala University	Xu, WP (corresponding author), Dalian Univ Technol, Sch Food & Environm, Panjin Campus, Liaoning 124221, Peoples R China.	Weiping.Xu@ki.se	Morris, Ulrika/AAY-8512-2020	Morris, Ulrika/0000-0003-4734-5754	Swedish International Development Agency (SIDA) [SWE 2009-193]; Swedish Civil Contingencies Agency (MSB) [2010-7991]; Swedish Medical Research Council (VR) [2009-3785]; Goljes foundation	Swedish International Development Agency (SIDA); Swedish Civil Contingencies Agency (MSB); Swedish Medical Research Council (VR)(Swedish Medical Research Council (SMRC)Swedish Research Council); Goljes foundation	Funding provided by Swedish International Development Agency (SIDA) [grant number SWE 2009-193], http://www.sida.se, AM, The Swedish Civil Contingencies Agency (MSB) [grant number 2010-7991], http://www.msb.se, AM, The Swedish Medical Research Council (VR) [grant number 2009-3785], http://www.vr.se, AB and Goljes foundation, http://www.lindhes.se/stiftelseforvaltning/ansokan-ombidrag, UM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemayehu S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-277; Baidjoe A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-272; Cnops L, 2011, CLIN MICROBIOL INFEC, V17, P1101, DOI 10.1111/j.1469-0691.2010.03344.x; Cook J, 2015, J INFECT DIS, V211, P1476, DOI 10.1093/infdis/jiu655; Costa DC, 2014, MEM I OSWALDO CRUZ, V109, P21, DOI 10.1590/0074-0276140102; Cotter C, 2013, LANCET, V382, P900, DOI 10.1016/S0140-6736(13)60310-4; Escalante AA, 1998, P NATL ACAD SCI USA, V95, P8124, DOI 10.1073/pnas.95.14.8124; Farrugia C, 2011, J CLIN MICROBIOL, V49, P2191, DOI 10.1128/JCM.02156-10; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Hasan AU, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-182; Hsiang MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029550; Hsiang MS, 2010, J CLIN MICROBIOL, V48, P3539, DOI 10.1128/JCM.00522-10; Hwang J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-339; Imwong M, 2014, J CLIN MICROBIOL, V52, P3303, DOI 10.1128/JCM.01057-14; Kamau E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071539; Kamau E, 2011, J CLIN MICROBIOL, V49, P2946, DOI 10.1128/JCM.00276-11; Lin JT, 2014, TRENDS PARASITOL, V30, P183, DOI 10.1016/j.pt.2014.02.004; Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; Preiser PR, 1996, EMBO J, V15, P684, DOI 10.1002/j.1460-2075.1996.tb00401.x; Putaporntip C, 2011, CLIN MICROBIOL INFEC, V17, P1484, DOI 10.1111/j.1469-0691.2011.03507.x; Qari SH, 1996, MOL PHYLOGENET EVOL, V6, P157, DOI 10.1006/mpev.1996.0068; Rougemont M, 2004, J CLIN MICROBIOL, V42, P5636, DOI 10.1128/JCM.42.12.5636-5643.2004; Shakely D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072912; Sharma I, 2001, INT J PARASITOL, V31, P1107, DOI 10.1016/S0020-7519(01)00218-1; Singh B, 1999, AM J TROP MED HYG, V60, P687, DOI 10.4269/ajtmh.1999.60.687; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Snounou Georges, 2002, Methods Mol Med, V72, P189, DOI 10.1385/1-59259-271-6:189; Steenkeste N, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-86; Strom GEA, 2014, T ROY SOC TROP MED H, V108, P488, DOI 10.1093/trstmh/tru084; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WOODEN J, 1993, PARASITOL TODAY, V9, P303, DOI 10.1016/0169-4758(93)90131-X	32	23	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120210	10.1371/journal.pone.0120210	http://dx.doi.org/10.1371/journal.pone.0120210			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774805	Green Published, gold, Green Submitted			2022-12-27	WOS:000351183500158
J	Wang, X; Zhao, YM; Yang, Y; Qin, M				Wang, Xin; Zhao, Yuming; Yang, Yuan; Qin, Man			Novel ENAM and LAMB3 Mutations in Chinese Families with Hypoplastic Amelogenesis Imperfecta	PLOS ONE			English	Article							JUNCTIONAL EPIDERMOLYSIS-BULLOSA; INTEGRIN BINDING; LAMININ FAMILY; HERLITZ; CHAINS; PHENOTYPE	Amelogenesis imperfecta is a group of inherited diseases affecting the quality and quantity of dental enamel. To date, mutations in more than ten genes have been associated with non-syndromic amelogenesis imperfecta (AI). Among these, ENAM and LAMB3 mutations are known to be parts of the etiology of hypoplastic AI in human cases. When both alleles of LAMB3 are defective, it could cause junctional epidermolysis bullosa (JEB), while with only one mutant allele in the C-terminus of LAMB3, it could result in severe hypoplastic AI without skin fragility. We enrolled three Chinese families with hypoplastic autosomal-dominant AI. Despite the diagnosis falling into the same type, the characteristics of their enamel hypoplasia were different. Screening of ENAM and LAMB3 genes was performed by direct sequencing of genomic DNA from blood samples. Disease-causing mutations were identified and perfectly segregated with the enamel defects in three families: a 19-bp insertion mutation in the exon 7 of ENAM (c.406_407insTCAAAAAAGCCGACCACAA, p.K136Ifs*16) in Family 1, a singlebase deletion mutation in the exon 5 of ENAM (c.139delA, p.M47Cfs*11) in Family 2, and a LAMB3 nonsense mutation in the last exon (c.3466C>T, p.Q1156X) in Family 3. Our results suggest that heterozygous mutations in ENAM and LAMB3 genes can cause hypoplastic AI with markedly different phenotypes in Chinese patients. And these findings extend the mutation spectrum of both genes and can be used for mutation screening of AI in the Chinese population.	[Wang, Xin; Zhao, Yuming; Yang, Yuan; Qin, Man] Peking Univ, Sch & Hosp Stomatol, Dept Pediat Dent, Beijing 100871, Peoples R China	Peking University	Qin, M (corresponding author), Peking Univ, Sch & Hosp Stomatol, Dept Pediat Dent, Beijing 100871, Peoples R China.	qinman@gmail.com	qin, man/AAD-3710-2020		Construction Project of the National Key Discipline of Pediatric Dentistry [2014-2016]	Construction Project of the National Key Discipline of Pediatric Dentistry	This work was supported by grants 2014-2016 from the Construction Project of the National Key Discipline of Pediatric Dentistry. QM, ZY and YY are the authors who received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aumailley M, 2013, CELL ADHES MIGR, V7, P48, DOI 10.4161/cam.22826; Bartlett John D, 2013, ISRN Dent, V2013, P684607, DOI 10.1155/2013/684607; Chaudhary Mayur, 2009, J Oral Maxillofac Pathol, V13, P70, DOI 10.4103/0973-029X.57673; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; Frank DE, 2004, J CELL SCI, V117, P1351, DOI 10.1242/jcs.01003; Gadhia K, 2012, BRIT DENT J, V212, P377, DOI 10.1038/sj.bdj.2012.314; Goldfinger LE, 1998, J CELL BIOL, V141, P255, DOI 10.1083/jcb.141.1.255; Hu JCC, 2007, CELLS TISSUES ORGANS, V186, P78, DOI 10.1159/000102683; Ido H, 2007, J BIOL CHEM, V282, P11144, DOI 10.1074/jbc.M609402200; Jeon IK, 2014, J DERMATOL, V41, P322, DOI 10.1111/1346-8138.12413; Kim JW, 2013, J DENT RES, V92, P899, DOI 10.1177/0022034513502054; Kim JW, 2008, AM J HUM GENET, V82, P489, DOI 10.1016/j.ajhg.2007.09.020; Kim JW, 2005, J DENT RES, V84, P278, DOI 10.1177/154405910508400314; Kittridge A, 2012, PEDIAT DERMATOL; Kukic P, 2010, FUTURE MED CHEM, V2, P647, DOI 10.4155/FMC.10.6; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kunneken K, 2004, J BIOL CHEM, V279, P5184, DOI 10.1074/jbc.M310424200; Lee KE, 2014, CLIN GENET; Lee SK, 2010, J DENT RES, V89, P1378, DOI 10.1177/0022034510382117; Mazzucchelli I, 2011, NEONATOLOGY, V99, P188, DOI 10.1159/000314076; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Nakano A, 2002, HUM GENET, V110, P41, DOI 10.1007/s00439-001-0630-1; Navdaev Alexei, 2008, Exp Cell Res, V314, P489, DOI 10.1016/j.yexcr.2007.10.027; Nishiuchi R, 2006, MATRIX BIOL, V25, P189, DOI 10.1016/j.matbio.2005.12.001; Ozdemir D, 2005, J DENT RES, V84, P1036, DOI 10.1177/154405910508401113; Parry DA, 2013, AM J HUM GENET, V92, P307, DOI 10.1016/j.ajhg.2013.01.003; Parry DA, 2012, AM J HUM GENET, V91, P565, DOI 10.1016/j.ajhg.2012.07.020; PAULSSON M, 1985, EMBO J, V4, P309, DOI 10.1002/j.1460-2075.1985.tb03630.x; Poulter JA, 2014, HUM MOL GENET; Poulter JA, 2014, EUR J HUM GENET, V22, P132, DOI 10.1038/ejhg.2013.76; Ravassipour DB, 2000, J DENT RES, V79, P1476, DOI 10.1177/00220345000790070801; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Salmivirta K, 1997, DEV DYNAM, V210, P206, DOI 10.1002/(SICI)1097-0177(199711)210:3<206::AID-AJA2>3.3.CO;2-S; Sept D, 1999, J MOL BIOL, V294, P1181, DOI 10.1006/jmbi.1999.3332; Seymen F, 2014, J DENT RES, V93, P988, DOI 10.1177/0022034514548222; Simmer SG, 2013, CLIN GENET, V83, P195, DOI 10.1111/j.1399-0004.2012.01887.x; Taniguchi Y, 2009, J BIOL CHEM, V284, P7820, DOI 10.1074/jbc.M809332200; Wang SK, 2014, J DENT RES, V93, P42, DOI 10.1177/0022034513512653; Wang SK, 2013, J DENT RES, V92, P266, DOI 10.1177/0022034513475626; Wang SK, 2014, HUM MOL GENET, V23, P2157, DOI 10.1093/hmg/ddt611; WITKOP CJ, 1988, J ORAL PATHOL MED, V17, P547, DOI 10.1111/j.1600-0714.1988.tb01332.x; Wlodek ST, 2000, BIOPOLYMERS, V53, P265, DOI 10.1002/(SICI)1097-0282(200003)53:3<265::AID-BIP6>3.3.CO;2-E	43	18	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0116514	10.1371/journal.pone.0116514	http://dx.doi.org/10.1371/journal.pone.0116514			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25769099	Green Published, gold, Green Submitted			2022-12-27	WOS:000351277500011
J	Ding, YH; Gao, H; Zhao, LF; Wang, X; Zheng, M				Ding, Yanhong; Gao, Han; Zhao, Lifang; Wang, Xian; Zheng, Ming			Mitofusin 2-Deficiency Suppresses Cell Proliferation through Disturbance of Autophagy	PLOS ONE			English	Article							RAT KIDNEY MITOCHONDRIA; MARIE-TOOTH-DISEASE; NEURODEGENERATIVE DISEASE; ENDOPLASMIC-RETICULUM; OXIDATIVE STRESS; SKELETAL-MUSCLE; MYOSIN VI; 2A GENE; MFN2; FUSION	Mitofusin2 (Mfn2), a mitochondrial outer membrane protein serving primarily as a mitochondrial fusion protein, has multiple functions in regulating cell biological processes. Defects of Mfn2 were found in diabetes, obesity, and neurodegenerative diseases. In the present study, we found that knockdown of Mfn2 by shRNA led to impaired autophagic degradation, inhibited mitochondrial oxygen consumption rate and cell glycolysis, reduced ATP production, and suppressed cell proliferation. Inhibition of autophagic degradation mimicked Mfn2-deficiency mediated cell proliferation suppression, while enhancement of autophagosome maturation restored the suppressed cell proliferation by Mfn2-deficiency. Thus, our findings revealed the role of Mfn2 in regulating cell proliferation and mitochondrial metabolism, and shed new light on understanding the mechanisms of Mfn2 deficiency related diseases.	[Ding, Yanhong; Gao, Han; Zhao, Lifang; Wang, Xian; Zheng, Ming] Peking Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Beijing 100871, Peoples R China	Peking University	Ding, YH (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Beijing 100871, Peoples R China.	zhengm@pku.edu.cn			National Key Basic Research Program of China [2013CB512103, 2014CB542206]; National Science Foundation of China [31371350, 30971062]	National Key Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Basic Research Program of China (2013CB512103 & 2014CB542206), and the National Science Foundation of China (31371350 & 30971062). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach D, 2005, DIABETES, V54, P2685, DOI 10.2337/diabetes.54.9.2685; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Baloh RH, 2007, J NEUROSCI, V27, P422, DOI 10.1523/JNEUROSCI.4798-06.2007; Cartoni R, 2009, EXP NEUROL, V218, P268, DOI 10.1016/j.expneurol.2009.05.003; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chen DD, 2012, MOL CELL, V45, P629, DOI 10.1016/j.molcel.2011.12.036; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Chen KH, 2004, NAT CELL BIOL, V6, P872, DOI 10.1038/ncb1161; Chen KH, 2014, FASEB J, V28, P382, DOI 10.1096/fj.13-230037; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; de Brito OM, 2010, EMBO J, V29, P2715, DOI 10.1038/emboj.2010.177; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; DELUCA HF, 1961, P NATL ACAD SCI USA, V47, P1744, DOI 10.1073/pnas.47.11.1744; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Jin BY, 2011, MED ONCOL, V28, pS373, DOI 10.1007/s12032-010-9662-5; Jin DZ, 2011, MOL CELL BIOCHEM, V351, P165, DOI 10.1007/s11010-011-0724-6; Krieger C, 2002, EUR J PHARMACOL, V447, P177, DOI 10.1016/S0014-2999(02)01842-3; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; Limor R, 2005, AM J HYPERTENS, V18, P299, DOI 10.1016/j.amjhyper.2004.09.008; Liu H, 2014, AUTOPHAGY, V10, P372, DOI 10.4161/auto.27163; Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Osellame LD, 2013, CELL METAB, V17, P941, DOI 10.1016/j.cmet.2013.04.014; Parra V, 2008, CARDIOVASC RES, V77, P387, DOI 10.1093/cvr/cvm029; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Pich S, 2005, HUM MOL GENET, V14, P1405, DOI 10.1093/hmg/ddi149; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Rosenstock TR, 2004, J NEUROCHEM, V88, P1220, DOI 10.1046/j.1471-4159.2003.02250.x; Sebastian D, 2012, P NATL ACAD SCI USA, V109, P5523, DOI 10.1073/pnas.1108220109; Shen T, 2007, J BIOL CHEM, V282, P23354, DOI 10.1074/jbc.M702657200; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; Tumbarello DA, 2013, J CELL SCI, V126, P2561, DOI 10.1242/jcs.095554; Tumbarello DA, 2012, NAT CELL BIOL, V14, P1024, DOI 10.1038/ncb2589; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; VASINGTON FD, 1962, J BIOL CHEM, V237, P2670; Wang WL, 2010, BIOCHEM BIOPH RES CO, V400, P587, DOI 10.1016/j.bbrc.2010.08.108; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhao T, 2012, J BIOL CHEM, V287, P23615, DOI 10.1074/jbc.M112.379164; Zheng M, 2010, J MOL MED, V88, P987, DOI 10.1007/s00109-010-0675-5	44	35	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0121328	10.1371/journal.pone.0121328	http://dx.doi.org/10.1371/journal.pone.0121328			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781899	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600202
J	Ma, XL; Yu, HY; Wang, YP; Wang, YH				Ma, Xiaolei; Yu, Haiyang; Wang, Yunpeng; Wang, Yinhai			Large-Scale Transportation Network Congestion Evolution Prediction Using Deep Learning Theory	PLOS ONE			English	Article							TRAFFIC CONGESTION	Understanding how congestion at one location can cause ripples throughout large-scale transportation network is vital for transportation researchers and practitioners to pinpoint traffic bottlenecks for congestion mitigation. Traditional studies rely on either mathematical equations or simulation techniques to model traffic congestion dynamics. However, most of the approaches have limitations, largely due to unrealistic assumptions and cumbersome parameter calibration process. With the development of Intelligent Transportation Systems (ITS) and Internet of Things (IoT), transportation data become more and more ubiquitous. This triggers a series of data-driven research to investigate transportation phenomena. Among them, deep learning theory is considered one of the most promising techniques to tackle tremendous high-dimensional data. This study attempts to extend deep learning theory into large-scale transportation network analysis. A deep Restricted Boltzmann Machine and Recurrent Neural Network architecture is utilized to model and predict traffic congestion evolution based on Global Positioning System (GPS) data from taxi. A numerical study in Ningbo, China is conducted to validate the effectiveness and efficiency of the proposed method. Results show that the prediction accuracy can achieve as high as 88% within less than 6 minutes when the model is implemented in a Graphic Processing Unit (GPU)-based parallel computing environment. The predicted congestion evolution patterns can be visualized temporally and spatially through a map-based platform to identify the vulnerable links for proactive congestion mitigation.	[Ma, Xiaolei; Yu, Haiyang; Wang, Yunpeng] Beihang Univ, Sch Transportat Sci & Engn, Beijing Key Lab Cooperat Vehicle Infrastruct Syst, Beijing 100191, Peoples R China; [Ma, Xiaolei; Yu, Haiyang; Wang, Yunpeng] SiPaiLou 2, Jiangsu Prov Collaborat Innovat Ctr Modern Urban, Nanjing, Jiangsu, Peoples R China; [Wang, Yinhai] Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98195 USA	Beihang University; University of Washington; University of Washington Seattle	Yu, HY (corresponding author), Beihang Univ, Sch Transportat Sci & Engn, Beijing Key Lab Cooperat Vehicle Infrastruct Syst, Beijing 100191, Peoples R China.	hyyu@buaa.edu.cn	Ma, Xiaolei/J-4069-2014; Wang, Yinhai/B-5396-2012	Ma, Xiaolei/0000-0002-3841-5792; Wang, Yinhai/0000-0002-4180-5628	Beijing Nova Programme; National Natural Science Foundation of China [51308021, 51408019, 71402011]; National Basic Research Program of China [2012CB725404]	Beijing Nova Programme(Beijing Municipal Science & Technology Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This research is supported by the Beijing Nova Programme, National Natural Science Foundation of China (Grant No. 51308021, No. 51408019, and No. 71402011) and National Basic Research Program of China (2012CB725404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aligawesa AK., 2009, DETECTION LOCALIZATI; [Anonymous], 2012, MODELING TEMPORAL DE; [Anonymous], 2014, CTV60 NVIDIA CORP; Bellman R, 1961, ADAPTIVE CONTROL PRO, DOI DOI 10.1515/9781400874668; BENGIO Y, 1994, IEEE T NEURAL NETWOR, V5, P157, DOI 10.1109/72.279181; Bengio Y, 2009, FOUND TRENDS MACH LE, V2, P1, DOI 10.1561/2200000006; Bergstra J., 2010, P 9 PYTH SCI C, P3, DOI DOI 10.25080/MAJORA-92BF1922-003; Chen SY, 2012, MATH PROBL ENG, V2012, DOI 10.1155/2012/732698; Cheng T, 2013, TRANSPORT RES C-EMER, V36, P296, DOI 10.1016/j.trc.2013.09.001; Colak S, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/11/113037; Golik P., 2013, INTERSPEECH; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Hinton GE, 2002, NEURAL COMPUT, V14, P1771, DOI 10.1162/089976602760128018; Huang WH, 2014, IEEE T INTELL TRANSP, V15, P2191, DOI 10.1109/TITS.2014.2311123; Husken M, 2003, NEUROCOMPUTING, V50, P223, DOI 10.1016/S0925-2312(01)00706-8; Langkvist M, 2014, PATTERN RECOGN LETT, V42, P11, DOI 10.1016/j.patrec.2014.01.008; Liu C, 2009, SIMUL MODEL PRACT TH, V17, P1566, DOI 10.1016/j.simpat.2009.06.001; Long JC, 2008, SCI CHINA SER F, V51, P948, DOI 10.1007/s11432-008-0038-9; Schatz MC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-474; Schrank D., 2012, TTIS 2012 URBAN MOBI, VVolume 4; Sutskever I, 2007, INT C ART INT STAT; Sutskever I., 2009, ADV NEURAL INFORM PR, P1601; Wang J, 2013, PHYSICA A, V392, P392, DOI 10.1016/j.physa.2012.08.020; Wang JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080178; Wang P, 2012, SCI REPORTS, V2; Yang S, 2013, TRANSPORT RES C-EMER, V26, P160, DOI 10.1016/j.trc.2012.08.005; Zhao L, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.026125	28	150	164	6	212	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119044	10.1371/journal.pone.0119044	http://dx.doi.org/10.1371/journal.pone.0119044			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25780910	Green Submitted, gold, Green Published			2022-12-27	WOS:000351284600046
J	Redolfi, A; Manset, D; Barkhof, F; Wahlund, LO; Glatard, T; Mangin, JF; Frisoni, GB				Redolfi, Alberto; Manset, David; Barkhof, Frederik; Wahlund, Lars-Olof; Glatard, Tristan; Mangin, Jean-Francois; Frisoni, Giovanni B.		Alzheimer's Dis Neuroimaging Initi	Head-to-Head Comparison of Two Popular Cortical Thickness Extraction Algorithms: A Cross-Sectional and Longitudinal Study	PLOS ONE			English	Article							AUTOMATED 3-D EXTRACTION; HUMAN CEREBRAL-CORTEX; ALZHEIMERS-DISEASE; SURFACE RECONSTRUCTION; MRI PHANTOM; ATROPHY; VALIDATION; CLASSIFICATION; REGISTRATION; SIMULATION	Background and Purpose The measurement of cortical shrinkage is a candidate marker of disease progression in Alzheimer's. This study evaluated the performance of two pipelines: Civet-CLASP (v1.1.9) and Freesurfer (v5.3.0). Methods Images from 185 ADNI1 cases (69 elderly controls (CTR), 37 stable MCI (sMCI), 27 progressive MCI (pMCI), and 52 Alzheimer (AD) patients) scanned at baseline, month 12, and month 24 were processed using the two pipelines and two interconnected e-infrastructures: neuGRID (https://neugrid4you.eu) and VIP (http://vip.creatis.insa-lyon.fr). The vertex-by-vertex cross-algorithm comparison was made possible applying the 3D gradient vector flow (GVF) and closest point search (CPS) techniques. Results The cortical thickness measured with Freesurfer was systematically lower by one third if compared to Civet's. Cross-sectionally, Freesurfer's effect size was significantly different in the posterior division of the temporal fusiform cortex. Both pipelines were weakly or mildly correlated with the Mini Mental State Examination score (MMSE) and the hippocampal volumetry. Civet differed significantly from Freesurfer in large frontal, parietal, temporal and occipital regions (p<0.05). In a discriminant analysis with cortical ROIs having effect size larger than 0.8, both pipelines gave no significant differences in area under the curve (AUC). Longitudinally, effect sizes were not significantly different in any of the 28 ROIs tested. Both pipelines weakly correlated with MMSE decay, showing no significant differences. Freesurfer mildly correlated with hippocampal thinning rate and differed in the supramarginal gyrus, temporal gyrus, and in the lateral occipital cortex compared to Civet (p<0.05). In a discriminant analysis with ROIs having effect size larger than 0.6, both pipelines yielded no significant differences in the AUC. Conclusions Civet appears slightly more sensitive to the typical AD atrophic pattern at the MCI stage, but both pipelines can accurately characterize the topography of cortical thinning at the dementia stage.	[Redolfi, Alberto; Frisoni, Giovanni B.] IRCCS San Giovanni di Dio Fatebenefratelli, Lab Epidemiol & Neuroimaging, Brescia, Italy; [Manset, David] Gnubila France, Argonay, France; [Barkhof, Frederik] Vrije Univ Amsterdam Med Ctr, Dept Radiol, Amsterdam, Netherlands; [Wahlund, Lars-Olof] Karolinska Inst, Div Clin Geriatr Novum, Dept Neurobiol Caring Sci & Soc, Stockholm, Sweden; [Glatard, Tristan] Univ Lyon, INSERM, CNRS, CREATIS, Lyon, France; [Glatard, Tristan] McGill Univ, Montreal Neurol Inst, McConnell Brain Imaging Ctr, Montreal, PQ, Canada; [Mangin, Jean-Francois] CEA, Neurospin, CATI, Gif Sur Yvette, France; [Frisoni, Giovanni B.] Univ Hosp Geneva, Memory Clin, Lab Neuroimaging Aging, Geneva, Switzerland; [Frisoni, Giovanni B.] Univ Hosp Geneva, LANVIE, Geneva, Switzerland; [Frisoni, Giovanni B.] Univ Geneva, Geneva, Switzerland	IRCCS Fatebenefratelli; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Karolinska Institutet; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; McGill University; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Geneva; University of Geneva; University of Geneva	Redolfi, A (corresponding author), IRCCS San Giovanni di Dio Fatebenefratelli, Lab Epidemiol & Neuroimaging, Brescia, Italy.	aredolfi@fatebenefratelli.it	Mangin, Jean-Francois/AAI-8983-2020; Glatard, Tristan/H-3656-2014; McClatchey, Richard H/M-4183-2015; Redolfi, Alberto/J-7675-2016; Barattieri di San Pietro, Chiara/V-5954-2018; Barkhof, Frederik/AAJ-6226-2020; Frisoni, Giovanni B./K-1360-2016; Frisoni, Giovanni/K-1360-2016	McClatchey, Richard H/0000-0002-0042-5960; Redolfi, Alberto/0000-0002-4145-9059; Barattieri di San Pietro, Chiara/0000-0003-4407-7037; Barkhof, Frederik/0000-0003-3543-3706; Frisoni, Giovanni B./0000-0002-6419-1753; wahlund, lars-olof/0000-0002-9905-8426; Frisoni, Giovanni/0000-0001-7075-7082	FP7 neuGRID4You; European Commission [283562]; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; Canadian Institutes of Health Research; NIH [P30 AG010129, K01 AG030514]; Dana Foundation; Alfonso Martin Escudero foundation; NATIONAL INSTITUTE ON AGING [U01AG024904] Funding Source: NIH RePORTER	FP7 neuGRID4You; European Commission(European CommissionEuropean Commission Joint Research Centre); Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; Alfonso Martin Escudero foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	G.B. Frisoni and D. Manset are funded by FP7 neuGRID4You funded by the European Commission (FP7/2007-2013) under grant agreement no. 283562. Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (NIH) (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. This research was also supported by NIH grants P30 AG010129, K01 AG030514, and the Dana Foundation. JQT is the William Maul Measy-Truman G. Schnabel Jr. M.D. Professor of Geriatric Medicine and Gerontology. JBT's work was supported by a grant from the Alfonso Martin Escudero foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta O, 2012, J NEUROSCI METH, V205, P96, DOI 10.1016/j.jneumeth.2011.12.011; Ardekani BA, 2013, CEREB CORTEX, V23, P2514, DOI 10.1093/cercor/bhs253; Brewer JB, 2009, AM J NEURORADIOL, V30, P578, DOI 10.3174/ajnr.A1402; Carrillo MC, 2012, ALZHEIMERS DEMENT, V8, P337, DOI 10.1016/j.jalz.2012.04.007; Clarkson MJ, 2011, NEUROIMAGE, V57, P856, DOI 10.1016/j.neuroimage.2011.05.053; Dahnke R, 2013, NEUROIMAGE, V65, P336, DOI 10.1016/j.neuroimage.2012.09.050; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Das SR, 2009, NEUROIMAGE, V45, P867, DOI 10.1016/j.neuroimage.2008.12.016; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dickerson Bradford C, 2005, NeuroRx, V2, P348, DOI 10.1007/BF03206676; Dickerson BC, 2009, NEUROBIOL AGING, V30, P432, DOI 10.1016/j.neurobiolaging.2007.07.022; Dickerson BC, 2009, CEREB CORTEX, V19, P497, DOI 10.1093/cercor/bhn113; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fox NC, 2009, J NUTR HEALTH AGING, V13, P350, DOI 10.1007/s12603-009-0040-y; Fox NC, 2005, NEUROLOGY, V64, P1563, DOI 10.1212/01.WNL.0000159743.08996.99; Frisoni GB, 2010, NAT REV NEUROL, V6, P67, DOI 10.1038/nrneurol.2009.215; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Glatard T, 2013, IEEE T MED IMAGING, V32, P110, DOI 10.1109/TMI.2012.2220154; Han X, 2004, NEUROIMAGE, V23, P997, DOI 10.1016/j.neuroimage.2004.06.043; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Hazlett HC, 2011, ARCH GEN PSYCHIAT, V68, P467, DOI 10.1001/archgenpsychiatry.2011.39; Jack CR, 2004, NEUROLOGY, V62, P591, DOI 10.1212/01.WNL.0000110315.26026.EF; Jones R, 1997, CLINICAL INVESTIGATI; Kabani N, 2001, NEUROIMAGE, V13, P375, DOI 10.1006/nimg.2000.0652; Kim JS, 2005, NEUROIMAGE, V27, P210, DOI 10.1016/j.neuroimage.2005.03.036; Knight WD, 2011, NEUROBIOL AGING, V32, P1765, DOI 10.1016/j.neurobiolaging.2009.11.013; Kuperberg GR, 2003, ARCH GEN PSYCHIAT, V60, P878, DOI 10.1001/archpsyc.60.9.878; Lee JK, 2006, NEUROIMAGE, V31, P572, DOI 10.1016/j.neuroimage.2005.12.044; Lee J, 2006, LECT NOTES COMPUT SC, V4190, P183; Lerch JP, 2005, NEUROIMAGE, V24, P163, DOI 10.1016/j.neuroimage.2004.07.045; Liu TM, 2008, NEUROIMAGE, V40, P991, DOI 10.1016/j.neuroimage.2007.12.027; MacDonald D, 2000, NEUROIMAGE, V12, P340, DOI 10.1006/nimg.1999.0534; Nakamura K, 2011, NEUROIMAGE, V54, P278, DOI 10.1016/j.neuroimage.2010.07.052; Querbes O, 2009, BRAIN, V132, P2036, DOI 10.1093/brain/awp105; Redolfi A, 2013, FUNCT NEUROL, V28, P175, DOI 10.11138/FNeur/2013.28.3.175; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Ridgway GR, 2012, NEUROLOGY, V79, P80, DOI 10.1212/WNL.0b013e31825dce28; Rosas HD, 2002, NEUROLOGY, V58, P695, DOI 10.1212/WNL.58.5.695; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Thompson PM, 2003, J NEUROSCI, V23, P994; Westman E, 2011, NEUROIMAGE, V58, P818, DOI 10.1016/j.neuroimage.2011.06.065; Wyman BT, 2013, ALZHEIMERS DEMENT, V9, P332, DOI 10.1016/j.jalz.2012.06.004	43	37	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0117692	10.1371/journal.pone.0117692	http://dx.doi.org/10.1371/journal.pone.0117692			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781983	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600014
J	Riccio, E; Sabbatini, M; Bruzzese, D; Capuano, I; Migliaccio, S; Andreucci, M; Pisani, A				Riccio, Eleonora; Sabbatini, Massimo; Bruzzese, Dario; Capuano, Ivana; Migliaccio, Silvia; Andreucci, Michele; Pisani, Antonio			Effect of Paricalcitol vs Calcitriol on Hemoglobin Levels in Chronic Kidney Disease Patients: A Randomized Trial	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; CHRONIC-RENAL-FAILURE; SECONDARY HYPERPARATHYROIDISM; ERYTHROPOIETIN RESISTANCE; 1,25-DIHYDROXYVITAMIN D-3; HEMODIALYSIS-PATIENTS; DIALYSIS PATIENTS; IMPROVES ANEMIA; INFLAMMATION; ALBUMINURIA	Background Recent studies suggest that vitamin D deficiency represents an additional cofactor of renal anemia, with several mechanisms accounting for this relationship. In line with it, the administration of vitamin D or its analogues has been associated with an improvement of anemia. There are no data, however, about a direct effect of paricalcitol on hemoglobin (Hb) levels. Therefore, we conducted a study to determine whether paricalcitol, compared to calcitriol, improves anemia in patients with chronic kidney disease (CKD). Methods In this randomized trial 60 CKD patients stage 3b-5 and anemia (Hb levels: 10-12.5 g/dL) were assigned (1: 1) to receive low doses of calcitriol (Group Calcitriol) or paricalcitol (Group Paricalcitol) for 6 months. All the patients had normal values of plasma calcium, phosphorus and PTH, a stable iron balance, and normal values of C-Reactive Protein. The primary end-point was to evaluate the effects of the two treatments on Hb levels; the modifications in 24hr-proteinuria (UProt) were also evaluated. Results A significant Group x Time interaction effect was observed in the longitudinal analysis of Hb levels (F(1,172)=31.4, p<0.001). Subjects in Paricalcitol experienced a significant monthly increase of Hb levels equal to +0.16 g/dL [95% C. I. 0.10 to +0.22, p<0.001) while in Group Calcitriol, Hb decrease throughout the follow-up with an average monthly rate of -0.10 g/dL (95% C. I.: -0.17 to -0.04, p<0.001). In Group Paricalcitol, UProt was significantly reduced after 6 months [0.35 (0.1-1.2) vs 0.59 (0.2-1.6), p<0.01], whereas no significant difference emerged in Group Calcitriol. Plasma levels of calcium, phosphate, PTH and of inflammation markers remained in the normal range in both groups throughout the study. Conclusions Short-term exposure to paricalcitol results in an independent increase in Hb levels, which occurred with no modification of iron balance, inflammatory markers, and PTH plasma concentrations, and was associated with a decrease in UProt.	[Riccio, Eleonora; Sabbatini, Massimo; Capuano, Ivana; Migliaccio, Silvia; Pisani, Antonio] Univ Naples Federico II, Dept Publ Hlth, Chair Nephrol, Naples, Italy; [Bruzzese, Dario] Univ Naples Federico II, Dept Publ Hlth, Chair Stat, Naples, Italy; [Andreucci, Michele] Magna Graecia Univ Catanzaro, Nephrol Unit, Catanzaro, Italy	University of Naples Federico II; University of Naples Federico II; Magna Graecia University of Catanzaro	Riccio, E (corresponding author), Univ Naples Federico II, Dept Publ Hlth, Chair Nephrol, Naples, Italy.	elyriccio@libero.it		PISANI, Antonio/0000-0003-0241-8323; Bruzzese, Dario/0000-0001-9911-4646; Migliaccio, Silvia/0000-0002-4563-6630				Agarwal R, 2005, KIDNEY INT, V68, P2823, DOI 10.1111/j.1523-1755.2005.00755.x; Albitar S, 1997, NEPHROL DIAL TRANSPL, V12, P514, DOI 10.1093/ndt/12.3.514; Alborzi P, 2008, HYPERTENSION, V52, P249, DOI 10.1161/HYPERTENSIONAHA.108.113159; Andress DL, 2006, KIDNEY INT, V69, P33, DOI 10.1038/sj.ki.5000045; Aucella F, 2003, NEPHRON CLIN PRACT, V95, pC121, DOI 10.1159/000074837; Barany P, 2001, NEPHROL DIAL TRANSPL, V16, P224, DOI 10.1093/ndt/16.2.224; Ben Alon D, 2002, EXP HEMATOL, V30, P403, DOI 10.1016/S0301-472X(02)00789-0; BERTOLI M, 1990, CLIN NEPHROL, V33, P98; Brancaccio D, 2004, J AM SOC NEPHROL, V15, pS21, DOI 10.1097/01.ASN.0000093369.09194.12; Capuano A, 2009, J NEPHROL, V22, P59; de Zeeuw D, 2010, LANCET, V376, P1543, DOI 10.1016/S0140-6736(10)61032-X; Del Vecchio L, 2005, J RENAL NUTR, V15, P137, DOI 10.1053/j.jrn.2004.09.024; Dusso A, 2011, BEST PRACT RES CL EN, V25, P647, DOI 10.1016/j.beem.2011.05.005; Fishbane S, 2009, AM J KIDNEY DIS, V54, P647, DOI 10.1053/j.ajkd.2009.04.036; Goicoechea M, 1998, NEPHRON, V78, P23, DOI 10.1159/000044877; Gravellone L, 2011, INT J NEPHROL, V2011, DOI 10.4061/2011/419524; Guerrero F, 2012, NEPHROL DIAL TRANSPL, V27, P2206, DOI 10.1093/ndt/gfr555; Gunnell J, 1999, AM J KIDNEY DIS, V33, P63, DOI 10.1016/S0272-6386(99)70259-3; Icardi A, 2013, NEPHROL DIAL TRANSPL, V28, P1672, DOI 10.1093/ndt/gft021; Keithi-Reddy SR, 2008, KIDNEY INT, V74, P782, DOI 10.1038/ki.2008.245; Kendrick J, 2009, AM J NEPHROL, V30, P64, DOI 10.1159/000202632; Kuhlmann A, 2004, AM J PHYSIOL-RENAL, V286, pF526, DOI 10.1152/ajprenal.00316.2003; Lee JH, 2008, J AM COLL CARDIOL, V52, P1949, DOI 10.1016/j.jacc.2008.08.050; Lin R, 2004, BIOESSAYS, V26, P21, DOI 10.1002/bies.10368; Marckmann P, 2012, NEPHROL DIAL TRANSPL, V27, P3523, DOI 10.1093/ndt/gfs138; Martin KJ, 1998, J AM SOC NEPHROL, V9, P1427; Matsui I, 2009, NEPHROL DIAL TRANSPL, V24, P2354, DOI 10.1093/ndt/gfp117; Meguro S, 2011, INT J ENDOCRINOL, V2011, DOI 10.1155/2011/362981; Monier-Faugere MC, 2007, CLIN J AM SOC NEPHRO, V2, P1255, DOI 10.2215/CJN.03461006; Nagpal S, 2005, ENDOCR REV, V26, P662, DOI 10.1210/er.2004-0002; Patel NM, 2010, KIDNEY INT, V77, P715, DOI 10.1038/ki.2009.551; Perez A, 1996, BRIT J DERMATOL, V134, P1070, DOI 10.1111/j.1365-2133.1996.tb07945.x; Rathaus M, 2009, G Ital Nefrol, V26, P338; Saab G, 2007, NEPHRON CLIN PRACT, V105, P132, DOI 10.1159/000098645; Sim JJ, 2010, ANN HEMATOL, V89, P447, DOI 10.1007/s00277-009-0850-3; Sprague SM, 2003, KIDNEY INT, V63, P1483, DOI 10.1046/j.1523-1755.2003.00878.x	37	26	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0118174	10.1371/journal.pone.0118174	http://dx.doi.org/10.1371/journal.pone.0118174			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781618	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600021
J	Halpern, BS; Longo, C; Lowndes, JSS; Best, BD; Frazier, M; Katona, SK; Kleisner, KM; Rosenberg, AA; Scarborough, C; Selig, ER				Halpern, Benjamin S.; Longo, Catherine; Lowndes, Julia S. Stewart; Best, Benjamin D.; Frazier, Melanie; Katona, Steven K.; Kleisner, Kristin M.; Rosenberg, Andrew A.; Scarborough, Courtney; Selig, Elizabeth R.			Patterns and Emerging Trends in Global Ocean Health	PLOS ONE			English	Article							INDEX; FISHERIES	International and regional policies aimed at managing ocean ecosystem health need quantitative and comprehensive indices to synthesize information from a variety of sources, consistently measure progress, and communicate with key constituencies and the public. Here we present the second annual global assessment of the Ocean Health Index, reporting current scores and annual changes since 2012, recalculated using updated methods and data based on the best available science, for 221 coastal countries and territories. The Index measures performance of ten societal goals for healthy oceans on a quantitative scale of increasing health from 0 to 100, and combines these scores into a single Index score, for each country and globally. The global Index score improved one point (from 67 to 68), while many country-level Index and goal scores had larger changes. Per-country Index scores ranged from 41-95 and, on average, improved by 0.06 points (range -8 to +12). Globally, average scores increased for individual goals by as much as 6.5 points (coastal economies) and decreased by as much as 1.2 points (natural products). Annual updates of the Index, even when not all input data have been updated, provide valuable information to scientists, policy makers, and resource managers because patterns and trends can emerge from the data that have been updated. Changes of even a few points indicate potential successes (when scores increase) that merit recognition, or concerns (when scores decrease) that may require mitigative action, with changes of more than 10-20 points representing large shifts that deserve greater attention. Goal scores showed remarkably little covariance across regions, indicating low redundancy in the Index, such that each goal delivers information about a different facet of ocean health. Together these scores provide a snapshot of global ocean health and suggest where countries have made progress and where a need for further improvement exists.	[Halpern, Benjamin S.; Longo, Catherine; Lowndes, Julia S. Stewart; Best, Benjamin D.; Frazier, Melanie; Scarborough, Courtney] Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; [Halpern, Benjamin S.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Halpern, Benjamin S.] Imperial Coll London, Ascot, Berks, England; [Best, Benjamin D.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Katona, Steven K.; Selig, Elizabeth R.] Conservat Int, Betty & Gordon Moore Ctr Sci & Oceans, Arlington, VA USA; [Kleisner, Kristin M.] Univ British Columbia, Sea Us Project, Vancouver, BC V5Z 1M9, Canada; [Rosenberg, Andrew A.] Union Concerned Scientists, Cambridge, MA USA	National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; Imperial College London; Duke University; Conservation International; University of British Columbia	Halpern, BS (corresponding author), Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA.	halpern@bren.ucsb.edu	Frazier, Melanie R/A-2367-2012	Scarborough, Courtney/0000-0001-7270-9228; Lowndes, Julia/0000-0003-1682-3872	Pacific Life Foundation; Thomas W. Haas Fund of the New Hampshire Charitable Foundation; Oak Foundation; Akiko Shiraki Dynner Fund for Ocean Exploration and Conservation; Darden Restaurants Inc. Foundation; Conservation International; University of California Santa Barbara's National Center for Ecological Analysis and Synthesis - David and Lucile Packard Foundation; New England Aquarium; National Geographic	Pacific Life Foundation; Thomas W. Haas Fund of the New Hampshire Charitable Foundation; Oak Foundation; Akiko Shiraki Dynner Fund for Ocean Exploration and Conservation; Darden Restaurants Inc. Foundation; Conservation International; University of California Santa Barbara's National Center for Ecological Analysis and Synthesis - David and Lucile Packard Foundation; New England Aquarium; National Geographic(National Geographic Society)	Beau and Heather Wrigley generously provided the founding grant. Additional financial and in-kind support was provided by the Pacific Life Foundation, Thomas W. Haas Fund of the New Hampshire Charitable Foundation, the Oak Foundation, Akiko Shiraki Dynner Fund for Ocean Exploration and Conservation, Darden Restaurants Inc. Foundation, Conservation International, New England Aquarium, National Geographic, and the University of California Santa Barbara's National Center for Ecological Analysis and Synthesis, which supported the Ecosystem Health Working Group as part of the Science of Ecosystem-Based Management project funded by the David and Lucile Packard Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, AGR OC HLTH ACT PLAN; Branch TA, 2013, NATURE, V495, pE5, DOI 10.1038/nature11974; *COMM AUSTR, 1998, AUSTR OC POL; Costello C, 2012, SCIENCE, V338, P517, DOI 10.1126/science.1223389; Elfes CT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092589; Halpern BS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098995; Halpern BS, 2013, NATURE, V495, pE7, DOI 10.1038/nature11975; Halpern BS, 2012, NATURE, V488, P615, DOI 10.1038/nature11397; Hanson T, 2009, CONSERV BIOL, V23, P578, DOI 10.1111/j.1523-1739.2009.01166.x; KIMURA DK, 1982, CAN J FISH AQUAT SCI, V39, P1467, DOI 10.1139/f82-198; Kleisner KM, 2013, AMBIO, V42, P910, DOI 10.1007/s13280-013-0447-x; Martell S, 2013, FISH FISH, V14, P504, DOI 10.1111/j.1467-2979.2012.00485.x; *PEW OC COMM, 2003, AM LIV OC CHART COUR; Puget Sound Partnership, 2008, PUG SOUND ACT AG PRO; Rosenberg A.A., 2014, FAO FISHERIES AQUACU, P175; Samhouri JF, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00366.1; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Selig ER, 2015, ECOSYSTEM S IN PRESS; Srinivasan U. Thara, 2010, Journal of Bioeconomics, V12, P183, DOI 10.1007/s10818-010-9090-9; Thorson JT, 2013, CAN J FISH AQUAT SCI, V70, P1829, DOI 10.1139/cjfas-2013-0280; Thorson JT, 2012, CAN J FISH AQUAT SCI, V69, P645, DOI 10.1139/F2012-016; United Nations Development Programme, 2012, RIS S HUM PROGR DIV; United States National Ocean Council, 2013, NAT OC POL IMPL PLAN; World Bank, 2013, WORLD DEV IND 2013, DOI [10.1596/978-0-8213-9824-1, DOI 10.1596/978-0-8213-9824-1]; Worldwide Governance Indicators, 2013, WORLDWIDE GOVERNANCE	25	65	66	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0117863	10.1371/journal.pone.0117863	http://dx.doi.org/10.1371/journal.pone.0117863			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774678	Green Submitted, Green Published, gold			2022-12-27	WOS:000351183500022
J	Harf, A; Skandrani, S; Sibeoni, J; Pontvert, C; Revah-Levy, A; Moro, MR				Harf, Aurelie; Skandrani, Sara; Sibeoni, Jordan; Pontvert, Caroline; Revah-Levy, Anne; Moro, Marie Rose			Cultural Identity and Internationally Adopted Children: Qualitative Approach to Parental Representations	PLOS ONE			English	Article							ETHNIC-IDENTITY; INTERCOUNTRY ADOPTION; MENTAL-HEALTH; SOCIALIZATION; FAMILIES; IDENTIFICATION; COMPETENCE	Approximately 30 000 children are adopted across national borders each year. A review of the literature on the cultural belonging of these internationally adopted children shows substantial differences between the literature from English-speaking countries and that from France and Europe in general. The objective of this study is to start from the discourse of French adoptive parents to explore their representations of their child's cultural belonging and their positions (their thoughts and representations) concerning connections with the child's country of birth and its culture. The study includes 51 French parents who adopted one or more children internationally. Each parent participated in a semi-structured interview, focused on the adoption procedure and their current associations with the child's birth country. The interviews were analyzed according to a qualitative phenomenological method, Interpretative Phenomenological Analysis. The principal themes that emerged from our analysis of the interviews made it possible to classify the parents into three different groups. The first group maintained no association with the child's country of birth and refused any multiplicity of cultural identities. The second group actively maintained regular associations with the child's country of birth and culture and affirmed that their family was multicultural. Finally, the third group adapted their associations with the child's birth country and its culture according to the child's questions and interests. Exploring parental representations of the adopted child enables professionals involved in adoption to provide better support to these families and to do preventive work at the level of family interactions.	[Harf, Aurelie; Sibeoni, Jordan; Pontvert, Caroline; Moro, Marie Rose] Univ Paris 05, Hop Cochin, AP HP,Sorbonne Paris Cite, Maison Solenn Maison Adolescents,Unite INSERM 669, Paris, France; [Skandrani, Sara] Univ Paris Ouest Nanterre Le Def, EA4430, Hop Cochin, Maison Solenn Maison Adolescents,AP HP, Paris, France; [Revah-Levy, Anne] Univ Paris 05, Hop Argenteuil, Unite INSERM 669, Ctr Soins Psychotherapeut Transit Adolescents,Sor, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Harf, A (corresponding author), Univ Paris 05, Hop Cochin, AP HP,Sorbonne Paris Cite, Maison Solenn Maison Adolescents,Unite INSERM 669, Paris, France.	aurelie.harf@cch.aphp.fr		revah-levy, anne/0000-0003-1805-6275; Sibeoni, Jordan/0000-0001-9613-5513				ANDUJO E, 1988, SOC WORK, V33, P531; [Anonymous], 2012, AUTRE CLIN CULT SOC, DOI DOI 10.3917/LAUTR.038.0151; Baden AL, 2002, J SOC DISTRESS HOMEL, V11, P167, DOI 10.1023/A:1014316018637; Basow SA, 2008, AM J ORTHOPSYCHIAT, V78, P473, DOI 10.1037/a0014450; Baxter L. A., 2004, BASICS COMMUNICATION; Bhatia S, 2001, CULT PSYCHOL, V7, P297, DOI 10.1177/1354067X0173003; Bowie F, 2007, ANTHROPOL QUART, V80, P623, DOI 10.1353/anq.2007.0018; Carstens C, 2000, INT SOC WORK, V43, P61, DOI 10.1177/a010521; Castle H, 2011, ADOPT Q, V14, P305, DOI 10.1080/10926755.2011.628266; Cederblad M, 1999, J CHILD PSYCHOL PSYC, V40, P1239, DOI 10.1111/1469-7610.00540; DeBerry KM, 1996, CHILD DEV, V67, P2375, DOI 10.2307/1131629; Docan-Morgan S, 2011, J SOC PERS RELAT, V28, P336, DOI 10.1177/0265407510382177; Eatough V, 2008, QUALITATIVE RES PSYC; Friedlander ML, 2000, J COUNS PSYCHOL, V47, P187; Harf A., 2014, PSYCHIAT EN IN PRESS; Harf A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075300; Harrigan MM, 2009, J SOC PERS RELAT, V26, P634, DOI 10.1177/0265407509353393; Hermans HJM, 1998, AM PSYCHOL, V53, P1111, DOI 10.1037/0003-066X.53.10.1111; Hjern A, 2002, LANCET, V360, P443, DOI 10.1016/S0140-6736(02)09674-5; Hollingsworth L. D., 1998, CHILD ADOLESC SOC WO, V15, P303, DOI [DOI 10.1023/A:1025163912090, 10.1023/A:1025163912090]; Howell S, 2003, J ROY ANTHROPOL INST, V9, P465, DOI 10.1111/1467-9655.00159; Hubinette T., 2012, INTERCOUNTRY ADOPTIO, P221; Huh NS, 2000, INT SOC WORK, V43, P75; Johnston KE, 2007, FAM RELAT, V56, P390, DOI 10.1111/j.1741-3729.2007.00468.x; Juffer F, 2005, JAMA-J AM MED ASSOC, V293, P2501, DOI 10.1001/jama.293.20.2501; Lee David C, 2005, Cultur Divers Ethnic Minor Psychol, V11, P130, DOI 10.1037/1099-9809.11.2.130; Lee RM, 2006, J FAM PSYCHOL, V20, P571, DOI 10.1037/0893-3200.20.4.571; Lee RM, 2003, COUNS PSYCHOL, V31, P709, DOI 10.1177/0011000003258087; Levy-Soussan P, 2010, DESTINS ADOPTION, P275; Levy-Soussan P, 2005, J PEDIAT PUERICULTUR, V18, P13; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; MAYS N, 1995, BRIT MED J, V311, P109, DOI 10.1136/bmj.311.6997.109; Neville HA, 2000, J COUNS PSYCHOL, V47, P59, DOI 10.1037/0022-0167.47.1.59; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Phinney J.S., 1997, HLTH RISKS DEV TRANS; Phinney J.S., 2007, IMMIGRANT FAMILIES C; Plummer K., 2001, DOCUMENTS LIFE, V2; Rotheram M.J., 1986, CHILDRENS ETHNIC SOC, P10; Rushton A, 1997, J CHILD PSYCHOL PSYC, V38, P147, DOI 10.1111/j.1469-7610.1997.tb01850.x; Scherman R, 2010, INT SOC WORK, V53, P528, DOI 10.1177/0020872810364753; Selman P, 2009, INT SOC WORK, V52, P575, DOI 10.1177/0020872809337681; Smith J.A., 2008, QUALITATIVE PSYCHOL, DOI [10.1111/jocn.12421, DOI 10.1111/JOCN.12421]; Soule M., 2002, PSYCHIAT ENFANT, V45, P77, DOI DOI 10.3917/PSYE.451.0077; Suter EA, 2008, J FAM COMMUN, V8, P126, DOI 10.1080/15267430701857406; Tessler R., 1999, W MEETS E AM ADOPT C; Thomas KA, 2007, J FAM ISSUES, V28, P1189, DOI 10.1177/0192513X07301115; Vonk ME, 2001, SOC WORK, V46, P246, DOI 10.1093/sw/46.3.246; Westues A., 1998, ADOPTION Q, V1, P33, DOI [10.1300/J145v01n04_03, DOI 10.1300/J145V01N04_03]; Whitley R, 2005, CAN J PSYCHIAT, V50, P108, DOI 10.1177/070674370505000206; Wrobel G. M., 2003, ADOPTION Q, V7, P53, DOI DOI 10.1300/J145V07N02_04; Yoon D.P., 2004, J ETHNIC CULTURAL DI, V13, P71, DOI [DOI 10.1300/J051V13N02_, 10.1300/J051v13n02_04, DOI 10.1300/J051V13N02_04]	52	7	7	5	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119635	10.1371/journal.pone.0119635	http://dx.doi.org/10.1371/journal.pone.0119635			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD6EY	25775255	Green Submitted, Green Published, gold			2022-12-27	WOS:000351183500108
J	Hogenkamp, PS; Sundbom, M; Nilsson, VC; Benedict, C; Schioth, HB				Hogenkamp, Pleunie S.; Sundbom, Magnus; Nilsson, Victor C.; Benedict, Christian; Schioth, Helgi B.			Patients Lacking Sustainable Long-Term Weight Loss after Gastric Bypass Surgery Show Signs of Decreased Inhibitory Control of Prepotent Responses	PLOS ONE			English	Article							BARIATRIC SURGERY; BRAIN ACTIVITY; OBESE-PATIENTS; FOOD PICTURES; GUT HORMONES; ACTIVATION	Background A considerable number of bariatric patients report poor long-term weight loss after Roux-enY gastric bypass (RYGB) surgery. One possibility for an underlying cause is an impairment of cognitive control that impedes this patient group's dietary efforts. Objective To investigate if patients having either poor or good weight loss response, similar to 12 years after RYGB-surgery, differ in their ability to inhibit prepotent responses when processing food cues during attentional operations-as measure of cognitive control. Methods In terms of weight loss following RYGB-surgery, 15 'poor responders' and 15 'good responders', matched for gender, age, education, preoperative body mass index, and years since surgery, were administered two tasks that measure sustained attention and response control: a go/no-go task and a Stroop interference task; both of which are associated with maladaptive eating behaviours. Results The poor responders (vs. good responders) needed significantly more time when conducting a go/no-go task (603 +/- 134 vs. 519 +/- 44 msec, p = 0.03), but the number of errors did not differ between groups. When conducting a Stroop interference task, poor responders read fewer inks than good responders (68 +/- 16 vs. 85 +/- 10 words, p = 0.002). Conclusion Patients lacking sustainable weight loss after RYGB-surgery showed poorer inhibitory control than patients that successfully lost weight. In the authors' view, these results suggest that cognitive behavioral therapies post-RYGB-surgery may represent a promising behavioral adjuvant to achieve sustainable weight loss in patients undergoing this procedure. Future studies should examine whether these control deficits in poor responders are food-specific or not.	[Hogenkamp, Pleunie S.; Nilsson, Victor C.; Benedict, Christian; Schioth, Helgi B.] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Sundbom, Magnus] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden	Uppsala University; Uppsala University	Hogenkamp, PS (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	pleunie.hogenkamp@neuro.uu.se	Benedict, Christian/K-2190-2017; Schioth, Helgi/AAQ-7239-2020	Benedict, Christian/0000-0002-8911-4068; Sundbom, Magnus/0000-0002-6243-2859	Swedish Research Council; NWO Rubicon [446-12-008]; Swedish Brain Research Foundation; L.R. Akerhams stiftelse; A. Karlssons & L. Erikssons stiftelse; Stiftelsen Olle Engkvist Byggmastare; Ingrid Thurings Foundation; Tore Nilsons stiftelse	Swedish Research Council(Swedish Research CouncilEuropean Commission); NWO Rubicon(Netherlands Organization for Scientific Research (NWO)); Swedish Brain Research Foundation; L.R. Akerhams stiftelse; A. Karlssons & L. Erikssons stiftelse; Stiftelsen Olle Engkvist Byggmastare(Swedish Research Council); Ingrid Thurings Foundation; Tore Nilsons stiftelse	This work study is supported by the Swedish Research Council, NWO Rubicon (446-12-008), Swedish Brain Research Foundation, L.R. Akerhams stiftelse, A. Karlssons & L. Erikssons stiftelse, Stiftelsen Olle Engkvist Byggmastare, Ingrid Thurings Foundation, Lars Hiertas Minne and Tore Nilsons stiftelse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batterink L, 2010, NEUROIMAGE, V52, P1696, DOI 10.1016/j.neuroimage.2010.05.059; Bruce JM, 2012, SURG OBES RELAT DIS, V8, P602, DOI 10.1016/j.soard.2011.07.006; Cappelleri JC, 2009, INT J OBESITY, V33, P611, DOI 10.1038/ijo.2009.74; Carnell S, 2012, OBES REV, V13, P43, DOI 10.1111/j.1467-789X.2011.00927.x; De Silva A, 2011, CELL METAB, V14, P700, DOI 10.1016/j.cmet.2011.09.010; Dirksen C, 2013, INT J OBESITY, V37, P1452, DOI 10.1038/ijo.2013.15; Edholm D, 2013, SURG OBES RELAT DIS, V9, P708, DOI 10.1016/j.soard.2012.02.011; Frank S, 2014, INT J OBESITY, V38, P341, DOI 10.1038/ijo.2013.60; Freiherr J, 2013, CNS DRUGS, V27, P505, DOI 10.1007/s40263-013-0076-8; Griffith PS, 2012, CAN J SURG, V55, P329, DOI 10.1503/cjs.002011; Guerrieri R, 2008, INT J OBESITY, V32, P708, DOI 10.1038/sj.ijo.0803770; Kelley AE, 2002, J NEUROSCI, V22, P3306; le Roux CW, 2006, ANN SURG, V243, P108, DOI 10.1097/01.sla.0000183349.16877.84; Magro DO, 2008, OBES SURG, V18, P648, DOI 10.1007/s11695-007-9265-1; Mason EE, SURGICAL CLIN N AM, V967, P1345; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Miras AD, 2012, AM J CLIN NUTR, V96, P467, DOI 10.3945/ajcn.112.036921; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Ness A, 2014, SURG OBES RELAT DIS, V10, P1188, DOI 10.1016/j.soard.2014.06.005; Nijs IMT, 2010, EAT BEHAV, V11, P258, DOI 10.1016/j.eatbeh.2010.07.002; Nosek BA, 2001, SOC COGNITION, V19, P625, DOI 10.1521/soco.19.6.625.20886; Ochner CN, 2012, NEUROSCI RES, V74, P138, DOI 10.1016/j.neures.2012.08.002; Ochner CN, 2011, ANN SURG, V253, P502, DOI 10.1097/SLA.0b013e318203a289; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; REINHOLD RB, 1982, SURG GYNECOL OBSTET, V155, P385; Scholtz S, 2014, GUT, V63, P891, DOI 10.1136/gutjnl-2013-305008; Schultes B, 2010, AM J CLIN NUTR, V92, P277, DOI 10.3945/ajcn.2009.29007; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Spitznagel MB, 2014, OBES SURG, V24, P1078, DOI 10.1007/s11695-014-1205-2; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sweeney TE, 2014, BEST PRACT RES CL GA, V28, P727, DOI 10.1016/j.bpg.2014.07.016; Vainik U, 2013, NEUROSCI BIOBEHAV R, V37, P279, DOI 10.1016/j.neubiorev.2012.11.008; van Hout GCM, 2005, OBES SURG, V15, P552, DOI 10.1381/0960892053723484; Watson TD, 2013, APPETITE, V71, P40, DOI 10.1016/j.appet.2013.07.007; Wilms B, 2013, J CLIN ENDOCR METAB, V98, P3776, DOI 10.1210/jc.2013-1087	35	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119896	10.1371/journal.pone.0119896	http://dx.doi.org/10.1371/journal.pone.0119896			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774526	Green Submitted, Green Published, gold			2022-12-27	WOS:000351183500138
J	Mamiya, H; Jeyadevan, B				Mamiya, Hiroaki; Jeyadevan, Balachandran			Nonequilibrium Magnetic Response of Anisotropic Superparamagnetic Nanoparticles and Possible Artifacts in Magnetic Particle Imaging	PLOS ONE			English	Article							SYSTEM; PHASE; SPIN; MPI	Magnetic responses of superparamagnetic nanoparticles to high-frequency AC magnetic fields with sufficiently large amplitudes are numerically simulated to exactly clarify the phenomena occurring in magnetic particle imaging. When the magnetic anisotropy energy inevitable in actual nanoparticles is taken into account in considering the magnetic potential, larger nanoparticles exhibit a delayed response to alternations of the magnetic fields. This kind of delay is rather remarkable in the lower-amplitude range of the field, where the assistance by the Zeeman energy to thermally activated magnetization reversal is insufficient. In some cases, a sign inversion of the third-order harmonic response was found to occur at some specific amplitude, despite the lack in DC bias magnetic field strength. Considering the attenuation of the AC magnetic field generated in the human body, it is possible that the phases of the signals from nanoparticles deep inside the body and those near the body surface are completely different. This may lead to artifacts in the reconstructed image. Furthermore, when the magnetic/thermal torque-driven rotation of the anisotropic nanoparticles as well as the magnetic anisotropy energy are taken into account, the simulated results show that, once the easy axes are aligned toward the direction of the DC bias magnetic field, it takes time to randomize them at the field-free point. During this relaxation, the third-order harmonic response depends highly upon the history of the magnetic field. This is because non-linearity of the anhysteretic magnetization curve for the superparamagnetic nanoparticles varies with the orientations of the easy axes. This history dependence may also lead to another artifact in magnetic particle imaging, when the scanning of the field-free point is faster than the Brownian relaxations.	[Mamiya, Hiroaki] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan; [Jeyadevan, Balachandran] Univ Shiga Prefecture, Hikone 5228533, Japan	National Institute for Materials Science; University Shiga Prefecture	Mamiya, H (corresponding author), Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan.	MAMIYA.Hiroaki@nims.go.jp	MAMIYA, Hiroaki/H-2520-2011	MAMIYA, Hiroaki/0000-0002-7840-3008	Japan Society for the Promotion of Science (JSPS) KAKENHI (B) [24310071]	Japan Society for the Promotion of Science (JSPS) KAKENHI (B)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by Japan Society for the Promotion of Science (JSPS) KAKENHI (B) Grant Number 24310071 (H. M. and B. J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arelaro AD, 2005, J APPL PHYS, V97, DOI 10.1063/1.1853931; Carrey J, 2011, J APPL PHYS, V109, DOI 10.1063/1.3551582; Chevry L, 2013, BIOMATERIALS, V34, P6299, DOI 10.1016/j.biomaterials.2013.05.002; Cimurs J, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.062315; Du YM, 2013, INT J MOL SCI, V14, P18682, DOI 10.3390/ijms140918682; Ferguson RM, 2011, MED PHYS, V38, P1619, DOI 10.1118/1.3554646; Franke J, 2013, INT WORKSH MAGN PART, P98041; Gleich B, 2005, NATURE, V435, P1214, DOI 10.1038/nature03808; Ichiyanagi K, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4819305; Knopp T, 2010, J PHYS A-MATH THEOR, V43, DOI 10.1088/1751-8113/43/1/012002; Konkle JJ, 2013, BIOMED ENG-BIOMED TE, V58, P565, DOI 10.1515/bmt-2012-0062; Krishnan KM, 2010, IEEE T MAGN, V46, P2523, DOI 10.1109/TMAG.2010.2046907; Kuimova MK, 2012, PHYS CHEM CHEM PHYS, V14, P12671, DOI 10.1039/c2cp41674c; Ludwig F, 2013, BIOMED ENG-BIOMED TE, V58, P535, DOI 10.1515/bmt-2013-0013; Mamiya H, 1998, IEEE T MAGN, V34, P1126, DOI 10.1109/20.706406; Mamiya H, 2000, PHYS REV LETT, V84, P6106, DOI 10.1103/PhysRevLett.84.6106; Mamiya H, 1999, PHYS REV LETT, V82, P4332, DOI 10.1103/PhysRevLett.82.4332; Mamiya H, 2013, J NANOMATER, V2013, DOI 10.1155/2013/752973; Mamiya H, 2011, SCI REP-UK, V1, DOI 10.1038/srep00157; Pankhurst QA, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/22/224001; Rosensweig RE, 2002, J MAGN MAGN MATER, V252, P370, DOI 10.1016/S0304-8853(02)00706-0; Ruckert MA, 2013, BIOMED ENG-BIOMED TE, V58, P593, DOI 10.1515/bmt-2013-0015; Sagawa T, 2007, BIOCHEM BIOPH RES CO, V355, P770, DOI 10.1016/j.bbrc.2007.02.031; Yoshida T, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.127002	24	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118156	10.1371/journal.pone.0118156	http://dx.doi.org/10.1371/journal.pone.0118156			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775017	gold, Green Submitted, Green Published			2022-12-27	WOS:000351183500025
J	O'Donnell, KM; Thompson, FR; Semlitsch, RD				O'Donnell, Katherine M.; Thompson, Frank R., III; Semlitsch, Raymond D.			Partitioning Detectability Components in Populations Subject to Within-Season Temporary Emigration Using Binomial Mixture Models	PLOS ONE			English	Article							RED-BACKED SALAMANDER; DETECTION PROBABILITIES; ESTIMATING ABUNDANCE; TERRESTRIAL SALAMANDERS; PLETHODON-CINEREUS; ECOLOGY; COUNTS; COVER	Detectability of individual animals is highly variable and nearly always < 1; imperfect detection must be accounted for to reliably estimate population sizes and trends. Hierarchical models can simultaneously estimate abundance and effective detection probability, but there are several different mechanisms that cause variation in detectability. Neglecting temporary emigration can lead to biased population estimates because availability and conditional detection probability are confounded. In this study, we extend previous hierarchical binomial mixture models to account for multiple sources of variation in detectability. The state process of the hierarchical model describes ecological mechanisms that generate spatial and temporal patterns in abundance, while the observation model accounts for the imperfect nature of counting individuals due to temporary emigration and false absences. We illustrate our model's potential advantages, including the allowance of temporary emigration between sampling periods, with a case study of southern red-backed salamanders Plethodon serratus. We fit our model and a standard binomial mixture model to counts of terrestrial salamanders surveyed at 40 sites during 3-5 surveys each spring and fall 2010-2012. Our models generated similar parameter estimates to standard binomial mixture models. Aspect was the best predictor of salamander abundance in our case study; abundance increased as aspect became more northeasterly. Increased time-since-rainfall strongly decreased salamander surface activity (i.e. availability for sampling), while higher amounts of woody cover objects and rocks increased conditional detection probability (i.e. probability of capture, given an animal is exposed to sampling). By explicitly accounting for both components of detectability, we increased congruence between our statistical modeling and our ecological understanding of the system. We stress the importance of choosing survey locations and protocols that maximize species availability and conditional detection probability to increase population parameter estimate reliability.	[O'Donnell, Katherine M.; Semlitsch, Raymond D.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Thompson, Frank R., III] US Forest Serv, USDA, No Res Stn, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; United States Department of Agriculture (USDA); United States Forest Service; University of Missouri System; University of Missouri Columbia	O'Donnell, KM (corresponding author), Univ Missouri, Div Biol Sci, 105 Tucker Hall, Columbia, MO 65211 USA.	odonnell.katie.m@gmail.com	O'Donnell, Katherine/AAG-1106-2020	O'Donnell, Katherine/0000-0001-9023-174X	GAANN Fellowship; U.S. Forest Service [09-JV-11242311-064]	GAANN Fellowship(US Department of Education); U.S. Forest Service(United States Department of Agriculture (USDA)United States Forest Service)	This project was funded by GAANN Fellowship (KMO) and U.S. Forest Service, Joint Venture Agreement 09-JV-11242311-064. U.S. Forest Service was responsible for overall study design, but was not involved in data collection or analysis, decision to publish, or preparation of the manuscript.	ANDREWARTHA HG, 1954, DISTRIBUTION ABUNDAN; [Anonymous], 2010, SALAMANDERS US CANAD; Bailey LL, 2004, J WILDLIFE MANAGE, V68, P14, DOI 10.2193/0022-541X(2004)068[0014:SATVID]2.0.CO;2; Bailey LL, 2004, J WILDLIFE MANAGE, V68, P1, DOI 10.2193/0022-541X(2004)068[0001:EDPPFP]2.0.CO;2; Bolker BM, 2013, METHODS ECOL EVOL, V4, P501, DOI 10.1111/2041-210X.12044; Buderman FE, 2012, POPUL ECOL, V54, P157, DOI 10.1007/s10144-011-0294-1; Chandler RB, 2011, ECOLOGY, V92, P1429, DOI 10.1890/10-2433.1; Dail D, 2011, BIOMETRICS, V67, P577, DOI 10.1111/j.1541-0420.2010.01465.x; Davic RD, 2004, ANNU REV ECOL EVOL S, V35, P405, DOI 10.1146/annurev.ecolsys.35.112202.130116; Dodd CK, 2004, HERPETOLOGICA, V60, P468, DOI 10.1655/03-60; Dodd Jr CK, 2003, MONITORING AMPHIBIAN; Donnelly M. A., 1994, MEASURING MONITORING, P183; FEDER ME, 1983, HERPETOLOGICA, V39, P291; Gelman A., 2007, DATA ANAL USING REGR; Gelman A, 2008, ANN APPL STAT, V2, P1360, DOI 10.1214/08-AOAS191; Grover MC, 1998, J HERPETOL, V32, P489, DOI 10.2307/1565202; Halstead BJ, 2012, ANIM CONSERV, V15, P133, DOI 10.1111/j.1469-1795.2012.00540.x; Herbeck LA, 2000, J HERPETOL, V34, P341, DOI 10.2307/1565354; Jaeger R.G., 1994, MEASURING MONITORING, P97; JAEGER RG, 1980, COPEIA, P265, DOI 10.2307/1444003; Jung RE, 2000, ENVIRON MONIT ASSESS, V63, P65, DOI 10.1023/A:1006413603057; Kabrick JM, 2014, FOR SCI, V60; Kendall WL, 1997, ECOLOGY, V78, P563; Kendall WL, 1999, ECOLOGY, V80, P2517, DOI 10.1890/0012-9658(1999)080[2517:ROCCRM]2.0.CO;2; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Kery M, 2008, COMMUNITY ECOL, V9, P207, DOI 10.1556/ComEc.9.2008.2.10; Kery M, 2008, AUK, V125, P336, DOI 10.1525/auk.2008.06185; Kery M, 2010, J ANIM ECOL, V79, P453, DOI 10.1111/j.1365-2656.2009.01632.x; Kery M, 2009, J APPL ECOL, V46, P1163, DOI 10.1111/j.1365-2664.2009.01724.x; KLEEBERGER SR, 1982, COPEIA, P409, DOI 10.2307/1444622; Liebgold EB, 2011, MOL ECOL, V20, P249, DOI 10.1111/j.1365-294X.2010.04946.x; MacKenzie DI, 2002, ECOLOGY, V83, P2387, DOI 10.2307/3071800; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Martin J, 2011, METHODS ECOL EVOL, V2, P595, DOI 10.1111/j.2041-210X.2011.00113.x; Mazerolle MJ, 2007, J HERPETOL, V41, P672, DOI 10.1670/07-061.1; McKenny HC, 2006, FOREST ECOL MANAG, V230, P186, DOI 10.1016/j.foreco.2006.04.034; O'Donnell KM, 2014, HERPETOLOGICA, V70, P259, DOI 10.1655/HERPETOLOGICA-D-13-00036; Peterman WE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062184; Plummer M., 2003, P 3 INT WORKSH DISTR; Pollock Kenneth H., 2004, P43; POLLOCK KH, 1990, WILDLIFE MONOGR, P1; Pollock KH, 2002, ENVIRONMETRICS, V13, P105, DOI 10.1002/env.514; Price SJ, 2012, HYDROBIOLOGIA, V679, P205, DOI 10.1007/s10750-011-0882-2; R Core Team, 2021, R LANGUAGE ENV STAT; Royle J. A., 2008, HIERARCHICAL MODELIN; Royle JA, 2007, ECOL MONOGR, V77, P465, DOI 10.1890/06-0912.1; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Semlitsch RD, 2014, CAN J ZOOL; Slobodkin L. B., 1980, GROWTH REGULATION AN; Smith CK, 2000, J HERPETOL, V34, P547, DOI 10.2307/1565270; SPOTILA JR, 1972, ECOL MONOGR, V42, P95, DOI 10.2307/1942232; Su Y.-S., 2013, R2JAGS PACKAGE RUNNI; TAUB FB, 1961, ECOLOGY, V42, P681, DOI 10.2307/1933498; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; Williams AK, 2004, J WILDLIFE MANAGE, V68, P418, DOI 10.2193/0022-541X(2004)068[0418:RFAISD]2.0.CO;2; Williams B. K., 2002, ANAL MANAGEMENT ANIM	56	18	18	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0117216	10.1371/journal.pone.0117216	http://dx.doi.org/10.1371/journal.pone.0117216			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775182	Green Submitted, Green Published, gold			2022-12-27	WOS:000351183500017
J	Tomita, S; Parker, DM; Jennings, JA; Wood, J				Tomita, Shinsuke; Parker, Daniel M.; Jennings, Julia A.; Wood, James			Household Demography and Early Childhood Mortality in a Rice-Farming Village in Northern Laos	PLOS ONE			English	Article							ALLOCATION; COMMUNITY; TANZANIA; CHILDREN	This paper extends Alexandr Chayanov's model of changing household demography (specifically the ratio of food consumers to food producers) and its influence on agricultural behavior so that it includes possible adverse effects of a rising ratio on nutritional status and early childhood mortality within the household. We apply the model to 35 years' worth of longitudinal demographic and economic data collected in the irrigated-rice growing village of Na Savang in northern Laos. When appropriate controls are included for other household variables, unobserved inter-household heterogeneity, and changes in local conditions and national policy over the study period, the analysis suggests that a unit increase in the household's consumer/producer ratio induces something like a nine-fold increase in the risk of death among household members aged less than five years. Monte Carlo simulation studies suggest that this may be an over-estimate but also that the effect is probably real and likely to be an important factor in household demography. At the very least, the results suggest that Chayanov's model still has theoretical relevance and deserves to be revived.	[Tomita, Shinsuke] Kyoto Univ, Grad Sch Agr, Kyoto, Japan; [Parker, Daniel M.; Wood, James] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; [Parker, Daniel M.; Wood, James] Penn State Univ, Populat Res Inst, University Pk, PA 16802 USA; [Jennings, Julia A.] SUNY Albany, Dept Anthropol, Albany, NY 12222 USA	Kyoto University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Wood, J (corresponding author), Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA.	jww3@psu.edu	Tomita, Shinsuke/GON-4388-2022; Parker, Daniel M./B-5471-2013	Parker, Daniel M./0000-0002-5352-7338; Jennings, Julia/0000-0003-0675-0016; Tomita, Shinsuke/0000-0001-7677-2232	research project of the Research Institute for Humanity and Nature (RIHN) Humanity and Nature (RIHN); Land-use of Muang in montane region of southeast Asia: process and population [19710205]; reconstruction process of rural societies in montane region of Southeast Asia: from asylum to the front line of exploitation [23681051]	research project of the Research Institute for Humanity and Nature (RIHN) Humanity and Nature (RIHN); Land-use of Muang in montane region of southeast Asia: process and population; reconstruction process of rural societies in montane region of Southeast Asia: from asylum to the front line of exploitation	Field work was supported by a research project of the Research Institute for Humanity and Nature (RIHN) Humanity and Nature (RIHN) titled "A Trans-Disciplinary Study on the Regional Eco-History in Tropical Monsoon Asia: 1945-2005." (PI: Tomoya Akimichi); Grant-in-Aids for Scientific Research of the Japanese Society for the Promotion of Science through research projects "Land-use of Muang in montane region of southeast Asia: process and population" (No. 19710205) (PI: Shinsuke Tomita); and "The reconstruction process of rural societies in montane region of Southeast Asia: from asylum to the front line of exploitation" (No. 23681051) (PI: Shinsuke Tomita). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badenoch Nathan, 2013, SE ASIAN STUD, V2, P29; Campbell C, 1996, Hist Fam, V1, P297, DOI 10.1016/S1081-602X(96)90026-3; Chayanov AV, 1925, ORG KRESTIANSKOGO KH; Chayanov AV, 1966, THEORY PEASANT EC; CHIBNIK M, 1984, CURR ANTHROPOL, V25, P335, DOI 10.1086/203141; Chibnik M., 1987, HOUSEHOLD EC THEIR T, P74; Dove M. R., 1984, Chayanov, peasants, and economic anthropology, P97; Dove M.R., 1985, SWIDDEN AGR INDONESI; DUE JM, 1984, CAN J AFR STUD, V18, P583, DOI 10.2307/484770; Durrenberger E. Paul, 1980, J ANTHROPOL RES, V36, P133; Ellis F., 1993, PEASANT EC FARM HOUS; Evans G, 1988, AGRARIAN CHANGE COMM; Evans Grant, 1990, LAO PEASANTS SOCIALI; Field CJ, 2005, J NUTR, V135, P1; Finlay JE, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000226; Hadley C, 2011, AM J PHYS ANTHROPOL, V144, P643, DOI 10.1002/ajpa.21463; Hagen EH, 2006, AM J PHYS ANTHROPOL, V130, P405, DOI 10.1002/ajpa.20272; Herring R. J., 1984, Chayanov, peasants, and economic anthropology, P133; HUNT D, 1979, J PEASANT STUD, V6, P247, DOI 10.1080/03066157908438075; Jennings J. A., 2010, THESIS PENNSYLVANIA; Katona P, 2008, CLIN INFECT DIS, V46, P1582, DOI 10.1086/587658; Knodel J, 1972, POPULATION ANAL STUD, P112; Kotegawa T., 2010, Pedologist, V54, P93; Kramer KL, 2002, CURR ANTHROPOL, V43, P511, DOI 10.1086/340239; Kramer KL, 2005, MAYA CHILDREN HELPER; LEE J, 2005, LIVING STANDARDS NEW; Lee RD, 2002, POPUL DEV REV, V28, P475, DOI 10.1111/j.1728-4457.2002.00475.x; Lefevre-Pontalis Pierre, 2000, TRAVELS UPPER LAOS B; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; May L, 2009, CYTOKINE, V45, P184, DOI 10.1016/j.cyto.2008.12.010; McGough J. P., 1984, Chayanov, peasants, and economic anthropology, P183; Minge-Kalman W., 1977, AM ETHNOL, V4, P273; Mosley WH, 1984, POPUL DEV REV, V10, P25, DOI 10.2307/2807954; Netting R. M., 1993, SMALLHOLDERS HOUSEHO, DOI DOI 10.1111/j.1558-5646.2009.00817.x; Norton Susan L., 1980, GENEALOGICAL DEMOGRA, P11; Parker DM, 2014, DEMOGR RES, V30, P1129, DOI 10.4054/DemRes.2014.30.39; PATNAIK U, 1979, J PEASANT STUD, V6, P375, DOI 10.1080/03066157908438083; Rodriguez L, 2011, INT J ENV RES PUB HE, V8, P1174, DOI 10.3390/ijerph8041174; Sawyer CC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001287; Schaible UE, 2007, PLOS MED, V4, P806, DOI 10.1371/journal.pmed.0040115; Schliesinger J., 2003, ETHNIC GROUPS LAOS, V1; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Sparks CS, 2013, AM J PHYS ANTHROPOL, V151, P191, DOI 10.1002/ajpa.22264; Sullivan JM, 1994, INFANT CHILD MORTALI, V15; Tannenbaum N, 1984, AM ANTHROPOL, V86, P924; Tomita S, 2008, AREA STUDIES FARMING, P133; Tomita S, 2008, ECOHISTORY LOCAL SOC, P181; Tomita S, 2011, NATION STATE BUILDIN, P321; Tschaianoff Chayanov A. V., 1931, SYSTEMATIC SOURCE BO, VII, P144; van Wissen, 1995, HOUSEHOLD DEMOGRAPHY; Wander K, 2013, AM J PHYS ANTHROPOL, V151, P183, DOI 10.1002/ajpa.22250; WIBER MG, 1985, J ANTHROPOL RES, V41, P427, DOI 10.1086/jar.41.4.3630573; Willekens FJC, 2009, ENCY LIFE SUPPORT SY, P86	53	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119191	10.1371/journal.pone.0119191	http://dx.doi.org/10.1371/journal.pone.0119191			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD6EY	25775467	Green Published, gold			2022-12-27	WOS:000351183500074
J	Zhao, QP; Xiong, T; Xu, XJ; Jiang, MS; Dong, HF				Zhao, Qin Ping; Xiong, Tao; Xu, Xing Jian; Jiang, Ming Sen; Dong, Hui Fen			De Novo Transcriptome Analysis of Oncomelania hupensis after Molluscicide Treatment by Next-Generation Sequencing: Implications for Biology and Future Snail Interventions	PLOS ONE			English	Article							REPUBLIC-OF-CHINA; SCHISTOSOMA-JAPONICUM; INTERMEDIATE HOST; NICLOSAMIDE; IDENTIFICATION; INFECTION	The freshwater snail Oncomelania hupensis is the only intermediate host of Schistosoma japonicum, which causes schistosomiasis. This disease is endemic in the Far East, especially in mainland China. Because niclosamide is the only molluscicide recommended by the World Health Organization, 50% wettable powder of niclosamide ethanolamine salt (WPN), the only chemical molluscicide available in China, has been widely used as the main snail control method for over two decades. Recently, a novel molluscicide derived from niclosamide, the salt of quinoid-2',5-dichloro-4'-nitro-salicylanilide (Liu Dai Shui Yang An, LDS), has been developed and proven to have the same molluscicidal effect as WPN, with lower cost and significantly lower toxicity to fish than WPN. The mechanism by which these molluscicides cause snail death is not known. Here, we report the next-generation transcriptome sequencing of O. hupensis; 145,008,667 clean reads were generated and assembled into 254,286 unigenes. Using GO and KEGG databases, 14,860 unigenes were assigned GO annotations and 4,686 unigenes were mapped to 250 KEGG pathways. Many sequences involved in key processes associated with biological regulation and innate immunity have been identified. After the snails were exposed to LDS and WPN, 254 unigenes showed significant differential expression. These genes were shown to be involved in cell structure defects and the inhibition of neurohumoral transmission and energy metabolism, which may cause snail death. Gene expression patterns differed after exposure to LDS and WPN, and these differences must be elucidated by the identification and annotation of these unknown unigenes. We believe that this first large-scale transcriptome dataset for O. hupensis will provide an opportunity for the in-depth analysis of this biomedically important freshwater snail at the molecular level and accelerate studies of the O. hupensis genome. The data elucidating the molluscicidal mechanism will be of great benefit in future snail control efforts.	[Zhao, Qin Ping; Xiong, Tao; Jiang, Ming Sen; Dong, Hui Fen] Wuhan Univ, Sch Basic Med Sci, Dept Parasitol, Wuhan 430072, Hubei Province, Peoples R China; [Xu, Xing Jian] Hubei Prov Ctr Dis Control & Prevent, Inst Schistosomiasis Control, Wuhan, Hubei Province, Peoples R China	Wuhan University	Dong, HF (corresponding author), Wuhan Univ, Sch Basic Med Sci, Dept Parasitol, Wuhan 430072, Hubei Province, Peoples R China.	hfdong@whu.edu.cn			National Science and Technology Major Project [2012ZX10004909]; Schistosomiasis control Project of Hubei Province [XF2012-3]	National Science and Technology Major Project; Schistosomiasis control Project of Hubei Province	The present study was supported by the National Science and Technology Major Project (grant 2012ZX10004909) and the Schistosomiasis control Project of Hubei Province (XF2012-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergquist R, 2010, ADV PARASIT, V72, P109, DOI 10.1016/S0065-308X(10)72005-4; Dai JR, 2008, PARASITOL RES, V103, P405, DOI 10.1007/s00436-008-0988-2; Dai JR, 2015, PARASITOLOGY, V142, P332, DOI 10.1017/S0031182014000870; Dheilly NM, 2014, DEV COMP IMMUNOL, V45, P56, DOI 10.1016/j.dci.2014.01.022; Graebing PW, 2004, J AGR FOOD CHEM, V52, P5924, DOI 10.1021/jf0401524; Gray DJ, 2014, INT J PARASITOL, V44, P659, DOI 10.1016/j.ijpara.2014.05.005; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Li Hongjun, 2006, Zhongguo Xuexichongbing Fangzhi Zazhi, V18, P427; Li Shi-Zhu, 2013, Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, V25, P557; Li WenGui, 1997, Chinese Journal of Parasitic Disease Control, V10, P42; Liu R, 2013, PARASITOL RES, V112, P1483, DOI 10.1007/s00436-013-3295-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McManus DP, 2009, EXPERT REV ANTI-INFE, V7, P473, DOI [10.1586/eri.09.17, 10.1586/ERI.09.17]; MOH, 2000, HDB SCHIST CONTR, P204; Oliveira EC, 2000, ECOTOX ENVIRON SAFE, V46, P342, DOI 10.1006/eesa.2000.1924; OSTROSKYWEGMAN P, 1986, MUTAT RES, V173, P81, DOI 10.1016/0165-7992(86)90015-1; Park SJ, 2011, BMB REP, V44, P517, DOI 10.5483/BMBRep.2011.44.8.517; Ross AGP, 2001, CLIN MICROBIOL REV, V14, P270, DOI 10.1128/CMR.14.2.270-295.2001; Seto EYW, 2008, ECOHEALTH, V5, P149, DOI 10.1007/s10393-008-0169-x; Shrivastava J, 2005, MOL ECOL, V14, P839, DOI 10.1111/j.1365-294X.2005.02443.x; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang H, 2012, EXP PARASITOL, V130, P374, DOI 10.1016/j.exppara.2012.02.004; Wang LD, 2008, LANCET, V372, P1793, DOI 10.1016/S0140-6736(08)61358-6; WHO, 1993, WHO TECH REP SER, V830, P51; WHO, 1985, WHO TECH REP SER, V728, P58; WHO Expert Committee, 2002, WHO TECH REP SER, V912, P7; Xing YunTian, 2010, Chinese Journal of Schistosomiasis Control, V22, P504; Yang GJ, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-260; Yang JinSun, 2007, Chinese Journal of Schistosomiasis Control, V19, P311; Yi YA, 2005, ACTA TROP, V96, P191, DOI 10.1016/j.actatropica.2005.07.014; Yuan Y, 2011, MALACOLOGIA, V53, P217, DOI 10.4002/040.053.0202; Zhang L, 2012, INT J MOL SCI, V13, P5844, DOI 10.3390/ijms13055844; Zhang SH, 2010, MALACOLOGIA, V53, P147, DOI 10.4002/040.053.0107; Zhang Tao, 2002, Chinese Journal of Schistosomiasis Control, V14, P234; Zhao QP, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000611; Zhao QP, 2010, MOL PHYLOGENET EVOL, V57, P215, DOI 10.1016/j.ympev.2010.05.026; Zhou XN, 2010, ADV PARASIT, V72, P145, DOI 10.1016/S0065-308X(10)72006-6; Zhou XN, 2005, ACTA TROP, V96, P97, DOI 10.1016/j.actatropica.2005.07.005; Zhu Dan-Dan, 2011, Acta Hydrobiologica Sinica, V35, P672	39	27	30	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118673	10.1371/journal.pone.0118673	http://dx.doi.org/10.1371/journal.pone.0118673			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775015	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500034
J	Zigdon, H; Savidor, A; Levin, Y; Meshcheriakova, A; Schiffmann, R; Futerman, AH				Zigdon, Hila; Savidor, Alon; Levin, Yishai; Meshcheriakova, Anna; Schiffmann, Raphael; Futerman, Anthony H.			Identification of a Biomarker in Cerebrospinal Fluid for Neuronopathic Forms of Gaucher Disease	PLOS ONE			English	Article							GENE-EXPRESSION; GLUCOCEREBROSIDASE; BETA	Gaucher disease, a recessive inherited metabolic disorder caused by defects in the gene encoding glucosylceramidase (GlcCerase), can be divided into three subtypes according to the appearance of symptoms associated with central nervous system involvement. We now identify a protein, glycoprotein non-metastatic B (GPNMB), that acts as an authentic marker of brain pathology in neurological forms of Gaucher disease. Using three independent techniques, including quantitative global proteomic analysis of cerebrospinal fluid (CSF) in samples from Gaucher disease patients that display neurological symptoms, we demonstrate a correlation between the severity of symptoms and GPNMB levels. Moreover, GPNMB levels in the CSF correlate with disease severity in a mouse model of Gaucher disease. GPNMB was also elevated in brain samples from patients with type 2 and 3 Gaucher disease. Our data suggest that GPNMB can be used as a marker to quantify neuropathology in Gaucher disease patients and as a marker of treatment efficacy once suitable treatments towards the neurological symptoms of Gaucher disease become available.	[Zigdon, Hila; Meshcheriakova, Anna; Futerman, Anthony H.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Savidor, Alon; Levin, Yishai] Weizmann Inst Sci, Nancy & Stephen Grand Israel Natl Ctr Personalize, Botton Inst Prot Profiling, IL-76100 Rehovot, Israel; [Schiffmann, Raphael] Baylor Res Inst, Inst Metab Dis, Dallas, TX USA	Weizmann Institute of Science; Weizmann Institute of Science; Baylor Scott & White Health; Baylor University Medical Center	Futerman, AH (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	tony.futerman@weizmann.ac.il		Futerman, Anthony/0000-0003-0013-0115	Minerva Foundation	Minerva Foundation	This work was supported by the Minerva Foundation.	Benko W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022410; Bloom GS, 2014, JAMA NEUROL, V71, P505, DOI 10.1001/jamaneurol.2013.5847; Burrow TA, 2014, MOL GENET METAB; Cimaz R, 2009, PEDIATR RHEUMATOL, V7, DOI 10.1186/1546-0096-7-18; Cluzeau CVM, 2012, HUM MOL GENET, V21, P3632, DOI 10.1093/hmg/dds193; Enquist IB, 2007, P NATL ACAD SCI USA, V104, P17483, DOI 10.1073/pnas.0708086104; Farfel-Becker T, 2011, HUM MOL GENET, V20, P1375, DOI 10.1093/hmg/ddr019; Furochi H, 2007, FEBS LETT, V581, P5743, DOI 10.1016/j.febslet.2007.11.036; Futerman A.H., 2006, GAUCHER DIS; Grabowski GA, 2006, GAUCHER DIS; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HOLLAK CEM, 1994, J CLIN INVEST, V93, P1288, DOI 10.1172/JCI117084; Hruska KS, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/78549; Kelstrup CD, 2012, J PROTEOME RES, V11, P3487, DOI 10.1021/pr3000249; McGeer PL, 2002, MUSCLE NERVE, V26, P459, DOI 10.1002/mus.10191; Mignot C, 2013, HAND CLINIC, V113, P1709, DOI 10.1016/B978-0-444-59565-2.00040-X; Mistry PK, 2010, P NATL ACAD SCI USA, V107, P19473, DOI 10.1073/pnas.1003308107; Moran MT, 2000, BLOOD, V96, P1969, DOI 10.1182/blood.V96.5.1969.h8001969_1969_1978; Myerowitz R, 2004, MOL GENET METAB, V83, P288, DOI 10.1016/j.ymgme.2004.06.020; Myerowitz R, 2002, HUM MOL GENET, V11, P1343, DOI 10.1093/hmg/11.11.1343; Parente MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032419; Pelled D, 2005, NEUROBIOL DIS, V18, P83, DOI 10.1016/j.nbd.2004.09.004; Premkumar L, 2005, J BIOL CHEM, V280, P23815, DOI 10.1074/jbc.M502799200; Ripoll VM, 2007, J IMMUNOL, V178, P6557, DOI 10.4049/jimmunol.178.10.6557; Schiffmann R, 1997, ANN NEUROL, V42, P613, DOI 10.1002/ana.410420412; Schiffmann R, 2008, ANN NEUROL, V64, P514, DOI 10.1002/ana.21491; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Tanaka H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00573; Tessitore Alessandra, 2009, Pathogenetics, V2, P4, DOI 10.1186/1755-8417-2-4; Vitner EB, 2014, NAT MED, V20, P204, DOI 10.1038/nm.3449; Vitner Einat B, 2013, Handb Exp Pharmacol, P405, DOI 10.1007/978-3-7091-1511-4_20; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839	32	42	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120194	10.1371/journal.pone.0120194	http://dx.doi.org/10.1371/journal.pone.0120194			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775479	Green Submitted, Green Published, gold			2022-12-27	WOS:000351183500155
J	Nemeckova, I; Serwadczak, A; Oujo, B; Jezkova, K; Rathouska, J; Fikrova, P; Varejckova, M; Bernabeu, C; Lopez-Novoa, JM; Chlopicki, S; Nachtigal, P				Nemeckova, Ivana; Serwadczak, Agnieszka; Oujo, Barbara; Jezkova, Katerina; Rathouska, Jana; Fikrova, Petra; Varejckova, Michala; Bernabeu, Carmelo; Lopez-Novoa, Jose M.; Chlopicki, Stefan; Nachtigal, Petr			High Soluble Endoglin Levels Do Not Induce Endothelial Dysfunction in Mouse Aorta	PLOS ONE			English	Article							OXIDATIVE STRESS; ATHEROSCLEROSIS; HYPERTENSION; PATHWAYS; ADHESION; PROTEIN; MICE	Increased levels of a soluble form of endoglin (sEng) circulating in plasma have been detected in various pathological conditions related to cardiovascular system. High concentration of sEng was also proposed to contribute to the development of endothelial dysfunction, but there is no direct evidence to support this hypothesis. Therefore, in the present work we analyzed whether high sEng levels induce endothelial dysfunction in aorta by using transgenic mice with high expression of human sEng. Transgenic mice with high expression of human sEng on CBAxC57BI/6J background (Sol-Eng(+)) and age-matched transgenic littermates that do not develop high levels of human soluble endoglin (control animals in this study) on chow diet were used. As expected, male and female Sol-Eng(+) transgenic mice showed higher levels of plasma concentrations of human sEng as well as increased blood arterial pressure, as compared to control animals. Functional analysis either in vivo or ex vivo in isolated aorta demonstrated that the endothelium-dependent vascular function was similar in Sol-Eng(+) and control mice. In addition, Western blot analysis showed no differences between Sol-Eng(+) and control mice in the protein expression levels of endoglin, endothelial NO-synthase (eNOS) and pro-inflammatory ICAM-1 and VCAM-1 from aorta. Our results demonstrate that high levels of soluble endoglin alone do not induce endothelial dysfunction in Sol-Eng(+) mice. However, these data do not rule out the possibility that soluble endoglin might contribute to alteration of endothelial function in combination with other risk factors related to cardiovascular disorders.	[Nemeckova, Ivana; Jezkova, Katerina; Rathouska, Jana; Fikrova, Petra; Varejckova, Michala; Nachtigal, Petr] Charles Univ Prague, Fac Pharm Hradec Kralove, Dept Biol & Med Sci, Hradec Kralove 50005, Czech Republic; [Serwadczak, Agnieszka; Chlopicki, Stefan] JCET, PL-30348 Krakow, Poland; [Chlopicki, Stefan] Jagiellonian Univ, Coll Med, Dept Expt Pharmacol, Chair Pharmacol, PL-31531 Krakow, Poland; [Oujo, Barbara; Lopez-Novoa, Jose M.] Univ Salamanca, Dept Physiol & Pharmacol, Renal & Cardiovasc Physiopathol Unit, Salamanca 37007, Spain; [Bernabeu, Carmelo] CSIC, Ctr Invest Biol, E-28040 Madrid, Spain; [Bernabeu, Carmelo] CIBERER, Madrid 28040, Spain	Charles University Prague; Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University; University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Nachtigal, P (corresponding author), Charles Univ Prague, Fac Pharm Hradec Kralove, Dept Biol & Med Sci, Heyrovskeho 1203, Hradec Kralove 50005, Czech Republic.	petr.nachtigal@faf.cuni.cz	Bernabeu, Carmelo/P-4662-2019; Fikrova, Petra/T-7875-2017; Lopez-Novoa, Jose M/A-3672-2008; Bernabeu, Carmelo/L-3226-2014; Nachtigal, Petr/S-8022-2017; Blazickova, Katerina/T-1215-2017; Nemeckova, Ivana/T-6610-2017; Rathouska, Jana/Q-2796-2016	Bernabeu, Carmelo/0000-0002-1563-6162; Fikrova, Petra/0000-0003-0484-6049; Bernabeu, Carmelo/0000-0002-1563-6162; Nachtigal, Petr/0000-0001-9568-7295; Blazickova, Katerina/0000-0002-1654-0277; Nemeckova, Ivana/0000-0002-9795-8471; Chlopicki, Stefan/0000-0002-2878-3858; Rathouska, Jana/0000-0001-6363-9715	Grant Agency of Charles University in Prague [300811/C, 1284214/C]; Charles University in Prague [SVV/2014/260064]; European Regional Development Fund under the Innovative Economy Program of the European Union [POIG.01.01.02-00-069/09]; Ministerio de Economia y Competitividad of Spain [SAF2010-19222, SAF2013-43421-R, SAF2010-15881]; Junta de Castilla y Leon [GR100]; Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER, CB); Red de Investigacion Cooperativa en Enfermedades Renales [RD12/0021/0032]; FEDER funds; Ministerio de Economia y Competitividad [BES-2008-005550]; European Social Fund; state budget of the Czech Republic [CZ.1.07/2.3.00/30.0061]	Grant Agency of Charles University in Prague; Charles University in Prague; European Regional Development Fund under the Innovative Economy Program of the European Union; Ministerio de Economia y Competitividad of Spain(Spanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon); Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER, CB); Red de Investigacion Cooperativa en Enfermedades Renales; FEDER funds(European Commission); Ministerio de Economia y Competitividad(Spanish Government); European Social Fund(European Social Fund (ESF)); state budget of the Czech Republic	This work was supported by grants from the Grant Agency of Charles University in Prague (300811/C and 1284214/C), Charles University in Prague (SVV/2014/260064), European Regional Development Fund under the Innovative Economy Program of the European Union (grant coordinated by JCET-UJ, No POIG.01.01.02-00-069/09), Ministerio de Economia y Competitividad of Spain (SAF2010-19222 and SAF2013-43421-R to CB and SAF2010-15881 to JML-N), Junta de Castilla y Leon (GR100 to JML-N), Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER, CB), and Red de Investigacion Cooperativa en Enfermedades Renales (RD12/0021/0032; REDINREN, JML-N). CIBERER and REDINREN are initiatives of the Instituto de Salud Carlos III (ISCIII) of Spain supported by FEDER funds. The Cardiovascular Phenotyping Unit of the University of Salamanca, including the telemetry equipment, was acquired with the support of the European Regional Development Funds (FEDER). BO is supported by a fellowship from Ministerio de Economia y Competitividad (BES-2008-005550). The publication is co-financed by the European Social Fund and the state budget of the Czech Republic (Project No. CZ.1.07/2.3.00/30.0061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernabeu C, 2007, J CELL BIOCHEM, V102, P1375, DOI 10.1002/jcb.21594; Blaha M, 2008, ATHEROSCLEROSIS, V197, P264, DOI 10.1016/j.atherosclerosis.2007.04.022; Blann AD, 1996, ATHEROSCLEROSIS, V120, P221, DOI 10.1016/0021-9150(95)05713-7; Blazquez-Medela AM, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-86; Castonguay R, 2011, J BIOL CHEM, V286, P30034, DOI 10.1074/jbc.M111.260133; Chamorro-Jorganes A, 2010, HYPERTENSION, V56, P484, DOI 10.1161/HYPERTENSIONAHA.110.152587; Cui S, 2008, CHINESE MED J-PEKING, V121, P128, DOI 10.1097/00029330-200801020-00007; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; Gregory AL, 2014, PLACENTA, V35, pS93, DOI 10.1016/j.placenta.2013.10.020; Hawinkels LJAC, 2010, CANCER RES, V70, P4141, DOI 10.1158/0008-5472.CAN-09-4466; Higashi Y, 2009, CIRC J, V73, P411, DOI 10.1253/circj.CJ-08-1102; Ikemoto T, 2012, HEART VESSELS, V27, P344, DOI 10.1007/s00380-011-0163-z; Jerkic M, 2004, FASEB J, V18, P609, DOI 10.1096/fj.03-0197fje; Joseph-Silverstein J, 1998, CANCER INVEST, V16, P176, DOI 10.3109/07357909809050034; Keaney John F. Jr., 2000, Molecular Aspects of Medicine, V21, P99, DOI 10.1016/S0098-2997(00)00005-4; Lopez-Novoa JM, 2010, AM J PHYSIOL-HEART C, V299, pH959, DOI 10.1152/ajpheart.01251.2009; Nachtigal P, 2012, ATHEROSCLEROSIS, V224, P4, DOI 10.1016/j.atherosclerosis.2012.03.001; Najemnik C, 1999, ACTA MED AUST, V26, P148; Rathouska J, 2011, PHARMACOL RES, V64, P53, DOI 10.1016/j.phrs.2011.03.008; Rossi E, 2013, BLOOD, V121, P403, DOI 10.1182/blood-2012-06-435347; Sauzeau V, 2006, NAT MED, V12, P841, DOI 10.1038/nm1426; Strasky Z, 2011, CIRC J, V75, P1747, DOI 10.1253/circj.CJ-10-1285; Tornavaca O, 2009, CIRCULATION, V119, P1908, DOI 10.1161/CIRCULATIONAHA.108.808543; Valbuena-Diez AC, 2012, CIRCULATION, V126, P2612, DOI 10.1161/CIRCULATIONAHA.112.101261; Valdivielso JM, 2001, AM J PHYSIOL-REG I, V280, pR771, DOI 10.1152/ajpregu.2001.280.3.R771; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Walshe TE, 2009, ARTERIOSCL THROM VAS, V29, P1185, DOI 10.1161/ATVBAHA.109.186742	27	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119665	10.1371/journal.pone.0119665	http://dx.doi.org/10.1371/journal.pone.0119665			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768936	Green Published, gold, Green Submitted			2022-12-27	WOS:000351277500090
J	Al Laham, N; Mediavilla, JR; Chen, L; Abdelateef, N; Abu Elamreen, F; Ginocchio, CC; Pierard, D; Becker, K; Kreiswirth, BN				Al Laham, Nahed; Mediavilla, Jose R.; Chen, Liang; Abdelateef, Nahed; Abu Elamreen, Farid; Ginocchio, Christine C.; Pierard, Denis; Becker, Karsten; Kreiswirth, Barry N.			MRSA Clonal Complex 22 Strains Harboring Toxic Shock Syndrome Toxin (TSST-1) Are Endemic in the Primary Hospital in Gaza, Palestine	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; METHICILLIN-RESISTANT; MOLECULAR CHARACTERIZATION; PATHOGENICITY ISLAND; SEQUENCE-ANALYSIS; EPIDEMIOLOGY; PREVALENCE; PATTERNS; HEALTHY; ISRAEL	Background Methicillin-resistant Staphylococcus aureus (MRSA) is an important pathogen in both community and healthcare-related settings worldwide. Current knowledge regarding the epidemiology of S. aureus and MRSA in Gaza is based on a single community-based carriage study. Here we describe a cross-sectional analysis of 215 clinical isolates collected from Al-Shifa Hospital in Gaza during 2008 and 2012. Methods All isolates were characterized by spa typing, SCCmec typing, and detection of genes encoding Panton-Valentine leukocidin (PVL) and toxic shock syndrome toxin (TSST-1). Representative genotypes were also subjected to multilocus sequence typing (MLST). Antibiotic susceptibility testing was performed using VITEK2 and MicroScan. Results MRSA represented 56.3% of all S. aureus strains, and increased in frequency from 2008 (54.8%) to 2012 (58.4%). Aside from beta-lactams, resistance was observed to tetracycline, erythromycin, clindamycin, gentamicin, and fluoroquinolones. Molecular typing identified 35 spa types representing 17 MLST clonal complexes (CC), with spa 998 (Ridom t223, CC22) and spa 70 (Ridom t044, CC80) being the most prevalent. SCCmec types I, III, IV, V and VI were identified among MRSA isolates, while type II was not detected. PVL genes lukF/S-PV) were detected in 40.0% of all isolates, while the TSST-1 gene (tst) was detected in 27.4% of all isolates, with surprisingly high frequency within CC22 (70.4%). Both PVL and TSST-1 genes were found in several isolates from 2012. Conclusions Molecular typing of clinical isolates from Gaza hospitals revealed unusually high prevalence of TSST-1 genes among CC22 MRSA, which is noteworthy given a recent community study describing widespread carriage of a CC22 MRSA clone known as the 'Gaza strain'. While the latter did not address TSST-1, tst-positive spa 998 (Ridom t223) has been detected in several neighboring countries, and described as endemic in an Italian NICU, suggesting international spread of a 'Middle Eastern variant' of pandemic CC22 strain EMRSA-15.	[Al Laham, Nahed] Al Azhar Univ Gaza, Dept Lab Med, Gaza, Israel; [Al Laham, Nahed; Mediavilla, Jose R.; Chen, Liang; Kreiswirth, Barry N.] Rutgers State Univ, Publ Hlth Res Inst, Newark, NJ 07102 USA; [Abdelateef, Nahed; Abu Elamreen, Farid] Minist Hlth, Cent Labs, Gaza, Israel; [Ginocchio, Christine C.] North Shore LIJ Hlth Syst, Dept Pathol & Lab Med, Lake Success, NY USA; [Ginocchio, Christine C.] Hofstra North Shore LIJ Sch Med, Hempstead, NY USA; [Pierard, Denis] Univ Hosp Brussels, Inst Med Microbiol, Brussels, Belgium; [Becker, Karsten] Univ Hosp Muenster, Inst Med Microbiol, Munster, Germany	Rutgers State University Newark; Rutgers State University New Brunswick; Northwell Health; Hofstra University; Northwell Health; University Hospital Brussels; University of Munster	Kreiswirth, BN (corresponding author), Rutgers State Univ, Publ Hlth Res Inst, Newark, NJ 07102 USA.	kreiswba@njms.rutgers.edu	Chen, Liang/Q-5337-2019; Al Laham, Nahed/HHD-2148-2022; Becker, Karsten/O-2302-2018	Chen, Liang/0000-0001-5845-2235; Becker, Karsten/0000-0002-6391-1341; Pierard, DEnis/0000-0002-7756-3691				Abou Shady HM, 2015, BRAZ J INFECT DIS, V19, P68, DOI 10.1016/j.bjid.2014.09.005; Adler A, 2012, J CLIN MICROBIOL, V50, P134, DOI 10.1128/JCM.05446-11; Adler A, 2010, J CLIN MICROBIOL, V48, P531, DOI 10.1128/JCM.02290-08; Adwan K, 2005, MICROB DRUG RESIST, V11, P75, DOI 10.1089/mdr.2005.11.75; Adwan K, 2013, AM J INFECT CONTROL, V41, P195, DOI 10.1016/j.ajic.2012.03.040; Al Laham Nahed A, 2012, J Infect Public Health, V5, P43, DOI 10.1016/j.jiph.2011.10.006; Al-Bakri AG, 2013, EPIDEMIOL INFECT, V141, P2384, DOI 10.1017/S0950268813000010; Alon D, 2011, EUR J CLIN MICROBIOL, V30, P1443, DOI 10.1007/s10096-011-1243-9; Aqel AA, 2015, J INFECT PUBLIC HEAL, V8, P90, DOI 10.1016/j.jiph.2014.05.007; Aqel AA, 2012, ACTA MICROBIOL IMM H, V59, P239, DOI 10.1556/AMicr.59.2012.2.8; Becker K, 2006, J CLIN MICROBIOL, V44, P229, DOI 10.1128/JCM.44.1.229-231.2006; Becker K, 1998, J CLIN MICROBIOL, V36, P2548, DOI 10.1128/JCM.36.9.2548-2553.1998; Becker K, 2003, J CLIN MICROBIOL, V41, P1434, DOI 10.1128/JCM.41.4.1434-1439.2003; Biber A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042864; Borg MA, 2007, J ANTIMICROB CHEMOTH, V60, P1310, DOI 10.1093/jac/dkm365; Chen LA, 2010, ANTIMICROB AGENTS CH, V54, P3347, DOI 10.1128/AAC.00001-10; Chen L, 2009, J CLIN MICROBIOL, V47, P3692, DOI 10.1128/JCM.00766-09; Chmelnitsky I, 2008, EUR J CLIN MICROBIOL, V27, P385, DOI 10.1007/s10096-007-0426-x; Dauwalder O, 2008, J CLIN MICROBIOL, V46, P3454, DOI 10.1128/JCM.01050-08; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; El-Mahdy TS, 2014, CLIN MICROBIOL INFEC, V20, P169, DOI 10.1111/1469-0691.12240; Elmanama AA, 2013, BURNS, V39, P1612, DOI 10.1016/j.burns.2013.04.011; Enany S, 2007, EUROSURVEILLANCE, V12, pE0709272, DOI DOI 10.2807/ESW.12.39.03274-EN; Enany S, 2010, MICROBIOL RES, V165, P152, DOI 10.1016/j.micres.2009.03.005; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Geraci DM, 2014, INFECTION, V42, P535, DOI 10.1007/s15010-013-0583-z; Geraci DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087760; Harastani HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103715; Harastani HH, 2014, INT J INFECT DIS, V19, P33, DOI 10.1016/j.ijid.2013.10.007; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Holden MTG, 2013, GENOME RES, V23, P653, DOI 10.1101/gr.147710.112; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Kaibni MH, 2009, J MED MICROBIOL, V58, P644, DOI 10.1099/jmm.0.007617-0; Kearns AM, 2008, STAPHYLOCOCCUS AUREU; Khalil W, 2012, DIAGN MICR INFEC DIS, V73, P228, DOI 10.1016/j.diagmicrobio.2012.03.012; Kock R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055040; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Li Z, 2011, PLOS ONE, V6, pe27; Lindsay JA, 1998, MOL MICROBIOL, V29, P527, DOI 10.1046/j.1365-2958.1998.00947.x; Mathema Barun, 2008, V431, P285; Mediavilla JR, 2012, CURR OPIN MICROBIOL, V15, P588, DOI 10.1016/j.mib.2012.08.003; Mellmann A, 2006, PLOS MED, V3, P348, DOI 10.1371/journal.pmed.0030033; Monecke S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-146; Nadig S, 2010, J MED MICROBIOL, V59, P815, DOI 10.1099/jmm.0.017632-0; Novick Richard P, 2007, Chem Immunol Allergy, V93, P42, DOI 10.1159/000100857; Regev-Yochay G, 2006, EUR J CLIN MICROBIOL, V25, P719, DOI 10.1007/s10096-006-0210-3; Sabri I, 2013, EUR J MICROBIOL IMMU, V3, P183, DOI 10.1556/EuJMI.3.2013.3.5; Said-Salim B, 2005, J CLIN MICROBIOL, V43, P3373, DOI 10.1128/JCM.43.7.3373-3379.2005; Schaumburg F, 2012, J CLIN MICROBIOL, V50, P3186, DOI 10.1128/JCM.01174-12; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Song Y, 2013, J MED MICROBIOL, V62, P274, DOI 10.1099/jmm.0.050971-0; Subedi A, 2007, MICROBIOL-SGM, V153, P3235, DOI 10.1099/mic.0.2007/006932-0; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tokajian S, 2014, CLIN MICROBIOL INFEC, V20, P624, DOI 10.1111/1469-0691.12691; Tokajian ST, 2010, EPIDEMIOL INFECT, V138, P707, DOI 10.1017/S0950268810000440; Udo EE, 2006, CLIN MICROBIOL INFEC, V12, P262, DOI 10.1111/j.1469-0691.2005.01350.x; Verkade E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041855; von Eiff C, 2004, DIAGN MICR INFEC DIS, V49, P157, DOI 10.1016/j.diagmicrobio.2004.03.009; Weber S, 2010, GENETIC FINGERPRINTI; Wikipedia contributors, 2014, DEM PAL TERR; Wolter DJ, 2008, J CLIN MICROBIOL, V46, P3548, DOI 10.1128/JCM.00985-08	64	30	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120008	10.1371/journal.pone.0120008	http://dx.doi.org/10.1371/journal.pone.0120008			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781188	Green Submitted, Green Published, gold			2022-12-27	WOS:000351284600118
J	Ansuini, C; Cavallo, A; Koul, A; Jacono, M; Yang, Y; Becchio, C				Ansuini, Caterina; Cavallo, Andrea; Koul, Atesh; Jacono, Marco; Yang, Yuan; Becchio, Cristina			Predicting Object Size from Hand Kinematics: A Temporal Perspective	PLOS ONE			English	Article							PREHENSION MOVEMENTS; PARKINSONS-DISEASE; GRASP; MOTOR; COORDINATION; MODULATION; TRANSPORT; STIMULATION; INFORMATION; COMPONENTS	Research on reach-to-grasp movements generally concentrates on kinematics values that are expression of maxima, in particular the maximum aperture of the hand and the peak of wrist velocity. These parameters provide a snapshot description of movement kinematics at a specific time point during reach, i.e., the maximum within a set of value, but do not allow to investigate how hand kinematics gradually conform to target properties. The present study was designed to extend the characterization of object size effects to the temporal domain. Thus, we computed the wrist velocity and the grip aperture throughout reach-to-grasp movements aimed at large versus small objects. To provide a deeper understanding of how joint movements varied over time, we also considered the time course of finger motion relative to hand motion. Results revealed that movement parameters evolved in parallel but at different rates in relation to object size. Furthermore, a classification analysis performed using a Support Vector Machine (SVM) approach showed that kinematic features taken as a group predicted the correct target size well before contact with the object. Interestingly, some kinematics features exhibited a higher ability to discriminate the target size than others did. These findings reinforce our knowledge about the relationship between kinematics and object properties and shed new light on the quantity and quality of information available in the kinematics of a reach-to-grasp movement over time. This might have important implications for our understanding of the action-perception coupling mechanism.	[Ansuini, Caterina; Koul, Atesh; Jacono, Marco; Becchio, Cristina] Fdn Ist Italiano Tecnol, Dept Robot Brain & Cognit Sci, Genoa, Italy; [Cavallo, Andrea; Becchio, Cristina] Univ Turin, Ctr Cognit Sci, Dept Psychol, Turin, Italy; [Yang, Yuan] Delft Univ Technol, Dept BioMech Engn, Delft, Netherlands	Istituto Italiano di Tecnologia - IIT; University of Genoa; University of Turin; Delft University of Technology	Becchio, C (corresponding author), Fdn Ist Italiano Tecnol, Dept Robot Brain & Cognit Sci, Genoa, Italy.	cristina.becchio@unito.it	Yang, Yuan/I-5936-2019; Koul, Atesh/I-2176-2019; Cavallo, Andrea/AAB-9615-2019	Yang, Yuan/0000-0003-2442-3713; Koul, Atesh/0000-0002-0917-9583; Cavallo, Andrea/0000-0002-3717-3760; Jacono, Marco/0000-0002-5750-4395	European Research Council under the European Union's Seventh Framework Programme/ERC [312919]	European Research Council under the European Union's Seventh Framework Programme/ERC(European Research Council (ERC))	This work received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement n. 312919. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aglioti SM, 2008, NAT NEUROSCI, V11, P1109, DOI 10.1038/nn.2182; Ansuini C, 2006, J NEUROPHYSIOL, V95, P2456, DOI 10.1152/jn.01107.2005; Ansuini C, 2010, BRAIN COGNITION, V74, P169, DOI 10.1016/j.bandc.2010.07.015; Berthier NE, 1996, J MOTOR BEHAV, V28, P187, DOI 10.1080/00222895.1996.9941744; Carpinella I, 2006, GAIT POSTURE, V23, P445, DOI 10.1016/j.gaitpost.2005.05.001; Carpinella I, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-19; Castiello U, 2005, NAT REV NEUROSCI, V6, P726, DOI 10.1038/nrn1744; Cavallo Andrea, 2013, Tropical Medicine & International Health, V18, P3507, DOI 10.1111/ejn.12343; Cavallo A, 2012, CEREB CORTEX, V22, P710, DOI 10.1093/cercor/bhr157; Chen YW, 2006, STUD FUZZ SOFT COMP, V207, P315; CHIEFFI S, 1993, EXP BRAIN RES, V94, P471; Duda RO, 2001, PATTERN CLASSIFICATI, V2nd, P20; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; FU QG, 1995, J NEUROPHYSIOL, V73, P836, DOI 10.1152/jn.1995.73.2.836; Fukuchi RK, 2011, J BIOMECH, V44, P540, DOI 10.1016/j.jbiomech.2010.09.031; Gangitano M, 2004, EUR J NEUROSCI, V20, P2193, DOI 10.1111/j.1460-9568.2004.03655.x; Gangitano M, 2001, NEUROREPORT, V12, P1489, DOI 10.1097/00001756-200105250-00038; GENTILUCCI M, 1991, NEUROPSYCHOLOGIA, V29, P361, DOI 10.1016/0028-3932(91)90025-4; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; JEANNEROD M, 1984, J MOTOR BEHAV, V16, P235; Jeannerod M., 1981, ATTENTION PERFORM, P153; MARTENIUK RG, 1990, HUM MOVEMENT SCI, V9, P149, DOI 10.1016/0167-9457(90)90025-9; Mason CR, 2004, J NEUROPHYSIOL, V91, P2826, DOI 10.1152/jn.00653.2003; Naish KR, 2014, NEUROPSYCHOLOGIA, V64, P331, DOI 10.1016/j.neuropsychologia.2014.09.034; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PAULIGNAN Y, 1991, EXP BRAIN RES, V83, P502; Santello M, 2002, J NEUROSCI, V22, P1426, DOI 10.1523/JNEUROSCI.22-04-01426.2002; Santello M, 1998, J NEUROPHYSIOL, V79, P1307, DOI 10.1152/jn.1998.79.3.1307; Sartori L, 2011, COGNITION, V119, P242, DOI 10.1016/j.cognition.2011.01.014; Schettino LF, 2009, INT J NEUROSCI, V119, P1905, DOI 10.1080/00207450903245296; Schettino LF, 2006, EXP BRAIN RES, V168, P186, DOI 10.1007/s00221-005-0080-4; Schettino LF, 2004, NEUROPSYCHOLOGIA, V42, P82, DOI 10.1016/S0028-3932(03)00150-7; Smeets JBJ, 1999, MOTOR CONTROL, V3, P237, DOI 10.1123/mcj.3.3.237; Theodoridis S., 2003, PATTERN RECOGNITION; Tolambiya A, 2012, NEUROSCIENCE, V210, P179, DOI 10.1016/j.neuroscience.2012.02.050; Tolambiya A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020732; Vapnik V., 2013, NATURE STAT LAERNING; WING AM, 1986, J MOTOR BEHAV, V18, P245; Winges SA, 2003, EXP BRAIN RES, V152, P489, DOI 10.1007/s00221-003-1571-9; Yang Y, 2014, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2014-38	40	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120432	10.1371/journal.pone.0120432	http://dx.doi.org/10.1371/journal.pone.0120432			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781473	Green Published, gold, Green Submitted			2022-12-27	WOS:000351284600160
J	Ayzenberg, I; Schlevogt, S; Metzdorf, J; Stahlke, S; Pedreitturia, X; Hunfeld, A; Couillard-Despres, S; Kleiter, I				Ayzenberg, Ilya; Schlevogt, Sibylle; Metzdorf, Judith; Stahlke, Sarah; Pedreitturia, Xiomara; Hunfeld, Anika; Couillard-Despres, Sebastien; Kleiter, Ingo			Analysis of Neurogenesis during Experimental Autoimmune Encephalomyelitis Reveals Pitfalls of Bioluminescence Imaging	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; ADULT HIPPOCAMPAL NEUROGENESIS; CENTRAL-NERVOUS-SYSTEM; INFLAMMATION ALTERS; SUBVENTRICULAR ZONE; PRECURSOR CELLS; SPINAL-CORD; MICE; PERMEABILITY	Bioluminescence imaging is a sensitive approach for longitudinal neuroimaging. Transgenic mice expressing luciferase under the promoter of doublecortin (DCX-luc), a specific marker of neuronal progenitor cells (NPC), allow monitoring of neurogenesis in living mice. Since the extent and time course of neurogenesis during autoimmune brain inflammation are controversial, we investigated neurogenesis in MOG-peptide induced experimental allergic encephalomyelitis (EAE) using DCX-luc reporter mice. We observed a marked, 2- to 4-fold increase of the bioluminescence signal intensity 10 days after EAE induction and a gradual decline 1-2 weeks thereafter. In contrast, immunostaining for DCX revealed no differences between EAE and control mice 2 and 4 weeks after immunization in zones of adult murine neurogenesis such as the dentate gyrus. Ex vivo bioluminescence imaging showed similar luciferase expression in brain homogenates of EAE and control animals. Apart from complete immunization including MOG-peptide also incomplete immunization with complete Freund's adjuvant and pertussis toxin resulted in a rapid increase of the in vivo bioluminescence signal. Blood-brain barrier (BBB) leakage was demonstrated 10 days after both complete and incomplete immunization and might explain the increased bioluminescence signal in vivo. We conclude, that acute autoimmune inflammation in EAE does not alter neurogenesis, at least at the stage of DCX-expressing NPC. Effects of immunization on the BBB integrity must be considered when luciferase is used as a reporter within the CNS during the active stage of EAE. Models with stable CNS-restricted luciferase expression could serve as technically convenient way to evaluate BBB integrity in a longitudinal manner.	[Ayzenberg, Ilya; Schlevogt, Sibylle; Metzdorf, Judith; Stahlke, Sarah; Pedreitturia, Xiomara; Kleiter, Ingo] Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, Bochum, Germany; [Hunfeld, Anika] Ruhr Univ Bochum, Dept Anim Physiol, Bochum, Germany; [Couillard-Despres, Sebastien] Paracelsus Med Univ, Inst Expt Neuroregenerat, Salzburg, Austria; [Couillard-Despres, Sebastien] Paracelsus Med Univ, SCI TReCS, Salzburg, Austria	Ruhr University Bochum; Ruhr University Bochum; Paracelsus Private Medical University; Paracelsus Private Medical University	Kleiter, I (corresponding author), Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, Bochum, Germany.	ingo.kleiter@rub.de	Ayzenberg, Ilya/AAK-5545-2020; Kleiter, Ingo/AAD-1132-2020	Kleiter, Ingo/0000-0002-8249-4408; Pedreiturria, Xiomara/0000-0002-3024-3826; Couillard-Despres, Sebastien/0000-0002-8486-6412; , Ilya/0000-0002-6009-792X	Bayer Healthcare; State Government of Salzburg (Austria); European Union [HEALTH-F2-2011-279288, HEALTH-346F2-2011-278850]	Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); State Government of Salzburg (Austria); European Union(European Commission)	Part of the study was supported by a research grant from Bayer Healthcare to IK. This manuscript has been made possible through the financial support from the State Government of Salzburg (Austria) and through funding from the European Union's Seventh Framework Program (FP7/2007-2013) under grant agreement no HEALTH-F2-2011-279288 (IDEA) and no HEALTH-346F2-2011-278850 (INMiND) to SCD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni R, 2005, J NEUROSCI, V25, P8217, DOI 10.1523/JNEUROSCI.1859-05.2005; Aswendt M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055662; Ben-Hur T, 2003, MOL CELL NEUROSCI, V24, P623, DOI 10.1016/S1044-7431(03)00218-5; Bennett J, 2010, J NEUROIMMUNOL, V229, P180, DOI 10.1016/j.jneuroim.2010.08.011; Berger F, 2008, EUR J NUCL MED MOL I, V35, P2275, DOI 10.1007/s00259-008-0870-6; BERGMAN RK, 1978, INFECT IMMUN, V21, P627, DOI 10.1128/IAI.21.2.627-637.1978; Calza L, 1998, P NATL ACAD SCI USA, V95, P3209, DOI 10.1073/pnas.95.6.3209; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Couillard-Despres S, 2008, MOL IMAGING, V7, P28, DOI 10.2310/7290.2008.0004; DeVries HE, 1997, PHARMACOL REV, V49, P143; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Giannakopoulou A, 2013, J NEUROSCI RES, V91, P890, DOI 10.1002/jnr.23226; Guo J, 2010, NEUROSIGNALS, V18, P1, DOI 10.1159/000242424; Hasan MT, 2001, GENESIS, V29, P116, DOI 10.1002/gene.1014; Hochgrafe K, 2013, MOL NEUROBIOL, V47, P868, DOI 10.1007/s12035-012-8379-1; Huber JD, 2001, AM J PHYSIOL-HEART C, V280, pH1241, DOI 10.1152/ajpheart.2001.280.3.H1241; Huehnchen P, 2011, GLIA, V59, P132, DOI 10.1002/glia.21082; Kim H, 2012, STEM CELLS, V30, P2820, DOI 10.1002/stem.1218; Kim H, 2012, GLIA, V60, P1117, DOI 10.1002/glia.22339; Kleiter I, 2007, J NEUROIMMUNOL, V187, P61, DOI 10.1016/j.jneuroim.2007.04.014; Lee KH, 2003, NUCL MED COMMUN, V24, P1003, DOI 10.1097/00006231-200309000-00009; LEMBERT N, 1995, BIOCHEM J, V305, P929, DOI 10.1042/bj3050929; Luo J, 2007, J CLIN INVEST, V117, P3306, DOI 10.1172/JCI31763; Luo J, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-6; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Nielsen HH, 2011, AM J PATHOL, V179, P2028, DOI 10.1016/j.ajpath.2011.06.006; Noubade R, 2008, AM J PATHOL, V173, P892, DOI 10.2353/ajpath.2008.080001; Picard-Riera N, 2002, P NATL ACAD SCI USA, V99, P13211, DOI 10.1073/pnas.192314199; Pluchino S, 2008, BRAIN, V131, P2564, DOI 10.1093/brain/awn198; Rabchevsky AG, 1999, BRAIN RES, V832, P84, DOI 10.1016/S0006-8993(99)01479-1; REIBER H, 1984, J NEUROL SCI, V63, P55, DOI 10.1016/0022-510X(84)90108-4; Sher F, 2012, CELL TRANSPLANT, V21, P1883, DOI 10.3727/096368911X637443; Toft-Hansen H, 2006, J IMMUNOL, V177, P7242, DOI 10.4049/jimmunol.177.10.7242; Tonra JR, 2001, J COMP NEUROL, V430, P131; Ziv Y, 2006, P NATL ACAD SCI USA, V103, P13174, DOI 10.1073/pnas.0603747103	35	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0118550	10.1371/journal.pone.0118550	http://dx.doi.org/10.1371/journal.pone.0118550			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25780928	Green Published, gold, Green Submitted			2022-12-27	WOS:000351284600026
J	Chambers, LW; Crowe, L; Lam, PP; MacDougall, D; McNeil, S; Roth, V; Suh, K; Dalzell, C; Baker, D; Ramsay, H; DeCoutere, S; Hall, HL; McCarthy, AE				Chambers, Larry W.; Crowe, Lois; Lam, Po-Po; MacDougall, Donna; McNeil, Shelly; Roth, Virginia; Suh, Kathryn; Dalzell, Catherine; Baker, Donna; Ramsay, Hilary; DeCoutere, Sarah; Hall, Heather L.; McCarthy, Anne E.			A New Approach to Improving Healthcare Personnel Influenza Immunization Programs: A Randomized Controlled Trial	PLOS ONE			English	Article							LONG-TERM-CARE; HOME STAFF; VACCINATION; WORKERS; MORTALITY; IMPLEMENTATION; RESIDENTS	Background Healthcare personnel influenza immunization rates remain sub-optimal. Following multiple studies and expert consultations, the "Successful Influenza Immunization Programs for Healthcare Personnel: A Guide for Program Planners" was produced. This trial assessed the impact of the Guide with facilitation in improving healthcare personnel influenza immunization rates in Canadian healthcare organizations. Methods A sample of 26 healthcare organizations across six Canadian provinces (ON, MB, NS, BC, SK, NL) was randomized to Intervention (n=13) or Control groups (n=13). Baseline influenza immunization rates were obtained for 2008-2009; the study groups were followed over two subsequent influenza seasons. The Intervention group received the Guide, facilitation support through workshops for managers and ongoing support. The Control groups conducted programs as usual. The Groups were compared using their reported influenza healthcare personnel influenza immunization rates and scores from a program assessment questionnaire. Findings Twenty-six organizations agreed to participate. 35% (9/26) of sites were acute care hospitals, 19% (5/26) continuing care, long-term care organizations or nursing homes, and 46% (12/26) were mixed acute care hospitals and long-term care or regional health authorities. The median rate of influenza immunization among healthcare personnel for the Intervention group was 43%, 44%, and 51% at three points in time respectively, and in the Control group: 62%, 57%, and 55% respectively. No significant differences were observed between the groups at the three points in time. However, there was a 7% increase in the median rates between the Baseline Year and Year Two in the Intervention group, and a 6% decrease in the Control group over the same time period, which was statistically significant (0.071 versus -0.058, p < 0.001). Interpretation This pragmatic randomized trial of the Guide with facilitation of its implementation improved healthcare personnel immunization rates, but these rates continued to be sub-optimal and below rates achievable in programs requiring personnel to be immunized.	[Chambers, Larry W.; Crowe, Lois; Dalzell, Catherine; Ramsay, Hilary; McCarthy, Anne E.] Bruyere Res Inst, Ottawa, ON, Canada; [Chambers, Larry W.] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Chambers, Larry W.] McMaster Univ, Dept Clin & Biostat, Hamilton, ON, Canada; [Chambers, Larry W.] York Univ, Fac Hlth, Toronto, ON M3J 2R7, Canada; [Chambers, Larry W.] Inst Clin & Evaluat Sci, Toronto, ON, Canada; [Crowe, Lois; McCarthy, Anne E.] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Lam, Po-Po] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [MacDougall, Donna] St Francis Xavier Univ, Antigonish, NS B2G 1C0, Canada; [MacDougall, Donna; McNeil, Shelly; DeCoutere, Sarah] Canadian Ctr Vaccinol, Halifax, NS, Canada; [McNeil, Shelly] Dalhousie Univ, Halifax, NS, Canada; [Roth, Virginia; Suh, Kathryn; McCarthy, Anne E.] Ottawa Hosp, Ottawa, ON, Canada; [Baker, Donna; Hall, Heather L.] Bruyere Continuing Care, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; McMaster University; York University - Canada; University of Toronto; University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; Saint Francis Xavier University - Canada; Dalhousie University; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Chambers, LW (corresponding author), Bruyere Res Inst, Ottawa, ON, Canada.	lchambers@alzheimer.ca	Chambers, Larry W/AAI-4959-2020	McNeil, Shelly/0000-0001-5444-4166; Crowe, Lois/0000-0002-6487-5821; McCarthy, Anne/0000-0001-7195-6366; Halperin, Donna/0000-0002-1034-9818	Canadian Institutes of Health Research [90189]; Bruyere Research Institute; Bruyere Continuing Care; Ottawa Hospital; Ottawa Hospital Research Institute; Canadian Center for Vaccinology; University of Ottawa; Immunize Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Bruyere Research Institute; Bruyere Continuing Care; Ottawa Hospital; Ottawa Hospital Research Institute; Canadian Center for Vaccinology(Canadian Institutes of Health Research (CIHR)); University of Ottawa; Immunize Canada	The trial was supported in part by grant no. 90189 from the Canadian Institutes of Health Research. Additional support was provided by the Bruyere Research Institute, Bruyere Continuing Care, The Ottawa Hospital, The Ottawa Hospital Research Institute, the Canadian Center for Vaccinology, the University of Ottawa and Immunize Canada. The funders had no role in the study design, data collection, analysis, interpretations of the data, in the writing of the report or in the decision to submit the paper for publication.	[Anonymous], 2005, PREV CHRON DIS VIT I; Babcock HM, 2010, CLIN INFECT DIS, V50, P459, DOI 10.1086/650752; Bernstein HH, 2010, PEDIATRICS, V126, P809, DOI 10.1542/peds.2010-2376; Carman WF, 2000, LANCET, V355, P93, DOI 10.1016/S0140-6736(99)05190-9; Chambers LW, 2012, J HOSP INFECT, V82, P194, DOI 10.1016/j.jhin.2012.08.003; Covinsky KE, 2003, J AM GERIATR SOC, V51, P451, DOI 10.1046/j.1532-5415.2003.51152.x; Elixhauser A, 2000, AHRQ PUBLICATION; Hayward AC, 2006, BRIT MED J, V333, P1241, DOI 10.1136/bmj.39010.581354.55; Huynh S, 2012, AM J INFECT CONTROL, V40, P771, DOI 10.1016/j.ajic.2011.10.011; Kelsey JL., 1996, METHODS OBSERVATIONA; Kwong JCCN., ONTARIO BURDEN INFEC; Lam PP, 2010, CAN MED ASSOC J, V182, pE542, DOI 10.1503/cmaj.091304; Lemaitre M, 2009, J AM GERIATR SOC, V57, P1580, DOI 10.1111/j.1532-5415.2009.02402.x; Miller BL, 2011, VACCINE, V29, P9398, DOI 10.1016/j.vaccine.2011.09.047; Poland GA, 2005, VACCINE, V23, P2251, DOI 10.1016/j.vaccine.2005.01.043; Potter J, 1997, J INFECT DIS, V175, P1, DOI 10.1093/infdis/175.1.1; Public Health Agency of Canada, 2014, REP INFL HOSP DEATHS; Quach S, 2013, AM J INFECT CONTROL, V41, P685, DOI 10.1016/j.ajic.2012.09.022; Rakita RM, 2010, INFECT CONT HOSP EP, V31, P881, DOI 10.1086/656210; Rycroft-Malone J, 2004, J NURS CARE QUAL, V19, P297, DOI 10.1097/00001786-200410000-00002; Schanzer DL, 2007, EPIDEMIOL INFECT, V135, P1109, DOI 10.1017/S0950268807007923; Stevenson CG, 2001, CAN MED ASSOC J, V164, P1413; Thomas RE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005187.pub4; Thompson M. G., 2010, Morbidity and Mortality Weekly Report, V59, P1057; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; van den Dool C, 2009, VACCINE, V27, P6261, DOI 10.1016/j.vaccine.2009.07.104; van den Dool C, 2008, PLOS MED, V5, P1453, DOI 10.1371/journal.pmed.0050200	27	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0118368	10.1371/journal.pone.0118368	http://dx.doi.org/10.1371/journal.pone.0118368			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781888	Green Submitted, gold, Green Published			2022-12-27	WOS:000351284600022
J	Chen, L; Liu, YS; Liu, HD; Kang, LM; Geng, JM; Gai, YZ; Ding, YL; Sun, HY; Li, YD				Chen, Li; Liu, Yushan; Liu, Hongdi; Kang, Limin; Geng, Jinman; Gai, Yuzhuo; Ding, Yunlong; Sun, Haiyue; Li, Yadong			Identification and Expression Analysis of MATE Genes Involved in Flavonoid Transport in Blueberry Plants	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; MEDICAGO-TRUNCATULA; PROANTHOCYANIDIN BIOSYNTHESIS; ANTHOCYANIN BIOSYNTHESIS; VACUOLAR SEQUESTRATION; SECONDARY METABOLITES; ALUMINUM TOLERANCE; IRON HOMEOSTASIS; SEED COAT; MULTIDRUG	Multidrug and toxic compound extrusion (MATE) proteins are the most recently identified family of multidrug transporters. In plants, this family is remarkably large compared to the human and bacteria counterpart, highlighting the importance of MATE proteins in this kingdom. Here 33 Unigenes annotated as MATE transporters were found in the blueberry fruit transcriptome, of which eight full-length cDNA sequences were identified and cloned. These proteins are composed of 477-517 residues, with molecular masses similar to 54 kDa, and theoretical isoelectric points from 5.35 to 8.41. Bioinformatics analysis predicted 10-12 putative transmembrane segments for VcMATEs, and localization to the plasma membrane without an N-terminal signal peptide. All blueberry MATE proteins shared 32.1-84.4% identity, among which VcMATE2, VcMATE3, VcMATE5, VcMATE7, VcMATE8, and VcMATE9 were more similar to the MATE-type flavonoid transporters. Phylogenetic analysis showed VcMATE2, VcMATE3, VcMATE5, VcMATE7, VcMATE8 and VcMATE9 clustered with MATE-type flavonoid transporters, indicating that they might be involved in flavonoid transport. VcMATE1 and VcMATE4 may be involved in the transport of secondary metabolites, the detoxification of xenobiotics, or the export of toxic cations. Real-time quantitative PCR demonstrated that the expression profile of the eight VcMATE genes varied spatially and temporally. Analysis of expression and anthocyanin accumulation indicated that there were some correlation between the expression profile and the accumulation of anthocyanins. These results showed VcMATEs might be involved in diverse physiological functions, and anthocyanins across the membranes might be mutually maintained by MATE-type flavonoid transporters and other mechanisms. This study will enrich the MATE-based transport mechanisms of secondary metabolite, and provide a new biotechonology strategy to develop better nutritional blueberry cultivars.	[Chen, Li; Liu, Yushan; Liu, Hongdi; Kang, Limin; Geng, Jinman; Gai, Yuzhuo; Ding, Yunlong; Sun, Haiyue; Li, Yadong] Jilin Agr Univ, Coll Hort, Changchun, Jilin, Peoples R China	Jilin Agricultural University	Sun, HY (corresponding author), Jilin Agr Univ, Coll Hort, Changchun, Jilin, Peoples R China.	haiyue-sun@hotmail.com; blueberryli@163.com			National Natural Science Foundation of China [31301755]; Special Fund for Agro-scientific Research in the Public Interest of China [201103037]; Doctoral Program Foundation of Institutions of Higher Education of China [2013223120004]; Preferred Foundation of Scientific Research for Returned Overseas Chinese Scholar, the state human resource ministry of china; Breeding Foundation of Jilin Province Department of Finance [2012004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest of China; Doctoral Program Foundation of Institutions of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Preferred Foundation of Scientific Research for Returned Overseas Chinese Scholar, the state human resource ministry of china; Breeding Foundation of Jilin Province Department of Finance	This work was supported by the National Natural Science Foundation of China (grant no. 31301755), the Special Fund for Agro-scientific Research in the Public Interest of China (grant no. 201103037), the Doctoral Program Foundation of Institutions of Higher Education of China (grant no. 2013223120004), the Preferred Foundation of Scientific Research for Returned Overseas Chinese Scholar, the state human resource ministry of china, and the Breeding Foundation of Jilin Province Department of Finance (2012004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abrahams S, 2002, PLANT PHYSIOL, V130, P561, DOI 10.1104/pp.006189; AI P, 2011, THESIS; Broun P, 2005, CURR OPIN PLANT BIOL, V8, P272, DOI 10.1016/j.pbi.2005.03.006; Brown MH, 1999, MOL MICROBIOL, V31, P394, DOI 10.1046/j.1365-2958.1999.01162.x; Burko Y, 2011, PLANT CELL PHYSIOL, V52, P518, DOI 10.1093/pcp/pcr007; Chai YR, 2009, MOL GENET GENOMICS, V281, P109, DOI 10.1007/s00438-008-0399-1; Chung YJ, 2001, J BACTERIOL, V183, P1012, DOI 10.1128/JB.183.3.1012-1021.2001; Debeaujon I, 2000, PLANT PHYSIOL, V122, P403, DOI 10.1104/pp.122.2.403; Debeaujon I, 2001, PLANT CELL, V13, P853, DOI 10.1105/tpc.13.4.853; Diener AC, 2001, PLANT CELL, V13, P1625, DOI 10.1105/tpc.13.7.1625; Durrett TP, 2007, PLANT PHYSIOL, V144, P197, DOI 10.1104/pp.107.097162; FRANCIS FJ, 1989, CRIT REV FOOD SCI, V28, P273, DOI 10.1080/10408398909527503; Gaxiola RA, 2007, FEBS LETT, V581, P2204, DOI 10.1016/j.febslet.2007.03.050; Gomez C, 2009, PLANT PHYSIOL, V150, P402, DOI 10.1104/pp.109.135624; Green LS, 2004, PLANT PHYSIOL, V136, P2523, DOI 10.1104/pp.104.045633; Hadacek F, 2002, CRIT REV PLANT SCI, V21, P273, DOI 10.1080/0735-260291044269; He XA, 2010, NATURE, V467, P991, DOI 10.1038/nature09408; Hvorup RN, 2003, EUR J BIOCHEM, V270, P799, DOI 10.1046/j.1432-1033.2003.03418.x; Jaakola L, 2001, MOL BIOTECHNOL, V19, P201, DOI 10.1385/MB:19:2:201; Jeong J, 2009, TRENDS PLANT SCI, V14, P280, DOI 10.1016/j.tplants.2009.02.006; Kocic B, 2011, J BUON, V16, P602; Lee J, 2005, J AOAC INT, V88, P1269; Li LG, 2002, J BIOL CHEM, V277, P5360, DOI 10.1074/jbc.M108777200; Li XY, 2012, GENE, V511, P54, DOI 10.1016/j.gene.2012.09.021; Liu JP, 2009, PLANT J, V57, P389, DOI 10.1111/j.1365-313X.2008.03696.x; Luo J, 2007, PLANT J, V50, P678, DOI 10.1111/j.1365-313X.2007.03079.x; Magalhaes JV, 2007, NAT GENET, V39, P1156, DOI 10.1038/ng2074; Marinova K, 2007, PLANT CELL, V19, P2023, DOI 10.1105/tpc.106.046029; MARRS KA, 1995, NATURE, V375, P397, DOI 10.1038/375397a0; Martens S, 2010, PHYTOCHEMISTRY, V71, P1040, DOI 10.1016/j.phytochem.2010.04.016; Mathews H, 2003, PLANT CELL, V15, P1689, DOI 10.1105/tpc.012963; Morita M, 2009, P NATL ACAD SCI USA, V106, P2447, DOI 10.1073/pnas.0812512106; Moriyama Y, 2008, XENOBIOTICA, V38, P1107, DOI [10.1080/00498250701883753, 10.1080/00498250701883753 ]; Nawrath C, 2002, PLANT CELL, V14, P275, DOI 10.1105/tpc.010376; Oakenfull RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054119; Otsuka M, 2005, P NATL ACAD SCI USA, V102, P17923, DOI 10.1073/pnas.0506483102; Pang YZ, 2007, PLANT PHYSIOL, V145, P601, DOI 10.1104/pp.107.107326; Peer WA, 2004, PLANT CELL, V16, P1898, DOI 10.1105/tpc.021501; Peters DJ, 2002, PLANT J, V32, P701, DOI 10.1046/j.1365-313X.2002.01458.x; Petrussa E, 2013, INT J MOL SCI, V14, P14950, DOI 10.3390/ijms140714950; Rogers EE, 2002, PLANT CELL, V14, P1787, DOI 10.1105/tpc.001495; Roytrakul Sittiruk, 2007, Phytochemistry Reviews, V6, P383, DOI 10.1007/s11101-006-9022-4; Sanoner P, 1999, J AGR FOOD CHEM, V47, P4847, DOI 10.1021/jf990563y; Seo PJ, 2012, BIOCHEM J, V442, P551, DOI 10.1042/BJ20111311; Shoji T, 2009, PLANT PHYSIOL, V149, P708, DOI 10.1104/pp.108.132811; Solovchenko A, 2003, J EXP BOT, V54, P1977, DOI 10.1093/jxb/erg199; Suzuki H, 2002, PLANT PHYSIOL, V130, P2142, DOI 10.1104/pp.010447; Tahara S, 2007, BIOSCI BIOTECH BIOCH, V71, P1387, DOI 10.1271/bbb.70028; Tanaka Y, 2010, BIOSCI BIOTECH BIOCH, V74, P1760, DOI 10.1271/bbb.100358; Tanaka Y, 2013, NATURE, V496, P247, DOI 10.1038/nature12014; Thompson EP, 2010, J EXP BOT, V61, P439, DOI 10.1093/jxb/erp312; WILLSON MF, 1990, AM NAT, V136, P790, DOI 10.1086/285132; Yazaki Kazufumi, 2008, Phytochemistry Reviews, V7, P513, DOI 10.1007/s11101-007-9079-8; Zhang W, 2004, BIOMED RES INT, V2004, P239; Zhang XH, 2012, J BIOL CHEM, V287, P27971, DOI 10.1074/jbc.M112.386979; Zhao J, 2011, PLANT CELL, V23, P1536, DOI 10.1105/tpc.110.080804; Zhao J, 2009, PLANT CELL, V21, P2323, DOI 10.1105/tpc.109.067819	57	42	46	5	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0118578	10.1371/journal.pone.0118578	http://dx.doi.org/10.1371/journal.pone.0118578			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781331	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600029
J	Idrovo, JP; Yang, WL; Jacob, A; Ajakaiye, MA; Cheyuo, C; Wang, ZM; Prince, JM; Nicastro, J; Coppa, GF; Wang, P				Idrovo, Juan-Pablo; Yang, Weng-Lang; Jacob, Asha; Ajakaiye, Michael A.; Cheyuo, Cletus; Wang, Zhimin; Prince, Jose M.; Nicastro, Jeffrey; Coppa, Gene F.; Wang, Ping			Combination of Adrenomedullin with Its Binding Protein Accelerates Cutaneous Wound Healing	PLOS ONE			English	Article							VASOACTIVE HORMONE ADRENOMEDULLIN; GUT ISCHEMIA; INJURY; SEPSIS; METALLOPROTEINASES; MECHANISMS; FLUIDS	Cutaneous wound continues to cause significant morbidity and mortality in the setting of diseases such as diabetes and cardiovascular diseases. Despite advances in wound care management, there is still an unmet medical need exists for efficient therapy for cutaneous wound. Combined treatment of adrenomedullin (AM) and its binding protein-1 (AMBP-1) is protective in various disease conditions. To examine the effect of the combination treatment of AM and AMBP-1 on cutaneous wound healing, full-thickness 2.0-cm diameter circular excision wounds were surgically created on the dorsum of rats, saline (vehicle) or AM/AMBP1 (96/320 mu g kg BW) was topically applied to the wound daily and wound size measured. At days 3, 7, and 14, skin samples were collected from the wound sites. AM/AMBP-1 treated group had significantly smaller wound surface area than the vehicle group over the 14-day time course. At day 3, AM/AMBP-1 promoted neutrophil infiltration (MPO), increased cytokine levels (IL-6 and TNF-alpha), angiogenesis (CD31, VEGF and TGF beta-1) and cell proliferation (Ki67). By day 7 and 14, AM/AMBP-1 treatment decreased MPO, followed by a rapid resolution of inflammation characterized by a decrease in cytokines. At the matured stage, AM/AMBP-1 treatment increased the alpha smooth muscle actin expression (mature blood vessels) and Masson-Trichrome staining (collagen deposition) along the granulation area, and increased MMP-9 and decreased MMP-2 mRNA expressions. TGF beta-1 mRNA levels in AM/AMBP-1 group were 5.3 times lower than those in the vehicle group. AM/AMBP-1 accelerated wound healing by promoting angiogenesis, collagen deposition and remodeling. Treatment also shortened the days to reach plateau for wound closure. Thus, AM/AMBP-1 may be further developed as a therapeutic for cutaneous wound healing.	[Idrovo, Juan-Pablo; Yang, Weng-Lang; Jacob, Asha; Ajakaiye, Michael A.; Cheyuo, Cletus; Wang, Zhimin; Prince, Jose M.; Nicastro, Jeffrey; Coppa, Gene F.; Wang, Ping] Hofstra North Shore LIJ Sch Med, Dept Surg, Manhasset, NY 11030 USA; [Yang, Weng-Lang; Jacob, Asha; Wang, Ping] Feinstein Inst Med Res, Ctr Translat Res, Manhasset, NY USA	Hofstra University; Northwell Health; Northwell Health	Wang, P (corresponding author), Hofstra North Shore LIJ Sch Med, Dept Surg, Manhasset, NY 11030 USA.	pwang@nshs.edu	Varghese, Asha/AAK-4922-2021; Idrovo, Juan-Pablo/AAA-4949-2021; Cheyuo, Cletus/AAM-5785-2021	Cheyuo, Cletus/0000-0002-9717-3738; Wang, Ping/0000-0002-1557-0394	US National Institute of Health [R01 HL07619]	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the grants from the US National Institute of Health (R01 HL07619) to PW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed NA, 1999, CRIT CARE MED, V27, P2459, DOI 10.1097/00003246-199911000-00023; Boo S, 2013, ADV WOUND CARE, V2, P238, DOI 10.1089/wound.2012.0394; Broughton G, 2006, PLAST RECONSTR SURG, V117, p6S, DOI 10.1097/01.prs.0000225429.76355.dd; Carrizo GJ, 2007, SURGERY, V141, P245, DOI 10.1016/j.surg.2006.05.017; Chaung WW, 2011, MOL MED, V17, P1075, DOI 10.2119/molmed.2010.00104; CROSS SE, 1995, BRIT J PLAST SURG, V48, P189, DOI 10.1016/0007-1226(95)90001-2; Davidson JM, 1998, ARCH DERMATOL RES, V290, pS1, DOI 10.1007/PL00007448; Desmouliere A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x; Dorsett-Martin WA, SOURCEBOOK MODELS BI, P631, DOI [10.1007/978-1-59745-285-4_65, DOI 10.1007/978-1-59745-285-4_65]; Elsasser TH, 1999, ENDOCRINOLOGY, V140, P4908, DOI 10.1210/en.140.10.4908; Eming S, 2008, BIOMATERIALS, V29, P2932, DOI 10.1016/j.biomaterials.2008.03.029; Gillitzer R, 2001, J LEUKOCYTE BIOL, V69, P513; Guidolin D, 2008, PEPTIDES, V29, P2013, DOI 10.1016/j.peptides.2008.07.009; Hinson JP, 2000, ENDOCR REV, V21, P138, DOI 10.1210/er.21.2.138; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hoffmann U, 2006, SCAND J INFECT DIS, V38, P867, DOI 10.1080/00365540600702058; KITAMURA K, 1993, BIOCHEM BIOPH RES CO, V192, P553, DOI 10.1006/bbrc.1993.1451; Koenen P, 2015, INT WOUND J, V12, P10, DOI 10.1111/iwj.12039; Koskela M, 2009, CRIT CARE, V13, DOI 10.1186/cc7932; Lazarus Gerald S., 1994, Wound Repair and Regeneration, V2, P165, DOI 10.1046/j.1524-475X.1994.20305.x; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Medina A, 2005, J BURN CARE REHABIL, V26, P306, DOI 10.1097/01.BCR.0000169887.04973.3A; Mogford JE, 2001, CUTANEOUS WOUND HEAL, P109; Pio R, 2001, J BIOL CHEM, V276, P12292, DOI 10.1074/jbc.M007822200; Qiang XL, 2008, MOL MED, V14, P443, DOI 10.2119/2008-00015.Qiang; Ribatti D, 2005, PEPTIDES, V26, P1670, DOI 10.1016/j.peptides.2005.02.017; Rico RM, 2002, J SURG RES, V102, P193, DOI 10.1006/jsre.2001.6316; RIPOCHE J, 1988, BIOCHEM J, V249, P593, DOI 10.1042/bj2490593; Ruckley C V, 1997, J Wound Care, V6, P442; SAKATA J, 1993, BIOCHEM BIOPH RES CO, V195, P921, DOI 10.1006/bbrc.1993.2132; Shah KG, 2010, J SURG RES, V163, P110, DOI 10.1016/j.jss.2010.03.064; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Trengove NJ, 1999, WOUND REPAIR REGEN, V7, P442, DOI 10.1046/j.1524-475X.1999.00442.x; Wu RQ, 2008, PEPTIDES, V29, P1223, DOI 10.1016/j.peptides.2008.02.021; Wu RQ, 2009, MOL MED, V15, P28, DOI 10.2119/molmed.2008.00092; WYSOCKI AB, 1993, J INVEST DERMATOL, V101, P64, DOI 10.1111/1523-1747.ep12359590; Yager DR, 1996, J INVEST DERMATOL, V107, P743, DOI 10.1111/1523-1747.ep12365637; Yang JT, 2009, ANN SURG, V249, P310, DOI 10.1097/SLA.0b013e3181961d43; Zhang FM, 2009, REGUL PEPTIDES, V152, P82, DOI 10.1016/j.regpep.2008.09.007; Zhou M, 2002, AM J PHYSIOL-REG I, V283, pR553, DOI 10.1152/ajpregu.00544.2001; Zudaire E, 2003, REGUL PEPTIDES, V112, P121, DOI 10.1016/S0167-0115(03)00030-2	41	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120225	10.1371/journal.pone.0120225	http://dx.doi.org/10.1371/journal.pone.0120225			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781901	Green Published, gold, Green Submitted			2022-12-27	WOS:000351284600142
J	Rigalli, JP; Ciriaci, N; Arias, A; Ceballos, MP; Villanueva, SSM; Luquita, MG; Mottino, AD; Ghanem, CI; Catania, VA; Ruiz, ML				Pablo Rigalli, Juan; Ciriaci, Nadia; Arias, Agostina; Paula Ceballos, Maria; Maris Villanueva, Silvina Stella; Gabriel Luquita, Marcelo; Domingo Mottino, Aldo; Ines Ghanem, Carolina; Alicia Catania, Viviana; Laura Ruiz, Maria			Regulation of Multidrug Resistance Proteins by Genistein in a Hepatocarcinoma Cell Line: Impact on Sorafenib Cytotoxicity	PLOS ONE			English	Article							PREGNANE X RECEPTOR; P-GLYCOPROTEIN; DOWN-REGULATION; HEPG2 CELLS; EFFLUX TRANSPORTERS; DRUG-RESISTANCE; HUMAN CYP3A4; EXPRESSION; INDUCTION; BINDING	Hepatocellular carcinoma (HCC) is the fifth most frequent cancer worldwide. Sorafenib is the only drug available that improves the overall survival of HCC patients. P-glycoprotein (P-gp), Multidrug resistance-associated proteins 2 and 3 (MRP2 and 3) and Breast cancer resistance protein (BCRP) are efflux pumps that play a key role in cancer chemoresistance. Their modulation by dietary compounds may affect the intracellular accumulation and therapeutic efficacy of drugs that are substrates of these transporters. Genistein (GNT) is a phytoestrogen abundant in soybean that exerts its genomic effects through Estrogen-Receptors and Pregnane-X-Receptor (PXR), which are involved in the regulation of the above-mentioned transporters. We evaluated the effect of GNT on the expression and activity of P-gp, MRP2, MRP3 and BCRP in HCC-derived HepG2 cells. GNT (at 1.0 and 10 mu M) increased P-gp and MRP2 protein expression and activity, correlating well with an increased resistance to sorafenib cytotoxicity as detected by the methylthiazole tetrazolium (MTT) assay. GNT induced P-gp and MRP2 mRNA expression at 10 but not at 1.0 mu M concentration suggesting a different pattern of regulation depending on the concentration. Induction of both transporters by 1.0 mu M GNT was prevented by cycloheximide, suggesting translational regulation. Downregulation of expression of the miR-379 by GNT could be associated with translational regulation of MRP2. Silencing of PXR abolished P-gp induction by GNT (at 1.0 and 10 mu M) and MRP2 induction by GNT (only at 10 mu M), suggesting partial mediation of GNT effects by PXR. Taken together, the data suggest the possibility of nutrient-drug interactions leading to enhanced chemoresistance in HCC when GNT is ingested with soy rich diets or dietary supplements.	[Pablo Rigalli, Juan; Ciriaci, Nadia; Arias, Agostina; Paula Ceballos, Maria; Maris Villanueva, Silvina Stella; Gabriel Luquita, Marcelo; Domingo Mottino, Aldo; Alicia Catania, Viviana; Laura Ruiz, Maria] Rosario Natl Univ, Fac Biochem & Pharmaceut Sci, Inst Expt Physiol IFISE CONICET, Rosario, Argentina; [Ines Ghanem, Carolina] Univ Buenos Aires, Fac Pharm & Biochem, Inst Pharmacol Invest ININFA CONICET, Buenos Aires, DF, Argentina	National University of Rosario; University of Buenos Aires	Ruiz, ML (corresponding author), Rosario Natl Univ, Fac Biochem & Pharmaceut Sci, Inst Expt Physiol IFISE CONICET, Rosario, Argentina.	ruiz@ifise-conicet.gov.ar	Rigalli, Juan Pablo/E-2099-2018	Rigalli, Juan Pablo/0000-0003-4168-9396; Ghanem, Carolina Ines/0000-0002-7426-459X; Ciriaci, Nadia/0000-0001-9786-8452	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT0360, PICT1503]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP0240]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by grants from Agencia Nacional de Promocion Cientifica y Tecnologica [PICT0360 (VAC) and PICT1503 (MLR)] and Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP0240 (ADM)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achira M, 1999, AAPS PHARMSCI, V1; Adlercreutz H, 2002, LANCET ONCOL, V3, P364, DOI 10.1016/S1470-2045(02)00777-5; Anwar SL, 2014, WORLD J GASTROENTERO, V20, P7894, DOI 10.3748/wjg.v20.i24.7894; Arias A, 2014, TOXICOLOGY, V320, P46, DOI 10.1016/j.tox.2014.03.007; BARNES S, 1995, J NUTR, V125, pS777, DOI 10.1093/jn/125.3_Suppl.777S; Barone Michele, 2012, J Gastrointest Cancer, V43, P13, DOI 10.1007/s12029-011-9332-7; Borst P, 2006, CANCER LETT, V234, P51, DOI 10.1016/j.canlet.2005.05.051; Cao Y, 2009, J EXPO SCI ENV EPID, V19, P223, DOI 10.1038/jes.2008.44; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Cui PH, 2013, BIOCHEM PHARMACOL, V86, P419, DOI 10.1016/j.bcp.2013.05.014; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Floyd KA, 2011, EXP EYE RES, V92, P120, DOI 10.1016/j.exer.2010.12.006; Folmer Y, 2007, CANCER GENE THER, V14, P875, DOI 10.1038/sj.cgt.7701082; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Geick A, 2001, J Biol Chem, V276, P14581; Ghassabian S, 2012, BIOCHEM PHARMACOL, V84, P215, DOI 10.1016/j.bcp.2012.04.001; Haenisch S, 2011, MOL PHARMACOL, V80, P314, DOI 10.1124/mol.110.070714; Herzog M, 2011, N-S ARCH PHARMACOL, V383, P1, DOI 10.1007/s00210-010-0568-8; Hishida M, 2013, INT J ONCOL, V43, P88, DOI 10.3892/ijo.2013.1951; Iyer R, 2010, EXPERT OPIN PHARMACO, V11, P1943, DOI 10.1517/14656566.2010.496453; Jansson MD, 2012, MOL ONCOL, V6, P590, DOI 10.1016/j.molonc.2012.09.006; Keubler A, 2012, DRUG METAB DISPOS, V40, P1178, DOI 10.1124/dmd.111.043844; Klaassen CD, 2010, PHARMACOL REV, V62, P1, DOI 10.1124/pr.109.002014; Kohle C, 2009, BIOCHEM PHARMACOL, V77, P689, DOI 10.1016/j.bcp.2008.05.020; Kool M, 1999, P NATL ACAD SCI USA, V96, P6914, DOI 10.1073/pnas.96.12.6914; Korita PV, 2010, ONCOL REP, V23, P965, DOI 10.3892/or_00000721; Kovalchuk O, 2008, MOL CANCER THER, V7, P2152, DOI 10.1158/1535-7163.MCT-08-0021; Kubitz R, 2005, METHOD ENZYMOL, V400, P542, DOI 10.1016/S0076-6879(05)00030-3; Lagas JS, 2010, MOL CANCER THER, V9, P319, DOI 10.1158/1535-7163.MCT-09-0663; Ruiz ML, 2013, BIOCHEM PHARMACOL, V86, P401, DOI 10.1016/j.bcp.2013.05.025; Li HY, 2012, HEPATO-GASTROENTEROL, V59, P2238, DOI 10.5754/hge11781; Li LH, 2009, PHARM RES-DORDR, V26, P872, DOI 10.1007/s11095-008-9788-8; Li YL, 2009, J NUTR, V139, P898, DOI 10.3945/jn.108.103572; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Ma J, 2013, CURR DRUG TARGETS, V14, P1150, DOI 10.2174/13894501113149990187; Manov I, 2007, J PHARMACOL EXP THER, V322, P1013, DOI 10.1124/jpet.107.121772; Martins Rute, 2012, PLoS One, V7, pe35461, DOI 10.1371/journal.pone.0035461; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Nies AT, 2007, PFLUG ARCH EUR J PHY, V453, P643, DOI 10.1007/s00424-006-0109-y; Rigalli JP, 2011, TOXICOLOGY, V285, P18, DOI 10.1016/j.tox.2011.03.015; Peck-Radosavljevic M, 2014, LIVER CANCER, V3, P125, DOI 10.1159/000343868; Rigalli JP, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001951; Roma MG, 2008, WORLD J GASTROENTERO, V14, P6786, DOI 10.3748/wjg.14.6786; Salleh N, 2013, INT J MED SCI, V10, P665, DOI 10.7150/ijms.5207; Schinkel AH, 2003, ADV DRUG DELIVER REV, V55, P3, DOI 10.1016/S0169-409X(02)00169-2; Shibayama Y, 2011, BIOL PHARM BULL, V34, P433, DOI 10.1248/bpb.34.433; SORMUNEN R, 1993, LAB INVEST, V68, P652; Sun L, 2013, MOL MED REP, V8, P1883, DOI 10.3892/mmr.2013.1742; Tu CC, 2013, J MOL ENDOCRINOL, V51, P203, DOI 10.1530/JME-13-0085; van Rooij E, 2011, CIRC RES, V108, P219, DOI 10.1161/CIRCRESAHA.110.227496; Vore M, 2011, FASEB J, V25; Wang H, 2013, PHYTOMEDICINE, V20, P985, DOI 10.1016/j.phymed.2013.04.014; Weiss J, 2003, J PHARMACOL EXP THER, V305, P197, DOI 10.1124/jpet.102.046532; Yang T, 2013, EXP BIOL MED, V238, P1024, DOI 10.1177/1535370213497321; Ye L, 2013, TOXICOL LETT, V216, P86, DOI 10.1016/j.toxlet.2012.11.011; Zhang T, 2013, BRIT J NUTR, V109, P223, DOI 10.1017/S0007114512001110	56	54	58	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119502	10.1371/journal.pone.0119502	http://dx.doi.org/10.1371/journal.pone.0119502			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781341	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600069
J	Pohl, P; Sandlund, M; Ahlgren, C; Bergvall-Kareborn, B; Lundin-Olsson, L; Wikman, AM				Pohl, Petra; Sandlund, Marlene; Ahlgren, Christina; Bergvall-Kareborn, Birgitta; Lundin-Olsson, Lillemor; Wikman, Anita Melander			Fall Risk Awareness and Safety Precautions Taken by Older Community-Dwelling Women and Men-A Qualitative Study Using Focus Group Discussions	PLOS ONE			English	Article							PREVENTION PROGRAMS; SELF-MANAGEMENT; ADULTS; CIRCUMSTANCES; CONSEQUENCES; EXPERIENCES; PERCEPTION; EXERCISE; PEOPLE; GENDER	Introduction Daily life requires frequent estimations of the risk of falling and the ability to avoid a fall. The objective of this study was to explore older women's and men's understanding of fall risk and their experiences with safety precautions taken to prevent falls. Methods A qualitative study with focus group discussions was conducted. Eighteen community-dwelling people [10 women and 8 men] with and without a history of falls were purposively recruited. Participants were divided into two groups, and each group met four times. A participatory and appreciative action and reflection approach was used to guide the discussions. All discussions were audio recorded and transcribed verbatim. Data were analysed by qualitative content analysis, and categories were determined inductively. Findings Three categories describing the process of becoming aware of fall risks in everyday life were identified: 1] Facing various feelings, 2] Recognizing one's fall risk, and 3] Taking precautions. Each category comprised several subcategories. The comprehensive theme derived from the categories was "Safety precautions through fall risk awareness". Three strategies of ignoring [continuing a risky activity], gaining insight [realizing the danger in a certain situation], and anticipating [thinking ahead and acting in advance] were related to all choices of actions and could fluctuate in the same person in different contexts. Conclusions The fall risk awareness process might be initiated for various reasons and can involve different feelings and precautions as well as different strategies. This finding highlights that there are many possible channels to reach older people with information about fall risk and fall prevention, including the media and their peers. The findings offer a deeper understanding of older peoples' conceptualizations about fall risk awareness and make an important contribution to the development and implementation of fall prevention programmes.	[Pohl, Petra; Sandlund, Marlene; Ahlgren, Christina; Lundin-Olsson, Lillemor] Umea Univ, Dept Community Med & Rehabil, Physiotherapy, S-90187 Umea, Sweden; [Bergvall-Kareborn, Birgitta] Lulea Univ Technol, Dept Business Adm Technol & Social Sci, S-97187 Lulea, Sweden; [Wikman, Anita Melander] Lulea Univ Technol, Dept Hlth Sci, Div Hlth & Rehabil, S-97187 Lulea, Sweden	Umea University; Lulea University of Technology; Lulea University of Technology	Pohl, P (corresponding author), Umea Univ, Dept Community Med & Rehabil, Physiotherapy, S-90187 Umea, Sweden.	Petra.Pohl@umu.se		Melander Wikman, Anita/0000-0002-8052-6680	Swedish Research Council [521-2011-3250]; Strategic Research Area for Care Sciences (SRA-C) and Umea University; King Gustav V's and Queen Victoria's Freemasons Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Strategic Research Area for Care Sciences (SRA-C) and Umea University; King Gustav V's and Queen Victoria's Freemasons Foundation	This work was supported by the Swedish Research Council (grant number 521-2011-3250), the Strategic Research Area for Care Sciences (SRA-C) and Umea University, and the King Gustav V's and Queen Victoria's Freemasons Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvesson M, 2011, QUALITATIVE RESEARCH; Ambrose AF, 2013, MATURITAS, V75, P51, DOI 10.1016/j.maturitas.2013.02.009; Ayalon L, 2013, EDUC GERONTOL, V39, P888, DOI 10.1080/03601277.2013.767620; Baltes PB, 1990, SUCCESSFUL AGING PER; Berg WP, 1997, AGE AGEING, V26, P261, DOI 10.1093/ageing/26.4.261; Connell BR, 1997, ARCH PHYS MED REHAB, V78, P179, DOI 10.1016/S0003-9993(97)90261-6; Cooperrider DL, 2005, APPRECIATIVE INQUIRY; Courtenay WH, 2000, SOC SCI MED, V50, P1385, DOI 10.1016/S0277-9536(99)00390-1; Deandrea S, 2010, EPIDEMIOLOGY, V21, P658, DOI 10.1097/EDE.0b013e3181e89905; Finucane ML, 2008, J RISK RES, V11, P983, DOI 10.1080/13669870802261595; Fiske ST, 2002, J PERS SOC PSYCHOL, V82, P878, DOI 10.1037//0022-3514.82.6.878; Ghaye T, 2008, REFLECT PRACT, V9, P361, DOI 10.1080/14623940802475827; Gillespie LD, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007146.pub2; Gopaul K, 2012, PHYS OCCUP THER GERI, V30, P53, DOI 10.3109/02703181.2011.649230; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Grove LJ, 2009, CLIN NURSE SPEC, V23, P25, DOI 10.1097/01.NUR.0000343080.57838.2f; Gustafson PE, 1998, RISK ANAL, V18, P805, DOI 10.1023/B:RIAN.0000005926.03250.c0; Hallrup LB, 2009, HEALTH SOC CARE COMM, V17, P379, DOI 10.1111/j.1365-2524.2008.00836.x; Host D, 2011, SCAND J PUBLIC HEALT, V39, P742, DOI 10.1177/1403494811421639; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Lang FR, 2002, J GERONTOL B-PSYCHOL, V57, pP501, DOI 10.1093/geronb/57.6.P501; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; Lorig KR, 2003, ANN BEHAV MED, V26, P1, DOI 10.1207/S15324796ABM2601_01; McInnes Elizabeth, 2004, Worldviews Evid Based Nurs, V1, P20, DOI 10.1111/j.1741-6787.2004.04013.x; McMahon S, 2011, INT J OLDER PEOPLE N, V6, P289, DOI 10.1111/j.1748-3743.2011.00299.x; Murphy SL, 2002, J AM GERIATR SOC, V50, P516, DOI 10.1046/j.1532-5415.2002.50119.x; Ohman A, 2005, J REHABIL MED, V37, P273, DOI 10.1080/16501970510040056; Robinson L, 2014, DISABIL REHABIL, V36, P379, DOI 10.3109/09638288.2013.797507; Rolison JJ, 2014, J GERONTOL B-PSYCHOL, V69, P870, DOI 10.1093/geronb/gbt081; Rush KL, 2012, J AGING STUD, V26, P448, DOI 10.1016/j.jaging.2012.06.004; Scheffer AC, 2008, AGE AGEING, V37, P19, DOI 10.1093/ageing/afm169; Simpson JM, 2003, BR J COMMUNITY NURS, V8, P154; Skelton DA, 2003, SCAND J MED SCI SPOR, V13, P77, DOI 10.1034/j.1600-0838.2003.00300.x; Slovic P, 2004, RISK ANAL, V24, P311, DOI 10.1111/j.0272-4332.2004.00433.x; Thatchenkery T, 2007, NEW HORIZ MANAG, P1; Tinetti ME, 2010, JAMA-J AM MED ASSOC, V303, P258, DOI 10.1001/jama.2009.2024; Tomioka K, 2011, J EPIDEMIOL, V21, P459, DOI 10.2188/jea.JE20110003; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042	40	24	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119630	10.1371/journal.pone.0119630	http://dx.doi.org/10.1371/journal.pone.0119630			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7QC	25781181	Green Published, gold			2022-12-27	WOS:000351284600078
J	Varnet, L; Knoblauch, K; Serniclaes, W; Meunier, F; Hoen, M				Varnet, Leo; Knoblauch, Kenneth; Serniclaes, Willy; Meunier, Fanny; Hoen, Michel			A Psychophysical Imaging Method Evidencing Auditory Cue Extraction during Speech Perception: A Group Analysis of Auditory Classification Images	PLOS ONE			English	Article							STOP-CONSONANT PERCEPTION; RECEPTIVE-FIELDS; PSYCHOACOUSTIC METHOD; SPECTRAL CONTRAST; PRECEDING LIQUID; COARTICULATION; IDENTIFICATION; COMPENSATION; RECOGNITION; NOISE	Although there is a large consensus regarding the involvement of specific acoustic cues in speech perception, the precise mechanisms underlying the transformation from continuous acoustical properties into discrete perceptual units remains undetermined. This gap in knowledge is partially due to the lack of a turnkey solution for isolating critical speech cues from natural stimuli. In this paper, we describe a psychoacoustic imaging method known as the Auditory Classification Image technique that allows experimenters to estimate the relative importance of time-frequency regions in categorizing natural speech utterances in noise. Importantly, this technique enables the testing of hypotheses on the listening strategies of participants at the group level. We exemplify this approach by identifying the acoustic cues involved in da/ga categorization with two phonetic contexts, Al- or Ar-. The application of Auditory Classification Images to our group of 16 participants revealed significant critical regions on the second and third formant onsets, as predicted by the literature, as well as an unexpected temporal cue on the first formant. Finally, through a cluster-based nonparametric test, we demonstrate that this method is sufficiently sensitive to detect fine modifications of the classification strategies between different utterances of the same phoneme.	[Varnet, Leo; Hoen, Michel] CNRS, Lyon Neurosci Res Ctr, Auditory Language Proc ALP Res Grp, UMR 5292, Lyon, France; [Knoblauch, Kenneth] INSERM, Stem Cell & Brain Res Inst, Integrat Neurosci Dept, U846, F-69500 Bron, France; [Varnet, Leo; Meunier, Fanny] CNRS, Lab Langage Cerveau & Cognit, Auditory Language Proc ALP Res Grp, UMR 5304, Lyon, France; [Hoen, Michel] INSERM, U1028, Lyon Neurosci Res Ctr, Brain Dynam & Cognit Team, F-69008 Lyon, France; [Varnet, Leo; Meunier, Fanny; Hoen, Michel] Univ Lyon 1, F-69365 Lyon, France; [Serniclaes, Willy] Univ Libre Bruxelles, UNESCOG, CP191, Brussels, Belgium	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite Libre de Bruxelles	Varnet, L (corresponding author), CNRS, Lyon Neurosci Res Ctr, Auditory Language Proc ALP Res Grp, UMR 5292, Lyon, France.	leo.varnet@isc.cnrs.fr	Michel, Hoen/C-7721-2012; Varnet, Léo/GQQ-5522-2022; Knoblauch, Kenneth/H-8156-2014	Michel, Hoen/0000-0003-2099-8130; Varnet, Léo/0000-0002-9702-2649; Knoblauch, Kenneth/0000-0002-4681-4638; SERNICLAES, WILLY/0000-0002-2047-0718	Ecole Doctorale Neurosciences et Cognition, Lyon-1 University, France; European Research Council [209234]; French National Research Agency (ANR) as part of the "Investissements d'Avenir" program [ANR-10-LABX-0083]	Ecole Doctorale Neurosciences et Cognition, Lyon-1 University, France; European Research Council(European Research Council (ERC)European Commission); French National Research Agency (ANR) as part of the "Investissements d'Avenir" program(French National Research Agency (ANR))	LV is funded by a PhD grant from the Ecole Doctorale Neurosciences et Cognition (http://nsco.universite-lyon.fr/), Lyon-1 University, France. This research was partially supported by a European Research Council (http://erc.europa.eu/) grant for the SpiN project (No. 209234) attributed to FM and by a public grant overseen by the French National Research Agency (ANR) as part of the "Investissements d'Avenir" program (reference: ANR-10-LABX-0083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbey CK, 2006, J VISION, V6, P335, DOI 10.1167/6.4.4; AHUMADA A, 1971, J ACOUST SOC AM, V49, P1751, DOI 10.1121/1.1912577; Ahumada AJ, 2002, J VISION, V2, P121, DOI 10.1167/2.1.8; Ahumada Jr AJ, 1996, ECVP96 ABSTRACTS, DOI [10.1155/2013/627230, DOI 10.1155/2013/627230]; Apoux F, 2009, HEARING RES, V255, P99, DOI 10.1016/j.heares.2009.06.005; Banai K, 2005, J NEUROSCI, V25, P9850, DOI 10.1523/JNEUROSCI.2373-05.2005; Bouet R, 2004, VISUAL NEUROSCI, V21, P283, DOI 10.1017/S0952523804213141; Calabrese A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016104; Chauvin A, 2005, J VISION, V5, P659, DOI 10.1167/5.9.1; Chi T, 2005, J ACOUST SOC AM, V118, P887, DOI 10.1121/1.1945807; DELATTRE PC, 1955, J ACOUST SOC AM, V27, P769, DOI 10.1121/1.1908024; Fant G, 1971, 2 ACOUSTIC THEORY SP; Fowler CA, 2006, PERCEPT PSYCHOPHYS, V68, P161, DOI 10.3758/BF03193666; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gold JM, 2000, CURR BIOL, V10, P663, DOI 10.1016/S0960-9822(00)00523-6; Gold JM, 2004, COGNITIVE SCI, V28, P167, DOI 10.1016/j.cogsci.2003.10.005; Holt LL, 2006, J ACOUST SOC AM, V119, P4016, DOI 10.1121/1.2195119; Holt LL, 2002, HEARING RES, V167, P156, DOI 10.1016/S0378-5955(02)00383-0; Johnson K., 2011, ACOUSTIC AUDITORY PH, V3rd ed.; Johnson KL, 2005, EAR HEARING, V26, P424, DOI 10.1097/01.aud.0000179687.71662.6e; Joosten ERM, 2012, BIOL CYBERN, V106, P465, DOI 10.1007/s00422-012-0510-x; Juneja A, 2012, J ACOUST SOC AM, V131, pEL256, DOI 10.1121/1.3684744; Kingdom F. A. A., 2010, PSYCHOPHYSICS PRACTI; Knoblauch K., 2012, MODELING PSYCHOPHYSI; Knoblauch K, 2008, J VISION, V8, DOI 10.1167/8.16.10; Kurki I, 2014, J VISION, V14, DOI 10.1167/14.11.6; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Li FP, 2012, J ACOUST SOC AM, V132, P2663, DOI 10.1121/1.4747008; Li FP, 2010, J ACOUST SOC AM, V127, P2599, DOI 10.1121/1.3295689; Liberman AM, 1954, PSYCHOL MONOGR-GEN A, V68, P1, DOI 10.1037/h0093673; LIBERMAN AM, 1967, PSYCHOL REV, V74, P431, DOI 10.1037/h0020279; Liu JG, 2014, CORTEX, V53, P60, DOI 10.1016/j.cortex.2014.01.013; Lotto AJ, 1998, PERCEPT PSYCHOPHYS, V60, P602, DOI 10.3758/BF03206049; Machens CK, 2004, J NEUROSCI, V24, P1089, DOI 10.1523/JNEUROSCI.4445-03.2004; MANN VA, 1980, PERCEPT PSYCHOPHYS, V28, P407, DOI 10.3758/BF03204884; MANN VA, 1981, J ACOUST SOC AM, V69, P548, DOI 10.1121/1.385483; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Menoret M, 2014, NEUROPSYCHOLOGIA, V55, P85, DOI 10.1016/j.neuropsychologia.2013.10.001; Mesgarani N, 2014, SCIENCE, V343, P1006, DOI 10.1126/science.1245994; Mesgarani N, 2012, NATURE, V485, P233, DOI 10.1038/nature11020; Mineault PJ, 2009, J VISION, V9, DOI 10.1167/9.10.17; Moore BCJ, 2008, PHILOS T R SOC B, V363, P917, DOI 10.1098/rstb.2007.2195; Nichols TE, 2003, HUMAN BRAIN FUNCTION; Norris D, 2000, BEHAV BRAIN SCI, V23, P299, DOI 10.1017/S0140525X00003241; Obleser J, 2009, TRENDS COGN SCI, V13, P14, DOI 10.1016/j.tics.2008.09.005; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Regnier MS, 2008, J ACOUST SOC AM, V123, P2801, DOI 10.1121/1.2897915; REPP BH, 1981, J ACOUST SOC AM, V69, P1154, DOI 10.1121/1.385695; SEGUI J, 1981, BRIT J PSYCHOL, V72, P471, DOI 10.1111/j.2044-8295.1981.tb01776.x; Slaney M., 1988, LYONS COCHLEAR MODEL, VVolume 13; Sonderegger M., 2010, P 32 ANN M COGN SCI; Stelzer J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00462; Thomas JP, 2005, J OPT SOC AM A, V22, P2257, DOI 10.1364/JOSAA.22.002257; Varnet L, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00865; Viswanathan N, 2010, J EXP PSYCHOL HUMAN, V36, P1005, DOI 10.1037/a0018391; Viswanathan N, 2009, PSYCHON B REV, V16, P74, DOI 10.3758/PBR.16.1.74; Willmore B, 2003, NETWORK-COMP NEURAL, V14, P553, DOI 10.1088/0954-898X/14/3/309; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Woolley SMN, 2006, J NEUROSCI, V26, P2499, DOI 10.1523/JNEUROSCI.3731-05.2006; Wu MCK, 2006, ANNU REV NEUROSCI, V29, P477, DOI 10.1146/annurev.neuro.29.051605.113024; Xu L, 2005, J ACOUST SOC AM, V117, P3255, DOI 10.1121/1.1886405	62	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0118009	10.1371/journal.pone.0118009	http://dx.doi.org/10.1371/journal.pone.0118009			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781470	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600020
J	Castrillo, M; Avalos, J				Castrillo, Marta; Avalos, Javier			The Flavoproteins CryD and VvdA Cooperate with the White Collar Protein WcoA in the Control of Photocarotenogenesis in Fusarium fujikuroi	PLOS ONE			English	Article							DEPENDENT CAROTENOID SYNTHESIS; NEUROSPORA-CRASSA; SCLEROTINIA-SCLEROTIORUM; LIGHT REGULATION; GENE-CLUSTER; BIOSYNTHESIS; MUTANTS; PHOTOLYASE; ENZYMES; DNA	Light stimulates carotenoid biosynthesis in the ascomycete fungus Fusarium fujikuroi through transcriptional activation of the structural genes of the pathway carRA, carB, and cart, but the molecular basis of this photoresponse is unknown. The F. fujikuroi genome contains genes for different predicted photoreceptors, including the WC protein WcoA, the DASH cryptochrome CryD and the Vivid-like flavoprotein VvdA. We formerly found that null mutants of wcoA, cryD or vvdA exhibit carotenoid photoinduction under continuous illumination. Here we show that the wild type exhibits a biphasic response in light induction kinetics experiments, with a rapid increase in carotenoid content in the first hours, a transient arrest and a subsequent slower increase. The mutants of the three photoreceptors show different kinetic responses: the wcoA mutants are defective in the rapid response, the cryD mutants are affected in the slower response, while the fast and slow responses were respectively enhanced and attenuated in the vvdA mutants. Transcriptional analyses of the car genes revealed a strong reduction of dark and light-induced transcript levels in the wcoA mutants, while minor or no reductions were found in the cryD mutants. Formerly, we found no change on carRA and carB photoinduction in vvdA mutants. Taken together, our data suggest a cooperative participation of WcoA and CryD in early and late stages of photoinduction of carotenoid biosynthesis in F. fujikuroi, and a possible modulation of WcoA activity by VvdA. An unexpected transcriptional induction by red light of vvdA, cryD and carRA genes suggest the participation of an additional red light-absorbing photoreceptor.	[Castrillo, Marta; Avalos, Javier] Univ Seville, Dept Genet, Seville, Spain	University of Sevilla	Avalos, J (corresponding author), Univ Seville, Dept Genet, Seville, Spain.	avalos@us.es	Avalos, Javier/B-4218-2011	Avalos, Javier/0000-0001-5484-2893	European funds (European Regional Development Fund, ERDF); Spanish Government (Ministerio de Economia y Competitividad) [BIO2006-01323, BIO2009-11131]; Andalusian Government (Consejeria de Economia, Innovacion, Ciencia y Empleo) [P07-CVI-02813, CTS-6638]	European funds (European Regional Development Fund, ERDF); Spanish Government (Ministerio de Economia y Competitividad)(Spanish Government); Andalusian Government (Consejeria de Economia, Innovacion, Ciencia y Empleo)	This work was supported by European funds (European Regional Development Fund, ERDF), the Spanish Government (Ministerio de Economia y Competitividad, projects BIO2006-01323 and BIO2009-11131), and Andalusian Government (Consejeria de Economia, Innovacion, Ciencia y Empleo, projects P07-CVI-02813 and CTS-6638). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. URLs: European Regional Development Fund: http://ec.europa.eu/regional_policy/thefunds/regional/index_en.cfm, Ministerio de Economia y Competitividad: http://www.mineco.gob.es/, Consejeria de Economia, Innovacion, Ciencia y Empleo: http://www.juntadeandalucia.es/organismos/economiainnovacioncienciayempleo.html.	Adam AL, 2011, FEMS MICROBIOL LETT, V318, P76, DOI 10.1111/j.1574-6968.2011.02241.x; Alejandre-Duran E, 2003, FUNGAL GENET BIOL, V40, P159, DOI 10.1016/S1087-1845(03)00089-6; Arrach N, 2002, MOL GENET GENOMICS, V266, P914, DOI 10.1007/s00438-001-0626-5; Avalos J, 2007, CURR ORG CHEM, V11, P721, DOI 10.2174/138527207780598729; AVALOS J, 1985, APPL ENVIRON MICROB, V49, P187, DOI 10.1128/AEM.49.1.187-191.1985; AVALOS J, 1990, FEMS MICROBIOL LETT, V66, P295; Avalos J., 1987, CURR GENET, V25, P1837, DOI DOI 10.1007/BF00384613; Avalos Javier, 2012, Methods Mol Biol, V898, P263, DOI 10.1007/978-1-61779-918-1_18; Avalos J, 2014, FUNG BIOL-US, P149, DOI 10.1007/978-1-4939-1191-2_8; Avalos J, 2010, FUNGAL GENET BIOL, V47, P930, DOI 10.1016/j.fgb.2010.05.001; BEJARANO ER, 1991, PLANTA, V183, P1, DOI 10.1007/BF00197560; BINDL E, 1970, PLANTA, V94, P156, DOI 10.1007/BF00387760; Castellanos F, 2010, FUNGAL GENET BIOL, V47, P468, DOI 10.1016/j.fgb.2010.02.001; Castrillo M, 2014, FUNGAL GENET BIOL, V71, P9, DOI 10.1016/j.fgb.2014.08.004; Castrillo M, 2013, APPL ENVIRON MICROB, V79, P2777, DOI 10.1128/AEM.03110-12; Chaves I, 2011, ANNU REV PLANT BIOL, V62, P335, DOI 10.1146/annurev-arplant-042110-103759; Corrochano LM, 2007, PHOTOCH PHOTOBIO SCI, V6, P725, DOI 10.1039/b702155k; Corrochano LM, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P417; Desjardins AE, 2007, INT J FOOD MICROBIOL, V119, P47, DOI 10.1016/j.ijfoodmicro.2007.07.024; Diaz-Sanchez V, 2012, APPL ENVIRON MICROB, V78, P7258, DOI 10.1128/AEM.01552-12; Diaz-Sanchez V, 2011, FEBS J, V278, P3164, DOI 10.1111/j.1742-4658.2011.08242.x; Estrada AF, 2008, FUNGAL GENET BIOL, V45, P705, DOI 10.1016/j.fgb.2007.12.003; Froehlich AC, 2010, EUKARYOT CELL, V9, P738, DOI 10.1128/EC.00380-09; Georgiou CD, 2001, MYCOL RES, V105, P1110, DOI 10.1016/S0953-7562(08)61974-7; Godin KS, 2007, RNA BIOL, V4, P69, DOI 10.4161/rna.4.2.4869; He QY, 2005, GENE DEV, V19, P2888, DOI 10.1101/gad.1369605; Hoffmeister D, 2007, NAT PROD REP, V24, P393, DOI 10.1039/b603084j; KLITTICH CJR, 1988, GENETICS, V118, P417; Linden H, 1997, FUNGAL GENET BIOL, V22, P141, DOI 10.1006/fgbi.1997.1013; Linnemannstons P, 2002, MOL GENET GENOMICS, V267, P593, DOI 10.1007/s00438-002-0690-5; LOPEZDIAZ I, 1980, PLANTA, V150, P134, DOI 10.1007/BF00582356; Malzahn E, 2010, CELL, V142, P762, DOI 10.1016/j.cell.2010.08.010; Navarro-Sampedro L, 2008, GENETICS, V178, P171, DOI 10.1534/genetics.107.079582; Pokorny R, 2008, P NATL ACAD SCI USA, V105, P21023, DOI 10.1073/pnas.0805830106; Prado MM, 2004, CURR GENET, V46, P47, DOI 10.1007/s00294-004-0508-6; Prado-Cabrero A, 2007, MOL MICROBIOL, V64, P448, DOI 10.1111/j.1365-2958.2007.05665.x; Proctor RH, 1997, MICROBIOL-SGM, V143, P2583, DOI 10.1099/00221287-143-8-2583; PUNT PJ, 1987, GENE, V56, P117, DOI 10.1016/0378-1119(87)90164-8; Rademacher W., 1997, FUNGAL BIOTECHNOLOGY, P193; RAU W, 1967, PLANTA, V72, P14, DOI 10.1007/BF00388141; RAU W, 1968, PLANTA, V80, P309, DOI 10.1007/BF00392400; Rodriguez-Ortiz R, 2013, MOL GENET GENOMICS, V288, P157, DOI 10.1007/s00438-013-0739-7; Rodriguez-Ortiz R, 2012, FUNGAL GENET BIOL, V49, P684, DOI 10.1016/j.fgb.2012.06.007; Rodriguez-Ortiz R, 2009, APPL ENVIRON MICROB, V75, P405, DOI 10.1128/AEM.01089-08; Ruiz-Roldan MC, 2008, EUKARYOT CELL, V7, P1227, DOI 10.1128/EC.00072-08; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Schmoll M, 2005, EUKARYOT CELL, V4, P1998, DOI 10.1128/EC.4.12.1998-2007.2005; SCHROTT EL, 1980, PLANTA, V150, P174, DOI 10.1007/BF00582363; Schwerdtfeger C, 2003, EMBO J, V22, P4846, DOI 10.1093/emboj/cdg451; Seibel C, 2012, EUKARYOT CELL, V11, P885, DOI 10.1128/EC.05321-11; Selby CP, 2006, P NATL ACAD SCI USA, V103, P17696, DOI 10.1073/pnas.0607993103; Shrode LB, 2001, FUNGAL GENET BIOL, V32, P169, DOI 10.1006/fgbi.2001.1264; Thewes S, 2005, MOL GENET GENOMICS, V274, P217, DOI 10.1007/s00438-005-0015-6; Tudzynski B, 2005, APPL MICROBIOL BIOT, V66, P597, DOI 10.1007/s00253-004-1805-1; Veluchamy S, 2008, FUNGAL GENET BIOL, V45, P1265, DOI 10.1016/j.fgb.2008.06.004; Wiemann P, 2009, MOL MICROBIOL, V72, P931, DOI 10.1111/j.1365-2958.2009.06695.x; Youssar L, 2005, MOL MICROBIOL, V55, P828, DOI 10.1111/j.1365-2958.2004.04424.x	57	21	24	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119785	10.1371/journal.pone.0119785	http://dx.doi.org/10.1371/journal.pone.0119785			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774802	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500122
J	Chen, M; Hu, P; Ling, N; Peng, H; Lei, Y; Hu, HD; Zhang, DZ; Ren, H				Chen, Min; Hu, Peng; Ling, Ning; Peng, Hui; Lei, Yu; Hu, Huaidong; Zhang, Dazhi; Ren, Hong			Enhanced Functions of Peripheral gamma delta T Cells in Chronic Hepatitis B Infection during Interferon alpha Treatment In Vivo and In Vitro	PLOS ONE			English	Article							VIRUS; RECEPTOR; THERAPY; REPLICATION; ACTIVATION; PLASTICITY; RESPONSES; SUBSETS; INNATE; INJURY	Background gamma delta T cells play an important role in infectious, autoimmune, or neoplastic diseases. Here, a study was conducted to investigate the dynamic changes in phenotype and function of peripheral gamma delta T cells in patients with chronic hepatitis B (CHB) during pegylated-interferon (pegIFN)-alpha treatment, and to explore their roles in IFN-alpha therapy. Methods Total 15 CHB patients with pegIFN-alpha therapy and 6 healthy controls (HC) were enrolled in this study. Flow cytometry was used for the study of frequency of peripheral gamma delta T cells, subtypes, effector or memory gamma delta T cells, and also the IFN-gamma+, TNF-alpha+, CD107a+ or Granzyme B+ gamma delta T cells in 10 patients at week 0, 4, 8, 12, 24, 36 and 48 of treatment. Another 5 CHB patients and 6 HC were recruited for the gamma delta T cell isolation, and gene expression in gamma delta T cells was evaluated before or after IFN-alpha treatment in vitro. Results Although gamma delta T cells decreased in CHB patients during pegIFN-alpha therapy, their capacities to produce TNF-alpha and to express CD107a were enhanced. More effector gamma delta T cells (CD27-CD45RA+) were found in the response group than in non-response group. Furthermore, IFN-alpha boosted the expression of Mx2 and cytokine genes in gamma delta T cells from CHB patients in vitro. Conclusion IFN-alpha could enhance the cytokine production or cytotoxicity potential of gamma delta T cells in vivo and in vitro. The enhanced function of gamma delta T cells might contribute to the effect of IFN-alpha treatment.	[Chen, Min; Hu, Peng; Ling, Ning; Lei, Yu; Hu, Huaidong; Zhang, Dazhi; Ren, Hong] Chongqing Med Univ, Affiliated Hosp 2, Key Lab Mol Biol Infect Dis, Inst Viral Hepatitis,Minist Educ, Chongqing, Peoples R China; [Peng, Hui] Chongqing Med Univ, Affiliated Hosp 2, Dept Lab Med, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Chen, M (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Key Lab Mol Biol Infect Dis, Inst Viral Hepatitis,Minist Educ, Chongqing, Peoples R China.	chenggming@aliyun.com; renhong0531@vip.sina.com.cn	Ling, Ning/AAF-3633-2019	Ling, Ning/0000-0003-1250-4073	National Natural Science Foundation of China [30901264]; National Science and Technology Major Project of China [2012ZX1002007001, 2011ZX09302005, 2012ZX09303001-001, 2012ZX10002003]; Medical Science Foundation Project of Health Bureau of Chongqing Province [2011-2-152]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project of China; Medical Science Foundation Project of Health Bureau of Chongqing Province	This work was supported by the National Natural Science Foundation of China (30901264), http://www.nsfc.gov.cn/, to Min Chen; the National Science and Technology Major Project of China (2012ZX1002007001, 2011ZX09302005, 2012ZX09303001-001, 2012ZX10002003), http://www.nmp.gov.cn/, to Hong Ren, and the Medical Science Foundation Project of Health Bureau of Chongqing Province (2011-2-152), http://www.cqwsjsw.gov.cn/, to Hui Peng. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlenstiel G, 2011, GASTROENTEROLOGY, V141, P1231, DOI 10.1053/j.gastro.2011.06.069; Ajuebor MN, 2008, J VIROL, V82, P9564, DOI 10.1128/JVI.00927-08; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Angelini DF, 2004, BLOOD, V104, P1801, DOI 10.1182/blood-2004-01-0331; Barcy S, 2008, J IMMUNOL, V180, P3417, DOI 10.4049/jimmunol.180.5.3417; Belloni L, 2012, J CLIN INVEST, V122, P529, DOI 10.1172/JCI58847; Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; BRINKMANN V, 1993, J EXP MED, V178, P1655, DOI 10.1084/jem.178.5.1655; Carding SR, 2002, NAT REV IMMUNOL, V2, P336, DOI 10.1038/nri797; Chen CY, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003501; Chen M, 2008, J INFECT DIS, V198, P1643, DOI 10.1086/593065; Chen M, 2012, J CLIN IMMUNOL, V32, P877, DOI 10.1007/s10875-012-9678-z; CHRISTMAS SE, 1990, IMMUNOLOGY, V71, P486; Cimini E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037014; Craxi A, 2003, ANTIVIR RES, V60, P87, DOI 10.1016/j.antiviral.2003.08.015; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; Di Mitri D, 2011, J IMMUNOL, V187, P2093, DOI 10.4049/jimmunol.1100978; Dill MT, 2014, J CLIN INVEST, V124, P1568, DOI 10.1172/JCI70408; Gioia C, 2002, J IMMUNOL, V168, P1484, DOI 10.4049/jimmunol.168.3.1484; Girardi M, 2006, J INVEST DERMATOL, V126, P25, DOI 10.1038/sj.jid.5700003; Goujon C, 2013, NATURE, V502, P559, DOI 10.1038/nature12542; Li N, 2012, HEPATOLOGY, V56, P803, DOI 10.1002/hep.25608; Liang TJ, 2009, HEPATOLOGY, V49, pS13, DOI 10.1002/hep.22881; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Lopez RD, 2002, IMMUNOL RES, V26, P207, DOI 10.1385/IR:26:1-3:207; Luoma AM, 2013, IMMUNITY, V39, P1032, DOI 10.1016/j.immuni.2013.11.001; Micco L, 2013, J HEPATOL, V58, P225, DOI 10.1016/j.jhep.2012.09.029; Parmar Simrit, 2003, Current Opinion in Oncology, V15, P431, DOI 10.1097/00001622-200311000-00005; Pinheiro MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050923; Qin G, 2012, J INFECT DIS, V205, P1646, DOI 10.1093/infdis/jis253; Siegers GM, 2014, MOL THER, V22, P1416, DOI 10.1038/mt.2014.104; Tan AT, 2008, J GASTROEN HEPATOL, V23, P833, DOI 10.1111/j.1440-1746.2008.05385.x; Trapani JA, 2003, CURR OPIN IMMUNOL, V15, P533, DOI 10.1016/S0952-7915(03)00107-9; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Zhang Z, 2011, HEPATOLOGY, V53, P73, DOI 10.1002/hep.23977	35	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120086	10.1371/journal.pone.0120086	http://dx.doi.org/10.1371/journal.pone.0120086			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774808	Green Submitted, Green Published, gold			2022-12-27	WOS:000351183500149
J	Gantz, L; Schrader, S; Ruben, R; Zivotofsky, AZ				Gantz, Liat; Schrader, Shlomo; Ruben, Ruthie; Zivotofsky, Ari Z.			Can the Red-Green Duochrome Test Be Used Prior to Correcting the Refractive Cylinder Component?	PLOS ONE			English	Article								Purpose A primary task of the eye care professional is determining the refraction, or optical correction, of a patient. The duochrome red-green test is a standard tool for verification of the final refraction. Traditionally, it is recommended for use both prior to and subsequent to determining the cylindrical or astigmatic component of the refraction. In order for it to be effective when used before correcting the cylinder it is necessary that the COLC (Circle of Least Confusion) be on the retina. This study examined whether it is necessarily true that the duochrome response in uncorrected astigmatism will be as trust-worthy as it is with corrected cylinders. Methods The red-green examination was performed monocularly under the following three conditions: a. fully corrected refraction for the subgroup of eyes that had spherical refractions and for the subgroup of eyes with sphero-cylindrical refractions. b. best sphere-only correction without cylinder correction in sphero-cylindrical eyes c. an induced cylinder error in spherical eyes. The interval between the last "red" response and the first "green" response for the right eyes as a group and separately for the physiological cylinder and induced cylinder correction sub-groups was calculated and compared using a paired, two-tailed t-test. Results The intervals between "red" and "green" responses were not significantly different in the population as a whole and in the uncorrected physiological cylinder and induced cylinder subgroups examined. Conclusion Based on the finding that the interval of red-green equality with fully corrected cylinder and without the cylindrical correction are not significantly different, the red-green duochrome test can indeed be used both before and after cylindrical correction.	[Gantz, Liat] Hadassah Acad Coll, Dept Optometry & Vis Sci, Jerusalem, Israel; [Schrader, Shlomo] Bar Ilan Univ, Dept Optometry, Ramat Gan, Israel; [Ruben, Ruthie; Zivotofsky, Ari Z.] Bar Ilan Univ, Leslie & Susan Gonda Goldschmied Multidisciplinar, Ramat Gan, Israel; [Ruben, Ruthie] CUNY Brooklyn Coll, New York, NY USA	Bar Ilan University; Bar Ilan University; City University of New York (CUNY) System	Zivotofsky, AZ (corresponding author), Bar Ilan Univ, Leslie & Susan Gonda Goldschmied Multidisciplinar, Ramat Gan, Israel.	ari.zivotofsky@biu.ac.il		Gantz, Liat/0000-0002-9604-3528	Bar Ilan - Yeshiva University summer internship; National Institute of Psychobiology in Israel (NIPI) Post-Doctoral Fellowship	Bar Ilan - Yeshiva University summer internship; National Institute of Psychobiology in Israel (NIPI) Post-Doctoral Fellowship	R. Ruben's work was supported in part by the Bar Ilan - Yeshiva University summer internship, and L. Gantz was supported by a National Institute of Psychobiology in Israel (NIPI) Post-Doctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham Lekha Mary, 2005, Indian Journal of Ophthalmology, V53, P105; Alpins NA, 1997, J CATARACT REFR SURG, V23, P65, DOI 10.1016/S0886-3350(97)80153-8; Anderson P, 1923, AUSTRALASIAN J OPTOM, V5, P170; Armstrong RA, 2013, OPHTHAL PHYSL OPT, V33, P7, DOI 10.1111/opo.12009; BARANYOVITS PR, 1988, BRIT J OPHTHALMOL, V72, P815, DOI 10.1136/bjo.72.11.815; Bennet A., 1963, OPTICIAN, V146, P291; Borish IM., 1975, CLIN REFRACTION, V3rd ed.; BRINKBO B, 1954, Acta Ophthalmol (Copenh), V32, P585; Chen SI, 2005, OPTOMETRY VISION SCI, V82, P101, DOI 10.1097/01.OPX.0000153251.39450.B4; Elliott DB, 2013, CLIN PROCEDURES PRIM; Error A., 2004, ARCH OPHTHALMOL-CHIC, V122, P495; Grosvenor TP, 2007, PRIMARY CARE OPTOMET; Keiri A., 2007, CLIN OPTICS REFRACTI; Kurtz D, 2003, CLIN PROCEDURES OCUL; Loo A, 1994, AM AC OPT EUR M AMST, P208; Otutu M, 2012, S AFR OPTOM, V71, P32; Pesudovs K, 2004, OPTOMETRY VISION SCI, V81, P554, DOI 10.1097/00006324-200407000-00018; Pointer JS, 2001, OPHTHAL PHYSL OPT, V21, P361, DOI 10.1016/S0275-5408(01)00012-6; RAY WA, 1985, INVEST OPHTH VIS SCI, V26, P1186; Rosa N, 2004, J REFRACT SURG, V20, P478; Rosenfield M, 1995, J Am Optom Assoc, V66, P87; Schwartz G.S., 2006, EYE EXAM COMPLETE GU; SIVAK JG, 1975, AM J OPTOM PHYS OPT, V52, P604; WESTHEIMER G, 1965, ANNU REV PSYCHOL, V16, P359, DOI 10.1146/annurev.ps.16.020165.002043; Wilkinson ME, 2009, ESSENTIAL OPTICS REV; Williamson-Noble F A, 1940, Br J Ophthalmol, V24, P43, DOI 10.1136/bjo.24.1.43	26	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118874	10.1371/journal.pone.0118874	http://dx.doi.org/10.1371/journal.pone.0118874			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775478	Green Published, gold			2022-12-27	WOS:000351183500047
J	Hatzirodos, N; Hummitzsch, K; Irving-Rodgers, HF; Rodgers, RJ				Hatzirodos, Nicholas; Hummitzsch, Katja; Irving-Rodgers, Helen F.; Rodgers, Raymond J.			Transcriptome Comparisons Identify New Cell Markers for Theca Interna and Granulosa Cells from Small and Large Antral Ovarian Follicles	PLOS ONE			English	Article							EXPRESSION; ATRESIA; PURITY; GROWTH	In studies using isolated ovarian granulosa and thecal cells it is important to assess the degree of cross contamination. Marker genes commonly used for granulosa cells include FSHR, CYP19A1 and AMH while CYP17A1 and INSL3 are used for thecal cells. To increase the number of marker genes available we compared expression microarray data from isolated theca interna with that from granulosa cells of bovine small (n = 10 for both theca and granulosa cells; 3-5 mm) and large (n = 4 for both theca and granulosa cells, > 9 mm) antral follicles. Validation was conducted by qRT-PCR analyses. Known markers such as CYP19A1, FSHR and NR5A2 and another 11 genes (LOC404103, MGARP, GLDC, CHST8, CSN2, GPX3, SLC35G1, CA8, CLGN, FAM78A, SLC16A3) were common to the lists of the 50 most up regulated genes in granulosa cells from both follicle sizes. The expression in theca interna was more consistent than in granulosa cells between the two follicle sizes. Many genes up regulated in theca interna were common to both sizes of follicles (MGP, DCN, ASPN, ALDH1A1, COL1A2, FN1, COL3A1, OGN, APOD, COL5A2, IGF2, NID1, LHFP, ACTA2, DUSP12, ACTG2, SPARCL1, FILIP1L, EGFLAM, ADAMDEC1, HPGD, COL12A1, FBLN5, RAMP2, COL15A1, PLK2, COL6A3, LOXL1, RARRES1, FLI1, LAMA2). Many of these were stromal extracellular matrix genes. MGARP, GLDC, CHST8, GPX3 were identified as new potential markers for granulosa cells, while FBLN5, OGN, RAMP2 were significantly elevated in the theca interna.	[Hatzirodos, Nicholas; Hummitzsch, Katja; Rodgers, Raymond J.] Univ Adelaide, Robinson Res Inst, Sch Paediat & Reprod Hlth, Discipline Obstet & Gynaecol, Adelaide, SA 5005, Australia; [Irving-Rodgers, Helen F.] Griffith Univ, Sch Med Sci, Gold Coast, Qld 4222, Australia	Robinson Research Institute; University of Adelaide; Griffith University	Rodgers, RJ (corresponding author), Univ Adelaide, Robinson Res Inst, Sch Paediat & Reprod Hlth, Discipline Obstet & Gynaecol, Adelaide, SA 5005, Australia.	ray.rodgers@adelaide.edu.au	Rodgers, Raymond J/C-3476-2009; Hummitzsch, Katja/K-6940-2013; Irving-Rodgers, Helen/E-3660-2010; Hatzirodos, Nick/K-6939-2013	Hummitzsch, Katja/0000-0001-5023-2668; Hatzirodos, Nick/0000-0002-1342-9741	National Health and Medical Research Council of Autralia; Australian Research Council of Australia; University of Adelaide	National Health and Medical Research Council of Autralia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council of Australia(Australian Research Council); University of Adelaide	Funding provided by National Health and Medical Research Council of Autralia, https://www.nhmrc.gov.au/, Australian Research Council of Australia, http://www.arc.gov.au/ and The University of Adelaide, http://www.adelaide.edu.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao B, 1998, J ANIM SCI, V76, P1903; Christenson LK, 2013, MOL ENDOCRINOL, V27, P1153, DOI 10.1210/me.2013-1093; Conley A, 1997, J STEROID BIOCHEM, V61, P407, DOI 10.1016/S0960-0760(97)80040-4; FADDY MJ, 1995, HUM REPROD, V10, P770, DOI 10.1093/oxfordjournals.humrep.a136036; Ferrero H, 2012, HUM REPROD, V27, P1781, DOI 10.1093/humrep/des096; Hatzirodos N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099706; Hatzirodos N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097489; Hatzirodos N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-40; Hatzirodos N, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-24, 10.1186/1471-2164-15-40]; HILLIER SG, 1981, J ENDOCRINOL, V89, pP3; Hummitzsch K, 2015, ENDOCR REV, V36, P65, DOI 10.1210/er.2014-1079; Hummitzsch K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055578; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irving-Rodgers HF, 2002, BIOL REPROD, V66, P934, DOI 10.1095/biolreprod66.4.934; Irving-Rodgers HF, 2001, REPRODUCTION, V122, P761, DOI 10.1530/rep.0.1220761; Ito K, 2002, FERTIL STERIL, V78, P205, DOI 10.1016/S0015-0282(02)03197-7; KATAOKA N, 1994, J REPROD FERTIL, V102, P73, DOI 10.1530/jrf.0.1020073; Li SKB, 2000, J BIOCHEM BIOPH METH, V45, P169, DOI 10.1016/S0165-022X(00)00107-X; Shyh-Chang N, 2013, SCIENCE, V339, P222, DOI 10.1126/science.1226603; ROBERTS AJ, 1990, ENDOCRINOLOGY, V127, P2907, DOI 10.1210/endo-127-6-2907; Rodgers RJ, 2010, REPRODUCTION, V139, P309, DOI 10.1530/REP-09-0177; Satchell L, 2013, ENDOCRINOLOGY, V154, P1897, DOI 10.1210/en.2012-2232; Nguyen T, 2012, MOL CELL ENDOCRINOL, V363, P62, DOI 10.1016/j.mce.2012.07.009; Young JM, 2010, REPRODUCTION, V140, P489, DOI 10.1530/REP-10-0094; Zhou MX, 2011, ENDOCRINOLOGY, V152, P2311, DOI 10.1210/en.2011-0050	25	44	51	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119800	10.1371/journal.pone.0119800	http://dx.doi.org/10.1371/journal.pone.0119800			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775029	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500124
J	Khatri, C; Chapman, SJ; Glasbey, J; Kelly, M; Nepogodiev, D; Bhangu, A; Fitzgerald, JE				Khatri, Chetan; Chapman, Stephen J.; Glasbey, James; Kelly, Michael; Nepogodiev, Dmitri; Bhangu, Aneel; Fitzgerald, J. Edward		STARSurg Comm	Social Media and Internet Driven Study Recruitment: Evaluating a New Model for Promoting Collaborator Engagement and Participation	PLOS ONE			English	Article							CLINICAL-TRIAL; EDUCATION; FACEBOOK; PROGRAM; IMPACT; UK	Aims A substantial challenge facing multicentre audit and research projects is timely recruitment of collaborators and their study centres. Cost-effective strategies are required and fee-free social media has previously been identified as a potential conduit. We investigated and evaluated the effectiveness of a novel multi-format social media and Internet strategy for targeted recruitment to a national multicentre cohort study. Methods Interventions involved a new Twitter account, including weekly live question-and-answer sessions, a new Facebook group page, online YouTube presentations and an information page on a national association website. Link tracking analysis was undertaken using Google Analytics, which was then related to subsequent registration. Social influence was calculated using the proprietary Klout score. Results Internet traffic analysis identified a total of 1562 unique registration site views, of which 285 originated from social media (18.2%). Some 528 unique registrations were received, with 96 via social media platforms (18.2%). Traffic source analysis identified a separate national association webpage as resulting in the majority of registration page views (15.8%), followed by Facebook (11.9%), Twitter (4.8%) and YouTube (1.5%). A combination of publicity through Facebook, Twitter and the dedicated national association webpage contributed to the greatest rise in registration traffic and accounted for 312 (48%) of the total registrations within a 2-week period. A Twitter 'social influence' (Klout) score of 42/100 was obtained during this period. Conclusions Targeted social media substantially aided study dissemination and collaborator recruitment. It acted as an adjunct to traditional methods, accounting for 18.2% of collaborator registration in a short time period with no associated financial costs. We provide a practical model for designing future recruitment campaigns, and recommend Facebook, Twitter and targeted websites as the most effective adjuncts for maximising cost-effective study recruitment.	[Khatri, Chetan] Univ London Imperial Coll Sci Technol & Med, Sch Med, London, England; [Chapman, Stephen J.] Univ Leeds, Leeds, W Yorkshire, England; [Glasbey, James] Cardiff Univ, Sch Med, Cardiff CF10 3AX, S Glam, Wales; [Kelly, Michael] Univ Liverpool, Sch Med, Liverpool L69 3BX, Merseyside, England; [Nepogodiev, Dmitri] Norwich Acad Fdn Programme, Norwich, Norfolk, England; [Bhangu, Aneel] Univ Birmingham, Old Queen Elizabeth Hosp, Acad Dept Surg, Coll Med & Dent Sci, Birmingham B15 2TH, W Midlands, England; [Fitzgerald, J. Edward] UCL, London, England	Imperial College London; University of Leeds; Cardiff University; University of Liverpool; University of Birmingham; University of London; University College London	Fitzgerald, JE (corresponding author), UCL, London, England.	james.fitzgerald.11@ucl.ac.uk	Nepogodiev, Dmitri/J-1041-2019; Chapman, Stephen J/I-2171-2019; Glasbey, James/I-2457-2019; Fitzgerald, James/F-2565-2013	Nepogodiev, Dmitri/0000-0002-2171-2862; Chapman, Stephen J/0000-0003-2413-5690; Glasbey, James/0000-0001-7688-5018; Fitzgerald, James/0000-0002-4453-5117; Khatri, Chetan/0000-0002-3961-1314	Association of Surgeons in Training (ASiT); National Institute for Health Research [ACF-2014-09-010] Funding Source: researchfish	Association of Surgeons in Training (ASiT); National Institute for Health Research(National Institute for Health Research (NIHR))	The Royal College of Surgeons (England) provided the venue for the national collaborators' meeting free of charge. A Regional Event Grant was received from the Association of Surgeons in Training (ASiT) as a contribution to the costs of the national collaborators' meeting. No further funding was applied for or received. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhangu A, 2013, LANCET, V382, P1091, DOI 10.1016/S0140-6736(13)62013-9; Bhatnagar S, 2014, CLIN PEDIATR, V53, P151, DOI 10.1177/0009922813506961; Bhangu A, 2014, BRIT J SURG, V101, P1413, DOI 10.1002/bjs.9614; Cork N, 2014, LANCET, V384, P1575, DOI 10.1016/S0140-6736(14)61983-8; Fenner Y, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1978; Frandsen M, 2014, NICOTINE TOB RES, V16, P247, DOI 10.1093/ntr/ntt157; Godino L, 2013, J ADV NURS, V69, P1125, DOI 10.1111/j.1365-2648.2012.06103.x; Kapp JM, 2013, J CANCER EDUC, V28, P134, DOI 10.1007/s13187-012-0443-z; Kendall B, 2012, CLIN TRIALS, V9, P358, DOI 10.1177/1740774512440760; Leonard A, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-23; Mapstone J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000013.pub3; McDonald AM, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-9; Menon U, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2079; Nepogodiev D, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005164; O'Connor A, 2014, J ADV NURS, V70, P599, DOI 10.1111/jan.12222; Ramo DE, 2010, NICOTINE TOB RES, V12, P768, DOI 10.1093/ntr/ntq086; Richiardi L, 2012, EPIDEMIOLOGY, V23, P175, DOI 10.1097/EDE.0b013e31823b5ee4; Sadler GR, 2007, CONTEMP CLIN TRIALS, V28, P423, DOI 10.1016/j.cct.2006.11.006; Robinson JL, 2007, PREV MED, V44, P499, DOI 10.1016/j.ypmed.2007.03.004; Rubin RR, 2002, CONTROL CLIN TRIALS, V23, P157; Ryan Gemma Sinead, 2013, Nurse Res, V21, P35, DOI 10.7748/nr2013.09.21.1.35.e302; Ryan T, 2011, COMPUT HUM BEHAV, V27, P1658, DOI 10.1016/j.chb.2011.02.004; Sandars J, 2007, POSTGRAD MED J, V83, P759, DOI 10.1136/pgmj.2007.063123; Treweek S, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-436; Treweek S, 2010, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000013.pub5, 10.1002/14651858.MR000013.pub4]; von Muhlen M, 2012, J AM MED INFORM ASSN, V19, P777, DOI 10.1136/amiajnl-2012-000990; Watson Judith M, 2006, BMC Med Res Methodol, V6, P34, DOI 10.1186/1471-2288-6-34	27	81	81	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118899	10.1371/journal.pone.0118899	http://dx.doi.org/10.1371/journal.pone.0118899			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD6EY	25775005	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000351183500052
J	Marra, A; Mona, S; Sa, RM; D'Onghia, G; Maiorano, P				Marra, Annamaria; Mona, Stefano; Sa, Rui M.; D'Onghia, Gianfranco; Maiorano, Porzia			Population Genetic History of Aristeus antennatus (Crustacea: Decapoda) in the Western and Central Mediterranean Sea	PLOS ONE			English	Article							RED SHRIMP; BATHYMETRIC PATTERNS; MITOCHONDRIAL-DNA; BALEARIC-ISLANDS; RISSO; DYNAMICS; BLUE; DIVERGENCE; ATLANTIC; CLIMATE	Aristeus antennatus is an ecologically and economically important deep-water species in the Mediterranean Sea. In this study we investigated the genetic variability of A. antennatus sampled from 10 sampling stations in the Western and Central Mediterranean. By comparing our new samples with available data from the Western area, we aim to identify potential genetic stocks of A. antennatus and to reconstruct its historical demography in the Mediterranean. We analyzed two regions of mitochondrial DNA in 319 individuals, namely COI and 16S. We found two main results: i) the genetic diversity values consistent with previous data within the Mediterranean and the absence of barriers to gene flow within the Mediterranean Sea; ii) a constant long-term effective population size in almost all demes but a strong signature of population expansion in the pooled sample about 50,000 years B.P./ago. We propose two explanation for our results. The first is based on the ecology of A. antennatus. We suggest the existence of a complex meta-population structured into two layers: a deeper-dwelling stock, not affected by fishing, which preserves the pattern of historical demography; and genetically homogeneous demes inhabiting the fishing grounds. The larval dispersal, adult migration and continuous movements of individuals from "virgin" deeper grounds not affected by fishing to upper fishing areas support an effective 'rescue effect' contributing to the recovery of the exploited stocks and explain their genetic homogeneity throughout the Mediterranean Sea. The second is based on the reproduction model of this shrimp: the high variance in offspring production calls for a careful interpretation of the data observed under classical population genetics and Kingman's coalescent. In both cases, management policies for A. antennatus will therefore require careful evaluation of the meta-population dynamics of all stocks in the Mediterranean. In the future, it will be particularly relevant to sample the deepest ones directly.	[Marra, Annamaria; D'Onghia, Gianfranco; Maiorano, Porzia] Univ Bari, Dept Biol, Bari, Italy; [Mona, Stefano] Ecole Prat Hautes Etud, Lab Biol Integrat Populat, Paris, France; [Sa, Rui M.] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales	Universita degli Studi di Bari Aldo Moro; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Cardiff University	Marra, A (corresponding author), Univ Bari, Dept Biol, Bari, Italy.	annamaria.annina.marra@gmail.com	Mona, Stefano/AAF-5061-2019; Sá, Rui M./AAG-4028-2019	Sá, Rui M./0000-0001-6407-4541; Maiorano, Porzia/0000-0001-5737-3025; Mona, Stefano/0000-0001-9087-0656				[Anonymous], 2008, STATUS DEEP SEA RED, P392; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beaumont MA, 2002, GENETICS, V162, P2025; Bertorelle G, 2010, MOL ECOL, V19, P2609, DOI 10.1111/j.1365-294X.2010.04690.x; Bertrand Jacques A., 2000, IFREMER Actes de Colloques, V26, P76; Bianchi CN, 2007, HYDROBIOLOGIA; Borsa P, 1997, MAR BIOL, V129, P233, DOI 10.1007/s002270050164; Bremer JRA, 2005, MOL PHYLOGENET EVOL, V36, P169, DOI 10.1016/j.ympev.2004.12.011; BROWN JH, 1977, ECOLOGY, V58, P445, DOI 10.2307/1935620; Calderon I, 2008, MAR BIOL, V154, P137, DOI 10.1007/s00227-008-0908-0; Cannas R, 2011, MARINE ECOLOGY, V33, P350; Carbonell A., 2010, Marine Biodiversity Records, V3, pe103; Carbonell A, 1999, FISH RES, V44, P1, DOI 10.1016/S0165-7836(99)00079-X; Chase MR, 1998, MAR BIOL, V131, P301, DOI 10.1007/s002270050323; Company JB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001431; D'Onghia G, 2005, FISH RES, V76, P22, DOI 10.1016/j.fishres.2005.05.007; D'Onghia G, 2009, FISH RES, V95, P236, DOI 10.1016/j.fishres.2008.09.025; Dall W, 1990, ADV MAR BIOL, P283; DANDO PR, 1981, MAR BIOL LETT, V2, P239; de Freitas A. J., 1985, INVEST REP OCEANOGR, V57, P1; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Etter RJ, 2005, EVOLUTION, V59, P1479, DOI 10.1111/j.0014-3820.2005.tb01797.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fernandez MV, 2013, J SEA RES, V76, P146, DOI 10.1016/j.seares.2012.08.004; Fiorentino F, 1998, DYNAMIQUE POPULATION, V35, P323; France SC, 1996, MAR BIOL, V126, P633, DOI 10.1007/BF00351330; Guijarro B, 2008, J MARINE SYST, V71, P385, DOI 10.1016/j.jmarsys.2007.04.003; Hedgecock D, 2011, B MAR SCI, V87, P971, DOI 10.5343/bms.2010.1051; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Heuer B, 2013, THEOR POPUL BIOL, V87, P90, DOI 10.1016/j.tpb.2012.11.006; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Holthuis L.B., 1980, SHRIMPS PRAWNS WORLD; Horwood J.W., 2000, P302; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Lambeck K, 2002, NATURE, V419, P199, DOI 10.1038/nature01089; Larmuseau MHD, 2009, MOL ECOL, V18, P4227, DOI 10.1111/j.1365-294X.2009.04331.x; Liu J, 2011, MOL ECOL, V20; Maggio T, 2009, MAR ECOL-EVOL PERSP, V30, P354, DOI 10.1111/j.1439-0485.2008.00277.x; Mona S, 2014, HEREDITY, V112, P291, DOI 10.1038/hdy.2013.105; Papaconstantinou C, 2001, AQUAT LIVING RESOUR, V14, P303, DOI 10.1016/S0990-7440(01)01128-7; Patarnello T, 2007, MOL ECOL, V16, P4426, DOI 10.1111/j.1365-294X.2007.03477.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2007, TRACER V 1 5; Ray C, 2003, MOL BIOL EVOL, V20; Relini LO, 2013, MAR ECOL-EVOL PERSP, V34, P90, DOI 10.1111/j.1439-0485.2012.00528.x; Relini M, 2000, SCI MAR, V64, P357, DOI 10.3989/scimar.2000.64n3357; Roasted M, 2012, R J, V4; Roldan MI, 2009, GENETICA, V136, P1, DOI 10.1007/s10709-008-9330-2; Sarda F, 2004, SCI MAR, V68, P7, DOI 10.3989/scimar.2004.68s37; Sarda F, 2004, SCI MAR, V68, P117, DOI 10.3989/scimar.2004.68s3117; Sarda F, 2003, J SHELLFISH RES, V22, P569; Sarda F, 2010, SCI MAR, V74, P569, DOI 10.3989/scimar.2010.74n3569; Serejo CS, 2007, SER LIVROS MUS NAC, V24, P133; Stadler T, 2009, GENETICS, V182, P205, DOI 10.1534/genetics.108.094904; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tellier A, 2014, MOL ECOL, V23, P2637, DOI 10.1111/mec.12755; Fernandez MV, 2011, MAR ECOL PROG SER, V421, P163, DOI 10.3354/meps08881; Wakeley J, 1999, GENETICS, V153, P1863; Wakeley J, 2013, THEOR POPUL BIOL, V87, P1, DOI 10.1016/j.tpb.2013.06.001; Waples RS, 2008, FISH FISH, V9, P423, DOI 10.1111/j.1467-2979.2008.00303.x; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354; WWF/IUCN, 2004, MED DEEP SEA EC OV T	64	17	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0117272	10.1371/journal.pone.0117272	http://dx.doi.org/10.1371/journal.pone.0117272			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775363	Green Submitted, gold, Green Published			2022-12-27	WOS:000351183500018
J	Munyai, TC; Foord, SH				Munyai, Thinandavha Caswell; Foord, Stefan Hendrik			Temporal Patterns of Ant Diversity across a Mountain with Climatically Contrasting Aspects in the Tropics of Africa	PLOS ONE			English	Article							SPECIES RICHNESS; ELEVATIONAL GRADIENTS; LATITUDINAL GRADIENTS; ECOLOGICAL DATA; BETA DIVERSITY; SCALE; AREA; TEMPERATURE; ASSEMBLAGE; ALTITUDE	Factors that drive species richness over space and time are still poorly understood and are often context specific. Identifying these drivers for ant diversity has become particularly relevant within the context of contemporary global change events. We report on a long-term biannual (wet and dry seasons), standardized sampling of epigeal ants over a five year period on the mesic and arid aspects of an inselberg (Soutpansberg Mountain Range) in the tropics of Africa. We detail seasonal, annual and long-term trends of species density, test the relative contribution of geometric constraints, energy, available area, climate, local environmental variables, time, and space in explaining ant species density patterns through Generalized Linear Mixed Models (GLMM) where replicates were included as random factors to account for temporal pseudo-replication. Seasonal patterns were very variable and we found evidence of decreased seasonal variation in species density with increased elevation. The extent and significance of a decrease in species density with increased elevation varied with season. Annual patterns point to an increase in ant diversity over time. Ant density patterns were positively correlated with mean monthly temperature but geometric constraints dominated model performance while soil characteristics were minor correlates. These drivers and correlates accounted for all the spatio-temporal variability in the database. Ant diversity was therefore mainly determined by geometric constraints and temperature while soil characteristics (clay and carbon content) accounted for smaller but significant amounts of variation. This study documents the role of season, elevation and their interaction in affecting ant species densities while highlighting the importance of neutral processes and temperature in driving these patterns.	[Munyai, Thinandavha Caswell; Foord, Stefan Hendrik] Univ Venda, Ctr Invas Biol, Thohoyandou, Limpopo Provinc, South Africa; [Munyai, Thinandavha Caswell] Univ Venda, Dept Ecol & Resource Management, Thohoyandou, Limpopo Provinc, South Africa; [Foord, Stefan Hendrik] Univ Venda, South African Res Chair Biodivers Value & Change, Thohoyandou, Limpopo Provinc, South Africa; [Foord, Stefan Hendrik] Univ Venda, Dept Zool, Thohoyandou, Limpopo Provinc, South Africa	University of Venda; University of Venda; University of Venda; University of Venda	Munyai, TC (corresponding author), Univ Venda, Ctr Invas Biol, Thohoyandou, Limpopo Provinc, South Africa.	caswell.munyai@gmail.com	Munyai, Caswell/AAD-3110-2020; Munyai, Caswell TC/F-9919-2013; Foord, Stefan Hendrik/F-3282-2018	Munyai, Caswell/0000-0002-1562-2385; Foord, Stefan Hendrik/0000-0002-9195-2562	Department of Science and Technology- National Research Foundation Centre of Excellence for Invasion Biology; University of Venda	Department of Science and Technology- National Research Foundation Centre of Excellence for Invasion Biology(Department of Science & Technology (India)); University of Venda	This work was financially supported by the Department of Science and Technology- National Research Foundation Centre of Excellence for Invasion Biology and the University of Venda to TCM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABENSPERGTRAUN M, 1995, AUST J ECOL, V20, P282, DOI 10.1111/j.1442-9993.1995.tb00540.x; ADIS J, 1979, ZOOL ANZ, V202, P177; Andersen Alan N., 2000, P25; [Anonymous], [No title captured]; Araujo Luzia Marcia, 2003, Lundiana, V4, P103; ATKIN L, 1988, J TROP ECOL, V4, P307, DOI 10.1017/S026646740000287X; Beck J, 2010, BASIC APPL ECOL, V11, P714, DOI 10.1016/j.baae.2010.08.009; Berger K, 2003, 1 SYNTHESIS ENV BIOL; Bestelmeyer BT, 2003, ECOL APPL, V13, P1750, DOI 10.1890/02-5089; Bishop TR, 2014, J BIOGEOGR, V41, P2256, DOI 10.1111/jbi.12368; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; Botes A, 2006, J BIOGEOGR, V33, P71, DOI 10.1111/j.1365-2699.2005.01336.x; Boulton AM, 2005, ENVIRON ENTOMOL, V34, P96, DOI 10.1603/0046-225X-34.1.96; Braschler B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031463; Cerda X, 1997, J ANIM ECOL, V66, P363, DOI 10.2307/5982; Chaladze G, 2012, J INSECT CONSERV, V16, P791, DOI 10.1007/s10841-012-9464-5; Chao A, 2012, ECOLOGY, V93, P2533, DOI 10.1890/11-1952.1; Clarke A, 2006, P ROY SOC B-BIOL SCI, V273, P2257, DOI 10.1098/rspb.2006.3545; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; Colwell RK, 2006, RANGEMODEL MONTE COR; Colwell RK, 2010, PHILOS T R SOC B, V365, P3695, DOI 10.1098/rstb.2010.0293; Cowling RM, 1995, BIODIVERSITY LETT, V2, P127; Crous CJ, 2014, INSECT CONSERV DIVER, V7, P185, DOI 10.1111/icad.12044; de Juan S, 2014, ECOGRAPHY, V37, P183, DOI 10.1111/j.1600-0587.2013.00048.x; Del Toro I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067973; Delsinne T, 2010, J ARID ENVIRON, V74, P1149, DOI 10.1016/j.jaridenv.2010.03.014; Dunn RR, 2006, ECOGRAPHY, V29, P251, DOI 10.1111/j.2006.0906-7590.04259.x; Ellison AM, 2002, TREES-STRUCT FUNCT, V16, P181, DOI 10.1007/s00468-001-0133-7; Fisher Brian L., 1998, Fieldiana Zoology, V90, P39; Fleishman E, 1998, ECOLOGY, V79, P2482, DOI 10.1890/0012-9658(1998)079[2482:AETORS]2.0.CO;2; Foord SH, 2015, J ARID ENVIRON, V113, P114, DOI 10.1016/j.jaridenv.2014.10.006; Hahn N, 2006, THESIS U PRETORIA; Hahn N., 2002, THESIS U KWAZULU NAT; Jacquemin J, 2012, APPL SOIL ECOL, V62, P163, DOI 10.1016/j.apsoil.2012.08.008; Jayatilaka P, 2011, J EXP BIOL, V214, P2730, DOI 10.1242/jeb.053710; Jocque R, 2008, ZOOKEYS, P59, DOI 10.3897/zookeys.1.10; Kattan GH, 2004, GLOBAL ECOL BIOGEOGR, V13, P451, DOI 10.1111/j.1466-822X.2004.00117.x; Kerr JT, 2006, ECOL LETT, V9, P149, DOI 10.1111/j.1461-0248.2005.00860.x; Kirchhof S, 2010, SALAMANDRA, V46, P147; Laliberte E, 2009, OECOLOGIA, V159, P377, DOI 10.1007/s00442-008-1214-8; Leal IR, 2014, BIOTROPICA, V46, P516, DOI 10.1111/btp.12126; Lobo JM, 2000, CAN ENTOMOL, V132, P307, DOI 10.4039/Ent132307-3; Lyons SK, 2002, ECOLOGY, V83, P47; McCain CM, 2007, GLOBAL ECOL BIOGEOGR, V16, P1, DOI 10.1111/j.1466-8238.2006.00263.x; McCain CM, 2007, ECOLOGY, V88, P76, DOI 10.1890/0012-9658(2007)88[76:AAMED]2.0.CO;2; Munyai TC, 2012, J INSECT CONSERV, V16, P677, DOI 10.1007/s10841-011-9449-9; Munyai TC, KOEDOE IN PRESS; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Paknia O, 2014, MYRMECOL NEWS, V20, P15; Parr CL, 2008, J ANIM ECOL, V77, P1191, DOI 10.1111/j.1365-2656.2008.01450.x; Parr CL, 2004, J APPL ECOL, V41, P630, DOI 10.1111/j.0021-8901.2004.00920.x; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Rahbek C, 1997, AM NAT, V149, P875, DOI 10.1086/286028; Ramon Giovanni, 2013, Metodos en Ecologia y Sistematica, V8, P37; ROHDE K, 1992, OIKOS, V65, P514, DOI 10.2307/3545569; Sabu TK, 2008, J INSECT SCI, V8, P1536; Samson DA, 1997, BIOTROPICA, V29, P349, DOI 10.1111/j.1744-7429.1997.tb00436.x; Sanders NJ, 2007, GLOBAL ECOL BIOGEOGR, V16, P640, DOI 10.1111/j.1466-8238.2007.00316.x; Sanders NJ, 2002, ECOGRAPHY, V25, P25, DOI 10.1034/j.1600-0587.2002.250104.x; Sanders NJ, 2003, GLOBAL ECOL BIOGEOGR, V12, P93, DOI 10.1046/j.1466-822X.2003.00324.x; STEVENS GC, 1992, AM NAT, V140, P893, DOI 10.1086/285447; Wielgoss A, 2010, AGR ECOSYST ENVIRON, V135, P253, DOI 10.1016/j.agee.2009.10.003; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	72	16	19	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0122035	10.1371/journal.pone.0122035	http://dx.doi.org/10.1371/journal.pone.0122035			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774670	Green Published, gold, Green Submitted			2022-12-27	WOS:000351183500220
J	Rostami, A; Mondani, H				Rostami, Amir; Mondani, Hernan			The Complexity of Crime Network Data: A Case Study of Its Consequences for Crime Control and the Study of Networks	PLOS ONE			English	Article							SOCIAL NETWORK; CENTRALITY; POLICE	The field of social network analysis has received increasing attention during the past decades and has been used to tackle a variety of research questions, from prevention of sexually transmitted diseases to humanitarian relief operations. In particular, social network analyses are becoming an important component in studies of criminal networks and in criminal intelligence analysis. At the same time, intelligence analyses and assessments have become a vital component of modern approaches in policing, with policy implications for crime prevention, especially in the fight against organized crime. In this study, we have a unique opportunity to examine one specific Swedish street gang with three different datasets. These datasets are the most common information sources in studies of criminal networks: intelligence, surveillance and co-offending data. We use the data sources to build networks, and compare them by computing distance, centrality, and clustering measures. This study shows the complexity factor by which different data sources about the same object of study have a fundamental impact on the results. The same individuals have different importance ranking depending on the dataset and measure. Consequently, the data source plays a vital role in grasping the complexity of the phenomenon under study. Researchers, policy makers, and practitioners should therefore pay greater attention to the biases affecting the sources of the analysis, and be cautious when drawing conclusions based on intelligence assessments and limited network data. This study contributes to strengthening social network analysis as a reliable tool for understanding and analyzing criminality and criminal networks.	[Rostami, Amir; Mondani, Hernan] Stockholm Univ, Dept Sociol, S-10691 Stockholm, Sweden	Stockholm University	Mondani, H (corresponding author), Stockholm Univ, Dept Sociol, S-10691 Stockholm, Sweden.	hernan.mondani@sociology.su.se	Mondani, Hernan/AAD-8412-2022	Mondani, Hernan/0000-0003-2685-9238; Rostami, Amir/0000-0003-0973-3481	Riksbankens Jubileumsfond (The Bank of Sweden Tercentenary Foundation) [P11-0866:1]	Riksbankens Jubileumsfond (The Bank of Sweden Tercentenary Foundation)	AR and HM are grateful to Riksbankens Jubileumsfond (The Bank of Sweden Tercentenary Foundation) grant nr. P11-0866:1 for financial support (http://anslag.rj.se/sv/anslag/43453). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastian M., 2009, GEPHI OPEN SOURCE SO, DOI DOI 10.13140/2.1.1341.1520; Brandes U, 2013, NETW SCI, V1, P1, DOI [10.1017/nws.2013.2, DOI 10.1017/NWS.2013.2]; Cordner GW, 1999, POLICE ADM INSTRUCTO; Crank J., 2004, UNDERSTANDING POLICE, V2nd ed.; Dickinson PJ, 2004, PATTERN ANAL APPL, V7, P243, DOI [10.1007/s10044-044-0222-5, 10.1007/s10044-004-0222-5]; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Gelman A, 2007, J AM STAT ASSOC, V102, P813, DOI 10.1198/016214506000001040; Gottschalk P, 2010, ADV POLICE THEORY PR; Hagberg AA, 2009, EXPLORING NETWORK ST; Harder S, 2013, FORMATIV EVALUERING; Kahneman D., 2011, THINKING FAST SLOW; Klovdahl AS, 2005, SOC NETWORKS, V27, P119, DOI 10.1016/j.socnet.2005.01.006; Kossinets G, 2009, AM J SOCIOL, V115, P405, DOI 10.1086/599247; Leinfelt F, 2012, STOCKHOLM GANG MODEL; Levi M., 2007, OXFORD HDB CRIMINOLO; Lu X, 2012, P NATL ACAD SCI; Morselli C, 2009, STUD ORGANIZE CRIME, V8, P1, DOI 10.1007/978-0-387-09526-4; Morselli C., 2013, CRIME NETWORKS; Newburn T., 2008, HDB POLICING; Newburn T., 2005, POLICING KEY READING; Pettersson T, 2002, TRE PERSPEKTIV BROTT; Ratcliffe J.H., 2008, INTELLIGENCE LED POL; Ressler S, 2006, HOMELAND SECURITY AF; Riesen K, 2013, LECT NOTES COMPUTER; Rikspolisstyrelsen, 2011, POL EN PRES INF; Rostami A, 2012, J CONTEMP CRIM JUST, VXX, P1; Rostami A, 2012, YOUTH GANGS IN INTERNATIONAL PERSPECTIVE: RESULTS FROM THE EUROGANG PROGRAM OF RESEARCH, P251, DOI 10.1007/978-1-4614-1659-3_15; Roxell L, 2007, PRISONERS NETWORK PR; Sarnecki J, 2001, DELINQUENT NETWORKS; SOU, 2001, BEH PERS POL VERKS; Strang S.J., 2014, NETWORKS NETWORK ANA, P1; Tilley N., 2008, HDB POLICING; Trulson CR., 2004, J CRIM JUSTICE EDUC, V15, P451, DOI DOI 10.1080/10511250400086071; Wasserman S., 1994, STRUCTURAL ANAL SOCI, V8; Watts D. J., 2011, EVERYTHING IS OBVIOU; Weisburd D, 2004, ANN AM ACAD POLIT SS, V593, P42, DOI 10.1177/0002716203262548; Wright A., 2002, POLICING INTRO CONCE	38	28	28	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119309	10.1371/journal.pone.0119309	http://dx.doi.org/10.1371/journal.pone.0119309			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD6EY	25775130	Green Published, gold			2022-12-27	WOS:000351183500080
J	Zub, KA; de Sousa, MML; Sarno, A; Sharma, A; Demirovic, A; Rao, S; Young, C; Aas, PA; Ericsson, I; Sundan, A; Jensen, ON; Slupphaug, G				Zub, Kamila Anna; de Sousa, Mirta Mittelstedt Leal; Sarno, Antonio; Sharma, Animesh; Demirovic, Aida; Rao, Shalini; Young, Clifford; Aas, Per Arne; Ericsson, Ida; Sundan, Anders; Jensen, Ole Norregaard; Slupphaug, Geir			Modulation of Cell Metabolic Pathways and Oxidative Stress Signaling Contribute to Acquired Melphalan Resistance in Multiple Myeloma Cells	PLOS ONE			English	Article							ALDO-KETO REDUCTASES; CANCER-CELLS; CYCLOOXYGENASE ISOZYMES; LACTATE-DEHYDROGENASE; URSODEOXYCHOLIC ACID; INDUCED APOPTOSIS; MAMMALIAN TARGET; PROTEIN-KINASE; BREAST-CANCER; INHIBITOR	Alkylating agents are widely used chemotherapeutics in the treatment of many cancers, including leukemia, lymphoma, multiple myeloma, sarcoma, lung, breast and ovarian cancer. Melphalan is the most commonly used chemotherapeutic agent against multiple myeloma. However, despite a 70-80% initial response rate, virtually all patients eventually relapse due to the emergence of drug-resistant tumour cells. By using global proteomic and transcriptomic profiling on melphalan sensitive and resistant RPMI8226 cell lines followed by functional assays, we discovered changes in cellular processes and pathways not previously associated with melphalan resistance in multiple myeloma cells, including a metabolic switch conforming to the Warburg effect (aerobic glycolysis), and an elevated oxidative stress response mediated by VEGF/IL8-signaling. In addition, up-regulated aldo-keto reductase levels of the AKR1C family involved in prostaglandin synthesis contribute to the resistant phenotype. Finally, selected metabolic and oxidative stress response enzymes were targeted by inhibitors, several of which displayed a selective cytotoxicity against the melphalan-resistant cells and should be further explored to elucidate their potential to overcome melphalan resistance.	[Zub, Kamila Anna; de Sousa, Mirta Mittelstedt Leal; Sarno, Antonio; Sharma, Animesh; Demirovic, Aida; Rao, Shalini; Aas, Per Arne; Ericsson, Ida; Sundan, Anders; Slupphaug, Geir] Norwegian Univ Sci & Technol NTNU, Dept Canc Res & Mol Med, Trondheim, Norway; [Sharma, Animesh; Slupphaug, Geir] Norwegian Univ Sci & Technol NTNU, PROMEC Core Facil Prote & Metabol, Trondheim, Norway; [Young, Clifford; Jensen, Ole Norregaard] Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Southern Denmark	Slupphaug, G (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Canc Res & Mol Med, Trondheim, Norway.	geir.slupphaug@ntnu.no	Slupphaug, Geir/AAN-3794-2020; Jensen, Ole Norregaard/J-1763-2012	Slupphaug, Geir/0000-0002-7498-3500; Jensen, Ole Norregaard/0000-0003-1862-8528; Sarno, Antonio/0000-0002-9308-8018; Young, Clifford/0000-0002-3945-286X	Research Council of Norway [183423, 183432]; Norwegian Cancer Society [TS-02-2008-0185]; Cancer Fund at St. Olavs Hospital, Trondheim [47063403]; Liaison Committee [81133200]; Villum Fonden [00007292] Funding Source: researchfish	Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society); Cancer Fund at St. Olavs Hospital, Trondheim; Liaison Committee; Villum Fonden(Villum Fonden)	Funding was provided by the Research Council of Norway (http://www.forskningsradet.no/en/Home_page/1177315753906), grant no. 183423 and 183432; the Norwegian Cancer Society (https://kreftforeningen.no/en/), grant no. TS-02-2008-0185; the Cancer Fund at St. Olavs Hospital, Trondheim (http://www.stolav.no/en/), grant no. 47063403; the Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU) (http://www.ntnu.no/dmf/rad/samorg), grant no. 81133200. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED AE, 1982, CANCER CHEMOTH PHARM, V8, P271; Anisimov VN, 2005, EXP GERONTOL, V40, P685, DOI 10.1016/j.exger.2005.07.007; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Bauman DR, 2005, MOL PHARMACOL, V67, P60, DOI 10.1124/mol.104.006569; BELLAMY WT, 1991, CANCER RES, V51, P995; Birtwistle L, 2009, MUTAT RES-FUND MOL M, V662, P67, DOI 10.1016/j.mrfmmm.2008.12.010; Brooks GA, 1999, P NATL ACAD SCI USA, V96, P1129, DOI 10.1073/pnas.96.3.1129; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Burczynski ME, 2001, J BIOL CHEM, V276, P2890, DOI 10.1074/jbc.M006655200; Byrns MC, 2010, J STEROID BIOCHEM, V118, P177, DOI 10.1016/j.jsbmb.2009.12.009; Byrns MC, 2009, CHEM-BIOL INTERACT, V178, P221, DOI 10.1016/j.cbi.2008.10.024; Chen Q, 2005, BLOOD, V106, P698, DOI 10.1182/blood-2004-11-4286; Chi Y, 2011, J PHARMACOL EXP THER, V339, P257, DOI 10.1124/jpet.111.183020; Currie CJ, 2012, DIABETES CARE, V35, P299, DOI 10.2337/dc11-1313; Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889; Das GC, 2006, MOL CARCINOGEN, V45, P635, DOI 10.1002/mc.20184; DeBerardinis RJ, 2008, GENET MED, V10, P267, DOI 10.1097/GIM.0b013e31818b0d9b; DeCensi A, 2010, CANCER PREV RES, V3, P1451, DOI 10.1158/1940-6207.CAPR-10-0157; Ding J, 2006, MOL CARCINOGEN, V45, P250, DOI 10.1002/mc.20175; Dowell JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070163; el Dein OS, 2012, BIOCHEM PHARMACOL, V83, P1172, DOI 10.1016/j.bcp.2012.01.017; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gharbi SI, 2007, BIOCHEM J, V404, P15, DOI 10.1042/BJ20061489; Gorman A, 1997, FEBS LETT, V404, P27, DOI 10.1016/S0014-5793(97)00069-0; Halestrap AP, 2004, PFLUG ARCH EUR J PHY, V447, P619, DOI 10.1007/s00424-003-1067-2; HARTLEY KO, 1995, CELL, V82, P849, DOI 10.1016/0092-8674(95)90482-4; Homolya L, 2003, BIOFACTORS, V17, P103, DOI 10.1002/biof.5520170111; Hu T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05810; Ikegami T, 2006, MOL CANCER THER, V5, P68, DOI 10.1158/1535-7163.MCT-05-0107; Khanim F, 2014, BRIT J CANCER, V110, P1506, DOI 10.1038/bjc.2014.83; Kim HS, 2014, PATHOBIOLOGY, V81, P78, DOI 10.1159/000357017; Kluza J, 2012, CANCER RES, V72, P5035, DOI 10.1158/0008-5472.CAN-12-0979; Kuma Y, 2005, J BIOL CHEM, V280, P19472, DOI 10.1074/jbc.M414221200; Kyle RA, 2009, CLIN LYMPHOMA MYELOM, V9, P278, DOI 10.3816/CLM.2009.n.056; Leseux L, 2006, BLOOD, V108, P4156, DOI 10.1182/blood-2006-05-026203; Ling YH, 2003, J BIOL CHEM, V278, P33714, DOI 10.1074/jbc.M302559200; Lonial S, 2009, BRIT J HAEMATOL, V145, P681, DOI 10.1111/j.1365-2141.2009.07649.x; Lyon RC, 2013, NEUROCHEM INT, V62, P113, DOI 10.1016/j.neuint.2012.10.007; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Masui K, 2014, TRENDS ENDOCRIN MET, V25, P364, DOI 10.1016/j.tem.2014.04.002; Masui K, 2013, CELL METAB, V18, P726, DOI 10.1016/j.cmet.2013.09.013; Mohamed D, 2008, ANAL BIOANAL CHEM, V392, P805, DOI 10.1007/s00216-008-2236-0; Mori S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088891; Niewisch MR, 2012, CELL PHYSIOL BIOCHEM, V29, P373, DOI 10.1159/000338492; Oancea M, 2004, INT J HEMATOL, V80, P224, DOI 10.1532/IJH97.04107; Ouellet M, 2004, BIOCHEM J, V377, P675, DOI 10.1042/BJ20030969; Page BDG, 2013, J MED CHEM, V56, P7190, DOI 10.1021/jm3017255; Penning T. M., 2014, CHEM BIOL INTERACT; Penning TM, 2007, ARCH BIOCHEM BIOPHYS, V464, P241, DOI 10.1016/j.abb.2007.04.024; Pizzuto R, 2012, BBA-BIOENERGETICS, V1817, P1679, DOI 10.1016/j.bbabio.2012.05.010; Plas DR, 2002, TRENDS ENDOCRIN MET, V13, P74; Podar K, 2005, BLOOD, V105, P1383, DOI 10.1182/blood-2004-07-2909; POVIRK LF, 1994, MUTAT RES-REV GENET, V318, P205, DOI 10.1016/0165-1110(94)90015-9; Raab MS, 2009, LANCET, V374, P324, DOI 10.1016/S0140-6736(09)60221-X; Raez LE, 2013, CANCER CHEMOTH PHARM, V71, P523, DOI 10.1007/s00280-012-2045-1; Reed TT, 2011, FREE RADICAL BIO MED, V51, P1302, DOI 10.1016/j.freeradbiomed.2011.06.027; Rizner TL, 2014, STEROIDS, V79, P49, DOI 10.1016/j.steroids.2013.10.012; Rothbarth J, 2002, CHEM-BIOL INTERACT, V140, P93, DOI 10.1016/S0009-2797(02)00014-5; Saeki T, 2012, NUTR CANCER, V64, P617, DOI 10.1080/01635581.2012.669876; Sanchez WY, 2013, BRIT J CANCER, V108, P1624, DOI 10.1038/bjc.2013.120; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Schneider MB, 2001, GASTROENTEROLOGY, V120, P1263, DOI 10.1053/gast.2001.23258; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shi Y, 2005, INT J INF TECH DECIS, V4, P1; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sousa MML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055493; Spanswick VJ, 2002, BLOOD, V100, P224, DOI 10.1182/blood.V100.1.224; Upadhyay M, 2013, PHARMACOL THERAPEUT, V137, P318, DOI 10.1016/j.pharmthera.2012.11.003; Vegran F, 2011, CANCER RES, V71, P2550, DOI 10.1158/0008-5472.CAN-10-2828; Verrax J, 2011, BIOCHEM PHARMACOL, V82, P1540, DOI 10.1016/j.bcp.2011.07.102; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Wlodarski P, 2005, CANCER RES, V65, P7800, DOI 10.1158/0008-5472.CAN-04-4180; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Xie JY, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-11; Yarde DN, 2009, CANCER RES, V69, P9367, DOI 10.1158/0008-5472.CAN-09-2616; Zhao Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.60	78	40	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119857	10.1371/journal.pone.0119857	http://dx.doi.org/10.1371/journal.pone.0119857			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25769101	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000351277500099
J	Abitbol, M; Bosse, P; Thomas, A; Tiret, L				Abitbol, Marie; Bosse, Philippe; Thomas, Anne; Tiret, Laurent			A Deletion in FOXN1 Is Associated with a Syndrome Characterized by Congenital Hypotrichosis and Short Life Expectancy in Birman Cats	PLOS ONE			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; KERATIN GENE-EXPRESSION; NUDE PHENOTYPE; MOUSE; MICE; DIFFERENTIATION; ALOPECIA; LOCUS; RAT; WHN	An autosomal recessive syndrome characterized by congenital hypotrichosis and short life expectancy has been described in the Birman cat breed (Felis silvestris catus). We hypothesized that a FOXN1 (forkhead box N1) loss-of-function allele, associated with the nude phenotype in humans, mice and rats, may account for the syndrome observed in Birman cats. To the best of our knowledge, spontaneous mutations in FOXN1 have never been described in non-human, non-rodent mammalian species. We identified a recessive c.1030_1033delCTGT deletion in FOXN1 in Birman cats. This 4-bp deletion was associated with the syndrome when present in two copies. Percentage of healthy carriers in our French panel of genotyped Birman cats was estimated to be 3.2%. The deletion led to a frameshift and a premature stop codon at position 547 in the protein. In silico, the truncated FOXN1 protein was predicted to lack the activation domain and critical parts of the forkhead DNA binding domain, both involved in the interaction between FOXN1 and its targets, a mandatory step to promote normal hair and thymic epithelial development. Our results enlarge the panel of recessive FOXN1 loss-of-function alleles described in mammals. A DNA test is available; it will help owners avoid matings at risk and should prevent the dissemination of this morbid mutation in domestic felines.	[Abitbol, Marie; Bosse, Philippe; Tiret, Laurent] Hop Henri Mondor, INSERM, U955, IMRB,Equipe 10, F-94010 Creteil, France; [Abitbol, Marie; Bosse, Philippe; Tiret, Laurent] Ecole Natl Vet Alfort, BNMS Genet Med Comparee Affect Neuromusculaires, Maisons Alfort, France; [Thomas, Anne] Antagene, La Tour De Salvagny, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Ecole Nationale Veterinaire d'Alfort (ENVA)	Abitbol, M (corresponding author), Hop Henri Mondor, INSERM, U955, IMRB,Equipe 10, F-94010 Creteil, France.	m.abitbol@vet-alfort.fr	Tiret, Laurent/K-3877-2017	Tiret, Laurent/0000-0001-8573-8335; Bosse, Philippe/0000-0001-5701-6415; Abitbol, Marie/0000-0002-5615-7897				Adriani M, 2004, ANN HUM GENET, V68, P265, DOI 10.1046/j.1529-8817.2004.00091.x; Amorosi S, 2008, CLIN GENET, V73, P380, DOI 10.1111/j.1399-0004.2008.00977.x; Barnay G, 1990, LES SECRETS DU CHAT; Basel MT, 2012, BIORESEARCH OPEN ACC, V1, P63, DOI 10.1089/biores.2012.9902; Benayoun BA, 2011, TRENDS GENET, V27, P224, DOI 10.1016/j.tig.2011.03.003; BOURDEAU P, 1988, RECL MED VET, V164, P17; Brissette JL, 1996, GENE DEV, V10, P2212, DOI 10.1101/gad.10.17.2212; Carpentier C, 1934, REV ZOOTECH, V10, P298; CASAL ML, 1994, J AM ANIM HOSP ASSOC, V30, P600; CASH JM, 1993, MAMM GENOME, V4, P37, DOI 10.1007/BF00364661; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Ramos MLC, 2008, J BURN CARE RES, V29, P363, DOI 10.1097/BCR.0b013e3181667557; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; Collet P, 1934, B SOC SCI VET LYON, V37, P175; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; FLANAGAN SP, 1966, GENET RES, V8, P295, DOI 10.1017/S0016672300010168; Frank J, 1999, NATURE, V398, P473, DOI 10.1038/18997; Gandolfi B, 2010, MAMM GENOME, V21, P509, DOI 10.1007/s00335-010-9290-6; Harding J, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt171; HENDYIBBS PM, 1984, J HERED, V75, P506; Huang J, 2014, J IMMUNOL, V193, P1496, DOI 10.4049/jimmunol.1400915; Jin KT, 2010, CLIN TRANSL ONCOL, V12, P473, DOI 10.1007/s12094-010-0540-6; Kelland LR, 2004, EUR J CANCER, V40, P827, DOI 10.1016/j.ejca.2003.11.028; Lee D, 1999, DEV BIOL, V208, P362, DOI 10.1006/dbio.1999.9221; LEROY P, 1983, ANN MED VET, V127, P513; Letard E, 1938, J HERED, V29, P173, DOI 10.1093/oxfordjournals.jhered.a104488; Letard E., 1933, Revue Veterinaire Toulouse, V85, P545; Masui N, 2004, EXP ANIM TOKYO, V53, P399, DOI 10.1538/expanim.53.399; Mecklenburg L, 2005, EXP DERMATOL, V14, P797, DOI 10.1111/j.1600-0625.2005.00362.x; MELLEN IDA M., 1939, JOUR HEREDITY, V30, P435, DOI 10.1093/jhered/30.10.435; Naper C, 2011, J INNATE IMMUN, V3, P289, DOI 10.1159/000324143; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; Neuber AE, 2006, VET DERMATOL, V17, P63, DOI 10.1111/j.1365-3164.2005.00492.x; Pelleitier M, 1975, Methods Achiev Exp Pathol, V7, P149; Pignata C, 1996, AM J MED GENET, V65, P167, DOI 10.1002/(SICI)1096-8628(19961016)65:2<167::AID-AJMG17>3.0.CO;2-O; Prowse DM, 1999, DEV BIOL, V212, P54, DOI 10.1006/dbio.1999.9328; REED C, 1979, LAB ANIM SCI, V29, P744; Rodriguez-Sosa JR, 2009, REPRODUCTION, V138, P187, DOI 10.1530/REP-09-0012; Romano R, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00187; Romano R, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/467101; Schlake T, 1997, P NATL ACAD SCI USA, V94, P3842, DOI 10.1073/pnas.94.8.3842; Schlake T, 2000, DEV DYNAM, V217, P368, DOI 10.1002/(SICI)1097-0177(200004)217:4<368::AID-DVDY4>3.0.CO;2-Z; Schorpp M, 2000, DEV DYNAM, V218, P537, DOI 10.1002/1097-0177(200007)218:3<537::AID-DVDY1007>3.0.CO;2-P; Schuddekopf K, 1996, P NATL ACAD SCI USA, V93, P9661, DOI 10.1073/pnas.93.18.9661; SHARKEY FE, 1984, CANCER METAST REV, V3, P341, DOI 10.1007/BF00051459; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wijchers PJEC, 2006, BIOCHEM J, V397, P233, DOI 10.1042/BJ20060387; Zhang ZJ, 2012, INT J BIOL SCI, V8, P1156, DOI 10.7150/ijbs.5033; Zhigachev A. I., 2000, Genetika, V36, P538	49	16	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120668	10.1371/journal.pone.0120668	http://dx.doi.org/10.1371/journal.pone.0120668			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781316	Green Submitted, gold, Green Published			2022-12-27	WOS:000351284600179
J	Ariza-Gracia, MA; Zurita, JF; Pinero, DP; Rodriguez-Matas, JF; Calvo, B				Ariza-Gracia, Miguel A.; Zurita, Jesus F.; Pinero, David P.; Rodriguez-Matas, Jose F.; Calvo, Begona			Coupled Biomechanical Response of the Cornea Assessed by Non-Contact Tonometry. A Simulation Study	PLOS ONE			English	Article							FINITE-ELEMENT SIMULATION; HUMAN EYE; AIR-PUFF; DEFORMATION; MODEL; SURGERY; FORMULATION; ANISOTROPY; PRESSURE	The mechanical response of the cornea subjected to a non-contact air-jet tonometry diagnostic test represents an interplay between its geometry, the corneal material behavior and the loading. The objective is to study this interplay to better understand and interpret the results obtained with a non-contact tonometry test. A patient-specific finite element model of a healthy eye, accounting for the load free configuration, was used. The corneal tissue was modeled as an anisotropic hyperelastic material with two preferential directions. Three different sets of parameters within the human experimental range obtained from inflation tests were considered. The influence of the IOP was studied by considering four pressure levels (10-28 mmHg) whereas the influence of corneal thickness was studied by inducing a uniform variation (300-600 microns). A Computer Fluid Dynamics (CFD) air-jet simulation determined pressure loading exerted on the anterior corneal surface. The maximum apex displacement showed a linear variation with IOP for all materials examined. On the contrary, the maximum apex displacement followed a cubic relation with corneal thickness. In addition, a significant sensitivity of the apical displacement to the corneal stiffness was also obtained. Explanation to this behavior was found in the fact that the cornea experiences bending when subjected to an air-puff loading, causing the anterior surface to work in compression whereas the posterior surface works in tension. Hence, collagen fibers located at the anterior surface do not contribute to load bearing. Non-contact tonometry devices give useful information that could be misleading since the corneal deformation is the result of the interaction between the mechanical properties, IOP, and geometry. Therefore, a non-contact tonometry test is not sufficient to evaluate their individual contribution and a complete in-vivo characterization would require more than one test to independently determine the membrane and bending corneal behavior.	[Ariza-Gracia, Miguel A.; Rodriguez-Matas, Jose F.; Calvo, Begona] Univ Zaragoza, Aragon Inst Engn Res I3A, Zaragoza, Spain; [Zurita, Jesus F.] Univ Publ Navarra, Dept Mech Engn Energet & Mat, Pamplona, Spain; [Pinero, David P.] Medimar Int Hosp, Ophthalmol Dept OFTALMAR, Alicante, Spain; [Pinero, David P.] Univ Alicante, Opt Pharmacol & Anat Dept, E-03080 Alicante, Spain; [Calvo, Begona] Bioengn Biomat & Nanomed Online Biomed Res Ctr CI, Zaragoza, Spain	University of Zaragoza; Universidad Publica de Navarra; Universitat d'Alacant	Ariza-Gracia, MA (corresponding author), Univ Zaragoza, Aragon Inst Engn Res I3A, Zaragoza, Spain.	mariza@unizar.es	Calvo, Begoña/F-4091-2011; Calvo, Begoña/ABF-6819-2021; Matas, Jose F Rodriguez/H-4589-2011	Calvo, Begoña/0000-0001-9713-1813; Calvo, Begoña/0000-0001-9713-1813; Matas, Jose F Rodriguez/0000-0001-7612-266X	European Union [FP7-SME-2013 606634]; Spanish Ministry of Economy and Competitiveness [DPI2011-27939-C02-01]	European Union(European Commission); Spanish Ministry of Economy and Competitiveness(Spanish Government)	The research leading these results has received funding from the European Union's Seven Framework Program managed by REA Research Executive agency http://ec.europa.eu/research/rea (FP7/2007-2013) under Grant Agreement no FP7-SME-2013 606634 and the Spanish Ministry of Economy and Competitiveness (DPI2011-27939-C02-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens J., 2004, THE PARAVIEW GUIDE; Alastrue V, 2006, J BIOMECH ENG-T ASME, V128, P150, DOI 10.1115/1.2132368; Ariza-Gracia MA, 2014, THESIS U ZARAGOZA; Asher R, 2014, SILICO CELL TISSUE S, V1, P3, DOI [DOI 10.1186/2196-050X-1-3, 10.1186/2196-050X-1-3]; Bryant MR, 1996, J BIOMECH ENG-T ASME, V118, P473, DOI 10.1115/1.2796033; Dorronsoro C, 2012, BIOMED OPT EXPRESS, V3, P473, DOI 10.1364/BOE.3.000473; Eilaghi A, 2010, J BIOMECH, V43, P1696, DOI 10.1016/j.jbiomech.2010.02.031; Elsheikh A, 2008, EXP EYE RES, V86, P783, DOI 10.1016/j.exer.2008.02.006; Elsheikh A, 2008, EXP EYE RES, V86, P445, DOI 10.1016/j.exer.2007.12.002; Elsheikh A, 2013, MED ENG PHYS, V35, P211, DOI 10.1016/j.medengphy.2012.09.006; Elsheikh A, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3148462; Faria-Correia F, 2013, J REFRACT SURG, V29, P356, DOI 10.3928/1081597X-20130129-03; Gasser TC, 2006, J R SOC INTERFACE, V3, P15, DOI 10.1098/rsif.2005.0073; Glass DH, 2008, INVEST OPHTH VIS SCI, V49, P3919, DOI 10.1167/iovs.07-1321; Hon Y, 2013, OPTOMETRY VISION SCI, V90, pE1, DOI 10.1097/OPX.0b013e318279eb87; Hong JX, 2013, INVEST OPHTH VIS SCI, V54, P659, DOI 10.1167/iovs.12-10984; Huseynova T, 2014, AM J OPHTHALMOL, V157, P885, DOI 10.1016/j.ajo.2013.12.024; Kling S, 2013, INVEST OPHTH VIS SCI, V54, P5078, DOI 10.1167/iovs.13-12509; Lanchares E, 2008, J BIOMECH, V41, P797, DOI 10.1016/j.jbiomech.2007.11.010; Nemeth G, 2013, J REFRACT SURG, V29, P558, DOI 10.3928/1081597X-20130719-06; Newton RH, 1998, BIOPHYS J, V75, P2508, DOI 10.1016/S0006-3495(98)77695-7; Pandolfi A, 2006, BIOMECH MODEL MECHAN, V5, P237, DOI 10.1007/s10237-005-0014-x; Pinsky P, 1991, J BIOMECH, V10, P907; Pinsky PM, 2005, J CATARACT REFR SURG, V31, P136, DOI 10.1016/j.jcrs.2004.10.048; Reznicek L, 2013, BRIT J OPHTHALMOL, V97, P1410, DOI 10.1136/bjophthalmol-2013-303400; Roberts CJ, 2014, J CATARACT REFR SURG, V40, P862, DOI 10.1016/j.jcrs.2014.04.019; Roy AS, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4002934; SIMO JC, 1987, COMPUT METHOD APPL M, V60, P153, DOI 10.1016/0045-7825(87)90107-1; Studer HP, 2013, J BIOMECH, V46, P751, DOI 10.1016/j.jbiomech.2012.11.018; Valbon BF, 2013, ARQ BRAS OFTALMOL, V76, P229, DOI 10.1590/S0004-27492013000400008; Whitford C, 2015, J MECH BEHAV BIOMED, V42, P76, DOI 10.1016/j.jmbbm.2014.11.006; YEOH OH, 1993, RUBBER CHEM TECHNOL, V66, P754, DOI 10.5254/1.3538343	32	60	65	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0121486	10.1371/journal.pone.0121486	http://dx.doi.org/10.1371/journal.pone.0121486			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25780915	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600206
J	De Spiegeleer, B; Verbeke, F; D'Hondt, M; Hendrix, A; Van De Wiele, C; Burvenich, C; Peremans, K; De Wever, O; Bracke, M; Wynendaele, E				De Spiegeleer, Bart; Verbeke, Frederick; D'Hondt, Matthias; Hendrix, An; Van De Wiele, Christophe; Burvenich, Christian; Peremans, Kathelijne; De Wever, Olivier; Bracke, Marc; Wynendaele, Evelien			The Quorum Sensing Peptides PhrG, CSP and EDF Promote Angiogenesis and Invasion of Breast Cancer Cells In Vitro	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; INTESTINAL-ABSORPTION; EXPRESSION; PERMEABILITY; MONOLAYERS; MICROBIOTA; MIGRATION; TRANSPORT; PROTEINS; KINETICS	The role of the human microbiome on cancer progression remains unclear. Therefore, in this study, we investigated the influence of some quorum sensing peptides, produced by diverse commensal or pathogenic bacteria, on breast cancer cell invasion and thus cancer outcome. Based on microscopy, transcriptome and Chick Chorioallantoic Membrane (CAM) analyses, four peptides (PhrG from B. subtilis, CSP from S. mitis and EDF from E. coli, together with its tripeptide analogue) were found to promote tumour cell invasion and angiogenesis, thereby potentially influencing tumour metastasis. Our results offer not only new insights on the possible role of the microbiome, but also further opportunities in cancer prevention and therapy by competing with these endogenous molecules and/or by modifying people's life style.	[De Spiegeleer, Bart; Verbeke, Frederick; D'Hondt, Matthias; Wynendaele, Evelien] Univ Ghent, Fac Pharmaceut Sci, Drug Qual & Registrat DruQuaR Grp, B-9000 Ghent, Belgium; [Hendrix, An; De Wever, Olivier; Bracke, Marc] Ghent Univ Hosp, Fac Med & Hlth Sci, Dept Radiat Oncol & Expt Canc Res, Ghent, Belgium; [Van De Wiele, Christophe] Ghent Univ Hosp, Fac Med & Hlth Sci, Dept Radiol & Nucl Med, Ghent, Belgium; [Burvenich, Christian] Univ Ghent, Fac Vet Med, Comparat Physiol & Biometr, Merelbeke, Belgium; [Peremans, Kathelijne] Univ Ghent, Fac Vet Med, Dept Med Imaging Med & Clin Biol Small Anim, Merelbeke, Belgium	Ghent University; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Ghent University; Ghent University	De Spiegeleer, B (corresponding author), Univ Ghent, Fac Pharmaceut Sci, Drug Qual & Registrat DruQuaR Grp, B-9000 Ghent, Belgium.	Bart.DeSpiegeleer@UGent.be	de wever, olivier/J-3094-2013; De Spiegeleer, Bart/A-2001-2008; Hendrix, An/L-5918-2019	de wever, olivier/0000-0002-5453-760X; De Spiegeleer, Bart/0000-0001-6794-3108; 	Special Research Fund of Ghent University [BOF 01J22510]; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen) [131356, 101529]	Special Research Fund of Ghent University(Ghent University); Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was supported by the Special Research Fund of Ghent University [Grant number BOF 01J22510 to BDS and EW, (https://www.ugent. be/en/research/funding/phd/bof/doc)] and the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen) [Grant numbers 131356 to FV and 101529 to MD, (http://www.iwt.be/)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hussaini H, 2011, MOL CANCER THER, V10, P9, DOI 10.1158/1535-7163.MCT-10-0677; Antunes F, 2013, CURR DRUG METAB, V14, P4, DOI 10.2174/138920013804545160; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Asiedu MK, 2014, ONCOGENE, V33, P1316, DOI 10.1038/onc.2013.57; Aungst BJ, 1996, J CONTROL RELEASE, V41, P19, DOI 10.1016/0168-3659(96)01353-3; Bodzioch M, 2009, GENOMICS, V94, P247, DOI 10.1016/j.ygeno.2009.05.006; Burgess DJ, 2013, NAT REV CANCER, V13, P148, DOI 10.1038/nrc3475; Cabrera-Rubio R, 2012, AM J CLIN NUTR, V96, P544, DOI 10.3945/ajcn.112.037382; Cattoor K, 2010, J AGR FOOD CHEM, V58, P4132, DOI 10.1021/jf904079h; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X; Daniel H, 2004, ANNU REV PHYSIOL, V66, P361, DOI 10.1146/annurev.physiol.66.032102.144149; De Wever O, 2010, INT J DEV BIOL, V54, P887, DOI 10.1387/ijdb.092948ow; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Erickson DL, 2002, INFECT IMMUN, V70, P1783, DOI 10.1128/IAI.70.4.1783-1790.2002; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Ge L, 2004, J BIOL CHEM, V279, P55419, DOI 10.1074/jbc.M410312200; Han XY, 2006, J CLIN MICROBIOL, V44, P160, DOI 10.1128/JCM.44.1.160-165.2006; Hickson J, 2009, CLIN EXP METASTAS, V26, P67, DOI 10.1007/s10585-008-9177-z; Hollier BG, 2013, CANCER RES, V73, P1981, DOI 10.1158/0008-5472.CAN-12-2962; Hubatsch I, 2007, NAT PROTOC, V2, P2111, DOI 10.1038/nprot.2007.303; Jahanfar S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005458.pub2; JUNGINGER HE, 1992, DRUG TARGETING DELIV; Kaufman E, 2002, CRIT REV ORAL BIOL M, V13, P197, DOI 10.1177/154411130201300209; Kumari A, 2008, ANAL BIOANAL CHEM, V391, P1619, DOI 10.1007/s00216-008-2002-3; LOGAN NA, 1988, J MED MICROBIOL, V25, P157, DOI 10.1099/00222615-25-3-157; Niyaz A, 2009, GUT PATHOG, DOI [10.1186/1757-4749-1-24., DOI 10.1186/1757-4749-1-24]; Pandey RN, 2010, ONCOGENE, V29, P3715, DOI 10.1038/onc.2010.122; Regazzo D, 2010, MOL NUTR FOOD RES, V54, P1428, DOI 10.1002/mnfr.200900443; Ribatti D, 2006, NAT PROTOC, V1, P85, DOI 10.1038/nprot.2006.13; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Schwabe RF, 2012, SCIENCE, V338, P52, DOI 10.1126/science.1229905; Shenoy SK, 2012, ONCOGENE, V31, P282, DOI 10.1038/onc.2011.238; Sys G, 2012, CANCER LETT, V326, P69, DOI 10.1016/j.canlet.2012.07.023; Taevernier L, 2014, J PEPT SCI, V20, pS299; Tomaskovic-Crook E, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2416; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Urbaniak C, 2014, APPL ENVIRON MICROB, V80, P3007, DOI 10.1128/AEM.00242-14; Vergote V, 2008, PEPTIDES, V29, P1740, DOI 10.1016/j.peptides.2008.05.018; Veuillez F, 2001, EUR J PHARM BIOPHARM, V51, P93, DOI 10.1016/S0939-6411(00)00144-2; World Health Organization, 2014, CANC HLTH TOP; World Health Organization, 2014, CANCER PROGRAM BREAS; Wynendaele E, 2013, NUCLEIC ACIDS RES, V41, pD655, DOI 10.1093/nar/gks1137; Xuan CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083744; Yee SY, 1997, PHARMACEUT RES, V14, P763, DOI 10.1023/A:1012102522787; Ziv E, 2000, MICROSC RES TECHNIQ, V49, P346, DOI 10.1002/(SICI)1097-0029(20000515)49:4<346::AID-JEMT3>3.0.CO;2-B; Zoudilova M, 2007, J BIOL CHEM, V282, P20634, DOI 10.1074/jbc.M701391200	47	52	52	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119471	10.1371/journal.pone.0119471	http://dx.doi.org/10.1371/journal.pone.0119471			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25780927	Green Published, gold, Green Submitted			2022-12-27	WOS:000351284600066
J	Guo, J; Roberts, L; Chen, Z; Merta, PJ; Glaser, KB; Glaser, B				Guo, Jun; Roberts, Lisa; Chen, Zhui; Merta, Philip J.; Glaser, Keith B.; Shah, O. Jameel			JAK2(V617F) Drives Mcl-1 Expression and Sensitizes Hematologic Cell Lines to Dual Inhibition of JAK2 and Bcl-xL	PLOS ONE			English	Article							DNA-BINDING ACTIVITY; BH3 MIMETIC ABT-737; CONSTITUTIVE ACTIVATION; FAMILY INHIBITOR; STAT PROTEINS; LEUKEMIA; APOPTOSIS; KINASE; PHOSPHORYLATION; CRITERIA	Constitutive activation of the Janus kinase (JAK)/signal transducer and activator of transcription (STAT) axis is fundamental to the molecular pathogenesis of a host of hematological disorders, including acute leukemias and myeloproliferative neoplasms (MPN). We demonstrate here that the major JAK2 mutation observed in these diseases (JAK2(V617F)) enforces Mcl-1 transcription via STAT3 signaling. Targeting this lesion with JAK inhibitor I (JAKi-I) attenuates STAT3 binding to the Mcl-1 promoter and suppresses Mcl-1 transcript and protein expression. The neutralization of Mcl-1 in JAK2(V617F)-harboring myelodyssplastic syndrome cell lines sensitizes them to apoptosis induced by the BH3-mimetic and Bcl-xL/Bcl-2 inhibitor, ABT-263. Moreover, simultaneously targeting JAK and Bcl-xL/-2 is synergistic in the presence of the JAK2(V617F) mutation. These findings suggest that JAK/Bcl-xL/-2 inhibitor combination therapy may have applicability in a range of hematological disorders characterized by activating JAK2 mutations.	[Guo, Jun; Roberts, Lisa; Chen, Zhui; Merta, Philip J.; Glaser, Keith B.; Shah, O. Jameel] AbbVie Inc, Res & Dev, Div Oncol, N Chicago, IL 60064 USA	AbbVie	Glaser, KB (corresponding author), AbbVie Inc, Res & Dev, Div Oncol, N Chicago, IL 60064 USA.	keith.glaser@abbvie.com			AbbVie	AbbVie(AbbVie)	JG, LR, PJM, OJS, and KG are or were employees of AbbVie. The design, research, and financial support for this research was provided by AbbVie. AbbVie participated in the interpretation of data, review, and approval of the manuscript.	BERENBAUM MC, 1981, ADV CANCER RES, V35, P269, DOI 10.1016/S0065-230X(08)60912-4; Birkenkamp KU, 2001, LEUKEMIA, V15, P1923, DOI 10.1038/sj.leu.2402317; Buettner R, 2002, CLIN CANCER RES, V8, P945; Carlesso N, 1996, J EXP MED, V183, P811, DOI 10.1084/jem.183.3.811; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; Choudhary C, 2007, BLOOD, V110, P370, DOI 10.1182/blood-2006-05-024018; Epling-Burnette PK, 2001, J CLIN INVEST, V107, P351, DOI 10.1172/JCI9940; Gabler K, 2013, J CELL MOL MED, V17, P265, DOI 10.1111/jcmm.12005; GouilleuxGruart V, 1996, BLOOD, V87, P1692; Harada H, 2004, P NATL ACAD SCI USA, V101, P15313, DOI 10.1073/pnas.0406837101; Hayakawa F, 1998, BRIT J HAEMATOL, V101, P521, DOI 10.1046/j.1365-2141.1998.00720.x; Ilaria RL, 1996, J BIOL CHEM, V271, P31704, DOI 10.1074/jbc.271.49.31704; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Ko TK, 2014, ONCOTERGAT, V1, P1; Lewis RS, 2008, EXPERT REV MOL DIAGN, V8, P73, DOI 10.1586/14737159.8.1.73; Lin X, 2007, ONCOGENE, V26, P3972, DOI 10.1038/sj.onc.1210166; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Mullighan CG, 2009, P NATL ACAD SCI USA, V106, P9414, DOI 10.1073/pnas.0811761106; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Puthier D, 1999, EUR J IMMUNOL, V29, P3945, DOI 10.1002/(SICI)1521-4141(199912)29:12<3945::AID-IMMU3945>3.0.CO;2-O; Reynoso D, 2011, MOL ONCOL, V5, P93, DOI 10.1016/j.molonc.2010.10.003; Rubert J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-24; Shoemaker AR, 2008, CLIN CANCER RES, V14, P3268, DOI 10.1158/1078-0432.CCR-07-4622; Sonbol MB, 2013, THER ADV HEMATOL, V4, P15, DOI 10.1177/2040620712461047; Tefferi A, 2008, LEUKEMIA, V22, P14, DOI 10.1038/sj.leu.2404955; Tefferi A, 2007, BLOOD, V110, P1092, DOI 10.1182/blood-2007-04-083501; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Vannucchi AM, 2011, BLOOD, V118, pA3835; Waibel M, 2013, CELL REP, V5, P1047, DOI 10.1016/j.celrep.2013.10.038; WeberNordt RM, 1996, BLOOD, V88, P809; Will B, 2010, BLOOD, V115, P2901, DOI 10.1182/blood-2009-03-209544; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	34	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0114363	10.1371/journal.pone.0114363	http://dx.doi.org/10.1371/journal.pone.0114363			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781882	Green Published, gold, Green Submitted			2022-12-27	WOS:000351284600002
J	Lin, CY; Chang, CY; Sun, CH; Li, TY; Chen, LC; Chang, ST; Wu, YT				Lin, Ching-Yueh; Chang, Chih-Ya; Sun, Chia-Hung; Li, Tsung-Ying; Chen, Liang-Cheng; Chang, Shin-Tsu; Wu, Yung-Tsan			Platelet Count and Early Outcome in Patients with Spontaneous Cerebellar Hemorrhage: A Retrospective Study	PLOS ONE			English	Article							SPONTANEOUS INTRACEREBRAL HEMORRHAGE; ACUTE STROKE; COAGULATION PARAMETERS; INDEPENDENT PREDICTOR; HEMATOMA ENLARGEMENT; RISK-FACTORS; EARLY DEATH; MANAGEMENT; VOLUME; HYPERGLYCEMIA	Introduction The importance of coagulation, hematology, and biochemical variables have been investigated in the stroke population but have not been systemically surveyed in cerebellar hemorrhage (CH) population. The aim of the study was to explore the predictive value of these factors for early outcome in this population. Materials and Methods Eighty patients with acute spontaneous CH were retrospectively analyzed. Clinical and laboratory data were collected on admission for analysis. The patients were divided by Glasgow outcome scale (GOS) score at discharge into the good outcome group (GOS score 4 or 5) and the poor outcome group (GOS score 1, 2, or 3). The association between early outcome and clinical or laboratory variables were investigated by binary logistic regression. Results There were 46 (57.5%) patients in the poor outcome group and 34 (42.5%) in the good outcome group. The platelet count (PC) was significantly lower in the poor outcome group (187.3 +/- 53.0 x 10(9)/l) compared with good outcome group (244.9 +/- 63.9 x 10(9)/l) (p < 0.001). Moreover, PC (OR 0.97; p = 0.004) was the strong predictor with poor early outcome. Conclusions We firstly show that lower PC is the independent predictor for poor early outcome in patients with spontaneous CH.	[Lin, Ching-Yueh; Chang, Chih-Ya; Sun, Chia-Hung; Li, Tsung-Ying; Chen, Liang-Cheng; Wu, Yung-Tsan] Triserv Gen Hosp, Dept Phys Med & Rehabil, Natl Def Med Ctr, Taipei, Taiwan; [Lin, Ching-Yueh; Chang, Chih-Ya; Sun, Chia-Hung; Li, Tsung-Ying; Chen, Liang-Cheng; Chang, Shin-Tsu; Wu, Yung-Tsan] Natl Def Med Ctr, Dept Phys Med & Rehabil, Sch Med, Taipei, Taiwan; [Chang, Shin-Tsu] Taichung Vet Gen Hosp, Dept Rehabil, Taichung, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Taichung Veterans General Hospital	Wu, YT (corresponding author), Triserv Gen Hosp, Dept Phys Med & Rehabil, Natl Def Med Ctr, 325,Sec 2,Cheng Kung Rd, Taipei, Taiwan.	crwu98@gmail.com	Li, Tsung-Ying/AAJ-2359-2020; Chang, Shin-Tsu/AAF-8506-2020; chihya, Chang/AAI-6537-2021	Chang, Shin-Tsu/0000-0003-4005-2094				Alexandrova ML, 2011, J CLIN NEUROSCI, V18, P247, DOI 10.1016/j.jocn.2010.07.125; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; DENNIS MS, 1993, STROKE, V24, P796, DOI 10.1161/01.STR.24.6.796; DERASMO E, 1990, J INTERN MED, V227, P11, DOI 10.1111/j.1365-2796.1990.tb00111.x; Diedler J, 2010, CRIT CARE, V14, DOI 10.1186/cc8961; Dolderer S, 2004, EUR NEUROL, V52, P112, DOI 10.1159/000080268; DONAUER E, 1994, ACTA NEUROCHIR, V131, P59, DOI 10.1007/BF01401454; Fang HY, 2005, EUR J NEUROL, V12, P226, DOI 10.1111/j.1468-1331.2004.01018.x; Fujii Y, 1998, STROKE, V29, P1160, DOI 10.1161/01.STR.29.6.1160; GAUR SPS, 1994, INDIAN J MED RES, V99, P259; Gonzalez-Duarte Alejandra, 2008, J Stroke Cerebrovasc Dis, V17, P204, DOI 10.1016/j.jstrokecerebrovasdis.2008.02.008; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; JENNETT B, 1975, LANCET, V1, P480; JUVELA S, 1995, ARCH NEUROL-CHICAGO, V52, P1193, DOI 10.1001/archneur.1995.00540360071018; Karagiannis A, 2007, CIRC J, V71, P1120, DOI 10.1253/circj.71.1120; Kawano-Castillo J, 2014, STROKE, V45, P683, DOI 10.1161/STROKEAHA.113.003826; Kimura K, 2007, J NEUROL SCI, V255, P90, DOI 10.1016/j.jns.2007.02.005; Kirollos RW, 2001, NEUROSURGERY, V49, P1378, DOI 10.1097/00006123-200112000-00015; KOBAYASHI S, 1994, NEUROSURGERY, V34, P246, DOI 10.1227/00006123-199402000-00006; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Matsukawa H, 2011, J STROKE CEREBROVASC, V20, P346, DOI 10.1016/j.jstrokecerebrovasdis.2010.02.005; Mayda-Domac F, 2010, J STROKE CEREBROVASC, V19, P66, DOI 10.1016/j.jstrokecerebrovasdis.2009.03.003; MEZZADRI JJM, 1993, ACTA NEUROCHIR, V122, P39, DOI 10.1007/BF01446984; MULLEY GP, 1983, THROMB HAEMOSTASIS, V50, P524; OMALLEY T, 1995, STROKE, V26, P995, DOI 10.1161/01.STR.26.6.995; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; Rajajee Venkatakrishna, 2004, J Stroke Cerebrovasc Dis, V13, P47, DOI 10.1016/j.jstrokecerebrovasdis.2004.01.002; Sansing LH, 2003, J NEUROSURG, V98, P985, DOI 10.3171/jns.2003.98.5.0985; Seo W, 2009, WORLDV EVID-BASED NU, V6, P36, DOI 10.1111/j.1741-6787.2008.00139.x; Smith NM, 1999, VASC MED, V4, P165, DOI 10.1177/1358836X9900400307; St Louis EK, 2000, CAN J NEUROL SCI, V27, P32; TANEDA M, 1987, J NEUROSURG, V67, P545, DOI 10.3171/jns.1987.67.4.0545; TOHGI H, 1991, STROKE, V22, P17, DOI 10.1161/01.STR.22.1.17; VANLOON J, 1993, ACTA NEUROCHIR, V122, P187, DOI 10.1007/BF01405527; Virgós-Señor B., 2006, Med. Intensiva, V30, P01; Weir CJ, 2003, STROKE, V34, P1951, DOI 10.1161/01.STR.0000081983.34771.D2; Wu YT, 2013, CEREBELLUM, V12, P165, DOI 10.1007/s12311-012-0410-6; Wu YT, 2012, CEREBELLUM, V11, P543, DOI 10.1007/s12311-011-0317-7	38	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119109	10.1371/journal.pone.0119109	http://dx.doi.org/10.1371/journal.pone.0119109			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781880	gold, Green Published, Green Submitted			2022-12-27	WOS:000351284600052
J	Naniwadekar, R; Shukla, U; Isvaran, K; Datta, A				Naniwadekar, Rohit; Shukla, Ushma; Isvaran, Kavita; Datta, Aparajita			Reduced Hornbill Abundance Associated with Low Seed Arrival and Altered Recruitment in a Hunted and Logged Tropical Forest	PLOS ONE			English	Article							NAMDAPHA-NATIONAL-PARK; LOWLAND RAIN-FOREST; ARUNACHAL-PRADESH; NEOTROPICAL TREE; NORTHEAST INDIA; WEST KALIMANTAN; DISPERSED TREES; EMPTY FOREST; DISTURBANCE; COMMUNITY	Logging and hunting are two key direct threats to the survival of wildlife in the tropics, and also disrupt important ecosystem processes. We investigated the impacts of these two factors on the different stages of the seed dispersal cycle, including abundance of plants and their dispersers and dispersal of seeds and recruitment, in a tropical forest in north-east India. We focused on hornbills, which are important seed dispersers in these forests, and their food tree species. We compared abundances of hornbill food tree species in a site with high logging and hunting pressures (heavily disturbed) with a site that had no logging and relatively low levels of hunting (less disturbed) to understand logging impacts on hornbill food tree abundance. We compared hornbill abundances across these two sites. We, then, compared the scatter-dispersed seed arrival of five large-seeded tree species and the recruitment of four of those species. Abundances of hornbill food trees that are preferentially targeted by logging were two times higher in the less disturbed site as compared to the heavily disturbed site while that of hornbills was 22 times higher. The arrival of scatter-dispersed seeds was seven times higher in the less disturbed site. Abundances of recruits of two tree species were significantly higher in the less disturbed site. For another species, abundances of younger recruits were significantly lower while that of older recruits were higher in the heavily disturbed site. Our findings suggest that logging reduces food plant abundance for an important frugivore-seed disperser group, while hunting diminishes disperser abundances, with an associated reduction in seed arrival and altered recruitment of animal-dispersed tree species in the disturbed site. Based on our results, we present a conceptual model depicting the relationships and pathways between vertebrate-dispersed trees, their dispersers, and the impacts of hunting and logging on these pathways.	[Naniwadekar, Rohit; Shukla, Ushma; Datta, Aparajita] Nat Conservat Fdn, Mysore, Karnataka, India; [Isvaran, Kavita] Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Naniwadekar, R (corresponding author), Nat Conservat Fdn, Mysore, Karnataka, India.	rohit@ncf-india.org		Naniwadekar, Rohit/0000-0002-9188-6083; Shukla, Ushma/0000-0001-8775-2800	Rufford Small Grants, United Kingdom [10475-2]; International Foundation for Science, Sweden [D/5136-1]	Rufford Small Grants, United Kingdom; International Foundation for Science, Sweden(International Foundation for Science)	This work was supported by Rufford Small Grants, United Kingdom, Grant no: 10475-2, URL: http://www.rufford.org/rsg/projects/rohit_naniwadekar_0; International Foundation for Science, Sweden, Grant no: D/5136-1, URL: www.ifs.se.	Aiyadurai A, 2010, ORYX, V44, P564, DOI 10.1017/S0030605309990937; [Anonymous], 2007, LME4 LINEAR MIXED EF; Beckman NG, 2007, BIOTROPICA, V39, P328, DOI 10.1111/j.1744-7429.2007.00273.x; Bennett EL, 1997, BIOL CONSERV, V82, P41, DOI 10.1016/S0006-3207(97)00012-8; Bhupathy S, 2013, TROP CONSERV SCI, V6, P241, DOI 10.1177/194008291300600206; Bicknell J, 2010, FOREST ECOL MANAG, V259, P2267, DOI 10.1016/j.foreco.2010.02.027; Brodie JF, 2009, ECOL APPL, V19, P854, DOI 10.1890/08-0955.1; CANNON CH, 1994, FOREST ECOL MANAG, V67, P49, DOI 10.1016/0378-1127(94)90007-8; Corlett RT, 2007, BIOTROPICA, V39, P292, DOI 10.1111/j.1744-7429.2007.00271.x; Curran LM, 1999, SCIENCE, V286, P2184, DOI 10.1126/science.286.5447.2184; Datta A, 1998, ORYX, V32, P285, DOI 10.1017/S0030605300030088; Datta A, 2003, BIOTROPICA, V35, P208, DOI 10.1111/j.1744-7429.2003.tb00280.x; Datta A., 2009, INDIAN BIRDS, V5, P108; Datta A., 2001, THESIS; Datta A, 2002, STATUS HORNBILLS HUN; Elston DA, 2001, PARASITOLOGY, V122, P563, DOI 10.1017/S0031182001007740; Fa JE, 2002, CONSERV BIOL, V16, P232, DOI 10.1046/j.1523-1739.2002.00275.x; Felton A, 2008, BIOL CONSERV, V141, P545, DOI 10.1016/j.biocon.2007.11.009; Felton AM, 2003, BIOL CONSERV, V114, P91, DOI 10.1016/S0006-3207(03)00013-2; Forget PM, 2007, CONSERV BIOL, V21, P106, DOI 10.1111/j.1523-1739.2006.00590.x; Gray MA, 2007, CONSERV BIOL, V21, P133, DOI 10.1111/j.1523-1739.2006.00557.x; Guariguata MR, 2000, CONSERV BIOL, V14, P1046, DOI 10.1046/j.1523-1739.2000.99148.x; Heydon MJ, 1997, J APPL ECOL, V34, P484, DOI 10.2307/2404892; Holbrook KM, 2009, ECOLOGY, V90, P1449, DOI 10.1890/08-1332.1; Holbrook KM, 2000, OECOLOGIA, V125, P249, DOI 10.1007/s004420000445; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; HOWE HF, 1985, ECOLOGY, V66, P781, DOI 10.2307/1940539; Jordano P., 2000, Seeds: the ecology of regeneration in plant communities, P125, DOI 10.1079/9780851994321.0125; Keenan Rodney J., 1993, Environmental Reviews, V1, P121, DOI 10.1139/a93-010; Kemp A.C., 1995, HORNBILLS BUCEROTIFO, V1; Kinnaird MF, 2007, THE ECOLOGY AND CONS; Kirika JM, 2008, CONSERV BIOL, V22, P318, DOI 10.1111/j.1523-1739.2007.00874.x; Kitamura S, 2011, ACTA OECOL, V37, P531, DOI 10.1016/j.actao.2011.01.015; Markl JS, 2012, CONSERV BIOL, V26, P1072, DOI 10.1111/j.1523-1739.2012.01927.x; Milner-Gulland EJ, 2003, TRENDS ECOL EVOL, V18, P351, DOI 10.1016/S0169-5347(03)00123-X; Naniwadekar R, 2014, THESIS; Nath PC, 2005, BIODIVERS CONSERV, V14, P2109, DOI 10.1007/s10531-004-4361-1; Nunez-Iturri G, 2008, BIOL CONSERV, V141, P1536, DOI 10.1016/j.biocon.2008.03.020; Peres CA, 2007, BIOTROPICA, V39, P304, DOI 10.1111/j.1744-7429.2007.00272.x; Proctor J, 1998, GLOBAL ECOL BIOGEOGR, V7, P141, DOI 10.2307/2997817; R Development Core Team, 2013, R LANG ENV STAT COMP, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; REDFORD KH, 1992, BIOSCIENCE, V42, P412, DOI 10.2307/1311860; Robinson J., 2000, HUNTING SUSTAINABILI; ROSENCRANZ A., 2007, ENV LAW REPORTER NEW, V37, P10032; Ruger N, 2009, J ECOL, V97, P1360, DOI 10.1111/j.1365-2745.2009.01552.x; Sethi P, 2009, CONSERV BIOL, V23, P710, DOI 10.1111/j.1523-1739.2008.01155.x; Srinivasan U, 2010, FORKTAIL, P92; Srivastava S, 2002, CURR SCI INDIA, V82, P1479; Stoner KE, 2007, BIOTROPICA, V39, P385, DOI 10.1111/j.1744-7429.2007.00291.x; Terborgh J, 2008, ECOLOGY, V89, P1757, DOI 10.1890/07-0479.1; Thiollay JM, 1997, BIODIVERS CONSERV, V6, P1155, DOI 10.1023/A:1018388202698; THIOLLAY JM, 1992, CONSERV BIOL, V6, P47, DOI 10.1046/j.1523-1739.1992.610047.x; Vanthomme H, 2010, BIOTROPICA, V42, P672, DOI 10.1111/j.1744-7429.2010.00630.x; Velho N, 2012, BIOL CONSERV, V153, P32, DOI 10.1016/j.biocon.2012.04.028; Wang BC, 2002, TRENDS ECOL EVOL, V17, P379, DOI 10.1016/S0169-5347(02)02541-7; Wenny DG, 2000, ECOL MONOGR, V70, P331, DOI 10.1890/0012-9615(2000)070[0331:SDSPAS]2.0.CO;2; Wright SJ, 2007, BIOTROPICA, V39, P363, DOI 10.1111/j.1744-7429.2007.00289.x	57	21	24	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120062	10.1371/journal.pone.0120062	http://dx.doi.org/10.1371/journal.pone.0120062			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781944	Green Accepted, Green Published, gold			2022-12-27	WOS:000351284600123
J	Prato, M; Magnetto, C; Jose, J; Khadjavi, A; Cavallo, F; Quaglino, E; Panariti, A; Rivolta, I; Benintende, E; Varetto, G; Argenziano, M; Troia, A; Cavalli, R; Guiot, C				Prato, Mauro; Magnetto, Chiara; Jose, Jithin; Khadjavi, Amina; Cavallo, Federica; Quaglino, Elena; Panariti, Alice; Rivolta, Ilaria; Benintende, Emilio; Varetto, Gianfranco; Argenziano, Monica; Troia, Adriano; Cavalli, Roberta; Guiot, Caterina			2H,3H-Decafluoropentane-Based Nanodroplets: New Perspectives for Oxygen Delivery to Hypoxic Cutaneous Tissues	PLOS ONE			English	Article							PHOTOACOUSTIC COMPUTED-TOMOGRAPHY; CHRONIC WOUNDS; BLOOD SUBSTITUTES; SURFACE-CHARGE; IN-VITRO; ULTRASOUND; NANOPARTICLES; THERAPY; HYDROGELS; DEXTRAN	Perfluoropentane (PFP)-based oxygen-loaded nanobubbles (OLNBs) were previously proposed as adjuvant therapeutic tools for pathologies of different etiology sharing hypoxia as a common feature, including cancer, infection, and autoimmunity. Here we introduce a new platform of oxygen nanocarriers, based on 2H,3H-decafluoropentane (DFP) as core fluorocarbon. These new nanocarriers have been named oxygen-loaded nanodroplets (OLNDs) since DFP is liquid at body temperature, unlike gaseous PFP. Dextran-shelled OLNDs, available either in liquid or gel formulations, display spherical morphology, similar to 600 nm diameters, anionic charge, good oxygen carrying capacity, and no toxic effects on human keratinocytes after cell internalization. In vitro OLNDs result more effective in releasing oxygen to hypoxic environments than former OLNBs, as demonstrated by analysis through oxymetry. In vivo, OLNDs effectively enhance oxy-hemoglobin levels, as emerged from investigation by photoacoustic imaging. Interestingly, ultrasound (US) treatment further improves transdermal oxygen release from OLNDs. Taken together, these data suggest that US-activated, DFP-based OLNDs might be innovative, suitable and cost-effective devices to topically treat hypoxia-associated pathologies of the cutaneous tissues.	[Prato, Mauro; Khadjavi, Amina; Guiot, Caterina] Univ Turin, Dipartimento Neurosci, Turin, Italy; [Magnetto, Chiara; Troia, Adriano] Ist Nazl Ric Metrol INRIM, Turin, Italy; [Jose, Jithin] FujiFilm VisualSon, Amsterdam, Netherlands; [Cavallo, Federica; Quaglino, Elena] Univ Turin, Ctr Mol Biotechnol, Dipartimento Biotecnol Mol & Sci Salute, Turin, Italy; [Panariti, Alice; Rivolta, Ilaria] Univ Milano Bicocca, Dipartimento Sci Salute, Monza, Italy; [Benintende, Emilio; Varetto, Gianfranco] Univ Turin, Dipartimento Sci Chirurg, Turin, Italy; [Argenziano, Monica; Cavalli, Roberta] Univ Turin, Dipartimento Sci & Tecnol Farmaco, Turin, Italy	University of Turin; Istituto Nazionale di Ricerca Metrologica (INRIM); Fujifilm Corporation; University of Turin; University of Milano-Bicocca; University of Turin; University of Turin	Prato, M (corresponding author), Univ Turin, Dipartimento Neurosci, Turin, Italy.	mauro.prato@unito.it; caterina.guiot@unito.it	Cavallo, Federica/C-5666-2011	Cavallo, Federica/0000-0003-4571-1060; Quaglino, Elena/0000-0002-8151-9124; Varetto, Gianfranco/0000-0003-4262-886X	Compagnia di San Paolo (Ateneo-SanPaolo) [ORTO11CE8R]; University of Torino	Compagnia di San Paolo (Ateneo-SanPaolo); University of Torino	Work funded by Compagnia di San Paolo (Ateneo-SanPaolo 2011 ORTO11CE8R grant to C. G.) and University of Torino (ex-60% grant to R. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Mottaleb MMA, 2012, J PHARM SCI-US, V101, P4231, DOI 10.1002/jps.23282; Bang JH, 2010, ADV MATER, V22, P1039, DOI 10.1002/adma.200904093; Bisazza A, 2008, IEEE ENG MED BIO, P2067, DOI 10.1109/IEMBS.2008.4649599; Bos GW, 2005, BIOMATERIALS, V26, P3901, DOI 10.1016/j.biomaterials.2004.10.008; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brimson CH, 2013, J EUR ACAD DERMATOL, V27, P411, DOI 10.1111/j.1468-3083.2012.04650.x; BROOKS DE, 1973, J COLLOID INTERF SCI, V43, P670, DOI 10.1016/0021-9797(73)90413-X; Cabrales P, 2013, ASAIO J, V59, P337, DOI 10.1097/MAT.0b013e318291fbaa; Castro CI, 2010, ARTIF ORGANS, V34, P622, DOI 10.1111/j.1525-1594.2009.00944.x; Cavalli R, 2009, INT J PHARMACEUT, V381, P160, DOI 10.1016/j.ijpharm.2009.07.010; Cavalli R, 2013, INT J PHARMACEUT, V456, P437, DOI 10.1016/j.ijpharm.2013.08.041; Cavalli R, 2012, INT J NANOMED, V7, P3309, DOI 10.2147/IJN.S30912; Cavalli R, 2009, INT J PHARMACEUT, V378, P215, DOI 10.1016/j.ijpharm.2009.05.058; Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; Davis SC, 2007, ARCH DERMATOL, V143, P1252, DOI 10.1001/archderm.143.10.1252; De Backer D, 2012, J CLIN MONIT COMPUT, V26, P361, DOI 10.1007/s10877-012-9383-8; De Groot CJ, 2001, BIOMATERIALS, V22, P1197, DOI 10.1016/S0142-9612(00)00266-0; Dietz I, 2012, MICROBES INFECT, V14, P311, DOI 10.1016/j.micinf.2011.11.003; Dushkin AV, 2013, PHARM CHEM J+, V46, P630, DOI 10.1007/s11094-013-0859-8; Gordillo GM, 2008, CLIN EXP PHARMACOL P, V35, P957, DOI 10.1111/j.1440-1681.2008.04934.x; Gordillo GM, 2009, INT J LOW EXTR WOUND, V8, P105, DOI 10.1177/1534734609335149; Jose J, 2011, OPT EXPRESS, V19, P2093, DOI 10.1364/OE.19.002093; Kagan D, 2012, ANGEW CHEM INT EDIT, V51, P7519, DOI 10.1002/anie.201201902; Kim JW, 2007, CANCER METAST REV, V26, P291, DOI 10.1007/s10555-007-9060-4; KNIGHTON DR, 1981, SURGERY, V90, P262; Kogan Paul, 2010, Bubble Sci Eng Technol, V2, P3, DOI 10.1179/175889610X12730566149100; Kotopoulis S, 2014, MOL IMAGING BIOL, V16, P53, DOI 10.1007/s11307-013-0672-5; Kotopoulis S, 2013, MED PHYS, V40, DOI 10.1118/1.4808149; Krafft MP, 1998, BIOCHIMIE, V80, P489, DOI 10.1016/S0300-9084(00)80016-4; Laser institute of America, 2007, AMERICAN NATIONAL ST; Laufer J, 2007, PHYS MED BIOL, V52, P141, DOI 10.1088/0031-9155/52/1/010; Lee O, 2013, SKIN RES TECHNOL, V19, pE390, DOI 10.1111/j.1600-0846.2012.00656.x; Liu YY, 2006, J CONTROL RELEASE, V114, P89, DOI 10.1016/j.jconrel.2006.05.018; Lopez RFV, 2011, BIOMATERIALS, V32, P933, DOI 10.1016/j.biomaterials.2010.09.060; Lundgren CEG, 2004, UNDERSEA HYPERBAR M, V31, P105; Magnetto C, 2014, RSC ADV, V4, P38433, DOI 10.1039/c4ra03524k; Mathieu Daniel, 2007, Int J Low Extrem Wounds, V6, P273, DOI 10.1177/1534734607310299; Modery-Pawlowski CL, 2013, BIOMACROMOLECULES, V14, P939, DOI 10.1021/bm400074t; Moller S, 2007, BIOMOL ENG, V24, P496, DOI 10.1016/j.bioeng.2007.08.014; PINNICK RG, 1990, APPL OPTICS, V29, P918, DOI 10.1364/AO.29.000918; Postema M, 2011, WORLD J GASTROENTERO, V17, P28, DOI 10.3748/wjg.v17.i1.28; Rapoport NY, 2004, ULTRASONICS, V42, P943, DOI 10.1016/j.ultras.2004.01.087; Resink S, 2011, OPT LETT, V36, P2809, DOI 10.1364/OL.36.002809; Riess JG, 1999, MRS BULL, V24, P42, DOI 10.1557/S0883769400052313; Ryman-Rasmussen JP, 2007, J INVEST DERMATOL, V127, P143, DOI 10.1038/sj.jid.5700508; Said HK, 2005, ARCH SURG-CHICAGO, V140, P998, DOI 10.1001/archsurg.140.10.998; Sen CK, 2009, WOUND REPAIR REGEN, V17, P1, DOI 10.1111/j.1524-475X.2008.00436.x; Sheikh AY, 2000, ARCH SURG-CHICAGO, V135, P1293, DOI 10.1001/archsurg.135.11.1293; Sola A, 2014, ACTA PAEDIATR, V103, P1009, DOI 10.1111/apa.12692; Sze A, 2003, J COLLOID INTERF SCI, V261, P402, DOI 10.1016/S0021-9797(03)00142-5; Takahashi M., 2009, MAT INTEGR, V22, P2; Thackham JA, 2008, WOUND REPAIR REGEN, V16, P321, DOI 10.1111/j.1524-475X.2008.00372.x; Torchilin V, 2009, EUR J PHARM BIOPHARM, V71, P431, DOI 10.1016/j.ejpb.2008.09.026; Wu X, 2010, SKIN PHARMACOL PHYS, V23, P117, DOI 10.1159/000270381; Xia YP, 2001, J INVEST DERMATOL, V116, P50, DOI 10.1046/j.1523-1747.2001.00209.x; Young Robert W, 2012, J Extra Corpor Technol, V44, P241; Zbytek B, 2013, DERM-ENDOCRINOL, V5, P239, DOI 10.4161/derm.22678	57	33	34	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119769	10.1371/journal.pone.0119769	http://dx.doi.org/10.1371/journal.pone.0119769			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781463	Green Published, gold, Green Submitted			2022-12-27	WOS:000351284600090
J	Qi, K; Li, LJ; Li, XD; Zhao, JL; Wang, Y; You, SJ; Hu, FH; Zhang, HT; Cheng, YT; Kang, S; Cui, HH; Duan, L; Jin, C; Zheng, QS; Yang, YJ				Qi, Kang; Li, Lujin; Li, Xiangdong; Zhao, Jinglin; Wang, Yang; You, Shijie; Hu, Fenghuan; Zhang, Haitao; Cheng, Yutong; Kang, Sheng; Cui, Hehe; Duan, Lian; Jin, Chen; Zheng, Qingshan; Yang, Yuejin			Cardiac Microvascular Barrier Function Mediates the Protection of Tongxinluo against Myocardial Ischemia/Reperfusion Injury	PLOS ONE			English	Article							K-ATP CHANNEL; REPERFUSED SWINE HEARTS; NITRIC-OXIDE SYNTHASE; NO-REFLOW PHENOMENON; ANGIOPOIETIN-LIKE 4; VASCULAR-PERMEABILITY; VE-CADHERIN; CARDIOMYOCYTE HYPERTROPHY; ENDOTHELIAL PERMEABILITY; ADHERENS JUNCTIONS	Objective Tongxinluo (TXL) has been shown to decrease myocardial necrosis after ischemia/ reperfusion (I/R) by simulating ischemia preconditioning (IPC). However, the core mechanism of TXL remains unclear. This study was designed to investigate the key targets of TXL against I/R injury (IRI) among the cardiac structure-function network. Materials and Methods To evaluate the severity of lethal IRI, a mathematical model was established according to the relationship between myocardial no-reflow size and necrosis size. A total of 168 miniswine were employed in myocardial I/R experiment. IRI severity among different interventions was compared and IPC and CCB groups were identified as the mildest and severest groups, respectively. Principal component analysis was applied to further determine 9 key targets of IPC in cardioprotection. Then, the key targets of TXL in cardioprotection were confirmed. Results Necrosis size and no-reflow size fit well with the Sigmoid Emaxmodel. Necrosis reduction space (NRS) positively correlates with I/R injury severity and necrosis size (R2= 0.92, R-2= 0.57, P< 0.01, respectively). Functional and structural indices correlate positively with NRS (R-2= 0.64, R-2= 0.62, P< 0.01, respectively). TXL recovers SUR2, iNOS activity, eNOS activity, VE-cadherin, beta-catenin, gamma-catenin and P-selectin with a trend toward the sham group. Moreover, TXL increases PKA activity and eNOS expression with a trend away fromthe sham group. Among the above nine indices, eNOS activity, eNOS, VE-cadherin, beta-catenin and gamma-catenin expression were significantly up-regulated by TXL compared with IPC (P>0.05) or CCB (P<0.05) and these five microvascular barrier-related indices may be the key targets of TXL inminimizing IRI. Conclusions Our study underlines the lethal IRI as one of the causes of myocardial necrosis. Pretreatment with TXL ameliorates myocardial IRI through promoting cardiac microvascular endothelial barrier function by simulating IPC.	[Qi, Kang; Li, Xiangdong; Zhao, Jinglin; You, Shijie; Hu, Fenghuan; Zhang, Haitao; Cheng, Yutong; Kang, Sheng; Cui, Hehe; Duan, Lian; Jin, Chen; Yang, Yuejin] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China; [Qi, Kang; Li, Xiangdong; Zhao, Jinglin; Wang, Yang; You, Shijie; Hu, Fenghuan; Zhang, Haitao; Cheng, Yutong; Kang, Sheng; Cui, Hehe; Duan, Lian; Jin, Chen; Yang, Yuejin] Peking Union Med Coll, Beijing 100037, Peoples R China; [Li, Lujin; Zheng, Qingshan] Shanghai Univ Chinese Med, Ctr Drug Clin Res, Shanghai 201203, Peoples R China; [Wang, Yang] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Biol Informat & Stat Ctr, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Shanghai University of Traditional Chinese Medicine; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS	Yang, YJ (corresponding author), Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China.	yangyjfw@126.com	Li, Lujin/ABA-6800-2021		National Basic Research Program (973 Program) of China [2012CB518602, 2005CB523303]; National Natural Science Foundation of China [81370223, 30770858, 30572439, 902090038]; Beijing Natural Science Foundation [7042044]; Capital Medical Development Scientific Research Fund [2002-3072]; Postgraduates' Innovative Foundation of Peking Union Medical College, China [2013-1002-39]	National Basic Research Program (973 Program) of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Capital Medical Development Scientific Research Fund; Postgraduates' Innovative Foundation of Peking Union Medical College, China	This study was supported by National Basic Research Program (973 Program) of China (No. 2012CB518602; No. 2005CB523303, http://www.973.gov.cn/AreaAppl.aspx; KQ, XL, JZ, SY, FH, HZ, YC, SK, HC, LD, CJ, YY), National Natural Science Foundation of China (No. 81370223; No. 30770858; No. 30572439; No. 902090038, http://www.nsfc.gov.cn; KQ, XL, JZ, SY, FH, HZ, YC, SK, HC, LD, CJ, YY), Beijing Natural Science Foundation (No. 7042044, http://www.bjnsf.org; JZ, SY, FH, CJ, YY), Capital Medical Development Scientific Research Fund (No. 2002-3072, http://www. bjhbkj. com; JZ, SY, FH, CJ, YY) and Postgraduates' Innovative Foundation of Peking Union Medical College, China (2013-1002-39; http://graduate. pumc. edu. cn/peiyang/view/86. aspx; KQ). All funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekkers SCAM, 2010, J AM COLL CARDIOL, V55, P1649, DOI 10.1016/j.jacc.2009.12.037; Bernardo NL, 1999, AM J PHYSIOL-HEART C, V276, pH1323, DOI 10.1152/ajpheart.1999.276.4.H1323; Bolli R, 2004, CIRC RES, V95, P125, DOI 10.1161/01.RES.0000137171.97172.d7; Bouleti C, 2013, EUR HEART J, V34, P3657, DOI 10.1093/eurheartj/eht153; Cheng YT, 2009, CHINESE MED J-PEKING, V122, P1529, DOI 10.3760/cma.j.issn.0366-6999.2009.13.011; Cheng YuTong, 2009, Shandong Medical Journal, V49, P4; Clement LC, 2014, NAT MED, V20, P37, DOI 10.1038/nm.3396; Corada M, 2001, BLOOD, V97, P1679, DOI 10.1182/blood.V97.6.1679; Csonka C, 2010, J PHARMACOL TOX MET, V61, P163, DOI 10.1016/j.vascn.2010.02.014; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Duan L, 2010, SHANDONG YI YAO, V50, P3; [段炼 DUAN Lian], 2010, [中国病理生理杂志, Chinese Journal of Pathophysiology], V26, P430; Facundo HTF, 2005, J BIOENERG BIOMEMBR, V37, P75, DOI 10.1007/s10863-005-4130-1; Galaup A, 2006, P NATL ACAD SCI USA, V103, P18721, DOI 10.1073/pnas.0609025103; Galaup A, 2012, CIRCULATION, V125, P140, DOI 10.1161/CIRCULATIONAHA.111.049072; Genda S, 2002, J AM COLL CARDIOL, V40, P1339, DOI 10.1016/S0735-1097(02)02156-3; Gerczuk PZ, 2012, J AM COLL CARDIOL, V59, P969, DOI 10.1016/j.jacc.2011.07.054; Giannotta M, 2013, DEV CELL, V26, P441, DOI 10.1016/j.devcel.2013.08.020; Guo JA, 2011, CIRC-HEART FAIL, V4, P79, DOI 10.1161/CIRCHEARTFAILURE.110.957969; Hausenloy DJ, 2006, CARDIOVASC RES, V70, P240, DOI 10.1016/j.cardiores.2006.01.017; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; Ikeno F, 2007, CARDIOVASC RES, V73, P699, DOI 10.1016/j.cardiores.2006.12.011; Kang Sheng, 2009, Cardiovascular & Hematological Disorders - Drug Targets, V9, P107; Karalliedde LD, 2009, AM J PHYSIOL-HEART C, V297, pH1967, DOI 10.1152/ajpheart.00944.2009; Kumar P, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001112; Lee WL, 2010, NEW ENGL J MED, V363, P689, DOI 10.1056/NEJMcibr1007320; Lee WW, 2012, J AM COLL CARDIOL, V59, P153, DOI 10.1016/j.jacc.2011.08.066; Li LJ, 2009, PHARMACOL RES, V60, P277, DOI 10.1016/j.phrs.2009.04.001; Li XD, 2013, INT J CARDIOL, V167, P2657, DOI 10.1016/j.ijcard.2012.06.121; Li XD, 2013, CHINESE MED J-PEKING, V126, P1469, DOI 10.3760/cma.j.issn.0366-6999.20130224; Li Xiang-dong, 2012, Zhonghua Xin Xue Guan Bing Za Zhi, V40, P945; Li XD, 2012, ACTA PHARMACOL SIN, V33, P879, DOI 10.1038/aps.2012.27; Li XD, 2012, MICROVASC RES, V84, P44, DOI 10.1016/j.mvr.2012.04.002; Li XD, 2010, AM J PHYSIOL-HEART C, V299, pH1255, DOI 10.1152/ajpheart.00459.2010; Li Z, 2012, BIOCHEM BIOPH RES CO, V425, P630, DOI 10.1016/j.bbrc.2012.07.130; Maeng YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068659; Milligan PA, 2013, CLIN PHARMACOL THER, V93, P502, DOI 10.1038/clpt.2013.54; Moey M, 2012, CIRC-HEART FAIL, V5, P504, DOI 10.1161/CIRCHEARTFAILURE.112.967489; Muscari C, 2004, LIFE SCI, V74, P1127, DOI 10.1016/j.lfs.2003.10.001; Nicholson JK, 2008, J PROTEOME RES, V7, P3637, DOI 10.1021/pr8005099; O'Rourke B, 2000, CIRC RES, V87, P845, DOI 10.1161/01.RES.87.10.845; OH B, 2013, EUR HEART J, V34, P932, DOI [10.1093/eurheartj/ehs396, DOI 10.1093/EURHEARTJ/EHS396]; Rezkalla SH, 2008, CATHETER CARDIO INTE, V72, P950, DOI 10.1002/ccd.21715; Ruder TD, 2013, FORENSIC SCI MED PAT, V9, P501, DOI 10.1007/s12024-013-9459-x; Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987; Wu ZQ, 2006, MOL PHARMACOL, V69, P866, DOI 10.1124/mol.106.016501; Xuan YT, 2007, CIRCULATION, V116, P535, DOI 10.1161/CIRCULATIONAHA.107.689471; Yang CJ, 2013, CARDIOVASC RES, V97, P33, DOI 10.1093/cvr/cvs287; Yang YJ, 2006, HEART, V92, P1131, DOI 10.1136/hrt.2005.077164; Yang YJ, 2007, EUR J HEART FAIL, V9, P30, DOI 10.1016/j.ejheart.2006.04.013; Zhang HT, 2010, CHINESE MED J-PEKING, V123, P2858, DOI 10.3760/cma.j.issn.0366-6999.2010.20.021; Zhang Hai-tao, 2009, Zhonghua Yi Xue Za Zhi, V89, P1421; Zhang L, 2009, AM J PHYSIOL-HEART C, V297, pH2004, DOI 10.1152/ajpheart.00208.2009; Zhao JL, 2006, BRIT J PHARMACOL, V149, P243, DOI 10.1038/sj.bjp.0706862; Zhao JL, 2007, MICROVASC RES, V73, P137, DOI 10.1016/j.mvr.2006.09.002; Zhao JL, 2006, CLIN CHIM ACTA, V374, P100, DOI 10.1016/j.cca.2006.05.039; Zhao JL, 2006, CORONARY ARTERY DIS, V17, P463, DOI 10.1097/00019501-200608000-00010; Zhao JL, 2006, CARDIOVASC DRUG THER, V20, P167, DOI 10.1007/s10557-006-8284-9; Zhao Jing-Lin, 2005, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V27, P486; Zhao JL, 2007, INT J CARDIOL, V115, P334, DOI 10.1016/j.ijcard.2006.03.017	62	19	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119846	10.1371/journal.pone.0119846	http://dx.doi.org/10.1371/journal.pone.0119846			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781461	Green Submitted, Green Published, gold			2022-12-27	WOS:000351284600100
J	Quan, FB; Dubessy, C; Galant, S; Kenigfest, NB; Djenoune, L; Leprince, J; Wyart, C; Lihrmann, I; Tostivint, H				Quan, Feng B.; Dubessy, Christophe; Galant, Sonya; Kenigfest, Natalia B.; Djenoune, Lydia; Leprince, Jerome; Wyart, Claire; Lihrmann, Isabelle; Tostivint, Herve			Comparative Distribution and In Vitro Activities of the Urotensin II-Related Peptides URP1 and URP2 in Zebrafish: Evidence for Their Colocalization in Spinal Cerebrospinal Fluid-Contacting Neurons	PLOS ONE			English	Article							ONCORHYNCHUS-MYKISS; GABA IMMUNOCYTOCHEMISTRY; ENDOGENOUS LIGAND; SEQUENCE-ANALYSIS; ORPHAN RECEPTOR; MESSENGER-RNAS; CORD NEURONS; RAT-BRAIN; EXPRESSION; SYSTEM	Urotensin II (UII) is an evolutionarily conserved neuropeptide initially isolated from teleost fish on the basis of its smooth muscle-contracting activity. Subsequent studies have demonstrated the occurrence of several UII-related peptides (URPs), such that the UII family is now known to include four paralogue genes called UII, URP, URP1 and URP2. These genes probably arose through the two rounds of whole genome duplication that occurred during early vertebrate evolution. URP has been identified both in tetrapods and teleosts. In contrast, URP1 and URP2 have only been observed in ray-finned and cartilaginous fishes, suggesting that both genes were lost in the tetrapod lineage. In the present study, the distribution of urp1 mRNA compared to urp2 mRNA is reported in the central nervous system of zebrafish. In the spinal cord, urp1 and urp2 mRNAs were mainly colocalized in the same cells. These cells were also shown to be GABAergic and express the gene encoding the polycystic kidney disease 2-like 1 (pkd2l1) channel, indicating that they likely correspond to cerebrospinal fluid-contacting neurons. In the hindbrain, urp1-expressing cells were found in the intermediate reticular formation and the glossopharyngeal-vagal motor nerve nuclei. We also showed that synthetic URP1 and URP2 were able to induce intracellular calcium mobilization in human UII receptor (hUT)-transfected CHO cells with similar potencies (pEC50=7.99 and 7.52, respectively) albeit at slightly lower potencies than human UII and mammalian URP (pEC50=9.44 and 8.61, respectively). The functional redundancy of URP1 and URP2 as well as the colocalization of their mRNAs in the spinal cord suggest the robustness of this peptidic system and its physiological importance in zebrafish.	[Quan, Feng B.; Kenigfest, Natalia B.; Djenoune, Lydia; Tostivint, Herve] UMR 7221 CNRS, Evolut Regulat Endocriniennes, Paris, France; [Quan, Feng B.; Kenigfest, Natalia B.; Djenoune, Lydia; Tostivint, Herve] Museum Natl Hist Nat, F-75231 Paris, France; [Dubessy, Christophe; Leprince, Jerome; Lihrmann, Isabelle] Univ Rouen, INSERM, U982, Mont St Aignan, France; [Dubessy, Christophe; Leprince, Jerome; Lihrmann, Isabelle] Univ Rouen, Lab Neuronal & Neuroendocrine Differentiat & Comm, Inst Res & Innovat Biomed, Mont St Aignan, France; [Dubessy, Christophe; Leprince, Jerome; Lihrmann, Isabelle] Univ Rouen, Normandy Univ, Mont St Aignan, France; [Galant, Sonya] Inst Alfred Fessard, CNRS UPR 3294, Lab Neurobiol & Dev, Gif Sur Yvette, France; [Kenigfest, Natalia B.] Russian Acad Sci, Sechenov Inst Evolutionary Physiol & Biochem, Lab Evolut Neuronal Interact, St Petersburg 196140, Russia; [Djenoune, Lydia; Wyart, Claire] Univ Paris 06, Sorbonne Univ, Inst Cerveau & Moelle Epiniere, ICM,Inserm 1127,CNRS,UMR 7225,UMR S 1127, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Museum National d'Histoire Naturelle (MNHN); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; Universite de Rouen Normandie; Universite de Rouen Normandie; Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Tostivint, H (corresponding author), UMR 7221 CNRS, Evolut Regulat Endocriniennes, Paris, France.	htostivi@mnhn.fr	Lihrmann, Isabelle/K-9126-2015; Wyart, Claire/H-3783-2016; Wyart, Claire/AAB-4603-2020; Tostivint, Hervé/P-8524-2019; Lihrmann, Isabelle/S-6464-2019; Dubessy, Christophe/C-2887-2015; Leprince, Jerome/N-9083-2017	Wyart, Claire/0000-0002-1668-4975; Wyart, Claire/0000-0002-1668-4975; Tostivint, Hervé/0000-0002-0719-0922; Lihrmann, Isabelle/0000-0002-4486-7074; Dubessy, Christophe/0000-0001-9252-0959; QUAN, Feng B/0000-0002-1948-7889; Leprince, Jerome/0000-0002-7814-9927; Djenoune, Lydia/0000-0002-9105-3575	Centre National de la Recherche Scientifique; Museum National d'Histoire Naturelle; Institut de la Sante et de la Recherche Medicale; University of Rouen; Conseil Regional de Haute-Normandie; network Ecole des Neurosciences de Paris (ENP); Fondation Bettencourt Schueller (FBS); City of Paris Emergence program; Atip/Avenir junior program from INSERM; CNRS; Fyssen foundation; International Reintegration Grant from Marie Curie Actions Framework Program; European Research Council (ERC) starter grant "OptoLoco"	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Museum National d'Histoire Naturelle; Institut de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Rouen; Conseil Regional de Haute-Normandie(Region Normandie); network Ecole des Neurosciences de Paris (ENP); Fondation Bettencourt Schueller (FBS); City of Paris Emergence program(Region Ile-de-France); Atip/Avenir junior program from INSERM; CNRS(Centre National de la Recherche Scientifique (CNRS)); Fyssen foundation; International Reintegration Grant from Marie Curie Actions Framework Program; European Research Council (ERC) starter grant "OptoLoco"(European Research Council (ERC))	This research was supported by funding obtained from the Centre National de la Recherche Scientifique and the Museum National d'Histoire Naturelle to HT, and from the Institut de la Sante et de la Recherche Medicale, the University of Rouen and the Conseil Regional de Haute-Normandie to CD and IL. CW received financial support from the network Ecole des Neurosciences de Paris (ENP), the Fondation Bettencourt Schueller (FBS), Mr Pierre Belle, the City of Paris Emergence program, the Atip/Avenir junior program from INSERM and CNRS, the Fyssen foundation, the International Reintegration Grant from Marie Curie Actions Framework Program 6, and the European Research Council (ERC) starter grant "OptoLoco". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agduhr E., 1922, Zeitschrift Ges Anat Munchen Abt 1, V66, P223, DOI 10.1007/BF02593586; Alunni A, 2013, DEVELOPMENT, V140, P3335, DOI 10.1242/dev.095018; Ames RS, 1999, NATURE, V401, P282, DOI 10.1038/45809; Becker T, 1997, J COMP NEUROL, V377, P577, DOI 10.1002/(SICI)1096-9861(19970127)377:4<577::AID-CNE8>3.0.CO;2-#; BERNHARDT RR, 1992, J COMP NEUROL, V326, P263, DOI 10.1002/cne.903260208; Boivin S, 2008, PEPTIDES, V29, P700, DOI 10.1016/j.peptides.2008.02.024; Boucard AA, 2003, BIOCHEM J, V370, P829, DOI 10.1042/BJ20021566; BUCHANAN JT, 1987, BRAIN RES, V408, P299, DOI 10.1016/0006-8993(87)90392-1; Chatenet D, 2004, PEPTIDES, V25, P1819, DOI 10.1016/j.peptides.2004.04.019; Chatenet D, 2006, J MED CHEM, V49, P7234, DOI 10.1021/jm0602110; Clemente D, 2004, J COMP NEUROL, V474, P75, DOI 10.1002/cne.20111; CONLON JM, 1992, BIOCHEM BIOPH RES CO, V188, P578, DOI 10.1016/0006-291X(92)91095-8; CONLON JM, 1992, NEUROENDOCRINOLOGY, V55, P230; Coulouarn Y, 1999, FEBS LETT, V457, P28, DOI 10.1016/S0014-5793(99)01003-0; Coulouarn Y, 1998, P NATL ACAD SCI USA, V95, P15803, DOI 10.1073/pnas.95.26.15803; DALE N, 1987, PROC R SOC SER B-BIO, V232, P193, DOI 10.1098/rspb.1987.0068; DALE N, 1987, PROC R SOC SER B-BIO, V232, P205, DOI 10.1098/rspb.1987.0069; Devos N, 2002, MECH DEVELOP, V115, P133, DOI 10.1016/S0925-4773(02)00082-5; Djenoune L, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00026; Dubessy C, 2008, J NEUROCHEM, V107, P361, DOI 10.1111/j.1471-4159.2008.05624.x; Higashijima S, 2000, J NEUROSCI, V20, P206, DOI 10.1523/JNEUROSCI.20-01-00206.2000; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; ICHIKAWA T, 1988, GEN COMP ENDOCR, V71, P493, DOI 10.1016/0016-6480(88)90279-1; Jalalvand E, 2014, J COMP NEUROL, V522, P1753, DOI 10.1002/cne.23542; Kinney WA, 2002, ANGEW CHEM INT EDIT, V41, P2940, DOI 10.1002/1521-3773(20020816)41:16<2940::AID-ANIE2940>3.0.CO;2-M; Kolmer W., 1921, Zeitschrift Ges Anat Munchen Abt 1, V60, P652, DOI 10.1007/BF02593657; Konno N, 2013, GEN COMP ENDOCR, V185, P44, DOI 10.1016/j.ygcen.2013.01.015; Labarrere P, 2003, J ENZYM INHIB MED CH, V18, P77, DOI 10.1080/1475636031000093507; LAMOTTE CC, 1991, J COMP NEUROL, V306, P290, DOI 10.1002/cne.903060206; Lancien F, 2004, BRAIN RES, V1023, P167, DOI 10.1016/j.brainres.2004.07.008; Lavecchia A, 2005, J MED CHEM, V48, P2480, DOI 10.1021/jm049110x; Le Mevel JC, 2008, PEPTIDES, V29, P830, DOI 10.1016/j.peptides.2007.06.020; Le Mevel Jean-Claude, 2012, Front Endocrinol (Lausanne), V3, P124, DOI 10.3389/fendo.2012.00124; LeMevel JC, 1996, AM J PHYSIOL-REG I, V271, pR1335, DOI 10.1152/ajpregu.1996.271.5.R1335; Leprince J, 2001, EUR J BIOCHEM, V268, P6045, DOI 10.1046/j.0014-2956.2001.02533.x; Lihrmann I, 2013, HDB BIOL ACTIVE PEPT, P957; Liu QY, 1999, BIOCHEM BIOPH RES CO, V266, P174, DOI 10.1006/bbrc.1999.1796; Lu WQ, 2006, ENDOCRINOLOGY, V147, P3692, DOI 10.1210/en.2005-1457; Martin SC, 1998, J COMP NEUROL, V396, P253; MCMASTER D, 1992, GEN COMP ENDOCR, V87, P275, DOI 10.1016/0016-6480(92)90032-F; Mori M, 1999, BIOCHEM BIOPH RES CO, V265, P123, DOI 10.1006/bbrc.1999.1640; Mueller T, 2004, BRAIN RES, V1011, P156, DOI 10.1016/j.brainres.2004.02.073; Nobata S, 2011, AM J PHYSIOL-REG I, V300, pR437, DOI 10.1152/ajpregu.00629.2010; Nothacker HP, 1999, NAT CELL BIOL, V1, P383, DOI 10.1038/14081; Ohata S, 2009, DEVELOPMENT, V136, P1653, DOI 10.1242/dev.033290; OHSAKO S, 1986, J NEUROSCI, V6, P2730; Orts-Del'Immagine A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087748; Park HC, 2004, DEVELOPMENT, V131, P5959, DOI 10.1242/dev.01456; Parmentier C, 2008, PEPTIDES, V29, P820, DOI 10.1016/j.peptides.2008.01.023; Parmentier C, 2011, ENDOCRINOLOGY, V152, P2330, DOI 10.1210/en.2010-1500; PEARSON D, 1980, P NATL ACAD SCI-BIOL, V77, P5021, DOI 10.1073/pnas.77.8.5021; Pelletier G, 2005, NEUROSCIENCE, V132, P689, DOI 10.1016/j.neuroscience.2004.12.045; Pelletier G, 2002, NEUROSCIENCE, V115, P525, DOI 10.1016/S0306-4522(02)00413-X; Quan FB, 2012, GEN COMP ENDOCR, V177, P205, DOI 10.1016/j.ygcen.2012.02.018; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sugo T, 2003, BIOCHEM BIOPH RES CO, V310, P860, DOI 10.1016/j.bbrc.2003.09.102; Tostivint H, 2006, P NATL ACAD SCI USA, V103, P2237, DOI 10.1073/pnas.0510700103; Tostivint H, 2014, J MOL ENDOCRINOL, V52, pT61, DOI 10.1530/JME-13-0274; Tostivint H, 2013, GEN COMP ENDOCR, V188, P110, DOI 10.1016/j.ygcen.2012.12.015; Vaudry H, 2010, ANN NY ACAD SCI, V1200, P53, DOI 10.1111/j.1749-6632.2010.05514.x; Vigh B, 1998, MICROSC RES TECHNIQ, V41, P57, DOI 10.1002/(SICI)1097-0029(19980401)41:1<57::AID-JEMT6>3.0.CO;2-R; WAUGH D, 1995, GEN COMP ENDOCR, V99, P323, DOI 10.1006/gcen.1995.1116; WAUGH D, 1993, GEN COMP ENDOCR, V92, P419, DOI 10.1006/gcen.1993.1178; Wulliman MF, 1996, NEUROANATOMY ZEBRAFI; Wyart C, 2009, NATURE, V461, P407, DOI 10.1038/nature08323; Yang LX, 2010, DEVELOPMENT, V137, P2713, DOI 10.1242/dev.048470; YULIS CR, 1988, CELL TISSUE RES, V254, P539; YULIS CR, 1988, GEN COMP ENDOCR, V70, P301, DOI 10.1016/0016-6480(88)90150-5; YULIS CR, 1986, P NATL ACAD SCI USA, V83, P7079, DOI 10.1073/pnas.83.18.7079	69	24	25	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119290	10.1371/journal.pone.0119290	http://dx.doi.org/10.1371/journal.pone.0119290			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781313	Green Published, gold, Green Submitted			2022-12-27	WOS:000351284600059
J	Silva, RA; Palladino, MV; Cavalheiro, RP; Machado, D; Cruz, BLG; Paredes-Gamero, EJ; Gomes-Marcondes, MCC; Zambuzzi, WF; Vasques, L; Nader, HB; Souza, ACS; Justo, GZ				Silva, Rodrigo A.; Palladino, Marcelly V.; Cavalheiro, Renan P.; Machado, Daisy; Cruz, Bread L. G.; Paredes-Gamero, Edgar J.; Gomes-Marcondes, Maria C. C.; Zambuzzi, Willian F.; Vasques, Luciana; Nader, Helena B.; Souza, Ana Carolina S.; Justo, Giselle Z.			Activation of the Low Molecular Weight Protein Tyrosine Phosphatase in Keratinocytes Exposed to Hyperosmotic Stress	PLOS ONE			English	Article							REDOX REGULATION; CELL-LINE; OSTEOBLAST ADHESION; SIGNALING PATHWAYS; VITAMIN-D; LMW-PTP; GROWTH; PHOSPHORYLATION; CYTOSKELETON; APOPTOSIS	Herein, we provide new contribution to the mechanisms involved in keratinocytes response to hyperosmotic shock showing, for the first time, the participation of Low Molecular Weight Protein Tyrosine Phosphatase (LMWPTP) activity in this event. We reported that sorbitol-induced osmotic stress mediates alterations in the phosphorylation of pivotal cytoskeletal proteins, particularly Src and cofilin. Furthermore, an increase in the expression of the phosphorylated form of LMWPTP, which was followed by an augment in its catalytic activity, was observed. Of particular importance, these responses occurred in an intracellular milieu characterized by elevated levels of reduced glutathione (GSH) and increased expression of the antioxidant enzymes glutathione peroxidase and glutathione reductase. Altogether, our results suggest that hyperosmostic stress provides a favorable cellular environment to the activation of LMWPTP, which is associated with increased expression of antioxidant enzymes, high levels of GSH and inhibition of Src kinase. Finally, the real contribution of LMWPTP in the hyperosmotic stress response of keratinocytes was demonstrated through analysis of the effects of ACP1 gene knockdown in stressed and non-stressed cells. LMWPTP knockdown attenuates the effects of sorbitol induced-stress in HaCaT cells, mainly in the status of Src kinase, Rac and STAT5 phosphorylation and activity. These results describe for the first time the participation of LMWPTP in the dynamics of cytoskeleton rearrangement during exposure of human keratinocytes to hyperosmotic shock, which may contribute to cell death.	[Silva, Rodrigo A.; Machado, Daisy; Cruz, Bread L. G.; Gomes-Marcondes, Maria C. C.; Justo, Giselle Z.] Univ Estadual Campinas, Dept Bioquim, Inst Biol, Sao Paulo, Brazil; [Palladino, Marcelly V.; Cavalheiro, Renan P.; Paredes-Gamero, Edgar J.; Nader, Helena B.; Justo, Giselle Z.] Univ Fed Sao Paulo, Dept Bioquim, Sao Paulo, SP, Brazil; [Zambuzzi, Willian F.] Univ Estadual Paulista, Dept Quim & Bioquim, IBB, Sao Paulo, Brazil; [Vasques, Luciana] Univ Sao Paulo, Dept Genet & Biol Evolut, Sao Paulo, SP, Brazil; [Souza, Ana Carolina S.] Univ Fed ABC, Ctr Ciencias Nat & Humanas, Sao Paulo, Brazil; [Justo, Giselle Z.] Univ Fed Sao Paulo, Dept Ciencias Biol, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Federal de Sao Paulo (UNIFESP); Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Federal do ABC (UFABC); Universidade Federal de Sao Paulo (UNIFESP)	Justo, GZ (corresponding author), Univ Estadual Campinas, Dept Bioquim, Inst Biol, Sao Paulo, Brazil.	giselle.zenker@unifesp.br	Nader, Helena Bonciani/D-9253-2012; Vasques, Luciana/C-7273-2012; Paredes-Gamero, Edgar J/C-4791-2012; Santos, Ana Carolina/GWR-2410-2022; Gomes-Marcondes, Maria Cristina Cintr c/C-3384-2012; Marcondes, Maria Cristina Cintra Gomes/S-9177-2019; Machado, Daisy/ABA-3731-2020; de Souza Galvão, Ana Carolina Santos/B-8114-2014; Machado, Daisy/A-4891-2013; Zambuzzi, Willian/ABD-8339-2020; da Silva, Rodrigo Augusto/G-1222-2012; Silva, Rodrigo/GXM-7197-2022; Zambuzzi, Willian Fernando/F-9519-2012	Vasques, Luciana/0000-0003-2229-6773; Paredes-Gamero, Edgar J/0000-0003-3686-8402; Gomes-Marcondes, Maria Cristina Cintr c/0000-0002-1713-756X; Marcondes, Maria Cristina Cintra Gomes/0000-0002-1713-756X; Machado, Daisy/0000-0002-6435-6159; de Souza Galvão, Ana Carolina Santos/0000-0003-1748-3494; Machado, Daisy/0000-0002-6435-6159; da Silva, Rodrigo Augusto/0000-0002-7754-1855; Zambuzzi, Willian Fernando/0000-0002-4149-5965; NADER, HELENA/0000-0002-7569-2166; Cruz, Bread/0000-0002-2287-6383	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Rede Nanocosmeticos/CNPq; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); FAPESP [2006/07315-3]; CNPq [PQ-2]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Rede Nanocosmeticos/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (www.fapesp.br), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(www.cnpq.br) and Rede Nanocosmeticos/CNPq. The authors also acknowledge support from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(www.capes.gov.br). R. A. S. is supported by a PhD scholarship from FAPESP (Grant nr. 2006/07315-3). W. F. Z. is supported by a fellowship from CNPq (PQ-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alho I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076307; Berger Angelika, 2014, Oncotarget, V5, P9564; BORENFREUND E, 1985, TOXICOL LETT, V24, P119, DOI 10.1016/0378-4274(85)90046-3; Boukamp P, 1997, GENE CHROMOSOME CANC, V19, P201, DOI 10.1002/(SICI)1098-2264(199708)19:4<201::AID-GCC1>3.0.CO;2-0; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Buricchi F, 2007, CELL ADHES MIGR, V1, P33, DOI 10.4161/cam.3911; Carlier MF, 2007, J BIOL CHEM, V282, P23005, DOI 10.1074/jbc.R700020200; Caselli A, 1998, J BIOL CHEM, V273, P32554, DOI 10.1074/jbc.273.49.32554; Chiarugi P, 2003, TRENDS BIOCHEM SCI, V28, P509, DOI 10.1016/S0968-0004(03)00174-9; Chiarugi P, 1998, J BIOL CHEM, V273, P6776, DOI 10.1074/jbc.273.12.6776; Chiarugi P, 2001, J BIOL CHEM, V276, P33478, DOI 10.1074/jbc.M102302200; Chiarugi P, 2007, ANTIOXID REDOX SIGN, V9, P1, DOI 10.1089/ars.2007.9.1; Chua BT, 2003, NAT CELL BIOL, V5, P1083, DOI 10.1038/ncb1070; Cirri P, 1998, J BIOL CHEM, V273, P32522, DOI 10.1074/jbc.273.49.32522; Dascalu A, 2000, J INVEST DERMATOL, V115, P714, DOI 10.1046/j.1523-1747.2000.00099.x; den Hertog J, 2008, FEBS J, V275, P831, DOI 10.1111/j.1742-4658.2008.06247.x; Di Ciano-Oliveira C, 2006, ACTA PHYSIOL, V187, P257, DOI 10.1111/j.1748-1716.2006.01535.x; Di Ciano-Oliveira C, 2003, AM J PHYSIOL-CELL PH, V285, pC555, DOI 10.1152/ajpcell.00086.2003; Diker-Cohen T, 2006, APOPTOSIS, V11, P519, DOI 10.1007/s10495-006-5115-1; Eisner V, 2006, FEBS LETT, V580, P4495, DOI 10.1016/j.febslet.2006.07.029; Ferreira CV, 2006, BIOCHIMIE, V88, P1859, DOI 10.1016/j.biochi.2006.08.007; Gomes-Marcondes MCC, 2002, CANCER LETT, V180, P69, DOI 10.1016/S0304-3835(02)00006-X; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Klamt F, 2009, NAT CELL BIOL, V11, P1241, DOI 10.1038/ncb1968; Lannutti F, 2012, J MOL GRAPH MODEL, V32, P9, DOI 10.1016/j.jmgm.2011.09.006; Vu LH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090025; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ly DL, 2013, AM J PHYSIOL-CELL PH, V304, pC115, DOI 10.1152/ajpcell.00290.2012; Maehly AC, 1957, METHODS BIOCH ANAL; Milani R, 2010, J CELL BIOCHEM, V109, P957, DOI 10.1002/jcb.22479; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; Pan XO, 2011, J BIOL CHEM, V286, P42403, DOI 10.1074/jbc.M111.302042; Quintela-Fandino M, 2010, P NATL ACAD SCI USA, V107, P2622, DOI 10.1073/pnas.0914492107; Raj D, 2006, J INVEST DERMATOL, V126, P243, DOI 10.1038/sj.jid.5700008; Raugei G, 2002, CELL MOL LIFE SCI, V59, P941, DOI 10.1007/s00018-002-8481-z; Ravid A, 2002, J ENDOCRINOL, V173, DOI 10.1677/joe.0.1730525; Rigacci S, 2003, BIOCHEM BIOPH RES CO, V312, P360, DOI 10.1016/j.bbrc.2003.10.126; Rigacci S, 2008, BIOCHEMISTRY-US, V47, P1482, DOI 10.1021/bi701131e; Rodriguez I, 2002, CELL SIGNAL, V14, P839, DOI 10.1016/S0898-6568(02)00031-1; Schober M, 2007, J CELL BIOL, V176, P667, DOI 10.1083/jcb.200608010; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Sheikh-Hamad D, 2004, AM J PHYSIOL-RENAL, V287, pF1102, DOI 10.1152/ajprenal.00225.2004; Souza AC, 2002, CELL MOL LIFE SCI, V66, P1140; Souza NJA, 2006, INT ENDOD J, V39, P40, DOI 10.1111/j.1365-2591.2005.01045.x; Thirone ACP, 2009, AM J PHYSIOL-CELL PH, V296, pC463, DOI 10.1152/ajpcell.00467.2008; Torsoni MA, 1998, BIOCHEM MOL BIOL INT, V46, P147; Uhlik MT, 2003, NAT CELL BIOL, V5, P1104, DOI 10.1038/ncb1071; Yu SP, 2000, P NATL ACAD SCI USA, V97, P9360, DOI 10.1073/pnas.97.17.9360; Zambuzzi WF, 2008, CELL PHYSIOL BIOCHEM, V22, P497, DOI 10.1159/000185506; Zambuzzi WF, 2009, J CELL BIOCHEM, V108, P134, DOI 10.1002/jcb.22236	52	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119020	10.1371/journal.pone.0119020	http://dx.doi.org/10.1371/journal.pone.0119020			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781955	Green Published, gold, Green Submitted			2022-12-27	WOS:000351284600044
J	Zinicola, M; Lima, F; Lima, S; Machado, V; Gomez, M; Dopfer, D; Guard, C; Bicalho, R				Zinicola, Martin; Lima, Fabio; Lima, Svetlana; Machado, Vinicius; Gomez, Marilia; Doepfer, Doerte; Guard, Charles; Bicalho, Rodrigo			Altered Microbiomes in Bovine Digital Dermatitis Lesions, and the Gut as a Pathogen Reservoir	PLOS ONE			English	Article							DAIRY-CATTLE; EXPERIMENTAL-INFECTION; HOLSTEIN COWS; HERD-LEVEL; UK CATTLE; TREPONEMES; PREVALENCE; DIVERSITY; ASSOCIATION; DYNAMICS	Bovine digital dermatitis (DD) is the most important infectious disease associated with lameness in cattle worldwide. Since the disease was first described in 1974, a series of Treponema species concurrent with other microbes have been identified in DD lesions, suggesting a polymicrobial etiology. However, the pathogenesis of DD and the source of the causative microbes remain unclear. Here we characterized the microbiomes of healthy skin and skin lesions in dairy cows affected with different stages of DD and investigated the gut microbiome as a potential reservoir for microbes associated with this disease. Discriminant analysis revealed that the microbiomes of healthy skin, active DD lesions (ulcerative and chronic ulcerative) and inactive DD lesions (healing and chronic proliferative) are completely distinct. Treponema denticola, Treponema maltophilum, Treponema medium, Treponema putidum, Treponema phagedenis and Treponema paraluiscuniculi were all found to be present in greater relative abundance in active DD lesions when compared with healthy skin and inactive DD lesions, and these same Treponema species were nearly ubiquitously present in rumen and fecal microbiomes. The relative abundance of Candidatus Amoebophilus asiaticus, a bacterium not previously reported in DD lesions, was increased in both active and inactive lesions when compared with healthy skin. In conclusion, our data support the concept that DD is a polymicrobial disease, with active DD lesions having a markedly distinct microbiome dominated by T. denticola, T. maltophilum, T. medium, T. putidum, T. phagedenis and T. paraluiscuniculi. Furthermore, these Treponema species are nearly ubiquitously found in rumen and fecal microbiomes, suggesting that the gut is an important reservoir of microbes involved in DD pathogenesis. Additionally, the bacterium Candidatus Amoebophilus asiaticus was highly abundant in active and inactive DD lesions.	[Zinicola, Martin; Lima, Fabio; Lima, Svetlana; Machado, Vinicius; Gomez, Marilia; Guard, Charles; Bicalho, Rodrigo] Cornell Univ, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [Doepfer, Doerte] Univ Wisconsin, Sch Vet Med, Dept Med Sci, Madison, WI 53706 USA	Cornell University; University of Wisconsin System; University of Wisconsin Madison	Bicalho, R (corresponding author), Cornell Univ, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	rcb28@cornell.edu	Lima, Fabio/A-9814-2018	Lima, Fabio/0000-0001-8377-6469	USDA/NIFA Federal Formula Funds project [NYC-478438]	USDA/NIFA Federal Formula Funds project	Funding was provided for research and publication by the USDA/NIFA Federal Formula Funds project NYC-478438. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert-Weissenberger C, 2007, CELL MOL LIFE SCI, V64, P432, DOI 10.1007/s00018-006-6391-1; Berry SL, 2012, VET J, V193, P654, DOI 10.1016/j.tvjl.2012.06.048; BLOWEY RW, 1994, VET REC, V135, P577; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Brown CC, 2000, AM J VET RES, V61, P928, DOI 10.2460/ajvr.2000.61.928; Bruijnis MRN, 2012, ANIMAL, V6, P962, DOI 10.1017/S1751731111002606; Capion N, 2012, J DAIRY SCI, V95, P6457, DOI 10.3168/jds.2012-5335; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cha E, 2010, PREV VET MED, V97, P1, DOI 10.1016/j.prevetmed.2010.07.011; Cheli R, 1974, 8 INT C DIS CATTLE, P208; Demirkan I, 1999, VET J, V157, P69, DOI 10.1053/tvjl.1998.0276; Dopfer D, 1997, VET REC, V140, P620, DOI 10.1136/vr.140.24.620; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ettema J, 2010, PREV VET MED, V95, P64, DOI 10.1016/j.prevetmed.2010.03.001; Evans NJ, 2008, VET MICROBIOL, V130, P141, DOI 10.1016/j.vetmic.2007.12.019; Evans NJ, 2012, VET MICROBIOL, V156, P102, DOI 10.1016/j.vetmic.2011.09.029; Evans NJ, 2011, APPL ENVIRON MICROB, V77, P138, DOI 10.1128/AEM.00993-10; Evans NJ, 2009, J CLIN MICROBIOL, V47, P689, DOI 10.1128/JCM.01914-08; Garbarino EJ, 2004, J DAIRY SCI, V87, P4123, DOI 10.3168/jds.S0022-0302(04)73555-9; Geishauser T, 2012, J DAIRY SCI, V95, P4556, DOI 10.3168/jds.2012-5380; Gilbert JA, 2010, STAND GENOMIC SCI, V3, P249, DOI [10.4056/aigs.1443528, 10.4056/sigs.1433550]; Gomez A, 2012, J DAIRY SCI, V95, P1821, DOI 10.3168/jds.2011-4754; GRAVES S, 1981, BRIT J VENER DIS, V57, P7; Holzhauer M, 2006, J DAIRY SCI, V89, P580, DOI 10.3168/jds.S0022-0302(06)72121-X; Klitgaard K, 2014, APPL ENVIRON MICROB, V80, P4427, DOI 10.1128/AEM.00873-14; Klitgaard K, 2013, J CLIN MICROBIOL, V51, P2212, DOI 10.1128/JCM.00320-13; Krull AC, 2014, INFECT IMMUN; Laven RA, 2006, VET J, V171, P79, DOI 10.1016/j.tvjl.2004.08.009; Lemon KP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004183; Losinger WC, 2006, J DAIRY RES, V73, P244, DOI 10.1017/S0022029906001798; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Moter A, 1998, MICROBIOL-UK, V144, P2459, DOI 10.1099/00221287-144-9-2459; Nordhoff M, 2008, VET MICROBIOL, V131, P293, DOI 10.1016/j.vetmic.2008.04.019; Rasmussen M, 2012, VET MICROBIOL, V160, P151, DOI 10.1016/j.vetmic.2012.05.018; Santos TMA, 2012, FEMS MICROBIOL ECOL, V79, P518, DOI 10.1111/j.1574-6941.2011.01234.x; Schlafer S, 2008, VET MICROBIOL, V128, P118, DOI 10.1016/j.vetmic.2007.09.024; Schmitz-Esser S, 2008, APPL ENVIRON MICROB, V74, P5822, DOI 10.1128/AEM.01093-08; Schmitz-Esser S, 2010, J BACTERIOL, V192, P1045, DOI 10.1128/JB.01379-09; Thomas V, 2007, LETT APPL MICROBIOL, V45, P349, DOI 10.1111/j.1472-765X.2007.02206.x; USDA, 2009, REF DAIL CATTL HLT 4; Vink WD, 2009, PREV VET MED, V92, P235, DOI 10.1016/j.prevetmed.2009.08.018; Walker RL, 1995, VET MICROBIOL, V47, P343, DOI 10.1016/0378-1135(95)00114-X; Walker RL, 1997, AM J VET RES, V58, P744; Yano T, 2010, VET MICROBIOL, V143, P352, DOI 10.1016/j.vetmic.2009.12.009; Zuerner RL, 2007, VET MICROBIOL, V125, P256, DOI 10.1016/j.vetmic.2007.06.001	47	69	70	5	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120504	10.1371/journal.pone.0120504	http://dx.doi.org/10.1371/journal.pone.0120504			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781328	Green Submitted, gold, Green Published			2022-12-27	WOS:000351284600169
J	Burnsed, JC; Chavez-Valdez, R; Hossain, MS; Kesavan, K; Martin, LJ; Zhang, JY; Northington, FJ				Burnsed, Jennifer C.; Chavez-Valdez, Raul; Hossain, Mir Shanaz; Kesavan, Kalpashri; Martin, Lee J.; Zhang, Jiangyang; Northington, Frances J.			Hypoxia-Ischemia and Therapeutic Hypothermia in the Neonatal Mouse Brain - A Longitudinal Study	PLOS ONE			English	Article							EMERGENCY CARDIOVASCULAR CARE; RANDOMIZED-CONTROLLED-TRIAL; WHOLE-BODY HYPOTHERMIA; DEVELOPING RAT-BRAIN; PERINATAL ASPHYXIA; CARDIOPULMONARY-RESUSCITATION; SYSTEMIC HYPOTHERMIA; MODERATE HYPOTHERMIA; CHILDHOOD OUTCOMES; CEREBRAL-ISCHEMIA	Therapeutic hypothermia is standard of care for infants with hypoxic ischemic encephalopathy. Murine models of hypoxic-ischemic injury exist; however, a well-established mouse model of therapeutic hypothermia following hypoxic-ischemic injury is lacking. The goal of this study was to develop a full-term-equivalent murine model of therapeutic hypothermia after hypoxia-ischemia and examine magnetic resonance imaging, behavior, and histology in a region and sex specific manner. Hypoxic-ischemic injury was induced at postnatal day 10 in C57BL6 mice using a modified Vannucci model. Mice were randomized to control, hypothermia (31 degrees C for 4h), or normothermia (36 degrees C) following hypoxic-ischemic injury and stratified by sex. T2-weighted magnetic resonance imaging was obtained at postnatal day 18 and 30 and regional and total cerebral and cerebellar volumes measured. Behavioral assessments were performed on postnatal day 14, 21, and 28. On postnatal day 18, normothermic mice had smaller cerebral volumes (p < 0.001 vs. controls and p = 0.009 vs. hypothermia), while at postnatal day 30 both injured groups had smaller volumes than controls. When stratified by sex, only normothermia treated male mice had smaller cerebral volumes (p = 0.001 vs. control; p = 0.008 vs. hypothermia) at postnatal day 18, which persisted at postnatal day 30 (p = 0.001 vs. control). Female mice had similar cerebral volumes between groups at both day 18 and 30. Cerebellar volumes of hypothermia treated male mice differed from control at day 18, but not at 30. Four hours of therapeutic hypothermia in this murine hypoxic-ischemic injury model provides sustained neuroprotection in the cerebrum of male mice. Due to variable degree of injury in female mice, response to therapeutic hypothermia is difficult to discern. Deficits in female behavior tests are not fully explained by imaging measures and likely represent injury not detectable by volume measurements alone.	[Burnsed, Jennifer C.; Chavez-Valdez, Raul; Hossain, Mir Shanaz; Kesavan, Kalpashri; Northington, Frances J.] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Neonatol, Baltimore, MD 21205 USA; [Martin, Lee J.] Johns Hopkins Univ, Sch Med, Dept Pathol, Div Neuropathol, Baltimore, MD 21205 USA; [Zhang, Jiangyang] Johns Hopkins Univ, Sch Med, Dept Radiol & Radiol Sci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Northington, FJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat, Div Neonatol, Baltimore, MD 21205 USA.	frances@jhmi.edu		Chavez-Valdez, Raul/0000-0002-0788-8028; Zhang, Jiangyang/0000-0003-4146-8163; Zhang, Jiangyang/0000-0003-0740-2662	National Institutes of Health (NIH) [R01 HD070996]; NIH [R01 HD074593]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD074593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070909] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding provided by National Institutes of Health (NIH) R01 HD070996 (FJN) and NIH R01 HD074593 (JZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham H, 2001, INT J DEV NEUROSCI, V19, P53, DOI 10.1016/S0736-5748(00)00065-4; Akisu M, 2003, PROSTAG LEUKOTR ESS, V69, P45, DOI 10.1016/S0952-3278(03)00055-3; Azzopardi D, 2014, NEW ENGL J MED, V371, P140, DOI 10.1056/NEJMoa1315788; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; BARNETT SA, 1974, DEV PSYCHOBIOL, V7, P563; Bhat MA, 2006, ARCH DIS CHILD-FETAL, V91, pF464, DOI 10.1136/fnn.2006.097915; Biran V, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/858929; Biran V, 2011, NEUROBIOL DIS, V41, P138, DOI 10.1016/j.nbd.2010.09.001; Bona E, 1998, PEDIATR RES, V43, P738, DOI 10.1203/00006450-199806000-00005; Bonifacio SL, 2012, AM J NEURORADIOL, V33, P2050, DOI 10.3174/ajnr.A3117; Bonifacio SI, 2011, J PEDIATR-US, V158, P360, DOI 10.1016/j.jpeds.2010.09.003; Carlsson Y, 2012, PEDIATR RES, V71, P566, DOI 10.1038/pr.2012.15; CERVOSNAVARRO J, 1991, CRIT REV NEUROBIOL, V6, P149; Chavez-Valdez R, 2014, NEUROSCIENCE, V260, P106, DOI 10.1016/j.neuroscience.2013.12.023; Cheong JL, PROGNOSTIC UTILITY M; Clancy B, 2007, NEUROINFORMATICS, V5, P79, DOI 10.1385/NI:5:1:79; Cuffe JSM, 2014, J PHYSIOL-LONDON, V592, P3127, DOI 10.1113/jphysiol.2014.272856; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; Ditelberg JS, 1996, PEDIATR RES, V39, P204, DOI 10.1203/00006450-199602000-00003; Eicher DJ, 2005, PEDIATR NEUROL, V32, P18, DOI 10.1016/j.pediatrneurol.2004.06.015; Fan XY, 2013, PEDIATR RES, V73, P18, DOI 10.1038/pr.2012.139; Gaskill BN, 2013, PHYSIOL BEHAV, V110, P87, DOI 10.1016/j.physbeh.2012.12.018; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Graham SM, 2004, COMPARATIVE MED, V54, P486; Guillet R, 2012, PEDIATR RES, V71, P205, DOI 10.1038/pr.2011.30; Gunn AJ, 2008, J PEDIATR-US, V152, P55, DOI 10.1016/j.jpeds.2007.06.003; Hagberg H, 2004, J NEUROCHEM, V90, P1068, DOI 10.1111/j.1471-4159.2004.02547.x; Hill CA, 2011, DEV NEUROSCI-BASEL, V33, P494, DOI 10.1159/000331651; Hill JM, DEV MILESTONES NEWBO, P131; Inder TE, 2004, J PEDIATR-US, V145, P835, DOI 10.1016/j.jpeds.2004.07.034; Jacobs SE, 2011, ARCH PEDIAT ADOL MED, V165, P692, DOI 10.1001/archpediatrics.2011.43; Jarvis S, 2005, ARCH DIS CHILD, V90, P474, DOI 10.1136/adc.2004.052670; Johnston MV, 2007, DEV MED CHILD NEUROL, V49, P74, DOI 10.1017/S0012162207000199; Kattwinkel J, 2010, CIRCULATION, V122, pS909, DOI 10.1161/CIRCULATIONAHA.110.971119; Kurinczuk JJ, 2010, EARLY HUM DEV, V86, P329, DOI 10.1016/j.earlhumdev.2010.05.010; Lin ZL, 2006, J PERINATOL, V26, P180, DOI 10.1038/sj.jp.7211412; Liu J, 2013, PEDIATR RES, V74, P170, DOI 10.1038/pr.2013.88; Lotocki G, 2006, EUR J NEUROSCI, V24, P2283, DOI 10.1111/j.1460-9568.2006.05123.x; McCullough LD, 2005, J CEREBR BLOOD F MET, V25, P502, DOI 10.1038/sj.jcbfm.9600059; Melnikova T, 2006, NEUROSCIENCE, V141, P1149, DOI 10.1016/j.neuroscience.2006.05.001; Nagy Z, DIFFUSION TENSOR IMA; Northington FJ, 2001, DEV NEUROSCI-BASEL, V23, P186, DOI 10.1159/000046141; Perlman JM, 2010, CIRCULATION, V122, P8516, DOI 10.1161/CIRCULATIONAHA.110.971127; Renolleau S, 2008, NEUROSCIENTIST, V14, P46, DOI 10.1177/1073858407308889; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Robertson NJ, 2008, LANCET, V372, P801, DOI 10.1016/S0140-6736(08)61329-X; Russell JC, 2008, J NEUROCHEM, V106, P1357, DOI 10.1111/j.1471-4159.2008.05482.x; Rutherford M, 2005, EARLY HUM DEV, V81, P13, DOI 10.1016/j.earlhumdev.2004.10.011; Rutherford M, 2010, EARLY HUM DEV, V86, P351, DOI 10.1016/j.earlhumdev.2010.05.014; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Shankaran S, 2002, AM J OBSTET GYNECOL, V187, P171, DOI 10.1067/mob.2002.122445; Shankaran S, 2014, CLIN PERINATOL, V41, P149, DOI 10.1016/j.clp.2013.10.008; Shankaran S, 2012, NEW ENGL J MED, V366, P2085, DOI 10.1056/NEJMoa1112066; SIRIMANNE ES, 1994, J NEUROSCI METH, V55, P7, DOI 10.1016/0165-0270(94)90034-5; Smith AL, 2014, EXP NEUROL, V254, P54, DOI 10.1016/j.expneurol.2014.01.003; Tam EWY, 2011, J PEDIATR-US, V158, P366, DOI 10.1016/j.jpeds.2010.09.005; Thoresen M, 2009, J CEREBR BLOOD F MET, V29, P707, DOI 10.1038/jcbfm.2008.163; Tusor N, 2012, PEDIATR RES, V72, P63, DOI 10.1038/pr.2012.40; van de Looij Y, LONGITUDINAL MR ASSE; Wagner BP, DELAYED POSTISCHEMIC; Wang Xiao-Yang, 2006, Zhongguo Dang Dai Er Ke Za Zhi, V8, P315; Weis SN, 2012, MITOCHONDRION, V12, P271, DOI 10.1016/j.mito.2011.10.002; Yager JY, 2009, PEDIATR NEUROL, V40, P156, DOI 10.1016/j.pediatrneurol.2008.10.025; Zhou WH, 2010, J PEDIATR-US, V157, P367, DOI 10.1016/j.jpeds.2010.03.030; Zhu CL, 2006, J NEUROCHEM, V96, P1016, DOI 10.1111/j.1471-4159.2005.03639.x	66	41	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118889	10.1371/journal.pone.0118889	http://dx.doi.org/10.1371/journal.pone.0118889			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774892	gold, Green Published, Green Submitted			2022-12-27	WOS:000351183500051
J	Calluso, C; Tosoni, A; Pezzulo, G; Spadone, S; Committeri, G				Calluso, Cinzia; Tosoni, Annalisa; Pezzulo, Giovanni; Spadone, Sara; Committeri, Giorgia			Interindividual Variability in Functional Connectivity as Long-Term Correlate of Temporal Discounting	PLOS ONE			English	Article							TEST-RETEST RELIABILITY; DEFAULT-MODE NETWORK; DECISION-MAKING; DELAYED REWARDS; SELF-CONTROL; FRONTOPARIETAL NETWORKS; BRAIN ACTIVITY; LIFE-SPAN; IMPULSIVITY; FUTURE	During intertemporal choice (IT) future outcomes are usually devaluated as a function of the delay, a phenomenon known as temporal discounting (TD). Based on task-evoked activity, previous neuroimaging studies have described several networks associated with TD. However, given its relevance for several disorders, a critical challenge is to define a specific neural marker able to predict TD independently of task execution. To this aim, we used resting-state functional connectivity MRI (fcMRI) and measured TD during economic choices several months apart in 25 human subjects. We further explored the relationship between TD, impulsivity and decision uncertainty by collecting standard questionnaires on individual trait/state differences. Our findings indicate that fcMRI within and between critical nodes of task-evoked neural networks associated with TD correlates with discounting behavior measured a long time afterwards, independently of impulsivity. Importantly, the nodes form an intrinsic circuit that might support all the mechanisms underlying TD, from the representation of subjective value to choice selection through modulatory effects of cognitive control and episodic prospection.	[Calluso, Cinzia; Tosoni, Annalisa; Spadone, Sara; Committeri, Giorgia] Univ G DAnnunzio, Dept Neurosci Imaging & Clin Sci, I-66013 Chieti, Italy; [Calluso, Cinzia; Tosoni, Annalisa; Spadone, Sara; Committeri, Giorgia] G DAnnunzio Fdn, Inst Adv Biomed Technol, I-66013 Chieti, Italy; [Pezzulo, Giovanni] CNR, Inst Cognit Sci & Technol, I-00185 Rome, Italy	G d'Annunzio University of Chieti-Pescara; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR)	Calluso, C (corresponding author), Univ G DAnnunzio, Dept Neurosci Imaging & Clin Sci, Via Vestini 33, I-66013 Chieti, Italy.	cinzia.calluso@unich.it	Tosoni, Annalisa/J-7410-2016; Committeri, Giorgia/AAC-1035-2022; Spadone, Sara/GZL-0599-2022; Calluso, Cinzia/B-9662-2017; Pezzulo, Giovanni/AAY-3586-2020	Tosoni, Annalisa/0000-0001-9004-2623; Spadone, Sara/0000-0002-2304-4984; Calluso, Cinzia/0000-0001-6693-0786; Pezzulo, Giovanni/0000-0001-6813-8282	University G. d'Annunzio; EU's FP7 [FP7-ICT-270108]; HFSP [RGY0088/2014]	University G. d'Annunzio; EU's FP7; HFSP(Human Frontier Science Program)	This work was supported by University G. d'Annunzio grants to GC and by the EU's FP7 under grant agreement no FP7-ICT-270108 and the HFSP under grant agreement RGY0088/2014 to GP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud H, 2006, SUPERLAB STIMULUS PR; Ainslie G, 1975, PSYCHOL BULL, V59, P257; Ballard K, 2009, NEUROIMAGE, V45, P143, DOI 10.1016/j.neuroimage.2008.11.004; Beck RC, 2009, EXP CLIN PSYCHOPHARM, V17, P345, DOI 10.1037/a0017078; Berns GS, 2007, TRENDS COGN SCI, V11, P482, DOI 10.1016/j.tics.2007.08.011; Bickel WK, 2008, DRUG ALCOHOL DEPEN, V90, P1; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Boettiger CA, 2007, J NEUROSCI, V27, P14383, DOI 10.1523/JNEUROSCI.2551-07.2007; Braun U, 2012, NEUROIMAGE, V59, P1404, DOI 10.1016/j.neuroimage.2011.08.044; Bretteville-Jensen AL, 1999, J HEALTH ECON, V18, P393, DOI 10.1016/S0167-6296(98)00057-5; Camchong J, 2011, BIOL PSYCHIAT, V69, P1117, DOI 10.1016/j.biopsych.2011.01.008; CAPRARA GV, 1993, PERS INDIV DIFFER, V15, P281, DOI 10.1016/0191-8869(93)90218-R; Carter AR, 2010, ANN NEUROL, V67, P365, DOI 10.1002/ana.21905; Casey BJ, 2011, P NATL ACAD SCI USA, V108, P14998, DOI 10.1073/pnas.1108561108; Catani M, 2005, BRAIN, V128, P2224, DOI 10.1093/brain/awh622; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Dayan P, 2002, NEURON, V36, P285, DOI 10.1016/S0896-6273(02)00963-7; Dayan P, 2009, PHARMACOPSYCHIATRY, V42, pS56, DOI 10.1055/s-0028-1124107; Dixon MR, 2006, J APPL BEHAV ANAL, V39, P413, DOI 10.1901/jaba.2006.173-05; Dixon MR, 2003, J APPL BEHAV ANAL, V36, P449, DOI 10.1901/jaba.2003.36-449; Figner B, 2010, NAT NEUROSCI, V13, P538, DOI 10.1038/nn.2516; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Fossati A, 2001, J CLIN PSYCHOL, V57, P815, DOI 10.1002/jclp.1051; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Freeman JB, 2010, BEHAV RES METHODS, V42, P226, DOI 10.3758/BRM.42.1.226; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gianotti LRR, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00054; Giedd JN, 2004, ANN NY ACAD SCI, V1021, P77, DOI 10.1196/annals.1308.009; Goudriaan AE, 2008, PSYCHOL MED, V38, P41, DOI 10.1017/S0033291707000694; GREEN L, 1994, PSYCHOL SCI, V5, P33, DOI 10.1111/j.1467-9280.1994.tb00610.x; Green L, 1999, BEHAV PROCESS, V46, P89, DOI 10.1016/S0376-6357(99)00021-2; Green L, 1996, PSYCHOL AGING, V11, P79, DOI 10.1037/0882-7974.11.1.79; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Guo CC, 2012, NEUROIMAGE, V61, P1471, DOI 10.1016/j.neuroimage.2012.03.027; Hacker CD, 2013, NEUROIMAGE, V82, P616, DOI 10.1016/j.neuroimage.2013.05.108; Han SD, 2013, EXP GERONTOL, V48, P1489, DOI 10.1016/j.exger.2013.10.003; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; HAXBY JV, 1993, BEHAV RES METH INSTR, V25, P400, DOI 10.3758/BF03204531; He BJ, 2007, NEURON, V53, P905, DOI 10.1016/j.neuron.2007.02.013; HOLLAND PW, 1977, COMMUN STAT A-THEOR, V6, P813, DOI 10.1080/03610927708827533; Hu S, 2012, HUM BRAIN MAPP, V33, P2785, DOI 10.1002/hbm.21399; Jacques PS, 2010, NEUROBIOL AGING, V31, P315, DOI 10.1016/j.neurobiolaging.2008.03.012; Jimura K, 2013, J NEUROSCI, V33, P344, DOI 10.1523/JNEUROSCI.0919-12.2013; Joreskog K, 2013, LISREL 9 0 STUDENT E; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kable JW, 2010, J NEUROPHYSIOL, V103, P2513, DOI 10.1152/jn.00177.2009; Kalenscher T, 2008, PROG NEUROBIOL, V84, P284, DOI 10.1016/j.pneurobio.2007.11.004; Kirby KN, 1999, J EXP PSYCHOL GEN, V128, P78, DOI 10.1037/0096-3445.128.1.78; Kirby KN, 2004, ADDICTION, V99, P461, DOI 10.1111/j.1360-0443.2003.00669.x; Kirby KN, 2009, PSYCHON B REV, V16, P457, DOI 10.3758/PBR.16.3.457; Laibson D, 1997, Q J ECON, V112, P443, DOI 10.1162/003355397555253; Li N, 2013, J NEUROSCI, V33, P4886, DOI 10.1523/JNEUROSCI.1342-12.2013; LOEWENSTEIN G, 1987, ECON J, V97, P666, DOI 10.2307/2232929; Loo R, 2000, PERS INDIV DIFFER, V29, P895, DOI 10.1016/S0191-8869(99)00241-X; Madden GJ, 1997, EXP CLIN PSYCHOPHARM, V5, P256, DOI 10.1037/1064-1297.5.3.256; Mazur JE, 1987, QUANTITATIVE ANAL BE, V5, P57; McClure SM, 2007, J NEUROSCI, V27, P5796, DOI 10.1523/JNEUROSCI.4246-06.2007; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; McCrae R.R., 1984, EMERGING LIVES ENDUR; Meindl T, 2010, HUM BRAIN MAPP, V31, P237, DOI 10.1002/hbm.20860; MISCHEL W, 1988, J PERS SOC PSYCHOL, V54, P687, DOI 10.1037/0022-3514.54.4.687; MISCHEL W, 1989, SCIENCE, V244, P933, DOI 10.1126/science.2658056; Mischel W, 2011, SOC COGN AFFECT NEUR, V6, P252, DOI 10.1093/scan/nsq081; Mitchell SH, 1999, PSYCHOPHARMACOLOGY, V146, P455, DOI 10.1007/PL00005491; Monterosso J, 1999, PSYCHOPHARMACOLOGY, V146, P339, DOI 10.1007/PL00005480; Odum AL, 2011, BEHAV PROCESS, V87, P1, DOI 10.1016/j.beproc.2011.02.007; Patton J.H., 1995, J CLIN PSYCHOL; Paus T, 2005, TRENDS COGN SCI, V9, P60, DOI 10.1016/j.tics.2004.12.008; Pennartz CMA, 2011, TRENDS NEUROSCI, V34, P548, DOI 10.1016/j.tins.2011.08.001; Peters J, 2011, TRENDS COGN SCI, V15, P227, DOI 10.1016/j.tics.2011.03.002; Peters J, 2010, NEURON, V66, P138, DOI 10.1016/j.neuron.2010.03.026; Pezzulo G, 2014, TRENDS COGN SCI, P1; Pezzulo G, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0470; Pezzulo G, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00092; Pezzulo G, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00079; Read D, 2004, ORGAN BEHAV HUM DEC, V94, P22, DOI 10.1016/j.obhdp.2004.01.002; Reynolds B, 2006, PERS INDIV DIFFER, V40, P305, DOI 10.1016/j.paid.2005.03.024; Scheres A, 2010, BIOL PSYCHIAT, V67, P641, DOI 10.1016/j.biopsych.2009.10.033; Schonberg T, 2007, J NEUROSCI, V27, P12860, DOI 10.1523/JNEUROSCI.2496-07.2007; Sestieri C, 2011, J NEUROSCI, V31, P4407, DOI 10.1523/JNEUROSCI.3335-10.2011; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Shulman GL, 2009, J NEUROSCI, V29, P4392, DOI 10.1523/JNEUROSCI.5609-08.2009; Talairach J., 1988, COPLANAR STEREOTAXIC; The Mathworks Inc, 2009, MATL R2009A; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Wang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021976; Wilson VB, 2011, J CHILD PSYCHOL PSYC, V52, P256, DOI 10.1111/j.1469-7610.2010.02347.x; Wu T, 2007, NEUROSCI LETT, V422, P164, DOI 10.1016/j.neulet.2007.06.011; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	93	17	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119710	10.1371/journal.pone.0119710	http://dx.doi.org/10.1371/journal.pone.0119710			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD6EY	25774886	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500113
J	Kilian, A; Balayo, C; Feldman, M; Koenker, H; Lokko, K; Ashton, RA; Bruce, J; Lynch, M; Boulay, M				Kilian, Albert; Balayo, Connie; Feldman, Mitra; Koenker, Hannah; Lokko, Kojo; Ashton, Ruth A.; Bruce, Jane; Lynch, Matthew; Boulay, Marc			The Effect of Single or Repeated Home Visits on the Hanging and Use of Insecticide-Treated Mosquito Nets following a Mass Distribution Campaign - A Cluster Randomized, Controlled Trial	PLOS ONE			English	Article							INTEGRATED CAMPAIGN; BEDNET USE; MALARIA; CHILDREN; PREVENTION; OWNERSHIP; COVERAGE; MODEL; TOGO	Background Study objective was to evaluate the effectiveness of commonly used post-campaign hang-up visits on the hanging and use of campaign nets. Methods A cluster-randomized trial was carried out in Uganda following an ITN distribution campaign. Five clusters (parishes, consisting of similar to 11 villages each) were randomly selected for each of the three study arms with between 7,534 and 9,401 households per arm. Arm 1 received one hang-up visit, while Arm 2 received two visits by volunteers four and seven months after the campaign. Visits consisted of assistance hanging the net and education on net use. The control arm was only exposed to messages during the campaign itself. Three cross-sectional surveys with a two-stage cluster sampling design, representative of the study populations, were carried out to capture the two key outcome variables of net hanging and ITN use. Sample size was calculated to detect at least a 15 percentage-points change in net use, and was 1811 at endline. The analysis used an intention-to-treat approach. Findings Both hanging and use of ITN increased during follow-up in a similar way in all three study arms. The proportion of the population using an ITN the previous night was 64.0% (95% CI 60.8, 67.2), for one additional visit, 68.2% (63.8, 72.2) for two visits and 64.0% (59.4, 68.5) for the control. The proportion of households with all campaign nets hanging increased from 55.7% to 72.5% at endline (p<0.0005 for trend), with no difference between study arms. Financial cost per household visited was estimated as USD 2.33 for the first visit and USD 2.24 for the second. Conclusions Behavior change communication provided during the campaign or through other channels was sufficient to induce high levels of net hanging and use and additional "hang-up" activities were not cost-effective.	[Kilian, Albert; Bruce, Jane] Malaria Consortium, London, England; [Kilian, Albert] Trop Hlth LLP, Montagut, Spain; [Balayo, Connie] Minist Hlth, Malaria Control Program, Kampala, Uganda; [Feldman, Mitra; Ashton, Ruth A.] Malaria Consortium Uganda, Kampala, Uganda; [Koenker, Hannah; Lokko, Kojo; Lynch, Matthew; Boulay, Marc] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Commun Programs, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Kilian, A (corresponding author), Malaria Consortium, London, England.	albert@trophealth.com	Ashton, Ruth/S-7822-2019; Ashton, Ruth/GPS-9349-2022	Ashton, Ruth/0000-0002-7248-7730; Feldman, Mitra/0000-0002-0193-0416	American people through the United States Agency for International Development (USAID) under the terms of USAID/JHU Cooperative Agreement [GHS-A-00-09-00014-00]	American people through the United States Agency for International Development (USAID) under the terms of USAID/JHU Cooperative Agreement(United States Agency for International Development (USAID))	The study was made possible by the generous support of the American people through the United States Agency for International Development (USAID) under the terms of USAID/JHU Cooperative Agreement No. GHS-A-00-09-00014-00 for the NetWorks Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaii JA, 2003, AM J TROP MED HYG, V68, P137, DOI 10.4269/ajtmh.2003.68.137; Alliance for Malaria Prevention, 2012, TOOL KIT MASS DISTR; [Anonymous], 2010, UG MAL IND SURV 2009; [Anonymous], 2007, INS TREAT MOSQ NETS; Baume CA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-264; Bennett A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037927; Boulay M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-342; Bowen HL, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-36; Cohee L, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-76; Deribew A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-99; Desrochers RE, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-260; Dunn CE, 2011, SOC SCI MED, V72, P408, DOI 10.1016/j.socscimed.2010.11.009; Eisele TP, 2009, AM J TROP MED HYG, V80, P209, DOI 10.4269/ajtmh.2009.80.209; Eng JLV, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-133; Graves PM, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-354; Hightower A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-183; Holtz TH, 2002, TROP MED INT HEALTH, V7, P220, DOI 10.1046/j.1365-3156.2002.00846.x; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Kakwani N, 1997, J ECONOMETRICS, V77, P87, DOI 10.1016/S0304-4076(96)01807-6; Keating J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-313; Kilian A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-314; Kolaczinski JH, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-102; Korenromp EL, 2003, TROP MED INT HEALTH, V8, P693, DOI 10.1046/j.1365-3156.2003.01084.x; Krezanoski PJ, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-186; Kulkarni MA, 2010, AM J TROP MED HYG, V82, P420, DOI 10.4269/ajtmh.2010.09-0597; Macintyre K, 2006, HLTH POLICY PLAN, V27, P316; Measure DHS, 2012, MAL IND SURV TAB KEY; MEASURE Evaluation MEASURE DHS President's Malaria Initiative Roll Back Malaria Partnership UNICEF World Health Organization, 2013, HOUS SURV IND MAL CO; Ngondi JM, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-92; Panter-Brick C, 2006, SOC SCI MED, V62, P2810, DOI 10.1016/j.socscimed.2005.10.009; Pulford J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-83; Rickard DG, 2011, PROG COMM HLTH PARTN, V5, P123, DOI 10.1353/cpr.2011.0018; ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P328, DOI 10.1177/109019817400200403; Singh M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-268; Stevens ER, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-162; Thawani N, 2009, J TROP MED-US, V2009, DOI 10.1155/2009/451719; Thwing J, 2008, TROP MED INT HEALTH, V13, P827, DOI 10.1111/j.1365-3156.2008.02070.x; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Wolkon A, 2010, AM J TROP MED HYG, V83, P1014, DOI 10.4269/ajtmh.2010.09-0599	39	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119078	10.1371/journal.pone.0119078	http://dx.doi.org/10.1371/journal.pone.0119078			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD6EY	25774676	gold, Green Published			2022-12-27	WOS:000351183500067
J	Lam, FW; Phillips, J; Landry, P; Magadi, S; Smith, CW; Rumbaut, RE; Burns, AR				Lam, Fong W.; Phillips, Jenny; Landry, Paul; Magadi, Sri; Smith, C. Wayne; Rumbaut, Rolando E.; Burns, Alan R.			Platelet Recruitment Promotes Keratocyte Repopulation following Corneal Epithelial Abrasion in the Mouse	PLOS ONE			English	Article							IN-SITU KERATOMILEUSIS; DELTA-T-CELLS; GROWTH-FACTORS; PHOTOREFRACTIVE KERATECTOMY; NEUTROPHIL EMIGRATION; MIGRATION; PROLIFERATION; TRANSPARENCY; SURGERY; REPAIR	Corneal abrasion not only damages the epithelium but also induces stromal keratocyte death at the site of injury. While a coordinated cascade of inflammatory cell recruitment facilitates epithelial restoration, it is unclear if this cascade is necessary for keratocyte recovery. Since platelet and neutrophil (PMN) recruitment after corneal abrasion is beneficial to epithelial wound healing, we wanted to determine if these cells play a role in regulating keratocyte repopulation after epithelial abrasion. A 2 mm diameter central epithelial region was removed from the corneas of C57BL/6 wildtype (WT), P-selectin deficient (P-sel(-/-)), and CD18 hypomorphic (CD18(hypo)) mice using the Algerbrush II. Corneas were studied at 6h intervals out to 48h post-injury to evaluate platelet and PMN cell numbers; additional corneas were studied at 1, 4, 14, and 28 days post injury to evaluate keratocyte numbers. In WT mice, epithelial abrasion induced a loss of anterior central keratocytes and keratocyte recovery was rapid and incomplete, reaching similar to 70% of uninjured baseline values by 4 days post-injury but no further improvement at 28 days post-injury. Consistent with a beneficial role for platelets and PMNs in wound healing, keratocyte recovery was significantly depressed at 4 days post-injury (similar to 30% of uninjured baseline) in P-sel(-/-) mice, which are known to have impaired platelet and PMN recruitment after corneal abrasion. Passive transfer of platelets from WT, but not P-sel(-/-), into P-sel(-/-) mice prior to injury restored anterior central keratocyte numbers at 4 days post-injury to P-sel(-/-) uninjured baseline levels. While PMN infiltration in injured CD18(hypo) mice was similar to injured WT mice, platelet recruitment was markedly decreased and anterior central keratocyte recovery was significantly reduced (similar to 50% of baseline) at 4-28 days post-injury. Collectively, the data suggest platelets and platelet P-selectin are critical for efficient keratocyte recovery after corneal epithelial abrasion.	[Lam, Fong W.; Smith, C. Wayne; Rumbaut, Rolando E.; Burns, Alan R.] Baylor Coll Med, Dept Pediat, Sect Leukocyte Biol, Houston, TX 77030 USA; [Lam, Fong W.; Rumbaut, Rolando E.] Michael E DeBakey VA Med Ctr, Ctr Translat Res Inflammatory Dis, Houston, TX 77030 USA; [Phillips, Jenny; Landry, Paul; Magadi, Sri; Burns, Alan R.] Univ Houston, Coll Optometry, Houston, TX 77204 USA; [Phillips, Jenny] Univ Wisconsin, Dept Pathol, Madison, WI 53706 USA	Baylor College of Medicine; Baylor College of Medicine; University of Houston System; University of Houston; University of Wisconsin System; University of Wisconsin Madison	Burns, AR (corresponding author), Baylor Coll Med, Dept Pediat, Sect Leukocyte Biol, 1100 Bates,CNRC 6058, Houston, TX 77030 USA.	aburns@optometry.uh.edu		Rumbaut, Rolando/0000-0002-8486-1013; Lam, Fong/0000-0003-2034-2625	National Institutes of Health [HL116524, EY017120, EY018239, P30EY007551]; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development; NATIONAL EYE INSTITUTE [P30EY007551, R01EY017120, R01EY018239] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079368, R01HL116524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000550] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development(US Department of Veterans Affairs); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was funded by the following sources: National Institutes of Health HL116524 (RER, CWS, ARB), National Institutes of Health EY017120 (ARB), National Institutes of Health EY018239 (CWS), National Institutes of Health P30EY007551 (core facility), and the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development (RER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anitua E, 2013, EXP EYE RES, V115, P153, DOI 10.1016/j.exer.2013.07.007; Baldwin HC, 2002, ACTA OPHTHALMOL SCAN, V80, P238, DOI 10.1034/j.1600-0420.2002.800303.x; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Comaish IF, 2002, J CATARACT REFR SURG, V28, P2206, DOI 10.1016/S0886-3350(02)01698-X; Cooper D, 2004, AM J PHYSIOL-HEART C, V286, pH1895, DOI 10.1152/ajpheart.01000.2003; Erie JC, 2006, AM J OPHTHALMOL, V141, P799, DOI 10.1016/j.ajo.2005.12.014; Erie JC, 2003, ARCH OPHTHALMOL-CHIC, V121, P770, DOI 10.1001/archopht.121.6.770; Etheredge L, 2009, INVEST OPHTH VIS SCI, V50, P3128, DOI 10.1167/iovs.08-3077; Gagen D, 2010, EXP EYE RES, V91, P676, DOI 10.1016/j.exer.2010.08.007; Geremicca W, 2010, BLOOD TRANSFUS-ITALY, V8, P107, DOI 10.2450/2009.0091-09; Gronert K, 2005, J BIOL CHEM, V280, P15267, DOI 10.1074/jbc.M410638200; Helena MC, 1998, INVEST OPHTH VIS SCI, V39, P276; Hodge C, 2011, J CATARACT REFR SURG, V37, P603, DOI 10.1016/j.jcrs.2010.12.036; Howard V., 2005, UNBIASED STEREOLOGY; Imanishi J, 2000, PROG RETIN EYE RES, V19, P113, DOI 10.1016/S1350-9462(99)00007-5; Jester JV, 2008, SEMIN CELL DEV BIOL, V19, P82, DOI 10.1016/j.semcdb.2007.09.015; Jester JV, 1999, J CELL SCI, V112, P613; Kamath S, 2001, EUR HEART J, V22, P1561, DOI 10.1053/euhj.2000.2515; Kamiyama K, 1998, CORNEA, V17, P315, DOI 10.1097/00003226-199805000-00013; Khachikian SS, 2010, J CATARACT REFR SURG, V36, P2015, DOI 10.1016/j.jcrs.2010.08.028; Lam FW, 2011, AM J PHYSIOL-HEART C, V300, pH468, DOI 10.1152/ajpheart.00491.2010; Li Z, 2007, AM J PATHOL, V171, P838, DOI 10.2353/ajpath.2007.070008; Li ZJ, 2006, INVEST OPHTH VIS SCI, V47, P4794, DOI 10.1167/iovs.06-0381; Li ZJ, 2006, AM J PATHOL, V169, P1590, DOI 10.2353/ajpath.2006.060415; Li ZJ, 2006, INVEST OPHTH VIS SCI, V47, P1947, DOI 10.1167/iovs.05-1193; Li ZJ, 2011, FASEB J, V25, P2659, DOI 10.1096/fj.11-184804; Li ZJ, 2004, J APPL PHYSIOL, V97, P641, DOI 10.1152/japplphysiol.00200.2004; Liu HS, 2012, J CELL MOL MED, V16, P1114, DOI 10.1111/j.1582-4934.2011.01418.x; Mitooka K, 2002, AM J OPHTHALMOL, V133, P307, DOI 10.1016/S0002-9394(01)01421-0; Mohan RR, 2003, EXP EYE RES, V76, P71, DOI 10.1016/S0014-4835(02)00251-8; Movahedan A, 2012, INVEST OPHTH VIS SCI, V53, P7476, DOI 10.1167/iovs.12-10735; Petrescu MS, 2007, INVEST OPHTH VIS SCI, V48, P5023, DOI 10.1167/iovs.07-0562; Petri B, 2010, BLOOD, V116, P4712, DOI 10.1182/blood-2010-03-276311; Petroll WM, 2012, J FUNCT BIOMATER, V3, P183, DOI 10.3390/jfb3010183; Rozman P, 2007, ACTA DERMATOVEN ALP, V16, P156; Rumbaut RE, 2006, AM J PHYSIOL-HEART C, V290, pH1671, DOI 10.1152/ajpheart.00305.2005; Scharffetter-Kochanek K, 1998, J EXP MED, V188, P119, DOI 10.1084/jem.188.1.119; Schmitz C, 2005, NEUROSCIENCE, V130, P813, DOI 10.1016/j.neuroscience.2004.08.050; Servold S A, 1991, Clin Podiatr Med Surg, V8, P937; Sharma GD, 2003, J BIOL CHEM, V278, P21989, DOI 10.1074/jbc.M302650200; Smith TL, 2011, THROMB RES, V127, P391, DOI 10.1016/j.thromres.2010.10.013; Walzog B, 1999, AM J PHYSIOL-GASTR L, V276, pG1125, DOI 10.1152/ajpgi.1999.276.5.G1125; WEIBEL ER, 1981, J HISTOCHEM CYTOCHEM, V29, P1043, DOI 10.1177/29.9.7026667; WILSON RW, 1993, J IMMUNOL, V151, P1571; Zieske JD, 2001, EXP EYE RES, V72, P33, DOI 10.1006/exer.2000.0926	45	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118950	10.1371/journal.pone.0118950	http://dx.doi.org/10.1371/journal.pone.0118950			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775402	Green Published, gold, Green Submitted			2022-12-27	WOS:000351183500055
J	Liu, B; Li, DJ; Xia, YP; Ruan, J; Xu, LL; Wu, HY				Liu, Bo; Li, Dajun; Xia, Yuanping; Ruan, Jian; Xu, Lili; Wu, Huanyi			Combinational Reasoning of Quantitative Fuzzy Topological Relations for Simple Fuzzy Regions	PLOS ONE			English	Article							SPATIAL OBJECTS; COMPLEX REGIONS; BOUNDARY	In recent years, formalization and reasoning of topological relations have become a hot topic as a means to generate knowledge about the relations between spatial objects at the conceptual and geometrical levels. These mechanisms have been widely used in spatial data query, spatial data mining, evaluation of equivalence and similarity in a spatial scene, as well as for consistency assessment of the topological relations of multi-resolution spatial databases. The concept of computational fuzzy topological space is applied to simple fuzzy regions to efficiently and more accurately solve fuzzy topological relations. Thus, extending the existing research and improving upon the previous work, this paper presents a new method to describe fuzzy topological relations between simple spatial regions in Geographic Information Sciences (GIS) and Artificial Intelligence (AI). Firstly, we propose a new definition for simple fuzzy line segments and simple fuzzy regions based on the computational fuzzy topology. And then, based on the new definitions, we also propose a new combinational reasoning method to compute the topological relations between simple fuzzy regions, moreover, this study has discovered that there are (1) 23 different topological relations between a simple crisp region and a simple fuzzy region; (2) 152 different topological relations between two simple fuzzy regions. In the end, we have discussed some examples to demonstrate the validity of the new method, through comparisons with existing fuzzy models, we showed that the proposed method can compute more than the existing models, as it is more expressive than the existing fuzzy models.	[Liu, Bo; Li, Dajun; Xia, Yuanping; Ruan, Jian; Xu, Lili; Wu, Huanyi] E China Inst Technol, Fac Geomat, Nanchang 330013, Peoples R China; [Liu, Bo] Wuhan Univ, State Key Lab Informat Engn Surveying Mapping & R, Wuhan 430079, Peoples R China	East China University of Technology; Wuhan University	Liu, B (corresponding author), E China Inst Technol, Fac Geomat, Nanchang 330013, Peoples R China.	bliu@whu.edu.cn	xu, li/GNH-3667-2022		National Natural Science Foundation of China [41201395, 41161069]; Science and Technology Project of Jiangxi Provincial Education Department [GJJ14479]; Open Foundation of Digital Land Key Lab of Jiangxi Province [DLLJ201308]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Jiangxi Provincial Education Department; Open Foundation of Digital Land Key Lab of Jiangxi Province	This work was partially supported by the National Natural Science Foundation of China (No. 41201395, 41161069), the Science and Technology Project of Jiangxi Provincial Education Department (No. GJJ14479) and the Open Foundation of Digital Land Key Lab of Jiangxi Province (No. DLLJ201308). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	CHANG CL, 1968, J MATH ANAL APPL, V24, P182, DOI 10.1016/0022-247X(68)90057-7; CLEMENTINI E, 1994, COMPUT GRAPH-UK, V18, P815, DOI 10.1016/0097-8493(94)90007-8; Clementini E, 1996, INFORM SCIENCES, V90, P121, DOI 10.1016/0020-0255(95)00289-8; Clementini E, 1997, INT J APPROX REASON, V16, P173, DOI 10.1016/S0888-613X(96)00127-2; Clementini E, 2000, DATA KNOWL ENG, V34, P251, DOI 10.1016/S0169-023X(00)00017-3; Clementini E., 1996, GEOGR OBJECTS INDETE, V2, P155; Cohn A.G., 1997, GEOINFORMATICA, V1, P275, DOI [DOI 10.1023/A:1009712514511, 10.1023/A:1009712514511]; Cohn A.G., 1996, GEOGRAPHIC OBJECTS I, V2, P171; Dilo A, 2007, INT J GEOGR INF SCI, V21, P397, DOI 10.1080/13658810601037096; Du SH, 2005, LECT NOTES COMPUT SC, V3612, P1261; Du SH, 2005, LECT NOTES COMPUT SC, V3612, P1274; Du SH, 2008, INFORM SCIENCES, V178, P52, DOI 10.1016/j.ins.2007.07.023; Du SH, 2008, ISPRS J PHOTOGRAMM, V63, P593, DOI 10.1016/j.isprsjprs.2008.02.004; Egenhofer M, 1994, INT J GEOGR INF SYST, V8, P133; Egenhofer M.J., 1991, CATEGORIZING BINARY; EGENHOFER MJ, 1991, INT J GEOGR INF SYST, V5, P161, DOI 10.1080/02693799108927841; Egenhofer MJ, 1997, J VISUAL LANG COMPUT, V8, P403, DOI 10.1006/jvlc.1997.0054; EGENHOFER MJ, 1995, INT J GEOGR INF SYST, V9, P555, DOI 10.1080/02693799508902056; Li C, 1999, INT J GEOGR INF SCI, V13, P209, DOI 10.1080/136588199241328; Liu KF, 2006, INT J GEOGR INF SCI, V20, P857, DOI 10.1080/13658810600711345; Liu KF, 2011, ISPRS J PHOTOGRAMM, V66, P103, DOI 10.1016/j.isprsjprs.2010.09.007; Liu KF, 2009, INT J APPL EARTH OBS, V11, P38, DOI 10.1016/j.jag.2008.06.001; Liu Y.-M., 1997, FUZZY TOPOLOGY; Long ZG, 2013, INT J GEOGR INF SCI, V27, P2006, DOI 10.1080/13658816.2013.781607; Paiva JAC, 1998, THESIS U MAINE; RANDELL DA, 1992, PRINCIPLES OF KNOWLEDGE REPRESENTATION AND REASONING: PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE (KR 92), P165; Shi WZ, 2007, COMPUT GEOSCI-UK, V33, P898, DOI 10.1016/j.cageo.2006.10.013; Shi WZ, 2010, IEEE T GEOSCI REMOTE, V48, P147, DOI 10.1109/TGRS.2009.2024302; Shi WZ, 2004, PHOTOGRAMM ENG REM S, V70, P921, DOI 10.14358/PERS.70.8.921; Tang XM, 2005, INT J REMOTE SENS, V26, P3025, DOI 10.1080/01431160500057863; Tang XM, 2004, THESIS U TWENTE; Tang XM, 2002, SDH C 02 9 12 JUL 20, P114; Winter S, 2000, INT J GEOGR INF SCI, V14, P411, DOI 10.1080/13658810050057579; WONG CK, 1974, J MATH ANAL APPL, V46, P316, DOI 10.1016/0022-247X(74)90242-X; WU GQ, 1991, FUZZY SET SYST, V39, P329, DOI 10.1016/0165-0114(91)90102-V; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X	36	3	3	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0117379	10.1371/journal.pone.0117379	http://dx.doi.org/10.1371/journal.pone.0117379			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775452	Green Submitted, Green Published, gold			2022-12-27	WOS:000351183500019
J	Magierowski, RH; Read, SM; Carter, SJB; Warfe, DM; Cook, LS; Lefroy, EC; Davies, PE				Magierowski, Regina H.; Read, Steve M.; Carter, Steven J. B.; Warfe, Danielle M.; Cook, Laurie S.; Lefroy, Edward C.; Davies, Peter E.			Inferring Landscape-Scale Land-Use Impacts on Rivers Using Data from Mesocosm Experiments and Artificial Neural Networks	PLOS ONE			English	Article							DEPOSITED FINE SEDIMENT; DISSOLVED NUTRIENTS; STRESSOR GRADIENTS; AQUATIC INSECTS; SUBSIDY-STRESS; STREAMS; RESPONSES; COMMUNITIES; REDUNDANCY; MICROCOSMS	Identifying land-use drivers of changes in river condition is complicated by spatial scale, geomorphological context, land management, and correlations among responding variables such as nutrients and sediments. Furthermore, variations in standard metrics, such as substratum composition, do not necessarily relate causally to ecological impacts. Consequently, the absence of a significant relationship between a hypothesised driver and a dependent variable does not necessarily indicate the absence of a causal relationship. We conducted a gradient survey to identify impacts of catchment-scale grazing by domestic livestock on river macroinvertebrate communities. A standard correlative approach showed that community structure was strongly related to the upstream catchment area under grazing. We then used data from a stream mesocosm experiment that independently quantified the impacts of nutrients and fine sediments on macroinvertebrate communities to train artificial neural networks (ANNs) to assess the relative influence of nutrients and fine sediments on the survey sites from their community composition. The ANNs developed to predict nutrient impacts did not find a relationship between nutrients and catchment area under grazing, suggesting that nutrients were not an important factor mediating grazing impacts on community composition, or that these ANNs had no generality or insufficient power at the landscape-scale. In contrast, ANNs trained to predict the impacts of fine sediments indicated a significant relationship between fine sediments and catchment area under grazing. Macro-invertebrate communities at sites with a high proportion of land under grazing were thus more similar to those resulting from high fine sediments in a mesocosm experiment than to those resulting from high nutrients. Our study confirms that 1) fine sediment is an important mediator of land-use impacts on river macroinvertebrate communities, 2) ANNs can successfully identify subtle effects and separate the effects of correlated variables, and 3) data from small-scale experiments can generate relationships that help explain landscape-scale patterns.	[Magierowski, Regina H.; Cook, Laurie S.; Davies, Peter E.] Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia; [Magierowski, Regina H.; Warfe, Danielle M.; Lefroy, Edward C.; Davies, Peter E.] Univ Tasmania, Ctr Environm, Hobart, Tas, Australia; [Read, Steve M.] Forestry Tasmania, Hobart, Tas, Australia; [Read, Steve M.] Univ Melbourne, Dept Forest & Ecosyst Sci, Creswick, Vic, Australia; [Carter, Steven J. B.] Univ Tasmania, Sch Math & Phys, Hobart, Tas, Australia; [Warfe, Danielle M.] Univ Tasmania, Tasmanian Sch Business & Econ, Hobart, Tas, Australia	University of Tasmania; University of Tasmania; University of Melbourne; University of Tasmania; University of Tasmania	Magierowski, RH (corresponding author), Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia.	reginam@utas.edu.au	Magierowski, Regina/B-4588-2013; Davies, Peter/J-7713-2014; Lefroy, Ted/J-7144-2014	Magierowski, Regina/0000-0002-7547-8549; Davies, Peter/0000-0003-2651-4061; Lefroy, Ted/0000-0002-3164-8948	Australian Government Department of the Environment, Commonwealth Environmental Research Facilities; Australian Government Department of the Environment, National Environment Research Program	Australian Government Department of the Environment, Commonwealth Environmental Research Facilities(Australian Government); Australian Government Department of the Environment, National Environment Research Program(Australian Government)	The Australian Government Department of the Environment, Commonwealth Environmental Research Facilities (http://www.environment.gov.au/science/nerp) funded the Landscape Logic Research Hub-Directed by ECL. The Australian Government Department of the Environment, National Environment Research Program (http://www.environment.gov.au/science/nerp) funded the Landscapes and Policy Research Hub-Directed by ECL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna V, 2004, FRESHWATER BIOL, V49, P960, DOI 10.1111/j.1365-2427.2004.01239.x; Allan JD, 2012, FRESHWATER BIOL, V57, P58, DOI 10.1111/j.1365-2427.2011.02683.x; Allan JD, 2004, ANNU REV ECOL EVOL S, V35, P257, DOI 10.1146/annurev.ecolsys.35.120202.110122; Allan JD, 1997, FRESHWATER BIOL, V37, P149, DOI 10.1046/j.1365-2427.1997.d01-546.x; Anderson M.J., 2008, PERMANOVA PRIMER GUI; [Anonymous], 2009, DPIPWE CART TASM LAN; BARBOUR MT, 1992, ENVIRON TOXICOL CHEM, V11, P437, DOI [10.1897/1552-8618(1992)11[437:EOERBB]2.0.CO;2, 10.1002/etc.5620110401]; Bende-Michl U, 2013, ENVIRON MONIT ASSESS, V185, P9191, DOI 10.1007/s10661-013-3246-8; Bergstrom U, 2006, AM NAT, V167, P246, DOI 10.1086/499372; Beyers DW, 1998, J N AM BENTHOL SOC, V17, P367, DOI 10.2307/1468339; Bond NR, 2003, FRESHWATER BIOL, V48, P455, DOI 10.1046/j.1365-2427.2003.01016.x; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Brown LE, 2011, J ANIM ECOL, V80, P884, DOI 10.1111/j.1365-2656.2011.01814.x; BRS, 2006, TECHN HDB SUPP AUSTR, V3; Burcher CL, 2007, ECOLOGY, V88, P228, DOI 10.1890/0012-9658(2007)88[228:TLCRCL]2.0.CO;2; Campbell I.C., 1985, Internationale Vereinigung fuer Theoretische und Angewandte Limnologie Verhandlungen, V22, P3250; CAMPBELL IC, 1989, AUST J MAR FRESH RES, V40, P519; Campbell IC, 1998, INT VER THEOR ANGEW, V26, P986; Carpenter SR, 1996, ECOLOGY, V77, P677, DOI 10.2307/2265490; CHESSMAN BC, 1986, AUST J MAR FRESH RES, V37, P129, DOI 10.1071/MF9860129; Clapcott JE, 2011, FRESHWATER BIOL, DOI 101111/j.1365-2427.2011.02696.x; Cooper SD, 1993, FRESHWATER BIOMONITO; CROSSLAND NO, 1992, TOXICOL LETT, V64-5, P511, DOI 10.1016/0378-4274(92)90226-A; DAVIES AL, 1993, FRESHWATER BIOL, V30, P47, DOI 10.1111/j.1365-2427.1993.tb00787.x; DAVIES PE, 1993, J HYDROL, V150, P481, DOI 10.1016/0022-1694(93)90122-P; Demuth H. B., 2014, NEURAL NETWORK DESIG; Downes B.J., 2002, MONITORING ECOLOGICA; DPIPWE, 2015, WAT INF SYST TASM; DPIPWE, 2005, CFEV DAT V1 0 CONS F; Drake JA, 1996, ECOLOGY, V77, P670, DOI 10.2307/2265489; Englund G, 2003, ADV ECOL RES, V33, P161, DOI 10.1016/S0065-2504(03)33011-9; Gravelle JA, 2009, FOREST ECOL MANAG, V257, P1663, DOI 10.1016/j.foreco.2009.01.017; Greet J, 2011, FRESHWATER BIOL, V56, P1231, DOI 10.1111/j.1365-2427.2011.02564.x; HAGAN MT, 1994, IEEE T NEURAL NETWOR, V5, P989, DOI 10.1109/72.329697; Hagan MT., 1997, NEURAL NETWORK DESIG; Harris GP, 2012, FRESHWATER BIOL, V57, P91, DOI 10.1111/j.1365-2427.2011.02640.x; Hauer F.R., 2007, METHODS STREAM ECOLO; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Ives AR, 1996, ECOLOGY, V77, P681, DOI 10.2307/2265491; Karle IM, 2007, J EXP MAR BIOL ECOL, V353, P265, DOI 10.1016/j.jembe.2007.09.014; King RS, 2005, ECOL APPL, V15, P137, DOI 10.1890/04-0481; Krasnicki T, 2001, AUSTR WIDE ASSESSMEN; Krebs C.J., 2014, ECOLOGICAL METHODOLO; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Lek S, 1996, ECOL MODEL, V90, P39, DOI 10.1016/0304-3800(95)00142-5; LENAT DR, 1994, HYDROBIOLOGIA, V294, P185, DOI 10.1007/BF00021291; Leprieur F, 2006, J APPL ECOL, V43, P930, DOI 10.1111/j.1365-2664.2006.01201.x; Lindenmayer D. B., 2011, B ECOL SOC AM, V92, P245, DOI DOI 10.1890/0012-9623-92.3.245; Linkov I, 2009, SCI TOTAL ENVIRON, V407, P5199, DOI 10.1016/j.scitotenv.2009.05.004; Magierowski RH, 2006, ECOL APPL, V16, P2264, DOI 10.1890/1051-0761(2006)016[2264:ROSOBI]2.0.CO;2; Magierowski RH, 2012, MAR FRESHWATER RES, V63, P762, DOI 10.1071/MF11267; Matthaei CD, 2010, J APPL ECOL, V47, P639, DOI 10.1111/j.1365-2664.2010.01809.x; McNie EC, 2007, ENVIRON SCI POLICY, V10, P17, DOI 10.1016/j.envsci.2006.10.004; Moore JC, 1996, ECOLOGY, V77, P694, DOI 10.2307/2265494; Mosisch TD, 2001, FRESHWATER BIOL, V46, P1269, DOI 10.1046/j.1365-2427.2001.00747.x; ODUM EP, 1979, BIOSCIENCE, V29, P349, DOI 10.2307/1307690; Olden JD, 2008, Q REV BIOL, V83, P171, DOI 10.1086/587826; Ozesmi SL, 2006, ECOL MODEL, V195, P83, DOI 10.1016/j.ecolmodel.2005.11.012; Park YS, 2003, ECOL MODEL, V160, P265, DOI 10.1016/S0304-3800(02)00258-2; Poff NL, 1997, J N AM BENTHOL SOC, V16, P391, DOI 10.2307/1468026; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ransom G., 2002, 23 COMM AUSTR U CANB; South NRM, 2009, TASMANIAN RIVER COND; Spivak AC, 2011, FRESHWATER BIOL, V56, P279, DOI 10.1111/j.1365-2427.2010.02495.x; Sponseller RA, 2001, FRESHWATER BIOL, V46, P1409, DOI 10.1046/j.1365-2427.2001.00758.x; STRAHLER AN, 1952, GEOL SOC AM BULL, V63, P923, DOI 10.1130/0016-7606(1952)63[923:DBOG]2.0.CO;2; Tilman D, 1997, SPATIAL ECOLOGY ROLE; Townsend CR, 2008, J APPL ECOL, V45, P1810, DOI 10.1111/j.1365-2664.2008.01548.x; UNDERWOOD AJ, 1988, MAR ECOL PROG SER, V46, P227, DOI 10.3354/meps046227; Wagenhoff A, 2013, FRESHWATER BIOL, V58, P1849, DOI 10.1111/fwb.12174; Wagenhoff A, 2012, J APPL ECOL, V49, P892, DOI 10.1111/j.1365-2664.2012.02162.x; Wagenhoff A, 2011, FRESHWATER BIOL, V56, P1916, DOI 10.1111/j.1365-2427.2011.02619.x; Wiens JA, 2002, FRESHWATER BIOL, V47, P501, DOI 10.1046/j.1365-2427.2002.00887.x; YULE C, 1986, AUST J MAR FRESH RES, V37, P121	74	5	5	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120901	10.1371/journal.pone.0120901	http://dx.doi.org/10.1371/journal.pone.0120901			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775245	Green Published, Green Accepted, gold			2022-12-27	WOS:000351183500198
J	Nomura, M; Kaneko, M; Okuma, Y; Nomura, J; Kusumi, I; Koyama, T; Nomura, Y				Nomura, Michio; Kaneko, Masayuki; Okuma, Yasunobu; Nomura, Jun; Kusumi, Ichiro; Koyama, Tsukasa; Nomura, Yasuyuki			Involvement of Serotonin Transporter Gene Polymorphisms (5-HTT) in Impulsive Behavior in the Japanese Population	PLOS ONE			English	Article							TRYPTOPHAN DEPLETION; PROMOTER POLYMORPHISM; RESPONSE-INHIBITION; PROLACTIN RESPONSE; PREFRONTAL CORTEX; REGULATORY REGION; AMYGDALA; ASSOCIATION; EMOTION; DEPRESSION	The serotonergic pathway has been implicated in the pathogenesis of impulsivity, and sensitivity to aversive outcomes may be linked to serotonin (5-HT) levels. Polymorphisms in the gene that encodes the serotonin transporter (5-HTT), which have differential effects on the level of serotonin transmission, display alternate responses to aversive stimuli. However, recent studies have shown that 5-HT does not affect motor function, which suggests that the functioning of the serotonin-transporter-linked polymorphic region (5-HTTLPR) does not directly affect the behavioral regulatory process itself, but instead exerts an effect via the evaluation of the potential risk associated with particular behavioral outputs. The aim of the present study was to examine the effect of specific 5-HTTLPR genotypes on the motor regulatory process, as observed during a Go/Nogo punishment feedback task. 5-HTT gene-linked promoter polymorphisms were analyzed by polymerase chain reaction, using lymphocytes from 61 healthy Japanese volunteers. Impulsivity was defined as the number of commission errors (responding when one should not) made during a Go/Nogo task. We found that the s/s genotype group made fewer impulsive responses, specifically under aversive conditions for committing such errors, compared to those in the s/l group, without affecting overall motor inhibition. These results suggest that 5-HTTLPRs do not directly affect the behavioral regulatory process itself, but may instead exert an effect on the evaluation of potential risk. The results also indicate that under such aversive conditions, decreased expression of 5-HTT may promote motor inhibitory control.	[Nomura, Michio] Kyoto Univ, Grad Sch Educ, Sakyo Ku, Kyoto, Japan; [Kaneko, Masayuki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Biochem, Minami Ku, Hiroshima, Japan; [Okuma, Yasunobu] Chiba Inst Sci, Fac Pharmaceut Sci, Dept Pharmacol, Choshi, Japan; [Nomura, Jun] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Biomed Res, Minami Ku, Hiroshima, Japan; [Kusumi, Ichiro; Koyama, Tsukasa] Hokkaido Univ, Grad Sch Med, Dept Psychiat, Sapporo, Hokkaido, Japan; [Nomura, Yasuyuki] Kurume Univ, Sch Med, Dept Pharmacol, Kurume, Fukuoka 830, Japan	Kyoto University; Hiroshima University; Hiroshima University; Hokkaido University; Kurume University	Nomura, M (corresponding author), Kyoto Univ, Grad Sch Educ, Sakyo Ku, Kyoto, Japan.	nomura.michio.8u@kyoto-u.ac.jp	Kaneko, Masayuki/F-9302-2011; Nomura, Jun/C-2411-2011	Kaneko, Masayuki/0000-0002-0477-0171; Nomura, Michio/0000-0003-1043-2811	Japan Society for the Promotion of Science [23500329]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from the Japan Society for the Promotion of Science (23500329). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MEN D; Armony JL, 1997, TRENDS COGN SCI, V1, P28, DOI 10.1016/S1364-6613(97)01007-3; Bakermans-Kranenburg MJ, 2008, SOC COGN AFFECT NEUR, V3, P128, DOI 10.1093/scan/nsn004; Barratt E. S., 1994, VIOLENCE MENTAL DISO, P61; Canli T, 2007, NAT NEUROSCI, V10, P1103, DOI 10.1038/nn1964; Canli T, 2006, P NATL ACAD SCI USA, V103, P16033, DOI 10.1073/pnas.0601674103; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; Chiao JY, 2010, P ROY SOC B-BIOL SCI, V277, P529, DOI 10.1098/rspb.2009.1650; Clark L, 2005, PSYCHOPHARMACOLOGY, V182, P570, DOI 10.1007/s00213-005-0104-6; Cools R, 2008, TRENDS COGN SCI, V12, P31, DOI 10.1016/j.tics.2007.10.011; Crockett MJ, 2009, J NEUROSCI, V29, P11993, DOI 10.1523/JNEUROSCI.2513-09.2009; Cyders MA, 2007, PSYCHOL ASSESSMENT, V19, P107, DOI 10.1037/1040-3590.19.1.107; Daruna J., 1993, IMPULSIVE CLIENT THE; Fallgatter AJ, 1999, INT J NEUROPSYCHOP, V2, P115, DOI 10.1017/S1461145799001455; Flint J, 2013, CURR OPIN NEUROBIOL, V23, P57, DOI 10.1016/j.conb.2012.07.005; Fredrickson BL, 2001, AM PSYCHOL, V56, P218, DOI 10.1037/0003-066X.56.3.218; Gelernter J, 1997, HUM GENET, V101, P243, DOI 10.1007/s004390050624; Gelfand M. J., 1998, 25 ANN C INT ASS CRO; Hare TA, 2005, BIOL PSYCHIAT, V57, P624, DOI 10.1016/j.biopsych.2004.12.038; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hart S.D., 1997, IMPULSIVITY THEORY A, P212; Homberg JR, 2011, BIOL PSYCHIAT, V69, P513, DOI 10.1016/j.biopsych.2010.09.024; Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850; ISEN AM, 1987, J PERS SOC PSYCHOL, V52, P1122, DOI 10.1037/0022-3514.52.6.1122; Jasinska AJ, 2009, J NEUROSCI, V29, P10461, DOI 10.1523/JNEUROSCI.2774-09.2009; Jennings KA, 2006, J NEUROSCI, V26, P8955, DOI 10.1523/JNEUROSCI.5356-05.2006; Kaufman J, 2004, P NATL ACAD SCI USA, V101, P17316, DOI 10.1073/pnas.0404376101; KINDLON D, 1995, J CHILD PSYCHOL PSYC, V36, P645, DOI 10.1111/j.1469-7610.1995.tb02319.x; Kumakiri C, 1999, NEUROSCI LETT, V263, P205, DOI 10.1016/S0304-3940(99)00098-1; Lee BT, 2008, GENES BRAIN BEHAV, V7, P899, DOI 10.1111/j.1601-183X.2008.00429.x; LeMarquand DG, 1998, NEUROPSYCHOPHARMACOL, V19, P333; LeMarquand DG, 1999, AM J PSYCHIAT, V156, P1771; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Masui K, 2009, PSYCHOLOGIA, V52, P137, DOI 10.2117/psysoc.2009.137; McMurran M, 2002, AGGRESSIVE BEHAV, V28, P439, DOI 10.1002/ab.80017; Mizuno T, 2006, J PSYCHOSOM RES, V60, P91, DOI 10.1016/j.jpsychores.2005.06.068; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Munafo MR, 2008, BIOL PSYCHIAT, V63, P852, DOI 10.1016/j.biopsych.2007.08.016; Murphy SE, 2013, MOL PSYCHIATR, V18, P512, DOI 10.1038/mp.2012.19; Newman JP, 1997, PERS INDIV DIFFER, V23, P583, DOI 10.1016/S0191-8869(97)00078-0; NEWMAN JP, 1990, PERS INDIV DIFFER, V11, P1101, DOI 10.1016/0191-8869(90)90021-I; Nomura M, 2004, NEUROIMAGE, V21, P352, DOI 10.1016/j.neuroimage.2003.09.021; Nomura M, 2006, PSYCHOPHARMACOLOGY, V187, P30, DOI 10.1007/s00213-006-0398-z; Osinsky R, 2008, EMOTION, V8, P584, DOI 10.1037/a0012826; Pener-Tessler R, 2013, DEV PSYCHOPATHOL, V25, P151, DOI 10.1017/S095457941200096X; PLUTCHIK R, 1995, IMPULSIVITY AGGRESSI, P7; Rao HY, 2007, BIOL PSYCHIAT, V62, P600, DOI 10.1016/j.biopsych.2006.11.028; Reist C, 2001, AM J MED GENET, V105, P363, DOI 10.1002/ajmg.1360; Rodriguez-Fornells A, 2002, PERS INDIV DIFFER, V32, P661, DOI 10.1016/S0191-8869(01)00068-X; Sagaspe P, 2011, NEUROIMAGE, V55, P1825, DOI 10.1016/j.neuroimage.2011.01.027; Sebastian A, 2013, NEUROIMAGE, V64, P601, DOI 10.1016/j.neuroimage.2012.09.020; Smeraldi E, 1998, MOL PSYCHIATR, V3, P508, DOI 10.1038/sj.mp.4000425; SOUBRIE P, 1986, BEHAV BRAIN SCI, V9, P319, DOI 10.1017/S0140525X00022871; Triandis HC, 2004, ACAD MANAGE EXEC, V18, P88, DOI 10.5465/AME.2004.12689599; Wager TD, 2005, NEUROIMAGE, V27, P323, DOI 10.1016/j.neuroimage.2005.01.054; Walderhaug E, 2002, PSYCHOPHARMACOLOGY, V164, P385, DOI 10.1007/s00213-002-1238-4; Whale R, 2000, PSYCHOPHARMACOLOGY, V150, P120, DOI 10.1007/s002130000432; Whiteside SP, 2001, PERS INDIV DIFFER, V30, P669, DOI 10.1016/S0191-8869(00)00064-7; Yoshida K, 2002, PROG NEURO-PSYCHOPH, V26, P383, DOI 10.1016/S0278-5846(01)00287-1; Zanardi R, 2000, J CLIN PSYCHOPHARM, V20, P105, DOI 10.1097/00004714-200002000-00021	62	13	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119743	10.1371/journal.pone.0119743	http://dx.doi.org/10.1371/journal.pone.0119743			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775400	Green Published, gold, Green Submitted			2022-12-27	WOS:000351183500117
J	Sun, XL; Jia, Q; Guo, YC; Zheng, XJ; Liang, KJ				Sun, Xinli; Jia, Qi; Guo, Yuchun; Zheng, Xiujuan; Liang, Kangjing			Whole-Genome Analysis Revealed the Positively Selected Genes during the Differentiation of indica and Temperate japonica Rice	PLOS ONE			English	Article							AXILLARY MERISTEM FORMATION; FLORAL ORGAN IDENTITY; ORYZA-SATIVA-L; TRANSCRIPTION FACTOR; CULTIVATED RICE; STRESS TOLERANCE; PHYLOGENETIC ANALYSIS; ENHANCED TOLERANCE; MAXIMUM-LIKELIHOOD; DOMESTICATED RICE	To investigate the selective pressures acting on the protein-coding genes during the differentiation of indica and japonica, all of the possible orthologous genes between the Nipponbare and 93-11 genomes were identified and compared with each other. Among these genes, 8,530 pairs had identical sequences, and 27,384 pairs shared more than 90% sequence identity. Only 2,678 pairs of genes displaying a Ka/Ks ratio significantly greater than one were revealed, and most of these genes contained only nonsynonymous sites. The genes without synonymous site were further analyzed with the SNP data of 1529 O. sativa and O. rufipogon accessions, and 1068 genes were identified to be under positive selection during the differentiation of indica and temperate japonica. The positively selected genes (PSGs) are unevenly distributed on 12 chromosomes, and the proteins encoded by the PSGs are dominant with binding, transferase and hydrolase activities, and especially enriched in the plant responses to stimuli, biological regulations, and transport processes. Meanwhile, the most PSGs of the known function and/or expression were involved in the regulation of biotic/abiotic stresses. The evidence of pervasive positive selection suggested that many factors drove the differentiation of indica and japonica, which has already started in wild rice but is much lower than in cultivated rice. Lower differentiation and less PSGs revealed between the Or-It and Or-IIIt wild rice groups implied that artificial selection provides greater contribution on the differentiation than natural selection. In addition, the phylogenetic tree constructed with positively selected sites showed that the japonica varieties exhibited more diversity than indica on differentiation, and Or-III of O. rufipogon exhibited more than Or-I.	[Sun, Xinli; Jia, Qi; Guo, Yuchun; Zheng, Xiujuan; Liang, Kangjing] Fujian Agr & Forestry Univ, Key Lab, Minist Educ Genet Breeding & Multiple Utilizat Cr, Fuzhou, Peoples R China; [Sun, Xinli; Jia, Qi; Guo, Yuchun; Zheng, Xiujuan; Liang, Kangjing] Fujian Agr & Forestry Univ, Coll Crop Sci, Fuzhou, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University	Sun, XL (corresponding author), Fujian Agr & Forestry Univ, Key Lab, Minist Educ Genet Breeding & Multiple Utilizat Cr, Fuzhou, Peoples R China.	xinlisun@hotmail.com		Sun, Xinli/0000-0002-6592-6168				Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Caicedo AL, 2007, PLOS GENET, V3, P1745, DOI 10.1371/journal.pgen.0030163; Chang T-T, 2003, ORIGIN DOMESTICATION; Chen JJ, 2008, P NATL ACAD SCI USA, V105, P11436, DOI 10.1073/pnas.0804761105; Cheng CY, 2003, MOL BIOL EVOL, V20, P67, DOI 10.1093/molbev/msg004; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; Figueiredo DD, 2012, J EXP BOT, V63, P3643, DOI 10.1093/jxb/ers035; Fitzgerald HA, 2005, PLANT J, V43, P335, DOI 10.1111/j.1365-313X.2005.02457.x; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; Garris AJ, 2005, GENETICS, V169, P1631, DOI 10.1534/genetics.104.035642; GLASZMANN JC, 1987, THEOR APPL GENET, V74, P21, DOI 10.1007/BF00290078; Gong XD, 2013, G3-GENES GENOM GENET, V3, P1769, DOI 10.1534/g3.113.007856; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Gutha LR, 2008, PLANT MOL BIOL, V68, P533, DOI 10.1007/s11103-008-9391-8; He ZW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002100; Hossain MA, 2010, PLANT MOL BIOL, V72, P557, DOI 10.1007/s11103-009-9592-9; Huang CL, 2012, PLANT J, V70, P769, DOI 10.1111/j.1365-313X.2012.04915.x; Huang XZ, 2009, NAT GENET, V41, P494, DOI 10.1038/ng.352; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Ikeda K, 2005, DEV BIOL, V282, P349, DOI 10.1016/j.ydbio.2005.03.016; Ikeda K, 2007, PLANT J, V51, P1030, DOI 10.1111/j.1365-313X.2007.03200.x; Ikeda-Kawakatsu K, 2009, PLANT PHYSIOL, V150, P736, DOI 10.1104/pp.109.136739; Jin J, 2008, NAT GENET, V40, P1365, DOI 10.1038/ng.247; Kaneda T, 2009, EMBO J, V28, P926, DOI 10.1038/emboj.2009.39; Kawahara Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049423; Khush GS, 1997, PLANT MOL BIOL, V35, P25, DOI 10.1023/A:1005810616885; Kishi-Kaboshi M, 2010, PLANT J, V63, P599, DOI 10.1111/j.1365-313X.2010.04264.x; Komatsu M, 2001, DEV BIOL, V231, P364, DOI 10.1006/dbio.2000.9988; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Kunihiro S, 2013, J EXP BOT, V64, P4517, DOI 10.1093/jxb/ert267; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lazzarotto F, 2011, NEW PHYTOL, V191, P234, DOI 10.1111/j.1469-8137.2011.03659.x; Lee S, 2003, PLANTA, V217, P904, DOI 10.1007/s00425-003-1066-8; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Londo JP, 2006, P NATL ACAD SCI USA, V103, P9578, DOI 10.1073/pnas.0603152103; Luo H, 2006, PLANT MOL BIOL, V62, P397, DOI 10.1007/s11103-006-9031-0; Mach J, 2009, PLANT CELL, V21, P1027, DOI 10.1105/tpc.109.210410; Matsui H, 2010, PLANT CELL PHYSIOL, V51, P2082, DOI 10.1093/pcp/pcq167; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Mizuta Y, 2010, P NATL ACAD SCI USA, V107, P20417, DOI 10.1073/pnas.1003124107; Molina J, 2011, P NATL ACAD SCI USA, V108, P8351, DOI 10.1073/pnas.1104686108; MORISHIMA H, 1981, JPN J BREED, V31, P402; Morita R, 2009, PLANT J, V59, P940, DOI 10.1111/j.1365-313X.2009.03919.x; Nagasawa N, 2003, DEVELOPMENT, V130, P705, DOI 10.1242/dev.00294; NEI M, 1986, MOL BIOL EVOL, V3, P418; Ning J, 2011, PLANT CELL, V23, P4334, DOI 10.1105/tpc.111.093419; Nonomura KI, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001265; Obata T, 2007, PLANT PHYSIOL, V144, P1978, DOI 10.1104/pp.107.101154; Oikawa T, 2009, PLANT CELL, V21, P1095, DOI 10.1105/tpc.108.065425; Oka H. I., 1988, Origin of cultivated rice.; Olsen KM, 2006, GENETICS, V173, P975, DOI 10.1534/genetics.106.056473; Ookawa T, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1132; Park CJ, 2008, PLOS BIOL, V6, P1910, DOI 10.1371/journal.pbio.0060231; Park HY, 2009, BIOCHEM BIOPH RES CO, V380, P597, DOI 10.1016/j.bbrc.2009.01.131; Park MR, 2010, PLANT CELL ENVIRON, V33, P2209, DOI 10.1111/j.1365-3040.2010.02221.x; Passaia G, 2013, PLANT SCI, V208, P93, DOI 10.1016/j.plantsci.2013.03.017; Rakshit S, 2007, THEOR APPL GENET, V114, P731, DOI 10.1007/s00122-006-0473-1; Rao KP, 2011, ARCH BIOCHEM BIOPHYS, V506, P73, DOI 10.1016/j.abb.2010.11.006; Schmidt R, 2013, PLANT CELL, V25, P2115, DOI 10.1105/tpc.113.113068; SECOND G, 1985, GENET SEL EVOL, V17, P89, DOI 10.1186/1297-9686-17-1-89; Simons KJ, 2006, GENETICS, V172, P547, DOI 10.1534/genetics.105.044727; Sun XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016079; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Sweeney MT, 2006, PLANT CELL, V18, P283, DOI 10.1105/tpc.105.038430; Taga Y, 2009, PLANT SIGNAL BEHAV, V4, P740, DOI [10.4161/psb.4.8.9087, 10.1038/emboj.2009.39]; Takano-Kai N, 2009, GENETICS, V182, P1323, DOI 10.1534/genetics.109.103002; Tan LB, 2008, NAT GENET, V40, P1360, DOI 10.1038/ng.197; Tang T, 2006, PLOS GENET, V2, P1824, DOI 10.1371/journal.pgen.0020199; Vannini C, 2004, PLANT J, V37, P115, DOI 10.1046/j.1365-313X.2003.01938.x; Wang DP, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-20; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; Wang Q, 2013, PLANT CELL REP, V32, P1075, DOI 10.1007/s00299-013-1389-2; WANG ZY, 1989, GENOME, V32, P1113, DOI 10.1139/g89-563; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Wright S, 1978, VARIABILITY NATURAL; Xiang Y, 2008, PLANT PHYSIOL, V148, P1938, DOI 10.1104/pp.108.128199; Xie GS, 2012, BIOCHEM J, V443, P95, DOI 10.1042/BJ20111792; Xie GS, 2009, FEBS LETT, V583, P2734, DOI 10.1016/j.febslet.2009.07.057; Yamada S, 2012, PLANT CELL PHYSIOL, V53, P2060, DOI 10.1093/pcp/pcs145; Yang F, 2012, PLANT J, V71, P61, DOI 10.1111/j.1365-313X.2012.04970.x; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yoshii M, 2009, PLANT J, V57, P615, DOI 10.1111/j.1365-313X.2008.03712.x; Yu YC, 2008, PLANT CELL, V20, P2946, DOI 10.1105/tpc.108.060426; Zhang LB, 2009, NEW PHYTOL, V184, P708, DOI 10.1111/j.1469-8137.2009.02984.x; Zhang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027565; Zhang T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043274; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2; Zhang Z, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-44; Zheng J, 2014, PLANT SCI, V214, P99, DOI 10.1016/j.plantsci.2013.10.003; Zhu BF, 2011, PLANT PHYSIOL, V155, P1301, DOI 10.1104/pp.110.168500; Zhu QH, 2005, NEW PHYTOL, V167, P249, DOI 10.1111/j.1469-8137.2005.01406.x	100	9	10	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119239	10.1371/journal.pone.0119239	http://dx.doi.org/10.1371/journal.pone.0119239			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774680	Green Submitted, Green Published, gold			2022-12-27	WOS:000351183500076
J	Yassine, S; Escoffier, J; Nahed, RA; Pierre, V; Karaouzene, T; Ray, PF; Arnoult, C				Yassine, Sandra; Escoffier, Jessica; Nahed, Roland Abi; Pierre, Virginie; Karaouzene, Thomas; Ray, Pierre F.; Arnoult, Christophe			Dynamics of Sun5 Localization during Spermatogenesis in Wild Type and Dpy19l2 Knock-Out Mice Indicates That Sun5 Is Not Involved in Acrosome Attachment to the Nuclear Envelope	PLOS ONE			English	Article							MEMBRANE PROTEIN; SPERM PROTEIN; GLOBOZOOSPERMIA; IDENTIFICATION; SPAG4; HEAD	The acrosome is an organelle that is central to sperm physiology and a defective acrosome biogenesis leads to globozoospermia, a severe male infertility. The identification of the actors involved in acrosome biogenesis is therefore particularly important to decipher the molecular pathogeny of globozoospermia. We recently showed that a defect in the DPY19L2 gene is present in more than 70% of globozoospermic men and demonstrated that Dpy19l2, located in the inner nuclear membrane, is the first protein involved in the attachment of the acrosome to the nuclear envelope (NE). SUN proteins serve to link the nuclear envelope to the cytoskeleton and are therefore good candidates to participate in acrosome-nucleus attachment, potentially by interacting with DPY19L2. In order to characterize new actors of acrosomal attachment, we focused on Sun5 (also called Spag4l), which is highly expressed in male germ cells, and investigated its localization during spermatogenesis. Using immunohistochemistry and Western blot experiments in mice, we showed that Sun5 transits through different cellular compartments during meiosis. In pachytene spermatocytes, it is located in a membranous compartment different to the reticulum. In round spermatids, it progresses to the Golgi and the NE before to be located to the tail/head junction in epididymal sperm. Interestingly, we demonstrate that Sun5 is not, as initially reported, facing the acrosome but is in fact excluded from this zone. Moreover, we show that in Dpy19l2 KO spermatids, upon the detachment of the acrosome, Sun5 relocalizes to the totality of the NE suggesting that the acrosome attachment excludes Sun5 from the NE facing the acrosome. Finally, Western-blot experiments demonstrate that Sun5 is glycosylated. Overall, our work, associated with other publications, strongly suggests that the attachment of the acrosome to the nucleus does not likely depend on the formation of SUN complexes.	[Yassine, Sandra; Escoffier, Jessica; Nahed, Roland Abi; Pierre, Virginie; Karaouzene, Thomas; Ray, Pierre F.; Arnoult, Christophe] Univ Grenoble Alpes, F-38000 Grenoble, France; [Yassine, Sandra; Escoffier, Jessica; Nahed, Roland Abi; Pierre, Virginie; Karaouzene, Thomas; Ray, Pierre F.; Arnoult, Christophe] INSERM U823, Equipe Genet Epigenet & Therapies Infertil, Inst Albert Bonniot, F-38000 Grenoble, France; [Karaouzene, Thomas; Ray, Pierre F.] CHU Grenoble, UF Biochim & Genet Mol, F-38000 Grenoble, France	Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Arnoult, C (corresponding author), Univ Grenoble Alpes, F-38000 Grenoble, France.	Christophe.arnoult@ujf-grenoble.fr	Escoffier, jessica/E-9498-2017; Escoffier, jessica/T-9857-2019; Abi Nahed, Roland/GNP-4140-2022; Ray, Pierre F/D-7315-2019; ARNOULT, christophe/E-8312-2013	Escoffier, jessica/0000-0001-8166-5845; Abi Nahed, Roland/0000-0002-8767-6462; Ray, Pierre F/0000-0003-1544-7449; ARNOULT, christophe/0000-0002-3753-5901	Gravit Foundation; Agence National de la Recherche [ICG2I]	Gravit Foundation; Agence National de la Recherche(French National Research Agency (ANR))	This study was supported by grants from Gravit Foundation (to CA), from the Agence National de la Recherche (Grant ICG2I to PR and CA).	Buettner FFR, 2013, MOL CELL, V50, P295, DOI 10.1016/j.molcel.2013.03.003; Chi YH, 2012, NUCLEUS-PHILA, V3, P418, DOI 10.4161/nucl.21714; Coutton C, 2012, HUM REPROD, V27, P2549, DOI 10.1093/humrep/des160; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Ding X, 2007, DEV CELL, V12, P863, DOI 10.1016/j.devcel.2007.03.018; Frohnert C, 2011, MOL HUM REPROD, V17, P207, DOI 10.1093/molehr/gaq099; Gob E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012072; Gronborg M, 2002, MOL CELL PROTEOMICS, V1, P517, DOI 10.1074/mcp.M200010-MCP200; Haque F, 2006, MOL CELL BIOL, V26, P3738, DOI 10.1128/MCB.26.10.3738-3751.2006; Harbuz R, 2011, AM J HUM GENET, V88, P351, DOI 10.1016/j.ajhg.2011.02.007; Ho HC, 2003, BIOL REPROD, V68, P1590, DOI 10.1095/biolreprod.102.011320; Hodzic DM, 2004, J BIOL CHEM, V279, P25805, DOI 10.1074/jbc.M313157200; Jiang XZ, 2011, DNA CELL BIOL, V30, P875, DOI 10.1089/dna.2010.1161; Kierszenbaum Abraham L, 2011, Spermatogenesis, V1, P221; Kierszenbaum AL, 2003, MOL BIOL CELL, V14, P4628, DOI 10.1091/mbc.E03-04-0226; Kim KS, 2001, BIOL REPROD, V64, P36, DOI 10.1095/biolreprod64.1.36; Korfali Nadia, 2009, V528, P201, DOI 10.1007/978-1-60327-310-7_15; Kracklauer MP, 2010, J CELL SCI, V123, P2763, DOI 10.1242/jcs.066589; Li B, 2014, TRAFFIC, V15, P347, DOI 10.1111/tra.12150; Padmakumar VC, 2005, J CELL SCI, V118, P3419, DOI 10.1242/jcs.02471; Pierre V, 2012, DEVELOPMENT, V139, P2955, DOI 10.1242/dev.077982; ROMRELL LJ, 1976, DEV BIOL, V49, P119, DOI 10.1016/0012-1606(76)90262-1; Shao XP, 1999, DEV BIOL, V211, P109, DOI 10.1006/dbio.1999.9297; Sosa BA, 2012, CELL, V149, P1035, DOI 10.1016/j.cell.2012.03.046; Tran D, 2012, J CELL SCI, V125, P2831, DOI 10.1242/jcs.102111; Yassine S, 2014, MOL HUM REPROD	26	31	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118698	10.1371/journal.pone.0118698	http://dx.doi.org/10.1371/journal.pone.0118698			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775128	Green Published, gold, Green Submitted			2022-12-27	WOS:000351183500035
J	Robinson, RJ; Hensel, EC; Morabito, PN; Roundtree, KA				Robinson, R. J.; Hensel, E. C.; Morabito, P. N.; Roundtree, K. A.			Electronic Cigarette Topography in the Natural Environment	PLOS ONE			English	Article							SMOKING TOPOGRAPHY; NICOTINE; TOBACCO; STANDARDS	This paper presents the results of a clinical, observational, descriptive study to quantify the use patterns of electronic cigarette users in their natural environment. Previously published work regarding puff topography has been widely indirect in nature, and qualitative rather than quantitative, with the exception of three studies conducted in a laboratory environment for limited amounts of time. The current study quantifies the variation in puffing behaviors among users as well as the variation for a given user throughout the course of a day. Puff topography characteristics computed for each puffing session by each subject include the number of subject puffs per puffing session, the mean puff duration per session, the mean puff flow rate per session, the mean puff volume per session, and the cumulative puff volume per session. The same puff topography characteristics are computed across all puffing sessions by each single subject and across all subjects in the study cohort. Results indicate significant inter-subject variability with regard to puffing topography, suggesting that a range of representative puffing topography patterns should be used to drive machine-puffed electronic cigarette aerosol evaluation systems.	[Robinson, R. J.; Hensel, E. C.; Morabito, P. N.; Roundtree, K. A.] Rochester Inst Technol, Dept Mech Engn, Rochester, NY 14623 USA	Rochester Institute of Technology	Robinson, RJ (corresponding author), Rochester Inst Technol, Dept Mech Engn, Rochester, NY 14623 USA.	rjreme@rit.edu	Hensel, Edward/Q-6753-2019	Hensel, Edward/0000-0002-2682-0766	Rochester Institute of Technology, Rochester NY; FSI, Inc., Farmington, NY	Rochester Institute of Technology, Rochester NY; FSI, Inc., Farmington, NY	This work was funded by an internal grant from the Rochester Institute of Technology, Rochester NY. Additional support was provided by FSI, Inc., Farmington, NY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Ahijevych K, 1997, RES NURS HEALTH, V20, P505, DOI 10.1002/(SICI)1098-240X(199712)20:6<505::AID-NUR5>3.0.CO;2-Q; Aung AT, 2004, ADDICT BEHAV, V29, P699, DOI 10.1016/j.addbeh.2004.02.012; Bialous SA, 2001, TOB CONTROL, V10, P96, DOI 10.1136/tc.10.2.96; Blank MD, 2009, NICOTINE TOB RES, V11, P896, DOI 10.1093/ntr/ntp083; Brauer LH, 1996, ADDICT BEHAV, V21, P233, DOI 10.1016/0306-4603(95)00054-2; BRIDGES RB, 1990, PHARMACOL BIOCHEM BE, V37, P29, DOI 10.1016/0091-3057(90)90037-I; Burling TA, 1996, J SUBST ABUSE, V8, P445, DOI 10.1016/S0899-3289(96)90005-X; Etter JF, 2011, ADDICTION, V106, P2017, DOI 10.1111/j.1360-0443.2011.03505.x; Evans SE, 2014, TOB CONTROL, V23, P23, DOI 10.1136/tobaccocontrol-2013-051489; Farsalinos KE, 2013, INT J ENV RES PUB HE, V10, P2500, DOI 10.3390/ijerph10062500; Goniewicz ML, 2014, ADDICTION, V109, P500, DOI 10.1111/add.12410; Goniewicz ML, 2013, NICOTINE TOB RES, V15, P158, DOI 10.1093/ntr/nts103; Goniewicz ML, 2014, TOB CONTROL, V23, P133, DOI 10.1136/tobaccocontrol-2012-050859; Hammond D, 2005, CANCER EPIDEM BIOMAR, V14, P1370, DOI 10.1158/1055-9965.EPI-04-0498; Hammond D., 2005, HUMAN SMOKING BEHAV; HATSUKAMI D, 1987, INT J ADDICT, V22, P719, DOI 10.3109/10826088709027453; HATSUKAMI DK, 1988, ADDICT BEHAV, V13, P91, DOI 10.1016/0306-4603(88)90031-7; Hua M, 2013, TOB CONTROL, V22, P103, DOI 10.1136/tobaccocontrol-2011-050226; Kosmider L, 2014, NICOTINE TOB RES, V16, P1319, DOI 10.1093/ntr/ntu078; Norton KJ, 2014, TOB INDUC DIS, V12, DOI 10.1186/1617-9625-12-17; Sazonov E, 2013, J STUD ALCOHOL DRUGS, V74, P956, DOI 10.15288/jsad.2013.74.956; Tan L., 2013, FUNDAMENTALS APPL, V2nd ed.; Trehy ML, 2011, J LIQ CHROMATOGR R T, V34, P1442, DOI 10.1080/10826076.2011.572213; Trtchounian A, 2010, NICOTINE TOB RES, V12, P905, DOI 10.1093/ntr/ntq114; Westenberger BJ, 2009, EVALUATION E CIGARAT; Williams M, 2011, NICOTINE TOB RES, V13, P1276, DOI 10.1093/ntr/ntr164	26	45	46	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129296	10.1371/journal.pone.0129296	http://dx.doi.org/10.1371/journal.pone.0129296			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	25775238	Green Submitted, Green Published, gold			2022-12-27	WOS:000355955300112
J	Avramopoulos, D; Pearce, BD; McGrath, J; Wolyniec, P; Wang, RH; Eckart, N; Hatzimanolis, A; Goes, FS; Nestadt, G; Mulle, J; Coneely, K; Hopkins, M; Ruczinski, I; Yolken, R; Pulver, AE				Avramopoulos, Dimitrios; Pearce, Brad D.; McGrath, John; Wolyniec, Paula; Wang, Ruihua; Eckart, Nicole; Hatzimanolis, Alexandros; Goes, Fernando S.; Nestadt, Gerald; Mulle, Jennifer; Coneely, Karen; Hopkins, Myfanwy; Ruczinski, Ingo; Yolken, Robert; Pulver, Ann E.			Infection and Inflammation in Schizophrenia and Bipolar Disorder: A Genome Wide Study for Interactions with Genetic Variation	PLOS ONE			English	Article							C-REACTIVE PROTEIN; TOXOPLASMA-GONDII INFECTION; PSYCHIATRIC-DISORDERS; ONSET SCHIZOPHRENIA; MILITARY PERSONNEL; IMMUNE-RESPONSE; KINASE SGK1; RISK LOCI; ANTIBODIES; AGENTS	Inflammation and maternal or fetal infections have been suggested as risk factors for schizophrenia (SZ) and bipolar disorder (BP). It is likely that such environmental effects are contingent on genetic background. Here, in a genome-wide approach, we test the hypothesis that such exposures increase the risk for SZ and BP and that the increase is dependent on genetic variants. We use genome-wide genotype data, plasma IgG antibody measurements against Toxoplasma gondii, Herpes simplex virus type 1, Cytomegalovirus, Human Herpes Virus 6 and the food antigen gliadin as well as measurements of C-reactive protein (CRP), a peripheral marker of inflammation. The subjects are SZ cases, BP cases, parents of cases and screened controls. We look for higher levels of our immunity/infection variables and interactions between them and common genetic variation genome-wide. We find many of the antibody measurements higher in both disorders. While individual tests do not withstand correction for multiple comparisons, the number of nominally significant tests and the comparisons showing the expected direction are in significant excess (permutation p=0.019 and 0.004 respectively). We also find CRP levels highly elevated in SZ, BP and the mothers of BP cases, in agreement with existing literature, but possibly confounded by our inability to correct for smoking or body mass index. In our genome-wide interaction analysis no signal reached genome-wide significance, yet many plausible candidate genes emerged. In a hypothesis driven test, we found multiple interactions among SZ-associated SNPs in the HLA region on chromosome 6 and replicated an interaction between CMV infection and genotypes near the CTNNA3 gene reported by a recent GWAS. Our results support that inflammatory processes and infection may modify the risk for psychosis and suggest that the genotype at SZ-associated HLA loci modifies the effect of these variables on the risk to develop SZ.	[Avramopoulos, Dimitrios; Eckart, Nicole] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Avramopoulos, Dimitrios; McGrath, John; Wolyniec, Paula; Wang, Ruihua; Hatzimanolis, Alexandros; Goes, Fernando S.; Nestadt, Gerald; Pulver, Ann E.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Pearce, Brad D.; Mulle, Jennifer; Coneely, Karen; Hopkins, Myfanwy] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Coneely, Karen] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA USA; [Ruczinski, Ingo] Johns Hopkins Univ, Sch Med, Bloomberg Sch Publ Heath, Baltimore, MD USA; [Yolken, Robert] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Emory University; Rollins School Public Health; Emory University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Avramopoulos, D (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.	adimitr1@jhmi.edu	yolken, robert/AAW-2556-2021; Hatzimanolis, Alex/GOG-7992-2022	McGrath, John A./0000-0002-9756-7892	NIMH [MH092515, MH092512, MH094268, MH085018];  [MH057314];  [MH058153];  [MH068406]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092515, R01MH068406, R01MH057314, R01MH058153, R01MH085018, R01MH092512, P50MH094268] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); ; ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The analyses reported in this manuscript were supported by NIMH grant MH092515 to D.A., MH092512 to B.D.P. The collection and storage of the clinical data and biological material was supported by MH057314, MH058153 and MH068406 to A.E.P. The schizophrenia research program of D.A. is also supported by NIMH grants MH094268 and MH085018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anacker C, 2013, P NATL ACAD SCI USA, V110, P8708, DOI 10.1073/pnas.1300886110; Arias I, 2012, SCHIZOPHR RES, V136, P128, DOI 10.1016/j.schres.2011.10.026; Atherton A, 2000, EUR J IMMUNOL, V30, P2540, DOI 10.1002/1521-4141(200009)30:9<2540::AID-IMMU2540>3.3.CO;2-J; Berrettini W, 2004, NEUROMOL MED, V5, P109, DOI 10.1385/NMM:5:1:109; Borglum AD, 2014, MOL PSYCHIATR, V19, P325, DOI 10.1038/mp.2013.2; Buka SL, 2001, ARCH GEN PSYCHIAT, V58, P1032, DOI 10.1001/archpsyc.58.11.1032; Cannon TD, 1998, ARCH GEN PSYCHIAT, V55, P67, DOI 10.1001/archpsyc.55.1.67; Cardno AG, 1999, ARCH GEN PSYCHIAT, V56, P162, DOI 10.1001/archpsyc.56.2.162; Cardno AG, 2014, SCHIZOPHRENIA BULL, V40, P504, DOI 10.1093/schbul/sbu016; Chen PL, 2009, AM J HUM GENET, V84, P21, DOI 10.1016/j.ajhg.2008.12.005; De Berardis D, 2008, INT J IMMUNOPATH PH, V21, P319, DOI 10.1177/039463200802100208; Dehghan A, 2011, CIRCULATION, V123, P731, DOI 10.1161/CIRCULATIONAHA.110.948570; Dickerson F, 2014, BIPOLAR DISORD, V16, P129, DOI 10.1111/bdi.12123; Dickerson F, 2013, SCHIZOPHR RES, V143, P198, DOI 10.1016/j.schres.2012.10.041; Dudbridge F, 2014, AM J HUM GENET, V95, P301, DOI 10.1016/j.ajhg.2014.07.014; Fallin MD, 2005, AM J HUM GENET, V77, P918, DOI 10.1086/497703; Fallin MD, 2003, AM J HUM GENET, V73, P601, DOI 10.1086/378158; Fawzi MH, 2011, PSYCHIAT RES, V190, P91, DOI 10.1016/j.psychres.2011.05.010; Firth MA, 2013, J EXP MED, V210, P2981, DOI 10.1084/jem.20130417; Hamdani N, 2013, J AFFECT DISORDERS, V148, P444, DOI 10.1016/j.jad.2012.11.034; Heikamp EB, 2014, NAT IMMUNOL, V15, P457, DOI 10.1038/ni.2867; Kannan G, 2013, NEUROBIOL DIS, V57, P5, DOI 10.1016/j.nbd.2013.05.012; Lang F, 2010, J PHYSIOL-LONDON, V588, P3349, DOI 10.1113/jphysiol.2010.190926; Leweke FM, 2004, EUR ARCH PSY CLIN N, V254, P4, DOI 10.1007/s00406-004-0481-6; Li YZ, 2013, SCHIZOPHR RES, V151, P36, DOI 10.1016/j.schres.2013.10.004; Male V, 2012, TRENDS IMMUNOL, V33, P98, DOI 10.1016/j.it.2011.10.002; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Miller Brian J, 2014, Clin Schizophr Relat Psychoses, V7, P223, DOI 10.3371/CSRP.MICU.020813; Mortensen PB, 2011, BIPOLAR DISORD, V13, P624, DOI 10.1111/j.1399-5618.2011.00962.x; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Mulle JG, 2010, AM J HUM GENET, V87, P229, DOI 10.1016/j.ajhg.2010.07.013; Niebuhr DW, 2008, SCHIZOPHRENIA BULL, V34, P1182, DOI 10.1093/schbul/sbm139; Okusaga O, 2013, WORLD J BIOL PSYCHIA, V14, P509, DOI 10.3109/15622975.2012.747699; Osland TM, 2011, J PSYCHOPHARMACOL, V25, P924, DOI 10.1177/0269881110379508; Pearce BD, 2012, BIOL PSYCHIAT, V72, P290, DOI 10.1016/j.biopsych.2012.01.003; Pribiag H, 2014, NEUROPHARMACOLOGY, V78, P13, DOI 10.1016/j.neuropharm.2013.06.008; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Rizzo LB, 2013, BIPOLAR DISORD, V15, P832, DOI 10.1111/bdi.12121; Scharpf RB, 2011, J STAT SOFTW, V40, P1; Schmitt A, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00019; Severance EG, 2014, BIPOLAR DISORD, V16, P230, DOI 10.1111/bdi.12159; Singh B, 2014, PSYCHIAT RES, V216, P277, DOI 10.1016/j.psychres.2014.02.004; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Smoller JW, 2003, AM J MED GENET C, V123C, P48, DOI 10.1002/ajmg.c.20013; Torrey EF, 2007, SCHIZOPHRENIA BULL, V33, P729, DOI 10.1093/schbul/sbl050; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; WEISS JB, 1983, J CLIN INVEST, V72, P96, DOI 10.1172/JCI110988; Yolken RH, 2008, MOL PSYCHIATR, V13, P470, DOI 10.1038/mp.2008.5; Yolken Robert, 2004, Herpes, V11 Suppl 2, p83A; ZHANG W, 1995, MOL CELL BIOL, V15, P6055	51	76	76	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0116696	10.1371/journal.pone.0116696	http://dx.doi.org/10.1371/journal.pone.0116696			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781172	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600008
J	Everman, S; Mandarino, LJ; Carroll, CC; Katsanos, CS				Everman, Sarah; Mandarino, Lawrence J.; Carroll, Chad C.; Katsanos, Christos S.			Effects of Acute Exposure to Increased Plasma Branched-Chain Amino Acid Concentrations on Insulin-Mediated Plasma Glucose Turnover in Healthy Young Subjects	PLOS ONE			English	Article							PROTEIN-METABOLISM; OBESITY; MUSCLE; RESISTANCE; LEUCINE; SENSITIVITY; ISOLEUCINE; MECHANISM; INFUSION; DISPOSAL	Background Plasma branched-chain amino acids (BCAA) are inversely related to insulin sensitivity of glucose metabolism in humans. However, currently, it is not known whether there is a cause-and-effect relationship between increased plasma BCAA concentrations and decreased insulin sensitivity. Objective To determine the effects of acute exposure to increased plasma BCAA concentrations on insulin-mediated plasma glucose turnover in humans. Methods Ten healthy subjects were randomly assigned to an experiment where insulin was infused at 40 mU/m(2)/min (40U) during the second half of a 6-hour intravenous infusion of a BCAA mixture (i.e., BCAA; N = 5) to stimulate plasma glucose turnover or under the same conditions without BCAA infusion (Control; N = 5). In a separate experiment, seven healthy subjects were randomly assigned to receive insulin infusion at 80 mU/m(2)/min (80U) in association with the above BCAA infusion (N = 4) or under the same conditions without BCAA infusion (N = 3). Plasma glucose turnover was measured prior to and during insulin infusion. Results Insulin infusion completely suppressed the endogenous glucose production (EGP) across all groups. The percent suppression of EGP was not different between Control and BCAA in either the 40U or 80U experiments (P > 0.05). Insulin infusion stimulated whole-body glucose disposal rate (GDR) across all groups. However, the increase (%) in GDR was not different [median (1st quartile - 3rd quartile)] between Control and BCAA in either the 40U ([199 (167-278) vs. 186 (94-308)] or 80 U ([491 (414-548) vs. 478 (409-857)] experiments (P > 0.05). Likewise, insulin stimulated the glucose metabolic clearance in all experiments (P < 0.05) with no differences between Control and BCAA in either of the experiments (P > 0.05). Conclusion Short-term exposure of young healthy subjects to increased plasma BCAA concentrations does not alter the insulin sensitivity of glucose metabolism.	[Everman, Sarah; Mandarino, Lawrence J.; Katsanos, Christos S.] Arizona State Univ, Mayo Clin Arizona, Ctr Metab & Vasc Biol, Scottsdale, AZ 85257 USA; [Mandarino, Lawrence J.; Katsanos, Christos S.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Carroll, Chad C.] Midwestern Univ, Dept Physiol, Glendale, AZ USA	Arizona State University; Mayo Clinic; Mayo Clinic Phoenix; Arizona State University; Arizona State University-Tempe; Midwestern University	Katsanos, CS (corresponding author), Arizona State Univ, Mayo Clin Arizona, Ctr Metab & Vasc Biol, Scottsdale, AZ 85257 USA.	christos.katsanos@asu.edu			Arizona State University; NIH/NIDDK [R01DK094062]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094062, U24DK100469] Funding Source: NIH RePORTER	Arizona State University; NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was conducted at the Center for Metabolic and Vascular Biology at Arizona State University and was funded in part by Arizona State University and by NIH/NIDDK grant R01DK094062 (CSK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2007, DIABETES CARE, V30, P89, DOI 10.2337/dc06-1519; Adams SH, 2011, ADV NUTR, V2, P445, DOI 10.3945/an.111.000737; ADIBI SA, 1968, J APPL PHYSIOL, V25, P52, DOI 10.1152/jappl.1968.25.1.52; Beckett PR, 1996, ANAL BIOCHEM, V240, P48, DOI 10.1006/abio.1996.0329; BODEN G, 1990, DIABETES, V39, P1079, DOI 10.2337/diabetes.39.9.1079; Brand HS, 1997, CLIN CHIM ACTA, V264, P37, DOI 10.1016/S0009-8981(97)00070-3; CABALLERO B, 1988, METABOLISM, V37, P672, DOI 10.1016/0026-0495(88)90089-3; Carroll CC, 2005, AM J PHYSIOL-ENDOC M, V288, pE479, DOI 10.1152/ajpendo.00393.2004; Doi M, 2003, BIOCHEM BIOPH RES CO, V312, P1111, DOI 10.1016/j.bbrc.2003.11.039; FELIG P, 1969, NEW ENGL J MED, V281, P811, DOI 10.1056/NEJM196910092811503; FLAKOLL PJ, 1991, JPEN-PARENTER ENTER, V15, P123, DOI 10.1177/0148607191015002123; Fujita S, 2006, J NUTR, V136, p277S, DOI 10.1093/jn/136.1.277S; Higuchi N, 2011, J CELL BIOCHEM, V112, P30, DOI 10.1002/jcb.22688; Ikehara O, 2008, BIOL PHARM BULL, V31, P469, DOI 10.1248/bpb.31.469; Koopmans SJ, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-25; Krebs M, 2002, DIABETES, V51, P599, DOI 10.2337/diabetes.51.3.599; Lackey DE, 2013, AM J PHYSIOL-ENDOC M, V304, pE1175, DOI 10.1152/ajpendo.00630.2012; Laferrere B, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002043; Lefort N, 2010, DIABETES, V59, P2444, DOI 10.2337/db10-0174; MARCHESINI G, 1991, CLIN NUTR, V10, P105, DOI 10.1016/0261-5614(91)90096-U; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Matthews DE, 2005, J NUTR, V135, p1580S, DOI 10.1093/jn/135.6.1580S; McCormack SE, 2013, PEDIATR OBES, V8, P52, DOI 10.1111/j.2047-6310.2012.00087.x; Menge BA, 2010, REGUL PEPTIDES, V160, P75, DOI 10.1016/j.regpep.2009.08.001; Mihalik SJ, 2012, DIABETES CARE, V35, P605, DOI [10.2337/DC11-1577, 10.2337/dc11-1577]; Nagata C, 2013, AM J EPIDEMIOL, V178, P1226, DOI 10.1093/aje/kwt112; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nishitani S, 2002, BIOCHEM BIOPH RES CO, V299, P693, DOI 10.1016/S0006-291X(02)02717-1; PISTERS PWT, 1991, METABOLISM, V40, P59, DOI 10.1016/0026-0495(91)90193-Z; Robinson MM, 2014, J CLIN ENDOCR METAB, V99, pE2574, DOI 10.1210/jc.2014-2736; ROMIJN JA, 1993, AM J PHYSIOL, V265, pE380, DOI 10.1152/ajpendo.1993.265.3.E380; She PX, 2007, AM J PHYSIOL-ENDOC M, V293, pE1552, DOI 10.1152/ajpendo.00134.2007; She P, 2007, CELL METAB, V6, P181, DOI 10.1016/j.cmet.2007.08.003; She PX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059443; Smith GI, 2014, DIABETES; Solini A, 1997, J CLIN ENDOCR METAB, V82, P2552, DOI 10.1210/jc.82.8.2552; STEELE R, 1959, ANN NY ACAD SCI, V82, P420, DOI 10.1111/j.1749-6632.1959.tb44923.x; Tatpati LL, 2010, J CLIN ENDOCR METAB, V95, P894, DOI 10.1210/jc.2009-1822; TESSARI P, 1985, DIABETOLOGIA, V28, P870, DOI 10.1007/BF00291080; Thalacker-Mercer AE, 2014, DIABETES, V63, P791, DOI 10.2337/db13-0396; Tremblay F, 2005, DIABETES, V54, P2674, DOI 10.2337/diabetes.54.9.2674; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Wolfe RR, 1992, RADIOACTIVE STABLE I; Yang XF, 2013, J BIOL CHEM, V288, P9313, DOI 10.1074/jbc.M112.409409; Zhang YY, 2007, DIABETES, V56, P1647, DOI 10.2337/db07-0123	45	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120049	10.1371/journal.pone.0120049	http://dx.doi.org/10.1371/journal.pone.0120049			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781654	Green Published, gold, Green Submitted			2022-12-27	WOS:000351284600121
J	Kwiecien, I; Radecka, I; Kowalczuk, M; Adamus, G				Kwiecien, Iwona; Radecka, Iza; Kowalczuk, Marek; Adamus, Grazyna			Transesterification of PHA to Oligomers Covalently Bonded with (Bio) Active Compounds Containing Either Carboxyl or Hydroxyl Functionalities	PLOS ONE			English	Article							MOLECULAR-LEVEL STRUCTURE; STRUCTURAL-CHARACTERIZATION; MASS-SPECTROMETRY; SYNTHETIC ANALOGS; ACID; POLYHYDROXYALKANOATES; BIOPOLYESTERS; BIOSYNTHESIS; COPOLYMERS	This manuscript presents the synthesis and structural characterisation of novel biodegradable polymeric controlled-release systems of pesticides with potentially higher resistance to weather conditions in comparison to conventional forms of pesticides. Two methods for the preparation of pesticide-oligomer conjugates using the transesterification reaction were developed. The first method of obtaining conjugates, which consist of bioactive compounds with the carboxyl group and polyhydroxyalkanoates (PHAs) oligomers, is "one-pot" transesterification. In the second method, conjugates of bioactive compounds with hydroxyl group and polyhydroxyalkanoates oligomers were obtained in two-step method, through cyclic poly(3-hydroxybutyrate) oligomers. The obtained pesticide-PHA conjugates were comprehensively characterised using GPC, 1H NMR and mass spectrometry techniques. The structural characterisation of the obtained products at the molecular level with the aid of mass spectrometry confirmed that both of the synthetic strategies employed led to the formation of conjugates in which selected pesticides were covalently bonded to PHA oligomers via a hydrolysable ester bond.	[Kwiecien, Iwona; Kowalczuk, Marek; Adamus, Grazyna] Polish Acad Sci, Ctr Polymer & Carbon Mat, Zabrze, Poland; [Radecka, Iza; Kowalczuk, Marek] Wolverhampton Univ, Fac Sci & Engn, Sch Biol Chem & Forens Sci, Wolverhampton, England	Polish Academy of Sciences; Centre of Polymer & Carbon Materials of the Polish Academy of Sciences; University of Wolverhampton	Kowalczuk, M (corresponding author), Polish Acad Sci, Ctr Polymer & Carbon Mat, Zabrze, Poland.	M.Kowalczuk@wlv.ac.uk; grazyna.adamus@cmpw-pan.edu.pl	Radecka, Iza/AAV-2925-2021; Kwiecień, Iwona/P-4787-2015	Kwiecień, Iwona/0000-0002-6353-5913; Kowalczuk, Marek/0000-0002-2877-7466; Adamus, Grazyna/0000-0001-5439-7400				ABATE R, 1995, MACROMOLECULES, V28, P7911, DOI 10.1021/ma00127a043; Adamus G, 2006, RAPID COMMUN MASS SP, V20, P804, DOI 10.1002/rcm.2365; Adamus G, 2014, ANAL CHIM ACTA, V808, P104, DOI 10.1016/j.aca.2013.09.001; Adamus G, 2009, MACROMOLECULES, V42, P4547, DOI 10.1021/ma900349u; Bowles RG, 1995, CROP PROT, V14, P593, DOI 10.1016/0261-2194(96)81770-4; Chen GQ, 2009, CHEM SOC REV, V38, P2434, DOI 10.1039/b812677c; Guo-Qiang C., 2001, REACT FUNCT POLYM, V48, P107, DOI [10.1016/S1381-5148(01)00042-6, DOI 10.1016/S1381-5148(01)00042-6]; Impallomeni G, 2002, BIOMACROMOLECULES, V3, P835, DOI 10.1021/bm025525t; Jendrossek D, 2002, ANNU REV MICROBIOL, V56, P403, DOI 10.1146/annurev.micro.56.012302.160838; Jiang X, 2012, BIOMACROMOLECULES, V13, P2926, DOI 10.1021/bm3009507; Koller M, 2010, FOOD TECHNOL BIOTECH, V48, P255; Kowalski WJ, 2013, AM SOC TEST MATER, V1558, P15, DOI 10.1520/STP155820120064; Kowalski WJ, 2012, ARCH ENVIRON PROT, V38, P119, DOI 10.2478/v10265-012-0034-4; Kwiecien I, 2014, DES MONOMERS POLYM, V17, P311, DOI 10.1080/15685551.2013.840505; Kwiecien I, 2012, RAPID COMMUN MASS SP, V26, P2673, DOI 10.1002/rcm.6391; Kwiecien M, 2013, BIOMACROMOLECULES, V14, P1181, DOI 10.1021/bm400141s; Lobo FA, 2011, POLYM BULL, V67, P479, DOI 10.1007/s00289-011-0447-6; Maksymiak M, 2013, RAPID COMMUN MASS SP, V27, P773, DOI 10.1002/rcm.6509; Muhr A, 2013, REACT FUNCT POLYM, V73, P1391, DOI 10.1016/j.reactfunctpolym.2012.12.009; Numata K, 2009, MATERIALS, V2, P1104, DOI 10.3390/ma2031104; Osanai Y, 2002, MACROMOL BIOSCI, V2, P88, DOI 10.1002/1616-5195(20020201)2:2<88::AID-MABI88>3.0.CO;2-5; Prudnikova SV, 2013, J POLYM ENVIRON, V21, P675, DOI 10.1007/s10924-012-0561-z; Savenkova L, 2002, PROCESS BIOCHEM, V37, P719, DOI 10.1016/S0032-9592(01)00263-1; SEEBACH D, 1992, ANGEW CHEM INT EDIT, V31, P434, DOI 10.1002/anie.199204341; Tappel RC, 2012, BIOMACROMOLECULES, V13, P2964, DOI 10.1021/bm301043t; Tripathi L, 2013, BIOMACROMOLECULES, V14, P862, DOI 10.1021/bm3019517; Vergili I, 2009, DESALINATION, V249, P1107, DOI 10.1016/j.desal.2009.06.043; Verlinden RAJ, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-11; Voinova ON, 2009, APPL BIOCHEM MICRO+, V45, P384, DOI 10.1134/S0003683809040061; Zawidlak-Wegrzynska B, 2010, EUR J MED CHEM, V45, P1833, DOI 10.1016/j.ejmech.2010.01.020	30	18	18	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120149	10.1371/journal.pone.0120149	http://dx.doi.org/10.1371/journal.pone.0120149			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781908	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600132
J	Tan, S; Cheng, JW; Zhang, L; Qin, C; Nong, DG; Li, WP; Tang, X; Wu, ZM; Hu, KL				Tan, Shu; Cheng, Jiao-Wen; Zhang, Li; Qin, Cheng; Nong, Ding-Guo; Li, Wei-Peng; Tang, Xin; Wu, Zhi-Ming; Hu, Kai-Lin			Construction of an Interspecific Genetic Map Based on InDel and SSR for Mapping the QTLs Affecting the Initiation of Flower Primordia in Pepper (Capsicum spp.)	PLOS ONE			English	Article							LINKAGE MAP; PLANT ARCHITECTURE; FRUIT TRAITS; ANNUUM; MARKERS; ARABIDOPSIS; SEQUENCE; IDENTIFICATION; SEGREGATION; COLLECTION	Re-sequencing permits the mining of genome-wide variations on a large scale and provides excellent resources for the research community. To accelerate the development and application of molecular markers and identify the QTLs affecting the flowering time-related trait in pepper, a total of 1,038 pairs of InDel and 674 SSR primers from different sources were used for genetic mapping using the F-2 population (n = 154) derived from a cross between BA3 (C. annuum) and YNXML (C. frutescens). Of these, a total of 224 simple PCR-based markers, including 129 InDels and 95 SSRs, were validated and integrated into a map, which was designated as the BY map. The BY map consisted of 13 linkage groups (LGs) and spanned a total genetic distance of 1,249.77 cM with an average marker distance of 5.60 cM. Comparative analysis of the genetic and physical map based on the anchored markers showed that the BY map covered nearly the whole pepper genome. Based on the BY map, one major and five minor QTLs affecting the number of leaves on the primary axis (Nle) were detected on chromosomes P2, P7, P10 and P11 in 2012. The major QTL on P2 was confirmed based on another subset of the same F2 population (n = 147) in 2014 with selective genotyping of markers from the BY map. With the accomplishment of pepper whole genome sequencing and annotations (release 2.0), 153 candidate genes were predicted to embed in the Nle2.2 region, of which 12 important flowering related genes were obtained. The InDel/SSR-based interspecific genetic map, QTLs and candidate genes obtained by the present study will be useful for the downstream isolation of flowering time-related gene and other genetic applications for pepper.	[Tan, Shu; Cheng, Jiao-Wen; Zhang, Li; Qin, Cheng; Li, Wei-Peng; Tang, Xin; Hu, Kai-Lin] South China Agr Univ, Coll Hort, Guangzhou, Guangdong, Peoples R China; [Qin, Cheng] Zunyi Acad Agr Sci, Pepper Inst, Zunyi, Guizhou, Peoples R China; [Qin, Cheng] Sichuan Agr Univ, Maize Res Inst, Key Lab Biol & Genet Improvement Maize Southwest, Chengdu, Peoples R China; [Nong, Ding-Guo] Guangxi Univ, Coll Agr, Nanning 530004, Peoples R China; [Wu, Zhi-Ming] Zhongkai Univ Agr & Engn, Coll Hort & Landscape Architecture, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; Sichuan Agricultural University; Guangxi University; Zhongkai University of Agriculture & Engineering	Hu, KL (corresponding author), South China Agr Univ, Coll Hort, Guangzhou, Guangdong, Peoples R China.	hukailin@scau.edu.cn	cheng, jiaowen/N-3870-2016	cheng, jiaowen/0000-0002-7004-5138; wu, zhi ming/0000-0001-8988-6060; Qin, Cheng/0000-0002-8519-4697	Guangdong Natural Science Foundation of China [S2011030001410]; National High Technology Research and Development Program ("863" Program) of China [2012AA100103]; National Natural Science Foundation of China [31372076]; Zunyi City Natural Science Foundation of China [201201]; Guizhou Province and Zunyi City Science and Technology Cooperation Project of China [201307]	Guangdong Natural Science Foundation of China(National Natural Science Foundation of Guangdong Province); National High Technology Research and Development Program ("863" Program) of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zunyi City Natural Science Foundation of China; Guizhou Province and Zunyi City Science and Technology Cooperation Project of China	This work was supported by the Guangdong Natural Science Foundation of China (S2011030001410), the National High Technology Research and Development Program ("863" Program) of China (2012AA100103), the National Natural Science Foundation of China (31372076), the Zunyi City Natural Science Foundation of China (No. 201201) and the Guizhou Province and Zunyi City Science and Technology Cooperation Project of China (No. 201307). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YK, 2013, BOT STUD, V54, DOI 10.1186/1999-3110-54-58; Ahn YK, 2014, GENE, V533, P494, DOI 10.1016/j.gene.2013.09.095; Alimi NA, 2013, EUPHYTICA, V190, P181, DOI 10.1007/s10681-012-0767-0; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barchi L, 2007, GENOME, V50, P51, DOI 10.1139/G06-140; Barchi L, 2009, THEOR APPL GENET, V118, P1157, DOI 10.1007/s00122-009-0970-0; Ben Chaim A, 2001, THEOR APPL GENET, V102, P1016, DOI 10.1007/s001220000461; Ben-Chaim A, 2000, J AM SOC HORTIC SCI, V125, P66, DOI 10.21273/JASHS.125.1.66; Ben-Chaim A, 2006, THEOR APPL GENET, V113, P1481, DOI 10.1007/s00122-006-0395-y; Chen XueJun, 2006, Acta Horticulturae Sinica, V33, P152; Cohen O, 2014, NEW PHYTOL, V202, P1014, DOI 10.1111/nph.12711; Cohen O, 2012, J EXP BOT, V63, P4947, DOI 10.1093/jxb/ers172; David-Schwartz R, 2013, PLANT SCI, V203, P8, DOI 10.1016/j.plantsci.2012.12.011; Dinh TT, 2012, DEVELOPMENT, V139, P1978, DOI 10.1242/dev.077073; Doyle MR, 2009, PLANT PHYSIOL, V151, P1688, DOI 10.1104/pp.109.145581; Duan MM, 2014, CONSTRUCTION INTRASP; Elitzur T, 2009, J EXP BOT, V60, P869, DOI 10.1093/jxb/ern334; Hou XH, 2010, PLANT J, V63, P880, DOI 10.1111/j.1365-313X.2010.04277.x; Ibiza VP, 2012, GENET RESOUR CROP EV, V59, P1077, DOI 10.1007/s10722-011-9744-z; Jeifetz D, 2011, PLANTA, V234, P1227, DOI 10.1007/s00425-011-1479-8; Kang BC, 2001, THEOR APPL GENET, V102, P531, DOI 10.1007/s001220051678; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Lee HR, 2009, MOL CELLS, V27, P21, DOI 10.1007/s10059-009-0002-6; Lee JM, 2004, THEOR APPL GENET, V108, P619, DOI 10.1007/s00122-003-1467-x; Lefebvre V, 2002, GENOME, V45, P839, DOI 10.1139/G02-053; Li HH, 2007, GENETICS, V175, P361, DOI 10.1534/genetics.106.066811; Li WP, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0219-3; Liu B, 2013, THEOR APPL GENET, V126, P231, DOI 10.1007/s00122-012-1976-6; Liu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065209; Livingstone KD, 1999, GENETICS, V152, P1183; Lu H, 2002, THEOR APPL GENET, V105, P622, DOI 10.1007/s00122-002-0970-9; Marame F, 2009, HEREDITAS, V146, P131, DOI 10.1111/j.1601-5223.2009.02101.x; Martinez-Lopez LA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-143; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; Mimura Y, 2010, J JPN SOC HORTIC SCI, V79, P56, DOI 10.2503/jjshs1.79.56; Minamiyama Y, 2006, MOL BREEDING, V18, P157, DOI 10.1007/s11032-006-9024-3; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nagy I, 2007, GENOME, V50, P668, DOI 10.1139/G07-047; Nicolai M, 2013, GENET RESOUR CROP EV, V60, P2375, DOI 10.1007/s10722-013-0006-0; Ogundiwin EA, 2005, GENOME, V48, P698, DOI 10.1139/G05-028; Pacurar DI, 2012, J EXP BOT, V63, P2491, DOI 10.1093/jxb/err422; Paran I, 2004, MOL BREEDING, V13, P251, DOI 10.1023/B:MOLB.0000022526.30914.31; Park SW, 2014, MOL BREEDING, V34, P963, DOI 10.1007/s11032-014-0089-0; Portis E, 2007, PLANT SCI, V172, P640, DOI 10.1016/j.plantsci.2006.11.016; Qin C, 2014, P NATL ACAD SCI USA, V111, P5135, DOI 10.1073/pnas.1400975111; Rao GU, 2003, THEOR APPL GENET, V106, P1457, DOI 10.1007/s00122-003-1204-5; Schmitz G, 1999, CURR OPIN PLANT BIOL, V2, P51, DOI 10.1016/S1369-5266(99)80010-7; SHIFRISS C, 1977, EUPHYTICA, V26, P491, DOI 10.1007/BF00027015; Sugita T, 2005, BREEDING SCI, V55, P287, DOI 10.1270/jsbbs.55.287; Sugita T, 2013, MOL BREEDING, V31, P909, DOI 10.1007/s11032-013-9844-x; Van Ooijen JW, 2006, SOFTWARE CALCULATION; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang S., 2007, WINDOWS QTL CARTOGRA; Wang XM, 2012, MOL BIOL CELL, V23, P1446, DOI 10.1091/mbc.E11-09-0797; Wu FN, 2009, THEOR APPL GENET, V118, P1279, DOI 10.1007/s00122-009-0980-y; Wu ZhiMing, 2012, Journal of South China Agricultural University, V33, P171; Wurschum T, 2006, PLANT CELL, V18, P295, DOI 10.1105/tpc.105.038398; Yan YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104652; Yarnes SC, 2013, GENOME, V56, P61, DOI 10.1139/gen-2012-0083; Yoon JB, 2006, BREEDING SCI, V56, P31, DOI 10.1270/jsbbs.56.31; Zong HX, 2013, CONSTRUCTION MOL LIN	61	19	24	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119389	10.1371/journal.pone.0119389	http://dx.doi.org/10.1371/journal.pone.0119389			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781878	Green Published, gold, Green Submitted			2022-12-27	WOS:000351284600062
J	Varghese, A; Ticktin, T; Mandle, L; Nath, S				Varghese, Anita; Ticktin, Tamara; Mandle, Lisa; Nath, Snehlata			Assessing the Effects of Multiple Stressors on the Recruitment of Fruit Harvested Trees in a Tropical Dry Forest, Western Ghats, India	PLOS ONE			English	Article							SIZE DISTRIBUTIONS; POPULATION-STRUCTURE; SPECIES COMPOSITION; PRODUCTS; SUSTAINABILITY; REGENERATION; DEMOGRAPHY; IMPACT; FIRE	The harvest of non-timber forest products (NTFPs), together with other sources of anthropogenic disturbance, impact plant populations greatly. Despite this, conservation research on NTFPs typically focuses on harvest alone, ignoring possible confounding effects of other anthropogenic and ecological factors. Disentangling anthropogenic disturbances is critical in regions such as India's Western Ghats, a biodiversity hotspot with high human density. Identifying strategies that permit both use and conservation of resources is essential to preserving biodiversity while meeting local needs. We assessed the effects of NTFP harvesting (fruit harvest from canopy and lopping of branches for fruit) in combination with other common anthropogenic disturbances (cattle grazing, fire frequency and distance from village), in order to identify which stressors have greater effects on recruitment of three tropical dry forest fruit tree species. Specifically, we assessed the structure of 54 populations of Phyllanthus emblica, P.indofischeri and Terminalia chebula spread across the Nilgiri Biosphere Reserve, Western Ghats to ask: (1) How are populations recruiting? and (2) What anthropogenic disturbance and environmental factors, specifically forest type and elevation, are the most important predictors of recruitment status? We combined participatory research with an information-theoretic model-averaging approach to determine which factors most affect population structure and recruitment status. Our models illustrate that for T. chebula, high fire frequency and high fruit harvest intensity decreased the proportion of saplings, while lopping branches or stems to obtain fruit increased it. For Phyllanthus spp, recruitment was significantly lower in plots with more frequent fire. Indices of recruitment of both species were significantly higher for plots in more open-canopy environments of savanna woodlands than in dry forests. Our research illustrates an approach for identifying which factors are most important in limiting recruitment of NTFP populations and other plant species that may be in decline, in order to design effective management strategies.	[Varghese, Anita; Nath, Snehlata] Keystone Fdn, Kotagiri 643217, The Nilgiris, India; [Varghese, Anita; Ticktin, Tamara; Mandle, Lisa] Univ Hawaii Manoa, Dept Bot, Honolulu, HI 96822 USA; [Mandle, Lisa] Stanford Univ, Nat Capital Project, Stanford, CA 94305 USA	University of Hawaii System; University of Hawaii Manoa; Stanford University	Varghese, A (corresponding author), Keystone Fdn, PB 35, Kotagiri 643217, The Nilgiris, India.	anita@keystone-foundation.org		Mandle, Lisa/0000-0002-1420-8529	Ford Foundation; NSF [OISE03-52827]	Ford Foundation; NSF(National Science Foundation (NSF))	The field work was funded by the Ford Foundation for work on NTFP in the NBR through a project to Snehlata Nath, Director Programs, Keystone Foundation. The data analysis and writing was supported by NSF grant OISE03-52827 to TT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D. R., 2008, MODEL BASED INFERENC; Anitha K, 2010, ECOL COMPLEX, V7, P217, DOI 10.1016/j.ecocom.2010.02.005; Asner GP, 2004, ANNU REV ENV RESOUR, V29, P261, DOI 10.1146/annurev.energy.29.062403.102142; Asouti E., 2008, Trees and woodlands of South India: archaeological perspectives; Bates D, 2012, LME4 LINEAR MIXED EF; Bawa KS, 2011, CONSERV BIOL, V25, P639, DOI 10.1111/j.1523-1739.2010.01640.x; Berkes F, 2008, SACRED ECOLOGY; Brummitt N, 2010, 1 ROYAL BOT GARD; Champion H. G., 1968, REVISED SURVEY FORES, P404; Cincotta RP, 2000, NATURE, V404, P990, DOI 10.1038/35010105; Condit R, 1998, AM NAT, V152, P495, DOI 10.1086/286186; Crone EE, 2011, ECOL LETT, V14, P1, DOI 10.1111/j.1461-0248.2010.01540.x; Cunningham A. B., 2001, Applied ethnobotany: people, wild plant use and conservation; de Souza IF, 2010, BIODIVERS CONSERV, V19, P1683, DOI 10.1007/s10531-010-9796-y; Feeley KJ, 2007, J TROP ECOL, V23, P191, DOI 10.1017/S0266467406003919; Franco M, 2004, ECOLOGY, V85, P531, DOI 10.1890/02-0651; Ganesan R., 2004, CONSERV SOC, V2, P365; Gaoue OG, 2010, CONSERV BIOL, V24, P605, DOI 10.1111/j.1523-1739.2009.01345.x; GOLDAMMER JG, 1988, AGROFOREST SYST, V6, P235, DOI 10.1007/BF02344761; John R, 2002, J VEG SCI, V13, P45, DOI 10.1658/1100-9233(2002)013[0045:DDICTS]2.0.CO;2; Kathriarachchi HS, 2004, CONSERV SOC, V2, P273; Keystone Foundation, 2007, HON TRAILS BLUE MOUN; Kodandapani N, 2004, FOR ECOL MANAG, V256, P607; Lykke AM, 1998, BIODIVERS CONSERV, V7, P1261, DOI 10.1023/A:1008877819286; Mazerolle MJ, 2011, AICCMODAVG MODEL SEL; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SY; Murali KS, 1996, ECON BOT, V50, P252, DOI 10.1007/BF02907329; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Otterstrom SM, 2006, BIOTROPICA, V38, P592, DOI 10.1111/j.1744-7429.2006.00188.x; Padmini S., 2001, Journal of Tropical Forest Science, V13, P297; Pain A., 2009, P BIOD LIV C COON IN; Prasad S, 2010, ECOL RES, V25, P225, DOI 10.1007/s11284-009-0650-1; Ravikumar K, 2000, ILLUSTRATED FIELD GU; Rist L, 2008, FOREST ECOL MANAG, V255, P1684, DOI 10.1016/j.foreco.2007.11.030; Rist L, 2012, FOREST ECOL MANAG, V268, P57, DOI 10.1016/j.foreco.2011.04.037; Rist L, 2010, ECOL SOC, V15; Saha S, 2003, ECOLOGY, V84, P3118, DOI 10.1890/02-3051; Sandemose P, 2009, THESIS NORWEGIAN I L; Schmidt IB, 2011, J APPL ECOL, V48, P815, DOI 10.1111/j.1365-2664.2011.01999.x; Scoles R, 2012, FOREST ECOL MANAG, V265, P71, DOI 10.1016/j.foreco.2011.10.027; Setty RS, 2008, ECOL SOC, V13; Setty RS, 2004, THESIS U MYSORE INDI; Shaanker RU, 1997, WRAP UP WORKSH CIFOR; Shaanker RU, 2004, CONSERV SOC, P347; Sinha A, 2005, BIODIVERS CONSERV, V14, P3537, DOI 10.1007/s10531-004-0827-4; Sinha A, 2002, FOREST ECOL MANAG, V168, P289, DOI 10.1016/S0378-1127(01)00747-2; SULLIVAN S, 1995, ECON BOT, V49, P357, DOI 10.1007/BF02863085; Sundaram B, 2011, THESIS MANIPAL U IND; Ticktin T, 2004, BIOL CONSERV, V120, P461, DOI 10.1016/j.biocon.2004.03.019; Ticktin T, 2004, J APPL ECOL, V41, P11, DOI 10.1111/j.1365-2664.2004.00859.x; Ticktin T, 2012, J APPL ECOL, V49, P774, DOI 10.1111/j.1365-2664.2012.02156.x; TRFfS Computing, 2011, R LANG ENV STAT COMP, DOI [10.1016/j.neuroimage.2011.01.013, DOI 10.1016/J.NEUROIMAGE.2011.01.013]; Wright SJ, 2003, ECOLOGY, V84, P3174, DOI 10.1890/02-0038; *WWF, 2002, FOR MAN OUTS PROT AR	54	15	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119634	10.1371/journal.pone.0119634	http://dx.doi.org/10.1371/journal.pone.0119634			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781482	gold, Green Published, Green Submitted			2022-12-27	WOS:000351284600080
J	Arizmendi-Mejia, R; Linares, C; Garrabou, J; Antunes, A; Ballesteros, E; Cebrian, E; Diaz, D; Ledoux, JB				Arizmendi-Mejia, Rosana; Linares, Cristina; Garrabou, Joaquim; Antunes, Agostinho; Ballesteros, Enric; Cebrian, Emma; Diaz, David; Ledoux, Jean-Baptiste			Combining Genetic and Demographic Data for the Conservation of a Mediterranean Marine Habitat-Forming Species	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; MULTILOCUS GENOTYPE DATA; MASS MORTALITY; EVOLUTIONARY PROCESSES; ENVIRONMENTAL-FACTORS; PARAMURICEA-CLAVATA; ECOLOGICAL CHANGE; COMPUTER-PROGRAM; F-STATISTICS; DIVERSITY	The integration of ecological and evolutionary data is highly valuable for conservation planning. However, it has been rarely used in the marine realm, where the adequate design of marine protected areas (MPAs) is urgently needed. Here, we examined the interacting processes underlying the patterns of genetic structure and demographic strucuture of a highly vulnerable Mediterranean habitat-forming species (i.e. Paramuricea clavata (Risso, 1826)), with particular emphasis on the processes of contemporary dispersal, genetic drift, and colonization of a new population. Isolation by distance and genetic discontinuities were found, and three genetic clusters were detected; each submitted to variations in the relative impact of drift and gene flow. No founder effect was found in the new population. The interplay of ecology and evolution revealed that drift is strongly impacting the smallest, most isolated populations, where partial mortality of individuals was highest. Moreover, the eco-evolutionary analyses entailed important conservation implications for P. clavata. Our study supports the inclusion of habitat-forming organisms in the design of MPAs and highlights the need to account for genetic drift in the development of MPAs. Moreover, it reinforces the importance of integrating genetic and demographic data in marine conservation.	[Arizmendi-Mejia, Rosana; Linares, Cristina] Univ Barcelona, Fac Biol, Dept Ecol, E-08028 Barcelona, Spain; [Arizmendi-Mejia, Rosana; Garrabou, Joaquim; Ledoux, Jean-Baptiste] CSIC, ICM, E-08003 Barcelona, Spain; [Antunes, Agostinho; Ledoux, Jean-Baptiste] Univ Porto, Ctr Interdisciplinar Invest Marinha & Ambiental, CIMAR CIIMAR, P-4050123 Oporto, Portugal; [Antunes, Agostinho] Univ Porto, Fac Ciencias, Dept Biol, P-4169007 Oporto, Portugal; [Ballesteros, Enric; Cebrian, Emma] CSIC, Ctr Estudis Avancats Blanes, Blanes 17300, Spain; [Diaz, David] Inst Espanol Oceanog, Palma De Mallorca 07015, Spain	University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Universidade do Porto; Universidade do Porto; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); Spanish Institute of Oceanography	Arizmendi-Mejia, R (corresponding author), Univ Barcelona, Fac Biol, Dept Ecol, Avinguda Diagonal 643, E-08028 Barcelona, Spain.	r.arizmendi@icm.csic.es	DIAZ, DAVID/AAS-8722-2021; Linares, Cristina/A-5244-2018; Cebrian, Emma/J-9640-2012	DIAZ, DAVID/0000-0003-0611-2516; Linares, Cristina/0000-0003-3855-2743; Ledoux, Jean-Baptiste/0000-0001-8796-6163; Cebrian, Emma/0000-0001-7588-0135; Antunes, Agostinho/0000-0002-1328-1732	Espais de Natura Balear; Spanish Ministry of Science and Innovation; Spanish Ministry of Economy and Competitivity [CTM2009-08045, CGL2012-32194]; Ramon y Cajal research contract [RyC-2011-08134]; CUR-DIUE-Generalitat de Catalunya and the European Social Fund [FI-DGR 2011]; JAE doc; Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BPD/74400/2010]; European Regional Development Fund (ERDF) through the COMPETE-Operational Competitiveness Programme; FCT [PEst-C/MAR/ LA0015/2013, PTDC/AAC-AMB/121301/2010, FCOMP-01-0124-FEDER-019490]	Espais de Natura Balear; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Economy and Competitivity(Spanish Government); Ramon y Cajal research contract(Spanish Government); CUR-DIUE-Generalitat de Catalunya and the European Social Fund; JAE doc; Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); European Regional Development Fund (ERDF) through the COMPETE-Operational Competitiveness Programme; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This study was partially funded by the Espais de Natura Balear (http://en.balearsnatura.com), the Spanish Ministry of Science and Innovation (http://www.micinn.es) and the Spanish Ministry of Economy and Competitivity (http://www.mineco.gob.es) through the Biorock (CTM2009-08045) and the Smart (CGL2012-32194) projects. Additional funding was provided by a Ramon y Cajal research contract (RyC-2011-08134) to CL, a PhD grant from the CUR-DIUE- Generalitat de Catalunya and the European Social Fund (FI-DGR 2011) (http://www.gencat.cat/ agaur) to RAM, and a JAE doc to EC. JBL was funded by a Postdoctoral grant (SFRH/BPD/74400/2010) from Fundacao para a Ciencia e a Tecnologia (FCT) (http://www.fct.pt) and AA was partially supported by the European Regional Development Fund (ERDF) through the COMPETE-Operational Competitiveness Programme and national funds through FCT, under the projects PEst-C/MAR/ LA0015/2013 and PTDC/AAC-AMB/121301/2010 (FCOMP-01-0124-FEDER-019490). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agell G, 2009, CONSERV GENET, V10, P2025, DOI 10.1007/s10592-009-9885-1; Allendorf F., 2007, CONSERVATION GENETIC; Almany GR, 2009, CORAL REEFS, V28, P339, DOI 10.1007/s00338-009-0484-x; Ardren WR, 2003, MOL ECOL, V12, P35, DOI 10.1046/j.1365-294X.2003.01705.x; Aurelle D, 2011, GENETICA, V139, P855, DOI 10.1007/s10709-011-9589-6; Aurelle D, 2010, MOL ECOL RESOUR, V10, P751, DOI 10.1111/j.1755-0998.2010.02871.x; Aurelle D, 2013, CONSERV GENET, V14, P705, DOI 10.1007/s10592-013-0464-0; Ballesteros E, 2006, OCEANOGR MAR BIOL, V44, P123; Beaumont MA, 2MOD; Beger M, 2003, BIOL CONSERV, V111, P53, DOI 10.1016/S0006-3207(02)00249-5; Belkhir K., 2004, GENETIX 4 05 LOGICIE; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bodkin JL, 1999, CONSERV BIOL, V13, P1378, DOI 10.1046/j.1523-1739.1999.98124.x; Castric V, 2004, MOL ECOL, V13, P1299, DOI 10.1111/j.1365-294X.2004.02129.x; Cerrano C, 2010, BIODIVERS CONSERV, V19, P153, DOI 10.1007/s10531-009-9712-5; Charlesworth B, 2003, ANNU REV ECOL EVOL S, V34, P99, DOI 10.1146/annurev.ecolsys.34.011802.132359; Coma R, 1998, ESTUAR COAST SHELF S, V47, P459, DOI 10.1006/ecss.1998.0375; COMA R, 1995, MAR ECOL PROG SER, V117, P185, DOI 10.3354/meps117185; COMA R, 1995, MAR ECOL PROG SER, V117, P173, DOI 10.3354/meps117173; Coma R, 2009, P NATL ACAD SCI USA, V106, P6176, DOI 10.1073/pnas.0805801106; Cornuet JM, 1999, GENETICS, V153, P1989; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; Cupido R, 2009, MAR ECOL PROG SER, V394, P195, DOI 10.3354/meps08260; Dailianis T, 2011, MOL ECOL, V20, P3757, DOI 10.1111/j.1365-294X.2011.05222.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Farkas TE, 2013, CURR BIOL, V23, P1835, DOI 10.1016/j.cub.2013.07.067; Ferriere R., 2004, EVOLUTIONARY CONSERV; Foll M, 2006, GENETICS, V174, P875, DOI 10.1534/genetics.106.059451; Foster KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071049; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Gaggiotti OE, 2010, MOL ECOL RESOUR, V10, P821, DOI 10.1111/j.1755-0998.2010.02873.x; Gaggiotti OE, 2009, EVOLUTION, V63, P2939, DOI 10.1111/j.1558-5646.2009.00779.x; Garrabou J, 2009, GLOBAL CHANGE BIOL, V15, P1090, DOI 10.1111/j.1365-2486.2008.01823.x; Gori A, 2011, MAR BIOL, V158, P1721, DOI 10.1007/s00227-011-1686-7; Goudet J, 2002, FSTAT PROGRAM ESTIMA, DOI DOI 10.1093/OXFORDJOURNALS.JHERED.A111627; Hairston NG, 2005, ECOL LETT, V8, P1114, DOI 10.1111/j.1461-0248.2005.00812.x; Hardy O, 2013, SPAGEDI 1 4 USERS MA; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hare MP, 2011, CONSERV BIOL, V25, P438, DOI 10.1111/j.1523-1739.2010.01637.x; Harrison HB, 2012, CURR BIOL, V22, P1023, DOI 10.1016/j.cub.2012.04.008; Hauser L, 2008, FISH FISH, V9, P333, DOI 10.1111/j.1467-2979.2008.00299.x; Hellberg ME, 2009, ANNU REV ECOL EVOL S, V40, P291, DOI 10.1146/annurev.ecolsys.110308.120223; Hendry A, 2013, CURR BIOL, V23, pR869, DOI 10.1016/j.cub.2013.08.023; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; HUGHES TP, 1980, SCIENCE, V209, P713, DOI 10.1126/science.209.4457.713; HUSBAND BC, 1992, EVOLUTION, V46, P1875, DOI 10.1111/j.1558-5646.1992.tb01175.x; Iacchei M, 2013, MOL ECOL, V22, P3476, DOI 10.1111/mec.12341; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Jones GP, 2007, OCEANOGRAPHY, V20, P100, DOI 10.5670/oceanog.2007.33; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kelleher G., 1999, GUIDELINES MARINE PR; Knaepkens G, 2004, BIOL CONSERV, V115, P403, DOI 10.1016/S0006-3207(03)00156-3; Lamy T, 2012, MOL ECOL, V21, P1394, DOI 10.1111/j.1365-294X.2012.05478.x; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; Ledoux JB, 2010, MOL ECOL, V19, P675, DOI 10.1111/j.1365-294X.2009.04516.x; Linares C, 2005, MAR ECOL PROG SER, V305, P127, DOI 10.3354/meps305127; Linares C, 2008, J APPL ECOL, V45, P688, DOI 10.1111/j.1365-2664.2007.01419.x; Linares C, 2007, ECOLOGY, V88, P918, DOI 10.1890/05-1931; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; LYNCH M, 1993, BIOTIC INTERACTIONS AND GLOBAL CHANGE, P234; Mayr E, 1942, SYSTEMATICS ORIGIN S; Mokhtar-Jamai K, 2011, MOL ECOL, V20, P3291, DOI 10.1111/j.1365-294X.2011.05176.x; Mokhtar-Jamai K, 2013, ECOL EVOL, V3, P1765, DOI 10.1002/ece3.588; Mora MS, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-9; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nicholson G, 2002, J ROY STAT SOC B, V64, P695, DOI 10.1111/1467-9868.00357; Niklas KJ, 2003, ECOL LETT, V6, P405, DOI 10.1046/j.1461-0248.2003.00440.x; Oostermeijer JGB, 2003, BIOL CONSERV, V113, P389, DOI 10.1016/S0006-3207(03)00127-7; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Palkovacs EP, 2014, EVOL APPL, V7, P212, DOI 10.1111/eva.12111; Palumbi SR, 2003, ECOL APPL, V13, pS146; Palumbi SR, 2004, ANNU REV ENV RESOUR, V29, P31, DOI 10.1146/annurev.energy.29.062403.102254; Palumbi SR, 2009, FRONT ECOL ENVIRON, V7, P204, DOI 10.1890/070135; Pearson GA, 2009, J ECOL, V97, P450, DOI 10.1111/j.1365-2745.2009.01481.x; Pelletier F, 2009, PHILOS T R SOC B, V364, P1483, DOI 10.1098/rstb.2009.0027; Pelletier F, 2007, SCIENCE, V315, P1571, DOI 10.1126/science.1139024; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pritchard JK, 2000, GENETICS, V155, P945; PRITCHARD JK, 2007, DOCUMENTATION STRUCT; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Rannala B., 2007, BAYESASS VERSION 3 0; Roberts C, 2012, CURR BIOL, V22, pR444, DOI 10.1016/j.cub.2012.04.030; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Serbezov D, 2012, GENETICS, V191, P579, DOI 10.1534/genetics.111.136580; SLOBODKIN LAWRENCE B., 1961; Stockwell CA, 2003, TRENDS ECOL EVOL, V18, P94, DOI 10.1016/S0169-5347(02)00044-7; Tallmon DA, 2008, MOL ECOL RESOUR, V8, P299, DOI 10.1111/j.1471-8286.2007.01997.x; Teixido N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023744; Toonen RJ, 2001, BIOTECHNIQUES, V31, P1320; Underwood JN, 2013, J NAT CONSERV, V21, P163, DOI 10.1016/j.jnc.2012.12.001; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wesseling I, 2001, INT REV HYDROBIOL, V86, P77, DOI 10.1002/1522-2632(200101)86:1<77::AID-IROH77>3.0.CO;2-7; Wilson GA, 2003, GENETICS, V163, P1177	100	28	28	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119585	10.1371/journal.pone.0119585	http://dx.doi.org/10.1371/journal.pone.0119585			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774522	gold, Green Published, Green Submitted			2022-12-27	WOS:000351183500102
J	Chandra, V; Das, T; Gulati, P; Biswas, NK; Rote, S; Chatterjee, U; Ghosh, SN; Deb, S; Saha, SK; Chowdhury, AK; Ghosh, S; Rudin, CM; Mukherjee, A; Basu, A; Dhara, S				Chandra, Vikas; Das, Tapojyoti; Gulati, Puneet; Biswas, Nidhan K.; Rote, Sarang; Chatterjee, Uttara; Ghosh, Samarendra N.; Deb, Sumit; Saha, Suniti K.; Chowdhury, Anup K.; Ghosh, Subhashish; Rudin, Charles M.; Mukherjee, Ankur; Basu, Analabha; Dhara, Surajit			Hedgehog Signaling Pathway Is Active in GBM with GLI1 mRNA Expression Showing a Single Continuous Distribution Rather than Discrete High/Low Clusters	PLOS ONE			English	Article							HUMAN HOMOLOG; PHASE-II; CANCER; GENE; VISMODEGIB; ACTIVATION; MUTATIONS; PLACEBO; ROLES; PTCH2	Hedgehog (Hh) signaling pathway is a valid therapeutic target in a wide range of malignancies. We focus here on glioblastoma multiforme (GBM), a lethal malignancy of the central nervous system (CNS). By analyzing RNA-sequencing based transcriptomics data on 149 clinical cases of TCGA-GBM database we show here a strong correlation (r = 0.7) between GLI1 and PTCH1 mRNA expression-as a hallmark of the canonical Hh-pathway activity in this malignancy. GLI1 mRNA expression varied in 3 orders of magnitude among the GBM patients of the same cohort showing a single continuous distribution-unlike the discrete high/low-GLI1 mRNA expressing clusters of medulloblastoma (MB). When compared with MB as a reference, the median GLI1 mRNA expression in GBM appeared 14.8 fold lower than that of the "high-Hh" cluster of MB but 5.6 fold higher than that of the " low-Hh" cluster of MB. Next, we demonstrated statistically significant up-and down-regulation of GLI1 mRNA expressions in GBM patient-derived low-passage neurospheres in vitro by sonic hedgehog ligand-enriched conditioned media (shh-CM) and by Hh-inhibitor drug vismodegib respectively. We also showed clinically achievable dose (50 ae M) of vismodegib alone to be sufficient to induce apoptosis and cell cycle arrest in these low-passage GBM neurospheres in vitro. Vismodegib showed an effect on the neurospheres, both by down-regulating GLI1 mRNA expression and by inducing apoptosis/cell cycle arrest, irrespective of their relative endogenous levels of GLI1 mRNA expression. We conclude from our study that this single continuous distribution pattern of GLI1 mRNA expression technically puts almost all GBM patients in a single group rather than discrete high-or low-clusters in terms of Hh-pathway activity. That is suggestive of therapies with Hh-pathway inhibitor drugs in this malignancy without a need for further stratification of patients on the basis of relative levels of Hh-pathway activity among them.	[Chandra, Vikas; Das, Tapojyoti; Biswas, Nidhan K.; Mukherjee, Ankur; Basu, Analabha; Dhara, Surajit] Natl Inst Biomed Genom, Kalyani 741251, W Bengal, India; [Gulati, Puneet; Rote, Sarang; Ghosh, Samarendra N.; Deb, Sumit; Chowdhury, Anup K.; Ghosh, Subhashish] Bangur Inst Neurol, Kolkata 700098, India; [Chatterjee, Uttara] Inst Post Grad Med Educ & Res, Kolkata 700020, India; [Saha, Suniti K.] Nil Ratan Sarkar Med Coll & Hosp, Kolkata 700014, India; [Rudin, Charles M.] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA	Department of Biotechnology (DBT) India; National Institute of Biomedical Genomics (NIBMG); Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata; Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata; Memorial Sloan Kettering Cancer Center	Dhara, S (corresponding author), Natl Inst Biomed Genom, PO NSS, Kalyani 741251, W Bengal, India.	sd1@nibmg.ac.in	Das, Tapojyoti/AAX-3858-2021; Rudin, Charles/R-2530-2019; biswas, Nidhan Kumar K/A-4383-2009	Rudin, Charles/0000-0001-5204-3465; biswas, Nidhan Kumar K/0000-0001-7960-3290; Das, Tapojyoti/0000-0002-4644-1499	National Institute of Biomedical Genomics (NIBMG), India; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	National Institute of Biomedical Genomics (NIBMG), India; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors received no specific funding for this work. This work was supported by an intramural fund of National Institute of Biomedical Genomics (NIBMG), India.	Amakye D, 2013, NAT MED, V19, P1410, DOI 10.1038/nm.3389; Bar EE, 2007, STEM CELLS, V25, P2524, DOI 10.1634/stemcells.2007-0166; Berlin J, 2013, CLIN CANCER RES, V19, P258, DOI 10.1158/1078-0432.CCR-12-1800; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Dahmane N, 2001, DEVELOPMENT, V128, P5201; Filbin MG, 2013, NAT MED, V19, P1518, DOI 10.1038/nm.3328; Gailani MR, 1996, NAT GENET, V14, P78, DOI 10.1038/ng0996-78; GORLIN RJ, 1960, NEW ENGL J MED, V262, P908, DOI 10.1056/NEJM196005052621803; GORLIN RJ, 1995, DERMATOL CLIN, V13, P113, DOI 10.1016/S0733-8635(18)30114-1; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Hu ZL, 2003, CANCER RES, V63, P923; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kaye SB, 2012, CLIN CANCER RES, V18, P6509, DOI 10.1158/1078-0432.CCR-12-1796; Li X, 2006, ONCOGENE, V25, P609, DOI 10.1038/sj.onc.1209077; Low JA, 2010, J CLIN ONCOL, V28, P5321, DOI 10.1200/JCO.2010.27.9943; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Ng JMY, 2011, NAT REV CANCER, V11, P493, DOI 10.1038/nrc3079; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Raffel C, 1997, CANCER RES, V57, P842; Rahnama F, 2004, BIOCHEM J, V378, P325, DOI 10.1042/BJ20031200; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Rudin CM, 2012, CLIN CANCER RES, V18, P3218, DOI 10.1158/1078-0432.CCR-12-0568; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Ruiz i Altaba A, 2007, TRENDS CELL BIOL, V17, P438, DOI 10.1016/j.tcb.2007.06.007; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Zaphiropoulos PG, 1999, CANCER RES, V59, P787	28	20	23	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0116390	10.1371/journal.pone.0116390	http://dx.doi.org/10.1371/journal.pone.0116390			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775002	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500007
J	Jacobus, AP; Gross, J				Jacobus, Ana Paula; Gross, Jeferson			Optimal Cloning of PCR Fragments by Homologous Recombination in Escherichia coli	PLOS ONE			English	Article							DNA CLONING; IN-VITRO; EFFICIENT	PCR fragments and linear vectors containing overlapping ends are easily assembled into a propagative plasmid by homologous recombination in Escherichia coli. Although this gaprepair cloning approach is straightforward, its existence is virtually unknown to most molecular biologists. To popularize this method, we tested critical parameters influencing the efficiency of PCR fragments cloning into PCR-amplified vectors by homologous recombination in the widely used E. coli strain DH5 alpha. We found that the number of positive colonies after transformation increases with the length of overlap between the PCR fragment and linear vector. For most practical purposes, a 20 bp identity already ensures high-cloning yields. With an insert to vector ratio of 2:1, higher colony forming numbers are obtained when the amount of vector is in the range of 100 to 250 ng. An undesirable cloning background of empty vectors can be minimized during vector PCR amplification by applying a reduced amount of plasmid template or by using primers in which the 50 termini are separated by a large gap. DpnI digestion of the plasmid template after PCR is also effective to decrease the background of negative colonies. We tested these optimized cloning parameters during the assembly of five independent DNA constructs and obtained 94% positive clones out of 100 colonies probed. We further demonstrated the efficient and simultaneous cloning of two PCR fragments into a vector. These results support the idea that homologous recombination in E. coli might be one of the most effective methods for cloning one or two PCR fragments. For its simplicity and high efficiency, we believe that recombinational cloning in E. coli has a great potential to become a routine procedure in most molecular biologyoriented laboratories.	[Jacobus, Ana Paula; Gross, Jeferson] Univ Sao Paulo, Dept Biol Sci, Luiz de Queiroz Coll Agr, Piracicaba, SP, Brazil	Universidade de Sao Paulo	Gross, J (corresponding author), Univ Sao Paulo, Dept Biol Sci, Luiz de Queiroz Coll Agr, Piracicaba, SP, Brazil.	jgross@usp.br	Jacobus, Ana/M-4114-2019; Ibrahim, Essam Hassan/G-1960-2018; Jacobus, Ana P/C-3159-2011	Jacobus, Ana/0000-0002-9092-931X; Ibrahim, Essam Hassan/0000-0003-0130-2257; Jacobus, Ana P/0000-0002-9092-931X	Sao Paulo research foundation [2013/15743-9]	Sao Paulo research foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Sao Paulo research foundation (http://www.fapesp.br/en/, Grant number 2013/15743-9 to JG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; BUBECK P, 1993, NUCLEIC ACIDS RES, V21, P3601, DOI 10.1093/nar/21.15.3601; Casali Nicola, 2003, Methods Mol Biol, V235, P27; Dutra BE, 2007, P NATL ACAD SCI USA, V104, P216, DOI 10.1073/pnas.0608293104; Eckert-Boulet N, 2012, YEAST, V29, P323, DOI 10.1002/yea.2912; Furuya K, 2012, YEAST, V29, P241, DOI 10.1002/yea.2907; Furuya K, 2009, YEAST, V26, P221, DOI 10.1002/yea.1662; Geu-Flores F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm106; Grundemann D, 1996, BIOTECHNIQUES, V21, P898; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Joska TM, 2014, J MICROBIOL METH, V100, P46, DOI 10.1016/j.mimet.2013.11.013; Kelwick Richard, 2014, Front Bioeng Biotechnol, V2, P60, DOI 10.3389/fbioe.2014.00060; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Lee J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079979; Li CK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-92; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Lovett ST, 2002, GENETICS, V160, P851; Maniatis T., 1982, MOL CLONING; OLINER JD, 1993, NUCLEIC ACIDS RES, V21, P5192, DOI 10.1093/nar/21.22.5192; Parrish JR, 2004, J PROTEOME RES, V3, P582, DOI 10.1021/pr0341134; Quan JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006441; Shao ZY, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn991; Stevenson J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083888; Zhang YM, 2000, NAT BIOTECHNOL, V18, P1314, DOI 10.1038/82449; Zhang YW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1288	26	84	108	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119221	10.1371/journal.pone.0119221	http://dx.doi.org/10.1371/journal.pone.0119221			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774528	Green Published, gold, Green Submitted			2022-12-27	WOS:000351183500075
J	Yanagisawa, S; Sakurada, Y; Miki, A; Matsumiya, W; Imoto, I; Honda, S				Yanagisawa, Suiho; Sakurada, Yoichi; Miki, Akiko; Matsumiya, Wataru; Imoto, Issei; Honda, Shigeru			The Association of Elastin Gene Variants with Two Angiographic Subtypes of Polypoidal Choroidal Vasculopathy	PLOS ONE			English	Article							FACTOR-H CFH; MACULAR DEGENERATION; SUSCEPTIBILITY; ARMS2; POLYMORPHISM; FEATURES	Objective To compare the association of elastin (ELN) gene variants between two different angiographic phenotypes of polypoidal choroidal vasculopathy (PCV). Methods We included 411 treatment-naive PCV patients and 350 controls in the present study. PCV was classified into two phenotypes (152 Type 1 and 259 Type 2) according to the presence or absence of feeding vessels found in indocyanine-green angiography. Single nucleotide polymorphisms (SNPs) in the ELN region including rs868005, rs884843, rs2301995, rs13239907 and rs2856728 were genotyped using TaqMan Genotyping Assays. Results In the allelic association analyses, rs868005 showed the strongest association with Type 2 PCV (allelic odds ratio 1.56; p = 7.4x10(-6)), while no SNP was significantly associated with Type 1 PCV. Genotype association analyses revealed the significant association of rs868005 with Type 2 PCV in log additive model and predominant model (odds ratio 1.75; p = 1.5x10(-6) and odds ratio 1.60; p = 0.0044, respectively), but not with Type 1 PCV. These findings were further corroborated by another control group in the literature. Conclusions There may be significantly different associations in genetic variants of elastin between two angiographic phenotypes of PCV.	[Yanagisawa, Suiho; Miki, Akiko; Matsumiya, Wataru; Honda, Shigeru] Kobe Univ, Grad Sch Med, Div Ophthalmol, Dept Surg,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Sakurada, Yoichi] Univ Yamanashi, Fac Med, Dept Ophthalmol, Chuo Ku, Kofu, Yamanashi 4093898, Japan; [Imoto, Issei] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Human Genet, Tokushima 7708503, Japan	Kobe University; University of Yamanashi; Tokushima University	Honda, S (corresponding author), Kobe Univ, Grad Sch Med, Div Ophthalmol, Dept Surg,Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	sighonda@med.kobe-u.ac.jp	Honda, Shigeru/W-4761-2019; Imoto, Issei/AAD-5799-2020	Imoto, Issei/0000-0002-4150-7938	Ministry of Education, Science and Culture, Tokyo, Japan [23592567]; Takeda Science Foundation, Osaka, Japan	Ministry of Education, Science and Culture, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation, Osaka, Japan(Takeda Science Foundation (TSF))	This study was supported by a Grant-in Aid (C) 23592567 from the Ministry of Education, Science and Culture, Tokyo, Japan (S.H.), and by a grant from the Takeda Science Foundation, Osaka, Japan (S.H.). The funding organization had no role in the design or conduct of this research.	Akagawa H, 2006, HUM MOL GENET, V15, P1722, DOI 10.1093/hmg/ddl096; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Fuse N, 2011, AM J OPHTHALMOL, V151, P550, DOI 10.1016/j.ajo.2010.08.048; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Hayashi H, 2010, INVEST OPHTH VIS SCI, V51, P5914, DOI 10.1167/iovs.10-5554; Honda S, 2014, OPHTHALMOLOGICA, V231, P59, DOI 10.1159/000355488; Japanese Study Group of Polypoidal Choroidal Vasculopathy, 2005, Nippon Ganka Gakkai Zasshi, V109, P417; Kawamura A, 2013, ACTA OPHTHALMOL, V91, pe474, DOI 10.1111/aos.12110; Kondo N, 2008, INVEST OPHTH VIS SCI, V49, P1101, DOI 10.1167/iovs.07-1145; Kondo N, 2007, AM J OPHTHALMOL, V144, P608, DOI 10.1016/j.ajo.2007.06.003; Kuroiwa S, 2004, CLIN EXP OPHTHALMOL, V32, P297, DOI 10.1111/j.1442-9071.2004.00827.x; Liang XY, 2012, INVEST OPHTH VIS SCI, V53, P3175, DOI 10.1167/iovs.11-8135; Lim TH, 2010, EYE, V24, P483, DOI 10.1038/eye.2009.323; Lima LH, 2011, OPHTHALMIC GENET, V32, P80, DOI 10.3109/13816810.2010.544362; Miki A, 2013, OPHTHALMIC GENET, V34, P146, DOI 10.3109/13816810.2012.749288; Nakajima M, 2004, JPN J OPHTHALMOL, V48, P249, DOI 10.1007/s10384-003-0057-4; Nakashizuka H, 2008, INVEST OPHTH VIS SCI, V49, P4729, DOI 10.1167/iovs.08-2134; Okubo A, 2002, BRIT J OPHTHALMOL, V86, P1093, DOI 10.1136/bjo.86.10.1093; Tanaka K, 2011, MOL VIS, V17, P2751; Tanaka K, 2011, INVEST OPHTH VIS SCI, V52, P7441, DOI 10.1167/iovs.11-7546; Terasaki H, 2002, BRIT J OPHTHALMOL, V86, P321, DOI 10.1136/bjo.86.3.321; Tsujikawa A, 2011, AM J OPHTHALMOL, V151, P961, DOI 10.1016/j.ajo.2011.01.002; Yamashiro K, 2011, INVEST OPHTH VIS SCI, V52, P8780, DOI 10.1167/iovs.11-8205; Yanagisawa S, 2011, MOL VIS, V17, P3574; Yannuzzi LA, 1999, ARCH OPHTHALMOL-CHIC, V117, P1503; Yannuzzi LA, 1997, ARCH OPHTHALMOL-CHIC, V115, P478, DOI 10.1001/archopht.1997.01100150480005; Yuzawa M, 2005, BRIT J OPHTHALMOL, V89, P602, DOI 10.1136/bjo.2004.049296; Zhang XZ, 2013, EXP EYE RES, V108, P16, DOI 10.1016/j.exer.2012.12.005	28	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120643	10.1371/journal.pone.0120643	http://dx.doi.org/10.1371/journal.pone.0120643			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775011	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500187
J	Wang, B; Shi, WZ; Miao, ZL				Wang, Bin; Shi, Wenzhong; Miao, Zelang			Confidence Analysis of Standard Deviational Ellipse and Its Extension into Higher Dimensional Euclidean Space	PLOS ONE			English	Article								Standard deviational ellipse (SDE) has long served as a versatile GIS tool for delineating the geographic distribution of concerned features. This paper firstly summarizes two existing models of calculating SDE, and then proposes a novel approach to constructing the same SDE based on spectral decomposition of the sample covariance, by which the SDE concept is naturally generalized into higher dimensional Euclidean space, named standard deviational hyper-ellipsoid (SDHE). Then, rigorous recursion formulas are derived for calculating the confidence levels of scaled SDHE with arbitrary magnification ratios in any dimensional space. Besides, an inexact-newton method based iterative algorithm is also proposed for solving the corresponding magnification ratio of a scaled SDHE when the confidence probability and space dimensionality are pre-specified. These results provide an efficient manner to supersede the traditional table lookup of tabulated chi-square distribution. Finally, synthetic data is employed to generate the 1-3 multiple SDEs and SDHEs. And exploratory analysis by means of SDEs and SDHEs are also conducted for measuring the spread concentrations of Hong Kong's H1N1 in 2009.	[Wang, Bin; Shi, Wenzhong; Miao, Zelang] Hong Kong Polytech Univ, Dept Land Surveying & Geoinformat, Kowloon, Hong Kong, Peoples R China	Hong Kong Polytechnic University	Wang, B (corresponding author), Hong Kong Polytech Univ, Dept Land Surveying & Geoinformat, Kowloon, Hong Kong, Peoples R China.	wbcumt@163.com	SHI, wen/GPW-9531-2022; Miao, Zelang/K-4774-2019; WANG, Bin/B-6748-2014	WANG, Bin/0000-0003-2565-1013; SHI, Wenzhong/0000-0002-3886-7027	AXA Research Fund; Ministry of Science and Technology of China [2012BAJ15B04]; National Natural Science Foundation [41331175]; National Administration of Surveying, Mapping and Geoinformation of China	AXA Research Fund(AXA Research Fund); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Administration of Surveying, Mapping and Geoinformation of China	Mr. Bin Wang is the beneficiary of a doctoral grant from the AXA Research Fund. This study was supported by grants from the Ministry of Science and Technology of China (Project no. 2012BAJ15B04), the National Natural Science Foundation (Project no. 41331175), and National Administration of Surveying, Mapping and Geoinformation of China (Ling Jun Ren Cai). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandersson A, 2004, STATA J, V4, P242, DOI 10.1177/1536867X0400400302; Andrews L. C., 1992, SPECIAL FUNCTIONS MA; Buliung RN, 2006, J TRANSP GEOGR, V14, P35, DOI 10.1016/j.jtrangeo.2004.10.008; Chainey S, 2008, SECUR J, V21, P4, DOI 10.1057/palgrave.sj.8350066; Cloutier V, 2008, J HYDROL, V353, P294, DOI 10.1016/j.jhydrol.2008.02.015; Cromley RG, 1992, DIGITAL CARTOGRAPHY; Fang KT, 2004, ENCY STAT SCI; Furfey PH, 1927, AM J SOCIOL, V33, P94, DOI 10.1086/214336; Gong JX, 2002, GEOGR ANAL, V34, P155, DOI 10.1111/j.1538-4632.2002.tb01082.x; Hardle W., 2012, APPL MULTIVARIATE ST; HUBER G, 1982, AM MATH MON, V89, P301, DOI 10.2307/2321716; Hubert M, 2009, WILEY INTERDISCIPLIN, V2, P36; Kelley C., 2003, SOLVING NONLINEAR EQ; Kent J., 2007, J INVEST PSYCHOL OFF, V165, P147, DOI [DOI 10.1002/JIP.72, 10.1002/jip.72]; KNUSEL L, 1986, SIAM J SCI STAT COMP, V7, P1022, DOI 10.1137/0907069; Kulldorff M, 2006, STAT MED, V25, P3929, DOI 10.1002/sim.2490; Lefever DW, 1926, AM J SOCIOL, V32, P88, DOI 10.1086/214027; Li Q., 2007, NONPARAMETRIC ECONOM; Nugraha, 2012, MALARIA J S1, V11, pP130, DOI [10.1186/1475-2875-11-S1-P130, DOI 10.1186/1475-2875-11-S1-P130]; Rousseeuw PJ, 1999, TECHNOMETRICS, V41, P212, DOI 10.2307/1270566; SMITH RC, 1986, INT J ROBOT RES, V5, P56, DOI 10.1177/027836498600500404; Trefethen L. N., 1997, NUMERICAL LINEAR ALG, V50; Wang BJ, 2008, SOIL SEDIMENT CONTAM, V17, P437, DOI 10.1080/15320380802146784; Wong DWS, 1998, URBAN GEOGR, V19, P77, DOI 10.2747/0272-3638.19.1.77; YUILL RS, 1971, GEOGR ANAL, VB 53, P28, DOI 10.2307/490885	25	99	102	10	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118537	10.1371/journal.pone.0118537	http://dx.doi.org/10.1371/journal.pone.0118537			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25769048	Green Submitted, Green Published, gold			2022-12-27	WOS:000351277500027
J	Asefa, NG; Ingale, L; Shumey, A; Yang, H				Asefa, Nigus Gebremedhin; Ingale, Lalit; Shumey, Ashenafi; Yang, Hannah			Prevalence and Factors Associated with Road Traffic Crash among Taxi Drivers in Mekelle Town, Northern Ethiopia, 2014: A Cross Sectional Study	PLOS ONE			English	Article							MORTALITY; ACCIDENTS; INJURIES	Objectives The 2013 World Health Organization Status Report on Road Safety estimated that approximately 1.24 million deaths occur annually due to road traffic crashes with most of the burden falling on low-and middle-income countries. The objective of this research is to study the prevalence of road traffic crashes in Mekelle, Tigray, Northern Ethiopia and to identify risk factors with the ultimate goal of informing prevention activities and policies. Methods This study used a cross-sectional design to measure the prevalence and factors associated with road traffic crashes among 4-wheeled minibus (n = 130) and 3-wheeled Bajaj (n = 582) taxi drivers in Mekelle, Ethiopia. Bivariate and multivariate logistic regression were used to evaluate the association between risk factors and drivers' involvement in a road traffic crash within the 3 years prior to the survey. Findings Among the 712 taxi drivers, 26.4%(n = 188) of them reported involvement in a road traffic crash within the past 3 years. Drivers who listened to mass media had decreased likelihood of road traffic crash involvement (AOR = 0.51, 0.33-0.78), while speedy driving (AOR = 4.57, 3.05-7.44), receipt of a prior traffic punishment (AOR = 4.57, 2.67-7.85), and driving a mechanically faulty taxi (AOR = 4.91, 2.81-8.61) were strongly associated with road traffic crash involvement. Receiving mobile phone calls while driving (AOR = 1.91, 1.24-2.92) and history of alcohol use (AOR = 1.51, 1.00-2.28) were also associated with higher odds of road traffic crash involvement. Conclusion The results of this study show that taxi drivers in Mekelle habitually place themselves at increased risk of road traffic crashes by violating traffic laws, especially related to speedy driving, mobile phone use, and taxi maintenance. This research can be used to support re-evaluation of the type, severity, and enforcement of traffic violation penalties.	[Asefa, Nigus Gebremedhin] Dr Tewelde Legesse Hlth Sci Coll, Mekelle, Tigray, Ethiopia; [Ingale, Lalit; Shumey, Ashenafi] Mekelle Univ, Coll Hlth Sci, Mekelle, Tigray, Ethiopia; [Yang, Hannah] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	Mekelle University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Asefa, NG (corresponding author), Dr Tewelde Legesse Hlth Sci Coll, Mekelle, Tigray, Ethiopia.	niguurayu2003@gmail.com	Yang, Hannah/ABC-1995-2020; INGALE, LALIT Tukaram/AAS-2020-2021	Yang, Hannah/0000-0002-9772-0041; G. Asefa, Nigus/0000-0001-5680-5527; INGALE, LALIT/0000-0003-0407-6064				Akloweg Y, 2011, INT J URBAN SCI, V15, P61, DOI 10.1080/12265934.2011.580153; Al-Ghaweel I, 2009, J FAM COMMUNITY MED, V16, P7; Arria AM, 2011, DRUG ALCOHOL DEPEN, V118, P306, DOI 10.1016/j.drugalcdep.2011.04.012; Bahadorimonfared A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065198; Bekibele CO, 2007, AFR J HLTH SCI, V14, P137; Dandona R, 2008, INJURY PREV, V14, P360, DOI 10.1136/ip.2008.019638; Gopalakrishnan S, 2012, J Family Med Prim Care, V1, P144, DOI 10.4103/2249-4863.104987; Harrison ELR, 2011, DRUG ALCOHOL DEPEN, V117, P31, DOI 10.1016/j.drugalcdep.2011.01.002; Hazen A, 2006, J NATL MED ASSOC, V98, P73; Hu GQ, 2011, B WORLD HEALTH ORGAN, V89, P41, DOI 10.2471/BLT.10.080317; Hyder AA, 2012, AM J PUBLIC HEALTH, V102, P1061, DOI 10.2105/AJPH.2011.300563; ISLAM M, 2012, J EMERGING TRENDS EC, V3, P907; Jeffrey S, 2009, INJURY PREV, V15, P13, DOI 10.1136/ip.2008.018630; Lam LT, 2004, ACCIDENT ANAL PREV, V36, P905, DOI 10.1016/j.aap.2003.10.001; Mishra Badrinarayan, 2010, Indian J Community Med, V35, P115, DOI 10.4103/0970-0218.62568; Peltzer K, 2003, ACCIDENT ANAL PREV, V35, P619, DOI 10.1016/S0001-4575(02)00035-0; Persson A., 2008, ADV TRANSPORTATION S, V15, P1; La QN, 2013, ACCIDENT ANAL PREV, V50, P451, DOI 10.1016/j.aap.2012.05.022; Shams M, 2011, ACCIDENT ANAL PREV, V43, P646, DOI 10.1016/j.aap.2010.10.007; Tigray Construction Roads and Transport Bureau, 2013, MAG 5 20 YEARS REP; Uchechukwu L, 2013, INT J APPL SCI TECHN, V3, P107; United Nations, 2009, EC COM AFR CAS STUD; World Health Organization, 2013, GLOB STAT REP ROAD S; Zhang XJ, 2013, IRAN J PUBLIC HEALTH, V42, P7	24	21	21	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0118675	10.1371/journal.pone.0118675	http://dx.doi.org/10.1371/journal.pone.0118675			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7QC	25781940	gold, Green Submitted, Green Published			2022-12-27	WOS:000351284600033
J	Chun, SM; Lee, JY; Choi, J; Lee, JH; Hwang, JJ; Kim, CS; Suh, YA; Jang, SJ				Chun, Sung-Min; Lee, Ji-Young; Choi, Jene; Lee, Je-Hwan; Hwang, Jung Jin; Kim, Chung-Soo; Suh, Young-Ah; Jang, Se Jin			Epigenetic Modulation with HDAC Inhibitor CG200745 Induces Anti-Proliferation in Non-Small Cell Lung Cancer Cells	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; SUBEROYLANILIDE HYDROXAMIC ACID; GROWTH-FACTOR RECEPTOR; DNA METHYLATION; C-MYC; LYMPHOMA; DEGRADATION; VORINOSTAT; THERAPY; BIOLOGY	Histone modification plays a pivotal role on gene regulation, as regarded as global epigenetic markers, especially in tumor related genes. Hence, chemical approaches targeting histone- modifying enzymes have emerged onto the main stage of anticancer drug discovery. Here, we investigated the therapeutic potentials and mechanistic roles of the recently developed histone deacetylase inhibitor, CG200745, in non-small cell lung cancer cells. Treatment with CG200745 increased the global level of histone acetylation, resulting in the inhibition of cell proliferation. ChIP-on-chip analysis with an H4K16ac antibody showed altered H4K16 acetylation on genes critical for cell growth inhibition, although decreased at the transcription start site of a subset of genes. Altered H4K16ac was associated with changes in mRNA expression of the corresponding genes, which were further validated in quantitative RT-PCR and western blotting assays. Our results demonstrated that CG200745 causes NSCLC cell growth inhibition through epigenetic modification of critical genes in cancer cell survival, providing pivotal clues as a promising chemotherapeutics against lung cancer.	[Chun, Sung-Min; Choi, Jene; Jang, Se Jin] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea; [Lee, Ji-Young; Hwang, Jung Jin; Suh, Young-Ah] Univ Ulsan, Coll Med, Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea; [Lee, Je-Hwan] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea; [Kim, Chung-Soo] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Urol, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Suh, YA (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea.	ysuh@amc.seoul.kr; jangsejin@amc.seoul.kr	Hwang, Jung Jin/F-3424-2014	Chun, Sung-Min/0000-0002-3357-1382	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI06C0868, HI10C2014]; Leading Foreign Research Institute Recruitment Program; Basic Research Promotion Fund; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology (MEST) [2011-0030105, KRF-2008-355-E00006, NRF-2014R1A1A2006192]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; Leading Foreign Research Institute Recruitment Program; Basic Research Promotion Fund(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology (MEST)	Supported grants for the study were the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI06C0868, HI10C2014), Leading Foreign Research Institute Recruitment Program, Basic Research Promotion Fund, and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (MEST) (2011-0030105, KRF-2008-355-E00006, NRF-2014R1A1A2006192). The funders had no role in study design, data collection andanalysis, decision to publish, or preparation of the manuscript.	Berg T, 2011, CURR TOP MICROBIOL, V348, P139, DOI 10.1007/82_2010_90; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Chen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079781; Dai Yan, 2008, Transl Oncogenomics, V3, P53; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Duvic M, 2007, BLOOD, V109, P31, DOI 10.1182/blood-2006-06-025999; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Ficner R, 2009, CURR TOP MED CHEM; Gallinari P, 2007, CELL RES, V17, P195, DOI 10.1038/sj.cr.7310149; Hess-Stumpp H, 2005, EUR J CELL BIOL, V84, P109, DOI 10.1016/j.ejcb.2004.12.010; Hwang JJ, 2012, INVEST NEW DRUG, V30, P1434, DOI 10.1007/s10637-011-9718-1; Kelly WK, 2005, NAT CLIN PRACT ONCOL, V2, P150, DOI 10.1038/ncponc0106; Kim MJ, 2012, ANTICANCER RES, V32, P3161; Kouraklis G., 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P477, DOI 10.2174/1568011023353921; Lai CJ, 2010, CANCER RES, V70, P3647, DOI 10.1158/0008-5472.CAN-09-3360; Marks PA, 2009, J CELL BIOCHEM, V107, P600, DOI 10.1002/jcb.22185; Marks PA, 2005, CELL CYCLE, V4, P549, DOI 10.4161/cc.4.4.1564; Marks PA, 2005, EXPERT OPIN INV DRUG, V14, P1497, DOI 10.1517/13543784.14.12.1497; Oh ET, 2012, INVEST NEW DRUG, V30, P435, DOI 10.1007/s10637-010-9568-2; Olsen EA, 2007, J CLIN ONCOL, V25, P3109, DOI 10.1200/JCO.2006.10.2434; Paluszczak J, 2006, J APPL GENET, V47, P365, DOI 10.1007/BF03194647; Postnikoff SDL, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00183; Sonnemann J, 2014, BRIT J CANCER, V110, P656, DOI 10.1038/bjc.2013.742; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Witta SE, 2006, CANCER RES, V66, P944, DOI 10.1158/0008-5472.CAN-05-1988; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Yoshida M, 2001, CANCER CHEMOTH PHARM, V48, pS20, DOI 10.1007/s002800100300; Zhang CL, 2005, J INVEST DERMATOL, V125, P1045, DOI 10.1111/j.0022-202X.2005.23925.x; Zhu JD, 2009, INT J BIOCHEM CELL B, V41, P147, DOI 10.1016/j.biocel.2008.09.003; Zhu Wei-Guo, 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P187, DOI 10.2174/1568011033482440	31	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119379	10.1371/journal.pone.0119379	http://dx.doi.org/10.1371/journal.pone.0119379			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781604	Green Published, gold, Green Submitted			2022-12-27	WOS:000351284600061
J	Linke, SJ; Frings, A; Ren, L; Gomolka, A; Schumacher, U; Reimer, R; Hansen, NO; Jowett, N; Richard, G; Miller, RJD				Linke, Stephan J.; Frings, Andreas; Ren, Ling; Gomolka, Amadeus; Schumacher, Udo; Reimer, Rudolph; Hansen, Nils-Owe; Jowett, Nathan; Richard, Gisbert; Miller, R. J. Dwayne			A New Technology for Applanation Free Corneal Trephination: The Picosecond Infrared Laser (PIRL)	PLOS ONE			English	Article							EXCIMER-LASER; PERSPECTIVES; WAVELENGTH; ABLATION	The impact of using a Femtosecond laser on final functional results of penetrating keratoplasty is low. The corneal incisions presented here result from laser ablations with ultrafast desorption by impulsive vibrational excitation (DIVE). The results of the current study are based on the first proof-of-principle experiments using a mobile, newly introduced picosecond infrared laser system, and indicate that wavelengths in the mid-infrared range centered at 3 mu m are efficient for obtaining applanation-free deep cuts on porcine corneas.	[Linke, Stephan J.; Frings, Andreas; Gomolka, Amadeus; Richard, Gisbert] Univ Med Ctr Hamburg Eppendorf UKE, Dept Ophthalmol, D-20246 Hamburg, Germany; [Linke, Stephan J.] CareVis Clin Baviera Germany & Austria, D-20246 Hamburg, Germany; [Ren, Ling; Hansen, Nils-Owe; Jowett, Nathan; Miller, R. J. Dwayne] Max Planck Inst Struct & Dynam Matter, D-22761 Hamburg, Germany; [Schumacher, Udo] Univ Med Ctr Hamburg Eppendorf UKE, Dept Anat & Expt Morphol, D-20246 Hamburg, Germany; [Reimer, Rudolph] Univ Med Ctr Hamburg Eppendorf UKE, Leibniz Inst Expt Virol, Heinrich Pette Inst, D-20246 Hamburg, Germany; [Jowett, Nathan] Univ Med Ctr Hamburg Eppendorf UKE, Dept Otorhinolaryngol, D-20246 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Max Planck Society; University of Hamburg; University Medical Center Hamburg-Eppendorf; Heinrich Pette Institute; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Frings, A (corresponding author), Univ Med Ctr Hamburg Eppendorf UKE, Dept Ophthalmol, Martinistr 52, D-20246 Hamburg, Germany.	afrings@uke.de		Jowett, Nate/0000-0002-5242-0264	European Research Council [ERC-adG-2011-291630]; CareVision/Clinica	European Research Council(European Research Council (ERC)European Commission); CareVision/Clinica	This study was funded by the European Research Council Advanced Investigator Grant "Miller: ERC-adG-2011-291630: SUREPIRL, Picosecond Infrared Laser for Scar Free Surgery with Preservation of Tissue Structure and Recognition of Tissue Type and Boundaries." CareVision/Clinica provided support in the form of salaries for authors Stephan J. Linke and Gisbert Richard, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amini-Nik S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013053; Aptel F, 2010, INVEST OPHTH VIS SCI, V51, P2459, DOI 10.1167/iovs.09-4586; Birnbaum F, 2011, OPHTHALMOLOGE, V108, P807, DOI 10.1007/s00347-011-2334-9; Birnbaum F, 2010, OPHTHALMOLOGE, V107, P186, DOI 10.1007/s00347-009-2092-0; Birnbaum F, 2013, GRAEF ARCH CLIN EXP, V251, P95, DOI 10.1007/s00417-012-2054-0; Bottcher A, 2013, LARYNGOSCOPE, V123, P2770, DOI 10.1002/lary.24124; Chamberlain WD, 2011, OPHTHALMOLOGY, V118, P486, DOI 10.1016/j.ophtha.2010.08.002; Cowan ML, 2005, NATURE, V434, P199, DOI 10.1038/nature03383; Crotti C, 2013, INVEST OPHTH VIS SCI, V54, P3340, DOI 10.1167/iovs.12-10694; Franjic K, 2010, PHYS CHEM CHEM PHYS, V12, P5225, DOI 10.1039/c000359j; Franjic K, 2009, OPT EXPRESS, V17, P22937, DOI 10.1364/OE.17.022937; Joos K, 1996, P SOC PHOTO-OPT INS, V2673, P89, DOI 10.1117/12.240051; Maier P, 2012, CORNEA, V31, P963, DOI 10.1097/ICO.0b013e3182400048; NAUMANN GOH, 1993, KLIN MONATSBL AUGENH, V203, P252, DOI 10.1055/s-2008-1045677; Naydis I, 2011, OPHTHALMOLOGE, V108, P252, DOI 10.1007/s00347-010-2272-y; OSTERTAG M, 1995, P SOC PHOTO-OPT INS, V2391, P138, DOI 10.1117/12.209876; Paltauf G, 2003, CHEM REV, V103, P487, DOI 10.1021/cr010436c; Peyrot DA, 2010, J REFRACT SURG, V26, P786, DOI 10.3928/1081597X-20100921-04; Plamann K, 2010, J OPTICS-UK, V12, DOI 10.1088/2040-8978/12/8/084002; Reinhard T, 2011, OPHTHALMOLOGE, V108, P805, DOI 10.1007/s00347-011-2329-6; Seitz B, 2004, OPHTHALMOLOGE, V101, P478, DOI 10.1007/s00347-003-0900-5; Seitz B, 2011, OPHTHALMOLOGE, V108, P817, DOI 10.1007/s00347-011-2333-x; Seitz B, 1999, OPHTHALMOLOGY, V106, P1156, DOI 10.1016/S0161-6420(99)90265-8; STERN D, 1989, ARCH OPHTHALMOL-CHIC, V107, P587, DOI 10.1001/archopht.1989.01070010601038; Szentmary N, 2007, CURR EYE RES, V32, P953, DOI 10.1080/02713680701689781; Szentmary N, 2007, CORNEA, V26, P414, DOI 10.1097/ICO.0b013e3180303b16; Vogel A, 2003, CHEM REV, V103, P577, DOI 10.1021/cr010379n; Walker R, 1997, J Biomed Opt, V2, P204, DOI 10.1117/12.268951	28	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120944	10.1371/journal.pone.0120944	http://dx.doi.org/10.1371/journal.pone.0120944			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781907	Green Submitted, Green Published, gold			2022-12-27	WOS:000351284600192
J	Motta, SS; Cluzel, P; Aldana, M				Sandoval Motta, Santiago; Cluzel, Philippe; Aldana, Maximino			Adaptive Resistance in Bacteria Requires Epigenetic Inheritance, Genetic Noise, and Cost of Efflux Pumps	PLOS ONE			English	Article							MULTIPLE-ANTIBIOTIC-RESISTANCE; ESCHERICHIA-COLI; MAR OPERON; EVOLUTION; REPRESSOR	Adaptive resistance emerges when populations of bacteria are subjected to gradual increases of antibiotics. It is characterized by a rapid emergence of resistance and fast reversibility to the non-resistant phenotype when the antibiotic is removed from the medium. Recent work shows that adaptive resistance requires epigenetic inheritance and heterogeneity of gene expression patterns that are, in particular, associated with the production of porins and efflux pumps. However, the precise mechanisms by which inheritance and variability govern adaptive resistance, and what processes cause its reversibility remain unclear. Here, using an efflux pump regulatory network (EPRN) model, we show that the following three mechanisms are essential to obtain adaptive resistance in a bacterial population: 1) intrinsic variability in the expression of the EPRN transcription factors; 2) epigenetic inheritance of the transcription rate of EPRN associated genes; and 3) energetic cost of the efflux pumps activity that slows down cell growth. While the first two mechanisms acting together are responsible for the emergence and gradual increase of the resistance, the third one accounts for its reversibility. In contrast with the standard assumption, our model predicts that adaptive resistance cannot be explained by increased mutation rates. Our results identify the molecular mechanism of epigenetic inheritance as the main target for therapeutic treatments against the emergence of adaptive resistance. Finally, our theoretical framework unifies known and newly identified determinants such as the burden of efflux pumps that underlie bacterial adaptive resistance to antibiotics.	[Sandoval Motta, Santiago; Aldana, Maximino] UNAM, Inst Ciencias Fis, Cuernavaca, Morelos, Mexico; [Cluzel, Philippe] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA	Universidad Nacional Autonoma de Mexico; Harvard University	Aldana, M (corresponding author), UNAM, Inst Ciencias Fis, Cuernavaca, Morelos, Mexico.	max@fis.unam.mx	Aldana, Maximino/D-9372-2017	Aldana, Maximino/0000-0002-3419-6641	Programa de Doctorado en Ciencias Biomedicas-UNAM; Centro de Ciencias Genomicas-UNAM; Consejo Nacional de Ciencia y Tecnologia-Mexico [269040/220732]; Direccion General de Asuntos del Personal Academico-UNAM through the Programa de Apoyos para la Superacion del Personal Academico; Fundacion Mexico in Harvard; Consejo Nacional de Ciencia y Tecnologia [129471]	Programa de Doctorado en Ciencias Biomedicas-UNAM; Centro de Ciencias Genomicas-UNAM; Consejo Nacional de Ciencia y Tecnologia-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico-UNAM through the Programa de Apoyos para la Superacion del Personal Academico; Fundacion Mexico in Harvard; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	SS acknowledges the Programa de Doctorado en Ciencias Biomedicas-UNAM, Centro de Ciencias Genomicas-UNAM and Consejo Nacional de Ciencia y Tecnologia-Mexico for support though a PhD fellowship (269040/220732). MA acknowledges Direccion General de Asuntos del Personal Academico-UNAM financial support, through the Programa de Apoyos para la Superacion del Personal Academico for a sabbatical fellowship, and Fundacion Mexico in Harvard for the Antonio Madero 2011-2012 fellowship. This work was also partly supported by a Consejo Nacional de Ciencia y Tecnologia grant, number 129471. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-52; Alekshun MN, 1997, ANTIMICROB AGENTS CH, V41, P2067, DOI 10.1128/AAC.41.10.2067; Alekshun MN, 1999, J BACTERIOL, V181, P4669, DOI 10.1128/JB.181.15.4669-4672.1999; Alekshun MN, 1999, TRENDS MICROBIOL, V7, P410, DOI 10.1016/S0966-842X(99)01589-9; Andersson DI, 2006, CURR OPIN MICROBIOL, V9, P461, DOI 10.1016/j.mib.2006.07.002; Barclay ML, 1992, ANTIMICROB AGENTS CH; Braoudaki M, 2004, J CLIN MICROBIOL; Casadesus J, 2006, MICROBIOL MOL BIOL R, V70, P830, DOI 10.1128/MMBR.00016-06; Cohen SP, 1989, ANTIMICROB AGENTS CH; Fernandez L, 2012, CLIN MICROBIOLOGY RE; GEORGE AM, 1983, J BACTERIOL, V155, P531, DOI 10.1128/JB.155.2.531-540.1983; HALE WB, 1994, J BACTERIOL, V176, P3438, DOI 10.1128/jb.176.11.3438-3441.1994; Hermsen R, 2012, P NATL ACAD SCI USA, V109, P10775, DOI 10.1073/pnas.1117716109; Klaas M, 2009, BIOCH BIOPHYSICA ACT; Lancaster AK, 2009, EVOLUTION, V63, P2350, DOI 10.1111/j.1558-5646.2009.00729.x; Levin BR, 2000, GENETICS, V154, P985; Li XZ, 2009, DRUGS, V69, P1555, DOI 10.2165/11317030-000000000-00000; Lobner-Olesen A, 2005, CURRENT OPINION MICR; Lobner-Olesen A, 2003, PNAS; Low DA, 2001, INFECT IMMUN; Ma D, 1996, MOL MICROBIOL; Martin RG, 1996, J BACTERIOL, V178, P2216, DOI 10.1128/jb.178.8.2216-2223.1996; Mazzariol A, 2000, ANTIMICROB AGENTS CH; Nikaido H., 1996, J BACTERIOLOGY, V178; Nikaido H, 2012, FEMS MICROBIOL REV, V36, P340, DOI 10.1111/j.1574-6976.2011.00290.x; Oethinger M, 1998, ANTIMICROB AGENTS CH, V42, P2089, DOI 10.1128/AAC.42.8.2089; Okusu H, 1996, J BACTERIOL, V178, P306, DOI 10.1128/JB.178.1.306-308.1996; Pigliucci M, 2003, EVOLUTION, V57, P1455; Pigliucci M, 2006, J EXP BIOL, V209, P2362, DOI 10.1242/jeb.02070; Rando OJ, 2007, CELL; Rosner JL, 2009, J BACTERIOL, V191, P5283, DOI 10.1128/JB.00507-09; Sanchez-Romero MA, 2014, P NATL ACAD SCI US; SEOANE AS, 1995, J BACTERIOL, V177, P3414, DOI 10.1128/jb.177.12.3414-3419.1995; SULAVIK MC, 1995, MOL MED, V1, P436, DOI 10.1007/BF03401581; Takatsuka Y, 2010, P NATL ACAD SCI USA, V107, P6559, DOI 10.1073/pnas.1001460107; Toprak E, 2011, NAT GENET; Viveiros M, 2002, ANTIMICROB AGENTS CH, V46, P2804, DOI 10.1128/AAC.46.9.2804-2810.2002; Webber MA, 2003, J ANTIMICROB CHEMOTH; Wood KB, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-48; Yu EW, 2003, J BACTERIOL	40	45	47	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0118464	10.1371/journal.pone.0118464	http://dx.doi.org/10.1371/journal.pone.0118464			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781931	gold, Green Published			2022-12-27	WOS:000351284600023
J	Schmidt, FM; Weschenfelder, J; Sander, C; Minkwitz, J; Thormann, J; Chittka, T; Mergl, R; Kirkby, KC; Fasshauer, M; Stumvoll, M; Holdt, LM; Teupser, D; Hegerl, U; Himmerich, H				Schmidt, Frank M.; Weschenfelder, Julia; Sander, Christian; Minkwitz, Juliane; Thormann, Julia; Chittka, Tobias; Mergl, Roland; Kirkby, Kenneth C.; Fasshauer, Mathias; Stumvoll, Michael; Holdt, Lesca M.; Teupser, Daniel; Hegerl, Ulrich; Himmerich, Hubertus			Inflammatory Cytokines in General and Central Obesity and Modulating Effects of Physical Activity	PLOS ONE			English	Article							ALTERNATIVELY ACTIVATED MACROPHAGES; ADIPOSE-TISSUE INFLAMMATION; LOW-GRADE INFLAMMATION; NECROSIS-FACTOR-ALPHA; ENERGY-EXPENDITURE; INSULIN-RESISTANCE; DIABETES-MELLITUS; INTERFERON-GAMMA; GM-CSF; INTERLEUKIN-10 LEVELS	Context Chronic systemic inflammation in obesity originates from local immune responses in visceral adipose tissue. However, assessment of a broad range of inflammation-mediating cytokines and their relationship to physical activity and adipometrics has scarcely been reported to date. Objective To characterize the profile of a broad range of pro-and anti-inflammatory cytokines and the impact of physical activity and energy expenditure in individuals with general obesity, central obesity, and non-obese subjects. Design, Setting, and Participants A cross-sectional study comprising 117 obese patients (body mass index (BMI) >= 30) and 83 non-obese community-based volunteers. Main Outcomes Measures Serum levels of interleukin (IL)-2, IL-4, IL-5, IL-10, IL-12, IL-13, granulocyte-macrophage colony-stimulating factor (GM-CSF), interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha were measured. Physical activity and energy expenditure (MET) were assessed with actigraphy. Adipometrics comprised BMI, weight, abdominal-, waist-and hip-circumference, waist to hip ratio (WHR), and waist-to-height-ratio (WHtR). Results General obesity was associated with significantly elevated levels of IL-5, IL-10, IL-12, IL-13, IFN-gamma and TNF-alpha, central obesity with significantly elevated IL-5, IL-10, IL-12, IL-13 and IFN-gamma-levels. In participants with general obesity, levels of IL-4, IL-10 and IL-13 were significantly elevated in participants with low physical activity, even when controlled for BMI which was negatively associated with physical acitivity. Cytokines significantly correlated with adipometrics, particularly in obese participants. Conclusions Results confirm up-regulation of certain pro-and anti-inflammatory cytokines in obesity. In obese subjects, physical activity may lower levels and thus reduce pro-inflammatory effects of cytokines that may link obesity, insulin resistance and diabetes.	[Sander, Christian; Minkwitz, Juliane; Thormann, Julia; Chittka, Tobias; Fasshauer, Mathias; Stumvoll, Michael; Hegerl, Ulrich; Himmerich, Hubertus] Univ Leipzig, Med Ctr, Integrated Res & Treatment Ctr Adipos Dis IFB, D-04109 Leipzig, Saxony, Germany; [Schmidt, Frank M.; Weschenfelder, Julia; Sander, Christian; Minkwitz, Juliane; Thormann, Julia; Chittka, Tobias; Mergl, Roland; Hegerl, Ulrich; Himmerich, Hubertus] Univ Hosp Leipzig, Dept Psychiat & Psychotherapy, Leipzig, Saxony, Germany; [Kirkby, Kenneth C.] Univ Tasmania, Dept Psychiat, Hobart, Tas, Australia; [Holdt, Lesca M.; Teupser, Daniel] Univ Munich, Inst Lab Med, Munich, Bavaria, Germany	Leipzig University; Leipzig University; University of Tasmania; University of Munich	Schmidt, FM (corresponding author), Univ Hosp Leipzig, Dept Psychiat & Psychotherapy, Leipzig, Saxony, Germany.	Frank.Schmidt2@medizin.uni-leipzig.de	Stumvoll, Michael/ABE-1121-2021; Himmerich, Hubertus/H-9218-2019; Sander, Christian/AAB-8674-2022	Stumvoll, Michael/0000-0001-6225-8240; Himmerich, Hubertus/0000-0003-1209-6073; Sander, Christian/0000-0002-5402-6631; Hegerl, Ulrich/0000-0002-3039-7470; Schmidt, Frank/0000-0002-8316-7601	Integrated Research and Treatment Centre for Adiposity Diseases (IFB), University of Leipzig; Federal Ministry of Education and Research (BMBF) [FKZ: 01EO1001]; Claussen-Simon-Foundation	Integrated Research and Treatment Centre for Adiposity Diseases (IFB), University of Leipzig; Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Claussen-Simon-Foundation	This study was supported by the Integrated Research and Treatment Centre for Adiposity Diseases (IFB), University of Leipzig, the Federal Ministry of Education and Research (BMBF), FKZ: 01EO1001, and the Claussen-Simon-Foundation. The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	AWATA T, 1994, DIABETOLOGIA, V37, P1159, DOI 10.1007/BF00418381; Bergman D, 2013, INTERN EMERG MED, V8, pS17, DOI 10.1007/s11739-013-0921-2; Beuther DA, 2006, AM J RESP CRIT CARE, V174, P112, DOI 10.1164/rccm.200602-231PP; Brooks-Worrell B, 2012, CLIN EXP IMMUNOL, V167, P40, DOI 10.1111/j.1365-2249.2011.04501.x; Bruun JM, 2006, AM J PHYSIOL-ENDOC M, V290, pE961, DOI 10.1152/ajpendo.00506.2005; Canoz M, 2008, CLIN INVEST MED, V31, pE373; Casiraghi F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073651; Denis GV, 2013, MOL ASPECTS MED, V34, P59, DOI 10.1016/j.mam.2012.10.004; Donath MY, 2008, NAT CLIN PRACT ENDOC, V4, P240, DOI 10.1038/ncpendmet0783; Drenowatz C, 2011, EUR J APPL PHYSIOL, V111, P883, DOI 10.1007/s00421-010-1695-0; El-Wakkad A, 2013, CYTOKINE, V61, P682, DOI 10.1016/j.cyto.2012.11.010; Engstrom G, 2003, DIABETES, V52, P2097, DOI 10.2337/diabetes.52.8.2097; Ertek S, 2012, ARCH MED SCI, V8, P794, DOI 10.5114/aoms.2012.31614; Esposito K, 2003, J CLIN ENDOCR METAB, V88, P1055, DOI 10.1210/jc.2002-021437; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Formoso G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052774; Fruhbeck G, 2001, AM J PHYSIOL-ENDOC M, V280, pE827, DOI 10.1152/ajpendo.2001.280.6.E827; Fruin ML, 2004, MED SCI SPORT EXER, V36, P1063, DOI 10.1249/01.MSS.0000128144.91337.38; Gao MM, 2013, MOL THER, V21, P1852, DOI 10.1038/mt.2013.125; Gaudreau S, 2007, J IMMUNOL, V179, P3638, DOI 10.4049/jimmunol.179.6.3638; Himmerich H, 2006, EUR CYTOKINE NETW, V17, P196, DOI 10.1684/ecn.2006.0037; Holguin F, 2011, J ALLERGY CLIN IMMUN, V127, P1486, DOI 10.1016/j.jaci.2011.03.036; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Indulekha K, 2011, CLIN BIOCHEM, V44, P281, DOI 10.1016/j.clinbiochem.2010.12.015; Ip WK, 2005, IMMUNOPHARM IMMUNOT, V27, P371, DOI 10.1080/08923970500240925; Jung SH, 2008, J NUTR BIOCHEM, V19, P371, DOI 10.1016/j.jnutbio.2007.05.007; Kasapis C, 2005, J AM COLL CARDIOL, V45, P1563, DOI 10.1016/j.jacc.2004.12.077; Kim DH, 2008, AM J PHYSIOL-ENDOC M, V295, pE1038, DOI 10.1152/ajpendo.00061.2008; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; Kudo M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00263; Lacey DC, 2012, J IMMUNOL, V188, P5752, DOI 10.4049/jimmunol.1103426; Liao XD, 2011, J CLIN INVEST, V121, P2736, DOI 10.1172/JCI45444; Liden CB, 2001, WHITE PAPERS BODY ME, V1, P1; Lucas R, 2013, CYTOKINE, V64, P310, DOI 10.1016/j.cyto.2013.05.025; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Machac S, 2013, DIABETES TECHNOL THE, V15, P413, DOI 10.1089/dia.2012.0235; Manigrasso MR, 2005, J CLIN ENDOCR METAB, V90, P5876, DOI 10.1210/jc.2005-0281; Martinez-Gomez D, 2010, INT J OBESITY, V34, P1501, DOI 10.1038/ijo.2010.114; Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Mora S, 2006, JAMA-J AM MED ASSOC, V295, P1412, DOI 10.1001/jama.295.12.1412; Nam H, 2013, BBA-MOL BASIS DIS, V1832, P11, DOI 10.1016/j.bbadis.2012.08.011; Newson RB, 2014, CLIN EXP ALLERGY, V44, P250, DOI 10.1111/cea.12221; O'Rourke RW, 2012, METABOLISM, V61, P1152, DOI 10.1016/j.metabol.2012.01.018; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Papazoglou D, 2006, OBESITY, V14, P2217, DOI 10.1038/oby.2006.260; Peters MC, 2013, AM J RESP CRIT CARE, V188, P633, DOI 10.1164/rccm.201307-1360ED; Pickup JC, 1998, DIABETOLOGIA, V41, P1241, DOI 10.1007/s001250051058; Pollard KM, 2013, DISCOV MED, V16, P123; Predieri B, 2013, OBESITY, V21, P2465, DOI 10.1002/oby.20427; Reed JA, 2005, J CLIN INVEST, V115, P3035, DOI 10.1172/JCI25681; Ruan H, 2003, CYTOKINE GROWTH F R, V14, P447, DOI 10.1016/S1359-6101(03)00052-2; SARVETNICK N, 1988, CELL, V52, P773, DOI 10.1016/0092-8674(88)90414-X; Schipper HS, 2012, TRENDS ENDOCRIN MET, V23, P407, DOI 10.1016/j.tem.2012.05.011; Schmidt FM, 2014, J PSYCHIATR RES, V55, P29, DOI 10.1016/j.jpsychires.2014.04.021; Shephard RJ, 2015, EUR J APPL PHYSIOL, V115, P1, DOI 10.1007/s00421-014-3031-6; Sideleva O, 2012, AM J RESP CRIT CARE, V186, P598, DOI 10.1164/rccm.201203-0573OC; Slinde F, 2013, OBESITY, V21, P2231, DOI 10.1002/oby.20363; St-Onge M, 2007, AM J CLIN NUTR, V85, P742, DOI 10.1093/ajcn/85.3.742; Suarez-Alvarez K, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/967067; Surendar J, 2011, DIABETES TECHNOL THE, V13, P477, DOI 10.1089/dia.2010.0178; Tateya Sanshiro, 2013, Front Endocrinol (Lausanne), V4, P93, DOI 10.3389/fendo.2013.00093; Tierney M, 2013, ARTHRIT CARE RES, V65, P888, DOI 10.1002/acr.21914; Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Van Dyken SJ, 2013, ANNU REV IMMUNOL, V31, P317, DOI 10.1146/annurev-immunol-032712-095906; Vernillo G, 2014, INT J SPORT NUTR EXE, V24, P565, DOI 10.1123/ijsnem.2014-0075; Warren JM, 2010, EUR J CARDIOV PREV R, V17, P127, DOI 10.1097/HJR.0b013e32832ed875; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Weschenfelder J, 2012, PSYCHIAT DANUB, V24, P112; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wittchen H.U., 1997, SKID STRUKTURIERTES; You TJ, 2013, SPORTS MED, V43, P243, DOI 10.1007/s40279-013-0023-3	74	237	239	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0121971	10.1371/journal.pone.0121971	http://dx.doi.org/10.1371/journal.pone.0121971			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781614	Green Published, gold, Green Submitted			2022-12-27	WOS:000351284600211
J	Wang, L; Wang, SM; Fu, XJ; Sun, L				Wang, Lu; Wang, Shumei; Fu, Xuejun; Sun, Li			Characteristics of an R-Phycoerythrin with Two gamma Subunits Prepared from Red Macroalga Polysiphonia urceolata	PLOS ONE			English	Article							ENERGY-TRANSFER; CRYSTAL-STRUCTURE; PHYCOBILISOMES; PURIFICATION; COMPLEX; ALGAE	An R-phycoerythrin (R-PE) was isolated by gel filtrations on Sepharose CL-4B and Sephadex G-150 from the phycobiliprotein extract of the marine red macroalga Polysiphonia urceolata Grev and further purified by ion exchange chromatography on DEAE-Sepharose Fast Flow. The purified R-PE showed three absorption peaks at 498 nm, 538 nm, 566 nm and one fluorescent emission maximum at 577 nm. Although the R-PE showed a single band on the examination by native PAGE, it exhibited two very close bands at pH about 4.7 in native isoelectric focusing (IEF). Polypeptide analysis of the R-PE demonstrated that it contained four chromophore-carrying subunits, alpha(18.2), beta(20.6),gamma(31.6) (gamma'),gamma(34.6) (gamma), and no color-less polypeptide; its subunit composition was 6 alpha(18.2):6 beta(20.6):1 gamma(31.6):2 gamma(34.6). The alpha and beta subunits were distributed within a acidic pH range from 5.0 to 6.0 in denaturing IEF and the. subunits were in a basic pH range from 7.6 to 8.1. These results reveal that the prepared R-PE may exist in two hexamers of. (alpha beta)(3) gamma(alpha beta)(3) gamma' and gamma(alpha beta)(3) gamma'(alpha beta)(3)gamma and that the R-PE participate in the rod domain assembly of P. urceolata phycobilisomes by stacking each of its trimer (alpha beta)(3) face-to-face with the aid of one gamma subunit (gamma or gamma').	[Wang, Lu; Fu, Xuejun; Sun, Li] Yantai Univ, Coll Life Sci, Yantai, Shandong, Peoples R China; [Wang, Shumei] Yantai Univ, Coll Photo Elect Informat Sci & Technol, Yantai, Peoples R China	Yantai University; Yantai University	Sun, L (corresponding author), Yantai Univ, Coll Life Sci, Yantai, Shandong, Peoples R China.	sunliytu@aliyun.com			National Natural Science Foundation of China [30571720, 40976083]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work had been supported by the National Natural Science Foundation of China (30571720, 40976083). The authors have not obtained new funding since the subjects completed two years ago. Therefore, there are no current funding sources for this study and no funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JF, 2011, TRENDS PLANT SCI, V16, P645, DOI 10.1016/j.tplants.2011.10.004; Amersham Biosciences, 2006, HDB REF; Amersham Biosciences, 2007, HDB REF; Amersham Biosciences, 2000, AM BOISCH HDB, V18-1020-90; [Anonymous], [No title captured]; APT KE, 1993, J BIOL CHEM, V268, P16208; Bermejo R, 2003, J CHROMATOGR B, V790, P317, DOI 10.1016/S1570-0232(03)00168-5; Bienvenut WV, 2005, ACCELERATION IMPROVE, P225; Broadhurst AV, 1997, CURRENT PROTOCOLS PR; Chang WR, 1996, J MOL BIOL, V262, P721, DOI 10.1006/jmbi.1996.0547; Coligan JE, 2003, CHEM ANAL CURRENT PR; de Marsac NT, 2003, PHOTOSYNTH RES, V76, P197; Galland-Irmouli AV, 2000, J CHROMATOGR B, V739, P117, DOI 10.1016/S0378-4347(99)00433-8; GANTT E, 1973, BIOCHIM BIOPHYS ACTA, V292, P858, DOI 10.1016/0005-2728(73)90036-4; Gantt E., 2003, LIGHT HARVESTING ANT, P307, DOI DOI 10.1007/978-94-017-2087-8_10; GLAZER AN, 1985, ANNU REV BIOPHYS BIO, V14, P47, DOI 10.1146/annurev.biophys.14.1.47; GLAZER AN, 1984, BIOCHIM BIOPHYS ACTA, V768, P29, DOI 10.1016/0304-4173(84)90006-5; GLAZER AN, 1989, J BIOL CHEM, V264, P1; GLAZER AN, 1986, BIOPHYS J, V49, P115, DOI 10.1016/S0006-3495(86)83616-5; HOLZWARTH AR, 1991, PHYSIOL PLANTARUM, V83, P518, DOI 10.1111/j.1399-3054.1991.tb00129.x; Jiang T, 2001, BIOPHYS J, V81, P1171, DOI 10.1016/S0006-3495(01)75774-8; Liu LN, 2005, BBA-BIOENERGETICS, V1708, P133, DOI 10.1016/j.bbabio.2005.04.001; Liu LN, 2005, J BIOTECHNOL, V116, P91, DOI 10.1016/j.jbiotec.2004.09.017; MacColl R, 1998, J STRUCT BIOL, V124, P311, DOI 10.1006/jsbi.1998.4062; Niu JF, 2006, PROTEIN EXPRES PURIF, V49, P23, DOI 10.1016/j.pep.2006.02.001; Ping W., 2000, PROGR PHYSL SCI, V31, P82; Price DC, 2012, SCIENCE, V335, P843, DOI 10.1126/science.1213561; Ritter S, 1997, PROTEIN PEPTIDE LETT, V4, P69; Ritter S, 1999, J STRUCT BIOL, V126, P86, DOI 10.1006/jsbi.1999.4106; Rossano R, 2003, J BIOTECHNOL, V101, P289, DOI 10.1016/S0168-1656(03)00002-6; Sidler W., 2004, MOL BIOL CYANOBACTER, P139; Simpson RJ, 2003, PROTEINS PROTEOMICS; SIMPSON RJ, 2004, PURIFYING PROTEINS P; Six C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r259; Su HN, 2010, PHOTOSYNTH RES, V106, P73, DOI 10.1007/s11120-010-9560-x; Sun L, 2004, J PHOTOCH PHOTOBIO B, V76, P1, DOI 10.1016/j.jphotobiol.2004.07.003; Sun L, 2003, J PHOTOCH PHOTOBIO B, V72, P45, DOI 10.1016/j.jphotobiol.2003.07.006; Sun L, 2003, IEEE J SEL TOP QUANT, V9, P177, DOI 10.1109/JSTQE.2003.812499; Sun L, 2000, PHOTOSYNTHETICA, V38, P601, DOI 10.1023/A:1012417725304; Sun L, 2009, HDB CYANOBACTERIA BI, P85; Sun L, 2011, J PHYCOL, V47, P1304, DOI 10.1111/j.1529-8817.2011.01067.x; Yu LH, 1990, ACTA BIOCH BIOPH SIN, V22, P221; [郑蔚然 ZHENG WeiranDING Yu-ting], 2008, [微生物学杂志, Journal of Mirobiology], V28, P70; Zimny-Arndt Ursula, 2009, V492, P65, DOI 10.1007/978-1-59745-493-3_4	44	12	12	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120333	10.1371/journal.pone.0120333	http://dx.doi.org/10.1371/journal.pone.0120333			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781487	Green Published, gold, Green Submitted			2022-12-27	WOS:000351284600150
J	Bai, J; Lei, Y; An, GL; He, L				Bai, Jun; Lei, Yun; An, Gai-li; He, Li			Down-Regulation of Deacetylase HDAC6 Inhibits the Melanoma Cell Line A375.S2 Growth through ROS-Dependent Mitochondrial Pathway	PLOS ONE			English	Article							CYTOCHROME-C; APOPTOSIS; CARDIOLIPIN; DYSFUNCTION; BIOGENESIS; GENERATION	Previous studies have shown that histone deacetylase 6 (HDAC6) plays critical roles in many cellular processes related to cancer. However, its biological roles in the development of melanoma remain unexplored. Our aim was to investigate whether HDAC6 has a biological role in human melanoma development and to understand its underlying mechanism. In the present study, HDAC6 expression was up-regulated in melanoma tissues and cell lines. Knockdown of HDAC6 significantly inhibited the proliferation and colony formation ability of A375. S2 cells, promoted cell arrest at G0/G1 phase and apoptosis. Additionally, western blotting assay showed that HDAC6 silencing suppressed Bcl-2 level and enhanced Bax level, then activated caspase-9 and caspase-3, and further activated the release of cytochrome c from mitochondria to cytoplasm, finally induced cell apoptosis involving the mitochondrial pathway. Knockdown of HDAC6 triggered a significant generation of ROS and disruption of mitochondrial membrane potential (MMP). Furthermore, ROS inhibitor, NAC reduced HDAC6 siRNA-induced ROS production, and blocked HDAC6 siRNA-induced loss of MMP and apoptosis. NAC also significantly blocked HDAC6 siRNA-induced mtDNA copy number decrease and mitochondrial biogenesis and degradation imbalance. In conclusion, the results showed that knockdown of HDAC6 induced apoptosis in human melanoma A375.S2 cells through a ROS-dependent mitochondrial pathway.	[Bai, Jun; Lei, Yun; An, Gai-li; He, Li] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 3, Dept Med Oncol,Shaanxi Prov Peoples Hosp, Xian 710049, Peoples R China	Xi'an Jiaotong University; Xi'an Medical University	Bai, J (corresponding author), Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 3, Dept Med Oncol,Shaanxi Prov Peoples Hosp, Xian 710049, Peoples R China.	baijun1155@163.com						Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Aldana-Masangkay GI, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/875824; Bo H, 2010, ANN NY ACAD SCI, V1201, P121, DOI 10.1111/j.1749-6632.2010.05618.x; Boyault C, 2007, ONCOGENE, V26, P5468, DOI 10.1038/sj.onc.1210614; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Huang SH, 2012, J AGR FOOD CHEM, V60, P665, DOI 10.1021/jf204193v; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Kamemura K, 2012, FEBS LETT, V586, P1379, DOI 10.1016/j.febslet.2012.03.060; Kang J, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/896751; Kaufmann SH, 2000, EXP CELL RES, V256, P42, DOI 10.1006/excr.2000.4838; Larisa P.M., 2007, FOCUS CELL APOPTOSIS, V1, P233; Lee W, 2013, BIOCHEM BIOPH RES CO, V430, P406, DOI 10.1016/j.bbrc.2012.11.030; Ling YH, 2003, J BIOL CHEM, V278, P33714, DOI 10.1074/jbc.M302559200; Liu MJ, 2004, TOXICOL APPL PHARM, V194, P141, DOI 10.1016/j.taap.2003.08.017; Ma Y, 2014, BIOCHEM BIOPH RES CO, V448, P8, DOI 10.1016/j.bbrc.2014.04.007; Paradies G, 2002, GENE, V286, P135, DOI 10.1016/S0378-1119(01)00814-9; Park SY, 2011, ONCOL REP, V25, P1677, DOI 10.3892/or.2011.1236; Petrosillo G, 2003, FASEB J, V17, P2202, DOI 10.1096/fj.03-0012com; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Shen W, 2008, DIABETOLOGIA, V51, P165, DOI 10.1007/s00125-007-0852-4; Ventura-Clapier R, 2008, CARDIOVASC RES, V79, P208, DOI 10.1093/cvr/cvn098; Yoboue Edgar D, 2012, Int J Cell Biol, V2012, P403870, DOI 10.1155/2012/403870; Yoon DH, 2013, TOXICOL APPL PHARM, V273, P659, DOI 10.1016/j.taap.2013.10.015; Zuckerman JE, 2011, J INVEST DERMATOL, V131, P453, DOI 10.1038/jid.2010.310	27	20	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0121247	10.1371/journal.pone.0121247	http://dx.doi.org/10.1371/journal.pone.0121247			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774669	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500211
J	Cedres, S; Ponce-Aix, S; Zugazagoitia, J; Sansano, I; Enguita, A; Navarro-Mendivil, A; Martinez-Marti, A; Martinez, P; Felip, E				Cedres, Susana; Ponce-Aix, Santiago; Zugazagoitia, Jon; Sansano, Irene; Enguita, Ana; Navarro-Mendivil, Alejandro; Martinez-Marti, Alex; Martinez, Pablo; Felip, Enriqueta			Analysis of Expression of Programmed Cell Death 1 Ligand 1 (PD-L1) in Malignant Pleural Mesothelioma (MPM)	PLOS ONE			English	Article							B7-H1 EXPRESSION; EXTRAPLEURAL PNEUMONECTOMY; INDUCTION CHEMOTHERAPY; SPONTANEOUS REGRESSION; T-CELLS; SURVIVAL; ANTIBODY; SAFETY; INFILTRATION; LYMPHOCYTES	Background The increasing incidence and poor outcome associated with MPM requires finding effective treatment for this disease. PD1/PD-L1 pathway plays a central role in tumor immune evasion and appears to be predictive and prognostic marker. PD-L1 is expressed in many different human cancers but its role in MPM has yet to be established. The aim of this study is to evaluate the expression of PD-L1 in MPM. Methods 119 MPM patients (p) from two institutions between November 2002 and February 2014 were reviewed. Formalin-fixed, paraffin-embedded tissue was stained with anti-PD-L1 (clone E1L3N). Cases showing more than 1% of tumor cells expression of PD-L1 were considered positive. Results PD-L1 was analyzed in 77 p with tumor tissue available and was positive in 20.7% p (14 samples in membrane, 16 in cytoplasm and 4 in immune infiltrate). PD-L1 intensity was weak in 56.2%, moderate in 25% and strong in 18.7% p. There was a significant relationship between PD-L1 expression and histology (PD-L1 expression 37.5% in no-epithelioid tumor and 13.2% in epithelioid; p=0.033). The median survival in p PD-L1 positive was 4.79 vs 16.3 months in p PD-L1 negative (p=0.012). Conclusions We have shown PD-L1 is expressed in 20% of patients, associated with no epithelioid histology and poor prognostic in MPM. Our results suggest PD-L1 warrants further exploration in selecting p for immunotherapy.	[Cedres, Susana; Navarro-Mendivil, Alejandro; Martinez-Marti, Alex; Martinez, Pablo; Felip, Enriqueta] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol, Med Oncol Serv, Barcelona, Spain; [Ponce-Aix, Santiago; Zugazagoitia, Jon] 12 Octubre Univ Hosp, Med Oncol Serv, Madrid, Spain; [Sansano, Irene] Vall dHebron Univ Hosp, Dept Pathol, Barcelona, Spain; [Enguita, Ana] 12 Octubre Univ Hosp, Dept Pathol, Madrid, Spain	Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); Hospital Universitario 12 de Octubre; Hospital Universitari Vall d'Hebron; Hospital Universitario 12 de Octubre	Cedres, S (corresponding author), Vall dHebron Univ Hosp, Vall dHebron Inst Oncol, Med Oncol Serv, Barcelona, Spain.	scedres@vhebron.net	FELIP, ENRIQUETA/AAG-6316-2019; Sansano, Irene/AAH-9731-2021	Sansano, Irene/0000-0003-0188-5210; FELIP, ENRIQUETA/0000-0002-7620-0098; MARTINEZ-MARTI, ALEX/0000-0002-6714-9526; Balmana, Judith/0000-0002-0762-6415				Allen RKA, 2007, MED J AUSTRALIA, V187, P413, DOI 10.5694/j.1326-5377.2007.tb01315.x; Anraku M, 2008, J THORAC CARDIOV SUR, V135, P823, DOI 10.1016/j.jtcvs.2007.10.026; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Calabro L, 2013, LANCET ONCOL, V14, P1104, DOI 10.1016/S1470-2045(13)70381-4; Ceresoli GL, 2001, LUNG CANCER, V34, P279, DOI 10.1016/S0169-5002(01)00257-4; Currie AJ, 2009, J IMMUNOL, V183, P7898, DOI 10.4049/jimmunol.0901060; de Perrot M, 2009, J CLIN ONCOL, V27, P1413, DOI 10.1200/JCO.2008.17.5604; Flores RM, 2005, LUNG CANCER-J IASLC, V49, pS71, DOI 10.1016/j.lungcan.2005.03.015; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Gandhi L, 2014, AACR ANN M APRIL6; Hamanishi J, 2007, P NATL ACAD SCI USA, V104, P3360, DOI 10.1073/pnas.0611533104; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hassan R, 2010, CLIN CANCER RES, V16, P6132, DOI 10.1158/1078-0432.CCR-10-2275; Herbst RS, 2013, J CLIN ONCOL S, V31; Inami K, 2010, CANCER SCI, V101, P969, DOI 10.1111/j.1349-7006.2009.01463.x; International Union Against Cancer, 2009, TNM CLASSIFICATION M; Jackaman C, 2009, EUR RESPIR J, V34, P162, DOI 10.1183/09031936.00101008; Karim R, 2009, CLIN CANCER RES, V15, P6341, DOI 10.1158/1078-0432.CCR-09-1652; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Konishi J, 2004, CLIN CANCER RES, V10, P5094, DOI 10.1158/1078-0432.CCR-04-0428; Kreitman RJ, 2009, CLIN CANCER RES, V15, P5274, DOI 10.1158/1078-0432.CCR-09-0062; Krug LM, 2010, CANCER IMMUNOL IMMUN, V59, P1467, DOI 10.1007/s00262-010-0871-8; LEIGH RA, 1982, S AFR MED J, V61, P1007; Mansfield AS, 2014, J THORAC ONCOL, V9, P1036, DOI 10.1097/JTO.0000000000000177; MARTINI N, 1987, ANN THORAC SURG, V43, P113, DOI 10.1016/S0003-4975(10)60182-8; Neragi-Miandoab Siyamek, 2008, Int J Surg, V6, P293, DOI 10.1016/j.ijsu.2008.04.004; Ohigashi Y, 2005, CLIN CANCER RES, V11, P2947, DOI 10.1158/1078-0432.CCR-04-1469; Opitz I, 2008, EUR J CARDIO-THORAC, V33, P501, DOI 10.1016/j.ejcts.2007.09.045; Parsa AT, 2007, NAT MED, V13, P84, DOI 10.1038/nm1517; Pilling JE, 2007, ANN THORAC SURG, V83, P314, DOI 10.1016/j.athoracsur.2006.05.070; Rena O, 2011, J SURG ONCOL, V104, P701, DOI 10.1002/jso.21901; Robinson BWS, 2001, LUNG CANCER-J IASLC, V32, P197, DOI 10.1016/S0169-5002(00)00217-8; Schalper K, 2014, CLIN CANCER RES, V20, P5064, DOI [10.1158/1078-0432.CCR-13-3271, DOI 10.1158/1078-0432.CCR-13-3271]; Seiwert TY, 2015, J CLIN ONCOL, V33; Soliman H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088557; Strome SE, 2003, CANCER RES, V63, P6501; Sznol M, 2013, CLIN CANCER RES, V19, P1021, DOI 10.1158/1078-0432.CCR-12-2063; Thompson RH, 2004, P NATL ACAD SCI USA, V101, P17174, DOI 10.1073/pnas.0406351101; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; van Meerbeeck JP, 2005, J CLIN ONCOL, V23, P6881, DOI 10.1200/JCO.20005.14.589; Velcheti V, 2014, LAB INVEST, V94, P107, DOI 10.1038/labinvest.2013.130; Velcheti V, 2013, J THORAC ONCOL, V8, P803, DOI 10.1097/JTO.0b013e318292be18; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Weber JS, 2013, J CLIN ONCOL, V31; Yamada N, 2010, CANCER IMMUNOL IMMUN, V59, P1543, DOI 10.1007/s00262-010-0881-6; Zou WP, 2008, NAT REV IMMUNOL, V8, P467, DOI 10.1038/nri2326	46	143	147	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e121071	10.1371/journal.pone.0121071	http://dx.doi.org/10.1371/journal.pone.0121071			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774992	Green Published, gold, Green Submitted			2022-12-27	WOS:000351183500205
J	Chen, DZ; Koh, V; Sng, C; Aquino, MC; Chew, P				Chen, David Z.; Koh, Victor; Sng, Chelvin; Aquino, Maria C.; Chew, Paul			Complications and Outcomes of Primary Phacotrabeculectomy with Mitomycin C in a Multi-Ethnic Asian Population	PLOS ONE			English	Article							LASER SUTURE LYSIS; ANGLE-CLOSURE GLAUCOMA; INTRAOCULAR-PRESSURE; CATARACT-EXTRACTION; LENS IMPLANTATION; TRABECULECTOMY; SURGERY; PHACOEMULSIFICATION; 5-FLUOROURACIL; MORPHOLOGY	Purpose To determine the occurrence of intraoperative and postoperative complications up to three years after primary phacotrabeculectomy with intraoperative use of Mitomycin C (MMC) in primary open angle (POAG) and primary angle closure glaucoma (PACG) patients, and the effect of postoperative complications on surgical outcome. Methods Retrospective review of 160 consecutive patients with POAG (n = 105) and PACG (n = 55), who underwent primary phacotrabeculectomy with MMC at the National University Hospital, Singapore, from January 1, 2008 to December 31, 2010. Data was collected using a standardized form that included patient demographic information, ocular characteristics and postoperative complications, including hypotony (defined as intraocular pressure < 6 mmHg), shallow anterior chamber (AC) and hyphema. Results The mean age +/- standard deviation (SD) of patients was 68.2 +/- 8.2 years. No patient lost light perception during duration of follow-up. 77% of the postoperative complications occurred within the first month only. The commonest complications were hypotony (n = 41, 25.6%), hyphema (n = 16, 10.0%) and shallow AC (n = 16, 10.0%). Five patients (3.1%) required reoperation for their complications. Early hypotony (defined as hypotony < 30 days postoperatively) was an independent risk factor for surgical failure (hazard ratio [HR], 5.1; 95% CI, 1.6-16.2; p = 0.01). Hypotony with another complication was also a risk factor for surgical failure (p < 0.02). Conclusions Hypotony, hyphema and shallow AC were the commonest postoperative complications in POAG and PACG patients after phacotrabeculectomy with MMC. Most complications were transient and self-limiting. Early hypotony within the first month was a significant risk factor for surgical failure.	[Chen, David Z.; Koh, Victor; Sng, Chelvin; Aquino, Maria C.; Chew, Paul] Natl Univ Hlth Syst, Dept Ophthalmol, Singapore, Singapore; [Chen, David Z.] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore	National University of Singapore; National University of Singapore	Chen, DZ (corresponding author), Natl Univ Hlth Syst, Dept Ophthalmol, Singapore, Singapore.	dzychen18@gmail.com	Chen, David/ABF-6773-2020	Chen, David/0000-0002-2153-3100; Sng, Chelvin/0000-0002-9837-6019				Aykan U, 2007, J GLAUCOMA, V16, P240, DOI 10.1097/IJG.0b013e31802d6ded; Belyea DA, 1997, J GLAUCOMA, V6, P90; Benson SE, 2005, BMC OPHTHALMOL, V5, P5; Blackwell B, 2001, ARCH OPHTHALMOL-CHIC, V119, P1771; Budenz DL, 1999, OPHTHALMIC SURG LAS, V30, P367; Buys YM, 2008, OPHTHALMOLOGY, V115, P1130, DOI 10.1016/j.ophtha.2007.09.007; Casson RJ, 2001, J CATARACT REFR SURG, V27, P1854, DOI 10.1016/S0886-3350(01)01127-0; Chia WLA, 1998, AUST NZ J OPHTHALMOL, V26, P19, DOI 10.1046/j.1440-1606.1998.00074.x; Cook C, 2012, CAN J OPHTHALMOL, V47, P223, DOI 10.1016/j.jcjo.2012.02.003; Foster PJ, 2000, ARCH OPHTHALMOL-CHIC, V118, P1105, DOI 10.1001/archopht.118.8.1105; Hayashi K, 2001, J CATARACT REFR SURG, V27, P1779, DOI 10.1016/S0886-3350(01)01036-7; Husain R, 2012, ARCH OPHTHALMOL-CHIC, V130, P165, DOI 10.1001/archophthalmol.2011.329; Kapetansky FM, 2003, J GLAUCOMA, V12, P316, DOI 10.1097/00061198-200308000-00005; Khamar MB, 2014, INDIAN J OPHTHALMOL, V62, P711, DOI 10.4103/0301-4738.136227; Kirwan JF, 2013, OPHTHALMOLOGY, V120, P2532, DOI 10.1016/j.ophtha.2013.07.049; KUPIN TH, 1995, AM J OPHTHALMOL, V119, P30, DOI 10.1016/S0002-9394(14)73810-3; Law SK, 2009, AM J OPHTHALMOL, V148, P685, DOI 10.1016/j.ajo.2009.05.032; Murthy SK, 2006, CAN J OPHTHALMOL, V41, P51, DOI 10.1016/S0008-4182(06)80067-0; Nassiri N, 2008, CORNEA, V27, P889, DOI 10.1097/ICO.0b013e31817618b0; Poley BJ, 2009, J CATARACT REFR SURG, V35, P1946, DOI 10.1016/j.jcrs.2009.05.061; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Ralli M, 2006, J GLAUCOMA, V15, P60, DOI 10.1097/01.ijg.0000195929.94922.a2; Rhee DJ, 1999, J CATARACT REFR SURG, V25, P546, DOI 10.1016/S0886-3350(99)80053-4; Shaarawy TM, 2009, GUIDELINES ON DESIGN; Shingleton BJ, 2001, J CATARACT REFR SURG, V27, P524, DOI 10.1016/S0886-3350(00)00641-6; Shingleton BJ, 2007, J CATARACT REFR SURG, V33, P1953, DOI 10.1016/j.jcrs.2007.06.039; Shrivastava A, 2010, CURR OPIN OPHTHALMOL, V21, P118, DOI 10.1097/ICU.0b013e3283360ac3; Sng CCA, 2011, EYE, V25, P619, DOI 10.1038/eye.2011.31; Tan YL, 2011, ARCH OPHTHALMOL-CHIC, V129, P987, DOI 10.1001/archophthalmol.2011.71; Tham CCY, 2008, OPHTHALMOLOGY, V115, P2167, DOI 10.1016/j.ophtha.2008.06.016; Wong JS, 1998, AUST NZ J OPHTHALMOL, V26, P283, DOI 10.1111/j.1442-9071.1998.tb01331.x	31	15	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118852	10.1371/journal.pone.0118852	http://dx.doi.org/10.1371/journal.pone.0118852			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775362	gold, Green Published, Green Submitted			2022-12-27	WOS:000351183500045
J	Ma, L; Jeffery, WR; Essner, JJ; Kowalko, JE				Ma, Li; Jeffery, William R.; Essner, Jeffrey J.; Kowalko, Johanna E.			Genome Editing Using TALENs in Blind Mexican Cavefish, Astyanax mexicanus	PLOS ONE			English	Article							PINK-EYED-DILUTION; AGGRESSIVE-BEHAVIOR; EVOLUTION; EFFICIENT; GENE; DNA; CONVERGENCE; FISH; STICKLEBACKS; ALBINISM	Astyanax mexicanus, a teleost fish that exists in a river-dwelling surface form and multiple cave-dwelling forms, is an excellent system for studying the genetic basis of evolution. Cavefish populations, which independently evolved from surface fish ancestors multiple times, have evolved a number of morphological and behavioral traits. Quantitative trait loci (QTL) analyses have been performed to identify the genetic basis of many of these traits. These studies, combined with recent sequencing of the genome, provide a unique opportunity to identify candidate genes for these cave-specific traits. However, tools to test the requirement of these genes must be established to evaluate the role of candidate genes in generating cave-specific traits. To address this need, we designed transcription activator-like effector nucleases (TALENs) to target two genes that contain coding changes in cavefish relative to surface fish and map to the same location as QTL for pigmentation, oculocutaneous albinism 2 (oca2) and melanocortin 1 receptor (mc1r). We found that surface fish genes can be mutated using this method. TALEN-induced mutations in oca2 result in mosaic loss of melanin pigmentation visible as albino patches in F-0 founder fish, suggesting biallelic gene mutations in F(0)s and allowing us to evaluate the role of this gene in pigmentation. The pigment cells in the albino patches can produce melanin upon treatment with L-DOPA, behaving similarly to pigment cells in albino cavefish and providing additional evidence that oca2 is the gene within the QTL responsible for albinism in cavefish. This technology has the potential to introduce a powerful tool for studying the role of candidate genes responsible for the evolution of cavefish traits.	[Ma, Li; Jeffery, William R.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Essner, Jeffrey J.; Kowalko, Johanna E.] Iowa State Univ, Genet Dev & Cell Biol Dept, Ames, IA 50011 USA	University System of Maryland; University of Maryland College Park; Iowa State University	Essner, JJ (corresponding author), Iowa State Univ, Genet Dev & Cell Biol Dept, Ames, IA 50011 USA.	jessner@iastate.edu		Essner, Jeffrey/0000-0001-8816-3848; Ma, Li/0000-0003-0233-3039	Department of Genetics, Development and Cell Biology at Iowa State University; National Institute of Health grant [R01-EY014619]; National Science Foundation grant [IBN-0542384]; NATIONAL EYE INSTITUTE [R01EY024941, R01EY014619] Funding Source: NIH RePORTER	Department of Genetics, Development and Cell Biology at Iowa State University; National Institute of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation grant(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by the Department of Genetics, Development and Cell Biology at Iowa State University and by National Institute of Health grant R01-EY014619 (WRJ) and National Science Foundation grant IBN-0542384 (WRJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansai S, 2013, GENETICS, V193, P739, DOI 10.1534/genetics.112.147645; Bannister S, 2014, GENETICS, V197, P77, DOI 10.1534/genetics.113.161091; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Bilandzija H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080823; Bilandzija H, 2012, EVOL DEV, V14, P196, DOI 10.1111/j.1525-142X.2012.00535.x; Bitinaite J, 1998, P NATL ACAD SCI USA, V95, P10570, DOI 10.1073/pnas.95.18.10570; Blackburn PR, 2013, ZEBRAFISH, V10, P116, DOI 10.1089/zeb.2013.9999; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; BRILLIANT MH, 1994, PIGM CELL RES, V7, P398, DOI 10.1111/j.1600-0749.1994.tb00068.x; BURCHARDS H, 1985, BEHAV PROCESS, V11, P225, DOI 10.1016/0376-6357(85)90017-8; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; Dong ZJ, 2014, ZEBRAFISH, V11, P265, DOI 10.1089/zeb.2014.0974; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Duboue ER, 2011, CURR BIOL, V21, P671, DOI 10.1016/j.cub.2011.03.020; Elipot Y, 2014, ZEBRAFISH, V11, P291, DOI 10.1089/zeb.2014.1005; Elipot Y, 2013, CURR BIOL, V23, P1, DOI 10.1016/j.cub.2012.10.044; Espinasa L, 2005, BEHAV PROCESS, V70, P144, DOI 10.1016/j.beproc.2005.06.003; Fukamachi S, 2004, GENETICS, V168, P1519, DOI 10.1534/genetics.104.030494; Gross JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055659; Gross JB, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-105; Gross JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000326; Gupta A, 2013, GENOME RES, V23, P1008, DOI 10.1101/gr.154070.112; Hinaux H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053553; Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Kowalko JE, 2013, P NATL ACAD SCI USA, V110, P16933, DOI 10.1073/pnas.1317192110; Kowalko JE, 2013, CURR BIOL, V23, P1874, DOI 10.1016/j.cub.2013.07.056; Lei Y, 2012, P NATL ACAD SCI USA, V109, P17484, DOI 10.1073/pnas.1215421109; Li MH, 2013, ENDOCRINOLOGY, V154, P4814, DOI 10.1210/en.2013-1451; Liu JY, 2012, J GENET GENOMICS, V39, P209, DOI 10.1016/j.jgg.2012.04.003; Liu Y, 2014, METHODS; McCauley DW, 2004, EVOL DEV, V6, P209, DOI 10.1111/j.1525-142X.2004.04026.x; McGaugh SE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6307; Meeker ND, 2007, BIOTECHNIQUES, V43, P610, DOI 10.2144/000112619; Menuet A, 2007, DEVELOPMENT, V134, P845, DOI 10.1242/dev.02780; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; O'Quin KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057281; Parzefall J., 1991, MEM BIOSPEL, V18, P29; Protas ME, 2006, NAT GENET, V38, P107, DOI 10.1038/ng1700; Protas M, 2008, EVOL DEV, V10, P196, DOI 10.1111/j.1525-142X.2008.00227.x; Protas M, 2007, CURR BIOL, V17, P452, DOI 10.1016/j.cub.2007.01.051; R-Core-Team, 2012, R LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; RINCHIK EM, 1993, NATURE, V361, P72, DOI 10.1038/361072a0; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; ROSEMBLAT S, 1994, P NATL ACAD SCI USA, V91, P12071, DOI 10.1073/pnas.91.25.12071; SCHEMMEL C, 1980, Z TIERPSYCHOL, V53, P9; SCHEMMEL C, 1974, Zeitschrift fuer Zoologische Systematik und Evolutionsforschung, V12, P196; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shin J, 2014, DEVELOPMENT, V141, P3807, DOI 10.1242/dev.108019; TEYKE T, 1990, BRAIN BEHAV EVOLUT, V35, P23, DOI 10.1159/000115853; Weber JN, 2013, NATURE, V493, P402, DOI 10.1038/nature11816; WILKENS H, 1988, EVOL BIOL, V23, P271; Yamamoto Y, 2004, NATURE, V431, P844, DOI 10.1038/nature02864; Yoshizawa M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-108; Yoshizawa M, 2010, CURR BIOL, V20, P1631, DOI 10.1016/j.cub.2010.07.017	58	33	34	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119370	10.1371/journal.pone.0119370	http://dx.doi.org/10.1371/journal.pone.0119370			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774757	Green Submitted, Green Published, gold			2022-12-27	WOS:000351183500086
J	Vogl, S; Lutz, RW; Schonfelder, G; Lutz, WK				Vogl, Silvia; Lutz, Roman W.; Schoenfelder, Gilbert; Lutz, Werner K.			CYP2C9 Genotype vs. Metabolic Phenotype for Individual Drug Dosing-A Correlation Analysis Using Flurbiprofen as Probe Drug	PLOS ONE			English	Article							CYTOCHROME-P450 2C9; ALLELIC VARIANT; WARFARIN; POLYMORPHISMS; TOLBUTAMIDE; PHARMACOGENETICS; 4-HYDROXYLATION; ASSOCIATION; IMPACT; RISK	Currently, genotyping of patients for polymorphic enzymes responsible for metabolic elimination is considered a possibility to adjust drug dose levels. For a patient to profit from this procedure, the interindividual differences in drug metabolism within one genotype should be smaller than those between different genotypes. We studied a large cohort of healthy young adults (283 subjects), correlating their CYP2C9 genotype to a simple phenotyping metric, using flurbiprofen as probe drug. Genotyping was conducted for CYP2C9*1, *2, *3. The urinary metabolic ratio MR (concentration of CYP2C9-dependent metabolite divided by concentration of flurbiprofen) determined two hours after flurbiprofen (8.75 mg) administration served as phenotyping metric. Linear statistical models correlating genotype and phenotype provided highly significant allele-specific MR estimates of 0.596 for the wild type allele CYP2C9*1, 0.405 for CYP2C9*2 (68 % of wild type), and 0.113 for CYP2C9*3 (19 % of wild type). If these estimates were used for flurbiprofen dose adjustment, taking 100 % for genotype *1/*1, an average reduction to 84 %, 60 %, 68 %, 43 %, and 19% would result for genotype *1/*2, *1/*3, *2/*2, *2/*3, and *3/*3, respectively. Due to the large individual variation within genotypes with coefficients of variation >= 20% and supposing the normal distribution, one in three individuals would be out of the average optimum dose by more than 20 %, one in 20 would be 40% off. Whether this problem also applies to other CYPs and other drugs has to be investigated case by case. Our data for the given example, however, puts the benefit of individual drug dosing to question, if it is exclusively based on genotype.	[Vogl, Silvia; Schoenfelder, Gilbert; Lutz, Werner K.] Univ Wurzburg, Inst Pharmacol & Toxicol, D-97070 Wurzburg, Germany; [Schoenfelder, Gilbert] Charite, Dept Clin Pharmacol & Toxicol, D-13353 Berlin, Germany; [Lutz, Roman W.] Swiss Fed Inst Technol, Seminar Stat, Zurich, Switzerland; [Schoenfelder, Gilbert] BfR Fed Inst Risk Assessment, Berlin, Germany	University of Wurzburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Swiss Federal Institutes of Technology Domain; ETH Zurich; Federal Institute for Risk Assessment	Vogl, S (corresponding author), Univ Wurzburg, Inst Pharmacol & Toxicol, D-97070 Wurzburg, Germany.	silvia.vogl@charite.de		Schonfelder, Gilbert/0000-0001-6134-1990				Aithal GP, 1999, LANCET, V353, P717, DOI 10.1016/S0140-6736(98)04474-2; Bosilkovska M, 2014, BASIC CLIN PHARMACOL, V115, P465, DOI 10.1111/bcpt.12231; Castellan AC, 2013, CLIN PHARMACOKINET, V52, P199, DOI 10.1007/s40262-013-0031-3; Conrado DJ, 2013, PHARMACOGENOMICS, V14, P215, DOI [10.2217/PGS.12.203, 10.2217/pgs.12.203]; Daali Y, 2012, CLIN PHARMACOL THER, V91, P489, DOI 10.1038/clpt.2011.247; Greenblatt DJ, 2006, J CLIN PHARMACOL, V46, P214, DOI 10.1177/0091270005283465; Greenblatt DJ, 2006, CLIN PHARMACOL THER, V79, P125, DOI 10.1016/j.clpt.2005.09.014; Herman D, 2005, PHARMACOGENOMICS J, V5, P193, DOI 10.1038/sj.tpj.6500308; Kirchheiner J, 2005, CLIN PHARMACOL THER, V77, P1, DOI 10.1016/j.clpt.2004.08.009; Kirchheiner J, 2002, PHARMACOGENETICS, V12, P101, DOI 10.1097/00008571-200203000-00004; Kirchheiner Julia, 2004, Per Med, V1, P63, DOI 10.1517/17410541.1.1.63; Lee CR, 2003, EUR J CLIN PHARMACOL, V58, P791, DOI 10.1007/s00228-003-0574-6; Lee CR, 2003, J CLIN PHARMACOL, V43, P84, DOI 10.1177/0091270002239710; MAGDALOU J, 1990, DRUG METAB DISPOS, V18, P692; Ramsden Diane, 2014, Drug Metab Dispos, V42, P1940, DOI 10.1124/dmd.114.057901; Sanderson S, 2005, GENET MED, V7, P97, DOI 10.1097/01.GIM.0000153664.65759.CF; Sistonen J, 2009, PHARMACOGENET GENOM, V19, P170, DOI 10.1097/FPC.0b013e32831ebb30; Stehle S, 2008, CLIN PHARMACOKINET, V47, P565, DOI 10.2165/00003088-200847090-00002; Subramanian M, 2010, DRUG METAB DISPOS, V38, P1003, DOI 10.1124/dmd.109.030155; Subramanian M, 2009, DRUG METAB DISPOS, V37, P1682, DOI 10.1124/dmd.109.026500; SullivanKlose TH, 1996, PHARMACOGENETICS, V6, P341, DOI 10.1097/00008571-199608000-00007; Temesvari M, 2012, J PHARMACOL EXP THER, V341, P294, DOI 10.1124/jpet.111.189597; Topic E, 2004, CLIN CHEM LAB MED, V42, P72, DOI 10.1515/CCLM.2004.014; TRACY TS, 1995, BIOCHEM PHARMACOL, V49, P1269, DOI 10.1016/0006-2952(95)00048-5; Tracy TS, 1996, BIOCHEM PHARMACOL, V52, P1305, DOI 10.1016/0006-2952(96)00501-1; Tracy TS, 2002, DRUG METAB DISPOS, V30, P385, DOI 10.1124/dmd.30.4.385; Verhoef TI, 2014, BRIT J CLIN PHARMACO, V77, P626, DOI 10.1111/bcp.12220; Wadelius M, 2004, PHARMACOGENOMICS J, V4, P40, DOI 10.1038/sj.tpj.6500220; Wu AHB, 2008, PHARMACOGENOMICS, V9, P169, DOI 10.2217/14622416.9.2.169; Yamazaki H, 1998, BIOCHEM PHARMACOL, V56, P243, DOI 10.1016/S0006-2952(98)00133-6; Zgheib NK, 2007, BRIT J CLIN PHARMACO, V63, P477, DOI 10.1111/j.1365-2125.2006.02781.x; Zgheib NK, 2006, CLIN PHARMACOL THER, V80, P257, DOI 10.1016/j.clpt.2006.06.005; Zhang SY, 2012, MOL PHARMACOL, V82, P529, DOI 10.1124/mol.112.078386; Zhou SF, 2008, CURR DRUG METAB, V9, P738, DOI 10.2174/138920008786049302; Zhou SF, 2010, TOXICOLOGY, V278, P165, DOI 10.1016/j.tox.2009.08.013; Zhou SF, 2009, DRUG METAB REV, V41, P89, DOI 10.1080/03602530902843483	36	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120403	10.1371/journal.pone.0120403	http://dx.doi.org/10.1371/journal.pone.0120403			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775139	Green Published, gold			2022-12-27	WOS:000351183500170
J	Zhang, Q; Sun, TJ; Zhang, YL				Zhang, Qian; Sun, Tongjun; Zhang, Yuelin			ER Quality Control Components UGGT and STT3a Are Required for Activation of Defense Responses in Bir1-1	PLOS ONE			English	Article							RECEPTOR-LIKE KINASE; DEFECTIVE BRASSINOSTEROID RECEPTOR; ENDOPLASMIC-RETICULUM; INNATE IMMUNITY; PLANT IMMUNITY; ARABIDOPSIS; CHAPERONES; RESISTANCE; PROTEINS; BIOGENESIS	The receptor-like kinase SUPPRESSOR OF BIR1, 1 (SOBIR1) functions as a critical regulator in plant immunity. It is required for activation of cell death and defense responses in Arabidopsis bak1-interacting receptor-like kinase 1,1 (bir1-1) mutant plants. Here we report that the ER quality control component UDP-glucose:glycoprotein glucosyltransferase (UGGT) is required for the biogenesis of SOBIR1 and mutations in UGGT suppress the spontaneous cell death and constitutive defense responses in bir1-1. Loss of function of STT3a, which encodes a subunit of the oligosaccharyltransferase complex, also suppresses the autoimmune phenotype in bir1-1. However, it has no effect on the accumulation of SOBIR1, suggesting that additional signaling components other than SOBIR1 may be regulated by ER quality control. Our study provides clear evidence that ER quality control play critical roles in regulating defense activation in bir1-1.	[Zhang, Qian; Sun, Tongjun; Zhang, Yuelin] Univ British Columbia, Dept Bot, Vancouver, BC, Canada	University of British Columbia	Zhang, YL (corresponding author), Univ British Columbia, Dept Bot, Vancouver, BC, Canada.	yuelin.zhang@ubc.ca	Sun, Tongjun/AGV-6839-2022		Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca/index_eng.asp) provided funding for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Bi DL, 2010, PLANT PHYSIOL, V153, P1771, DOI 10.1104/pp.110.158501; Caplan JL, 2009, CELL HOST MICROBE, V6, P457, DOI 10.1016/j.chom.2009.10.005; Dejgaard S, 2004, CURR ISSUES MOL BIOL, V6, P29; Gao MH, 2009, CELL HOST MICROBE, V6, P34, DOI 10.1016/j.chom.2009.05.019; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Jin H, 2007, MOL CELL, V26, P821, DOI 10.1016/j.molcel.2007.05.015; Jin H, 2009, P NATL ACAD SCI USA, V106, P13612, DOI 10.1073/pnas.0906144106; Koiwa H, 2003, PLANT CELL, V15, P2273, DOI 10.1105/tpc.013862; Li J, 2009, P NATL ACAD SCI USA, V106, P15973, DOI 10.1073/pnas.0905532106; Liebrand TWH, 2014, TRENDS PLANT SCI, V19, P123, DOI 10.1016/j.tplants.2013.10.003; Liebrand TWH, 2014, MOL PLANT PATHOL, V15, P109, DOI 10.1111/mpp.12071; Liebrand TWH, 2013, P NATL ACAD SCI USA, V110, P10010, DOI 10.1073/pnas.1220015110; Liebrand TWH, 2012, PLANT PHYSIOL, V159, P1819, DOI 10.1104/pp.112.196741; Liu JM, 2013, PLANT PHYSIOL, V161, P2146, DOI 10.1104/pp.112.212431; Nekrasov V, 2009, EMBO J, V28, P3428, DOI 10.1038/emboj.2009.262; Saijo Y, 2009, EMBO J, V28, P3439, DOI 10.1038/emboj.2009.263; Sun TJ, 2014, PLANT J, V77, P748, DOI 10.1111/tpj.12425; Zhang WG, 2013, PLANT CELL, V25, P4227, DOI 10.1105/tpc.113.117010; Zhang YL, 2003, PLANT CELL, V15, P2647, DOI 10.1105/tpc.014894	20	8	8	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120245	10.1371/journal.pone.0120245	http://dx.doi.org/10.1371/journal.pone.0120245			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775181	gold, Green Published, Green Submitted			2022-12-27	WOS:000351183500161
J	Damalas, D; Maravelias, CD; Osio, GC; Maynou, F; Sbrana, M; Sartor, P				Damalas, Dimitrios; Maravelias, Christos D.; Osio, Giacomo C.; Maynou, Francesc; Sbrana, Mario; Sartor, Paolo			"Once upon a Time in the Mediterranean" Long Term Trends of Mediterranean Fisheries Resources Based on Fishers' Traditional Ecological Knowledge	PLOS ONE			English	Article							JOHN DORY; DEMERSAL; CONSEQUENCES; ANECDOTES; DECLINE; MESH	We investigate long-term changes in the Mediterranean marine resources driving the trawl fisheries by analysing fishers' perceptions (Traditional Ecological Knowledge, TEK) throughout the Mediterranean Sea during the last 80 years. To this end, we conducted an extended set of interviews with experienced fishers that enabled us to classify species (or taxa) as 'decreasing' or 'increasing' both in terms of abundance, as well as average size in the catch. The aspect that most clearly emerged in all the investigated areas over time was the notable increase of fishing capacity indicators, such as engine power and fishing depth range. Atlantic mackerel, poor cod, scorpionfishes, striped seabream, and John Dory demonstrated a decreasing trend in the fishers' perceived abundance, while Mediterranean parrotfish, common pandora, cuttlefish, blue and red shrimp, and mullets gave indications of an increasing temporal trend. Although, as a rule, trawler captains did not report any cataclysmic changes (e.g. extinctions), when they were invited to estimate total catches, a clear decreasing pattern emerged; this being a notable finding taking into account the steep escalation of fishing efficiency during the past century. The overall deteriorating status of stocks in most Mediterranean regions calls for responsible management and design of rebuilding plans. This should include historical information accounting for past exploitation patterns that could help defining a baseline of fish abundance prior to heavy industrial fisheries exploitation.	[Damalas, Dimitrios; Osio, Giacomo C.] European Commiss, Joint Res Ctr, Inst Protect & Secur Citizen, Fisheries & Aquaculture Sect,Maritime Affairs Uni, Via E Fermi 2749, I-21027 Ispra, Italy; [Damalas, Dimitrios; Maravelias, Christos D.] Hellen Ctr Marine Res, Anavissos 19013, Attica, Greece; [Maynou, Francesc] CSIC, Inst Ciencias Mar, E-08003 Barcelona, Spain; [Sbrana, Mario; Sartor, Paolo] Consorzio Ctr Interuniv Biol Marina Ecol Applicat, I-57128 Livorno, Italy	European Commission Joint Research Centre; EC JRC ISPRA Site; Hellenic Centre for Marine Research; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM)	Damalas, D (corresponding author), European Commiss, Joint Res Ctr, Inst Protect & Secur Citizen, Fisheries & Aquaculture Sect,Maritime Affairs Uni, Via E Fermi 2749, I-21027 Ispra, Italy.	shark@hcmr.gr	Maravelias, Christos/W-4151-2019; Maynou, Francesc/A-6433-2011	Maynou, Francesc/0000-0001-7200-6485; Maravelias, Christos/0000-0002-2440-3707; SARTOR, PAOLO/0000-0001-7239-8255; Sbrana, Mario/0000-0002-9562-8372	European Commission [MARE/2008/11: Lot 4]	European Commission(European CommissionEuropean Commission Joint Research Centre)	The data acquisition was supported by the European Commission through project EVOMED ("The 20th Century evolution of Mediterranean exploited demersal resources under increasing fishing disturbance and environmental change" (no MARE/2008/11: Lot 4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Audzijonyte A, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1103; Azzurro E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024885; Bahamon N, 2006, FISH RES, V81, P15, DOI 10.1016/j.fishres.2006.05.020; Berthelot S, 1868, ETUDE PECHES MARITIM, DOI [10.1542/peds.2010-2442, DOI 10.1542/PEDS.2010-2442]; Bertrand JA, 2002, SCI MAR, V66, P9, DOI 10.3989/scimar.2002.66s29; Boudreau SA, 2010, MAR ECOL PROG SER, V403, P181, DOI 10.3354/meps08473; Briand F., 2008, CIESM WORKSHOP MONOG, V33, P168; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cardinale M, 2013, DG MARE EC 17 SEPT; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Coll M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003881; Collette B, IUCN 2013 IUCN RED L; Colloca F, 2013, FISH FISH, V14, P89, DOI 10.1111/j.1467-2979.2011.00453.x; Cortes-Sanchez M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024026; Damalas D, 2014, REV FISH SCI AQUAC, V22, P112, DOI 10.1080/10641262.2013.839620; Desse J, 1994, FOUILLES RECENTES KH, P335; Dunn MR, 2001, ICES J MAR SCI, V58, P96, DOI 10.1006/jmsc.2000.0993; EC (European Commission), 2008, OFFICIAL J EUROPEA L, V60; EC (European Commission), 2000, OFFICIAL J EUROPEA L, V176; FAO, 2014, GLOB PROD STAT 1950; Farrugio H, 1993, SCI MAR, V57, P105; Ferretti F, 2008, CONSERV BIOL, V22, P952, DOI 10.1111/j.1523-1739.2008.00938.x; Ferretti F, 2010, ECOL LETT, V13, P1055, DOI 10.1111/j.1461-0248.2010.01489.x; Fortibuoni T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015502; Haedrich RL, 1997, FISH RES, V31, P229, DOI 10.1016/S0165-7836(97)00023-4; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Joutard P, 1983, HIST ED, V25, P137; Jukic-Peladic S, 2001, FISH RES, V53, P95, DOI 10.1016/S0165-7836(00)00232-0; Katsanevakis S, 2009, FISH OCEANOGR, V18, P439, DOI 10.1111/j.1365-2419.2009.00523.x; Lleonart J, 2003, SCI MAR, V67, P37, DOI 10.3989/scimar.2003.67s137; Lotze HK, 2011, ECOSYSTEMS, V14, P198, DOI 10.1007/s10021-010-9404-8; Lozano JA, 1993, HIST ORAL; Matta F, 1958, B PESCA PISC IDROBIO, VXXXIV; Matta F, 1954, B PESCA PISCIC IDROB, P9; Maynou F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021818; McClenachan L, 2009, CONSERV BIOL, V23, P636, DOI 10.1111/j.1523-1739.2008.01152.x; Morato T, 2006, FISH FISH, V7, P24, DOI 10.1111/j.1467-2979.2006.00205.x; NHRF, 2010, FISH GREEK SEAS; Osio GC., 2012, THESIS; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Saenz-Arroyo A, 2005, FISH FISH, V6, P121, DOI 10.1111/j.1467-2979.2005.00185.x; Sala A, 2008, FISH RES, V93, P8, DOI 10.1016/j.fishres.2008.02.003; Sanez-Reguart A, 1795, DICCIONARIO HIST ART, V5; Sarda Francesc, 2003, Journal of Northwest Atlantic Fishery Science, V31, P127; Sartor P, 2011, SI2539097; Swartz W, 2011, PLOS ONE, V5; Vasilakopoulos P, 2014, CURR BIOL, V24, P1643, DOI 10.1016/j.cub.2014.05.070; Venables WN, 2004, FISH RES, V70, P319, DOI 10.1016/j.fishres.2004.08.011; Vrgoc N, 2006, J APPL ICHTHYOL, V22, P205, DOI 10.1111/j.1439-0426.2006.00733.x; Wood S., 2011, R PACKAGE VERSION, V0, P1; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279	52	21	22	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119330	10.1371/journal.pone.0119330	http://dx.doi.org/10.1371/journal.pone.0119330			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781459	Green Published, gold, Green Submitted			2022-12-27	WOS:000351284600060
J	Kathuria, S; Sharma, C; Singh, PK; Agarwal, P; Agarwal, K; Hagen, F; Meis, JF; Chowdhary, A				Kathuria, Shallu; Sharma, Cheshta; Singh, Pradeep Kumar; Agarwal, Puneet; Agarwal, Kshitij; Hagen, Ferry; Meis, Jacques F.; Chowdhary, Anuradha			Molecular Epidemiology and In-Vitro Antifungal Susceptibility of Aspergillus terreus Species Complex Isolates in Delhi, India: Evidence of Genetic Diversity by Amplified Fragment Length Polymorphism and Microsatellite Typing	PLOS ONE			English	Article							EMERGING FUNGAL PATHOGEN; AMPHOTERICIN-B; MIC DISTRIBUTIONS; CUTOFF VALUES; FUMIGATUS; INFECTIONS; SPP.; VORICONAZOLE; RESISTANCE; PATIENT	Aspergillus terreus is emerging as an etiologic agent of invasive aspergillosis in immuno-compromised individuals in several medical centers in the world. Infections due to A. terreus are of concern due to its resistance to amphotericin B, in vivo and in vitro, resulting in poor response to antifungal therapy and high mortality. Herein we examined a large collection of molecularly characterized, geographically diverse A. terreus isolates (n = 140) from clinical and environmental sources in India for the occurrence of cryptic A. terreus species. The population structure of the Indian A. terreus isolates and their association with those outside India was determined using microsatellite based typing (STR) technique and Amplified Fragment Length Polymorphism analysis (AFLP). Additionally, in vitro antifungal susceptibility of A. terreus isolates was determined against 7 antifungals. Sequence analyses of the calmodulin locus identified the recently described cryptic species A. hortai, comprising 1.4% of Aspergillus section Terrei isolates cultured from cases of aspergilloma and probable invasive aspergillosis not reported previously. All the nine markers used for STR typing of A. terreus species complex proved to be highly polymorphic. The presence of high genetic diversity revealing 75 distinct genotypes among 101 Indian A. terreus isolates was similar to the marked heterogeneity noticed in the 47 global A. terreus population exhibiting 38 unique genotypes mainly among isolates from North America and Europe. Also, AFLP analysis showed distinct banding patterns for genotypically diverse A. terreus isolates. Furthermore, no correlation between a particular genotype and amphotericin B susceptibility was observed. Overall, 8% of the A. terreus isolates exhibited low MICs of amphotericin B. All the echinocandins and azoles (voriconazole, posaconazole and isavuconazole) demonstrated high potency against all the isolates. The study emphasizes the need of molecular characterization of A. terreus species complex isolates to better understand the ecology, acquisition and transmission of this species.	[Kathuria, Shallu; Sharma, Cheshta; Singh, Pradeep Kumar; Chowdhary, Anuradha] Univ Delhi, Vallabhbhai Patel Chest Inst, Dept Med Mycol, Delhi 110007, India; [Agarwal, Puneet] Univ Delhi, Vallabhbhai Patel Chest Inst, Dept Pulm Med, Delhi 110007, India; [Agarwal, Kshitij] Rajan Babu Inst Pulm Med & TB, Dept Pulm Med, Delhi, India; [Hagen, Ferry; Meis, Jacques F.] Canisius Wilhelmina Hosp, Dept Med Microbiol & Infect Dis, Nijmegen, Netherlands; [Meis, Jacques F.] Radboudumc, Dept Med Microbiol, Nijmegen, Netherlands	University of Delhi; University of Delhi; Canisius-Wilhelmina Hospital; Radboud University Nijmegen	Chowdhary, A (corresponding author), Univ Delhi, Vallabhbhai Patel Chest Inst, Dept Med Mycol, Delhi 110007, India.	dranuradha@hotmail.com	Meis, Jacques F/A-9241-2010; Sharma, Cheshta/J-7966-2019; Kathuria, Shallu/AAN-5835-2020; Hagen, Ferry/B-9044-2009; Chowdhary, Anuradha/ABF-1252-2020	Meis, Jacques F/0000-0003-3253-6080; Hagen, Ferry/0000-0002-5622-1916; Chowdhary, Anuradha/0000-0002-2028-7462; Singh, Pradeep Kumar/0000-0003-1492-598X; Sharma, Cheshta/0000-0003-3216-263X	Astellas; Basilea; Merck; University Grants Commission Research fellowship, Delhi, India [F.2-15/2003 SA-I]	Astellas(Astellas Pharmaceuticals); Basilea; Merck(Merck & Company); University Grants Commission Research fellowship, Delhi, India	JFM received grants from Astellas, Basilea and Merck. CS is supported by a University Grants Commission Research fellowship (F.2-15/2003 SA-I), Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arabatzis M, 2013, MYCOLOGIA, V105, P71, DOI 10.3852/11-426; Arendrup MC, 2012, J INFECT DIS, V206, P981, DOI 10.1093/infdis/jis442; Ascioglu S, 2002, CLIN INFECT DIS, V34, P7, DOI 10.1086/323335; Auberger J, 2008, DIAGN MICR INFEC DIS, V62, P336, DOI 10.1016/j.diagmicrobio.2008.06.012; Baddley JW, 2003, J CLIN MICROBIOL, V41, P5525, DOI 10.1128/JCM.41.12.5525-5529.2003; Bain JM, 2007, J CLIN MICROBIOL, V45, P1469, DOI 10.1128/JCM.00064-07; Balajee SA, 2009, EUKARYOT CELL, V8, P713, DOI 10.1128/EC.00272-08; Blum G, 2008, CLIN MICROBIOL INFEC, V14, P1146, DOI 10.1111/j.1469-0691.2008.02099.x; Chazalet V, 1998, J CLIN MICROBIOL, V36, P1494, DOI 10.1128/JCM.36.6.1494-1500.1998; Chowdhary A, 2013, MYCOSES, V56, P1, DOI 10.1111/j.1439-0507.2012.02190.x; Chowdhary A, 2014, FUTURE MICROBIOL, V9, P697, DOI 10.2217/fmb.14.27; Chowdhary A, 2014, CRIT REV MICROBIOL, V40, P30, DOI 10.3109/1040841X.2012.754401; Chowdhary A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052871; Chowdhary A, 2013, J CLIN MICROBIOL, V51, P585, DOI 10.1128/JCM.02943-12; Clinical and Laboratory Standards Institute (CLSI), 2008, CLSI DOCUMENT M38 A2; de Valk HA, 2007, J CLIN MICROBIOL, V45, P1415, DOI 10.1128/JCM.02423-06; Denning DW, 2013, MED MYCOL, V51, P361, DOI 10.3109/13693786.2012.738312; DESHAZO RD, 1995, J ALLERGY CLIN IMMUN, V96, P24, DOI 10.1016/S0091-6749(95)70029-3; Espinel-Ingroff A, 2011, ANTIMICROB AGENTS CH, V55, P5150, DOI 10.1128/AAC.00686-11; Espinel-Ingroff A, 2011, ANTIMICROB AGENTS CH, V55, P2855, DOI 10.1128/AAC.01730-10; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Hachem R, 2014, J ANTIMICROB CHEMOTH, V69, P3148, DOI 10.1093/jac/dku241; Hadrich I, 2013, MED MYCOL, V51, P586, DOI 10.3109/13693786.2012.761359; Hong SB, 2005, MYCOLOGIA, V97, P1316, DOI 10.3852/mycologia.97.6.1316; Klaassen CHW, 2012, MOL ECOL, V21, P57, DOI 10.1111/j.1365-294X.2011.05364.x; LANGERON Maurice, 1922, Bulletin de la Societe de Pathologie Exotique, V15, P383; Lass-Florl C, 2007, J CLIN MICROBIOL, V45, P2686, DOI 10.1128/JCM.00917-07; Lass-Florl C, 2009, ANTIMICROB AGENTS CH, V53, P794, DOI 10.1128/AAC.00335-08; Lass-Florl C, 2000, J HOSP INFECT, V46, P31, DOI 10.1053/jhin.2000.0799; Lass-Florl C, 2005, BRIT J HAEMATOL, V131, P201, DOI 10.1111/j.1365-2141.2005.05763.x; Maertens J, 2004, BRIT J HAEMATOL, V126, P852, DOI 10.1111/j.1365-2141.2004.05140.x; Mutschlechner W, 2013, MED MYCOL, V51, P876, DOI 10.3109/13693786.2013.793458; Neal COS, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-203; Pfaller M, 2011, J CLIN MICROBIOL, V49, P586, DOI 10.1128/JCM.02136-10; Pfaller MA, 2002, ANTIMICROB AGENTS CH, V46, P1032, DOI 10.1128/AAC.46.4.1032-1037.2002; Pringle A, 2005, EVOLUTION, V59, P1886, DOI 10.1111/j.0014-3820.2005.tb01059.x; Raper KB, 1965, THE GENUS ASPERGILLU; Rougeron A, 2014, CLIN MICROBIOL INFEC, V20, P327, DOI 10.1111/1469-0691.12323; Ruping MJGT, 2011, J HOSP INFECT, V78, P226, DOI 10.1016/j.jhin.2011.01.020; Rydholm C, 2006, EUKARYOT CELL, V5, P650, DOI 10.1128/EC.5.4.650-657.2006; Salas V, 2013, ANTIMICROB AGENTS CH, V57, P1532, DOI 10.1128/AAC.01436-12; Salas V, 2011, ANTIMICROB AGENTS CH, V55, P676, DOI 10.1128/AAC.00736-10; Samson RA, 2011, STUD MYCOL, P39, DOI 10.3114/sim.2011.69.04; Steinbach WJ, 2004, ANTIMICROB AGENTS CH, V48, P3217, DOI 10.1128/AAC.48.9.3217-3225.2004; Sutton DA, 1999, J CLIN MICROBIOL, V37, P2343, DOI 10.1128/JCM.37.7.2343-2345.1999; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tortorano AM, 2008, J CHEMOTHERAPY, V20, P756, DOI 10.1179/joc.2008.20.6.756; Verweij PE, 1996, J CLIN MICROBIOL, V34, P2595, DOI 10.1128/JCM.34.10.2595-2597.1996; Walsh TJ, 2003, J INFECT DIS, V188, P305, DOI 10.1086/377210	49	44	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0118997	10.1371/journal.pone.0118997	http://dx.doi.org/10.1371/journal.pone.0118997			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781896	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600042
J	Li, H; Guo, XX; Wang, CY; Ji, WQ				Li, Hao; Guo, Xiaoxue; Wang, Changyou; Ji, Wanquan			Spontaneous and Divergent Hexaploid Triticales Derived from Common Wheat x Rye by Complete Elimination of D-Genome Chromosomes	PLOS ONE			English	Article							OCTOPLOID TRITICALE; CYTOSINE METHYLATION; SECALE-CEREALE; ALLOPOLYPLOIDS; POLYPLOIDY; EVOLUTION; GLUTENIN; CULTIVARS; RESPONSES; HYBRIDS	Background Hexaploid triticale could be either synthesized by crossing tetraploid wheat with rye, or developed by crossing hexaploid wheat with a hexaploid triticale or an octoploid triticale. Methodology/Principal Findings Here two hexaploid triticales with great morphologic divergence derived from common wheat cultivar M8003 (Triticum aestivum L.) x Austrian rye (Secale cereale L.) were reported, exhibiting high resistance for powdery mildew and stripe rust and potential for wheat improvement. Sequential fluorescence in situ hybridization (FISH) and genomic in situ hybridization (GISH) karyotyping revealed that D-genome chromosomes were completely eliminated and the whole A-genome, B-genome and R-genome chromosomes were retained in both lines. Furthermore, plentiful alterations of wheat chromosomes including 5A and 7B were detected in both triticales and additionally altered 5B, 7A chromosome and restructured chromosome 2A was assayed in N9116H and N9116M, respectively, even after selfing for several decades. Besides, meiotic asynchrony was displayed and a variety of storage protein variations were assayed, especially in the HMW/LMW-GS region and secalins region in both triticales. Conclusion This study confirms that whole D-genome chromosomes could be preferentially eliminated in the hybrid of common wheat x rye, "genome shock" was accompanying the allopolyploidization of nascent triticales, and great morphologic divergence might result from the genetic variations. Moreover, new hexaploid triticale lines contributing potential resistance resources for wheat improvement were produced.	[Li, Hao; Guo, Xiaoxue; Wang, Changyou; Ji, Wanquan] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Li, Hao; Guo, Xiaoxue; Wang, Changyou; Ji, Wanquan] Northwest A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Ji, WQ (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.; Ji, WQ (corresponding author), Northwest A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China.	chywang2004@126.com; jiwanquan2008@126.com		LI, HAO/0000-0001-8271-9163	Key Technologies RAMP;D Program of China [2013BAD01B02-6]; National Basic Research 973 Program of China [2011CB944601]; Zhongying Tang Foundation of USA	Key Technologies RAMP;D Program of China; National Basic Research 973 Program of China(National Basic Research Program of China); Zhongying Tang Foundation of USA	This work was supported by Key Technologies R&D Program of China (grant number 2013BAD01B02-6), the National Basic Research 973 Program of China (grant number 2011CB944601) and Zhongying Tang Foundation of USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiour N, 2002, EUPHYTICA, V123, P295, DOI 10.1023/A:1015092613786; Bento M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001402; Cheng ZJ, 2002, GENES GENET SYST, V77, P23, DOI 10.1266/ggs.77.23; De Bustos A, 2003, THEOR APPL GENET, V107, P74, DOI 10.1007/s00122-003-1234-z; Dennett AL, 2013, EUPHYTICA, V194, P235, DOI 10.1007/s10681-013-0950-y; Dou QW, 2006, THEOR APPL GENET, V114, P41, DOI 10.1007/s00122-006-0408-x; Feuillet C, 2008, TRENDS GENET, V24, P24, DOI 10.1016/j.tig.2007.11.001; FOX PN, 1990, EUPHYTICA, V47, P57, DOI 10.1007/BF00040364; Fu DL, 2009, SCIENCE, V323, P1357, DOI 10.1126/science.1166289; Guedes-Pinto H., 1996, TRITICALE TODAY TOMO; Han FP, 2006, P NATL ACAD SCI USA, V103, P3238, DOI 10.1073/pnas.0509650103; Han FP, 2003, GENOME, V46, P716, DOI [10.1139/g03-049, 10.1139/G03-049]; Han FP, 2005, GENETICS, V170, P1239, DOI 10.1534/genetics.104.039263; Hao M, 2013, EUPHYTICA, V193, P347, DOI 10.1007/s10681-013-0930-2; Kalinka A, 2010, NUCLEUS CALCUTTA, V53, P69, DOI 10.1007/s13237-010-0002-0; Li H, 2014, GENOME, V57, P89, DOI 10.1139/gen-2013-0153; Liu B, 2001, GENOME, V44, P321, DOI 10.1139/gen-44-3-321; Lukaszewski A. J., 1987, Plant Breeding Reviews, V5, P41; LUKASZEWSKI AJ, 1983, THEOR APPL GENET, V64, P239, DOI 10.1007/BF00303771; Lukens LN, 2006, PLANT PHYSIOL, V140, P336, DOI 10.1104/pp.105.066308; Ma XF, 2004, GENOME, V47, P839, DOI [10.1139/g04-051, 10.1139/G04-051]; Ma XF, 2005, CYTOGENET GENOME RES, V109, P236, DOI 10.1159/000082406; Ma XF, 2008, ANN BOT-LONDON, V101, P825, DOI 10.1093/aob/mcm331; Madlung A, 2005, PLANT J, V41, P221, DOI 10.1111/j.1365-313X.2004.02297.x; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; MCINTYRE CL, 1990, GENOME, V33, P635, DOI 10.1139/g90-094; Mikhailova L. A., 2009, Russian Agricultural Sciences, V35, P320, DOI 10.3103/S1068367409050097; Muntzing A., 1979, FORTSCHRITTE PFLANZE; MUNTZING A, 1963, P 2 INT WHEAT GEN S, V2, P291; NAKAGOSHI N, 1984, Journal of Science of the Hiroshima University Series B Division 2 (Botany), V19, P1; Oettler G, 2005, J AGR SCI-CAMBRIDGE, V143, P329, DOI 10.1017/S0021859605005290; Otto SP, 2007, CELL, V131, P452, DOI 10.1016/j.cell.2007.10.022; Salmanowicz BP, 2007, J APPL GENET, V48, P347, DOI 10.1007/BF03195231; Sasaki M, 1985, P 15 INT GRASSL C KY, P253; SCOLES GJ, 1974, Z PFLANZENZUCHT, V73, P13; Shaked H, 2001, PLANT CELL, V13, P1749, DOI 10.1105/tpc.13.8.1749; Soltis DE, 2009, AM J BOT, V96, P336, DOI 10.3732/ajb.0800079; Tang ZX, 2008, GENOME, V51, P399, DOI 10.1139/G08-027; Tang ZX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110282; Tang ZX, 2014, J APPL GENET, V55, P313, DOI 10.1007/s13353-014-0215-z; Tang ZX, 2012, J PLANT RES, V125, P283, DOI 10.1007/s10265-011-0432-z; Udall JA, 2006, CROP SCI, V46, pS3, DOI 10.2135/cropsci2006.07.0489tpg; WEIMARCK A, 1974, HEREDITAS, V77, P281; Wicker T, 2013, NAT GENET, V45, P1092, DOI 10.1038/ng.2704; Yuan ZW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023511; Zhang HK, 2013, P NATL ACAD SCI USA, V110, P19466, DOI 10.1073/pnas.1319598110; Zhang HK, 2013, P NATL ACAD SCI USA, V110, P3447, DOI 10.1073/pnas.1300153110; Zhao JX, 2010, GENET RESOUR CROP EV, V57, P387, DOI 10.1007/s10722-009-9477-4; Zhou JP, 2012, GENET RESOUR CROP EV, V59, P1161, DOI 10.1007/s10722-011-9751-0	49	19	22	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120421	10.1371/journal.pone.0120421	http://dx.doi.org/10.1371/journal.pone.0120421			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781330	Green Submitted, Green Published, gold			2022-12-27	WOS:000351284600159
J	Marno, H; Csibra, G				Marno, Hanna; Csibra, Gergely			Toddlers Favor Communicatively Presented Information over Statistical Reliability in Learning about Artifacts	PLOS ONE			English	Article							ADAPTATION; COGNITION; PEDAGOGY	Observed associations between events can be validated by statistical information of reliability or by testament of communicative sources. We tested whether toddlers learn from their own observation of efficiency, assessed by statistical information on reliability of interventions, or from communicatively presented demonstration, when these two potential types of evidence of validity of interventions on a novel artifact are contrasted with each other. Eighteen-month-old infants observed two adults, one operating the artifact by a method that was more efficient (2/3 probability of success) than that of the other (1/3 probability of success). Compared to the Baseline condition, in which communicative signals were not employed, infants tended to choose the less reliable method to operate the artifact when this method was demonstrated in a communicative manner in the Experimental condition. This finding demonstrates that, in certain circumstances, communicative sanctioning of reliability may override statistical evidence for young learners. Such a bias can serve fast and efficient transmission of knowledge between generations.	[Marno, Hanna] SISSA, Language Cognit & Dev Lab, I-34014 Trieste, Italy; [Csibra, Gergely] Cent European Univ, Cognit Dev Ctr, Budapest, Hungary; [Csibra, Gergely] Univ London, Dept Psychol Sci, London, England	International School for Advanced Studies (SISSA); Central European University; University of London	Marno, H (corresponding author), SISSA, Language Cognit & Dev Lab, I-34014 Trieste, Italy.	hanna.marno@gmail.com	Csibra, Gergely/C-4345-2008; Marno, Hanna/AFT-8847-2022	Csibra, Gergely/0000-0002-7044-3056; Marno, Hanna/0000-0003-2509-267X	Advance Investigator Grant (OSTREFCOM) from the European Research Council	Advance Investigator Grant (OSTREFCOM) from the European Research Council	This work was supported by an Advance Investigator Grant (OSTREFCOM) from the European Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brugger A, 2007, CHILD DEV, V78, P806, DOI 10.1111/j.1467-8624.2007.01034.x; Csibra G, 2006, ATTENTION PERFORM, P249; Csibra G, 2011, PHILOS T R SOC B, V366, P1149, DOI 10.1098/rstb.2010.0319; Csibra G, 2009, TRENDS COGN SCI, V13, P148, DOI 10.1016/j.tics.2009.01.005; Fiser J, 2010, TRENDS COGN SCI, V14, P119, DOI 10.1016/j.tics.2010.01.003; Gergely C, 2010, MIND LANG, V25, P141; Griffiths TL, 2007, PSYCHOL REV, V114, P211, DOI 10.1037/0033-295X.114.2.211; Griffiths TL, 2006, PSYCHOL SCI, V17, P767, DOI 10.1111/j.1467-9280.2006.01780.x; Hernik M, 2009, CURR OPIN NEUROBIOL, V19, P34, DOI 10.1016/j.conb.2009.05.003; Kiraly I, 2013, J EXP CHILD PSYCHOL, V116, P471, DOI 10.1016/j.jecp.2012.12.003; Kushnir T, 2005, PSYCHOL SCI, V16, P678, DOI 10.1111/j.1467-9280.2005.01595.x; Nielsen M, 2006, DEV PSYCHOL, V42, P555, DOI 10.1037/0012-1649.42.3.555; Tenenbaum JB, 2011, SCIENCE, V331, P1279, DOI 10.1126/science.1192788; Tomasello M, 1999, ANNU REV ANTHROPOL, V28, P509, DOI 10.1146/annurev.anthro.28.1.509; Waismeyer A, 2015, DEVELOPMENTAL SCI, V18, P175, DOI 10.1111/desc.12208	15	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0122129	10.1371/journal.pone.0122129	http://dx.doi.org/10.1371/journal.pone.0122129			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7QC	25780917	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000351284600216
J	Toufaily, C; Lokossou, AG; Vargas, A; Rassart, E; Barbeau, B				Toufaily, Chirine; Lokossou, Adjimon Gatien; Vargas, Amandine; Rassart, Eric; Barbeau, Benoit			A CRE/AP-1-Like Motif Is Essential for Induced Syncytin-2 Expression and Fusion in Human Trophoblast-Like Model	PLOS ONE			English	Article							ACTIVATING TRANSCRIPTION FACTOR-4; HUMAN PLACENTA; HERV-W; ENV GLYCOPROTEIN; ENVELOPE PROTEIN; RECEPTOR ASCT2; CELL-FUSION; BEWO CELLS; IN-VIVO; GENE	Syncytin-2 is encoded by the envelope gene of Endogenous Retrovirus-FRD (ERVFRD-1) and plays a critical role in fusion of placental trophoblasts leading to the formation of the multinucleated syncytiotrophoblast. Its expression is consequently regulated in a strict manner. In the present study, we have identified a forskolin-responsive region located between positions -300 to -150 in the Syncytin-2 promoter region. This 150 bp region in the context of a minimal promoter mediated an 80-fold induction of promoter activity following forskolin stimulation. EMSA analyses with competition experiments with nuclear extracts from for-skolin-stimulated BeWo cells demonstrated that the -211 to -177 region specifically bound two forskolin-induced complexes, one of them containing a CRE/AP-1-like motif. Site-directed mutagenesis of the CRE/AP-1 binding site in the context of the Syncytin-2 promoter or a heterologous promoter showed that this motif was mostly essential for forskolin-induced promoter activity. Transfection experiments with dominant negative mutants and constitutively activated CREB expression vectors in addition to Chromatin Immunoprecipitation suggested that a CREB family member, CREB2 was binding and acting through the CRE/AP-1 motif. We further demonstrated the binding of JunD to this same motif. Similar to forskolin and soluble cAMP, CREB2 and JunD overexpression induced Syncytin-2 promoter activity in a CRE/AP-1-dependent manner and Syncytin-2 expression. In addition, BeWo cell fusion was induced by both CREB2 and JunD overexpression, while being repressed following silencing of either gene. These results thereby demonstrate that induced expression of Syncytin-2 is highly dependent on the interaction of bZIP-containing transcription factors to a CRE/AP-1 motif and that this element is important for the regulation of Syncytin-2 expression, which results in the formation of the peripheral syncytiotrophoblast layer.	[Barbeau, Benoit] Univ Quebec, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada; Univ Quebec, Ctr Rech BioMed, Montreal, PQ H3C 3P8, Canada	University of Quebec; University of Quebec Montreal; University of Quebec; University of Quebec Montreal	Barbeau, B (corresponding author), Univ Quebec, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada.	barbeau.benoit@uqam.ca	Barbeau, Benoit/A-1174-2010; LOKOSSOU, Gatien Adjimon/J-7008-2015	Barbeau, Benoit/0000-0002-4108-8155; LOKOSSOU, Gatien Adjimon/0000-0001-7269-7183; Toufaily, Chirine/0000-0002-6845-141X	National Sciences and Engineering Research Council of Canada (NSERC) [298527]; institutional FARE scholarship; NSERC Graham Bell Ph.D. scholarship; Canada Research Chair in Human Retrovirology	National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); institutional FARE scholarship; NSERC Graham Bell Ph.D. scholarship; Canada Research Chair in Human Retrovirology	This work was supported by a grant from the National Sciences and Engineering Research Council of Canada (NSERC) (#298527) (BB). CT was supported by an institutional FARE scholarship. AV was supported by a NSERC Graham Bell Ph.D. scholarship. BB holds a Canada Research Chair in Human Retrovirology (Tier 2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameri K, 2008, INT J BIOCHEM CELL B, V40, P14, DOI 10.1016/j.biocel.2007.01.020; Baczyk D, 2009, CELL DEATH DIFFER, V16, P719, DOI 10.1038/cdd.2009.1; Bai H, 2009, MOL REPROD DEV, V76, P1143, DOI 10.1002/mrd.21082; Bamberger AM, 2004, MOL HUM REPROD, V10, P223, DOI 10.1093/molehr/gah011; Blaise S, 2004, J VIROL, V78, P1050, DOI 10.1128/JVI.78.2.1050-1054.2004; Blaise S, 2003, P NATL ACAD SCI USA, V100, P13013, DOI 10.1073/pnas.2132646100; Blond JL, 2000, J VIROL, V74, P3321, DOI 10.1128/JVI.74.7.3321-3329.2000; Blond JL, 1999, J VIROL, V73, P1175, DOI 10.1128/JVI.73.2.1175-1185.1999; Caselli E, 2012, AIDS RES HUM RETROV, V28, P907, DOI [10.1089/AID.2011.0252, 10.1089/aid.2011.0252]; Chang CW, 2005, MOL CELL BIOL, V25, P8401, DOI 10.1128/MCB.25.19.8401-8414.2005; Chen CP, 2008, BIOL REPROD, V79, P815, DOI 10.1095/biolreprod.108.069765; Chen CP, 2006, BJOG-INT J OBSTET GY, V113, P152, DOI 10.1111/j.1471-0528.2005.00843.x; Cheng YH, 2005, BIOL REPROD, V73, P500, DOI 10.1095/biolreprod.105.039941; Cheng YH, 2004, BIOL REPROD, V70, P694, DOI 10.1095/biolreprod.103.023473; CHEVRAY PM, 1992, P NATL ACAD SCI USA, V89, P5789, DOI 10.1073/pnas.89.13.5789; Daoud G, 2005, J PHYSIOL-LONDON, V566, P409, DOI 10.1113/jphysiol.2005.089326; Delidaki M, 2011, MOL CELL ENDOCRINOL, V332, P213, DOI 10.1016/j.mce.2010.10.013; Du KY, 2000, MOL CELL BIOL, V20, P4320, DOI 10.1128/MCB.20.12.4320-4327.2000; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; Esnault C, 2008, P NATL ACAD SCI USA, V105, P17532, DOI 10.1073/pnas.0807413105; Frendo JL, 2003, MOL CELL BIOL, V23, P3566, DOI 10.1128/MCB.23.10.3566-3574.2003; Gachon F, 1998, J VIROL, V72, P8332, DOI 10.1128/JVI.72.10.8332-8337.1998; Gimenez J, 2009, DNA RES, V16, P195, DOI 10.1093/dnares/dsp011; GONZALEZ GA, 1991, MOL CELL BIOL, V11, P1306, DOI 10.1128/MCB.11.3.1306; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; Handwerger S, 2000, J PEDIATR ENDOCR MET, V13, P343, DOI 10.1515/JPEM.2000.13.4.343; Keith JC, 2002, AM J OBSTET GYNECOL, V187, P1122, DOI 10.1067/mob.2002.128512; Knerr I, 2002, AM J OBSTET GYNECOL, V186, P210, DOI 10.1067/mob.2002.119636; Knerr I, 2005, FEBS LETT, V579, P3991, DOI 10.1016/j.febslet.2005.06.029; Knerr I, 2003, AM J OBSTET GYNECOL, V189, P583, DOI 10.1067/S0002-9378(03)00538-6; Knerr I, 2004, MOL HUM REPROD, V10, P581, DOI 10.1093/molehr/gah070; Kudaka W, 2008, PLACENTA, V29, P282, DOI 10.1016/j.placenta.2007.11.009; Kudo Y, 2002, PLACENTA, V23, P536, DOI 10.1053/plac.2002.0839; Lacroix MC, 2002, ENDOCRINE, V19, P73, DOI 10.1385/ENDO:19:1:73; Langbein M, 2008, MOL REPROD DEV, V75, P175, DOI 10.1002/mrd.20729; Langlois M, 2004, VIROLOGY, V329, P395, DOI 10.1016/j.virol.2004.09.003; Lee X, 2001, PLACENTA, V22, P808, DOI 10.1053/plac.2001.0722; Liang CY, 2010, BIOL REPROD, V83, P387, DOI 10.1095/biolreprod.110.083915; Malassine A, 2007, PLACENTA, V28, P185, DOI 10.1016/j.placenta.2006.03.001; Malassine A, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-6; Mameli G, 2007, VIROLOGY, V362, P120, DOI 10.1016/j.virol.2006.12.019; Marin M, 2003, J VIROL, V77, P2936, DOI 10.1128/JVI.77.5.2936-2945.2003; Matouskova M, 2006, EXP CELL RES, V312, P1011, DOI 10.1016/j.yexcr.2005.12.010; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; Morrish DW, 1998, J REPROD IMMUNOL, V39, P179, DOI 10.1016/S0165-0378(98)00021-7; Mu YX, 2011, VIRUS RES, V156, P81, DOI 10.1016/j.virusres.2011.01.001; Muyan M, 1997, PLACENTA, V18, P237, DOI 10.1016/S0143-4004(97)80056-2; PATTILLO RA, 1968, SCIENCE, V159, P1467, DOI 10.1126/science.159.3822.1467; Prudhomme S, 2004, J VIROL, V78, P12157, DOI 10.1128/JVI.78.22.12157-12168.2004; Reddy TR, 1997, ONCOGENE, V14, P2785, DOI 10.1038/sj.onc.1201119; Schubert SW, 2008, NUCLEIC ACIDS RES, V36, P3834, DOI 10.1093/nar/gkn306; Toufaily C, 2013, PLACENTA, V34, P85, DOI 10.1016/j.placenta.2012.10.012; Uzan J, 2011, VASC HEALTH RISK MAN, V7, P467, DOI 10.2147/VHRM.S20181; Vargas A, 2011, REPROD SCI, V18, P1085, DOI 10.1177/1933719111404608; Vargas A, 2009, J MOL BIOL, V392, P301, DOI 10.1016/j.jmb.2009.07.025; WALTON KM, 1992, MOL ENDOCRINOL, V6, P647, DOI 10.1210/me.6.4.647; Yu CC, 2002, J BIOL CHEM, V277, P50062, DOI 10.1074/jbc.M209316200; Zhou Z, 2014, PLACENTA, V35, P907, DOI 10.1016/j.placenta.2014.07.017; Zhuang XW, 2014, CURR PHARM DESIGN, V20, P1796, DOI 10.2174/13816128113199990541	60	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0121468	10.1371/journal.pone.0121468	http://dx.doi.org/10.1371/journal.pone.0121468			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781974	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600205
J	Denis, M; Mehrmohammadi, M; Song, PF; Meixner, DD; Fazzio, RT; Pruthi, S; Whaley, DH; Chen, SG; Fatemi, M; Alizad, A				Denis, Max; Mehrmohammadi, Mohammad; Song, Pengfei; Meixner, Duane D.; Fazzio, Robert T.; Pruthi, Sandhya; Whaley, Dana H.; Chen, Shigao; Fatemi, Mostafa; Alizad, Azra			Comb-Push Ultrasound Shear Elastography of Breast Masses: Initial Results Show Promise	PLOS ONE			English	Article							WAVE ELASTOGRAPHY; DIFFERENTIATING BENIGN; US; MAMMOGRAPHY; TISSUE; PERFORMANCE; TECHNOLOGY; DIAGNOSIS; MODULUS; LESIONS	Purpose or Objective To evaluate the performance of Comb-push Ultrasound Shear Elastography (CUSE) for classification of breast masses. Materials and Methods CUSE is an ultrasound-based quantitative two-dimensional shear wave elasticity imaging technique, which utilizes multiple laterally distributed acoustic radiation force (ARF) beams to simultaneously excite the tissue and induce shear waves. Female patients who were categorized as having suspicious breast masses underwent CUSE evaluations prior to biopsy. An elasticity estimate within the breast mass was obtained from the CUSE shear wave speed map. Elasticity estimates of various types of benign and malignant masses were compared with biopsy results. Results Fifty-four female patients with suspicious breast masses from our ongoing study are presented. Our cohort included 31 malignant and 23 benign breast masses. Our results indicate that the mean shear wave speed was significantly higher in malignant masses (6 +/- 1.58 m/s) in comparison to benign masses (3.65 +/- 1.36 m/s). Therefore, the stiffness of the mass quantified by the Young's modulus is significantly higher in malignant masses. According to the receiver operating characteristic curve (ROC), the optimal cut-off value of 83 kPa yields 87.10% sensitivity, 82.61% specificity, and 0.88 for the area under the curve (AUC). Conclusion CUSE has the potential for clinical utility as a quantitative diagnostic imaging tool adjunct to B-mode ultrasound for differentiation of malignant and benign breast masses.	[Denis, Max; Mehrmohammadi, Mohammad; Song, Pengfei; Chen, Shigao; Fatemi, Mostafa; Alizad, Azra] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA; [Meixner, Duane D.; Fazzio, Robert T.; Whaley, Dana H.] Mayo Clin, Coll Med, Dept Radiol, Rochester, MN USA; [Pruthi, Sandhya; Alizad, Azra] Mayo Clin, Coll Med, Dept Internal Med, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Alizad, A (corresponding author), Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA.	Alizad.azra@mayo.edu		Fatemi, Mostafa/0000-0002-6603-9077; Song, Pengfei/0000-0002-9103-6345; Mehrmohammadi, Mohammad/0000-0002-9264-9354	National Institutes of Health-National Cancer Institute [R01CA148994-04S1, R01CA148994, R01CA168575]; NATIONAL CANCER INSTITUTE [R01CA168575, R01CA148994] Funding Source: NIH RePORTER	National Institutes of Health-National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by grants R01CA148994-04S1, R01CA148994, and R01CA168575 from the National Institutes of Health-National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasiou A, 2010, RADIOLOGY, V256, P297, DOI 10.1148/radiol.10090385; Bai M, 2012, J ULTRAS MED, V31, P289, DOI 10.7863/jum.2012.31.2.289; Barr RG, 2012, J ULTRAS MED, V31, P895, DOI 10.7863/jum.2012.31.6.895; Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; Bercoff J, 2003, ULTRASOUND MED BIOL, V29, P1387, DOI 10.1016/S0301-5629(03)00978-5; Berg WA, 2008, JAMA-J AM MED ASSOC, V299, P2151, DOI 10.1001/jama.299.18.2151; Berg WA, 2012, JAMA-J AM MED ASSOC, V307, P1394, DOI 10.1001/jama.2012.388; Berg WA, 2012, RADIOLOGY, V262, P435, DOI 10.1148/radiol.11110640; Burnside ES, 2007, RADIOLOGY, V245, P401, DOI 10.1148/radiol.2452061805; Chang JM, 2011, BREAST CANCER RES TR, V129, P89, DOI 10.1007/s10549-011-1627-7; Chang JM, 2011, RADIOLOGY, V259, P59, DOI 10.1148/radiol.10101414; Chen SC, 2004, ULTRASOUND OBST GYN, V23, P188, DOI 10.1002/uog.930; Cohn NA, 1997, IEEE T ULTRASON FERR, V44, P1304, DOI 10.1109/58.656634; Correas J-M, 2013, Diagn Interv Imaging, V94, P551, DOI 10.1016/j.diii.2013.01.017; Corsetti V, 2011, EUR J CANCER, V47, P1021, DOI 10.1016/j.ejca.2010.12.002; Cosgrove DO, 2012, EUR RADIOL, V22, P1023, DOI 10.1007/s00330-011-2340-y; Evans A, 2012, BRIT J CANCER, V107, P224, DOI 10.1038/bjc.2012.253; Evans A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2787; Fink M, 2010, PHYS TODAY, V63, P28, DOI 10.1063/1.3326986; Gennisson JL, 2007, J ACOUST SOC AM, V122, P3211, DOI 10.1121/1.2793605; GORDON PB, 1995, CANCER, V76, P626, DOI 10.1002/1097-0142(19950815)76:4<626::AID-CNCR2820760413>3.0.CO;2-Z; Ianculescu V, 2014, EUR J RADIOL, V83, P773, DOI 10.1016/j.ejrad.2014.01.021; KASAI C, 1985, IEEE T SON ULTRASON, V32, P458, DOI 10.1109/T-SU.1985.31615; Kolb TM, 2002, RADIOLOGY, V225, P165, DOI 10.1148/radiol.2251011667; Krouskop TA, 1998, ULTRASONIC IMAGING, V20, P260, DOI 10.1177/016173469802000403; Latorre-Ossa H, 2012, IEEE T ULTRASON FERR, V59, P833, DOI 10.1109/TUFFC.2012.2262; Lee SH, 2014, RADIOLOGY, V270, P344, DOI 10.1148/radiol.13130561; Li GL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076322; Mehrmohammadi M, 2014, COMB PUSH ULTRASOUND; Montaldo G, 2009, IEEE T ULTRASON FERR, V56, P489, DOI 10.1109/TUFFC.2009.1067; Nightingale K, 2002, ACOUSTIC RAD FORCE I, P525; Ohlinger R, 2004, ULTRASCHALL MED, V25, P48, DOI 10.1055/s-2003-45244; Plecha DM, 2014, RADIOLOGY; Rahbar G, 1999, RADIOLOGY, V213, P889, DOI 10.1148/radiology.213.3.r99dc20889; Sandrin L., 2002, ACOUST IMAGING, P485, DOI 10.1007/0-306-47107-8_68.; Sarvazyan AP, 1998, ULTRASOUND MED BIOL, V24, P1419, DOI 10.1016/S0301-5629(98)00110-0; Sarvazyan A, 2011, CURR MED IMAGING, V7, P255, DOI 10.2174/157340511798038684; Schaefer FKW, 2011, EUR J RADIOL, V77, P450, DOI 10.1016/j.ejrad.2009.08.026; SEWELL CW, 1995, RADIOL CLIN N AM, V33, P1067; Song PF, 2014, ULTRASOUND MED BIOL, V40, P1343, DOI 10.1016/j.ultrasmedbio.2013.12.026; Song PF, 2013, IEEE T MED IMAGING, V32, P1435, DOI 10.1109/TMI.2013.2257831; Song PF, 2012, IEEE T MED IMAGING, V31, P1821, DOI 10.1109/TMI.2012.2205586; STAVROS AT, 1995, RADIOLOGY, V196, P123, DOI 10.1148/radiology.196.1.7784555; Tanter M, 2008, ULTRASOUND MED BIOL, V34, P1373, DOI 10.1016/j.ultrasmedbio.2008.02.002; Teh W, 1998, EUR J CANCER, V34, P449, DOI 10.1016/S0959-8049(97)10066-1; Varghese T, 2000, ULTRASOUND MED BIOL, V26, P839, DOI 10.1016/S0301-5629(00)00199-X; Yao MH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/142504	47	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119398	10.1371/journal.pone.0119398	http://dx.doi.org/10.1371/journal.pone.0119398			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774978	Green Published, gold			2022-12-27	WOS:000351183500088
J	Fonseca, BF; Predes, D; Cerqueira, DM; Reis, AH; Amado, NG; Cayres, MCL; Kuster, RM; Oliveira, FL; Mendes, FA; Abreu, JG				Fonseca, Barbara F.; Predes, Danilo; Cerqueira, Debora M.; Reis, Alice H.; Amado, Nathalia G.; Cayres, Marina C. L.; Kuster, Ricardo M.; Oliveira, Felipe L.; Mendes, Fabio A.; Abreu, Jose G.			Derricin and Derricidin Inhibit Wnt/beta-Catenin Signaling and Suppress Colon Cancer Cell Growth In Vitro	PLOS ONE			English	Article							COLORECTAL-CANCER; BETA-CATENIN; WNT PATHWAY; ACTIVATION; MODULATORS; CHALCONES; POTENT; PROLIFERATION; FLAVONOIDS; QUERCETIN	Overactivation of the Wnt/beta-catenin pathway in adult tissues has been implicated in many diseases, such as colorectal cancer. Finding chemical substances that can prevent this phenomenon is an emerging problem. Recently, several natural compounds have been described as Wnt/beta-catenin inhibitors and might be promising agents for the control of carcinogenesis. Here, we describe two natural substances, derricin and derricidin, belonging to the chalcone subclass, that show potent transcriptional inhibition of the Wnt/beta-catenin pathway. Both chalcones are able to affect the cell distribution of beta-catenin, and inhibit Wnt-specific reporter activity in HCT116 cells and in Xenopus embryos. Derricin and derricidin also strongly inhibited canonical Wnt activity in vitro, and rescued the Wnt-induced double axis phenotype in Xenopus embryos. As a consequence of Wnt/beta-catenin inhibition, derricin and derricidin treatments reduce cell viability and lead to cell cycle arrest in colorectal cancer cell lines. Taken together, our results strongly support these chalcones as novel negative modulators of the Wnt/beta-catenin pathway and colon cancer cell growth in vitro.	[Fonseca, Barbara F.; Predes, Danilo; Cerqueira, Debora M.; Reis, Alice H.; Amado, Nathalia G.; Cayres, Marina C. L.; Oliveira, Felipe L.; Mendes, Fabio A.; Abreu, Jose G.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, Brazil; [Kuster, Ricardo M.] Univ Fed Rio de Janeiro, Inst Pesquisas Prod Nat, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Abreu, JG (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, Brazil.	garciajr@icb.ufrj.br	Cerqueira, Debora Malta/AAB-6204-2020; Kuster, Ricardo/AAG-3975-2019; Oliveira, Felipe L/H-9902-2012; Predes, Danilo/J-7558-2015; Cerqueira, Debora Malta/CAF-4323-2022; Mendes, Fabio/J-6911-2015; Abreu, Jose G/G-6159-2010; Abreu, Jose G/ABB-1199-2021	Predes, Danilo/0000-0003-1864-0324; Abreu, Jose G/0000-0002-9875-7786; Abreu, Jose G/0000-0002-1363-1755; Kuster, Ricardo Machado/0000-0002-8961-5348; Reis, Alice/0000-0002-7431-5502; Leite de Oliveira, Felipe/0000-0001-6193-1616; Malta Cerqueira Sant'Anna Santos, Debora/0000-0001-9773-4606; Fonseca, Barbara/0000-0001-6403-4099	Brazilian funding agency Conselho Nacional de Desenvolvimento cientifico e Tecnologico; Brazilian funding agency Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro; Brazilian funding agency Coordenacao de Aperfeicoamento de Pessoal de Nivel superior	Brazilian funding agency Conselho Nacional de Desenvolvimento cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian funding agency Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro; Brazilian funding agency Coordenacao de Aperfeicoamento de Pessoal de Nivel superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was funded by Brazilian funding agencies Conselho Nacional de Desenvolvimento cientifico e Tecnologico, Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, and Coordenacao de Aperfeicoamento de Pessoal de Nivel superior.	Amado NG, 2014, J BIOL CHEM, V289, P35456, DOI 10.1074/jbc.M114.621599; Amado NG, 2014, INT J MOL SCI, V15, P12094, DOI 10.3390/ijms150712094; Amado NG, 2012, CURR TOP MED CHEM, V12, P2103; Amado NG, 2011, LIFE SCI, V89, P545, DOI 10.1016/j.lfs.2011.05.003; Amado NG, 2009, ANTI-CANCER DRUG, V20, P543, DOI 10.1097/CAD.0b013e32832d1149; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Bosman F., 2010, WHO CLASSIFICATION T, V4th; Crozier A, 2009, NAT PROD REP, V26, P1001, DOI 10.1039/b802662a; Cunha GMD, 2003, PHYTOTHER RES, V17, P155, DOI 10.1002/ptr.1096; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; De Mello J F, 1974, Rev Inst Antibiot (Recife), V14, P39; Dimmock JR, 1999, CURR MED CHEM, V6, P1125; DONASCIM.MC, 1972, PHYTOCHEMISTRY, V11, P3023, DOI 10.1016/0031-9422(72)80097-9; Han JB, 2013, MOL CANCER RES, V11, P207, DOI 10.1158/1541-7786.MCR-12-0670; Hua ZH, 2013, J MED CHEM, V56, P10003, DOI 10.1021/jm401317z; Ji T, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-55; Jing H, 2010, CANCER LETT, V294, P167, DOI 10.1016/j.canlet.2010.01.035; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Leow PC, 2014, EUR J MED CHEM, V71, P67, DOI 10.1016/j.ejmech.2013.10.073; Lepourcelet M, 2004, CANCER CELL, V5, P91, DOI 10.1016/S1535-6108(03)00334-9; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Miyoshi Yasuo, 1992, Human Molecular Genetics, V1, P229; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Narwal M, 2013, J MED CHEM, V56, P7880, DOI 10.1021/jm401463y; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Pahlke G, 2006, J AGR FOOD CHEM, V54, P7075, DOI 10.1021/jf0612530; Park CH, 2005, BIOCHEM BIOPH RES CO, V328, P227, DOI 10.1016/j.bbrc.2004.12.151; Park S, 2013, BIOL PHARM BULL, V36, P1040, DOI 10.1248/bpb.b13-00158; Pericleous M, 2013, J GASTROINTEST ONCOL, V4, P409, DOI 10.3978/j.issn.2078-6891.2013.003; Sak Katrin, 2014, Pharmacogn Rev, V8, P122, DOI 10.4103/0973-7847.134247; Senderowicz AM, 2003, ONCOGENE, V22, P6609, DOI 10.1038/sj.onc.1206954; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Sparks AB, 1998, CANCER RES, V58, P1130; Thorne CA, 2010, NAT CHEM BIOL, V6, P829, DOI 10.1038/NCHEMBIO.453; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; VINDELOV LL, 1985, EUR J RESPIR DIS, V66, P313; Wang HJ, 2012, TECHNOLOGICAL ENTREPRENEURSHIP IN CHINA: HOW DOES IT WORK, P1; Wenzel H, 2000, CANCER RES, V60, P3823; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Yang G, 2007, CANCER EPIDEM BIOMAR, V16, P1219, DOI 10.1158/1055-9965.EPI-07-0097	41	25	25	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120919	10.1371/journal.pone.0120919	http://dx.doi.org/10.1371/journal.pone.0120919			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775405	Green Submitted, Green Published, gold			2022-12-27	WOS:000351183500199
J	Fu, GF; Jiang, N; Hu, HY; Mahapatra, T; Yin, YP; Mahapatra, S; Wang, XL; Chen, XS; Babu, GR; Xu, XQ; Ding, P; Qiu, T; Liu, XY; Guo, HX; Huan, XP; Tang, WM				Fu, Geng-Feng; Jiang, Ning; Hu, Hai-Yang; Mahapatra, Tanmay; Yin, Yue-Ping; Mahapatra, Sanchita; Wang, Xiao-Liang; Chen, Xiang-Sheng; Babu, Giridhar R.; Xu, Xiao-Qin; Ding, Ping; Qiu, Tao; Liu, Xiao-Yan; Guo, Hongxiong; Huan, Xi-Ping; Tang, Weiming			The Epidemic of HIV, Syphilis, Chlamydia and Gonorrhea and the Correlates of Sexual Transmitted Infections among Men Who Have Sex with Men in Jiangsu, China, 2009	PLOS ONE			English	Article							UNPROTECTED ANAL INTERCOURSE; INCREASING PREVALENCE; SAN-FRANCISCO; RISK-FACTORS; SETTINGS	Background In China, the HIV/AIDS epidemic is expanding among men who have sex with men (MSM). As independent risk factors of HIV infection, the epidemics of Chlamydia (CT) and Gonorrhea (NG) in MSM were not well studied, particular for the risk factors of these infectious. The objectives of current reported study were to understand the dynamics of HIV and other sexual transmitted infections (STIs) among MSM in Jiangsu, China, and to measure factors that correlated with STIs. Methods In order to gain more participants, a multisite cross-sectional study design was used in our study, by using convenience-sampling to recruit MSM in two Changzhou and Yangzhou, Jiangsu, China, between the July and October of 2009. Results In this comprehensive survey involving MSM in two cities of Jiangsu province of China, the prevalence of STIs of CT (6.54%), NG (3.63%), syphilis (20.34%) and HIV (11.62%) were measured. Overall, the STIs prevalence (CT, NG or syphilis) for the participants in our study was 26.39%, meanwhile, 3.4% (14 out of the 413) participants had at least two kinds of STIs. Meeting casual partners at parks, public restrooms or other public areas, having had anal sex with men in the past six months, having had STI symptoms in the past year were positively correlated with STIs positive, with adjusted ORs of 4.61(95% CI 1.03-20.75), 1.91 (95% CI 1.14-3.21) and 2.36(95% CI 1.07,5.24). Conclusion Our study findings reiterate the fact that Chinese MSM are highly susceptible to acquiring syphilis, CT, NG and HIV, and there is an urgent need for intervention targeted towards this population. Behavioral measures should constitute an important part of the targeted intervention. Furthermore, the already implemented preventive and diagnostic services for HIV should be expanded to include syphilis CT and NG, too.	[Fu, Geng-Feng; Hu, Hai-Yang; Wang, Xiao-Liang; Xu, Xiao-Qin; Ding, Ping; Qiu, Tao; Liu, Xiao-Yan; Guo, Hongxiong; Huan, Xi-Ping] Jiangsu Prov Ctr Dis Prevent & Control, Nanjing, Jiangsu, Peoples R China; [Jiang, Ning; Yin, Yue-Ping; Chen, Xiang-Sheng] Chinese Ctr Dis Control & Prevent, Natl Ctr STD Control, Nanjing, Jiangsu, Peoples R China; [Mahapatra, Tanmay; Mahapatra, Sanchita; Babu, Giridhar R.] Univ Calif Los Angeles, Dept Epidemiol, Los Angeles, CA USA; [Tang, Weiming] Univ North Carolina Project China, Guangzhou, Guangdong, Peoples R China	Chinese Center for Disease Control & Prevention; Jiangsu Provincial Center for Disease Control & Prevention; University of California System; University of California Los Angeles	Huan, XP (corresponding author), Jiangsu Prov Ctr Dis Prevent & Control, Nanjing, Jiangsu, Peoples R China.	huanxp@vip.sina.com; weimingtangscience@gmail.com	Guo, Hongxiong/GPS-7405-2022; Babu, Giridhara R./C-2482-2011	Babu, Giridhara R./0000-0003-4370-8933; Tang, Weiming/0000-0002-9026-707X	Ministry of Health and the Ministry of Sciences and Technology in China [2008ZX10001-005]; NIH program [1D43TW009532-01]; National Natural Science Foundation of China [81373125]; Jiangsu Provincial Technologies Research Program [BE2009685]; Jiangsu Province's Outstanding Medical Academic Leader Program [RC2011086, 2011087]; FOGARTY INTERNATIONAL CENTER [D43TW009532] Funding Source: NIH RePORTER	Ministry of Health and the Ministry of Sciences and Technology in China; NIH program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Technologies Research Program; Jiangsu Province's Outstanding Medical Academic Leader Program; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the Mega Project of China National Science Research for the 11th Five-Year Plan (2008ZX10001-005) from the Ministry of Health and the Ministry of Sciences and Technology in China, NIH program 1D43TW009532-01, National Natural Science Foundation of China (Grant No. 81373125), Jiangsu Provincial Technologies Research Program (BE2009685), Jiangsu Province's Outstanding Medical Academic Leader Program (RC2011086, 2011087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binson D, 2001, AM J PUBLIC HEALTH, V91, P1482, DOI 10.2105/AJPH.91.9.1482; Choi KH, 2004, AIDS EDUC PREV, V16, P19, DOI 10.1521/aeap.16.1.19.27721; DiClemente RJ, 2008, PSYCHOSOM MED, V70, P598, DOI 10.1097/PSY.0b013e3181775edb; Feng LG, 2009, JAIDS-J ACQ IMM DEF, V52, P79, DOI 10.1097/QAI.0b013e3181a4f53e; Feng YJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS74, DOI 10.1097/QAI.0b013e3181c7dd16; Freeman EE, 2007, SEX TRANSM INFECT, V83, pI17, DOI 10.1136/sti.2006.023549; Gao L, 2009, SEX TRANSM INFECT, V85, P354, DOI 10.1136/sti.2008.034702; Guo HX, 2009, SEX TRANSM DIS, V36, P120, DOI 10.1097/OLQ.0b013e31818d3fa0; Hampton MC, 2012, AIDS BEHAV, P1; Hong FC, 2009, SEX TRANSM INFECT, V85, P42, DOI 10.1136/sti.2008.031682; Jiang J, 2006, SEX TRANSM DIS, V33, P118, DOI 10.1097/01.olq.0000199763.14766.2b; Kent CK, 2005, CLIN INFECT DIS, V41, P67, DOI 10.1086/430704; MOH WHO, 2011, 2011 EST HIV AIDS EP; Nusbaum Margaret R H, 2004, J Am Osteopath Assoc, V104, P527; Pham QD, 2012, SEX TRANSM DIS, V39, P799, DOI 10.1097/OLQ.0b013e318265b180; Ranjan M, 2011, SEX TRANSM INFECT, V87, pA49, DOI 10.1136/sextrans-2011-050109.59; Ruan SM, 2008, AIDS BEHAV, V12, P469, DOI 10.1007/s10461-008-9361-9; Ruan YH, 2009, AIDS BEHAV, V13, P663, DOI 10.1007/s10461-008-9503-0; Tang W, 2013, AIDS BEHAV, P1; Tucker JD, 2010, NEW ENGL J MED, V362, P1658, DOI 10.1056/NEJMp0911149; Wang KL, 2012, INT J EPIDEMIOL, V41, P423, DOI 10.1093/ije/dyr182; Wong H., 2013, J SEXUALLY TRANSMITT, DOI [10.1155/2013/958967, DOI 10.1155/2013/958967]; Wong W, 2005, SEX TRANSM DIS, V32, P458, DOI 10.1097/01.olq.0000168280.34424.58; Wu ZY, 2013, CLIN INFECT DIS, V57, P298, DOI 10.1093/cid/cit210; Wu ZY, 2010, JAIDS-J ACQ IMM DEF, V53, pS1, DOI 10.1097/QAI.0b013e3181c7d379; Xiao Y, 2010, JAIDS-J ACQ IMM DEF, V53, pS66, DOI 10.1097/QAI.0b013e3181c7db43; Xu C, 2011, ACTA U MED ANHUI, V6; Zhang YQ, 2012, SEX TRANSM INFECT, V88, P444, DOI 10.1136/sextrans-2011-050295; Zhong F, 2011, AIDS BEHAV, V15, P1058, DOI 10.1007/s10461-009-9619-x	29	17	17	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118863	10.1371/journal.pone.0118863	http://dx.doi.org/10.1371/journal.pone.0118863			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD6EY	25775451	Green Published, gold, Green Submitted			2022-12-27	WOS:000351183500046
J	Petermann, JS; Kratina, P; Marino, NAC; MacDonald, AAM; Srivastava, DS				Petermann, Jana S.; Kratina, Pavel; Marino, Nicholas A. C.; MacDonald, A. Andrew M.; Srivastava, Diane S.			Resources Alter the Structure and Increase Stochasticity in Bromeliad Microfauna Communities	PLOS ONE			English	Article							BETA DIVERSITY; METACOMMUNITY STRUCTURE; RELATIVE IMPORTANCE; SPECIES COMPOSITION; PLANT BIODIVERSITY; SCALE-DEPENDENCE; DISPERSAL; PREDATORS; PREY; PRODUCTIVITY	Although stochastic and deterministic processes have been found to jointly shape structure of natural communities, the relative importance of both forces may vary across different environmental conditions and across levels of biological organization. We tested the effects of abiotic environmental conditions, altered trophic interactions and dispersal limitation on the structure of aquatic microfauna communities in Costa Rican tank bromeliads. Our approach combined natural gradients in environmental conditions with experimental manipulations of bottom-up interactions (resources), top-down interactions (predators) and dispersal at two spatial scales in the field. We found that resource addition strongly increased the abundance and reduced the richness of microfauna communities. Community composition shifted in a predictable way towards assemblages dominated by flagellates and ciliates but with lower abundance and richness of algae and amoebae. While all functional groups responded strongly and predictably to resource addition, similarity among communities at the species level decreased, suggesting a role of stochasticity in species-level assembly processes. Dispersal limitation did not affect the communities. Since our design excluded potential priority effects we can attribute the differences in community similarity to increased demographic stochasticity of resource-enriched communities related to erratic changes in population sizes of some species. In contrast to resources, predators and environmental conditions had negligible effects on community structure. Our results demonstrate that bromeliad microfauna communities are strongly controlled by bottom-up forces. They further suggest that the relative importance of stochasticity may change with productivity and with the organizational level at which communities are examined.	[Petermann, Jana S.] Free Univ Berlin, Inst Biol, D-14195 Berlin, Germany; [Petermann, Jana S.] Berlin Brandenburg Inst Adv Biodivers Res BBIB, D-14195 Berlin, Germany; [Petermann, Jana S.] Salzburg Univ, Dept Ecol & Evolut, A-5020 Salzburg, Austria; [Kratina, Pavel] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Marino, Nicholas A. C.] Univ Fed Rio de Janeiro, Inst Biol, Dept Ecol, Rio De Janeiro, RJ, Brazil; [MacDonald, A. Andrew M.; Srivastava, Diane S.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [MacDonald, A. Andrew M.; Srivastava, Diane S.] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada	Free University of Berlin; Salzburg University; University of London; Queen Mary University London; Universidade Federal do Rio de Janeiro; University of British Columbia; University of British Columbia	Petermann, JS (corresponding author), Free Univ Berlin, Inst Biol, Konigin Luise Str 1-3, D-14195 Berlin, Germany.	jana.petermann@fu-berlin.de	Marino, Nicholas A.C./L-8286-2015; Kratina, Pavel/O-5192-2019; Petermann, Jana/AAK-9787-2020; Petermann, Jana/E-2130-2013	Marino, Nicholas A.C./0000-0002-5702-5466; Kratina, Pavel/0000-0002-9144-7937; Petermann, Jana/0000-0002-3898-5656; Petermann, Jana/0000-0002-3898-5656	Swiss National Science Foundation [PBZHP3-128263]; Velux Foundation [651]; National Geographic Society [8833]; Natural Sciences and Engineering Research Council of Canada (NSERC)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Velux Foundation(Velux Fonden); National Geographic Society(National Geographic Society); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	JSP was supported by grants from the Swiss National Science Foundation (PBZHP3-128263, www.snf.ch), the Velux Foundation (651, www.veluxstiftung.ch) and the National Geographic Society (8833, www.nationalgeographic.com). PK was supported by Natural Sciences and Engineering Research Council of Canada (NSERC, www.nserccrsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2007, ECOL LETT, V10, P95, DOI 10.1111/j.1461-0248.2006.00996.x; Altermatt F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019525; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Benzing D.H., 1990, VASCULAR EPIPHYTES; Cadotte MW, 2006, AM NAT, V167, P913, DOI 10.1086/504850; Chalcraft DR, 2008, ECOLOGY, V89, P2165, DOI 10.1890/07-0971.1; Chase JM, 2003, OECOLOGIA, V136, P489, DOI 10.1007/s00442-003-1311-7; Chase JM, 2007, P NATL ACAD SCI USA, V104, P17430, DOI 10.1073/pnas.0704350104; Chase JM, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00117.1; Chase JM, 2011, PHILOS T R SOC B, V366, P2351, DOI 10.1098/rstb.2011.0063; Chase JM, 2010, SCIENCE, V328, P1388, DOI 10.1126/science.1187820; Chase JM, 2009, ECOL LETT, V12, P1210, DOI 10.1111/j.1461-0248.2009.01362.x; Chesson P, 2008, NATURE, V456, P235, DOI 10.1038/nature07248; De Bie T, 2012, ECOL LETT, V15, P740, DOI 10.1111/j.1461-0248.2012.01794.x; de Boer MK, 2014, OIKOS, V123, P762, DOI 10.1111/j.1600-0706.2013.00927.x; Declerck SAJ, 2013, ISME J, V7, P533, DOI 10.1038/ismej.2012.138; Dickson TL, 2011, ECOL LETT, V14, P380, DOI 10.1111/j.1461-0248.2011.01599.x; Donohue I, 2009, ECOLOGY, V90, P3470, DOI 10.1890/09-0415.1; Farjalla VF, 2012, ECOLOGY, V93, P1752, DOI 10.1890/11-1144.1; Foissner W., 2009, PROTIST DIVERSITY GE; Fukami T, 2005, ECOL LETT, V8, P1283, DOI 10.1111/j.1461-0248.2005.00829.x; Gardezi T, 2008, AM NAT, V171, P800, DOI 10.1086/587520; Gilbert B, 2008, OIKOS, V117, P944, DOI 10.1111/j.0030-1299.2008.16300.x; Haddad NM, 2008, ECOL LETT, V11, P348, DOI 10.1111/j.1461-0248.2007.01149.x; Harrison S, 2006, J ECOL, V94, P110, DOI 10.1111/j.1365-2745.2005.01078.x; Helsen K, 2012, OIKOS, V121, P2121, DOI 10.1111/j.1600-0706.2012.20499.x; Howeth JG, 2010, J ANIM ECOL, V79, P1000, DOI 10.1111/j.1365-2656.2010.01715.x; Hoyle M, 2004, OIKOS, V105, P359, DOI 10.1111/j.0030-1299.2004.12832.x; Hubbell Stephen P., 2001, V32, pi; Kneitel JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041809; Kneitel JM, 2003, AM NAT, V162, P165, DOI 10.1086/376585; Kraft NJB, 2011, SCIENCE, V333, P1755, DOI 10.1126/science.1208584; Laybourn-Parry J., 1992, PROTOZOAN PLANKTON E; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; MAGUIRE B, 1963, ECOL MONOGR, V33, P161, DOI 10.2307/1948560; Mata TM, 2013, OIKOS, V122, P149, DOI 10.1111/j.1600-0706.2012.20401.x; NAEEM S, 1990, ECOLOGY, V71, P1422, DOI 10.2307/1938279; Ngai JT, 2008, ECOSCIENCE, V15, P160, DOI 10.2980/15-2-3098; Ngai JT, 2006, SCIENCE, V314, P963, DOI 10.1126/science.1132598; Oksanen J., 2016, R PACKAG; Petermann JS, 2010, ECOLOGY, V91, P408, DOI 10.1890/08-2304.1; Pinheiro J., 2011, NLME LINEAR NONLINEA; Pinheiro J, 2001, MIXED EFFECTS MODELS; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Scheffer M, 2006, P NATL ACAD SCI USA, V103, P6230, DOI 10.1073/pnas.0508024103; Silvertown J, 1999, NATURE, V400, P61, DOI 10.1038/21877; Simonis JL, 2014, ECOLOGY, V95, P1545, DOI 10.1890/13-1185.1; Srivastava DS, 2006, OECOLOGIA, V149, P493, DOI 10.1007/s00442-006-0467-3; Srivastava DS, 2009, ECOL LETT, V12, P1016, DOI 10.1111/j.1461-0248.2009.01357.x; Starzomski BM, 2010, ECOL ENTOMOL, V35, P53, DOI 10.1111/j.1365-2311.2009.01155.x; Steiner CF, 2004, ECOLOGY, V85, P107, DOI 10.1890/03-3010; terHorst CP, 2011, J EVOLUTION BIOL, V24, P36, DOI 10.1111/j.1420-9101.2010.02140.x; Terhorst CP, 2010, ECOLOGY, V91, P629, DOI 10.1890/09-1481.1; Tilman D., 1982, Monographs in Population Biology, pi; Vanschoenwinkel B, 2008, ECOGRAPHY, V31, P567, DOI 10.1111/j.0906-7590.2008.05442.x; Violle C, 2011, ECOL LETT, V14, P782, DOI 10.1111/j.1461-0248.2011.01644.x; Walker E D, 2010, Community Ecol, V11, P171, DOI 10.1556/ComEc.11.2010.2.5; WALLACE JB, 1980, ANNU REV ENTOMOL, V25, P103, DOI 10.1146/annurev.en.25.010180.000535; Weisse T, 2008, BIODIVERS CONSERV, V17, P243, DOI 10.1007/s10531-007-9249-4; Yoshida T, 2003, NATURE, V424, P303, DOI 10.1038/nature01767	60	7	9	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118952	10.1371/journal.pone.0118952	http://dx.doi.org/10.1371/journal.pone.0118952			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775464	Green Submitted, gold, Green Published			2022-12-27	WOS:000351183500056
J	Storch, TT; Pegoraro, C; Finatto, T; Quecini, V; Rombaldi, CV; Girardi, CL				Storch, Tatiane Timm; Pegoraro, Camila; Finatto, Taciane; Quecini, Vera; Rombaldi, Cesar Valmor; Girardi, Cesar Luis			Identification of a Novel Reference Gene for Apple Transcriptional Profiling under Postharvest Conditions	PLOS ONE			English	Article							REAL-TIME; RT-PCR; ETHYLENE BIOSYNTHESIS; EXPRESSION; FRUIT; NORMALIZATION; ARABIDOPSIS; VALIDATION; PERCEPTION; SELECTION	Reverse Transcription quantitative PCR (RT-qPCR) is one of the most important techniques for gene expression profiling due to its high sensibility and reproducibility. However, the reliability of the results is highly dependent on data normalization, performed by comparisons between the expression profiles of the genes of interest against those of constitutively expressed, reference genes. Although the technique is widely used in fruit postharvest experiments, the transcription stability of reference genes has not been thoroughly investigated under these experimental conditions. Thus, we have determined the transcriptional profile, under these conditions, of three genes commonly used as reference-ACTIN (MdACT), PROTEIN DISULPHIDE ISOMERASE (MdPDI) and UBIQUITIN-CONJUGATING ENZYME E2 (MdUBC)-along with two novel candidates-HISTONE 1 (MdH1) and NUCLEOSSOME ASSEMBLY 1 PROTEIN (MdNAP1). The expression profile of the genes was investigated throughout five experiments, with three of them encompassing the postharvest period and the other two, consisting of developmental and spatial phases. The transcriptional stability was comparatively investigated using four distinct software packages: BestKeeper, Norm-Finder, geNorm and DataAssist. Gene ranking results for transcriptional stability were similar for the investigated software packages, with the exception of BestKeeper. The classic reference gene MdUBC ranked among the most stably transcribed in all investigated experimental conditions. Transcript accumulation profiles for the novel reference candidate gene MdH1 were stable throughout the tested conditions, especially in experiments encompassing the postharvest period. Thus, our results present a novel reference gene for postharvest experiments in apple and reinforce the importance of checking the transcription profile of reference genes under the experimental conditions of interest.	[Storch, Tatiane Timm; Pegoraro, Camila; Finatto, Taciane; Quecini, Vera; Girardi, Cesar Luis] Empresa Brasileira Pesquisa Agr Uva & Vinho, Bento Goncalves, Brazil; [Storch, Tatiane Timm; Rombaldi, Cesar Valmor] Univ Fed Pelotas, Pelotas, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal de Pelotas	Girardi, CL (corresponding author), Empresa Brasileira Pesquisa Agr Uva & Vinho, Bento Goncalves, Brazil.	cesar.girardi@embrapa.br	Pegoraro, Camila/P-2940-2015; Rombaldi, Cesar/T-2940-2019; Pegoraro, Camila/L-2265-2019; Finatto, Taciane/O-9510-2014; Quecini, Vera/AAM-7724-2020	Pegoraro, Camila/0000-0003-1376-9751; Pegoraro, Camila/0000-0003-1376-9751; Finatto, Taciane/0000-0002-6873-3783; Quecini, Vera/0000-0001-7806-3309; Rombaldi, Cesar/0000-0002-6995-2937	Embrapa/SEG [02.10.01.002]; CNPq Productivity Research Grant; CAPES Institutional Doctorate Grant;  [02986/9]	Embrapa/SEG; CNPq Productivity Research Grant; CAPES Institutional Doctorate Grant; 	The work was supported by the following: Research Grant 02.10.01.002 from Embrapa/SEG to CLG (https://sistemas.sede.embrapa.br/ideare); CNPq Productivity Research Grant to CVR (http://www.cnpq.br/); CAPES Institutional Doctorate Grant to TTS (http://www.capes.gov.br/bolsas/bolsas-nopais/ds-e-proap); and Post Doctoral Grant 02986/9 to CP (www.capes.gov.br/bolsas/bolsas-no-pais/pnpd). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Embrapa, the funding agency with which one or more of the authors is affiliated, is a government research institution (https://www.embrapa.br/en/home) similar to the United States Department of Agriculture (USDA) and provides competitive funding to research projects without playing a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Ay N, 2014, J EXP BOT, V65, P3875, DOI 10.1093/jxb/eru132; Bapat VA, 2010, BIOTECHNOL ADV, V28, P94, DOI 10.1016/j.biotechadv.2009.10.002; Bennett AB, 2008, PLANT SCI, V175, P130, DOI 10.1016/j.plantsci.2008.03.004; Borowski JM, 2014, PLANTA, V239, P1187, DOI 10.1007/s00425-014-2041-2; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Carruthers LM, 1998, BIOCHEMISTRY-US, V37, P14776, DOI 10.1021/bi981684e; Chandna R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036918; Dal Cin V, 2005, J EXP BOT, V56, P2995, DOI 10.1093/jxb/eri296; de Vega-Bartol JJ, 2013, PLANT CELL REP, V32, P715, DOI 10.1007/s00299-013-1407-4; Dekkers BJW, 2012, PLANT CELL PHYSIOL, V53, P28, DOI 10.1093/pcp/pcr113; Dong MT, 2012, CURR GENET, V58, P13, DOI 10.1007/s00294-011-0361-3; Espley RV, 2007, PLANT J, V49, P414, DOI 10.1111/j.1365-313X.2006.02964.x; Fan CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056573; Gimeno J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091474; Goulao LF, 2008, TRENDS FOOD SCI TECH, V19, P4, DOI 10.1016/j.tifs.2007.07.002; Gu CS, 2014, SCI WORLD J, DOI 10.1155/2014/532713; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Harb J, 2012, POSTHARVEST BIOL TEC, V64, P94, DOI 10.1016/j.postharvbio.2011.10.001; Harshman SW, 2013, NUCLEIC ACIDS RES, V41, P9593, DOI 10.1093/nar/gkt700; Haushalter KA, 2003, NAT REV MOL CELL BIO, V4, P613, DOI 10.1038/nrm1177; Imai T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086492; Ling H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097469; Lopez-Pardo R, 2013, MOL BREEDING, V31, P39, DOI 10.1007/s11032-012-9766-z; Mann HS, 2008, J AM SOC HORTIC SCI, V133, P152, DOI 10.21273/JASHS.133.1.152; Merchante C, 2013, CURR OPIN PLANT BIOL, V16, P554, DOI 10.1016/j.pbi.2013.08.001; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Nobile PM, 2011, J EXP BOT, V62, P4309, DOI 10.1093/jxb/err146; OUDET P, 1975, CELL, V4, P281, DOI 10.1016/0092-8674(75)90149-X; Park YJ, 2006, BIOCHEM CELL BIOL, V84, P549, DOI 10.1139/O06-088; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Rios G, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00247; Saha G. C., 2012, American Journal of Plant Sciences, V3, P235, DOI 10.4236/ajps.2012.32028; Schaffer RJ, 2007, PLANT PHYSIOL, V144, P1899, DOI 10.1104/pp.106.093765; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vimolmangkang S, 2014, GENE, V534, P78, DOI 10.1016/j.gene.2013.10.007; Wei JM, 2010, POSTHARVEST BIOL TEC, V56, P147, DOI 10.1016/j.postharvbio.2009.12.003; Yang XT, 2013, POSTHARVEST BIOL TEC, V78, P55, DOI 10.1016/j.postharvbio.2012.11.012; Yi H, 2006, PLANT CELL, V18, P1575, DOI 10.1105/tpc.105.039719; ZENG Y, 2002, PLANT MOL BIOL REP, V20, pA417, DOI DOI 10.1007/BF02772130; Zhu X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084730	43	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120599	10.1371/journal.pone.0120599	http://dx.doi.org/10.1371/journal.pone.0120599			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774904	Green Published, gold, Green Submitted			2022-12-27	WOS:000351183500186
J	Tao-Cheng, JH; Yang, YJ; Reese, TS; Dosemeci, A				Tao-Cheng, Jung-Hwa; Yang, Yijung; Reese, Thomas S.; Dosemeci, Ayse			Differential Distribution of Shank and GKAP at the Postsynaptic Density	PLOS ONE			English	Article							EXCITATORY SYNAPSES; PROTEINS; HOMER; COMPLEX; FAMILY	Shank and GKAP are scaffold proteins and binding partners at the postsynaptic density (PSD). The distribution and dynamics of Shank and GKAP were studied in dissociated hippocampal cultures by pre-embedding immunogold electron microscopy. Antibodies against epitopes containing their respective mutual binding sites were used to verify the expected juxtapositioning of Shank and GKAP. If all Shank and GKAP molecules at the PSD were bound to each other, the distribution of label for the two proteins should coincide. However, labels for the mutual binding sites showed significant differences in distribution, with a narrow distribution for GKAP located close to the postsynaptic membrane, and a wider distribution for Shank extending deeper into the cytoplasm. Upon depolarization with high K+, neither the intensity nor distribution of label for GKAP changed, but labeling intensity for Shank at the PSD increased to similar to 150% of controls while the median distance of label from postsynaptic membrane increased by 7.5 nm. These results indicate a preferential recruitment of Shank to more distal parts of the PSD complex. Conversely, upon incubation in Ca2+-free medium containing EGTA, the labeling intensity of Shank at the PSD decreased to similar to 70% of controls and the median distance of label from postsynaptic membrane decreased by 9 nm, indicating a preferential loss of Shank molecules in more distal parts of the PSD complex. These observations identify two pools of Shank at the PSD complex, one relatively stable pool, closer to the postsynaptic membrane that can bind to GKAP, and another more dynamic pool at a location too far away to bind to GKAP.	[Tao-Cheng, Jung-Hwa] NINDS, EM Facil, NIH, Bethesda, MD 20892 USA; [Yang, Yijung; Reese, Thomas S.; Dosemeci, Ayse] NINDS, Neurobiol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Tao-Cheng, JH (corresponding author), NINDS, EM Facil, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	chengs@ninds.nih.gov			Intramural Research Program of the National Institute of Neurological Disorders and Stroke; National Institutes of Health, United States of America; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003113] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health, United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by the Intramural Research Program of the National Institute of Neurological Disorders and Stroke, National Institutes of Health, United States of America.	Baron MK, 2006, SCIENCE, V311, P531, DOI 10.1126/science.1118995; Boeckers TM, 2006, CELL TISSUE RES, V326, P409, DOI 10.1007/s00441-006-0274-5; Boeckers TM, 2005, J NEUROCHEM, V92, P519, DOI 10.1111/j.1471-4159.2004.02910.x; Boeckers TM, 1999, J NEUROSCI, V19, P6506; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Grabrucker AM, 2011, EMBO J, V30, P569, DOI 10.1038/emboj.2010.336; Hayashi MK, 2009, CELL, V137, P159, DOI 10.1016/j.cell.2009.01.050; Kuriu T, 2006, J NEUROSCI, V26, P7693, DOI 10.1523/JNEUROSCI.0522-06.2006; Moutin E, 2012, J CELL SCI, V125, P2030, DOI 10.1242/jcs.098160; Naisbitt S, 1997, J NEUROSCI, V17, P5687; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Peters A., 1991, FINE STRUCTURE NERVO; Petralia RS, 2005, MOL CELL NEUROSCI, V29, P436, DOI 10.1016/j.mcn.2005.03.013; Rostaing P, 2006, EUR J NEUROSCI, V24, P3463, DOI 10.1111/j.1460-9568.2006.05234.x; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Sheng M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005678; Shin SM, 2012, NAT NEUROSCI, V15, P1655, DOI 10.1038/nn.3259; Tao-Cheng JH, 2014, NEUROSCIENCE, V266, P80, DOI 10.1016/j.neuroscience.2014.01.066; Tao-Cheng JH, 2010, NEUROSCIENCE, V168, P11, DOI 10.1016/j.neuroscience.2010.03.041; Tao-Cheng JH, 2014, BIOCHEM BIOPH RES CO, V450, P808, DOI 10.1016/j.bbrc.2014.06.049; Thalhammer A, 2009, J NEUROCHEM, V109, P297, DOI 10.1111/j.1471-4159.2009.05951.x; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Valtschanoff JG, 2001, J NEUROSCI, V21, P1211; Verpelli C, 2012, ADV EXP MED BIOL, V970, P29, DOI 10.1007/978-3-7091-0932-8_2	25	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118750	10.1371/journal.pone.0118750	http://dx.doi.org/10.1371/journal.pone.0118750			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775468	gold, Green Submitted, Green Published			2022-12-27	WOS:000351183500038
J	Xu, YD; Fu, WJ; Wang, ZX; Li, G; Zhang, X				Xu, Yongde; Fu, Weijun; Wang, Zhongxin; Li, Gang; Zhang, Xu			A Tissue-Specific Scaffold for Tissue Engineering-Based Ureteral Reconstruction	PLOS ONE			English	Article							SMALL-INTESTINAL SUBMUCOSA; EXTRACELLULAR-MATRIX; IN-VITRO; UROTHELIAL CELLS; DIFFERENTIATION; PROLIFERATION; UROPLAKIN; MEMBRANE; CULTURE; MODEL	Terminally differentiated somatic cells can rapidly change phenotypes when they are isolated from their native tissue and cultured in vitro. This problem may become a barrier to tissue engineering-based organ reconstruction, which utilizes somatic cells. The present study was designed to validate the feasibility of maintaining the urothelial cell phenotype in a tissue-specific ureteral scaffold. The tissue-specific scaffold was fabricated by blending poly (L-lactic acid) (PLLA) and ureteral extracellular matrix (UECM) using electrostatic spinning technology. PLLA was used to enhance the mechanical properties, and UECM was used to mimic the natural components of the ureter. Primary urothelial cells (UCs), derived from ureteral mucosa, were seeded onto the tissue-specific scaffold to assess cell adhesion, proliferation and phenotypes at designated time points. The results showed that UCs in the tissue-specific scaffold exhibited better proliferation compared to cells in pure PLLA or a PLLA-small intestinal submucosa (PLLA-SIS) scaffold (p<0.05). At different time points, the expression of a UC-specific marker (UroplakinIII) in the tissue-specific scaffold was significantly higher than its expression in pure PLLA or a PLLA-SIS scaffold (p<0.05). Therefore, the tissue-specific scaffold appears to be an ideal substrate for promoting UC survival and phenotype maintenance.	[Xu, Yongde; Fu, Weijun; Wang, Zhongxin] Chinese Peoples Liberat Army Gen Hosp, Hainan Branch, Dept Urol, Sanya, Peoples R China; [Zhang, Xu] Chinese Peoples Liberat Army Gen Hosp, Dept Urol, Beijing, Peoples R China; [Li, Gang] 309th Hosp PLA, Inst Organ Transplantat PLA, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Fu, WJ (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Hainan Branch, Dept Urol, Sanya, Peoples R China.	fuweijun@hotmail.com			Beijing Natural Science Foundation [7142145]	Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by the Beijing Natural Science Foundation (No. 7142145) (PI Weijun Fu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043; Chen Y, 2008, J MATER SCI-MATER M, V19, P2261, DOI 10.1007/s10856-007-3335-8; Chun SY, 2007, BIOMATERIALS, V28, P4251, DOI 10.1016/j.biomaterials.2007.05.020; Daoud J, 2010, BIOMATERIALS, V31, P1676, DOI 10.1016/j.biomaterials.2009.11.057; Fu WJ, 2012, J BIOMED MATER RES A, V100A, P1725, DOI 10.1002/jbm.a.34134; Fu WJ, 2009, BJU INT, V104, P263, DOI 10.1111/j.1464-410X.2009.08366.x; Hodde J P, 1996, Tissue Eng, V2, P209, DOI 10.1089/ten.1996.2.209; Hoganson DM, 2010, BIOMATERIALS, V31, P6934, DOI 10.1016/j.biomaterials.2010.05.026; Hu JA, 2010, BIOMATERIALS, V31, P7971, DOI 10.1016/j.biomaterials.2010.07.028; Huet C, 2001, J ENDOCRINOL, V169, P347, DOI 10.1677/joe.0.1690347; Lindberg K, 2001, BURNS, V27, P254, DOI 10.1016/S0305-4179(00)00113-3; Luo JC, 2011, BIOMATERIALS, V32, P706, DOI 10.1016/j.biomaterials.2010.09.017; McClelland R, 2008, TISSUE ENG PT A, V14, P59, DOI 10.1089/ten.a.2007.0058; Pietrzak WS, 2010, J CRANIOFAC SURG, V21, P177, DOI 10.1097/SCS.0b013e3181c50e9c; Scriven SD, 1997, J UROLOGY, V158, P1147, DOI 10.1016/S0022-5347(01)64407-0; Sicari BM, 2012, BIOMATERIALS, V33, P5524, DOI 10.1016/j.biomaterials.2012.04.017; SOUTHGATE J, 1994, LAB INVEST, V71, P583; TEOFILI L, 1992, ANN HEMATOL, V65, P22, DOI 10.1007/BF01715121; Turner AM, 2008, EUR UROL, V54, P1423, DOI 10.1016/j.eururo.2008.03.068; WU XR, 1990, J BIOL CHEM, V265, P19170; YU J, 1990, J CELL BIOL, V111, P1207, DOI 10.1083/jcb.111.3.1207; Zhang YY, 2006, BJU INT, V98, P1100, DOI 10.1111/j.1464-410X.2006.06447.x; Zhang YY, 2009, BIOMATERIALS, V30, P4021, DOI 10.1016/j.biomaterials.2009.04.005; Zhang YY, 2004, TISSUE ENG, V10, P181, DOI 10.1089/107632704322791835; Zhang YY, 2000, J UROLOGY, V164, P928, DOI 10.1016/S0022-5347(05)67220-5	25	7	8	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120244	10.1371/journal.pone.0120244	http://dx.doi.org/10.1371/journal.pone.0120244			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775033	gold, Green Published, Green Submitted			2022-12-27	WOS:000351183500160
J	Zhang, CL; Zhao, HY; Li, J; Liu, HB; Wang, F; Wei, YJ; Su, JZ; Zhang, DW; Liu, TF; Zhang, Y				Zhang, Chunlong; Zhao, Hongyan; Li, Jie; Liu, Hongbo; Wang, Fang; Wei, Yanjun; Su, Jianzhong; Zhang, Dongwei; Liu, Tiefu; Zhang, Yan			The Identification of Specific Methylation Patterns across Different Cancers	PLOS ONE			English	Article							MOLECULAR INTERACTION DATABASE; PROTEIN INTERACTION DATABASE; BREAST-CANCER; DNA METHYLATION; GASTRIC-CANCER; COLORECTAL-CANCER; PROMOTER METHYLATION; EXPRESSION; CELLS; GENES	Abnormal DNA methylation is known as playing an important role in the tumorgenesis. It is helpful for distinguishing the specificity of diagnosis and therapeutic targets for cancers based on characteristics of DNA methylation patterns across cancers. High throughput DNA methylation analysis provides the possibility to comprehensively filter the epigenetics diversity across various cancers. We integrated whole-genome methylation data detected in 798 samples from seven cancers. The hierarchical clustering revealed the existence of cancer-specific methylation pattern. Then we identified 331 differentially methylated genes across these cancers, most of which (266) were specifically differential methylation in unique cancer. A DNA methylation correlation network (DMCN) was built based on the methylation correlation between these genes. It was shown the hubs in the DMCN were inclined to cancer-specific genes in seven cancers. Further survival analysis using the part of genes in the DMCN revealed high-risk group and low-risk group were distinguished by seven biomarkers (PCDHB15, WBSCR17, IGF1, GYPC, CYGB, ACTG2, and PRRT1) in breast cancer and eight biomarkers (ZBTB32, OR51B4, CCL8, TMEFF2, SALL3, GPSM1, MAGEA8, and SALL1) in colon cancer, respectively. At last, a protein-protein interaction network was introduced to verify the biological function of differentially methylated genes. It was shown that MAP3K14, PTN, ACVR1 and HCK sharing different DNA methylation and gene expression across cancers were relatively high degree distribution in PPI network. The study suggested that not only the identified cancer-specific genes provided reference for individual treatment but also the relationship across cancers could be explained by differential DNA methylation.	[Zhang, Chunlong; Li, Jie; Liu, Hongbo; Wang, Fang; Wei, Yanjun; Su, Jianzhong; Zhang, Yan] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China; [Zhao, Hongyan; Liu, Tiefu] Harbin Med Univ, Affiliated Hosp 4, Dept Gastroenterol, Harbin, Peoples R China; [Zhang, Dongwei] Harbin Med Univ, Affiliated Hosp 2, Dept Gen Surg, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Liu, TF (corresponding author), Harbin Med Univ, Affiliated Hosp 4, Dept Gastroenterol, Harbin, Peoples R China.	liutiefu2014@sina.com; tyozhang@ems.hrbmu.edu.cn	Liu, Hongbo/M-2162-2015	Liu, Hongbo/0000-0002-0733-8616	National Natural Science Foundation of China [31371334, 61203262, 61403112, 61402139]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Support was provided by the National Natural Science Foundation of China [no. 31371334, 61203262, 61403112, 61402139]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Magid AF, 2014, ACS MED CHEM LETT, V5, P456, DOI [10.1021/ml5000838, 10.1021/ml500276a]; Antony P, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-901; Anwar S, 2000, EUR J SURG ONCOL, V26, P635, DOI 10.1053/ejso.2000.0974; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Armendariz BG, 2014, EUR J NEUROSCI; Asiaf A, 2014, ASIAN PAC J CANCER P, V15, P6397, DOI 10.7314/APJCP.2014.15.15.6397; Barchitta M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109478; Bediaga NG, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2721; Bernatsky S, 2005, ARTHRITIS RHEUM-US, V52, P1481, DOI 10.1002/art.21029; Beuming T, 2005, BIOINFORMATICS, V21, P827, DOI 10.1093/bioinformatics/bti098; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Choo Kong-Bung, 2011, Malays J Pathol, V33, P61; Correa Candace R, 2009, Eur J Cancer, V45 Suppl 1, P420, DOI 10.1016/S0959-8049(09)70073-5; Dallol A, 2003, CANCER RES, V63, P1054; Daniunaite K, 2014, J UROL; Davis CD, 2004, EXP BIOL MED, V229, P988, DOI 10.1177/153537020422901002; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Delgado-Cruzata L, 2012, EPIGENETICS-US, V7, P868, DOI 10.4161/epi.20830; Deng JY, 2014, AM J CANCER RES, V4, P518; Gallagher WM, 2001, FEBS LETT, V489, P59, DOI 10.1016/S0014-5793(00)02389-9; Ghasemi R, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.31; Giani C, 1996, J CLIN ENDOCR METAB, V81, P990, DOI 10.1210/jc.81.3.990; Gokul Gopinathan, 2013, Subcell Biochem, V61, P597, DOI 10.1007/978-94-007-4525-4_26; Greten FR, 2004, CANCER LETT, V206, P193, DOI 10.1016/j.canlet.2003.08.029; Gu H, 2010, NAT METHODS, V7, P133, DOI 10.1038/nmeth.1414; Guardiola M, 2014, ATHEROSCLEROSIS, V237, P528, DOI 10.1016/j.atherosclerosis.2014.10.029; Guerrero-Setas D, 2013, MODERN PATHOL, V26, P1111, DOI 10.1038/modpathol.2013.32; Isserlin R, 2011, DATABASE-OXFORD, DOI 10.1093/database/baq037; Kang C, 2014, WORLD J GASTROENTERO, V20, P6433, DOI 10.3748/wjg.v20.i21.6433; Kawano H, 2014, ANN SURG ONCOL, V21, pS696, DOI 10.1245/s10434-014-3818-z; Kiga K, 2014, RNA BIOL; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Krupp M, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-53; Li G, 2013, GENE; Li YX, 2014, DNA CELL BIOL, V33, P455, DOI 10.1089/dna.2013.2291; Licata L, 2012, NUCLEIC ACIDS RES, V40, pD857, DOI 10.1093/nar/gkr930; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Litovkin K, 2014, J CANCER RES CLIN, V140, P1849, DOI 10.1007/s00432-014-1738-8; Liu ZQ, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00194; Mahon KL, 2014, BR J CANC; Miura D, 2014, J NIPPON MED SCH, V81, P211, DOI 10.1272/jnms.81.211; MURRAY TI, 1992, CANCER, V69, P2232, DOI 10.1002/1097-0142(19920501)69:9<2232::AID-CNCR2820690904>3.0.CO;2-0; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nakamura J, 2014, WORLD J GASTROENTERO, V20, P11991, DOI 10.3748/wjg.v20.i34.11991; Oh JH, 2014, CANCER PREV RES, V7, P585, DOI 10.1158/1940-6207.CAPR-13-0320; Pagel P, 2005, BIOINFORMATICS, V21, P832, DOI 10.1093/bioinformatics/bti115; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Prasad A, 2008, J BIOL CHEM, V283, P26624, DOI 10.1074/jbc.M800679200; Pu H, 2014, CARCINOGENESIS; Sadr-Nabavi A, 2009, INT J CANCER, V124, P1727, DOI 10.1002/ijc.24108; Sakoda LC, 2008, CANCER EPIDEM BIOMAR, V17, P1066, DOI 10.1158/1055-9965.EPI-07-2680; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Schreiber G, 2010, CURR OPIN CHEM BIOL, V14, P511, DOI 10.1016/j.cbpa.2010.06.165; Soreide K, 2006, BRIT J SURG, V93, P395, DOI 10.1002/bjs.5328; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Sutherland JE, 2003, ANN NY ACAD SCI, V983, P151, DOI 10.1111/j.1749-6632.2003.tb05970.x; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van den Broek AJ, 2014, EUR J HUM GENET; Varisli L, 2013, GENET TEST MOL BIOMA, V17, P562, DOI 10.1089/gtmb.2012.0524; Varley KE, 2013, GENOME RES, V23, P555, DOI 10.1101/gr.147942.112; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Vidigal JA, 2014, TRENDS CELL BIOL; Vivanco I, 2014, BR J CANC; Wang L, 2014, ACTA BIOCH BIOPHYS S; Wang WQ, 2010, EXP CELL RES, V316, P2456, DOI 10.1016/j.yexcr.2010.05.027; Wei Z, 2007, BIOINFORMATICS, V23, P1537, DOI 10.1093/bioinformatics/btm129; Wu BK, 2014, CELL CYCLE, V13, P3222, DOI 10.4161/15384101.2014.950886; Wu MC, 2014, EPIGENETICS-US, V9, P318, DOI 10.4161/epi.27119; Yu XP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-79	69	35	37	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120361	10.1371/journal.pone.0120361	http://dx.doi.org/10.1371/journal.pone.0120361			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774687	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500166
J	Zhang, YT; Zhang, DL; Jiang, YR; Sun, WQ; Wang, Y; Chen, WJ; Li, SH; Shi, L; Shen, XM; Zhang, J; Jiang, F				Zhang, Yunting; Zhang, Donglan; Jiang, Yanrui; Sun, Wanqi; Wang, Yan; Chen, Wenjuan; Li, Shenghui; Shi, Lu; Shen, Xiaoming; Zhang, Jun; Jiang, Fan			Association between Physical Activity and Teacher-Reported Academic Performance among Fifth-Graders in Shanghai: A Quantile Regression	PLOS ONE			English	Article							ACHIEVEMENT; EDUCATION; CHILDREN; INTERVENTIONS; EXERCISE; INCREASE; FITNESS; YOUTH	Introduction A growing body of literature reveals the causal pathways between physical activity and brain function, indicating that increasing physical activity among children could improve rather than undermine their scholastic performance. However, past studies of physical activity and scholastic performance among students often relied on parent-reported grade information, and did not explore whether the association varied among different levels of scholastic performance. Our study among fifth-grade students in Shanghai sought to determine the association between regular physical activity and teacher-reported academic performance scores (APS), with special attention to the differential associational patterns across different strata of scholastic performance. Method A total of 2,225 students were chosen through a stratified random sampling, and a complete sample of 1470 observations were used for analysis. We used a quantile regression analysis to explore whether the association between physical activity and teacher-reported APS differs by distribution of APS. Results Minimal-intensity physical activity such as walking was positively associated with academic performance scores (beta = 0.13, SE = 0.04). The magnitude of the association tends to be larger at the lower end of the APS distribution (beta = 0.24, SE = 0.08) than in the higher end of the distribution (beta = 0.00, SE = 0.07). Conclusion Based upon teacher-reported student academic performance, there is no evidence that spending time on frequent physical activity would undermine student's APS. Those students who are below the average in their academic performance could be worse off in academic performance if they give up minimal-intensity physical activity. Therefore, cutting physical activity time in schools could hurt the scholastic performance among those students who were already at higher risk for dropping out due to inadequate APS.	[Zhang, Yunting; Li, Shenghui; Zhang, Jun] Shanghai Jiao Tong Univ, Sch Publ Hlth, Shanghai 200030, Peoples R China; [Zhang, Yunting] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Child Hlth Advocacy Inst, Shanghai 200030, Peoples R China; [Zhang, Donglan] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Hlth Policy & Management, Los Angeles, CA USA; [Jiang, Yanrui; Sun, Wanqi; Wang, Yan; Chen, Wenjuan; Shen, Xiaoming; Jiang, Fan] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Dev & Behav Pediat, Shanghai 200030, Peoples R China; [Shi, Lu] Clemson Univ, Dept Publ Hlth Sci, Clemson, SC USA; [Shen, Xiaoming; Zhang, Jun] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Shanghai Key Lab Childrens Environm Hlth,Minist E, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of California System; University of California Los Angeles; Shanghai Jiao Tong University; Clemson University; Shanghai Jiao Tong University	Zhang, J (corresponding author), Shanghai Jiao Tong Univ, Sch Publ Hlth, Shanghai 200030, Peoples R China.	zhangjunjim@gmail.com; fanjiang@shsmu.edu.cn	Shi, Lu/AAG-5414-2021; Jiang, Fan/AGX-9052-2022; Jiang, Fan/AHA-6297-2022; Meijer, Anna/K-5118-2016	Jiang, Fan/0000-0003-0634-101X; 	Chinese National Natural Science Foundation [81422040, 81172685]; MOE New Century Excellent Talents [NCET-13-0362]; Ministry of Science and Technology [2010CB535000]; Ministry of Health [201002006]; Shanghai Science and Technology Commission [12411950405, 13QH1401800]; Shanghai Municipal Committee of Education [11SG19]; Shanghai Key Discipline of Public Health	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); MOE New Century Excellent Talents; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health; Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Municipal Committee of Education; Shanghai Key Discipline of Public Health	The study was supported by Chinese National Natural Science Foundation (81422040, 81172685); MOE New Century Excellent Talents (NCET-13-0362); Ministry of Science and Technology (2010CB535000); Ministry of Health (201002006), Shanghai Science and Technology Commission (12411950405, 13QH1401800); Shanghai Municipal Committee of Education (11SG19), Shanghai Key Discipline of Public Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonell C, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3078; Bruni O, 2006, SLEEP MED, V7, P43, DOI 10.1016/j.sleep.2005.09.003; Centers For Disease Control, 2013, MAK DIFF YOUR SCH CH; Chomitz VR, 2009, J SCHOOL HEALTH, V79, P30, DOI 10.1111/j.1746-1561.2008.00371.x; Coe DP, 2006, MED SCI SPORT EXER, V38, P1515, DOI 10.1249/01.mss.0000227537.13175.1b; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; Cooper H, 2007, BATTLE HOMEWORK; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Drollette ES, 2012, MED SCI SPORT EXER, V44, P2017, DOI 10.1249/MSS.0b013e318258bcd5; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Floel A, 2010, NEUROIMAGE, V49, P2756, DOI 10.1016/j.neuroimage.2009.10.043; Good T. L., 2003, LOOKING CLASSROOMS, V9th; Griew P, 2010, PREV MED, V51, P282, DOI 10.1016/j.ypmed.2010.06.009; Group of China Obesity Task Force, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P97; Jago R, 2004, PREV MED, V39, P157, DOI 10.1016/j.ypmed.2004.01.014; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Ji CY, 2009, INT J CARDIOL, V132, P1, DOI 10.1016/j.ijcard.2008.07.003; [姜艳蕊 JIANG YanRui], 2011, [中国心理卫生杂志, Chinese Mental Health Journal], V25, P444; Kahn EB, 2002, AM J PREV MED, V22, P73, DOI 10.1016/S0749-3797(02)00434-8; Lai X., 2007, J PHYS ED, V14, P125; Law M, 2006, DEV MED CHILD NEUROL, V48, P337, DOI 10.1017/S0012162206000740; Ministry of Education of PRC, 2010, OUTL CHIN MED LONG T; Ministry of Education of PRC, 2007, HEALTH MEDICINE RESE, V4, P5; Ministry of Education of PRC, 2011, REG ENS ONE HOUR PHY; Ministry of Health of PRC, 1998, STAND DAIL STUD TIM; Perry JC, 2010, COUNS PSYCHOL, V38, P269, DOI 10.1177/0011000009349272; Ploughman M, 2008, DEV NEUROREHABIL, V11, P236, DOI 10.1080/17518420801997007; Poropat AE, 2009, PSYCHOL BULL, V135, P322, DOI 10.1037/a0014996; Rasberry CN, 2011, PREV MED, V52, pS10, DOI 10.1016/j.ypmed.2011.01.027; Raver CC, 2011, CHILD DEV, V82, P362, DOI 10.1111/j.1467-8624.2010.01561.x; Roger Koenker, 2005, QUANTILEREGRESSION; Sallis JF, 1999, RES Q EXERCISE SPORT, V70, P127, DOI 10.1080/02701367.1999.10608030; Sektnan M, 2010, EARLY CHILD RES Q, V25, P464, DOI 10.1016/j.ecresq.2010.02.005; Shanghai Bureau of Statistics, 2010, SHANGH STAT YB; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Tan C, 2000, ED RES, V12, P30; Tremblay MS, 2000, PEDIATR EXERC SCI, V12, P312, DOI 10.1123/pes.12.3.312; Trudeau F, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-10; van Sluijs EMF, 2007, BMJ-BRIT MED J, V335, P703, DOI 10.1136/bmj.39320.843947.BE; Xu Y, 2002, J PHYS ED, V9, P116	40	12	12	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0115483	10.1371/journal.pone.0115483	http://dx.doi.org/10.1371/journal.pone.0115483			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD6EY	25774525	Green Submitted, Green Published, gold			2022-12-27	WOS:000351183500003
J	Wang, WM; Zhang, Y; Lu, WY; Liu, KY				Wang, Weimin; Zhang, Yao; Lu, Wenyi; Liu, Kaiyan			Mitochondrial Reactive Oxygen Species Regulate Adipocyte Differentiation of Mesenchymal Stem Cells in Hematopoietic Stress Induced by Arabinosylcytosine	PLOS ONE			English	Article							BONE-MARROW ADIPOCYTES; OXIDATIVE STRESS; COMPLEX III; PPAR-GAMMA; ADIPOGENESIS; CHEMOTHERAPY; ENGRAFTMENT; OSTEOBLASTOGENESIS; BIOGENESIS; METABOLISM	Objective The increase in adipocytes induced by chemotherapeutic drugs may play a negative role in hematopoietic recovery. However, the mechanism underlying adipocyte differentiation of mesenchymal stem cells (MSCs) in hematopoietic stress is still unknown. Hence, the involvement of reactive oxygen species (ROS) in adipocyte differentiation under hematopoietic stress was investigated in vitro and in vivo. Methods The roles of cellular ROS in adipogenesis were investigated in vivo through an adipocyte hyperplasia marrow model under hematopoietic stress induced by arabinosylcytosine (AraC) and in vitro via adipocyte differentiation of human MSCs. ROS levels were detected using the CM-H(2)DCFDA probe and Mito-SOX dye. Adipogenesis was evaluated by histopathology and oil red O staining, whereas detection of mRNA levels of antioxidant enzymes and adipogenesis markers was performed using quantitative real-time polymerase chain reaction analysis. Results ROS were found to play an important role in regulating adipocyte differentiation of MSCs by activating peroxisome proliferator-activated receptor gamma (PPAR.,) while the antioxidant N-acetyl-L-cysteine acts through ROS to inhibit adipocyte differentiation. The elevated ROS levels induced by Ara-C were caused by both over-generation of mitochondrial ROS and reduction of antioxidant enzymes (Cu/Zn Superoxide dismutase and catalase). Our findings suggest that a mitochondrial-targeted antioxidant could diminish adipocyte differentiation.	[Wang, Weimin; Zhang, Yao; Lu, Wenyi; Liu, Kaiyan] Peking Univ, Peoples Hosp, Dept Hematol, Beijing 100871, Peoples R China; [Wang, Weimin; Zhang, Yao; Lu, Wenyi; Liu, Kaiyan] Peking Univ, Inst Hematol, Beijing 100871, Peoples R China	Peking University; Peking University	Liu, KY (corresponding author), Peking Univ, Peoples Hosp, Dept Hematol, Beijing 100871, Peoples R China.	liukaiyan@medmail.com.cn			National Natural Science Foundation of China [81270572]; National Basic Research 973 Program [2013CB733701]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research 973 Program(National Basic Research Program of China)	Funding: The authors were supported by fundings from National Natural Science Foundation of China (Grant Number: 81270572) and National Basic Research 973 Program (Grant Number: 2013CB733701). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; Belaid-Choucair Z, 2008, STEM CELLS, V26, P1556, DOI 10.1634/stemcells.2008-0068; Bethel M, 2013, CURR OSTEOPOROS REP, V11, P99, DOI 10.1007/s11914-013-0135-6; Calzadilla P, 2011, INT J MOL SCI, V12, P6936, DOI 10.3390/ijms12106936; Carew JS, 2003, LEUKEMIA, V17, P1437, DOI 10.1038/sj.leu.2403043; Carriere A, 2004, J BIOL CHEM, V279, P40462, DOI 10.1074/jbc.M407258200; Carriere A, 2009, ARTERIOSCL THROM VAS, V29, P1093, DOI 10.1161/ATVBAHA.109.188318; Chen CT, 2008, STEM CELLS, V26, P960, DOI 10.1634/stemcells.2007-0509; DAMON LE, 1994, LEUKEMIA, V8, P535; del Canizo C, 1999, BONE MARROW TRANSPL, V23, P901; del Canizo MC, 1999, HAEMATOLOGICA, V84, P511; DOMENECH J, 1994, BRIT J HAEMATOL, V88, P488, DOI 10.1111/j.1365-2141.1994.tb05064.x; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gagnon A, 2001, J CELL PHYSIOL, V189, P14, DOI 10.1002/jcp.1132; Gimble JM, 1996, BONE, V19, P421, DOI 10.1016/S8756-3282(96)00258-X; Higuchi M, 2013, STEM CELLS DEV, V22, P878, DOI 10.1089/scd.2012.0306; Hole PS, 2011, BLOOD, V117, P5816, DOI 10.1182/blood-2011-01-326025; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Hu LP, 2014, BLOOD, V124, pE45, DOI 10.1182/blood-2014-03-559369; Imhoff BR, 2010, DIFFERENTIATION, V80, P31, DOI 10.1016/j.diff.2010.04.005; Jitschin R, 2014, BLOOD, V123, P2663, DOI 10.1182/blood-2013-10-532200; Kanda Y, 2011, LIFE SCI, V89, P250, DOI 10.1016/j.lfs.2011.06.007; Kim JH, 2014, CELL BIOL INT, V38, P32, DOI 10.1002/cbin.10170; Kong Y, 2013, BIOL BLOOD MARROW TR, V19, P1465, DOI 10.1016/j.bbmt.2013.07.014; Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200; Lee KH, 2004, BONE MARROW TRANSPL, V33, P729, DOI 10.1038/sj.bmt.1704428; Lee OH, 2012, PHYTOTHER RES, V26, P403, DOI 10.1002/ptr.3568; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Nuttall ME, 2004, CURR OPIN PHARMACOL, V4, P290, DOI 10.1016/j.coph.2004.03.002; Regina Jitschin ADH, 2014, BLOOD; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Tormos KV, 2011, CELL METAB, V14, P537, DOI 10.1016/j.cmet.2011.08.007; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Wagegg M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046483; Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; Zhu RJ, 2013, INT J HEMATOL, V97, P58, DOI 10.1007/s12185-012-1233-4	40	64	67	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120629	10.1371/journal.pone.0120629	http://dx.doi.org/10.1371/journal.pone.0120629			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768922	Green Published, gold, Green Submitted			2022-12-27	WOS:000351277500130
J	Wang, XH; Yang, J; Ai, DN; Zheng, YC; Tang, SY; Wang, YT				Wang, Xuehu; Yang, Jian; Ai, Danni; Zheng, Yongchang; Tang, Songyuan; Wang, Yongtian			Adaptive Mesh Expansion Model (AMEM) for Liver Segmentation from CT Image	PLOS ONE			English	Article							REPRESENTATION	This study proposes a novel adaptive mesh expansion model (AMEM) for liver segmentation from computed tomography images. The virtual deformable simplex model (DSM) is introduced to represent the mesh, in which the motion of each vertex can be easily manipulated. The balloon, edge, and gradient forces are combined with the binary image to construct the external force of the deformable model, which can rapidly drive the DSM to approach the target liver boundaries. Moreover, tangential and normal forces are combined with the gradient image to control the internal force, such that the DSM degree of smoothness can be precisely controlled. The triangular facet of the DSM is adaptively decomposed into smaller triangular components, which can significantly improve the segmentation accuracy of the irregularly sharp corners of the liver. The proposed method is evaluated on the basis of different criteria applied to 10 clinical data sets. Experiments demonstrate that the proposed AMEM algorithm is effective and robust and thus outperforms six other up-to-date algorithms. Moreover, AMEM can achieve a mean overlap error of 6.8% and a mean volume difference of 2.7%, whereas the average symmetric surface distance and the root mean square symmetric surface distance can reach 1.3 mm and 2.7 mm, respectively.	[Wang, Xuehu; Yang, Jian; Ai, Danni; Tang, Songyuan; Wang, Yongtian] Beijing Inst Technol, Beijing Engn Res Ctr Mixed Real & Adv Display, Sch Opt & Elect, Beijing 100081, Peoples R China; [Zheng, Yongchang] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Liver Surg, Beijing 100730, Peoples R China; [Zheng, Yongchang] Peking Union Med Coll, Beijing 100730, Peoples R China	Beijing Institute of Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Yang, J (corresponding author), Beijing Inst Technol, Beijing Engn Res Ctr Mixed Real & Adv Display, Sch Opt & Elect, Beijing 100081, Peoples R China.	jyang@bit.edu.cn			National Basic Research Program of China [2010CB732505, 2013CB328806]; Key Projects in the National Science & Technology Pillar Program [2013BAI01B01]; National Hi-Tech Research and Development Program [2013AA013703]	National Basic Research Program of China(National Basic Research Program of China); Key Projects in the National Science & Technology Pillar Program; National Hi-Tech Research and Development Program(National High Technology Research and Development Program of China)	This work was supported by the National Basic Research Program of China (2010CB732505, 2013CB328806), the Key Projects in the National Science & Technology Pillar Program (2013BAI01B01) and the National Hi-Tech Research and Development Program (2013AA013703). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anter AM, 2013, FED CONF COMPUT SCI, P193; Baghdadi L, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-237; Belaid A, 2011, IEEE T INF TECHNOL B, V15, P138, DOI 10.1109/TITB.2010.2090889; Chen Y, 2012, PHYS MED BIOL, V57, DOI 10.1088/0031-9155/57/9/2667; Chen Y, 2011, EUR J RADIOL, V80, pE42, DOI 10.1016/j.ejrad.2010.07.003; Chi Y, 2007, P MICCAI WORKSH 3D S, P167; Ciecholewski M, 2014, J SIGNAL PROCESS SYS, V74, P151, DOI 10.1007/s11265-013-0755-1; Delingette H., 1994, Proceedings of the 1994 IEEE Workshop on Motion of Non-Rigid and Articulated Objects (Cat. No.94TH0671-8), P152, DOI 10.1109/MNRAO.1994.346242; Delingette H, 1999, INT J COMPUT VISION, V32, P111, DOI 10.1023/A:1008157432188; DELINGETTE H, 1994, 1994 IEEE COMPUTER SOCIETY CONFERENCE ON COMPUTER VISION AND PATTERN RECOGNITION, PROCEEDINGS, P856, DOI 10.1109/CVPR.1994.323913; Gao Y, 2012, MED IMAGE ANAL, V16, P1216, DOI 10.1016/j.media.2012.06.002; Goldenstein S, 2005, COMPUT GRAPH FORUM, V24, P729, DOI 10.1111/j.1467-8659.2005.00898.x; HEBERT M, 1995, IEEE T PATTERN ANAL, V17, P681, DOI 10.1109/34.391410; Heimann T., 2007, 3D SEGMENTATION CLIN, P161; Heimann T, 2009, IEEE T MED IMAGING, V28, P1251, DOI 10.1109/TMI.2009.2013851; Heimann T, 2009, MED IMAGE ANAL, V13, P543, DOI 10.1016/j.media.2009.05.004; Kainmuller D., 2007, P MICCAI WORKSHOP 3D, V109, P116; KASS M, 1987, INT J COMPUT VISION, V1, P321, DOI 10.1007/BF00133570; Ling H., 2008, IEEE C COMP VIS PATT, P1, DOI DOI 10.1109/CVPR.2008.4587393; Mainenti PP, 2010, ABDOM IMAGING, V35, P511, DOI 10.1007/s00261-009-9555-2; McInerney T., 1993, [1993] Proceedings Fourth International Conference on Computer Vision, P518, DOI 10.1109/ICCV.1993.378169; Mohamadnejad M, 2011, GASTROINTEST ENDOSC, V73, P71, DOI 10.1016/j.gie.2010.08.050; Montagnat J, 1997, LECT NOTES COMPUT SC, V1205, P13, DOI 10.1007/BFb0029220; Muller M, 2007, J VIS COMMUN IMAGE R, V18, P109, DOI 10.1016/j.jvcir.2007.01.005; Okada T, 2008, ACAD RADIOL, V15, P1390, DOI 10.1016/j.acra.2008.07.008; Oliveira DAB, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-30; Rikxoort E., 2007, P MICCAI WORKSH 3 D, P101; Rusko L, 2009, MED IMAGE ANAL, V13, P871, DOI 10.1016/j.media.2009.07.009; Saddi M., 2007, P MICCAI WORKSH 3D S, P207; Seghers D., 2007, P MICCAI WORKSH 3 D, P135; Soler L, 2001, Comput Aided Surg, V6, P131, DOI 10.1002/igs.1016; Zhang ST, 2012, MED IMAGE ANAL, V16, P1385, DOI 10.1016/j.media.2012.07.007; Zhang X, 2010, IEEE T BIO-MED ENG, V57, P2622, DOI 10.1109/TBME.2010.2056369; Zheng CX, 2012, ACM T GRAPHIC, V31, DOI 10.1145/2185520.2185594	34	13	13	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118064	10.1371/journal.pone.0118064	http://dx.doi.org/10.1371/journal.pone.0118064			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25769030	gold, Green Published, Green Submitted			2022-12-27	WOS:000351277500019
J	Booij, L; Szyf, M; Carballedo, A; Frey, EM; Morris, D; Dymov, S; Vaisheva, F; Ly, V; Fahey, C; Meaney, J; Gill, M; Frodl, T				Booij, Linda; Szyf, Moshe; Carballedo, Angela; Frey, Eva-Maria; Morris, Derek; Dymov, Sergiy; Vaisheva, Farida; Ly, Victoria; Fahey, Ciara; Meaney, James; Gill, Michael; Frodl, Thomas			DNA Methylation of the Serotonin Transporter Gene in Peripheral Cells and Stress-Related Changes in Hippocampal Volume: A Study in Depressed Patients and Healthy Controls	PLOS ONE			English	Article							IOWA ADOPTEE SAMPLE; EARLY-LIFE STRESS; SLC6A4 METHYLATION; BRAIN-DEVELOPMENT; MAJOR DEPRESSION; CHILDHOOD TRAUMA; ENVIRONMENT; ABUSE; RISK; METAANALYSIS	Serotonin plays an important role in the etiology of depression. Serotonin is also crucial for brain development. For instance, animal studies have demonstrated that early disruptions in the serotonin system affect brain development and emotion regulation in later life. A plausible explanation is that environmental stressors reprogram the serotonin system through epigenetic processes by altering serotonin system gene expression. This in turn may affect brain development, including the hippocampus, a region with dense serotonergic innervations and important in stress-regulation. The aim of this study was to test whether greater DNA methylation in specific CpG sites at the serotonin transporter promoter in peripheral cells is associated with childhood trauma, depression, and smaller hippocampal volume. We were particularly interested in those CpG sites whose state of methylation in peripheral cells had previously been associated with in vivo measures of brain serotonin synthesis. Thirty-three adults with Major Depressive Disorder (MDD) (23 females) and 36 matched healthy controls (21 females) were included in the study. Depressive symptoms, childhood trauma, and high-resolution structural MRI for hippocampal volume were assessed. Sitespecific serotonin transporter methylation was assessed using pyrosequencing. Childhood trauma, being male, and smaller hippocampal volume were independently associated with greater peripheral serotonin transporter methylation. Greater serotonin transporter methylation in the depressed group was observed only in SSRI-treated patients. These results suggest that serotonin transporter methylation may be involved in physiological gene-environment interaction in the development of stress-related brain alterations. The results provide some indications that site-specific serotonin transporter methylation may be a biomarker for serotonin-associated stress-related psychopathology.	[Booij, Linda] Queens Univ, Dept Psychiat & Psychol, Kingston, ON, Canada; [Booij, Linda] Hop St Justine, Res Ctr, Montreal, PQ H3T 1C5, Canada; [Booij, Linda] Univ Montreal, Montreal, PQ, Canada; [Booij, Linda] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Szyf, Moshe; Dymov, Sergiy; Vaisheva, Farida; Ly, Victoria] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Carballedo, Angela; Morris, Derek; Gill, Michael; Frodl, Thomas] Univ Dublin, Trinity Coll Dublin, Dept Psychiat, Dublin, Ireland; [Frey, Eva-Maria; Frodl, Thomas] Univ Regensburg, Dept Psychiat & Psychotherapy, D-93053 Regensburg, Germany; [Fahey, Ciara; Gill, Michael] Univ Dublin, Neuropsychiat Genet Res Grp, Dept Psychiat, Trinity Coll Dublin, Dublin, Ireland; [Fahey, Ciara; Gill, Michael] Univ Dublin, Inst Mol Med, Trinity Coll Dublin, Dublin, Ireland; [Meaney, James; Frodl, Thomas] St James Hosp, Ctr Adv Med Imaging, Dublin 8, Ireland; [Meaney, James; Frodl, Thomas] Univ Dublin Trinity Coll, Dublin 2, Ireland; [Gill, Michael; Frodl, Thomas] Univ Dublin, Trinity Coll Dublin, Inst Neurosci, Dublin, Ireland	Queens University - Canada; Universite de Montreal; Universite de Montreal; McGill University; McGill University; Trinity College Dublin; University of Regensburg; Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; Trinity College Dublin	Booij, L (corresponding author), Queens Univ, Dept Psychiat & Psychol, Kingston, ON, Canada.	linda.booij@queensu.ca	Frodl, Thomas Stefan/GQZ-9107-2022; Frodl, Thomas/D-8118-2012	Frodl, Thomas Stefan/0000-0002-8113-6959; Frodl, Thomas/0000-0002-8113-6959; Meaney, James FM/0000-0003-1596-4972; Gill, Michael/0000-0003-0206-5337	New Investigator Award from the Canadian Institutes of Health Research (CIHR); GlaxoSmithKline-Canadian Institutes of Health Research (GSK-CIHR) professorship in pharmacology; Fonds de Recherche en Sante-Quebec [25223]; CIHR [106422]; Brain and Behavior Research Foundation-NARSAD Young Investigator Award [19560]; Science Foundation Ireland (SFI) [G20330]	New Investigator Award from the Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); GlaxoSmithKline-Canadian Institutes of Health Research (GSK-CIHR) professorship in pharmacology(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche en Sante-Quebec; CIHR(Canadian Institutes of Health Research (CIHR)); Brain and Behavior Research Foundation-NARSAD Young Investigator Award; Science Foundation Ireland (SFI)(Science Foundation Ireland)	Dr. Linda Booij is supported by a New Investigator Award from the Canadian Institutes of Health Research (CIHR). Dr. Moshe Szyf is supported by a GlaxoSmithKline-Canadian Institutes of Health Research (GSK-CIHR) professorship in pharmacology. The DNA methylation analyses were facilitated by grants from the Fonds de Recherche en Sante-Quebec (25223), CIHR (106422), and a Brain and Behavior Research Foundation-NARSAD Young Investigator Award (19560) awarded to Dr. Booij. Furthermore, the clinical part of the study with patient recruitment, neuroimaging and genetic data analysis was supported by Science Foundation Ireland (SFI, G20330) within a Stokes Professorship grant to Dr. Thomas Frodl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorge MS, 2004, SCIENCE, V306, P879, DOI 10.1126/science.1101678; Avila L, 2010, PLACENTA, V31, P1070, DOI 10.1016/j.placenta.2010.09.011; Beach SRH, 2011, PSYCHOSOM MED, V73, P83, DOI 10.1097/PSY.0b013e3181fdd074; Beach SRH, 2010, AM J MED GENET B, V153B, P710, DOI 10.1002/ajmg.b.31028; Beck A., 1996, PEARSON; Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0; BERNSTEIN DP, 1994, AM J PSYCHIAT, V151, P1132, DOI 10.1176/ajp.151.8.1132; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bonnin A, 2012, NEUROPSYCHOPHARMACOL, V37, P299, DOI 10.1038/npp.2011.194; Booij L, 2015, J PSYCHIATR NEUROSCI, V40, P5, DOI 10.1503/jpn.140099; Booij L, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0251; Carboni L, 2010, PROG NEURO-PSYCHOPH, V34, P1037, DOI 10.1016/j.pnpbp.2010.05.019; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Chal V, 2005, J CLIN LAB ANAL, V19, P182, DOI 10.1002/jcla.20075; Cohen J., 2003, APPLIED MULTIPLE REG; Cohen J., 2003, APPL MULTIPLE REGRES; Dannlowski U, 2014, HUM BRAIN MAPP, V35, P5356, DOI 10.1002/hbm.22555; Esaki T, 2005, P NATL ACAD SCI USA, V102, P5582, DOI 10.1073/pnas.0501509102; Frodl T, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.14; Frodl T, 2013, NEUROBIOL DIS, V52, P24, DOI 10.1016/j.nbd.2012.03.012; Frodl T, 2010, NEUROPSYCHOPHARMACOL, V35, P1383, DOI 10.1038/npp.2010.8; Gabory A, 2009, MOL CELL ENDOCRINOL, V304, P8, DOI 10.1016/j.mce.2009.02.015; Gold SM, 2010, BIOL PSYCHIAT, V68, P553, DOI 10.1016/j.biopsych.2010.04.025; Gould E, 1999, NEUROPSYCHOPHARMACOL, V21, pS46, DOI 10.1016/S0893-133X(99)00045-7; HAMILTON M, 1969, PSYCHIAT NEUROL NEUR, V72, P201; Hariri AR, 2006, TRENDS COGN SCI, V10, P182, DOI 10.1016/j.tics.2006.02.011; Heim C, 2001, BIOL PSYCHIAT, V49, P1023, DOI 10.1016/S0006-3223(01)01157-X; Heim C, 2012, EXP NEUROL, V233, P102, DOI 10.1016/j.expneurol.2011.10.032; Heyn H, 2012, P NATL ACAD SCI USA, V109, P10522, DOI 10.1073/pnas.1120658109; Huang YS, 2013, BIOL PSYCHIAT, V74, P62, DOI 10.1016/j.biopsych.2013.01.005; Kang HJ, 2013, PROG NEURO-PSYCHOPH, V44, P23, DOI 10.1016/j.pnpbp.2013.01.006; Karg K, 2011, ARCH GEN PSYCHIAT, V68, P444, DOI 10.1001/archgenpsychiatry.2010.189; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Mahar I, 2014, NEUROSCI BIOBEHAV R, V38, P173, DOI 10.1016/j.neubiorev.2013.11.009; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; McKinnon MC, 2009, J PSYCHIATR NEUROSCI, V34, P41; Nestler EJ, 2014, JAMA PSYCHIAT, V71, P454, DOI 10.1001/jamapsychiatry.2013.4291; Philibert R, 2007, AM J MED GENET B, V144B, P101, DOI 10.1002/ajmg.b.30414; Philibert RA, 2008, AM J MED GENET B, V147B, P543, DOI 10.1002/ajmg.b.30657; Rabl U, 2014, J NEUROSCI, V34, P9917, DOI 10.1523/JNEUROSCI.3113-13.2014; Risch N, 2009, JAMA-J AM MED ASSOC, V301, P2462, DOI 10.1001/jama.2009.878; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; Szyf M, 2009, BBA-GEN SUBJECTS, V1790, P878, DOI 10.1016/j.bbagen.2009.01.009; Tang M, 2014, HIPPOCAMPUS, V24, P493, DOI 10.1002/hipo.22242; Teschendorff AE, 2010, GENOME RES, V20, P440, DOI 10.1101/gr.103606.109; Uddin M, 2013, DEPRESS ANXIETY, V30, P1151, DOI 10.1002/da.22167; Uher R, 2011, J AFFECT DISORDERS, V135, P56, DOI 10.1016/j.jad.2011.03.010; van Ijzendoorn MH, 2010, BIOL PSYCHIAT, V68, P405, DOI 10.1016/j.biopsych.2010.05.008; Van Leemput K, 2009, HIPPOCAMPUS, V19, P549, DOI 10.1002/hipo.20615; Wang DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039501; Wang YG, 2011, J NEUROTRAUM, V28, P259, DOI 10.1089/neu.2010.1648; Wankerl M, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.37; Zhao JY, 2013, PSYCHOSOM MED, V75, P523, DOI 10.1097/PSY.0b013e3182924cf4	53	89	91	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119061	10.1371/journal.pone.0119061	http://dx.doi.org/10.1371/journal.pone.0119061			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781010	Green Published, gold, Green Submitted			2022-12-27	WOS:000351284600047
J	Cao, DH; Jiang, J; Tsukamoto, T; Liu, RM; Ma, L; Jia, ZF; Kong, F; Oshima, M; Cao, XY				Cao, Donghui; Jiang, Jing; Tsukamoto, Tetsuya; Liu, Ruming; Ma, Lin; Jia, Zhifang; Kong, Fei; Oshima, Masanobu; Cao, Xueyuan			Canolol Inhibits Gastric Tumors Initiation and Progression through COX-2/PGE2 Pathway in K19-C2mE Transgenic Mice	PLOS ONE			English	Article							PROSTAGLANDIN E-2; 4-VINYL-2,6-DIMETHOXYPHENOL CANOLOL; OXIDATIVE STRESS; HELICOBACTER-PYLORI; COLORECTAL-CANCER; CARCINOMA CELLS; COLON-CANCER; RECEPTOR; PREVENTION; EP2	4-vinyl-2, 6-dimethoxyphenol (canolol) is an antioxidant phenolic compound extracted from crude canola oil. In current research, K19-C2mE transgenic mice, developing hyperplastic tumors spontaneously in the glandular stomach, were used to study the mechanisms involved in the anti-inflammation and anti-tumor effects of canolol. Tg mice receiving canolol diet had a reduced tumor incidence, to 41.2%, compared with Non-treatment Tg mice, 77.8% of which had gastric tumor (P= 0.002). Besides that, the mean tumor diameter was decreased from 6.5mm to 4.5mm (P< 0.001) after canolol administration. COX-2/PGE2 pathway is known to play pivotal role in inflammation-induced gastric tumorigenesis. The neutrophils and lymphocytes infiltration was suppressed significantly, and the mRNA levels of the proinflammatory cytokines COX-2, IL-1 beta and IL-12b were also downregulated in gastric mucosa. Additionally, immunohistochemical analysis showed that COX-2, EP2, Gas and beta-catenin, key factors involving in PGE2 signal transduction, were positive staining with higher H scores in Non-treatment Tg mice, while the expressions were suppressed significantly by 0.1% canolol (P< 0.001). In addition, tumor-suppressor miR-7 was reactivated after canolol administration, and COX-2 was showed to be a functional target of miR-7 to suppress the tumor progression. In conclusion, canolol could inhibit the gastritis-related tumor initiation and progression, and the suppression effect was correlated with the blocking up of canonical COX-2/PGE2 signaling pathway and might be regulated by miR-7.	[Cao, Donghui; Jiang, Jing; Jia, Zhifang; Kong, Fei] Jilin Univ, Hosp 1, Div Clin Epidemiol, Changchun 130021, Jilin, Peoples R China; [Tsukamoto, Tetsuya] Fujita Hlth Univ, Sch Med, Dept Diagnost Pathol 1, Toyoake, Aichi 47011, Japan; [Liu, Ruming; Ma, Lin; Cao, Xueyuan] Jilin Univ, Hosp 1, Dept Gastr & Colorectal Surg, Changchun 130021, Jilin, Peoples R China; [Oshima, Masanobu] Kanazawa Univ, Canc Res Inst, Kanazawa, Ishikawa 920, Japan	Jilin University; Fujita Health University; Jilin University; Kanazawa University	Cao, XY (corresponding author), Jilin Univ, Hosp 1, Dept Gastr & Colorectal Surg, Changchun 130021, Jilin, Peoples R China.	caoxy@aliyun.com	Oshima, Masanobu/F-9958-2014; Tsukamoto, Tetsuya/ABD-4397-2020	Oshima, Masanobu/0000-0002-3304-0004; Tsukamoto, Tetsuya/0000-0002-7502-8724	National Natural Science Foundation of China [81273065, 81072369]; Norman Bethune Program of Jilin University [2013025]; Youth Foundation of The First Hospital of Jilin University [JDYY42013018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Norman Bethune Program of Jilin University; Youth Foundation of The First Hospital of Jilin University	This work was supported by National Natural Science Foundation of China (81273065, XYC), National Natural Science Foundation of China (81072369, JJ), Norman Bethune Program of Jilin University (2013025, JJ), The Youth Foundation of The First Hospital of Jilin University (JDYY42013018, DHC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao X, 2008, INT J CANCER, V122, P1445, DOI 10.1002/ijc.23245; Cathcart MC, 2012, BBA-REV CANCER, V1825, P49, DOI 10.1016/j.bbcan.2011.09.004; Dong X, 2011, MOL VIS, V17, P2040; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Fang J, 2013, CARCINOGENESIS, V34, P2833, DOI 10.1093/carcin/bgt309; Fang YX, 2012, HEPATOLOGY, V55, P1852, DOI 10.1002/hep.25576; Fujino H, 2002, J BIOL CHEM, V277, P2614, DOI 10.1074/jbc.M109440200; Harris RE, 2005, ONCOL REP, V13, P559; Hedin L, 2013, ROLE OF PROSTAGLANDI; Hull MA, 2004, MOL CANCER THER, V3, P1031; Jiang JX, 2013, J PHARMACOL EXP THER, V344, P360, DOI 10.1124/jpet.112.200444; Jiang J, 2013, ONCOL LETT, V5, P1562, DOI 10.3892/ol.2013.1230; Kasbohm EA, 2005, J BIOL CHEM, V280, P11583, DOI 10.1074/jbc.M414423200; Kong D, 2012, ONCOGENE, V31, P3949, DOI 10.1038/onc.2011.558; Kong XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041523; Kuper H, 2000, J INTERN MED, V248, P171, DOI 10.1046/j.1365-2796.2000.00742.x; Kuwahara H, 2009, MICROBIOL IMMUNOL, V53, P1, DOI 10.1111/j.1348-0421.2008.00089.x; Manuel D, 2012, BIOCHEM J, V443, P451, DOI [10.1042/BJ20111052, DOI 10.1042/BJ20111052]; MCCARTY KS, 1985, ARCH PATHOL LAB MED, V109, P716; Oshima H, 2004, EMBO J, V23, P1669, DOI 10.1038/sj.emboj.7600170; Pai R, 2002, NAT MED, V8, P289, DOI 10.1038/nm0302-289; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Rial NS, 2009, INT J CANCER, V124, P2270, DOI 10.1002/ijc.24226; Seno H, 2002, CANCER RES, V62, P506; Shao JY, 2005, J BIOL CHEM, V280, P26565, DOI 10.1074/jbc.M413056200; Sheng HM, 2001, J BIOL CHEM, V276, P18075, DOI 10.1074/jbc.M009689200; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Tsai JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086537; Tsuchiya S, 2003, GENES CELLS, V8, P747, DOI 10.1046/j.1365-2443.2003.00672.x; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang D, 2006, GUT, V55, P115, DOI 10.1136/gut.2004.047100; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Xu L, 2012, MOL BIOL CELL	34	20	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120938	10.1371/journal.pone.0120938	http://dx.doi.org/10.1371/journal.pone.0120938			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781635	Green Submitted, Green Published, gold			2022-12-27	WOS:000351284600191
J	Dou, YL; Fu, BQ; Sun, R; Li, WT; Hu, WF; Tian, ZG; Wei, HM				Dou, Yaling; Fu, Binqing; Sun, Rui; Li, Wenting; Hu, Wanfu; Tian, Zhigang; Wei, Haiming			Influenza Vaccine Induces Intracellular Immune Memory of Human NK Cells	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; GAMMA-INTERFERON; VIRUS; INFECTION; RECOGNITION; ACTIVATION; RESPONSES; SUBSET; NKP46; HEMAGGLUTININS	Influenza vaccines elicit antigen-specific antibodies and immune memory to protect humans from infection with drift variants. However, what supports or limits vaccine efficacy and duration is unclear. Here, we vaccinated healthy volunteers with annual vaccine formulations and investigated the dynamics of T cell, natural killer (NK) cell and antibody responses upon restimulation with heterologous or homologous influenza virus strains. Influenza vaccines induced potential memory NK cells with increased antigen-specific recall IFN-gamma responses during the first 6 months. In the absence of significant changes in other NK cell markers (CD45RO, NKp44, CXCR6, CD57, NKG2C, CCR7, CD62L and CD27), influenza vaccines induced memory NK cells with the distinct feature of intracellular NKp46 expression. Indeed, surface NKp46 was internalized, and the dynamic increase in NKp46(intracellular)(+)CD56(dim) NK cells positively correlated with increased IFN-gamma production to influenza virus restimulation after vaccination. In addition, anti-NKp46 antibodies blocked IFN-gamma responses. These findings provide insights into a novel mechanism underlying vaccineinduced immunity and NK-related diseases, which may help to design persisting and universal vaccines in the future.	[Dou, Yaling; Fu, Binqing; Sun, Rui; Li, Wenting; Tian, Zhigang; Wei, Haiming] Univ Sci & Technol China, Inst Immunol, Sch Life Sci, Hefei 230026, Peoples R China; [Dou, Yaling; Fu, Binqing; Sun, Rui; Li, Wenting; Tian, Zhigang; Wei, Haiming] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China; [Hu, Wanfu] Anhui Prov Ctr Dis Control & Prevent, Hefei, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Wei, HM (corresponding author), Univ Sci & Technol China, Inst Immunol, Sch Life Sci, Hefei 230026, Peoples R China.	tzg@ustc.edu.cn; ustcwhm@ustc.edu.edu.cn	Dou, Yaling/AHB-7820-2022; Tian, Zhigang/J-3512-2013		Natural Science Foundation of China [81330071, 31021061]; National Basic Research Project (973 Project) [2012CB519004, 2013CB944902, 2013CB530506]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Project (973 Project)(National Basic Research Program of China)	This work was supported by grants from the Natural Science Foundation of China (#81330071, #31021061) and the National Basic Research Project (973 Project 2012CB519004, 2013CB944902, 2013CB530506). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Careem MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032821; Arnon TI, 2001, EUR J IMMUNOL, V31, P2680, DOI 10.1002/1521-4141(200109)31:9<2680::AID-IMMU2680>3.0.CO;2-A; Bar-On Y, 2014, J INFECT DIS, V210, P410, DOI 10.1093/infdis/jiu094; Berahovich RD, 2006, J IMMUNOL, V177, P7833, DOI 10.4049/jimmunol.177.11.7833; Bjorkstrom NK, 2011, J EXP MED, V208, P13, DOI 10.1084/jem.20100762; Bot A, 1998, J VIROL, V72, P6637, DOI 10.1128/JVI.72.8.6637-6645.1998; Cooper MA, 2009, P NATL ACAD SCI USA, V106, P1915, DOI 10.1073/pnas.0813192106; Doherty PC, 2006, NAT IMMUNOL, V7, P449, DOI 10.1038/ni1343; Dougan SK, 2013, NATURE, V503, P406, DOI 10.1038/nature12637; Draghi M, 2007, J IMMUNOL, V178, P2688, DOI 10.4049/jimmunol.178.5.2688; ENNIS FA, 1981, LANCET, V2, P891; Fehniger TA, 2007, IMMUNITY, V26, P798, DOI 10.1016/j.immuni.2007.04.010; Fu XY, 2011, IMMUNOLOGY, V134, P41, DOI 10.1111/j.1365-2567.2011.03464.x; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Guo HL, 2009, IMMUNOL CELL BIOL, V87, P579, DOI 10.1038/icb.2009.60; Hanna J, 2004, J CLIN INVEST, V114, P1612, DOI 10.1172/JCI200422787; He XS, 2006, J VIROL, V80, P11756, DOI 10.1128/JVI.01460-06; He XS, 2004, J CLIN INVEST, V114, P1812, DOI 10.1172/JCI200422797; Horowitz A, 2012, J IMMUNOL, V188, P5054, DOI 10.4049/jimmunol.1102710; Horowitz A, 2010, J IMMUNOL, V185, P2808, DOI 10.4049/jimmunol.1000844; Jiang XJ, 2013, CELL MOL IMMUNOL, V10, P196, DOI 10.1038/cmi.2013.8; Jost S, 2011, IMMUNOLOGY, V132, P516, DOI 10.1111/j.1365-2567.2010.03394.x; Juelke K, 2010, BLOOD, V116, P1299, DOI 10.1182/blood-2009-11-253286; Lall S, 2014, CELL, V156, P381, DOI DOI 10.1016/J.CELL.2014.01.036; Lall S, 2014, CELL, V156, P383; Long BR, 2008, CLIN VACCINE IMMUNOL, V15, P120, DOI 10.1128/CVI.00357-07; Lopez-Verges S, 2011, P NATL ACAD SCI USA, V108, P14725, DOI 10.1073/pnas.1110900108; Lopez-Verges S, 2010, BLOOD, V116, P3865, DOI 10.1182/blood-2010-04-282301; Ma Y, 2013, IMMUNITY, V38, P729, DOI 10.1016/j.immuni.2013.03.003; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Mao HW, 2010, J VIROL, V84, P4148, DOI 10.1128/JVI.02340-09; Mao HW, 2009, J VIROL, V83, P9215, DOI 10.1128/JVI.00805-09; Min-Oo G, 2013, TRENDS IMMUNOL, V34, P251, DOI 10.1016/j.it.2013.02.005; Nabekura T, 2014, IMMUNITY; Narni-Mancinelli E, 2012, SCIENCE, V335, P344, DOI 10.1126/science.1215621; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; Romee R, 2012, BLOOD, V120, P4751, DOI 10.1182/blood-2012-04-419283; Slutter B, 2013, J IMMUNOL, V190, P3854, DOI 10.4049/jimmunol.1202790; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; van Helden MJG, 2012, J IMMUNOL, V189, P2333, DOI 10.4049/jimmunol.1200008; Vossen MTM, 2008, J IMMUNOL, V180, P3739, DOI 10.4049/jimmunol.180.6.3739	43	47	49	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0121258	10.1371/journal.pone.0121258	http://dx.doi.org/10.1371/journal.pone.0121258			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781472	Green Published, gold, Green Submitted			2022-12-27	WOS:000351284600200
J	Yu, J; Liang, XL; Wang, ZK; Guo, X; Sun, TM; Guo, XJ				Yu, Jia; Liang, Xinlei; Wang, Zhaokun; Guo, Xin; Sun, Tiemin; Guo, Xingjie			Separation of Folinic Acid Diastereomers in Capillary Electrophoresis Using a New Cationic beta-Cyclodextrin Derivative	PLOS ONE			English	Article							CHIRAL SEPARATION; ELECTROMIGRATION TECHNIQUES; THEORETICAL ASPECTS; ENANTIOMERS; SINGLE	A method for the separation of folinic acid diastereomers by capillary electrophoresis in chiral separation media was developed. Aiming to achieve a good separation of the anionic analytes, a newly synthesized cationic beta-cyclodextrin derivative, mono-6-deoxy-6-piperdine-beta-cyclodextrin, was applied as the chiral selector. The effect of background electrolyte pH, the concentration of the cyclodextrin additive, and organic modifier on the separation was investigated. A good separation of folinic acid diastereomers was obtained with 30 mmol/L phosphate buffer at pH 6.50 containing 6.0 mmol/L of mono-6-deoxy-6-piperdine-beta-cyclodextrin in 10% acetonitrile. Based on the capillary electrophoresis data, the binding constants of each diastereomer with mono-6-deoxy-6-piperdine-beta-cyclodextrin were determined. Moreover, a computational modeling study, using the semi-empirical PM3 method, was used to discuss the possible mechanism of separation of folinic acid with mono-6deoxy-6-piperdine-beta-cyclodextrin.	[Yu, Jia; Liang, Xinlei; Wang, Zhaokun; Guo, Xingjie] Shenyang Pharmaceut Univ, Minist Educ, Sch Pharm, Dept Pharmaceut Anal, Shenyang, Liaoning Provin, Peoples R China; [Guo, Xin; Sun, Tiemin] Shenyang Pharmaceut Univ, Minist Educ, Key Lab Struct Based Drug Design & Discovery, Shenyang, Liaoning Provin, Peoples R China	Shenyang Pharmaceutical University; Shenyang Pharmaceutical University	Guo, XJ (corresponding author), Shenyang Pharmaceut Univ, Minist Educ, Sch Pharm, Dept Pharmaceut Anal, Shenyang, Liaoning Provin, Peoples R China.	syykdx410@163.com			National Natural Science Foundation of China [81273476]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81273476). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Azzam KM, 2010, ANAL CHIM ACTA, V674, P249, DOI 10.1016/j.aca.2010.06.046; Aturki Z, 2003, J SEP SCI, V26, P844, DOI 10.1002/jssc.200301480; Bertrand R, 1988, Adv Exp Med Biol, V244, P13; Gubitz G, 2008, J CHROMATOGR A, V1204, P140, DOI 10.1016/j.chroma.2008.07.071; Koval D, 2003, J SEP SCI, V26, P653, DOI 10.1002/jssc.200301382; PENN SG, 1995, J PHYS CHEM-US, V99, P3875, DOI 10.1021/j100011a065; Scriba GKE, 2002, J PHARMACEUT BIOMED, V27, P373, DOI 10.1016/S0731-7085(01)00653-7; Servais AC, 2012, J CHROMATOGR A, V1232, P59, DOI 10.1016/j.chroma.2011.10.010; STRAW JA, 1984, CANCER RES, V44, P3114; Suliman FO, 2012, J MOL STRUCT, V1019, P43, DOI 10.1016/j.molstruc.2012.03.055; Vespalec R, 2000, CHEM REV, V100, P3715, DOI 10.1021/cr9411583; Wan H, 2000, J CHROMATOGR A, V875, P43, DOI 10.1016/S0021-9673(99)01209-1; WREN SAC, 1992, J CHROMATOGR, V603, P235, DOI 10.1016/0021-9673(92)85366-2; WREN SAC, 1993, J CHROMATOGR, V635, P113, DOI 10.1016/0021-9673(93)83120-H; Xiao Y, 2010, J SEP SCI, V33, P1797, DOI 10.1002/jssc.200900732; Yu J, 2014, BIOMED CHROMATOGR, V28, P868, DOI 10.1002/bmc.3187	16	8	8	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120216	10.1371/journal.pone.0120216	http://dx.doi.org/10.1371/journal.pone.0120216			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781478	gold, Green Published, Green Submitted			2022-12-27	WOS:000351284600140
J	Amat-ur-Rasool, H; Saghir, A; Idrees, M				Amat-ur-Rasool, Hafsa; Saghir, Anam; Idrees, Muhammad			Computational Prediction and Analysis of Envelop Glycoprotein Epitopes of DENV-2 and DENV-3 Pakistani Isolates: A First Step towards Dengue Vaccine Development	PLOS ONE			English	Article							WEST-NILE-VIRUS; NEUTRALIZING EPITOPES; DOMAIN-III; ORGANIZATION; EXPRESSION; PROTEINS	Dengue fever of tropics is a mosquito transmitted devastating disease caused by dengue virus (DENV). There is no effective vaccine available, so far, against any of its four serotypes (DENV-1, DENV-2, DENV-3, and DENV-4). There is a need for the development of preventive and therapeutic vaccines against DENV to decrease the prevalence of dengue fever, especially in Pakistan. In this research, linear and conformational B-cell epitopes of envelope glycoprotein of DENV-2 and DENV-3 (the most prevalent serotypes in Pakistan) were predicted. We used Kolaskar and Tongaonkar method for linear epitope prediction, Emini's method for surface accessibility prediction and Karplus and Schulz's algorithm for flexibility determination. To propose three dimensional epitopes, the E proteins for both serotypes were homology modeled by using Phyre2 V 2.0 server, and ElliPro was used for the prediction of surface epitopes on their globular structure. Total 21 and 19 linear epitopes were predicted for DENV-2 and DENV-3 Pakistani isolates respectively. Whereas, 5 and 4 discontinuous epitopes were proposed for DENV-2 and DENV-3 Pakistani isolates respectively. Moreover, the values of surface accessibility, flexibility and solvent-accessibility can be helpful in analyzing vaccines against DENV-2 and DENV-3. In conclusion, the proposed continuous and discontinuous antigenic peptides can be valuable candidates for diagnostic and therapeutics of DENV.	[Amat-ur-Rasool, Hafsa; Saghir, Anam; Idrees, Muhammad] Univ Punjab, Natl Ctr Excellence Mol Biol, Lahore, Pakistan	National Center of Excellence in Molecular Biology - Pakistan; University of Punjab	Idrees, M (corresponding author), Univ Punjab, Natl Ctr Excellence Mol Biol, Lahore, Pakistan.	idreeskhan@cemb.edu.pk	Idrees, Muhammad/K-6032-2012	Idrees, Muhammad/0000-0002-3081-7631; Amat Ur Rasool, D. Hafsa/0000-0001-9664-3796; Idrees, Muhammad/0000-0001-5783-1372				BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; Gromowski GD, 2008, J VIROL, V82, P8828, DOI 10.1128/JVI.00606-08; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2; HAYES CG, 1982, T ROY SOC TROP MED H, V76, P431, DOI 10.1016/0035-9203(82)90130-4; HENCHAL EA, 1990, CLIN MICROBIOL REV, V3, P376, DOI 10.1128/CMR.3.4.376-396.1990; Hua Zhong, 2009, Journal of Biomedical Science & Engineering, V2, P123, DOI 10.4236/jbise.2009.22022; Idrees S, 2012, GENET VACCINES THER, V10, DOI [10.1186/1479-0556-10-10, DOI 10.1186/1479-0556-10-10]; Jahan Fridous, 2011, Asia Pac Fam Med, V10, P1, DOI 10.1186/1447-056X-10-1; KARPLUS PA, 1985, NATURWISSENSCHAFTEN, V72, P212, DOI 10.1007/BF01195768; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Khan E, 2008, J CLIN VIROL, V43, P176, DOI 10.1016/j.jcv.2008.06.003; Khan E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012505; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; Koo C, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-275; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Li L, 2005, VIROLOGY, V335, P99, DOI 10.1016/j.virol.2005.02.011; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; MONATH TP, 1994, P NATL ACAD SCI USA, V91, P2395, DOI 10.1073/pnas.91.7.2395; Ponomarenko J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-514; Qureshi Jazibeh A., 1997, JPMA (Journal of the Pakistan Medical Association), V47, P178; Seema, 2005, INDIAN J CLIN BIOCHE, V20, P92, DOI 10.1007/BF02867407; Singh H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062216; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Zamudio-Meza H, 2009, J GEN VIROL, V90, P2902, DOI 10.1099/vir.0.014159-0	28	7	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119854	10.1371/journal.pone.0119854	http://dx.doi.org/10.1371/journal.pone.0119854			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775090	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500134
J	Bancks, MP; Odegaard, AO; Koh, WP; Yuan, JM; Gross, MD; Pereira, MA				Bancks, Michael P.; Odegaard, Andrew O.; Koh, Woon-Puay; Yuan, Jian-Min; Gross, Myron D.; Pereira, Mark A.			Glycated Hemoglobin and Incident Type 2 Diabetes in Singaporean Chinese Adults: The Singapore Chinese Health Study	PLOS ONE			English	Article							FASTING PLASMA-GLUCOSE; HBA1C; RISK; A1C; HBA(1C); DIAGNOSIS; WOMEN	Background The American Diabetes Association recently included glycated hemoglobin in the diagnostic criteria for diabetes, but research on the utility of this biomarker in Southeast Asians is scant. The aim of this study was to evaluate the association between percent HbA1c and incident diabetes in an Asian population of adult men and women without reported diabetes. Methods Data analysis of 5,770 men and women enrolled in the Singapore Chinese Health Study who provided a blood sample at the follow-up I visit (1999-2004) and had no cancer and no reported history of diabetes or cardiovascular disease events. Diabetes was defined as self-report of physician diagnosis, identified at the follow-up II visit (2006-2010). Results Hazard ratios (and 95% confidence intervals) for incident diabetes by 5 categories of HbA1c were estimated with Cox regression models and continuous HbA1c with cubic spline analysis. Compared to individuals with an HbA1c <= 5.7% (<= 39 mmol/mol), individuals with HbA1c 5.8-5.9% (40-41 mmol/mol), 6.0-6.1% (42-43 mmol/mol), 6.2-6.4% (44-47 mmol/mol), and >= 6.5% (>= 48 mmol/mol) had significantly increased risk for incident diabetes during follow- up. In cubic spline analysis, levels below 5.7% HbA1c were not significantly associated with incident diabetes. Conclusions Our study found a strong and graded association with HbA1c 5.8% and above with incident diabetes in Chinese men and women.	[Bancks, Michael P.; Odegaard, Andrew O.; Gross, Myron D.; Pereira, Mark A.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Koh, Woon-Puay] Duke NUS Grad Med Sch Singapore, Singapore, Singapore; [Koh, Woon-Puay] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Yuan, Jian-Min] Univ Pittsburgh, Inst Canc, Div Canc Control & Populat Sci, Pittsburgh, PA USA; [Yuan, Jian-Min] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA	University of Minnesota System; University of Minnesota Twin Cities; National University of Singapore; National University of Singapore; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bancks, MP (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA.	banck005@umn.edu		Yuan, Jian-Min/0000-0002-4620-3108; Pereira, Mark/0000-0002-6704-5276; Bancks, Michael/0000-0003-3694-6060	National Institutes of Health (NIH) [R01 CA55069, R35 CA53890, R01 CA80205, R01 CA144034]; NIH [R01 DK080720]; NIH Training Grant [T32HL007779]; NATIONAL CANCER INSTITUTE [R01CA144034, R35CA053890, R01CA080205, R01CA055069] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007779] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The parent cohort study - Singapore Chinese Health Study was supported by National Institutes of Health (NIH) grants R01 CA55069, R35 CA53890, R01 CA80205, and R01 CA144034. The measurement of glycated hemoglobin (HbA1c) was supported by NIH grant R01 DK080720. MB was supported by the NIH Training Grant T32HL007779 to conduct the current work (URL: http://www.nih.gov/science/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Boltri JM, 2005, ETHNIC DIS, V15, P562; Chamnan P, 2011, DIABETES CARE, V34, P950, DOI 10.2337/dc09-2326; Droumaguet C, 2006, DIABETES CARE, V29, P1619, DOI 10.2337/dc05-2525; Edelman D, 2004, J GEN INTERN MED, V19, P1175, DOI 10.1111/j.1525-1497.2004.40178.x; George PP, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-44; Heianza Y, 2012, DIABETIC MED, V29, pE279, DOI 10.1111/j.1464-5491.2012.03686.x; Herman WH, 2012, J CLIN ENDOCR METAB, V97, P1067, DOI 10.1210/jc.2011-1894; Hughes RCE, 2014, DIABETES CARE, V37, P2953, DOI 10.2337/dc14-1312; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Law LSC, 2011, DIABETES RES CLIN PR, V91, pE53, DOI 10.1016/j.diabres.2010.11.014; Little RR, 2003, CLIN CHEM LAB MED, V41, P1191, DOI 10.1515/CCLM.2003.183; Ministry of Health Singapore, 2014, MOH CLIN PRACT GUID; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Odegaard AO, 2008, AM J CLIN NUTR, V88, P979, DOI 10.1093/ajcn/88.4.979; Odegaard AO, 2011, DIABETES CARE, V34, P880, DOI 10.2337/dc10-2350; Odegaard AO, 2010, AM J EPIDEMIOL, V171, P701, DOI 10.1093/aje/kwp452; Pradhan AD, 2007, AM J MED, V120, P720, DOI 10.1016/j.amjmed.2007.03.022; Ramachandran A, 2012, DIABETIC MED, V29, P94, DOI 10.1111/j.1464-5491.2011.03392.x; Sato KK, 2009, DIABETES CARE, V32, P644, DOI 10.2337/dc08-1631; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Sevket O, 2014, J OBSTET GYNAECOL, V34, P690, DOI 10.3109/01443615.2014.925855; Steffes M, 2005, CLIN CHEM, V51, P753, DOI 10.1373/clinchem.2004.042143; Venkataraman K, 2012, DIABETIC MED, V29, P911, DOI 10.1111/j.1464-5491.2012.03599.x; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; Zhang XP, 2010, DIABETES CARE, V33, P1665, DOI 10.2337/dc09-1939	27	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119884	10.1371/journal.pone.0119884	http://dx.doi.org/10.1371/journal.pone.0119884			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775375	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000351183500136
J	Brison, CM; Mullen, SM; Wuerth, ME; Podolsky, K; Cook, M; Herman, JA; Walter, JD; Meeks, SL; Spiegel, PC				Brison, Caileen M.; Mullen, Steven M.; Wuerth, Michelle E.; Podolsky, Kira; Cook, Matthew; Herman, Jacob A.; Walter, Justin D.; Meeks, Shannon L.; Spiegel, P. Clint			The 1.7 angstrom X-Ray Crystal Structure of the Porcine Factor VIII C2 Domain and Binding Analysis to Anti-Human C2 Domain Antibodies and Phospholipid Surfaces	PLOS ONE			English	Article							PREVIOUSLY UNTREATED PATIENTS; RECOMBINANT FACTOR-VIII; HEMOPHILIA-A PATIENTS; MEMBRANE-BINDING; VONWILLEBRAND-FACTOR; MONOCLONAL-ANTIBODY; TERNARY COMPLEX; LIGHT-CHAIN; C1 DOMAIN; FACTOR-V	The factor VIII C2 domain is essential for binding to activated platelet surfaces as well as the cofactor activity of factor VIII in blood coagulation. Inhibitory antibodies against the C2 domain commonly develop following factor VIII replacement therapy for hemophilia A patients, or they may spontaneously arise in cases of acquired hemophilia. Porcine factor VIII is an effective therapeutic for hemophilia patients with inhibitor due to its low cross-reactivity; however, the molecular basis for this behavior is poorly understood. In this study, the X-ray crystal structure of the porcine factor VIII C2 domain was determined, and superposition of the human and porcine C2 domains demonstrates that most surface-exposed differences cluster on the face harboring the "non-classical" antibody epitopes. Furthermore, antibody-binding results illustrate that the "classical" 3E6 antibody can bind both the human and porcine C2 domains, although the inhibitory titer to human factor VIII is 41 Bethesda Units (BU)/mg IgG versus 0.8 BU/mg IgG to porcine factor VIII, while the non-classical G99 antibody does not bind to the porcine C2 domain nor inhibit porcine factor VIII activity. Further structural analysis of differences between the electrostatic surface potentials suggest that the C2 domain binds to the negatively charged phospholipid surfaces of activated platelets primarily through the 3E6 epitope region. In contrast, the G99 face, which contains residue 2227, should be distal to the membrane surface. Phospholipid binding assays indicate that both porcine and human factor VIII C2 domains bind with comparable affinities, and the human K2227A and K2227E mutants bind to phospholipid surfaces with similar affinities as well. Lastly, the G99 IgG bound to PS-immobilized factor VIII C2 domain with an apparent dissociation constant of 15.5 nM, whereas 3E6 antibody binding to PS-bound C2 domain was not observed.	[Brison, Caileen M.; Mullen, Steven M.; Wuerth, Michelle E.; Podolsky, Kira; Cook, Matthew; Herman, Jacob A.; Walter, Justin D.; Spiegel, P. Clint] Western Washington Univ, Dept Chem, Bellingham, WA 98225 USA; [Meeks, Shannon L.] Emory Univ, Dept Pediat, Aflac Canc & Blood Disorders Ctr, Atlanta, GA 30322 USA	Western Washington University; Emory University	Spiegel, PC (corresponding author), Western Washington Univ, Dept Chem, Bellingham, WA 98225 USA.	Paul.Spiegel@wwu.edu		Herman, Jacob/0000-0002-2069-5810; Meeks, Shannon/0000-0002-3683-8644; Podolsky, Kira/0000-0003-3152-6593	National Institutes of Health [R15 HL103518]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL103518, U54HL112309] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the National Institutes of Health R15 HL103518 (P.C.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ARAI M, 1989, J CLIN INVEST, V83, P1978, DOI 10.1172/JCI114107; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barrow RT, 2006, J THROMB HAEMOST, V4, P2223, DOI 10.1111/j.1538-7836.2006.02135.x; Bloem E, 2013, J BIOL CHEM, V288, P29670, DOI 10.1074/jbc.M113.473116; BRAY GL, 1994, BLOOD, V83, P2428; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DeFrates SR, 2013, PHARMACOTHERAPY, V33, P157, DOI 10.1002/phar.1173; Dimitrov JD, 2010, J THROMB HAEMOST, V8, P1524, DOI 10.1111/j.1538-7836.2010.03878.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FOSTER PA, 1987, J BIOL CHEM, V262, P8443; Franchini M, 2008, BLOOD, V112, P250, DOI 10.1182/blood-2008-03-143586; Giangrande PLF, 2012, HAEMOPHILIA, V18, P305, DOI 10.1111/j.1365-2516.2012.02803.x; Gilbert GE, 2012, BLOOD, V120, P1923, DOI 10.1182/blood-2012-01-408245; Gilbert GE, 2002, J BIOL CHEM, V277, P6374, DOI 10.1074/jbc.M104732200; GITSCHIER J, 1984, NATURE, V312, P326, DOI 10.1038/312326a0; Hay Charles R. M., 2000, Haematologica, V85, P21; Hay CR, 2000, HAEMATOLOGICA, V85, P4; HILLEUBANKS DC, 1989, P NATL ACAD SCI USA, V86, P6508, DOI 10.1073/pnas.86.17.6508; Hoots WK, 2001, HAEMOPHILIA, V7, P4, DOI 10.1046/j.1365-2516.2001.00099.x; Hsu TC, 2008, BLOOD, V111, P200, DOI 10.1182/blood-2007-01-068957; Jacquemin MG, 1998, BLOOD, V92, P496, DOI 10.1182/blood.V92.2.496.414k16_496_506; KANE WH, 1988, BLOOD, V71, P539; KASPER CK, 1975, THROMB DIATH HAEMOST, V34, P612; Kempton CL, 2012, HAEMOPHILIA, V18, P798, DOI 10.1111/j.1365-2516.2012.02789.x; Kreuz W, 2002, SEMIN THROMB HEMOST, V28, P285, DOI 10.1055/s-2002-32664; Lenting PJ, 1998, BLOOD, V92, P3983, DOI 10.1182/blood.V92.11.3983.423k51_3983_3996; Liu Z, 2010, J BIOL CHEM, V285, P8824, DOI 10.1074/jbc.M109.080168; LOLLAR P, 1989, BIOCHEMISTRY-US, V28, P666, DOI 10.1021/bi00428a038; Lu JH, 2011, BLOOD, V117, P3181, DOI 10.1182/blood-2010-08-301663; Lusher JM, 2003, HAEMOPHILIA, V9, P38, DOI 10.1046/j.1365-2516.2003.00708.x; Markovitz RC, 2013, BLOOD, V121, P2785, DOI 10.1182/blood-2012-09-456582; Mauser-Bunschoten EP, 2001, HAEMOPHILIA, V7, P364, DOI 10.1046/j.1365-2516.2001.00513.x; Meeks SL, 2009, J THROMB HAEMOST, V7, P658, DOI 10.1111/j.1538-7836.2009.03299.x; Meeks SL, 2008, BLOOD, V112, P1151, DOI 10.1182/blood-2008-01-132639; Meeks SL, 2007, BLOOD, V110, P4234, DOI 10.1182/blood-2007-06-096842; Mei BS, 2010, BLOOD, V116, P270, DOI 10.1182/blood-2009-11-254755; Nguyen PCT, 2014, BLOOD, V123, P2732, DOI 10.1182/blood-2013-09-527275; Nirnjee SM, 2005, TRENDS CARDIOVAS MED, V15, P41, DOI 10.1016/j.tcm.2005.01.002; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parker ET, 2004, J THROMB HAEMOST, V2, P605, DOI 10.1111/j.1538-7836.2004.00685.x; Pratt KP, 1999, NATURE, V402, P439, DOI 10.1038/46601; Prescott R, 1997, BLOOD, V89, P3663, DOI 10.1182/blood.V89.10.3663.3663_3663_3671; Saenko EL, 1997, J BIOL CHEM, V272, P18007, DOI 10.1074/jbc.272.29.18007; SAENKO EL, 1994, J BIOL CHEM, V269, P11601; Scharrer I, 1999, HAEMOPHILIA, V5, P145; Scott DW, 2014, HAEMOPHILIA, V20, P80, DOI 10.1111/hae.12407; Shen BW, 2008, BLOOD, V111, P1240, DOI 10.1182/blood-2007-08-109918; SHIMA M, 1995, BRIT J HAEMATOL, V91, P714, DOI 10.1111/j.1365-2141.1995.tb05374.x; SHIMA M, 1993, THROMB HAEMOSTASIS, V69, P240; Soucie JM, 2000, TRANSFUSION, V40, P708, DOI 10.1046/j.1537-2995.2000.40060708.x; Spiegel PC, 2004, CHEM BIOL, V11, P1413, DOI 10.1016/j.chembiol.2004.08.006; Spiegel PC, 2001, BLOOD, V98, P13, DOI 10.1182/blood.V98.1.13; Spiegel PC, 2004, J BIOL CHEM, V279, P53691, DOI 10.1074/jbc.M409389200; Spiegel PC, 2002, BRIT J HAEMATOL, V119, P310, DOI 10.1046/j.1365-2141.2002.03845.x; Stennicke HR, 2013, BLOOD, V121, P2108, DOI 10.1182/blood-2012-01-407494; TOOLE JJ, 1984, NATURE, V312, P342, DOI 10.1038/312342a0; Toschi V, 2010, CURR OPIN MOL THER, V12, P617; VANDIEIJEN G, 1981, J BIOL CHEM, V256, P3433; Wakabayashi H, 2013, J BIOL CHEM, V288, P31289, DOI 10.1074/jbc.M113.497289; Wakabayashi H, 2010, J BIOL CHEM, V285, P25176, DOI 10.1074/jbc.M110.106906; Walter JD, 2013, BLOOD, V122, P4270, DOI 10.1182/blood-2013-08-519124; Walter JD, 2013, J BIOL CHEM, V288, P9905, DOI 10.1074/jbc.M112.424564	63	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0122447	10.1371/journal.pone.0122447	http://dx.doi.org/10.1371/journal.pone.0122447			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775247	gold, Green Submitted, Green Published			2022-12-27	WOS:000351183500225
J	Downs, CT; Awuah, A; Jordaan, M; Magagula, L; Mkhize, T; Paine, C; Raymond-Bourret, E; Hart, LA				Downs, Colleen T.; Awuah, Adwoa; Jordaan, Maryna; Magagula, Londiwe; Mkhize, Truth; Paine, Christine; Raymond-Bourret, Esmaella; Hart, Lorinda A.			Too Hot to Sleep? Sleep Behaviour and Surface Body Temperature of Wahlberg's Epauletted Fruit Bat	PLOS ONE			English	Article							EPOMOPHORUS-WAHLBERGI; CLIMATE-CHANGE; THERMOREGULATION; RISK; WAKE	The significance of sleep and factors that affect it have been well documented, however, in light of global climate change the effect of temperature on sleep patterns has only recently gained attention. Unlike many mammals, bats (order: Chiroptera) are nocturnal and little is known about their sleep and the effects of ambient temperature (T-a) on their sleep. Consequently we investigated seasonal temperature effects on sleep behaviour and surface body temperature of free-ranging Wahlberg's epauletted fruit bat, Epomophorus wahlbergi, at a tree roost. Sleep behaviours of E. wahlbergi were recorded, including: sleep duration and sleep incidences (i.e. one eye open and both eyes closed). Sleep differed significantly across all the individuals in terms of sleep duration and sleep incidences. Individuals generally spent more time awake than sleeping. The percentage of each day bats spent asleep was significantly higher during winter (27.6%), compared with summer (15.6%). In summer, 20.7% of the sleeping bats used one eye open sleep, and this is possibly the first evidence of one-eye-sleep in non-marine mammals. Sleep duration decreased with extreme heat as bats spent significantly more time trying to cool by licking their fur, spreading their wings and panting. Skin temperatures of E. wahlbergi were significantly higher when T-a was >= 35 degrees C and no bats slept at these high temperatures. Consequently extremely hot days negatively impact roosting fruit bats, as they were forced to be awake to cool themselves. This has implications for these bats given predicted climate change scenarios.	[Downs, Colleen T.; Awuah, Adwoa; Jordaan, Maryna; Magagula, Londiwe; Mkhize, Truth; Paine, Christine; Raymond-Bourret, Esmaella; Hart, Lorinda A.] Univ KwaZulu Natal, Sch Life Sci, ZA-3209 Pietermaritzburg, South Africa	University of Kwazulu Natal	Downs, CT (corresponding author), Univ KwaZulu Natal, Sch Life Sci, P Bag X01, ZA-3209 Pietermaritzburg, South Africa.	Downs@ukzn.ac.za	Hart, Lorinda A/A-8391-2019; Downs, Colleen T./A-7770-2010	Downs, Colleen T./0000-0001-8334-1510; Hart, Lorinda/0000-0002-3942-0374				Acerbi A, 2011, ANIM BEHAV, V81, P801, DOI 10.1016/j.anbehav.2011.01.015; Altringham JD, 2011, BATS: FROM EVOLUTION TO CONSERVATION, 2ND EDITION, P1; Baxter C, 2014, BRISBANE TIMES  0106; BERGER RJ, 1995, BEHAV BRAIN RES, V69, P65, DOI 10.1016/0166-4328(95)00002-B; BERTRAM BCR, 1980, ANIM BEHAV, V28, P278, DOI 10.1016/S0003-3472(80)80030-3; BESHIR MY, 1981, APPL ERGON, V12, P29, DOI 10.1016/0003-6870(81)90091-0; Bonnet MH, 2003, SLEEP MED REV, V7, P297, DOI 10.1053/smrv.2001.0245; Burbank RC, 1934, J PHYSIOL-LONDON, V82, P459, DOI 10.1113/jphysiol.1934.sp003197; Cameron GN, 2001, J MAMMAL, V82, P652, DOI 10.1644/1545-1542(2001)082<0652:GWEOGC>2.0.CO;2; Capellini I, 2008, EVOLUTION, V62, P1764, DOI 10.1111/j.1558-5646.2008.00392.x; Capellini I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004609; Dawson TJ, 2000, PHYSIOL BIOCHEM ZOOL, V73, P374, DOI 10.1086/316751; Downs CT, 2012, J THERM BIOL, V37, P144, DOI 10.1016/j.jtherbio.2011.12.003; du Plessis KL, 2012, GLOBAL CHANGE BIOL, V18, P3063, DOI 10.1111/j.1365-2486.2012.02778.x; Dunnett GE, 1953, BR J ANIM BEHAV, V1, P91; Ferrara M, 2001, SLEEP MED REV, V5, P155, DOI 10.1053/smrv.2000.0138; Flanigan W.F., 1972, SLEEPING BRAIN PERSP, P14; Fuchs T, 2006, ANIM BEHAV, V72, P951, DOI 10.1016/j.anbehav.2006.03.008; HAINSWORTH FR, 1972, CAN J PHYSIOL PHARM, V50, P172, DOI 10.1139/y72-026; Heller C., 2005, PRINCIPLES PRACTICE, P292, DOI DOI 10.1016/B0-72-160797-7/50031-8; HERREID CF, 1967, PHYSIOL ZOOL, V40, P1; HOCK RJ, 1951, BIOL BULL-US, V101, P289, DOI 10.2307/1538547; Jhaveri KA, 2007, BRAIN BEHAV IMMUN, V21, P975, DOI 10.1016/j.bbi.2007.03.007; Jordaan LA, 2012, BIOL INVASIONS, V14, P959, DOI 10.1007/s10530-011-0131-7; KARL TR, 1993, B AM METEOROL SOC, V74, P1007, DOI 10.1175/1520-0477(1993)074<1007:ANPORG>2.0.CO;2; KENWARD RE, 1978, J ANIM ECOL, V47, P449, DOI 10.2307/3793; LaVal RK, 2004, J MAMMAL, V85, P237, DOI 10.1644/BWG-016; Lesku JA, 2006, AM NAT, V168, P441, DOI 10.1086/506973; Lima SL, 2005, ANIM BEHAV, V70, P723, DOI 10.1016/j.anbehav.2005.01.008; Lyamin OI, 2004, ARCH ITAL BIOL, V142, P557; Maloney SK, 1999, PHYSIOL BIOCHEM ZOOL, V72, P385, DOI 10.1086/316677; Mann ME, 1999, GEOPHYS RES LETT, V26, P759, DOI 10.1029/1999GL900070; McNab B.K., 1982, P151; Monadjem A., 2010, BATS SO AFRICA BIOGE; Mukesh ASRP, 2012, TELEGRAPH; Okamoto-Mizuno K, 2005, PHYSIOL BEHAV, V83, P759, DOI 10.1016/j.physbeh.2004.09.009; Pinjarkar V, 2010, TIMES INDIA; Preston BT, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-7; Rattenborg NC, 1999, BEHAV BRAIN RES, V105, P163, DOI 10.1016/S0166-4328(99)00070-4; Rattenborg NC, 2000, NEUROSCI BIOBEHAV R, V24, P817, DOI 10.1016/S0149-7634(00)00039-7; Rattenborg NC, 2008, BIOL LETTERS, V4, P402, DOI 10.1098/rsbl.2008.0203; REEDER WG, 1951, J MAMMAL, V32, P389, DOI 10.2307/1375787; Rogers N L, 2001, Semin Clin Neuropsychiatry, V6, P295, DOI 10.1053/scnp.2001.27907; Rollinson DP, 2014, AFR ZOOL, V49, P173, DOI 10.3377/004.049.0218; Siegel JM, 2005, NATURE, V437, P1264, DOI 10.1038/nature04285; Sinha RK, 2006, PHYSIOL BEHAV, V89, P364, DOI 10.1016/j.physbeh.2006.06.022; Sinha Rakesh Kumar, 2008, J Clin Monit Comput, V22, P261, DOI 10.1007/s10877-008-9128-x; Sinha RK, 2004, MED BIOL ENG COMPUT, V42, P282, DOI 10.1007/BF02344701; Skinner J.D., 2005, MAMMALS SO AFRICAN S, DOI DOI 10.1017/CBO9781107340992; Solomon S., 2007, PHYS SCI BASIS WORKI; Steinmeyer C, 2010, ANIM BEHAV, V80, P853, DOI 10.1016/j.anbehav.2010.08.005; THOMAS SP, 1991, AM J PHYSIOL, V260, pR960, DOI 10.1152/ajpregu.1991.260.5.R960; Thomas T C, 2000, Sleep Res Online, V3, P141; Thomson SC, 1998, PHILOS T ROY SOC B, V353, P1595, DOI 10.1098/rstb.1998.0312; Thomson SC, 1999, J COMP PHYSIOL B, V169, P187, DOI 10.1007/s003600050210; VANTWYVER H, 1970, ELECTROEN CLIN NEURO, V29, P181, DOI 10.1016/0013-4694(70)90121-5; Welbergen JA, 2008, P ROY SOC B-BIOL SCI, V275, P419, DOI 10.1098/rspb.2007.1385; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Zepelin H, 1994, PRINCIPLES PRACTICE, P91; Zhao XD, 2010, BEHAV BRAIN RES, V208, P497, DOI 10.1016/j.bbr.2009.12.027	60	15	15	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119419	10.1371/journal.pone.0119419	http://dx.doi.org/10.1371/journal.pone.0119419			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775371	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500091
J	Gomez, GF; Bickersmith, SA; Gonzalez, R; Conn, JE; Correa, MM				Gomez, Giovan F.; Bickersmith, Sara A.; Gonzalez, Ranulfo; Conn, Jan E.; Correa, Margarita M.			Molecular Taxonomy Provides New Insights into Anopheles Species of the Neotropical Arribalzagia Series	PLOS ONE			English	Article							RIBOSOMAL DNA; DIPTERA-CULICIDAE; GENETIC DIVERSITY; MALARIA VECTOR; POPULATION-STRUCTURE; NUNEZTOVARI DIPTERA; CONCERTED EVOLUTION; MAXIMUM-LIKELIHOOD; MOSQUITOS DIPTERA; COMPLEX DIPTERA	Phylogenetic analysis of partial mitochondrial cytochrome oxidase c subunit I (COI) and nuclear internal transcribed spacer 2 (ITS2) sequences were used to evaluate initial identification and to investigate phylogenetic relationships of seven Anopheles morphospecies of the Arribalzagia Series from Colombia. Phylogenetic trees recovered highly supported clades for An. punctimaculas. s., An. calderoni, An. malefactor s. l., An. neomaculipalpus, An. apicimacula s. l., An. mattogrossensis and An. peryassui. This study provides the first molecular confirmation of An. malefactorfrom Colombia and discovered conflicting patterns of divergence for the molecular markers among specimens from northeast and northern Colombia suggesting the presence of two previously unrecognized Molecular Operational Taxonomic Units (MOTUs). Furthermore, two highly differentiated An. apicimacula MOTUs previously found in Panama were detected. Overall, the combined molecular dataset facilitated the detection of known and new Colombian evolutionary lineages, and constitutes the baseline for future research on their bionomics, ecology and potential role as malaria vectors.	[Gomez, Giovan F.; Correa, Margarita M.] Univ Antioquia, Grp Microbiol Mol, Escuela Microbiol, Medellin, Antioquia, Colombia; [Bickersmith, Sara A.; Conn, Jan E.] New York State Dept Hlth, Wadsworth Ctr, Griffin Lab, Singerlands, NY USA; [Gonzalez, Ranulfo] Univ Valle, Fac Ciencias Nat & Exactas, Cali, Valle Del Cauca, Colombia; [Conn, Jan E.] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY USA	Universidad de Antioquia; Wadsworth Center; Universidad del Valle; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Correa, MM (corresponding author), Univ Antioquia, Grp Microbiol Mol, Escuela Microbiol, Medellin, Antioquia, Colombia.	margaritcorrea@gmail.com	Gómez, Giovan F./AAN-8904-2021	Gómez, Giovan F./0000-0003-2277-6953; Conn, Jan/0000-0002-5301-7020; Gonzalez, Ranulfo/0000-0003-4047-8677; Bickersmith, Sara/0000-0002-2748-0425	Comite para el Desarrollo de la Investigacion-CODI [8700-689]; Estrategia para la Sostenibilidad de Grupos, Universidad de Antioquia [E01719]; US National Institutes of Health [2R01 A154139]; Departamento Administrativo de Ciencia, Tecnologia e Innovacion-COLCIENCIAS, Colombia, Convocatoria [511-2010]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054139] Funding Source: NIH RePORTER	Comite para el Desarrollo de la Investigacion-CODI; Estrategia para la Sostenibilidad de Grupos, Universidad de Antioquia; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Departamento Administrativo de Ciencia, Tecnologia e Innovacion-COLCIENCIAS, Colombia, Convocatoria; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by Comite para el Desarrollo de la Investigacion-CODI, Grant No. 8700-689 to MMC, Estrategia para la Sostenibilidad de Grupos 2013-2014, Universidad de Antioquia Grant No. E01719, and US National Institutes of Health grant 2R01 A154139 to JEC. GFG received financial support for his doctoral studies from Departamento Administrativo de Ciencia, Tecnologia e Innovacion-COLCIENCIAS, Colombia, Convocatoria 511-2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 1906, P BIOL SOC WASH; [Anonymous], MAL ENT VECT CONTR L; [Anonymous], REV PERU EPIDEMOLOGI; [Anonymous], ENTOMOLOGIA MED FACU; [Anonymous], GENEIOUS VERSION 6 0; [Anonymous], 1987, COLOMB MED; [Anonymous], 1922, AM J HYG; [Anonymous], 2002, CULICIDOLOGIA MED; [Anonymous], REV BIOMEDICA; [Anonymous], 2018, SANTIAGO CALI U VALL, DOI DOI 10.25100/PEU.309; Bourke BP, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-111; Brochero H, 2008, BIOMEDICA, V28, P18, DOI 10.7705/biomedica.v28i1.105; Brown SDJ, 2012, MOL ECOL RESOUR, V12, P562, DOI 10.1111/j.1755-0998.2011.03108.x; Castelo AT, 2002, BIOINFORMATICS, V18, P634, DOI 10.1093/bioinformatics/18.4.634; Chaparro P, 2012, BIOMEDICA, V32, P29, DOI 10.1590/S0120-41572012000500005; Choochote W, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-36; Cienfuegos AV, 2011, ACTA TROP, V118, P128, DOI 10.1016/j.actatropica.2011.02.004; Collins FH, 1996, INSECT MOL BIOL, V5, P1, DOI 10.1111/j.1365-2583.1996.tb00034.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Donnelly MJ, 2004, HEREDITY, V92, P61, DOI 10.1038/sj.hdy.6800377; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Foster PG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054063; FRITZ GN, 1994, MOL BIOL EVOL, V11, P406; Ganley ARD, 2007, GENOME RES, V17, P184, DOI 10.1101/gr.5457707; Gomez G, 2013, MOL ECOL RESOUR, V13, P1082, DOI 10.1111/1755-0998.12126; Gonzalez R, 2010, MEM I OSWALDO CRUZ, V105, P1001, DOI 10.1590/S0074-02762010000800009; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gutierrez LA, 2008, ACTA TROP, V107, P99, DOI 10.1016/j.actatropica.2008.04.019; Harbach R. E., 2013, MOSQUITO TAXONOMIC I; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218; HEINEMANN S J, 1978, Mosquito Systematics, V10, P493; Jorger KM, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-59; Keller A, 2009, GENE, V430, P50, DOI 10.1016/j.gene.2008.10.012; Khalin A. V., 2012, Parazitologiya (St. Petersburg), V46, P253; Li C, 2007, J HERED, V98, P51, DOI 10.1093/jhered/esl037; Liao DQ, 1999, AM J HUM GENET, V64, P24, DOI 10.1086/302221; Loaiza JR, 2012, INFECT GENET EVOL, V12, P1, DOI 10.1016/j.meegid.2011.08.004; Loaiza JR, 2013, ACTA TROP, V128, P61, DOI 10.1016/j.actatropica.2013.06.012; Lucumi-Aragon D, 2011, REV COLOMB ENTOMOL, V37, P256; Manguin S, 1999, AM J TROP MED HYG, V60, P364, DOI 10.4269/ajtmh.1999.60.364; Masters BC, 2011, MOL ECOL RESOUR, V11, P154, DOI 10.1111/j.1755-0998.2010.02896.x; Matson R, 2008, AM J TROP MED HYG, V78, P492, DOI 10.4269/ajtmh.2008.78.492; McKeon SN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-271; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Montoya-Lerma J, 2011, MEM I OSWALDO CRUZ, V106, P223, DOI 10.1590/S0074-02762011000900028; Myers Norman, 2000, Nature (London), V403, P853, DOI 10.1038/35002501; Onyabe DY, 1999, INSECT MOL BIOL, V8, P435, DOI 10.1046/j.1365-2583.1999.00134.x; Packer L, 2009, MOL ECOL RESOUR, V9, P42, DOI 10.1111/j.1755-0998.2009.02631.x; Rodriguez JCP, 2011, MEM I OSWALDO CRUZ, V106, P114, DOI 10.1590/S0074-02762011000900015; Paskewitz S.M., 1993, Insect Molecular Biology, V2, P247, DOI 10.1111/j.1365-2583.1994.tb00144.x; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Ramos MF, 2008, MEM I OSWALDO CRUZ, V103, P85, DOI 10.1590/S0074-02762008000100013; REY H, 1945, AM J TROP MED, V25, P501; Rona LDP, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-207; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rosenberg NA, 2007, EVOLUTION, V61, P317, DOI 10.1111/j.1558-5646.2007.00023.x; Rosero DA, 2010, REV COLOMB ENTOMOL, V36, P260; Ruiz F, 2005, MEM I OSWALDO CRUZ, V100, P155, DOI 10.1590/S0074-02762005000200008; Sallum MAM, 2000, ANN ENTOMOL SOC AM, V93, P745, DOI 10.1603/0013-8746(2000)093[0745:POADCB]2.0.CO;2; Scheffers BR, 2012, TRENDS ECOL EVOL, V27, P501, DOI 10.1016/j.tree.2012.05.008; Sharma D, 2004, BIOINFORMATICS, V20, P1405, DOI 10.1093/bioinformatics/bth103; Tadei Wanderli Pedro, 2000, Revista do Instituto de Medicina Tropical de Sao Paulo, V42, P87, DOI 10.1590/S0036-46652000000200005; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Ulrich JN, 2013, TRENDS PARASITOL, V29, P104, DOI 10.1016/j.pt.2013.01.002; Walton C, 1999, MED VET ENTOMOL, V13, P24, DOI 10.1046/j.1365-2915.1999.00142.x; Walton C, 2000, MOL BIOL EVOL, V17, P962, DOI 10.1093/oxfordjournals.molbev.a026377; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WILKERSON R C, 1991, Mosquito Systematics, V23, P25; WILKERSON RC, 1990, J MED ENTOMOL, V27, P207, DOI 10.1093/jmedent/27.2.207; Wilkerson RC, 2004, J MED ENTOMOL, V41, P392, DOI 10.1603/0022-2585-41.3.392; Wilkerson RC, 1999, J MED ENTOMOL, V36, P345, DOI 10.1093/jmedent/36.3.345; WILKERSON RC, 1990, J AM MOSQUITO CONTR, V6, P7; Wilkerson RC, 1997, P ENTOMOL SOC WASH, V99, P461; WILKERSON RC, 1990, J MED ENTOMOL, V27, P225, DOI 10.1093/jmedent/27.2.225; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; Wong J, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-143; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Zapata MA, 2007, AM J TROP MED HYG, V77, P67, DOI 10.4269/ajtmh.2007.77.67; Zarowiecki M, 2011, PARASITOLOGY, V138, P1723, DOI 10.1017/S003118201100062X	87	19	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119488	10.1371/journal.pone.0119488	http://dx.doi.org/10.1371/journal.pone.0119488			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774795	Green Published, gold, Green Submitted			2022-12-27	WOS:000351183500095
J	Gresa-Arribas, N; Arino, H; Martinez-Hernandez, E; Petit-Pedrol, M; Sabater, L; Saiz, A; Dalmau, J; Graus, F				Gresa-Arribas, Nuria; Arino, Helena; Martinez-Hernandez, Eugenia; Petit-Pedrol, Mar; Sabater, Lidia; Saiz, Albert; Dalmau, Josep; Graus, Francesc			Antibodies to Inhibitory Synaptic Proteins in Neurological Syndromes Associated with Glutamic Acid Decarboxylase Autoimmunity	PLOS ONE			English	Article							STIFF-PERSON-SYNDROME; DEPENDENT DIABETES-MELLITUS; LIMBIC ENCEPHALITIS; CEREBELLAR-ATAXIA; RECEPTOR ANTIBODIES; GABA(A) RECEPTOR; AUTOANTIBODIES; DISORDERS; GEPHYRIN; SPECTRUM	Antibodies to glutamic acid decarboxylase (GAD-ab) associate to different neurological syndromes. It is unknown if the diversity in syndrome association represents epitopes in different immunodominant domains or co-existence of antibodies to other proteins of the inhibitory synapsis. We examined the serum and CSF of 106 patients with anti-GAD related syndromes (39 cerebellar ataxia, 32 stiff-person syndrome [SPS], 18 epilepsy, and 17 limbic encephalitis [LE]). GAD65-ab titres were quantified by ELISA. Immunoblot was used to determine if the antibody-targeted epitopes of GAD65 and GAD67 were linear. A cell-based assay (CBA) with HEK293 cells expressing the GAD65 N-terminal, central catalytic domain, or C-terminal was used to investigate the immunodominant domains. Antibodies to GAD67, gamma-aminobutyric acid A receptor (GABAaR), glycine receptor (GlyR), GABAaR-associated protein (GABARAP), and gephyrin were determined with CBA. GAD-ab internalization was investigated using cultured rat hippocampal neurons. CSF GAD65-ab titres were higher in patients with cerebellar ataxia and LE compared to those with SPS (p = 0.02). GAD67-ab were identified in 81% of sera and 100% of CSF. GAD65-ab recognized linear epitopes in 98% of the patients and GAD67-ab in 42% (p < 0.001). The GAD65 catalytic domain was recognized by 93% of sera, and the three domains by 22% of sera and 74% of CSF (p < 0.001). Six patients had GABAaR-ab and another 6 had GlyR-ab without association to distinctive symptoms. None of the patients had gephyrin-or GABARAP-ab. GAD65-ab were not internalized by live neurons. Overall, these findings show that regardless of the neurological syndrome, the CSF immune response against GAD is more widespread than that of the serum and that there is no specific association between clinical phenotype and the presence of antibodies against other proteins of the inhibitory synapsis.	[Gresa-Arribas, Nuria; Arino, Helena; Martinez-Hernandez, Eugenia; Petit-Pedrol, Mar; Sabater, Lidia; Saiz, Albert; Dalmau, Josep; Graus, Francesc] IDIBAPS, Neuroimmunol Program, Barcelona, Spain; [Arino, Helena; Martinez-Hernandez, Eugenia; Saiz, Albert; Graus, Francesc] Univ Barcelona, Hosp Clin, Serv Neurol, Barcelona, Spain; [Dalmau, Josep] ICREA, Barcelona, Spain; [Dalmau, Josep] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; ICREA; University of Pennsylvania	Graus, F (corresponding author), IDIBAPS, Neuroimmunol Program, Barcelona, Spain.	fgraus@clinic.ub.es	Sabater, Lidia/U-7570-2019; Martinez-Hernandez, Eugenia/L-3310-2014; Ariño, Helena/C-3248-2018; Petit-Pedrol, Mar MPP/K-9657-2015; Graus, Francesc/K-9904-2018; Sabater, Lidia/C-7627-2018	Martinez-Hernandez, Eugenia/0000-0002-8317-7068; Ariño, Helena/0000-0003-4036-1671; Petit-Pedrol, Mar MPP/0000-0002-3220-9488; Graus, Francesc/0000-0002-8924-8322; Dalmau, Josep/0000-0001-5856-2813; Sabater, Lidia/0000-0001-8556-6166	NIH [RO1NS077851, RO1MH094741]; Fondo Investigaciones Sanitarias, Spain [11/01780, 12/00611]; Fundacio la Marato TV3; Hospital Clinic, Barcelona; EMH by a grant of Instituto Carlos III, Madrid, Spain [CM12/00055]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077851] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondo Investigaciones Sanitarias, Spain(Instituto de Salud Carlos III); Fundacio la Marato TV3; Hospital Clinic, Barcelona; EMH by a grant of Instituto Carlos III, Madrid, Spain; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); ICREA(ICREA)	This work was supported by NIH grants RO1NS077851, RO1MH094741 (JD); grants 11/01780 (JD) and 12/00611 (FG) from the Fondo Investigaciones Sanitarias, Spain; and Fundacio la Marato TV3 (JD). HA is supported by a post-residency grant of Hospital Clinic, Barcelona, and EMH by a grant of Instituto Carlos III (CM12/00055), Madrid, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos H, 2013, NEUROLOGY, V81, P1962, DOI 10.1212/01.wnl.0000436617.40779.65; Alexopoulos H, 2013, EXPERT REV CLIN IMMU, V9, P1043, DOI 10.1586/1744666X.2013.845527; Ali F, 2011, J AUTOIMMUN, V37, P79, DOI 10.1016/j.jaut.2011.05.005; Ances BM, 2005, BRAIN, V128, P1764, DOI 10.1093/brain/awh526; Arino H, 2014, JAMA NEUROL, V71, P1009, DOI 10.1001/jamaneurol.2014.1011; Bernal F, 2003, NEUROLOGY, V60, P230, DOI 10.1212/01.WNL.0000041495.87539.98; Boronat A, 2011, NEUROLOGY, V76, P795, DOI 10.1212/WNL.0b013e31820e7b8d; Burbelo PD, 2008, BIOCHEM BIOPH RES CO, V366, P1, DOI 10.1016/j.bbrc.2007.11.077; BUTLER MH, 1993, J EXP MED, V178, P2097, DOI 10.1084/jem.178.6.2097; Butler MH, 2000, NEURON, V26, P307, DOI 10.1016/S0896-6273(00)81165-4; Chang TS, 2013, JAMA NEUROL, V70, P1140, DOI 10.1001/jamaneurol.2013.3499; Chang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072921; Chen ZW, 2007, J NEUROCHEM, V100, P279, DOI 10.1111/j.1471-4159.2006.04206.x; Dalakas MC, 2001, NEW ENGL J MED, V345, P1870, DOI 10.1056/NEJMoa01167; Dalakas MC, 2001, NEUROLOGY, V57, P780, DOI 10.1212/WNL.57.5.780; Dinkel K, 1998, ANN NEUROL, V44, P194, DOI 10.1002/ana.410440209; Fenalti G, 2008, DIABETES, V57, P1293, DOI 10.2337/db07-1461; Graus F, 2004, J NEUROL NEUROSUR PS, V75, P1135, DOI 10.1136/jnnp.2003.034447; Gultekin SH, 2000, BRAIN, V123, P1481, DOI 10.1093/brain/123.7.1481; Hampe CS, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-82; Han GC, 2005, J IMMUNOL, V174, P4516, DOI 10.4049/jimmunol.174.8.4516; Hansen N, 2013, EXP NEUROL, V239, P202, DOI 10.1016/j.expneurol.2012.10.013; Honnorat J, 2001, ARCH NEUROL-CHICAGO, V58, P225, DOI 10.1001/archneur.58.2.225; Hughes EG, 2010, J NEUROSCI, V30, P5866, DOI 10.1523/JNEUROSCI.0167-10.2010; Ishida K, 2007, J NEUROL NEUROSUR PS, V78, P190, DOI 10.1136/jnnp.2006.091116; Jarius S, 2010, J NEUROIMMUNOL, V229, P219, DOI 10.1016/j.jneuroim.2010.07.019; KIM J, 1994, J EXP MED, V180, P595, DOI 10.1084/jem.180.2.595; Lancaster E, 2010, LANCET NEUROL, V9, P67, DOI 10.1016/S1474-4422(09)70324-2; Leypoldt F, 2014, ANN NEW YORK ACAD SC; Malter MP, 2010, ANN NEUROL, V67, P470, DOI 10.1002/ana.21917; Manto MU, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-3; Manto MU, 2007, ANN NEUROL, V61, P544, DOI 10.1002/ana.21123; McKeon A, 2013, JAMA NEUROL, V70, P44, DOI 10.1001/jamaneurol.2013.574; McKeon A, 2012, ARCH NEUROL-CHICAGO, V69, P230, DOI 10.1001/archneurol.2011.991; Petit-Pedrol M, 2014, LANCET NEUROL, V13, P276, DOI 10.1016/S1474-4422(13)70299-0; Planaguma J, 2015, BRAIN, V138, P94, DOI 10.1093/brain/awu310; Raju R, 2005, J IMMUNOL, V175, P7755, DOI 10.4049/jimmunol.175.11.7755; Raju R, 2006, BRAIN, V129, P3270, DOI 10.1093/brain/awl245; Rakocevic G, 2006, NEUROLOGY, V67, P1068, DOI 10.1212/01.wnl.0000237558.83349.d0; RICHTER W, 1993, P NATL ACAD SCI USA, V90, P2832, DOI 10.1073/pnas.90.7.2832; Sabater L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060438; Saiz A, 1997, NEUROLOGY, V49, P1026, DOI 10.1212/WNL.49.4.1026; Saiz A, 2008, BRAIN, V131, P2553, DOI 10.1093/brain/awn183; Skorstad G, 2008, EUR J NEUROL, V15, P973, DOI 10.1111/j.1468-1331.2008.02221.x; SOLIMENA M, 1988, NEW ENGL J MED, V318, P1012, DOI 10.1056/NEJM198804213181602; Tyagarajan SK, 2014, NAT REV NEUROSCI, V15, P141, DOI 10.1038/nrn3670; Vega-Flores G, 2014, CEREB CORTEX, V24, P2093, DOI 10.1093/cercor/bht060	47	95	103	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0121364	10.1371/journal.pone.0121364	http://dx.doi.org/10.1371/journal.pone.0121364			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774787	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500212
J	Healy, GN; Winkler, EAH; Brakenridge, CL; Reeves, MM; Eakin, EG				Healy, Genevieve N.; Winkler, Elisabeth A. H.; Brakenridge, Charlotte L.; Reeves, Marina M.; Eakin, Elizabeth G.			Accelerometer-Derived Sedentary and Physical Activity Time in Overweight/Obese Adults with Type 2 Diabetes: Cross-Sectional Associations with Cardiometabolic Biomarkers	PLOS ONE			English	Article							DELIVERED WEIGHT-LOSS; ACTIVITY INTERVENTION; RANDOMIZED-TRIAL; LIVING WELL; BEHAVIOR; RISK; INTENSITY; VALIDITY; OUTCOMES; GLUCOSE	Objective To examine the associations of sedentary time and physical activity with biomarkers of cardiometabolic health, including the potential collective impact of shifting mean time use from less-to more-active behaviours (cross-sectionally, using isotemporal substitution), in adults with type 2 diabetes. Methods Participants with overweight/obese body mass index (BMI; >= 25 kg/m(2)) (n = 279; 158 men, mean [SD] age = 58.2 [8.6] years) wore Actigraph GT1M accelerometers (waking hours; seven days) to assess moderate-to vigorous-intensity physical activity (MVPA), light-intensity activity, and sedentary time (segregated into non-prolonged [accumulated in bouts <30min] and prolonged [accumulated in bouts >= 30 min]). Cross-sectional associations with waist circumference, BMI, fasting blood (HbA(1c), glucose, triacylglycerols, high-density lipoprotein cholesterol), and blood pressure of these activity variables (30 min/day increments) were examined adjusted for confounders and wear then, if significant, examined using isotemporal substitution modelling. Results Waist circumference and BMI were significantly (p<0.05) associated with more prolonged sedentary time and less light-intensity activity. Light intensity activity was also significantly associated with lower fasting plasma glucose (relative rate: 0.98, 95% CI: 0.97, 1.00; p<0.05). No biomarker was significantly associated with non-prolonged sedentary time or MVPA. Lower mean prolonged sedentary time (-30 min/day) with higher mean light intensity time (+30 min/day) was significantly associated with lower waist circumference (beta = -0.77, 95% CI: -1.33, -0.22 cm). Lower mean prolonged sedentary time (-30 min/day) with either 30 min/day higher mean non-prolonged sedentary time (beta = -0.35, 95% CI: -0.70, -0.01 kg/m(2)) or light-intensity time (beta = -0.36, -0.61, -0.11 kg/m(2)) was associated with significantly lower average BMI. Conclusions Significantly improved mean levels of waist circumference and BMI were observed when shifting time from prolonged sedentary to non-prolonged sedentary or light-intensity activity (cross-sectionally). Lifestyle interventions in overweight/obese adults with type 2 diabetes might consider targeting shifts in these non-MVPA activities to more rigorously evaluate their potential cardiometabolic benefit in this population.	[Healy, Genevieve N.; Winkler, Elisabeth A. H.; Brakenridge, Charlotte L.; Reeves, Marina M.; Eakin, Elizabeth G.] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia; [Healy, Genevieve N.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Healy, Genevieve N.] Curtin Univ, Sch Physiotherapy, Perth, WA 6845, Australia	University of Queensland; Baker Heart and Diabetes Institute; Curtin University	Healy, GN (corresponding author), Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia.	g.healy@uq.edu.au	Winkler, Elisabeth/AAD-7153-2022; Brakenridge, Charlotte/A-1589-2015; Eakin, Elizabeth G/F-7918-2010; Healy, Genevieve/A-7408-2008; Reeves, Marina M/B-3813-2009	Winkler, Elisabeth/0000-0003-1452-6102; Brakenridge, Charlotte/0000-0003-4540-7659; Eakin, Elizabeth G/0000-0002-8835-9995; Healy, Genevieve/0000-0001-7093-7892; Reeves, Marina M/0000-0003-3052-2013	National Health and Medical Research Council (NHMRC) project grant; ADS-Servier National Diabetes Strategy Grant in Memory of Barry Young; NHMRC Training Fellowship [569861]; Heart Foundation Postdoctoral Fellowship [PH 12B 7054]; NHMRC Senior Research Fellowship [511001]; National Breast Cancer Foundation Early Career Fellowship [ECF-13-09]	National Health and Medical Research Council (NHMRC) project grant(National Health and Medical Research Council (NHMRC) of Australia); ADS-Servier National Diabetes Strategy Grant in Memory of Barry Young; NHMRC Training Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Heart Foundation Postdoctoral Fellowship; NHMRC Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Breast Cancer Foundation Early Career Fellowship	This study was supported by a National Health and Medical Research Council (NHMRC) project grant. The accelerometer collection was supported by an ADS-Servier National Diabetes Strategy Grant in Memory of Barry Young. GNH is supported by a NHMRC [#569861] Training Fellowship and a Heart Foundation Postdoctoral Fellowship [PH 12B 7054]. EGE is supported by a NHMRC Senior Research Fellowship [#511001]. MMR is supported by a National Breast Cancer Foundation Early Career Fellowship [ECF-13-09]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aadahl M, 2014, AM J PREV MED, V47, P576, DOI 10.1016/j.amepre.2014.06.020; Avery L, 2012, DIABETES CARE, V35, P2681, DOI 10.2337/dc11-2452; Balboa-Castillo T, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-47; Bergouignan A, 2011, J APPL PHYSIOL, V111, P1201, DOI 10.1152/japplphysiol.00698.2011; Buman MP, 2014, AM J EPIDEMIOL, V179, P323, DOI 10.1093/aje/kwt292; Buman MP, 2010, AM J EPIDEMIOL, V172, P1155, DOI 10.1093/aje/kwq249; Cichosz SL, 2013, DIABETIC MED, V30, P1063, DOI 10.1111/dme.12199; Colberg SR, 2010, MED SCI SPORT EXER, V42, P2282, DOI 10.1249/MSS.0b013e3181eeb61c; Cooper AR, 2012, DIABETOLOGIA, V55, P589, DOI 10.1007/s00125-011-2408-x; Department of Health and Ageing, 1999, NAT PHYS ACT GUID AU; Dunstan DW, 2012, DIABETES CARE, V35, P976, DOI 10.2337/dc11-1931; Duvivier BMFM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055542; Eakin EG, 2013, ANN BEHAV MED, V46, P193, DOI 10.1007/s12160-013-9498-2; Eakin EG, 2014, DIABETES CARE, V37, P2177, DOI 10.2337/dc13-2427; Eakin EG, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-452; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Gando Y, 2014, J PHYS ACT HEALTH, V11, P266, DOI 10.1123/jpah.2012-0071; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Healy GN, 2011, AM J PREV MED, V41, P216, DOI 10.1016/j.amepre.2011.05.005; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Henson J, 2013, DIABETOLOGIA, V56, P1012, DOI 10.1007/s00125-013-2845-9; Hodge A, 2000, AUST NZ J PUBL HEAL, V24, P576, DOI 10.1111/j.1467-842X.2000.tb00520.x; Koster A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037696; Lewis J, 1995, NUTTAB95 NUTR DAT TA; Loprinzi PD, 2013, AGING MENT HEALTH, V17, P801, DOI 10.1080/13607863.2013.801066; Loprinzi PD, 2013, J DIABETES COMPLICAT, V27, P134, DOI 10.1016/j.jdiacomp.2012.09.004; Mekary RA, 2013, AM J EPIDEMIOL, V178, P474, DOI 10.1093/aje/kws590; Mekary RA, 2009, AM J EPIDEMIOL, V170, P519, DOI 10.1093/aje/kwp163; Newby PK, 2003, AM J CLIN NUTR, V78, P941, DOI 10.1093/ajcn/78.5.941; SCHMIDT FH, 1961, KLIN WOCHENSCHR, V39, P1244, DOI 10.1007/BF01506150; Stamatakis E, 2012, PREV MED, V54, P82, DOI 10.1016/j.ypmed.2011.10.009; Strath SJ, 2003, INT J SPORTS MED, V24, P298, DOI 10.1055/s-2003-39504; Thomas DR, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002968.pub2; Thomas N, 2004, POSTGRAD MED J, V80, P287, DOI 10.1136/pgmj.2003.010553; Trost SG, 2012, MED SCI SPORT EXER, V44, P1801, DOI 10.1249/MSS.0b013e318258ac11	35	74	74	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119140	10.1371/journal.pone.0119140	http://dx.doi.org/10.1371/journal.pone.0119140			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775249	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500072
J	Nishihara, H; Shimizu, F; Sano, Y; Takeshita, Y; Maeda, T; Abe, M; Koga, M; Kanda, T				Nishihara, Hideaki; Shimizu, Fumitaka; Sano, Yasuteru; Takeshita, Yukio; Maeda, Toshihiko; Abe, Masaaki; Koga, Michiaki; Kanda, Takashi			Fingolimod Prevents Blood-Brain Barrier Disruption Induced by the Sera from Patients with Multiple Sclerosis	PLOS ONE			English	Article							ORAL FINGOLIMOD; WHITE-MATTER; RAT MODEL; FTY720; EXPRESSION; LESIONS; INTERFERON; THERAPY	Objective Effect of fingolimod in multiple sclerosis (MS) is thought to involve the prevention of lymphocyte egress from lymphoid tissues, thereby reducing autoaggressive lymphocyte infiltration into the central nervous system across blood-brain barrier (BBB). However, brain microvascular endothelial cells (BMECs) represent a possible additional target for fingolimod in MS patients by directly repairing the function of BBB, as S1P receptors are also expressed by BMECs. In this study, we evaluated the effects of fingolimod on BMECs and clarified whether fingolimod-phosphate restores the BBB function after exposure to MS sera. Methods Changes in tight junction proteins, adhesion molecules and transendothelial electrical resistance (TEER) in BMECs were evaluated following incubation in conditioned medium with or without fingolimod/fingolimod-phosphate. In addition, the effects of sera derived from MS patients, including those in the relapse phase of relapse-remitting (RR) MS, stable phase of RRMS and secondary progressive MS (SPMS), on the function of BBB in the presence of fingolimod-phosphate were assessed. Results Incubation with fingolimod-phosphate increased the claudin-5 protein levels and TEER values in BMECs, although it did not change the amount of occludin, ICAM-1 or MelCAM proteins. Pretreatment with fingolimod-phosphate restored the changes in the claudin-5 and VCAM-1 protein/mRNA levels and TEER values in BMECs after exposure to MS sera. Conclusions Pretreatment with fingolimod-phosphate prevents BBB disruption caused by both RRMS and SPMS sera via the upregulation of claudin-5 and downregulation of VCAM-1 in BMECs, suggesting that fingolimod-phosphate is capable of directly modifying the BBB. BMECs represent a possible therapeutic target for fingolimod in MS patients.	[Nishihara, Hideaki; Shimizu, Fumitaka; Sano, Yasuteru; Takeshita, Yukio; Maeda, Toshihiko; Abe, Masaaki; Koga, Michiaki; Kanda, Takashi] Yamaguchi Univ, Grad Sch Med, Dept Neurol & Clin Neurosci, Ube, Yamaguchi 755, Japan	Yamaguchi University	Kanda, T (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Neurol & Clin Neurosci, Ube, Yamaguchi 755, Japan.	tkanda@yamaguchi-u.ac.jp	Koga, Michiaki/L-4825-2019; Nishihara, Hideaki/AAJ-7563-2021	Koga, Michiaki/0000-0002-1356-955X; Nishihara, Hideaki/0000-0002-2990-835X	Japan Society for the Promotion of Science, Tokyo, Japan [24790886, 22790821, 23659457, 25293203, 26670443]; Ministry of Health, Labour and Welfare of Japan [K2002528]; National Center of Neurology and Psychiatry [25-4]; Yamaguchi University Hospital; Novartis Pharma K.K.; Mitsubishi Tanabe Pharma; Grants-in-Aid for Scientific Research [26461271] Funding Source: KAKEN	Japan Society for the Promotion of Science, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); National Center of Neurology and Psychiatry(National Center for Neurology & Psychiatry - Japan); Yamaguchi University Hospital; Novartis Pharma K.K.(Novartis); Mitsubishi Tanabe Pharma(Mitsubishi Tanabe Pharma Corporation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	TK received the funding. This work was supported in part by research grants (Nos. 24790886, Nos. 22790821, Nos. 23659457, Nos. 25293203 and Nos. 26670443) from the Japan Society for the Promotion of Science, Tokyo, Japan (https://www.jsps.go.jp/english/), a research grant (K2002528) from Health and Labor Sciences Research Grants for research on intractable diseases (Neuroimmunological Disease Research Committee) from the Ministry of Health, Labour and Welfare of Japan (http://www.mhlw.go.jp/english/index.html), an Intramural Research Grant (25-4) for Neurological and Psychiatric Disorders from the National Center of Neurology and Psychiatry and a Translational Research Promotion Grant from Yamaguchi University Hospital. This study was sponsored by Novartis Pharma K.K. and Mitsubishi Tanabe Pharma and conducted as collaborative research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balatoni B, 2007, BRAIN RES BULL, V74, P307, DOI 10.1016/j.brainresbull.2007.06.023; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; BROSNAN CF, 1995, NEUROLOGY, V45, pS16, DOI 10.1212/WNL.45.6_Suppl_6.S16; Calabresi PA, 2014, LANCET NEUROL, V13, P545, DOI 10.1016/S1474-4422(14)70049-3; Choi YS, 2012, BIOCHEM BIOPH RES CO, V421, P305, DOI 10.1016/j.bbrc.2012.04.005; Chun J, 2010, CLIN NEUROPHARMACOL, V33, P91, DOI 10.1097/WNF.0b013e3181cbf825; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Engelhardt B, 2010, CLIN EXP NEUROIMMUNO, V1, P79, DOI DOI 10.1111/J.1759-1961.2010.009.X; Engelhardt B, 2008, NEURODEGENER DIS, V5, P16, DOI 10.1159/000109933; Foster CA, 2009, BRAIN PATHOL, V19, P254, DOI 10.1111/j.1750-3639.2008.00182.x; Hla T, 2011, NEUROLOGY, V76, pS3, DOI 10.1212/WNL.0b013e31820d5ec1; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; KERMODE AG, 1990, BRAIN, V113, P1477, DOI 10.1093/brain/113.5.1477; Khatri B, 2011, LANCET NEUROL, V10, P520, DOI 10.1016/S1474-4422(11)70099-0; Kira J, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-21; Kirk J, 2003, J PATHOL, V201, P319, DOI 10.1002/path.1434; Leech S, 2007, NEUROPATH APPL NEURO, V33, P86, DOI 10.1111/j.1365-2990.2006.00781.x; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; McQuaid S, 2009, BIOCHEM SOC T, V37, P329, DOI 10.1042/BST0370329; Mehling M, 2011, NEUROLOGY, V76, pS20, DOI 10.1212/WNL.0b013e31820db341; Miron VE, 2008, J NEUROL SCI, V274, P13, DOI 10.1016/j.jns.2008.06.031; Miron VE, 2008, AM J PATHOL, V173, P1143, DOI 10.2353/ajpath.2008.080478; Plumb J, 2002, BRAIN PATHOL, V12, P154; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Sano Y., 2013, CLIN EXP NEUROIMMUNO, V4, P92, DOI [10.1111/cen3.12001, DOI 10.1111/CEN3.12001, 10.1111]; Sano Y, 2010, J CELL PHYSIOL, V225, P519, DOI 10.1002/jcp.22232; Shimizu F, 2013, THE BLOOD BRAIN BARR; Shimizu F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092872; Shimizu F, 2012, J NEUROL NEUROSUR PS, V83, P288, DOI 10.1136/jnnp-2011-300434; Soliven B, 2011, NEUROLOGY, V76, pS9, DOI 10.1212/WNL.0b013e31820d9507; Takeshita Y, 2012, IMMUNOL REV, V248, P228, DOI 10.1111/j.1600-065X.2012.01127.x; Tasaki A, 2014, J NEUROL NEUROSUR PS, V85, P419, DOI 10.1136/jnnp-2013-305907; Varley CL, 2006, J CELL PHYSIOL, V208, P407, DOI 10.1002/jcp.20676; Wang L, 2011, EUR RESPIR J, V38, P78, DOI 10.1183/09031936.00047810; Wei Y, 2011, ANN NEUROL, V69, P119, DOI 10.1002/ana.22186; Zhang ZL, 2006, WORLD J GASTROENTERO, V12, P4241, DOI 10.3748/wjg.v12.i26.4241	38	31	32	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0121488	10.1371/journal.pone.0121488	http://dx.doi.org/10.1371/journal.pone.0121488			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774903	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500213
J	Perera, BPU; Teruyama, R; Kim, J				Perera, Bambarendage P. U.; Teruyama, Ryoichi; Kim, Joomyeong			Yy1 Gene Dosage Effect and Bi-Allelic Expression of Peg3	PLOS ONE			English	Article							TRANSCRIPTION FACTOR YY1; IMPRINTED GENE; EVOLUTION; BINDING; SEQUENCE; CELLS	In the current study, we tested the in vivo effects of Yy1 gene dosage on the Peg3 imprinted domain with various breeding schemes utilizing two sets of mutant alleles. The results indicated that a half dosage of Yy1 coincides with the up-regulation of Peg3 and Zim1, suggesting a repressor role of Yy1 in this imprinted domain. This repressor role of Yy1 is consistent with the observations derived from previous in vitro studies. The current study also provided an unexpected observation that the maternal allele of Peg3 is also normally expressed, and thus the expression of Peg3 is bi-allelic in the specific areas of the brain, including the choroid plexus, the PVN (Paraventricular Nucleus) and the SON (Supraoptic Nucleus) of the hypothalamus. The exact roles of the maternal allele of Peg3 in these cell types are currently unknown, but this new finding confirms the previous prediction that the maternal allele may be functional in specific cell types based on the lethality associated with the homozygotes for several mutant alleles of the Peg3 locus. Overall, these results confirm the repressor role of Yy1 in the Peg3 domain and also provide a new insight regarding the bi-allelic expression of Peg3 in mouse brain.	[Perera, Bambarendage P. U.; Teruyama, Ryoichi; Kim, Joomyeong] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Kim, J (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	jkim@lsu.edu		Perera, Bambarendage/0000-0002-7774-0985; Teruyama, Ryoichi/0000-0002-9356-8310	National Institute of Health [R01-GM066225, R01-GM097074]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066225, R01GM097074] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by National Institute of Health (J. K. R01-GM066225, R01-GM097074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affar E, 2006, MOL CELL BIOL, V26, P3565, DOI 10.1128/MCB.26.9.3565-3581.2006; Alfieri C, 2013, GENE DEV, V27, P2367, DOI 10.1101/gad.226621.113; Basu A, 2014, NUCLEIC ACIDS RES, V42, P2208, DOI 10.1093/nar/gkt1187; Broad KD, 2011, P NATL ACAD SCI USA, V108, P15237, DOI 10.1073/pnas.1106022108; Buraschi S, 2013, P NATL ACAD SCI USA, V110, pE2582, DOI 10.1073/pnas.1305732110; Calame K, 2007, GENE DEV, V21, P1145, DOI 10.1101/gad.1559007; Charalambous M, 2004, DEV BIOL, V271, P488, DOI 10.1016/j.ydbio.2004.04.022; Choo JH, 2008, GENE, V409, P28, DOI 10.1016/j.gene.2007.10.036; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Do Kim J, 2009, NUCLEIC ACIDS RES, V37, P5656, DOI 10.1093/nar/gkp613; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Friedel Roland H., 2007, Briefings in Functional Genomics & Proteomics, V6, P180, DOI 10.1093/bfgp/elm022; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Huang JM, 2009, GENE, V442, P18, DOI 10.1016/j.gene.2009.04.016; Ideraabdullah FY, 2008, MUTAT RES-FUND MOL M, V647, P77, DOI 10.1016/j.mrfmmm.2008.08.008; Karam R, 2013, BBA-GENE REGUL MECH, V1829, P624, DOI 10.1016/j.bbagrm.2013.03.002; Khan H, 2006, GENOME RES, V16, P78, DOI 10.1101/gr.4001406; Kim J, 2004, GENOMICS, V84, P47, DOI 10.1016/j.ygeno.2004.02.007; Kim J, 2003, HUM MOL GENET, V12, P233, DOI 10.1093/hmg/ddg028; Kim J, 2001, GENOMICS, V77, P91, DOI 10.1006/geno.2001.6621; Kim J, 1997, GENOME RES, V7, P532, DOI 10.1101/gr.7.5.532; KIM J, 2013, NATL GEOGR, V224, P8; Kim J, 2005, RAPIDLY EVOLVING IMF; Kim J, 2006, 2006 IEEE INTERNATIONAL SYMPOSIUM ON ELECTROMAGNETIC COMPATIBILITY, VOLS 1-3, PROCEEDINGS, P16; Kim JD, 2007, GENOMICS, V89, P262, DOI 10.1016/j.ygeno.2006.09.009; Kim J, 2008, EPIGENETICS-US, V3, P115, DOI 10.4161/epi.3.3.6176; Kim J, 2008, HUM MOL GENET, V17, P391, DOI 10.1093/hmg/ddm316; Kim J, 2012, HUM MOL GENET, V21, P2677, DOI 10.1093/hmg/dds092; Klymenko T, 2006, GENE DEV, V20, P1110, DOI 10.1101/gad.377406; Kuroiwa Y, 1996, NAT GENET, V12, P186, DOI 10.1038/ng0296-186; Laplante M, 2013, J CELL SCI, V126, P1713, DOI 10.1242/jcs.125773; Lucifero D, 2002, GENOMICS, V79, P530, DOI 10.1006/geno.2002.6732; Lucifero D, 2004, HUM MOL GENET, V13, P839, DOI 10.1093/hmg/ddh104; Oei SL, 2004, GENOMICS, V83, P873, DOI 10.1016/j.ygeno.2003.11.001; Relaix F, 1996, DEV BIOL, V177, P383, DOI 10.1006/dbio.1996.0172; Schlesinger S, 2013, CELL REP, V4, P50, DOI 10.1016/j.celrep.2013.06.003; Spahn L, 2003, NAT GENET, V35, P11, DOI 10.1038/ng0903-11; Thiaville MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075417; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085	39	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119493	10.1371/journal.pone.0119493	http://dx.doi.org/10.1371/journal.pone.0119493			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774914	Green Submitted, gold, Green Published			2022-12-27	WOS:000351183500096
J	Romero, M; Caniffi, C; Bouchet, G; Costa, MA; Elesgaray, R; Arranz, C; Tomat, AL				Romero, Mariana; Caniffi, Carolina; Bouchet, Gonzalo; Costa, Maria A.; Elesgaray, Rosana; Arranz, Cristina; Tomat, Analia L.			Chronic Treatment with Atrial Natriuretic Peptide in Spontaneously Hypertensive Rats: Beneficial Renal Effects and Sex Differences	PLOS ONE			English	Article							NITRIC-OXIDE; BLOOD-PRESSURE; OXIDATIVE STRESS; ANTIOXIDANT THERAPY; GENDER-DIFFERENCES; CELL-DEATH; ESTROGEN; DISEASE; KIDNEY; EXPRESSION	Objective The aim of this study was to investigate the effects of chronic treatment with atrial natriuretic peptide (ANP) on renal function, nitric oxide (NO) system, oxidative stress, collagen content and apoptosis in kidneys of spontaneously hypertensive rats (SHR), as well as sex-related differences in the response to the treatment. Methods 10 week-old male and female SHR were infused with ANP (100 ng/h/rat) or saline (NaCl 0.9%) for 14 days (subcutaneous osmotic pumps). Systolic blood pressure (SBP) was recorded and diuresis and natriuresis were determined. After treatment, renal NO synthase (NOS) activity and eNOS expression were evaluated. Thiobarbituric acid-reactive substances (TBARS), glutathione concentration and glutathione peroxidase (GPx) and superoxide dismutase (SOD) activities were determined in the kidney. Collagen was identified in renal slices by Sirius red staining and apoptosis by Tunel assay. Results Female SHR showed lower SBP, oxidative stress, collagen content and apoptosis in kidney, and higher renal NOS activity and eNOS protein content, than males. ANP lowered SBP, increased diuresis, natriuresis, renal NOS activity and eNOS expression in both sexes. Renal response to ANP was more marked in females than in males. In kidney, ANP reduced TBARS, renal collagen content and apoptosis, and increased glutathione concentration and activity of GPx and SOD enzymes in both sexes. Conclusions Female SHR exhibited less organ damage than males. Chronic ANP treatment would ameliorate hypertension and end-organ damage in the kidney by reducing oxidative stress, increasing NO-system activity, and diminishing collagen content and apoptosis, in both sexes.	[Romero, Mariana; Caniffi, Carolina; Bouchet, Gonzalo; Costa, Maria A.; Elesgaray, Rosana; Arranz, Cristina; Tomat, Analia L.] Univ Buenos Aires, IQUIMEFA CONICET, Catedra Fisiol, Fac Farm & Bioquim, RA-1113 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Tomat, AL (corresponding author), Univ Buenos Aires, IQUIMEFA CONICET, Catedra Fisiol, Fac Farm & Bioquim, Junin 956,Piso 7, RA-1113 Buenos Aires, DF, Argentina.	atomat@ffyb.uba.ar			UBACYT from Universidad de Buenos Aires, Argentina, MAC [20020100100060 (2011-2014)]; CONICET, Argentina, CA [PIP-112-200801-01121]	UBACYT from Universidad de Buenos Aires, Argentina, MAC; CONICET, Argentina, CA	This study was partially supported by grants: UBACYT No 20020100100060 (2011-2014) from Universidad de Buenos Aires, Argentina, MAC; and PIP-112-200801-01121 from CONICET, Argentina, CA.	Antus B, 2003, NEPHROL DIAL TRANSPL, V18, P54, DOI 10.1093/ndt/18.1.54; Baldini PM, 2005, MOL CELL BIOCHEM, V272, P19, DOI 10.1007/s11010-005-4779-0; Baylis C, 2012, CURR OPIN NEPHROL HY, V21, P1, DOI 10.1097/MNH.0b013e32834d54ca; Bilzer M, 1999, AM J PHYSIOL-GASTR L, V276, pG1137, DOI 10.1152/ajpgi.1999.276.5.G1137; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROSNIHAN KB, 1994, AM J HYPERTENS, V7, P576, DOI 10.1093/ajh/7.7.576; Buege J A, 1978, Methods Enzymol, V52, P302; Chang HR, 2005, CHINESE J PHYSIOL, V48, P15; Collins AJ, 2011, AM J KIDNEY DIS, V57, pA8, DOI 10.1053/j.ajkd.2010.10.007; Costa MA, 2006, LIFE SCI, V78, P1543, DOI 10.1016/j.lfs.2005.07.024; Costa MA, 2004, J HYPERTENS, V22, pS183, DOI 10.1097/00004872-200406002-00634; Costa MA, 2010, AM J PHYSIOL-HEART C, V298, pH778, DOI 10.1152/ajpheart.00488.2009; Costa MD, 2004, REGUL PEPTIDES, V118, P151, DOI 10.1016/j.regpep.2003.12.009; Costa MD, 2000, HYPERTENSION, V35, P1119, DOI 10.1161/01.HYP.35.5.1119; Dantas APV, 2004, CARDIOVASC RES, V61, P22, DOI 10.1016/j.cardiores.2003.10.010; Das S, 2010, ENDOCRINOLOGY, V151, P5841, DOI 10.1210/en.2010-0655; De Vito P, 2010, PEPTIDES, V31, P1412, DOI 10.1016/j.peptides.2010.04.001; Dubey RK, 2002, CARDIOVASC RES, V53, P688, DOI 10.1016/S0008-6363(01)00527-2; Elesgaray R, 2012, AM J PHYSIOL-RENAL, V302, pF1385, DOI 10.1152/ajprenal.00624.2011; Filippatos GS, 2001, AM J PHYSIOL-LUNG C, V281, pL749, DOI 10.1152/ajplung.2001.281.4.L749; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Fukai T, 2002, CARDIOVASC RES, V55, P239, DOI 10.1016/S0008-6363(02)00328-0; Gatson JW, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-30; Hall JE, 2008, HYPERTENSION, V51, P951, DOI 10.1161/HYPERTENSIONAHA.107.009813; Huang A, 1997, AM J PHYSIOL-HEART C, V272, pH1804, DOI 10.1152/ajpheart.1997.272.4.H1804; Iseki K, 1997, KIDNEY INT, V51, P850, DOI 10.1038/ki.1997.119; Ji H, 2007, GENDER MED, V4, P56, DOI 10.1016/S1550-8579(07)80009-X; Kishimoto I, 1996, P NATL ACAD SCI USA, V93, P6215, DOI 10.1073/pnas.93.12.6215; Koeners MP, 2007, HYPERTENSION, V50, P1077, DOI 10.1161/HYPERTENSIONAHA.107.095794; Lacy F, 2000, HYPERTENSION, V36, P878, DOI 10.1161/01.HYP.36.5.878; Lindner V, 1998, CIRC RES, V83, P224, DOI 10.1161/01.RES.83.2.224; Tomat AL, 2008, AM J PHYSIOL-REG I, V295, pR543, DOI 10.1152/ajpregu.00050.2008; MAEHLY AC, 1954, METHOD BIOCHEM ANAL, V1, P357; McCullough PA, 2011, AM J KIDNEY DIS, V57, pS1, DOI 10.1053/j.ajkd.2010.11.011; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Nishikimi T, 2009, REGUL PEPTIDES, V154, P44, DOI 10.1016/j.regpep.2009.02.006; Ogawa Y, 2012, J AM SOC NEPHROL, V23, P1198, DOI 10.1681/ASN.2011100985; Ortiz A, 2001, J CELL MOL MED, V5, P18, DOI 10.1111/j.1582-4934.2001.tb00135.x; Pare G, 2002, CIRC RES, V90, P1087, DOI 10.1161/01.RES.0000021114.92282.FA; Pelzer T, 2000, BIOCHEM BIOPH RES CO, V268, P192, DOI 10.1006/bbrc.2000.2073; Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014; Rakhit RD, 2001, HEART, V86, P368, DOI 10.1136/heart.86.4.368; Reckelhoff JF, 1998, HYPERTENSION, V31, P435, DOI 10.1161/01.HYP.31.1.435; Reckelhoff JF, 2001, HYPERTENSION, V37, P1199, DOI 10.1161/01.HYP.37.5.1199; Romero M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071992; Schnackenberg CG, 1999, HYPERTENSION, V33, P424, DOI 10.1161/01.HYP.33.1.424; Shono M, 2007, CIRC J, V71, P1040, DOI 10.1253/circj.71.1040; Smith RS, 2005, LIFE SCI, V76, P2457, DOI 10.1016/j.lfs.2004.11.028; Sullivan JC, 2007, AM J PHYSIOL-REG I, V292, pR764, DOI 10.1152/ajpregu.00322.2006; Tain YL, 2010, J PINEAL RES, V49, P390, DOI 10.1111/j.1600-079X.2010.00806.x; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Tomat AL, 2007, LIFE SCI, V80, P1292, DOI 10.1016/j.lfs.2006.12.035; Vaziri ND, 2004, CURR OPIN NEPHROL HY, V13, P93, DOI 10.1097/00041552-200401000-00013; Vaziri ND, 2000, HYPERTENSION, V36, P957, DOI 10.1161/01.HYP.36.6.957; VERDON CP, 1995, ANAL BIOCHEM, V224, P502, DOI 10.1006/abio.1995.1079; WIINBERG N, 1995, AM J HYPERTENS, V8, P978, DOI 10.1016/0895-7061(95)00216-2; Wilcox CS, 2005, AM J PHYSIOL-REG I, V289, pR913, DOI 10.1152/ajpregu.00250.2005; Yang SM, 2000, J CARDIOVASC PHARM, V36, P242, DOI 10.1097/00005344-200008000-00015	58	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120362	10.1371/journal.pone.0120362	http://dx.doi.org/10.1371/journal.pone.0120362			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774801	Green Published, gold, Green Submitted			2022-12-27	WOS:000351183500167
J	Macias-Cortes, ED; Llanes-Gonzalez, L; Aguilar-Faisal, L; Asbun-Bojalil, J				del Carmen Macias-Cortes, Emma; Llanes-Gonzalez, Lidia; Aguilar-Faisal, Leopoldo; Asbun-Bojalil, Juan			Individualized Homeopathic Treatment and Fluoxetine for Moderate to Severe Depression in Peri- and Postmenopausal Women (HOMDEP-MENOP Study): A Randomized, Double-Dummy, Double-Blind, Placebo-Controlled Trial	PLOS ONE			English	Article							DOMESTIC VIOLENCE; SYMPTOMS; TRANSITION; HEALTH; ANTIDEPRESSANTS; COMPLEMENTARY; VENLAFAXINE; DISORDER; MIDDLE; LEVEL	Background Perimenopausal period refers to the interval when women's menstrual cycles become irregular and is characterized by an increased risk of depression. Use of homeopathy to treat depression is widespread but there is a lack of clinical trials about its efficacy in depression in peri- and postmenopausal women. The aim of this study was to assess efficacy and safety of individualized homeopathic treatment versus placebo and fluoxetine versus placebo in peri- and postmenopausal women with moderate to severe depression. Methods/Design A randomized, placebo-controlled, double-blind, double-dummy, superiority, three-arm trial with a 6 week follow-up study was conducted. The study was performed in a public research hospital in Mexico City in the outpatient service of homeopathy. One hundred thirty-three peri- and postmenopausal women diagnosed with major depression according to DSM-IV (moderate to severe intensity) were included. The outcomes were: change in the mean total score among groups on the 17-item Hamilton Rating Scale for Depression, Beck Depression Inventory and Greene Scale, after 6 weeks of treatment, response and remission rates, and safety. Efficacy data were analyzed in the intention-to-treat population (ANOVA with Bonferroni post-hoc test). Results After a 6-week treatment, homeopathic group was more effective than placebo by 5 points in Hamilton Scale. Response rate was 54.5% and remission rate, 15.9%. There was a significant difference among groups in response rate definition only, but not in remission rate. Fluoxetine-placebo difference was 3.2 points. No differences were observed among groups in the Beck Depression Inventory. Homeopathic group was superior to placebo in Greene Climacteric Scale (8.6 points). Fluoxetine was not different from placebo in Greene Climacteric Scale. Conclusion Homeopathy and fluoxetine are effective and safe antidepressants for climacteric women. Homeopathy and fluoxetine were significantly different from placebo in response definition only. Homeopathy, but not fluoxetine, improves menopausal symptoms scored by Greene Climacteric Scale.	[del Carmen Macias-Cortes, Emma; Aguilar-Faisal, Leopoldo; Asbun-Bojalil, Juan] Inst Politecn Nacl, Escuela Super Med, Div Estudios Posgrad, Mexico City 07738, DF, Mexico; [del Carmen Macias-Cortes, Emma] Secretaria Salud Mexico, Hosp Juarez Mexico, Consulta Externa Homeopatia, Mexico City, DF, Mexico; [Llanes-Gonzalez, Lidia] Secretaria Salud Mexico, Hosp Juarez Mexico, Unidad Salud Mental, Mexico City, DF, Mexico	Instituto Politecnico Nacional - Mexico	Macias-Cortes, ED (corresponding author), Inst Politecn Nacl, Escuela Super Med, Div Estudios Posgrad, Mexico City 07738, DF, Mexico.	ecmc2008@hotmail.es	ASBUN, JUAN/C-3979-2016; Macias-Cortes, Emma/AAG-8402-2020	Aguilar Faisal, J. Leopoldo/0000-0003-0519-3254				Adler UC, 2009, EVID BASED COMPLEMEN; [Anonymous], 2013, DIAGN STAT MAN MENT, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Becker KD, 2010, J INTERPERS VIOLENCE, V25, P1699, DOI 10.1177/0886260509354578; Bell IR, 2004, RHEUMATOLOGY, V43, P577, DOI 10.1093/rheumatology/keh111; BLAZER DG, 1994, AM J PSYCHIAT, V151, P979; Bobes J, 2003, MED CLIN-BARCELONA, V120, P693, DOI 10.1157/13047695; Bordet MF, 2008, HOMEOPATHY, V97, P10, DOI 10.1016/j.homp.2007.11.005; Bromberger JT, 2007, J AFFECT DISORDERS, V103, P267, DOI 10.1016/j.jad.2007.01.034; BUNGAY GT, 1980, BRIT MED J, V281, P181, DOI 10.1136/bmj.281.6234.181; Calleja N, 2011, INVENTARIO ESCALAS P, P230; Carrasco JL, 2005, INT J CLIN PRACT, V59, P1428, DOI 10.1111/j.1368-5031.2005.00681.x; Carroll DG, 2009, PHARMACOTHERAPY, V29, P1357, DOI 10.1592/phco.29.11.1357; Chan AW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7586; Clayton Anita H, 2010, Prim Care Companion J Clin Psychiatry, V12, DOI 10.4088/PCC.08r00747blu; Cohen LS, 2006, ARCH GEN PSYCHIAT, V63, P385, DOI 10.1001/archpsyc.63.4.385; Davidson JRT, 2011, J CLIN PSYCHIAT, V72, P795, DOI 10.4088/JCP.10r06580; Dawes S E, 2010, Int J Cult Ment Health, V3, P34; Dean ME, 2007, J ALTERN COMPLEM MED, V13, P19, DOI 10.1089/acm.2006.6352; Macias-Cortes ED, 2013, TRIALS, V14, DOI [10.1186/1468-6708-14-105, 10.1186/1745-6215-14-105]; Ernst E, 2010, MED J AUSTRALIA, V192, P458, DOI 10.5694/j.1326-5377.2010.tb03585.x; Ferrari G, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.25519; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Freeman EW, 2006, ARCH GEN PSYCHIAT, V63, P375, DOI 10.1001/archpsyc.63.4.375; Freeman MP, 2010, J CLIN PSYCHIAT, V71, P682, DOI 10.4088/JCP.10r05976blu; Gibbons RD, 2012, ARCH GEN PSYCHIAT, V69, P572, DOI 10.1001/archgenpsychiatry.2011.2044; Greene JG, 1998, MATURITAS, V29, P25, DOI 10.1016/S0378-5122(98)00025-5; Hale GE, 2007, J CLIN ENDOCR METAB, V92, P3060, DOI 10.1210/jc.2007-0066; HAY AG, 1994, BRIT J PSYCHIAT, V164, P513, DOI 10.1192/bjp.164.4.513; Hernandez-Valencia Marcelino, 2010, Ginecol Obstet Mex, V78, P232; HOLTE A, 1991, MATURITAS, V13, P193, DOI 10.1016/0378-5122(91)90194-U; Instituto Nacional de Estadistica y Geografia INEGI, 2013, MUJ HOMBR MEX 2013, P126; Jacobs J, 2005, J ALTERN COMPLEM MED, V11, P21, DOI 10.1089/acm.2005.11.21; Janssen I, 2008, ARCH INTERN MED, V168, P1568, DOI 10.1001/archinte.168.14.1568; Jewkes R, 2002, LANCET, V359, P1423, DOI 10.1016/S0140-6736(02)08357-5; Jonas W., 1996, HEALING HOMEOPATHY; Jonas WB, 2003, ANN INTERN MED, V138, P393, DOI 10.7326/0003-4819-138-5-200303040-00009; Kessler RC, 2003, J AFFECT DISORDERS, V74, P5, DOI 10.1016/S0165-0327(02)00426-3; Kirsch I., 2002, PREV TREAT, V5, P23, DOI [DOI 10.1037/1522-3736.5.1.523A, 10.1037/1522-3736.5.1.523a]; Koenig MA, 2003, DEMOGRAPHY, V40, P269, DOI 10.2307/3180801; Kornstein SG, 2014, J CLIN PSYCHIAT, V75, P62, DOI 10.4088/JCP.12m07841; Levine TR, 2002, HUM COMMUN RES, V28, P612, DOI 10.1093/hcr/28.4.612; Linde K, 1998, J ALTERN COMPLEM MED, V4, P371, DOI 10.1089/acm.1998.4.371; Ludtke R, 2008, J CLIN EPIDEMIOL, V61, P1197, DOI 10.1016/j.jclinepi.2008.06.015; National Institute for Clinical Excellence, 2004, DEPR MAN DEPR PRIM S, P670; Nemeroff CB, 2007, J PSYCHIATR RES, V41, P351, DOI 10.1016/j.jpsychires.2005.07.009; Pinto-Meza A, 2006, J AFFECT DISORDERS, V93, P53, DOI 10.1016/j.jad.2006.02.010; Ramos-Brieva J A, 1986, Actas Luso Esp Neurol Psiquiatr Cienc Afines, V14, P324; Rapkin AJ, 2007, AM J OBSTET GYNECOL, V196, P97, DOI 10.1016/j.ajog.2006.05.056; Schulz KF, 2010, PLOS MED, V24; Shang AJ, 2005, LANCET, V366, P726, DOI 10.1016/S0140-6736(05)67177-2; Shifren JL, 2000, J WOMEN HEALTH GEN-B, V9, pS3, DOI 10.1089/152460900318795; Snapinn Steven M, 2000, Curr Control Trials Cardiovasc Med, V1, P19, DOI 10.1186/CVM-1-1-019; Soares CN, 2001, CNS SPECTRUMS, V2, P167; SuarezMendoza AA, 1997, ARTHRIT CARE RES, V10, P194, DOI 10.1002/art.1790100307; Thompson EA, 2010, MATURITAS, V66, P350, DOI 10.1016/j.maturitas.2010.02.003; Wise PM, 1996, SCIENCE, V273, P67, DOI 10.1126/science.273.5271.67; World Health Organisation (WHO), 1996, TRAC EL HUM NUTR HLT	57	24	24	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118440	10.1371/journal.pone.0118440	http://dx.doi.org/10.1371/journal.pone.0118440			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768800	Green Submitted, Green Published, gold			2022-12-27	WOS:000351277500025
J	Dong, GY; Peng, C; Luo, J; Wang, CM; Han, L; Wu, B; Ji, GJ; He, HX				Dong, Guoying; Peng, Chao; Luo, Jing; Wang, Chengmin; Han, Le; Wu, Bin; Ji, Guangju; He, Hongxuan			Adamantane-Resistant Influenza A Viruses in the World (1902-2013): Frequency and Distribution of M2 Gene Mutations	PLOS ONE			English	Article							A(H3N2) VIRUSES; AMANTADINE-RESISTANCE; RIMANTADINE; A(H1N1); SEASON; SURVEILLANCE; PROPHYLAXIS; AUSTRALIA; EMERGENCE	Adamantanes (amantadine and rimantadine) have been used to prevent and treat influenza A virus infections for many years; however, resistance to these drugs has been widely reported in the world. To investigate the frequency and distribution of M2 gene mutations in adamantane-resistant influenza variants circulated in the world between 1902 and 2013, 31251 available M2 protein sequences from different HA-subtype influenza A viruses (H1-H17) were analyzed and adamantane resistance-associated mutations were compared (L26F, V27A, A30T, A30V, S31N, G34E, and L38F). We find that 45.2% (n = 14132) of influenza A (H1-H17) viruses circulating globally were resistant to adamantanes, and the vast majority of resistant viruses (95%) bear S31N mutations. Whereas, only about 1% have V27A mutations and other mutations (L26F, A30T, G34E, and L38F) were extremely rare (their prevalence appeared to be < 0.2%). Our results confirm that H1, H3, H5, H7, H9, and H17 subtype influenza A viruses exhibit high-level resistance to adamantanes. In contrast, the appearance of adamantane-resistant mutants in H2, H4, H6, H10, and H11 subtypes was rare. However, no adamantane resistance viruses were identified among other HA subtypes (H8, H12-H16). Our findings indicate that the frequency and distribution of adamantane- resistant influenza variants varied among different HA subtypes, host species, years of isolation, and geographical areas. This comprehensive study raises concerns about the increasing prevalence of adamantane-resistant influenza A viruses and highlights the importance of monitoring the emergence and worldwide spread of adamantaneresistant variants.	[Dong, Guoying; Peng, Chao; Han, Le] Beijing Normal Univ, Coll Global Change & Earth Syst Sci, Beijing 100875, Peoples R China; [Dong, Guoying; Luo, Jing; Wang, Chengmin; Wu, Bin; He, Hongxuan] Chinese Acad Sci, Inst Zool, Natl Res Ctr Wildlife Born Dis, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Dong, Guoying; Ji, Guangju] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China	Beijing Normal University; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS	Dong, GY (corresponding author), Beijing Normal Univ, Coll Global Change & Earth Syst Sci, Beijing 100875, Peoples R China.	dongguoying88@aliyun.com; gj28@ibp.ac.cn; hehx@ioz.ac.cn		Ji, Guangju/0000-0001-8626-3490	National High Technology Research and Development Program (863 Program) of China [2012AA12A407]; National Key Basic Research and Development Program (973 Program) of China [2010CB530302]	National High Technology Research and Development Program (863 Program) of China(National High Technology Research and Development Program of China); National Key Basic Research and Development Program (973 Program) of China(National Basic Research Program of China)	This work was supported by grants from the National High Technology Research and Development Program (863 Program) of China (2012AA12A407) and the National Key Basic Research and Development Program (973 Program) of China (2010CB530302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed Y, 2005, ANTIMICROB AGENTS CH, V49, P556, DOI 10.1128/AAC.49.2.556-559.2005; Astrahan P, 2004, PROTEINS, V55, P251, DOI 10.1002/prot.20018; Aubin JT, 2005, EMERG INFECT DIS, V11, P1515; Barr IG, 2007, ANTIVIR RES, V75, P173, DOI 10.1016/j.antiviral.2007.01.006; Barr IG, 2007, ANTIVIR RES, V73, P112, DOI 10.1016/j.antiviral.2006.08.002; BEAN WJ, 1989, J INFECT DIS, V159, P1050, DOI 10.1093/infdis/159.6.1050; BELSHE RB, 1989, J INFECT DIS, V159, P430, DOI 10.1093/infdis/159.3.430; BELSHE RB, 1988, J VIROL, V62, P1508, DOI 10.1128/JVI.62.5.1508-1512.1988; Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020; Bright RA, 2005, LANCET, V366, P1175, DOI 10.1016/S0140-6736(05)67338-2; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P44; Cheung CL, 2006, J INFECT DIS, V193, P1626, DOI 10.1086/504723; COX NJ, 1994, EUR J EPIDEMIOL, V10, P467, DOI 10.1007/BF01719678; Deyde VM, 2008, J INFECT DIS, V197, P632, DOI 10.1086/525056; Deyde VM, 2007, J INFECT DIS, V196, P249, DOI 10.1086/518936; DOLIN R, 1982, NEW ENGL J MED, V307, P580, DOI 10.1056/NEJM198209023071002; Englund Janet A, 2002, Semin Pediatr Infect Dis, V13, P120, DOI 10.1053/spid.2002.122999; Gerdil C, 2003, VACCINE, V21, P1776, DOI 10.1016/S0264-410X(03)00071-9; HAY AJ, 1986, J ANTIMICROB CHEMOTH, V18, P19, DOI 10.1093/jac/18.Supplement_B.19; Hayden FG, 2006, NEW ENGL J MED, V354, P785, DOI 10.1056/NEJMp068030; HAYDEN FG, 1992, CURR TOP MICROBIOL, V176, P119; Hayden FG, 1996, ANTIVIRAL DRUG RESIS, P59; He GM, 2008, ANTIVIR RES, V77, P72, DOI 10.1016/j.antiviral.2007.08.007; Hurt AC, 2007, ANTIVIR RES, V73, P228, DOI 10.1016/j.antiviral.2006.10.004; Ilyushina NA, 2007, ANTIVIR THER, V12, P363; REUMAN PD, 1989, ANTIVIR RES, V11, P27, DOI 10.1016/0166-3542(89)90018-1; Saito R, 2008, J INFECT DIS, V197, P630, DOI 10.1086/525055; Shiraishi K, 2003, J INFECT DIS, V188, P57, DOI 10.1086/375799; Tang JW, 2008, J MED VIROL, V80, P895, DOI 10.1002/jmv.21155; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wu B, 2009, CHINESE SCI BULL, V54, P2179, DOI 10.1007/s11434-009-0421-y; Ziegler T, 1999, J INFECT DIS, V180, P935, DOI 10.1086/314994	32	98	107	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119115	10.1371/journal.pone.0119115	http://dx.doi.org/10.1371/journal.pone.0119115			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768797	Green Published, Green Submitted, gold			2022-12-27	WOS:000351277500065
J	Haas, BW; Brook, M; Remillard, L; Ishak, A; Anderson, IW; Filkowski, MM				Haas, Brian W.; Brook, Michael; Remillard, Laura; Ishak, Alexandra; Anderson, Ian W.; Filkowski, Megan M.			I Know How You Feel: The Warm-Altruistic Personality Profile and the Empathic Brain	PLOS ONE			English	Article							RIGHT TEMPOROPARIETAL JUNCTION; PERSPECTIVE-TAKING; SOCIAL COGNITION; 5-FACTOR MODEL; FACET SCALES; BIG 5; METAANALYSIS; NEUROSCIENCE; INVENTORY; ACCURACY	The ability to empathize with other people is a critical component of human social relationships. Empathic processing varies across the human population, however it is currently unclear how personality traits are associated with empathic processing. This study was designed to test the hypothesis that specific personality traits are associated with behavioral and biological indicators of improved empathy. Extraversion and Agreeableness are personality traits designed to measure individual differences in social-cognitive functioning, however each trait-dimension includes elements that represent interpersonal social functioning and elements that do not represent interpersonal social functioning. We tested the prediction that interpersonal elements of Extraversion (Warmth) and Agreeableness (Altruism) are associated with empathy and non-interpersonal elements of Extraversion and Agreeableness are not associated with empathy. We quantified empathic processing behaviorally (empathic accuracy task using video vignettes) and within the brain (fMRI and an emotional perspective taking task) in 50 healthy subjects. Converging evidence shows that highly warm and altruistic people are well skilled in recognizing the emotional states of other people and exhibit greater activity in brain regions important for empathy (temporoparietal junction and medial prefrontal cortex) during emotional perspective taking. A mediation analysis further supported the association between warm-altruistic personality and empathic processing; indicating that one reason why highly warm-altruistic individuals may be skilled empathizers is that they engage the temporoparietal junction and medial prefrontal cortex more. Together, these findings advance the way the behavioral and neural basis of empathy is understood and demonstrates the efficacy of personality scales to measure individual differences in interpersonal social function.	[Haas, Brian W.; Remillard, Laura; Ishak, Alexandra; Anderson, Ian W.; Filkowski, Megan M.] Univ Georgia, Dept Psychol, Athens, GA 30602 USA; [Haas, Brian W.] Univ Georgia, Interdisciplinary Neurosci Grad Program, Athens, GA 30602 USA; [Brook, Michael] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Chicago, IL USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Northwestern University; Feinberg School of Medicine	Haas, BW (corresponding author), Univ Georgia, Dept Psychol, Athens, GA 30602 USA.	bhaas@uga.edu			University of Georgia, Office of the Vice President for Research	University of Georgia, Office of the Vice President for Research	Funding: This study was funded by the University of Georgia, Office of the Vice President for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler A., 1964, SOCIAL INTEREST CHAL; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; [Anonymous], 2001, EMOTIONS SOCIAL PSYC; Ashton MC, 2002, J PERS SOC PSYCHOL, V83, P245, DOI 10.1037//0022-3514.83.1.245; Bastian VA, 2005, PERS INDIV DIFFER, V39, P1135, DOI 10.1016/j.paid.2005.04.006; BATSON CD, 1988, J PERS SOC PSYCHOL, V55, P52, DOI 10.1037/0022-3514.55.1.52; Martos MPB, 2013, SCAND J PSYCHOL, V54, P407, DOI 10.1111/sjop.12058; Brook M, 2013, J ABNORM PSYCHOL, V122, P156, DOI 10.1037/a0030261; Christov-Moore L, 2014, NEUROSCI BIOBEHAV R, V46, P604, DOI 10.1016/j.neubiorev.2014.09.001; Costa A, 2008, BEHAV NEUROL, V19, P71, DOI 10.1155/2008/694632; Costa P., 2008, SAGE HDB PERSONALITY, V2, P179, DOI [10.4135/9781849200479.n9, DOI 10.4135/9781849200479.N9]; Costa P, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0089254, 10.1371/journal.pone.0094842]; COSTA PT, 1991, PERS INDIV DIFFER, V12, P887, DOI 10.1016/0191-8869(91)90177-D; COSTA PT, 1995, J PERS ASSESS, V64, P21, DOI 10.1207/s15327752jpa6401_2; Cote S, 2011, J PERS SOC PSYCHOL, V101, P217, DOI 10.1037/a0023171; Davis M.H., 1997, EMPATHIC ACCURACY, P144; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Decety J, 2011, EMOT REV, V3, P92, DOI 10.1177/1754073910374662; Decety J, 2010, DEV NEUROSCI-BASEL, V32, P257, DOI 10.1159/000317771; Depue RA, 2005, BEHAV BRAIN SCI, V28, P313; DEPUE RA, 2005, BEHAV BRAIN SCI, V28, P350, DOI DOI 10.1017/S0140525X05000063; Derntl B, 2010, PSYCHONEUROENDOCRINO, V35, P67, DOI 10.1016/j.psyneuen.2009.10.006; DeYoung CG, 2007, J PERS SOC PSYCHOL, V93, P880, DOI 10.1037/0022-3514.93.5.880; DeYoung CG, 2013, J PERS, V81, P465, DOI 10.1111/jopy.12020; DeYoung CG, 2010, PSYCHOL SCI, V21, P820, DOI 10.1177/0956797610370159; Giardina A, 2011, NEUROSCI LETT, V495, P150, DOI 10.1016/j.neulet.2011.03.059; Gonzalez-Liencres C, 2013, NEUROSCI BIOBEHAV R, V37, P1537, DOI 10.1016/j.neubiorev.2013.05.001; Graziano W., 2013, HDB COGNITION EMOTIO, P347; Grezes J, 2002, NEUROPSYCHOLOGIA, V40, P212, DOI 10.1016/S0028-3932(01)00089-6; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; Hall JA, 2009, J NONVERBAL BEHAV, V33, P149, DOI 10.1007/s10919-009-0070-5; Ickes W.J., 1997, EMPATHIC ACCURACY; Jang KL, 2002, PERS INDIV DIFFER, V33, P83, DOI 10.1016/S0191-8869(01)00137-4; John O. P., 2008, HDB PERSONALITY THEO, V3, P114; Kraus MW, 2010, PSYCHOL SCI, V21, P1716, DOI 10.1177/0956797610387613; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Mars RB, 2012, CEREB CORTEX, V22, P1894, DOI 10.1093/cercor/bhr268; McBride C, 2005, PERS INDIV DIFFER, V38, P129, DOI 10.1016/j.paid.2004.03.014; MCCRAE RR, 1989, J PERS SOC PSYCHOL, V56, P586, DOI 10.1037/0022-3514.56.4.586; McCrae RR, 2005, J PERS ASSESS, V84, P261, DOI 10.1207/s15327752jpa8403_05; Mitchell JP, 2005, J COGNITIVE NEUROSCI, V17, P1306, DOI 10.1162/0898929055002418; Mooradian TA, 2011, AM J PSYCHOL, V124, P99, DOI 10.5406/amerjpsyc.124.1.0099; Moran JM, 2006, J COGNITIVE NEUROSCI, V18, P1586, DOI 10.1162/jocn.2006.18.9.1586; Morishima Y, 2012, NEURON, V75, P73, DOI 10.1016/j.neuron.2012.05.021; Oswald PA, 1996, J SOC PSYCHOL, V136, P613, DOI 10.1080/00224545.1996.9714045; PIEDMONT RL, 1993, J PERS ASSESS, V60, P302, DOI 10.1207/s15327752jpa6002_8; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Preston SD, 2012, EMOT REV, V4, P24, DOI 10.1177/1754073911421378; Realo A, 2002, TRAMES-J HUMANIT SOC, V16, P205; RICHENDOLLER NR, 1994, PERS INDIV DIFFER, V17, P303, DOI 10.1016/0191-8869(94)90278-X; Sanfey AG, 2007, SCIENCE, V318, P598, DOI 10.1126/science.1142996; Sollberger M, 2009, NEUROPSYCHOLOGIA, V47, P2812, DOI 10.1016/j.neuropsychologia.2009.06.006; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; UNDERWOOD B, 1982, PSYCHOL BULL, V91, P143, DOI 10.1037/0033-2909.91.1.143; Van Overwalle F, 2009, NEUROIMAGE, V48, P564, DOI 10.1016/j.neuroimage.2009.06.009; Watson D., 1997, HDB PERSONALITY PSYC; WIGGINS JS, 1979, J PERS SOC PSYCHOL, V37, P395, DOI 10.1037/0022-3514.37.3.395; Young L, 2010, P NATL ACAD SCI USA, V107, P6753, DOI 10.1073/pnas.0914826107	59	17	17	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120639	10.1371/journal.pone.0120639	http://dx.doi.org/10.1371/journal.pone.0120639			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7NO	25769028	Green Submitted, Green Published, gold			2022-12-27	WOS:000351277500131
J	Brulhart-Meynet, MC; Braunersreuther, V; Brinck, J; Montecucco, F; Prost, JC; Thomas, A; Galan, K; Pelli, G; Pedretti, S; Vuilleumier, N; Mach, F; Lecour, S; James, RW; Frias, MA				Brulhart-Meynet, Marie-Claude; Braunersreuther, Vincent; Brinck, Jonas; Montecucco, Fabrizio; Prost, Jean-Christophe; Thomas, Aurelien; Galan, Katia; Pelli, Graziano; Pedretti, Sarah; Vuilleumier, Nicolas; Mach, Francois; Lecour, Sandrine; James, Richard W.; Frias, Miguel A.			Improving Reconstituted HDL Composition for Efficient Post-Ischemic Reduction of Ischemia Reperfusion Injury	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEINS; APOLIPOPROTEIN-A-I; RANDOMIZED CONTROLLED-TRIAL; TYPE-2 DIABETES-MELLITUS; ACUTE CORONARY SYNDROMES; SPHINGOSINE 1-PHOSPHATE; ISCHEMIA/REPERFUSION INJURY; RABBIT HEART; ATHEROSCLEROSIS; PROTECT	Background New evidence shows that high density lipoproteins (HDL) have protective effects beyond their role in reverse cholesterol transport. Reconstituted HDL (rHDL) offer an attractive means of clinically exploiting these novel effects including cardioprotection against ischemia reperfusion injury (IRI). However, basic rHDL composition is limited to apolipoprotein AI (apoAI) and phospholipids; addition of bioactive compound may enhance its beneficial effects. Objective The aim of this study was to investigate the role of rHDL in post-ischemic model, and to analyze the potential impact of sphingosine-1-phosphate (S1P) in rHDL formulations. Methods and Results The impact of HDL on IRI was investigated using complementary in vivo, ex vivo and in vitro IRI models. Acute post-ischemic treatment with native HDL significantly reduced infarct size and cell death in the ex vivo, isolated heart (Langendorff) model and the in vivo model (-48%, p<0.01). Treatment with rHDL of basic formulation (apoAI + phospholipids) had a non-significant impact on cell death in vitro and on the infarct size ex vivo and in vivo. In contrast, rHDL containing S1P had a highly significant, protective influence ex vivo, and in vivo (-50%, p<0.01). This impact was comparable with the effects observed with native HDL. Pro-survival signaling proteins, Akt, STAT3 and ERK1/2 were similarly activated by HDL and rHDL containing S1P both in vitro (isolated cardiomyocytes) and in vivo. Conclusion HDL afford protection against IRI in a clinically relevant model (post-ischemia). rHDL is significantly protective if supplemented with S1P. The protective impact of HDL appears to target directly the cardiomyocyte.	[Brulhart-Meynet, Marie-Claude; Brinck, Jonas; James, Richard W.; Frias, Miguel A.] Fac Med, Dept Internal Med, Serv Endocrinol Diabetol Hypertens & Nutr, Geneva, Switzerland; [Braunersreuther, Vincent; Montecucco, Fabrizio; Galan, Katia; Pelli, Graziano; Mach, Francois] Univ Hosp Geneva, Dept Internal Med, Div Cardiol, Geneva, Switzerland; [Braunersreuther, Vincent; Montecucco, Fabrizio; Vuilleumier, Nicolas] Univ Hosp Geneva, Dept Genet & Lab Med, Serv Lab Med, Geneva, Switzerland; [Montecucco, Fabrizio; Vuilleumier, Nicolas] Univ Hosp Geneva, Dept Human Prot Sci, Geneva, Switzerland; [Montecucco, Fabrizio] Univ Genoa, IRCCS Azienda Osped Univ San Martino, IST Inst Nazl Ric Cancro, Clin Internal Med 1,Dept Internal Med,Sch Med, Genoa, Italy; [Prost, Jean-Christophe; Thomas, Aurelien] Univ Lausanne, CURML, Toxicol Unit, Lausanne, Switzerland; [Pedretti, Sarah; Lecour, Sandrine] Univ Cape Town, Fac Hlth Sci, Hatter Inst Cardiovasc Res Africa, ZA-7925 Cape Town, South Africa	University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Genoa; IRCCS AOU San Martino IST; University of Lausanne; University of Cape Town	Frias, MA (corresponding author), Fac Med, Dept Internal Med, Serv Endocrinol Diabetol Hypertens & Nutr, Geneva, Switzerland.	Miguel.Frias@unige.ch	Montecucco, Fabrizio/K-8543-2016; Brinck, Jonas/L-7924-2018	Montecucco, Fabrizio/0000-0003-0823-8729; , Nicolas/0000-0002-1122-438X; Thomas, Aurelien/0000-0001-6790-2285; , sandrine/0000-0003-1942-8974; Prost, Jean-Christophe/0000-0002-8820-706X	Swiss South African Joint Research Programme [JRP 16]; Swiss National Science Foundation (SNSF) [31-135221]; Fondation Prevot; Wolfermann Nageli Stiftung; Jubilaumsstiftung SwissLife; Novartis Consumer Health Foundation; Fondation pour la luttre contre le cancer et investigations medico-biologiques; National Research Foundation; University of Cape Town; South African Medical Research Council; Swiss National Science Foundation [32003B_134963/1, 310030_118245]	Swiss South African Joint Research Programme; Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Fondation Prevot; Wolfermann Nageli Stiftung; Jubilaumsstiftung SwissLife; Novartis Consumer Health Foundation; Fondation pour la luttre contre le cancer et investigations medico-biologiques; National Research Foundation; University of Cape Town; South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study was supported in part by the Swiss South African Joint Research Programme (JRP 16) to SL and RWJ; the Swiss National Science Foundation (SNSF grant 31-135221 to RWJ); Fondation Prevot; Wolfermann Nageli Stiftung; Jubilaumsstiftung SwissLife; Novartis Consumer Health Foundation; Fondation pour la luttre contre le cancer et investigations medico-biologiques to MAF; and the National Research Foundation, the University of Cape Town, and South African Medical Research Council to SL. This work was also supported by Swiss National Science Foundation Grants to Dr. F. Montecucco (#32003B_134963/1) and to Prof. F. Mach (#310030_118245). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Braunersreuther V, 2010, J MOL CELL CARDIOL, V48, P789, DOI 10.1016/j.yjmcc.2009.07.029; Calabresi L, 2003, CIRC RES, V92, P330, DOI 10.1161/01.RES.0000054201.60308.1A; Chenevard R, 2012, CARDIOVASC THER, V30, pe51, DOI 10.1111/j.1755-5922.2010.00221.x; Drew BG, 2009, CIRCULATION, V119, P2103, DOI 10.1161/CIRCULATIONAHA.108.843219; Frias MA, 2008, CARDIOVASC RES, V80, P69, DOI 10.1093/cvr/cvn171; Frias MA, 2013, ATHEROSCLEROSIS, V228, P110, DOI 10.1016/j.atherosclerosis.2013.02.003; Frias MA, 2010, CARDIOVASC RES, V85, P118, DOI 10.1093/cvr/cvp289; JAMES RW, 1989, BIOCHIM BIOPHYS ACTA, V1002, P292, DOI 10.1016/0005-2760(89)90343-3; JONAS A, 1986, METHOD ENZYMOL, V128, P553; Kiya Y, 2009, ATHEROSCLEROSIS, V203, P137, DOI 10.1016/j.atherosclerosis.2008.05.056; Luscher TF, 2014, CIRC RES, V114, P171, DOI 10.1161/CIRCRESAHA.114.300935; Marchesi M, 2004, J PHARMACOL EXP THER, V311, P1023, DOI 10.1124/jpet.104.070789; Marchesi M, 2008, ATHEROSCLEROSIS, V197, P572, DOI 10.1016/j.atherosclerosis.2007.08.028; Montecucco F, 2013, ANTIOXID REDOX SIGN, V18, P630, DOI 10.1089/ars.2011.4487; Nieuwdorp M, 2008, DIABETOLOGIA, V51, P1081, DOI 10.1007/s00125-008-0975-2; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; Patel S, 2009, J AM COLL CARDIOL, V53, P962, DOI 10.1016/j.jacc.2008.12.008; Rossoni G, 2004, J PHARMACOL EXP THER, V308, P79, DOI 10.1124/jpet.103.057141; Sattler K, 2014, CELL PHYSIOL BIOCHEM, V34, P172, DOI 10.1159/000362993; Sattler KJE, 2010, BASIC RES CARDIOL, V105, P821, DOI 10.1007/s00395-010-0112-5; Shaw JA, 2008, CIRC RES, V103, P1084, DOI 10.1161/CIRCRESAHA.108.182063; Smith RM, 2002, CARDIOVASC RES, V55, P553, DOI 10.1016/S0008-6363(02)00283-3; Somers SJ, 2012, CARDIOVASC DRUG THER, V26, P227, DOI 10.1007/s10557-012-6376-2; Sutter I, 2014, J LIPID RES, V55, P1730, DOI 10.1194/jlr.M050021; Tao R, 2010, AM J PHYSIOL-HEART C, V298, pH1022, DOI 10.1152/ajpheart.00902.2009; Tardif JC, 2007, JAMA-J AM MED ASSOC, V297, P1675, DOI 10.1001/jama.297.15.jpc70004; Theilmeier G, 2006, CIRCULATION, V114, P1403, DOI 10.1161/CIRCULATIONAHA.105.607135	28	37	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119664	10.1371/journal.pone.0119664	http://dx.doi.org/10.1371/journal.pone.0119664			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781943	gold, Green Published			2022-12-27	WOS:000351284600083
J	Chen, MS; Fang, GX; Wang, LD; Wang, ZH; Zhao, YX; Si, L				Chen, Mingsheng; Fang, Guixia; Wang, Lidan; Wang, Zhonghua; Zhao, Yuxin; Si, Lei			Who Benefits from Government Healthcare Subsidies? An Assessment of the Equity of Healthcare Benefits Distribution in China	PLOS ONE			English	Article							INCOME DISTRIBUTIONS; UNIVERSAL COVERAGE; SOUTH-AFRICA; POOR; SYSTEM; REFORM; CHALLENGES; LORENZ; GHANA	Background Improving the equitable distribution of government healthcare subsidies (GHS), particularly among low-income citizens, is a major goal of China's healthcare sector reform in China. Objectives This study investigates the distribution of GHS in China between socioeconomic populations at two different points in time, examines the comparative distribution of healthcare benefits before and after healthcare reforms in Northwest China, compares the parity of distribution between urban and rural areas, and explores factors that influence equitable GHS distribution. Methods Benefit incidence analysis of GHS progressivity was performed, and concentration and Kakwani indices for outpatient, inpatient, and total healthcare were calculated. Two rounds of household surveys that used multistage stratified samples were conducted in 2003 (13,564 respondents) and 2008 (12,973 respondents). Data on socioeconomics, healthcare payments, and healthcare utilization were collected using household interviews. Results High-income individuals generally reap larger benefits from GHS, as reflected by positive concentration indices, which indicates a regressive system. Concentration indices for inpatient care were 0.2199 (95% confidence interval [CI], 0.0829 to 0.3568) and 0.4445 (95% CI, 0.3000 to 0.5890) in 2002 (urban vs. rural, respectively), and 0.3925 (95% CI, 0.2528 to 0.5322) and 0.4084 (95% CI, 0.2977 to 0.5190) in 2007. Outpatient healthcare subsidies showed different distribution patterns in urban and rural areas following the redesign of rural healthcare insurance programs (urban vs. rural: 0.1433 [95% CI, 0.0263 to 0.2603] and 0.3662 [95% CI, 0.2703 to 0.4622] in 2002, respectively; 0.3063 [95% CI, 0.1657 to 0.4469] and -0.0273 [95% CI, -0.1702 to 0.1156] in 2007). Conclusions Our study demonstrates an inequitable distribution of GHS in China from 2002 to 2007; however, the inequity was reduced, especially in rural outpatient services. Future healthcare reforms in China should not only focus on expanding the coverage, but also on improving the equity of distribution of healthcare benefits.	[Chen, Mingsheng; Wang, Zhonghua] Nanjing Med Univ, Sch Hlth Policy & Management, Nanjing, Jiangsu, Peoples R China; [Fang, Guixia; Wang, Lidan; Si, Lei] Anhui Med Univ, Sch Hlth Adm, Hefei, Peoples R China; [Zhao, Yuxin] Minist Hlth Peoples Republ China, Natl Hlth Dev Res Ctr, Beijing, Peoples R China; [Si, Lei] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia	Nanjing Medical University; Anhui Medical University; University of Tasmania; Menzies Institute for Medical Research	Wang, ZH (corresponding author), Nanjing Med Univ, Sch Hlth Policy & Management, Nanjing, Jiangsu, Peoples R China.	wzh04@126.com	Si, Lei/AAM-3218-2020	Si, Lei/0000-0002-3044-170X	Research Foundation for Bright Scholars of Nanjing Medical University [KY107RC011306]; Federation of Philosophy and Social Sciences Circles of Jiangsu Province (Talent Development Project) [14SRB-27]	Research Foundation for Bright Scholars of Nanjing Medical University; Federation of Philosophy and Social Sciences Circles of Jiangsu Province (Talent Development Project)	This work was supported by Research Foundation for Bright Scholars of Nanjing Medical University (grant number: KY107RC011306) and Federation of Philosophy and Social Sciences Circles of Jiangsu Province (Talent Development Project) (grant number: 14SRB-27). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazili J, 2012, HEALTH POLICY PLANN, V27, pi13, DOI 10.1093/heapol/czs004; Babiarz KS, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5617; BEACH CM, 1985, INT ECON REV, V26, P439, DOI 10.2307/2526594; BISHOP JA, 1992, AM ECON REV, V82, P262; BISHOP JA, 1994, INT ECON REV, V35, P479, DOI 10.2307/2527065; Borghi J, 2009, ADV HEALTH ECON HEAL, V21, P133, DOI 10.1108/S0731-2199(2009)0000021009; Brown PH, 2009, HEALTH ECON, V18, pS47, DOI 10.1002/hec.1508; Castro-Leal F, 1999, WORLD BANK RES OBSER, V14, P49, DOI 10.1093/wbro/14.1.49; Castro-Leal F, 2000, B WORLD HEALTH ORGAN, V78, P66; China National Health Economics Institute, 2012, CHINA NATIONAL HEALT; Chou WL, 2009, HEALTH ECON, V18, pS137, DOI 10.1002/hec.1511; Cuenca JS., 2008, BENEFIT INCIDENCE AN; Davidson R, 1997, ECONOMETRICA, V65, P1453, DOI 10.2307/2171744; Davoodi HR, 2003, HOW USEFUL ARE BENEF, P225; Deaton A, 1997, THE ANALYSIS OF HOUS; Demery L., 2003, IMPACT EC POLICIES P, P41; Halasa Y., 2010, Eastern Mediterranean Health Journal, V16, P467; Hu SL, 2008, LANCET, V372, P1846, DOI 10.1016/S0140-6736(08)61368-9; Huang J, 2004, CHINESE HEALTH ECONO, V23, P9; KAKWANI NC, 1977, ECON J, V87, P71, DOI 10.2307/2231833; King EM, 2001, POLICY RESEARCH REPO; Lin WC, 2009, HEALTH ECON, V18, pS83, DOI 10.1002/hec.1500; Macha J, 2012, HEALTH POLICY PLANN, V27, pi46, DOI 10.1093/heapol/czs024; Mahal A, 2006, LANCET, V368, P1308, DOI 10.1016/S0140-6736(06)69533-0; Mahal A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071853; Meerman J., 1979, PUBLIC EXPENDITURE I; Mills A, 2012, LANCET, V380, P126, DOI 10.1016/S0140-6736(12)60357-2; Mtei G, 2012, HEALTH POLICY PLANN, V27, pi23, DOI 10.1093/heapol/czs018; National Bureau of statistics of China, 2008, CHINA LABOR STATISTI; O'Donnell O, 2008, ANALYZING HEALTH EQU; Prakongsai P, 2006, VALUE HEALTH, V9, pA211, DOI 10.1016/S1098-3015(10)63231-7; Qian DF, 2009, HEALTH POLICY PLANN, V24, P324, DOI 10.1093/heapol/czp016; Selowsky M., 1979, WHO BENEFITS FROM GO; Wagstaff A, 2008, PUBLIC FINANCE IN CHINA: REFORM AND GROWTH FOR A HARMONIOUS SOCIETY, P265; Wagstaff A, 2009, HEALTH ECON, V18, pS7, DOI 10.1002/hec.1518; World Health Organization, 2000, WORLD HEALTH REPORT; World Health Organization, 2004, IMPLEMENTING THE NEW; Yip W, 2008, HEALTH AFFAIR, V27, P460, DOI 10.1377/hlthaff.27.2.460; Yip WCM, 2012, LANCET, V379, P833, DOI 10.1016/S0140-6736(11)61880-1; Zhang L., 2006, INSURING RURAL CHINA; Zhao Y, 2004, CHINESE HLTH EC, V23, P5	41	22	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119840	10.1371/journal.pone.0119840	http://dx.doi.org/10.1371/journal.pone.0119840			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7QC	25781163	Green Submitted, Green Published, gold			2022-12-27	WOS:000351284600098
J	Haustein, S; Costas, R; Lariviere, V				Haustein, Stefanie; Costas, Rodrigo; Lariviere, Vincent			Characterizing Social Media Metrics of Scholarly Papers: The Effect of Document Properties and Collaboration Patterns	PLOS ONE			English	Article							CITATION ANALYSIS; IMPACT; AUTHORSHIP; COUNTS; TWEETS; WORDS; TITLE	A number of new metrics based on social media platforms-grouped under the term "altmetrics" - have recently been introduced as potential indicators of research impact. Despite their current popularity, there is a lack of information regarding the determinants of these metrics. Using publication and citation data from 1.3 million papers published in 2012 and covered in Thomson Reuters' Web of Science as well as social media counts from Altmetric. com, this paper analyses the main patterns of five social media metrics as a function of document characteristics (i.e., discipline, document type, title length, number of pages and references) and collaborative practices and compares them to patterns known for citations. Results show that the presence of papers on social media is low, with 21.5% of papers receiving at least one tweet, 4.7% being shared on Facebook, 1.9% mentioned on blogs, 0.8% found on Google+ and 0.7% discussed in mainstream media. By contrast, 66.8% of papers have received at least one citation. Our findings show that both citations and social media metrics increase with the extent of collaboration and the length of the references list. On the other hand, while editorials and news items are seldom cited, it is these types of document that are the most popular on Twitter. Similarly, while longer papers typically attract more citations, an opposite trend is seen on social media platforms. Finally, contrary to what is observed for citations, it is papers in the Social Sciences and humanities that are the most often found on social media platforms. On the whole, these findings suggest that factors driving social media and citations are different. Therefore, social media metrics cannot actually be seen as alternatives to citations; at most, they may function as complements to other type of indicators.	[Haustein, Stefanie; Lariviere, Vincent] Univ Montreal, Ecole Bibliothecon & Sci Informat, Montreal, PQ, Canada; [Costas, Rodrigo] Leiden Univ, Ctr Sci & Technol Studies, Leiden, Netherlands; [Lariviere, Vincent] Univ Quebec, CIRST, OST, Montreal, PQ H3C 3P8, Canada	Universite de Montreal; Leiden University; Leiden University - Excl LUMC; University of Quebec; University of Quebec Montreal	Haustein, S (corresponding author), Univ Montreal, Ecole Bibliothecon & Sci Informat, CP 6128,Succ Ctr Ville, Montreal, PQ, Canada.	stefanie.haustein@umontreal.ca	Haustein, Stefanie/AAH-3636-2020; Lariviere, Vincent/AAF-3179-2019; Haustein, Stefanie/C-6748-2011	Haustein, Stefanie/0000-0003-0157-1430; Haustein, Stefanie/0000-0003-0157-1430	Alfred P. Sloan Foundation [G-2014-3-25]	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	This work was supported by the Alfred P. Sloan Foundation Grant # G-2014-3-25. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1917, SCI PROGR; Biglu MH, 2008, SCIENTOMETRICS, V74, P453, DOI 10.1007/s11192-007-1815-8; Bordons M, 1998, MED CLIN-BARCELONA, V111, P489; Bornmann L, 2008, J DOC, V64, P45, DOI 10.1108/00220410810844150; Bourdieu Pierre, 1999, INDIANS GUYANA; Bradford S. C., 1934, ENGINEERING, P85; Buter RK, 2011, J INFORMETR, V5, P608, DOI 10.1016/j.joi.2011.05.008; CLARKE BL, 1964, SCIENCE, V143, P822, DOI 10.1126/science.143.3608.822; Cole J. R., 1973, SOCIAL STRATIFICATIO; Costas R., 2012, P 17 INT C SCI TECHN, P447; Costas R, 2015, J ASS INFOR IN PRESS; Costas R, 2012, J AM SOC INF SCI TEC, V63, P2433, DOI 10.1002/asi.22662; Cronin B., 1984, CITATION PROCESS ROL; Edge D, 1979, Hist Sci, V17, P102; Falagas ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049476; GARFIELD E, 1964, SCIENCE, V144, P649, DOI 10.1126/science.144.3619.649; Glanzel W, 2001, SCIENTOMETRICS, V50, P199, DOI 10.1023/A:1010561321723; Gross P L, 1927, Science, V66, P385, DOI 10.1126/science.66.1713.385; Harzing AW, 2013, SCIENTOMETRICS, V94, P23, DOI 10.1007/s11192-012-0738-1; Haustein S, 2015, J ASS INFOR IN PRESS; Haustein S, 2014, IT-INF TECHNOL, V56, P207, DOI 10.1515/itit-2014-1048; Haustein S, 2014, J ASSOC INF SCI TECH, V65, P656, DOI 10.1002/asi.23101; HERBERTZ H, 1995, SCIENTOMETRICS, V33, P117, DOI 10.1007/BF02020777; Hsu JW, 2011, SCIENTOMETRICS, V86, P317, DOI 10.1007/s11192-010-0265-x; Lariviere V, 2015, J AM SOC IN IN PRESS, DOI 10.1002/asi.22796; Lewison G, 2005, SCIENTOMETRICS, V63, P341, DOI 10.1007/s11192-005-0216-0; LI X., 2012, P 17 INT C SCI TECHN, V17, P541, DOI DOI 10.1007/s11192-011-0580-x; Li XM, 2012, SCIENTOMETRICS, V91, P461, DOI 10.1007/s11192-011-0580-x; Lotka A.J., 1926, J WASH ACAD SCI, V16, P317, DOI DOI 10.1002/ASI.4630280610; Lovaglia MJ., 1991, AM SOCIOL, V22, P49, DOI [DOI 10.1007/BF02691867, 10.1007/BF02691867]; MACROBERTS MH, 1989, TRENDS BIOCHEM SCI, V14, P8, DOI 10.1016/0968-0004(89)90077-7; MACROBERTS MH, 1987, J AM SOC INFORM SCI, V38, P305, DOI 10.1002/(SICI)1097-4571(198707)38:4<305::AID-ASI11>3.0.CO;2-I; MERTON Robert King., 1973, THEORETICAL SOCIOLOG; Mohammadi E, 2015, J ASS INFOR IN PRESS; Neylon C., 2014, ALTMETRICS WHAT ARE; Neylon C, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000242; Nicolaisen J, 2007, ANNU REV INFORM SCI, V41, P609, DOI 10.1002/aris.2007.1440410120; Onodera N, 2015, J ASSOC INF SCI TECH, V66, P739, DOI 10.1002/asi.23209; Prie J, 2010, ALTMETRICS MANIFESTO; Priem J., 2010, 1 MONDAY, V15, DOI DOI 10.5210/FM.V15I7.2874; Robinson-Garcia N, 2014, PROF INFORM, V23, P359, DOI 10.3145/epi.2014.jul.03; Rousseau R, 2013, CHINESE SCI BULL, V58, P10; Shema H, 2015, J ASS INFOR IN PRESS; Sigogneau A, 2000, SCIENTOMETRICS, V47, P589, DOI 10.1023/A:1005628218890; Sud P, 2014, SCIENTOMETRICS, V98, P1131, DOI 10.1007/s11192-013-1117-2; Thelwall M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064841; van Leeuwen T, 2013, SCIENTOMETRICS, V95, P817, DOI 10.1007/s11192-012-0904-5; Waltman L, 2014, J ASSOC INF SCI TECH, V65, P433, DOI 10.1002/asi.23040; Webster GD, 2009, EVOL PSYCHOL-US, V7, P348; Wouters P., 2012, USERS NARCISSISM CON; Wouters P. F., 1999, INFORMALISIERUNG; Zahedi Z, 2014, SCIENTOMETRICS, V101, P1491, DOI 10.1007/s11192-014-1264-0; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL; ZUCKERMAN H, 1987, SCIENTOMETRICS, V12, P329, DOI 10.1007/BF02016675	54	158	164	6	200	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120495	10.1371/journal.pone.0120495	http://dx.doi.org/10.1371/journal.pone.0120495			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7QC	25780916	Green Published, gold, Green Submitted			2022-12-27	WOS:000351284600166
J	Hua, Y; Wang, B; Wallen, GR; Shao, P; Ni, CP; Hua, QZ				Hua, Yan; Wang, Bo; Wallen, Gwenyth R.; Shao, Pei; Ni, Chunping; Hua, Qianzhen			Health-Promoting Lifestyles and Depression in Urban Elderly Chinese	PLOS ONE			English	Article							OLDER-ADULTS; SCALE GDS; SYMPTOMS; DISEASE; VALIDATION; BEHAVIORS; PROFILE; PEOPLE; RISK	Objective To explore health-promoting lifestyles, depression and provide further insight into the relationship between health-promoting lifestyles and depression in an urban community sample of elderly Chinese people. Methods A cross-sectional descriptive and correlational study of 954 community-dwelling urban elderly Chinese (aged >= 60) was conducted from July to December 2010. Lifestyles and depression were assessed using the revised Chinese Version of the Health-Promoting Lifestyle Profile (HPLP-C) and the Geriatric Depression Scale (GDS), respectively. Results In this cohort, 15.8% of elderly urban adults met the criteria for depression. Over half of the sample (62.1%) scored greater than 100 on the HPLP-C, with range of score sum from 55 to 160. There were significant correlations between self-actualization (OR = 1.167, 95%CI: 1.111-1.226), nutrition (OR = 1.118, 95%CI: 1.033-1.209), physical activity (OR = 1.111, 95%CI: 1.015-1.216) and depression among community-dwelling elderly Chinese. Limitations This was a cross-sectional study. The significant associations found do not represent directional causation. Further longitudinal follow-up is recommended to investigate the specific causal relationship between lifestyles and depression. Conclusions Depression was common with medium to high levels of health-promoting lifestyles among urban elderly Chinese people. Lifestyle behaviors such as self-actualization, good nutrition habits and frequent physical activity were correlated to fewer depressive symptoms. Healthy lifestyles should be further developed in this population and measures should be taken for improving their depression.	[Hua, Yan; Shao, Pei; Ni, Chunping; Hua, Qianzhen] Fourth Mil Med Univ, Sch Nursing, Xian 710032, Shaanxi Provinc, Peoples R China; [Wang, Bo] Fourth Mil Med Univ, Dept Epidemiol, Sch Prevent Med, Xian 710032, Shaanxi Provinc, Peoples R China; [Wallen, Gwenyth R.] NIH, Ctr Clin, Bethesda, MD 20892 USA	Air Force Military Medical University; Air Force Military Medical University; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Ni, CP (corresponding author), Fourth Mil Med Univ, Sch Nursing, Xian 710032, Shaanxi Provinc, Peoples R China.	pingchuni@163.com; qianzhen@fmmu.edu.cn						Acton GJ, 2000, WESTERN J NURS RES, V22, P796, DOI 10.1177/01939450022044764; Ariyo AA, 2000, CIRCULATION, V102, P1773; Boult C, 2001, J AM GERIATR SOC, V49, P351, DOI 10.1046/j.1532-5415.2001.49076.x; Bu XM, 2005, CHINESE J CLIN REHAB, V9, P152; Cao WJ, 2012, ARCH GERONTOL GERIAT, V55, P632, DOI 10.1016/j.archger.2012.07.003; Chan ACM, 1996, J AGING HEALTH, V8, P238, DOI 10.1177/089826439600800205; Chang L. C., 2009, J CLIN NURS, V20, P190; Chen M.Y., 1997, CHANG GUNG NURS, V8, P14; Chen R, 1999, INT J GERIATR PSYCH, V14, P821, DOI 10.1002/(SICI)1099-1166(199910)14:10<821::AID-GPS21>3.0.CO;2-0; Cole MG, 1997, AM J GERIAT PSYCHIAT, V5, P4; Fernandez-San Martin MI, 2002, INT J GERIATR PSYCH, V17, P279, DOI 10.1002/gps.588; Fragar L, 2013, J RURAL HEALTH, V29, P12, DOI 10.1111/j.1748-0361.2012.00423.x; Gan ZY, 2012, J AFFECT DISORDERS, V136, P988, DOI 10.1016/j.jad.2011.06.046; Gao SJ, 2009, INT J GERIATR PSYCH, V24, P1358, DOI 10.1002/gps.2271; Garcia-Pena C, 2008, J GEN INTERN MED, V23, P1973, DOI 10.1007/s11606-008-0799-2; Green LW, 1992, PATIENT EDUC COUNS, V19, P298; Hidaka BH, 2012, J AFFECT DISORDERS, V140, P205, DOI 10.1016/j.jad.2011.12.036; Hua QZ, 2008, CHIN J MOD NURS, V14, P2619; Kang SW, 2012, INT J NURS PRACT, V18, P268, DOI 10.1111/j.1440-172X.2012.02036.x; Lai D, 2010, INT J GERIATR PSYCH, V25, P503, DOI 10.1002/gps.2369; Li YM, 2012, INT J GERIATR PSYCH, V27, P31, DOI 10.1002/gps.2685; Lim LL, 2011, ASIA-PAC PSYCHIAT, V3, P46, DOI 10.1111/j.1758-5872.2011.00119.x; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; Mohamadian H, 2011, NURS HEALTH SCI, V13, P141, DOI 10.1111/j.1442-2018.2011.00591.x; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nualnetr N, 2012, J PHYS THER SCI, V24, P1003, DOI 10.1589/jpts.24.1003; Pender N.J., 1987, HLTH PROMOTION NURSI, V2nd ed., P9; RAPP SR, 1988, J CONSULT CLIN PSYCH, V56, P509, DOI 10.1037/0022-006X.56.4.509; SALAMERO M, 1992, ACTA PSYCHIAT SCAND, V86, P283, DOI 10.1111/j.1600-0447.1992.tb03267.x; Sanhueza C, 2013, J HUM NUTR DIET, V26, P56, DOI 10.1111/j.1365-277X.2012.01283.x; Sharp LK, 2002, AM FAM PHYSICIAN, V66, P1001; Stokes SC, 2002, J GERONTOLOGICAL SOC, V36, P27, DOI DOI 10.1300/J083V36N01_; Unutzer J, 2000, INT PSYCHOGERIATR, V12, P15, DOI 10.1017/S1041610200006177; WALKER SN, 1987, NURS RES, V36, P76; Wang T, 2006, CHINESE NURSING RES, V20, P2662; Wen Z, 2010, INT J GERIATR PSYCH, V25, P554, DOI 10.1002/gps.2364; Wilson M, 2005, FAM COMMUNITY HEALTH, V28, P51, DOI 10.1097/00003727-200501000-00008; Wong SY, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-119; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	39	29	33	5	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0117998	10.1371/journal.pone.0117998	http://dx.doi.org/10.1371/journal.pone.0117998			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7QC	25781326	gold, Green Published, Green Submitted			2022-12-27	WOS:000351284600019
J	Merrick, CJ; Jiang, RHY; Skillman, KM; Samarakoon, U; Moore, RM; Dzikowski, R; Ferdig, MT; Duraisingh, MT				Merrick, Catherine J.; Jiang, Rays H. Y.; Skillman, Kristen M.; Samarakoon, Upeka; Moore, Rachel M.; Dzikowski, Ron; Ferdig, Michael T.; Duraisingh, Manoj T.			Functional Analysis of Sirtuin Genes in Multiple Plasmodium falciparum Strains	PLOS ONE			English	Article							MUTUALLY EXCLUSIVE EXPRESSION; CHONDROITIN SULFATE-A; VIRULENCE GENES; ANTIGENIC VARIATION; MALARIA PARASITES; DIFFERENTIAL EXPRESSION; TELOMERE LENGTH; VARIANT ANTIGEN; ARRAY CGH; TRANSCRIPTION	Plasmodium falciparum, the causative agent of severe human malaria, employs antigenic variation to avoid host immunity. Antigenic variation is achieved by transcriptional switching amongst polymorphic var genes, enforced by epigenetic modification of chromatin. The histone-modifying 'sirtuin' enzymes PfSir2a and PfSir2b have been implicated in this process. Disparate patterns of var expression have been reported in patient isolates as well as in cultured strains. We examined var expression in three commonly used laboratory strains (3D7, NF54 and FCR-3) in parallel. NF54 parasites express significantly lower levels of var genes compared to 3D7, despite the fact that 3D7 was originally a clone of the NF54 strain. To investigate whether this was linked to the expression of sirtuins, genetic disruption of both sirtuins was attempted in all three strains. No dramatic changes in var gene expression occurred in NF54 or FCR-3 following PfSir2b disruption, contrasting with previous observations in 3D7. In 3D7, complementation of the PfSir2a genetic disruption resulted in a significant decrease in previously-elevated var gene expression levels, but with the continued expression of multiple var genes. Finally, rearranged chromosomes were observed in the 3D7 PfSir2a knockout line. Our results focus on the potential for parasite genetic background to contribute to sirtuin function in regulating virulence gene expression and suggest a potential role for sirtuins in maintaining genome integrity.	[Merrick, Catherine J.; Jiang, Rays H. Y.; Skillman, Kristen M.; Moore, Rachel M.; Duraisingh, Manoj T.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Samarakoon, Upeka; Ferdig, Michael T.] Univ Notre Dame, Dept Biol Sci, Eck Inst Global Hlth, Notre Dame, IN 46556 USA; [Dzikowski, Ron] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Microbiol & Mol Genet, Kuvin Ctr Study Infect & Trop Dis,IMRIC, IL-91010 Jerusalem, Israel	Harvard University; Harvard T.H. Chan School of Public Health; University of Notre Dame; Hebrew University of Jerusalem	Duraisingh, MT (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	mduraisi@hsph.harvard.edu	Dzikowski, Ron/HHZ-2430-2022; Ferdig, Michael/C-6627-2016; Merrick, Catherine/AAD-9154-2022	Merrick, Catherine/0000-0001-7583-2176	Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Diseases award; Charles H. Hood Foundation; NIH [AI071121]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071121] Funding Source: NIH RePORTER	Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Diseases award; Charles H. Hood Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Diseases award to MTD, a Charles H. Hood Foundation fellowship to CJM, and by NIH Grant AI071121 to MTF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; BIGGS BA, 1989, P NATL ACAD SCI USA, V86, P2428, DOI 10.1073/pnas.86.7.2428; Bopp SER, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003293; Brancucci NMB, 2014, CELL HOST MICROBE, V16, P165, DOI 10.1016/j.chom.2014.07.004; Bull PC, 2002, TRENDS MICROBIOL, V10, P55, DOI 10.1016/S0966-842X(01)02278-8; Chen QJ, 1998, NATURE, V394, P392, DOI 10.1038/28660; Chiang YJ, 2010, P NATL ACAD SCI USA, V107, P10148, DOI 10.1073/pnas.0913125107; Coleman BI, 2014, CELL HOST MICROBE, V16, P177, DOI 10.1016/j.chom.2014.06.014; CORCORAN LM, 1986, CELL, V44, P87, DOI 10.1016/0092-8674(86)90487-3; Deshmukh AS, 2012, NUCLEIC ACIDS RES, V40, P5313, DOI 10.1093/nar/gks202; Duffy MF, 2002, MOL MICROBIOL, V43, P1285, DOI 10.1046/j.1365-2958.2002.02822.x; Duraisingh MT, 2005, CELL, V121, P13, DOI 10.1016/j.cell.2005.01.036; Dzikowski R, 2007, EMBO REP, V8, P959, DOI 10.1038/sj.embor.7401063; Dzikowski R, 2006, PLOS PATHOG, V2, P184, DOI 10.1371/journal.ppat.0020022; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fastman Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034168; Fernandez V, 2002, MOL BIOCHEM PARASIT, V121, P195, DOI 10.1016/S0166-6851(02)00038-5; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Figueiredo LM, 2002, EMBO J, V21, P815, DOI 10.1093/emboj/21.4.815; Frank M, 2008, INT J PARASITOL, V38, P1099, DOI 10.1016/j.ijpara.2008.01.010; Frank M, 2007, MOL MICROBIOL, V64, P1486, DOI 10.1111/j.1365-2958.2007.05736.x; Frank M, 2006, INT J PARASITOL, V36, P975, DOI 10.1016/j.ijpara.2006.05.007; Freitas-Junior LH, 2005, CELL, V121, P25, DOI 10.1016/j.cell.2005.01.037; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; HernandezRivas R, 1997, MEM I OSWALDO CRUZ, V92, P815, DOI 10.1590/S0074-02761997000600017; Janes JH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002032; Jensen ATR, 2004, J EXP MED, V199, P1179, DOI 10.1084/jem.20040274; Jiang LB, 2013, NATURE, V499, P223, DOI 10.1038/nature12361; Joergensen L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001083; Kaestli M, 2006, J INFECT DIS, V193, P1567, DOI 10.1086/503776; KEMP DJ, 1985, NATURE, V315, P347, DOI 10.1038/315347a0; Kirkman LA, 1996, EXP PARASITOL, V83, P147, DOI 10.1006/expr.1996.0058; Kyriacou HM, 2006, MOL BIOCHEM PARASIT, V150, P211, DOI 10.1016/j.molbiopara.2006.08.005; Lopez-Rubio JJ, 2009, CELL HOST MICROBE, V5, P179, DOI 10.1016/j.chom.2008.12.012; Mackinnon MJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000644; Mancio-Silva L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2539; Merrick CJ, 2007, EUKARYOT CELL, V6, P2081, DOI 10.1128/EC.00114-07; Merrick CJ, 2010, INT J PARASITOL, V40, P35, DOI 10.1016/j.ijpara.2009.06.012; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Mok BW, 2007, MOL BIOCHEM PARASIT, V151, P184, DOI 10.1016/j.molbiopara.2006.11.006; Mok BW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001982; Narala SR, 2008, MOL BIOL CELL, V19, P1210, DOI 10.1091/mbc.E07-09-0965; Nkrumah LJ, 2006, NAT METHODS, V3, P615, DOI 10.1038/NMETH904; Palacios JA, 2010, J CELL BIOL, V191, P1299, DOI 10.1083/jcb.201005160; Peters JM, 2007, J INFECT DIS, V195, P748, DOI 10.1086/511436; Picard F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-27; Polakova S, 2009, P NATL ACAD SCI USA, V106, P2688, DOI 10.1073/pnas.0809793106; Rottmann M, 2006, INFECT IMMUN, V74, P3904, DOI 10.1128/IAI.02073-05; Rudner AD, 2005, MOL CELL BIOL, V25, P4514, DOI 10.1128/MCB.25.11.4514-4528.2005; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Scherf A, 1998, EMBO J, V17, P5418, DOI 10.1093/emboj/17.18.5418; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Tan JC, 2009, GENOMICS, V93, P543, DOI 10.1016/j.ygeno.2009.02.007; Tonkin CJ, 2009, PLOS BIOL, V7, P771, DOI 10.1371/journal.pbio.1000084; TRAGER W, 1978, NATURE, V273, P621, DOI 10.1038/273621a0; Viebig NK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000910; Viebig NK, 2005, EMBO REP, V6, P775, DOI 10.1038/sj.embor.7400466; Voss TS, 2006, NATURE, V439, P1004, DOI 10.1038/nature04407; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001	62	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0118865	10.1371/journal.pone.0118865	http://dx.doi.org/10.1371/journal.pone.0118865			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25780929	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000351284600036
J	O'Connor, C; Campos, J; Osinski, JM; Gronostajski, RM; Michie, AM; Keeshan, K				O'Connor, Caitriona; Campos, Joana; Osinski, Jason M.; Gronostajski, Richard M.; Michie, Alison M.; Keeshan, Karen			Nfix Expression Critically Modulates Early B Lymphopoiesis and Myelopoiesis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR EBF; C/EBP-ALPHA; MULTIPOTENT PROGENITORS; CELL DIFFERENTIATION; LINEAGE COMMITMENT; REGULATORY ELEMENT; DISTAL ENHANCER; STEM-CELLS; PU.1; PROTEINS	The commitment of stem and progenitor cells toward specific hematopoietic lineages is tightly controlled by a number of transcription factors that regulate differentiation programs via the expression of lineage restricting genes. Nuclear factor one (NFI) transcription factors are important in regulating hematopoiesis and here we report an important physiological role of NFIX in B-and myeloid lineage commitment and differentiation. We demonstrate that NFIX acts as a regulator of lineage specification in the haematopoietic system and the expression of Nfix was transcriptionally downregulated as B cells commit and differentiate, whilst maintained in myeloid progenitor cells. Ectopic Nfix expression in vivo blocked early B cell development stage, coincident with the stage of its downregulation. Furthermore, loss of Nfix resulted in the perturbation of myeloid and lymphoid cell differentiation, and a skewing of gene expression involved in lineage fate determination. Nfix was able to promote myeloid differentiation of total bone marrow cells under B cell specific culture conditions but not when expressed in the hematopoietic stem cell (HSPC), consistent with its role in HSPC survival. The lineage choice determined by Nfix correlated with transcriptional changes in a number of genes, such as E2A, C/EBP, and Id genes. These data highlight a novel and critical role for NFIX transcription factor in hematopoiesis and in lineage specification.	[O'Connor, Caitriona; Campos, Joana; Michie, Alison M.; Keeshan, Karen] Univ Glasgow, Inst Canc Sci, Paul OGorman Leukaemia Res Ctr, Glasgow, Lanark, Scotland; [Osinski, Jason M.; Gronostajski, Richard M.] SUNY Buffalo, Genet Genom & Bioinformat Program, Buffalo, NY 14260 USA; [Osinski, Jason M.; Gronostajski, Richard M.] SUNY Buffalo, Dept Biochem, Buffalo, NY 14260 USA	University of Glasgow; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Keeshan, K (corresponding author), Univ Glasgow, Inst Canc Sci, Paul OGorman Leukaemia Res Ctr, Glasgow, Lanark, Scotland.	Karen.keeshan@glasgow.ac.uk	Keeshan, Karen/L-5615-2013	Keeshan, Karen/0000-0001-7266-0890; O'Connor, Caitriona/0000-0002-7638-9804; Michie, Alison/0000-0002-5404-475X	Kay Kendall foundation [KKL501]; Howat foundation; Children with Cancer UK; Science Foundation Ireland PIYRA; Marie Curie EU-FP7-PEOPLE-IRG; Children's Leukaemia Research Project grant; MRC [MR/K014854/1]; Medical Research Council [MR/K014854/1, G0601099] Funding Source: researchfish; MRC [G0601099] Funding Source: UKRI	Kay Kendall foundation; Howat foundation; Children with Cancer UK; Science Foundation Ireland PIYRA(Science Foundation Ireland); Marie Curie EU-FP7-PEOPLE-IRG; Children's Leukaemia Research Project grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors wish to thank the Kay Kendall foundation (KKL501), and the Howat foundation for Flow cytometry facility funding. KK was supported by funds from the Howat Foundation, Children with Cancer UK, Science Foundation Ireland PIYRA award and Marie Curie EU-FP7-PEOPLE-IRG. This work was also supported by Children's Leukaemia Research Project grant (CO) and an MRC project grant (MR/K014854/1; AMM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagger FO, 2012, BLOOD, V119, P6394, DOI 10.1182/blood-2012-05-427310; Bain G, 1997, IMMUNITY, V6, P145, DOI 10.1016/S1074-7613(00)80421-5; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Bereshchenko O, 2009, CANCER CELL, V16, P390, DOI 10.1016/j.ccr.2009.09.036; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Campbell CE, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-52; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Cochrane SW, 2009, BLOOD, V113, P1016, DOI 10.1182/blood-2008-06-164996; Dahl R, 2003, NAT IMMUNOL, V4, P1029, DOI 10.1038/ni973; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Dengler HS, 2008, NAT IMMUNOL, V9, P1388, DOI 10.1038/ni.1667; Dias S, 2008, IMMUNITY, V29, P217, DOI 10.1016/j.immuni.2008.05.015; Driller K, 2007, MOL CELL BIOL, V27, P3855, DOI 10.1128/MCB.02293-06; Ebralidze AK, 2008, GENE DEV, V22, P2085, DOI 10.1101/gad.1654808; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; Guo H, 2012, BLOOD, V119, P4408, DOI 10.1182/blood-2011-12-397091; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Holmes R, 2009, COLD SPRING HARB PRO, V2009; Holmfeldt P, 2013, BLOOD; Keeshan K, 2010, BLOOD, V116, P4948, DOI 10.1182/blood-2009-10-247361; Kueh HY, 2013, SCIENCE, V341, P670, DOI 10.1126/science.1240831; Leddin M, 2011, BLOOD, V117, P2827, DOI 10.1182/blood-2010-08-302976; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Mansson R, 2008, BLOOD, V112, P1048, DOI 10.1182/blood-2007-11-125385; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Nakagawa R, 2012, EUR J IMMUNOL, V42, P1005, DOI 10.1002/eji.201141442; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Pongubala JMR, 2008, NAT IMMUNOL, V9, P203, DOI 10.1038/ni1555; Riddell J, 2014, CELL, V157, P549, DOI 10.1016/j.cell.2014.04.006; Rosa A, 2007, P NATL ACAD SCI USA, V104, P19849, DOI 10.1073/pnas.0706963104; Rosenbauer F, 2006, NAT GENET, V38, P27, DOI 10.1038/ng1679; Semerad CL, 2009, P NATL ACAD SCI USA, V106, P1930, DOI 10.1073/pnas.0808866106; Singh H, 2005, P NATL ACAD SCI USA, V102, P4949, DOI 10.1073/pnas.0500480102; Starnes LM, 2010, LEUKEMIA, V24, P1220, DOI 10.1038/leu.2010.78; Starnes LM, 2009, BLOOD, V114, P1753, DOI 10.1182/blood-2008-12-196196; Thal MA, 2009, P NATL ACAD SCI USA, V106, P552, DOI 10.1073/pnas.0802550106; Yeamans C, 2007, BLOOD, V110, P3136, DOI 10.1182/blood-2007-03-080291; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006	39	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120102	10.1371/journal.pone.0120102	http://dx.doi.org/10.1371/journal.pone.0120102			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25780920	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000351284600126
J	Romagnan, JB; Legendre, L; Guidi, L; Jamet, JL; Jamet, D; Mousseau, L; Pedrotti, ML; Picheral, M; Gorsky, G; Sardet, C; Stemmann, L				Romagnan, Jean-Baptiste; Legendre, Louis; Guidi, Lionel; Jamet, Jean-Louis; Jamet, Dominique; Mousseau, Laure; Pedrotti, Maria-Luiza; Picheral, Marc; Gorsky, Gabriel; Sardet, Christian; Stemmann, Lars			Comprehensive Model of Annual Plankton Succession Based on the Whole-Plankton Time Series Approach	PLOS ONE			English	Article							NORTHWESTERN MEDITERRANEAN-SEA; VILLEFRANCHE-SUR-MER; LIGURIAN SEA; GRAZING IMPACT; HYDROGRAPHIC CONDITIONS; MARINE ECOSYSTEMS; TROPHIC CASCADES; LIFE-CYCLES; PEG-MODEL; PHYTOPLANKTON	Ecological succession provides a widely accepted description of seasonal changes in phytoplankton and mesozooplankton assemblages in the natural environment, but concurrent changes in smaller (i.e. microbes) and larger (i.e. macroplankton) organisms are not included in the model because plankton ranging from bacteria to jellies are seldom sampled and analyzed simultaneously. Here we studied, for the first time in the aquatic literature, the succession of marine plankton in the whole-plankton assemblage that spanned 5 orders of magnitude in size from microbes to macroplankton predators (not including fish or fish larvae, for which no consistent data were available). Samples were collected in the northwestern Mediterranean Sea (Bay of Villefranche) weekly during 10 months. Simultaneously collected samples were analyzed by flow cytometry, inverse microscopy, FlowCam, and ZooScan. The whole-plankton assemblage underwent sharp reorganizations that corresponded to bottom-up events of vertical mixing in the water-column, and its development was top-down controlled by large gelatinous filter feeders and predators. Based on the results provided by our novel whole-plankton assemblage approach, we propose a new comprehensive conceptual model of the annual plankton succession (i.e. whole plankton model) characterized by both stepwise stacking of four broad trophic communities from early spring through summer, which is a new concept, and progressive replacement of ecological plankton categories within the different trophic communities, as recognised traditionally.	[Romagnan, Jean-Baptiste; Legendre, Louis; Guidi, Lionel; Mousseau, Laure; Pedrotti, Maria-Luiza; Picheral, Marc; Gorsky, Gabriel; Stemmann, Lars] Univ Paris 06, Sorbonne Univ, UMR LOV 7093, F-75005 Paris, France; [Romagnan, Jean-Baptiste; Legendre, Louis; Guidi, Lionel; Mousseau, Laure; Pedrotti, Maria-Luiza; Picheral, Marc; Gorsky, Gabriel; Stemmann, Lars] CNRS, UMR LOV 7093, F-75005 Paris, France; [Sardet, Christian] Univ Paris 06, Sorbonne Univ, UMR BioDev 7009, F-75005 Paris, France; [Sardet, Christian] CNRS, UMR BioDev 7009, F-75005 Paris, France; [Jamet, Jean-Louis; Jamet, Dominique] Univ Sud Toulon Var, F-83000 La Garde, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS)	Romagnan, JB (corresponding author), Univ Paris 06, Sorbonne Univ, UMR LOV 7093, F-75005 Paris, France.	romagnan@obs-vlfr.fr	Jamet, Jean-Louis JLJ/G-9893-2013; Guidi, Lionel/B-3977-2012; JAMET, Dominique/AAT-9861-2021; stemmann, lars/Q-8458-2019; stemmann, lars/E-6899-2011	Jamet, Jean-Louis JLJ/0000-0002-2296-6231; Guidi, Lionel/0000-0002-6669-5744; JAMET, Dominique/0000-0003-2575-3722; stemmann, lars/0000-0001-8935-4531; Gorsky, Gabriel/0000-0002-1099-8711	Universite de Nice, France through a Ministere de l'enseignement superieur et de la recherche, Pres; European Union [262584]	Universite de Nice, France through a Ministere de l'enseignement superieur et de la recherche, Pres; European Union(European Commission)	JBR received funding from Universite de Nice, France through a Ministere de l'enseignement superieur et de la recherche, Pres. Euromediterranee doctoral fellowship. JBR received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no262584, JERICO. MP and LS received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no262584, JERICO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN TFH, 1977, ECOLOGY, V58, P1076, DOI 10.2307/1936927; Andersen V., 1998, P125; Barber RT, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2006GB002726; Behrenfeld MJ, 2010, ECOLOGY, V91, P977, DOI 10.1890/09-1207.1; Bernard KS, 2012, DEEP-SEA RES PT I, V62, P111, DOI 10.1016/j.dsr.2011.12.015; BOUCHER J, 1987, J MAR RES, V45, P133, DOI 10.1357/002224087788400891; BUSTILLOSGUZMAN J, 1995, MAR ECOL PROG SER, V124, P247, DOI 10.3354/meps124247; Calbet A, 2001, J PLANKTON RES, V23, P319, DOI 10.1093/plankt/23.3.319; Casini M, 2009, P NATL ACAD SCI USA, V106, P197, DOI 10.1073/pnas.0806649105; CLAUSTRE H, 1989, J EXP MAR BIOL ECOL, V129, P17, DOI 10.1016/0022-0981(89)90060-9; D'Alcala MR, 2004, SCI MAR, V68, P65; D'Ortenzio F, 2009, BIOGEOSCIENCES, V6, P139, DOI 10.5194/bg-6-139-2009; Deibel D, 2012, ICES J MAR SCI, V69, P358, DOI 10.1093/icesjms/fsr159; Dubischar CD, 1997, DEEP-SEA RES PT II, V44, P415, DOI 10.1016/S0967-0645(96)00064-1; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Falkowski PG, 2003, GLO CH IGBP, P99; Fernex FE, 1996, ESTUAR COAST SHELF S, V43, P359, DOI 10.1006/ecss.1996.0075; Ferraris M, 2012, J PLANKTON RES, V34, P874, DOI 10.1093/plankt/fbs049; FERRIERPAGES C, 1994, MAR ECOL PROG SER, V108, P283, DOI 10.3354/meps108283; Garcia-Comas C, 2011, J MARINE SYST, V87, P216, DOI 10.1016/j.jmarsys.2011.04.003; Gasparini S, 2013, PLANKTON IDENTIFIER; Goberville E, 2010, MAR ECOL PROG SER, V408, P129, DOI 10.3354/meps08564; Gomez F, 2003, J PLANKTON RES, V25, P323, DOI 10.1093/plankt/25.4.323; Gorsky G, 2010, J PLANKTON RES, V32, P285, DOI 10.1093/plankt/fbp124; Haskell AGE, 1999, J PLANKTON RES, V21, P1725, DOI 10.1093/plankt/21.9.1725; Hay S, 2006, CURR BIOL, V16, pR679, DOI 10.1016/j.cub.2006.08.010; Hereu CM, 2006, MAR ECOL PROG SER, V318, P123, DOI 10.3354/meps318123; Hood RR, 2006, DEEP-SEA RES PT II, V53, P459, DOI 10.1016/j.dsr2.2006.01.025; Jamet JL, 2005, MAR FRESHWATER RES, V56, P69, DOI 10.1071/MF04102; Landry MR, 2002, HYDROBIOLOGIA, V480, P29, DOI 10.1023/A:1021272731737; Landry MR, 2000, MAR ECOL PROG SER, V201, P57, DOI 10.3354/meps201057; Le Quere C, 2005, GLOBAL CHANGE BIOL, V11, P2016, DOI 10.1111/j.1365-2468.2005.01004.x; LEGENDRE P, 1985, AM NAT, V125, P257, DOI 10.1086/284340; LEVASSEUR M, 1984, MAR ECOL PROG SER, V19, P211, DOI 10.3354/meps019211; Licandro P, 2006, LIMNOL OCEANOGR, V51, P1832, DOI 10.4319/lo.2006.51.4.1832; Madin LP, 2006, DEEP-SEA RES PT I, V53, P804, DOI 10.1016/j.dsr.2005.12.018; Mann KH, 2006, DYNAMICS MARINE ECOS; MARGALEF R, 1978, OCEANOL ACTA, V1, P493; Margalef R., 1967, Oceanography and Marine Biology, V5, P257; Margalef R., 1968, PERSPECTIVES ECOLOGI; Margalef R., 1958, PERSPECTIVES MARINE, P323; Marie D, 1999, CURRENT PROTOCOLS CY; Marty JC, 2010, BIOGEOSCIENCES, V7, P2117, DOI 10.5194/bg-7-2117-2010; Millot C, 1999, J MARINE SYST, V20, P423, DOI 10.1016/S0924-7963(98)00078-5; Molinero JC, 2008, J MARINE SYST, V69, P271, DOI 10.1016/j.jmarsys.2005.11.023; NIVAL P, 1976, ANN I OCEANOGR PARIS, V52, P57; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; ODUM EP, 1977, SCIENCE, V195, P1289, DOI 10.1126/science.195.4284.1289; Piterbarg L, 2014, J MARINE SYST, V129, P381, DOI 10.1016/j.jmarsys.2013.08.003; Richardson AJ, 2009, TRENDS ECOL EVOL, V24, P312, DOI 10.1016/j.tree.2009.01.010; Ryther JH, 1963, MARINE BIOL 1, P25; Sabates A, 2010, HYDROBIOLOGIA, V645, P153, DOI 10.1007/s10750-010-0221-z; Sarthou G, 2005, J SEA RES, V53, P25, DOI 10.1016/j.seares.2004.01.007; Sherr EB, 2007, MAR ECOL PROG SER, V352, P187, DOI 10.3354/meps07161; Sieracki CK, 1998, MAR ECOL PROG SER, V168, P285, DOI 10.3354/meps168285; SOMMER U, 1986, ARCH HYDROBIOL, V106, P433; Sommer U, 2008, INT REV HYDROBIOL, V93, P506, DOI 10.1002/iroh.200711039; Sommer U, 2012, ANNU REV ECOL EVOL S, V43, P429, DOI 10.1146/annurev-ecolsys-110411-160251; SOURNIA A, 1990, OCEANOL ACTA, V13, P413; Stemmann L, 2008, J MARINE SYST, V70, P1, DOI 10.1016/j.jmarsys.2007.02.014; Verity PG, 1996, MAR ECOL PROG SER, V130, P277, DOI 10.3354/meps130277	61	27	28	2	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119219	10.1371/journal.pone.0119219	http://dx.doi.org/10.1371/journal.pone.0119219			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25780912	gold, Green Published, Green Submitted			2022-12-27	WOS:000351284600056
J	Ruan, WK; An, J; Wu, YH				Ruan, Wenke; An, Jian; Wu, Yanhua			Polymorphisms of Chicken TLR3 and 7 in Different Breeds	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-3; DISEASE VIRUS; GENE POLYMORPHISM; INFECTION; SUSCEPTIBILITY; LINES; ASSOCIATION; TYPE-1; RECOGNITION; FIBROSIS	Toll-like receptors (TLRs) mediate immune responses via the recognition of pathogen-associated molecular patterns (PAMPs), thus playing important roles in host defense. Among the chicken (Ch) TLR family, ChTLR3 and 7 have been shown to recognize viral RNA. In our earlier studies, we have reported polymorphisms of TLR1, 2, 4, 5, 15 and 21. In the present study, we amplified TLR3 and 7 genes from different chicken breeds and analyzed their sequences. We identified 7 amino acid polymorphism sites in ChTLR3 with 6 outer part sites and 1 inner part site, and 4 amino acid polymorphism sites in ChTLR7 with 3 outer part sites and 1 inner part site. These results demonstrate that ChTLR genes are polymorphic among different chicken breeds, suggesting a varied resistance across numerous chicken breeds. This information might help improve chicken health by breeding and vaccination.	[Ruan, Wenke; An, Jian] Beijing Univ Agr, Coll Anim Sci & Technol, Beijing 102206, Peoples R China; [Wu, Yanhua] Capital Med Univ, Sch Basic Med Sci, Dept Microbiol, Beijing 100069, Peoples R China	Beijing University of Agriculture; Capital Medical University	Ruan, WK (corresponding author), Beijing Univ Agr, Coll Anim Sci & Technol, Beijing 102206, Peoples R China.	wenkeruan@hotmail.com; wuyanhua@ccmu.edu.cn			Beijing Natural Science Foundation (Beijing, China) [6122009]; Beijing Education Committee Programs of science and technology (Beijing, China) [KM201310020007]	Beijing Natural Science Foundation (Beijing, China)(Beijing Natural Science Foundation); Beijing Education Committee Programs of science and technology (Beijing, China)	This work was supported by the following sources: 1. Beijing Natural Science Foundation (no. 6122009, Beijing, China). The funders had a role in study design, data collection and analysis, and decision to publish. 2. The Beijing Education Committee Programs of science and technology (KM201310020007, Beijing, China). The funders had a role in study design and data collection and analysis.	Al-Qahtani A, 2012, J MED VIROL, V84, P1353, DOI 10.1002/jmv.23271; Beutler B, 2002, CURR TOP MICROBIOL, V270, P1; Boyd AC, 2012, J IMMUNOL, V189, P4930, DOI 10.4049/jimmunol.1101790; Brownlie R, 2011, CELL TISSUE RES, V343, P121, DOI 10.1007/s00441-010-1026-0; BUMSTEAD N, 1993, POULTRY SCI, V72, P403, DOI 10.3382/ps.0720403; Cheng JH, 2014, ARCH VIROL, V159, P2937, DOI 10.1007/s00705-014-2148-6; COOK J, 1990, ADV EXP MED BIOL, V276, P491; Guo XF, 2012, ARCH VIROL, V157, P2189, DOI 10.1007/s00705-012-1403-y; Higuchi M, 2008, DEV COMP IMMUNOL, V32, P147, DOI 10.1016/j.dci.2007.05.003; Hu XM, 2014, VET RES COMMUN, V38, P149, DOI 10.1007/s11259-014-9598-x; Ishizaki Y, 2008, J NEUROVIROL, V14, P486, DOI 10.1080/13550280802298120; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Keestra AM, 2008, MOL IMMUNOL, V45, P1298, DOI 10.1016/j.molimm.2007.09.013; Keestra AM, 2010, J IMMUNOL, V185, P460, DOI 10.4049/jimmunol.0901921; Lee SO, 2013, TRANSPL INFECT DIS, V15, P111, DOI 10.1111/tid.12033; Misch EA, 2008, CLIN SCI, V114, P347, DOI 10.1042/CS20070214; O'Dwyer DN, 2013, AM J RESP CRIT CARE, V188, P1442, DOI 10.1164/rccm.201304-0760OC; Philbin VJ, 2005, IMMUNOLOGY, V114, P507, DOI 10.1111/j.1365-2567.2005.02125.x; Poulsen DJ, 1998, POULTRY SCI, V77, P17, DOI 10.1093/ps/77.1.17; Ruan WK, 2012, POULTRY SCI, V91, P2512, DOI 10.3382/ps.2012-02319; Ruan WK, 2012, POULTRY SCI, V91, P101, DOI 10.3382/ps.2011-01808; Ruan WK, 2011, POULTRY SCI, V90, P1941, DOI 10.3382/ps.2011-01489; Ruan WK, 2012, MOL BIOL REP, V39, P3419, DOI 10.1007/s11033-011-1113-7; Saif Y. M., 2008, DIS POULTRY; Schott E, 2007, J HEPATOL, V47, P203, DOI 10.1016/j.jhep.2007.03.021; Sironi L, 2008, VIROLOGY, V380, P152, DOI 10.1016/j.virol.2008.07.022; Stewart CR, 2012, J INTERF CYTOK RES, V32, P46, DOI 10.1089/jir.2011.0036; Sun SF, 2008, POULTRY SCI, V87, P1725, DOI 10.3382/ps.2007-00202; Williams SM, 2004, AVIAN DIS, V48, P61, DOI 10.1637/7052	30	13	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119967	10.1371/journal.pone.0119967	http://dx.doi.org/10.1371/journal.pone.0119967			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781886	Green Published, gold, Green Submitted			2022-12-27	WOS:000351284600112
J	Shi, LJ; Zhou, YY; Ou, JJ; Gong, JB; Wang, SH; Cui, XL; Lyu, HL; Zhao, JP; Luo, XR				Shi, Lijuan; Zhou, Yuanyue; Ou, Jianjun; Gong, Jingbo; Wang, Suhong; Cui, Xilong; Lyu, Hailong; Zhao, Jingping; Luo, Xuerong			Different Visual Preference Patterns in Response to Simple and Complex Dynamic Social Stimuli in Preschool-Aged Children with Autism Spectrum Disorders	PLOS ONE			English	Article							CIRCUMSCRIBED ATTENTION; YOUNG-CHILDREN; EYE-MOVEMENTS; IMPAIRMENT; FIXATION; FACES; INDIVIDUALS; INFORMATION; SITUATIONS; TRACKING	Eye-tracking studies in young children with autism spectrum disorder (ASD) have shown a visual attention preference for geometric patterns when viewing paired dynamic social images (DSIs) and dynamic geometric images (DGIs). In the present study, eye-tracking of two different paired presentations of DSIs and DGIs was monitored in a group of 13 children aged 4 to 6 years with ASD and 20 chronologically age-matched typically developing children (TDC). The results indicated that compared with the control group, children with ASD attended significantly less to DSIs showing two or more children playing than to similar DSIs showing a single child. Visual attention preference in 4- to 6-year-old children with ASDs, therefore, appears to be modulated by the type of visual stimuli.	[Shi, Lijuan; Zhou, Yuanyue; Ou, Jianjun; Gong, Jingbo; Wang, Suhong; Cui, Xilong; Lyu, Hailong; Zhao, Jingping; Luo, Xuerong] Cent S Univ, Mental Hlth Inst, Xiangya Hosp 2, Changsha, Hunan, Peoples R China; [Shi, Lijuan; Zhou, Yuanyue; Ou, Jianjun; Gong, Jingbo; Wang, Suhong; Cui, Xilong; Lyu, Hailong; Zhao, Jingping; Luo, Xuerong] Cent S Univ, Key Lab Psychiat & Mental Hlth Hunan Prov, Changsha, Hunan, Peoples R China; [Zhou, Yuanyue] Hangzhou Seventh Peoples Hosp, Hangzhou, Zhejiang, Peoples R China; [Gong, Jingbo] Tradit Chinese Med Univ Hunan, Changsha, Hunan, Peoples R China; [Wang, Suhong] Soochow Univ, Dept Neurosci, Affiliated Hosp 3, Changzhou, Jiangsu, Peoples R China	Central South University; Central South University; Hunan University of Chinese Medicine; Soochow University - China	Luo, XR (corresponding author), Cent S Univ, Mental Hlth Inst, Xiangya Hosp 2, Changsha, Hunan, Peoples R China.	luoxr@vip.sina.com	zhao, jing/B-3868-2019; Cui, Xilong/HHM-6692-2022	Lyu, Hailong/0000-0003-2587-0769	Major State Basic Research Development Program of China (973 Program) [2012CB517901]; Hunan Provincial Innovation Foundation For Postgraduate [CX2013B117]; Ministry of Health Science and technology industry special fund [201302002]; National Natural Science of Foundation of China (NSFC) [81101018]; Changzhou Science and Technology Application Project [CJ20112009, CJ20130026]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); Hunan Provincial Innovation Foundation For Postgraduate; Ministry of Health Science and technology industry special fund; National Natural Science of Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Changzhou Science and Technology Application Project	This work was supported by grants from the Major State Basic Research Development Program of China (973 Program, No. 2012CB517901), the Hunan Provincial Innovation Foundation For Postgraduate (No. CX2013B117), the Ministry of Health Science and technology industry special fund (No. 201302002), the National Natural Science of Foundation of China (NSFC, No. 81101018), and Changzhou Science and Technology Application Project (Nos. CJ20112009, CJ20130026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Association AP DSM-IV APA on, 2000, DIAGN STAT MAN MENT; Caldara R, 2011, BEHAV RES METHODS, V43, P864, DOI 10.3758/s13428-011-0092-x; Chawarska K, 2013, BIOL PSYCHIAT, V74, P195, DOI 10.1016/j.biopsych.2012.11.022; Chawarska K, 2012, J CHILD PSYCHOL PSYC, V53, P903, DOI 10.1111/j.1469-7610.2012.02538.x; Creasey GL, 1998, PLAY SOCIAL COMPETEN, P116; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; Dawson G, 2005, DEV NEUROPSYCHOL, V27, P403, DOI 10.1207/s15326942dn2703_6; Elison JT, 2012, RES AUTISM SPECT DIS, V6, P842, DOI 10.1016/j.rasd.2011.11.005; Fletcher-Watson S, 2009, NEUROPSYCHOLOGIA, V47, P248, DOI 10.1016/j.neuropsychologia.2008.07.016; Goldinger SD, 2009, J EXP PSYCHOL LEARN, V35, P1105, DOI 10.1037/a0016548; Hosozawa M, 2012, PEDIATRICS, V129, pE1453, DOI 10.1542/peds.2011-2278; Jones W, 2008, ARCH GEN PSYCHIAT, V65, P946, DOI 10.1001/archpsyc.65.8.946; Joseph RM, 2004, DEV PSYCHOPATHOL, V16, P137, DOI 10.1017/S095457940404444X; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Klin A, 2003, PHILOS T R SOC B, V358, P345, DOI 10.1098/rstb.2002.1202; Liu SY, 2011, J EXP CHILD PSYCHOL, V108, P180, DOI 10.1016/j.jecp.2010.06.008; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Mandell DS, 2005, PEDIATRICS, V116, P1480, DOI 10.1542/peds.2005-0185; Matson JL, 2014, INT J DEV NEUROSCI, V39, P44, DOI 10.1016/j.ijdevneu.2014.02.003; McPartland J, 2004, J CHILD PSYCHOL PSYC, V45, P1235, DOI 10.1111/j.1469-7610.2004.00318.x; Nakano T, 2010, P ROY SOC B-BIOL SCI, V277, P2935, DOI 10.1098/rspb.2010.0587; Parish-Morris J, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00185; Parten MB, 1932, J ABNORM SOC PSYCH, V27, P243, DOI 10.1037/h0074524; Pierce K, 2011, ARCH GEN PSYCHIAT, V68, P101, DOI 10.1001/archgenpsychiatry.2010.113; Sang B., 1990, PSYCHOL SCI, V5, P20, DOI DOI 10.16719/J.CNKI.1671-6981.1990.05.004; Sasson NJ, 2014, J AUTISM DEV DISORD, V44, P584, DOI 10.1007/s10803-013-1910-z; Sasson NJ, 2011, J AUTISM DEV DISORD, V41, P242, DOI 10.1007/s10803-010-1038-3; Sasson NJ, 2008, AUTISM RES, V1, P31, DOI 10.1002/aur.4; Speer LL, 2007, AUTISM, V11, P265, DOI 10.1177/1362361307076925; Wolf JM, 2008, AUTISM RES, V1, P329, DOI 10.1002/aur.56; Xiao WS, 2014, DEV PSYCHOBIOL, V56, P262, DOI 10.1002/dev.21196	32	38	41	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0122280	10.1371/journal.pone.0122280	http://dx.doi.org/10.1371/journal.pone.0122280			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7QC	25781170	gold, Green Published			2022-12-27	WOS:000351284600218
J	Curci, PL; De Paola, D; Danzi, D; Vendramin, GG; Sonnante, G				Curci, Pasquale L.; De Paola, Domenico; Danzi, Donatella; Vendramin, Giovanni G.; Sonnante, Gabriella			Complete Chloroplast Genome of the Multifunctional Crop Globe Artichoke and Comparison with Other Asteraceae	PLOS ONE			English	Article							DNA; GENE; SEQUENCE; MICROSATELLITES; IDENTIFICATION; EVOLUTION; TOOLS; WILD; MITOCHONDRIAL; ORGANIZATION	With over 20,000 species, Asteraceae is the second largest plant family. High-throughput sequencing of nuclear and chloroplast genomes has allowed for a better understanding of the evolutionary relationships within large plant families. Here, the globe artichoke chloroplast (cp) genome was obtained by a combination of whole-genome and BAC clone high-throughput sequencing. The artichoke cp genome is 152,529 bp in length, consisting of two single-copy regions separated by a pair of inverted repeats (IRs) of 25,155 bp, representing the longest IRs found in the Asteraceae family so far. The large (LSC) and the small (SSC) single-copy regions span 83,578 bp and 18,641 bp, respectively. The artichoke cp sequence was compared to the other eight Asteraceae complete cp genomes available, revealing an IR expansion at the SSC/IR boundary. This expansion consists of 17 bp of the ndhF gene generating an overlap between the ndhF and ycf1 genes. A total of 127 cp simple sequence repeats (cpSSRs) were identified in the artichoke cp genome, potentially suitable for future population studies in the Cynara genus. Parsimony-informative regions were evaluated and allowed to place a Cynara species within the Asteraceae family tree. The eight most informative coding regions were also considered and tested for "specific barcode" purpose in the Asteraceae family. Our results highlight the usefulness of cp genome sequencing in exploring plant genome diversity and retrieving reliable molecular resources for phylogenetic and evolutionary studies, as well as for specific barcodes in plants.	[Curci, Pasquale L.; De Paola, Domenico; Danzi, Donatella; Sonnante, Gabriella] CNR, Inst Biosci & Bioresources, Bari, Italy; [Vendramin, Giovanni G.] CNR, Inst Biosci & Bioresources, Sesto Fiorentino, FI, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR)	Sonnante, G (corresponding author), CNR, Inst Biosci & Bioresources, Bari, Italy.	gabriella.sonnante@ibbr.cnr.it	Vendramin, Giovanni G/K-9731-2014	Vendramin, Giovanni G/0000-0001-9921-7872; Danzi, Donatella/0000-0003-4393-5087; SONNANTE, GABRIELLA/0000-0003-0993-6828; Curci, Pasquale Luca/0000-0002-5780-3029; De Paola, Domenico/0000-0001-5667-3114	Italian Ministry of Economy and Finance [191/2009]; BiodiverSO - PSR Puglia	Italian Ministry of Economy and Finance; BiodiverSO - PSR Puglia	This research was supported by a dedicated grant from the Italian Ministry of Economy and Finance to the National Research Council for the project Innovazione e Sviluppo del Mezzogiorno - Conoscenze Integrate per Sostenibilita ed Innovazione del Made in Italy Agroalimentare (C.I.S.I. A.)-Legge n. 191/2009, and by the project BiodiverSO - PSR Puglia 2007-2013 Mis. 214/4 subaz. a), http://biodiversitapuglia.it/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed I, 2013, MOL ECOL RESOUR, V13, P929, DOI 10.1111/1755-0998.12128; Barres L, 2013, AM J BOT, V100, P867, DOI 10.3732/ajb.1200058; Bausher MG, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-21; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bradley RK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000392; Bremer K., 1994, ASTERACEAE CLADISTIC; Calabrese N, 2012, ACTA HORTIC, V942, P153, DOI 10.17660/ActaHortic.2012.942.18; Chung HJ, 2006, PLANT CELL REP, V25, P1369, DOI 10.1007/s00299-006-0196-4; Dempewolf H, 2010, MOL ECOL RESOUR, V10, P1048, DOI 10.1111/j.1755-0998.2010.02859.x; Dong WP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035071; Doorduin L, 2011, DNA RES, V18, P93, DOI 10.1093/dnares/dsr002; Drescher A, 2000, PLANT J, V22, P97, DOI 10.1046/j.1365-313x.2000.00722.x; Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Gatto A, 2013, ANN BOT-LONDON, V112, P855, DOI 10.1093/aob/mct150; Gebhardt R, 1997, TOXICOL APPL PHARM, V144, P279, DOI 10.1006/taap.1997.8130; Grassi F, 2002, VITIS, V41, P157; Jansen RK, 2005, METHOD ENZYMOL, V395, P348, DOI 10.1016/S0076-6879(05)95020-9; Jansen RK, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-32; Kode V, 2005, PLANT J, V44, P237, DOI 10.1111/j.1365-313X.2005.02533.x; Kraft K, 1997, PHYTOMEDICINE, V4, P369, DOI 10.1016/S0944-7113(97)80049-9; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kumar S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-131; Kuroda H, 2003, NATURE, V425, P86, DOI 10.1038/nature01909; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Li R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078568; Li XW, 2015, BIOL REV, V90, P157, DOI 10.1111/brv.12104; Liu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057533; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Martin G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067350; Martin GE, 2014, ANN BOT-LONDON, V113, P1197, DOI 10.1093/aob/mcu050; Martinez-Alberola F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079685; Melotto-Passarin DM, 2011, GENET MOL RES, V10, P2024, DOI 10.4238/vol10-3gmr1019; MILLIGAN BG, 1989, MOL BIOL EVOL, V6, P355; Mudunuri SB, 2007, BIOINFORMATICS, V23, P1181, DOI 10.1093/bioinformatics/btm097; Negro D, 2012, J FOOD SCI, V77, pC244, DOI 10.1111/j.1750-3841.2011.02531.x; Nie XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036869; Odintsova MS, 2006, BIOTECHNOL INTELL UN, P57, DOI 10.1007/978-0-387-36672-2_6; OGIHARA Y, 1988, P NATL ACAD SCI USA, V85, P8573, DOI 10.1073/pnas.85.22.8573; OLMSTEAD RG, 1994, AM J BOT, V81, P1205, DOI 10.2307/2445483; Ortiz S., 2009, SYSTEMATICS EVOLUTIO, P193; PALMER JD, 1982, CELL, V29, P537, DOI 10.1016/0092-8674(82)90170-2; Panero JL, 2008, MOL PHYLOGENET EVOL, V47, P757, DOI 10.1016/j.ympev.2008.02.011; Provan J, 2001, TRENDS ECOL EVOL, V16, P142, DOI 10.1016/S0169-5347(00)02097-8; Qian J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057607; Ravi V, 2008, PLANT SYST EVOL, V271, P101, DOI 10.1007/s00606-007-0608-0; ROHDE W, 1994, J GEN VIROL, V75, P2141, DOI 10.1099/0022-1317-75-9-2141; Rottenberg A, 1996, GENET RESOUR CROP EV, V43, P53, DOI 10.1007/BF00126940; Sasaki T, 2003, MOL BIOL EVOL, V20, P1028, DOI 10.1093/molbev/msg098; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; Sonnante G, 2002, GENET RESOUR CROP EV, V49, P247, DOI 10.1023/A:1015574627621; Sonnante G, 2007, ANN BOT-LONDON, V100, P1095, DOI 10.1093/aob/mcm127; Sonnante G, 2010, PLANT PHYSIOL, V153, P1224, DOI 10.1104/pp.109.150144; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Swofford DL., 2003, PAUP PHYLOGENETIC AN; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tangphatsornruang S, 2010, DNA RES, V17, P11, DOI 10.1093/dnares/dsp025; Timme RE, 2007, AM J BOT, V94, P302, DOI 10.3732/ajb.94.3.302; Ueda M, 2008, MOL BIOL EVOL, V25, P1566, DOI 10.1093/molbev/msn102; Umashankar V, 2007, BIOINFORMATION, V2, P62; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wolf PG, 2010, GENOME, V53, P731, DOI [10.1139/G10-061, 10.1139/g10-061]; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yang JK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053939, 10.1371/journal.pone.0073053]; Yi DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035872	67	87	91	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120589	10.1371/journal.pone.0120589	http://dx.doi.org/10.1371/journal.pone.0120589			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774672	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500184
J	Guo, T; Chang, L; Xiao, YS; Liu, QY				Guo, Tao; Chang, Lei; Xiao, Yusha; Liu, Quanyan			S-Adenosyl-L-Methionine for the Treatment of Chronic Liver Disease: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							URSODEOXYCHOLIC ACID; FATTY LIVER; CONTROLLED-TRIAL; ADENOSYLMETHIONINE; CHOLESTASIS; MECHANISMS; CIRRHOSIS; THERAPY	It has been well established that S-adenosyl-L-methionine (SAMe) is the principal methyl donor in methyltransferase reactions and that SAMe supplementation restores hepatic glutathione (GSH) deposits and attenuates liver injury. However, the effectiveness of SAMe therapy in chronic liver disease has not been adequately addressed. We searched globally recognized electronic databases, including PubMed, the Cochrane Database and EMBASE, to retrieve relevant randomized controlled trials (RCTs) of chronic liver disease published in the past 20 years. We then performed a systematic review and meta-analysis of the enrolled trials that met the inclusion criteria. The results showed that twelve RCTs from 11 studies, which examined 705 patients, were included in this research. For liver function, certain results obtained from data synthesis and independent comparisons demonstrated significant differences between the levels of total bilirubin (TBIL) and aspartate transaminase (AST). However, no studies identified significant differences regarding alanine transaminase (ALT) levels. An analysis of the adverse events and long-term prognosis also indicated no significant differences between the SAMe and the placebo groups. In a subgroup analysis of gravidas and children, several of the included data indicated that there was a significant difference in the pruritus score. Furthermore, the results regarding ursodeoxycholic acid (UDCA) and stronger neo-minophagen C (SNMC) indicated that both treatments were more effective than SAMe was in certain chronic liver diseases. These findings suggest that SAMe could be used as the basis of a medication regimen for liver function improvement because of its safety. However, SAMe also demonstrated limited clinical value in the treatment of certain chronic liver diseases.	[Guo, Tao; Chang, Lei; Xiao, Yusha; Liu, Quanyan] Wuhan Univ, Zhongnan Hosp, Digest Dis Res Ctr, Dept Gen Surg, Wuhan 430071, Peoples R China	Wuhan University	Liu, QY (corresponding author), Wuhan Univ, Zhongnan Hosp, Digest Dis Res Ctr, Dept Gen Surg, Wuhan 430071, Peoples R China.	lqy@whu.edu.cn			National Natural Science Foundation of China [30872491/C160402, 81372552, 81172349/H1617]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No. 30872491/C160402, 81372552 and 81172349/H1617). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; Anstee QM, 2012, J HEPATOL, V57, P1097, DOI 10.1016/j.jhep.2012.04.041; Avila MA, 2000, J HEPATOL, V33, P907, DOI 10.1016/S0168-8278(00)80122-1; Beuers U, 2001, HEPATOLOGY, V33, P1206, DOI 10.1053/jhep.2001.24034; Binder T, 2006, Ceska Gynekol, V71, P92; Cai JX, 1998, CANCER RES, V58, P1444; Cai JX, 1996, HEPATOLOGY, V24, P1090; Cederbaum AI, 2010, WORLD J GASTROENTERO, V16, P1366, DOI 10.3748/wjg.v16.i11.1366; Chavez M, 2000, AM J HEALTH-SYST PH, V57, P119, DOI 10.1093/ajhp/57.2.119; Copple BL, 2010, SEMIN LIVER DIS, V30, P195, DOI 10.1055/s-0030-1253228; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dhiman RK, 2005, DIGEST DIS SCI, V50, P1807, DOI 10.1007/s10620-005-2942-9; Feld JJ, 2011, GASTROENTEROLOGY, V140, P830, DOI 10.1053/j.gastro.2010.09.010; Filipowicz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015492; Gurung V, 2013, COCHRANE DB SYST REV, V6, pD493; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Horowitz S, 1999, ALTERN COMPLEMENT TH, V5, P266; Huang Jin-yang, 2004, Zhongguo Zhong Xi Yi Jie He Za Zhi, V24, P309; Kumar D, 2001, J GASTROEN HEPATOL, V16, P3, DOI 10.1046/j.1440-1746.2001.02376.x; LIEBER CS, 1990, HEPATOLOGY, V11, P165, DOI 10.1002/hep.1840110203; Lieber CS, 2002, AM J CLIN NUTR, V76, p1148S, DOI 10.1093/ajcn/76.5.1148S; Loenen WAM, 2006, BIOCHEM SOC T, V34, P330, DOI 10.1042/BST0340330; Lu SC, 2000, INT J BIOCHEM CELL B, V32, P391, DOI 10.1016/S1357-2725(99)00139-9; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mato JM, 1999, J HEPATOL, V30, P1081, DOI 10.1016/S0168-8278(99)80263-3; Mato JM, 2007, HEPATOLOGY, V45, P1306, DOI 10.1002/hep.21650; Medici V, 2011, ALCOHOL CLIN EXP RES, V35, P1960, DOI 10.1111/j.1530-0277.2011.01547.x; Nicastri PL, 1998, BRIT J OBSTET GYNAEC, V105, P1205, DOI 10.1111/j.1471-0528.1998.tb09976.x; Qin B, 2000, Zhonghua Gan Zang Bing Za Zhi, V8, P158; Rambaldi A, 2006, COCHRANE DB SYST REV, V2, pD2235; Rodrigues CMP, 1998, J CLIN INVEST, V101, P2790, DOI 10.1172/JCI1325; Roncaglia N, 2004, BJOG-INT J OBSTET GY, V111, P17, DOI 10.1046/j.1471-0528.2003.00029.x; Stelmakh VV, 2013, TERAPEVT ARKH, V85, P71; Su ZR, 2013, HEPATO-GASTROENTEROL, V60, P1136, DOI 10.5754/hge11072; Sun QF, 2010, MED SCI MONITOR, V16, pPR9; Wortham M, 2008, DIGEST DIS SCI, V53, P2761, DOI 10.1007/s10620-007-0193-7; Yang HP, 2009, HEPATOLOGY, V49, P1982, DOI 10.1002/hep.22908; Zhu Shi-Shu, 2010, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V24, P136	38	32	40	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0122124	10.1371/journal.pone.0122124	http://dx.doi.org/10.1371/journal.pone.0122124			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774783	Green Published, gold, Green Submitted			2022-12-27	WOS:000351183500221
J	Itagaki, K; Kaczmarek, E; Lee, YT; Tang, IT; Isal, B; Adibnia, Y; Sandler, N; Grimm, MJ; Segal, BH; Otterbein, E; Hauser, CJ				Itagaki, Kiyoshi; Kaczmarek, Elzbieta; Lee, Yen Ting; Tang, I. Tien; Isal, Burak; Adibnia, Yashar; Sandler, Nicola; Grimm, Melissa J.; Segal, Brahm H.; Otterbein, E.; Hauser, Carl J.			Mitochondrial DNA Released by Trauma Induces Neutrophil Extracellular Traps	PLOS ONE			English	Article							NADPH OXIDASE; MAP KINASE; INFLAMMATION; THROMBOSIS; IMMUNITY; INJURY	Neutrophil extracellular traps (NETs) are critical for anti-bacterial activity of the innate immune system. We have previously shown that mitochondrial damage-associated molecular patterns (mtDAMPs), including mitochondrial DNA (mtDNA), are released into the circulation after injury. We therefore questioned whether mtDNA is involved in trauma-induced NET formation. Treatment of human polymorphoneutrophils (PMN) with mtDNA induced robust NET formation, though in contrast to phorbol myristate acetate (PMA) stimulation, no NADPH-oxidase involvement was required. Moreover, formation of mtDNA-induced NETs was completely blocked by TLR9 antagonist, ODN-TTAGGG. Knowing that infective outcomes of trauma in elderly people are more severe than in young people, we measured plasma mtDNA and NET formation in elderly and young trauma patients and control subjects. MtDNA levels were significantly higher in the plasma of elderly trauma patients than young patients, despite lower injury severity scores in the elderly group. NETs were not visible in circulating PMN isolated from either young or old control subjects. NETs were however, detected in PMN isolated from young trauma patients and to a lesser extent from elderly patients. Stimulation by PMA induced widespread NET formation in PMN from both young volunteers and young trauma patients. NET response to PMA was much less pronounced in both elderly volunteers' PMN and in trauma patients' PMN. We conclude that mtDNA is a potent inducer of NETs that activates PMN via TLR9 without NADPH-oxidase involvement. We suggest that decreased NET formation in the elderly regardless of higher mtDNA levels in their plasma may result from decreased levels of TLR9 and/or other molecules, such as neutrophil elastase and myeloperoxidase that are involved in NET generation. Further study of the links between circulating mtDNA and NET formation may elucidate the mechanisms of trauma-related organ failure as well as the greater susceptibility to secondary infection in elderly trauma patients.	[Itagaki, Kiyoshi; Kaczmarek, Elzbieta; Lee, Yen Ting; Tang, I. Tien; Isal, Burak; Adibnia, Yashar; Sandler, Nicola; Otterbein, E.; Hauser, Carl J.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg, Boston, MA 02215 USA; [Kaczmarek, Elzbieta] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Vasc Biol Res Ctr, Boston, MA 02215 USA; [Grimm, Melissa J.; Segal, Brahm H.] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA; [Grimm, Melissa J.; Segal, Brahm H.] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA; [Segal, Brahm H.] SUNY Buffalo, Sch Med, Dept Med, Buffalo, NY 14260 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Roswell Park Cancer Institute; Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Itagaki, K (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg, Boston, MA 02215 USA.	kitagaki@bidmc.harvard.edu; chauser@bidmc.harvard.edu	Segal, Brahm/AAW-2706-2020; Hauser, Carl J./Y-1189-2019; Itagaki, Kiyoshi/M-5501-2015	Itagaki, Kiyoshi/0000-0002-6033-1122; Adibnia, Yashar/0000-0001-9298-6150; Hauser, Carl/0000-0003-3167-1846	 [5 R01 GM089711 04]; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089711] Funding Source: NIH RePORTER	; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by 5 R01 GM089711 04 to CJH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almyroudis NG, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00045; Arai Y, 2014, BIOCHEM BIOPH RES CO, V443, P556, DOI 10.1016/j.bbrc.2013.12.007; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V., 2010, JOVE-J VIS EXP, V36, P1724, DOI [10.3791/1724, DOI 10.3791/1724/J0VE.C0M/VIDE0/1724]; Brinkmann V, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00413; Fuchs TA, 2012, ARTERIOSCL THROM VAS, V32, P1777, DOI 10.1161/ATVBAHA.111.242859; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Gaszner Peter, 2004, Neuropsychopharmacol Hung, V6, P90; Ginde AA, 2014, SHOCK, V42, P99, DOI 10.1097/SHK.0000000000000182; Grassle S, 2014, ARTERIOSCL THROM VAS, V34, P1382, DOI 10.1161/ATVBAHA.113.303016; Hauser CJ, 2010, J ORTHOP TRAUMA, V24, P534, DOI 10.1097/BOT.0b013e3181ec4991; Itagaki K, 2002, J IMMUNOL, V168, P4063, DOI 10.4049/jimmunol.168.8.4063; Knudson M Margaret, 2004, Curr Opin Crit Care, V10, P539, DOI 10.1097/01.ccx.0000144941.09650.9f; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Parker H, 2012, J LEUKOCYTE BIOL, V92, P841, DOI 10.1189/jlb.1211601; Remijsen Q, 2011, CELL RES, V21, P290, DOI 10.1038/cr.2010.150; Renshaw M, 2002, J IMMUNOL, V169, P4697, DOI 10.4049/jimmunol.169.9.4697; SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3; Sapey E, 2014, BLOOD, V123, P239, DOI 10.1182/blood-2013-08-519520; Shaw AC, 2013, NAT REV IMMUNOL, V13, P875, DOI 10.1038/nri3547; Sun SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059989; Tseng CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041454; van Kessel KPM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00467; von Bruhl ML, 2012, J EXP MED, V209, P819, DOI 10.1084/jem.20112322; Zhang Q, 2010, SHOCK, V34, P55, DOI 10.1097/SHK.0b013e3181cd8c08; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	28	114	117	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120549	10.1371/journal.pone.0120549	http://dx.doi.org/10.1371/journal.pone.0120549			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774524	Green Submitted, gold, Green Published			2022-12-27	WOS:000351183500183
J	Kadowaki, T; Nishiyama, Y; Hisabori, T; Hihara, Y				Kadowaki, Taro; Nishiyama, Yoshitaka; Hisabori, Toru; Hihara, Yukako			Identification of OmpR-Family Response Regulators Interacting with Thioredoxin in the Cyanobacterium Synechocystis sp PCC 6803	PLOS ONE			English	Article							HIGH-LIGHT; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; REDOX; RPAB; SYSTEM; PHOTOSYNTHESIS; MECHANISM; PROTEINS; STRESS	The redox state of the photosynthetic electron transport chain is known to act as a signal to regulate the transcription of key genes involved in the acclimation responses to environmental changes. We hypothesized that the protein thioredoxin (Trx) acts as a mediator connecting the redox state of the photosynthetic electron transport chain and transcriptional regulation, and established a screening system to identify transcription factors (TFs) that interact with Trx. His-tagged TFs and S-tagged mutated form of Trx, TrxM(C35S), whose active site cysteine 35 was substituted with serine to trap the target interacting protein, were co-expressed in E. coli cells and Trx-TF complexes were detected by immuno-blotting analysis. We examined the interaction between Trx and ten OmpR family TFs encoded in the chromosome of the cyanobacterium Synechocystis sp. PCC 6803 (S.6803). Although there is a highly conserved cysteine residue in the receiver domain of all OmpR family TFs, only three, RpaA (Slr0115), RpaB (Slr0946) and ManR (Slr1837), were identified as putative Trx targets. The recombinant forms of wild-type TrxM, RpaA, RpaB and ManR proteins from S.6803 were purified following over-expression in E. coli and their interaction was further assessed by monitoring changes in the number of cysteine residues with free thiol groups. An increase in the number of free thiols was observed after incubation of the oxidized TFs with Trx, indicating the reduction of cysteine residues as a consequence of interaction with Trx. Our results suggest, for the first time, the possible regulation of OmpR family TFs through the supply of reducing equivalents from Trx, as well as through the phospho-transfer from its cognate sensor histidine kinase.	[Kadowaki, Taro; Nishiyama, Yoshitaka; Hihara, Yukako] Saitama Univ, Grad Sch Sci & Engn, Saitama 3388570, Japan; [Hisabori, Toru] Tokyo Inst Technol, Chem Resources Lab, Yokohama, Kanagawa 227, Japan; [Hisabori, Toru; Hihara, Yukako] Japan Sci & Technol Agcy JST, CREST, Saitama, Japan	Saitama University; Tokyo Institute of Technology; Japan Science & Technology Agency (JST)	Hihara, Y (corresponding author), Saitama Univ, Grad Sch Sci & Engn, Saitama 3388570, Japan.	hihara@molbiol.saitama-u.ac.jp	Hihara, Yukako/E-3461-2010; Hihara, Yukako/AAX-2065-2020; Hisabori, Toru/E-5205-2014; Hihara, Yukako/AAO-6742-2020	Hisabori, Toru/0000-0003-2046-0277; Hihara, Yukako/0000-0003-1916-2053	Network Joint Research Center for Materials and Devices [2014243]; Ministry of Education, Culture, Sports, Science and Technology [23570047]; Core Research of Evolutional Science & Technology program from the Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [25119704] Funding Source: KAKEN	Network Joint Research Center for Materials and Devices; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research of Evolutional Science & Technology program from the Japan Science and Technology Agency; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Network Joint Research Center for Materials and Devices (No. 2014243) (to Y.H.), Grant-in-Aid for Scientific Research (C) (No. 23570047) from the Ministry of Education, Culture, Sports, Science and Technology (to Y.H.), and Core Research of Evolutional Science & Technology program from the Japan Science and Technology Agency (to Y.H.).	Ansong C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00325; Ashby MK, 1999, FEMS MICROBIOL LETT, V181, P253, DOI 10.1016/S0378-1097(99)00547-9; Carroll RK, 2009, J BIOL CHEM, V284, P12008, DOI 10.1074/jbc.M806261200; Collet JF, 2010, ANTIOXID REDOX SIGN, V13, P1205, DOI 10.1089/ars.2010.3114; Perez-Perez ME, 2006, PROTEOMICS, V6, pS186, DOI 10.1002/pmic.200500215; Fey V, 2005, J EXP BOT, V56, P1491, DOI 10.1093/jxb/eri180; Guo J, 2014, MOL CELL PROTEOMICS, V13, P3270, DOI 10.1074/mcp.M114.041160; Hanaoka M, 2008, PLANT J, V56, P327, DOI 10.1111/j.1365-313X.2008.03600.x; Hanaoka M, 2012, J BIOL CHEM, V287, P26321, DOI 10.1074/jbc.M111.338251; Hihara Y, 2003, J BACTERIOL, V185, P1719, DOI 10.1128/JB.185.5.1719-1725.2003; Hisabori T, 2007, PHOTOCHEM PHOTOBIOL, V83, P145, DOI 10.1562/2006-02-27-IR-816; Hishiya S, 2008, PLANT CELL PHYSIOL, V49, P11, DOI 10.1093/pcp/pcm158; Horiuchi M, 2010, BIOCHEM J, V431, P135, DOI 10.1042/BJ20100789; Hosoya-Matsuda N, 2005, J BIOL CHEM, V280, P840, DOI 10.1074/jbc.M411493200; Husain M, 2010, P NATL ACAD SCI USA, V107, P14396, DOI 10.1073/pnas.1005299107; Itou H, 2001, J BIOCHEM-TOKYO, V129, P343, DOI 10.1093/oxfordjournals.jbchem.a002863; Kappell AD, 2007, ARCH MICROBIOL, V187, P337, DOI 10.1007/s00203-007-0213-1; Kim HY, 2008, BIOCHEM BIOPH RES CO, V371, P490, DOI 10.1016/j.bbrc.2008.04.101; Kumar JK, 2004, P NATL ACAD SCI USA, V101, P3759, DOI 10.1073/pnas.0308701101; Lawlor DW, 2009, ANN BOT-LONDON, V103, P561, DOI [10.1093/aob/mcn244, 10.1093/aob/mcn256]; Lindahl M, 2003, P NATL ACAD SCI USA, V100, P16107, DOI 10.1073/pnas.2534397100; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Majeed W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045139; Menon S, 2001, BIOCHEMISTRY-US, V50, P5948; Moronta-Barrios F, 2012, MICROBIOL-SGM, V158, P1229, DOI 10.1099/mic.0.057679-0; Muramatsu M, 2012, J PLANT RES, V125, P11, DOI 10.1007/s10265-011-0454-6; Nakamura K, 2006, J BIOL CHEM, V281, P36758, DOI 10.1074/jbc.M606797200; Oelze ML, 2008, BBA-GEN SUBJECTS, V1780, P1261, DOI 10.1016/j.bbagen.2008.03.015; Ogawa T, 2002, J BIOL CHEM, V277, P28981, DOI 10.1074/jbc.M204175200; Pfannschmidt T, 2003, TRENDS PLANT SCI, V8, P33, DOI 10.1016/S1360-1385(02)00005-5; Seino Y, 2009, J BACTERIOL, V191, P1581, DOI 10.1128/JB.01588-08; Seki A, 2007, J BIOL CHEM, V282, P36887, DOI 10.1074/jbc.M707582200; Shumskaya MA, 2005, J BIOL CHEM, V280, P21531, DOI 10.1074/jbc.m412174200; Sippola K, 1999, PLANT MOL BIOL, V41, P425, DOI 10.1023/A:1006347808475; Takai N, 2006, P NATL ACAD SCI USA, V103, P12109, DOI 10.1073/pnas.0602955103; Tarrago L, 2010, J BIOL CHEM, V285, P14964, DOI 10.1074/jbc.M110.108373; Toro-Roman A, 2005, PROTEIN SCI, V14, P3077, DOI 10.1110/ps.051722805; Yamaguchi K, 2002, PLANT CELL, V14, P2901, DOI 10.1105/tpc.006262	38	14	14	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119107	10.1371/journal.pone.0119107	http://dx.doi.org/10.1371/journal.pone.0119107			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774906	Green Submitted, Green Published, gold			2022-12-27	WOS:000351183500069
J	Magierowski, M; Jasnos, K; Kwiecien, S; Drozdowicz, D; Surmiak, M; Strzalka, M; Ptak-Belowska, A; Wallace, JL; Brzozowski, T				Magierowski, Marcin; Jasnos, Katarzyna; Kwiecien, Slawomir; Drozdowicz, Danuta; Surmiak, Marcin; Strzalka, Malgorzata; Ptak-Belowska, Agata; Wallace, John L.; Brzozowski, Tomasz			Endogenous Prostaglandins and Afferent Sensory Nerves in Gastroprotective Effect of Hydrogen Sulfide against Stress-Induced Gastric Lesions	PLOS ONE			English	Article							LIPID-PEROXIDATION; INJURY; DAMAGE; NEUROPEPTIDES; PATHOGENESIS; INVOLVEMENT; INHIBITION; ULCERATION; RESOLUTION; MUCOSA	Hydrogen sulfide (H2S) plays an important role in human physiology, exerting vasodilatory, neuromodulatory and anti-inflammatory effects. H2S has been implicated in the mechanism of gastrointestinal integrity but whether this gaseous mediator can affect hemorrhagic lesions induced by stress has been little elucidated. We studied the effect of the H2S precursor L-cysteine, H2S-donor NaHS, the H2S synthesizing enzyme (CSE) activity inhibitor-D, L-propargylglycine (PAG) and the gastric H2S production by CSE/CBS/3-MST activity in water immersion and restraint stress (WRS) ulcerogenesis and the accompanying changes in gastric blood flow (GBF). The role of endogenous prostaglandins (PGs) and sensory afferent nerves releasing calcitonin gene-related peptide (CGRP) in the mechanism of gastroprotection induced by H2S was examined in capsaicin-denervated rats and those pre-treated with capsazepine to inhibit activity of vanilloid receptors (VR-1). Rats were pre-treated with vehicle, NaHS, the donor of H2S and or L-cysteine, the H2S precursor, with or without the concurrent treatment with 1) nonselective (indomethacin) and selective cyclooxygenase (COX)-1 (SC-560) or COX-2 (rofecoxib) inhibitors. The expression of mRNA and protein for COX-1 and COX-2 were analyzed in gastric mucosa pretreated with NaHS with or without PAG. Both NaHS and L-cysteine dose-dependently attenuated severity of WRS-induced gastric lesions and significantly increased GBF. These effects were significantly reduced by pretreatment with PAG and capsaicin denervation. NaHS increased gastric H2S production via CSE/CBS but not 3-MST activity. Inhibition of COX-1 and COX-2 activity significantly diminished NaHS-and L-cysteine-induced protection and hyperemia. NaHS increased expression of COX-1, COX-2 mRNAs and proteins and raised CGRP mRNA expression. These effects of NaHS on COX-1 and COX-2 protein contents were reversed by PAG and capsaicin denervation. We conclude that H2S exerts gastroprotection against WRS-induced gastric lesions by the mechanism involving enhancement in gastric	[Magierowski, Marcin; Jasnos, Katarzyna; Kwiecien, Slawomir; Drozdowicz, Danuta; Surmiak, Marcin; Strzalka, Malgorzata; Ptak-Belowska, Agata; Brzozowski, Tomasz] Jagiellonian Univ, Coll Med, Dept Physiol, Krakow, Poland; [Wallace, John L.] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada	Jagiellonian University; Collegium Medicum Jagiellonian University; University of Calgary	Brzozowski, T (corresponding author), Jagiellonian Univ, Coll Med, Dept Physiol, Krakow, Poland.	mpbrzozo@cyf-kr.edu.pl	Wallace, John/AAL-3763-2021; Surmiak, Marcin/GYU-3390-2022	Surmiak, Marcin/0000-0001-8396-1488; Magierowski, Marcin/0000-0003-0175-5600; Kwiecien, Slawomir/0000-0002-4806-8042	Jagiellonian University Medical College for Marcin Magierowski, Department of Physiology, Jagiellonian University Medical College, Cracow, Poland [K/DSC/001380]; Malopolskie Centre of Entrepreneurship	Jagiellonian University Medical College for Marcin Magierowski, Department of Physiology, Jagiellonian University Medical College, Cracow, Poland; Malopolskie Centre of Entrepreneurship	This study was supported by a grant from the Jagiellonian University Medical College (No. K/DSC/001380) for Marcin Magierowski, Department of Physiology, Jagiellonian University Medical College, Cracow, Poland. Marcin Magierowski is supported by a scholarship for PhD candidates from Malopolskie Centre of Entrepreneurship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboubakr EM, 2013, ARCH PHARM RES, V36, P1507, DOI 10.1007/s12272-013-0194-3; Bhatia V, 2005, J GASTROEN HEPATOL, V20, P332, DOI 10.1111/j.1440-1746.2004.03508.x; Biernat J, 2005, J PHYSIOL PHARMACOL, V56, P133; Blackler R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035196; Brzozowski T, 2001, MICROSC RES TECHNIQ, V53, P343, DOI 10.1002/jemt.1102; Brzozowski T, 2008, REGUL PEPTIDES, V148, P6, DOI 10.1016/j.regpep.2008.02.003; Brzozowski T, 2008, J PHARMACOL EXP THER, V326, P105, DOI 10.1124/jpet.108.136457; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Chavez-Pina AE, 2010, EUR J PHARMACOL, V630, P131, DOI 10.1016/j.ejphar.2009.12.017; Fiorucci S, 2005, GASTROENTEROLOGY, V129, P1210, DOI 10.1053/j.gastro.2005.07.060; Flannigan KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071962; HAWKEY CJ, 1986, GUT, V27, P1484, DOI 10.1136/gut.27.12.1484; Konturek PC, 2000, SCAND J GASTROENTERO, V35, P452; KONTUREK PC, 2009, J PHYSIOL PHARMACOL, V60, P41; KONTUREK SJ, 1982, DIGEST DIS SCI, V27, P967, DOI 10.1007/BF01391740; Kwiecien S, 2007, J PHYSIOL PHARMACOL, V58, P149; Kwiecien S, 2004, J PHYSIOL PHARMACOL, V55, P337; Kwiecien S, 2012, J PHYSIOL PHARMACOL, V63, P143; Kwiecien S, 2002, J PHYSIOL PHARMACOL, V53, P39; Kwiecien S, 2010, GASTROENTEROL POL, V17, P234; Lou LX, 2008, CLIN EXP PHARMACOL P, V35, P223, DOI 10.1111/j.1440-1681.2007.04812.x; Magierowski M, 2013, J PHARMACOL EXP THER, V347, P717, DOI 10.1124/jpet.113.207233; Magierowski M, 2013, POSTEP HIG MED DOSW, V67, P150, DOI 10.5604/17322693.1038356; Mard SA, 2012, DIGEST DIS SCI, V57, P1496, DOI 10.1007/s10620-012-2051-5; Mok YYP, 2008, INFLAMM RES, V57, P512, DOI 10.1007/s00011-008-7231-6; Morsy MA, 2010, LIFE SCI, V87, P692, DOI 10.1016/j.lfs.2010.10.004; Shibuya N, 2009, J BIOCHEM, V146, P623, DOI 10.1093/jb/mvp111; STIPANUK MH, 1982, BIOCHEM J, V206, P267, DOI 10.1042/bj2060267; SWAROOP M, 1992, J BIOL CHEM, V267, P11455; WALLACE JL, 1990, AM J PHYSIOL, V259, pG462, DOI 10.1152/ajpgi.1990.259.3.G462; Wallace JL, 2007, FASEB J, V21, P4070, DOI 10.1096/fj.07-8669com; Wallace JL, 2007, GASTROENTEROLOGY, V132, P261, DOI 10.1053/j.gastro.2006.11.042; Wallace JL, 2012, ANTIOXID REDOX SIGN, V17, P58, DOI 10.1089/ars.2011.4351; Wallace JL, 2009, GASTROENTEROLOGY, V137, P569, DOI 10.1053/j.gastro.2009.04.012; Wang R, 2003, ANTIOXID REDOX SIGN, V5, P493, DOI 10.1089/152308603768295249; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Yonezawa D, 2007, TOXICOLOGY, V241, P11, DOI 10.1016/j.tox.2007.07.020; Zanardo RC, 1996, FASEB J, V20, P2118; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008	39	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118972	10.1371/journal.pone.0118972	http://dx.doi.org/10.1371/journal.pone.0118972			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774496	gold, Green Published, Green Submitted			2022-12-27	WOS:000351183500057
J	Marquez, M; Romero-Cores, P; Montes-Oca, M; Martin-Aspas, A; Soto-Cardenas, MJ; Guerrero, F; Fernandez-Gutierrez, C; Giron-Gonzalez, JA				Marquez, Mercedes; Romero-Cores, Paula; Montes-Oca, Monserrat; Martin-Aspas, Andres; Soto-Cardenas, Maria-Jose; Guerrero, Francisca; Fernandez-Gutierrez, Clotilde; Giron-Gonzalez, Jose-Antonio			Immune Activation Response in Chronic HIV-Infected Patients: Influence of Hepatitis C Virus Coinfection	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; REGULATORY T-CELLS; LIPOPOLYSACCHARIDE-BINDING PROTEIN; PLASMA-LEVELS; CD4; INDIVIDUALS; CIRRHOSIS; RECOVERY; COUNTS	Objectives We have analyzed the parameters (bacterial translocation, immune activation and regulation, presence of HCV coinfection) which could be implicated in an inappropriate immune response from individuals with chronic HIV infection. The influence of them on the evolution of CD4+ T cell count has been investigated. Patients and methods Seventy HIV-infected patients [monoinfected by HIV (n = 20), HCV-coinfected (with (n = 25) and without (n = 25) liver cirrhosis)] and 25 healthy controls were included. Median duration of HIV infection was 20 years. HIV- and HCV-related parameters, as well as markers relative to bacterial translocation, monocyte and lymphocyte activation and regulation were considered as independent variables. Dependent variables were the increase of CD4+ T cell count during the follow-up (12 months). Results Increased values of bacterial translocation, measured by lipopolysaccharide-binding protein, monocyte and lymphocyte activation markers and T regulatory lymphocytes were detected in HIV-monoinfected and HIV/HCV coinfected patients. Serum sCD14 and IL-6 were increased in HIV/HCV-coinfected patients with liver cirrhosis in comparison with those with chronic hepatitis or HIV-monoinfected individuals. Time with undetectable HIV load was not related with these parameters. The presence of cirrhosis was negatively associated with a CD4+ T cell count increase. Conclusion In patients with a chronic HIV infection, a persistent increase of lipopolysaccharide-binding protein and monocyte and lymphocyte modifications are present. HCV-related cirrhosis is associated with more elevated serum concentrations of monocyte-derived markers. Cirrhosis influences the continued immune reconstitution of these patients.	[Marquez, Mercedes; Romero-Cores, Paula; Montes-Oca, Monserrat; Martin-Aspas, Andres; Soto-Cardenas, Maria-Jose; Guerrero, Francisca; Giron-Gonzalez, Jose-Antonio] Univ Cadiz, Hosp Univ Puerta Mar, Serv Med Interna Enfermedades Infecciosas, Cadiz, Spain; [Fernandez-Gutierrez, Clotilde] Univ Cadiz, Hosp Univ Puerta Mar, Microbiol Serv, Cadiz, Spain	Universidad de Cadiz; Hospital Universitario Puerta del Mar; Universidad de Cadiz; Hospital Universitario Puerta del Mar	Giron-Gonzalez, JA (corresponding author), Univ Cadiz, Hosp Univ Puerta Mar, Serv Med Interna Enfermedades Infecciosas, Cadiz, Spain.	joseantonio.giron@uca.es	Girón-González, José-Antonio/H-3990-2014; Girón-González, José-Antonio/AAG-4199-2020	Girón-González, José-Antonio/0000-0002-7482-5828; Girón-González, José-Antonio/0000-0002-7482-5828; Martin-Aspas, Andres/0000-0002-3086-9095; Fernandez Gutierrez del Alamo, Clotilde/0000-0003-2664-3103; Marquez-Coello, Mercedes/0000-0003-3948-6258	Instituto de Salud Carlos III [PI08/0869, PI11/00605]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work has been performed with grants from the Instituto de Salud Carlos III (PI08/0869 and PI11/00605). Jose A. Giron-Gonzalez has a grant for "Intensificacion de Actividad Investigadora" 2013, Servicio Andaluz de Salud, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aandahl EM, 2004, J VIROL, V78, P2454, DOI 10.1128/JVI.78.5.2454-2459.2004; Abad-Fernandez M, 2013, JAIDS-J ACQ IMM DEF, V64, P149, DOI 10.1097/QAI.0b013e31829a2f12; Albillos A, 2003, HEPATOLOGY, V37, P208, DOI 10.1053/jhep.2003.50038; Antonucci G, 2005, CLIN INFECT DIS, V40, pE101, DOI 10.1086/430445; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Boettler T, 2005, J VIROL, V79, P7860, DOI 10.1128/JVI.79.12.7860-7867.2005; Boulware DR, 2011, J INFECT DIS, V203, P1637, DOI 10.1093/infdis/jir134; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Romero-Sanchez MC, 2012, J INFECTION, V65, P431, DOI 10.1016/j.jinf.2012.06.008; De Luca A, 2002, ARCH INTERN MED, V162, P2125, DOI 10.1001/archinte.162.18.2125; Arjona MMD, 2011, JAIDS-J ACQ IMM DEF, V56, P420, DOI 10.1097/QAI.0b013e31820ef408; DeHovitz JA, 2000, J INFECT DIS, V182, P1527, DOI 10.1086/315875; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629; Florence E, 2003, HIV Med, V4, P255, DOI 10.1046/j.1468-1293.2003.00156.x; Gaardbo JC, 2008, CLIN EXP IMMUNOL, V154, P80, DOI 10.1111/j.1365-2249.2008.03725.x; Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909; Gras L, 2007, JAIDS-J ACQ IMM DEF, V45, P183, DOI 10.1097/QAI.0b013e31804d685b; Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Hsu DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077479; Hunt PW, 2012, CURR HIV-AIDS REP, V9, P139, DOI 10.1007/s11904-012-0118-8; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Kaufmann GR, 2005, CLIN INFECT DIS, V41, P361, DOI 10.1086/431484; Kovacs A, 2008, J INFECT DIS, V197, P1402, DOI 10.1086/587696; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lange CG, 2003, J ANTIMICROB CHEMOTH, V51, P1, DOI 10.1093/jac/dkg071; Macias J, 2006, GUT, V55, P409, DOI 10.1136/gut.2005.065904; Marquez M, 2009, CLIN EXP IMMUNOL, V158, P219, DOI 10.1111/j.1365-2249.2009.04005.x; Miller MF, 2005, CLIN INFECT DIS, V41, P713, DOI 10.1086/432618; Mira JA, 2013, CLIN INFECT DIS, V56, P1646, DOI 10.1093/cid/cit103; Mocroft A, 2007, LANCET, V370, P407, DOI 10.1016/S0140-6736(07)60948-9; Moore DM, 2006, HIV MED, V7, P383, DOI 10.1111/j.1468-1293.2006.00397.x; Negredo E, 2010, CLIN INFECT DIS, V50, P1300, DOI 10.1086/651689; Paiardini M, 2013, IMMUNOL REV, V254, P78, DOI 10.1111/imr.12079; Ping Y, 2003, CLIN IMMUNOL, V106, P95; Pitrak DL, 2001, AIDS, V15, P1317, DOI 10.1097/00002030-200107060-00018; Rallon NI, 2009, CLIN EXP IMMUNOL, V155, P35, DOI 10.1111/j.1365-2249.2008.03797.x; Robbins GK, 2009, CLIN INFECT DIS, V48, P350, DOI 10.1086/595888; Rosignoli G, 2009, CLIN EXP IMMUNOL, V157, P90, DOI 10.1111/j.1365-2249.2009.03960.x; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Schacker TW, 2005, AIDS, V19, P2169, DOI 10.1097/01.aids.0000194801.51422.03; Schumann RR, 2000, CHEM IMMUNOL, V74, P42; Shevach EM, 2006, IMMUNITY, V25, P195, DOI 10.1016/j.immuni.2006.08.003; Ubeda M, 2010, HEPATOLOGY, V52, P2086, DOI 10.1002/hep.23961	44	32	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119568	10.1371/journal.pone.0119568	http://dx.doi.org/10.1371/journal.pone.0119568			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775475	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500101
J	Yang, GY; Wang, LQ; Ren, J; Zhang, Y; Li, ML; Zhu, YT; Luo, J; Cheng, YJ; Li, WY; Wayne, PM; Liu, JP				Yang, Guo-Yan; Wang, Li-Qiong; Ren, Jun; Zhang, Yan; Li, Meng-Ling; Zhu, Yu-Ting; Luo, Jing; Cheng, Yan-Jun; Li, Wen-Yuan; Wayne, Peter M.; Liu, Jian-Ping			Evidence Base of Clinical Studies on Tai Chi: A Bibliometric Analysis	PLOS ONE			English	Article							AEROBIC CAPACITY; ELDERLY-PEOPLE; EXERCISE; FEAR	Background The safety and health benefits of Tai Chi mind-body exercise has been documented in a large number of clinical studies focused on specific diseases and health conditions. The objective of this systematic review is to more comprehensively summarize the evidence base of clinical studies of Tai Chi for healthcare. Methods and Findings We searched for all types of clinical studies on Tai chi in PubMed, the Cochrane Library and four major Chinese electronic databases from their inception to July 2013. Data were analyzed using SPSS17.0 software. A total of 507 studies published between 1958 and 2013 were identified, including 43 (8.3%) systematic reviews of clinical studies, 255 (50.3%) randomized clinical trials, 90 (17.8%) non-randomized controlled clinical studies, 115 (22.7%) case series and 4 (0.8%) case reports. The top 10 diseases/conditions was hypertension, diabetes, osteoarthritis, osteoporosis or osteopenia, breast cancer, heart failure, chronic obstructive pulmonary disease, coronary heart disease, schizophrenia, and depression. Many healthy participants practiced Tai Chi for the purpose of health promotion or preservation. Yang style Tai Chi was the most popular, and Tai Chi was frequently practiced two to three 1-hour sessions per week for 12 weeks. Tai Chi was used alone in more than half of the studies (58.6%), while in other studies Tai Chi was applied in combination with other therapies including medications, health education and other physical therapies. The majority of studies (94.1%) reported positive effects of Tai Chi, 5.1% studies reported uncertain effects and 0.8% studies reported negative effects. No serious adverse events related to Tai Chi were reported. Conclusions The quantity and evidence base of clinical studies on Tai Chi is substantial. However, there is a wide variation in Tai Chi intervention studied and the reporting of Tai Chi intervention needs to be improved. Further well-designed and reported studies are recommended to confirm the effects of Tai Chi for the frequently reported diseases/conditions.	[Yang, Guo-Yan; Wang, Li-Qiong; Ren, Jun; Li, Wen-Yuan; Liu, Jian-Ping] Beijing Univ Chinese Med, Ctr Evidence Based Chinese Med, Beijing, Peoples R China; [Zhang, Yan; Li, Meng-Ling; Zhu, Yu-Ting; Luo, Jing; Cheng, Yan-Jun; Liu, Jian-Ping] Beijing Univ Chinese Med, Sch Basic Med Sci, Beijing, Peoples R China; [Luo, Jing] China Acad Chinese Med Sci, Xiyuan Hosp, Beijing, Peoples R China; [Cheng, Yan-Jun] China Acad Chinese Med Sci, Guanganmen Hosp, Beijing, Peoples R China; [Wayne, Peter M.] Brigham & Womens Hosp, Osher Ctr Integrat Med, Boston, MA 02115 USA; [Wayne, Peter M.] Harvard Univ, Sch Med, Boston, MA USA	Beijing University of Chinese Medicine; Beijing University of Chinese Medicine; China Academy of Chinese Medical Sciences; Xiyuan Hospital, CACMS; China Academy of Chinese Medical Sciences; Guang'anmen Hospital, CACMS; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Liu, JP (corresponding author), Beijing Univ Chinese Med, Ctr Evidence Based Chinese Med, Beijing, Peoples R China.	Liujp@bucm.edu.cn	Yang, Guoyan/AAG-7873-2021; 罗, 静/HCH-9782-2022	Yang, Guoyan/0000-0002-8012-2379; Luo, Jing/0000-0002-2454-2168; Liu, Jianping/0000-0002-0320-061X	Beijing University of Chinese Medicine [2011-CXTD-09]	Beijing University of Chinese Medicine	This work was supported by the Program of Innovative Research Team of Beijing University of Chinese Medicine (2011-CXTD-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, INTERNATIONAL STATIS; Gu L., 2007, CVPR, P1; Kang JW, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2010-000035; Lan C, 2008, AM J CHINESE MED, V36, P1041, DOI 10.1142/S0192415X08006442; Li FZ, 2007, J AGING PHYS ACTIV, V15, P139, DOI 10.1123/japa.15.2.139; Li JY, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep022; Liu B, 2011, J TRADIT CHIN MED, V31, P141, DOI 10.1016/S0254-6272(11)60029-0; Maciaszek J, 2010, AM J CHINESE MED, V38, P219, DOI 10.1142/S0192415X10007798; MacPherson H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000261; McGibbon CA, 2005, BMC NEUROL, V5, DOI 10.1186/1471-2377-5-3; Pan L, 2013, EUR J HEART FAIL, V15, P316, DOI 10.1093/eurjhf/hfs170; Sjosten N, 2008, AGING MENT HEALTH, V12, P30, DOI 10.1080/13607860701366079; Song QP, 2014, RES SPORTS MED, V22, P172, DOI 10.1080/15438627.2014.881823; Song R, 2010, J ALTERN COMPLEM MED, V16, P227, DOI 10.1089/acm.2009.0165; Su, 2012, STUDY ON TAI CHI, P1; Sun YX, 1988, CHINESE JOURNAL OF R, V8, P2; Tang H, 2012, STUDY ON TAI CHI, P3; Taylor-Piliae Ruth E., 2008, V52, P40, DOI 10.1159/000134283; Wang D, 1958, CHINESE JOURNAL OF A, V5, P33; Wayne PM, 2014, ARCH PHYS MED REHAB, V95, P2470, DOI 10.1016/j.apmr.2014.05.005; Yan JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061806; Yan JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061672; Yeh Gloria Y, 2008, Prev Cardiol, V11, P82; Yeh GY, 2009, J CARDIOPULM REHABIL, V29, P152, DOI 10.1097/HCR.0b013e3181a33379; Yu W, 1997, CHINESE JOURNAL OF C, V6, P78; [曾永红 Zeng Yonghong], 2012, [中国康复理论与实践, Chinese Journal of Rehabilitation Theory and Practice], V18, P1148; Zou WL, 1995, ANTHOLOGY OF MEDICIN, V16, P19	27	59	62	3	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120655	10.1371/journal.pone.0120655	http://dx.doi.org/10.1371/journal.pone.0120655			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775125	Green Submitted, Green Published, gold			2022-12-27	WOS:000351183500188
J	Zhang, CQ; Zhao, XQ; Wang, CX; Liu, LP; Ding, YC; Akbary, F; Pu, YH; Zou, XY; Du, WL; Jing, J; Pan, YS; Wong, KS; Wang, YJ; Wang, YL				Zhang, Changqing; Zhao, Xingquan; Wang, Chunxue; Liu, Liping; Ding, Yuchuan; Akbary, Fauzia; Pu, Yuehua; Zou, Xinying; Du, Wanliang; Jing, Jing; Pan, Yuesong; Wong, Ka Sing; Wang, Yongjun; Wang, Yilong		Chinese IntraCranial	Prediction Factors of Recurrent Ischemic Events in One Year after Minor Stroke	PLOS ONE			English	Article							CAROTID-ARTERY-DISEASE; HIGH EARLY RISK; CEREBRAL INFARCTION; VASCULAR EVENTS; ATTACK; STENOSIS; SCORE; EDUCATION; PERFUSION; PATTERNS	Background The risk of a subsequent stroke following a minor stroke is high. However, there are no effective rating scales to predict recurrent stroke following a minor one. Therefore, we assessed the risk factors associated with recurrent ischemic stroke or transient ischemic attack (TIA) within one year of minor stroke onset in order to identify possible risk factors. Methods Eight hundred and sixty-three non-cardioembolic ischemic stroke patients in the Chinese IntraCranial AtheroSclerosis Study that presented with minor stroke, defined as an admission National Institutes of Health stroke scale (NIHSS) score of <= 3, were consecutively enrolled in our study. Clinical information and imaging features upon admission, and any recurrent ischemic stroke or TIA within one year was recorded. Cox regression was used to identify risk factors associated with recurrent ischemic stroke or TIA within the year following stroke onset. Results A total of 50 patients (6.1%) experienced recurrent ischemic stroke or TIA within one year of minor stroke onset. Multivariate Cox regression model identified lower admission NIHSS score (HR, 1.75; 95% CI, 1.32 to 2.33; P<0.0001), history of coronary heart disease (HR, 2.62; 95% CI, 1.17 to 5.86; P = 0.02), severe stenosis or occlusion of large cerebral artery (HR, 4.68; 95% CI, 1.87 to 11.7; P = 0.001), and multiple acute cerebral infarcts (HR, 2.61; 95% CI, 1.01 to 6.80; P = 0.05) as independent risk factors for recurrent ischemic stroke or TIA within one year. Conclusions Some minor stroke patients are at higher risk for recurrent ischemic stroke or TIA. Urgent and intensified therapy may be reasonable in these patients.	[Zhang, Changqing; Zhao, Xingquan; Wang, Chunxue; Liu, Liping; Pu, Yuehua; Zou, Xinying; Du, Wanliang; Jing, Jing; Pan, Yuesong; Wang, Yongjun; Wang, Yilong] Capital Med Univ, Beijing Tian Tan Hosp, Dept Neurol, Beijing, Peoples R China; [Ding, Yuchuan; Akbary, Fauzia] Wayne State Univ, Sch Med, Detroit, MI USA; [Wong, Ka Sing] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China	Capital Medical University; Wayne State University; Chinese University of Hong Kong; Prince of Wales Hospital	Wang, YJ (corresponding author), Capital Med Univ, Beijing Tian Tan Hosp, Dept Neurol, Beijing, Peoples R China.	yongjunwang1962@gmail.com; yilong528@gmail.com	liu, li/HGC-0900-2022; Pan, Yuesong/AAI-6303-2020; Wong, Ka Sing Lawrence/N-3434-2015; Ding, yu/GWV-1732-2022	Pan, Yuesong/0000-0003-3082-6789; Wong, Ka Sing Lawrence/0000-0002-2031-9866; 	Ministry of Science and Technology [2013BAI09B03, 2012ZX09303-005-001, 2011BAI08B02]; Ministry of Health of the People's Republic of China [2013BAI09B03, 2012ZX09303-005-001, 2011BAI08B02]; Beijing Municipal Science & Technology Commission [Z131100002613005]; S.H. Ho Cardiovascular Disease and Stroke Center of the Chinese University of Hong Kong	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health of the People's Republic of China; Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission); S.H. Ho Cardiovascular Disease and Stroke Center of the Chinese University of Hong Kong	This study was funded by the Ministry of Science and Technology and the Ministry of Health of the People's Republic of China, grant no. National S&T Major Project of China (2013BAI09B03, 2012ZX09303-005-001, 2011BAI08B02), Beijing Municipal Science & Technology Commission (Z131100002613005), and in part by the S.H. Ho Cardiovascular Disease and Stroke Center of the Chinese University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarenco P, 2013, STROKE, V44, P1505, DOI 10.1161/STROKEAHA.111.000142; Amarenco P, 2011, STROKE, V42, P22, DOI 10.1161/STROKEAHA.110.584086; Ay H, 2005, ANN NEUROL, V58, P688, DOI 10.1002/ana.20617; Ay H, 2010, NEUROLOGY, V74, P128, DOI 10.1212/WNL.0b013e3181ca9cff; Barber PA, 2001, NEUROLOGY, V56, P1015, DOI 10.1212/WNL.56.8.1015; Chandratheva A, 2011, STROKE, V42, P632, DOI 10.1161/STROKEAHA.110.593301; Chaves CJ, 2003, ARCH NEUROL-CHICAGO, V60, P237, DOI 10.1001/archneur.60.2.237; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Coull AJ, 2004, BMJ-BRIT MED J, V328, P326, DOI 10.1136/bmj.37991.635266.44; Coutts SB, 2008, INT J STROKE, V3, P3, DOI 10.1111/j.1747-4949.2008.00182.x; D'Amore C, 2012, FRONT NEUROL NEUROSC, V30, P181, DOI 10.1159/000333638; Foerster M, 2009, AM J CARDIOL, V103, P361, DOI 10.1016/j.amjcard.2008.09.089; FOX AJ, 1993, RADIOLOGY, V186, P316, DOI 10.1148/radiology.186.2.8421726; Giles MF, 2007, LANCET NEUROL, V6, P1063, DOI 10.1016/S1474-4422(07)70274-0; Giles MF, 2010, STROKE, V41, P1907, DOI 10.1161/STROKEAHA.110.578971; Grant Edward G, 2003, Ultrasound Q, V19, P190, DOI 10.1097/00013644-200312000-00005; Johnston SC, 2007, LANCET, V369, P283, DOI 10.1016/S0140-6736(07)60150-0; Johnston SC, 2003, STROKE, V34, P2446, DOI 10.1161/01.STR.0000090842.81076.68; Kim JM, 2012, ARCH NEUROL-CHICAGO, V69, P1470, DOI 10.1001/archneurol.2012.1018; Lin HJ, 2007, J CLIN NEUROSCI, V14, P17, DOI 10.1016/j.jocn.2005.07.026; Lindsay AC, 2012, JACC-CARDIOVASC IMAG, V5, P388, DOI 10.1016/j.jcmg.2011.10.007; Merwick A, 2010, LANCET NEUROL, V9, P1060, DOI 10.1016/S1474-4422(10)70240-4; Momjian-Mayor I, 2005, STROKE, V36, P567, DOI 10.1161/01.STR.0000155727.82242.e1; Ois A, 2008, STROKE, V39, P1717, DOI 10.1161/STROKEAHA.107.505438; Pu YH, 2013, STROKE, V44, P2109, DOI 10.1161/STROKEAHA.113.001522; Rothwell PM, 2003, LANCET, V361, P107, DOI 10.1016/S0140-6736(03)12228-3; Rothwell PM, 2005, LANCET, V366, P29, DOI 10.1016/S0140-6736(05)66702-5; Samuels OB, 2000, AM J NEURORADIOL, V21, P643; Smith EE, 2005, STROKE, V36, P2497, DOI 10.1161/01.STR.0000185798.78817.f3; Szabo K, 2001, STROKE, V32, P1323, DOI 10.1161/01.STR.32.6.1323; Wang YJ, 2013, NEW ENGL J MED, V369, P11, DOI 10.1056/NEJMoa1215340; Wong KSL, 2010, LANCET NEUROL, V9, P489, DOI 10.1016/S1474-4422(10)70060-0; Wong KS, 2002, ANN NEUROL, V52, P74, DOI 10.1002/ana.10250	33	16	16	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120105	10.1371/journal.pone.0120105	http://dx.doi.org/10.1371/journal.pone.0120105			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774939	gold, Green Submitted, Green Published			2022-12-27	WOS:000351183500150
J	Doorakkers, E; Konings, P; Mattsson, F; Lagergren, J; Brusselaers, N				Doorakkers, Eva; Konings, Peter; Mattsson, Fredrik; Lagergren, Jesper; Brusselaers, Nele			Early Complications Following Oesophagectomy for Cancer in Relation to Long-Term Healthcare Utilisation: A Prospective Population-Based Cohort Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; SURGICAL COMPLICATIONS; PERSISTING SYMPTOMS; SURVIVORS; SURGERY; COSTS	Background Little is known about how early postoperative complications after oesophagectomy for cancer influence healthcare utilisation in the long-term. We hypothesised that these complications also increase healthcare utilisation long after the recovery period. Methods This was a prospective, nationwide Swedish population-based cohort study of patients who underwent curatively intended oesophagectomy for cancer in 2001-2005 and survived at least 1 year postoperatively (n = 390). Total days of in-hospitalisation, number of hospitalisations and number of visits to the outpatient clinic within 5 years of surgery were analysed using quasi-Poisson models with adjustment for patient, tumour and treatment characteristics and are expressed as incidence rate ratios (IRR) and 95% confidence intervals (CI). Results There was an increased in-hospitalisation period 1-5 years after surgery in patients with more than 1 complication (IRR 1.5, 95% CI 1.0-2.4). The IRR for the number of hospitalisations by number of complications was 1.1 (95% CI 0.7-1.6), and 1.2 (95% CI 0.9-1.6) for number of outpatient visits in patients with more than 1 complication. The IRR for in-hospitalisation period 1-5 years following oesophagectomy was 1.8 (95% CI 1.0-3.0) for patients with anastomotic insufficiency and 1.5 (95% CI 0.9-2.5) for patients with cardiovascular or cerebrovascular complications. We found no association with number of hospitalisations (IRR 1.2, 95% CI 0.7-2.0) or number of outpatient visits (IRR 1.3, 95% CI 0.9-1.7) after anastomotic insufficiency, or after cardiovascular or cerebrovascular complications (IRR 1.2, 95% CI 0.7-1.9) and (IRR 1.1, 95% CI 0.8-1.5) respectively. Conclusion This study showed an increased total in-hospitalisation period 1-5 years after oesophagectomy for cancer in patients with postoperative complications, particularly following anastomotic insufficiency.	[Doorakkers, Eva; Konings, Peter; Mattsson, Fredrik; Lagergren, Jesper; Brusselaers, Nele] Karolinska Inst, Dept Mol Med & Surg, Upper Gastrointestinal Surg, Stockholm, Sweden; [Doorakkers, Eva] Radboud Univ Nijmegen, Dept Surg, NL-6525 ED Nijmegen, Netherlands; [Lagergren, Jesper] Kings Coll London, Div Canc Studies, London, England	Karolinska Institutet; Radboud University Nijmegen; University of London; King's College London	Brusselaers, N (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Upper Gastrointestinal Surg, Stockholm, Sweden.	nele.brusselaers@ki.se	Brusselaers, Nele/I-3501-2012	Brusselaers, Nele/0000-0003-0137-447X; Konings, Peter/0000-0002-8637-5916	Swedish Research Council (SIMSAM); Swedish Cancer Society	Swedish Research Council (SIMSAM)(Swedish Research Council); Swedish Cancer Society(Swedish Cancer Society)	Funding: This work was supported by the Swedish Research Council (SIMSAM) and Swedish Cancer Society (non-restricted educational grants). www.simsam.nu; www.cancerfonden.se. The funding sources had no role in the design and conduct of the study, collection, management, analysis and interpretation of the data, or preparation, review or approval of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Brusselaers N, 2013, GUT; Carrott PW, 2012, J AM COLL SURGEONS, V215, P331, DOI 10.1016/j.jamcollsurg.2012.04.030; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Derogar M, 2013, J CLIN ONCOL, V31, P551, DOI 10.1200/JCO.2012.46.1517; Derogar M, 2012, J CLIN ONCOL, V30, P1615, DOI 10.1200/JCO.2011.40.3568; Dimick JB, 2003, J AM COLL SURGEONS, V196, P671, DOI 10.1016/S1072-7515(03)00122-4; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Gordon LG, 2011, BRIT J SURG, V98, P1589, DOI 10.1002/bjs.7599; Issa DE, 2014, EUR J CANC CARE; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Lagergren J, 2013, CA-CANCER J CLIN, V63, P232, DOI 10.3322/caac.21185; Lagergren J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6280; Lang K, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-227; Mols F, 2007, EUR J CANCER, V43, P2211, DOI 10.1016/j.ejca.2007.06.022; Mols F, 2007, INT J CANCER, V121, P871, DOI 10.1002/ijc.22739; Peuckmann V, 2009, EUR J CANCER, V45, P625, DOI 10.1016/j.ejca.2008.09.027; Rutegard M, 2012, EJSO-EUR J SURG ONC, V38, P555, DOI 10.1016/j.ejso.2012.02.177; Sobin, 2009, UICC TNM CLASSIFICAT; Treanor C, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-316; van der Schaaf M, 2012, BRIT J SURG, V99, P95, DOI 10.1002/bjs.7750; van der Schaaf M, 2013, ANN SURG ONCOL, V20, P1639, DOI 10.1245/s10434-012-2690-y; Viklund P, 2006, ANN SURG, V243, P204, DOI 10.1097/01.sla.0000197698.17794.eb; Viklund P, 2005, WORLD J SURG, V29, P841, DOI 10.1007/s00268-005-7887-9	24	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0121080	10.1371/journal.pone.0121080	http://dx.doi.org/10.1371/journal.pone.0121080			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768921	Green Published, Green Submitted, gold			2022-12-27	WOS:000351277500138
J	Wu, XZ; Zhao, M; Pan, BS; Zhang, J; Peng, MT; Wang, LL; Hao, XK; Huang, XZ; Mu, RQ; Guo, W; Qiao, R; Chen, WX; Jiang, H; Ma, YY; Shang, H				Wu, Xinzhong; Zhao, Min; Pan, Baishen; Zhang, Jie; Peng, Mingting; Wang, Lanlan; Hao, Xiaoke; Huang, Xianzhang; Mu, Runqing; Guo, Wei; Qiao, Rui; Chen, Wenxiang; Jiang, Hong; Ma, Yueyun; Shang, Hong			Complete Blood Count Reference Intervals for Healthy Han Chinese Adults	PLOS ONE			English	Article							BETA-THALASSEMIA; REFERENCE VALUES; POPULATION; WOMEN	Background Complete blood count (CBC) reference intervals are important to diagnose diseases, screen blood donors, and assess overall health. However, current reference intervals established by older instruments and technologies and those from American and European populations are not suitable for Chinese samples due to ethnic, dietary, and lifestyle differences. The aim of this multicenter collaborative study was to establish CBC reference intervals for healthy Han Chinese adults. Methods A total of 4,642 healthy individuals (2,136 males and 2,506 females) were recruited from six clinical centers in China (Shenyang, Beijing, Shanghai, Guangzhou, Chengdu, and Xi'an). Blood samples collected in K2EDTA anticoagulant tubes were analyzed. Analysis of variance was performed to determine differences in consensus intervals according to the use of data from the combined sample and selected samples. Results Median and mean platelet counts from the Chengdu center were significantly lower than those from other centers. Red blood cell count (RBC), hemoglobin (HGB), and hematocrit (HCT) values were higher in males than in females at all ages. Other CBC parameters showed no significant instrument-, region-, age-, or sex-dependent difference. Thalassemia carriers were found to affect the lower or upper limit of different RBC profiles. Conclusion We were able to establish consensus intervals for CBC parameters in healthy Han Chinese adults. RBC, HGB, and HCT intervals were established for each sex. The reference interval for platelets for the Chengdu center should be established independently.	[Wu, Xinzhong; Huang, Xianzhang] Guangzhou Univ Chinese Med, Affiliated Hosp 2, Dept Lab Sci, Guangzhou, Guangdong, Peoples R China; [Zhao, Min; Mu, Runqing; Shang, Hong] China Med Univ, Affiliated Hosp 1, Dept Clin Lab Med, Shenyang 110001, Peoples R China; [Pan, Baishen; Guo, Wei] Fudan Univ, Zhongshan Hosp, Dept Clin Lab Med, Shanghai 200433, Peoples R China; [Zhang, Jie; Qiao, Rui] Peking Univ, Hosp 3, Dept Lab Med, Beijing 100871, Peoples R China; [Peng, Mingting; Chen, Wenxiang] Beijing Hosp, Natl Ctr Clin Labs, Beijing, Peoples R China; [Wang, Lanlan; Jiang, Hong] Sichuan Univ, Dept Lab Med, West China Hosp, Chengdu, Sichuan, Peoples R China; [Hao, Xiaoke; Ma, Yueyun] Fourth Mil Med Univ, Xijing Hosp, Dept Clin Lab Med, Xian 710032, Shaanxi, Peoples R China	Guangzhou University of Chinese Medicine; China Medical University; Fudan University; Peking University; Beijing Hospital; Sichuan University; Air Force Military Medical University	Shang, H (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Clin Lab Med, Shenyang 110001, Peoples R China.	hongshang100@hotmail.com	ma, yue/GXE-9897-2022; Guo, Wei/AAA-1205-2020	Guo, Wei/0000-0001-6189-0543; hao, xiaoke/0000-0001-9948-0048	National Key Technologies R&D Program of China [2012BAI37B01]	National Key Technologies R&D Program of China(National Key Technology R&D Program)	This work was supported by National Key Technologies R&D Program of China (2012BAI37B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abolghasemi H, 2007, J PEDIAT HEMATOL ONC, V29, P233, DOI 10.1097/MPH.0b013e3180437e02; Adetifa IMO, 2009, INT J LAB HEMATOL, V31, P615, DOI 10.1111/j.1751-553X.2008.01087.x; Birgens H, 2007, SCAND J CLIN LAB INV, V67, P11, DOI 10.1080/00365510601046417; CAI SP, 1994, HUM MUTAT, V3, P59, DOI 10.1002/humu.1380030110; Cheng Calvino Ka-Wing, 2004, Lab Hematol, V10, P42, DOI 10.1532/LH96.04010; Cong Yu-long, 2003, Zhonghua Yi Xue Za Zhi, V83, P1201; Cui Yu-Gui, 2003, Zhonghua Nan Ke Xue, V9, P248; England J M, 1984, Clin Lab Haematol, V6, P69; ENGLAND JM, 1994, CLIN LAB HAEMATOL, V16, P131; Galanello R, 2003, PREVENTION THALASSEM, V1, P35; Ge MA, 2010, J FORMOS MED ASSOC, V109, P656, DOI 10.1016/S0929-6646(10)60106-4; Ge Miao, 2004, Yale Journal of Biology and Medicine, V77, P117; Hong Haiyu, 2011, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V25, P1064; Horowitz GL., 2010, DEFINING ESTABLISHIN; International Committee for Standardization in Haematology Expert Panel on Blood Cell Sizing, 1980, J CLIN PATHOL, V33, P1; Karita E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004401; Kibaya RS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003327; Klee G, 2001, AM J CLIN PATHOL, V115, P460; Kratz A, 2004, NEW ENGL J MED, V351, P1548, DOI 10.1056/NEJMcpc049016; Lin M, 2012, CLIN GENET, V81, P165, DOI 10.1111/j.1399-0004.2011.01627.x; Lun ZR, 2005, LANCET INFECT DIS, V5, P31, DOI 10.1016/S1473-3099(04)01252-6; Paul A K, 2012, Mymensingh Med J, V21, P125; Roshan TM, 2009, INT J LAB HEMATOL, V31, P505, DOI 10.1111/j.1751-553X.2008.01068.x; Ryan K, 2010, BRIT J HAEMATOL, V149, P35, DOI 10.1111/j.1365-2141.2009.08054.x; SAXENA S, 1990, ARCH PATHOL LAB MED, V114, P715; Sirdah MM, 2008, J CLIN LAB ANAL, V22, P353, DOI 10.1002/jcla.20265; Trent Ronald J A, 2006, Clin Biochem Rev, V27, P27; Wang Xia, 2011, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V28, P135; Xu XM, 2004, J CLIN PATHOL, V57, P517, DOI 10.1136/jcp.2003.014456; Ye YW, 2006, NATL GUID CLIN LAB P, P1017; Ye YW, 1997, NATIONAL GUIDE TO CL, P613; Yoo WG, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001208; Zhang JW, 2003, HEMOGLOBIN HEMOGLOBI, P215; Zwart A, 1996, J CLIN PATHOL, V49, P271, DOI 10.1136/jcp.49.4.271	34	40	45	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119669	10.1371/journal.pone.0119669	http://dx.doi.org/10.1371/journal.pone.0119669			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25769040	Green Published, Green Submitted, gold			2022-12-27	WOS:000351277500091
J	Stetter, MG; Schmid, K; Ludewig, U				Stetter, Markus G.; Schmid, Karl; Ludewig, Uwe			Uncovering Genes and Ploidy Involved in the High Diversity in Root Hair Density, Length and Response to Local Scarce Phosphate in Arabidopsis thaliana	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; P-I STARVATION; PHOSPHORUS AVAILABILITY; AUXIN; ETHYLENE; ELONGATION; PLANTS; ARCHITECTURE; ACQUISITION; ACCESSIONS	Plant root hairs increase the root surface to enhance the uptake of sparingly soluble and immobile nutrients, such as the essential nutrient phosphorus, from the soil. Here, root hair traits and the response to scarce local phosphorus concentration were studied in 166 accessions of Arabidopsis thaliana using split plates. Root hair density and length were correlated, but highly variable among accessions. Surprisingly, the well-known increase in root hair density under low phosphorus was mostly restricted to genotypes that had less and shorter root hairs under P sufficient conditions. By contrast, several accessions with dense and long root hairs even had lower hair density or shorter hairs in local scarce phosphorus. Furthermore, accessions with whole-genome duplications developed more dense but phosphorus-insensitive root hairs. The impact of genome duplication on root hair density was confirmed by comparing tetraploid accessions with their diploid ancestors. Genomewide association mapping identified candidate genes potentially involved in root hair responses tp scarce local phosphate. Knock-out mutants in identified candidate genes (CYR1, At1g32360 and RLP48) were isolated and differences in root hair traits in the mutants were confirmed. The large diversity in root hair traits among accessions and the diverse response when local phosphorus is scarce is a rich resource for further functional analyses.	[Stetter, Markus G.; Ludewig, Uwe] Univ Hohenheim, Inst Crop Sci, Nutr Crop Physiol, D-70593 Stuttgart, Germany; [Stetter, Markus G.; Schmid, Karl] Univ Hohenheim, Inst Plant Breeding Seed Sci & Populat Genet, D-70593 Stuttgart, Germany	University Hohenheim; University Hohenheim	Ludewig, U (corresponding author), Univ Hohenheim, Inst Crop Sci, Nutr Crop Physiol, Fruwirthstr 20, D-70593 Stuttgart, Germany.	u.ludewig@uni-hohenheim.de	Stetter, Markus G/ABA-8503-2021	Stetter, Markus G/0000-0001-7136-0589	Hohenheim-Rehovot	Hohenheim-Rehovot	This work was partially financed by a Hohenheim-Rehovot partnership grant to UL, and by regular University expenses from the University of Hohenheim. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SJ, 2004, PLANT PHYSIOL, V134, P1135, DOI 10.1104/pp.103.034660; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Bates TR, 2001, PLANT SOIL, V236, P243, DOI 10.1023/A:1012791706800; Bustos R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001102; Chao DY, 2013, SCIENCE, V341, P658, DOI 10.1126/science.1240561; Chen ZH, 2007, BIOCHEM J, V405, P191, DOI 10.1042/BJ20070102; Chen ZH, 2008, PLANT CELL PHYSIOL, V49, P1902, DOI 10.1093/pcp/pcn157; Chiou TJ, 2011, ANNU REV PLANT BIOL, V62, P185, DOI 10.1146/annurev-arplant-042110-103849; Cordell D, 2009, GLOBAL ENVIRON CHANG, V19, P292, DOI 10.1016/j.gloenvcha.2008.10.009; Datta S, 2011, PLANT SOIL, V346, P1, DOI 10.1007/s11104-011-0845-4; Deal RB, 2010, DEV CELL, V18, P1030, DOI 10.1016/j.devcel.2010.05.013; DEIKMAN J, 1995, PLANTA, V195, P440, DOI 10.1007/BF00202603; FOEHSE D, 1983, PLANT SOIL, V74, P359, DOI 10.1007/BF02181353; Gahoonia TS, 2003, PLANT CELL ENVIRON, V26, P1759, DOI 10.1046/j.1365-3040.2003.01093.x; Horton MW, 2012, NAT GENET, V44, P212, DOI 10.1038/ng.1042; Jones VAS, 2012, ANN BOT-LONDON, V110, P205, DOI 10.1093/aob/mcs136; Kapulnik Y, 2011, J EXP BOT, V62, P2915, DOI 10.1093/jxb/erq464; Lan P, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r67; Lei M, 2011, NEW PHYTOL, V189; Li WF, 2010, MOL PLANT, V3, P212, DOI 10.1093/mp/ssp086; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Lynch JP, 2013, ANN BOT-LONDON, V112, P347, DOI 10.1093/aob/mcs293; Ma Z, 2001, PLANT CELL ENVIRON, V24, P459, DOI 10.1046/j.1365-3040.2001.00695.x; MASUCCI JD, 1994, PLANT PHYSIOL, V106, P1335, DOI 10.1104/pp.106.4.1335; Miura K, 2011, PLANT PHYSIOL, V155, P1000, DOI 10.1104/pp.110.165191; Muller M, 2004, PLANT PHYSIOL, V134, P409, DOI 10.1104/pp.103.029066; Narang RA, 2000, PLANT PHYSIOL, V124, P1786, DOI 10.1104/pp.124.4.1786; Pitts RJ, 1998, PLANT J, V16, P553, DOI 10.1046/j.1365-313x.1998.00321.x; Rahman A, 2002, PLANT PHYSIOL, V130, P1908, DOI 10.1104/pp.010546; Ravi M, 2010, NATURE, V464, P615, DOI 10.1038/nature08842; Savage N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075452; Segura V, 2012, NAT GENET, V44, P825, DOI 10.1038/ng.2314; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Svistoonoff S, 2007, NAT GENET, V39, P792, DOI 10.1038/ng2041; Thibaud MC, 2010, PLANT J, V64, P775, DOI 10.1111/j.1365-313X.2010.04375.x; Ward JT, 2008, PLANT PHYSIOL, V147, P1181, DOI 10.1104/pp.108.118562; Weigel D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-107; Yang HY, 2014, PLANT CELL ENVIRON, V37, P1404, DOI 10.1111/pce.12244	39	38	39	4	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120604	10.1371/journal.pone.0120604	http://dx.doi.org/10.1371/journal.pone.0120604			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781967	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600174
J	Bick, MJ; Malik, S; Mustaev, A; Darst, SA				Bick, Matthew J.; Malik, Sohail; Mustaev, Arkady; Darst, Seth A.			TFIIB Is Only similar to 9 angstrom Away from the 5 '-End of a Trimeric RNA Primer in a Functional RNA Polymerase II Preinitiation Complex	PLOS ONE			English	Article							TRANSCRIPTION FACTOR TFIIF; CORE PROMOTER ELEMENT; STRUCTURAL BASIS; ACTIVE-CENTER; DEPENDENT TRANSCRIPTION; CRYSTAL-STRUCTURE; INITIATION-FACTOR; LARGEST SUBUNIT; DNA; HOLOENZYME	Recent X-ray crystallographic studies of Pol II in complex with the general transcription factor (GTF) IIB have begun to provide insights into the mechanism of transcription initiation. These structures have also shed light on the architecture of the transcription preinitiation complex (PIC). However, structural characterization of a functional PIC is still lacking, and even the topological arrangement of the GTFs in the Pol II complex is a matter of contention. We have extended our activity-based affinity crosslinking studies, initially developed to investigate the interaction of bacterial RNA polymerase with s, to the eukaryotic transcription machinery. Towards that end, we sought to identify GTFs that are within the Pol II active site in a functioning PIC. We provide biochemical evidence that TFIIB is located within similar to 9 angstrom of the -2 site of promoter DNA, where it is positioned to play a role in de novo transcription initiation.	[Bick, Matthew J.; Darst, Seth A.] Rockefeller Univ, Lab Mol Biophys, New York, NY 10021 USA; [Malik, Sohail] Rockefeller Univ, Lab Biochem & Mol Biol, New York, NY 10021 USA; [Mustaev, Arkady] New Jersey Inst Technol, Dept Chem & Environm Sci, Newark, NJ 07102 USA	Rockefeller University; Rockefeller University; New Jersey Institute of Technology	Darst, SA (corresponding author), Rockefeller Univ, Lab Mol Biophys, 1230 York Ave, New York, NY 10021 USA.	darst@mail.rockefeller.edu		Bick, Matthew/0000-0002-9585-859X	National Institutes of Health [GM081697]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081697] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health, grant number GM081697; http://nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; Cabart P, 2011, P NATL ACAD SCI USA, V108, P15786, DOI 10.1073/pnas.1104591108; Campbell EA, 2002, MOL CELL, V9, P527, DOI 10.1016/S1097-2765(02)00470-7; Chen HT, 2004, CELL, V119, P169, DOI 10.1016/j.cell.2004.09.028; Chen HT, 2003, MOL CELL, V12, P437, DOI 10.1016/S1097-2765(03)00306-X; Chen HT, 2007, NAT STRUCT MOL BIOL, V14, P696, DOI 10.1038/nsmb1272; CHIANG CM, 1993, PEPTIDE RES, V6, P62; Chung WH, 2003, MOL CELL, V12, P1003, DOI 10.1016/S1097-2765(03)00387-3; CONAWAY JW, 1990, SCIENCE, V248, P1550, DOI 10.1126/science.2193400; Deng WS, 2005, GENE DEV, V19, P2418, DOI 10.1101/gad.342405; Eichner J, 2010, EMBO J, V29, P706, DOI 10.1038/emboj.2009.386; Elsby LM, 2006, EMBO REP, V7, P898, DOI 10.1038/sj.embor.7400767; Faitar SL, 2001, MOL CELL BIOL, V21, P4427, DOI 10.1128/MCB.21.14.4427-4440.2001; Feklistov A, 2011, CELL, V147, P1257, DOI 10.1016/j.cell.2011.10.041; Fishburn J, 2012, MOL CELL BIOL, V32, P12, DOI 10.1128/MCB.06242-11; Freire-Picos MA, 2005, NUCLEIC ACIDS RES, V33, P5045, DOI 10.1093/nar/gki825; Ge H, 1996, METHOD ENZYMOL, V274, P57; Ghazy MA, 2004, MOL CELL BIOL, V24, P10975, DOI 10.1128/MCB.24.24.10975-10985.2004; GOODRICH JA, 1994, CELL, V77, P145, DOI 10.1016/0092-8674(94)90242-9; GRACHEV MA, 1987, EUR J BIOCHEM, V163, P113, DOI 10.1111/j.1432-1033.1987.tb10743.x; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; HOFFMANN A, 1990, NATURE, V346, P387, DOI 10.1038/346387a0; HOLSTEGE FCP, 1995, EMBO J, V14, P810, DOI 10.1002/j.1460-2075.1995.tb07059.x; Iyer L. M., 2011, J STRUCT BIOL; JOKERST RS, 1989, MOL GEN GENET, V215, P266, DOI 10.1007/BF00339727; Kornberg RD, 2007, P NATL ACAD SCI USA, V104, P12955, DOI 10.1073/pnas.0704138104; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Kulbachinskiy A, 2006, J BIOL CHEM, V281, P18273, DOI 10.1074/jbc.C600060200; Kumar KP, 1998, P NATL ACAD SCI USA, V95, P9767, DOI 10.1073/pnas.95.17.9767; Lagrange T, 1998, GENE DEV, V12, P34, DOI 10.1101/gad.12.1.34; Lane WJ, 2010, J MOL BIOL, V395, P671, DOI 10.1016/j.jmb.2009.10.062; LI Y, 1994, SCIENCE, V263, P805, DOI 10.1126/science.8303296; Liu X, 2011, CELL, V147, P1218, DOI 10.1016/j.cell.2011.11.033; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; LONETTO M, 1992, J BACTERIOL, V174, P3843, DOI 10.1128/jb.174.12.3843-3849.1992; Malik S, 1998, P NATL ACAD SCI USA, V95, P2192, DOI 10.1073/pnas.95.5.2192; MALIK S, 1993, MOL CELL BIOL, V13, P6253, DOI 10.1128/MCB.13.10.6253; Malik S, 2003, METHOD ENZYMOL, V364, P257; MCCRACKEN S, 1991, SCIENCE, V253, P900, DOI 10.1126/science.1652156; Mekler V, 2002, CELL, V108, P599, DOI 10.1016/S0092-8674(02)00667-0; Minakhin L, 2001, P NATL ACAD SCI USA, V98, P892, DOI 10.1073/pnas.98.3.892; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Murakami KS, 2003, METHOD ENZYMOL, V370, P42; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; Pal M, 2005, MOL CELL, V19, P101, DOI 10.1016/j.molcel.2005.05.024; PAN GH, 1994, J BIOL CHEM, V269, P30101; Pardee TS, 1998, J BIOL CHEM, V273, P17859, DOI 10.1074/jbc.273.28.17859; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Sainsbury S, 2013, NATURE, V493, P437, DOI 10.1038/nature11715; SCHMIDT MC, 1986, FEBS LETT, V194, P305, DOI 10.1016/0014-5793(86)80106-5; Schwartz EC, 2008, CHEM BIOL, V15, P1091, DOI 10.1016/j.chembiol.2008.09.008; SEVERINOV K, 1994, J BIOL CHEM, V269, P20826; Sikorski TW, 2009, CURR OPIN CELL BIOL, V21, P344, DOI 10.1016/j.ceb.2009.03.006; SOPTA M, 1989, NATURE, V341, P410, DOI 10.1038/341410a0; SUN ZW, 1995, P NATL ACAD SCI USA, V92, P3127, DOI 10.1073/pnas.92.8.3127; SWEETSER D, 1987, P NATL ACAD SCI USA, V84, P1192, DOI 10.1073/pnas.84.5.1192; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Thompson NE, 2009, J BIOL CHEM, V284, P24754, DOI 10.1074/jbc.M109.030486; TYREE CM, 1993, GENE DEV, V7, P1254, DOI 10.1101/gad.7.7a.1254; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Zhang GY, 1998, SCIENCE, V281, P262, DOI 10.1126/science.281.5374.262; Zhang Y, 2012, SCIENCE, V338, P1076, DOI 10.1126/science.1227786	63	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119007	10.1371/journal.pone.0119007	http://dx.doi.org/10.1371/journal.pone.0119007			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774659	gold, Green Published, Green Submitted			2022-12-27	WOS:000351183500058
J	Hohwu, L; Zhu, JL; Graversen, L; Li, J; Sorensen, TIA; Obel, C				Hohwu, Lena; Zhu, Jin Liang; Graversen, Lise; Li, Jiong; Sorensen, Thorkild I. A.; Obel, Carsten			Prenatal Parental Separation and Body Weight, Including Development of Overweight and Obesity Later in Childhood	PLOS ONE			English	Article							DIVORCE; STRESS; ASSOCIATION; ADIPOSITY; BMI	Background Early parental separation may be a stress factor causing a long-term alteration in the hypothalamic-pituitary-adrenal-axis activity possibly impacting on the susceptibility to develop overweight and obesity in offspring. We aimed to examine the body mass index (BMI) and the risk of overweight and obesity in children whose parents lived separately before the child was born. Methods A follow-up study was conducted using data from the Aarhus Birth Cohort in Denmark and included 2876 children with measurements of height and weight at 9-11-years-of-age, and self-reported information on parental cohabitation status at child birth and at 9-11-years-of-age. Quantile regression was used to estimate the difference in median BMI between children whose parents lived separately (n = 124) or together (n = 2752) before the birth. We used multiple logistic regression to calculate odds ratio (OR) for overweight and obesity, adjusted for gender, parity, breast feeding status, and maternal pre-pregnancy BMI, weight gain during pregnancy, age and educational level at child birth; with and without possible intermediate factors birth weight and maternal smoking during pregnancy. Due to a limited number of obese children, OR for obesity was adjusted for the a priori confounder maternal pre-pregnancy BMI only. Results The difference in median BMI was 0.54 kg/m(2) (95% confidence intervals (CI): 0.10; 0.98) between children whose parents lived separately before birth and children whose parents lived together. The risk of overweight and obesity was statistically significantly increased in children whose parents lived separately before the birth of the child; OR 2.29 (95% CI: 1.18; 4.45) and OR 2.81 (95% CI: 1.05; 7.51), respectively. Additional, adjustment for possible intermediate factors did not substantially change the estimates. Conclusion Parental separation before child birth was associated with higher BMI, and increased risk of overweight and obesity in 9-11-year-old children; this may suggest a fetal programming effect or unmeasured difference in psychosocial factors between separated and nonseparated parents.	[Hohwu, Lena; Zhu, Jin Liang; Graversen, Lise; Li, Jiong; Obel, Carsten] Aarhus Univ, Dept Publ Hlth, Aarhus, Denmark; [Sorensen, Thorkild I. A.] Bispebjerg & Frederiksbjerg Hosp, Inst Prevent Med, Copenhagen, Denmark; [Sorensen, Thorkild I. A.] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark	Aarhus University; Novo Nordisk Foundation; University of Copenhagen	Hohwu, L (corresponding author), Aarhus Univ, Dept Publ Hlth, Aarhus, Denmark.	lena.hohwu@ph.au.dk	li, jiong/L-6534-2014; Obel, Carsten/H-9605-2016	li, jiong/0000-0002-1716-8067; Hohwu, Lena/0000-0002-9887-7745; Obel, Carsten/0000-0001-5004-1933; li, jiong/0000-0003-1125-026X	European Research Council [ERC-StG-2010- 260242-PROGEURO]; Danish Medical Research Council [09-072986]; full PhD fellowship at Aarhus University, Denmark	European Research Council(European Research Council (ERC)European Commission); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); full PhD fellowship at Aarhus University, Denmark	This work was supported by European Research Council (ERC-StG-2010- 260242-PROGEURO to JL; the Danish Medical Research Council (project no. 09-072986). LH is supported by a full PhD fellowship at Aarhus University, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajslev TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011136; AMATO PR, 1991, PSYCHOL BULL, V110, P26, DOI 10.1037/0033-2909.110.1.26; Amato PR, 2000, J MARRIAGE FAM, V62, P1269, DOI 10.1111/j.1741-3737.2000.01269.x; Arkes J, 2012, OBESITY, V20, P1696, DOI 10.1038/oby.2012.84; Bloch M, 2007, HORM BEHAV, V51, P516, DOI 10.1016/j.yhbeh.2007.01.009; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Cole TJ, 1998, STAT MED, V17, P407, DOI 10.1002/(SICI)1097-0258(19980228)17:4&lt;407::AID-SIM742&gt;3.0.CO;2-L; Gitau R, 1998, LANCET, V352, P707, DOI 10.1016/S0140-6736(05)60824-0; Gluckman PD, 2008, INT J OBESITY, V32, pS62, DOI 10.1038/ijo.2008.240; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Gnanalingham MG, 2005, AM J PHYSIOL-REG I, V289, pR1407, DOI 10.1152/ajpregu.00375.2005; HEDEGAARD M, 1993, BMJ-BRIT MED J, V307, P234, DOI 10.1136/bmj.307.6898.234; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Howe LD, 2011, INT J PEDIATR OBES, V6, pE144, DOI 10.3109/17477166.2010.500387; Huffman FG, 2010, INT J ENV RES PUB HE, V7, P2800, DOI 10.3390/ijerph7072800; Ingstrup KG, 2012, J OBES, V2012, DOI 10.1155/2012/462845; Li JO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011896; LISSAU I, 1994, LANCET, V343, P324, DOI 10.1016/S0140-6736(94)91163-0; Mack KY, 2001, DEATH STUD, V25, P419, DOI 10.1080/074811801750257527; Mairesse J, 2007, AM J PHYSIOL-ENDOC M, V292, pE1526, DOI 10.1152/ajpendo.00574.2006; Mueller BR, 2006, PHYSIOL BEHAV, V88, P605, DOI 10.1016/j.physbeh.2006.05.019; O'Donnell KJ, 2012, PSYCHONEUROENDOCRINO, V37, P818, DOI 10.1016/j.psyneuen.2011.09.014; Paternain L, 2012, NEUROENDOCRINOLOGY, V96, P249, DOI 10.1159/000341684; Pesonen AK, 2010, PSYCHONEUROENDOCRINO, V35, P758, DOI 10.1016/j.psyneuen.2009.10.017; Reynolds RM, 2013, PSYCHONEUROENDOCRINO, V38, P1, DOI 10.1016/j.psyneuen.2012.08.012; Reynolds RM, 2010, J STEROID BIOCHEM, V122, P3, DOI 10.1016/j.jsbmb.2010.01.009; Schmeer KK, 2012, SOC SCI RES, V41, P820, DOI 10.1016/j.ssresearch.2012.01.007; Seckl JR, 2004, ANN NY ACAD SCI, V1032, P63, DOI 10.1196/annals.1314.006; SKODOL AE, 1989, AM J PSYCHIAT, V146, P61; Sun SMS, 2006, HANDBOOK OF PEDIATRIC OBESITY: ETIOLOGY, PATHOPHYSIOLOGY, AND PREVENTION, P19; Watt TT, 2013, J COMMUN HEALTH, V38, P513, DOI 10.1007/s10900-012-9641-1; Welberg LAM, 2005, J ENDOCRINOL, V186, pR7, DOI 10.1677/joe.1.06374; Welberg LAM, 2001, J NEUROENDOCRINOL, V13, P113, DOI 10.1046/j.1365-2826.2001.00601.x; Yannakoulia M, 2008, OBESITY, V16, P1382, DOI 10.1038/oby.2008.70	34	21	21	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119138	10.1371/journal.pone.0119138	http://dx.doi.org/10.1371/journal.pone.0119138			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD6EY	25775129	gold, Green Submitted, Green Published			2022-12-27	WOS:000351183500071
J	Jones-Hall, YL; Kozik, A; Nakatsu, C				Jones-Hall, Yava L.; Kozik, Ariangela; Nakatsu, Cindy			Ablation of Tumor Necrosis Factor Is Associated with Decreased Inflammation and Alterations of the Microbiota in a Mouse Model of Inflammatory Bowel Disease	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; ALPHA-DEFICIENT MICE; ULCERATIVE-COLITIS; CROHNS-DISEASE; GUT MICROBIOME; TNF-ALPHA; PATHOGENESIS; BACTERIA; GENETICS; THERAPY	Inflammatory bowel disease (IBD) is associated with prolonged, excess secretions of Tumor Necrosis Factor (TNF). Many patients with IBD have successful management of IBD symptoms by blocking TNF secretion or signaling. However, some patients are non-responsive to this therapy, eventually become refractory to therapy, or Alterations in the microbiota that are associated with the lack of TNF could be a contributing cause of this therapeutic insufficiency seen in some patients. Here we use wildtype (WT) and mice lacking Tnf (Tnf(-/-)) in an acute TNBS colitis model to investigate the role of TNF in colitis and how its presence or absence affects the colonic microbiota. As expected, Tnf(-/-) had less severe inflammation than WT mice. Microbiome analysis revealed significant Tnf dependent-differences in alpha and beta diversity. There were also notable differences in many species that were also primarily Tnf dependent. Taken together, our data indicates that TNF contributes significantly to the inflammation and microbiotal alterations in that occur in IBD.	[Jones-Hall, Yava L.; Kozik, Ariangela] Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA; [Nakatsu, Cindy] Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA; [Kozik, Ariangela] Purdue Univ, Interdisciplinary Life Sci Program PULSe, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Jones-Hall, YL (corresponding author), Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA.	yljones@purdue.edu	Kozik, Ariangela/AAV-2395-2021	Kozik, Ariangela/0000-0003-2322-4085; Jones-Hall, Yava/0000-0003-4030-9830				Abreu C, 2013, J CROHNS COLITIS, V10; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Ardizzone S, 2005, DRUGS, V65, P2253, DOI 10.2165/00003495-200565160-00002; Bel S, 2014, P NATL ACAD SCI USA, V111, P4964, DOI 10.1073/pnas.1319114111; Bien J, 2013, THER ADV GASTROENTER, V6, P53, DOI 10.1177/1756283X12454590; Blumberg RS, 2009, DIGEST DIS, V27, P455, DOI 10.1159/000235851; Bosshard PP, 2002, INT J SYST EVOL MICR, V52, P1263, DOI [10.1099/ijs.0.02056-0, 10.1099/00207713-52-4-1263]; BRAEGGER CP, 1992, LANCET, V339, P89, DOI 10.1016/0140-6736(92)90999-J; Bushman FD, 2013, ANAEROBE, V30; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Colombel JF, 2004, GASTROENTEROLOGY, V126, P19, DOI 10.1053/j.gastro.2003.10.047; Curtis JR, 2007, ARTHRITIS RHEUM-US, V56, P1125, DOI 10.1002/art.22504; Feagan B G, 2001, Can J Clin Pharmacol, V8, P188; Fries Walter, 2008, Int J Med Sci, V5, P169; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Iizuka M, 2011, WORLD J GASTROENTERO, V17, P2161, DOI 10.3748/wjg.v17.i17.2161; Jain VV, 2006, RESP MED, V100, P1291, DOI 10.1016/j.rmed.2005.09.020; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kostic AD, 2014, GASTROENTEROLOGY, V146, P1489, DOI 10.1053/j.gastro.2014.02.009; Leone V, 2013, J GASTROENTEROL, V48, P315, DOI 10.1007/s00535-013-0777-2; Li K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032118; Liu ZJ, 2009, WORLD J GASTROENTERO, V15, P5784, DOI 10.3748/wjg.15.5784; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Masuda H, 1995, J Clin Lab Immunol, V46, P111; Matsuo K, 1997, GUT, V40, P782, DOI 10.1136/gut.40.6.782; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Monteleone I, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/297645; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Naito Y, 2003, J GASTROEN HEPATOL, V18, P560, DOI 10.1046/j.1440-1746.2003.03034.x; Neurath M, 2000, Int Rev Immunol, V19, P51, DOI 10.3109/08830180009048389; Neurath MF, 2014, MUCOSAL IMMUNOL, V7, P6, DOI 10.1038/mi.2013.73; Neurath MF, 1997, EUR J IMMUNOL, V27, P1743, DOI 10.1002/eji.1830270722; Nossa CW, 2010, WORLD J GASTROENTERO, V16, P4135, DOI 10.3748/wjg.v16.i33.4135; Noti M, 2010, J EXP MED, V207, P1057, DOI 10.1084/jem.20090849; Oliva S, 2012, ALIMENT PHARM THER, V35, P327, DOI 10.1111/j.1365-2036.2011.04939.x; Papa E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039242; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Presley LL, 2010, APPL ENVIRON MICROB, V76, P936, DOI 10.1128/AEM.01561-09; Qiu W, 2011, J CLIN INVEST, V121, P1722, DOI 10.1172/JCI42917; Reimund JM, 1996, J CLIN IMMUNOL, V16, P144, DOI 10.1007/BF01540912; Rooks MG, 2014, ISME J, V8, P1403, DOI 10.1038/ismej.2014.3; Sarowska J, 2013, ADV CLIN EXP MED, V22, P759; Sartor RB, 2012, AM J GASTROENTEROL S, V1, P15, DOI DOI 10.1038/AJGSUP.2012.4; Sha SM, 2013, DIAGN MICR INFEC DIS, V75, P245, DOI 10.1016/j.diagmicrobio.2012.11.022; Shen C, 2007, INFLAMM BOWEL DIS, V13, P308, DOI 10.1002/ibd.20005; Sheng YH, 2012, J GASTROEN HEPATOL, V27, P28, DOI 10.1111/j.1440-1746.2011.06909.x; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Thukral Chandrashekhar, 2005, Curr Treat Options Gastroenterol, V8, P223, DOI 10.1007/s11938-005-0014-z; Tilg H, 2014, GUT, V63, P1513, DOI 10.1136/gutjnl-2014-306928; Tuomisto H, 2010, ECOGRAPHY, V33, P2, DOI 10.1111/j.1600-0587.2009.05880.x; Van Deventer SJH, 1997, ALIMENT PHARM THERAP, V11, P116; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Wood KL, 2003, AM J RESP CRIT CARE, V167, P1279, DOI 10.1164/rccm.200206-563OC; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Zeissig S, 2004, GUT, V53, P1295, DOI 10.1136/gut.2003.036632	65	44	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119441	10.1371/journal.pone.0119441	http://dx.doi.org/10.1371/journal.pone.0119441			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775453	Green Submitted, Green Published, gold			2022-12-27	WOS:000351183500092
J	Larson, B; Tindikahwa, A; Mwidu, G; Kibuuka, H; Magala, F				Larson, Bruce; Tindikahwa, Allan; Mwidu, George; Kibuuka, Hannah; Magala, Fred			How Much Does It Cost to Improve Access to Voluntary Medical Male Circumcision among High-Risk, Low-Income Communities in Uganda?	PLOS ONE			English	Article							IGNORE METHODOLOGICAL PROBLEMS	The Ugandan Ministry of Health has endorsed voluntary medical male circumcision as an HIV prevention strategy and has set ambitious goals (e.g., 4.2 million circumcisions by 2015). Innovative strategies to improve access for hard to reach, high risk, and poor populations are essential for reaching such goals. In 2009, the Makerere University Walter Reed Project began the first facility-based VMMC program in Uganda in a non-research setting. In addition, a mobile clinic began providing VMMC services to more remote, rural locations in 2011. The primary objective of this study was to estimate the average cost of performing VMMCs in the mobile clinic compared to those performed in health facilities (fixed sites). The difference between such costs is the cost of improving access to VMMC.	[Larson, Bruce] Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02118 USA; [Larson, Bruce] Boston Univ, Dept Int Hlth, Sch Publ Hlth, Boston, MA 02118 USA; [Tindikahwa, Allan; Mwidu, George; Kibuuka, Hannah; Magala, Fred] Makerere Univ, Walter Reed Project, Kampala 256, Uganda	Boston University; Boston University; Makerere University	Larson, B (corresponding author), Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02118 USA.	blarson@bu.edu		Larson, Bruce/0000-0002-9322-2387	Henry M. Jackson Foundation (HJF) [W81XWH-07-2-0067]	Henry M. Jackson Foundation (HJF)	Funding for BL to contribute to this study was provided by the Henry M. Jackson Foundation (HJF) Cooperative Agreement # W81XWH-07-2-0067. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auvert B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002679; Barnighausen T, 2012, P NATL ACAD SCI USA, V109, P21271, DOI 10.1073/pnas.1209017110; Booker CS, 2013, JAMA PEDIATR, V167, P198, DOI 10.1001/jamapediatrics.2013.832; Bratt JH, 2013, J ACQ IMMUN DEF SYND, V11, P11; Edgil D, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001128; Evens E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098221; Frick KD, 2009, MED CARE, V47, pS76, DOI 10.1097/MLR.0b013e31819bc064; Galukande Moses, 2012, Pan Afr Med J, V13, P88; Gray RH, 2007, AIDS, V21, P845, DOI 10.1097/QAD.0b013e3280187544; Hankins C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001127; Hay JW, 2013, JAMA PEDIATR, V167, P198, DOI 10.1001/jamapediatrics.2013.829; Kacker S, 2013, JAMA PEDIATR, V167, P199, DOI 10.1001/jamapediatrics.2013.835; Kahn JG, 2006, PLOS MED, V3, P2349, DOI 10.1371/journal.pmed.0030517; Londish GJ, 2008, INT J EPIDEMIOL, V37, P1246, DOI 10.1093/ije/dyn038; Muhamadi L, 2013, PAN AFR MED J, V15, DOI 10.11604/pamj.2013.15.117.2540; Mwidu G, 2010, RETROSPECTIVE CLINIC; Sgaier SK, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001641; Thirumurthy H, 2014, JAMA-J AM MED ASSOC, V312, P703, DOI 10.1001/jama.2014.9087; Verguet S, 2013, COST EFF RESOUR ALLO, V11, P1478; White RG, 2008, AIDS, V22, P1841, DOI 10.1097/QAD.0b013e32830e0137; Williams BG, 2006, PLOS MED, V3, P1032, DOI 10.1371/journal.pmed.0030262	21	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119484	10.1371/journal.pone.0119484	http://dx.doi.org/10.1371/journal.pone.0119484			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774677	Green Published, gold			2022-12-27	WOS:000351183500094
J	Lecroisey, C; Le Petillon, Y; Escriva, H; Lammert, E; Laudet, V				Lecroisey, Claire; Le Petillon, Yann; Escriva, Hector; Lammert, Eckhard; Laudet, Vincent			Identification, Evolution and Expression of an Insulin-Like Peptide in the Cephalochordate Branchiostoma lanceolatum	PLOS ONE			English	Article							II GENE-EXPRESSION; GROWTH-FACTOR; AMPHIOXUS; FAMILY; VERTEBRATE; INSIGHTS; GENOME; DUPLICATION; PHYLOGENY; RECEPTORS	Insulin is one of the most studied proteins since it is central to the regulation of carbohydrate and fat metabolism in vertebrates and its expression and release are disturbed in diabetes, the most frequent human metabolic disease worldwide. However, the evolution of the function of the insulin protein family is still unclear. In this study, we present a phylogenetic and developmental analysis of the Insulin Like Peptide (ILP) in the cephalochordate amphioxus. We identified an ILP in the European amphioxus Branchiostoma lanceolatum that displays structural characteristics of both vertebrate insulin and Insulin-like Growth Factors (IGFs). Our phylogenetic analysis revealed that amphioxus ILP represents the sister group of both vertebrate insulin and IGF proteins. We also characterized both temporal and spatial expression of ILP in amphioxus. We show that ilp is highly expressed in endoderm and paraxial mesoderm during development, and mainly expressed in the gut of both the developing embryo and adult. We hypothesize that ILP has critical implications in both developmental processes and metabolism and could display IGF-and insulin-like functions in amphioxus supporting the idea of a common ancestral protein.	[Lecroisey, Claire; Laudet, Vincent] Univ Lyon, CNRS, Ecole Normale Super Lyon, Mol Zool Team,Inst Genom Fonct Lyon, Lyon, France; [Le Petillon, Yann; Escriva, Hector] Observ Oceanol, BIOM, CNRS, UMR 7232, F-66650 Banyuls Sur Mer, France; [Lammert, Eckhard] Univ Dusseldorf, Inst Metab Physiol, D-40225 Dusseldorf, Germany	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Heinrich Heine University Dusseldorf	Laudet, V (corresponding author), Univ Lyon, CNRS, Ecole Normale Super Lyon, Mol Zool Team,Inst Genom Fonct Lyon, Lyon, France.	Vincent.Laudet@ens-lyon.fr	Escriva, Hector/K-8325-2013	Escriva, Hector/0000-0001-7577-5028; Laudet, Vincent/0000-0003-4022-4175	Agence Nationale de la Recherche [ANR-2010-BLAN-1234 01]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was funded by the Agence Nationale de la Recherche (http://www.agence- nationale-recherche. fr). Grant number: ANR-2010-BLAN-1234 01 (CL HE VL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Anctil M, 2009, COMP BIOCHEM PHYS D, V4, P268, DOI 10.1016/j.cbd.2009.07.001; Benitez CM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012401; Bertrand S, 2011, P NATL ACAD SCI USA, V108, P9160, DOI 10.1073/pnas.1014235108; CHAN SJ, 1990, P NATL ACAD SCI USA, V87, P9319, DOI 10.1073/pnas.87.23.9319; Chan SJ, 2000, AM ZOOL, V40, P213; Claeys I, 2002, PEPTIDES, V23, P807, DOI 10.1016/S0196-9781(01)00666-0; D'Ercole AJ, 2008, ENDOCRINOLOGY, V149, P5958, DOI 10.1210/en.2008-0920; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; DEVASKAR SU, 1993, REGUL PEPTIDES, V48, P55, DOI 10.1016/0167-0115(93)90335-6; Fuentes M, 2004, J EXP ZOOL PART B, V302B, P384, DOI 10.1002/jez.b.20025; Fuentes M, 2007, J EXP ZOOL PART B, V308B, P484, DOI 10.1002/jez.b.21179; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guo B, 2009, CELL TISSUE RES, V338, P67, DOI 10.1007/s00441-009-0824-8; Holland LZ, 2008, GENOME RES, V18, P1100, DOI 10.1101/gr.073676.107; Holland ND, 2009, ACTA ZOOL-STOCKHOLM, V90, P372, DOI 10.1111/j.1463-6395.2008.00379.x; Holland PWH, 1997, ADVANCES IN COMPARATIVE ENDOCRINOLOGY, TOMES 1 AND 2, P247; HOLLAND PWH, 1992, DEVELOPMENT, V116, P653; LEE JE, 1990, DEVELOPMENT, V110, P151; Li H, 2006, INVERTEBR BIOL, V125, P172, DOI 10.1111/j.1744-7410.2006.00050.x; Liu MY, 2011, MOL CELL ENDOCRINOL, V343, P45, DOI 10.1016/j.mce.2011.06.004; McRory JE, 1997, DNA CELL BIOL, V16, P939, DOI 10.1089/dna.1997.16.939; Murphy Coleen T, 2013, WormBook, P1, DOI 10.1895/wormbook.1.164.1; Olinski RP, 2006, MOL BIOL EVOL, V23, P10, DOI 10.1093/molbev/msj002; OLIVA AA, 1995, P NATL ACAD SCI USA, V92, P3591, DOI 10.1073/pnas.92.8.3591; Oulion S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036554; Penn O, 2010, MOL BIOL EVOL, V27, P1759, DOI 10.1093/molbev/msq066; Perillo M, 2014, GEN COMP ENDOCR, V205, P68, DOI 10.1016/j.ygcen.2014.06.014; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pieler T, 2006, BIOL CELL, V98, P79, DOI 10.1042/BC20050069; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Reinecke M, 1998, INT REV CYTOL, V183, P1, DOI 10.1016/S0074-7696(08)60142-4; REINECKE M, 1981, CELL TISSUE RES, V219, P445; Schubert M, 2008, DEV GENES EVOL, V218, P651, DOI 10.1007/s00427-008-0251-y; SMIT AB, 1988, NATURE, V331, P535, DOI 10.1038/331535a0; Theodosiou M, 2011, J EXP ZOOL PART B, V316B, P263, DOI 10.1002/jez.b.21397; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Villasenor A, 2012, SEMIN CELL DEV BIOL, V23, P685, DOI 10.1016/j.semcdb.2012.06.003; Wang S, 2003, BIOCHEMISTRY-US, V42, P9687, DOI 10.1021/bi0346289; Wang YF, 2012, FISH SHELLFISH IMMUN, V32, P1068, DOI 10.1016/j.fsi.2012.03.001; Welsch U., 1975, S ZOOLOGICAL SOC LON, V36, P17; Wilkinson TN, 2005, ANN NY ACAD SCI, V1041, P530, DOI 10.1196/annals.1282.079; Wilkinson TN, 2007, ADV EXP MED BIOL, V612, P1; Wu Q, 2006, ANNU REV ENTOMOL, V51, P1, DOI 10.1146/annurev.ento.51.110104.151011; Zhou JF, 2013, ENDOCRINOLOGY, V154, P3753, DOI 10.1210/en.2013-1201	47	19	19	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119461	10.1371/journal.pone.0119461	http://dx.doi.org/10.1371/journal.pone.0119461			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774519	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500093
J	Lindberg, AS; Oksa, J; Antti, H; Malm, C				Lindberg, Ann-Sofie; Oksa, Juha; Antti, Henrik; Malm, Christer			Multivariate Statistical Assessment of Predictors of Firefighters' Muscular and Aerobic Work Capacity	PLOS ONE			English	Article							CONTAINED BREATHING APPARATUS; PERSONAL PROTECTIVE EQUIPMENT; PHYSICAL-FITNESS; PHYSIOLOGICAL DEMANDS; FIRE-FIGHTERS; ABILITY TEST; PERFORMANCE; TASKS; RESPONSES; BALANCE	Physical capacity has previously been deemed important for firefighters physical work capacity, and aerobic fitness, muscular strength, and muscular endurance are the most frequently investigated parameters of importance. Traditionally, bivariate and multivariate linear regression statistics have been used to study relationships between physical capacities and work capacities among firefighters. An alternative way to handle datasets consisting of numerous correlated variables is to use multivariate projection analyses, such as Orthogonal Projection to Latent Structures. The first aim of the present study was to evaluate the prediction and predictive power of field and laboratory tests, respectively, on firefighters' physical work capacity on selected work tasks. Also, to study if valid predictions could be achieved without anthropometric data. The second aim was to externally validate selected models. The third aim was to validate selected models on firefighters' and on civilians'. A total of 38 (26 men and 12 women) + 90 (38 men and 52 women) subjects were included in the models and the external validation, respectively. The best prediction (R-2) and predictive power (Q(2)) of Stairs, Pulling, Demolition, Terrain, and Rescue work capacities included field tests (R-2 = 0.73 to 0.84, Q(2) = 0.68 to 0.82). The best external validation was for Stairs work capacity (R-2 = 0.80) and worst for Demolition work capacity (R-2 = 0.40). In conclusion, field and laboratory tests could equally well predict physical work capacities for fire-fighting work tasks, and models excluding anthropometric data were valid. The predictive power was satisfactory for all included work tasks except Demolition.	[Lindberg, Ann-Sofie; Malm, Christer] Umea Univ, Sports Med Unit, Umea, Sweden; [Lindberg, Ann-Sofie; Malm, Christer] Winternet, Boden, Sweden; [Oksa, Juha] Finnish Inst Occupat Hlth, Phys Work Capac Team, Oulu, Finland; [Antti, Henrik] Umea Univ, Dept Chem, Umea, Sweden	Umea University; Finnish Institute of Occupational Health; Umea University	Lindberg, AS (corresponding author), Umea Univ, Sports Med Unit, Umea, Sweden.	ann-sofie.lindberg@winter-net.se	Malm, Christer B/O-3458-2014	Malm, Christer B/0000-0002-8436-2476	Swedish Civil Contingencies Agency	Swedish Civil Contingencies Agency	Funders of the work were the Swedish Civil Contingencies Agency, https://www.msb.se/en/?ResetTargetNavigation=true. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, ARB MED KONTR ARB AR, P18; Bakri I, 2012, ERGONOMICS, V55, P782, DOI 10.1080/00140139.2012.663506; Barr D, 2010, APPL ERGON, V41, P161, DOI 10.1016/j.apergo.2009.07.001; Bergkvist M, 1992, UTVARDERING TEST BED; Brown LE, 2001, J EXERC PHYSL ONLINE, V4; DAVIS PO, 1982, MED SCI SPORT EXER, V14, P65, DOI 10.1249/00005768-198201000-00013; Deblasi F., 2003, ISOKINETIC TESTING D; Dreger RW, 2007, APPL PHYSIOL NUTR ME, V32, P454, DOI 10.1139/H07-020; Dreger RW, 2006, ERGONOMICS, V49, P911, DOI 10.1080/00140130600667451; Eriksson L., 2013, MULTI MEGAVARIATE DA; Garver JN, 2005, J STRENGTH COND RES, V19, P310; GAVHED DCE, 1989, EUR J APPL PHYSIOL O, V59, P115, DOI 10.1007/BF02396588; Gentzler M, 2010, WORK, V37, P227, DOI 10.3233/WOR-2010-1075; GLEDHILL N, 1992, CAN J SPORT SCI, V17, P207; GLEDHILL N, 1992, CAN J SPORT SCI, V17, P199; Harvey DG, 2008, EUR J APPL PHYSIOL, V103, P89, DOI 10.1007/s00421-008-0673-2; Henderson ND, 2007, PERS PSYCHOL, V60, P431, DOI 10.1111/j.1744-6570.2007.00079.x; Henderson ND, 2010, PERS PSYCHOL, V63, P999, DOI 10.1111/j.1744-6570.2010.01196.x; Hooper AJ, 2001, APPL ERGON, V32, P399, DOI 10.1016/S0003-6870(01)00007-2; Huang CJ, 2010, INT J PSYCHOPHYSIOL, V75, P312, DOI 10.1016/j.ijpsycho.2009.12.013; Kluth K, 2004, OCCUPATIONAL ERGONOM, V4, P89; Kong PW, 2012, RES Q EXERCISE SPORT, V83, P546; Koopmans L, 2011, J OCCUP ENVIRON MED, V53, P856, DOI 10.1097/JOM.0b013e318226a763; Levels K, 2014, APPL ERGON, V45, P1504, DOI 10.1016/j.apergo.2014.04.011; Lindberg AS, 2014, INT J OCCUP SAF ERGO, V20, P309, DOI 10.1080/10803548.2014.11077042; Lindberg AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091215; Lindberg AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068047; Lord C, 2012, APPL ERGON, V43, P191, DOI 10.1016/j.apergo.2011.05.003; LOUHEVAARA V, 1994, INT J IND ERGONOM, V13, P139, DOI 10.1016/0169-8141(94)90080-9; Lund A, 2013, TESTING NORMALITY LA; Lusa S, 2006, INT ARCH OCC ENV HEA, V79, P419, DOI 10.1007/s00420-005-0059-2; LUSA S, 1994, J OCCUP ENVIRON MED, V36, P70; Malm C, 2005, 2 RADD; McArdle WD., 2001, EXERCISE PHYSL ENERG; Michaelides MA, 2011, J STRENGTH COND RES, V25, P956, DOI 10.1519/JSC.0b013e3181cc23ea; Michaelides MA, 2008, RES Q EXERCISE SPORT, V79, P468, DOI 10.1080/02701367.2008.10599513; OCONNELL ER, 1986, J OCCUP ENVIRON MED, V28, P282; Oksa J, 2013, APPL PHYSIOL NUTR ME, V38, P292, DOI 10.1139/apnm-2012-0180; Perroni F, 2014, APPL ERGON, V45, P456, DOI 10.1016/j.apergo.2013.06.005; Phillips M, 2011, APPL ERGON, V42, P411, DOI 10.1016/j.apergo.2010.08.020; Phillips M, 2012, APPL ERGON, V43, P435, DOI 10.1016/j.apergo.2011.06.018; Punakallio A, 2005, SAFETY SCI, V43, P455, DOI 10.1016/j.ssci.2005.08.009; Punakallio A, 2003, AVIAT SPACE ENVIR MD, V74, P1151; Rhea MR, 2004, J STRENGTH COND RES, V18, P348; Schneiders AG, 2010, J SCI MED SPORT, V13, P196, DOI 10.1016/j.jsams.2009.05.004; Sharkey BJ., 2008, HARD WORK DEFINING P; Sheaff AK, 2010, J STRENGTH COND RES, V24, P3112, DOI 10.1519/JSC.0b013e3181f0a8d5; SJODIN B, 1981, INT J SPORTS MED, V2, P166, DOI 10.1055/s-2008-1034605; Son SY, 2014, APPL ERGON, V45, P1019, DOI 10.1016/j.apergo.2013.12.006; Sonnentag, 2002, PSYCHOL MANAGEMENT I; Sothmann MS, 2004, ERGONOMICS, V47, P864, DOI 10.1080/00140130410001670372; Sothmann MS., 1990, HUM PERFORM, V3, P217; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; ┼strand PO., 2003, TXB WORK PHYSL PHYSL; Taylor NAS, 2012, EUR J APPL PHYSIOL, V112, P2913, DOI 10.1007/s00421-011-2267-7; Tokmakidis S, 1995, COACHING SPORT SCI J, V1, P19; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; United States Department of Agriculture US Forest Service, 2002, PACK TEST WORK CAP T; von Heimburg ED, 2006, ERGONOMICS, V49, P111, DOI 10.1080/00140130500435793; Williams-Bell FM, 2009, MED SCI SPORT EXER, V41, P653, DOI 10.1249/MSS.0b013e31818ad117; Williford HN, 1999, ERGONOMICS, V42, P1179, DOI 10.1080/001401399185063; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9	62	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118945	10.1371/journal.pone.0118945	http://dx.doi.org/10.1371/journal.pone.0118945			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD6EY	25775243	gold, Green Submitted, Green Published			2022-12-27	WOS:000351183500054
J	Martin, JR; Kosem, A; van Wassenhove, V				Martin, Jean-Remy; Koesem, Anne; van Wassenhove, Virginie			Hysteresis in Audiovisual Synchrony Perception	PLOS ONE			English	Article							TEMPORAL-ORDER JUDGMENT; SIMULTANEITY; ADAPTATION; SPEECH; TIME; RECALIBRATION; INTEGRATION; ASYNCHRONY; RECOGNITION; PLASTICITY	The effect of stimulation history on the perception of a current event can yield two opposite effects, namely: adaptation or hysteresis. The perception of the current event thus goes in the opposite or in the same direction as prior stimulation, respectively. In audiovisual (AV) synchrony perception, adaptation effects have primarily been reported. Here, we tested if perceptual hysteresis could also be observed over adaptation in AV timing perception by varying different experimental conditions. Participants were asked to judge the synchrony of the last (test) stimulus of an AV sequence with either constant or gradually changing AV intervals (constant and dynamic condition, respectively). The onset timing of the test stimulus could be cued or not (prospective vs. retrospective condition, respectively). We observed hysteretic effects for AV synchrony judgments in the retrospective condition that were independent of the constant or dynamic nature of the adapted stimuli; these effects disappeared in the prospective condition. The present findings suggest that knowing when to estimate a stimulus property has a crucial impact on perceptual simultaneity judgments. Our results extend beyond AV timing perception, and have strong implications regarding the comparative study of hysteresis and adaptation phenomena.	[Martin, Jean-Remy] Univ Paris 06, IEC, Paris, France; [Martin, Jean-Remy] CNRS, EHESS, ENS, IJN, Paris, France; [Koesem, Anne; van Wassenhove, Virginie] Univ Paris 11, INSERM, U992, CEA,DSV,I2BM,Cognit Neuroimaging Unit,NeuroSpin, F Gif Yvette, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Martin, JR (corresponding author), Univ Paris 06, IEC, Paris, France.	jeanremy08@gmail.com	van Wassenhove, Virginie/F-4129-2010; Kosem, Anne/M-2344-2019	van Wassenhove, Virginie/0000-0002-2569-5502; Kosem, Anne/0000-0002-2692-9999	Marie Curie International Reintegration Grant (IRG) [249222]; European Research Council-Starting Grant (ERC-YStG) [263584]; National Funding Agency for Research Grant (ANR) [R10JCJC-1904]; doctoral school Cerveau Cognition Comportement (ED3C, Paris, France); Direction Generale de l'Armement (DGA); Commissariat a l'Energie Atomique (CEA)	Marie Curie International Reintegration Grant (IRG)(European Commission); European Research Council-Starting Grant (ERC-YStG); National Funding Agency for Research Grant (ANR)(French National Research Agency (ANR)); doctoral school Cerveau Cognition Comportement (ED3C, Paris, France); Direction Generale de l'Armement (DGA); Commissariat a l'Energie Atomique (CEA)(French Atomic Energy Commission)	This work was supported by a Marie Curie International Reintegration Grant (IRG)-249222, an European Research Council-Starting Grant (ERC-YStG)-263584 and an National Funding Agency for Research Grant (ANR)-R10JCJC-1904 to V.vW, a scholarship from the doctoral school Cerveau Cognition Comportement (ED3C, Paris, France) to J.R.M. and from the Direction Generale de l'Armement (DGA) and the Commissariat a l'Energie Atomique (CEA) to A.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstis S, 1998, TRENDS COGN SCI, V2, P111, DOI 10.1016/S1364-6613(98)01142-5; Barlow H, 1990, VISION CODING EFFICI; Buckthought A, 2008, VISION RES, V48, P819, DOI 10.1016/j.visres.2007.12.013; Cai MB, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00470; Chopin A, 2012, CURR BIOL, V22, P622, DOI 10.1016/j.cub.2012.02.021; Di Luca M, 2009, J VISION, V9, DOI 10.1167/9.12.7; Dienes Z., 2008, UNDERSTANDING PSYCHO; Dienes Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00781; Dienes Z, 2011, PERSPECT PSYCHOL SCI, V6, P274, DOI 10.1177/1745691611406920; Fechner G. T., 1860, ELEMENTE PSYCHOPHYSI; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; Fujisaki W, 2009, EXP BRAIN RES, V198, P245, DOI 10.1007/s00221-009-1870-x; Garcia-Perez MA, 2012, PSYCHON B REV, V19, P820, DOI 10.3758/s13423-012-0278-y; Gepshtein S, 2005, EXP BRAIN RES, V160, P487, DOI 10.1007/s00221-004-2038-3; Gibson JJ, 1937, PSYCHOL REV, V44, P222, DOI 10.1037/h0061358; Heron J, 2010, EUR J NEUROSCI, V31, P1755, DOI 10.1111/j.1460-9568.2010.07194.x; HIRSH I J, 1964, Annee Psychol, V64, P1; Hock HS, 2010, SEEING PERCEIVING, V23, P173, DOI 10.1163/187847510X503597; Hock HS, 2005, SPATIAL VISION, V18, P317, DOI 10.1163/1568568054089393; Hock HS, 1997, PERCEPT PSYCHOPHYS, V59, P1077, DOI 10.3758/BF03205522; Kleinschmidt A, 2002, NEURON, V34, P659, DOI 10.1016/S0896-6273(02)00694-3; Kosem A, 2014, NEUROIMAGE, V92, P274, DOI 10.1016/j.neuroimage.2014.02.010; Kosem A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040936; Kopinska A, 2004, PERCEPTION, V33, P1049, DOI 10.1068/p5169; Large ME, 2005, J NEUROPHYSIOL, V93, P3453, DOI 10.1152/jn.00934.2004; Lewald J, 2003, COGNITIVE BRAIN RES, V16, P468, DOI 10.1016/S0926-6410(03)00074-0; Love SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054798; Melloni L, 2011, J NEUROSCI, V31, P1386, DOI 10.1523/JNEUROSCI.4570-10.2011; Miyazaki M, 2006, NAT NEUROSCI, V9, P875, DOI 10.1038/nn1712; Muller T, 2014, ANN NY ACAD SCI, V1326, P60, DOI 10.1111/nyas.12545; Navarra J, 2005, COGNITIVE BRAIN RES, V25, P499, DOI 10.1016/j.cogbrainres.2005.07.009; Noppeney U, 2008, CEREB CORTEX, V18, P598, DOI 10.1093/cercor/bhm091; Prinzmetal W, 1998, J EXP PSYCHOL HUMAN, V24, P261, DOI 10.1037/0096-1523.24.1.261; Roach NW, 2011, P ROY SOC B-BIOL SCI, V278, P1314, DOI 10.1098/rspb.2010.1737; Roseboom W, 2011, PSYCHOL SCI, V22, P872, DOI 10.1177/0956797611413293; Sanchez-Garcia C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025198; Sato Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019377; Schwiedrzik CM, 2014, CEREB CORTEX, V24, P1152, DOI 10.1093/cercor/bhs396; Slutsky DA, 2001, NEUROREPORT, V12, P7, DOI 10.1097/00001756-200101220-00009; Soto-Faraco S, 2009, J EXP PSYCHOL HUMAN, V35, P580, DOI 10.1037/a0013483; Stocker AA, 2005, J VIS, V5, P928, DOI [10.1167/5.8.928, DOI 10.1167/5.8.928]; Stromeyer CF., 1978, FORM COLOR AFTEREFFE, P97; Sugita Y, 2003, NATURE, V421, P911, DOI 10.1038/421911a; Van der Burg E, 2008, J EXP PSYCHOL HUMAN, V34, P1053, DOI 10.1037/0096-1523.34.5.1053; Van der Burg E, 2013, J NEUROSCI, V33, P14633, DOI 10.1523/JNEUROSCI.1182-13.2013; van Eijk RLJ, 2008, PERCEPT PSYCHOPHYS, V70, P955, DOI 10.3758/PP.70.6.955; van Wassenhove V, 2007, NEUROPSYCHOLOGIA, V45, P598, DOI 10.1016/j.neuropsychologia.2006.01.001; van Wassenhove V, 2009, PHILOS T R SOC B, V364, P1815, DOI 10.1098/rstb.2009.0023; Vroomen J, 2004, COGNITIVE BRAIN RES, V22, P32, DOI 10.1016/j.cogbrainres.2004.07.003; Vroomen J, 2010, ATTEN PERCEPT PSYCHO, V72, P871, DOI 10.3758/APP.72.4.871; Yamamoto S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040379; Zampini M, 2005, PERCEPT PSYCHOPHYS, V67, P531, DOI 10.3758/BF03193329; Zilber N, 2014, NEUROIMAGE, V93, P32, DOI 10.1016/j.neuroimage.2014.02.017	53	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119365	10.1371/journal.pone.0119365	http://dx.doi.org/10.1371/journal.pone.0119365			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774653	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500085
J	Riphagen, IJ; Kleefstra, N; Drion, I; Alkhalaf, A; van Diepen, M; Cao, Q; Groenier, KH; Landman, GWD; Navis, G; Bilo, HJG; Bakker, SJL				Riphagen, Ineke J.; Kleefstra, Nanne; Drion, Iefke; Alkhalaf, Alaa; van Diepen, Merel; Cao, Qi; Groenier, Klaas H.; Landman, Gijs W. D.; Navis, Gerjan; Bilo, Henk J. G.; Bakker, Stephan J. L.			Comparison of Methods for Renal Risk Prediction in Patients with Type 2 Diabetes (ZODIAC-36)	PLOS ONE			English	Article							COMPETING RISKS; PROGNOSTIC MODELS; NEPHROPATHY; EQUATION	Background Patients with diabetes are at high risk of death prior to reaching end-stage renal disease, but most models predicting the risk of kidney disease do not take this competing risk into account. We aimed to compare the performance of Cox regression and competing risk models for prediction of early-and late-stage renal complications in type 2 diabetes. Methods Patients with type 2 diabetes participating in the observational ZODIAC study were included. Prediction models for (micro) albuminuria and 50% increase in serum creatinine (SCr) were developed using Cox regression and competing risk analyses. Model performance was assessed by discrimination and calibration. Results During a total follow-up period of 10 years, 183 out of 640 patients (28.6%) with normoalbuminuria developed (micro) albuminuria, and 22 patients (3.4%) died without developing (micro) albuminuria (i.e. experienced the competing event). Seventy-nine out of 1,143 patients (6.9%) reached the renal end point of 50% increase in SCr, while 219 (19.2%) died without developing the renal end point. Performance of the Cox and competing risk models predicting (micro) albuminuria was similar and differences in predicted risks were small. However, the Cox model increasingly overestimated the risk of increase in SCr in presence of a substantial number of competing events, while the performance of the competing risk model was quite good. Conclusions In this study, we demonstrated that, in case of substantial numbers of competing events, it is important to account for the competing risk of death in renal risk prediction in patients with type 2 diabetes.	[Riphagen, Ineke J.; Navis, Gerjan; Bakker, Stephan J. L.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, Groningen, Netherlands; [Kleefstra, Nanne; Drion, Iefke; Alkhalaf, Alaa; Groenier, Klaas H.; Landman, Gijs W. D.; Bilo, Henk J. G.] Isala Clin, Ctr Diabet, Zwolle, Netherlands; [Kleefstra, Nanne] Langerhans Med Res Grp, Zwolle, Netherlands; [Kleefstra, Nanne; Bilo, Henk J. G.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands; [van Diepen, Merel] Leiden Univ, Dept Clin Epidemiol, Med Ctr, Leiden, Netherlands; [Cao, Qi] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Groenier, Klaas H.] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, Groningen, Netherlands	University of Groningen; Isala Clinics; Langerhans Medical Research Group; University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen; University of Groningen	Riphagen, IJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, Groningen, Netherlands.	i.j.riphagen@umcg.nl	Bakker, Stephan J. L./J-4023-2015; Landman, Gijs/AAJ-5540-2021	Bakker, Stephan J. L./0000-0003-3356-6791; Landman, Gijs/0000-0002-6852-6450; Kleefstra, Nanne/0000-0003-1473-8519	Netherlands Heart Foundation; Dutch Diabetes Research Foundation; Dutch Kidney Foundation; Center for Translational Molecular Medicine, project PREDICCt [01C-104]	Netherlands Heart Foundation(Netherlands Heart Foundation); Dutch Diabetes Research Foundation; Dutch Kidney Foundation; Center for Translational Molecular Medicine, project PREDICCt	IJR, MvD, and SJLB received support from the Netherlands Heart Foundation, Dutch Diabetes Research Foundation, and Dutch Kidney Foundation, together participating in the framework of the Center for Translational Molecular Medicine (www.ctmm.nl), project PREDICCt (grant 01C-104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AI, 2003, KIDNEY INT, V63, P225, DOI 10.1046/j.1523-1755.2003.00712.x; Afghahi H, 2011, NEPHROL DIAL TRANSPL, V26, P1236, DOI 10.1093/ndt/gfq535; Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI 10.2337/dc11-S011; Andersen PK, 2012, INT J EPIDEMIOL, V41, P861, DOI 10.1093/ije/dyr213; [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc12-s004, 10.2337/dc35-S011]; de Goeij MC, 2013, NEPHROL DIAL TRANSPL; Ejerblad E, 2006, J AM SOC NEPHROL, V17, P1695, DOI 10.1681/ASN.2005060638; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Grams ME, 2013, NAT REV NEPHROL, V9, P18, DOI 10.1038/nrneph.2012.248; Gross JL, 2005, DIABETES CARE, V28, P164, DOI 10.2337/diacare.28.1.164; Halbesma N, 2011, CLIN J AM SOC NEPHRO, V6, P1731, DOI 10.2215/CJN.08590910; Harel O, 2007, STAT MED, V26, P3057, DOI 10.1002/sim.2787; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Haynes R, 2014, AM J KIDNEY DIS; Hippisley-Cox J, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-49; Jardine MJ, 2012, AM J KIDNEY DIS; Keane WF, 2006, CLIN J AM SOC NEPHRO, V1, P761, DOI 10.2215/CJN.01381005; Kshirsagar AV, 2008, ARCH INTERN MED, V168, P2466, DOI 10.1001/archinte.168.22.2466; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Noordzij M, 2013, NEPHROL DIAL TRANSPL, V28, P2670, DOI 10.1093/ndt/gft355; Royston P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b604; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Sun GW, 1996, J CLIN EPIDEMIOL, V49, P907, DOI 10.1016/0895-4356(96)00025-X; Ubink-Vetmaat LJ, 2005, NETH J MED, V63, P103; van Hateren KJJ, 2013, DIABETES CARE, V36, P1347, DOI 10.2337/dc12-0428; Wolbers M, 2009, EPIDEMIOLOGY, V20, P555, DOI 10.1097/EDE.0b013e3181a39056; Wood AM, 2008, STAT MED, V27, P3227, DOI 10.1002/sim.3177	29	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120477	10.1371/journal.pone.0120477	http://dx.doi.org/10.1371/journal.pone.0120477			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775414	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500181
J	Kim, JH; Shim, SR; Doo, SW; Yang, WJ; Yoo, BW; Kim, JM; Ko, YM; Song, ES; Lim, IS; Lee, HJ; Song, YS				Kim, Jae Heon; Shim, Sung Ryul; Doo, Seung Whan; Yang, Won Jae; Yoo, Byung Wook; Kim, Joyce Mary; Ko, Young Myoung; Song, Eun Seop; Lim, Ik Sung; Lee, Hong Jun; Song, Yun Seob			Bladder Recovery by Stem Cell Based Cell Therapy in the Bladder Dysfunction Induced by Spinal Cord Injury: Systematic Review and Meta-Analysis	PLOS ONE			English	Article							MARROW STROMAL CELLS; EXTERNAL URETHRAL SPHINCTER; NEURAL PRECURSOR CELLS; URINARY-TRACT FUNCTION; CENTRAL-NERVOUS-SYSTEM; PROMOTE RECOVERY; DELAYED TRANSPLANTATION; PSEUDORABIES VIRUS; RAT; INJECTION	Background Bladder dysfunction induced by spinal cord injury (SCI) can become problematic and severely impair the quality of life. Preclinical studies of spinal cord injury have largely focused on the recovery of limb function while neglecting to investigate bladder recovery. Objective The present study was performed to investigate and review the effect of stem cell-based cell therapy on bladder recovery in SCI. Methods We conducted a meta-analysis of urodynamic findings of experimental trials that included studies of stem cell-based cell therapy in SCI. Relevant studies were searched using MEDLINE, EMBASE and Cochrane Library (January 1990 -December 2012). Final inclusion was determined by a urodynamic study involving detailed numerical values. Urodynamic parameters for analysis included voiding pressure, residual urine, bladder capacity and non-voiding contraction (NVC). Meta-analysis of the data, including findings from urodynamic studies, was performed using the Mantel-Haenszel method. Results A total of eight studies were included with a sample size of 224 subjects. The studies were divided into different subgroups by different models of SCI. After a stem cell-based cell therapy, voiding pressure (-6.35, p < 0.00001, I-2 = 77%), NVC (-3.58, p < 0.00001, I-2 = 82%), residual urine (-024, p = 0.004, I-2 = 95%) showed overall significant improvement. Bladder capacity showed improvement after treatment only in the transection type (-0.23, p = 0.0002, I-2 = 0%). Conclusion After stem cell-based cell therapy in SCI, partial bladder recovery including improvement of voiding pressure, NVC, and residual urine was demonstrated. Additional studies are needed to confirm the detailed mechanism and to obtain an ideal treatment strategy for bladder recovery.	[Kim, Jae Heon; Doo, Seung Whan; Yang, Won Jae; Song, Yun Seob] Soonchunhyang Univ, Sch Med, Soonchunyang Univ Hosp, Dept Urol, Seoul, South Korea; [Shim, Sung Ryul] Soonchunhyang Univ, Sch Med, Soonchunyang Univ Hosp, Inst Clin Mol Biol Res, Seoul, South Korea; [Yoo, Byung Wook] Soonchunhyang Univ, Sch Med, Dept Family Med, Seoul, South Korea; [Kim, Joyce Mary] Soonchunhyang Univ Hosp, Int Clin Ctr, Seoul, South Korea; [Ko, Young Myoung] Pohang Univ Sci & Technol, Dept Ind & Management Engn, Pohang, South Korea; [Song, Eun Seop] Inha Univ, Sch Med, Dept Obstet & Gynecol, Inchon, South Korea; [Lim, Ik Sung] Namseoul Univ, Coll Engn, Dept Ind Management & Engn, Cheonan, South Korea; [Lee, Hong Jun] Chung Ang Univ, Coll Med, Med Res Inst, Seoul 156756, South Korea	Soonchunhyang University; Soonchunhyang University; Soonchunhyang University; Soonchunhyang University; Soonchunhyang University Hospital; Pohang University of Science & Technology (POSTECH); Inha University; Namseoul University; Chung Ang University; Chung Ang University Hospital	Lee, HJ (corresponding author), Chung Ang Univ, Coll Med, Med Res Inst, Seoul 156756, South Korea.	leehj71@gmail.com; yssong@schmc.ac.kr	shim, sungryul/D-3792-2016	shim, sungryul/0000-0003-4143-7383	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012-R1A1A2039317]; Soonchunhyang University Research Fund [20130616]	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); Soonchunhyang University Research Fund	This research was supported by Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012-R1A1A2039317) and Soonchunhyang University Research Fund (20130616).	Adams M, 2004, SPINAL CORD, V42, P273, DOI 10.1038/sj.sc.3101597; Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; Athwal BS, 2001, BRAIN, V124, P369, DOI 10.1093/brain/124.2.369; Barber MD, 2009, OBSTET GYNECOL, V114, P600, DOI 10.1097/AOG.0b013e3181b2b1ae; de Groat WC, 1997, UROLOGY, V50, P36, DOI 10.1016/S0090-4295(97)00587-6; Erdogan B, 2013, NEUROL NEUROCHIR POL, V47, P138, DOI 10.5114/ninp.2013.33824; Fawcett JW, 2007, SPINAL CORD, V45, P190, DOI 10.1038/sj.sc.3102007; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Geffner LF, 2008, CELL TRANSPLANT, V17, P1277, DOI 10.3727/096368908787648074; Hernandez J, 2011, CURR STEM CELL RES T, V6, P273, DOI 10.2174/157488811796575323; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Hu Y, 2012, SPINAL CORD, V50, P202, DOI 10.1038/sc.2011.128; Jin Y, 2011, J NEUROTRAUM, V28, P579, DOI 10.1089/neu.2010.1626; Karimi-Abdolrezaee S, 2006, J NEUROSCI, V26, P3377, DOI 10.1523/JNEUROSCI.4184-05.2006; KRUSE MN, 1993, AM J PHYSIOL, V264, pR1157, DOI 10.1152/ajpregu.1993.264.6.R1157; Lee JW, 2000, J COMP NEUROL, V418, P484; Lepore AC, 2005, BRAIN RES, V1045, P206, DOI 10.1016/j.brainres.2005.03.050; MARSON L, 1995, NEUROSCI LETT, V190, P41, DOI 10.1016/0304-3940(95)11495-I; Mitsui T, 2005, J NEUROSCI, V25, P9624, DOI 10.1523/JNEUROSCI.2175-05.2005; Mitsui T, 2005, EXP NEUROL, V194, P410, DOI 10.1016/j.expneurol.2005.02.022; Mitsui T, 2003, J UROLOGY, V170, P1421, DOI 10.1097/01.ju.0000075501.05758.33; Mitsui T, 2011, BRAIN RES, V1418, P23, DOI 10.1016/j.brainres.2011.08.023; Nagatomi J, 2004, ANN BIOMED ENG, V32, P1409, DOI 10.1114/B:ABME.0000042228.89106.48; Neuhuber B, 2008, J NEUROSURG-SPINE, V9, P390, DOI 10.3171/SPI.2008.9.10.390; NOTO H, 1991, BRAIN RES, V549, P95, DOI 10.1016/0006-8993(91)90604-T; Park WB, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-119; Pikov V, 2001, J NEUROSCI, V21, P559, DOI 10.1523/JNEUROSCI.21-02-00559.2001; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Ronaghi M, 2010, STEM CELLS, V28, P93, DOI 10.1002/stem.253; Seki S, 2002, J UROLOGY, V168, P2269, DOI 10.1016/S0022-5347(05)64369-8; Suzuki R, 2002, NAT NEUROSCI, V5, P1319, DOI 10.1038/nn966; Temeltas G, 2009, J UROLOGY, V181, P2774, DOI 10.1016/j.juro.2009.01.093; THOMAS DG, 1979, PRACTITIONER, V223, P339; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Tsuruoka M, 2004, NEUROSCI LETT, V362, P236, DOI 10.1016/j.neulet.2004.03.026; UEYAMA T, 1987, ANAT EMBRYOL, V177, P37, DOI 10.1007/BF00325288; UVELIUS B, 1984, J UROLOGY, V132, P587, DOI 10.1016/S0022-5347(17)49753-9; Vaquero J, 2009, HISTOL HISTOPATHOL, V24, P107, DOI 10.14670/HH-24.107; Weld KJ, 2000, J UROLOGY, V163, P1228, DOI 10.1016/S0022-5347(05)67730-0; Yezierski RP, 2005, NEUROSIGNALS, V14, P182, DOI 10.1159/000087657; Yoshiyama M, 1999, UROLOGY, V54, P929, DOI 10.1016/S0090-4295(99)00234-4	42	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0113491	10.1371/journal.pone.0113491	http://dx.doi.org/10.1371/journal.pone.0113491			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781610	Green Submitted, gold, Green Published			2022-12-27	WOS:000351284600001
J	Tokuda, S; Furuse, M				Tokuda, Shinsaku; Furuse, Mikio			Claudin-2 Knockout by TALEN-Mediated Gene Targeting in MDCK Cells: Claudin-2 Independently Determines the Leaky Property of Tight Junctions in MDCK Cells	PLOS ONE			English	Article							SUBCELLULAR-LOCALIZATION; ZONULAE-OCCLUDENTES; EPITHELIAL-CELLS; EXPRESSION; STRANDS; CATION; DNA; IDENTIFICATION; PERMEABILITY; SELECTIVITY	Tight junctions (TJs) regulate the movements of substances through the paracellular pathway, and claudins are major determinants of TJ permeability. Claudin-2 forms high conductive cation pores in TJs. The suppression of claudin-2 expression by RNA interference in Madin-Darby canine kidney (MDCK) II cells (a low-resistance strain of MDCK cells) was shown to induce a three-fold increase in transepithelial electrical resistance (TER), which, however, was still lower than in high-resistance strains of MDCK cells. Because RNA interference-mediated knockdown is not complete and only reduces gene function, we considered the possibility that the remaining claudin-2 expression in the knockdown study caused the lower TER in claudin-2 knockdown cells. Therefore, we investigated the effects of claudin-2 knockout in MDCK II cells by establishing claudin-2 knockout clones using transcription activator-like effector nucleases (TALENs), a recently developed genome editing method for gene knockout. Surprisingly, claudin-2 knockout increased TER by more than 50-fold in MDCK II cells, and TER values in these cells (3000-4000 Omega.cm(2)) were comparable to those in the high-resistance strains of MDCK cells. Claudin-2 re-expression restored the TER of claudin-2 knockout cells dependent upon claudin-2 protein levels. In addition, we investigated the localization of claudin-1, -2, -3, -4, and -7 at TJs between control MDCK cells and their respective knockout cells using their TALENs. Claudin-2 and -7 were less efficiently localized at TJs between control and their knockout cells. Our results indicate that claudin-2 independently determines the 'leaky' property of TJs in MDCK II cells and suggest the importance of knockout analysis in cultured cells.	[Tokuda, Shinsaku; Furuse, Mikio] Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Div Cell Biol, Kobe, Hyogo 6500017, Japan; [Furuse, Mikio] Natl Inst Physiol Sci, Div Cerebral Struct, Okazaki, Aichi 4448787, Japan; [Furuse, Mikio] Grad Univ Adv Studies SOKENDAI, Dept Physiol Sci, Okazaki, Aichi 4448585, Japan	Kobe University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan	Tokuda, S (corresponding author), Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Div Cell Biol, Kobe, Hyogo 6500017, Japan.	furuse@nips.ac.jp		Furuse, Mikio/0000-0003-2847-8156	Japan Society for the Promotion of Science (JSPS) [LS084]; JSPS [26291043]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The Funding Program for Next Generation World Leading Researchers (NEXT Program) from the Japan Society for the Promotion of Science (JSPS) [LS084 to M.F.];the Grant-in-Aid for Scientific Research (B) from JSPS [26291043 to M.F.] URL: http://www.jsps.go.jp/.	Amasheh S, 2002, J CELL SCI, V115, P4969, DOI 10.1242/jcs.00165; Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; CEREIJIDO M, 1983, J EXP BIOL, V106, P205; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; CLAUDE P, 1973, J CELL BIOL, V58, P390, DOI 10.1083/jcb.58.2.390; Coyne CB, 2003, AM J PHYSIOL-LUNG C, V285, pL1166, DOI 10.1152/ajplung.00182.2003; Daugherty BL, 2007, J BIOL CHEM, V282, P30005, DOI 10.1074/jbc.M703547200; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; Fujita H, 2006, J HISTOCHEM CYTOCHEM, V54, P933, DOI 10.1369/jhc.6A6944.2006; Furuse M, 1998, J CELL BIOL, V143, P391, DOI 10.1083/jcb.143.2.391; Furuse M, 1999, J CELL BIOL, V147, P891, DOI 10.1083/jcb.147.4.891; Furuse M, 2001, J CELL BIOL, V153, P263, DOI 10.1083/jcb.153.2.263; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Grau J, 2013, BIOINFORMATICS, V29, P2931, DOI 10.1093/bioinformatics/btt501; Gunzel D, 2013, PHYSIOL REV, V93, P525, DOI 10.1152/physrev.00019.2012; Hou JH, 2006, J BIOL CHEM, V281, P36117, DOI 10.1074/jbc.M608853200; ITOH M, 1991, J CELL BIOL, V115, P1449, DOI 10.1083/jcb.115.5.1449; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; KIMIZUKA H, 1964, J THEOR BIOL, V6, P290, DOI 10.1016/0022-5193(64)90035-9; Larre I, 2010, P NATL ACAD SCI USA, V107, P11387, DOI 10.1073/pnas.1000500107; Li WY, 2004, AM J PHYSIOL-RENAL, V286, pF1063, DOI 10.1152/ajprenal.00384.2003; Lim TS, 2008, J MOL BIOL, V381, P681, DOI 10.1016/j.jmb.2008.06.009; Mineta K, 2011, FEBS LETT, V585, P606, DOI 10.1016/j.febslet.2011.01.028; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Piontek J, 2008, FASEB J, V22, P146, DOI 10.1096/fj.07-8319com; Piontek J, 2011, CELL MOL LIFE SCI, V68, P3903, DOI 10.1007/s00018-011-0680-z; POWELL DW, 1981, AM J PHYSIOL, V241, pG275, DOI 10.1152/ajpgi.1981.241.4.G275; Rahner C, 2001, GASTROENTEROLOGY, V120, P411, DOI 10.1053/gast.2001.21736; Reuss L., 2001, TIGHT JUNCTIONS, V2, P61; RICHARDSON JCW, 1981, BIOCHIM BIOPHYS ACTA, V673, P26, DOI 10.1016/0304-4165(81)90307-X; Rosenthal R, 2010, J CELL SCI, V123, P1913, DOI 10.1242/jcs.060665; Saitou M, 1997, EUR J CELL BIOL, V73, P222; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Tokuda S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104994; Tokuda S, 2010, BIOCHEM BIOPH RES CO, V393, P390, DOI 10.1016/j.bbrc.2010.02.002; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Van Itallie CM, 2008, J CELL SCI, V121, P298, DOI 10.1242/jcs.021485; Van Itallie CM, 2003, AM J PHYSIOL-RENAL, V285, pF1078, DOI 10.1152/ajprenal.00116.2003; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Wu CJ, 2013, J BIOL CHEM, V288, P12253, DOI 10.1074/jbc.M113.457499; Yamazaki Y, 2011, MOL BIOL CELL, V22, P1495, DOI 10.1091/mbc.E10-12-1003; Yu ASL, 2010, J BIOL CHEM, V285, P37060, DOI 10.1074/jbc.M110.146621; Yu ASL, 2009, J GEN PHYSIOL, V133, P111, DOI 10.1085/jgp.200810154	46	24	25	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119869	10.1371/journal.pone.0119869	http://dx.doi.org/10.1371/journal.pone.0119869			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781928	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600103
J	Wang, F; Wang, XJ; Yu, XL; Fu, L; Liu, YY; Ma, LX; Zhai, C				Wang, Fei; Wang, Xiaojuan; Yu, Xiaolan; Fu, Lin; Liu, Yunyun; Ma, Lixin; Zhai, Chao			High-Level Expression of Endo-beta-N-Acetylglucosaminidase H from Streptomyces plicatus in Pichia pastoris and Its Application for the Deglycosylation of Glycoproteins	PLOS ONE			English	Article							BACTERIAL PNGASE F; HUMAN ERYTHROPOIETIN; RECOMBINANT PROTEINS; ENDOGLYCOSIDASE-H; ESCHERICHIA-COLI; YEAST; GLYCOSYLATION; CLONING; GENE; PURIFICATION	Endo-beta-N-acetylglucosaminidase H (Endo H, EC3.2.1.96) is a glycohydrolase that is widely used in the study of glycoproteins. The present study aimed to assess the effect of high-level endo-beta-N-acetylglucosaminidase H expression in Pichia pastoris. The DNA coding sequence of this enzyme was optimized based on the codon usage bias of Pichia pastoris and synthesized through overlapping PCR. This novel gene was cloned into a pHBM905A vector and introduced into Pichia pastoris GS115 for secretary expression. The yield of the target protein reached approximately 397 mg/l after a 6-d induction with 1% (v/v) methanol in shake flasks, which is much higher than that observed upon heterologous expression in Escherichia coli and silkworm. This recombinant enzyme was purified and its enzymatic features were studied. Its specific activity was 461573 U/mg. Its optimum pH and temperature were pH 5.5 and 37 degrees C, respectively. Moreover, our study showed that the N-linked glycan side-chains of several recombinant proteins expressed in Pichia pastoris can be efficiently removed through either the co-fermentation of this recombinant strain with strains expressing substrates or by mixing the cell culture supernatants of the endo-beta-N-acetylglucosaminidase H expressing strain with strains expressing substrates after fermentation. This is the first report of high-level endo-beta-N-acetylglucosaminidase H expression in Pichia pastoris and the application of this enzyme in the deglycosylation of raw glycoproteins heterologously expressed in Pichia pastoris using simplified methods.	[Wang, Fei; Wang, Xiaojuan; Yu, Xiaolan; Fu, Lin; Liu, Yunyun; Ma, Lixin; Zhai, Chao] Hubei Univ, Hubei Key Lab Ind Biotechnol, Hubei Collaborat Innovat Ctr Green Transformat Bi, Coll Life Sci, Wuhan, Peoples R China	Hubei University	Ma, LX (corresponding author), Hubei Univ, Hubei Key Lab Ind Biotechnol, Hubei Collaborat Innovat Ctr Green Transformat Bi, Coll Life Sci, Wuhan, Peoples R China.	malixing@hubu.edu.cn; chaozhai@hotmail.com			National Natural Science Foundation of China [31100057, 31172320, 31340036]; National 973 Program of China [2013CB910801]; Nature Science Fund for Creative Research Groups of Hubei Province of China [2012FFA034]; Foundation for High and New Technology Industrial Innovative Research Groups of the Wuhan Science and technology Bureau's department [2014070504020239]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Program of China(National Basic Research Program of China); Nature Science Fund for Creative Research Groups of Hubei Province of China; Foundation for High and New Technology Industrial Innovative Research Groups of the Wuhan Science and technology Bureau's department	Funding provided by National Natural Science Foundation of China (http://www.nsfc.gov.cn/), Chao Zhai received the funding: No31100057; Xiaolan yu received the funding: No. 31172320 and 31340036; National 973 Program of China (http://www.973.gov.cn/AreaAppl.aspx), Lixin Ma received the funding: No. 2013CB910801; Nature Science Fund for Creative Research Groups of Hubei Province of China (http://www.hbstd.gov.cn/), Lixin Ma received the funding: No. 2012FFA034; Foundation for High and New Technology Industrial Innovative Research Groups of the Wuhan Science and technology Bureau's department (http://www.whst.gov.cn/), Lixin Ma received the funding: No. 2014070504020239. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bretthauer RK, 1999, BIOTECHNOL APPL BIOC, V30, P193; BUCKHOLZ RG, 1991, BIO-TECHNOL, V9, P1067, DOI 10.1038/nbt1191-1067; Carr PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh160; Celik E, 2012, BIOTECHNOL ADV, V30, P1108, DOI 10.1016/j.biotechadv.2011.09.011; Cereghino JL, 2000, FEMS MICROBIOL REV, V24, P45, DOI 10.1111/j.1574-6976.2000.tb00532.x; CHEN GQ, 1994, J AM CHEM SOC, V116, P8799, DOI 10.1021/ja00098a045; Choi BK, 2003, P NATL ACAD SCI USA, V100, P5022, DOI 10.1073/pnas.0931263100; De Pourcq K, 2010, APPL MICROBIOL BIOT, V87, P1617, DOI 10.1007/s00253-010-2721-1; ELLIOTT S, 1989, GENE, V79, P167, DOI 10.1016/0378-1119(89)90102-9; Frisch E, 2013, ANAL BIOCHEM, V433, P65, DOI 10.1016/j.ab.2012.10.015; Frisch E, 2011, ELECTROPHORESIS, V32, P3510, DOI 10.1002/elps.201100250; Geisse S, 1996, PROTEIN EXPRES PURIF, V8, P271, DOI 10.1006/prep.1996.0101; Guo HB, 2002, CANCER RES, V62, P6837; Kim YK, 2005, BIOTECHNOL BIOENG, V92, P452, DOI 10.1002/bit.20605; LIN FK, 1985, P NATL ACAD SCI USA, V82, P7580, DOI 10.1073/pnas.82.22.7580; Lisowska E, 2012, ELS; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Mamedov T, 2013, BIOENGINEERED, V4, P338, DOI 10.4161/bioe.23449; Mamedov T, 2012, PLANT BIOTECHNOL J, V10, P773, DOI 10.1111/j.1467-7652.2012.00694.x; Milek RLB, 2000, VACCINE, V18, P1402, DOI 10.1016/S0264-410X(99)00392-8; Mitsudome T, 2014, APPL BIOCHEM BIOTECH, V172, P3978, DOI 10.1007/s12010-014-0814-5; MIYAZONO K, 1992, J BIOL CHEM, V267, P5668; Mowla SJ, 2001, J BIOL CHEM, V276, P12660, DOI 10.1074/jbc.M008104200; MURAMATS.T, 1971, J BIOL CHEM, V246, P5534; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Rao B, 2010, YEAST, V27, P285, DOI 10.1002/yea.1753; ROBBINS PW, 1981, J BIOL CHEM, V256, P640; Sambrook J., 2001, MOL CLONING LAB MANU; Shental-Bechor D, 2009, CURR OPIN STRUC BIOL, V19, P524, DOI 10.1016/j.sbi.2009.07.002; TARENTINO AL, 1976, J BIOL CHEM, V251, P6537; TRIMBLE RB, 1978, J BIOL CHEM, V253, P4508; TRUMBLY RJ, 1985, J BIOL CHEM, V260, P5683; Zhang GM, 2006, BIOCATAL BIOTRANSFOR, V24, P371, DOI 10.1080/10242420600768771	33	17	25	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120458	10.1371/journal.pone.0120458	http://dx.doi.org/10.1371/journal.pone.0120458			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781897	Green Published, gold, Green Submitted			2022-12-27	WOS:000351284600162
J	David-Barrett, T; Rotkirch, A; Carney, J; Izquierdo, IB; Krems, JA; Townley, D; McDaniell, E; Byrne-Smith, A; Dunbar, RIM				David-Barrett, Tamas; Rotkirch, Anna; Carney, James; Izquierdo, Isabel Behncke; Krems, Jaimie A.; Townley, Dylan; McDaniell, Elinor; Byrne-Smith, Anna; Dunbar, Robin I. M.			Women Favour Dyadic Relationships, but Men Prefer Clubs: Cross-Cultural Evidence from Social Networking	PLOS ONE			English	Article							SEX-DIFFERENCES; FRIENDSHIP; FACEBOOK; GIRLS; SIZE; EXPECTATIONS; COOPERATION; EVOLUTION; FEMALES; FEATHER	The ability to create lasting, trust-based friendships makes it possible for humans to form large and coherent groups. The recent literature on the evolution of sociality and on the network dynamics of human societies suggests that large human groups have a layered structure generated by emotionally supported social relationships. There are also gender differences in adult social style which may involve different trade-offs between the quantity and quality of friendships. Although many have suggested that females tend to focus on intimate relations with a few other females, while males build larger, more hierarchical coalitions, the existence of such gender differences is disputed and data from adults is scarce. Here, we present cross-cultural evidence for gender differences in the preference for close friendships. We use a sample of similar to 112,000 profile pictures from nine world regions posted on a popular social networking site to show that, in self-selected displays of social relationships, women favour dyadic relations, whereas men favour larger, all-male cliques. These apparently different solutions to quality-quantity trade-offs suggest a universal and fundamental difference in the function of close friendships for the two sexes.	[David-Barrett, Tamas; Carney, James; Izquierdo, Isabel Behncke; Townley, Dylan; McDaniell, Elinor; Byrne-Smith, Anna; Dunbar, Robin I. M.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Rotkirch, Anna] Populat Res Inst, Helsinki 00101, Finland; [Krems, Jaimie A.] Arizona State Univ, Dept Social Psychol, Tempe, AZ 85287 USA	University of Oxford; Arizona State University; Arizona State University-Tempe	David-Barrett, T (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	tamas.david-barrett@psy.ox.ac.uk		Krems, Jaimie Arona/0000-0002-2590-2241; Carney, James/0000-0001-6064-7867; David-Barrett, Tamas/0000-0002-8979-3136	EU FP7 EINS grant [288021]; European Research Council Advanced grant; EU Marie Curie Fellowship [297854]	EU FP7 EINS grant; European Research Council Advanced grant(European Research Council (ERC)); EU Marie Curie Fellowship(European Commission)	This study was supported by EU FP7 EINS grant agreement No 288021 to TDB, European Research Council Advanced grant to RD, EU Marie Curie Fellowship, grant agreement No 297854 to JC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiseshan A, 2011, AM J PRIMATOL, V73, P1107, DOI 10.1002/ajp.20987; Apicella CL, 2012, NATURE, V481, P497, DOI 10.1038/nature10736; Back MD, 2010, PSYCHOL SCI, V21, P372, DOI 10.1177/0956797609360756; Baron-Cohen S, 2003, J AUTISM DEV DISORD, V33, P509, DOI 10.1023/A:1025879411971; Belle D., 1989, CHILDRENS SOCIAL NET; Benenson JF, 2006, DEV PSYCHOL, V42, P272, DOI 10.1037/0012-1649.42.2.272; Benenson JF, 2004, EVOL HUM BEHAV, V25, P258, DOI 10.1016/j.evolhumbehav.2004.05.002; Benenson JF, 2012, J EXP CHILD PSYCHOL, V113, P587, DOI 10.1016/j.jecp.2012.08.003; Benenson JF, 2011, PSYCHOL SCI, V22, P538, DOI 10.1177/0956797611402511; BRUCKNER E, 1993, EUR SOCIOL REV, V9, P249, DOI 10.1093/oxfordjournals.esr.a036680; Burleson BR, 1997, PERS RELATIONSHIP, V4, P229, DOI 10.1111/j.1475-6811.1997.tb00142.x; CALDWELL MA, 1982, SEX ROLES, V8, P721; Campbell A, 2002, MIND HER OWN EVOLUTI; Chapais Bernard, 2008, PRIMEVAL KINSHIP PAI, DOI DOI 10.1111/btp.12564; David-Barrett T, 2013, P ROYAL SOC B, V280; David-Barrett T, 2014, BEHAV ECOL, V25, P58, DOI 10.1093/beheco/art085; David-Barrett T, 2012, J THEOR BIOL, V308, P88, DOI 10.1016/j.jtbi.2012.05.007; DEWAAL FBM, 1984, ETHOL SOCIOBIOL, V5, P239, DOI 10.1016/0162-3095(84)90004-9; DUCK S, 1993, SEX ROLES, V28, P709, DOI 10.1007/BF00289989; Dunbar RIM, 2012, PHILOS T ROYAL SOC B; Durant KT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049169; Essock-Vitale SM, 1985, ETHOLOGY AND SOCIOBI, V6; Fabes RA, 2003, CHILD DEV, V74, P1039, DOI 10.1111/1467-8624.00586; Fehr B, 2004, J PERS SOC PSYCHOL, V86, P265, DOI 10.1037/0022-3514.86.2.265; Fehr BA., 1996, FRIENDSHIP PROCESSES, DOI DOI 10.4135/9781483327440; FOLEY RA, 1989, SCIENCE, V243, P901, DOI 10.1126/science.2493158; Fortunato L, 2011, HUM BIOL, V83, P107, DOI 10.3378/027.083.0107; Furuichi T, 2011, EVOL ANTHROPOL, V20, P131, DOI 10.1002/evan.20308; Geary DC, 2003, DEV REV, V23, P444, DOI 10.1016/j.dr.2003.08.001; Guyer AE, 2009, CHILD DEV, V80, P1000, DOI 10.1111/j.1467-8624.2009.01313.x; Hall JA, 2011, J SOC PERS RELAT, V28, P723, DOI 10.1177/0265407510386192; Hamilton MJ, 2007, P ROY SOC B-BIOL SCI, V274, P2195, DOI 10.1098/rspb.2007.0564; Heim P, 2001, THE COMPANY OF WOMEN; Heim P, 2003, THE COMPANY OF WOMEN; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Hill RA, 2003, HUM NATURE-INT BIOS, V14, P53, DOI 10.1007/s12110-003-1016-y; Hruschka D., 2010, FRIENDSHIP DEVELOPME; Hum NJ, 2011, COMPUT HUM BEHAV, V27, P1828, DOI 10.1016/j.chb.2011.04.003; Ip GWM, 2006, J PERS SOC PSYCHOL, V90, P368, DOI 10.1037/0022-3514.90.3.368; Kanai R, 2012, P ROY SOC B-BIOL SCI, V279, P1327, DOI 10.1098/rspb.2011.1959; Krause J, 2009, BEHAV ECOL SOCIOBIOL, V63, P967, DOI 10.1007/s00265-009-0747-0; Langergraber K, 2009, AM J PRIMATOL, V71, P840, DOI 10.1002/ajp.20711; Lehmann J, 2009, P ROY SOC B-BIOL SCI, V276, P4417, DOI 10.1098/rspb.2009.1409; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Mendelson AL, 2010, THE NETWORKED SELF I; Nadkarni A, 2012, PERS INDIV DIFFER, V52, P243, DOI 10.1016/j.paid.2011.11.007; Oxley NL, 2002, PSYCHOL REP, V91, P537, DOI 10.2466/PR0.91.6.537-544; Palchykov V, 2012, SCI REP-UK, V2, DOI 10.1038/srep00370; Rose AJ, 2006, PSYCHOL BULL, V132, P98, DOI 10.1037/0033-2909.132.1.98; Rotkirch A, 2014, EVOL PSYCHOL-US, V12, P673; Samter W, 1997, PERS RELATIONSHIP, V4, P413, DOI 10.1111/j.1475-6811.1997.tb00154.x; Saramaki J, 2014, P NATL ACAD SCI USA, V111, P942, DOI 10.1073/pnas.1308540110; Savin-Williams RC, 1980, SOCIAL INTERACTIONS, P343; Scelza BA, 2011, HUM NATURE-INT BIOS, V22, P377, DOI 10.1007/s12110-011-9125-5; Seielstad MT, 1998, NAT GENET, V20, P278, DOI 10.1038/3088; Seyfarth RM, 2012, ANNU REV PSYCHOL, V63, P153, DOI 10.1146/annurev-psych-120710-100337; Sheets VL, 2005, SEX ROLES, V52, P131, DOI 10.1007/s11199-005-1200-0; Shultz S, 2011, NATURE, V479, P219, DOI 10.1038/nature10601; Silk JB, 2007, SCIENCE, V317, P1347, DOI 10.1126/science.1140734; Silk JB, 2006, BEHAV ECOL SOCIOBIOL, V61, P183, DOI 10.1007/s00265-006-0249-2; Silk JB, 2009, P ROY SOC B-BIOL SCI, V276, P3099, DOI 10.1098/rspb.2009.0681; Sutcliffe A, 2012, BRIT J PSYCHOL; Taylor SE, 2000, PSYCHOL REV, V107, P411, DOI 10.1037/0033-295X.107.3.411; Tiger L, 1974, COMPACT SELECTED DIM, P42; Ueno K., 2006, CLOSE RELATIONSHIPS; Vigil JM, 2007, HUM NATURE-INT BIOS, V18, P143, DOI 10.1007/s12110-007-9003-3; Walther JB, 2008, HUM COMMUN RES, V34, P28, DOI 10.1111/j.1468-2958.2007.00312.x; Wang SS, 2010, COMPUT HUM BEHAV, V26, P226, DOI 10.1016/j.chb.2009.10.001; Wrangham RW, 2000, PRIMATE MALES, P248; Wrangham RW, 1987, PRIMATE MODELS OF HO; Zhou WX, 2005, P ROY SOC B-BIOL SCI, V272, P439, DOI 10.1098/rspb.2004.2970	73	59	61	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118329	10.1371/journal.pone.0118329	http://dx.doi.org/10.1371/journal.pone.0118329			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD6EY	25775258	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000351183500027
J	Hatzitaki, V; Stergiou, N; Sofianidis, G; Kyvelidou, A				Hatzitaki, Vassilia; Stergiou, Nicholas; Sofianidis, George; Kyvelidou, Anastasia			Postural Sway and Gaze Can Track the Complex Motion of a Visual Target	PLOS ONE			English	Article							PURSUIT EYE-MOVEMENTS; OLDER-ADULTS; STRONG ANTICIPATION; NONLINEAR DYNAMICS; FRACTAL DYNAMICS; VARIABILITY; SYNCHRONIZATION; TASK; GAIT; INFORMATION	Variability is an inherent and important feature of human movement. This variability has form exhibiting a chaotic structure. Visual feedback training using regular predictive visual target motions does not take into account this essential characteristic of the human movement, and may result in task specific learning and loss of visuo-motor adaptability. In this study, we asked how well healthy young adults can track visual target cues of varying degree of complexity during whole-body swaying in the Anterior-Posterior (AP) and Medio-Lateral (ML) direction. Participants were asked to track three visual target motions: a complex (Lorenz attractor), a noise (brown) and a periodic (sine) moving target while receiving online visual feedback about their performance. Postural sway, gaze and target motion were synchronously recorded and the degree of force-target and gaze-target coupling was quantified using spectral coherence and Cross-Approximate entropy. Analysis revealed that both force-target and gaze-target coupling was sensitive to the complexity of the visual stimuli motions. Postural sway showed a higher degree of coherence with the Lorenz attractor than the brown noise or sinusoidal stimulus motion. Similarly, gaze was more synchronous with the Lorenz attractor than the brown noise and sinusoidal stimulus motion. These results were similar regardless of whether tracking was performed in the AP or ML direction. Based on the theoretical model of optimal movement variability tracking of a complex signal may provide a better stimulus to improve visuo-motor adaptation and learning in postural control.	[Hatzitaki, Vassilia; Sofianidis, George] Aristotle Univ Thessaloniki, Sch Phys Educ & Sport Sci, Motor Control & Learning Lab, GR-54006 Thessaloniki, Greece; [Stergiou, Nicholas; Kyvelidou, Anastasia] Univ Nebraska, Omaha, NE 68182 USA	Aristotle University of Thessaloniki; University of Nebraska System	Kyvelidou, A (corresponding author), Univ Nebraska, Biomech Res Bldg, Omaha, NE 68182 USA.	akyvelidou@unomaha.edu	Kyvelidou, Anastasia/W-3223-2019	Kyvelidou, Anastasia/0000-0001-7560-3648; Hatzitaki, Vassilia/0000-0002-4384-6976	University of Nebraska Faculty Research International grant "A USA-Greece partnership to promote research in Biomechanics and Motor Control"; National Institutes of Health Centers of Biomedical Research Excellence [1P20GM109090-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109090] Funding Source: NIH RePORTER	University of Nebraska Faculty Research International grant "A USA-Greece partnership to promote research in Biomechanics and Motor Control"; National Institutes of Health Centers of Biomedical Research Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by the University of Nebraska Faculty Research International grant (2013-2014) "A USA-Greece partnership to promote research in Biomechanics and Motor Control", to NS VH; and National Institutes of Health Centers of Biomedical Research Excellence (1P20GM109090-01), to NS AK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Born RT, 2002, ANN NY ACAD SCI, V956, P453, DOI 10.1111/j.1749-6632.2002.tb02853.x; Buzzi UH, 2003, CLIN BIOMECH, V18, P435, DOI 10.1016/S0268-0033(03)00029-9; Cavanaugh JT, 2010, J GERONTOL A-BIOL, V65, P197, DOI 10.1093/gerona/glp144; COLLEWIJN H, 1988, ANN NY ACAD SCI, V545, P105; COLLINS JJ, 1994, PHYS REV LETT, V73, P764, DOI 10.1103/PhysRevLett.73.764; Duarte M, 2002, EXP BRAIN RES, V146, P60, DOI 10.1007/s00221-002-1154-1; GIBSON JJ, 1950, AM J PSYCHOL, V63, P367, DOI 10.2307/1418003; Giveans MR, 2011, ECOL PSYCHOL, V23, P247, DOI 10.1080/10407413.2011.617215; GOLDBERGER A L, 1990, Scientific American, V262, P42; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Hatzitaki V, 2009, GAIT POSTURE, V29, P296, DOI 10.1016/j.gaitpost.2008.09.011; Hatzitaki V, 2007, EXP BRAIN RES, V182, P525, DOI 10.1007/s00221-007-1007-z; Hausdorff JM, 1997, J APPL PHYSIOL, V82, P262; Haworth JL, 2014, EXP BRAIN RES, V232, P2797, DOI 10.1007/s00221-014-3962-5; Hong SL, 2006, J MOTOR BEHAV, V38, P88, DOI 10.3200/JMBR.38.2.88-100; Hove MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032600; HU MH, 1994, J GERONTOL, V49, pM52, DOI 10.1093/geronj/49.2.M52; Jeka J, 2006, EXP BRAIN RES, V174, P517, DOI 10.1007/s00221-006-0502-y; Kaipust JP, 2013, ANN BIOMED ENG, V41, P1595, DOI 10.1007/s10439-012-0654-9; Kowler E, 2011, VISION RES, V51, P1457, DOI 10.1016/j.visres.2010.12.014; Lizama LEC, 2013, J BIOMECH, V46, P2831, DOI 10.1016/j.jbiomech.2013.08.018; Maioli C, 2007, J NEUROSCI, V27, P7168, DOI 10.1523/JNEUROSCI.1832-07.2007; Miall RC, 1995, EXP BRAIN RES, V107, P267; Oullier O, 2002, HUM MOVEMENT SCI, V21, P147, DOI 10.1016/S0167-9457(02)00093-3; Pincus S, 1996, P NATL ACAD SCI USA, V93, P2083, DOI 10.1073/pnas.93.5.2083; Radhakrishnan SM, 2010, GAIT POSTURE, V32, P650, DOI 10.1016/j.gaitpost.2010.09.010; Schwartz O, 2001, NAT NEUROSCI, V4, P819, DOI 10.1038/90526; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Sofianidis G, 2012, HUM MOVEMENT SCI, V31, P553, DOI 10.1016/j.humov.2011.07.007; Stephen DG, 2008, PHYSICA A, V387, P5271, DOI 10.1016/j.physa.2008.05.015; Stepp N, 2010, COGN SYST RES, V11, P148, DOI 10.1016/j.cogsys.2009.03.003; Stergiou Nicholas, 2006, J Neurol Phys Ther, V30, P120; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Stoffregen TA, 2006, MOTOR CONTROL, V10, P24, DOI 10.1123/mcj.10.1.24; Suzuki Y, 2012, J THEOR BIOL, V310, P55, DOI 10.1016/j.jtbi.2012.06.019; Torre K, 2013, BRAIN COGNITION, V83, P342, DOI 10.1016/j.bandc.2013.10.002; Vorberg D, 2002, J MATH PSYCHOL, V46, P56, DOI 10.1006/jmps.2001.1375; Vorberg D., 1996, HDB PERCEPT ACTION, P181, DOI [10.1016/S1874-5822(06)80007-1, DOI 10.1016/S1874-5822(06)80007-1, 10.1016/S1874-5822(06)80007-1.]; West BJ, 2010, MED HYPOTHESES, V75, P475, DOI 10.1016/j.mehy.2010.04.028	39	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119828	10.1371/journal.pone.0119828	http://dx.doi.org/10.1371/journal.pone.0119828			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD6EY	25774508	Green Submitted, Green Published, gold			2022-12-27	WOS:000351183500129
J	Vaque, JP; Martinez, N; Varela, I; Fernandez, F; Mayorga, M; Derdak, S; Beltran, S; Moreno, T; Almaraz, C; De las Heras, G; Bayes, M; Gut, I; Crespo, J; Piris, MA				Vaque, Jose P.; Martinez, Nerea; Varela, Ignacio; Fernandez, Fidel; Mayorga, Marta; Derdak, Sophia; Beltran, Sergi; Moreno, Thaidy; Almaraz, Carmen; De las Heras, Gonzalo; Bayes, Monica; Gut, Ivo; Crespo, Javier; Piris, Miguel A.			Colorectal Adenomas Contain Multiple Somatic Mutations That Do Not Coincide with Synchronous Adenocarcinoma Specimens	PLOS ONE			English	Article							HUMAN COLON; GENOME; CANCER; ALIGNMENT; PROTEIN	We have performed a comparative ultrasequencing study of multiple colorectal lesions obtained simultaneously from four patients. Our data show that benign lesions (adenomatous or hyperplastic polyps) contain a high mutational load. Additionally multiple synchronous colorectal lesions show non overlapping mutational signatures highlighting the degree of heterogeneity between multiple specimens in the same patient. Observations in these cases imply that considering not only the number of mutations but an effective oncogenic combination of mutations can determine the malignant progression of colorectal lesions.	[Vaque, Jose P.; Martinez, Nerea; Almaraz, Carmen; Piris, Miguel A.] Inst Invest Marques de Valdecilla, IDIVAL, Canc Genom Grp, Santander, Spain; [Varela, Ignacio; Moreno, Thaidy] IBBTEC UC CSIC SODERCAN Inst Biomed & Biotecnol C, Santander, Spain; [Fernandez, Fidel; Mayorga, Marta; Piris, Miguel A.] Hosp Univ Marques de Valdecilla, Dept Pathol, Santander, Spain; [Derdak, Sophia; Beltran, Sergi; Bayes, Monica; Gut, Ivo] CNAG, Barcelona, Spain; [De las Heras, Gonzalo; Crespo, Javier] Hosp Univ Marques de Valdecilla, Gastroenterol & Hepatol Unit, Santander, Spain; [Crespo, Javier] IFIMAV, Infect Immun & Digest Pathol Grp, Santander, Spain	Hospital Universitario Marques de Valdecilla (HUMV); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV)	Vaque, JP (corresponding author), Inst Invest Marques de Valdecilla, IDIVAL, Canc Genom Grp, Santander, Spain.	jpvaque@idival.org	Magunacelaya, Nerea Martinez/M-5040-2016; Gut, Ivo/ABF-3188-2020; Varela, Ignacio/G-1699-2016; Beltran, Sergi/I-3408-2015; Varela, Ignacio/AAA-7680-2021; Piris, Miguel A/B-7067-2008; Vaqué, José P/H-8413-2015; Piris, Miguel A/AAP-1445-2020	Magunacelaya, Nerea Martinez/0000-0002-3983-0867; Gut, Ivo/0000-0001-7219-632X; Varela, Ignacio/0000-0002-0969-506X; Beltran, Sergi/0000-0002-2810-3445; Varela, Ignacio/0000-0002-0969-506X; Piris, Miguel A/0000-0001-5839-3634; Vaqué, José P/0000-0002-3913-2495; Piris, Miguel A/0000-0001-5839-3634; Moreno Rodriguez, Thaidy/0000-0003-3588-3889; Crespo, Javier/0000-0001-8248-0172	isciii, FEDER [PI12/00357]; Grant Fundacion Aecc; Grant SODERCAN-Gobierno de Cantabria; Spanish "Ministerio de Ciencia e Innovacion" (RETICS) [SAF2008-03871]; Spanish Ministerio de Economia y Competitividad subprograma Ramon y Cajal	isciii, FEDER; Grant Fundacion Aecc; Grant SODERCAN-Gobierno de Cantabria; Spanish "Ministerio de Ciencia e Innovacion" (RETICS); Spanish Ministerio de Economia y Competitividad subprograma Ramon y Cajal	Funding provided by Grant PI12/00357 (isciii, FEDER funds) to JPV, Grant Fundacion Aecc to MAP, Grant SODERCAN-Gobierno de Cantabria to MAP and Grant from the Spanish "Ministerio de Ciencia e Innovacion" (RETICS, SAF2008-03871) to MAP. IV is funded by Spanish Ministerio de Economia y Competitividad subprograma Ramon y Cajal. The authors would like to thank Servicio Santander Supercomputacion for their IT support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Derrien T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030377; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; KONISHI F, 1982, J CLIN PATHOL, V35, P830, DOI 10.1136/jcp.35.8.830; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Marco-Sola S, 2012, NAT METHODS, V9, P1185, DOI [10.1038/NMETH.2221, 10.1038/nmeth.2221]; Martinez N, 2014, LEUKEMIA, V28, P1334, DOI 10.1038/leu.2013.365; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nikolaev SI, 2012, CANCER RES, V72, P6279, DOI 10.1158/0008-5472.CAN-12-3869; O'Hayre M, 2013, NAT REV CANCER, V13, P412, DOI 10.1038/nrc3521; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang K, 2010, NUCLEIC ACIDS RES, V38, P7248, DOI 10.1093/nar/gkq601; Zhou DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053310	16	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119946	10.1371/journal.pone.0119946	http://dx.doi.org/10.1371/journal.pone.0119946			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775023	Green Submitted, Green Published, gold			2022-12-27	WOS:000351183500142
J	Arndt, S; Landthaler, M; Zimmermann, JL; Unger, P; Wacker, E; Shimizu, T; Li, YF; Morfill, GE; Bosserhoff, AK; Karrer, S				Arndt, Stephanie; Landthaler, Michael; Zimmermann, Julia L.; Unger, Petra; Wacker, Eva; Shimizu, Tetsuji; Li, Yang-Fang; Morfill, Gregor E.; Bosserhoff, Anja-Katrin; Karrer, Sigrid			Effects of Cold Atmospheric Plasma (CAP) on beta-Defensins, Inflammatory Cytokines, and Apoptosis-Related Molecules in Keratinocytes In Vitro and In Vivo	PLOS ONE			English	Article							ARGON PLASMA; ANTIMICROBIAL PEPTIDES; PRESSURE PLASMA; CHRONIC WOUNDS; EXPRESSION; BARRIER; GENE; DECONTAMINATION; TISSUE; CELLS	Cold atmospheric plasma (CAP) has been gaining increasing interest as a new approach for the treatment of skin diseases or wounds. Although this approach has demonstrated promising antibacterial activity, its exact mechanism of action remains unclear. This study explored in vitro and in vivo whether CAP influences gene expression and molecular mechanisms in keratinocytes. Our results revealed that a 2 min CAP treatment using the MicroPlaSter beta in analogy to the performed clinical studies for wound treatment induces expression of IL-8, TGF-beta 1, and TGF-beta 2. In vitro and in vivo assays indicated that keratinocyte proliferation, migration, and apoptotic mechanisms were not affected by the CAP treatment under the applied conditions. Further, we observed that antimicrobial peptides of the beta-defensin family are upregulated after CAP treatment. In summary, our results suggest that a 2 min application of CAP induces gene expression of key regulators important for inflammation and wound healing without causing proliferation, migration or cell death in keratinocytes. The induction of beta-defensins in keratinocytes describes an absolutely new plasma strategy. Activation of antimicrobial peptides supports the well-known antibacterial effect of CAP treatment, whereas the mechanism of beta-defensin activation by CAP is not investigated so far.	[Arndt, Stephanie; Wacker, Eva] Univ Regensburg, Inst Pathol, D-93042 Regensburg, Germany; [Landthaler, Michael; Unger, Petra; Karrer, Sigrid] Univ Hosp Regensburg, Dept Dermatol, D-93042 Regensburg, Germany; [Zimmermann, Julia L.; Shimizu, Tetsuji; Li, Yang-Fang; Morfill, Gregor E.] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany; [Bosserhoff, Anja-Katrin] Univ Erlangen Nurnberg, Inst Biochem & Mol Med, D-91054 Erlangen, Germany	University of Regensburg; University of Regensburg; Max Planck Society; University of Erlangen Nuremberg	Karrer, S (corresponding author), Univ Hosp Regensburg, Dept Dermatol, D-93042 Regensburg, Germany.	sigrid.karrer@klinik.uni-regensburg.de	Shimizu, Tetsuji/L-1478-2018; Bosserhoff, Anja/GNH-4801-2022	Shimizu, Tetsuji/0000-0001-9432-1152; Bosserhoff, Anja/0000-0001-8147-394X; Li, Yangfang/0000-0002-5346-3741				Afshar M, 2013, VET DERMATOL, V24, P32, DOI 10.1111/j.1365-3164.2012.01082.x; Ahn HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028154; Arndt S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079325; Arndt S, 2013, EXP DERMATOL, V22, P284, DOI 10.1111/exd.12127; Arndt S, 2010, GASTROENTEROLOGY, V138, P372, DOI 10.1053/j.gastro.2009.09.048; Boxhammer V, 2013, MUTAT RES-GEN TOX EN, V753, P23, DOI 10.1016/j.mrgentox.2012.12.015; Braig S, 2013, ONCOGENE, V32, P837, DOI 10.1038/onc.2012.115; Brown Rebeccah L., 1995, Wound Repair and Regeneration, V3, P25, DOI 10.1046/j.1524-475X.1995.30108.x; Canady J, 2013, J INVEST DERMATOL, V133, P647, DOI 10.1038/jid.2012.389; Clausen ML, 2013, BRIT J DERMATOLOGY; Daeschlein G, 2012, J HOSP INFECT, V81, P177, DOI 10.1016/j.jhin.2012.02.012; Daeschlein G, 2012, J DTSCH DERMATOL GES, V10, P509, DOI 10.1111/j.1610-0387.2012.07857.x; Deilmann M, 2009, PLASMA PROCESSES S1, pi; Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154; Garcia-Alcantara E, 2013, ARCH MED RES, V44, P169, DOI 10.1016/j.arcmed.2013.02.001; Gethin Georgina, 2012, Br J Community Nurs, VSuppl, pS17; Gibson AL, 2012, WOUND REPAIR REGEN, V20, P414, DOI 10.1111/j.1524-475X.2012.00786.x; Gillitzer R, 2001, J LEUKOCYTE BIOL, V69, P513; Grose R, 2004, MOL BIOTECHNOL, V28, P147, DOI 10.1385/MB:28:2:147; Haertel B, 2012, CELL BIOL INT, V36, P1217, DOI 10.1042/CBI20120139; Haertel B, 2011, EXP DERMATOL, V20, P282, DOI 10.1111/j.1600-0625.2010.01159.x; Harder Juergen, 2005, V86, P22, DOI 10.1159/000086650; Harder J, 2010, J INVEST DERMATOL, V130, P1355, DOI 10.1038/jid.2009.432; Heinlin J, 2013, J EUR ACAD DERMATOL, V27, P324, DOI 10.1111/j.1468-3083.2011.04395.x; Heinlin J, 2011, J EUR ACAD DERMATOL, V25, P1, DOI 10.1111/j.1468-3083.2010.03702.x; Heinlin J, 2013, RANDOMIZED PLACEBOCO; Heinlin J, 2013, WOUND REPAIR REGENER; Isbary G, 2012, BRIT J DERMATOL, V167, P404, DOI 10.1111/j.1365-2133.2012.10923.x; Isbary G, 2010, BRIT J DERMATOL, V163, P78, DOI 10.1111/j.1365-2133.2010.09744.x; Kalghatgi SU, 2008, IEEE ENG MED BIO, P3578, DOI 10.1109/IEMBS.2008.4649979; Kalghatgi SU, 2009, C P ANN INT C IEEE E, P6030, DOI DOI 10.1109/IEMBS.2009.5333168; KAPPELMANN M, 2012, ONCOGENE; Kieft IE, 2005, IEEE T PLASMA SCI, V33, P771, DOI 10.1109/TPS.2005.844528; Kieft IE, 2004, BIOELECTROMAGNETICS, V25, P362, DOI 10.1002/bem.20005; Kieft IE, 2006, IEEE T PLASMA SCI, V34, P1331, DOI 10.1109/TPS.2006.876511; KONDO S, 1993, J INVEST DERMATOL, V101, P690, DOI 10.1111/1523-1747.ep12371677; KULKARNI AB, 1995, AM J PATHOL, V146, P264; Lademann O, 2011, SKIN PHARMACOL PHYS, V24, P284, DOI 10.1159/000329913; Levine JH, 1993, AM J PATHOL, V143, P368; Lupu Andreea-Roxana, 2009, Roum Arch Microbiol Immunol, V68, P136; Maisch T, 2012, J IND MICROBIOL BIOT, V39, P1367, DOI 10.1007/s10295-012-1137-6; Maisch T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034610; Maisch T, 2012, APPL ENVIRON MICROB, V78, P4242, DOI 10.1128/AEM.07235-11; Portugal M, 2007, BIOMED PHARMACOTHER, V61, P412, DOI 10.1016/j.biopha.2007.05.010; Roberts Anita B., 1995, Wound Repair and Regeneration, V3, P408, DOI 10.1046/j.1524-475X.1995.30405.x; Selcuk M, 2008, BIORESOURCE TECHNOL, V99, P5104, DOI 10.1016/j.biortech.2007.09.076; Shashurin A, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3020223; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Yonson S, 2006, J PHYS D APPL PHYS, V39, P3508, DOI 10.1088/0022-3727/39/16/S08; Yu Y, 2011, J HUAZHONG U SCI-MED, V31, P390, DOI 10.1007/s11596-011-0387-2	51	82	84	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120041	10.1371/journal.pone.0120041	http://dx.doi.org/10.1371/journal.pone.0120041			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768736	Green Submitted, Green Published, gold			2022-12-27	WOS:000351277500105
J	Carrick, RT; Bates, ORJ; Benson, BE; Habel, N; Bates, JHT; Spector, PS				Carrick, Richard T.; Bates, Oliver R. J.; Benson, Bryce E.; Habel, Nicole; Bates, Jason H. T.; Spector, Peter S.			Prospectively Quantifying the Propensity for Atrial Fibrillation: A Mechanistic Formulation	PLOS ONE			English	Article							CRITICAL MASS HYPOTHESIS; IMPULSE PROPAGATION; REFRACTORY PERIOD; CATHETER ABLATION; HEART; MODEL; SUSCEPTIBILITY; INSIGHTS; DENSITY; IMPACT	The goal of this study was to determine quantitative relationships between electrophysiologic parameters and the propensity of cardiac tissue to undergo atrial fibrillation. We used a computational model to simulate episodes of fibrillation, which we then characterized in terms of both their duration and the population dynamics of the electrical waves which drove them. Monte Carlo sampling revealed that episode durations followed an exponential decay distribution and wave population sizes followed a normal distribution. Half-lives of reentrant episodes increased exponentially with either increasing tissue area to boundary length ratio (A/BL) or decreasing action potential duration (APD), resistance (R) or capacitance (C). We found that the qualitative form of fibrillatory activity (e.g., multi-wavelet reentry (MWR) vs. rotors) was dependent on the ratio of resistance and capacitance to APD; MWR was reliably produced below a ratio of 0.18. We found that a composite of these electrophysiologic parameters, which we term the fibrillogenicity index (Fb = A/(BL*APD*R*C)), reliably predicted the duration of MWR episodes (r(2) = 0.93). Given that some of the quantities comprising Fb are amenable to manipulation (via either pharmacologic treatment or catheter ablation), these findings provide a theoretical basis for the development of titrated therapies of atrial fibrillation.	[Carrick, Richard T.; Benson, Bryce E.; Bates, Jason H. T.] Univ Vermont, Coll Engn & Math Sci, Dept Bioengn, Burlington, VT USA; [Bates, Oliver R. J.] Boston Univ, Coll Engn, Dept Biomed Engn, Boston, MA 02215 USA; [Habel, Nicole; Spector, Peter S.] Univ Vermont, Coll Med, Dept Med Cardiol, Burlington, VT 05405 USA; [Bates, Jason H. T.] Univ Vermont, Coll Med, Dept Med Pulm Dis & Crit Care Med, Burlington, VT USA	University of Vermont; Boston University; University of Vermont; University of Vermont	Spector, PS (corresponding author), Univ Vermont, Coll Med, Dept Med Cardiol, Burlington, VT 05405 USA.	peter.spector@uvm.edu		Carrick, Richard/0000-0001-5589-1216	Evslin Family Foundation, Inc.	Evslin Family Foundation, Inc.	The Peter Spector laboratory at the University of Vermont received funding from the Evslin Family Foundation, Inc., a non-profit angel donor group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Allessie M, 1985, CARDIAC ELECTROPHYSI, P265, DOI DOI 10.1016/J.HRTHM.2012.03.008; Allessie MA, 2010, CIRC-ARRHYTHMIA ELEC, V3, P606, DOI 10.1161/CIRCEP.109.910125; Byrd GD, 2005, CIRCULATION, V112, pI7, DOI 10.1161/CIRCULATIONAHA.104.526210; Calkins H, 2009, CIRC-ARRHYTHMIA ELEC, V2, P349, DOI 10.1161/CIRCEP.108.824789; Carrick RT, 2013, CIRC-ARRHYTHMIA ELEC, V6, P1229, DOI 10.1161/CIRCEP.113.000759; Charitos EI, 2014, J AM COLL CARDIOL, V63, P2840, DOI 10.1016/j.jacc.2014.04.019; COX JL, 1991, J THORAC CARDIOV SUR, V101, P584; de Groot NMS, 2010, CIRCULATION, V122, P1674, DOI 10.1161/CIRCULATIONAHA.109.910901; Garrey WE, 1914, AM J PHYSIOL, V33, P397, DOI 10.1152/ajplegacy.1914.33.3.397; Go AS, 2014, JAMA-J AM MED ASSOC, V285, P2370; Jacquemet V, 2005, EUROPACE, V7, pS83, DOI 10.1016/j.eupc.2005.03.017; Jacquemet V, 2008, AM J PHYSIOL-HEART C, V294, pH2040, DOI 10.1152/ajpheart.01298.2007; Jacquemet V, 2007, EUROPACE, V9, P29, DOI 10.1093/europace/eum207; January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI [10.1161/CIR.0000000000000041, 10.1016/j.jacc.2014.03.022, 10.1161/CIR.0000000000000142, 10.1016/j.jacc.2014.03.021]; Kojodjojo P, 2007, J CARDIOVASC ELECTR, V18, P269, DOI 10.1111/j.1540-8167.2007.00723.x; Lee AM, 2013, J THORAC CARDIOV SUR, V146, P593, DOI 10.1016/j.jtcvs.2012.04.021; Lloyd-Jones DM, 2004, CIRCULATION, V110, P1042, DOI 10.1161/01.CIR.0000140263.20897.42; McDowell KS, 2011, BIOPHYS J, V101, P1307, DOI 10.1016/j.bpj.2011.08.009; MOE GK, 1964, AM HEART J, V67, P200, DOI 10.1016/0002-8703(64)90371-0; MOE GK, 1962, ARCH INT PHARMACOD T, V140, P183; Oral H, 2002, CIRCULATION, V105, P1077, DOI 10.1161/hc0902.104712; RENSMA PL, 1988, CIRC RES, V62, P395, DOI 10.1161/01.RES.62.2.395; Sanoski CA, 2009, J MANAGE CARE PHARM, V15, pS4; Spector PS, 2012, EUROPACE, V14, pV106, DOI 10.1093/europace/eus278; Spector PS, 2011, CIRC-ARRHYTHMIA ELEC, V4, P586, DOI 10.1161/CIRCEP.110.961524; Tilz RR, 2012, J AM COLL CARDIOL, V60, P1921, DOI 10.1016/j.jacc.2012.04.060; WANG JJ, 1993, CIRCULATION, V88, P1030, DOI 10.1161/01.CIR.88.3.1030; WIJFFELS MCEF, 1995, CIRCULATION, V92, P1954, DOI 10.1161/01.CIR.92.7.1954; Wright M, 2008, J CARDIOVASC ELECTR, V19, P583, DOI 10.1111/j.1540-8167.2008.01187.x	29	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118746	10.1371/journal.pone.0118746	http://dx.doi.org/10.1371/journal.pone.0118746			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768978	Green Submitted, Green Published, gold			2022-12-27	WOS:000351277500042
J	Ma, J; Kanakala, S; He, YH; Zhang, JL; Zhong, XL				Ma, Jun; Kanakala, S.; He, Yehua; Zhang, Junli; Zhong, Xiaolan			Transcriptome Sequence Analysis of an Ornamental Plant, Ananas comosus var. bracteatus, Revealed the Potential Unigenes Involved in Terpenoid and Phenylpropanoid Biosynthesis	PLOS ONE			English	Article							RNA-SEQ; EXPRESSION; GENOME; L.; DISCOVERY	Background Ananas comosus var. bracteatus (Red Pineapple) is an important ornamental plant for its colorful leaves and decorative red fruits. Because of its complex genome, it is difficult to understand the molecular mechanisms involved in the growth and development. Thus high-throughput transcriptome sequencing of Ananas comosus var. bracteatus is necessary to generate large quantities of transcript sequences for the purpose of gene discovery and functional genomic studies. Results The Ananas comosus var. bracteatus transcriptome was sequenced by the Illumina paired-end sequencing technology. We obtained a total of 23.5 million high quality sequencing reads, 1,555,808 contigs and 41,052 unigenes. In total 41,052 unigenes of Ananas comosus var. bracteatus, 23,275 unigenes were annotated in the NCBI non-redundant protein database and 23,134 unigenes were annotated in the Swiss-Port database. Out of these, 17,748 and 8,505 unigenes were assigned to gene ontology categories and clusters of orthologous groups, respectively. Functional annotation against Kyoto Encyclopedia of Genes and Genomes Pathway database identified 5,825 unigenes which were mapped to 117 pathways. The assembly predicted many unigenes that were previously unknown. The annotated unigenes were compared against pineapple, rice, maize, Arabidopsis, and sorghum. Unigenes that did not match any of those five sequence datasets are considered to be Ananas comosus var. bracteatus unique. We predicted unigenes encoding enzymes involved in terpenoid and phenylpropanoid biosynthesis. Conclusion The sequence data provide the most comprehensive transcriptomic resource currently available for Ananas comosus var. bracteatus. To our knowledge; this is the first report on the de novo transcriptome sequencing of the Ananas comosus var. bracteatus. Unigenes obtained in this study, may help improve future gene expression, genetic and genomics studies in Ananas comosus var. bracteatus.	[Ma, Jun; Zhang, Junli; Zhong, Xiaolan] Sichuan Agr Univ, Coll Landscape Architecture, Chengdu, Sichuan, Peoples R China; [Kanakala, S.] Agr Res Org, Volcani Ctr, Inst Plant Protect, IL-50250 Bet Dagan, Israel; [He, Yehua] South China Agr Univ, Hort Biotechnol Coll, Guangzhou, Guangdong, Peoples R China	Sichuan Agricultural University; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; South China Agricultural University	Ma, J (corresponding author), Sichuan Agr Univ, Coll Landscape Architecture, Chengdu, Sichuan, Peoples R China.	junma365@hotmail.com	Surapathrudu, Kanakala/I-3791-2019	Surapathrudu, Kanakala/0000-0003-4702-3990	Natural Science Foundation of China [31300585]; Sichuan Agricultural University, China	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan Agricultural University, China	This work was funded by the Natural Science Foundation of China (31300585) and special funds by Sichuan Agricultural University, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bancroft I, 2011, NAT BIOTECHNOL, V29, P762, DOI 10.1038/nbt.1926; Cazarolli LH, 2008, MINI-REV MED CHEM, V8, P1429, DOI 10.2174/138955708786369564; Chan Esther T., 2009, Journal of Biology (London), V8, P33, DOI 10.1186/jbiol130; Collins JL, 1960, PINEAPPLE BOT UTILIS; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Croteau R., 2000, BIOCH MOL BIOL PLANT, P1250, DOI DOI 10.1201/B11003-3; d'Eeckenbrugge Geo Coppens, 2003, P13, DOI 10.1079/9780851995038.0013; Dewick, 2002, MED NATURAL PRODUCTS; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Ferreyra MLF, 2012, FRONT PLANT SCI, V3, p1e15; Fraser Christopher M, 2011, Arabidopsis Book, V9, pe0152, DOI 10.1199/tab.0152; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hematy K, 2009, CURR OPIN PLANT BIOL, V12, P406, DOI 10.1016/j.pbi.2009.06.007; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; Ito Y, 2006, J PHARMACOL SCI, V102, P196, DOI 10.1254/jphs.FP0060711; Kai T, 2005, DEV BIOL, V283, P486, DOI 10.1016/j.ydbio.2005.04.018; Kalaiselvi M., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, pS1341; Koia JH, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-240; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Liu MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046766; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Mol J, 1998, TRENDS PLANT SCI, V3, P212, DOI 10.1016/S1360-1385(98)01242-4; Montinola LR, 1991, PINA; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Moyle R, 2005, J EXP BOT, V56, P101, DOI 10.1093/jxb/eri015; Moyle RL, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-21; Neuteboom LW, 2002, PLANT SCI, V163, P1021, DOI 10.1016/S0168-9452(02)00277-7; Ong WD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046937; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rocha FD, 2000, AN ACAD BRAS CIENC, V72, P295; TAKATA RH, 1976, LLOYDIA, V39, P409; TAUSSIG SJ, 1988, J ETHNOPHARMACOL, V22, P191, DOI 10.1016/0378-8741(88)90127-4; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; Wang GY, 2005, NATURAL PRODUCTS: DRUG DISCOVERY AND THERAPEUTIC MEDICINE, P197, DOI 10.1007/978-1-59259-976-9_9; Wen L, 1999, J AGR FOOD CHEM, V47, P850, DOI 10.1021/jf9808067	36	19	21	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119153	10.1371/journal.pone.0119153	http://dx.doi.org/10.1371/journal.pone.0119153			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25769053	Green Submitted, gold, Green Published			2022-12-27	WOS:000351277500067
J	Carnesecchi, J; Malbouyres, M; de Mets, R; Balland, M; Beauchef, G; Vie, K; Chamot, C; Lionnet, C; Ruggiero, F; Vanacker, JM				Carnesecchi, Julie; Malbouyres, Marilyne; de Mets, Richard; Balland, Martial; Beauchef, Gallic; Vie, Katell; Chamot, Christophe; Lionnet, Claire; Ruggiero, Florence; Vanacker, Jean-Marc			Estrogens Induce Rapid Cytoskeleton Re-Organization in Human Dermal Fibroblasts via the Non-Classical Receptor GPR30	PLOS ONE			English	Article							ACTIN CYTOSKELETON; POTENTIAL ROLE; UP-REGULATION; SEX STEROIDS; SKIN; ESTRADIOL; 17-BETA-ESTRADIOL; CELLS; TAMOXIFEN; COLLAGEN	The post-menopausal decrease in estrogen circulating levels results in rapid skin deterioration pointing out to a protective effect exerted by these hormones. The identity of the skin cell type responding to estrogens is unclear as are the cellular and molecular processes they elicit. Here, we reported that lack of estrogens induces rapid re-organization of the human dermal fibroblast cytoskeleton resulting in striking cell shape change. This morphological change was accompanied by a spatial re-organization of focal adhesion and a substantial reduction of their number as evidenced by vinculin and actin co-staining. Cell morphology and cytoskeleton organization was fully restored upon 17 beta-estradiol (E2) addition. Treatment with specific ER antagonists and cycloheximide respectively showed that the E2 acts independently of the classical Estrogen Receptors and that cell shape change is mediated by non-genomic mechanisms. E2 treatment resulted in a rapid and transient activation of ERK1/2 but not Src or PI3K. We show that human fibroblasts express the nonclassical E2 receptor GPR30 and that its agonist G-1 phenocopies the effect of E2. Inhibiting GPR30 through treatment with the G-15 antagonist or specific shRNA impaired E2 effects. Altogether, our data reveal a novel mechanism by which estrogens act on skin fibroblast by regulating cell shape through the non-classical G protein-coupled receptor GPR30 and ERK1/2 activation.	[Carnesecchi, Julie; Malbouyres, Marilyne; Ruggiero, Florence; Vanacker, Jean-Marc] Univ Lyon 1, Ecole Normale Super Lyon, Inst Genom Fonct Lyon, CNRS,UMR5242, F-69365 Lyon, France; [de Mets, Richard; Balland, Martial] Univ Grenoble 1, CNRS, UMR 5588, Lab Interdisciplinaire Phys, Grenoble, France; [Beauchef, Gallic; Vie, Katell] Lab Clarins, Pontoise, France; [Chamot, Christophe; Lionnet, Claire] PLATIM, US8, BioSci Gerland UMS3444, Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Vanacker, JM (corresponding author), Univ Lyon 1, Ecole Normale Super Lyon, Inst Genom Fonct Lyon, CNRS,UMR5242, F-69365 Lyon, France.	jean-marc.vanacker@ens-lyon.fr		Balland, martial/0000-0002-6585-9735; Carnesecchi, Julie/0000-0002-3872-2215; RUGGIERO, Florence/0000-0003-2915-5359	Clarins Laboratories	Clarins Laboratories(Randox Laboratories)	This work was funded by Clarins Laboratories. The funder provided support in the form of salaries for authors GB and KV, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors (in the section "contributed materials/reagents") are articulated in the 'author contributions' section.	Affinito P, 1999, MATURITAS, V33, P239, DOI 10.1016/S0378-5122(99)00077-8; Ashcroft GS, 2003, AM J CLIN DERMATOL, V4, P737, DOI 10.2165/00128071-200304110-00002; Ashcroft GS, 1997, NAT MED, V3, P1209, DOI 10.1038/nm1197-1209; Baumann L, 2007, J PATHOL, V211, P241, DOI 10.1002/path.2098; Bianco S, 2009, J BIOL CHEM, V284, P23286, DOI 10.1074/jbc.M109.028191; Della Torre S, 2011, CELL METAB, V13, P205, DOI 10.1016/j.cmet.2011.01.002; DEPASQUALE JA, 1994, J CELL SCI, V107, P1241; Ding QM, 2009, AM J PHYSIOL-CELL PH, V297, pC1178, DOI 10.1152/ajpcell.00185.2009; Elineni KK, 2011, BIOPHYS J, V101, P2903, DOI 10.1016/j.bpj.2011.11.013; Fisher GJ, 2009, AM J PATHOL, V174, P101, DOI 10.2353/ajpath.2009.080599; Flamini MI, 2009, MOL HUM REPROD, V15, P675, DOI 10.1093/molehr/gap045; Gallant ND, 2005, MOL BIOL CELL, V16, P4329, DOI 10.1091/mbc.E05-02-0170; Ge CT, 2012, ENDOCRINOLOGY, V153, P3504, DOI 10.1210/en.2012-1200; Giretti MS, 2008, STEROIDS, V73, P895, DOI 10.1016/j.steroids.2008.01.011; Haczynski J, 2004, INT J MOL MED, V13, P903; HASSELQUIST MB, 1980, J CLIN ENDOCR METAB, V50, P76, DOI 10.1210/jcem-50-1-76; Hattori T, 2011, J INVEST DERMATOL, V131, P1469, DOI 10.1038/jid.2011.63; Hirahara Y, 2013, NEUROSCIENCE, V235, P187, DOI 10.1016/j.neuroscience.2012.12.070; Kim DH, 2013, CELL ADHES MIGR, V7, P293, DOI 10.4161/cam.24804; Kohl E, 2011, J EUR ACAD DERMATOL, V25, P873, DOI 10.1111/j.1468-3083.2010.03963.x; Lanvin O, 2007, J BIOL CHEM, V282, P28328, DOI 10.1074/jbc.M704295200; Le Romancer M, 2010, STEROIDS, V75, P560, DOI 10.1016/j.steroids.2010.01.013; Levin ER, 2009, TRENDS ENDOCRIN MET, V20, P477, DOI 10.1016/j.tem.2009.06.009; Lin BC, 2009, CANCER RES, V69, P5415, DOI 10.1158/0008-5472.CAN-08-1622; Maggiolini M, 2004, J BIOL CHEM, V279, P27008, DOI 10.1074/jbc.M403588200; Maggiolini M, 2010, J ENDOCRINOL, V204, P105, DOI 10.1677/JOE-09-0242; McDonnell DP, 2002, SCIENCE, V296, P1642, DOI 10.1126/science.1071884; Mine S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004066; Muthukumaran P, 2012, BIOCHEM BIOPH RES CO, V423, P503, DOI 10.1016/j.bbrc.2012.05.149; Nawaz Z, 1999, P NATL ACAD SCI USA, V96, P1858, DOI 10.1073/pnas.96.5.1858; Naylor EC, 2011, MATURITAS, V69, P249, DOI 10.1016/j.maturitas.2011.04.011; Pelletier G, 2004, HISTOL HISTOPATHOL, V19, P629, DOI 10.14670/HH-19.629; Phillips TJ, 2008, J AM ACAD DERMATOL, V59, P397, DOI 10.1016/j.jaad.2008.05.009; Prossnitz ER, 2008, J STEROID BIOCHEM, V109, P350, DOI 10.1016/j.jsbmb.2008.03.006; Prossnitz ER, 2009, MOL CELL ENDOCRINOL, V308, P32, DOI 10.1016/j.mce.2009.03.026; Razandi M, 2000, J BIOL CHEM, V275, P38540, DOI 10.1074/jbc.M007555200; Rittie L, 2008, ARCH DERMATOL, V144, P1129, DOI 10.1001/archderm.144.9.1129; Sanchez AM, 2012, J NEUROENDOCRINOL, V24, P195, DOI 10.1111/j.1365-2826.2011.02258.x; Santolla MF, 2012, J BIOL CHEM, V287, P43234, DOI 10.1074/jbc.M112.417303; SAPINO A, 1986, CANCER RES, V46, P2526; Shah M G, 2001, Am J Clin Dermatol, V2, P143; Sharma G, 2011, ENDOCRINOLOGY, V152, P3030, DOI 10.1210/en.2011-0091; Simoncini T, 2006, MOL ENDOCRINOL, V20, P1756, DOI 10.1210/me.2005-0259; Stevenson S, 2007, CLIN INTERV AGING, V2, P283; Surazynski A, 2003, INT J MOL MED, V12, P803; Thornton MJ, 2013, DERM-ENDOCRINOL, V5, P264, DOI 10.4161/derm.23872; Thornton MJ, 2005, EXPERT OPIN THER TAR, V9, P617, DOI 10.1517/14728222.9.3.617; Thornton MJ, 2003, EXP DERMATOL, V12, P181, DOI 10.1034/j.1600-0625.2003.120209.x; TORRESALEMAN I, 1992, GLIA, V6, P180, DOI 10.1002/glia.440060305; Tsoureli-Nikita E, 2006, PHOTOCH PHOTOBIO SCI, V5, P160, DOI 10.1039/b507492d; Tsui KH, 2011, TAIWAN J OBSTET GYNE, V50, P474, DOI 10.1016/j.tjog.2011.10.013; Wend Korinna, 2012, Front Endocrinol (Lausanne), V3, P19, DOI 10.3389/fendo.2012.00019	52	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120672	10.1371/journal.pone.0120672	http://dx.doi.org/10.1371/journal.pone.0120672			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781607	gold, Green Published, Green Submitted			2022-12-27	WOS:000351284600181
J	Kim, M; Jung, S; Lee, SH; Lee, JH				Kim, Minjoo; Jung, Saem; Lee, Sang-Hyun; Lee, Jong Ho			Association between Arterial Stiffness and Serum L-Octanoylcarnitine and Lactosylceramide in Overweight Middle-Aged Subjects: 3-Year Follow-Up Study	PLOS ONE			English	Article							BODY-MASS INDEX; AMINO-ACID-METABOLISM; PULSE-WAVE VELOCITY; ALL-CAUSE MORTALITY; INSULIN-RESISTANCE; FATTY-ACID; LIQUID-CHROMATOGRAPHY; OBESITY; PLASMA; EXPRESSION	Existing data on the association between being overweight and cardiovascular morbidity and mortality risk in adults are inconsistent. We prospectively and longitudinally investigated the effects of weight on arterial stiffness and plasma metabolites in middle-aged subjects (aged 40-55 years). A group of 59 individuals who remained within the range of overweight during repeated measurements over a 3-year period was compared with a control group of 59 normal weight subjects who were matched for age and gender. Changes in metabolites by UPLC-LTQ-Orbitrap mass spectrometry and changes in brachial-ankle pulse wave velocity (ba-PWV) were examined. At baseline, the overweight group showed higher BMI, waist circumference, triglyceride, free fatty acid (FFA), glucose, insulin, and hs-CRP, and lower HDL-cholesterol than controls. After 3 years, the changes in waist circumference, diastolic and systolic blood pressure (DBP and SBP), triglyceride, FFA, glucose, insulin, hs-CRP, and ba-PWV observed in the overweight group were significantly different from those in the control group after adjusting for baseline levels. Furthermore, the overweight group showed greater increases in L-octanoylcarnitine (q=0.006) and decanoylcarnitine (q=0.007), and higher peak intensities of L-leucine, L-octanoylcarnitine, and decanoylcarnitine. Multiple linear regression analysis showed that the change in ba-PWV was independently and positively associated with changes in L-octanoylcarnitine, lactosylceramide, and SBP, and with baseline BMI. Our results indicate that the duration of overweight is an important aggravating factor for arterial stiffness, especially during middle age. Additionally, an age-related increase in plasma L-octanoylcarnitine, lactosylceramide, SBP, and baseline BMI are independent predictors of increased arterial stiffness in middle-aged individuals.	[Kim, Minjoo; Jung, Saem; Lee, Jong Ho] Yonsei Univ, Coll Human Ecol, Dept Food & Nutr, Natl Leading Res Lab Clin Nutrigenet Nutrigen, Seoul 120749, South Korea; [Kim, Minjoo; Jung, Saem; Lee, Jong Ho] Yonsei Univ, Coll Human Ecol, Dept Food & Nutr, Brain Korea PLUS Project 21, Seoul 120749, South Korea; [Lee, Sang-Hyun] Ilsan Hosp, Natl Hlth Insurance Corp, Dept Family Practice, Goyang, South Korea; [Lee, Jong Ho] Yonsei Univ, Res Inst Sci Aging, Seoul 120749, South Korea	Yonsei University; Yonsei University; NHIS Ilsan Hospital; Yonsei University	Lee, JH (corresponding author), Yonsei Univ, Coll Human Ecol, Dept Food & Nutr, Natl Leading Res Lab Clin Nutrigenet Nutrigen, Seoul 120749, South Korea.	jhleeb@yonsei.ac.kr	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454	Bio-Synergy Research Projects [NRF-2012M3A9C4048762]; Mid-Career Researcher Program of the National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning, Republic of Korea [NRF-20100015017]	Bio-Synergy Research Projects; Mid-Career Researcher Program of the National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning, Republic of Korea	This work is supported by the Bio-Synergy Research Projects (NRF-2012M3A9C4048762) and Mid-Career Researcher Program (NRF-20100015017) of the National Research Foundation (NRF) funded by the Ministry of Science, ICT & Future Planning, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SH, 2011, ADV NUTR, V2, P445, DOI 10.3945/an.111.000737; Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754; Ahn Y, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-61; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Borrell LN, 2014, AM J PUBLIC HEALTH, V104, P512, DOI 10.2105/AJPH.2013.301597; Chakraborti S, 2003, CELL SIGNAL, V15, P637, DOI 10.1016/S0898-6568(02)00144-4; Choo J, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-5; De Guzman JM, 2013, AGE, V35, P1091, DOI 10.1007/s11357-012-9430-x; Draznin B, 2006, DIABETES, V55, P2392, DOI 10.2337/db06-0391; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Gong NL, 2004, P NATL ACAD SCI USA, V101, P6490, DOI 10.1073/pnas.0308684101; Goodpaster Bret H, 2002, Curr Diab Rep, V2, P216, DOI 10.1007/s11892-002-0086-2; Herman MA, 2010, J BIOL CHEM, V285, P11348, DOI 10.1074/jbc.M109.075184; HOPPEL CL, 1980, AM J PHYSIOL, V238, pE409, DOI 10.1152/ajpendo.1980.238.5.E409; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kangas P, 2013, METABOLISM, V62, P1114, DOI 10.1016/j.metabol.2013.02.009; 최현정, 2005, [Journal of THE KOREAN DIETETIC ASSOCIATION, 대한영양사협회 학술지], V11, P159; Kim JY, 2010, J PROTEOME RES, V9, P4368, DOI 10.1021/pr100101p; Kim OY, 2013, CLIN EXP HYPERTENS, V35, P382, DOI 10.3109/10641963.2012.739232; Kolade OO, 2012, INT J OBESITY, V36, P93, DOI 10.1038/ijo.2011.79; Krssak M, 1999, DIABETOLOGIA, V42, P113, DOI 10.1007/s001250051123; Lackey DE, 2013, AM J PHYSIOL-ENDOC M, V304, pE1175, DOI 10.1152/ajpendo.00630.2012; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Madonna R, 2012, REV ESP CARDIOL, V65, P309, DOI [10.1016/j.rec.2011.11.009, 10.1016/j.recesp.2011.11.010]; Mai M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082459; Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235; McDonough C, 2013, DIABETES OBES METAB, V15, P342, DOI 10.1111/dom.12033; Mihalik SJ, 2012, DIABETES CARE, V35, P605, DOI [10.2337/DC11-1577, 10.2337/dc11-1577]; Mihalik SJ, 2010, OBESITY, V18, P1695, DOI 10.1038/oby.2009.510; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Rajesh M, 2005, CIRC RES, V97, P796, DOI 10.1161/01.RES.0000185327.45463.A8; Ramos-Roman MA, 2012, METABOLISM, V61, P202, DOI 10.1016/j.metabol.2011.06.008; Redman LM, 2011, J CLIN ENDOCR METAB, V96, pE312, DOI 10.1210/jc.2010-1971; SALOMAA V, 1995, CIRCULATION, V91, P1432, DOI 10.1161/01.CIR.91.5.1432; Seiler SE, 2014, J LIPID RES, V55, P635, DOI 10.1194/jlr.M043448; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Stephens FB, 2007, J PHYSIOL-LONDON, V581, P431, DOI 10.1113/jphysiol.2006.125799; Sutton-Tyrrell K, 2001, HYPERTENSION, V38, P429, DOI 10.1161/01.HYP.38.3.429; Tomiyama H, 2010, CIRC J, V74, P24, DOI 10.1253/circj.CJ-09-0534; Tsuchikura S, 2010, ATHEROSCLEROSIS, V211, P480, DOI 10.1016/j.atherosclerosis.2010.03.037; Tsuchikura S, 2010, J ATHEROSCLER THROMB, V17, P658, DOI 10.5551/jat.3616; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Wildman RP, 2003, HYPERTENSION, V42, P468, DOI 10.1161/01.HYP.0000090360.78539.CD; Williams R, 2006, MOL BIOSYST, V2, P174, DOI 10.1039/b516356k; Yang L, 2008, CHEM RES TOXICOL, V21, P2280, DOI 10.1021/tx800225q; 심연정, 2009, Journal of Nutrition and Health, V42, P577; Zhao XJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE384, DOI 10.1152/ajpendo.90748.2008	48	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119519	10.1371/journal.pone.0119519	http://dx.doi.org/10.1371/journal.pone.0119519			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781947	gold, Green Published, Green Submitted			2022-12-27	WOS:000351284600073
J	Large, SI; Fay, G; Friedland, KD; Link, JS				Large, Scott I.; Fay, Gavin; Friedland, Kevin D.; Link, Jason S.			Quantifying Patterns of Change in Marine Ecosystem Response to Multiple Pressures	PLOS ONE			English	Article							FISH COMMUNITY; ECOLOGICAL INDICATORS; CLIMATE; MANAGEMENT; FISHERIES; THRESHOLDS; TRENDS; SIZE; CLASSIFICATION; CONSERVATION	The ability to understand and ultimately predict ecosystem response to multiple pressures is paramount to successfully implement ecosystem-based management. Thresholds shifts and nonlinear patterns in ecosystem responses can be used to determine reference points that identify levels of a pressure that may drastically alter ecosystem status, which can inform management action. However, quantifying ecosystem reference points has proven elusive due in large part to the multi-dimensional nature of both ecosystem pressures and ecosystem responses. We used ecological indicators, synthetic measures of ecosystem status and functioning, to enumerate important ecosystem attributes and to reduce the complexity of the Northeast Shelf Large Marine Ecosystem (NES LME). Random forests were used to quantify the importance of four environmental and four anthropogenic pressure variables to the value of ecological indicators, and to quantify shifts in aggregate ecological indicator response along pressure gradients. Anthropogenic pressure variables were critical defining features and were able to predict an average of 8-13% (up to 25-66% for individual ecological indicators) of the variation in ecological indicator values, whereas environmental pressures were able to predict an average of 1-5 % (up to 9-26% for individual ecological indicators) of ecological indicator variation. Each pressure variable predicted a different suite of ecological indicator's variation and the shapes of ecological indicator responses along pressure gradients were generally nonlinear. Threshold shifts in ecosystem response to exploitation, the most important pressure variable, occurred when commercial landings were 20 and 60% of total surveyed biomass. Although present, threshold shifts in ecosystem response to environmental pressures were much less important, which suggests that anthropogenic pressures have significantly altered the ecosystem structure and functioning of the NES LME. Gradient response curves provide ecologically informed transformations of pressure variables to explain patterns of ecosystem structure and functioning. By concurrently identifying thresholds for a suite of ecological indicator responses to multiple pressures, we demonstrate that ecosystem reference points can be evaluated and used to support ecosystem-based management.	[Large, Scott I.; Fay, Gavin; Link, Jason S.] NOAA Fisheries, Woods Hole, MA USA; [Friedland, Kevin D.] NOAA Fisheries, Narragansett, RI USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Large, SI (corresponding author), ICES Secretariat, Copenhagen, Denmark.	largesi@gmail.com		Fay, Gavin/0000-0003-0425-9952; Link, Jason/0000-0003-2740-7161; Large, Scott/0000-0001-7199-9972	Fisheries and the Environment Program	Fisheries and the Environment Program	This study was supported by the Fisheries and the Environment Program (JSL and KDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azarovitz T.R., 1981, Canadian Special Publication of Fisheries and Aquatic Sciences, V58, P62; Baker MR, 2014, DEEP-SEA RES PT II, V109, P215, DOI 10.1016/j.dsr2.2014.03.001; Beaugrand G, 2008, ECOL LETT, V11, P1157, DOI 10.1111/j.1461-0248.2008.01218.x; Blanchard JL, 2005, ICES J MAR SCI, V62, P405, DOI 10.1016/j.icesjms.2005.01.006; Brander KM, 2007, P NATL ACAD SCI USA, V104, P19709, DOI 10.1073/pnas.0702059104; Brander K, 2010, J MARINE SYST, V79, P389, DOI 10.1016/j.jmarsys.2008.12.015; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bundy A, 2010, ICES J MAR SCI, V67, P745, DOI 10.1093/icesjms/fsp283; Christensen NL, 1996, ECOL APPL, V6, P665, DOI 10.2307/2269460; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Darling ES, 2008, ECOL LETT, V11, P1278, DOI 10.1111/j.1461-0248.2008.01243.x; Ecosystem Assessment Program (EcoAP), 2011, 1207 NE FISH SCI CTR, V12-07, P38; Ellis N, 2012, ECOLOGY, V93, P156, DOI 10.1890/11-0252.1; Fewster RM, 2000, ECOLOGY, V81, P1970, DOI 10.2307/177286; Gaichas SK, 2012, MAR ECOL PROG SER, V459, P159, DOI 10.3354/meps09841; Gislason H, 1998, ICES J MAR SCI, V55, P362, DOI 10.1006/jmsc.1997.0323; Greene CH, 2008, ECOLOGY, V89, pS24, DOI 10.1890/07-0550.1; Groffman PM, 2006, ECOSYSTEMS, V9, P1289, DOI 10.1007/s10021-006-0177-z; Hall S, 1999, BLACKWELL SCI OXFORD; Hsieh CH, 2006, NATURE, V443, P859, DOI 10.1038/nature05232; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jennings S, 1999, J ANIM ECOL, V68, P617, DOI 10.1046/j.1365-2656.1999.00312.x; Jennings S, 1998, ADV MAR BIOL, V34, P201, DOI 10.1016/S0065-2881(08)60212-6; Jennings S, 2005, FISH FISH, V6, P212, DOI 10.1111/j.1467-2979.2005.00189.x; Lackey RT, 1998, LANDSCAPE URBAN PLAN, V40, P21, DOI 10.1016/S0169-2046(97)00095-9; Large SI, 2013, ICES J MAR SCI, V70, P755, DOI 10.1093/icesjms/fst067; Large SI, 2015, MAR ECOL PROG SER; Link J, 2002, NEFSC ECOSYST STATUS, V2, P245; Link J. S., 2010, ECOSYSTEM BASED FISH; Link JS, 2012, MAR ECOL PROG SER, V459, P293, DOI 10.3354/meps09829; Link JS, 2005, ICES J MAR SCI, V62, P569, DOI 10.1016/j.icesjms.2004.12.015; Link JS, 2002, FISH B-NOAA, V100, P381; Link JS, 2002, CAN J FISH AQUAT SCI, V59, P1429, DOI 10.1139/F02-115; Link JS, 2000, NMFSNE15 NOAA; Mangel M, 1996, ECOL APPL, V6, P338, DOI 10.2307/2269369; Martin J, 2009, ECOL APPL, V19, P1079, DOI 10.1890/08-0255.1; Methratta ET, 2006, N AM J FISH MANAGE, V26, P473, DOI 10.1577/M05-041.1; Mills KE, 2013, GLOBAL CHANGE BIOL, V19, P3046, DOI 10.1111/gcb.12298; Murawski SA, 2000, ICES J MAR SCI, V57, P649, DOI 10.1006/jmsc.2000.0738; NEFC, 1988, EV BOTT TRAWL SURV P; NEFSC, 1998, NMFSNE115 NOAA, P149; NEFSC (Northeast Fisheries Science Center), 2009, EC STAT REP NE US CO, P34; Nicholson MD, 2004, ICES J MAR SCI, V61, P35, DOI 10.1016/j.icesjms.2003.09.004; Nye JA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1420; Overholtz WJ, 2000, ICES J MAR SCI, V57, P1147, DOI 10.1006/jmsc.2000.0802; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pitcher CR, 2012, J APPL ECOL, V49, P670, DOI 10.1111/j.1365-2664.2012.02148.x; R Core Team, 2021, R LANGUAGE ENV STAT; Rice J, 1996, ICES J MAR SCI, V53, P1214, DOI 10.1006/jmsc.1996.0146; Rice JC, 2009, ICES J MAR SCI, V66, P433, DOI 10.1093/icesjms/fsp021; Shin YJ, 2010, ICES J MAR SCI, V67, P692, DOI 10.1093/icesjms/fsp294; Shin YJ, 2010, ICES J MAR SCI, V67, P717, DOI 10.1093/icesjms/fsp287; Slocombe DS, 1998, ENVIRON MANAGE, V22, P483, DOI 10.1007/s002679900121; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Trenkel VM, 2003, CAN J FISH AQUAT SCI, V60, P67, DOI 10.1139/F02-163	57	42	42	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119922	10.1371/journal.pone.0119922	http://dx.doi.org/10.1371/journal.pone.0119922			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781166	gold, Green Published, Green Submitted			2022-12-27	WOS:000351284600108
J	Ott, C; Dorsch, E; Fraunholz, M; Straub, S; Kozjak-Pavlovic, V				Ott, Christine; Dorsch, Eva; Fraunholz, Martin; Straub, Sebastian; Kozjak-Pavlovic, Vera			Detailed Analysis of the Human Mitochondrial Contact Site Complex Indicate a Hierarchy of Subunits	PLOS ONE			English	Article							OUTER-MEMBRANE; CRISTAE MORPHOLOGY; PROTEIN; BIOGENESIS; MITOFILIN; ORGANIZATION; SAM50; COMPONENT; METAXIN	Mitochondrial inner membrane folds into cristae, which significantly increase its surface and are important for mitochondrial function. The stability of cristae depends on the mitochondrial contact site (MICOS) complex. In human mitochondria, the inner membrane MICOS complex interacts with the outer membrane sorting and assembly machinery (SAM) complex, to form the mitochondrial intermembrane space bridging complex (MIB). We have created knockdown cell lines of most of the MICOS and MIB components and have used them to study the importance of the individual subunits for the cristae formation and complex stability. We show that the most important subunits of the MIB complex in human mitochondria are Mic60/Mitofilin, Mic19/CHCHD3 and an outer membrane component Sam50. We provide additional proof that ApoO indeed is a subunit of the MICOS and MIB complexes and propose the name Mic23 for this protein. According to our results, Mic25/CHCHD6, Mic27/ApoOL and Mic23/ApoO appear to be periphery subunits of the MICOS complex, because their depletion does not affect cristae morphology or stability of other components.	[Ott, Christine; Dorsch, Eva; Fraunholz, Martin; Straub, Sebastian; Kozjak-Pavlovic, Vera] Univ Wurzburg, Chair Microbiol, Bioctr, D-97070 Wurzburg, Germany	University of Wurzburg	Kozjak-Pavlovic, V (corresponding author), Univ Wurzburg, Chair Microbiol, Bioctr, D-97070 Wurzburg, Germany.	vera.kozjak@uni-wuerzburg.de	Kozjak-Pavlovic, Vera/E-1494-2013	Kozjak-Pavlovic, Vera/0000-0001-9658-7018; Fraunholz, Martin/0000-0002-4581-6244	 [KO3882/1-1];  [SFB630]	; 	This work is supported by KO3882/1-1, http://www.dfg.de/, and SFB630, http://www.dfg.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhaja AK, 2012, MOL BIOL CELL, V23, P247, DOI 10.1091/mbc.E11-09-0774; An J, 2012, J BIOL CHEM, V287, P7411, DOI 10.1074/jbc.M111.277103; Armstrong LC, 1999, J CELL BIOCHEM, V74, P11, DOI 10.1002/(SICI)1097-4644(19990701)74:1<11::AID-JCB2>3.0.CO;2-V; Armstrong LC, 1997, J BIOL CHEM, V272, P6510, DOI 10.1074/jbc.272.10.6510; Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Darshi M, 2011, J BIOL CHEM, V286, P2918, DOI 10.1074/jbc.M110.171975; Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092; Harner M, 2011, EMBO J, V30, P4356, DOI 10.1038/emboj.2011.379; Head BP, 2011, MOL BIOL CELL, V22, P831, DOI 10.1091/mbc.E10-07-0600; Hoppins S, 2011, J CELL BIOL, V195, P323, DOI 10.1083/jcb.201107053; John GB, 2005, MOL BIOL CELL, V16, P1543, DOI 10.1091/mbc.e04-08-0697; Kozjak-Pavlovic V, 2007, EMBO REP, V8, P576, DOI 10.1038/sj.embor.7400982; Kozjak-Pavlovic V, 2014, J MOL BIOL, V426, P908, DOI 10.1016/j.jmb.2013.12.001; Kozjak-Pavlovic V, 2011, J BIOL CHEM, V286, P27019, DOI 10.1074/jbc.M111.232249; Kozjak-Pavlovic V, 2010, J MOL BIOL, V397, P219, DOI 10.1016/j.jmb.2010.01.047; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Ott C, 2012, MOL CELL BIOL, V32, P1173, DOI 10.1128/MCB.06388-11; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; Pfanner N, 2014, J CELL BIOL, V204, P1083, DOI 10.1083/jcb.201401006; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Turkieh A, 2014, J CLIN INVEST, V124, P2277, DOI 10.1172/JCI74668; von der Malsburg K, 2011, DEV CELL, V21, P694, DOI 10.1016/j.devcel.2011.08.026; Weber TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063683; Wiedemann N, 2003, NATURE, V424, P565, DOI 10.1038/nature01753; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Xie J, 2007, FEBS LETT, V581, P3545, DOI 10.1016/j.febslet.2007.06.052	27	83	89	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120213	10.1371/journal.pone.0120213	http://dx.doi.org/10.1371/journal.pone.0120213			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781180	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600138
J	Papinutto, N; Schlaeger, R; Panara, V; Zhu, AH; Caverzasi, E; Stern, WA; Hauser, SL; Henry, RG				Papinutto, Nico; Schlaeger, Regina; Panara, Valentina; Zhu, Alyssa H.; Caverzasi, Eduardo; Stern, William A.; Hauser, Stephen L.; Henry, Roland G.			Age, Gender and Normalization Covariates for Spinal Cord Gray Matter and Total Cross-Sectional Areas at Cervical and Thoracic Levels: A 2D Phase Sensitive Inversion Recovery Imaging Study	PLOS ONE			English	Article							REMITTING MULTIPLE-SCLEROSIS; SURFACE-BASED ANALYSIS; IN-VIVO; GREY-MATTER; ATROPHY; SEGMENTATION; MRI; DISABILITY; VOLUME; BRAIN	The source of inter-subject variability and the influence of age and gender on morphometric characteristics of the spinal cord, such as the total cross-sectional area (TCA), the gray matter (GM) and white matter (WM) areas, currently remain under investigation. Understanding the effect of covariates such as age, gender, brain volumes, and skull-and vertebra-derived metrics on cervical and thoracic spinal cord TCA and GM areas in healthy subjects would be fundamental for exploring compartment specific changes in neurological diseases affecting the spinal cord. Using Magnetic Resonance Imaging at 3T we investigated 32 healthy subjects using a 2D phase sensitive inversion recovery sequence and we measured TCA, GM and WM areas at 4 cervical and thoracic levels of the spinal cord. We assessed age and gender relationships of cord measures and explored associations between cord measures and a) brain volumes and b) skull-and vertebra-derived metrics. Age and gender had a significant effect on TCA, WM and GM areas (with women and elderly having smaller values than men and younger people respectively), but not on the GM area/TCA ratio. The total intracranial volume and C3 vertebra dimensions showed the highest correlations with cord measures. When used in multi-regression models, they reduced cord areas group variability by approximately a third. Age and gender influences on cord measures and normalization strategies here presented might be of use in the study of compartment specific changes in various neurological diseases affecting the spinal cord.	[Papinutto, Nico; Schlaeger, Regina; Zhu, Alyssa H.; Caverzasi, Eduardo; Stern, William A.; Hauser, Stephen L.; Henry, Roland G.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Schlaeger, Regina] Univ Basel, Dept Neurol, Basel, Switzerland; [Panara, Valentina] Univ G DAnnunzio, ITAB Inst Adv Biomed Technol, Chieti, Italy; [Henry, Roland G.] Univ Calif San Francisco, Bioengn Grad Grp, San Francisco, CA 94143 USA; [Henry, Roland G.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Henry, Roland G.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of Basel; G d'Annunzio University of Chieti-Pescara; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Papinutto, N (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	nico.papinutto@ucsf.edu	Hauser, Stephen L/J-2978-2016; Caverzasi, Eduardo/P-1707-2019; Panara, Valentina/AAB-2744-2019	Panara, Valentina/0000-0001-9655-3926; Caverzasi, Eduardo/0000-0002-0350-0460	National Institutes of Health [R01 NS049477, 1U19A1067152]; National Multiple Sclerosis Society [RG 2899-D11]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049477] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the National Institutes of Health (R01 NS049477; 1U19A1067152), and the National Multiple Sclerosis Society (RG 2899-D11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta F, 2007, NEUROIMAGE, V36, P728, DOI 10.1016/j.neuroimage.2007.03.048; Asman AJ, 2014, MED IMAGE ANAL, V18, P460, DOI 10.1016/j.media.2014.01.003; Asman AJ, 2013, LECT NOTES COMPUT SC, V8149, P759, DOI 10.1007/978-3-642-40811-3_95; Bjartmar C, 2000, ANN NEUROL, V48, P893, DOI 10.1002/1531-8249(200012)48:6<893::AID-ANA10>3.3.CO;2-2; Cadotte D. W., 2014, AJNR AM J NEURORADIO; Cronin CG, 2009, CLIN RADIOL, V64, P64, DOI 10.1016/j.crad.2008.03.012; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; El Mendili MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095516; Engl C, 2013, NEURORADIOLOGY, V55, P963, DOI 10.1007/s00234-013-1204-3; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fradet L, 2014, SPINE, V39, pE262, DOI 10.1097/BRS.0000000000000125; Furby J, 2008, MULT SCLER J, V14, P1068, DOI 10.1177/1352458508093617; Gilmore CP, 2009, BRAIN PATHOL, V19, P642, DOI 10.1111/j.1750-3639.2008.00228.x; Grados F, 2009, JOINT BONE SPINE, V76, P241, DOI 10.1016/j.jbspin.2008.07.017; Healy BC, 2012, J NEUROIMAGING, V22, pE12, DOI 10.1111/j.1552-6569.2011.00629.x; Horsfield MA, 2010, NEUROIMAGE, V50, P446, DOI 10.1016/j.neuroimage.2009.12.121; Ishikawa M, 2003, SPINAL CORD, V41, P159, DOI 10.1038/sj.sc.3101375; Israel H, 2005, ARCH NEUROL-CHICAGO, V62, P1157, DOI 10.1001/archneur.62.7.1157; Kato F, 2012, EUR SPINE J, V21, P1499, DOI 10.1007/s00586-012-2176-4; Kearney H, 2013, MULT SCLER RELAT DIS, V2, P103, DOI 10.1016/j.msard.2012.09.005; Kearney H, 2014, J MAGN RESON IMAGING, V39, P617, DOI 10.1002/jmri.24194; Klein JP, 2011, AM J NEURORADIOL, V32, P1138, DOI 10.3174/ajnr.A2459; Losseff NA, 1996, BRAIN, V119, P701, DOI 10.1093/brain/119.3.701; Lukas C, 2013, RADIOLOGY, V269, P541, DOI 10.1148/radiol.13122566; Mamata H, 2005, J MAGN RESON IMAGING, V22, P38, DOI 10.1002/jmri.20357; Mann RS, 2007, J MAGN RESON IMAGING, V26, P61, DOI 10.1002/jmri.20959; Oh J, 2014, J NEUROIMAGING, V24, P577, DOI 10.1111/jon.12097; Papinutto N, 2015, J MAGN RESON IMAGING, V42, P698, DOI 10.1002/jmri.24819; PAVLOV H, 1987, RADIOLOGY, V164, P771, DOI 10.1148/radiology.164.3.3615879; Powers JM, 2000, J NEUROPATH EXP NEUR, V59, P89, DOI 10.1093/jnen/59.2.89; Rashid W, 2006, J MAGN RESON IMAGING, V23, P473, DOI 10.1002/jmri.20545; Rocca MA, 2011, NEUROLOGY, V76, P2096, DOI 10.1212/WNL.0b013e31821f46b8; Sanfilipo MP, 2004, NEUROIMAGE, V22, P1732, DOI 10.1016/j.neuroimage.2004.03.037; Schlaeger R, 2014, ANN NEUROL, V76, P568, DOI 10.1002/ana.24241; SHERMAN JL, 1990, AM J NEURORADIOL, V11, P369; Singh Kern, 2005, Spine J, V5, P615, DOI 10.1016/j.spinee.2005.05.385; Song F, 2008, J NEUROIMAGING, V18, P320, DOI 10.1111/j.1552-6569.2007.00222.x; Taso M, 2014, MAGN RESON MATER PHY, V27, P257, DOI 10.1007/s10334-013-0403-6; Ulbrich EJ, 2014, RADIOLOGY, V271, P172, DOI 10.1148/radiol.13120370; Vaithianathar L, 2003, J NEUROL, V250, P307, DOI 10.1007/s00415-003-1001-8; Vedantam A, 2013, J MAGN RESON IMAGING, V38, P861, DOI 10.1002/jmri.24039; Wang K, 2014, EUR J RADIOL, V83, P2196, DOI 10.1016/j.ejrad.2014.09.010; Yanase M, 2006, J SPINAL DISORD TECH, V19, P125, DOI 10.1097/01.bsd.0000181294.67212.79; Yiannakas MC, 2012, NEUROIMAGE, V63, P1054, DOI 10.1016/j.neuroimage.2012.07.048; Yiannakas MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105544; Zivadinov R, 2008, AM J NEURORADIOL, V29, P319, DOI 10.3174/ajnr.A0813	47	38	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0118576	10.1371/journal.pone.0118576	http://dx.doi.org/10.1371/journal.pone.0118576			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781178	gold, Green Published			2022-12-27	WOS:000351284600028
J	Vanneste, S; Van de Heyning, P; De Ridder, D				Vanneste, Sven; Van de Heyning, Paul; De Ridder, Dirk			Tinnitus: A Large VBM-EEG Correlational Study	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; VOXEL-BASED MORPHOMETRY; ANTERIOR THALAMUS; COCHLEAR NUCLEUS; AUDITORY-CORTEX; PHANTOM SOUND; TOMOGRAPHY; DISTRESS; EPILEPSY; LOCALIZATION	A surprising fact in voxel-based morphometry (VBM) studies performed in tinnitus is that not one single region is replicated in studies of different centers. The question then rises whether this is related to the low sample size of these studies, the selection of non-representative patient subgroups, or the absence of stratification according to clinical characteristics. Another possibility is that VBM is not a good tool to study functional pathologies such as tinnitus, in contrast to pathologies like Alzheimer's disease where it is known the pathology is related to cell loss. In a large sample of 154 tinnitus patients VBM and QEEG (Quantitative Electroencephalography) was performed and evaluated by a regression analysis. Correlation analyses are performed between VBM and QEEG data. Uncorrected data demonstrated structural differences in grey matter in hippocampal and cerebellar areas related to tinnitus related distress and tinnitus duration. After control for multiple comparisons, only cerebellar VBM changes remain significantly altered. Electrophysiological differences are related to distress, tinnitus intensity, and tinnitus duration in the subgenual anterior cingulate cortex, dorsal anterior cingulate cortex, hippocampus, and parahippocampus, which confirms previous results. The absence of QEEG-VBM correlations suggest functional changes are not reflected by co-occurring structural changes in tinnitus, and the absence of VBM changes (except for the cerebellum) that survive correct statistical analysis in a large study population suggests that VBM might not be very sensitive for studying tinnitus.	[Vanneste, Sven; Van de Heyning, Paul] Univ Antwerp, Fac Med, Dept Translat Neurosci, B-2020 Antwerp, Belgium; [Vanneste, Sven] Univ Texas Dallas, Sch Behav & Brain Sci, Dallas, TX 75230 USA; [Van de Heyning, Paul] Univ Antwerp Hosp, ENT Dept, Antwerp, Belgium; [De Ridder, Dirk] Univ Otago, Dunedin Sch Med, Dept Surg Sci, Dunedin, New Zealand	University of Antwerp; University of Texas System; University of Texas Dallas; University of Antwerp; University of Otago	Vanneste, S (corresponding author), Univ Antwerp, Fac Med, Dept Translat Neurosci, B-2020 Antwerp, Belgium.	ven.vanneste@utdallas.edu	Heyning, Paul H Vande/I-8278-2017	Heyning, Paul H Vande/0000-0002-8424-3717; Vanneste, Sven/0000-0003-1513-5752	Research Foundation Flanders (FWO); Tinnitus Research Initiative (TRI); Antwerp University TOP Project	Research Foundation Flanders (FWO)(FWO); Tinnitus Research Initiative (TRI); Antwerp University TOP Project	This work was supported by the Research Foundation Flanders (FWO), the Tinnitus Research Initiative (TRI) and Antwerp University TOP Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Kareem IA, 2011, J MAGN RESON IMAGING, V33, P24, DOI 10.1002/jmri.22391; Adjamian P, 2009, HEARING RES, V253, P15, DOI 10.1016/j.heares.2009.04.001; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; AXELSSON A, 1989, British Journal of Audiology, V23, P53, DOI 10.3109/03005368909077819; Axelsson Alf, 2000, Noise Health, V2, P47; Betting LE, 2010, HUM BRAIN MAPP, V31, P1327, DOI 10.1002/hbm.20944; Boyen K, 2012, HEAR RES; Brett M, 2002, NAT REV NEUROSCI, V3, P243, DOI 10.1038/nrn756; British Society of Audiology, 2008, REC PROC PUR TON AIR; Brozoski TJ, 2007, HEARING RES, V228, P168, DOI 10.1016/j.heares.2007.02.003; Buckner RL, 2011, J NEUROPHYSIOL, V106, P2322, DOI 10.1152/jn.00339.2011; Congedo M, 2002, EUREKA VERSION 3 0; Cronlein T, 2007, PROG BRAIN RES, V166, P227, DOI 10.1016/S0079-6123(07)66021-X; De Ridder D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024273; De Ridder D, 2011, P NATL ACAD SCI USA, V108, P8075, DOI 10.1073/pnas.1018466108; Dierks T, 2000, CLIN NEUROPHYSIOL, V111, P1817, DOI 10.1016/S1388-2457(00)00427-2; Dille MF, 2010, J AM ACAD AUDIOL, V21, P409, DOI 10.3766/jaaa.21.6.6; Dobie RA, 2003, OTOLARYNG CLIN N AM, V36, P383, DOI 10.1016/S0030-6665(02)00168-8; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Ferreira LK, 2011, NEUROBIOL AGING, V32, P1733, DOI 10.1016/j.neurobiolaging.2009.11.008; Fuchs M, 2002, CLIN NEUROPHYSIOL, V113, P702, DOI 10.1016/S1388-2457(02)00030-5; Hallam RS, 2004, INT J AUDIOL, V43, P218, DOI 10.1080/14992020400050030; Heller AJ, 2003, OTOLARYNG CLIN N AM, V36, P239, DOI 10.1016/S0030-6665(02)00160-3; HILLER W, 1992, J PSYCHOSOM RES, V36, P337, DOI 10.1016/0022-3999(92)90070-I; HILLER W, 1994, BRIT J CLIN PSYCHOL, V33, P231, DOI 10.1111/j.2044-8260.1994.tb01117.x; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; HUANG CM, 1982, BRAIN RES, V244, P1, DOI 10.1016/0006-8993(82)90897-6; Husain FT, 2011, BRAIN RES, V1369, P74, DOI 10.1016/j.brainres.2010.10.095; Johnsrude IS, 2002, AUDIOL NEURO-OTOL, V7, P251, DOI 10.1159/000064446; Jurcak V, 2007, NEUROIMAGE, V34, P1600, DOI 10.1016/j.neuroimage.2006.09.024; Kaltenbach JA, 2000, HEARING RES, V140, P165, DOI 10.1016/S0378-5955(99)00197-5; Koepp MJ, 2005, LANCET NEUROL, V4, P42, DOI 10.1016/S1474-4422(04)00965-2; Landgrebe M, 2009, NEUROIMAGE, V46, P213, DOI 10.1016/j.neuroimage.2009.01.069; Leaver AM, 2011, NEURON, V69, P33, DOI 10.1016/j.neuron.2010.12.002; Li J, 2011, NEUROSCI BIOBEHAV RE; Lockwood AH, 2001, NEUROLOGY, V56, P472, DOI 10.1212/WNL.56.4.472; Mahoney CJ, 2011, J NEUROL NEUROSURG P; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; May A, 2007, CEREB CORTEX, V17, P205, DOI 10.1093/cercor/bhj138; McCombe A, 2001, CLIN OTOLARYNGOL, V26, P388, DOI 10.1046/j.1365-2273.2001.00490.x; Meeus O, 2007, B-ENT, P11; Meeus O., 2011, OTOL NEUROTOL; Meeus O., 2009, EUR ARCH OTO-RHINO-L; Melcher JR, 2012, HEAR RES; Mirz F, 2000, ACTA OTO-LARYNGOL, P241; Mirz F, 2000, NEUROREPORT, V11, P633, DOI 10.1097/00001756-200002280-00039; Moller AR, 2007, PROG BRAIN RES, V166, P3, DOI 10.1016/S0079-6123(07)66001-4; Muhlau M, 2006, CEREB CORTEX, V16, P1283, DOI 10.1093/cercor/bhj070; Mulert C, 2004, NEUROIMAGE, V22, P83, DOI 10.1016/j.neuroimage.2003.10.051; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Norena A, 2002, AUDIOL NEURO-OTOL, V7, P358, DOI 10.1159/000066156; Osaki Y, 2005, NEUROREPORT, V16, P1625, DOI 10.1097/01.wnr.0000183899.85277.08; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Petacchi A, 2005, HUM BRAIN MAPP, V25, P118, DOI 10.1002/hbm.20137; Pizzagalli D, 2001, AM J PSYCHIAT, V158, P405, DOI 10.1176/appi.ajp.158.3.405; Pizzagalli DA, 2004, MOL PSYCHIATR, V9, P393, DOI 10.1038/sj.mp.4001469; Ramnani N, 2006, NAT REV NEUROSCI, V7, P511, DOI 10.1038/nrn1953; Salvi RJ, 2000, HEARING RES, V147, P261, DOI 10.1016/S0378-5955(00)00136-2; Schecklmann M, 2013, BRAIN STRUCT FUNCT, V218, P1061, DOI 10.1007/s00429-013-0520-z; Schlee W, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-16; Schlee W, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-80; Schlee W, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-11; SCHMAHMANN JD, 1991, ARCH NEUROL-CHICAGO, V48, P1178, DOI 10.1001/archneur.1991.00530230086029; Schreiber BE, 2010, LANCET, V375, P1203, DOI 10.1016/S0140-6736(09)62071-7; Schwartze M, 2012, INT J PSYCHOPHYSIOL, V83, P200, DOI 10.1016/j.ijpsycho.2011.11.003; Shulman A, 1999, Int Tinnitus J, V5, P92; Smits M, 2007, NEURORADIOLOGY, V49, P669, DOI 10.1007/s00234-007-0231-3; Tisserand DJ, 2004, CEREB CORTEX, V14, P966, DOI 10.1093/cercor/bhh057; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van der Loo E, 2011, AUTON NEUROSCI-BASIC, V165, P191, DOI 10.1016/j.autneu.2011.06.007; van der Loo E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007396; Vanneste S., 2011, NEUROSCIENCE; Vanneste S., 2010, CLIN NEUROPHYSIOL; Vanneste S, 2014, CEREB CORTEX, V24, P2268, DOI 10.1093/cercor/bht068; Vanneste S, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00031; Vanneste S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031182; Vanneste S, 2011, EUR J NEUROSCI, V34, P718, DOI 10.1111/j.1460-9568.2011.07793.x; Vanneste S, 2011, CLIN NEUROPHYSIOL, V122, P578, DOI 10.1016/j.clinph.2010.07.022; Vanneste S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013618; Vanneste S, 2010, NEUROIMAGE, V52, P470, DOI 10.1016/j.neuroimage.2010.04.029; Vitacco D, 2002, HUM BRAIN MAPP, V17, P4, DOI 10.1002/hbm.10038; Volpe U, 2007, BRAIN RES BULL, V73, P220, DOI 10.1016/j.brainresbull.2007.03.003; Wong PCM, 2010, EAR HEARING, V31, P471, DOI 10.1097/AUD.0b013e3181d709c2; Zumsteg D, 2006, CLIN NEUROPHYSIOL, V117, P192, DOI 10.1016/j.clinph.2005.09.015; Zumsteg D, 2005, NEUROLOGY, V65, P1657, DOI 10.1212/01.wnl.0000184516.32369.1a; Zumsteg D, 2006, EPILEPSIA, V47, P1958, DOI 10.1111/j.1528-1167.2006.00824.x; Zumsteg D, 2006, CLIN NEUROPHYSIOL, V117, P1602, DOI 10.1016/j.clinph.2006.04.008	88	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0115122	10.1371/journal.pone.0115122	http://dx.doi.org/10.1371/journal.pone.0115122			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781934	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600003
J	Xie, WS; Pariollaud, M; Wixted, WE; Chitnis, N; Fornwald, J; Truong, M; Pao, C; Liu, Y; Ames, RS; Callahan, J; Solari, R; Sanchez, Y; Diehl, A; Li, H				Xie, Wensheng; Pariollaud, Marie; Wixted, William E.; Chitnis, Nilesh; Fornwald, James; Truong, Maggie; Pao, Christina; Liu, Yan; Ames, Robert S.; Callahan, James; Solari, Roberto; Sanchez, Yolanda; Diehl, Alan; Li, Hu			Identification and Characterization of PERK Activators by Phenotypic Screening and Their Effects on NRF2 Activation	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; CIGARETTE-SMOKE; CELL-SURVIVAL; MOLECULAR-MECHANISMS; GENE-REGULATION; PATHWAY; DISEASE; CANCER; DYSFUNCTION	Endoplasmic reticulum stress plays a critical role to restore the homeostasis of protein production in eukaryotic cells. This vital process is hence involved in many types of diseases including COPD. PERK, one branch in the ER stress signaling pathways, has been reported to activate NRF2 signaling pathway, a known protective response to COPD. Based on this scientific rationale, we aimed to identify PERK activators as a mechanism to achieve NRF2 activation. In this report, we describe a phenotypic screening assay to identify PERK activators. This assay measures phosphorylation of GFP-tagged eIF2a upon PERK activation via a cellbased LanthaScreen technology. To obtain a robust assay with sufficient signal to background and low variation, multiple parameters were optimized including GFP-tagged eIF2a BacMam concentration, cell density and serum concentration. The assay was validated by a tool compound, Thapsigargin, which induces phosphorylation of eIF2a. In our assay, this compound showed maximal signal window of approximately 2.5-fold with a pEC(50) of 8.0, consistent with literature reports. To identify novel PERK activators through phosphorylation of eIF2a, a focused set of 8,400 compounds was screened in this assay at 10 ae M. a number of hits were identified and validated. The molecular mechanisms for several selected hits were further characterized in terms of PERK activation and effects on PERK downstreamcomponents. Specificity of these compounds in activating PERK was demonstrated with a PERK specific inhibitor and in PERK knockout mouse embryonic fibroblast (MEF) cells. In addition, these hits showed NRF2-dependent anti-oxidant gene induction. In summary, our phenotypic screening assay is demonstrated to be able to identify PERK specific activators. The identified PERK activators could potentially be used as chemical probes to further investigate this pathway as well as the link between PERK activation and NRF2 pathway activation.	[Xie, Wensheng; Fornwald, James; Truong, Maggie; Pao, Christina; Ames, Robert S.; Li, Hu] GlaxoSmithKline, Platform Technol & Sci, Dept Biol Sci, Collegeville, PA 19426 USA; [Pariollaud, Marie; Wixted, William E.; Callahan, James; Sanchez, Yolanda] GlaxoSmithKline, Resp Therapy Area, Stress & Repair Discovery Performance Unit, King Of Prussia, PA USA; [Chitnis, Nilesh; Diehl, Alan] Med Univ S Carolina, Dept Biochem & Mol Biol, Hollings Canc Ctr, Charleston, SC 29425 USA; [Liu, Yan] GlaxoSmithKline, Platform Technol & Sci, Dept Sample Management Technol, Collegeville, PA USA; [Solari, Roberto] GlaxoSmithKline, Resp Therapy Area, Stress & Repair Discovery Performance Unit, Stevenage, Herts, England	GlaxoSmithKline; GlaxoSmithKline; Medical University of South Carolina; GlaxoSmithKline; GlaxoSmithKline	Li, H (corresponding author), GlaxoSmithKline, Platform Technol & Sci, Dept Biol Sci, Collegeville, PA 19426 USA.	hu.li@gsk.com			GlaxoSmithKline; Biotechnology and Biological Sciences Research Council [1237048] Funding Source: researchfish	GlaxoSmithKline(GlaxoSmithKline); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	GlaxoSmithKline provided support in the form of salaries for authors WX, MP, WEW, JF, MT, CP, YL, RSA, JC, RS, YS, and HL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonyushkin T, 2010, ARTERIOSCL THROM VAS, V30, P1007, DOI 10.1161/ATVBAHA.110.204354; Axten JM, 2012, J MED CHEM, V55, P7193, DOI 10.1021/jm300713s; Blumental-Perry A, 2012, CURR MOL MED, V12, P883, DOI 10.2174/156652412801318764; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Cullinan SB, 2006, INT J BIOCHEM CELL B, V38, P317, DOI 10.1016/j.biocel.2005.09.018; Cullinan SB, 2004, J BIOL CHEM, V279, P20108, DOI 10.1074/jbc.M314219200; Eftekharzadeh B, 2010, BIOCHIMIE, V92, P245, DOI 10.1016/j.biochi.2009.12.001; Fornwald James A., 2007, V388, P95; Hamanaka RB, 2005, MOL BIOL CELL, V16, P5493, DOI 10.1091/mbc.E05-03-0268; He CH, 2001, J BIOL CHEM, V276, P20858, DOI 10.1074/jbc.M101198200; Hu R, 2010, ANTIOXID REDOX SIGN, V13, P1679, DOI 10.1089/ars.2010.3276; Iwawaki T, 2006, BIOCHEM BIOPH RES CO, V350, P709, DOI 10.1016/j.bbrc.2006.09.100; Kelsen SG, 2012, PULM PHARMACOL THER, V25, P447, DOI 10.1016/j.pupt.2012.07.005; Kenche H, 2013, FASEB J, V27, P965, DOI 10.1096/fj.12-216234; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Liu HP, 2013, CANCER CHEMOTH PHARM, V72, P251, DOI 10.1007/s00280-013-2193-y; Min T, 2011, J MOL MED, V89, P577, DOI 10.1007/s00109-011-0732-8; Ribeiro CMP, 2012, CURR MOL MED, V12, P872; Schonthal AH, 2013, BIOCHEM PHARMACOL, V85, P653, DOI 10.1016/j.bcp.2012.09.012; Singh A, 2009, FREE RADICAL BIO MED, V46, P376, DOI 10.1016/j.freeradbiomed.2008.10.026; Somborac-Bacura A, 2013, EXP PHYSIOL, V98, P316, DOI 10.1113/expphysiol.2012.067249; Sussan TE, 2009, P NATL ACAD SCI USA, V106, P250, DOI 10.1073/pnas.0804333106; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Viana RJS, 2012, MOL NEUROBIOL, V46, P522, DOI 10.1007/s12035-012-8301-x; Wootton LL, 2006, J BIOL CHEM, V281, P6970, DOI 10.1074/jbc.M510978200; Xie WS, 2012, ASSAY DRUG DEV TECHN, V10, P514, DOI 10.1089/adt.2011.436; Yates MS, 2007, MOL CANCER THER, V6, P154, DOI 10.1158/1535-7163.MCT-06-0516	29	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119738	10.1371/journal.pone.0119738	http://dx.doi.org/10.1371/journal.pone.0119738			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25780921	gold, Green Submitted, Green Published			2022-12-27	WOS:000351284600086
J	Yamagami, K; Yamamoto, T; Sakai, S; Mioka, T; Sano, T; Igarashi, Y; Tanaka, K				Yamagami, Kanako; Yamamoto, Takaharu; Sakai, Shota; Mioka, Tetsuo; Sano, Takamitsu; Igarashi, Yasuyuki; Tanaka, Kazuma			Inositol Depletion Restores Vesicle Transport in Yeast Phospholipid Flippase Mutants	PLOS ONE			English	Article							UNFOLDED-PROTEIN-RESPONSE; P-TYPE ATPASE; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; PLASMA-MEMBRANE; AMINOPHOSPHOLIPID TRANSLOCASE; SPHINGOLIPID SYNTHESIS; PHOSPHATIDIC-ACID; POLARIZED GROWTH; GENE DISRUPTION	In eukaryotic cells, type 4 P-type ATPases function as phospholipid flippases, which translocate phospholipids from the exoplasmic leaflet to the cytoplasmic leaflet of the lipid bilayer. Flippases function in the formation of transport vesicles, but the mechanism remains unknown. Here, we isolate an arrestin-related trafficking adaptor, ART5, as a multicopy suppressor of the growth and endocytic recycling defects of flippase mutants in budding yeast. Consistent with a previous report that Art5p downregulates the inositol transporter Itr1p by endocytosis, we found that flippase mutations were also suppressed by the disruption of ITR1, as well as by depletion of inositol from the culture medium. Interestingly, inositol depletion suppressed the defects in all five flippase mutants. Inositol depletion also partially restored the formation of secretory vesicles in a flippase mutant. Inositol depletion caused changes in lipid composition, including a decrease in phosphatidylinositol and an increase in phosphatidylserine. A reduction in phosphatidylinositol levels caused by partially depleting the phosphatidylinositol synthase Pis1p also suppressed a flippase mutation. These results suggest that inositol depletion changes the lipid composition of the endosomal/TGN membranes, which results in vesicle formation from these membranes in the absence of flippases.	[Yamagami, Kanako; Yamamoto, Takaharu; Mioka, Tetsuo; Sano, Takamitsu; Tanaka, Kazuma] Hokkaido Univ, Grad Sch Life Sci, Inst Med Genet, Div Mol Interact, Sapporo, Hokkaido, Japan; [Sakai, Shota; Igarashi, Yasuyuki] Hokkaido Univ, Grad Sch Adv Life Sci, Lab Biomembrane & Biofunct Chem, Sapporo, Hokkaido, Japan; [Sakai, Shota; Igarashi, Yasuyuki] Hokkaido Univ, Frontier Res Ctr Postgenome Sci & Technol, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University	Tanaka, K (corresponding author), Hokkaido Univ, Grad Sch Life Sci, Inst Med Genet, Div Mol Interact, Sapporo, Hokkaido, Japan.	k-tanaka@igm.hokudai.ac.jp	Tanaka, Kazuma/A-4240-2012	Mioka, Tetsuo/0000-0002-4653-1718	Japan Society for the Promotion of Science KAKENHI [21570192, 21370085]; Grants-in-Aid for Scientific Research [25840064] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI grants 21570192 (TY) and 21370085 (KT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECKER GW, 1977, J BIOL CHEM, V252, P8684; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOTSTEIN D, 1979, GENE, V8, P17, DOI 10.1016/0378-1119(79)90004-0; Brachmann CB, 1998, YEAST, V14, P115; Breslow DK, 2010, MOL CELL, V40, P267, DOI 10.1016/j.molcel.2010.10.005; BROACH JR, 1979, GENE, V8, P121, DOI 10.1016/0378-1119(79)90012-X; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Chen BH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001235; Chen CY, 1999, J CELL BIOL, V147, P1223, DOI 10.1083/jcb.147.6.1223; Daleke DL, 2007, J BIOL CHEM, V282, P821, DOI 10.1074/jbc.R600035200; Dickson RC, 2008, J LIPID RES, V49, P909, DOI 10.1194/jlr.R800003-JLR200; Dimova R, 2014, ADV COLLOID INTERFAC, V208, P225, DOI 10.1016/j.cis.2014.03.003; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; Furuta N, 2007, MOL BIOL CELL, V18, P295, DOI 10.1091/mbc.E06-05-0461; Gall WE, 2002, CURR BIOL, V12, P1623, DOI 10.1016/S0960-9822(02)01148-X; Gaspar ML, 2006, J BIOL CHEM, V281, P22773, DOI 10.1074/jbc.M603548200; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Graham TR, 2010, CURR OPIN CELL BIOL, V22, P430, DOI 10.1016/j.ceb.2010.05.002; Guthrie G., 1991, METHOD ENZYMOL, V194, P1; Hachiro T, 2013, J BIOL CHEM, V288, P3594, DOI 10.1074/jbc.M112.416263; Hanson PK, 2003, J BIOL CHEM, V278, P36041, DOI 10.1074/jbc.M305263200; Henry SA, 2014, CHEM PHYS LIPIDS, V180, P23, DOI 10.1016/j.chemphyslip.2013.12.013; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Hua ZL, 2003, MOL BIOL CELL, V14, P4971, DOI 10.1091/mbc.E03-07-0463; Hua ZL, 2002, MOL BIOL CELL, V13, P3162, DOI 10.1091/mbc.E02-03-0172; Jani NM, 2009, FEMS YEAST RES, V9, P552, DOI 10.1111/j.1567-1364.2009.00514.x; Jesch SA, 2005, J BIOL CHEM, V280, P9106, DOI 10.1074/jbc.M411770200; Jesch SA, 2006, J BIOL CHEM, V281, P24070, DOI 10.1074/jbc.M604541200; Jesch SA, 2010, J BIOL CHEM, V285, P41947, DOI 10.1074/jbc.M110.188607; Kato U, 2013, J BIOL CHEM, V288, P4922, DOI 10.1074/jbc.M112.402701; KELLEY MJ, 1988, J BIOL CHEM, V263, P18078; Lenoir G, 2007, CURR OPIN CHEM BIOL, V11, P654, DOI 10.1016/j.cbpa.2007.09.008; Lenoir G, 2009, J BIOL CHEM, V284, P17956, DOI 10.1074/jbc.M109.013722; Levano K, 2012, J NEUROCHEM, V120, P302, DOI 10.1111/j.1471-4159.2011.07543.x; Lewis MJ, 2000, MOL BIOL CELL, V11, P23, DOI 10.1091/mbc.11.1.23; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Liu K, 2008, MOL BIOL CELL, V19, P3526, DOI 10.1091/mbc.E08-01-0025; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mioka T, 2014, MICROBIOLOGYOPEN, V3, P803, DOI 10.1002/mbo3.211; Misu K, 2003, MOL BIOL CELL, V14, P730, DOI 10.1091/mbc.E02-06-0314; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Mori K, 2000, P NATL ACAD SCI USA, V97, P4660, DOI 10.1073/pnas.050010197; Nagiec MM, 1997, J BIOL CHEM, V272, P9809, DOI 10.1074/jbc.272.15.9809; Nakano K, 2008, MOL BIOL CELL, V19, P1783, DOI 10.1091/mbc.E07-07-0646; Natarajan P, 2009, NAT CELL BIOL, V11, P1421, DOI 10.1038/ncb1989; NIKAWA J, 1991, J BIOL CHEM, V266, P11184; Nikko E, 2008, EMBO REP, V9, P1216, DOI 10.1038/embor.2008.199; Noji T, 2006, BIOCHEM BIOPH RES CO, V344, P323, DOI 10.1016/j.bbrc.2006.03.095; Nunez LR, 2008, J BIOL CHEM, V283, P34204, DOI 10.1074/jbc.M806391200; O'Donnell AF, 2010, MOL BIOL CELL, V21, P3552, DOI 10.1091/mbc.E10-07-0636; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; PATTON JL, 1991, J BACTERIOL, V173, P3101, DOI 10.1128/JB.173.10.3101-3108.1991; Pittet M, 2007, BBA-MOL CELL BIOL L, V1771, P405, DOI 10.1016/j.bbalip.2006.05.015; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Puts CF, 2012, J BIOL CHEM, V287, P30529, DOI 10.1074/jbc.M112.371088; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; Sakane H, 2006, CELL STRUCT FUNCT, V31, P87, DOI 10.1247/csf.06021; Santiago TC, 2003, J BIOL CHEM, V278, P38723, DOI 10.1074/jbc.M303008200; Schneiter R, 1999, J CELL BIOL, V146, P741, DOI 10.1083/jcb.146.4.741; Sciorra VA, 2005, MOL BIOL CELL, V16, P776, DOI 10.1091/mbc.e04-08-0700; Sebastian TT, 2012, BBA-MOL CELL BIOL L, V1821, P1068, DOI 10.1016/j.bbalip.2011.12.007; Shamu Caroline E., 1994, Trends in Cell Biology, V4, P56, DOI 10.1016/0962-8924(94)90011-6; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Siggs OM, 2011, NAT IMMUNOL, V12, P434, DOI 10.1038/ni.2012; Strahl T, 2007, BBA-MOL CELL BIOL L, V1771, P353, DOI 10.1016/j.bbalip.2007.01.015; Takahashi Y, 2011, J BIOCHEM, V149, P423, DOI 10.1093/jb/mvq155; Takeda M, 2014, EUKARYOT CELL, V13, P363, DOI 10.1128/EC.00279-13; Tanaka K, 2011, J BIOCHEM, V149, P131, DOI 10.1093/jb/mvq140; Tsui MM, 2010, ADV ENZYME REGUL, V50, P324, DOI 10.1016/j.advenzreg.2009.12.002; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Villa-Garcia MJ, 2011, MOL GENET GENOMICS, V285, P125, DOI 10.1007/s00438-010-0592-x; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wicky S, 2004, MOL CELL BIOL, V24, P7402, DOI 10.1128/MCB.24.17.7402-7418.2004; Wilson MSC, 2013, BIOCHEM J, V452, P369, DOI 10.1042/BJ20130118; Xu P, 2009, J CELL SCI, V122, P2866, DOI 10.1242/jcs.047423; Xu Q, 2012, FEBS LETT, V586, P1803, DOI 10.1016/j.febslet.2012.05.018; Yabas M, 2011, NAT IMMUNOL, V12, P441, DOI 10.1038/ni.2011; Young BP, 2010, SCIENCE, V329, P1085, DOI 10.1126/science.1191026; ZINSER E, 1993, J BACTERIOL, V175, P2853, DOI 10.1128/JB.175.10.2853-2858.1993	83	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120108	10.1371/journal.pone.0120108	http://dx.doi.org/10.1371/journal.pone.0120108			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781026	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600127
J	Yang, BL; Wu, WC; Fang, KC; Wang, YC; Huo, TI; Huang, YH; Yang, HI; Su, CW; Lin, HC; Lee, FY; Wu, JC; Lee, SD				Yang, Bi-Ling; Wu, Wen-Chieh; Fang, Kuan-Chieh; Wang, Yuan-Chen; Huo, Teh-Ia; Huang, Yi-Hsiang; Yang, Hwai-I; Su, Chien-Wei; Lin, Han-Chieh; Lee, Fa-Yauh; Wu, Jaw-Ching; Lee, Shou-Dong			External Validation of Fatty Liver Index for Identifying Ultrasonographic Fatty Liver in a Large-Scale Cross-Sectional Study in Taiwan	PLOS ONE			English	Article							ALANINE AMINOTRANSFERASE LEVEL; NONALCOHOLIC STEATOHEPATITIS; RISK-FACTORS; METABOLIC SYNDROME; HEPATIC STEATOSIS; HEART-DISEASE; PREVALENCE; POPULATION; FIBROSIS; EPIDEMIOLOGY	Background and Aims The fatty liver index (FLI) is an algorithm involving the waist circumference, body mass index, and serum levels of triglyceride and gamma-glutamyl transferase to identify fatty liver. Although some studies have attempted to validate the FLI, few studies have been conducted for external validation among Asians. We attempted to validate FLI to predict ultrasonographic fatty liver in Taiwanese subjects. Methods We enrolled consecutive subjects who received health check-up services at the Taipei Veterans General Hospital from 2002 to 2009. Ultrasonography was applied to diagnose fatty liver. The ability of the FLI to detect ultrasonographic fatty liver was assessed by analyzing the area under the receiver operating characteristic (AUROC) curve. Results Among the 29,797 subjects enrolled in this study, fatty liver was diagnosed in 44.5% of the population. Subjects with ultrasonographic fatty liver had a significantly higher FLI than those without fatty liver by multivariate analysis (odds ratio 1.045; 95% confidence interval, CI 1.044-1.047, p < 0.001). Moreover, FLI had the best discriminative ability to identify patients with ultrasonographic fatty liver (AUROC: 0.827, 95% confidence interval, 0.822-0.831). An FLI < 25 (negative likelihood ratio (LR-) 0.32) for males and < 10 (LR-0.26) for females rule out ultrasonographic fatty liver. Moreover, an FLI >= 35 (positive likelihood ratio (LR+) 3.12) for males and >= 20 (LR+ 4.43) for females rule in ultrasonographic fatty liver. Conclusions FLI could accurately identify ultrasonographic fatty liver in a large-scale population in Taiwan but with lower cut-off value than the Western population. Meanwhile the cut-off value was lower in females than in males.	[Yang, Bi-Ling; Fang, Kuan-Chieh; Huo, Teh-Ia; Huang, Yi-Hsiang; Su, Chien-Wei; Lin, Han-Chieh; Lee, Fa-Yauh] Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol, Taipei, Taiwan; [Yang, Bi-Ling; Lee, Shou-Dong] Cheng Hsin Gen Hosp, Dept Med, Div Gastroenterol, Taipei, Taiwan; [Wu, Wen-Chieh] Taipei City Hosp, Ren Ai Branch, Dept Med, Div Gastroenterol, Taipei, Taiwan; [Wu, Wen-Chieh; Wang, Yuan-Chen; Su, Chien-Wei; Lin, Han-Chieh; Lee, Fa-Yauh; Lee, Shou-Dong] Natl Yang Ming Univ, Fac Med, Sch Med, Taipei 112, Taiwan; [Wang, Yuan-Chen] Taipei Vet Gen Hosp, Healthcare Ctr, Taipei, Taiwan; [Huo, Teh-Ia] Natl Yang Ming Univ, Dept & Inst Pharmacol, Taipei 112, Taiwan; [Huang, Yi-Hsiang; Wu, Jaw-Ching] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan; [Yang, Hwai-I] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Wu, Jaw-Ching] Taipei Vet Gen Hosp, Dept Med Res, Div Translat Res, Taipei, Taiwan	Taipei Veterans General Hospital; Cheng Hsin General Hospital; Taipei City Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Taipei Veterans General Hospital	Su, CW (corresponding author), Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol, Taipei, Taiwan.	cwsu2@vghtpe.gov.tw	Su, Chien-Wei/AHC-8307-2022; Su, Chien-Wei/C-1521-2012; Yang, Hwai-I/A-9470-2008	Su, Chien-Wei/0000-0003-3889-7004; Su, Chien-Wei/0000-0003-3889-7004; Yang, Hwai-I/0000-0002-3433-942X; Huang, Yi-Hsiang/0000-0001-5241-5425	National Science Council of Taiwan [NSC 101-2314-B-075-013-MY2]; Taipei Veterans General Hospital [V103C-055]; Ministry of Education, Aim for the Top University Plan [103AC-T402]; Center of Excellence for Cancer Research at TVGH, Taipei, Taiwan [MOHW103-TD-B-111-02]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital); Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan); Center of Excellence for Cancer Research at TVGH, Taipei, Taiwan	This work was supported by grants from the National Science Council of Taiwan (NSC 101-2314-B-075-013-MY2), Taipei Veterans General Hospital (V103C-055), and partly by a grant from the Ministry of Education, Aim for the Top University Plan (103AC-T402), and the Center of Excellence for Cancer Research at TVGH (MOHW103-TD-B-111-02), Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Angulo P, 2013, GASTROENTEROLOGY, V145, P782, DOI 10.1053/j.gastro.2013.06.057; Armstrong MJ, 2014, HEPATOLOGY, V59, P1174, DOI 10.1002/hep.26717; Ayonrinde OT, 2011, HEPATOLOGY, V53, P800, DOI 10.1002/hep.24097; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Bedogni G, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-98; Calori G, 2011, HEPATOLOGY, V54, P145, DOI 10.1002/hep.24356; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Charlton MR, 2011, GASTROENTEROLOGY, V141, P1249, DOI 10.1053/j.gastro.2011.06.061; Chen CH, 2007, J GASTROEN HEPATOL, V22, P1482, DOI 10.1111/j.1440-1746.2006.04615.x; Chen KH, 2014, TAIWAN J PUBLIC HLTH, V33, P197; Cheng YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072049; Dasarathy S, 2009, J HEPATOL, V51, P1061, DOI 10.1016/j.jhep.2009.09.001; Fan JG, 2009, J HEPATOL, V50, P204, DOI 10.1016/j.jhep.2008.10.010; Gastaldelli A, 2009, HEPATOLOGY, V49, P1537, DOI 10.1002/hep.22845; Han SI, 2014, HEPATOLOGY, V59, P1791, DOI 10.1002/hep.26951; Hernaez R, 2011, HEPATOLOGY, V54, P1082, DOI 10.1002/hep.24452; Hyysalo J, 2014, J HEPATOL, V60, P839, DOI 10.1016/j.jhep.2013.12.009; Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x; Kim D, 2012, HEPATOLOGY, V56, P605, DOI 10.1002/hep.25593; Koehler EM, 2013, CLIN GASTROENTEROL H, V11, P1201, DOI 10.1016/j.cgh.2012.12.031; Koehler EM, 2012, J HEPATOL, V57, P1305, DOI 10.1016/j.jhep.2012.07.028; Lee JY, 2007, J HEPATOL, V47, P239, DOI 10.1016/j.jhep.2007.02.007; Loomba R, 2012, HEPATOLOGY, V56, P943, DOI 10.1002/hep.25772; Nascimbeni F, 2013, J HEPATOL, V59, P859, DOI 10.1016/j.jhep.2013.05.044; Pais R, 2013, J HEPATOL, V59, P550, DOI 10.1016/j.jhep.2013.04.027; Palaniappan LP, 2011, INT J OBESITY, V35, P393, DOI 10.1038/ijo.2010.152; Paradis V, 2009, HEPATOLOGY, V49, P851, DOI 10.1002/hep.22734; Sanyal Arun J, 2002, Gastroenterology, V123, P1705, DOI 10.1053/gast.2002.36572; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Treeprasertsuk S, 2012, LIVER INT, V32, P945, DOI 10.1111/j.1478-3231.2011.02753.x; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Welzel TM, 2013, AM J GASTROENTEROL, V108, P1314, DOI 10.1038/ajg.2013.160; Wong RJ, 2014, WORLD J HEPATOL, V6, P263, DOI 10.4254/wjh.v6.i5.263; Wong VWS, 2013, J GASTROEN HEPATOL, V28, P18, DOI 10.1111/jgh.12011; Wong VWS, 2012, GUT, V61, P409, DOI 10.1136/gutjnl-2011-300342; Wu WC, 2012, ALIMENT PHARM THER, V36, P560, DOI 10.1111/j.1365-2036.2012.05224.x; Yang JD, 2014, HEPATOLOGY, V59, P1406, DOI 10.1002/hep.26761; Younossi ZM, 2011, CLIN GASTROENTEROL H, V9, P524, DOI 10.1016/j.cgh.2011.03.020	39	83	82	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120443	10.1371/journal.pone.0120443	http://dx.doi.org/10.1371/journal.pone.0120443			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781622	Green Published, gold, Green Submitted			2022-12-27	WOS:000351284600161
J	Carta, G; Murru, E; Lisai, S; Sirigu, A; Piras, A; Collu, M; Batetta, B; Gambelli, L; Banni, S				Carta, Gianfranca; Murru, Elisabetta; Lisai, Sara; Sirigu, Annarita; Piras, Antonio; Collu, Maria; Batetta, Barbara; Gambelli, Luisa; Banni, Sebastiano			Dietary Triacylglycerols with Palmitic Acid in the sn-2 Position Modulate Levels of N-Acylethanolamides in Rat Tissues	PLOS ONE			English	Article							CONJUGATED LINOLEIC-ACID; ESSENTIAL FATTY ACIDS; 5,8,11-EICOSATRIENOIC ACID; PPAR-ALPHA; RISK; OBESITY; OLEOYLETHANOLAMIDE; METABOLISM; OVERWEIGHT; ENDOCANNABINOIDS	Background Several evidences suggest that the position of palmitic acid (PA) in dietary triacylglycerol (TAG) influences different biological functions. We aimed at evaluating whether dietary fat with highly enriched (87%) PA in sn-2 position (Hsn-2 PA), by increasing PA incorporation into tissue phospholipids (PL), modifies fatty acid profile and biosynthesis of fatty acid-derived bioactive lipids, such as endocannabinoids and their congeners. Study Design Rats were fed for 5 weeks diets containing Hsn-2 PA or fat with PA randomly distributed in TAG with 18.8% PA in sn-2 position (Lsn-2 PA), and similar total PA concentration. Fatty acid profile in different lipid fractions, endocannabinoids and congeners were measured in intestine, liver, visceral adipose tissue, muscle and brain. Results Rats on Hsn-2 PA diet had lower levels of anandamide with concomitant increase of its congener palmitoylethanolamide and its precursor PA into visceral adipose tissue phospholipids. In addition, we found an increase of oleoylethanolamide, an avid PPAR alpha ligand, in liver, muscle and brain, associated to higher levels of its precursor oleic acid in liver and muscle, probably derived by elongation and further delta 9 desaturation of PA. Changes in endocannabinoids and congeners were associated to a decrease of circulating TNF alpha after LPS challenge, and to an improved feed efficiency. Conclusions Dietary Hsn-2 PA, by modifying endocannabinoids and congeners biosynthesis in different tissues may potentially concur in the physiological regulation of energy metabolism, brain function and body fat distribution.	[Carta, Gianfranca; Murru, Elisabetta; Lisai, Sara; Sirigu, Annarita; Piras, Antonio; Collu, Maria; Batetta, Barbara; Banni, Sebastiano] Univ Cagliari, Dipartimento Sci Biomed, Cagliari, Italy; [Gambelli, Luisa] Loders Croklaan Europe, Wormerveer, Netherlands	University of Cagliari	Banni, S (corresponding author), Univ Cagliari, Dipartimento Sci Biomed, Cagliari, Italy.	banni@unica.it	Murru, Elisabetta/AAW-4909-2021; Banni, Sebastiano/F-1906-2018; Carta, Gianfranca/AAB-8947-2022; Collu, Maria/F-7113-2012	Banni, Sebastiano/0000-0003-4805-1387; Carta, Gianfranca/0000-0002-3527-4197; Murru, Maria Elisabetta/0000-0002-7394-5780; Batetta, Barbara/0000-0001-6932-778X; Collu, Maria/0000-0001-5406-2934	Loders Croklaan Europe, Wormerveer, The Netherlands; Loders Croklaan Europe	Loders Croklaan Europe, Wormerveer, The Netherlands(Netherlands Government); Loders Croklaan Europe	Loders Croklaan Europe, Wormerveer, The Netherlands, co-funded the study. Loders Croklaan Europe, whose company provided funding towards this study, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annuzzi G, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-43; Arenz S, 2004, INT J OBESITY, V28, P1247, DOI 10.1038/sj.ijo.0802758; Banni S, 1996, J NUTR BIOCHEM, V7, P150, DOI 10.1016/0955-2863(95)00193-X; Banni S, 2001, J LIPID RES, V42, P1056; Banni S, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-7; Batetta B, 2009, J NUTR, V139, P1495, DOI 10.3945/jn.109.104844; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Campolongo P, 2009, P NATL ACAD SCI USA, V106, P8027, DOI 10.1073/pnas.0903038106; COCKSHUTT AM, 1991, BIOCHIM BIOPHYS ACTA, V1085, P248, DOI 10.1016/0005-2760(91)90101-M; Contreras AV, 2013, ADV NUTR, V4, P439, DOI 10.3945/an.113.003798; DEWEY KG, 1993, AM J CLIN NUTR, V57, P140, DOI 10.1093/ajcn/57.2.140; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fu J, 2005, NEUROPHARMACOLOGY, V48, P1147, DOI 10.1016/j.neuropharm.2005.02.013; FULCO AJ, 1959, J BIOL CHEM, V234, P1411; Galan-Rodriguez B, 2009, NEUROPHARMACOLOGY, V56, P653, DOI 10.1016/j.neuropharm.2008.11.006; Gillman MW, 2001, JAMA-J AM MED ASSOC, V285, P2461, DOI 10.1001/jama.285.19.2461; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Guzman M, 2004, J BIOL CHEM, V279, P27849, DOI 10.1074/jbc.M404087200; Harder T, 2005, AM J EPIDEMIOL, V162, P397, DOI 10.1093/aje/kwi222; Hoareau L, 2009, OBESITY, V17, P431, DOI 10.1038/oby.2008.591; Ichi I, 2014, BBA-MOL CELL BIOL L, V1841, P204, DOI 10.1016/j.bbalip.2013.10.013; Innis SM, 2013, PROSTAG LEUKOTR ESS, V89, P145, DOI 10.1016/j.plefa.2013.03.003; Innis SM, 2011, ADV NUTR, V2, P275, DOI 10.3945/an.111.000448; Ip C, 1999, J NUTR, V129, P2135, DOI 10.1093/jn/129.12.2135; Karaliota S, 2009, OBESITY, V17, P1830, DOI 10.1038/oby.2009.177; Kien CL, 2013, DIABETES, V62, P1054, DOI 10.2337/db12-0363; Le HD, 2009, PROSTAG LEUKOTR ESS, V81, P165, DOI 10.1016/j.plefa.2009.05.020; Lo Verme J, 2005, CELL MOL LIFE SCI, V62, P708, DOI 10.1007/s00018-004-4494-0; Lo Verme J, 2005, MOL PHARMACOL, V67, P15, DOI 10.1124/mol.104.006353; Mantovani G, 1997, EUR J CANCER, V33, P602, DOI 10.1016/S0959-8049(96)00486-8; Matias I, 2008, BBA-MOL CELL BIOL L, V1781, P52, DOI 10.1016/j.bbalip.2007.11.001; MEAD JF, 1956, J BIOL CHEM, V219, P705; Melis M, 2013, CNS NEUROL DISORD-DR, V12, P70, DOI 10.2174/1871527311312010012; Melis M, 2008, J NEUROSCI, V28, P13985, DOI 10.1523/JNEUROSCI.3221-08.2008; Melis MP, 2001, EUR J LIPID SCI TECH, V103, P617, DOI 10.1002/1438-9312(200109)103:9<617::AID-EJLT6170>3.3.CO;2-3; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; OAKLEY JR, 1977, ARCH DIS CHILD, V52, P79, DOI 10.1136/adc.52.1.79; Owen CG, 2005, AM J CLIN NUTR, V82, P1298, DOI 10.1093/ajcn/82.6.1298; Owen CG, 2005, PEDIATRICS, V115, P1367, DOI 10.1542/peds.2004-1176; Petrosino S, 2010, BIOCHIMIE, V92, P724, DOI 10.1016/j.biochi.2010.01.006; Quigley MA, 2006, AM J EPIDEMIOL, V163, P870, DOI 10.1093/aje/kwj134; Ross AC, 2003, J NUTR, V133, p291S, DOI 10.1093/jn/133.1.291S; Samulin J, 2008, COMP BIOCHEM PHYS B, V151, P147, DOI 10.1016/j.cbpb.2008.06.010; Sarro-Ramirez Andrea, 2013, Central Nervous System Agents in Medicinal Chemistry, V13, P88; Silvestri C, 2013, CELL METAB, V17, P475, DOI 10.1016/j.cmet.2013.03.001; Snodgrass RG, 2013, J IMMUNOL, V191, P4337, DOI 10.4049/jimmunol.1300298; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Thabuis C, 2008, LIPIDS, V43, P887, DOI 10.1007/s11745-008-3217-y; Young BE, 2012, ADV NUTR, V3, P675, DOI 10.3945/an.112.002238	51	38	42	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120424	10.1371/journal.pone.0120424	http://dx.doi.org/10.1371/journal.pone.0120424			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775474	Green Published, gold, Green Submitted			2022-12-27	WOS:000351183500173
J	Chung, S; Spruston, N; Koh, S				Chung, Sungkwon; Spruston, Nelson; Koh, Sookyong			Age-Dependent Changes in Intrinsic Neuronal Excitability in Subiculum after Status Epilepticus	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; SPONTANEOUS RECURRENT SEIZURES; EARLY-LIFE SEIZURES; PYRAMIDAL NEURONS; KAINIC ACID; IN-VITRO; LONG-TERM; INTERICTAL ACTIVITY; ENTORHINAL CORTEX; RAT HIPPOCAMPUS	Kainic acid-induced status epilepticus (KA-SE) in mature rats results in the development of spontaneous recurrent seizures and a pattern of cell death resembling hippocampal sclerosis in patients with temporal lobe epilepsy. In contrast, KA-SE in young animals before postnatal day (P) 18 is less likely to cause cell death or epilepsy. To investigate whether changes in neuronal excitability occur in the subiculum after KA-SE, we examined the age-dependent effects of SE on the bursting neurons of subiculum, the major output region of the hippocampus. Patch-clamp recordings were used to monitor bursting in pyramidal neurons in the subiculum of rat hippocampal slices. Neurons were studied either one or 2-3 weeks following injection of KA or saline (control) in immature (P15) or more mature (P30) rats, which differ in their sensitivity to KA as well as the long-term sequelae of the KA-SE. A significantly greater proportion of subicular pyramidal neurons from P15 rats were strong-bursting neurons and showed increased frequency-dependent bursting compared to P30 animals. Frequency-dependent burst firing was enhanced in P30, but not in P15 rats following KA-SE. The enhancement of bursting induced by KA-SE in more mature rats suggests that the frequency-dependent limitation of repetitive burst firing, which normally occurs in the subiculum, is compromised following SE. These changes could facilitate the initiation of spontaneous recurrent seizures or their spread from the hippocampus to other parts of the brain.	[Chung, Sungkwon] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Dept Physiol, Suwon, South Korea; [Spruston, Nelson] Janelia Res Campus, Sci Program, Ashburn, VA USA; [Koh, Sookyong] Northwestern Univ, Feinberg Sch Med, Stanley Manne Childrens Res Inst, Neurobiol Program, Chicago, IL 60611 USA	Sungkyunkwan University (SKKU); Northwestern University; Feinberg School of Medicine	Koh, S (corresponding author), Northwestern Univ, Feinberg Sch Med, Stanley Manne Childrens Res Inst, Neurobiol Program, Chicago, IL 60611 USA.	skoh@luriechildrens.org	CHUNG, SUNGKWON/ABF-8293-2021	Spruston, Nelson/0000-0003-3118-1636	NIH/NINDS [R01 NS073768, NS35180]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073768] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by NIH/NINDS R01 NS073768 (SK) and NS35180 (NS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albala B.J., 1984, BRAIN RES, V315, P139; Andrioli A, 2007, NEUROSCIENCE, V149, P131, DOI 10.1016/j.neuroscience.2007.07.029; Behr J, 2000, BRAIN RES, V867, P259, DOI 10.1016/S0006-8993(00)02324-6; Ben-Ari Y, 2000, TRENDS NEUROSCI, V23, P580, DOI 10.1016/S0166-2236(00)01659-3; Ben-Ari Y, 2001, EPILEPSIA, V42, P5, DOI 10.1046/j.1528-1157.2001.042suppl.3005.x; Benini R, 2005, J PHYSIOL-LONDON, V566, P885, DOI 10.1113/jphysiol.2005.088708; Boido D, 2014, CEREB CORTEX, V24, P163, DOI 10.1093/cercor/bhs298; Bulinski JC, 1998, PROG NEUROBIOL, V55, P641, DOI 10.1016/S0301-0082(98)00023-9; Cohen I, 2002, SCIENCE, V298, P1418, DOI 10.1126/science.1076510; Cooper DC, 2005, PLOS BIOL, V3, P1123, DOI 10.1371/journal.pbio.0030175; de Guzman P, 2006, HIPPOCAMPUS, V16, P843, DOI 10.1002/hipo.20215; de la Prida LM, 2004, J NEUROSCI, V24, P5525, DOI 10.1523/JNEUROSCI.0309-04.2004; Drexel M, 2011, NEUROSCIENCE, V189, P316, DOI 10.1016/j.neuroscience.2011.05.021; Dube C, 2000, ANN NEUROL, V47, P336, DOI 10.1002/1531-8249(200003)47:3<336::AID-ANA9>3.0.CO;2-W; Elliott RC, 2003, J NEUROSCI, V23, P2218; Engel J, 1996, NEW ENGL J MED, V334, P647, DOI 10.1056/NEJM199603073341008; Fabo D, 2008, BRAIN, V131, P485, DOI 10.1093/brain/awm297; Graef JD, 2009, J NEUROSCI, V29, P4430, DOI 10.1523/JNEUROSCI.0198-09.2009; Graves AR, 2012, NEURON, V76, P776, DOI 10.1016/j.neuron.2012.09.036; Hargus NJ, 2011, NEUROBIOL DIS, V41, P361, DOI 10.1016/j.nbd.2010.10.004; HEINEMANN U, 1993, HIPPOCAMPUS, V3, P89; Hellier JL, 1998, EPILEPSY RES, V31, P73, DOI 10.1016/S0920-1211(98)00017-5; Holmes GL, 1998, ANN NEUROL, V44, P845, DOI 10.1002/ana.410440602; Huang L, 2012, BRAIN BEHAV, V2, P532, DOI 10.1002/brb3.70; JENSEN FE, 1992, EPILEPSIA, V33, P971, DOI 10.1111/j.1528-1157.1992.tb01746.x; Jung HY, 2001, J NEUROSCI, V21, P3312, DOI 10.1523/JNEUROSCI.21-10-03312.2001; Knopp A, 2005, J COMP NEUROL, V483, P476, DOI 10.1002/cne.20460; Knopp A, 2008, BRAIN, V131, P1516, DOI 10.1093/brain/awn095; Koh S, 1999, NEUROLOGY, V53, P915, DOI 10.1212/WNL.53.5.915; Koh S, 2004, EPILEPSIA, V45, P569, DOI 10.1111/j.0013-9580.2004.69103.x; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Mlsna LM, 2013, EPILEPSY BEHAV, V29, P190, DOI 10.1016/j.yebeh.2013.07.018; Moore SJ, 2009, NEURON, V61, P287, DOI 10.1016/j.neuron.2008.12.013; MOSHE SL, 1983, ANN NEUROL, V13, P552, DOI 10.1002/ana.410130514; Naber PA, 1998, J COMP NEUROL, V393, P284; NADLER JV, 1981, LIFE SCI, V29, P2031; NITECKA L, 1984, NEUROSCIENCE, V13, P1073, DOI 10.1016/0306-4522(84)90289-6; O'Mara SM, 2001, PROG NEUROBIOL, V64, P129, DOI 10.1016/S0301-0082(00)00054-X; Palma E, 2006, P NATL ACAD SCI USA, V103, P8465, DOI 10.1073/pnas.0602979103; Perez Y, 1996, EUR J NEUROSCI, V8, P736, DOI 10.1111/j.1460-9568.1996.tb01259.x; Pike FG, 1999, J PHYSIOL-LONDON, V518, P571, DOI 10.1111/j.1469-7793.1999.0571p.x; Pitkanen A, 2011, LANCET NEUROL, V10, P173, DOI 10.1016/S1474-4422(10)70310-0; Raol YSH, 2003, ANN NEUROL, V53, P503, DOI 10.1002/ana.10490; Richichi C, 2008, NEUROBIOL DIS, V29, P297, DOI 10.1016/j.nbd.2007.09.003; Sanchez RM, 2001, EPILEPSIA, V42, P577, DOI 10.1046/j.1528-1157.2001.12000.x; Schwarcz R, 2002, EPILEPSY RES, V50, P161, DOI 10.1016/S0920-1211(02)00077-3; Schwarcz R, 2000, ANN NY ACAD SCI, V911, P328; Shah MM, 2004, NEURON, V44, P495, DOI 10.1016/j.neuron.2004.10.011; SPERBER EF, 1991, DEV BRAIN RES, V60, P88, DOI 10.1016/0165-3806(91)90158-F; Staff NP, 2000, J NEUROPHYSIOL, V84, P2398, DOI 10.1152/jn.2000.84.5.2398; STAFSTROM CE, 1992, DEV BRAIN RES, V65, P227, DOI 10.1016/0165-3806(92)90184-X; SWANSON LW, 1977, J COMP NEUROL, V172, P49, DOI 10.1002/cne.901720104; WASTERLAIN CG, 1976, NEUROLOGY, V26, P975, DOI 10.1212/WNL.26.10.975; Wellmer J, 2002, EUR J NEUROSCI, V16, P259, DOI 10.1046/j.1460-9568.2002.02086.x; Williams PA, 2009, J NEUROSCI, V29, P2103, DOI 10.1523/JNEUROSCI.0980-08.2009; Wittenberg GM, 2006, J NEUROSCI, V26, P6610, DOI 10.1523/JNEUROSCI.5388-05.2006; Witter MP, 2006, BEHAV BRAIN RES, V174, P251, DOI 10.1016/j.bbr.2006.06.022; Wozny C, 2005, EPILEPSIA, V46, P17, DOI 10.1111/j.1528-1167.2005.01066.x; Wozny C, 2003, SCIENCE, V301, P463; Zhang X, 2002, J NEUROSCI, V22, P6052	60	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119411	10.1371/journal.pone.0119411	http://dx.doi.org/10.1371/journal.pone.0119411			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775210	gold, Green Published, Green Submitted			2022-12-27	WOS:000351183500090
J	Dyer, KD; Rosenberg, HF				Dyer, Kimberly D.; Rosenberg, Helene F.			Physiologic Concentrations of HMGB1 Have No Impact on Cytokine-Mediated Eosinophil Survival or Chemotaxis in Response to Eotaxin-2 (CCL24)	PLOS ONE			English	Article							MOBILITY GROUP BOX-1; MOLECULAR-PATTERN MOLECULES; SERUM-LEVELS; PROTEIN; EXPRESSION; INFLAMMATION; ACTIVATION; RECEPTORS; RAGE	HMGB1 is an alarmin that can stimulate the innate immune system alone or in a complex with other inflammatory mediators. Given the recent interest in HMGB1 with respect to the pathogenesis of eosinophil-associated disorders, including asthmatic inflammation and chronic rhinosinusitis, we have explored the role of this mediator and in promoting eosinophil activation. HMGB1 receptors RAGE and TLR4 but not TLR2 were detected on freshly isolated human eosinophils from healthy donors. Physiologic and relevant pathophysiologic levels of biologically-active HMGB1 had no effect on survival of human eosinophils alone or in combination with pro-survival cytokines IL-5, IL-3, or GM-CSF, and increasing concentrations of HMGB1 had no impact on surface expression of RAGE, TLR2 or TLR4. Similarly, HMGB1 did not elicit chemotaxis of human eosinophils alone and had no effect in combination with the eosinophil chemotactic agent, eotaxin-2 (CCL24). However, surface expression of TLR2 and TLR4 increased in response to cell stress, notably on eosinophils that remain viable after 48 hours without IL-5. As such, HMGB1 signaling on eosinophils may be substantially more detailed, and may involve complex immunostimulatory pathways other than or in addition to those evaluated here.	[Dyer, Kimberly D.; Rosenberg, Helene F.] NIAID, Inflammat Immunobiol Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Dyer, KD (corresponding author), NIAID, Inflammat Immunobiol Sect, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	kdyer@niaid.nih.gov			NIAID Division of Intramural Research [AI000941]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000941] Funding Source: NIH RePORTER	NIAID Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by the NIAID Division of Intramural Research #AI000941 to HFR. Funding supported the design, execution and interpretation of the results. Source of funding did not play a role in the performance, decision to publish or preparation of the manuscript.	Bellussi LM, 2013, J BIOL REG HOMEOS AG, V27, P791; Berthelot F, 2012, J INNATE IMMUN, V4, P41, DOI 10.1159/000328798; Calogero S, 1999, NAT GENET, V22, P276, DOI 10.1038/10338; Chen DS, 2014, INT FORUM ALLERGY RH, V4, P453, DOI 10.1002/alr.21294; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Chen T, 2014, EXP DERMATOL, V23, P419, DOI 10.1111/exd.12422; Chen T, 2013, ARCH DERMATOL RES, V305, P263, DOI 10.1007/s00403-013-1330-0; Curran CS, 2011, INT IMMUNOL, V23, P713, DOI 10.1093/intimm/dxr083; Dyer KD, 2013, METHODS MOL BIOL, V1032, P59, DOI 10.1007/978-1-62703-496-8_5; Gero D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065994; Goldstein RS, 2007, MOL MED, V13, P210, DOI 10.2119/2006-00108.Goldstein; Harris HE, 2012, NAT REV RHEUMATOL, V8, P195, DOI 10.1038/nrrheum.2011.222; Hou CC, 2011, MOL MED, V17, P807, DOI 10.2119/molmed.2010.00173; Ilmarinen Pinja, 2014, J Cell Death, V7, P1, DOI 10.4137/JCD.S13588; Kang R, 2014, MOL ASPECTS MED, V40, P1, DOI 10.1016/j.mam.2014.05.001; Keyel PA, 2014, CYTOKINE, V69, P136, DOI 10.1016/j.cyto.2014.03.007; Kvarnhammar AM, 2012, IMMUNOLOGY, V136, P11, DOI 10.1111/j.1365-2567.2012.03556.x; Lotfi R, 2009, J IMMUNOL, V183, P5023, DOI 10.4049/jimmunol.0900504; Lotze MT, 2007, IMMUNOL REV, V220, P60, DOI 10.1111/j.1600-065X.2007.00579.x; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Musumeci D, 2014, PHARMACOL THERAPEUT, V141, P347, DOI 10.1016/j.pharmthera.2013.11.001; Nagase H, 2003, J IMMUNOL, V171, P3977, DOI 10.4049/jimmunol.171.8.3977; Paris G, 2014, INT FORUM ALLERGY RH, V4, P15, DOI 10.1002/alr.21237; Percopo CM, 2010, EXP DERMATOL, V19, P467, DOI 10.1111/j.1600-0625.2009.00974.x; Rosenberg HF, 2013, NAT REV IMMUNOL, V13, P9, DOI 10.1038/nri3341; Sabroe I, 2002, J IMMUNOL, V168, P4701, DOI 10.4049/jimmunol.168.9.4701; Salpietro C, 2013, INT ARCH ALLERGY IMM, V161, P116, DOI 10.1159/000345246; Schleimer RP, 2013, EOSINOPHILS IN HEALTH AND DISEASE, P508; Shim EJ, 2012, CLIN EXP ALLERGY, V42, P958, DOI 10.1111/j.1365-2222.2012.03998.x; Sukkar MB, 2012, BRIT J PHARMACOL, V167, P1161, DOI 10.1111/j.1476-5381.2012.01984.x; Tsung A, 2014, J INTERN MED, V276, P425, DOI 10.1111/joim.12276; Ueno H, 2004, AM J RESP CRIT CARE, V170, P1310, DOI 10.1164/rccm.200402-188OC; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wibisono D, 2010, ANN RHEUM DIS, V69, P1888, DOI 10.1136/ard.2009.119172; Wong CK, 2007, AM J RESP CELL MOL, V37, P85, DOI 10.1165/rcmb.2006-0457OC; Yanai H, 2014, J INTERN MED, V276, P444, DOI 10.1111/joim.12285; Yanai H, 2013, P NATL ACAD SCI USA, V110, P20699, DOI 10.1073/pnas.1320808110; Yang H, 2013, J LEUKOCYTE BIOL, V93, P865, DOI 10.1189/jlb.1212662; Zickert A, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3747	39	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118887	10.1371/journal.pone.0118887	http://dx.doi.org/10.1371/journal.pone.0118887			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774667	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500049
J	Gu, LQ; Robinson, RAS				Gu, Liqing; Robinson, Rena A. S.			Multiple Proteases to Localize Oxidation Sites	PLOS ONE			English	Article							ELECTRON-TRANSFER DISSOCIATION; TOP-DOWN PROTEOMICS; MASS-SPECTROMETRY; PROTEIN CARBONYLATION; METHIONINE RESIDUES; ION MOBILITY; IDENTIFICATION; PEPTIDES; PHENYLALANINE; PATHWAY	Proteins present in cellular environments with high levels of reactive oxygen and nitrogen species and/or low levels of antioxidants are highly susceptible to oxidative post-translational modification (PTM). Irreversible oxidative PTMs can generate a complex distribution of modified protein molecules, recently termed as proteoforms. Using ubiquitin as a model system, we mapped oxidative modification sites using trypsin, Lys-C, and Glu-C peptides. Several M+16 Da proteoforms were detected as well as proteoforms that include other previously unidentified oxidative modifications. This work highlights the use of multiple protease digestions to give insights to the complexity of oxidative modifications possible in bottom-up analyses.	[Gu, Liqing; Robinson, Rena A. S.] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Robinson, RAS (corresponding author), Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA.	rena@pitt.edu	Hensel, Edward/Q-6753-2019	Hensel, Edward/0000-0002-2682-0766	University of Pittsburgh Start-Up Funds (RASR)	University of Pittsburgh Start-Up Funds (RASR)	This research was supported by the University of Pittsburgh Start-Up Funds (RASR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aye TT, 2005, ANAL CHEM, V77, P5814, DOI 10.1021/ac050353m; BACARESEHAMILTON AJ, 1985, PEPTIDES, V6, P17, DOI 10.1016/0196-9781(85)90069-5; Bakhtiar R, 2005, BIOCHEM BIOPH RES CO, V334, P1, DOI 10.1016/j.bbrc.2005.05.138; Borazjani A, 2011, CHEM-BIOL INTERACT, V194, P1, DOI 10.1016/j.cbi.2011.08.007; Brodbelt JS, 2009, MASS SPECTROM REV, V28, P390, DOI 10.1002/mas.20216; Catherman AD, 2013, MOL CELL PROTEOMICS, V12, P3465, DOI 10.1074/mcp.M113.030114; Chalkley RJ, 2005, METHOD ENZYMOL, V402, P289, DOI 10.1016/S0076-6879(05)02009-4; Ciechanover A, 2000, J CELL BIOCHEM, P40; Dekker L, 2014, PROTEOMICS, V14, P1239, DOI 10.1002/pmic.201300366; Deterding LJ, 2007, ANAL CHEM, V79, P6236, DOI 10.1021/ac070935z; Downard KM, 2012, RAPID COMMUN MASS SP, V26, P226, DOI 10.1002/rcm.5320; Fedorova M, 2014, MASS SPECTROM REV, V33, P79, DOI 10.1002/mas.21381; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Ge Y, 2003, PROTEIN SCI, V12, P2320, DOI 10.1110/ps.03244403; Gregorich ZR, 2014, PROTEOMICS, V14, P1195, DOI 10.1002/pmic.201300432; Hartmer RG, 2009, RAPID COMMUN MASS SP, V23, P2273, DOI 10.1002/rcm.4145; Hayes CS, 1998, J BACTERIOL, V180, P2694, DOI 10.1128/JB.180.10.2694-2700.1998; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Kastle M, 2011, CURR PHARM DESIGN, V17, P4007, DOI 10.2174/138161211798764898; Levine RL, 2001, EXP GERONTOL, V36, P1495, DOI 10.1016/S0531-5565(01)00135-8; Li H., 2014, J AM SOC MASS SPECTR; Liu H, 2014, ASMS ANNUAL CONFEREN; Lourette N, 2010, J AM SOC MASS SPECTR, V21, P930, DOI 10.1016/j.jasms.2010.02.027; Madian AG, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010892; Madian AG, 2010, J PROTEOME RES, V9, P3766, DOI 10.1021/pr1002609; Madian AG, 2010, J PROTEOME RES, V9, P1330, DOI 10.1021/pr900890k; Maleknia SD, 1999, ANAL CHEM, V71, P3965, DOI 10.1021/ac990500e; MASKOS Z, 1992, ARCH BIOCHEM BIOPHYS, V296, P521, DOI 10.1016/0003-9861(92)90606-W; McClintock C, 2008, ANAL CHEM, V80, P3304, DOI 10.1021/ac702493a; Mikesh LM, 2006, BBA-PROTEINS PROTEOM, V1764, P1811, DOI 10.1016/j.bbapap.2006.10.003; Mirzaei H, 2005, ANAL CHEM, V77, P2386, DOI 10.1021/ac0484373; Moller IM, 2011, J PROTEOMICS, V74, P2228, DOI 10.1016/j.jprot.2011.05.004; Moradian A, 2014, PROTEOMICS, V14, P489, DOI 10.1002/pmic.201300256; Ntai I, 2014, ANAL CHEM, V86, P4961, DOI 10.1021/ac500395k; Peng Y, 2014, MOL CELL PROTEOMICS, V13, P2752, DOI 10.1074/mcp.M114.040675; Robinson RAS, 2012, ANAL CHEM, V84, P4677, DOI 10.1021/ac202000v; Rogowska-Wrzesinska A, 2014, FREE RADICAL RES, P1; Shang F, 2011, FREE RADICAL BIO MED, V51, P5, DOI 10.1016/j.freeradbiomed.2011.03.031; Sharp JS, 2003, ANAL BIOCHEM, V313, P216, DOI 10.1016/S0003-2697(02)00612-7; Shi HL, 2013, J PHYS CHEM B, V117, P164, DOI 10.1021/jp3099544; Smith LM, 2013, NAT METHODS, V10, P186, DOI 10.1038/nmeth.2369; SOLAR S, 1985, RADIAT PHYS CHEM, V26, P103, DOI 10.1016/0146-5724(85)90039-1; STADTMAN ER, 1991, J BIOL CHEM, V266, P2005; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; Stadtman ER, 1997, CHEM RES TOXICOL, V10, P485, DOI 10.1021/tx960133r; Swaney DL, 2010, J PROTEOME RES, V9, P1323, DOI 10.1021/pr900863u; Sze SK, 2003, ANAL CHEM, V75, P1599, DOI 10.1021/ac020446t; Sze SK, 2002, P NATL ACAD SCI USA, V99, P1774, DOI 10.1073/pnas.251691898; Wang LW, 2012, J BIOL CHEM, V287, P6169, DOI 10.1074/jbc.M111.329748; Wells JM, 2005, METHOD ENZYMOL, V402, P148, DOI 10.1016/S0076-6879(05)02005-7; Wiesner J, 2008, PROTEOMICS, V8, P4466, DOI 10.1002/pmic.200800329; Xu GH, 2007, CHEM REV, V107, P3514, DOI 10.1021/cr0682047; Yi Donghui, 2005, J Biomol Tech, V16, P364; Yuan ZF, 2014, ANNU REV ANAL CHEM, V7, P113, DOI 10.1146/annurev-anchem-071213-015959; Zhao C, 2006, ANAL CHEM, V78, P5134, DOI 10.1021/ac060525v	55	45	46	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0116606	10.1371/journal.pone.0116606	http://dx.doi.org/10.1371/journal.pone.0116606			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775238	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000351183500009
J	Hayat, T; Anwar, MS; Farooq, M; Alsaedi, A				Hayat, Tasawar; Anwar, Muhammad Shoaib; Farooq, Muhammad; Alsaedi, Ahmad			Mixed Convection Flow of Viscoelastic Fluid by a Stretching Cylinder with Heat Transfer	PLOS ONE			English	Article							POWER-LAW FLUID; STAGNATION-POINT FLOW; BOUNDARY-LAYER-FLOW; MASS-TRANSFER; INCLINED PLATE; MAXWELL FLUID; SURFACE; SHEET	Flow of viscoelastic fluid due to an impermeable stretching cylinder is discussed. Effects of mixed convection and variable thermal conductivity are present. Thermal conductivity is taken temperature dependent. Nonlinear partial differential system is reduced into the nonlinear ordinary differential system. Resulting nonlinear system is computed for the convergent series solutions. Numerical values of skin friction coefficient and Nusselt number are computed and discussed. The results obtained with the current method are in agreement with previous studies using other methods as well as theoretical ideas. Physical interpretation reflecting the contribution of influential parameters in the present flow is presented. It is hoped that present study serves as a stimulus for modeling further stretching flows especially in polymeric and paper production processes.	[Hayat, Tasawar; Anwar, Muhammad Shoaib; Farooq, Muhammad] Quaid I Azam Univ 45320, Dept Math, Islamabad 44000, Pakistan; [Hayat, Tasawar; Alsaedi, Ahmad] King Abdulaziz Univ, Fac Sci, Nonlinear Anal & Appl Math NAAM Res Grp, Jeddah 21589, Saudi Arabia	Quaid I Azam University; King Abdulaziz University	Farooq, M (corresponding author), Quaid I Azam Univ 45320, Dept Math, Islamabad 44000, Pakistan.	hfarooq99@yahoo.com	Hayat, Tasawar/E-9449-2015; Farooq, Muhammad/AAX-3841-2020; Hayat, Tasawar/A-3853-2013; Alsaedi, Ahmed/A-2094-2013; Hayat, Tasawar/Y-2524-2019; Anwar, Muhammad Shoaib/AAU-8840-2021	Farooq, Muhammad/0000-0002-5481-6393; Alsaedi, Ahmed/0000-0003-3452-8922; Anwar, Muhammad Shoaib/0000-0001-5141-9838	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, Saudi Arabia	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, Saudi Arabia	This paper was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, Saudi Arabia. The funder has no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. No additional external funding received for this study.	Andersson HI, 2006, INT J NONLIN MECH, V41, P1228, DOI 10.1016/j.ijnonlinmec.2006.12.006; Dalir N, 2014, ALEX ENG J, V53, P769, DOI 10.1016/j.aej.2014.08.005; Das K, 2012, COMPUT MATH APPL, V63, P255, DOI 10.1016/j.camwa.2011.11.018; El-Aziz M. Abd, 2013, J EGYPTIAN MATH SOC, V21, P385, DOI DOI 10.1016/J.JOEMS.2013.02.010; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2011, CHEM ENG SCI, V66, P2660, DOI 10.1016/j.ces.2011.03.008; Hakeem A.K.A., 2014, J KING SAUDI U ENG S, V26, P168; Hassanien IA, 1998, MATH COMPUT MODEL, V28, P105, DOI 10.1016/S0895-7177(98)00148-4; Hayat T, 2013, COMPUT FLUIDS, V86, P103, DOI 10.1016/j.compfluid.2013.07.003; Hayat T., 2013, J EGYPTIAN MATH SOC, V21, P379, DOI [10.1016/j.joems.2013.02.009, DOI 10.1016/J.JOEMS.2013.02.009]; Hayat T, 2014, INT J NUMER METHOD H, V24, P760, DOI 10.1108/HFF-09-2012-0219; Hayat T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090038; Hsiao KL, 2014, ARAB J SCI ENG, V39, P4325, DOI 10.1007/s13369-014-1065-z; Kumar BR, 2013, INT J HEAT MASS TRAN, V56, P370, DOI 10.1016/j.ijheatmasstransfer.2012.09.001; Liao S., 2003, PERTURBATION INTRO H, DOI 10.1201/9780203491164; Liao S., 2012, HOMOTOPY ANAL METHOD; Lok YY, 2012, INT J THERM SCI, V59, P186, DOI 10.1016/j.ijthermalsci.2012.04.008; Moradi A, 2013, INT J THERM SCI, V64, P129, DOI 10.1016/j.ijthermalsci.2012.08.014; Mukhopadhyay S, 2013, AIN SHAMS ENG J, V4, P933, DOI 10.1016/j.asej.2013.04.004; Mukhopadhyay S, 2014, CHINESE PHYS B, V23, DOI 10.1088/1674-1056/23/4/044702; Nadeem S, 2012, MATH PROBL ENG, V2012, DOI 10.1155/2012/640289; Pal D, 2014, J EGYPT MATH SOC, V22, P123, DOI [10.1016/j.joems.2013.05.010, DOI 10.1016/J.JOEMS.2013.05.010]; Pal D, 2013, APPL MATH COMPUT, V219, P7556, DOI 10.1016/j.amc.2012.10.119; Panigrahi S, 2014, APPL MATH MECH-ENGL, V35, P1525, DOI 10.1007/s10483-014-1888-6; Patil PM, 2012, COMPUT FLUIDS, V56, P17, DOI 10.1016/j.compfluid.2011.11.008; Ramzan M, 2013, EUR PHYS J PLUS, V128, DOI 10.1140/epjp/i2013-13049-5; Rashidi MM, 2014, ARAB J SCI ENG, V39, P5113, DOI 10.1007/s13369-014-1140-5; Rashidi M. M, 2014, ADV MECH ENG, V2014, DOI DOI 10.1155/2014/735939; Seshadri R, 2014, J APPL ANAL COMPUT, V4, P389; Shehzad SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068139; Singh V., 2012, INT J APPL MATH MECH, V8, P41; Turkyilmazoglu M, 2013, INT J MECH SCI, V77, P263, DOI 10.1016/j.ijmecsci.2013.10.011; Turkyilmazoglu M, 2013, INT J HEAT MASS TRAN, V57, P82, DOI 10.1016/j.ijheatmasstransfer.2012.10.006; Turkyilmazoglu M, 2012, COMMUN NONLINEAR SCI, V17, P4097, DOI 10.1016/j.cnsns.2012.01.030; Vajravelu K, 2012, APPL MATH COMPUT, V219, P3993, DOI 10.1016/j.amc.2012.10.034; Vajravelu K, 2013, NONLINEAR ANAL-REAL, V14, P455, DOI 10.1016/j.nonrwa.2012.07.008; Vajravelu K, 2011, COMPUT MATH APPL, V62, P93, DOI 10.1016/j.camwa.2011.04.055	37	36	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118815	10.1371/journal.pone.0118815	http://dx.doi.org/10.1371/journal.pone.0118815			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775032	Green Submitted, gold, Green Published			2022-12-27	WOS:000351183500043
J	Nemeth, D; Janacsek, K; Turi, Z; Lukacs, A; Peckham, D; Szanka, S; Gazso, D; Lovassy, N; Ullman, MT				Nemeth, Dezso; Janacsek, Karolina; Turi, Zsolt; Lukacs, Agnes; Peckham, Don; Szanka, Szilvia; Gazso, Dorottya; Lovassy, Noemi; Ullman, Michael T.			The Production of Nominal and Verbal Inflection in an Agglutinative Language: Evidence from Hungarian	PLOS ONE			English	Article							PAST-TENSE MORPHOLOGY; ALZHEIMERS-DISEASE; PLURAL INFLECTION; CHILDREN; STORAGE; RULES; CONSISTENCY; IMPAIRMENT; REGULARITY; EXCEPTION	The contrast between regular and irregular inflectional morphology has been useful in investigating the functional and neural architecture of language. However, most studies have examined the regular/irregular distinction in non-agglutinative Indo-European languages (primarily English) with relatively simple morphology. Additionally, the majority of research has focused on verbal rather than nominal inflectional morphology. The present study attempts to address these gaps by introducing both plural and past tense production tasks in Hungarian, an agglutinative non-Indo-European language with complex morphology. Here we report results on these tasks from healthy Hungarian native-speaking adults, in whom we examine regular and irregular nominal and verbal inflection in a within-subjects design. Regular and irregular nouns and verbs were stem on frequency, word length, and phonological structure, and both accuracy and response times were acquired. The results revealed that the regular/irregular contrast yields similar patterns in Hungarian, for both nominal and verbal inflection, as in previous studies of non-agglutinative Indo-European languages: the production of irregular inflected forms was both less accurate and slower than of regular forms, both for plural and past-tense inflection. The results replicate and extend previous findings to an agglutinative language with complex morphology. Together with previous studies, the evidence suggests that the regular/irregular distinction yields a basic behavioral pattern that holds across language families and linguistic typologies. Finally, the study sets the stage for further research examining the neurocognitive substrates of regular and irregular morphology in an agglutinative non-Indo-European language.	[Nemeth, Dezso; Janacsek, Karolina] Eotvos Lorand Univ, Inst Psychol, Budapest, Hungary; [Janacsek, Karolina] Georgetown Univ, Dept Psychol, Washington, DC 20057 USA; [Turi, Zsolt] Univ Gottingen, Dept Clin Neurophysiol, D-37073 Gottingen, Germany; [Lukacs, Agnes] Budapest Univ Technol & Econ, Dept Cognit Sci, Budapest, Hungary; [Peckham, Don] Univ Szeged, Dept English Language Teacher Educ & Appl Linguis, Szeged, Hungary; [Szanka, Szilvia; Gazso, Dorottya; Lovassy, Noemi] Univ Szeged, Inst Psychol, Szeged, Hungary; [Ullman, Michael T.] Georgetown Univ, Dept Neurosci, Brain & Language Lab, Washington, DC USA	Eotvos Lorand University; Georgetown University; University of Gottingen; Budapest University of Technology & Economics; Szeged University; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Szeged University; Georgetown University	Nemeth, D (corresponding author), Eotvos Lorand Univ, Inst Psychol, Budapest, Hungary.	nemethd@gmail.com	Nemeth, Dezso/B-9142-2009; Janacsek, Karolina/P-2957-2019; Janacsek, Karolina/H-8639-2017	Nemeth, Dezso/0000-0002-9629-5856; Janacsek, Karolina/0000-0001-7829-8220; Janacsek, Karolina/0000-0001-7829-8220; Turi, Zsolt/0000-0002-8130-7949	Hungarian Scientific Research Fund [OTKA NF105878, OTKA MB 84743]; Eotvos Hungarian State Scholarship	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Eotvos Hungarian State Scholarship	The authors are grateful to the Hungarian Scientific Research Fund (OTKA NF105878 and OTKA MB 84743) and Eotvos Hungarian State Scholarship (to KJ) for supporting their work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre M, 1999, J MEM LANG, V40, P41, DOI 10.1006/jmla.1998.2607; Almor A, 2002, BRAIN LANG, V83, P149; Baayen RH, 2008, JOURNAL OF MEMORY AN; Babcock L, 2012, BILING-LANG COGN, V15, P820, DOI 10.1017/S1366728912000053; Balaguer RDD, 2006, HUM BRAIN MAPP, V27, P874, DOI 10.1002/hbm.20228; Berent I, 2002, J PSYCHOLINGUIST RES, V31, P459, DOI 10.1023/A:1021256819323; Boudelaa S, 2002, LANG COGNITIVE PROC, V17, P321, DOI 10.1080/01690960143000245; Bowden HW, 2010, LANG LEARN, V60, P44, DOI 10.1111/j.1467-9922.2009.00551.x; Brovetto C., 2005, SELECTED P 7 HISPANI, P98; Butler R, 2012, Q J EXP PSYCHOL, V65, P1633, DOI 10.1080/17470218.2012.661441; Clahsen H, 1999, BEHAV BRAIN SCI, V22, P991, DOI 10.1017/S0140525X99002228; Clahsen H, 2004, J CHILD LANG, V31, P683, DOI 10.1017/S0305000904006506; Cohen-Shikora ER, 2013, BEHAV RES METHODS, V45, P151, DOI 10.3758/s13428-012-0240-y; Cortese MJ, 2006, COGN NEUROPSYCHOL, V23, P856, DOI 10.1080/02643290500483124; Dye CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074683; Fujiwara M, 2000, THESIS GEORGETOWN U, P1; Fujiwara M, 1999, COMPUTATION DEFAULT; Halacsy P, 2004, CREATING OPEN LANGUA; Halle M., 1993, DISTRIBUTED MORPHOLO; Holland R, 2012, NEUROPSYCHOLOGIA, V50, P3713, DOI 10.1016/j.neuropsychologia.2012.10.019; Joanisse MF, 1999, P NATL ACAD SCI USA, V96, P7592, DOI 10.1073/pnas.96.13.7592; Joanisse MF, 2005, COGN AFFECT BEHAV NE, V5, P282, DOI 10.3758/CABN.5.3.282; Justus T, 2011, NEUROPSYCHOLOGIA, V49, P1, DOI 10.1016/j.neuropsychologia.2010.10.027; Keuleers E, 2007, COGNITIVE PSYCHOL, V54, P283, DOI 10.1016/j.cogpsych.2006.07.002; Kornai A, 2006, WEB BASED FREQUENCY, P1; Kornai Andras, 1994, HUNGARIAN MORPHOLOGY; Littell RC, 2002, SAS LINEAR MODELS; Locker L, 2007, BEHAV RES METHODS, V39, P723, DOI 10.3758/BF03192962; Lukacs A, 1999, BEHAV BRAIN SCI, V22, P1030, DOI 10.1017/S0140525X99402225; Lukacs A, 2001, SZABALYOK KIVETELEK, P119; Lukacs A, 2004, WILLIAMS SYNDROME LA, P187; Lukacs A, 2010, INT J LANG COMM DIS, V45, P145, DOI 10.3109/13682820902781060; Marcus GF, 1995, COGNITIVE PSYCHOL, V29, P189, DOI 10.1006/cogp.1995.1015; McClelland JL, 2002, TRENDS COGN SCI, V6, P465, DOI 10.1016/S1364-6613(02)01993-9; Nemeth D, 2013, J NEUROLINGUIST, V26, P462, DOI 10.1016/j.jneuroling.2013.02.002; Nemeth D, 2012, BRAIN LANG, V121, P248, DOI 10.1016/j.bandl.2012.04.001; Pinker S, 2002, TRENDS COGN SCI, V6, P456, DOI 10.1016/S1364-6613(02)01990-3; Pinker S., 1999, WORDS RULES INGREDIE; Pleh C, 2003, BRAIN LANG, V86, P377, DOI 10.1016/S0093-934X(02)00537-0; Pleh C, 2002, AGY TUDAT, P153; PLUNKETT K, 1991, COGNITION, V38, P43, DOI 10.1016/0010-0277(91)90022-V; PLUNKETT K, 1993, COGNITION, V48, P21, DOI 10.1016/0010-0277(93)90057-3; Prado EL, 2009, J EXP PSYCHOL LEARN, V35, P849, DOI 10.1037/a0015286; Rodriguez-Gonzalez E, 2012, SPAN J PSYCHOL, V15, P35, DOI 10.5209/rev_SJOP.2012.v15.n1.37282; Rounds Carol, 2001, HUNGARIAN ESSENTIAL; Rumelhart D., PARALLEL DISTRIBUTED, V1; Sach M, 2004, NEUROREPORT, V15, P533, DOI 10.1097/00001756-200403010-00030; Say Tessa., 2002, STORAGE COMPUTATION, P93, DOI [DOI 10.1007/978-94-010-0355-1, 10.1007/978-94-010-0355-1_4, DOI 10.1007/978-94-010-0355-1_4]; Ullman MT, 2008, HANDBOOK OF THE NEUROSCIENCE OF LANGUAGE, P189, DOI 10.1016/B978-0-08-045352-1.00018-5; Ullman MT, 2005, CORTEX, V41, P399, DOI 10.1016/S0010-9452(08)70276-4; Ullman MT, 2001, NAT REV NEUROSCI, V2, P717, DOI 10.1038/35094573; Ullman MT, 2004, COGNITION, V92, P231, DOI 10.1016/j.cognition.2003.10.008; Ullman MT, 1997, J COGNITIVE NEUROSCI, V9, P266, DOI 10.1162/jocn.1997.9.2.266; Ullman MT, 2007, J COGNITIVE NEUROS S, P98; Ullman MT, FUNCTIONAL NEU UNPUB; Vaknin V, 2011, MENT LEX, V6, P197, DOI 10.1075/ml.6.2.01vak; van der Lely HKJ, 2001, LANG COGNITIVE PROC, V16, P177, DOI 10.1080/01690960042000076; Walenski M, 2007, NEUROPSYCHOLOGIA, V45, P2447, DOI 10.1016/j.neuropsychologia.2007.04.001; Walenski M, 2009, NEUROPSYCHOLOGIA, V47, P1245, DOI 10.1016/j.neuropsychologia.2008.12.038; Wium K, 2008, CLIN LINGUIST PHONET, V22, P401, DOI 10.1080/02699200801919406; Woollams AM, 2009, J MEM LANG, V61, P55, DOI 10.1016/j.jml.2009.02.002; Yim H, 2006, LECT NOTES COMPUT SC, V4232, P247	62	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119003	10.1371/journal.pone.0119003	http://dx.doi.org/10.1371/journal.pone.0119003			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7NO	25769039	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000351277500059
J	Arredondo, A; Aviles, R				Arredondo, Armando; Aviles, Raul			Costs and Epidemiological Changes of Chronic Diseases: Implications and Challenges for Health Systems	PLOS ONE			English	Article							LATIN-AMERICA; HYPERTENSION; PREVALENCE; BURDEN	Background The need to integrate economic and epidemiological aspects in the clinical perspective leads to a proposal for the analysis of health disparities and to an evaluation of the health services and of the new challenges which are now being faced by health system reforms in middle income countries. Objective To identify the epidemiological changes, the demand for health services and economic burden from chronic diseases (diabetes and hypertension) in a middle income county. Methods We conducted longitudinal analyses of costs and epidemiological changes for diabetes and hypertension in the Mexican health system. The study population included both the insured and uninsured populations. The cost-evaluation method was used, based on the instrumentation and consensus techniques. To estimate the epidemiological changes and financial consequences for 2014-2016, six models were constructed according to the Box-Jenkins technique, using confidence intervals of 95%, and the Box-Pierce test. Results Regarding epidemiological changes expected in both diseases for 2014 vs. 2016, an increase is expected, although results predict a greater increase for diabetes, 8-12% in all three studied institutions, (p < .05). Indeed, in the case of diabetes, the increase was 41469 cases for uninsured population (SSA) and 65737 for the insured population (IMSS and ISSSTE). On hypertension cases the increase was 38109 for uninsured vs 62895 for insured. Costs in US$ ranged from $699 to $748 for annual case management per patient in the case of diabetes, and from $485 to $622 in patients with hypertension. Comparing financial consequences of health services required by insured and uninsured populations, the greater increase (23%) will be for the insured population (p < .05). The financial requirements of both diseases will amount to 19.5% of the total budget for the uninsured and 12.5% for the insured population. Conclusions If the risk factors and the different health care models remain as they currently are, the economic impact of expected epidemiological changes on the social security system will be particularly strong. Another relevant challenge is the appearance of internal competition in the use and allocation of financial resources with programs for other chronic and infectious diseases.	[Arredondo, Armando; Aviles, Raul] Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico	Instituto Nacional de Salud Publica	Arredondo, A (corresponding author), Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico.	armando.arredondo@umontreal.ca						Aboderin I, 2001, M EXP 2 4 MAY 2001, P33; Amos AF, 2010, DIABETES MED 1997 S5, V14, P51, DOI DOI 10.1002/(SICI)1096-9136(199712)14:5+; Arredondo A., 2009, TEMAS SELECTOS SISTE, P101; Arredondo Armando, 2013, Am J Public Health, V103, pe1, DOI 10.2105/AJPH.2012.301106; Arredondo A, 2014, AM J HYPERTENS, V27, P635, DOI 10.1093/ajh/hpu010; Arredondo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068443; Arredondo A, 2011, VALUE HEALTH, V14, pS85, DOI 10.1016/j.jval.2011.05.022; Banco de Mexico, 2014, IND NAC PREC SERV ME, P57, DOI [10.1016/j.jphotobiol.2014.11.014, DOI 10.1016/J.JPHOTOBIOL.2014.11.014]; Barcelo A, 2003, B WORLD HEALTH ORGAN, V81, P19; Barquera S, 2013, GLOBAL HLTH GOVERNAN, V9, P1744; Barreto SM, 2012, INT J EPIDEMIOL, V41, P557, DOI 10.1093/ije/dys017; Brealey R., 1993, FUNDAMENTOS FINANCIA, P43, DOI [10.1055/s-0031-1275710, DOI 10.1055/S-0031-1275710]; Campos-Nonato I, 2013, SALUD PUBLICA MEXICO, V55, pS144, DOI 10.21149/spm.v55s2.5110; Cercone J, 2014, BANCO MUNDIAL IESE, V2, P6; dos Santos JC, 2012, REV ESC ENFERM USP, V46, P1125, DOI 10.1590/S0080-62342012000500013; Elliott WJ, 1996, POSTGRAD MED, V99, P241, DOI 10.1080/00325481.1996.11946111; Frenk J, 1994, DEMANDA OFERTA SERVI, P18; Galvez A, 2007, ESTUDIOS DE SOMBRA, P13; Garcia C, 2001, SALUD PUBLICA MEXICO, V4, P415; Gaziano TA, 2010, INT AM DEV BANK, P54; Glassman A, 2010, HEALTH AFFAIR, V29, P2142, DOI 10.1377/hlthaff.2010.1038; Hernandez-Avila M, 2013, SALUD PUBLICA MEXICO, V55, pS129, DOI 10.21149/spm.v55s2.5108; Instituto Nacional de Salud Publica, 2014, MET EST DEM ESP ENF, P34; Instituto Nacional de Salud Publica, 2012, ENC NAC SAL NUTR 201, P74; International Diabetes Federation, 2010, DECL INT LAW PRINC R, P29; Johnson Samuel, 2013, J Med Econ, V16, P1414, DOI 10.3111/13696998.2013.849713; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Murray A, 2005, STAT MODELLING GLIM, P112; Peckham R, 2014, J PUBLIC HEALTH-UK, V36, P13, DOI 10.1093/pubmed/fdt083; Quentin T, 2013, WORLD BANK TECHNICAL; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Snowdon A., 2012, MEASURING WHAT MATTE, P12; SSA, 2013, PROGR SECT SAL PLAN; SSA, 2013, REP AN CAS ENG CRON, P1, DOI [10.7334/psicothema2012.167, DOI 10.7334/PSICOTHEMA2012.167]; SSA IMSS ISSSTE, 2014, B INF EST CAS MORB H, P57; Stevens G, 2008, PLOS MED, V5, P900, DOI 10.1371/journal.pmed.0050125; Teixeira JC, 2012, REV PANAM SALUD PUBL, V32, P419, DOI 10.1590/S1020-49892012001400005; Villarreal-Rios E, 2002, SALUD PUBLICA MEXICO, V44, P7, DOI 10.1590/S0036-36342002000100001; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; World Health Organization, 2009, GUID ASS SOC EC IMP, P37; Zhang P, 2010, DIABETES RES CLIN PR, V87, P293, DOI 10.1016/j.diabres.2010.01.026	41	29	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0118611	10.1371/journal.pone.0118611	http://dx.doi.org/10.1371/journal.pone.0118611			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781625	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600031
J	Chen, YC; Chang, JG; Jong, YJ; Liu, TY; Yuo, CY				Chen, Yu-Chia; Chang, Jan-Gowth; Jong, Yuh-Jyh; Liu, Ting-Yuan; Yuo, Chung-Yee			High Expression Level of Tra2-beta 1 Is Responsible for Increased SMN2 Exon 7 Inclusion in the Testis of SMA Mice	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; MOTOR-NEURON SMN; GENE-PRODUCT; SPLICING ENHANCER; SINGLE NUCLEOTIDE; MESSENGER-RNA; MOUSE MODEL; SURVIVAL; COMPLEX; COMPONENT	Spinal muscular atrophy (SMA) is an inherited neuromuscular disease caused by deletion or mutation of SMN1 gene. All SMA patients carry a nearly identical SMN2 gene, which produces low level of SMN protein due to mRNA exon 7 exclusion. Previously, we found that the testis of SMA mice (smn(-/-) SMN2) expresses high level of SMN2 full-length mRNA, indicating a testis-specific mechanism for SMN2 exon 7 inclusion. To elucidate the underlying mechanism, we established primary cultures of testis cells from SMA mice and analyzed them for SMN2 exon 7 splicing. We found that primary testis cells after a 2-hour culture still expressed high level of SMN2 full-length mRNA, but the level decreased after longer cultures. We then compared the protein levels of relevant splicing factors, and found that the level of Tra2-beta 1 also decreased during testis cell culture, correlated with SMN2 full-length mRNA downregulation. In addition, the testis of SMA mice expressed the highest level of Tra2-beta 1 among the many tissues examined. Furthermore, overexpression of Tra2-beta 1, but not ASF/SF2, increased SMN2 minigene exon 7 inclusion in primary testis cells and spinal cord neurons, whereas knockdown of Tra2-beta 1 decreased SMN2 exon 7 inclusion in primary testis cells of SMA mice. Therefore, our results indicate that high expression level of Tra2-beta 1 is responsible for increased SMN2 exon 7 inclusion in the testis of SMA mice. This study also suggests that the expression level of Tra2-beta 1 may be a modifying factor of SMA disease and a potential target for SMA treatment.	[Chen, Yu-Chia; Jong, Yuh-Jyh; Liu, Ting-Yuan] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan; [Chang, Jan-Gowth] China Med Univ Hosp, Epigenome Res Ctr, Taichung, Taiwan; [Chang, Jan-Gowth] China Med Univ Hosp, Dept Lab Med, Taichung, Taiwan; [Chang, Jan-Gowth] China Med Univ, Sch Med, Taichung, Taiwan; [Jong, Yuh-Jyh] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Pediat, Kaohsiung, Taiwan; [Jong, Yuh-Jyh] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Clin Lab, Kaohsiung, Taiwan; [Jong, Yuh-Jyh] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Yuo, Chung-Yee] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan	Kaohsiung Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Yang Ming Chiao Tung University; Kaohsiung Medical University	Yuo, CY (corresponding author), Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan.	m815006@kmu.edu.tw			Ministry of Science and Technology, Taiwan, R. O. C. [NSC98-2320-B-037-025-MY3, NSC98-2321-B-037-062-, NSC99-2321-B-037-002-, NSC100-2321-B-039-007-]	Ministry of Science and Technology, Taiwan, R. O. C.(Ministry of Science and Technology, Taiwan)	CYY was supported by the Ministry of Science and Technology, Taiwan, R. O. C. (NSC98-2320-B-037-025-MY3). JGC was supported by the Ministry of Science and Technology, Taiwan, R. O. C. (NSC98-2321-B-037-062-), (NSC99-2321-B-037-002-), (NSC100-2321-B-039-007-). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila AM, 2007, J CLIN INVEST, V117, P659, DOI 10.1172/JCI29562; Baccon J, 2002, J BIOL CHEM, V277, P31957, DOI 10.1074/jbc.M203478200; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Burglen L, 1996, GENOMICS, V32, P479, DOI 10.1006/geno.1996.0147; Carissimi C, 2006, J BIOL CHEM, V281, P8126, DOI 10.1074/jbc.M512243200; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Cauchi RJ, 2010, BIOESSAYS, V32, P1077, DOI 10.1002/bies.201000088; Chari A, 2009, CURR OPIN CELL BIOL, V21, P387, DOI 10.1016/j.ceb.2009.02.004; Charroux B, 2000, J CELL BIOL, V148, P1177, DOI 10.1083/jcb.148.6.1177; Charroux B, 1999, J CELL BIOL, V147, P1181, DOI 10.1083/jcb.147.6.1181; Chen HH, 2008, MOL CELL BIOL, V28, P6929, DOI 10.1128/MCB.01332-08; Coady TH, 2011, WIRES RNA, V2, P546, DOI 10.1002/wrna.76; Grimmler M, 2005, HUM MOL GENET, V14, P3099, DOI 10.1093/hmg/ddi343; Gubitz AK, 2002, J BIOL CHEM, V277, P5631, DOI 10.1074/jbc.M109448200; Helmken C, 2003, HUM GENET, V114, P11, DOI 10.1007/s00439-003-1025-2; Helmken C, 2000, HUM GENET, V107, P554, DOI 10.1007/s004390000409; Hofmann Y, 2000, P NATL ACAD SCI USA, V97, P9618, DOI 10.1073/pnas.160181697; Hofmann Y, 2002, HUM MOL GENET, V11, P2037, DOI 10.1093/hmg/11.17.2037; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Jean-Philippe J, 2013, INT J MOL SCI, V14, P18999, DOI 10.3390/ijms140918999; Kashima T, 2003, NAT GENET, V34, P460, DOI 10.1038/ng1207; Kolb SJ, 2007, J CHILD NEUROL, V22, P990, DOI 10.1177/0883073807305666; Kolb SJ, 2011, ARCH NEUROL-CHICAGO, V68, P979, DOI 10.1001/archneurol.2011.74; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Mercuri E, 2012, LANCET NEUROL, V11, P443, DOI 10.1016/S1474-4422(12)70061-3; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Nurputra DK, 2013, ANN HUM GENET, V77, P435, DOI 10.1111/ahg.12031; Ogino S, 2002, AM J MED GENET, V110, P301, DOI 10.1002/ajmg.10425; Patel AA, 2003, NAT REV MOL CELL BIO, V4, P960, DOI 10.1038/nrm1259; Pellizzoni L, 2002, J BIOL CHEM, V277, P7540, DOI 10.1074/jbc.M110141200; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; Seo J, 2013, BBA-MOL BASIS DIS, V1832, P2180, DOI 10.1016/j.bbadis.2013.08.005; Wirth Brunhilde, 2006, Semin Pediatr Neurol, V13, P121, DOI 10.1016/j.spen.2006.06.008; Workman E, 2012, BRAIN RES, V1462, P93, DOI 10.1016/j.brainres.2012.02.051; Young PJ, 2002, HUM MOL GENET, V11, P577, DOI 10.1093/hmg/11.5.577; Zhang ML, 2001, GENE THER, V8, P1532, DOI 10.1038/sj.gt.3301550	38	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120721	10.1371/journal.pone.0120721	http://dx.doi.org/10.1371/journal.pone.0120721			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781985	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600185
J	Liu-Seifert, H; Andersen, SW; Lipkovich, I; Holdridge, KC; Siemers, E				Liu-Seifert, Hong; Andersen, Scott W.; Lipkovich, Ilya; Holdridge, Karen C.; Siemers, Eric			A Novel Approach to Delayed-Start Analyses for Demonstrating Disease-Modifying Effects in Alzheimer's Disease	PLOS ONE			English	Article							DOUBLE-BLIND; TRIAL; SOLANEZUMAB; PROGRESSION; SAFETY	One method for demonstrating disease modification is a delayed-start design, consisting of a placebo-controlled period followed by a delayed-start period wherein all patients receive active treatment. To address methodological issues in previous delayed-start approaches, we propose a new method that is robust across conditions of drug effect, discontinuation rates, and missing data mechanisms. We propose a modeling approach and test procedure to test the hypothesis of noninferiority, comparing the treatment difference at the end of the delayed-start period with that at the end of the placebo-controlled period. We conducted simulations to identify the optimal noninferiority testing procedure to ensure the method was robust across scenarios and assumptions, and to evaluate the appropriate modeling approach for analyzing the delayed-start period. We then applied this methodology to Phase 3 solanezumab clinical trial data for mild Alzheimer's disease patients. Simulation results showed a testing procedure using a proportional noninferiority margin was robust for detecting disease-modifying effects; conditions of high and moderate discontinuations; and with various missing data mechanisms. Using all data from all randomized patients in a single model over both the placebo-controlled and delayed-start study periods demonstrated good statistical performance. In analysis of solanezumab data using this methodology, the noninferiority criterion was met, indicating the treatment difference at the end of the placebo-controlled studies was preserved at the end of the delayed-start period within a pre-defined margin. The proposed noninferiority method for delayed-start analysis controls Type I error rate well and addresses many challenges posed by previous approaches. Delayed-start studies employing the proposed analysis approach could be used to provide evidence of a disease-modifying effect. This method has been communicated with FDA and has been successfully applied to actual clinical trial data accrued from the Phase 3 clinical trials of solanezumab.	[Liu-Seifert, Hong; Andersen, Scott W.; Lipkovich, Ilya; Holdridge, Karen C.; Siemers, Eric] Eli Lilly & Co, Indianapolis, IN 46285 USA	Eli Lilly	Liu-Seifert, H (corresponding author), Eli Lilly & Co, Indianapolis, IN 46285 USA.	liu-seifert_hong@lilly.com			Eli Lilly and Company	Eli Lilly and Company(Eli Lilly)	Funding was provided by Eli Lilly and Company. Eli Lilly and Company was the funding source and was involved in all stages of the study conduct and analysis.	American Psychiatric Association, 2000, DIAGN STAT MAN TEXT; [Anonymous], 2010, WORLD ALZHEIMER REPO; Balding DJ, 2004, APPL LONGITUDINAL AN; Bhattaram VA, 2009, AAPS J, V11, P456, DOI 10.1208/s12248-009-9123-2; Bynum JPW, 2004, J AM GERIATR SOC, V52, P187, DOI 10.1111/j.1532-5415.2004.52054.x; Carlson C, 2013, ALZHEIMERS DEMENT SU, V9, P139; DAVIS KL, 1992, NEW ENGL J MED, V327, P1253, DOI 10.1056/NEJM199210293271801; Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889; FDA, 2010, GUID IND NON CLIN TR; [FDA Research CfDEa], 2013, GUID IND ALZH DIS DE; Food and Drug Administration. Center for Drug Evaluation and Research (CDER), 2011, PER CENTR NERV SYST; Galimberti Daniela, 2011, Ther Adv Neurol Disord, V4, P203, DOI 10.1177/1756285611404470; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003529; Hung HMJ, 2003, STAT MED, V22, P213, DOI 10.1002/sim.1315; Ito K, 2010, ALZHEIMERS DEMENT, V6, P39, DOI 10.1016/j.jalz.2009.05.665; James BD, 2014, NEUROLOGY, V82, P1045, DOI 10.1212/WNL.0000000000000240; Katz Russell, 2004, NeuroRx, V1, P307, DOI 10.1007/BF03206615; Leber P, 1997, ALZ DIS ASSOC DIS, V11, pS10; Mallinckrodt C H, 2001, J Biopharm Stat, V11, P9, DOI 10.1081/BIP-100104194; Mallinckrodt CH, 2013, PREVENTION TREATMENT; Mallinckrodt CH, 2012, ESSENTIALS CNS DRUG; Mallinckrodt CH, 2008, DRUG INF J, V42, P303, DOI 10.1177/009286150804200402; Mani RB, 2008, ISCTM AUT M TOR CAN; Molenberghs G, 2004, BIOSTATISTICS, V5, P445, DOI 10.1093/biostatistics/kxh001; Molenberghs G., 2007, MISSING DATA CLIN ST; National Research Council, 2010, PREVENTION TREATMENT; Olanow CW, 2009, NEW ENGL J MED, V361, P1268, DOI 10.1056/NEJMoa0809335; Rogers SL, 1998, NEUROLOGY, V50, P136, DOI 10.1212/WNL.50.1.136; Rosler M, 1999, BMJ-BRIT MED J, V318, P633, DOI 10.1136/bmj.318.7184.633; Schwartz TA, 2006, STAT MED, V25, P3396, DOI 10.1002/sim.2651; Sperling RA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002609; Uenaka K, 2012, CLIN NEUROPHARMACOL, V35, P25, DOI 10.1097/WNF.0b013e31823a13d3; Verbeke G, 2000, LINEAR MIXED MODELS; Wilcock GK, 2000, BRIT MED J, V321, P1; Zhang RY, 2011, CLIN TRIALS, V8, P5, DOI 10.1177/1740774510392255	35	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119632	10.1371/journal.pone.0119632	http://dx.doi.org/10.1371/journal.pone.0119632			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781335	Green Submitted, gold, Green Published			2022-12-27	WOS:000351284600079
J	Griffiths, S; Wingen, L; Pietragalla, J; Garcia, G; Hasan, A; Miralles, D; Calderini, DF; Ankleshwaria, JB; Waite, ML; Simmonds, J; Snape, J; Reynolds, M				Griffiths, Simon; Wingen, Luzie; Pietragalla, Julian; Garcia, Guillermo; Hasan, Ahmed; Miralles, Daniel; Calderini, Daniel F.; Ankleshwaria, Jignaben Bipinchandra; Waite, Michelle Leverington; Simmonds, James; Snape, John; Reynolds, Matthew			Genetic Dissection of Grain Size and Grain Number Trade-Offs in CIMMYT Wheat Germplasm	PLOS ONE			English	Article							SPRING WHEAT; SEED SIZE; 1BL/1RS TRANSLOCATION; QTL ANALYSIS; BREAD WHEAT; YIELD; ENVIRONMENTS; WEIGHT; POPULATION; TRAITS	Grain weight (GW) and number per unit area of land (GN) are the primary components of grain yield in wheat. In segregating populations both yield components often show a negative correlation among themselves. Here we use a recombinant doubled haploid population of 105 individuals developed from the CIMMYT varieties Weebill and Bacanora to understand the relative contribution of these components to grain yield and their interaction with each other. Weebill was chosen for its high GW and Bacanora for high GN. The population was phenotyped in Mexico, Argentina, Chile and the UK. Two loci influencing grain yield were indicated on 1B and 7B after QTL analysis. Weebill contributed the increasing alleles. The 1B effect, which is probably caused by to the 1BL. 1RS rye introgression in Bacanora, was a result of increased GN, whereas, the 7B QTL controls GW. We concluded that increased in GW from Weebill 7B allele is not accompanied by a significant reduction in grain number. The extent of the GW and GN trade-off is reduced. This makes this locus an attractive target for marker assisted selection to develop high yielding bold grain varieties like Weebill. AMMI analysis was used to show that the 7B Weebill allele appears to contribute to yield stability.	[Griffiths, Simon; Wingen, Luzie; Ankleshwaria, Jignaben Bipinchandra; Waite, Michelle Leverington; Simmonds, James; Snape, John] John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England; [Pietragalla, Julian; Reynolds, Matthew] CIMMYT Int, Mexico City 06600, DF, Mexico; [Garcia, Guillermo; Miralles, Daniel] Univ Buenos Aires, Fac Agron, Dept Prod Vegetal, Catedra Cerealicultura, Buenos Aires, DF, Argentina; [Garcia, Guillermo; Miralles, Daniel] Univ Buenos Aires, Fac Agron, IFEVA CONICET, Buenos Aires, DF, Argentina; [Hasan, Ahmed; Calderini, Daniel F.] Univ Austral Chile, Plant Prod & Plant Protect Inst, Valdivia, Chile	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; CGIAR; International Maize & Wheat Improvement Center (CIMMYT); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Universidad Austral de Chile	Griffiths, S (corresponding author), John Innes Ctr Plant Sci Res, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	simon.griffiths@jic.ac.uk	Reynolds, Matthew M/S-3578-2016; Calderini, Daniel F/D-7922-2015; hasan, ahmed/B-3788-2010; Wingen, Luzie/AAF-3703-2019	Reynolds, Matthew M/0000-0002-4291-4316; Calderini, Daniel F/0000-0001-7873-5101; Wingen, Luzie/0000-0002-4682-4764; Snape, john/0000-0002-9241-3931; Simmonds, James/0000-0003-4936-1694; Garcia, Guillermo/0000-0001-7690-4100; Hasan, Ahmed/0000-0001-6762-9098	UK by the Biotechnology and Biological Sciences Research Council (BBSRC); BBSRC [BBS/E/J/000C0617] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0617] Funding Source: researchfish	UK by the Biotechnology and Biological Sciences Research Council (BBSRC); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded in the UK by the Biotechnology and Biological Sciences Research Council (BBSRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammiraju JSS, 2001, THEOR APPL GENET, V102, P726, DOI 10.1007/s001220051703; Breseghello F, 2007, FIELD CROP RES, V101, P172, DOI 10.1016/j.fcr.2006.11.008; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Bustos DV, 2013, FIELD CROP RES, V145, P106, DOI 10.1016/j.fcr.2013.01.015; Calderini DF, 2001, EUPHYTICA, V119, P199, DOI 10.1023/A:1017597923568; Fischer RA, 2008, FIELD CROP RES, V105, P15, DOI 10.1016/j.fcr.2007.04.002; FISCHER RA, 1985, J AGR SCI, V105, P447, DOI 10.1017/S0021859600056495; Foulkes MJ, 2011, J EXP BOT, V62, P469, DOI 10.1093/jxb/erq300; Garcia GA, 2013, CROP SCI, V53, P2577, DOI 10.2135/cropsci2012.11.0669; Gauch HG, 2008, CROP SCI, V48, P866, DOI 10.2135/cropsci2007.09.0513; Gegas VC, 2010, PLANT CELL, V22, P1046, DOI 10.1105/tpc.110.074153; GOLLOB HF, 1968, PSYCHOMETRIKA, V33, P73, DOI 10.1007/BF02289676; GRIEVE CM, 1992, PLANT SOIL, V147, P197, DOI 10.1007/BF00029071; Kuchel H, 2007, THEOR APPL GENET, V115, P1029, DOI 10.1007/s00122-007-0629-7; LAURIE DA, 1988, THEOR APPL GENET, V76, P393, DOI 10.1007/BF00265339; Lopes MS, 2012, FIELD CROP RES, V128, P129, DOI 10.1016/j.fcr.2011.12.017; MARSHALL DR, 1986, AUST J AGR RES, V37, P331, DOI 10.1071/AR9860331; Monneveux P, 2003, CEREAL RES COMMUN, V31, P371; Parry MAJ, 2011, J EXP BOT, V62, P453, DOI 10.1093/jxb/erq304; Peake AS, 2011, CROP PASTURE SCI, V62, P276, DOI 10.1071/CP10219; RDevelopmentCoreTeam, 2008, R LANG ENV STAT COMP; Reynolds M, 2011, J EXP BOT, V62, P439, DOI 10.1093/jxb/erq311; Roeder MIS, 2008, FUNCT INTEGR GENOMIC, V8, P79, DOI 10.1007/s10142-007-0053-8; Sadras VO, 2007, FIELD CROP RES, V100, P125, DOI 10.1016/j.fcr.2006.07.004; Sayre KD, 1997, CROP SCI, V37, P36, DOI 10.2135/cropsci1997.0011183X003700010006x; Singh R, 2009, CEREAL RES COMMUN, V37, P441, DOI 10.1556/CRC.37.2009.3.13; Tsilo TJ, 2010, THEOR APPL GENET, V121, P717, DOI 10.1007/s00122-010-1343-4; Wang Y, 2012, MOL BREEDING, V29, P661, DOI 10.1007/s11032-011-9580-z; Wiersma JJ, 2001, CROP SCI, V41, P999, DOI 10.2135/cropsci2001.414999x; Wu X., 2012, P ACM SIGCOMM, P7; Xiao YG, 2011, CROP PASTURE SCI, V62, P625, DOI 10.1071/CP11037; Zhao CH, 2012, FIELD CROP RES, V127, P79, DOI 10.1016/j.fcr.2011.11.008	32	69	73	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118847	10.1371/journal.pone.0118847	http://dx.doi.org/10.1371/journal.pone.0118847			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775191	Green Published, gold			2022-12-27	WOS:000351183500044
J	Heath, MR; Cook, RM				Heath, Michael R.; Cook, Robin M.			Hind-Casting the Quantity and Composition of Discards by Mixed Demersal Fisheries in the North Sea	PLOS ONE			English	Article							BY-CATCH; ECOSYSTEM APPROACH; OBSERVER SURVEYS; SAMPLING DESIGN; FISH; SELECTIVITY; COD; MANAGEMENT; STRATEGY; CONSEQUENCES	Many commercial fisheries seek to maximise the economic value of the catch that they bring ashore and market for human consumption by discarding undersize or low value fish. Information on the quantity, size and species composition of discarded fish is vital for stock assessments and for devising legislation to minimise the practice. However, except for a few major species, data are usually extremely sparse and reliant on observers aboard a small sample of fishing vessels. Expanding these data to estimate total regional discards is highly problematic. Here, we develop a method for utilising additional information from scientific trawl surveys to model the quantities of fish discarded by the commercial fisheries. As a case-study, we apply the model to the North Sea over the period 1978-2011, and show a long-term decline in the overall quantity of fish discarded, but an increase in the proportion of catch which is thrown away. The composition of discarded catch has shifted from predominantly (similar to 80%) roundfish, to > 50% flatfish. Undersized plaice constitute the largest single fraction of discards, unchanged from the beginning of the 20th century. Overall, around 60% of discarded fish are rejected on the basis of size rather than for reasons of species value or quota restrictions. The analysis shows that much more information can be gained on discarding by utilising additional sources of data rather than relying solely on information gathered by observers. In addition, it is clear that reducing fishing intensity and rebuilding stocks is likely to be more effective at reducing discards in the long term, than any technical legislation to outlaw the practice in the short term.	[Heath, Michael R.; Cook, Robin M.] Univ Strathclyde, Dept Math & Stat, Glasgow, Lanark, Scotland	University of Strathclyde	Heath, MR (corresponding author), Univ Strathclyde, Dept Math & Stat, Glasgow, Lanark, Scotland.	m.heath@strath.ac.uk	Heath, Michael R/D-5765-2013; Cook, Robin M/D-6261-2013	Cook, Robin/0000-0002-9604-0204; Heath, Michael/0000-0001-6602-3107	Marine Science and Technology Scotland (MASTS) [HR09011]; NERC [NE/L003120/1] Funding Source: UKRI; Natural Environment Research Council [NE/L003120/1] Funding Source: researchfish	Marine Science and Technology Scotland (MASTS); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Both authors were supported by the Marine Science and Technology Scotland (MASTS) pooling scheme (Scottish Funding Council grant reference HR09011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts G, 2009, ICES J MAR SCI, V66, P763, DOI 10.1093/icesjms/fsp033; Allard J, 1997, CAN J FISH AQUAT SCI, V54, P2955, DOI 10.1139/cjfas-54-12-2955; Allen M, 2002, FISH RES, V55, P11, DOI 10.1016/S0165-7836(01)00308-3; Alverson DL, 1997, AM FISH S S, V20, P115; Anderson L.G., 1994, MAR RESOUR ECON, V9, P209, DOI DOI 10.1086/mre.9.3.42629081; Anon, 2005, 2005286 SCOTT STAT I, P286; [Anonymous], 1961, 1961543 UK STAT INST, P543; [Anonymous], 1979, 1979741 UK STAT INST, P741; Baudron A. R., 2014, FISH FISHERIES; Beare D, 2005, J SEA RES, V53, P205, DOI 10.1016/j.seares.2004.06.003; Beare DJ, 2004, MAR ECOL PROG SER, V284, P269, DOI 10.3354/meps284269; Bellido J. M., 2007, Boletin Instituto Espanol de Oceanografia, V23, P73; Bellido JM, 2011, HYDROBIOLOGIA, V670, P317, DOI 10.1007/s10750-011-0721-5; Benoit HP, 2009, CAN J FISH AQUAT SCI, V66, P2025, DOI 10.1139/F09-116; Bicknell AWJ, 2013, J APPL ECOL, V50, P649, DOI 10.1111/1365-2664.12072; Borges L, 2005, FISH RES, V75, P29, DOI 10.1016/j.fishres.2005.05.002; Borges L, 2006, ICES J MAR SCI, V63, P1086, DOI 10.1016/j.icesjms.2006.03.017; Camphuysen C.J., 1995, 19955 NIOZ; Camphuysen CJ, 1997, ICES J MAR SCI, V54, P654; Casey J., 1996, Journal of Northwest Atlantic Fishery Science, V19, P91; Catchpole TL, 2006, MAR POLICY, V30, P821, DOI 10.1016/j.marpol.2006.04.002; Catchpole TL, 2006, MAR ECOL PROG SER, V313, P215, DOI 10.3354/meps313215; Catchpole TL, 2011, FISH RES, V107, P94, DOI 10.1016/j.fishres.2010.10.012; Catchpole TL, 2005, MAR POLICY, V29, P421, DOI 10.1016/j.marpol.2004.07.001; Catchpole TL, 2008, ICES J MAR SCI, V65, P267, DOI 10.1093/icesjms/fsn016; Catchpole TL, 2010, J ENVIRON MANAGE, V91, P717, DOI 10.1016/j.jenvman.2009.09.035; Cook RM, 2013, FISH RES, V143, P1, DOI 10.1016/j.fishres.2013.01.003; Cotter AJR, 2007, FISH FISH, V8, P123, DOI 10.1111/j.1467-2679.2007.00241.x; COULL KA, 1989, 43 SCOTT FISH; Crowder LB, 1998, FISHERIES, V23, P8, DOI 10.1577/1548-8446(1998)023&lt;0008:FBIFM&gt;2.0.CO;2; Deas B, 2012, 72 N SEA REG ADV COU; Delaney AE, 2007, ICES J MAR SCI, V64, P804, DOI 10.1093/icesjms/fsm015; Depestele J, 2011, ICES J MAR SCI, V68, P1719, DOI 10.1093/icesjms/fsr030; Diamond B, 2011, REV FISH SCI, V19, P231, DOI 10.1080/10641262.2011.585432; Eliasen SQ, 2014, ICES J MAR SCI, V71, P1298, DOI 10.1093/icesjms/fst120; Enever R, 2009, FISH RES, V95, P40, DOI 10.1016/j.fishres.2008.07.008; European Commission, 2009, GREEN PAP REF COMM F; European Commission, 2007, SEC2007380 EUR COMM; European Commission, 2006, DISC COMM VESS OP EX; Fernandes PG, 2011, ICES J MAR SCI, V68, P1734, DOI 10.1093/icesjms/fsr131; Frandsen RP, 2010, ICES J MAR SCI, V67, P1721, DOI 10.1093/icesjms/fsq050; Furness RW, 2007, MAR ECOL PROG SER, V350, P235, DOI 10.3354/meps07191; Furness RW, 2003, SCI MAR, V67, P33, DOI 10.3989/scimar.2003.67s233; FURNESS RW, 1992, ARDEA, V80, P105; GILLIS DM, 1995, BEHAV ECOL, V6, P146, DOI 10.1093/beheco/6.2.146; GILLIS DM, 1995, CAN J FISH AQUAT SCI, V52, P402, DOI 10.1139/f95-042; Graham N, 2004, FISH RES, V67, P151, DOI 10.1016/j.fishres.2003.09.037; Graham N, 2007, ICES J MAR SCI, V64, P744, DOI 10.1093/icesjms/fsm059; Greenstreet S.P.R., 2012, ICES J MAR SCI, V69, P343, DOI DOI 10.1093/ICESJMS/FSR201; Greenstreet SPR, 2012, ICES J MAR SCI, V69, P1789, DOI 10.1093/icesjms/fss148; Greenstreet SPR, 2011, ICES J MAR SCI, V68, P1, DOI 10.1093/icesjms/fsq156; Groenewold S, 2000, ICES J MAR SCI, V57, P1395, DOI 10.1006/jmsc.2000.0914; Hall SJ, 2005, FISH FISH, V6, P134, DOI 10.1111/j.1467-2979.2005.00183.x; Hammond TR, 2005, ICES J MAR SCI, V62, P1118, DOI 10.1016/j.icesjms.2005.04.015; Heath MR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4893; ICES, 2010, ICES WORKSH EC IND D; ICES, 2012, 2012ACOM13 ICES ADV; *ICES, 2010, 2010SSGESST06 ICES C; ICES, 2000, 2000ACFM11 ICES CM; ICES, 2004, 2004ACFM12 ICES CM; ICES, 2011, ICES ADV 2011 N SEA; ICES, 2007, 2007ACFM06 ICES CM; ICES, 1993, 1993ASSESS5 ICES CM; ICES, 2010, 2010ACOM21 ICES ADV; Jenkins SR, 2004, J SEA RES, V51, P69, DOI 10.1016/j.seares.2003.05.002; Jensen F, 2002, RESOUR ENERGY ECON, V24, P281, DOI 10.1016/S0928-7655(02)00003-9; Kelleher K., 2005, 470 FAO UN; Kennelly SJ, 2002, FISH FISH, V3, P340, DOI 10.1046/j.1467-2979.2002.00090.x; Kingsley MCS, 2002, ICES J MAR SCI, V59, P649, DOI 10.1006/jmsc.2002.1299; Lassen H, 2012, 311 ICES; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; Mackinson S, 2007, 142 CEF LOW, V142; Mark Freeberg J.G.Pope, 1994, GLOBAL ASSESSMENT FI; Miller CP, 2005, 1505 FISH RES SERV; Oro D, 2013, ECOL LETT, V16, P1501, DOI 10.1111/ele.12187; Patterson KR, 1998, ICES J MAR SCI, V55, P878, DOI 10.1006/jmsc.1998.0351; Poos JJ, 2010, ICES J MAR SCI, V67, P323, DOI 10.1093/icesjms/fsp241; Punt AE, 2006, FISH RES, V79, P239, DOI 10.1016/j.fishres.2006.04.007; Rochet MJ, 2005, CAN J FISH AQUAT SCI, V62, P224, DOI 10.1139/F04-185; Rockmann C, 2011, C06811 IMARES; Sarda F, 2013, FISH FISHERIES; Stratoudakis Y, 1999, ICES J MAR SCI, V56, P592, DOI 10.1006/jmsc.1999.0500; Stratoudakis Y, 1998, CAN J FISH AQUAT SCI, V55, P1632, DOI 10.1139/cjfas-55-7-1632; Suuronen P, 2007, ICES J MAR SCI, V64, P1603, DOI 10.1093/icesjms/fsm124; Symes D, 1997, OCEAN COAST MANAGE, V35, P137, DOI 10.1016/S0964-5691(97)00030-6; Tamsett D, 1999, FISH RES, V42, P117, DOI 10.1016/S0165-7836(99)00030-2; Tasker ML, 2000, ICES J MAR SCI, V57, P531, DOI 10.1006/jmsc.2000.0714; Uhlmann SS, 2014, ICES J MAR SCI, V71, P1235, DOI 10.1093/icesjms/fst030; Vestergaard N., 1996, MARINE RESOURCE EC, V11, P247, DOI DOI 10.1086/mre.11.4.42629169; Votier SC, 2004, NATURE, V427, P727, DOI 10.1038/nature02315; Votier SC, 2010, J APPL ECOL, V47, P487, DOI 10.1111/j.1365-2664.2010.01790.x; Williams N, 2011, CURR BIOL, V21, pR3, DOI 10.1016/j.cub.2010.12.027; [No title captured]	93	12	12	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0117078	10.1371/journal.pone.0117078	http://dx.doi.org/10.1371/journal.pone.0117078			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774938	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000351183500015
J	Kwon, J; Namgoong, S; Kim, NH				Kwon, Jeongwoo; Namgoong, Suk; Kim, Nam-Hyung			CRISPR/Cas9 as Tool for Functional Study of Genes Involved in Preimplantation Embryo Development	PLOS ONE			English	Article							ONE-STEP GENERATION; GENOME; KNOCKOUT; MOUSE; ZEBRAFISH; PIGS; KNOCKDOWN; INJECTION; OOCYTES; CELLS	The CRISPR/Cas9 system has proven to be an efficient gene-editing tool for genome modification of cells and organisms. However, the applicability and efficiency of this system in pig embryos have not been studied in depth. Here, we aimed to remove porcine OCT4 function as a model case using the CRISPR/Cas9 system. Injection of Cas9 and single-guide RNA (sgRNA) against OCT4 decreased the percentages of OCT4-positive embryos to 37-50% of total embryos, while similar to 100% of control embryos exhibited clear OCT4 immunostaining. We assessed the mutation status near the guide sequence using polymerase chain reaction (PCR) and DNA sequencing, and a portion of blastocysts (20% in exon 2 and 50% in exon 5) had insertions/deletions near protospacer-adjacent motifs (PAMs). Different target sites had frequent deletions, but different concentrations of sgRNA made no impact. OCT4 mRNA levels dramatically decreased at the 8-cell stage, and they were barely detectable in blastocysts, while mRNA levels of other genes, including NANOG, and CDX2 were not affected. In addition, the combination of two sgRNAs led to large-scale deletion (about 1.8 kb) in the same chromosome. Next, we injected an enhanced green fluorescent protein (eGFP) vector targeting the OCT4 exon with Cas9 and sgRNA to create a knockin. We confirmed eGFP fluorescence in blastocysts in the inner cell mass, and also checked the mutation status using PCR and DNA sequencing. A significant portion of blastocysts had eGFP sequence insertions near PAM sites. The CRISPR/CAS9 system provides a good tool for gene functional studies by deleting target genes in the pig.	[Kwon, Jeongwoo; Namgoong, Suk; Kim, Nam-Hyung] Chungbuk Natl Univ, Dept Anim Sci, Cheongju 362763, Chungcheongbuk, South Korea	Chungbuk National University	Namgoong, S (corresponding author), Chungbuk Natl Univ, Dept Anim Sci, Cheongju 362763, Chungcheongbuk, South Korea.	suknamgoong@chungbuk.ac.kr; nhkim@chungbuk.ac.kr			Next Generation Biogreen 21 Program, RDA, Republic of Korea [PJ011126]	Next Generation Biogreen 21 Program, RDA, Republic of Korea	This study was supported by a grant from the Next Generation Biogreen 21 Program (PJ011126), RDA, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auer TO, 2014, NAT PROTOC, V9, P2823, DOI 10.1038/nprot.2014.187; Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Bae S, 2014, NAT METHODS, V11, P705, DOI 10.1038/nmeth.3015; Boch J, 2011, NAT BIOTECHNOL, V29, P135, DOI 10.1038/nbt.1767; Brevini TAL, 2010, STEM CELL REV REP, V6, P484, DOI 10.1007/s12015-010-9153-2; Cao ZB, 2014, THERIOGENOLOGY, V81, P496, DOI 10.1016/j.theriogenology.2013.10.025; Carbery ID, 2010, GENETICS, V186, P451, DOI 10.1534/genetics.110.117002; Carlson DF, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2011.5; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Cho SW, 2013, GENETICS, V195, P1177, DOI 10.1534/genetics.113.155853; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Choi PS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4728; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Doench JG, 2014, NAT BIOTECHNOL; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Fujii W, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt772; Funahashi H, 2003, REPROD FERT DEVELOP, V15, P167, DOI 10.1071/RD02076; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Guo XG, 2014, DEVELOPMENT, V141, P707, DOI 10.1242/dev.099853; Hacking DF, 2008, EARLY HUM DEV, V84, P821, DOI 10.1016/j.earlhumdev.2008.09.011; Hai T, 2014, CELL RES, V24, P372, DOI 10.1038/cr.2014.11; Harrison MM, 2014, GENE DEV, V28, P1859, DOI 10.1101/gad.248252.114; Hauschild J, 2011, P NATL ACAD SCI USA, V108, P12013, DOI 10.1073/pnas.1106422108; Heo Y, 2014, STEM CELLS DEV; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Hyttel P, 2000, BIOL REPROD, V63, P1848, DOI 10.1095/biolreprod63.6.1848; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Kanzler B, 2003, MECH DEVELOP, V120, P1423, DOI 10.1016/j.mod.2003.09.008; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Kukulski W, 2012, METHOD CELL BIOL, V111, P235, DOI 10.1016/B978-0-12-416026-2.00013-3; Landecker H, 2009, NAT METHODS, V6, P707, DOI 10.1038/nmeth1009-707; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Lillico SG, 2013, SCI REP-UK, V3, DOI 10.1038/srep02847; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Narbonne P, 2012, CURR OPIN GENET DEV, V22, P450, DOI 10.1016/j.gde.2012.09.002; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Sakurai N, 2013, J REPROD DEVELOP, V59, P353, DOI 10.1262/jrd.2013-003; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Schmid-Burgk JL, 2013, NAT BIOTECHNOL, V31, P76, DOI 10.1038/nbt.2460; Schnell U, 2012, NAT METHODS, V9, P152, DOI [10.1038/nmeth.1855, 10.1038/NMETH.1855]; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Svoboda P, 2000, DEVELOPMENT, V127, P4147; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Torres R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4964; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Whitworth KM, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.121723; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Zheng Z, 2013, J REPROD DEVELOP, V59, P557, DOI 10.1262/jrd.2013-050; Zhou NR, 2014, ANIM REPROD SCI, V148, P153, DOI 10.1016/j.anireprosci.2014.06.002; Zhou X, 2014, GENERATION CRISPR CA	57	10	11	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120501	10.1371/journal.pone.0120501	http://dx.doi.org/10.1371/journal.pone.0120501			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775469	gold, Green Published, Green Submitted			2022-12-27	WOS:000351183500182
J	Liao, XF; Ren, JJ; Wei, CH; Ross, AC; Cecere, TE; Jortner, BS; Ahmed, SA; Luo, XM				Liao, Xiaofeng; Ren, Jingjing; Wei, Cheng-Hsin; Ross, A. Catharine; Cecere, Thomas E.; Jortner, Bernard S.; Ahmed, S. Ansar; Luo, Xin M.			Paradoxical Effects of All-Trans-Retinoic Acid on Lupus-Like Disease in the MRL/lpr Mouse Model	PLOS ONE			English	Article							REGULATORY T-CELLS; B-CELLS; DENDRITIC CELLS; VITAMIN-A; X-RECEPTOR; TGF-BETA; IN-VITRO; PATHOGENESIS; ACTIVATION; TISSUE	Roles of all-trans-retinoic acid (tRA), a metabolite of vitamin A (VA), in both tolerogenic and immunogenic responses are documented. However, how tRA affects the development of systemic autoimmunity is poorly understood. Here we demonstrate that tRA have paradoxical effects on the development of autoimmune lupus in the MRL/lpr mouse model. We administered, orally, tRA or VA mixed with 10% of tRA (referred to as VARA) to female mice starting from 6 weeks of age. At this age, the mice do not exhibit overt clinical signs of lupus. However, the immunogenic environment preceding disease onset has been established as evidenced by an increase of total IgM/IgG in the plasma and expansion of lymphocytes and dendritic cells in secondary lymphoid organs. After 8 weeks of tRA, but not VARA treatment, significantly higher pathological scores in the skin, brain and lung were observed. These were accompanied by a marked increase in B-cell responses that included autoantibody production and enhanced expression of plasma cell-promoting cytokines. Paradoxically, the number of lymphocytes in the mesenteric lymph node decreased with tRA that led to significantly reduced lymphadenopathy. In addition, tRA differentially affected renal pathology, increasing leukocyte infiltration of renal tubulointerstitium while restoring the size of glomeruli in the kidney cortex. In contrast, minimal induction of inflammation with tRA in the absence of an immunogenic environment in the control mice was observed. Altogether, our results suggest that under a predisposed immunogenic environment in autoimmune lupus, tRA may decrease inflammation in some organs while generating more severe disease in others.	[Liao, Xiaofeng; Ren, Jingjing; Cecere, Thomas E.; Jortner, Bernard S.; Ahmed, S. Ansar; Luo, Xin M.] Virginia Tech, Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA; [Wei, Cheng-Hsin; Ross, A. Catharine] Penn State Univ, Dept Nutr Sci, University Pk, PA 16802 USA	Virginia Polytechnic Institute & State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Luo, XM (corresponding author), Virginia Tech, Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA.	xinluo@vt.edu	Cecere, Thomas E/N-9266-2016; Luo, Xin M/J-6544-2016	Luo, Xin M/0000-0002-2809-5836	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041479] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK041479] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adamson, 1996, Oncologist, V1, P305; Ait-Azzouzene D, 2010, J IMMUNOL, V185, P1015, DOI 10.4049/jimmunol.1000698; Anolik JH, 2013, LUPUS, V22, P342, DOI 10.1177/0961203312471576; Apostolidis SA, 2011, LUPUS, V20, P120, DOI 10.1177/0961203310389100; Campbell JJ, 1999, NATURE, V400, P776, DOI 10.1038/23495; Chen F, 2010, J CLIN INVEST, V120, P2040, DOI 10.1172/JCI40253; Chen Q, 2007, CELL IMMUNOL, V249, P37, DOI 10.1016/j.cellimm.2007.11.001; Chen QY, 2011, CLIN VACCINE IMMUNOL, V18, P1015, DOI 10.1128/CVI.00004-11; Chen QY, 2005, P NATL ACAD SCI USA, V102, P14142, DOI 10.1073/pnas.0505018102; Ching KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032001; Clark AG, 2013, AUTOIMMUNITY, V46, P188, DOI 10.3109/08916934.2012.746671; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Crispin JC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/943254; Crispin JC, 2010, TRENDS MOL MED, V16, P47, DOI 10.1016/j.molmed.2009.12.005; de Lema GP, 2004, KIDNEY INT, V66, P1018, DOI 10.1111/j.1523-1755.2004.00850.x; Degos L, 2001, ONCOGENE, V20, P7140, DOI 10.1038/sj.onc.1204763; DRICKAMER LC, 1974, DEV PSYCHOBIOL, V7, P257, DOI 10.1002/dev.420070310; Elias KM, 2008, BLOOD, V111, P1013, DOI 10.1182/blood-2007-06-096438; Fehr EM, 2013, J AUTOIMMUN, V40, P86, DOI 10.1016/j.jaut.2012.08.003; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Hall JA, 2011, IMMUNITY, V34, P435, DOI 10.1016/j.immuni.2011.03.003; Hammerschmidt SI, 2011, J CLIN INVEST, V121, P3051, DOI 10.1172/JCI44262; Hellman P, 2007, HUM IMMUNOL, V68, P324, DOI 10.1016/j.humimm.2007.01.018; Hochheiser K, 2013, J CLIN INVEST, V123, P4242, DOI 10.1172/JCI70143; Iikuni N, 2009, J IMMUNOL, V183, P1518, DOI 10.4049/jimmunol.0901163; Illei GG, 2001, ANN INTERN MED, V135, P248, DOI 10.7326/0003-4819-135-4-200108210-00009; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Iwata M, 2003, INT IMMUNOL, V15, P1017, DOI 10.1093/intimm/dxg101; James ML, 2010, PEDIATR RES, V67, P591, DOI 10.1203/PDR.0b013e3181dbac3d; Kalaaji M, 2006, AM J PATHOL, V168, P1779, DOI 10.2353/ajpath.2006.051329; KALIN JR, 1981, DRUG METAB DISPOS, V9, P196; Kinoshita K, 2003, J IMMUNOL, V170, P5793, DOI 10.4049/jimmunol.170.11.5793; Kinoshita K, 2010, AM J KIDNEY DIS, V55, P344, DOI 10.1053/j.ajkd.2009.06.012; Klebanoff CA, 2013, J EXP MED, V210, P1961, DOI 10.1084/jem.20122508; Kreft B, 1996, J AUTOIMMUN, V9, P463, DOI 10.1006/jaut.1996.0063; Lech M, 2013, J AM SOC NEPHROL, V24, P1357, DOI 10.1681/ASN.2013010026; Lech M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020118; Liu J, 2006, GENES IMMUN, V7, P156, DOI 10.1038/sj.gene.6364286; Liu Z, 2012, NAT MED, V18, P871, DOI 10.1038/nm.2752; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Marill J, 2003, CURR DRUG METAB, V4, P1, DOI 10.2174/1389200033336900; Merrill JT, 2010, ARTHRITIS RHEUM-US, V62, P222, DOI 10.1002/art.27233; Mic FA, 2003, P NATL ACAD SCI USA, V100, P7135, DOI 10.1073/pnas.1231422100; Montane J, 2011, J CLIN INVEST, V121, P3024, DOI 10.1172/JCI43048; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Nacionales DC, 2009, J IMMUNOL, V182, P4226, DOI 10.4049/jimmunol.0800771; Navarra SV, 2011, LANCET, V377, P721, DOI 10.1016/S0140-6736(10)61354-2; Nowling TK, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3528; Nozaki Y, 2005, CLIN EXP IMMUNOL, V139, P74, DOI 10.1111/j.1365-2249.2005.02654.x; Pau E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036761; Perry D, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/271694; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Rodriguez W, 2006, ARTHRITIS RHEUM-US, V54, P325, DOI 10.1002/art.21556; Ross AC, 2007, NEONATOLOGY, V92, P26, DOI 10.1159/000100083; Ross AC, 2006, J LIPID RES, V47, P1844, DOI 10.1194/jlr.M600061-JLR200; Rottman JB, 2010, VET PATHOL, V47, P664, DOI 10.1177/0300985810370005; Sawalha AH, 2012, J AUTOIMMUN, V38, pJ216, DOI 10.1016/j.jaut.2011.11.008; Shima Y, 2005, NEPHRON EXP NEPHROL, V100, pE54, DOI 10.1159/000084655; Sobel ES, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3387; Stephensen CB, 2002, J IMMUNOL, V168, P4495, DOI 10.4049/jimmunol.168.9.4495; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Teichmann LL, 2010, IMMUNITY, V33, P967, DOI 10.1016/j.immuni.2010.11.025; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Villares R, 2009, EUR J IMMUNOL, V39, P1671, DOI 10.1002/eji.200839123; WALSH SJ, 1995, J RHEUMATOL, V22, P1663; Weiner HL, 2011, IMMUNOL REV, V241, P241, DOI 10.1111/j.1600-065X.2011.01017.x; Wright GP, 2009, P NATL ACAD SCI USA, V106, P19078, DOI 10.1073/pnas.0907396106; Yamada H, 2007, J NUTR, V137, P2696, DOI 10.1093/jn/137.12.2696; Young LJ, 2008, NAT IMMUNOL, V9, P1244, DOI 10.1038/ni.1665; Yung S, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/139365; Zhang Z, 2009, J IMMUNOL, V183, P3160, DOI 10.4049/jimmunol.0900385; Zhou WD, 2001, KIDNEY INT, V59, P1227, DOI 10.1046/j.1523-1755.2001.0590041227.x	75	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118176	10.1371/journal.pone.0118176	http://dx.doi.org/10.1371/journal.pone.0118176			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775135	Green Published, gold, Green Submitted			2022-12-27	WOS:000351183500026
J	Tyc, O; Wolf, AB; Garbeva, P				Tyc, Olaf; Wolf, Alexandra B.; Garbeva, Paolina			The Effect of Phylogenetically Different Bacteria on the Fitness of Pseudomonas fluorescens in Sand Microcosms	PLOS ONE			English	Article							SOIL; DIVERSITY; COMPETITION; EVOLUTION; GROWTH	In most environments many microorganisms live in close vicinity and can interact in various ways. Recent studies suggest that bacteria are able to sense and respond to the presence of neighbouring bacteria in the environment and alter their response accordingly. This ability might be an important strategy in complex habitats such as soils, with great implications for shaping the microbial community structure. Here, we used a sand microcosm approach to investigate how Pseudomonas fluorescens Pf0-1 responds to the presence of monocultures or mixtures of two phylogenetically different bacteria, a Gram-negative (Pedobacter sp. V48) and a Gram-positive (Bacillus sp. V102) under two nutrient conditions. Results revealed that under both nutrient poor and nutrient rich conditions confrontation with the Gram-positive Bacillus sp. V102 strain led to significant lower cell numbers of Pseudomonas fluorescens Pf0-1, whereas confrontation with the Gram-negative Pedobacter sp. V48 strain did not affect the growth of Pseudomonas fluorescens Pf0-1. However, when Pseudomonas fluorescens Pf0-1 was confronted with the mixture of both strains, no significant effect on the growth of Pseudomonas fluorescens Pf0-1 was observed. Quantitative real-time PCR data showed up-regulation of genes involved in the production of a broad-spectrum antibiotic in Pseudomonas fluorescens Pf0-1 when confronted with Pedobacter sp. V48, but not in the presence of Bacillus sp. V102. The results provide evidence that the performance of bacteria in soil depends strongly on the identity of neighbouring bacteria and that inter-specific interactions are an important factor in determining microbial community structure.	[Tyc, Olaf; Wolf, Alexandra B.; Garbeva, Paolina] Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, NL-6700 AB Wageningen, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Tyc, O (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, POB 50, NL-6700 AB Wageningen, Netherlands.	o.tyc@nioo.knaw.nl	Garbeva, Paolina/C-3727-2011; Tyc, Olaf/AAQ-1262-2021; KNAW, NIOO-KNAW/A-4320-2012	Garbeva, Paolina/0000-0002-2359-5719; Tyc, Olaf/0000-0001-9949-0975; KNAW, NIOO-KNAW/0000-0002-3835-159X	Netherlands Organization for Scientific Research (NWO) MEERVOUD personal grant [836.09.004]	Netherlands Organization for Scientific Research (NWO) MEERVOUD personal grant	This work is supported by the Netherlands Organization for Scientific Research (NWO) MEERVOUD personal grant issued to Paolina Garbeva (836.09.004).	Allen B, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001549; Becker J, 2012, ECOL LETT, V15, P468, DOI 10.1111/j.1461-0248.2012.01759.x; COMPEAU G, 1988, APPL ENVIRON MICROB, V54, P2432, DOI 10.1128/AEM.54.10.2432-2438.1988; Cornforth DM, 2013, NAT REV MICROBIOL, V11, P285, DOI 10.1038/nrmicro2977; Czaran T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006655; D'Onofrio A, 2010, CHEM BIOL, V17, P254, DOI 10.1016/j.chembiol.2010.02.010; de Boer W, 2007, FEMS MICROBIOL ECOL, V59, P177, DOI 10.1111/j.1574-6941.2006.00197.x; Demoling F, 2007, SOIL BIOL BIOCHEM, V39, P2485, DOI 10.1016/j.soilbio.2007.05.002; Foster KR, 2012, CURR BIOL, V22, P1845, DOI 10.1016/j.cub.2012.08.005; Gans J, 2005, SCIENCE, V309, P1387, DOI 10.1126/science.1112665; Garbeva P, 2014, FEMS MICROBIOL ECOL, V87, P639, DOI 10.1111/1574-6941.12252; Garbeva P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027266; Garbeva P, 2011, ISME J, V5, P973, DOI 10.1038/ismej.2010.196; Garbeva P, 2009, MICROB ECOL, V58, P36, DOI 10.1007/s00248-009-9502-3; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Inglis RF, 2012, EVOLUTION, V66, P3472, DOI 10.1111/j.1558-5646.2012.01706.x; Jousset A, 2011, ECOL LETT, V14, P537, DOI 10.1111/j.1461-0248.2011.01613.x; Mitri S, 2013, ANNU REV GENET, V47, P247, DOI 10.1146/annurev-genet-111212-133307; Sanchez S, 2010, J ANTIBIOT, V63, P442, DOI 10.1038/ja.2010.78; TORSVIK V, 1990, APPL ENVIRON MICROB, V56, P782, DOI 10.1128/AEM.56.3.782-787.1990; Traxler MF, 2013, MBIO, V4, DOI 10.1128/mBio.00459-13; Tyc O, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00567; Uroz S, 2010, ENV MICROBIOL REP, V2, P281, DOI 10.1111/j.1758-2229.2009.00117.x; van den Berg H. A., 2008, Computational Mathematics and Modeling, V19, P406, DOI 10.1007/s10598-008-9013-y; van Wezel GP, 2011, NAT PROD REP, V28, P1311, DOI 10.1039/c1np00003a; VASI F, 1994, AM NAT, V144, P432, DOI 10.1086/285685	26	13	13	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119838	10.1371/journal.pone.0119838	http://dx.doi.org/10.1371/journal.pone.0119838			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774766	gold, Green Published, Green Submitted			2022-12-27	WOS:000351183500131
J	Birkeland, MS; Nielsen, MB; Knardahl, S; Heir, T				Birkeland, Marianne Skogbrott; Nielsen, Morten Birkeland; Knardahl, Stein; Heir, Trond			Associations between Work Environment and Psychological Distress after a Workplace Terror Attack: The Importance of Role Expectations, Predictability and Leader Support	PLOS ONE			English	Article							MENTAL-HEALTH; FOLLOW-UP; STRESS; EMPLOYEES; SYMPTOMS; IMPACT	Experiencing terrorism is associated with high levels of psychological distress among survivors. The aim of the present study was to examine whether work environmental factors such as role clarity and predictability, role conflicts, and leader support may protect against elevated levels of psychological distress after a workplace terrorist attack. Data from approximately 1800 ministerial employees were collected ten months after the 2011 Oslo bombing attack which targeted the Norwegian ministries. The results show that after a traumatic event, lower role conflicts, higher role clarity, higher predictability, and higher leader support were independently associated with lower psychological distress. These findings suggest that the workplace environment may be a facilitator of employees' mental health after stressful events.	[Birkeland, Marianne Skogbrott; Heir, Trond] Norwegian Ctr Violence & Traumat Stress Studies, Oslo, Norway; [Nielsen, Morten Birkeland; Knardahl, Stein] Natl Inst Occupat Hlth, Oslo, Norway; [Nielsen, Morten Birkeland; Knardahl, Stein] Univ Bergen, Dept Psychosocial Sci, Bergen, Norway; [Heir, Trond] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway	University of Bergen; University of Oslo	Birkeland, MS (corresponding author), Norwegian Ctr Violence & Traumat Stress Studies, Oslo, Norway.	marianne.s.birkeland@gmail.com		Nielsen, Morten Birkeland/0000-0001-7858-8623	Norwegian ExtraFoundation for Health and Rehabilitation through EXTRA funds [2.13/2/0021]	Norwegian ExtraFoundation for Health and Rehabilitation through EXTRA funds	This project has been financially supported by the Norwegian ExtraFoundation for Health and Rehabilitation through EXTRA funds. Grant number: 2.13/2/0021. URL: http://www.extrastiftelsen.no/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler A.B., 2013, MILITARY BEHAV HLTH, V1, P41, DOI [10.1080/21635781.2012.721063, DOI 10.1080/21635781.2012.721063]; Albertsen K, 2010, SCAND J PUBLIC HEALT, V38, P81, DOI 10.1177/1403494809352104; Bliese PD, 2000, WORK STRESS, V14, P65, DOI 10.1080/026783700417230; Bonanno George A, 2010, Psychol Sci Public Interest, V11, P1, DOI 10.1177/1529100610387086; Borritz M, 2005, J OCCUP ENVIRON MED, V47, P1015, DOI 10.1097/01.jom.0000175155.50789.98; Britt TW, 2004, MIL MED, V169, P541, DOI 10.7205/MILMED.169.7.541; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; Dallner A, 2000, VALIDATION GEN NORDI, V12, P12; Derogatis LR, 1973, PSYCHOL MEASUREMENT; Finne LB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102514; Galea S, 2002, NEW ENGL J MED, V346, P982, DOI 10.1056/NEJMsa013404; Gershon RRM, 2009, CRIM JUSTICE BEHAV, V36, P275, DOI 10.1177/0093854808330015; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; Hannah ST, 2009, LEADERSHIP QUART, V20, P897, DOI 10.1016/j.leaqua.2009.09.006; Hansen MB, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002692; Janoff-Bulman R., 1992, SHATTERED ASSUMPTION; Kuntz JR., 2013, NEW ZEAL J PSYCHOL, V42, P57; Lang J, 2007, J OCCUP HEALTH, V12, P1116; Muthen B., 1998, MPLUS VERSION 7 11; Netterstrom B, 2008, EPIDEMIOL REV, V30, P118, DOI 10.1093/epirev/mxn004; Nielsen K, 2008, WORK STRESS, V22, P16, DOI 10.1080/02678370801979430; Nielsen ML, 2004, WORK STRESS, V18, P323, DOI 10.1080/02678370412331324806; Nieuwenhuijsen K, 2010, OCCUP MED-OXFORD, V60, P277, DOI 10.1093/occmed/kqq081; North CS, 2010, J OCCUP ENVIRON MED, V52, P713, DOI 10.1097/JOM.0b013e3181e48b01; Ortqvist D., 2006, INT J STRESS MANAGE, V13, P399, DOI [10.1037/1072-5245.13.4.399, DOI 10.1037/1072-5245.13.4.399, DOI 10.1037/1072-5245.-13.4.399]; Peus C, 2011, J ORGAN BEHAV, V32, P955, DOI 10.1002/job.751; Regehr C., 2007, TRAUMATOLOGY, V13, P49, DOI [10.1177/1534765607299912, DOI 10.1177/1534765607299912]; Rosenthal, 1964, ORG STRESS STUDIES R; Ross C. E., 2013, HDB SOCIOLOGY MENTAL, P379, DOI [DOI 10.1007/978-94-007-4276-5_19, 10.1007/978-94-007-4276-5_19]; Rugulies R, 2006, AM J EPIDEMIOL, V163, P877, DOI 10.1093/aje/kwj119; Schlenger WE, 2002, JAMA-J AM MED ASSOC, V288, P581, DOI 10.1001/jama.288.5.581; Schmidt S, 2014, EUR J WORK ORGAN PSY, V23, P91, DOI 10.1080/1359432X.2012.711523; Skakon J, 2010, WORK STRESS, V24, P107, DOI 10.1080/02678373.2010.495262; Stansfeld S, 2006, SCAND J WORK ENV HEA, V32, P443, DOI 10.5271/sjweh.1050; Stansfeld SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081115; Strand BH, 2003, NORD J PSYCHIAT, V57, P113, DOI 10.1080/08039480310000932; Tolin DF, 2006, PSYCHOL BULL, V132, P959, DOI 10.1037/0033-2909.132.6.959	37	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119492	10.1371/journal.pone.0119492	http://dx.doi.org/10.1371/journal.pone.0119492			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7NO	25769023	Green Published, gold			2022-12-27	WOS:000351277500083
J	Lizunov, VA; Stenkula, KG; Blank, PS; Troy, A; Lee, JP; Skarulis, MC; Cushman, SW; Zimmerberg, J				Lizunov, Vladimir A.; Stenkula, Karin G.; Blank, Paul S.; Troy, Aaron; Lee, Jo-Ping; Skarulis, Monica C.; Cushman, Samuel W.; Zimmerberg, Joshua			Human Adipose Cells In Vitro Are Either Refractory or Responsive to Insulin, Reflecting Host Metabolic State	PLOS ONE			English	Article							GLUT4 VESICLES; FAT-CELLS; SENSITIVITY; FUSION; TISSUE; HETEROGENEITY; RESISTANCE; OBESITY	While intercellular communication processes are frequently characterized by switch-like transitions, the endocrine system, including the adipose tissue response to insulin, has been characterized by graded responses. Yet here individual cells from adipose tissue biopsies are best described by a switch-like transition between the basal and insulin-stimulated states for the trafficking of the glucose transporter GLUT4. Two statistically-defined populations best describe the observed cellular heterogeneity, representing the fractions of refractive and responsive adipose cells. Furthermore, subjects exhibiting high systemic insulin sensitivity indices (SI) have high fractions of responsive adipose cells in vitro, while subjects exhibiting decreasing SI have increasing fractions of refractory cells in vitro. Thus, a two-component model best describes the relationship between cellular refractory fraction and subject SI. Since isolated cells exhibit these different response characteristics in the presence of constant culture conditions and milieu, we suggest that a physiological switching mechanism at the adipose cellular level ultimately drives systemic SI.	[Lizunov, Vladimir A.; Blank, Paul S.; Troy, Aaron; Zimmerberg, Joshua] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Phys Biol, NIH, Bethesda, MD USA; [Stenkula, Karin G.; Lee, Jo-Ping; Cushman, Samuel W.] NIDDK, Expt Diabet Metab & Nutr Sect, NIH, Bethesda, MD 20892 USA; [Skarulis, Monica C.] NIDDK, Diabet Endocrinol & Obes Branch, NIH, Bethesda, MD 20892 USA; [Stenkula, Karin G.] Lund Univ, Expt Med Sci, Lund, Sweden	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Lund University	Zimmerberg, J (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Phys Biol, NIH, Bethesda, MD USA.	joshz@mail.nih.gov	Blank, Paul/Q-9673-2019	Stenkula, Karin/0000-0002-0739-1150; Troy, Aaron/0000-0001-9844-5718	Intramural Research Programs of Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075007] Funding Source: NIH RePORTER; Novo Nordisk Fonden [NNF13OC0004953] Funding Source: researchfish	Intramural Research Programs of Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the Intramural Research Programs of Eunice Kennedy Shriver National Institute of Child Health and Human Development and National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Bluher M, 2004, J BIOL CHEM, V279, P31891, DOI 10.1074/jbc.M404569200; Burchfield JG, 2013, TRAFFIC, V14, P259, DOI 10.1111/tra.12035; Cantley JL, 2013, P NATL ACAD SCI USA, V110, P1869, DOI 10.1073/pnas.1219456110; Cizmeci D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083640; Crivat G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077953; Franck N, 2007, DIABETOLOGIA, V50, P1716, DOI 10.1007/s00125-007-0713-1; Giri Lopamudra, 2004, Theor Biol Med Model, V1, P2, DOI 10.1186/1742-4682-1-2; GLIEMANN J, 1972, ISRAEL J MED SCI, V8, P807; Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986; Jorgensen AB, 2014, NEW ENGL J MED, V371, P32, DOI 10.1056/NEJMoa1308027; Khalifeh-Soltani A, 2014, NAT MED, V20, P175, DOI 10.1038/nm.3450; Kraus D, 2014, NATURE, V508, P258, DOI 10.1038/nature13198; Lee YK, 2013, NAT CELL BIOL, V15, P568, DOI 10.1038/ncb2776; Lizunov VA, 2005, J CELL BIOL, V169, P481, DOI 10.1083/jcb.200412069; Lizunov VA, 2013, DIABETES, V62, P3114, DOI 10.2337/db12-1741; Lizunov VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057559; Lizunov VA, 2009, J BIOL CHEM, V284, P7914, DOI 10.1074/jbc.M806460200; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Macotela Y, 2009, DIABETES, V58, P803, DOI 10.2337/db08-1054; McLaugblin T, 2007, DIABETOLOGIA, V50, P1707, DOI 10.1007/s00125-007-0708-y; Muniyappa R, 2008, AM J PHYSIOL-ENDOC M, V294, pE15, DOI 10.1152/ajpendo.00645.2007; Pekkurnaz G, 2014, CELL IN PRESS, V158, P1, DOI [10.1182/asheducation-2014.1.158, DOI 10.1182/ASHEDUCATION-2014.1.158]; Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055; Smith U, 1999, ANN NY ACAD SCI, V892, P119, DOI 10.1111/j.1749-6632.1999.tb07790.x; Solinas G, 2006, P NATL ACAD SCI USA, V103, P16454, DOI 10.1073/pnas.0607626103; Stenkula KG, 2010, CELL METAB, V12, P250, DOI 10.1016/j.cmet.2010.08.005; Thompson D, 2012, PHYSIOL REV, V92, P157, DOI 10.1152/physrev.00012.2011; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007	30	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119291	10.1371/journal.pone.0119291	http://dx.doi.org/10.1371/journal.pone.0119291			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768970	gold, Green Published, Green Submitted			2022-12-27	WOS:000351277500074
J	Nakayama, J; Raines, TA; Lynch, KR; Slack-Davis, JK				Nakayama, John; Raines, Timothy A.; Lynch, Kevin R.; Slack-Davis, Jill K.			Decreased Peritoneal Ovarian Cancer Growth in Mice Lacking Expression of Lipid Phosphate Phosphohydrolase 1	PLOS ONE			English	Article							LYSOPHOSPHATIDIC ACID; CELL-MIGRATION; SIGNALING PATHWAY; IN-VIVO; INVASION; METASTASIS; ACTIVATION; AUTOTAXIN; ADHESION; MOUSE	Lysophosphatidic acid (LPA) is a bioactive lipid that enhances ovarian cancer cell proliferation, migration and invasion in vitro and stimulates peritoneal metastasis in vivo. LPA is generated through the action of autotaxin or phospholipases, and degradation begins with lipid phosphate phosphohydrolase (LPP)-dependent removal of the phosphate. While the effects of LPA on ovarian cancer progression are clear, the effects of LPA metabolism within the tumor microenvironment on peritoneal metastasis have not been reported. We examined the contribution of lipid phosphatase activity to ovarian cancer peritoneal metastasis using mice deficient in LPP1 expression. Homozygous deletion of LPP1 (LPP1 KO) results in elevated levels and decreased turnover of LPA in vivo. Within 2 weeks of intraperitoneal injection of syngeneic mouse ovarian cancer cells, we observed enhanced tumor seeding in the LPP1 KO mice compared to wild type. However, tumor growth plateaued in the LPP1 KO mice by 3 weeks while tumors continued to grow in wild type mice. The decreased tumor burden was accompanied by increased apoptosis and no change in proliferation or angiogenesis. Tumor growth was restored and apoptosis reversed with exogenous administration of LPA. Together, these observations demonstrate that the elevated levels of LPA per se in LPP1 KO mice do not inhibit tumor growth. Rather, the data support the notion that either elevated LPA concentration or altered LPA metabolism affects other growth-promoting contributions of the tumor microenvironment.	[Nakayama, John] Univ Virginia, Ctr Canc, Dept Obstet & Gynecol, Charlottesville, VA 22908 USA; [Raines, Timothy A.; Slack-Davis, Jill K.] Univ Virginia, Ctr Canc, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA; [Lynch, Kevin R.] Univ Virginia, Ctr Canc, Dept Pharmacol, Charlottesville, VA 22908 USA; [Lynch, Kevin R.; Slack-Davis, Jill K.] Univ Virginia, Ctr Canc, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia	Slack-Davis, JK (corresponding author), Univ Virginia, Ctr Canc, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA.	jks6a@virginia.edu			National Institutes of Health/National Cancer Institute [CA142783]; National Institutes of Health General Medical Sciences [GM067958-09]; University of Virginia Gynecologic Oncology Fellowship Program; NATIONAL CANCER INSTITUTE [T32CA009109, R01CA142783, P30CA044579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067958] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Virginia Gynecologic Oncology Fellowship Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: This work was supported by the National Institutes of Health/National Cancer Institute grant CA142783 supported JKS-D and KRL, who was also supported by National Institutes of Health General Medical Sciences grant GM067958-09. TAR was supported by a diversity supplement to CA142783. JN was supported by the University of Virginia Gynecologic Oncology Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bian D, 2006, ONCOGENE, V25, P2234, DOI 10.1038/sj.onc.1209261; Bian DF, 2004, CANCER RES, V64, P4209, DOI 10.1158/0008-5472.CAN-04-0060; Brindley DN, 2009, J LIPID RES, V50, pS225, DOI 10.1194/jlr.R800055-JLR200; Cai QC, 2012, FASEB J, V26, P3306, DOI 10.1096/fj.12-207597; Escalante-Alcalde D, 2003, DEVELOPMENT, V130, P4623, DOI 10.1242/dev.00635; Fang XJ, 2000, BIOCHEM J, V352, P135, DOI 10.1042/0264-6021:3520135; Fang XJ, 2000, ANN NY ACAD SCI, V905, P188; Fishman DA, 2001, CANCER RES, V61, P3194; Goldsmith Zachariah G, 2011, Genes Cancer, V2, P563, DOI 10.1177/1947601911419362; Hong GY, 1999, FEBS LETT, V460, P513, DOI 10.1016/S0014-5793(99)01400-3; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kim KS, 2006, CANCER RES, V66, P7983, DOI 10.1158/0008-5472.CAN-05-4381; Knowlden S, 2014, J IMMUNOL, V192, P851, DOI 10.4049/jimmunol.1302831; Koh JS, 1998, J CLIN INVEST, V102, P716, DOI 10.1172/JCI1002; Lagadari M, 2009, INT IMMUNOL, V21, P667, DOI 10.1093/intimm/dxp035; Li HB, 2005, J BIOL CHEM, V280, P10564, DOI 10.1074/jbc.M412152200; Li H, 2009, MOL CANCER THER, V8, P1692, DOI 10.1158/1535-7163.MCT-08-1106; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Mishra RS, 2008, J EXP MED, V205, P347, DOI 10.1084/jem.20071243; Oda SK, 2013, CANCER IMMUNOL RES, V1, P245, DOI 10.1158/2326-6066.CIR-13-0043-T; Pages C, 2001, PROSTAG OTH LIPID M, V64, P1, DOI 10.1016/S0090-6980(01)00110-1; Prewett M, 1999, CANCER RES, V59, P5209; Ptaszynska MM, 2008, MOL CANCER RES, V6, P352, DOI 10.1158/1541-7786.MCR-07-0143; Ren J, 2006, CANCER RES, V66, P3006, DOI 10.1158/0008-5472.CAN-05-1292; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Slack-Davis JK, 2009, CANCER RES, V69, P1469, DOI 10.1158/0008-5472.CAN-08-2678; So J, 2004, GYNECOL ONCOL, V95, P314, DOI 10.1016/j.ygyno.2004.08.001; Sutphen R, 2004, CANCER EPIDEM BIOMAR, V13, P1185; Tanyi JL, 2003, CLIN CANCER RES, V9, P3534; Tanyi JL, 2003, CANCER RES, V63, P1073; Tokumura A, 2007, LIFE SCI, V80, P1641, DOI 10.1016/j.lfs.2006.12.041; Tomsig JL, 2009, BIOCHEM J, V419, P611, DOI 10.1042/BJ20081888; Xiao YJ, 2001, ANAL BIOCHEM, V290, P302, DOI 10.1006/abio.2001.5000; Xu Y, 1995, CLIN CANCER RES, V1, P1223; Yu SX, 2008, JNCI-J NATL CANCER I, V100, P1630, DOI 10.1093/jnci/djn378; Zhang YF, 2012, J IMMUNOL, V189, P3914, DOI 10.4049/jimmunol.1201604	36	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120071	10.1371/journal.pone.0120071	http://dx.doi.org/10.1371/journal.pone.0120071			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25769037	Green Submitted, Green Published, gold			2022-12-27	WOS:000351277500107
J	Peters, MAK; Balzer, J; Shams, L				Peters, Megan A. K.; Balzer, Jonathan; Shams, Ladan			Smaller = Denser, and the Brain Knows It: Natural Statistics of Object Density Shape Weight Expectations	PLOS ONE			English	Article							VISUAL SIZE CUES; MANIPULATIVE FORCES; PRECISION GRIP; INTEGRATION; PERCEPTION; HEAVINESS; EXPERIENCE; ILLUSIONS; MODELS; MEMORY	If one nondescript object's volume is twice that of another, is it necessarily twice as heavy? As larger objects are typically heavier than smaller ones, one might assume humans use such heuristics in preparing to lift novel objects if other informative cues (e.g., material, previous lifts) are unavailable. However, it is also known that humans are sensitive to statistical properties of our environments, and that such sensitivity can bias perception. Here we asked whether statistical regularities in properties of liftable, everyday objects would bias human observers' predictions about objects' weight relationships. We developed state-of-the-art computer vision techniques to precisely measure the volume of everyday objects, and also measured their weight. We discovered that for liftable man-made objects, "twice as large" doesn't mean "twice as heavy": Smaller objects are typically denser, following a power function of volume. Interestingly, this "smaller is denser" relationship does not hold for natural or unliftable objects, suggesting some ideal density range for objects designed to be lifted. We then asked human observers to predict weight relationships between novel objects without lifting them; crucially, these weight predictions quantitatively match typical weight relationships shown by similarly-sized objects in everyday environments. These results indicate that the human brain represents the statistics of everyday objects and that this representation can be quantitatively abstracted and applied to novel objects. Finally, that the brain possesses and can use precise knowledge of the nonlinear association between size and weight carries important implications for implementation of forward models of motor control in artificial systems.	[Peters, Megan A. K.; Shams, Ladan] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; [Balzer, Jonathan] Univ Calif Los Angeles, Dept Comp Sci, Los Angeles, CA 90095 USA; [Shams, Ladan] Univ Calif Los Angeles, Dept Bioengn, Engn 5 5121, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Peters, MAK (corresponding author), Univ Calif Los Angeles, Dept Psychol, 1285 Franz Hall,Box 951563, Los Angeles, CA 90095 USA.	meganakpeters@ucla.edu		Peters, Megan/0000-0002-0248-0816	National Science Foundation Graduate Research Fellowship Program; National Science Foundation [BCS-1057625]; Office of Naval Research (ONR) [N00014-13-1-0563]; Air Force Research Laboratory (AFRL) [FA8650-11-1-7156:P00004]; Division Of Behavioral and Cognitive Sci [1057969] Funding Source: National Science Foundation	National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); Office of Naval Research (ONR)(Office of Naval Research); Air Force Research Laboratory (AFRL)(United States Department of DefenseUS Air Force Research Laboratory); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. M. A. K. P. was supported by the National Science Foundation Graduate Research Fellowship Program. L. S. was supported by National Science Foundation grant BCS-1057625. This research was also supported in part by ongoing Office of Naval Research (ONR) N00014-13-1-0563 and Air Force Research Laboratory (AFRL) FA8650-11-1-7156:P00004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WJ, 2004, NAT NEUROSCI, V7, P1057, DOI 10.1038/nn1312; ANDERSON NH, 1970, PERCEPT PSYCHOPHYS, V8, P1, DOI 10.3758/BF03208919; Aslin RN, 2012, CURR DIR PSYCHOL SCI, V21, P170, DOI 10.1177/0963721412436806; Balzer J, 2013, IEEE WORKSH APPL COM; Baugh LA, 2012, J NEUROPHYSIOL, V108, P1262, DOI 10.1152/jn.00263.2012; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benjamini Y, 2010, J R STAT SOC B, V72, P405, DOI 10.1111/j.1467-9868.2010.00746.x; Brayanov JB, 2010, J NEUROPHYSIOL, V103, P1518, DOI 10.1152/jn.00814.2009; Buckingham G, 2014, EXP BRAIN RES, V232, P1623, DOI 10.1007/s00221-014-3926-9; Buckingham G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054709; Buckingham G, 2010, EXP BRAIN RES, V205, P283, DOI 10.1007/s00221-010-2353-9; Buckingham G, 2009, J NEUROPHYSIOL, V102, P3111, DOI 10.1152/jn.00515.2009; Charpentier A., 1891, ARCHIVE PHYSIOLOGIE, V3, P122; Craje C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076855; CROSS DV, 1975, PERCEPT PSYCHOPHYS, V18, P79, DOI 10.3758/BF03204091; Fiser J, 2009, LEARN BEHAV, V37, P141, DOI 10.3758/LB.37.2.141; Flanagan JR, 2008, CURR BIOL, V18, P1742, DOI 10.1016/j.cub.2008.09.042; Flanagan JR, 2000, NAT NEUROSCI, V3, P737, DOI 10.1038/76701; Flanagan JR, 2001, CAN J EXP PSYCHOL, V55, P87, DOI 10.1037/h0087355; FRAYMAN BJ, 1981, PERCEPT PSYCHOPHYS, V29, P56, DOI 10.3758/BF03198840; Geisler WS, 2009, VISUAL NEUROSCI, V26, P109, DOI 10.1017/S0952523808080875; Gekas N, 2013, J VISION, V13, DOI 10.1167/13.4.8; Girshick AR, 2011, NAT NEUROSCI, V14, P926, DOI 10.1038/nn.2831; Goldreich D, 2012, SEEING PERCEIVING, V25, P365, DOI 10.1163/187847612X634445; Goodale MA, 2011, VISION RES, V51, P1567, DOI 10.1016/j.visres.2010.07.027; GORDON AM, 1991, EXP BRAIN RES, V85, P226; GORDON AM, 1991, EXP BRAIN RES, V83, P477; GORDON AM, 1992, EXP BRAIN RES, V90, P399; Grandy MS, 2006, J NEUROPHYSIOL, V95, P3887, DOI 10.1152/jn.00851.2005; Hadjiosif AM, 2011, IEEE ENG MED BIO, P4057, DOI 10.1109/IEMBS.2011.6091008; Hedges JH, 2011, J VISION, V11, DOI 10.1167/11.6.14; Huang I, 1945, J GEN PSYCHOL, V33, P65, DOI 10.1080/00221309.1945.10544495; Hunt RH, 2001, J EXP PSYCHOL GEN, V130, P658, DOI 10.1037//0096-3445.130.4.658; JOHANSSON RS, 1988, EXP BRAIN RES, V71, P72; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Mitchel AD, 2011, J EXP PSYCHOL LEARN, V37, P1081, DOI 10.1037/a0023700; Mon-Williams M, 2000, EXP BRAIN RES, V135, P405, DOI 10.1007/s002210000538; ROSS HE, 1982, PERCEPT PSYCHOPHYS, V31, P429, DOI 10.3758/BF03204852; ROSS J, 1970, PERCEPT PSYCHOPHYS, V7, P161, DOI 10.3758/BF03208648; Sanborn AN, 2013, PSYCHOL REV, V120, P411, DOI 10.1037/a0031912; Schwartz O, 2007, NAT REV NEUROSCI, V8, P522, DOI 10.1038/nrn2155; Scott SH, 2004, NAT REV NEUROSCI, V5, P534, DOI 10.1038/nrn1427; Seitz AR, 2007, PERCEPTION, V36, P1445, DOI 10.1068/p5843; Series P, 2011, FRONT HUM NEUROSCI, V7, P1; Soatto S., 2011, STEPS THEORY VISUAL; STEVENS JC, 1970, PERCEPT PSYCHOPHYS, V8, P225, DOI 10.3758/BF03210210; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858	49	21	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119794	10.1371/journal.pone.0119794	http://dx.doi.org/10.1371/journal.pone.0119794			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7NO	25768977	Green Published, Green Submitted, gold			2022-12-27	WOS:000351277500098
J	Vaagenes, IC; Tsai, SY; Ton, ST; Husak, VA; McGuire, SO; O'Brien, TE; Kartje, GL				Vaagenes, Ian C.; Tsai, Shih-Yen; Ton, Son T.; Husak, Vicki A.; McGuire, Susan O.; O'Brien, Timothy E.; Kartje, Gwendolyn L.			Binge Ethanol Prior to Traumatic Brain Injury Worsens Sensorimotor Functional Recovery in Rats	PLOS ONE			English	Article							COGNITIVE RECOVERY; ADULT-RATS; STROKE; NEUROGENESIS; PREVALENCE; PLASTICITY; DRINKING; THERAPY; TRENDS; DAMAGE	A significant number of patients suffering from traumatic brain injury (TBI) have a high blood alcohol level at the time of injury. Furthermore, drinking alcohol in a binge-like pattern is now recognized as a national problem, leading to a greater likelihood of being injured. Our objective was to determine the consequences of a binge paradigm of alcohol intoxication at the time of TBI on long-term functional outcome using a sensitive test of sensorimotor function. We trained adult, male, Sprague Dawley rats on the skilled forelimb reaching task and then administered a single binge dose of ethanol (2g/kg, i.p.) or saline for three consecutive days (for a total of 3 doses). One hour after the final ethanol dose, rats underwent a TBI to the sensorimotor cortex corresponding to the preferred reaching forelimb. Animals were then tested for seven weeks on the skilled forelimb reaching task to assess the profile of recovery. We found that the group given ethanol prior to TBI displayed a slower recovery curve with a lower recovery plateau as compared to the control group. Therefore, even a relatively short (3 day) episode of binge alcohol exposure can negatively impact long-term recovery from a TBI, underscoring this significant public health problem.	[Vaagenes, Ian C.; Tsai, Shih-Yen; Ton, Son T.; Husak, Vicki A.; McGuire, Susan O.; Kartje, Gwendolyn L.] Edward Hines Jr VA Hosp, Res Serv, Hines, IL 60141 USA; [Kartje, Gwendolyn L.] Loyola Univ, Med Ctr, Dept Mol Pharmacol & Therapeut, Maywood, IL 60153 USA; [Ton, Son T.; Kartje, Gwendolyn L.] Loyola Univ, Med Ctr, Neurosci Res Inst, Maywood, IL 60153 USA; [O'Brien, Timothy E.] Loyola Univ, Dept Math & Stat, Chicago, IL 60611 USA; [McGuire, Susan O.] Univ Illinois, Coll Med, Dept Anesthesiol, Chicago, IL 60680 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Loyola University Chicago; Loyola University Chicago; Loyola University Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Vaagenes, IC (corresponding author), Edward Hines Jr VA Hosp, Res Serv, Hines, IL 60141 USA.	Ian.Vaagenes@va.gov	McGuire, Susan O/AAD-8582-2020		National Institute of Health [R21 AA020951]; National Institute on Alcohol Abuse and Alcoholism [T32 AA013526]; Department of Veterans Affairs; Office of Academic Affiliations; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA013527, R21AA020951, T32AA013526] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Department of Veterans Affairs(US Department of Veterans Affairs); Office of Academic Affiliations(US Department of Veterans Affairs); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Funding: This research was supported by a grant from the National Institute of Health R21 AA020951, an National Institute on Alcohol Abuse and Alcoholism training grant T32 AA013526, the Department of Veterans Affairs and the Office of Academic Affiliations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews EM, 2008, EXP NEUROL, V211, P588, DOI 10.1016/j.expneurol.2008.02.027; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Bombardier CH, 1998, BRAIN INJURY, V12, P725, DOI 10.1080/026990598122124; Chen X, 2014, NEUROSCIENCE, V266, P235, DOI 10.1016/j.neuroscience.2013.11.036; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Gillani RL, 2010, BEHAV BRAIN RES, V208, P415, DOI 10.1016/j.bbr.2009.12.015; Hansson AC, 2010, INT J NEUROPSYCHOPH, V13, P583, DOI 10.1017/S1461145710000246; Hayes DM, 2013, ALCOHOL CLIN EXP RES, V37, P425, DOI 10.1111/j.1530-0277.2012.01955.x; Hingson RW, 2009, J STUD ALCOHOL DRUGS, P12, DOI 10.15288/jsads.2009.s16.12; Janis LS, 1998, J NEUROTRAUM, V15, P105, DOI 10.1089/neu.1998.15.105; Kanny Dafna, 2012, Morbidity and Mortality Weekly Report, V61, P14; Kelly DF, 1997, J NEUROSURG, V86, P876, DOI 10.3171/jns.1997.86.5.0876; Klein A, 2012, NEUROSCI BIOBEHAV R, V36, P1030, DOI 10.1016/j.neubiorev.2011.12.010; Morales D, 2006, J NEUROTRAUM, V23, P976, DOI 10.1089/neu.2006.23.976; ODONOGHUE DL, 1986, BRAIN RES, V385, P311, DOI 10.1016/0006-8993(86)91078-4; Olthuis JV, 2011, J AM COLL HEALTH, V59, P239, DOI 10.1080/07448481.2010.497523; Opreanu RC, 2010, J AM COLL SURGEONS, V210, P997, DOI 10.1016/j.jamcollsurg.2010.01.036; Ostrovskaya O, 2011, J PHARMACOL EXP THER, V337, P171, DOI 10.1124/jpet.110.176990; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Prasad RM, 2001, J NEUROTRAUM, V18, P1019, DOI 10.1089/08977150152693719; Pu HJ, 2013, J CEREBR BLOOD F MET, V33, P1474, DOI 10.1038/jcbfm.2013.108; Savola O, 2005, ALCOHOL ALCOHOLISM, V40, P269, DOI 10.1093/alcalc/agh159; Seymour AB, 2005, J CEREBR BLOOD F MET, V25, P1366, DOI 10.1038/sj.jcbfm.9600134; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Thurman V DJC, 2007, BRAIN INJURY MED; Tsai SY, 2011, STROKE, V42, P186, DOI 10.1161/STROKEAHA.110.590083; Wainwright PE, 2007, DEV PSYCHOBIOL, V49, P664, DOI 10.1002/dev.20245; Wolf WA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108031; YAMAKAMI I, 1995, J NEUROSURG, V82, P813, DOI 10.3171/jns.1995.82.5.0813; Young ME, 2009, LEARN MOTIV, V40, P160, DOI 10.1016/j.lmot.2008.10.004; Zhang LX, 1999, J NEUROTRAUM, V16, P243, DOI 10.1089/neu.1999.16.243	32	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120356	10.1371/journal.pone.0120356	http://dx.doi.org/10.1371/journal.pone.0120356			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768795	Green Published, gold, Green Submitted			2022-12-27	WOS:000351277500121
J	Westhrin, M; Xie, ML; Olderoy, MO; Sikorski, P; Strand, BL; Standal, T				Westhrin, Marita; Xie, Minli; Olderoy, Magnus O.; Sikorski, Pawel; Strand, Berit L.; Standal, Therese			Osteogenic Differentiation of Human Mesenchymal Stem Cells in Mineralized Alginate Matrices	PLOS ONE			English	Article							COLLAGEN FIBRIL; BONE-FORMATION; IN-VIVO; MICROSPHERES; IMMOBILIZATION; HYDROXYAPATITE; MICROCAPSULES; BIOMATERIALS; SCLEROSTIN; SCAFFOLDS	Mineralized biomaterials are promising for use in bone tissue engineering. Culturing osteogenic cells in such materials will potentially generate biological bone grafts that may even further augment bone healing. Here, we studied osteogenic differentiation of human mesenchymal stem cells (MSC) in an alginate hydrogel system where the cells were co-immobilized with alkaline phosphatase (ALP) for gradual mineralization of the microenvironment. MSC were embedded in unmodified alginate beads and alginate beads mineralized with ALP to generate a polymer/hydroxyapatite scaffold mimicking the composition of bone. The initial scaffold mineralization induced further mineralization of the beads with nanosized particles, and scanning electron micrographs demonstrated presence of collagen in the mineralized and unmineralized alginate beads cultured in osteogenic medium. Cells in both types of beads sustained high viability and metabolic activity for the duration of the study (21 days) as evaluated by live/dead staining and alamar blue assay. MSC in beads induced to differentiate in osteogenic direction expressed higher mRNA levels of osteoblast-specific genes (RUNX2, COL1AI, SP7, BGLAP) than MSC in traditional cell cultures. Furthermore, cells differentiated in beads expressed both sclerostin (SOST) and dental matrix protein-1 (DMP1), markers for late osteoblasts/osteocytes. In conclusion, Both ALP-modified and unmodified alginate beads provide an environment that enhance osteogenic differentiation compared with traditional 2D culture. Also, the ALP-modified alginate beads showed profound mineralization and thus have the potential to serve as a bone substitute in tissue engineering.	[Westhrin, Marita; Standal, Therese] Norwegian Univ Sci & Technol, Kristian Gerhard Jebsen Ctr Myeloma Res, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Standal, Therese] Norwegian Univ Sci & Technol, Ctr Mol Inflammat Res, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Xie, Minli; Olderoy, Magnus O.; Sikorski, Pawel] Norwegian Univ Sci & Technol, Dept Phys, N-7034 Trondheim, Norway; [Strand, Berit L.] Norwegian Univ Sci & Technol, Dept Biotechnol, N-7034 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Standal, T (corresponding author), Norwegian Univ Sci & Technol, Kristian Gerhard Jebsen Ctr Myeloma Res, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway.	therese.standal@ntnu.no	Strand, Berit Løkensgard/O-3999-2015; Sikorski, Pawel/A-2304-2009	Strand, Berit Løkensgard/0000-0002-9951-0355; Sikorski, Pawel/0000-0001-9413-1623; Standal, Therese/0000-0003-3314-8522	Research Council of Norway [193072, 182047, 182695-I40, 217708/O10]; Central Norway Regional Health Authority (RHA); Norwegian University of Science and Technology (NTNU); K. G. Jebsen Center for Myeloma Research; Norwegian Cancer Society	Research Council of Norway(Research Council of Norway); Central Norway Regional Health Authority (RHA); Norwegian University of Science and Technology (NTNU); K. G. Jebsen Center for Myeloma Research; Norwegian Cancer Society(Norwegian Cancer Society)	Funding: This work has been supported by the Research Council of Norway project numbers 193072, 182047, 182695-I40 and 217708/O10, the Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU), the K. G. Jebsen Center for Myeloma Research and the Norwegian Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bidarra SJ, 2010, BIOMACROMOLECULES, V11, P1956, DOI 10.1021/bm100264a; Chan G, 2001, TRENDS BIOTECHNOL, V26, P382; CHAPMAN JA, 1990, ELECTRON MICROSC REV, V3, P143, DOI 10.1016/0892-0354(90)90018-N; Cohen J, 2011, J BIOMED MATER RES A, V96A, P93, DOI 10.1002/jbm.a.32961; Cohen MM, 2009, AM J MED GENET A, V149A, P2629, DOI 10.1002/ajmg.a.33021; Cordonnier T, 2010, J MATER SCI-MATER M, V21, P981, DOI 10.1007/s10856-009-3916-9; COX R. W., 1967, J ROY MICROSC SOC, V87, P123; Evangelista MB, 2007, BIOMATERIALS, V28, P3644, DOI 10.1016/j.biomaterials.2007.04.028; Gamie Z, 2012, EXPERT OPIN BIOL TH, V12, P713, DOI 10.1517/14712598.2012.679652; Grellier M, 2009, BIOMATERIALS, V30, P3271, DOI 10.1016/j.biomaterials.2009.02.033; Habibovic P, 2007, J TISSUE ENG REGEN M, V1, P25, DOI 10.1002/term.5; Hamid R, 2004, TOXICOL IN VITRO, V18, P703, DOI 10.1016/j.tiv.2004.03.012; Johnson AJ, 2010, ACTA BIOMATERIALIA, V1; Kolk A, 2012, J CRANIO MAXILL SURG, V40, P706, DOI 10.1016/j.jcms.2012.01.002; Ling YF, 2005, J BONE MINER RES, V20, P2169, DOI 10.1359/JBMR.050815; Malaval L, 1999, J CELL BIOCHEM, V74, P616; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; McMahon RE, 2013, J BIOMED MATER RES B, V101B, P387, DOI 10.1002/jbm.b.32823; Morch YA, 2007, BIOMACROMOLECULES, V8, P2809, DOI 10.1021/bm700502b; Moshaverinia A, 2013, BIOMATERIALS, V34, P6572, DOI 10.1016/j.biomaterials.2013.05.048; Neve A, 2013, J CELL PHYSIOL, V228, P1149, DOI 10.1002/jcp.24278; Niinomi M, 2012, ACTA BIOMATER, V8, P3888, DOI 10.1016/j.actbio.2012.06.037; Ohyama Y, 2004, ENDOCRINOLOGY, V145, P4685, DOI 10.1210/en.2003-1492; Olderoy MO, 2012, J MATER SCI-MATER M, V23, P1619, DOI 10.1007/s10856-012-4655-x; OYAAS J, 1995, BIOTECHNOL BIOENG, V47, P492, DOI 10.1002/bit.260470411; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Qi MRG, 2012, XENOTRANSPLANTATION, V19, P355, DOI 10.1111/xen.12009; Qiao PY, 2013, MAT SCI ENG C-MATER, V33, P4633, DOI 10.1016/j.msec.2013.07.022; Rokstad AM, 2013, BIOMATERIALS, V34, P621, DOI 10.1016/j.biomaterials.2012.10.012; Schaffler MB, 2012, CURR OSTEOPOROS REP, V10, P118, DOI 10.1007/s11914-012-0105-4; SMIDSROD O, 1990, TRENDS BIOTECHNOL, V8, P71, DOI 10.1016/0167-7799(90)90139-O; Starborg T, 2008, METHOD CELL BIOL, V88, P319, DOI 10.1016/S0091-679X(08)00417-2; Stevens MM, 2008, MATER TODAY, V11, P18, DOI 10.1016/S1369-7021(08)70086-5; Strand BL, 2003, J BIOMED MATER RES A, V64A, P540, DOI 10.1002/jbm.a.10337; Strand BL, 2002, J MICROENCAPSUL, V19, P615, DOI 10.1080/02652040210144243; Suarez-Gonzalez D, 2010, J BIOMED MATER RES A, V95A, P222, DOI 10.1002/jbm.a.32833; Szpalski C, 2012, TISSUE ENG PART B-RE, V18, P246, DOI [10.1089/ten.TEB.2011.0427, 10.1089/ten.teb.2011.0427]; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; Wang J, 2014, BIO-MED MATER ENG, V24, P835, DOI 10.3233/BME-130875; Weir MD, 2010, ACTA BIOMATER, V6, P4118, DOI 10.1016/j.actbio.2010.04.029; Xie ML, 2012, RSC ADV, V2, P1457, DOI 10.1039/c1ra00750e; Xie ML, 2010, ACTA BIOMATER, V6, P3665, DOI 10.1016/j.actbio.2010.03.034; Zhao LA, 2010, BIOMATERIALS, V31, P6502, DOI 10.1016/j.biomaterials.2010.05.017	43	72	72	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120374	10.1371/journal.pone.0120374	http://dx.doi.org/10.1371/journal.pone.0120374			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25769043	Green Submitted, Green Published, gold			2022-12-27	WOS:000351277500123
J	Yan, CA; Zhang, WC; Zhang, ZJ; Liu, YM; Deng, C; Nie, N				Yan, Chang-An; Zhang, Wanchang; Zhang, Zhijie; Liu, Yuanmin; Deng, Cai; Nie, Ning			Assessment of Water Quality and Identification of Polluted Risky Regions Based on Field Observations & GIS in the Honghe River Watershed, China	PLOS ONE			English	Article							SYSTEMS; INDEX; BASIN; INDIA	Water quality assessment at the watershed scale requires not only an investigation of water pollution and the recognition of main pollution factors, but also the identification of polluted risky regions resulted in polluted surrounding river sections. To realize this objective, we collected water samplings from 67 sampling sites in the Honghe River watershed of China with Grid GIS method to analyze six parameters including dissolved oxygen (DO), ammonia nitrogen (NH3-N), nitrate nitrogen (NO3-N), nitrite nitrogen (NO2-N), total nitrogen (TN) and total phosphorus (TP). Single factor pollution index and comprehensive pollution index were adopted to explore main water pollutants and evaluate water quality pollution level. Based on two evaluate methods, Geo-statistical analysis and Geographical Information System (GIS) were used to visualize the spatial pollution characteristics and identifying potential polluted risky regions. The results indicated that the general water quality in the watershed has been exposed to various pollutants, in which TP, NO2-N and TN were the main pollutants and seriously exceeded the standard of Category III. The zones of TP, TN, DO, NO2-N and NH3-N pollution covered 99.07%, 62.22%, 59.72%, 37.34% and 13.82% of the watershed respectively, and they were from medium to serious polluted. 83.27% of the watershed in total was polluted by comprehensive pollutants. These conclusions may provide useful and effective information for watershed water pollution control and management.	[Yan, Chang-An; Liu, Yuanmin; Deng, Cai; Nie, Ning] Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resource Reuse, Nanjing 210093, Jiangsu, Peoples R China; [Yan, Chang-An] Kunming Inst Environm Sci, Kunming 650032, Peoples R China; [Zhang, Wanchang; Liu, Yuanmin; Deng, Cai; Nie, Ning] Chinese Acad Sci, Inst Remote Sensing & Digital Earth RADI, Key Lab Digital Earth Sci, Beijing 100094, Peoples R China; [Zhang, Zhijie] Nanjing Univ Posts & Telecommun, Coll Automat, Nanjing 210093, Jiangsu, Peoples R China	Nanjing University; Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS; Nanjing University of Posts & Telecommunications	Zhang, WC (corresponding author), Chinese Acad Sci, Inst Remote Sensing & Digital Earth RADI, Key Lab Digital Earth Sci, Beijing 100094, Peoples R China.	wchzhang@126.com			National Basic Research Program of China (973) [2010CB951404]; National Natural Science Foundation of China [41175088, 40971024]	National Basic Research Program of China (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973, Grant No. 2010CB951404) and the National Natural Science Foundation of China (No. 41175088 and No. 40971024) to W.C.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahearn DS, 2005, J HYDROL, V313, P234, DOI 10.1016/j.jhydrol.2005.02.038; [Anonymous], 1990, GB124091990 NAT SMC; [Anonymous], 2011, CHIN ENV QUAL COMM; Chang H, 2005, HYDROBIOLOGIA, V544, P321, DOI 10.1007/s10750-005-1894-6; Chang H, 2008, WATER RES, V42, P3285, DOI 10.1016/j.watres.2008.04.006; Deutsch CV, 1996, COMPUT GEOSCI, V22, P765, DOI 10.1016/0098-3004(96)00005-2; Donohue I, 2006, WATER RES, V40, P91, DOI 10.1016/j.watres.2005.10.027; Facchinelli A, 2001, ENVIRON POLLUT, V114, P313, DOI 10.1016/S0269-7491(00)00243-8; Gong C. L., 2007, CHONGQING ENV SCI, V10, P910; Gong X, 2014, RSC ADV, V4, P54494, DOI 10.1039/c4ra09979f; Henan Provincial Bureau of Statistics, 2012, HEN STAT YB 2012; Jasmin I, 2014, ENVIRON MONIT ASSESS, V186, P935, DOI 10.1007/s10661-013-3425-7; Jiang H.H., 1999, ENV MONIT CHINA, V15, P46; Jiang WJ, 2014, ENVIRON SCI TECHNOL, V48, P8078, DOI 10.1021/es405804m; Jiang YP, 2006, PROCEEDINGS OF THE CONFERENCE OF GLOBAL CHINESE SCHOLARS ON HYDRODYNAMICS, P528; Jonnalagadda SB, 2001, WATER RES, V35, P2371, DOI 10.1016/S0043-1354(00)00533-9; Li T, 2007, ENVIRON ENG SCI, V26, P451; [刘聚涛 Liu Jutao], 2010, [环境污染与防治, Environmental Pollution & Control], V32, P20; Liu Q, 2012, THESIS NANJING U; Meng W, 2009, J ENVIRON SCI, V21, P1017, DOI 10.1016/S1001-0742(08)62377-3; Ministry of Environmental Protection of the People's Republic of China, 2002, MON AN METH WAT WAST, P200; Ministry of Environmental Protection of the People's Republic of China, 2002, 912002 HJT MIN ENV P; Ministry of Environmental Protection of the People's Republic of China State Administration for Quality Supervision and Inspection and Quarantine of China, 1999, GHZB11999 MIN ENV PR; Ministry of Environmental Protection of the People's Republic of China State Administration for Quality Supervision and Inspection and Quarantine of China, 2002, 38382002 GB MIN ENV, DOI [10.1016/j.chemosphere.2011.07.064, DOI 10.1016/J.CHEMOSPHERE.2011.07.064]; NIEMI GJ, 1990, ENVIRON MANAGE, V14, P571, DOI 10.1007/BF02394710; Ouyang Y, 2005, WATER RES, V39, P2621, DOI 10.1016/j.watres.2005.04.024; [庞振凌 PANG ZhenLing], 2008, [生态学报, Acta Ecologica Sinica], V28, P1810; Shankar BS, 2008, ENVIRON ENG SCI, V25, P911, DOI 10.1089/ees.2007.0231; Vairavamoorthy K, 2007, ENVIRON MODELL SOFTW, V22, P951, DOI 10.1016/j.envsoft.2006.05.027; Varol M, 2012, RIVER RES APPL, V28, P1428, DOI 10.1002/rra.1533; Wan W, 2013, INT J CHEM PETROLEUM, V2, P1; Xu Zu-xin, 2005, Journal of Tongji University (Natural Science), V33, P482; Yao JY, 2009, ENV SCI MANAGEMENT, V34, P172; Zhang C.X., 2007, RATIONAL ALLOCATION	34	47	49	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119130	10.1371/journal.pone.0119130	http://dx.doi.org/10.1371/journal.pone.0119130			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768942	Green Submitted, Green Published, gold			2022-12-27	WOS:000351277500066
J	Bush, PC; Mainen, ZF				Bush, Paul C.; Mainen, Zachary F.			Columnar Architecture Improves Noise Robustness in a Model Cortical Network	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; ORIENTATION COLUMNS; MICRO-ORGANIZATION; SPATIAL-FREQUENCY; SYNAPTIC STRENGTH; SINGLE NEURONS; LAYER 4; CAT; INHIBITION; CONNECTIVITY	Cortical columnar architecture was discovered decades ago yet there is no agreed upon explanation for its function. Indeed, some have suggested that it has no function, it is simply an epiphenomenon of developmental processes. To investigate this problem we have constructed a computer model of one square millimeter of layer 2/3 of the primary visual cortex (V1) of the cat. Model cells are connected according to data from recent paired cell studies, in particular the connection probability between pyramidal cells is inversely proportional both to the distance separating the cells and to the distance between the preferred parameters (features) of the cells. We find that these constraints, together with a columnar architecture, produce more tightly clustered populations of cells when compared to the random architecture seen in, for example, rodents. This causes the columnar network to converge more quickly and accurately on the pattern representing a particular stimulus in the presence of noise, suggesting that columnar connectivity functions to improve pattern recognition in cortical circuits. The model also suggests that synaptic failure, a phenomenon exhibited by weak synapses, may conserve metabolic resources by reducing transmitter release at these connections that do not contribute to network function.	[Bush, Paul C.; Mainen, Zachary F.] Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, Lisbon, Portugal	Fundacao Champalimaud	Bush, PC (corresponding author), Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, Lisbon, Portugal.	paul.bush@neuro.fchampalimaud.org		Mainen, Zachary/0000-0001-7913-9109	Champalimaud Foundation	Champalimaud Foundation	This study was supported by the Champalimaud Foundation, http://www.fchampalimaud.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NM, 2010, NEURON, V65, P399, DOI 10.1016/j.neuron.2010.01.009; Almeida LEF, 2009, J NEUROSCI, V29, P12702, DOI 10.1523/JNEUROSCI.1166-09.2009; Bernacchia A, 2013, NEURAL COMPUT, V25, P1732, DOI 10.1162/NECO_a_00451; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Binzegger T, 2007, J NEUROSCI, V27, P12242, DOI 10.1523/JNEUROSCI.3753-07.2007; Boucsein C, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00032; Bush P, 1996, J COMPUT NEUROSCI, V3, P91, DOI 10.1007/BF00160806; BUSH PC, 1994, J NEUROPHYSIOL, V71, P2183, DOI 10.1152/jn.1994.71.6.2183; Cano-Colino M, 2014, CEREB CORTEX, V24, P2449, DOI 10.1093/cercor/bht096; Carandini M, 1997, J NEUROSCI, V17, P8621; da Costa NM, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00016; DeAngelis GC, 1999, J NEUROSCI, V19, P4046; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; Douglas RJ, 2007, CURR BIOL, V17, pR496, DOI 10.1016/j.cub.2007.04.024; Ecker AS, 2010, SCIENCE, V327, P584, DOI 10.1126/science.1179867; Feldmeyer D, 2013, PROG NEUROBIOL, V103, P3, DOI 10.1016/j.pneurobio.2012.11.002; Feldmeyer D, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00024; George D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000532; GILBERT CD, 1989, J NEUROSCI, V9, P2432; Girman SV, 1999, J NEUROPHYSIOL, V82, P301, DOI 10.1152/jn.1999.82.1.301; Gupta N, 2011, CURR BIOL, V21, pR504, DOI 10.1016/j.cub.2011.05.044; Hardingham NR, 2007, J NEUROPHYSIOL, V97, P2965, DOI 10.1152/jn.01352.2006; HATA Y, 1991, J PHYSIOL-LONDON, V441, P593, DOI 10.1113/jphysiol.1991.sp018769; Hofer SB, 2011, NAT NEUROSCI, V14, P1045, DOI 10.1038/nn.2876; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Horton JC, 2005, PHILOS T R SOC B, V360, P837, DOI 10.1098/rstb.2005.1623; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; HUBEL DH, 1974, J COMP NEUROL, V158, P267, DOI 10.1002/cne.901580304; Hubener M, 1997, J NEUROSCI, V17, P9270; Issa NP, 2000, J NEUROSCI, V20, P8504, DOI 10.1523/JNEUROSCI.20-22-08504.2000; Kaschube M, 2010, SCIENCE, V330, P1113, DOI 10.1126/science.1194869; Katzner S, 2011, J NEUROSCI, V31, P5931, DOI 10.1523/JNEUROSCI.5753-10.2011; Knoblauch A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096485; Ko H, 2013, NATURE, V496, P96, DOI 10.1038/nature12015; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Koch C, 1989, METHODS IN NEURONAL; Kwan AC, 2012, CURR BIOL, V22, P1459, DOI 10.1016/j.cub.2012.06.007; Martin KAC, 2013, J NEUROSCI, V33, P7325, DOI 10.1523/JNEUROSCI.4071-12.2013; Meyers EM, 2008, J NEUROPHYSIOL, V100, P1407, DOI 10.1152/jn.90248.2008; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; Nauhaus I, 2012, NAT NEUROSCI, V15, P1683, DOI 10.1038/nn.3255; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Ohki K, 2007, CURR OPIN NEUROBIOL, V17, P401, DOI 10.1016/j.conb.2007.07.007; ORBAN GA, 1990, P NATL ACAD SCI USA, V87, P1134, DOI 10.1073/pnas.87.3.1134; Oswald AMM, 2008, J NEUROPHYSIOL, V99, P2998, DOI 10.1152/jn.01160.2007; Palm G, 2013, NEURAL NETWORKS, V37, P163, DOI 10.1016/j.neunet.2012.08.013; Perin R, 2011, P NATL ACAD SCI USA, V108, P5419, DOI 10.1073/pnas.1016051108; Poggio T., 2012, NATURE PRECEDINGS; Priebe NJ, 2012, NEURON, V75, P194, DOI 10.1016/j.neuron.2012.06.011; Rolls E.T., 2008, MEMORY ATTENTION DEC; Rumelhart D.E., 1988, PARALLEL DISTRIBUTED, V1, DOI [10.1016/B978-1-4832-1446-7.50010-8, DOI 10.1016/B978-1-4832-1446-7.50010-8]; Saez I, 2009, J NEUROSCI, V29, P15286, DOI 10.1523/JNEUROSCI.2980-09.2009; Saez I, 2009, J NEUROSCI, V29, P4930, DOI 10.1523/JNEUROSCI.0046-09.2009; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SILLITO AM, 1980, BRAIN RES, V194, P517, DOI 10.1016/0006-8993(80)91234-2; Sippy T, 2013, J NEUROSCI, V33, P9813, DOI 10.1523/JNEUROSCI.4579-12.2013; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Swindale NV, 2000, NAT NEUROSCI, V3, P822, DOI 10.1038/77731; Thomson AM, 2007, FRONT NEUROSCI-SWITZ, V1, P19, DOI 10.3389/neuro.01.1.1.002.2007; Tkacik G, 2010, P NATL ACAD SCI USA, V107, P14419, DOI 10.1073/pnas.1004906107; Van Hooser SD, 2005, J NEUROSCI, V25, P19, DOI 10.1523/JNEUROSCI.4042-04.2005; Volgushev M, 2000, EUR J NEUROSCI, V12, P257, DOI 10.1046/j.1460-9568.2000.00909.x; Womelsdorf T, 2012, P NATL ACAD SCI USA, V109, P4302, DOI 10.1073/pnas.1114223109; Yeh CI, 2009, P NATL ACAD SCI USA, V106, P14652, DOI 10.1073/pnas.0907406106; Yen SC, 2007, J NEUROPHYSIOL, V97, P1326, DOI 10.1152/jn.00747.2006; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0	70	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119072	10.1371/journal.pone.0119072	http://dx.doi.org/10.1371/journal.pone.0119072			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781314	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600049
J	Ebina, H; Kanemura, Y; Misawa, N; Sakuma, T; Kobayashi, T; Yamamoto, T; Koyanagi, Y				Ebina, Hirotaka; Kanemura, Yuka; Misawa, Naoko; Sakuma, Tetsushi; Kobayashi, Tomoko; Yamamoto, Takashi; Koyanagi, Yoshio			A High Excision Potential of TALENs for Integrated DNA of HIV-Based Lentiviral Vector	PLOS ONE			English	Article							CD4(+) T-CELLS; REAL-TIME PCR; BINDING SPECIFICITY; GENE CORRECTION; CCR5; NUCLEASES; EFFICIENCY; INFECTION; STEM	DNA-editing technology has made it possible to rewrite genetic information in living cells. Human immunodeficiency virus (HIV) provirus, an integrated form of viral complementary DNA in host chromosomes, could be a potential target for this technology. We recently reported that HIV proviral DNA could be excised from the chromosomal DNA of HIV-based lentiviral DNA-transduced T cells after multiple introductions of a clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9 endonuclease system targeting HIV long terminal repeats (LTR). Here, we generated a more efficient strategy that enables the excision of HIV proviral DNA using customized transcription activator-like effector nucleases (TALENs) targeting the same HIV LTR site. A single transfection of TALEN-encoding mRNA, prepared from in vitro transcription, resulted in more than 80% of lentiviral vector DNA being successfully removed from the T cell lines. Furthermore, we developed a lentiviral vector system that takes advantage of the efficient proviral excision with TALENs and permits the simple selection of gene-transduced and excised cells in T cell lines.	[Ebina, Hirotaka; Kanemura, Yuka; Misawa, Naoko; Koyanagi, Yoshio] Kyoto Univ, Inst Virus Res, Lab Viral Pathogenesis, Sakyo Ku, Kyoto 6068507, Japan; [Sakuma, Tetsushi; Yamamoto, Takashi] Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Hiroshima 7398526, Japan; [Kobayashi, Tomoko] Tokyo Univ Agr, Fac Agr, Dept Anim Sci, Hlth Anim Lab, Atsugi, Kanagawa 2430034, Japan	Kyoto University; Hiroshima University; Tokyo University of Agriculture	Ebina, H (corresponding author), Kyoto Univ, Inst Virus Res, Lab Viral Pathogenesis, Sakyo Ku, 53 Shogoin Kawara Cho, Kyoto 6068507, Japan.	hebina@virus.kyoto-u.ac.jp	Sakuma, Tetsushi/A-7615-2013; Yamamoto, Takashi/U-4790-2017	Sakuma, Tetsushi/0000-0003-0396-1563; Yamamoto, Takashi/0000-0002-6516-2903	Ministry of Health, Labor and Welfare of Japan (Research on HIV/AIDS); Japan Society for the Promotion of Science [B24790438, B24390112, S22220007, 26670168]; Ministry of Education, Culture, Sports, Science and Technology [24115008]; Takeda Science Foundation; Grants-in-Aid for Scientific Research [26670168] Funding Source: KAKEN	Ministry of Health, Labor and Welfare of Japan (Research on HIV/AIDS)(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Ministry of Health, Labor and Welfare of Japan (Research on HIV/AIDS); Japan Society for the Promotion of Science (Grant-in-Aid for Young Scientists B24790438, Grant-in-Aid for Scientific Research B24390112, Grant-in-Aid for Scientific Research S22220007, Grant-in-Aid for Challenging Exploratory Research 26670168); the Ministry of Education, Culture, Sports, Science and Technology (Grant-in-Aid for Scientific Research on Innovative Areas 24115008); and the Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; CLOUSE KA, 1989, J IMMUNOL, V142, P431; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Craigie R, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006890; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Duda K, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku251; Ebina H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02510; Ebina H, 2012, VIROLOGY, V427, P44, DOI 10.1016/j.virol.2012.02.004; Eisele E, 2012, IMMUNITY, V37, P377, DOI 10.1016/j.immuni.2012.08.010; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Godbey WT, 2008, BIOTECHNOL BIOENG, V100, P765, DOI 10.1002/bit.21811; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Kawano Y, 1997, J VIROL, V71, P8456, DOI 10.1128/JVI.71.11.8456-8466.1997; Kawano Y, 2004, J VIROL, V78, P11352, DOI 10.1128/JVI.78.20.11352-11359.2004; Lee K, 2010, CELL HOST MICROBE, V7, P221, DOI 10.1016/j.chom.2010.02.007; Lewinski MK, 2005, J VIROL, V79, P6610, DOI 10.1128/JVI.79.11.6610-6619.2005; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; Mitchell R, 2003, MOL THER, V8, P674, DOI 10.1016/S1525-0016(03)00215-6; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; MIYOSHI I, 1982, GANN MONOGR CANC RES, P219; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Osborn MJ, 2013, MOL THER, V21, P1151, DOI 10.1038/mt.2013.56; Pelascini LPL, 2013, HUM GENE THER METHOD, V24, P399, DOI 10.1089/hgtb.2013.107; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Qu XY, 2013, NUCLEIC ACIDS RES, V41, P7771, DOI 10.1093/nar/gkt571; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sakuma T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03379; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Shinoda Y, 2009, VIRUS GENES, V39, P165, DOI 10.1007/s11262-009-0382-x; Siliciano RF, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a007096; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Suzuki Y, 2003, VIRUS GENES, V27, P177, DOI 10.1023/A:1025732728195; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Yamamoto SP, 2011, MICROBES INFECT, V13, P339, DOI 10.1016/j.micinf.2010.12.002	46	44	46	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120047	10.1371/journal.pone.0120047	http://dx.doi.org/10.1371/journal.pone.0120047			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781496	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600120
J	Kim, YR; Kim, MA; Sagong, B; Bae, SH; Lee, HJ; Kim, HJ; Choi, JY; Lee, KY; Kim, UK				Kim, Ye-Ri; Kim, Min-A; Sagong, Borum; Bae, Seung-Hyun; Lee, Hyo-Jeong; Kim, Hyung-Jong; Choi, Jae Young; Lee, Kyu-Yup; Kim, Un-Kyung			Evaluation of the Contribution of the EYA4 and GRHL2 Genes in Korean Patients with Autosomal Dominant Non-Syndromic Hearing Loss	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; MUTATION; DFNA10; MORPHOGENESIS; PROTEINS	EYA4 and GRHL2 encode transcription factors that play an important role in regulating many developmental stages. Since EYA4 and GRHL2 were identified as the transcription factors for the DFNA10 and DFNA28, 8 EYA4 mutations and 2 GRHL2 mutations have been reported worldwide. However, these genes have been reported in few studies of the Korean population. In this study, we performed a genetic analysis of EYA4 and GRHL2 in 87 unrelated Korean patients with autosomal dominant non-syndromic hearing loss (NSHL). A total of 4 genetic variants in the EYA4 gene were identified, including the 2 nonsense mutations p. S288X and p.Q393X. The novel mutation p. Q393X (c. 1177C> T) resulted in a change in the codon at amino acid position 393 from a glutamine to a stop codon. The p. Q393X allele was predicted to encode a truncated protein lacking the entire C-terminal Eya homolog region (Eya HR), which is essential for the interaction with the transcription factor SIX3. The p. S288X (c. 863C> A) mutation was found in a Korean family from a previous study. We analyzed p. S288X-linked microsatellite markers and determined that p. S288X might be a founder mutation and a hotspot mutation in Koreans. In GRHL2, a total of 4 genetic variants were identified, but none were associated with hearing loss in Korean patients. This suggests that GRHL2 may not be a main causal gene for autosomal dominant NSHL in Korean patients. In conclusion, our data provide fundamental information to predict the genotypes of Korean patients diagnosed with autosomal dominant NSHL.	[Kim, Ye-Ri; Kim, Min-A; Sagong, Borum; Bae, Seung-Hyun; Kim, Un-Kyung] Kyungpook Natl Univ, Coll Nat Sci, Dept Biol, Daegu, South Korea; [Kim, Ye-Ri; Kim, Min-A; Sagong, Borum; Bae, Seung-Hyun; Kim, Un-Kyung] Kyungpook Natl Univ, Sch Life Sci, Plus KNU Creat BioRes Grp BK21, Daegu, South Korea; [Lee, Hyo-Jeong; Kim, Hyung-Jong] Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea; [Choi, Jae Young] Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea; [Lee, Kyu-Yup] Kyungpook Natl Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Daegu, South Korea	Kyungpook National University; Kyungpook National University; Hallym University; Yonsei University; Yonsei University Health System; Kyungpook National University	Kim, UK (corresponding author), Kyungpook Natl Univ, Coll Nat Sci, Dept Biol, Daegu, South Korea.	kimuk@knu.ac.kr	Lee, Hyo-Jeong/AAK-7973-2020	Lee, Hyo-Jeong/0000-0003-2258-0803	Korean Health Technology Research & Development Project, Ministry of Health & Welfare, Republic of Korea [HI12C1004]	Korean Health Technology Research & Development Project, Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant from the Korean Health Technology Research & Development Project, Ministry of Health & Welfare, Republic of Korea (HI12C1004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2009, HUM MUTAT, V30, pE946, DOI 10.1002/humu.21094; Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Baek JI, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-60; Bouchard M, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-89; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; De Leenheer EMR, 2002, ADV OTO-RHINO-LARYNG, V61, P73; Duncan JS, 2011, INT J DEV BIOL, V55, P297, DOI 10.1387/ijdb.103178jd; Han YC, 2011, HUM MOL GENET, V20, P3213, DOI 10.1093/hmg/ddr234; Hildebrand MS, 2007, AM J MED GENET A, V143A, P1599, DOI 10.1002/ajmg.a.31860; Karis A, 2001, J COMP NEUROL, V429, P615, DOI 10.1002/1096-9861(20010122)429:4<615::AID-CNE8>3.0.CO;2-F; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; LIU XZ, 1994, ANN OTO RHINOL LARYN, V103, P428, DOI 10.1177/000348949410300602; Makishima T, 2007, AM J MED GENET A, V143A, P1592, DOI 10.1002/ajmg.a.31793; MONSELL EM, 1995, OTOLARYNG HEAD NECK, V113, P186, DOI 10.1016/S0194-5998(95)70103-6; Peters LM, 2002, HUM MOL GENET, V11, P2877, DOI 10.1093/hmg/11.23.2877; Pfister M, 2002, MOL MED, V8, P607, DOI 10.1007/BF03402171; Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8; Schmulian Dunay, 2005, J Am Acad Audiol, V16, P5, DOI 10.3766/jaaa.16.1.2; Schonberger J, 2005, NAT GENET, V37, P418, DOI 10.1038/ng1527; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Tadjuidje E, 2013, CELL MOL LIFE SCI, V70, P1897, DOI 10.1007/s00018-012-1144-9; Tan MX, 2014, INT J MOL MED, V34, P1467, DOI 10.3892/ijmm.2014.1939; Wayne S, 2001, HUM MOL GENET, V10, P195, DOI 10.1093/hmg/10.3.195	23	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119443	10.1371/journal.pone.0119443	http://dx.doi.org/10.1371/journal.pone.0119443			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781927	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600063
J	Lee, CH; Jin, MU; Jung, HM; Lee, JT; Kwon, TG				Lee, Chang-Hwan; Jin, Myoung Uk; Jung, Hong-Moon; Lee, Jung-Tae; Kwon, Tae-Geon			Effect of Dual Treatment with SDF-1 and BMP-2 on Ectopic and Orthotopic Bone Formation	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; OSTEOBLAST PROGENITOR CELLS; MARROW STROMAL CELLS; MORPHOGENETIC PROTEIN-2; FACTOR-I; GROWTH-FACTOR; REGENERATION; DIFFERENTIATION; RECRUITMENT; MIGRATION	Purposes The potent stem cell homing factor stromal cell-derived factor-1 (SDF-1) actively recruits mesenchymal stem cells from circulation and from local bone marrow. It is well established that bone morphogenetic protein-2 (BMP-2) induces ectopic and orthotopic bone formation. However, the exact synergistic effects of BMP-2 and SDF-1 in ectopic and orthotopic bone regeneration models have not been fully investigated. The purpose of this study was to evaluate the potential effects of simultaneous SDF-1 and BMP-2 treatment on bone formation. Materials and Methods Various doses of SDF-1 were loaded onto collagen sponges with or without BMP-2. These sponges were implanted into subcutaneous pockets and critical-size calvarial defects in C57BL/6 mice. The specimens were harvested 4 weeks post-surgery and the degree of bone formation in specimens was evaluated by histomorphometric and radiographic density analyses. Osteogenic potential and migration capacity of mesenchymal cells and capillary tube formation of endothelial cells following dual treatment with SDF-1 and BMP-2 were evaluated with in vitro assays. Results SDF-1-only-treated implants did not yield significant in vivo bone formation and SDF-1 treatment did not enhance BMP-2-induced ectopic and orthotopic bone regeneration. In vitro experiments showed that concomitant use of BMP-2 and SDF-1 had no additive effect on osteoblastic differentiation, cell migration or angiogenesis compared to BMP-2 or SDF-1 treatment alone. Conclusions These findings imply that sequence-controlled application of SDF-1 and BMP-2 must be further investigated for the enhancement of robust osteogenesis in bone defects.	[Lee, Chang-Hwan; Jung, Hong-Moon; Lee, Jung-Tae; Kwon, Tae-Geon] Kyungpook Natl Univ, Sch Dent, Dept Oral & Maxillofacial Surg, Daegu, South Korea; [Jin, Myoung Uk] Kyungpook Natl Univ, Sch Dent, Dept Conservat Dent, Daegu, South Korea	Kyungpook National University; Kyungpook National University	Kwon, TG (corresponding author), Kyungpook Natl Univ, Sch Dent, Dept Oral & Maxillofacial Surg, Daegu, South Korea.	kwondk@knu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [2012-0009330]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science, and Technology (2012-0009330).	Argintar E, 2011, INJURY, V42, P730, DOI 10.1016/j.injury.2010.11.016; Dar A, 2011, LEUKEMIA, V25, P1286, DOI 10.1038/leu.2011.62; Epstein Nancy E, 2013, Surg Neurol Int, V4, pS106, DOI 10.4103/2152-7806.109452; Fiedler J, 2002, J CELL BIOCHEM, V87, P305, DOI 10.1002/jcb.10309; Finkenzeller G, 2012, MICROVASC RES, V84, P81, DOI 10.1016/j.mvr.2012.03.010; Fujio M, 2011, BONE, V49, P693, DOI 10.1016/j.bone.2011.06.024; Higashino K, 2011, TISSUE ENG PT A, V17, P523, DOI 10.1089/ten.tea.2010.0168; Hosogane N, 2010, INT J BIOCHEM CELL B, V42, P1132, DOI 10.1016/j.biocel.2010.03.020; Inai K, 2008, DEV BIOL, V315, P383, DOI 10.1016/j.ydbio.2007.12.028; Jagodzinski M, 2013, ADV BIOCHEM ENG BIOT, V130, P69, DOI 10.1007/10_2012_145; Jin QM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097035; Kaewsrichan J, 2011, ARCH ORAL BIOL, V56, P90, DOI 10.1016/j.archoralbio.2010.09.003; Kakudo N, 2006, LIFE SCI, V79, P1847, DOI 10.1016/j.lfs.2006.06.033; Kitaori T, 2009, ARTHRITIS RHEUM-US, V60, P813, DOI 10.1002/art.24330; Knight MN, 2013, ADV WOUND CARE, V2, P306, DOI 10.1089/wound.2012.0420; Kortesidis A, 2005, BLOOD, V105, P3793, DOI 10.1182/blood-2004-11-4349; Kucia M, 2004, J MOL HISTOL, V35, P233; Liu YS, 2014, BIOMATERIALS, V35, P4489, DOI 10.1016/j.biomaterials.2014.02.025; Maegawa N, 2007, J TISSUE ENG REGEN M, V1, P306, DOI 10.1002/term.41; Mckay WF, 2007, INT ORTHOP, V31, P729, DOI 10.1007/s00264-007-0418-6; Mori T, 2004, MOL CANCER THER, V3, P29; Noordzij M, 2011, NEPHRON CLIN PRACT, V118, pC319, DOI 10.1159/000322830; Otsuru S, 2008, STEM CELLS, V26, P223, DOI 10.1634/stemcells.2007-0515; Otsuru S, 2007, BIOCHEM BIOPH RES CO, V354, P453, DOI 10.1016/j.bbrc.2006.12.226; Patel ZS, 2008, BONE, V43, P931, DOI 10.1016/j.bone.2008.06.019; Ponomaryov T, 2000, J CLIN INVEST, V106, P1331, DOI 10.1172/JCI10329; Raida M, 2006, INT J MOL MED, V18, P735; Ratanavaraporn J, 2011, BIOMATERIALS, V32, P2797, DOI 10.1016/j.biomaterials.2010.12.052; Scott MA, 2012, STEM CELLS DEV, V21, P655, DOI 10.1089/scd.2011.0517; Siddiqui NA, 2013, CURR STEM CELL RES T, V8, P192; Stocum DL, 2008, DEV DYNAM, V237, P3648, DOI 10.1002/dvdy.21774; Sukegawa A, 2012, TISSUE ENG PT A, V18, P934, DOI [10.1089/ten.tea.2011.0380, 10.1089/ten.TEA.2011.0380]; Trubiani O, 2008, J CELL PHYSIOL, V214, P706, DOI 10.1002/jcp.21266; Walker David H, 2002, Neurosurg Focus, V13, pe3; Wise JK, 2012, TISSUE ENG PT A, V18, P861, DOI [10.1089/ten.tea.2011.0187, 10.1089/ten.TEA.2011.0187]; Zara JN, 2011, TISSUE ENG PT A, V17, P1389, DOI [10.1089/ten.tea.2010.0555, 10.1089/ten.TEA.2010.0555]; Zwingenberger S, 2014, TISSUE ENG PT A, V20, P810, DOI 10.1089/ten.TEA.2013.0222	37	24	26	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120051	10.1371/journal.pone.0120051	http://dx.doi.org/10.1371/journal.pone.0120051			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781922	gold, Green Published, Green Submitted			2022-12-27	WOS:000351284600122
J	Liu, M; Gao, J; Yin, FQ; Gong, GS; Qin, C; Ye, KH; Zhang, M; Sun, XF; Zhou, Y; Zhang, YJ				Liu, Ming; Gao, Jian; Yin, Fuqiang; Gong, Guoshu; Qin, Cheng; Ye, Kunhao; Zhang, Min; Sun, Xiaofang; Zhou, You; Zhang, Youju			Transcriptome Analysis of Maize Leaf Systemic Symptom Infected by Bipolaris zeicola	PLOS ONE			English	Article							COCHLIOBOLUS-CARBONUM; GENE-EXPRESSION; ARABIDOPSIS; CORN; RESISTANCE; POPULATIONS; LEAVES; TEMPERATURE; COMPLEXITY; DIVERSITY	Bipolaris zeicola is a fungal pathogen that causes Northern corn leaf spot (NCLS), which is a serious foliar disease in maize and one of the most significant pathogens affecting global food security. Here, we report a genome-wide transcriptional profile analysis using next-generation sequencing (NGS) of maize leaf development after inoculation with B. zeicola. We performed High-Throughput Digital Gene Expression analysis to identify differentially expressed genes (DEGs) in resistant inbred Mo17 lines after infection with B. zeicola at four successive disease development stages-CP (contact period), PP (penetration period), IP (incubation period), and DP (disease period); the expression of the genes was compared with those in a CK (mock-treatment) control. In addition, a sensitive maize line (Zheng58) was used for the comparisons with the Mo17. Among all tested genes, 466 differentially expressed genes were identified in all libraries, and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis of these genes suggested that they are involved in many biological processes related to systemic symptom development, such as plant hormone signal transduction, starch and sucrose metabolism, phenylpropanoid biosynthesis and photosynthesis. Our systematic analysis provides comprehensive transcriptomic information regarding systemic symptom development in fungal-infected plants. This information will help in furthering our understanding of the detailed mechanisms of plant responses to fungal infection.	[Liu, Ming; Gao, Jian; Yin, Fuqiang; Gong, Guoshu; Ye, Kunhao; Zhang, Min; Sun, Xiaofang; Zhou, You; Zhang, Youju] Sichuan Agr Univ, Coll Agr Sci, Chengdu, Peoples R China; [Liu, Ming; Yin, Fuqiang] Xichang Coll, Sch Agr Sci, Xichang, Peoples R China; [Qin, Cheng] Minist Agr, Key Lab Biol & Genet Improvement Maize Southwest, Wenjiang, Sichuan, Peoples R China; [Qin, Cheng] Sichuan Agr Univ, Maize Res Inst, Wenjiang, Sichuan, Peoples R China	Sichuan Agricultural University; Xichang College; Ministry of Agriculture & Rural Affairs; Sichuan Agricultural University	Gong, GS (corresponding author), Sichuan Agr Univ, Coll Agr Sci, Chengdu, Peoples R China.	guoshugong@126.com		Qin, Cheng/0000-0002-8519-4697; gao, jian/0000-0001-7636-911X	Sichuan Innovational Team of Industry Technology System of Modern Agriculture	Sichuan Innovational Team of Industry Technology System of Modern Agriculture	Support was provided by the Sichuan Innovational Team of Industry Technology System of Modern Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-325; BEERS RF, 1952, J BIOL CHEM, V195, P133; Bent AF, 2007, ANNU REV PHYTOPATHOL, V45, P399, DOI 10.1146/annurev.phyto.45.062806.094427; Blake JA, 2008, CURRENT PROTOCOLS IN; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broglie KE, 2008, WO Patent, Patent No. [2,008,157,432, 2008157432]; COMSTOCK JC, 1973, PHYTOPATHOLOGY, V63, P24, DOI 10.1094/Phyto-63-24; Dardick C, 2007, MOL PLANT MICROBE IN, V20, P1004, DOI 10.1094/MPMI-20-8-1004; Davidson RM, 2011, PLANT GENOME-US, V4, P191, DOI 10.3835/plantgenome2011.05.0015; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Figueiredo A, 2008, J EXP BOT, V59, P3371, DOI 10.1093/jxb/ern187; Fu DL, 2009, SCIENCE, V323, P1357, DOI 10.1126/science.1166289; Fukuoka S, 2009, SCIENCE, V325, P998, DOI 10.1126/science.1175550; Ge XC, 2007, PLANT PHYSIOL, V145, P204, DOI 10.1104/pp.107.103374; GILBERT HS, 1984, ANAL BIOCHEM, V137, P282, DOI 10.1016/0003-2697(84)90086-1; HAMID AH, 1982, PHYTOPATHOLOGY, V72, P1166, DOI 10.1094/Phyto-72-1166; Hanssen IM, 2011, PLANT PHYSIOL, V156, P301, DOI 10.1104/pp.111.173906; HOLLEY RN, 1989, PLANT DIS, V73, P562, DOI 10.1094/PD-73-0562; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Jambunathan N, 2006, PLANTA, V224, P1, DOI 10.1007/s00425-005-0183-y; JONES MJ, 1993, PHYTOPATHOLOGY, V83, P366, DOI 10.1094/Phyto-83-366; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; LEONARD KJ, 1990, PHYTOPATHOLOGY, V80, P1154, DOI 10.1094/Phyto-80-1154; Li PH, 2010, NAT GENET, V42, P1060, DOI 10.1038/ng.703; Liu Y, 1999, PLANT PROT, V25, P53; LODGE DJ, 1984, CAN J BOT, V62, P995, DOI 10.1139/b84-138; Marathe R, 2004, PLANT MOL BIOL, V55, P501, DOI 10.1007/s11103-004-0439-0; Multani DS, 1998, P NATL ACAD SCI USA, V95, P1686, DOI 10.1073/pnas.95.4.1686; Mwangi S. M., 1998, THESIS VIRGINIA POLY; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; ODonnell PJ, 1996, SCIENCE, V274, P1914, DOI 10.1126/science.274.5294.1914; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Penninckx IAMA, 1996, PLANT CELL, V8, P2309, DOI 10.1105/tpc.8.12.2309; Quint M, 2006, CURR OPIN PLANT BIOL, V9, P448, DOI [10.1016/j.pbi.2006.07.006, 10.1104/pp.17.00765]; Sadasivam S., 1992, MANICKAM A BIOCHEMIC, V256; SCHENCK NC, 1974, PHYTOPATHOLOGY, V64, P619, DOI 10.1094/Phyto-64-619; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Senthil G, 2005, J GEN VIROL, V86, P2615, DOI 10.1099/vir.0.81043-0; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; SUMNER DR, 1974, PHYTOPATHOLOGY, V64, P168; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tiwari SB, 2004, PLANT CELL, V16, P533, DOI 10.1105/tpc.017384; UPADHYAYA A, 1985, J PLANT PHYSIOL, V121, P453, DOI 10.1016/S0176-1617(85)80081-X; Uzarowska A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-15; Wang XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058969; WELZ HG, 1995, EUR J PLANT PATHOL, V101, P301, DOI 10.1007/BF01874786; WELZ HG, 1993, PHYTOPATHOLOGY, V83, P593, DOI 10.1094/Phyto-83-593; Yang HX, 2011, PLANT J, V65, P503, DOI 10.1111/j.1365-313X.2010.04439.x; Yonekura-Sakakibara K, 2008, PLANT CELL, V20, P2160, DOI 10.1105/tpc.108.058040; ZAUBERMAN G, 1991, SCI HORTIC-AMSTERDAM, V47, P89, DOI 10.1016/0304-4238(91)90030-3	52	9	10	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119858	10.1371/journal.pone.0119858	http://dx.doi.org/10.1371/journal.pone.0119858			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781606	gold, Green Published, Green Submitted			2022-12-27	WOS:000351284600101
J	Patrono, E; Di Segni, M; Patella, L; Andolina, D; Valzania, A; Latagliata, EC; Felsani, A; Pompili, A; Gasbarri, A; Puglisi-Allegra, S; Ventura, R				Patrono, Enrico; Di Segni, Matteo; Patella, Loris; Andolina, Diego; Valzania, Alessandro; Latagliata, Emanuele Claudio; Felsani, Armando; Pompili, Assunta; Gasbarri, Antonella; Puglisi-Allegra, Stefano; Ventura, Rossella			When Chocolate Seeking Becomes Compulsion: Gene-Environment Interplay	PLOS ONE			English	Article							INDUCED CORTICOSTERONE SECRETION; CONDITIONED PLACE PREFERENCE; STRESS-INDUCED SENSITIZATION; EXCESSIVE SUGAR INTAKE; DOPAMINE D2 RECEPTOR; INBRED MOUSE STRAINS; DRUG-ADDICTION; ANIMAL-MODEL; EATING-DISORDERS; FOOD ADDICTION	Background Eating disorders appear to be caused by a complex interaction between environmental and genetic factors, and compulsive eating in response to adverse circumstances characterizes many eating disorders. Materials and Methods We compared compulsion-like eating in the form of conditioned suppression of palatable food-seeking in adverse situations in stressed C57BL/6J and DBA/2J mice, two well-characterized inbred strains, to determine the influence of gene-environment interplay on this behavioral phenotype. Moreover, we tested the hypothesis that low accumbal D2 receptor (R) availability is a genetic risk factor of food compulsion-like behavior and that environmental conditions that induce compulsive eating alter D2R expression in the striatum. To this end, we measured D1R and D2R expression in the striatum and D1R, D2R and alpha 1R levels in the medial prefrontal cortex, respectively, by western blot. Results Exposure to environmental conditions induces compulsion-like eating behavior, depending on genetic background. This behavioral pattern is linked to decreased availability of accumbal D2R. Moreover, exposure to certain environmental conditions upregulates D2R and downregulates alpha 1R in the striatum and medial prefrontal cortex, respectively, of compulsive animals. These findings confirm the function of gene-environment interplay in the manifestation of compulsive eating and support the hypothesis that low accumbal D2R availability is a "constitutive" genetic risk factor for compulsion-like eating behavior. Finally, D2R upregulation and alpha 1R downregulation in the striatum and medial prefrontal cortex, respectively, are potential neuroadaptive responses that parallel the shift from motivated to compulsive eating.	[Di Segni, Matteo; Andolina, Diego; Valzania, Alessandro; Latagliata, Emanuele Claudio; Puglisi-Allegra, Stefano; Ventura, Rossella] Santa Lucia Fdn, Rome, Italy; [Di Segni, Matteo; Valzania, Alessandro; Latagliata, Emanuele Claudio; Puglisi-Allegra, Stefano; Ventura, Rossella] Univ Roma La Sapienza, Dept Psychol, I-00185 Rome, Italy; [Di Segni, Matteo; Valzania, Alessandro; Latagliata, Emanuele Claudio; Puglisi-Allegra, Stefano; Ventura, Rossella] Univ Roma La Sapienza, Ctr Daniel Bovet, I-00185 Rome, Italy; [Patrono, Enrico; Patella, Loris; Andolina, Diego; Pompili, Assunta; Gasbarri, Antonella] Univ Aquila, Dept Appl Clin Sci & Biotechnol, Coppito, Italy; [Felsani, Armando] CNR, Inst Cellular Biol & Neurobiol, Rome, Italy	IRCCS Santa Lucia; Sapienza University Rome; Sapienza University Rome; University of L'Aquila; Consiglio Nazionale delle Ricerche (CNR)	Ventura, R (corresponding author), Santa Lucia Fdn, Rome, Italy.	rossella.ventura@uniroma1.it	Ventura, Rossella/AAA-8816-2019; Felsani, Armando/D-1784-2010; Di Segni, Matteo/K-6000-2016; Puglisi-Allegra, Stefano/ABI-7468-2020	Ventura, Rossella/0000-0002-7601-8683; Felsani, Armando/0000-0001-8851-6295; Di Segni, Matteo/0000-0002-1453-579X; Puglisi-Allegra, Stefano/0000-0002-9433-2000; Gasbarri, Antonella/0000-0003-0708-6524; Patrono, Enrico/0000-0002-9056-9537; Emanuele Claudio, Latagliata/0000-0001-8402-2757	Ministero dell'Istruzione dell'Universita e della Ricerca: Ateneo [C26A13L3PZ]; FIRB, Italy [RBFR10RZ0N_001]	Ministero dell'Istruzione dell'Universita e della Ricerca: Ateneo; FIRB, Italy(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	The work was supported by Ministero dell'Istruzione dell'Universita e della Ricerca: Ateneo 2013 (C26A13L3PZ); FIRB 2010 (RBFR10RZ0N_001), Italy.	Adam TC, 2007, PHYSIOL BEHAV, V91, P449, DOI 10.1016/j.physbeh.2007.04.011; Alcaro A, 2007, BRAIN RES REV, V56, P283, DOI 10.1016/j.brainresrev.2007.07.014; Alsio J, 2012, FRONT NEUROENDOCRIN, V33, P127, DOI 10.1016/j.yfrne.2012.01.002; Andolina D, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu074; Avena NM, 2008, NEUROSCI BIOBEHAV R, V32, P20, DOI 10.1016/j.neubiorev.2007.04.019; Avena NM, 2012, NEUROPHARMACOLOGY, V63, P87, DOI 10.1016/j.neuropharm.2011.11.010; Bello NT, 2010, PHARMACOL BIOCHEM BE, V97, P25, DOI 10.1016/j.pbb.2010.04.016; Berridge KC, 2010, BRAIN RES, V1350, P43, DOI 10.1016/j.brainres.2010.04.003; Bertolino A, 2009, BRAIN, V132, P417, DOI 10.1093/brain/awn248; Blouet C, 2010, BEHAV BRAIN RES, V209, P1, DOI 10.1016/j.bbr.2009.12.024; Bray GA, 2004, AM J CLIN NUTR, V79, P537; Bulik CM, 2005, J PSYCHIATR NEUROSCI, V30, P335; Cabib S, 1998, NEUROSCIENCE, V84, P193, DOI 10.1016/S0306-4522(97)00468-5; CABIB S, 1985, BEHAV NEURAL BIOL, V44, P239, DOI 10.1016/S0163-1047(85)90254-7; Cabib S, 2002, BEHAV BRAIN RES, V130, P103, DOI 10.1016/S0166-4328(01)00422-3; Cabib S, 2000, SCIENCE, V289, P463, DOI 10.1126/science.289.5478.463; Cabib S, 2012, NEUROSCI BIOBEHAV R, V36, P79, DOI 10.1016/j.neubiorev.2011.04.012; Campbell IC, 2011, NEUROSCI BIOBEHAV R, V35, P784, DOI 10.1016/j.neubiorev.2010.09.012; Carr KD, 2002, PHYSIOL BEHAV, V76, P353, DOI 10.1016/S0031-9384(02)00759-X; Casper RC, 2008, PSYCHOPHARMACOLOGY, V199, P313, DOI 10.1007/s00213-008-1102-2; Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925; Cifani C, 2009, PSYCHOPHARMACOLOGY, V204, P113, DOI 10.1007/s00213-008-1442-y; Colantuoni C, 2001, NEUROREPORT, V12, P3549, DOI 10.1097/00001756-200111160-00035; Colelli V, 2010, GENES BRAIN BEHAV, V9, P703, DOI 10.1111/j.1601-183X.2010.00604.x; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; Corwin RL, 2011, PHYSIOL BEHAV, V104, P87, DOI 10.1016/j.physbeh.2011.04.041; Crawley JN, 1997, PSYCHOPHARMACOLOGY, V132, P107, DOI 10.1007/s002130050327; Dalley JW, 2007, SCIENCE, V315, P1267, DOI 10.1126/science.1137073; Dallman MF, 2003, P NATL ACAD SCI USA, V100, P11696, DOI 10.1073/pnas.1934666100; DEROCHE V, 1995, J NEUROSCI, V15, P7181; Dietrich MO, 2009, EUR J NEUROSCI, V30, P1688, DOI 10.1111/j.1460-9568.2009.06963.x; Drouin C, 2002, J NEUROSCI, V22, P2873, DOI 10.1523/JNEUROSCI.22-07-02873.2002; Elmer GI, 2010, PSYCHOPHARMACOLOGY, V208, P309, DOI 10.1007/s00213-009-1732-z; Everitt BJ, 2008, PHILOS T R SOC B, V363, P3125, DOI 10.1098/rstb.2008.0089; Fallon S, 2007, NEUROCHEM RES, V32, P1772, DOI 10.1007/s11064-007-9343-8; Fetsko LA, 2003, BRAIN RES, V967, P191, DOI 10.1016/S0006-8993(02)04277-4; Fish E, 2010, TCE-THE CHEM ENG, P2; Gjedde A, 2010, P NATL ACAD SCI USA, V107, P3870, DOI 10.1073/pnas.0912319107; Guarnieri DJ, 2012, BIOL PSYCHIAT, V71, P358, DOI 10.1016/j.biopsych.2011.06.028; Gubner NR, 2010, ALCOHOL CLIN EXP RES, V34, P1353, DOI 10.1111/j.1530-0277.2010.01219.x; Hadad NA, 2014, PSYCHOPHARMACOLOGY, V231, P1897, DOI 10.1007/s00213-014-3461-1; Hagan MM, 2003, INT J EAT DISORDER, V34, P183, DOI 10.1002/eat.10168; Halpern CH, 2013, J NEUROSCI, V33, P7122, DOI 10.1523/JNEUROSCI.3237-12.2013; Heyne A, 2009, ADDICT BIOL, V14, P373, DOI 10.1111/j.1369-1600.2009.00175.x; Hoebel BG, 2009, J ADDICT MED, V3, P33, DOI 10.1097/ADM.0b013e31819aa621; Ifland JR, 2009, MED HYPOTHESES, V72, P518, DOI 10.1016/j.mehy.2008.11.035; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; Kalra SP, 2004, J ADDICT DIS, V23, P5, DOI 10.1300/J069v23n03_02; Latagliata EC, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-15; Lenoir M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000698; Olsen CM, 2011, NEUROPHARMACOLOGY, V61, P1109, DOI 10.1016/j.neuropharm.2011.03.010; Orsini C, 2005, PSYCHOPHARMACOLOGY, V181, P327, DOI 10.1007/s00213-005-2259-6; Orsini C, 2008, PSYCHOPHARMACOLOGY, V198, P287, DOI 10.1007/s00213-008-1137-4; Oswald KD, 2011, INT J EAT DISORDER, V44, P203, DOI 10.1002/eat.20808; Parker G, 2006, J AFFECT DISORDERS, V92, P149, DOI 10.1016/j.jad.2006.02.007; Parylak SL, 2011, PHYSIOL BEHAV, V104, P149, DOI 10.1016/j.physbeh.2011.04.063; Patel S, 2006, BEHAV BRAIN RES, V170, P197, DOI 10.1016/j.bbr.2006.02.019; Petrovich GD, 2007, J NEUROSCI, V27, P6436, DOI 10.1523/JNEUROSCI.5001-06.2007; Puglisi-Allegra S, 2000, NEUROREPORT, V11, P1361, DOI 10.1097/00001756-200004270-00042; Puglisi-Allegra S, 2012, REV NEUROSCIENCE, V23, P509, DOI 10.1515/revneuro-2012-0076; Puglisi-Allegra S, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00031; PuglisiAllegra S, 1997, PROG NEUROBIOL, V51, P637, DOI 10.1016/S0301-0082(97)00008-7; Rogers PJ, 2000, PHARMACOL BIOCHEM BE, V66, P3, DOI 10.1016/S0091-3057(00)00197-0; Rolls ET, 2008, ACTA PHYSIOL HUNG, V95, P131, DOI 10.1556/APhysiol.95.2008.2.1; ROUGEPONT F, 1995, J NEUROSCI, V15, P7189; Rutter M, 2008, J ABNORM CHILD PSYCH, V36, P969, DOI 10.1007/s10802-008-9256-2; Salamone JD, 2007, PSYCHOPHARMACOLOGY, V191, P461, DOI 10.1007/s00213-006-0668-9; Salamone JD, 2012, NEURON, V76, P470, DOI 10.1016/j.neuron.2012.10.021; Sara SJ, 2012, NEURON, V76, P130, DOI 10.1016/j.neuron.2012.09.011; Schroeder BE, 2001, NEUROSCIENCE, V105, P535, DOI 10.1016/S0306-4522(01)00221-4; Solecki W, 2009, PSYCHOPHARMACOLOGY, V207, P245, DOI 10.1007/s00213-009-1672-7; Stelzel C, 2010, J NEUROSCI, V30, P14205, DOI 10.1523/JNEUROSCI.1062-10.2010; Stice E, 2008, SCIENCE, V322, P449, DOI 10.1126/science.1161550; Stice E, 2011, CURR TOP BEHAV NEURO, V6, P81, DOI 10.1007/7854_2010_89; Stice E, 2010, J NEUROSCI, V30, P13105, DOI 10.1523/JNEUROSCI.2105-10.2010; Szklarczyk K, 2012, GENES BRAIN BEHAV, V11, P977, DOI 10.1111/j.1601-183X.2012.00850.x; Teegarden SL, 2008, PHYSIOL BEHAV, V93, P713, DOI 10.1016/j.physbeh.2007.11.030; Tomer R, 2008, BIOL PSYCHOL, V77, P98, DOI 10.1016/j.biopsycho.2007.08.001; Trifilieff P, 2013, MOL PSYCHIATR, V18, P1025, DOI 10.1038/mp.2013.57; Trifilieff P, 2014, NEUROPHARMACOLOGY, V76, P498, DOI 10.1016/j.neuropharm.2013.06.031; Usiello A, 2000, NATURE, V408, P199, DOI 10.1038/35041572; van den Bos R, 2006, BEHAV BRAIN RES, V171, P350, DOI 10.1016/j.bbr.2006.03.035; van der Veen R, 2007, PSYCHOPHARMACOLOGY, V193, P179, DOI 10.1007/s00213-007-0777-0; Ventura R, 2007, P NATL ACAD SCI USA, V104, P5181, DOI 10.1073/pnas.0610178104; Volkow N, 2005, NAT NEUROSCI, V8, P1429, DOI 10.1038/nn1105-1429; Volkow ND, 2013, OBES REV, V14, P2, DOI 10.1111/j.1467-789X.2012.01031.x; Volkow ND, 2009, NEUROPHARMACOLOGY, V56, P3, DOI 10.1016/j.neuropharm.2008.05.022; Volkow ND, 2003, J CLIN INVEST, V111, P1444, DOI 10.1172/JCI200318533; Volkow ND, 2005, NAT NEUROSCI, V8, P555, DOI 10.1038/nn1452; Volkow ND, 2008, PHILOS T R SOC B, V363, P3191, DOI 10.1098/rstb.2008.0107; Volkow ND, 2008, NEUROIMAGE, V42, P1537, DOI 10.1016/j.neuroimage.2008.06.002; Volkow ND, 2011, TRENDS COGN SCI, V15, P37, DOI 10.1016/j.tics.2010.11.001; Wang GJ, 2009, J ADDICT MED, V3, P8, DOI 10.1097/ADM.0b013e31819a86f7; Wang GJ, 2004, J ADDICT DIS, V23, P39, DOI 10.1300/J069v23n03_04; Ward RD, 2012, NEUROPSYCHOPHARMACOL, V37, P1699, DOI 10.1038/npp.2012.15; Weinshenker D, 2007, NEUROPSYCHOPHARMACOL, V32, P1433, DOI 10.1038/sj.npp.1301263; Young JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004227; Zhang XY, 2005, BIOL PSYCHIAT, V57, P1202, DOI 10.1016/j.biopsych.2005.02.003	98	15	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120191	10.1371/journal.pone.0120191	http://dx.doi.org/10.1371/journal.pone.0120191			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781028	Green Submitted, Green Published, gold			2022-12-27	WOS:000351284600137
J	Rang, J; He, H; Wang, T; Ding, XZ; Zuo, MX; Quan, MF; Sun, YJ; Yu, ZQ; Hu, SB; Xia, LQ				Rang, Jie; He, Hao; Wang, Ting; Ding, Xuezhi; Zuo, Mingxing; Quan, Meifang; Sun, Yunjun; Yu, Ziquan; Hu, Shengbiao; Xia, Liqiu			Comparative Analysis of Genomics and Proteomics in Bacillus thuringiensis 4.0718	PLOS ONE			English	Article							MASS-SPECTROMETRY; SEQUENCE; PROTEOGENOMICS; PROTEINS; REVEALS; CEREUS	Bacillus thuringiensis is a widely used biopesticide that produced various insecticidal active substances during its life cycle. Separation and purification of numerous insecticide active substances have been difficult because of the relatively short half- life of such substances. On the other hand, substances can be synthetized at different times during development, so samples at different stages have to be studied, further complicating the analysis. A dual genomic and proteomic approach would enhance our ability to identify such substances, and particularily using mass spectrometry- based proteomic methods. The comparative analysis for genomic and proteomic data have showed that not all of the products deduced from the annotated genome could be identified among the proteomic data. For instance, genome annotation results showed that 39 coding sequences in the whole genome were related to insect pathogenicity, including five cry genes. However, Cry2Ab, Cry1Ia, Cytotoxin K, Bacteriocin, Exoenzyme C3 and Alveolysin could not be detected in the proteomic data obtained. The sporulation- related proteins were also compared analysis, results showed that the great majority sporulation- related proteins can be detected by mass spectrometry. This analysis revealed Spo0A similar to P, SigF, SigE(+), SigK(+) and SigG(+), all known to play an important role in the process of spore formation regulatory network, also were displayed in the proteomic data. Through the comparison of the two data sets, it was possible to infer that some genes were silenced or were expressed at very low levels. For instance, found that cry2Ab seems to lack a functional promoter while cry1Ia may not be expressed due to the presence of transposons. With this comparative study a relatively complete database can be constructed and used to transform hereditary material, thereby prompting the high expression of toxic proteins. A theoretical basis is provided for constructing highly virulent engineered bacteria and for promoting the application of proteogenomics in the life sciences.	[Rang, Jie; He, Hao; Wang, Ting; Ding, Xuezhi; Zuo, Mingxing; Quan, Meifang; Sun, Yunjun; Yu, Ziquan; Hu, Shengbiao; Xia, Liqiu] Hunan Normal Univ, Coll Life Sci, Hunan Prov Key Lab Microbial Mol Biol, State Key Lab Breeding Base Microbial Mol Biol, Changsha, Hunan, Peoples R China	Hunan Normal University	Ding, XZ (corresponding author), Hunan Normal Univ, Coll Life Sci, Hunan Prov Key Lab Microbial Mol Biol, State Key Lab Breeding Base Microbial Mol Biol, Changsha, Hunan, Peoples R China.	dingxuezhi@hunnu.edu.cn; Xialq@hunnu.edu.cn			National Natural Science Foundation of China [31370116]; National Basic Research Program (973) of China [2012CB722301]; National High Technology Research and Development program (863) of China [2011AA10A203]; Key Project of Hunan Provincial Education Department [13CY002, 10CY013, 12K033]; Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province [20134486]; national and provincial research funding	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program (973) of China(National Basic Research Program of China); National High Technology Research and Development program (863) of China(National High Technology Research and Development Program of China); Key Project of Hunan Provincial Education Department(Hunan Provincial Education Department); Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province; national and provincial research funding	This work was supported by the National Natural Science Foundation of China (31370116), the National Basic Research Program (973) of China (2012CB722301), the National High Technology Research and Development program (863) of China (2011AA10A203), the Key Project of Hunan Provincial Education Department (13CY002, 10CY013, 12K033) and the Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province (20134486). Because of this paper's research project funded by the national and provincial research funding, capital is mainly used for purchasing reagents, consumables, instruments, sample test and graduate labor allowance, etc.	Asano S, 1997, APPL ENVIRON MICROB, V63, P1054, DOI 10.1128/AEM.63.3.1054-1057.1997; BERGDOLL MS, 1988, METHODS ENZYMOL, V165, P306; Borchert N, 2010, GENOME RES, V20, P837, DOI 10.1101/gr.103119.109; Challacombe JF, 2007, J BACTERIOL, V189, P3680, DOI 10.1128/JB.00241-07; Chitov T, 2008, J FOOD SAFETY, V28, P467, DOI 10.1111/j.1745-4565.2008.00125.x; COOLBAUGH JC, 1978, CAN J MICROBIOL, V24, P1289, DOI 10.1139/m78-209; FENN JB, 1989, SCIENCE, V246, P64, DOI 10.1126/science.2675315; Francke U, 2001, J Pediatr Endocrinol Metab, V14 Suppl 6, P1395; Ge BX, 1998, FEMS MICROBIOL LETT, V165, P35, DOI 10.1111/j.1574-6968.1998.tb13124.x; Gupta N, 2008, GENOME RES, V18, P1133, DOI 10.1101/gr.074344.107; Han CS, 2006, J BACTERIOL, V188, P7711, DOI 10.1128/JB.01430-06; Han XM, 2008, CURR OPIN CHEM BIOL, V12, P483, DOI 10.1016/j.cbpa.2008.07.024; Hasnain S E, 2001, Indian J Med Microbiol, V19, P114; He J, 2011, J BACTERIOL, V193, P3407, DOI 10.1128/JB.05085-11; He J, 2010, J BACTERIOL, V192, P4074, DOI 10.1128/JB.00562-10; HOFTE H, 1989, MICROBIOL REV, V53, P242; Huang SY, 2012, APPL ENVIRON MICROB, V78, P5270, DOI 10.1128/AEM.00424-12; Jaffe JD, 2004, PROTEOMICS, V4, P59, DOI 10.1002/pmic.200300511; Liu GM, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00080-13; Liu T, 2007, CHEM REV, V107, P3621, DOI 10.1021/cr068288j; Liu Zi-duo, 2000, Acta Entomologica Sinica, V43, P207; Murawska E, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00108-13; Norman AD, 2013, GENOME ANNOUNCEMENTS, V1; Peri S, 2001, TRENDS GENET, V17, P685, DOI 10.1016/S0168-9525(01)02493-3; Polevoda B, 2003, J MOL BIOL, V325, P595, DOI 10.1016/S0022-2836(02)01269-X; Renuse S, 2011, PROTEOMICS, V11, P620, DOI 10.1002/pmic.201000615; THOMPSON NE, 1984, INFECT IMMUN, V43, P887, DOI 10.1128/IAI.43.3.887-894.1984; Wu DD, 2011, PROTEOMICS, V11, P2580, DOI 10.1002/pmic.201000392; Yates JR, 2004, ANNU REV BIOPH BIOM, V33, P297, DOI 10.1146/annurev.biophys.33.111502.082538	29	13	13	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119065	10.1371/journal.pone.0119065	http://dx.doi.org/10.1371/journal.pone.0119065			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781161	gold, Green Published, Green Submitted			2022-12-27	WOS:000351284600048
J	Soisson, O; Lube, J; Germano, A; Hammer, KH; Josten, C; Sichting, F; Winkler, D; Milani, TL; Hammer, N				Soisson, Odette; Lube, Juliane; Germano, Andresa; Hammer, Karl-Heinz; Josten, Christoph; Sichting, Freddy; Winkler, Dirk; Milani, Thomas L.; Hammer, Niels			Pelvic Belt Effects on Pelvic Morphometry, Muscle Activity and Body Balance in Patients with Sacroiliac Joint Dysfunction	PLOS ONE			English	Article							CROSS-TALK; RADIOSTEREOMETRIC ANALYSIS; PHYSICAL-EXAMINATION; STATISTICAL-METHODS; PROVOCATION TESTS; WEIGHT-BEARING; BACK-PAIN; DIAGNOSIS; MANIPULATION; RELIABILITY	Introduction The sacroiliac joint (SIJ) is frequently involved in low back and pelvic girdle pain. However, morphometrical and functional characteristics related to SIJ pain are poorly defined. Pelvic belts represent one treatment option, but evidence still lacks as to their pain-reducing effects and the mechanisms involved. Addressing these two issues, this case-controlled study compares morphometric, functional and clinical data in SIJ patients and healthy controls and evaluates the effects of short-term pelvic belt application. Methods Morphometric and functional data pertaining to pelvic belt effects were compared in 17 SIJ patients and 17 controls. Lumbar spine and pelvis morphometries were obtained from 3T magnetic resonance imaging. Functional electromyography data of pelvis and leg muscles and center of pressure excursions were measured in one-leg stance. The numerical rating scale was used to evaluate immediate pain-reducing effects. Results Pelvic morphometry was largely unaltered in SIJ patients and also by pelvic belt application. The angle of lumbar lateral flexion was significantly larger in SIJ patients without belt application. Muscle activity and center of pressure were unaffected by SIJ pain or by belt application in one-leg stance. Nine of 17 patients reported decreased pain intensities under moderate belt application, four reported no change and four reported increased pain intensity. For the entire population investigated here, this qualitative description was not confirmed on a statistical significant level. Discussion Minute changes were observed in the alignment of the lumbar spine in the frontal plane in SIJ patients. The potential pain-decreasing effects of pelvic belts could not be attributed to altered muscle activity, pelvic morphometry or body balance in a static short-term application. Long-term belt effects will therefore be of prospective interest.	[Soisson, Odette; Lube, Juliane; Hammer, Niels] Univ Leipzig, Inst Anat, Fac Med, D-04109 Leipzig, Germany; [Soisson, Odette; Germano, Andresa; Sichting, Freddy; Milani, Thomas L.] Tech Univ Chemnitz, Inst Appl Kinesiol, D-09111 Chemnitz, Germany; [Soisson, Odette; Josten, Christoph; Hammer, Niels] Univ Leipzig, Fac Med, Dept Trauma & Reconstruct Surg, D-04109 Leipzig, Germany; [Hammer, Karl-Heinz] Orthopedist Osteologist & Pain Specialist, Kirchberg, Germany; [Winkler, Dirk] Univ Leipzig, Fac Med, Dept Neurosurg, D-04109 Leipzig, Germany	Leipzig University; Technische Universitat Chemnitz; Leipzig University; Leipzig University	Hammer, N (corresponding author), Univ Leipzig, Inst Anat, Fac Med, D-04109 Leipzig, Germany.	nlshammer@googlemail.com		Hammer, Niels/0000-0001-8230-9383	Bauerfeind AG	Bauerfeind AG	Bauerfeind AG provided financial and material support for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman SJ, 2014, CLINICOECONOMIC OUTC, V6, P63, DOI 10.2147/CEOR.S54158; Al-Khayer A, 2008, J SPINAL DISORD TECH, V21, P359, DOI 10.1097/BSD.0b013e318145ab96; Antonio S, 2013, J BODYW MOV THER, V17, P512, DOI 10.1016/j.jbmt.2013.04.004; Arab AM, 2011, J MAN MANIP THER, V19, P5, DOI 10.1179/106698110X12804993426848; Arumugam A, 2012, J MANIP PHYSIOL THER, V35, P390, DOI 10.1016/j.jmpt.2012.04.019; Arumugam A, 2012, MANUAL THER, V17, P275, DOI 10.1016/j.math.2012.01.010; Ashman Bryan, 2010, Evid Based Spine Care J, V1, P35, DOI 10.1055/s-0030-1267066; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Attias N, 2001, J COMPUT ASSIST TOMO, V25, P975, DOI 10.1097/00004728-200111000-00024; Baque P, 2005, SURG RADIOL ANAT, V27, P487, DOI 10.1007/s00276-005-0027-2; Barker PJ, 2014, CLIN ANAT, V27, P234, DOI 10.1002/ca.22233; Beales DJ, 2010, MANUAL THER, V15, P190, DOI 10.1016/j.math.2009.10.008; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Buchowski Jacob M, 2005, Spine J, V5, P520, DOI 10.1016/j.spinee.2005.02.022; Buford WL, 2010, IEEE ENG MED BIO, P5117, DOI 10.1109/IEMBS.2010.5626195; Childs JD, 2005, SPINE, V30, P1331, DOI 10.1097/01.brs.0000164099.92112.29; Childs JD, 2004, J MANIP PHYSIOL THER, V27, P306, DOI 10.1016/j.jmpt.2004.04.004; Chmelova J, 2011, ACTA CHIR ORTHOP TR, V78, P46; Cohen SP, 2005, ANESTH ANALG, V101, P1440, DOI 10.1213/01.ANE.0000180831.60169.EA; Cohen SP, 2003, REGION ANESTH PAIN M, V28, P113, DOI 10.1053/rapm.2003.50029; Cohen SP, 2008, ANESTHESIOLOGY, V109, P279, DOI 10.1097/ALN.0b013e31817f4c7c; Cohen SP, 2013, EXPERT REV NEUROTHER, V13, P99, DOI [10.1586/ERN.12.148, 10.1586/ern.12.148]; Collins SL, 1997, PAIN, V72, P95, DOI 10.1016/S0304-3959(97)00005-5; Cusi MF, 2010, J BODYW MOV THER, V14, P152, DOI 10.1016/j.jbmt.2009.12.004; DE LUCA CJ, 1988, ELECTROEN CLIN NEURO, V69, P568, DOI 10.1016/0013-4694(88)90169-1; Dimar JR, 2008, EUR SPINE J, V17, P1373, DOI 10.1007/s00586-008-0755-1; Dreyfuss P, 1996, SPINE, V21, P2594, DOI 10.1097/00007632-199611150-00009; Dussault RG, 2000, RADIOLOGY, V214, P273, DOI 10.1148/radiology.214.1.r00ja28273; Ebraheim NA, 2010, J TRAUMA, V69, P1226, DOI 10.1097/TA.0b013e3181e4f3f8; Fick R, 1904, HDB ANATOMIE MECHANI; Forst Stacy L, 2006, Pain Physician, V9, P61; Fortin J D, 1993, J Back Musculoskelet Rehabil, V3, P31, DOI 10.3233/BMR-1993-3308; Fortin J D, 1999, Am J Orthop (Belle Mead NJ), V28, P687; Freburger JK, 2001, PHYS THER, V81, P1135, DOI 10.1093/ptj/81.5.1135; Fritz J, 2008, AM J ROENTGENOL, V191, P1717, DOI 10.2214/AJR.08.1075; Fritz Jan, 2011, Top Magn Reson Imaging, V22, P143, DOI 10.1097/RMR.0b013e31827e5de1; Fukatsu Hiroshi, 2003, Magn Reson Med Sci, V2, P37, DOI 10.2463/mrms.2.37; Gary JL, 2014, J ORTHOP TRAUMA, V28, P41, DOI 10.1097/BOT.0b013e318299ce1b; GROB KR, 1995, Z RHEUMATOL, V54, P117; Hayashi S, 2013, ANAT CELL BIOL, V46, P149, DOI 10.5115/acb.2013.46.2.149; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Hermens HJ, 1997, EUROPEAN APPL SURFAC; Hu H, 2010, J BIOMECH, V43, P532, DOI 10.1016/j.jbiomech.2009.09.035; Hungerford BA, 2007, PHYS THER, V87, P879, DOI 10.2522/ptj.20060014; JACOB HAC, 1995, CLIN BIOMECH, V10, P352, DOI 10.1016/0268-0033(95)00003-4; Joseph L, 2012, MANUAL THER, V17, pE7, DOI 10.1016/j.math.2011.09.003; Jung HS, 2013, MANUAL THER, V18, P143, DOI 10.1016/j.math.2012.09.003; Kamali F, 2012, J BODYW MOV THER, V16, P29, DOI 10.1016/j.jbmt.2011.02.002; Karaman H, 2011, ACTA NEUROCHIR, V153, P1461, DOI 10.1007/s00701-011-1003-8; Kibsgard TJ, 2013, EUR SPINE J, V22, P871, DOI 10.1007/s00586-012-2512-8; Kim Jong T, 2013, Open Orthop J, V7, P51, DOI 10.2174/1874325001307010051; KOH TJ, 1993, J BIOMECH, V26, P151, DOI 10.1016/0021-9290(93)90086-T; Laplante BL, 2012, PAIN PHYSICIAN, V15, P171; Laslett M, 2005, MANUAL THER, V10, P207, DOI 10.1016/j.math.2005.01.003; Laslett M, 2008, J MAN MANIP THER, V16, P142, DOI 10.1179/jmt.2008.16.3.142; Maas ET, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-260; Mahaudens P, 2014, SPINE J, V14, P1510, DOI 10.1016/j.spinee.2013.08.050; Maigne JY, 1996, SPINE, V21, P1889, DOI 10.1097/00007632-199608150-00012; Manchikanti L, 2013, PAIN PHYSICIAN, V16, pE635; Mason LW, 2013, EUR SPINE J, V22, P2325, DOI 10.1007/s00586-013-2825-2; Matsumoto Sonoko, 2012, Masui, V61, P993; McGuire R, 2002, EVID BASED SPINE J, V3, P21; McKenzie-Brown Ann Marie, 2005, Pain Physician, V8, P115; Mendez-Sanchez R, 2014, J ALTERN COMPLEM MED, V20, P251, DOI 10.1089/acm.2013.0192; Mens J, 2006, J BIOMECH, V39, P627, DOI 10.1016/j.jbiomech.2005.01.016; Mens JMA, 2006, CLIN BIOMECH, V21, P122, DOI 10.1016/j.clinbiomech.2005.08.016; Merskey H, 1994, CLASSIFICATION CHRON, DOI DOI 10.1016/0304-3959(86)90113-2; Miller AN, 2012, J AM ACAD ORTHOP SUR, V20, P8, DOI 10.5435/JAAOS-20-01-008; Orakifar N, 2012, ARCH PHYS MED REHAB, V93, P56, DOI 10.1016/j.apmr.2011.05.027; PANJABI MM, 1992, J SPINAL DISORD, V5, P383, DOI 10.1097/00002517-199212000-00001; Park KM, 2010, J ELECTROMYOGR KINES, V20, P1141, DOI 10.1016/j.jelekin.2010.05.009; Parreira RB, 2013, J APPL BIOMECH, V29, P312, DOI 10.1123/jab.29.3.312; Patel N, 2012, PAIN MED, V13, P383, DOI 10.1111/j.1526-4637.2012.01328.x; Pel JJM, 2008, J BIOMECH, V41, P1878, DOI 10.1016/j.jbiomech.2008.04.002; Plastaras CT, 2012, PM&R, V4, P473, DOI 10.1016/j.pmrj.2012.02.001; Pomarino D, 2013, ORTHOP UNFALLCHIR Z, V9, P420, DOI DOI 10.3238/oup.2013.0420-0425; Pool-Goudzwaard AL, 2001, J ANAT, V199, P457, DOI 10.1046/j.1469-7580.2001.19940457.x; Puhakka KB, 2004, SKELETAL RADIOL, V33, P15, DOI 10.1007/s00256-003-0691-4; Robert R, 1998, SURG RADIOL ANAT, V20, P93; Rudolf Leonard, 2012, Open Orthop J, V6, P495, DOI 10.2174/1874325001206010495; Rupert MP, 2009, PAIN PHYSICIAN, V12, P399; Saint-Martin M., 1912, COMPTES RENDUS ASSOD, V14, P95; Sakamoto N, 2001, Spine (Phila Pa 1976), V26, pE468, DOI 10.1097/00007632-200110150-00008; Salaffi F, 2004, EUR J PAIN, V8, P283, DOI 10.1016/j.ejpain.2003.09.004; Schutz Uwe, 2006, Acta Orthop Belg, V72, P296; SCHWARZER AC, 1995, SPINE, V20, P31, DOI 10.1097/00007632-199501000-00007; Shadmehr A, 2012, J BACK MUSCULOSKELET, V25, P27, DOI 10.3233/BMR-2012-0307; Shi Ning-Ning, 2013, Zhongguo Gu Shang, V26, P102; Sichting F, 2014, PAIN PHYSICIAN, V17, P43; SNIJDERS CJ, 1993, CLIN BIOMECH, V8, P285, DOI 10.1016/0268-0033(93)90002-Y; Spiker William Ryan, 2012, Evid Based Spine Care J, V3, P41, DOI 10.1055/s-0032-1328142; STARK DD, 1985, AM J ROENTGENOL, V144, P947, DOI 10.2214/ajr.144.5.947; Stokes IAF, 2001, J SPINAL DISORD, V14, P317, DOI 10.1097/00002517-200108000-00006; Sturesson B, 2000, SPINE, V25, P214, DOI 10.1097/00007632-200001150-00012; Sturesson B, 2000, SPINE, V25, P364, DOI 10.1097/00007632-200002010-00018; Szadek KM, 2009, J PAIN, V10, P354, DOI 10.1016/j.jpain.2008.09.014; Takasaki H, 2009, MANUAL THER, V14, P484, DOI 10.1016/j.math.2008.11.003; Tate CM, 2006, MED SCI SPORT EXER, V38, P122, DOI 10.1249/01.mss.0000179400.67734.01; TURKER KS, 1990, NEUROSCI LETT, V111, P164, DOI 10.1016/0304-3940(90)90362-D; van Onna M, 2011, ANN RHEUM DIS, V70, P1981, DOI 10.1136/annrheumdis-2011-200025; Visser LH, 2013, EUR SPINE J, V22, P1657, DOI 10.1007/s00586-013-2660-5; Vleeming A, 2012, J ANAT, V221, P537, DOI 10.1111/j.1469-7580.2012.01564.x; VLEEMING A, 1992, CLIN BIOMECH, V7, P170, DOI 10.1016/0268-0033(92)90032-Y; VLEEMING A, 1989, CLIN BIOMECH, V4, P201, DOI 10.1016/0268-0033(89)90002-8; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Weiner DK, 2006, J AM GERIATR SOC, V54, P11, DOI 10.1111/j.1532-5415.2005.00534.x; WEISL H, 1954, ACTA ANAT, V20, P201; Wise CL, 2008, J SPINAL DISORD TECH, V21, P579, DOI 10.1097/BSD.0b013e31815ecc4b	109	17	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0116739	10.1371/journal.pone.0116739	http://dx.doi.org/10.1371/journal.pone.0116739			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781325	Green Submitted, Green Published, gold			2022-12-27	WOS:000351284600009
J	Tian, Y; Choi, CH; Li, QK; Rahmatpanah, FB; Chen, X; Kim, SR; Veltri, R; Chia, D; Zhang, Z; Mercola, D; Zhang, H				Tian, Yuan; Choi, Caitlin H.; Li, Qing Kay; Rahmatpanah, Farah B.; Chen, Xin; Kim, Sara Ruth; Veltri, Robert; Chia, David; Zhang, Zhen; Mercola, Dan; Zhang, Hui			Overexpression of Periostin in Stroma Positively Associated with Aggressive Prostate Cancer	PLOS ONE			English	Article							EXPRESSION; PROGRESSION; PROTEIN; MICROENVIRONMENT; METASTASIS	Background Periostin is an important extracellular matrix protein involved in cell development and adhesion. Previously, we identified periostin to be up-regulated in aggressive prostate cancer (CaP) using quantitative glycoproteomics and mass spectrometry. The expression of periostin was further evaluated in primary radical prostatectomy (RP) prostate tumors and adjacent non-tumorous prostate tissues using immunohistochemistry (IHC). Our IHC results revealed a low background periostin levels in the adjacent non-tumorous prostate tissues, but overexpressed periostin levels in the peritumoral stroma of primary CaP tumors. Methods In this study, periostin expression in CaP was further examined on multiple tissue microarrays (TMAs), which were conducted in four laboratories. To achieve consistent staining, all TMAs were stained with same protocol and scored by same image computation tool to determine the total periostin staining intensities. The TMAs were further scored by pathologists to characterize the stromal staining and epithelial staining. Results The periostin staining was observed mainly in peritumoral stromal cells and in some cases in tumor epithelial cells though the stronger staining was found in peritumoral stromal cells. Both periostin stromal staining and epithelial staining can differentiate BPH from CaP including low grade CaP (Gleason score <= 6), with significant p-value of 2.2e-16 and 0.001, respectively. Periostin epithelial staining differentiated PIN from low grade CaP (Gleason score <= 6) (p=0.001), while periostin stromal staining differentiated low grade Cap (Gleason score <= 6) from high grade Cap (Gleason score <= 6) (p=1.7e-05). In addition, a positive correlation between total periostin staining and Gleason score was observed (r=0.87, p=0.002). Conclusions The results showed that periostin staining was positively correlated with increasing Gleason score and the aggressiveness of prostate disease.	[Tian, Yuan; Choi, Caitlin H.; Li, Qing Kay; Veltri, Robert; Zhang, Zhen; Zhang, Hui] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21218 USA; [Rahmatpanah, Farah B.; Chen, Xin; Mercola, Dan] Univ Calif Irvine, Dept Pathol, Irvine, CA 92717 USA; [Kim, Sara Ruth; Chia, David] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA	Johns Hopkins University; University of California System; University of California Irvine; University of California System; University of California Los Angeles	Zhang, H (corresponding author), Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21218 USA.	hzhang32@jhmi.edu	mercola, dan/L-4182-2013	mercola, dan/0000-0002-0281-9840	National Institutes of Health, National Cancer Institute; Early Detection Research Network (EDRN) [U01CA152813]; Early Detection Research Network NCI [CA86366]; NATIONAL CANCER INSTITUTE [U24CA086366, T32CA009054, U24CA160036, U01CA152813] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107153] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Early Detection Research Network (EDRN)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Early Detection Research Network NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health, National Cancer Institute, the Early Detection Research Network (EDRN, U01CA152813) to HZ and Early Detection Research Network NCI CA86366 to DC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Erkan M, 2007, GASTROENTEROLOGY, V132, P1447, DOI 10.1053/j.gastro.2007.01.031; Gunia S, 2013, J CLIN PATHOL, V66, P297, DOI 10.1136/jclinpath-2012-201262; Kikuchi Y, 2008, J HISTOCHEM CYTOCHEM, V56, P753, DOI 10.1369/jhc.2008.951061; Krajewska M, 2008, CLIN CANCER RES, V14, P3011, DOI 10.1158/1078-0432.CCR-07-1955; Krajewska M, 2007, PROSTATE, V67, P907, DOI 10.1002/pros.20578; Kudo Y, 2007, HISTOL HISTOPATHOL, V22, P1167, DOI 10.14670/HH-22.1167; Kyutoku M, 2011, INT J MOL MED, V28, P181, DOI 10.3892/ijmm.2011.712; Li MX, 2012, CLIN EXP METASTAS, V29, P865, DOI 10.1007/s10585-012-9465-5; Maresh EL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-680; Michaylira CZ, 2010, CANCER RES, V70, P5281, DOI 10.1158/0008-5472.CAN-10-0704; Morra L, 2012, LUNG CANCER, V76, P183, DOI 10.1016/j.lungcan.2011.10.013; Nuzzo PV, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-625; Ruan K, 2009, CELL MOL LIFE SCI, V66, P2219, DOI 10.1007/s00018-009-0013-7; Seligson DB, 2007, CLIN CANCER RES, V13, P6056, DOI 10.1158/1078-0432.CCR-07-0960; Tian Y, 2011, PROTEOMICS, V11, P4677, DOI 10.1002/pmic.201000811; Tian Y, 2011, ANAL CHEM, V83, P7013, DOI 10.1021/ac200815q; Tischler V, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-273; Wang HJ, 2013, INT J ONCOL, V42, P1716, DOI 10.3892/ijo.2013.1847; Wu GQ, 2013, CANCER BIOTHER RADIO, V28, P298, DOI 10.1089/cbr.2012.1374; Xu DY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046670; Zhu M, 2010, GYNECOL ONCOL, V119, P337, DOI 10.1016/j.ygyno.2010.07.008	21	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0121502	10.1371/journal.pone.0121502	http://dx.doi.org/10.1371/journal.pone.0121502			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781169	Green Published, gold			2022-12-27	WOS:000351284600208
J	Voss, R; Quaas, MF; Schmidt, JO; Kapaun, U				Voss, Rudi; Quaas, Martin F.; Schmidt, Joern O.; Kapaun, Ute			Ocean Acidification May Aggravate Social-Ecological Trade-Offs in Coastal Fisheries	PLOS ONE			English	Article							AGE-SPECIFIC MORTALITY; ATLANTIC; CARBON; COD	Ocean Acidification (OA) will influence marine ecosystems by changing species abundance and composition. Major effects are described for calcifying organisms, which are significantly impacted by decreasing pH values. Direct effects on commercially important fish are less well studied. The early life stages of fish populations often lack internal regulatory mechanisms to withstand the effects of abnormal pH. Negative effects can be expected on growth, survival, and recruitment success. Here we study Norwegian coastal cod, one of the few stocks where such a negative effect was experimentally quantified, and develop a framework for coupling experimental data on OA effects to ecological-economic fisheries models. In this paper, we scale the observed physiological responses to the population level by using the experimentally determined mortality rates as part of the stock-recruitment relationship. We then use an ecological-economic optimization model, to explore the potential effect of rising CO2 concentration on ecological (stock size), economic (profits), consumer-related (harvest) and social (employment) indicators, with scenarios ranging from present day conditions up to extreme acidification. Under the assumptions of our model, yields and profits could largely be maintained under moderate OA by adapting future fishing mortality (and related effort) to changes owing to altered pH. This adaptation comes at the costs of reduced stock size and employment, however. Explicitly visualizing these ecological, economic and social tradeoffs will help in defining realistic future objectives. Our results can be generalized to any stressor (or stressor combination), which is decreasing recruitment success. The main findings of an aggravation of trade-offs will remain valid. This seems to be of special relevance for coastal stocks with limited options for migration to avoid unfavorable future conditions and subsequently for coastal fisheries, which are often small scale local fisheries with limited operational ranges.	[Voss, Rudi; Quaas, Martin F.; Schmidt, Joern O.; Kapaun, Ute] Univ Kiel, Dept Econ, Kiel, Germany; [Quaas, Martin F.] Kiel Inst World Econ, Kiel, Germany	University of Kiel; Institut fur Weltwirtschaft an der Universitat Kiel (IFW)	Voss, R (corresponding author), Univ Kiel, Dept Econ, Wilhelm Seelig Pl 1, Kiel, Germany.	voss@economics.uni-kiel.de	Voss, Rudi/A-6113-2011; Quaas, Martin/C-4220-2012; Schmidt, Jörn Oliver/A-7714-2008; /AAL-3738-2021	Quaas, Martin/0000-0003-0812-8829; Schmidt, Jörn Oliver/0000-0002-4420-6532; Voss, Rudi/0000-0002-4299-8791	Cluster of Excellence "Future Ocean" of Kiel University; German Ministry for Education and Research (BMBF) through the project 'Biological Impacts of Ocean ACIDification' (BIOACID) [FKZ 03F0608A]	Cluster of Excellence "Future Ocean" of Kiel University; German Ministry for Education and Research (BMBF) through the project 'Biological Impacts of Ocean ACIDification' (BIOACID)(Federal Ministry of Education & Research (BMBF))	This study has been carried out with financial support from the Cluster of Excellence "Future Ocean" of Kiel University. The research leading to the paper has also received funding by the German Ministry for Education and Research (BMBF) through the project 'Biological Impacts of Ocean ACIDification' (BIOACID, FKZ 03F0608A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHESON JM, 1981, ANNU REV ANTHROPOL, V10, P275, DOI 10.1146/annurev.an.10.100181.001423; BARLOW J, 1991, MAR MAMMAL SCI, V7, P50, DOI 10.1111/j.1748-7692.1991.tb00550.x; Baumann H, 2012, NAT CLIM CHANGE, V2, P38, DOI 10.1038/NCLIMATE1291; Bellerby RGJ, 2005, GEOPH MONOG SERIES, V158, P189; Biastoch A, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047222; Caldeira K, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002671; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Cheung WWL, 2013, NATURE, V497, P365, DOI 10.1038/nature12156; Cooley SR, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/2/024007; Denman K, 2011, ICES J MAR SCI, V68, P1019, DOI 10.1093/icesjms/fsr074; Fabry VJ, 2009, OCEANOGRAPHY, V22, P160, DOI 10.5670/oceanog.2009.105; Fowler Charles W., 2013, U S National Marine Fisheries Service Marine Fisheries Review, V75, P1; Frommel AY, 2013, MAR BIOL, V160, P1825, DOI 10.1007/s00227-011-1876-3; Frommel AY, 2012, NAT CLIM CHANGE, V2, P42, DOI 10.1038/nclimate1324; Halpern BS, 2013, P NATL ACAD SCI USA, V110, P6229, DOI 10.1073/pnas.1217689110; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Houde Edward D., 2009, Journal of Northwest Atlantic Fishery Science, V41, P53; ICES, 2012, REP ARCT FISH WORK G; Le Quesne WJF, 2012, FISH FISH, V13, P333, DOI 10.1111/j.1467-2979.2011.00423.x; McWhinnie SF, 2006, FISHERIES CTR RES RE, V14, P77; Myers RA, 1996, MAR ECOL PROG SER, V138, P293, DOI 10.3354/meps138293; Rabinovich JE, 2010, ENTOMOL EXP APPL, V135, P252, DOI 10.1111/j.1570-7458.2010.00986.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Steinacher M, 2009, BIOGEOSCIENCES, V6, P515, DOI 10.5194/bg-6-515-2009; Tahvonen O, 2013, ENVIRON RESOUR ECON, V54, P21, DOI 10.1007/s10640-012-9579-x; Thomsen J, 2010, BIOGEOSCIENCES, V7, P3879, DOI 10.5194/bg-7-3879-2010; Voss R, 2014, MAR ECOL PROG SER, V498, P1, DOI 10.3354/meps10639; Voss R, 2012, PROG OCEANOGR, V107, P61, DOI 10.1016/j.pocean.2012.05.003	28	9	9	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120376	10.1371/journal.pone.0120376	http://dx.doi.org/10.1371/journal.pone.0120376			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25780914	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600156
J	Wang, LH; Fu, SH; Cao, L; Lei, WW; Cao, YX; Song, JD; Tang, Q; Zhang, HL; Feng, Y; Yang, WH; Liang, GD				Wang, Lihua; Fu, Shihong; Cao, Lei; Lei, Wenwen; Cao, Yuxi; Song, Jingdong; Tang, Qing; Zhang, Hailin; Feng, Yun; Yang, Weihong; Liang, Guodong			Isolation and Identification of a Natural Reassortant Mammalian Orthoreovirus from Least Horseshoe Bat in China	PLOS ONE			English	Article							REOVIRUS; VIRUS; TYPE-3; CHILD	Background Mammalian orthoreoviruses (MRVs) have a wide geographic distribution and can infect virtually all mammals. Infections in humans may be either symptomatic or asymptomatic. This study describes the isolation and identification of a natural reassortant MRV from least horseshoe bats (Rhinolophus pusillu) in China, referred to as RpMRV-YN2012. Methods and Results The RpMRV-YN2012 was obtained from urine samples of Rhinolophus pusillus by cell culture. Negative-staining electron microscopy revealed that RpMRV-YN2012 was a non-enveloped icosahedral virus with similar to 75 nm in diameter. Polyacrylamide gel electrophoresis (PAGE) migration patterns of the genome segments showed that RpMRV-YN2012 contained 10 segments in a 3: 3: 4 arrangement. The whole genome sequence of RpMRV2012 was determined. The consensus terminal sequences of all segments of 5'-GCUAh center dot center dot center dot yUCAUC-3' (h = A, U or C; y = C or U) were similar to the MRV species within the genus Orthoreovirus. Its evolution and evidence of genetic reassortment were analyzed by sequence comparison and phylogenetic analysis. The results showed that RpMRV-YN2012 is a novel serotype 2 MRV that may have originated from reassortment among bat, human, and/or pig MRV strains which associated with diarrhea, acute gastroenteritis and necrotizing encephalopathy in animals and humans. Conclusions RpMRV-YN2012 is a novel bat reassortant MRV, which may have resulted from a reassortment involving MRVs known to infect humans and animals. It is necessary to identify whether RpMRV-YN2012 is associated with diarrhea, acute gastroenteritis and necrotizing encephalopathy in clinical patients. In addition, we should carefully monitor its evolution and virulence in real time.	[Wang, Lihua; Fu, Shihong; Cao, Lei; Lei, Wenwen; Cao, Yuxi; Song, Jingdong; Tang, Qing; Liang, Guodong] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Key Lab Med Virol, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Wang, Lihua; Fu, Shihong; Cao, Lei; Lei, Wenwen; Cao, Yuxi; Song, Jingdong; Tang, Qing; Liang, Guodong] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China; [Zhang, Hailin; Feng, Yun; Yang, Weihong] Yunnan Inst Endem Dis Control & Prevent, Kunming, Yunnan, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Yunnan Institute for Endemic Disease Control & Prevention	Liang, GD (corresponding author), Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Key Lab Med Virol, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	gdliang@hotmail.com	wang, lin/HHM-2225-2022; wang, lin/GSE-3040-2022; wang, lili/HDL-7210-2022	Wang, Lin-Fa/0000-0003-2752-0535	National Natural Science Foundation of China [81290342]; Ministry of Science and Technology, China [2011CB504702]; National Key Technology R & D Program of the Ministry of Science and Technology [2014BAI13B04]; State Key Laboratory for Infectious Disease Prevention and Control [2014SKLID03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology, China(Ministry of Science and Technology, China); National Key Technology R & D Program of the Ministry of Science and Technology(National Key Technology R&D Program); State Key Laboratory for Infectious Disease Prevention and Control	Funding provided by National Natural Science Foundation of China (81290342); Ministry of Science and Technology, China (2011CB504702); National Key Technology R & D Program of the Ministry of Science and Technology (2014BAI13B04) and State Key Laboratory for Infectious Disease Prevention and Control (2014SKLID03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attoui H, 2011, FAMILY REOVIRIDAE, P541; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Cheng P, 2009, J CLIN VIROL, V45, P79, DOI 10.1016/j.jcv.2009.03.001; Chua KB, 2007, P NATL ACAD SCI USA, V104, P11424, DOI 10.1073/pnas.0701372104; Chua KB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025434; Chua KB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003803; Chua KB, 2003, MICROBES INFECT, V5, P487, DOI 10.1016/S1286-4579(03)00067-4; Dai YM, 2012, J VIROL, V86, P12456, DOI 10.1128/JVI.02254-12; Day JM, 2009, INFECT GENET EVOL, V9, P390, DOI 10.1016/j.meegid.2009.01.011; Du LF, 2010, ARCH VIROL, V155, P1295, DOI 10.1007/s00705-010-0690-4; GARD GP, 1973, ARCH GES VIRUSFORSCH, V43, P34, DOI 10.1007/BF01249346; Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711; Keller BC, 2006, J VIROL, V80, P9424, DOI 10.1128/JVI.00768-06; Kohl C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043106; Kuzmin Ivan V, 2011, Emerg Health Threats J, V4, P7159, DOI 10.3402/ehtj.v4i0.7159; Leary TP, 2002, J VIROL METHODS, V104, P161, DOI 10.1016/S0166-0934(02)00058-7; Lelli D, 2013, ZOONOSES PUBLIC HLTH, V60, P84, DOI 10.1111/zph.12001; Mackenzie JS, 2005, J NEUROVIROL, V11, P434, DOI 10.1080/13550280591002487; Omatsu T, 2007, COMP IMMUNOL MICROB, V30, P357, DOI 10.1016/j.cimid.2007.05.006; Ouattara LA, 2011, EMERG INFECT DIS, V17, P1436, DOI 10.3201/eid1708.101528; Schiff L.A., 2007, FIELDS VIROLOGY, V2, P1853; Steyer A, 2013, J CLIN MICROBIOL, V51, P3818, DOI 10.1128/JCM.01531-13; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thalmann CM, 2010, VIROLOGY, V402, P26, DOI 10.1016/j.virol.2009.11.048; Tyler KL, 2004, J INFECT DIS, V189, P1664, DOI 10.1086/383129; van der Poel WHM, 2006, VECTOR-BORNE ZOONOT, V6, P315, DOI 10.1089/vbz.2006.6.315; Wang LH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039845, 10.1371/journal.pone.0051769, 10.1371/journal.pone.0045491, 10.1371/journal.pone.0044596]; Wong S, 2007, REV MED VIROL, V17, P67, DOI 10.1002/rmv.520; Zhang CF, 2011, VIRUS GENES, V43, P342, DOI 10.1007/s11262-011-0642-4	30	19	23	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0118598	10.1371/journal.pone.0118598	http://dx.doi.org/10.1371/journal.pone.0118598			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781475	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600030
J	Wang, P; Tong, JJ; Ma, XH; Song, FL; Fan, L; Guo, CM; Shi, W; Yu, SJ; Yao, KH; Yang, YH				Wang, Ping; Tong, Jing-jing; Ma, Xiu-hua; Song, Feng-li; Fan, Ling; Guo, Cui-mei; Shi, Wei; Yu, Sang-jie; Yao, Kai-hu; Yang, Yong-hong			Serotypes, Antibiotic Susceptibilities, and Multi-Locus Sequence Type Profiles of Streptococcus agalactiae Isolates Circulating in Beijing, China	PLOS ONE			English	Article							GROUP-B-STREPTOCOCCUS; TELITHROMYCIN SUSCEPTIBILITY; PREGNANT-WOMEN; UNITED-STATES; EPIDEMIOLOGY; RESISTANCE; DISEASE; INFECTIONS; DIVERSITY; ERYTHROMYCIN	Background To investigate the serotypes, antibiotic susceptibilities, and multi-locus sequence type (MLST) profiles of Streptococcus agalactiae (S. agalactiae) in Beijing to provide references for the prevention and treatment of S. agalactiae infections. Methods All isolates were identified using the CAMP test and the latex-agglutination assay and serotyped using a Strep-B-Latex kit, after which they were assessed for antibiotic susceptibility, macrolide-resistance genes, and MLST profiles. Results In total, 56 S. agalactiae isolates were identified in 863 pregnant women (6.5%). Serotypes Ia, Ib, II, III, and V were identified, among which types III (32.1%), Ia (17.9%), Ib (16.1%), and V (14.3%) were the predominant serotypes. All isolates were susceptible to penicillin and ceftriaxone. The nonsusceptiblity rates measured for erythromycin, clarithromycin, azithromycin, telithromycin, clindamycin, tetracycline, and levofloxacin were 85.7%, 92.9%, 98.2%, 30.4%, 73.2%, 91%, and 39.3%, respectively. We identified 14 sequence types (STs) for the 56 isolates, among which ST19 (30.4%) was predominant. The rate of fluoroquinolone resistance was higher in serotype III than in the other serotypes. Among the 44 erythromycin-resistant isolates, 32 (72.7%) carried ermB. Conclusion S. agalactiae isolates of the serotypes Ia, Ib, III, and V are common in Beijing. Among the S. agalactiae isolates, the macrolide and clindamycin resistance rates are extremely high. Most of the erythromycin-resistant isolates carry ermB.	[Wang, Ping; Tong, Jing-jing; Shi, Wei; Yu, Sang-jie; Yao, Kai-hu; Yang, Yong-hong] Capital Med Univ, Key Lab Major Dis Children, Beijing 100045, Peoples R China; [Wang, Ping; Tong, Jing-jing; Shi, Wei; Yu, Sang-jie; Yao, Kai-hu; Yang, Yong-hong] Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Res Inst, Natl Key Discipline Pediat,Minist Educ, Beijing 100045, Peoples R China; [Ma, Xiu-hua; Song, Feng-li] Capital Med Univ, Peoples Hosp Beijing Daxing Dist, Dept Obstet, Beijing 102600, Peoples R China; [Wang, Ping; Fan, Ling; Guo, Cui-mei] Capital Med Univ, Beijing Obstet & Genecol Hosp, Dept Obstet, Beijing 100026, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University; Capital Medical University	Yao, KH (corresponding author), Capital Med Univ, Key Lab Major Dis Children, Beijing 100045, Peoples R China.	jiuhu2655@sina.com; yyh628628@sina.com			Research Funds of Profession Quota Budget from Beijing Municipal Science and Technology Commission [2014-bjsekyjs-3]	Research Funds of Profession Quota Budget from Beijing Municipal Science and Technology Commission	This study was financially supported by the Research Funds of Profession Quota Budget from Beijing Municipal Science and Technology Commission (2014-bjsekyjs-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Pinto TCA, 2013, BRAZ J INFECT DIS, V17, P131, DOI 10.1016/j.bjid.2012.09.006; Adong Shen, 2001, CHIN J PERINAT MED, V4, P233; [Anonymous], 1996, MMWR Recomm Rep, V45, P1; ANTHONY BF, 1979, J PEDIATR-US, V95, P431, DOI 10.1016/S0022-3476(79)80530-2; Bergeron MG, 2000, NEW ENGL J MED, V343, P175, DOI 10.1056/NEJM200007203430303; Betriu C, 2003, ANTIMICROB AGENTS CH, V47, P1112, DOI 10.1128/AAC.47.3.1112-1114.2003; Bingen E, 2004, ANTIMICROB AGENTS CH, V48, P677, DOI 10.1128/AAC.48.2.677-680.2004; Bliss SJ, 2002, CLIN INFECT DIS, V34, P184, DOI 10.1086/338258; Borchardt SM, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-57; Dahesh S, 2008, ANTIMICROB AGENTS CH, V52, P2915, DOI 10.1128/AAC.00461-08; Desjardins M, 2004, J CLIN MICROBIOL, V42, P5620, DOI 10.1128/JCM.42.12.5620-5623.2004; Dutra VG, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-323; EASMON CSF, 1981, BRIT MED J, V283, P459, DOI 10.1136/bmj.283.6289.459; Edmond KM, 2012, LANCET, V379, P547, DOI 10.1016/S0140-6736(11)61651-6; Farrell DJ, 2004, ANTIMICROB AGENTS CH, V48, P1882, DOI 10.1128/AAC.48.5.1882-1884.2004; Gherardi G, 2007, J CLIN MICROBIOL, V45, P2909, DOI 10.1128/JCM.00999-07; Gonzalez JJ, 2005, ANTIMICROB AGENTS CH, V49, P2525, DOI 10.1128/AAC.49.6.2525-2527.2005; Heath PT, 2011, EXPERT REV VACCINES, V10, P685, DOI [10.1586/erv.11.61, 10.1586/ERV.11.61]; Hsueh PR, 2001, ANTIMICROB AGENTS CH, V45, P3205, DOI 10.1128/AAC.45.11.3205-3208.2001; Ippolito DL, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-336; Jones N, 2003, J CLIN MICROBIOL, V41, P2530, DOI 10.1128/JCM.41.6.2530-2536.2003; Jones N, 2006, CLIN INFECT DIS, V42, P915, DOI 10.1086/500324; Jones N, 2006, J CLIN PATHOL, V59, P363, DOI 10.1136/jcp.2005.029058; Kawamura Y, 2003, ANTIMICROB AGENTS CH, V47, P3605, DOI 10.1128/AAC.47.11.3605-3609.2003; Kimura K, 2008, ANTIMICROB AGENTS CH, V52, P2890, DOI 10.1128/AAC.00185-08; Lee Wen-Tsung, 2014, J MICROBIOL IMMUNOL; Lu B, 2014, CLIN MICROBIOL INFEC, V20, pO370, DOI 10.1111/1469-0691.12416; Manning SD, 2008, CLIN INFECT DIS, V46, P1829, DOI 10.1086/588296; Manning SD, 2009, J CLIN MICROBIOL, V47, P1143, DOI 10.1128/JCM.01424-08; Martins ER, 2012, J CLIN MICROBIOL, V50, P1219, DOI 10.1128/JCM.05488-11; Martins ER, 2011, J CLIN MICROBIOL, V49, P2911, DOI 10.1128/JCM.00271-11; Melin P, 2013, VACCINE, V31, pD31, DOI 10.1016/j.vaccine.2013.05.012; Nagano N, 2012, J ANTIMICROB CHEMOTH, V67, P849, DOI 10.1093/jac/dkr546; Palmeiro JK, 2011, VACCINE, V29, P3729, DOI 10.1016/j.vaccine.2011.02.102; Palmeiro JK, 2010, J CLIN MICROBIOL, V48, P4397, DOI 10.1128/JCM.00419-10; Persson E, 2004, CLIN MICROBIOL INFEC, V10, P791, DOI 10.1111/j.1469-0691.2004.00931.x; Phares CR, 2008, JAMA-J AM MED ASSOC, V299, P2056, DOI 10.1001/jama.299.17.2056; REGAN JA, 1991, OBSTET GYNECOL, V77, P604; RUBENS CE, 1987, P NATL ACAD SCI USA, V84, P7208, DOI 10.1073/pnas.84.20.7208; Schrag Stephanie, 2002, MMWR Recomm Rep, V51, P1; Schuchat A, 1998, CLIN MICROBIOL REV, V11, P497, DOI 10.1128/CMR.11.3.497; Shen A-dong, 2005, Zhonghua Er Ke Za Zhi, V43, P661; Shen AD, 1998, CHINESE MED J-PEKING, V111, P615; Takaya A, 2010, FEMS MICROBIOL LETT, V307, P87, DOI 10.1111/j.1574-6968.2010.01962.x; Ueno H, 2012, JPN J INFECT DIS, V65, P516, DOI 10.7883/yoken.65.516; van der Mee-Marquet N, 2009, J MED MICROBIOL, V58, P169, DOI 10.1099/jmm.0.005827-0; Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1; Wang H, 2013, ANTIMICROB AGENTS CH, V57, P1538, DOI 10.1128/AAC.02317-12; Yao KH, 2013, J CLIN MICROBIOL, V51, P503, DOI 10.1128/JCM.02417-12; Zhang JH, 1995, CHUNG HUA LIU HSING, V16, P36; Zhou L, 2011, VACCINE, V29, P7704, DOI 10.1016/j.vaccine.2011.07.137	51	51	61	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120035	10.1371/journal.pone.0120035	http://dx.doi.org/10.1371/journal.pone.0120035			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781346	gold, Green Published, Green Submitted			2022-12-27	WOS:000351284600119
J	Blanchard, MG; de Baaij, JHF; Verkaart, SAJ; Lameris, AL; Basmadjian, C; Zhao, Q; Desaubry, L; Bindels, RJM; Hoenderop, JGJ				Blanchard, Maxime G.; de Baaij, Jeroen H. F.; Verkaart, Sjoerd A. J.; Lameris, Anke L.; Basmadjian, Christine; Zhao, Qian; Desaubry, Laurent; Bindels, Rene J. M.; Hoenderop, Joost G. J.			Flavaglines Stimulate Transient Receptor Potential Melastatin Type 6 (TRPM6) Channel Activity	PLOS ONE			English	Article							INSULIN-RECEPTOR; KINASE DOMAIN; LIPID RAFTS; PROTEIN; PHOSPHORYLATION; HYPOMAGNESEMIA; PROHIBITINS; ACTIVATION; SURVIVAL; PODOCIN	Magnesium (Mg2+) is essential for enzymatic activity, brain function and muscle contraction. Blood Mg2+ concentrations are tightly regulated between 0.7 and 1.1 mM by Mg2+ (re) absorption in kidney and intestine. The apical entry of Mg2+ in (re) absorbing epithelial cells is mediated by the transient receptor potential melastatin type 6 (TRPM6) ion channel. Here, flavaglines are described as a novel class of stimulatory compounds for TRPM6 activity. Flavaglines are a group of natural and synthetic compounds that target the ubiquitously expressed prohibitins and thereby affect cellular signaling. By whole-cell patch clamp analyses, it was demonstrated that nanomolar concentrations of flavaglines increases TRPM6 activity by similar to 2 fold. The stimulatory effects were dependent on the presence of the alpha-kinase domain of TRPM6, but did not require its phosphotransferase activity. Interestingly, it was observed that two natural occurring TRPM6 mutants with impaired insulin-sensitivity, TRPM6-p. Val1393Ile and TRPM6-p.Lys1584Glu, are not sensitive to flavagline stimulation. In conclusion, we have identified flavaglines as potent activators of TRPM6 activity. Our results suggest that flavaglines stimulate TRPM6 via the insulin receptor signaling pathway.	[Blanchard, Maxime G.; de Baaij, Jeroen H. F.; Verkaart, Sjoerd A. J.; Lameris, Anke L.; Bindels, Rene J. M.; Hoenderop, Joost G. J.] Radboud Univ Nijmegen, Dept Physiol, Radboud Inst Mol Life Sci, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Basmadjian, Christine; Zhao, Qian; Desaubry, Laurent] Univ Strasbourg, Lab Therapeut Innovat UMR7200, CNRS, Fac Pharm, Illkirch Graffenstaden, France	Radboud University Nijmegen; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Hoenderop, JGJ (corresponding author), Radboud Univ Nijmegen, Dept Physiol, Radboud Inst Mol Life Sci, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	joost.hoenderop@radboudumc.nl	Desaubry, Laurent G/R-5446-2017; de Baaij, Jeroen/P-5704-2015; Bindels, René JM/B-9824-2013; Hoenderop, Joost G.J./H-8047-2014	Desaubry, Laurent G/0000-0002-1192-2970; de Baaij, Jeroen/0000-0003-2372-8486; Bindels, René JM/0000-0003-1167-1339; Hoenderop, Joost G.J./0000-0002-1816-8544; Blanchard, Maxime/0000-0001-8955-2239	Netherlands Organization for Scientific Research [ZonMW 9120.8026, NWO Vici 016.130.668]; EURenOmics project from the European Union seventh framework programme (FP7) [305608]; Association Nationale Recherche Technologie (ANRT); Association d'Aide a la Recherche et a l'Enseignement en Cancerologie (AAREC Filia Research)	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); EURenOmics project from the European Union seventh framework programme (FP7); Association Nationale Recherche Technologie (ANRT)(French National Research Agency (ANR)); Association d'Aide a la Recherche et a l'Enseignement en Cancerologie (AAREC Filia Research)	This work was supported by grants from the Netherlands Organization for Scientific Research (ZonMW 9120.8026, NWO Vici 016.130.668) and the EURenOmics project from the European Union seventh framework programme (FP7/2007-2013, agreement no. 305608). The authors also thank the Association Nationale Recherche Technologie (ANRT) and the Association d'Aide a la Recherche et a l'Enseignement en Cancerologie (AAREC Filia Research) for fellowships to C. Basmadjian and Q. Zhao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ande SR, 2009, BIOCHEM BIOPH RES CO, V390, P1023, DOI 10.1016/j.bbrc.2009.10.101; Anderson M, 2013, AM J PHYSIOL-CELL PH, V305, pC276, DOI 10.1152/ajpcell.00095.2013; Basmadjian C, 2013, FUTURE MED CHEM, V5, P2185, DOI 10.4155/fmc.13.177; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Brandao K, 2014, CELL MOL LIFE SCI, V71, P4853, DOI 10.1007/s00018-014-1647-7; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Cao G, 2008, CURR BIOL, V18, P168, DOI 10.1016/j.cub.2007.12.058; Cao G, 2010, J BIOL CHEM, V285, P26081, DOI 10.1074/jbc.M110.103655; Cao G, 2009, J BIOL CHEM, V284, P14788, DOI 10.1074/jbc.M808752200; Chowdhury I, 2014, J CELL PHYSIOL, V229, P998, DOI 10.1002/jcp.24531; Cohen AW, 2003, AM J PHYSIOL-CELL PH, V285, pC222, DOI 10.1152/ajpcell.00006.2003; de Baaij JHF, 2013, AM J PHYSIOL-RENAL, V305, pF1563, DOI 10.1152/ajprenal.00322.2013; de Baaij JHF, 2012, CLIN KIDNEY J, V5, P15, DOI 10.1093/ndtplus/sfr164; Huber TB, 2007, NEPHRON EXP NEPHROL, V106, pE27, DOI 10.1159/000101789; Morino-Koga S, 2013, J CELL PHYSIOL, V228, P439, DOI 10.1002/jcp.24149; Nair AV, 2012, P NATL ACAD SCI USA, V109, P11324, DOI 10.1073/pnas.1113811109; Okada S, 2008, J BIOL CHEM, V283, P35455, DOI 10.1074/jbc.M806531200; Pan L, 2014, NAT PROD REP, V31, P924, DOI 10.1039/c4np00006d; Polier G, 2012, CHEM BIOL, V19, P1093, DOI 10.1016/j.chembiol.2012.07.012; Ryazanova LV, 2004, J BIOL CHEM, V279, P3708, DOI 10.1074/jbc.M308820200; Schlingmann KP, 2002, NAT GENET, V31, P166, DOI 10.1038/ng889; Song YQ, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-4; Thebault S, 2009, J AM SOC NEPHROL, V20, P78, DOI 10.1681/ASN.2008030327; Thebault S, 2008, J BIOL CHEM, V283, P19999, DOI 10.1074/jbc.M800167200; Thuaud F, 2013, CHEM BIOL, V20, P316, DOI 10.1016/j.chembiol.2013.02.006; Thuaud F, 2011, J MED CHEM, V54, P411, DOI 10.1021/jm101318b; Thuaud F, 2009, J MED CHEM, V52, P5176, DOI 10.1021/jm900365v; Vainio S, 2002, EMBO REP, V3, P95, DOI 10.1093/embo-reports/kvf010; van der Wijst J, 2014, BIOCHEM J, V460, P165, DOI 10.1042/BJ20131639; Voets T, 2004, J BIOL CHEM, V279, P19, DOI 10.1074/jbc.M311201200; Walder RY, 2002, NAT GENET, V31, P171, DOI 10.1038/ng901; Xie J, 2011, SCI REP-UK, V1, DOI 10.1038/srep00146; Yogi A, 2009, AM J PHYSIOL-REG I, V296, pR201, DOI 10.1152/ajpregu.90602.2008; Zhang Z, 2014, J BIOL CHEM, V289, P5217, DOI 10.1074/jbc.M113.512285	34	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119028	10.1371/journal.pone.0119028	http://dx.doi.org/10.1371/journal.pone.0119028			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774985	gold, Green Published			2022-12-27	WOS:000351183500061
J	Kassavou, A; Turner, A; French, DP				Kassavou, Aikaterini; Turner, Andrew; French, David P.			The Role of Walkers' Needs and Expectations in Supporting Maintenance of Attendance at Walking Groups: A Longitudinal Multi-Perspective Study of Walkers and Walk Group Leaders	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; INTERVENTIONS	Background There is good evidence that when people's needs and expectations regarding behaviour change are met, they are satisfied with that change, and maintain those changes. Despite this, there is a dearth of research on needs and expectations of walkers when initially attending walking groups and whether and how these needs and expectations have been satisfied after a period of attendance. Equally, there is an absence of research on how people who lead these groups understand walkers' needs and walk leaders' actions to address them. The present study was aimed at addressing both of these gaps in the research. Methods Two preliminary thematic analyses were conducted on face-to-face interviews with ( a) eight walkers when they joined walking groups, five of whom were interviewed three months later, and (b) eight walk leaders. A multi-perspective analysis building upon these preliminary analyses identified similarities and differences within the themes that emerged from the interviews with walkers and walk leaders. Results Walkers indicated that their main needs and expectations when joining walking groups were achieving long-term social and health benefits. At the follow up interviews, walkers indicated that satisfaction with meeting similar others within the groups was the main reason for continued attendance. Their main source of dissatisfaction was not feeling integrated in the existing walking groups. Walk leaders often acknowledged the same reasons for walkers joining and maintaining attendance at walking. However, they tended to attribute dissatisfaction and drop out to uncontrollable environmental factors and/or walkers' personalities. Walk leaders reported a lack of efficacy to effectively address walkers' needs. Conclusions Interventions to increase retention of walkers should train walk leaders with the skills to help them modify the underlying psychological factors affecting walkers' maintenance at walking groups. This should result in greater retention of walkers in walking groups, thereby allowing walkers to receive the long-term social and health benefits of participation in these groups.	[Kassavou, Aikaterini] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Behav Sci Grp,Primary Care Unit, Cambridge, England; [Turner, Andrew] Coventry Univ, Appl Res Ctr Hlth & Lifestyle Intervent, Coventry, W Midlands, England; [French, David P.] Univ Manchester, Sch Psychol Sci, Manchester Ctr Hlth Psychol, Manchester, Lancs, England	University of Cambridge; Coventry University; University of Manchester	Kassavou, A (corresponding author), Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Behav Sci Grp,Primary Care Unit, Cambridge, England.	kk532@medschl.cam.ac.uk	French, David P/K-7283-2012	French, David P/0000-0002-7663-7804; Kassavou, Aikaterini/0000-0002-6562-4143; Turner, Andrew/0000-0001-6538-4242	Coventry University (Faculty of Health and Life Sciences)	Coventry University (Faculty of Health and Life Sciences)	AK was funded with a PhD studentship by Coventry University (Faculty of Health and Life Sciences). DF and AT acted as supervisors. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allender S, 2008, HEALTH PROMOT INT, V23, P160, DOI 10.1093/heapro/dan012; American Volkssport Association, 2011, AM VOLKSSP ASS FUN F; Ashley A, 2011, HLTH ED J, V60, P265; Ashley A, 2001, PRIM HEALTH CARE RES, V2, P98; Bandura A, 1997, SELF EFFICACY EXERCI, DOI [10.1080/08870440802254597, DOI 10.1080/08870440802254597]; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; CHAMBERLAIN K, 2004, RES METHODS CLIN HLT, V0005, P00069; Chief Medical Officers of England Scotland Wales and Northern Ireland, 2011, START ACT STAY ACT R; Coleman RJ, 2011, NATURAL ENGLAND COMM; Dillman D. A., 2000, MAIL INTERNET SURVEY, V2; DUNCAN HH, 1995, J APPL GERONTOL, V14, P64, DOI 10.1177/073346489501400105; Duncan HH., 1993, THESIS VIRGINIA POLY; Foster G, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005108.pub2; Hynds H, 2009, PRIMARY HLTH CARE RE; Jancey J, 2006, AM J HEALTH BEHAV, V30, P626, DOI 10.5993/AJHB.30.6.9; Jancey JM, 2008, GERONTOLOGIST, V48, P251, DOI 10.1093/geront/48.2.251; Jancey JM, 2008, AM J HEALTH PROMOT, V22, P318, DOI 10.4278/ajhp.22.5.318; Kassavou A., 2012, THESIS COVENTRY U; Kassavou A, 2015, J HEALTH PSYCHOL, V20, P1328, DOI 10.1177/1359105313511839; Kassavou A, 2014, HEALTH PSYCHOL, V33, P752, DOI 10.1037/hea0000015; Kassavou A, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-18; Kendall M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4122; Knox PR, 2011, EVALUATION WALKING S; Krieger James, 2009, Am J Public Health, V99 Suppl 3, pS593, DOI 10.2105/AJPH.2009.164384; Michie S, 2008, ADDICTION, V103, P886, DOI 10.1111/j.1360-0443.2007.02112.x; OBrien L, 2009, PRIMARY HLTH CARE RE; Ogilvie D, 2007, BMJ-BRIT MED J, V334, P1204, DOI 10.1136/bmj.39198.722720.BE; Rothman AJ, 2000, HEALTH PSYCHOL, V19, P64, DOI 10.1037/0278-6133.19.Suppl1.64; Rothman AJ, 2011, HDB SELF REGULATION, P106; US Department of Health and Human Services, 2008, PHYS ACT GUID AM BE; Walking for Health, 2013, WALK HLTH SUPP YOU G; Yardley L., 2004, RES METHODS CLIN HLT, P39, DOI DOI 10.4135/9781849209793	32	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118754	10.1371/journal.pone.0118754	http://dx.doi.org/10.1371/journal.pone.0118754			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD6EY	25774527	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500039
J	Kollndorfer, K; Kowalczyk, K; Frasnelli, J; Hoche, E; Unger, E; Mueller, CA; Krajnik, J; Trattnig, S; Schopf, V				Kollndorfer, Kathrin; Kowalczyk, Ksenia; Frasnelli, Johannes; Hoche, Elisabeth; Unger, Ewald; Mueller, Christian A.; Krajnik, Jacqueline; Trattnig, Siegfried; Schoepf, Veronika			Same Same but Different. Different Trigeminal Chemoreceptors Share the Same Central Pathway	PLOS ONE			English	Article							INDEPENDENT COMPONENTS; ODOR IDENTIFICATION; OLFACTORY FUNCTION; CHEMICAL SENSES; HUMAN AWARENESS; IMAGING DATA; ION-CHANNEL; TRP CHANNEL; PAIN; STIMULI	Intranasal trigeminal sensations are important in everyday life of human beings, as they play a governing role in protecting the airways from harm. Trigeminal sensations arise from the binding of a ligand to various sub-types of transient receptor potential (TRP) channels located on mucosal branches of the trigeminal nerve. Which underlying neural networks are involved in the processing of various trigeminal inputs is still unknown. To target this unresolved question fourteen healthy human subjects were investigated by completing three functional magnetic resonance imaging (fMRI) scanning sessions during which three trigeminal substances, activating varying sub-types of chemoreceptors and evoking different sensations in the nose were presented: CO2, menthol and cinnamaldehyde. We identified similar functional networks responding to all stimuli: an olfactory network, a somatosensory network and an integrative network. The processing pathway of all three stimulants was represented by the same functional networks, although CO2 evokes painful but virtually odor-less sensations, and the two other stimulants, menthol and cinnamaldehyde are perceived as mostly non painful with a clear olfactory percept. Therefore, our results suggest a common central processing pathway for trigeminal information regardless of the trigeminal chemoreceptor and sensation type.	[Kollndorfer, Kathrin; Kowalczyk, Ksenia; Hoche, Elisabeth; Krajnik, Jacqueline; Schoepf, Veronika] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria; [Kollndorfer, Kathrin] Med Univ Vienna, Dept Pediat & Adolescent Med, Vienna, Austria; [Frasnelli, Johannes] Univ Montreal, Dept Psychol, Ctr Rech Neuropsychol & Cognit, Montreal, PQ H3C 3J7, Canada; [Frasnelli, Johannes] Hop Sacre Coeur, Ctr Rech, Montreal, PQ H4J 1C5, Canada; [Unger, Ewald] Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria; [Mueller, Christian A.] Med Univ Vienna, Dept Otorhinolaryngol, Vienna, Austria; [Trattnig, Siegfried] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, High Field MR Ctr, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Universite de Montreal; Universite de Montreal; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Schopf, V (corresponding author), Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria.	veronika.schoepf@uni-graz.at	Frasnelli, Johannes/D-9206-2018	Frasnelli, Johannes/0000-0002-8863-3982; Kollndorfer, Kathrin/0000-0002-5983-5307; Unger, Ewald/0000-0003-0275-9988; Schopf, Veronika/0000-0003-1937-4216; Trattnig, Siegfried/0000-0003-1623-3303	Austrian Science Fund (FWF) [P23205-B09]; Austrian Science Fund (FWF) [P 23205] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	K. Kollndorfer and JK were funded by a grant of the Austrian Science Fund (FWF; P23205-B09) to VS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht J, 2010, BRAIN RES REV, V62, P183, DOI 10.1016/j.brainresrev.2009.11.001; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Baykara RA, 2013, J BACK MUSCULOSKELET, V26, P367, DOI 10.3233/BMR-130393; Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; Bensafi M, 2008, NEUROSCIENCE, V154, P832, DOI 10.1016/j.neuroscience.2008.03.079; Brass M, 2010, BRAIN STRUCT FUNCT, V214, P603, DOI 10.1007/s00429-010-0269-6; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Carlson KS, 2013, J NEUROSCI, V33, P13873, DOI 10.1523/JNEUROSCI.0422-13.2013; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Craig AD, 2011, ANN NY ACAD SCI, V1225, P72, DOI 10.1111/j.1749-6632.2011.05990.x; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2005, TRENDS COGN SCI, V9, P566, DOI 10.1016/j.tics.2005.10.005; Frasnelli J, 2007, INT J PSYCHOPHYSIOL, V65, P177, DOI 10.1016/j.ijpsycho.2007.03.007; Frasnelli J, 2006, NEUROSCIENCE, V142, P541, DOI 10.1016/j.neuroscience.2006.06.005; Frasnelli J, 2011, NEUROSCIENCE, V189, P377, DOI 10.1016/j.neuroscience.2011.04.065; Frasnelli J, 2010, NEUROSCI LETT, V468, P259, DOI 10.1016/j.neulet.2009.11.008; Frasnelli J, 2007, CEREB CORTEX, V17, P2268, DOI 10.1093/cercor/bhl135; Frasnelli J, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00288; Frasnelli J, 2009, CHEM SENSES, V34, P139, DOI 10.1093/chemse/bjn068; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; Hummel T, 2003, TOXICOL LETT, V140, P273, DOI 10.1016/S0378-4274(03)00078-X; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Hummel T, 2009, ANN NY ACAD SCI, V1170, P190, DOI 10.1111/j.1749-6632.2009.03910.x; Iannilli E, 2008, PAIN, V139, P376, DOI 10.1016/j.pain.2008.05.007; Iannilli E, 2007, BRAIN RES, V1139, P235, DOI 10.1016/j.brainres.2006.12.082; Ingvar M, 1999, PHILOS T R SOC B, V354, P1347, DOI 10.1098/rstb.1999.0483; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kleemann AM, 2009, PHYSIOL BEHAV, V97, P401, DOI 10.1016/j.physbeh.2009.03.013; KOBAL G, 1989, EXPERIENTIA, V45, P130, DOI 10.1007/BF01954845; Kobal G., 1996, Rhinology (Utrecht), V34, P222; Kobal G, 2001, EUR ARCH OTO-RHINO-L, V258, P168, DOI 10.1007/s004050100328; Kobal G, 2000, EUR ARCH OTO-RHINO-L, V257, P205, DOI 10.1007/s004050050223; Kobal G, 1981, ELEKTROPHYSIOLOGISCH; Lundstrom JN, 2011, ACS CHEM NEUROSCI, V2, P5, DOI 10.1021/cn1000843; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Peyron R, 2002, NEUROIMAGE, V17, P1336, DOI 10.1006/nimg.2002.1315; Salas MM, 2009, EUR J NEUROSCI, V29, P1568, DOI 10.1111/j.1460-9568.2009.06702.x; Schopf V, 2011, NEUROIMAGE, V55, P185, DOI 10.1016/j.neuroimage.2010.11.010; Seidel S, 2011, ROFO-FORTSCHR RONTG, V183, P1051, DOI 10.1055/s-0031-1281768; Seubert J, 2013, NEUROIMAGE, V66, P333, DOI 10.1016/j.neuroimage.2012.10.030; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Stuck BA, 2011, NEUROSCIENCE, V176, P442, DOI 10.1016/j.neuroscience.2011.01.009; Tedeschi G, 2013, NEUROL SCI, V34, pS47, DOI 10.1007/s10072-013-1383-z; THURAUF N, 1991, NEUROSCI LETT, V128, P297, DOI 10.1016/0304-3940(91)90283-Y; Tracey I, 2008, BRIT J ANAESTH, V101, P32, DOI 10.1093/bja/aen102; Treede RD, 1999, PAIN, V79, P105, DOI 10.1016/S0304-3959(98)00184-5; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; von Skramlik E, 1924, Z SINNESPHYSIOL, V56, P69, DOI DOI 10.1107/S0108767309007235; Wang YYY, 2010, J NEUROSCI, V30, P12958, DOI 10.1523/JNEUROSCI.2715-10.2010; Wiesmann M, 2006, NEUROIMAGE, V32, P293, DOI 10.1016/j.neuroimage.2006.03.022; Zaitsev M, 2004, MAGNET RESON MED, V52, P1156, DOI 10.1002/mrm.20261	54	23	23	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0121091	10.1371/journal.pone.0121091	http://dx.doi.org/10.1371/journal.pone.0121091			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775237	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500207
J	Li, DY; Wan, JQ; Ma, YW; Wang, Y; Huang, MZ; Chen, YM				Li, Dongya; Wan, Jinquan; Ma, Yongwen; Wang, Yan; Huang, Mingzhi; Chen, Yangmei			Stormwater Runoff Pollutant Loading Distributions and Their Correlation with Rainfall and Catchment Characteristics in a Rapidly Industrialized City	PLOS ONE			English	Article							1ST FLUSH LOAD; SURFACE RUNOFF; URBAN; QUALITY; WATERSHEDS; AREA	Fast urbanization and industrialization in developing countries result in significant stormwater runoff pollution, due to drastic changes in land-use, from rural to urban. A three-year study on the stormwater runoff pollutant loading distributions of industrial, parking lot and mixed commercial and residential catchments was conducted in the Tongsha reservoir watershed of Dongguan city, a typical, rapidly industrialized urban area in China. This study presents the changes in concentration during rainfall events, event mean concentrations (EMCs) and event pollution loads per unit area (EPLs). The first flush criterion, namely the mass first flush ratio (MFFn), was used to identify the first flush effects. The impacts of rainfall and catchment characterization on EMCs and pollutant loads percentage transported by the first 40% of runoff volume (FF40) were evaluated. The results indicated that the pollutant wash-off process of runoff during the rainfall events has significant temporal and spatial variations. The mean rainfall intensity (I), the impervious rate (IMR) and max 5-min intensity (I-max5) are the critical parameters of EMCs, while I-max5, antecedent dry days (ADD) and rainfall depth (RD) are the critical parameters of FF40. Intercepting the first 40% of runoff volume can remove 55% of TSS load, 53% of COD load, 58% of TN load, and 61% of TP load, respectively, according to all the storm events. These results may be helpful in mitigating stormwater runoff pollution for many other urban areas in developing countries.	[Li, Dongya; Wan, Jinquan; Ma, Yongwen; Wang, Yan; Huang, Mingzhi; Chen, Yangmei] S China Univ Technol, Coll Environm & Energy, Guangzhou 510006, Guangdong, Peoples R China; [Wan, Jinquan] Minist Educ, Key Lab Pollut Control & Ecosyst Restorat Ind Clu, Guangzhou 510006, Guangdong, Peoples R China; [Ma, Yongwen] S China Univ Technol, State Key Lab Pulp & Paper Engn, Guangzhou 510640, Guangdong, Peoples R China	South China University of Technology; South China University of Technology	Wan, JQ (corresponding author), S China Univ Technol, Coll Environm & Energy, Guangzhou 510006, Guangdong, Peoples R China.	ppjqwan@scut.edu.cn	wang, yan/AAS-9297-2021	Huang, Mingzhi/0000-0002-2592-3544	National Natural Science Foundation of China [51208206]; Guangdong Provincial Department of Science [2012A032300015]; Guangdong Natural Science Foundation [S2011040000389]; China Postdoctoral Science Foundation [2012M511570, 2013T60807]; High-level Personnel Foundation of Guangdong Higher Education Institutions, State key laboratory of Pulp and Paper Engineering in China [201213]; Fundamental Research Funds for the Central Universities [2013ZZ0031]; national water pollution control and management major projects [2008ZX07211006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Department of Science; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); High-level Personnel Foundation of Guangdong Higher Education Institutions, State key laboratory of Pulp and Paper Engineering in China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); national water pollution control and management major projects	This research has been supported by National Natural Science Foundation of China (No. 51208206), Guangdong Provincial Department of Science (No. 2012A032300015), Guangdong Natural Science Foundation (No. S2011040000389), China Postdoctoral Science Foundation (2012M511570, 2013T60807), High-level Personnel Foundation of Guangdong Higher Education Institutions, State key laboratory of Pulp and Paper Engineering in China (201213), the Fundamental Research Funds for the Central Universities (2013ZZ0031) and the national water pollution control and management major projects (2008ZX07211006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Public Health Association (APHA), 2005, STANDARD METHODS EXA; Batroney T, 2010, J HYDROL ENG, V15, P123, DOI 10.1061/(ASCE)HE.1943-5584.0000167; Bertrand-Krajewski JL, 1998, WATER RES, V32, P2341, DOI 10.1016/S0043-1354(97)00420-X; Brezonik PL, 2002, WATER RES, V36, P1743, DOI 10.1016/S0043-1354(01)00375-X; Chang MT, 2004, J ENVIRON MANAGE, V73, P307, DOI 10.1016/j.jenvman.2004.06.014; Chow MF, 2013, ENVIRON MONIT ASSESS, V185, P8321, DOI 10.1007/s10661-013-3175-6; Davis AP, 2001, CHEMOSPHERE, V44, P997, DOI 10.1016/S0045-6535(00)00561-0; Deletic A, 1998, WATER RES, V32, P2462, DOI 10.1016/S0043-1354(97)00470-3; Francey M, 2010, J ENVIRON ENG, V136, P381, DOI 10.1061/(ASCE)EE.1943-7870.0000038; Geiger F.W., 1987, INT C URB STORM DRAI, P40; Gupta K, 1996, WATER RES, V30, P1244, DOI 10.1016/0043-1354(95)00282-0; Han YH, 2006, WATER SCI TECHNOL, V53, P235, DOI 10.2166/wst.2006.057; Kang JH, 2006, WATER RES, V40, P3820, DOI 10.1016/j.watres.2006.09.007; Kim LH, 2007, SCI TOTAL ENVIRON, V376, P178, DOI 10.1016/j.scitotenv.2006.12.053; Kleinman PJA, 2006, J ENVIRON QUAL, V35, P1248, DOI 10.2134/jeq2006.0015; Lee JH, 2000, WATER RES, V34, P1773, DOI 10.1016/S0043-1354(99)00325-5; Lee JH, 2002, SCI TOTAL ENVIRON, V293, P163, DOI 10.1016/S0048-9697(02)00006-2; Liu A, 2013, SCI TOTAL ENVIRON, V444, P255, DOI 10.1016/j.scitotenv.2012.11.053; Lundholm J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009677; Qin HP, 2010, SCI TOTAL ENVIRON, V408, P4613, DOI 10.1016/j.scitotenv.2010.07.021; Rijal G, 2009, WATER SCI TECHNOL, V60, P1847, DOI 10.2166/wst.2009.598; Sansalone JJ, 2004, J ENVIRON ENG, V130, P1301, DOI 10.1061/(ASCE)0733-9372(2004)130:11(1301); Taebi A, 2004, J ENVIRON ENG SCI, V3, P301, DOI 10.1139/s04-018; Yusop Z, 2005, WATER SCI TECHNOL, V52, P125, DOI 10.2166/wst.2005.0302; Zgheib S, 2012, WATER RES, V46, P6683, DOI 10.1016/j.watres.2011.12.012; Zgheib S, 2011, WATER RES, V45, P913, DOI 10.1016/j.watres.2010.09.032; Zhang Z, 2008, SCI TOTAL ENVIRON, V390, P215, DOI 10.1016/j.scitotenv.2007.09.045	27	63	65	2	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118776	10.1371/journal.pone.0118776	http://dx.doi.org/10.1371/journal.pone.0118776			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774922	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500042
J	Park, SJ; Choi, NK; Seo, KH; Park, KH; Woo, SJ				Park, Sang Jun; Choi, Nam-Kyong; Seo, Kyung Ha; Park, Kyu Hyung; Woo, Se Joon			Retinal Vein Occlusion and Pregnancy, Pre-Eclampsia, and Eclampsia: The Results from a Nationwide, Population-Based Study Using the National Claim Database	PLOS ONE			English	Article							RISK-FACTORS; BRANCH; THROMBOPHILIA; THROMBOSIS; DISORDERS	Objective To investigate the incidence of retinal vein occlusion (RVO) in pregnant women and in the subpopulation of pregnant women with pre-eclampsia/eclampsia compared to that in the age-matched general female population to determine if there is increased risk of RVO in pregnancy. Design Nationwide population-based retrospective study using data entered into the Korean national health claims database from 2007 to 2011. Setting and Participants Of the incident RVO cases in the database, RVO cases that occurred during the pregnancy-associated period, which spanned a 52-week period from 40-weeks-before to 12-weeks-after childbirth, were identified. Of these cases, the presence of pre-eclampsia/eclampsia was determined. Main Outcome and Measure The standardized incidence ratios (SIRs) of RVO in the general pregnant population and in the pregnant population with pre-eclampsia/eclampsia were determined with respect to the age-matched general female population. Results Pregnancy-related RVO was identified in 33 cases from the 1.8 million women who experience childbirth during the study period, while the expected number of cases calculated by the direct standardization to the age-matched general population was 113. Of the 33 patients, 12 patients (36.4%) had pre-eclampsia or eclampsia. The SIR for the general pregnant population in reference to the age-matched general female population was 0.29 (95% CI, 0.20-0.41). In contrast, the SIR for the pregnant population with pre-eclampsia/eclampsia in reference to the age-matched general female population and the age-matched general pregnant population was 67.50 (95% CI, 34.88-117.92) and 246.50 (95% CI, 127.37-430.59), respectively. Conclusions and Relevance The results suggest that pre-eclampsia/eclampsia is a risk factor for RVO, while pregnancy itself may not be a risk factor for RVO.	[Park, Sang Jun; Park, Kyu Hyung; Woo, Se Joon] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Ophthalmol, Seongnam, South Korea; [Choi, Nam-Kyong; Seo, Kyung Ha] Seoul Natl Univ Hosp, Med Res Collaborating Ctr, Seoul 110744, South Korea; [Choi, Nam-Kyong; Seo, Kyung Ha] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Choi, Nam-Kyong] Seoul Natl Univ, Med Res Ctr, Inst Environm Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Woo, SJ (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Ophthalmol, Seongnam, South Korea.	sejoon1@snu.ac.kr	Park, Sang Jun/C-3234-2015	Park, Sang Jun/0000-0003-0542-2758; Hahn, Seokyung/0000-0002-4684-4917; Choi, Nam-Kyong/0000-0003-1153-9928	Seoul National University Bundang Hospital Research Fund [12-2013-019, 14-2014-022]	Seoul National University Bundang Hospital Research Fund	This study was supported by the grants (12-2013-019 and 14-2014-022) from the Seoul National University Bundang Hospital Research Fund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], DIRECT STANDARDIZATI; APPIAH AP, 1989, ANN OPHTHALMOL, V21, P153; CHEW EY, 1987, OPHTHALMOLOGY, V94, P1545; Eldor A, 2001, J THROMB THROMBOLYS, V12, P23, DOI 10.1023/A:1012730325902; Eldor A, 2001, THROMB HAEMOSTASIS, V86, P104; Errera MH, 2013, SURV OPHTHALMOL, V58, P127, DOI 10.1016/j.survophthal.2012.08.001; Ferrara A, 2007, DIABETES CARE, V30, pS141, DOI 10.2337/dc07-s206; GABSI S, 1994, J FR OPHTALMOL, V17, P350; GOMBOS G M, 1975, Annals of Ophthalmology, V7, P215; Gonzalvo FJ, 2000, ACTA OPHTHALMOL SCAN, V78, P596, DOI 10.1034/j.1600-0420.2000.078005596.x; Gray G, 2012, BEST PRACT RES CL OB, V26, P53, DOI 10.1016/j.bpobgyn.2011.10.003; Green W R, 1981, Retina, V1, P27; Hayreh SS, 2005, PROG RETIN EYE RES, V24, P493, DOI 10.1016/j.preteyeres.2004.12.001; Herbold TM, 2005, OPHTHALMOLOGE, V102, P726, DOI 10.1007/s00347-004-1099-9; Hutcheon JA, 2011, BEST PRACT RES CL OB, V25, P391, DOI 10.1016/j.bpobgyn.2011.01.006; Kamel H, 2014, NEW ENGL J MED, V370, P1307, DOI 10.1056/NEJMoa1311485; Lake SR, 1999, BRIT J OPHTHALMOL, V83, P630; Larsen EC, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-154; Lavik EB, 2013, DRUG DELIV, V1, P734; Matti AI, 2010, CAN J OPHTHALMOL, V45, P541, DOI 10.3129/i10-039; McLaughlin R, 2008, ANN EPIDEMIOL, V18, P928, DOI 10.1016/j.annepidem.2008.09.002; McLoone EM, 2004, EUR J OPHTHALMOL, V14, P65, DOI 10.1177/112067210401400112; O'Mahoney PRA, 2008, ARCH OPHTHALMOL-CHIC, V126, P692, DOI 10.1001/archopht.126.5.692; Park SJ, 2014, OPHTHALMOLOGY, V121, P1933, DOI 10.1016/j.ophtha.2014.04.029; Park SJ, 2014, OPHTHALMOLOGY, V121, P1274, DOI 10.1016/j.ophtha.2013.12.024; Park SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080174; Rahman I, 2006, EYE, V20, P955, DOI 10.1038/sj.eye.6702065; Rogers S, 2010, OPHTHALMOLOGY, V117, P313, DOI [10.1016/j.ophtha.2009.07.017, 10.1016/j.ophtha.2010.01.060]; Rogers SL, 2010, OPHTHALMOLOGY, V117, P1094, DOI 10.1016/j.ophtha.2010.01.058; Roos NM, 2012, OBSTET GYNECOL SURV, V67, P242, DOI 10.1097/OGX.0b013e318250a457; Stem MS, 2013, OPHTHALMOLOGY, V120, P362, DOI 10.1016/j.ophtha.2012.07.080; Thornton C, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.02.042; Valachis A, 2010, OBSTET GYNECOL SURV, V65, P786, DOI 10.1097/OGX.0b013e31821285bf	33	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120067	10.1371/journal.pone.0120067	http://dx.doi.org/10.1371/journal.pone.0120067			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774513	Green Submitted, Green Published, gold			2022-12-27	WOS:000351183500147
J	Ribeiro, AF; Pellini, ACG; Kitagawa, BY; Marques, D; Madalosso, G; Figueira, GDN; Fred, J; Albernaz, RKM; Marques, TRMPC; Zanetta, DMT				Ribeiro, Ana Freitas; Guedes Pellini, Alessandra Cristina; Kitagawa, Beatriz Yuko; Marques, Daniel; Madalosso, Geraldine; Nogueira Figueira, Gerrita de Cassia; Fred, Joao; Mangabeira Albernaz, Ricardo Kerti; Marques Pinto Carvalhanas, Telma Regina; Trevisan Zanetta, Dirce Maria			Risk Factors for Death from Influenza A (H1N1)pdm09, State of Sao Paulo, Brazil, 2009	PLOS ONE			English	Article							PANDEMIC H1N1 2009; CRITICALLY-ILL PATIENTS; UNITED-STATES; HOSPITALIZED-PATIENTS; A(H1N1) INFECTION; EPIDEMIOLOGY; VIRUS; 1ST	This case-control study aimed to assess the risk factors for death from influenza A(H1N1) pdm09 in patients with laboratory confirmation, who had severe acute respiratory illness-SARI and were hospitalized between June 28th and August 29th 2009, in the metropolitan regions of Sao Paulo and Campinas, Brazil. Medical charts of all the 193 patients who died (cases) and the 386 randomly selected patients who recovered (controls) were investigated in 177 hospitals. Household interviews were conducted with those who had survived and the closest relative of those who had died. 73.6% of cases and 38.1% of controls were at risk of developing influenza-related complications. The 18-to-59-year age group (OR = 2.31, 95% CI: 1.31-4.10 (reference up to 18 years of age)), presence of risk conditions for severity of influenza (OR = 1.99, 95% CI: 1.11-3.57, if one or OR = 6.05, 95% CI: 2.76-13.28, if more than one), obesity (OR = 2.73, 95% CI: 1.28-5.83), immunosuppression (OR = 3.43, 95% CI: 1.28-9.19), and search for previous care associated with the hospitalization (OR = 3.35, 95% CI: 1.75-6.40) were risk factors for death. Antiviral treatment performed within 72 hours of the onset of symptoms (OR = 0.17, 95% CI: 0.08-0.37, if within 48hours, and OR = 0.30, 95% CI: 0.11-0.81, if between 48 and 72 hours) was protective against death. The identification of high-risk patients and early treatment are important factors for reducing morbi-mortality from influenza.	[Ribeiro, Ana Freitas; Guedes Pellini, Alessandra Cristina; Kitagawa, Beatriz Yuko; Marques, Daniel; Madalosso, Geraldine; Nogueira Figueira, Gerrita de Cassia; Fred, Joao; Mangabeira Albernaz, Ricardo Kerti; Marques Pinto Carvalhanas, Telma Regina] State Sao Paulo Dept Hlth, Dis Control Coordinat, Epidemiol Surveillance Ctr, Sao Paulo, Brazil; [Ribeiro, Ana Freitas; Trevisan Zanetta, Dirce Maria] Univ Sao Paulo, Sch Publ Hlth, Dept Epidemiol, Sao Paulo, Brazil	Coordenadoria de Controle de Doencas da Secretaria de Estado; Universidade de Sao Paulo	Ribeiro, AF (corresponding author), State Sao Paulo Dept Hlth, Dis Control Coordinat, Epidemiol Surveillance Ctr, Sao Paulo, Brazil.	anafribeiro@uol.com.br	Zanetta, Dirce M T/G-4950-2013; Alessandra, Pellini C. G./K-5156-2013; Ribeiro, Ana Freitas/P-6862-2015	Alessandra, Pellini C. G./0000-0002-3799-9415; Zanetta, Dirce Maria/0000-0002-7273-5087; Madalosso, Geraldine/0000-0001-9501-6205; MARQUES, DANIEL/0000-0001-7281-3316	Sao Paulo State Secretary of Health	Sao Paulo State Secretary of Health	Sao Paulo State Secretary of Health financed the data collection. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, Wkly Epidemiol Rec, V84, P481; [Anonymous], SUBS PREV PROM SAL; Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2010, B EL EP; Brasil. Ministerio do Planejamento Orcamento e Gestao. Instituto Brasileiro de Geografia e Estatistica Censo Demografico, 2010, NUPCIALIDADE FECUNDI; Centers for Disease Control and Prevention, PEOPLE AT HIGH RISK; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Chowell G, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-97; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Fowlkes AL, 2011, CLIN INFECT DIS, V52, pS60, DOI 10.1093/cid/ciq022; Fuhrman C, 2010, EUROSURVEILLANCE, V15, P17; Fukasawa L. O., 2010, Revista do Instituto Adolfo Lutz, V69, P131; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Godoy P, 2011, REV ESP SALUD PUBLIC, V85, P81, DOI [10.1590/S1135-57272011000100015, 10.1590/S1135-57272011000100010]; Gonzalez-Velez AE, 2011, MED INTENSIVA, V35, P463, DOI 10.1016/j.medin.2011.03.007; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Jhung MA, 2011, CLIN INFECT DIS, V52, pS13, DOI 10.1093/cid/ciq008; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Lee EH, 2010, CLIN INFECT DIS, V50, P1498, DOI 10.1086/652446; Libster R, 2010, NEW ENGL J MED, V362, P45, DOI 10.1056/NEJMoa0907673; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Mertz D, 2013, BMJ-BRIT MED J, V347, P1; Mytton OT, 2012, EPIDEMIOL INFECT, V140, P1533, DOI 10.1017/S0950268811001968; Nguyen-Van-Tam JS, 2010, THORAX, V65, P645, DOI 10.1136/thx.2010.135210; OLIVEIRA WK, 2009, EURO SURVEILL, V14; Paulo Sao, 2009, INF TECN AT INFL A H, V6, P19; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Peralta PS, 2010, REV ESP SALUD PUBLIC, V84, P547, DOI [10.1590/S1135-57272010000500008, 10.1590/s1135-57272010000500008]; Skarbinski J, 2011, CLIN INFECT DIS, V52, pS50, DOI 10.1093/cid/ciq021; SP-Leituras, 2013, BIBL VIV; Ward KA, 2011, EMERG INFECT DIS, V17, P1409, DOI 10.3201/eid1708.100842; WHO-World Health Organization, PAND H1N1 2009 SWIN; WHO-World Health Organization, PAND H1N1 2009 WORLD; World Health Organization, 2008, WKLY EPIDEMIOL RECOR, V83, P365; Yokota RTC, 2011, EMERG INFECT DIS, V17, P1467, DOI 10.3201/eid1708.101233	38	25	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118772	10.1371/journal.pone.0118772	http://dx.doi.org/10.1371/journal.pone.0118772			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774804	Green Submitted, Green Published, gold			2022-12-27	WOS:000351183500041
J	Wagner, A				Wagner, Andreas			Causal Drift, Robust Signaling, and Complex Disease	PLOS ONE			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; IMPAIRED GLUCOSE-TOLERANCE; GENOME-WIDE ASSOCIATION; KINASE-C-ZETA; MISSING HERITABILITY; SKELETAL-MUSCLE; GLY972ARG POLYMORPHISM; GENETIC INTERACTIONS; REGULATORY NETWORKS; EVOLUTION	The phenotype of many regulatory circuits in which mutations can cause complex, polygenic diseases is to some extent robust to DNA mutations that affect circuit components. Here I demonstrate how such mutational robustness can prevent the discovery of genetic disease determinants. To make my case, I use a mathematical model of the insulin signaling pathway implicated in type 2 diabetes, whose signaling output is governed by 15 genetically determined parameters. Using multiple complementary measures of a parameter's importance for this phenotype, I show that any one disease determinant that is crucial in one genetic background will be virtually irrelevant in other backgrounds. In an evolving population that drifts through the parameter space of this or other robust circuits through DNA mutations, the genetic changes that can cause disease will vary randomly over time. I call this phenomenon causal drift. It means that mutations causing disease in one (human or non-human) population may have no effect in another population, and vice versa. Causal drift casts doubt on our ability to infer the molecular mechanisms of complex diseases from non-human model organisms.	[Wagner, Andreas] Univ Zurich, Inst Evolutionary Biol & Environm Studies, CH-8057 Zurich, Switzerland; [Wagner, Andreas] Swiss Inst Bioinformat, Lausanne, Switzerland; [Wagner, Andreas] Santa Fe Inst, Santa Fe, NM 87501 USA	University of Zurich; Swiss Institute of Bioinformatics; The Santa Fe Institute	Wagner, A (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	andreas.wagner@ieu.uzh.ch			Swiss National Science Foundation, University Priority Research Program in Evolutionary Biology at the University of Zurich [31003A_146137]	Swiss National Science Foundation, University Priority Research Program in Evolutionary Biology at the University of Zurich	This work was supported by Swiss National Science Foundation grant 31003A_146137, University Priority Research Program in Evolutionary Biology at the University of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Agresti A, 2013, CATEGORICAL DATA ANA; Alessi DR, 1998, BBA-MOL CELL BIOL L, V1436, P151, DOI 10.1016/S0005-2760(98)00133-7; ALMIND K, 1993, LANCET, V342, P828, DOI 10.1016/0140-6736(93)92694-O; Baba T, 2007, LIFE SCI, V81, P850, DOI 10.1016/j.lfs.2007.07.023; BAR RS, 1976, J CLIN INVEST, V58, P1123, DOI 10.1172/JCI108565; Beeson M, 2003, DIABETES, V52, P1926, DOI 10.2337/diabetes.52.8.1926; Bezerra RMN, 2002, DIABETES CARE, V25, P550, DOI 10.2337/diacare.25.3.550; Bloom JS, 2013, NATURE, V494, P234, DOI 10.1038/nature11867; Bluthgen N, 2003, J THEOR BIOL, V225, P293, DOI 10.1016/S0022-5193(03)00247-9; Borisov N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.19; Brannmark C, 2013, J BIOL CHEM, V288, P9867, DOI 10.1074/jbc.M112.432062; Brem RB, 2005, NATURE, V436, P701, DOI 10.1038/nature03865; Britton OJ, 2013, P NATL ACAD SCI USA, V110, pE2098, DOI 10.1073/pnas.1304382110; Brown KS, 2004, PHYS BIOL, V1, P184, DOI 10.1088/1478-3967/1/3/006; Brown KS, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.021904; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Bush WS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002822; Chan SH, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-100; Chew YH, 2009, MOL CELL ENDOCRINOL, V303, P13, DOI 10.1016/j.mce.2009.01.018; Cozzone D, 2008, DIABETOLOGIA, V51, P512, DOI 10.1007/s00125-007-0913-8; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Cusi K, 2000, J CLIN INVEST, V105, P311, DOI 10.1172/JCI7535; DEFRONZO RA, 1985, J CLIN INVEST, V76, P149, DOI 10.1172/JCI111938; Delattre M, 2001, BIOESSAYS, V23, P807, DOI 10.1002/bies.1116; Delattre M, 2001, CURR BIOL, V11, P631, DOI 10.1016/S0960-9822(01)00202-0; DOHM GL, 1988, J CLIN INVEST, V82, P486, DOI 10.1172/JCI113622; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Erguler K, 2011, MOL BIOSYST, V7, P1593, DOI 10.1039/c0mb00107d; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; Felix MA, 2008, HEREDITY, V100, P132, DOI 10.1038/sj.hdy.6800915; Felix MA, 2000, DEV BIOL, V221, P68, DOI 10.1006/dbio.2000.9665; Slezak DF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013283; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; FREIDENBERG GR, 1987, J CLIN INVEST, V79, P240, DOI 10.1172/JCI112789; Frojdo S, 2009, BBA-MOL BASIS DIS, V1792, P83, DOI 10.1016/j.bbadis.2008.10.019; Garvey WT, 1998, J CLIN INVEST, V101, P2377, DOI 10.1172/JCI1557; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Hafner M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000534; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Hildebrandt MAT, 2009, J CLIN ONCOL, V27, P857, DOI 10.1200/JCO.2008.17.6297; HITMAN GA, 1995, DIABETOLOGIA, V38, P481, DOI 10.1007/s001250050309; IMAI Y, 1994, J CLIN ENDOCR METAB, V79, P1655, DOI 10.1210/jc.79.6.1655; Ingolia NT, 2004, PLOS BIOL, V2, P805, DOI 10.1371/journal.pbio.0020123; Kampourakis K, 2014, EMBO REP, V15, P472, DOI 10.1002/embr.201438641; Kitano H, 2004, DIABETES, V53, pS6, DOI 10.2337/diabetes.53.suppl_3.S6; Kong Ling-fang, 2005, Zhonghua Yixue Yichuanxue Zazhi, V22, P387; Li C, 2010, BMC SYST BIOL, V4, DOI [10.1186/1752-0509-4-39, 10.1186/1752-0509-4-92]; Li QX, 2013, CLIN CANCER RES, V19, P6252, DOI 10.1158/1078-0432.CCR-13-1093; Lithell HO, 1996, BMJ-BRIT MED J, V312, P406; Lizcano JM, 2002, CURR BIOL, V12, pR236, DOI 10.1016/S0960-9822(02)00777-7; Machta BB, 2013, SCIENCE, V342, P604, DOI 10.1126/science.1238723; Makroglou A, 2006, APPL NUMER MATH, V56, P559, DOI 10.1016/j.apnum.2005.04.023; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Martchenko M, 2007, CURR BIOL, V17, P1007, DOI 10.1016/j.cub.2007.05.017; NIBBERING PH, 1990, J IMMUNOL METHODS, V129, P143, DOI 10.1016/0022-1759(90)90432-U; NOLAN JJ, 1994, J CLIN ENDOCR METAB, V78, P471, DOI 10.1210/jc.78.2.471; Nyman E, 2012, TRENDS ENDOCRIN MET, V23, P107, DOI 10.1016/j.tem.2011.12.007; Ocaranza MP, 2010, HYPERTENSION, V55, P23, DOI 10.1161/HYPERTENSIONAHA.109.141960; PATTI ME, 1995, J BIOL CHEM, V270, P24670, DOI 10.1074/jbc.270.42.24670; Pechlivanis S, 2007, ENDOCR-RELAT CANCER, V14, P733, DOI 10.1677/ERC-07-0107; Pedersen O, 1999, EXP CLIN ENDOCR DIAB, V107, P113, DOI 10.1055/s-0029-1212085; Pirola L, 2004, DIABETOLOGIA, V47, P170, DOI 10.1007/s00125-003-1313-3; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Ravichandran LV, 2001, J BIOL CHEM, V276, P3543, DOI 10.1074/jbc.M007231200; Saithong T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015589; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schwartz MW, 2013, NATURE, V503, P59, DOI 10.1038/nature12709; Scriver CR, 1999, TRENDS GENET, V15, P267, DOI 10.1016/S0168-9525(99)01761-8; Sedaghat AR, 2002, AM J PHYSIOL-ENDOC M, V283, pE1084, DOI 10.1152/ajpendo.00571.2001; Shao HF, 2008, P NATL ACAD SCI USA, V105, P19910, DOI 10.1073/pnas.0810388105; Slatkin M, 2009, GENETICS, V182, P845, DOI 10.1534/genetics.109.102798; Sommer RJ, 2012, ADV EXP MED BIOL, V751, P79, DOI 10.1007/978-1-4614-3567-9_4; Sommer RJ, 1997, DEVELOPMENT, V124, P243; STAGSTED J, 1993, J PHARMACOL EXP THER, V267, P997; Stelling J, 2004, P NATL ACAD SCI USA, V101, P13210, DOI 10.1073/pnas.0401463101; Storgaard H, 2004, J CLIN ENDOCR METAB, V89, P1301, DOI 10.1210/jc.2003-031243; Stumvoll M, 2001, DIABETES, V50, P882, DOI 10.2337/diabetes.50.4.882; Tanay A, 2005, P NATL ACAD SCI USA, V102, P7203, DOI 10.1073/pnas.0502521102; Tsong AE, 2006, NATURE, V443, P415, DOI 10.1038/nature05099; Tzur A, 2009, SCIENCE, V325, P167, DOI 10.1126/science.1174294; Van Obberghen E, 2001, EUR J CLIN INVEST, V31, P966, DOI 10.1046/j.1365-2362.2001.00896.x; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; Wagner A, 2005, P NATL ACAD SCI USA, V102, P11775, DOI 10.1073/pnas.0501094102; Wang H, 2001, DIABETES, V50, P1949, DOI 10.2337/diabetes.50.8.1949; WANG YX, 2012, PLOS GENET, V8, DOI DOI 10.1371/JOURNAL.PCBI.1002459; Waterfall JJ, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.150601; Waters SB, 1996, TRENDS CELL BIOL, V6, P1, DOI 10.1016/0962-8924(96)81024-5; Weatherall DJ, 2001, NAT REV GENET, V2, P245, DOI 10.1038/35066048; White MF, 1997, DIABETOLOGIA, V40, pS2, DOI 10.1007/s001250051387; Zamora-Sillero E, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-142; Zhang JJ, 2010, BIOPHYS J, V99, P1034, DOI 10.1016/j.bpj.2010.05.036; Zhao L, 2008, NMR BIOMED, V21, P159, DOI 10.1002/nbm.1173; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	96	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118413	10.1371/journal.pone.0118413	http://dx.doi.org/10.1371/journal.pone.0118413			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774510	Green Published, Green Accepted, gold			2022-12-27	WOS:000351183500030
J	Guo, ZL; Cui, GF				Guo, Ziliang; Cui, Guofa			Establishment of Nature Reserves in Administrative Regions of Mainland China	PLOS ONE			English	Article							BIODIVERSITY CONSERVATION; HOTSPOTS	Nature reserves are widely considered as one available strategy for protecting biodiversity, which is threatened by habitat fragmentation, and wildlife extinction. The Chinese government has established a goal of protecting 15% of its land area by 2015. We quantitated the characteristics and distribution of nature reserves in mainland China and evaluated the expansion process for national nature reserves. National nature reserves occupy 64.15% of the total area of nature reserves. Steppe and meadow ecosystem, ocean and seacoast ecosystem, and wild plant nature reserves represent lower percentages, particularly in national nature reserves, in which they comprised 0.76%, 0.54%, and 0.69%, respectively, of the area. Furthermore, medium and small nature reserves compose 92.32% of all nature reserves. The land area under any legal protection has reached 14.80%, although only 9.78% is strictly protected. However, if 9 super-large national nature reserves, located in Southwest and Northwest China were removed, the percentage of strictly protected area decreases to 2.66% of the land area of China. The areas contained in nature reserves in each province are not proportional to the areas of the provinces, particularly for national nature reserves, with higher protection rates in Southwest and Northwest China than in other regions. Of the 31 provinces, 22 provinces feature strict protection of less than 4% of their areas by national nature reserves; these provinces are mainly located in East, Central, South, and North China. Moreover, the unevenness indexes of the distribution of nature reserves and national nature reserves are 0.39 and 0.58, respectively. The construction of nature reserves has entered a steady development stage after a period of rapid expansion in mainland China. In recent years, the total area of national nature reserves has increased slowly, while the total area of nature reserves has not increased, although the number of nature reserves continues increase.	[Guo, Ziliang; Cui, Guofa] Beijing Forestry Univ, Sch Nat Conservat, Beijing, Peoples R China	Beijing Forestry University	Cui, GF (corresponding author), Beijing Forestry Univ, Sch Nat Conservat, Beijing, Peoples R China.	fa6716@163.com			Special Research Funds of Forestry Industry for Public Welfare of China [201104029]	Special Research Funds of Forestry Industry for Public Welfare of China	The authors are grateful for the support of the Special Research Funds of Forestry Industry for Public Welfare of China, Grant. No. 201104029. The funder's website is as follows: http://www.forestry.gov.cn.	Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Cantu C, 2004, BIOL CONSERV, V115, P411, DOI 10.1016/S0006-3207(03)00158-7; CBD (Convention on Biological Diversity), 2014, 2010 BIOD TARG; Chen WL, 2012, B BIOL FR BELG, V47, P1; Chen Yahan, 2009, Shengwu Duoyangxing, V17, P664, DOI 10.3724/SP.J.1003.2009.08324; Cui GF, 2000, J BEIJING FORESTRY U, V22, P123; DIAMOND J M, 1975, Biological Conservation, V7, P129, DOI 10.1016/0006-3207(75)90052-X; Editorial Committee of China National Biodiversity Conservation Strategy and Action Plan, 2011, CHIN NAT BIOD CONS S; Evans D, 2012, NATURE CONSERVATION, V1, P11, DOI DOI 10.3897/NATURECONSERVATION.1.1808; Fan ZM, 2013, J GEOGR SCI, V23, P258, DOI 10.1007/s11442-013-1008-8; Ferretti Valentina, 2013, Environment Development and Sustainability, V15, P859, DOI 10.1007/s10668-012-9400-6; Gaston KJ, 2003, P ROY SOC B-BIOL SCI, V270, P1293, DOI 10.1098/rspb.2002.2303; Han NY, 2000, J NATURAL RESOURCES, V15, P201, DOI DOI 10.3321/J.ISSN:1000-3037.2000.03.002; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Huang HW, 2011, BOT J LINN SOC, V166, P282, DOI 10.1111/j.1095-8339.2011.01157.x; IUCN, 2014, IUCN PROT AR CAT SYS; Jenkins CN, 2009, BIOL CONSERV, V142, P2166, DOI 10.1016/j.biocon.2009.04.016; Jongman R.H., 2004, ECOLOGICAL NETWORKS; KAKWANI NC, 1977, ECONOMETRICA, V45, P719, DOI 10.2307/1911684; [马克平 Keping Ma], 2011, [生物多样性, Biodiversity Science], V19, P1; [李延梅 LI Yan-Mei], 2009, [生态学报, Acta Ecologica Sinica], V29, P2115; Liu ChengLin, 2008, Journal of Nanjing Forestry University (Natural Sciences Edition), V32, P138; Liu WJ, 2011, J BEIJING FORESTRY U, V33, P49; [卢爱刚 Lu Aigang], 2010, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V24, P7; Ma Jianzhang, 2012, Shengwu Duoyangxing, V20, P551, DOI 10.3724/SP.J.1003.2012.08118; Mendel LC, 2002, CONSERV BIOL, V16, P1520, DOI 10.1046/j.1523-1739.2002.01155.x; Mittermeier RA, 1997, MEGADIVERSITY EARTHS; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Myers N, 2003, BIOSCIENCE, V53, P916; Peng L, 2013, FORESTRY RESOURCES M, V5, P31; Purugganan MD, 2009, NATURE, V457, P843, DOI 10.1038/nature07895; Tang Xiaoping, 2005, Shengwu Duoyangxing, V13, P81; Tang ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019116; The People's Republic of China Ministry of Environmental Protection, 2014, WORK PRES NAT RES; United Nations, 2011, MILL DEV GOALS REP 2; Wang LL, 2012, J EMCC, V22, P19; Wang YS, 2003, ENV PROTECTION, V5, P19; [王智 Wang Zhi], 2004, [农村生态环境, Rural Eco-Environment], V20, P72; Xue D.Y., 1994, CHINA ENVIRON SCI, V4, P246; Yan X, 1989, J NE FORESTRY U, V17, P79; Yuan Hu, 2009, Biodiversity Science, V17, P280, DOI 10.3724/SP.J.1003.2009.08293; Zang RH., 2002, ECONOMICS; Zhang J., 2007, J SHANXI AGR U SOCIA, V6, P275, DOI [DOI 10.3969/J.ISSN.1671-816X.2007.03.015, 10.3969/j.issn.1671-816X.2007.03.015]	44	21	25	8	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119650	10.1371/journal.pone.0119650	http://dx.doi.org/10.1371/journal.pone.0119650			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768791	Green Published, Green Submitted, gold			2022-12-27	WOS:000351277500089
J	Homann, G; Vieth, V; Weiss, D; Nikolaou, K; Heindel, W; Notohamiprodjo, M; Bockenfeld, Y				Homann, Georg; Vieth, Volker; Weiss, Daniel; Nikolaou, Konstantin; Heindel, Walter; Notohamiprodjo, Mike; Boeckenfeld, Yvonne			Semi-Quantitative vs. Volumetric Determination of Endolymphatic Space in Meniere's Disease Using Endolymphatic Hydrops 3T-HR-MRI after Intravenous Gadolinium Injection	PLOS ONE			English	Article							DIAGNOSIS; FLUID; MRI	Magnetic resonance imaging enhances the clinical diagnosis of Meniere's disease. This is accomplished by in vivo detection of endolymphatic hydrops, which are graded using different semi-quantitative grading systems. We evaluated an established, semi-quantitative endolymphatic hydrops score and with a quantitative method for volumetric assessment of the endolymphatic size. 11 patients with Meniere's disease and 2 healthy subjects underwent high resolution endolymphatic hydrops 3 Tesla MRI with highly T2 weighted FLAIR and T2DRIVE sequences. The degree of endolymphatic hydrops was rated semi-quantitatively and compared to the results of 3D-volumetry. Moreover, the grade of endolymphatic hydrops was correlated with pure tone audiometry. Semi-quantitative grading and volumetric evaluation of the endolymphatic hydrops are in accordance (r = 0.92) and the grade of endolymphatic hydrops correlates with pure tone audiometry. Patients with a sickness duration of >= 30 months showed a significant higher total labyrinth fluid volume (p = 0.03). Fast, semi-quantitative evaluation of endolymphatic hydrops is highly reliable compared to quantitative/volumetric assessment. Endolymphatic space is significantly higher in patients with longer sickness duration.	[Homann, Georg; Nikolaou, Konstantin; Notohamiprodjo, Mike] Univ Tubingen, Dept Diagnost & Intervent Radiol, Tubingen, Germany; [Vieth, Volker; Heindel, Walter] Univ Hosp Munster, Dept Clin Radiol, Munster, Germany; [Weiss, Daniel; Boeckenfeld, Yvonne] Univ Hosp Munster, Dept Otorhinolaryngol Head & Neck Surg, Munster, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Munster; University of Munster	Homann, G (corresponding author), Univ Tubingen, Dept Diagnost & Intervent Radiol, Tubingen, Germany.	georg.homann@med.uni-tuebingen.de		Bier, Georg/0000-0002-1034-5681	Japan society for the promotion of science	Japan society for the promotion of science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Funding: This study has been supported by a travel grant of the Japan society for the promotion of science (https://www.jsps.go.jp) to GH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroll M, 2012, OTOL NEUROTOL, V33, P816, DOI 10.1097/MAO.0b013e3182536ac6; Buckingham RA, 2001, ANN OTO RHINOL LARYN, V110, P113, DOI 10.1177/000348940111000204; Chung WH, 2004, OTOL NEUROTOL, V25, P144, DOI 10.1097/00129492-200403000-00011; Dinh TAD, 2009, PFLUG ARCH EUR J PHY, V458, P379, DOI 10.1007/s00424-008-0622-2; Fang ZM, 2012, J LARYNGOL OTOL, V126, P454, DOI 10.1017/S0022215112000060; Foster CA, 2013, MED HYPOTHESES, V81, P1108, DOI 10.1016/j.mehy.2013.10.015; Gurkov R, 2015, EUR RADIOL, V25, P585, DOI 10.1007/s00330-014-3414-4; Gurkov R, 2013, EUR ARCH OTO-RHINO-L, V270, P1231, DOI 10.1007/s00405-012-2087-3; Homann G, 2014, ROFO-FORTSCHR RONTG, V186, P225, DOI 10.1055/s-0033-1356221; Jerin C, 2014, OTOL NEUROTOL, V35, P880, DOI 10.1097/MAO.0000000000000393; Kirby SE, 2009, J PSYCHOSOM RES, V66, P111, DOI 10.1016/j.jpsychores.2008.05.027; Krombach GA, 2005, EUR RADIOL, V15, P1505, DOI 10.1007/s00330-005-2750-9; Liu F, 2012, ACTA OTO-LARYNGOL, V132, P234, DOI 10.3109/00016489.2011.637232; Melhem ER, 1998, AM J NEURORADIOL, V19, P1819; MONSELL EM, 1995, OTOLARYNG HEAD NECK, V113, P181, DOI 10.1016/S0194-5998(95)70102-8; Muzzi E, 2008, AM J OTOLARYNG, V29, P188, DOI 10.1016/j.amjoto.2007.04.011; Naganawa S, 2013, MAGN RESON MED SCI, V12, P261, DOI 10.2463/mrms.2013-0019; Naganawa S, 2012, MAGN RESON MED SCI, V11, P213, DOI 10.2463/mrms.11.213; Naganawa S, 2012, MAGN RESON MED SCI, V11, P145, DOI 10.2463/mrms.11.145; Nakashima T, 2010, ACTA OTO-LARYNGOL, V130, P338, DOI [10.1080/00016480903143986, 10.3109/00016480903143986]; Nakashima T, 2009, ACTA OTO-LARYNGOL, V129, P5, DOI 10.1080/00016480902729827; Salt AN, 2010, OTOLARYNG CLIN N AM, V43, P971, DOI 10.1016/j.otc.2010.05.007; Seo YJ, 2013, AURIS NASUS LARYNX, V40, P167, DOI 10.1016/j.anl.2012.07.009; Shi HB, 2014, OTOL NEUROTOL, V35, P315, DOI 10.1097/MAO.0000000000000196; Shimono M, 2013, OTOL NEUROTOL, V34, P1241, DOI 10.1097/MAO.0b013e3182990e81; STAHLE J, 1974, ACTA OTO-LARYNGOL, V78, P36, DOI 10.3109/00016487409126323; YAZAWA Y, 1994, ACTA OTO-LARYNGOL, P67	27	25	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120357	10.1371/journal.pone.0120357	http://dx.doi.org/10.1371/journal.pone.0120357			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768940	Green Published, Green Submitted, gold			2022-12-27	WOS:000351277500122
J	Kazim, SF; Cardenas-Aguayo, MD; Arif, M; Blanchard, J; Fayyaz, F; Grundke-Iqbal, I; Iqbal, K				Kazim, Syed Faraz; Cardenas-Aguayo, Maria del Carmen; Arif, Mohammad; Blanchard, Julie; Fayyaz, Fatima; Grundke-Iqbal, Inge; Iqbal, Khalid			Sera from Children with Autism Induce Autistic Features Which Can Be Rescued with a CNTF Small Peptide Mimetic in Rats	PLOS ONE			English	Article							DENTATE GYRUS NEUROGENESIS; BEHAVIORAL TASKS RELEVANT; NEURONAL PROGENITOR CELLS; ANXIETY-RELATED BEHAVIOR; OXIDATIVE STRESS; NEUROTROPHIC FACTOR; ULTRASONIC VOCALIZATIONS; MOUSE MODEL; REFLEX-ONTOGENY; ALZHEIMERS-DISEASE	Autism is a neurodevelopmental disorder characterized clinically by impairments in social interaction and verbal and non-verbal communication skills as well as restricted interests and repetitive behavior. It has been hypothesized that altered brain environment including an imbalance in neurotrophic support during early development contributes to the pathophysiology of autism. Here we report that sera from children with autism which exhibited abnormal levels of various neurotrophic factors induced cell death and oxidative stress in mouse primary cultured cortical neurons. The effects of sera from autistic children were rescued by pre-treatment with a ciliary neurotrophic factor (CNTF) small peptide mimetic, Peptide 6 (P6), which was previously shown to exert its neuroprotective effect by modulating CNTF/JAK/STAT pathway and LIF signaling and by enhancing brain derived neurotrophic factor (BDNF) expression. Similar neurotoxic effects and neuroinflammation were observed in young Wistar rats injected intracerebroventricularly with autism sera within hours after birth. The autism sera injected rats demonstrated developmental delay and deficits in social communication, interaction, and novelty. Both the neurobiological changes and the behavioral autistic phenotype were ameliorated by P6 treatment. These findings implicate the involvement of neurotrophic imbalance during early brain development in the pathophysiology of autism and a proof of principle of P6 as a potential therapeutic strategy for autism.	[Kazim, Syed Faraz; Cardenas-Aguayo, Maria del Carmen; Arif, Mohammad; Blanchard, Julie; Fayyaz, Fatima; Grundke-Iqbal, Inge; Iqbal, Khalid] New York State Inst Basic Res Dev Disabil NYSIBR, Dept Neurochem, Inge Grundke Iqbal Res Floor, Staten Isl, NY 10314 USA; [Kazim, Syed Faraz] Suny Downstate Med Ctr, Neural & Behav Sci Grad Program, Brooklyn, NY 11203 USA; [Kazim, Syed Faraz; Iqbal, Khalid] SUNY Downstate NYSIBR Ctr Dev Neurosci CDN, Staten Isl, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Iqbal, K (corresponding author), New York State Inst Basic Res Dev Disabil NYSIBR, Dept Neurochem, Inge Grundke Iqbal Res Floor, Staten Isl, NY 10314 USA.	khalid.iqbal.ibr@gmail.com	del Carmen Cardenas-Aguayo, Maria/AAH-5073-2020	del Carmen Cardenas-Aguayo, Maria/0000-0001-9156-2161; Fayyaz, Fatima/0000-0002-1635-444X	New York State Office of People with Developmental Disabilities; EVER NeuroPharma GmbH, Unterach, Austria; SUNY Downstate/NYSIBR Center for Developmental Neuroscience (CDN) Program	New York State Office of People with Developmental Disabilities; EVER NeuroPharma GmbH, Unterach, Austria; SUNY Downstate/NYSIBR Center for Developmental Neuroscience (CDN) Program	This work was supported in part by the New York State Office of People with Developmental Disabilities and EVER NeuroPharma GmbH, Unterach, Austria. S.F. Kazim is supported by SUNY Downstate/NYSIBR Center for Developmental Neuroscience (CDN) Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah MW, 2013, ACTA PSYCHIAT SCAND, V128, P61, DOI 10.1111/acps.12020; Acosta Maria T, 2003, Curr Neurol Neurosci Rep, V3, P149, DOI 10.1007/s11910-003-0067-0; Al-Ayadhi LY, 2012, NEUROCHEM RES, V37, P394, DOI 10.1007/s11064-011-0624-x; ALLIN J T, 1971, Developmental Psychobiology, V4, P149, DOI 10.1002/dev.420040206; ALLIN JT, 1972, ANIM BEHAV, V20, P175, DOI 10.1016/S0003-3472(72)80189-1; ALTMAN J, 1975, ANIM BEHAV, V23, P896, DOI 10.1016/0003-3472(75)90114-1; Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; Andersen SL, 2003, NEUROSCI BIOBEHAV R, V27, P3, DOI 10.1016/S0149-7634(03)00005-8; Askvig JM, 2013, EXP NEUROL, V240, P75, DOI 10.1016/j.expneurol.2012.10.023; Bailey A, 1998, BRAIN, V121, P889, DOI 10.1093/brain/121.5.889; Baio J., 2012, MORBIDITY MORTALITY, V61; Bauer S, 2006, J NEUROSCI, V26, P12089, DOI 10.1523/JNEUROSCI.3047-06.2006; BELL RW, 1974, DEV PSYCHOBIOL, V7, P235, DOI 10.1002/dev.420070307; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; Bernd P, 2008, GENE EXPRESSION, V14, P241, DOI 10.3727/105221608786883799; Beversdorf DQ, 2005, J AUTISM DEV DISORD, V35, P471, DOI 10.1007/s10803-005-5037-8; Blanchard J, 2011, J NEUROPATH EXP NEUR, V70, P1070, DOI 10.1097/NEN.0b013e318236e9ad; Blanchard J, 2010, ACTA NEUROPATHOL, V120, P605, DOI 10.1007/s00401-010-0734-6; Blanchard J, 2010, J ALZHEIMERS DIS, V21, P1185, DOI [10.3233/JAD-2010-100069, 10.3233/JAD-2010-1000069]; BLUMBERG MS, 1991, NEUROSCI BIOBEHAV R, V15, P383, DOI 10.1016/S0149-7634(05)80031-4; Bolognin S, 2012, ACTA NEUROPATHOL, V123, P133, DOI 10.1007/s00401-011-0908-x; Bonaguidi MA, 2005, DEVELOPMENT, V132, P5503, DOI 10.1242/dev.02166; Bourgeron T, 2009, CURR OPIN NEUROBIOL, V19, P231, DOI 10.1016/j.conb.2009.06.003; Branchi I, 2003, NEUROSCI BIOBEHAV R, V27, P141, DOI 10.1016/S0149-7634(03)00016-2; Cardenas-Aguayo MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053596; Cardenas-Aguayo MD, 2003, J HEMATOTH STEM CELL, V12, P735; Chapleau CA, 2009, J NEURODEV DISORD, V1, P185, DOI 10.1007/s11689-009-9027-6; Chauhan A, 2004, LIFE SCI, V75, P2539, DOI 10.1016/j.lfs.2004.04.038; Chauhan Abha, 2006, Pathophysiology, V13, P171, DOI 10.1016/j.pathophys.2006.05.007; Chen HH, 2007, NEUROBIOL AGING, V28, P1148, DOI 10.1016/j.neurobiolaging.2006.05.036; Chen ZY, 2001, CURR PROTEIN PEPT SC, V2, P261, DOI 10.2174/1389203013381125; Chohan MO, 2015, NEUROSURGERY, V76, P201, DOI 10.1227/NEU.0000000000000577; Chohan MO, 2011, NEUROBIOL AGING, V32, P1420, DOI 10.1016/j.neurobiolaging.2009.08.008; Correia CT, 2010, GENES BRAIN BEHAV, V9, P841, DOI 10.1111/j.1601-183X.2010.00627.x; Courchesne E, 2003, JAMA-J AM MED ASSOC, V290, P337, DOI 10.1001/jama.290.3.337; Courchesne E, 2001, NEUROLOGY, V57, P245, DOI 10.1212/WNL.57.2.245; Courchesne E, 2007, NEURON, V56, P399, DOI 10.1016/j.neuron.2007.10.016; Crawley JN, 2007, NEUROPEPTIDES, V41, P145, DOI 10.1016/j.npep.2007.02.002; Crawley JN, 2004, MENT RETARD DEV D R, V10, P248, DOI 10.1002/mrdd.20039; Dam K, 2000, DEV BRAIN RES, V121, P179, DOI 10.1016/S0165-3806(00)00044-4; Dawson G, 2007, BIOL PSYCHIAT, V61, P458, DOI 10.1016/j.biopsych.2006.07.016; DECHIARA TM, 1995, CELL, V83, P313, DOI 10.1016/0092-8674(95)90172-8; Dissanayake C, 2006, DEV PSYCHOPATHOL, V18, P381, DOI 10.1017/S0954579406060202; Doussard-Roosevelt JA, 2003, DEV PSYCHOPATHOL, V15, P277, DOI 10.1017/S0954579403000154; Ebadi M, 1996, PROG NEUROBIOL, V48, P1, DOI 10.1016/0301-0082(95)00029-1; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; Finn TP, 1998, J NEUROBIOL, V34, P283, DOI 10.1002/(SICI)1097-4695(19980215)34:3<283::AID-NEU7>3.0.CO;2-Z; FOX WM, 1965, ANIM BEHAV, V13, P234, DOI 10.1016/0003-3472(65)90041-2; Garcia KLP, 2012, J NEUROPATH EXP NEUR, V71, P289, DOI 10.1097/NEN.0b013e31824b27e4; Guerin P, 1996, DEV MED CHILD NEUROL, V38, P203; Hashimoto K, 2006, PROG NEURO-PSYCHOPH, V30, P1529, DOI 10.1016/j.pnpbp.2006.06.018; Hazlett HC, 2005, ARCH GEN PSYCHIAT, V62, P1366, DOI 10.1001/archpsyc.62.12.1366; HILL JM, 1993, BRAIN RES, V603, P222, DOI 10.1016/0006-8993(93)91241-J; HILL JM, 1991, PEPTIDES, V12, P187, DOI 10.1016/0196-9781(91)90186-S; Hill Joanna M., 2008, V39, P131, DOI 10.1007/978-1-60327-099-1_10; HOFER MA, 1980, J COMP PHYSIOL PSYCH, V94, P271, DOI 10.1037/h0077665; HOLTZMAN DM, 1994, WESTERN J MED, V161, P246; Hutter-Paier B, 1998, J NEURAL TRANSM-SUPP, P363; Iqbal K, 2014, NEURAL REGEN RES, V9, P1518, DOI 10.4103/1673-5374.139477; Ishii J, 2007, NEUROSCI LETT, V423, P225, DOI 10.1016/j.neulet.2007.07.029; Katoh-Semba R, 2007, INT J DEV NEUROSCI, V25, P367, DOI 10.1016/j.ijdevneu.2007.07.002; Kaur N, 2005, J NEUROCHEM, V92, P1521, DOI 10.1111/j.1471-4159.2004.02990.x; Kazim SF, 2014, NEUROBIOL DIS, V71, P110, DOI 10.1016/j.nbd.2014.07.001; Kemper TL, 2002, MOL PSYCHIATR, V7, pS12, DOI 10.1038/sj.mp.4001165; Kemper TL, 1998, J NEUROPATH EXP NEUR, V57, P645, DOI 10.1097/00005072-199807000-00001; Kern JK, 2006, J TOXICOL ENV HEAL B, V9, P485, DOI 10.1080/10937400600882079; Krasnoperova MG, 2003, ZH NEVROPATOL PSIKH, V103, P15; Kromkhun Pudcharaporn, 2013, Lab Anim Res, V29, P77, DOI 10.5625/lar.2013.29.2.77; Laurence JA, 2005, CEREBELLUM, V4, P206, DOI 10.1080/14734220500208846; Linker RA, 2002, NAT MED, V8, P620, DOI 10.1038/nm0602-620; Longo FM, 2007, CURR ALZHEIMER RES, V4, P503, DOI 10.2174/156720507783018316; Lord C, 2000, NEURON, V28, P355, DOI 10.1016/S0896-6273(00)00115-X; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; Lotz B, 1996, NEUROLOGY, V46, P1244; Lu B, 2013, NAT REV NEUROSCI, V14, P401, DOI 10.1038/nrn3505; Lubics A, 2005, BEHAV BRAIN RES, V157, P157, DOI 10.1016/j.bbr.2004.06.019; Mazur-Kolecka B, 2007, BRAIN RES, V1168, P11, DOI 10.1016/j.brainres.2007.06.084; Mazur-Kolecka B, 2014, BRAIN DEV-JPN, V36, P322, DOI 10.1016/j.braindev.2013.04.015; Mazur-Kolecka B, 2009, NEUROTOX RES, V16, P87, DOI 10.1007/s12640-009-9052-y; Metcalf D, 2003, STEM CELLS, V21, P5, DOI 10.1634/stemcells.21-1-5; Miller MT, 2005, INT J DEV NEUROSCI, V23, P201, DOI 10.1016/j.ijdevneu.2004.06.007; Miyazaki K, 2004, BRAIN DEV-JPN, V26, P292, DOI 10.1016/S0387-7604(03)00168-2; Moon C, 2002, P NATL ACAD SCI USA, V99, P9015, DOI 10.1073/pnas.132131699; Moy SS, 2007, BEHAV BRAIN RES, V176, P4, DOI 10.1016/j.bbr.2006.07.030; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Murai KK, 2007, NEUROSCIENTIST, V13, P657, DOI 10.1177/1073858407304393; Muthaiyah B, 2011, NEUROCHEM RES, V36, P2096, DOI 10.1007/s11064-011-0533-z; Naito H, 2000, EXP ANIM TOKYO, V49, P289, DOI 10.1538/expanim.49.289; Nelson KB, 2001, ANN NEUROL, V49, P597, DOI 10.1002/ana.1024.abs; Nickl-Jockschat T, 2011, MOL PSYCHIATR, V16, P478, DOI 10.1038/mp.2010.103; Nickl-Jockschat T., 2014, COMPREHENSIVE GUIDE, P741; NOIROT E, 1968, ANIM BEHAV, V16, P129, DOI 10.1016/0003-3472(68)90123-1; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; OSWALT GL, 1975, DEV PSYCHOBIOL, V8, P129, DOI 10.1002/dev.420080205; Pardo-Villamizar CA, 2010, Autism: Oxidative Stress, Inflammation, and Immune Abnormalities, P225; Polleux F, 2004, MENT RETARD DEV D R, V10, P303, DOI 10.1002/mrdd.20044; Polsek D, 2011, TRANSL NEUROSCI, V2, P256, DOI 10.2478/s13380-011-0024-3; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Reglodi D, 2003, BEHAV BRAIN RES, V140, P131, DOI 10.1016/S0166-4328(02)00289-9; Ricci S, 2013, NEUROTOX RES, V24, P491, DOI 10.1007/s12640-013-9393-4; Rola R, 2007, FREE RADICAL BIO MED, V42, P1133, DOI 10.1016/j.freeradbiomed.2007.01.020; Sajdel-Sulkowska EM, 2010, AUTISM: OXIDATIVE STRESS, INFLAMMATION, AND IMMUNE ABNORMALITIES, P47; Scattoni ML, 2009, NEUROSCI BIOBEHAV R, V33, P508, DOI 10.1016/j.neubiorev.2008.08.003; Scattoni ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003067; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schwarting RKW, 2012, BRAZ J MED BIOL RES, V45, P337, DOI 10.1590/S0100-879X2012007500038; Shair HN, 2007, BEHAV BRAIN RES, V182, P180, DOI 10.1016/j.bbr.2007.02.016; Shimazaki T, 2001, J NEUROSCI, V21, P7642, DOI 10.1523/JNEUROSCI.21-19-07642.2001; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; SMART JL, 1971, BRAIN RES, V28, P85, DOI 10.1016/0006-8993(71)90526-9; SMART JL, 1971, BRAIN RES, V33, P303, DOI 10.1016/0006-8993(71)90105-3; Sparks BF, 2002, NEUROLOGY, V59, P184, DOI 10.1212/WNL.59.2.184; Tatebayashi Y, 2003, ACTA NEUROPATHOL, V105, P225, DOI 10.1007/s00401-002-0636-3; Taurines R, 2014, J NEURAL TRANSM, V121, P1117, DOI 10.1007/s00702-014-1162-x; Toso L, 2008, OBSTET GYNECOL, V112, P1242, DOI 10.1097/AOG.0b013e31818c91dc; Tsai SJ, 2005, MED HYPOTHESES, V65, P79, DOI 10.1016/j.mehy.2005.01.034; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; Wang XC, 2014, ACTA NEUROPATHOL, V127, P243, DOI 10.1007/s00401-013-1175-9; Wohr M, 2008, BEHAV NEUROSCI, V122, P310, DOI 10.1037/0735-7044.122.2.310; Wu CL, 2009, NEUROTOXICOLOGY, V30, P718, DOI 10.1016/j.neuro.2009.03.008; Wu CL, 2009, BIOCHEM BIOPH RES CO, V385, P112, DOI 10.1016/j.bbrc.2009.04.145; Yang Mu, 2011, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0826s56; Young DM, 2010, P NATL ACAD SCI USA, V107, P11074, DOI 10.1073/pnas.1005620107	124	17	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118627	10.1371/journal.pone.0118627	http://dx.doi.org/10.1371/journal.pone.0118627			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25769033	gold, Green Published, Green Submitted			2022-12-27	WOS:000351277500035
J	Lee, YH; Liu, XY; Qiu, FM; O'Connor, TR; Yen, Y; Ann, DK				Lee, Young-Ho; Liu, Xiyong; Qiu, Fuming; O'Connor, Timothy R.; Yen, Yun; Ann, David K.			HP1 beta Is a Biomarker for Breast Cancer Prognosis and PARP Inhibitor Therapy	PLOS ONE			English	Article							GENE-EXPRESSION SIGNATURE; POLY(ADP-RIBOSE) POLYMERASE; HETEROCHROMATIN PROTEIN-1; SYNTHETIC LETHALITY; MOLECULAR PORTRAITS; OVARIAN-CANCER; KI-67 PROTEIN; DNA-DAMAGE; TUMORS; MARKER	Members of the heterochromatin protein 1 family (HP1 alpha, beta and gamma) are mostly associated with heterochromatin and play important roles in gene regulation and DNA damage response. Altered expression of individual HP1 subtype has profound impacts on cell proliferation and tumorigenesis. We analyzed the expression profile of HP1 family by data mining using a published microarray data set coupled with retrospective immunohistochemistry analyses of archived breast cancer biospecimens. We found that the patient group overexpressing HP1 beta mRNA is associated with poorly differentiated breast tumors and with a significantly lower survival rate. Immunohistochemical staining against HP1 alpha, HP1 beta and HP1. shows that respective HP1 expression level is frequently altered in breast cancers. 57.4 - 60.1% of samples examined showed high HP1 beta expression and 39.9 - 42.6 % of examined tumors showed no or low expression of each HP1 subtype. Interestingly, comparative analysis on HP1 expression profile and breast cancer markers revealed a positive correlation between the respective expression level of all three HP1 subtypes and Ki-67, a cell proliferation and well-known breast cancer marker. To explore the effect of individual HP1 on PARP inhibitor therapy for breast cancer, MCF7 breast cancer cells and individually HP1-depleted MCF7 cells were treated with PARP inhibitor ABT-888 with or without carboplatin. Notably, HP1 beta-knockdown cells are hypersensitive to the PARP inhibitor ABT-888 alone and its combination with carboplatin. In summary, while increased HP1 beta expression is associated with the poor prognosis in breast cancer, compromised HP1 beta abundance may serve as a useful predictive marker for chemotherapy, including PARP inhibitors against breast cancer.	[Lee, Young-Ho; Liu, Xiyong; Yen, Yun; Ann, David K.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Pharmacol, Duarte, CA 91010 USA; [Qiu, Fuming] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Med Oncol, Hangzhou 310003, Zhejiang, Peoples R China; [O'Connor, Timothy R.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; Zhejiang University; City of Hope; Beckman Research Institute of City of Hope	Lee, YH (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Pharmacol, Duarte, CA 91010 USA.	lyh205@gmail.com; dann@coh.org	Yen, Yun/H-9591-2016; Lee, Young-Ho/G-2361-2014; Liu, Xiyong/E-1646-2019	Lee, Young-Ho/0000-0001-6415-4912; Liu, Xiyong/0000-0002-0259-3669	National Institutes of Health Research [R01DE10742, R01DE14183]; NATIONAL CANCER INSTITUTE [R01CA176611, P30CA033572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE010742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014183] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding: This work was supported by National Institutes of Health Research Grants R01DE10742 and R01DE14183 to DA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo B, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2852; Ball AR, 2009, J CELL BIOL, V185, P573, DOI 10.1083/jcb.200904033; Bast RC, 2010, J CLIN ONCOL, V28, P3545, DOI 10.1200/JCO.2010.28.5791; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Chalasani P, 2013, ONCOLOGIST; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Clark CC, 2012, MOL CANCER THER, V11, P1948, DOI 10.1158/1535-7163.MCT-11-0597; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; de Azambuja E, 2007, BRIT J CANCER, V96, P1504, DOI 10.1038/sj.bjc.6603756; De Koning L, 2009, EMBO MOL MED, V1, P178, DOI 10.1002/emmm.200900022; Dedes KJ, 2011, CELL CYCLE, V10, P1192, DOI 10.4161/cc.10.8.15273; Dialynas GK, 2008, MUTAT RES-FUND MOL M, V647, P13, DOI 10.1016/j.mrfmmm.2008.09.007; Dinant C, 2009, MOL CELL BIOL, V29, P6335, DOI 10.1128/MCB.01048-09; Eissenberg JC, 2000, CURR OPIN GENET DEV, V10, P204, DOI 10.1016/S0959-437X(00)00058-7; Arranz EE, 2012, TRANSL ONCOL, V5, P398, DOI 10.1593/tlo.12244; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Hiragami K, 2005, CELL MOL LIFE SCI, V62, P2711, DOI 10.1007/s00018-005-5287-9; Huang E, 2003, LANCET, V361, P1590, DOI 10.1016/S0140-6736(03)13308-9; Inwald EC, 2013, BREAST CANCER RES TR, V139, P539, DOI 10.1007/s10549-013-2560-8; Jonat W, 2011, ANN ONCOL, V22, P500, DOI 10.1093/annonc/mdq732; Kametaka A, 2002, GENES CELLS, V7, P1231, DOI 10.1046/j.1365-2443.2002.00596.x; Keam B, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2834; Kirschmann DA, 2000, CANCER RES, V60, P3359; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lee YH, 2013, NUCLEIC ACIDS RES, V41, P5784, DOI 10.1093/nar/gkt231; McCabe N, 2006, CANCER RES, V66, P8109, DOI 10.1158/0008-5472.CAN-06-0140; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; O'Donovan PJ, 2010, CARCINOGENESIS, V31, P961, DOI 10.1093/carcin/bgq069; Penning TD, 2009, J MED CHEM, V52, P514, DOI 10.1021/jm801171j; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rigakos G, 2012, ONCOLOGIST, V17, P956, DOI 10.1634/theoncologist.2012-0028; Scholzen T, 2002, J PATHOL, V196, P135, DOI 10.1002/path.1016; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Slezak J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-148; Trihia H, 2003, CANCER, V97, P1321, DOI 10.1002/cncr.11188; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Urruticoechea A, 2005, J CLIN ONCOL, V23, P7212, DOI 10.1200/JCO.2005.07.501; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Weigelt B, 2010, J PATHOL, V220, P263, DOI 10.1002/path.2648; Wysham WZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030042	45	60	62	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0121207	10.1371/journal.pone.0121207	http://dx.doi.org/10.1371/journal.pone.0121207			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25769025	Green Published, gold			2022-12-27	WOS:000351277500139
J	Chetty, S; Govender, P; Zupkosky, J; Pillay, M; Ghebremichael, M; Moosa, MYS; Ndung'u, T; Porichis, F; Kasprowicz, VO				Chetty, Shivan; Govender, Pamla; Zupkosky, Jennifer; Pillay, Mona; Ghebremichael, Musie; Moosa, Mahomed-Yunus S.; Ndung'u, Thumbi; Porichis, Filippos; Kasprowicz, Victoria O.			Co-Infection with Mycobacterium tuberculosis Impairs HIV-Specific CD8+and CD4+T Cell Functionality	PLOS ONE			English	Article							T-CELLS; INFECTION; RESPONSES; REPLICATION; CYTOKINES; INDUCTION; LOAD	The ability of antigen-specific T cells to simultaneously produce multiple cytokines is thought to correlate with the functional capacity and efficacy of T cells. These 'polyfunctional' T cells have been associated with control of HIV. We aimed to assess the impact of co-infection with Mycobacterium tuberculosis (MTB) on HIV-specific CD8+ and CD4+ T cell function. We assessed T cell functionality in 34 South African adults by investigating the IFN-gamma, IL-2, TNF-alpha, IL-21 and IL-17 cytokine secretion capacity, using polychromatic flow cytometry, following HIV Gag-specific stimulation of peripheral blood mononuclear cells. We show that MTB is associated with lower HIV-specific T cell function in co-infected as compared to HIV mono-infected individuals. This decline in function was greatest in co-infection with active Tuberculosis (TB) compared to co-infection with latent MTB (LTBI), suggesting that mycobacterial load may contribute to this loss of function. The described impact of MTB on HIV-specific T cell function may be a mechanism for increased HIV disease progression in co-infected subjects as functionally impaired T cells may be less able to control HIV.	[Chetty, Shivan; Govender, Pamla; Pillay, Mona; Ndung'u, Thumbi; Kasprowicz, Victoria O.] Univ KwaZulu Natal, HIV Pathogenesis Programme, Doris Duke Med Res Inst, Durban, South Africa; [Chetty, Shivan; Ndung'u, Thumbi; Kasprowicz, Victoria O.] Univ KwaZulu Natal, KwaZulu Natal Res Inst TB & HIV K RITH, Durban, South Africa; [Zupkosky, Jennifer; Ghebremichael, Musie; Ndung'u, Thumbi; Porichis, Filippos; Kasprowicz, Victoria O.] MGH MIT & Harvard, Ragon Inst, Cambridge, MA USA; [Moosa, Mahomed-Yunus S.] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Div Internal Med, Dept Infect Dis, Durban, South Africa; [Ndung'u, Thumbi] Max Planck Inst Infect Biol, Berlin, Germany	University of Kwazulu Natal; University of Kwazulu Natal; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Kwazulu Natal; Max Planck Society	Kasprowicz, VO (corresponding author), Univ KwaZulu Natal, HIV Pathogenesis Programme, Doris Duke Med Res Inst, Durban, South Africa.	vkasprowicz@mgh.harvard.edu		Ndung'u, Thumbi/0000-0003-2962-3992	Howard Hughes Medical Institute; Harvard University CFAR grant [P30 AI060354]; South African Medical Research Council (MRC); CU-SA Fogarty AITRP programme; National Heart Lung and Blood Institute of the National Institutes of Health [RO1 HL-092565, R37 AI067073, P01 AI-080192]; Massachusetts General Hospital Executive Committee on Research; Harvard Global Health Institute (HGHI); South African Research Chairs Initiative; Victor Daitz Foundation; Victor Daitz Information Gateway, an initiative of the Victor Daitz Foundation; University of KwaZulu-Natal; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, R37AI067073, P01AI080192, R01AI067073] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Harvard University CFAR grant; South African Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CU-SA Fogarty AITRP programme; National Heart Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Massachusetts General Hospital Executive Committee on Research; Harvard Global Health Institute (HGHI); South African Research Chairs Initiative; Victor Daitz Foundation; Victor Daitz Information Gateway, an initiative of the Victor Daitz Foundation; University of KwaZulu-Natal; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors would like to thank the following funders: the Howard Hughes Medical Institute (support for T. N., V. O. K.), the Harvard University CFAR grant (P30 AI060354), the South African Medical Research Council (MRC) and The CU-SA Fogarty AITRP programme (S. C.), the National Heart Lung and Blood Institute of the National Institutes of Health (RO1 HL-092565 and R37 AI067073 and P01 AI-080192). F. P. is supported by fellowship grants of the Massachusetts General Hospital Executive Committee on Research and the Harvard Global Health Institute (HGHI). T. N. is also supported by the South African Research Chairs Initiative and the Victor Daitz Foundation. Open access publication of this article has been made possible through support from the Victor Daitz Information Gateway, an initiative of the Victor Daitz Foundation and the University of KwaZulu-Natal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Chevalier MF, 2011, J VIROL, V85, P733, DOI 10.1128/JVI.02030-10; Day CL, 2008, J INFECT DIS, V197, P990, DOI 10.1086/529048; Day CL, 2011, J IMMUNOL, V187, P2222, DOI 10.4049/jimmunol.1101122; Garrait V, 1997, J IMMUNOL, V159, P2824; Geldmacher C, 2008, J INFECT DIS, V198, P1590, DOI 10.1086/593017; Geldmacher C, 2010, J EXP MED, V207, P2869, DOI 10.1084/jem.20100090; Goletti D, 1998, J INFECT DIS, V177, P1332, DOI 10.1086/515276; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Hoshino Y, 2002, J EXP MED, V195, P495, DOI 10.1084/jem.20011614; Kannanganat S, 2007, J VIROL, V81, P8468, DOI 10.1128/JVI.00228-07; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Kaufmann DE, 2009, J IMMUNOL, V182, P5891, DOI 10.4049/jimmunol.0803771; Mitchell JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037920; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08	15	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0118654	10.1371/journal.pone.0118654	http://dx.doi.org/10.1371/journal.pone.0118654			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781898	Green Submitted, Green Published, gold			2022-12-27	WOS:000351284600032
J	Ghunaim, H; Behnke, JM; Aigha, I; Sharma, A; Doiphode, SH; Deshmukh, A; Abu-Madi, MM				Ghunaim, Haitham; Behnke, Jerzy M.; Aigha, Idil; Sharma, Aarti; Doiphode, Sanjay H.; Deshmukh, Anand; Abu-Madi, Marawan M.			Analysis of Resistance to Antimicrobials and Presence of Virulence/Stress Response Genes in Campylobacter Isolates from Patients with Severe Diarrhoea	PLOS ONE			English	Article							FLUOROQUINOLONE RESISTANCE; CIPROFLOXACIN RESISTANCE; ANTIBIOTIC-RESISTANCE; CHICKEN CARCASSES; JEJUNI REQUIRES; INT-407 CELLS; PREVALENCE; STRAINS; MECHANISMS; INVASION	Campylobacter infections are a major cause of diarrhoea world-wide and two of the antimicrobials used for their control (erythromycin and ciprofloxacin) have been losing efficacy in recent years. In a sample of 174 genotyped isolates from the stools of patients with severe diarrhoea in Qatar, collected between 2005 and 2012, 63.2% showed resistance to ciprofloxacin, 8.6% to erythromycin, 0.57% to chloramphenicol and all were sensitive to gentamycin. While 33.9% of isolates were sensitive to all four antimicrobials, 59.8% were resistant to at least one, 6.3% were resistant to two and none showed resistance to three antimicrobials. There was no host sex-or age-dependence among isolates resistant to ciprofloxacin and erythromycin and no significant variation was found with the region of origin of the patients. All isolates were screened for the presence of 3 virulence factors (ciaB, cadF and cdtB) and two stress-response factors (htrB and clpP), all of which were present in more than 50% of the isolates. Host sex-, age- and region of origin-dependent variations in prevalence were found for some of these factors. Data analysis for the combination of virulence factors and their effect on antimicrobial resistance indicated that the prevalence of resistance to both erythromycin and ciprofloxacin was higher in isolates harbouring ciaB but not clpP. Prevalence of resistance to ciprofloxacin was similar in clpP positive and negative isolates also possessing htrB, while for htrB-negative isolates prevalence was higher in the absence of clpP. These results are discussed and their implications are highlighted.	[Ghunaim, Haitham; Aigha, Idil; Sharma, Aarti; Abu-Madi, Marawan M.] Qatar Univ, Coll Arts & Sci, Dept Hlth Sci, Doha, Qatar; [Behnke, Jerzy M.] Univ Nottingham, Sch Life Sci, Nottingham NG7 2RD, England; [Doiphode, Sanjay H.; Deshmukh, Anand] Hamad Med Corp, Dept Lab Med & Pathol, Doha, Qatar	Qatar University; University of Nottingham; Hamad Medical Corporation	Abu-Madi, MM (corresponding author), Qatar Univ, Coll Arts & Sci, Dept Hlth Sci, POB 2713, Doha, Qatar.	abumadi@qu.edu.qa		Deshmukh, Anand/0000-0001-9784-7192	National Priority Research Program grant from the Qatar National Research Fund [NPRP4-1283-3-327]; Hamad Medical Corporation [13334/13]	National Priority Research Program grant from the Qatar National Research Fund(Qatar National Research Fund (QNRF)); Hamad Medical Corporation	This publication was made possible by a National Priority Research Program grant number NPRP4-1283-3-327 from the Qatar National Research Fund (http://www.qnrf.org/), a member of Qatar Foundation, and Hamad Medical Corporation (http://www.hmc.org.qa) grant #13334/13. The statements made herein are solely the responsibility of the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Madi MA, 2013, AM J TROP MED HYG, V88, P1185, DOI 10.4269/ajtmh.13-0006; Adib N, 2014, TROP BIOMED, V31, P17; Al-Mahmeed A, 2006, J MED MICROBIOL, V55, P839, DOI 10.1099/jmm.0.46500-0; [Anonymous], BIOMED RES INT; Bagger-Skjot L, 2007, SCAND J INFECT DIS, V39, P724, DOI 10.1080/00365540701242400; Barnard C, 2007, ASKING QUESTION BIOL; Chan KF, 2001, APPL ENVIRON MICROB, V67, P4186, DOI 10.1128/AEM.67.9.4186-4191.2001; Chansiripornchai N, 2009, J VET MED SCI, V71, P839, DOI 10.1292/jvms.71.839; CLSI, 2010, METH ANT DIL DISK SU, DOI [10.1016/j.vetmic.2010.01.010, DOI 10.1016/J.VETMIC.2010.01.010]; CLSI, 2014, PERFORMANCE STANDARD; COVER TL, 1990, FEMS MICROBIOL LETT, V70, P301, DOI 10.1016/S0378-1097(05)80012-6; Datta S, 2003, J MED MICROBIOL, V52, P345, DOI 10.1099/jmm.0.05056-0; Deckert A, 2010, J FOOD PROTECT, V73, P1317, DOI 10.4315/0362-028X-73.7.1317; Dorrell N, 2001, GENOME RES, V11, P1706, DOI 10.1101/gr.185801; Dryden MS, 1996, CLIN INFECT DIS, V22, P1019, DOI 10.1093/clinids/22.6.1019; Ender M, 2004, ANTIMICROB AGENTS CH, V48, P2295, DOI 10.1128/AAC.48.6.2295-2297.2004; England PH, 2014, UK STAND MICR INV IN; Garcia LS, 2010, CLIN MICROBIOLOGY PR; Gilbert M, 2002, J BIOL CHEM, V277, P327, DOI 10.1074/jbc.M108452200; Helms M, 2005, J INFECT DIS, V191, P1050, DOI 10.1086/428453; Hickey TE, 2000, INFECT IMMUN, V68, P6535, DOI 10.1128/IAI.68.12.6535-6541.2000; Hou FQ, 2012, SCAND J INFECT DIS, V44, P439, DOI 10.3109/00365548.2011.652163; Iovine NM, 2013, VIRULENCE, V4, P230, DOI 10.4161/viru.23753; JIMENEZ A, 1994, J ANTIMICROB CHEMOTH, V33, P188, DOI 10.1093/jac/33.1.188; Konkel ME, 1998, INFECT IMMUN, V66, P3666, DOI 10.1128/IAI.66.8.3666-3672.1998; Konkel ME, 2004, J BACTERIOL, V186, P3296, DOI 10.1128/JB.186.11.3296-3303.2004; Konkel ME, 1999, J CLIN MICROBIOL, V37, P510, DOI 10.1128/JCM.37.3.510-517.1999; Li CC, 1998, SCAND J INFECT DIS, V30, P39, DOI 10.1080/003655498750002286; Liao CH, 2012, J INFECTION, V65, P392, DOI 10.1016/j.jinf.2012.06.014; Luo ND, 2005, P NATL ACAD SCI USA, V102, P541, DOI 10.1073/pnas.0408966102; McDermott PF, 2002, J INFECT DIS, V185, P837, DOI 10.1086/339195; McGowan-Spicer LL, 2008, J FOOD PROTECT, V71, P760, DOI 10.4315/0362-028X-71.4.760; Momtaz H, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-39; Monteville MR, 2003, MICROBIOL-SGM, V149, P153, DOI 10.1099/mic.0.25820-0; Moore JE, 2005, VET RES, V36, P351, DOI 10.1051/vetres:2005012; Nachamkin I, 2002, EMERG INFECT DIS, V8, P1501, DOI 10.3201/eid0812.020115; Nelson JM, 2004, J INFECT DIS, V190, P1150, DOI 10.1086/423282; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Paulander W, 2009, GENETICS, V183, P539, DOI 10.1534/genetics.109.106104; Payot S, 2006, MICROBES INFECT, V8, P1967, DOI 10.1016/j.micinf.2005.12.032; Pearson BM, 2003, FEBS LETT, V554, P224, DOI 10.1016/S0014-5793(03)01164-5; Perez-Boto D, 2014, AVIAN PATHOL, V43, P176, DOI 10.1080/03079457.2014.898245; Rivera-Amill V, 2001, J INFECT DIS, V183, P1607, DOI 10.1086/320704; Rohlf F.J., 1995, STAT TABLES; Rozynek E, 2005, J MED MICROBIOL, V54, P615, DOI 10.1099/jmm.0.45988-0; Rozynek E, 2008, J FOOD PROTECT, V71, P602; Saenz Y, 2000, ANTIMICROB AGENTS CH, V44, P267, DOI 10.1128/AAC.44.2.267-271.2000; Sonnevend A, 2006, J MED MICROBIOL, V55, P1533, DOI 10.1099/jmm.0.46744-0; Stintzi A, 2003, J BACTERIOL, V185, P2009, DOI 10.1128/JB.185.6.2009-2016.2003; Strachan NJC, 2008, EPIDEMIOL INFECT, V136, P1492, DOI 10.1017/S0950268807009934; Szymanski CM, 2012, GUT MICROBES, V3, P135, DOI 10.4161/gmic.19488; Unicomb LE, 2006, CLIN INFECT DIS, V42, P1368, DOI 10.1086/503426; Whitehouse CA, 1998, INFECT IMMUN, V66, P1934, DOI 10.1128/IAI.66.5.1934-1940.1998; Wiemer D, 2011, INT J MED MICROBIOL, V301, P577, DOI 10.1016/j.ijmm.2011.06.001; Young KT, 2007, NAT REV MICROBIOL, V5, P665, DOI 10.1038/nrmicro1718	55	33	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119268	10.1371/journal.pone.0119268	http://dx.doi.org/10.1371/journal.pone.0119268			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781009	Green Submitted, gold, Green Published			2022-12-27	WOS:000351284600057
J	Gigante, B; Strawbridge, RJ; Velasquez, IM; Golabkesh, Z; Silveira, A; Goel, A; Baldassarre, D; Veglia, F; Tremoli, E; Clarke, R; Watkins, H; Hamsten, A; Humphries, SE; de Faire, U				Gigante, Bruna; Strawbridge, Rona J.; Velasquez, Ilais Moreno; Golabkesh, Zahra; Silveira, Angela; Goel, Anuj; Baldassarre, Damiano; Veglia, Fabrizio; Tremoli, Elena; Clarke, Robert; Watkins, Hugh; Hamsten, Anders; Humphries, Steve E.; de Faire, Ulf			Analysis of the Role of Interleukin 6 Receptor Haplotypes in the Regulation of Circulating Levels of Inflammatory Biomarkers and Risk of Coronary Heart Disease	PLOS ONE			English	Article							C-REACTIVE PROTEIN; GENE; EXPRESSION; VARIANT; LOCUS; WOMEN	Variants at the interleukin 6 receptor (IL6R) gene regulate inflammation and are associated with risk of coronary heart disease (CHD). The aim of the present study was to investigate the effects of IL6R haplotypes on circulating levels of inflammatory biomarkers and risk of CHD. We performed a discovery analysis in SHEEP, a myocardial infarction (MI) case control study (n = 2,774) and replicated our results in two large, independent European populations, PROCARDIS, a CHD case control study (n = 7,998), and IMPROVE (n = 3,711) a prospective cardiovascular cohort study. Two major haplotype blocks (rs12083537A/G and rs4075015A/T-block 1; and rs8192282G/A, rs4553185T/C, rs8192284A/C, rs4240872T/C and rs7514452T/C-block 2) were identified in the IL6R gene. IL6R haplotype associations with C-reactive protein (CRP), fibrinogen, IL6, soluble IL6R (sIL6R), IL6, IL8 and TNF-alpha in SHEEP, CRP and fibrinogen in PROCARDIS and CRP in IMPROVE as well as association with risk of MI and CHD, were analyzed by THESIAS. Haplotypes in block 1 were associated neither with circulating inflammatory biomarkers nor with the MI/CHD risk. Haplotypes in block 2 were associated with circulating levels of CRP, in all three study populations, with fibrinogen in SHEEP and PROCARDIS, with IL8 and sIL6Rin SHEEP and with a modest, non significant, increase (7%) in MI/CHD risk in the three populations studied. Our results indicate that IL6R haplotypes regulate the circulating levels of inflammatory biomarkers. Lack of association with the risk of CHD may be explained by the combined effect of SNPs with opposite effect on the CHD risk, the sample size as well as by structural changes affecting sIL6R stability in the circulation.	[Gigante, Bruna; Velasquez, Ilais Moreno; Golabkesh, Zahra; de Faire, Ulf] Inst Environm Med IMM, Unit Cardiovasc Epidemiol, Stockholm, Sweden; [Gigante, Bruna] Danderyd Hosp, Dept Clin Sci, Div Cardiovasc Med, Stockholm, Sweden; [Strawbridge, Rona J.; Silveira, Angela; Hamsten, Anders] Karolinska Inst, Atherosclerosis Res Unit, Dept Med Solna, Cardiovasc Genet & Genom Grp, Stockholm, Sweden; [Goel, Anuj; Watkins, Hugh] Univ Oxford, Wellcome Trust Ctr Human Genet, Dept Cardiovasc Med, Oxford, England; [Baldassarre, Damiano; Veglia, Fabrizio; Tremoli, Elena] Univ Milan, Dipartimento Sci Farmacol & Biomol, Milan, Italy; [Baldassarre, Damiano; Tremoli, Elena] IRCCS, Ctr Cardiol Monzino, Milan, Italy; [Clarke, Robert] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Hamsten, Anders; de Faire, Ulf] Karolinska Univ Hosp, Dept Cardiol, Stockholm, Sweden; [Humphries, Steve E.] UCL, Ctr Cardiovasc Genet, London WC1E 6BT, England	Danderyds Hospital; Karolinska Institutet; University of Oxford; Wellcome Centre for Human Genetics; University of Milan; IRCCS Centro Cardiologico Monzino; University of Oxford; Karolinska Institutet; Karolinska University Hospital; University of London; University College London	Gigante, B (corresponding author), Inst Environm Med IMM, Unit Cardiovasc Epidemiol, Stockholm, Sweden.	bruna.gigante@ki.se	Veglia, Fabrizio/K-1958-2016; Baldassarre, Damiano/J-3295-2016; Strawbridge, Rona/H-5422-2012; Gigante, Bruna/I-9252-2012; TREMOLI, ELENA/I-8126-2018	Veglia, Fabrizio/0000-0002-9378-8874; Baldassarre, Damiano/0000-0002-2766-8882; Strawbridge, Rona/0000-0001-8506-3585; Gigante, Bruna/0000-0003-4508-7990; Watkins, Hugh/0000-0002-5287-9016; Moreno Velasquez, Ilais/0000-0001-6058-8983; Humphries, Stephen E/0000-0002-8221-6547; Silveira, Angela/0000-0003-2063-4935; TREMOLI, ELENA/0000-0002-0929-6106; Goel, Anuj/0000-0003-2307-4021	European Community Sixth Framework Program [LSHM-CT-2007-037273]; AstraZeneca; British Heart Foundation; Oxford British Heart Foundation Centre of Research Excellence; Wellcome Trust [075491/Z/04]; Swedish Research Council [8691, 0593]; Knut and Alice Wallenberg Foundation; Swedish Heart-Lung Foundation; Torsten and Ragnar Soderberg Foundation; Strategic Cardiovascular and Diabetes Program of Karolinska Institutet; Strategic Cardiovascular and Diabetes Program of Stockholm County Council; Foundation for Strategic Research [560283]; European Commission [QLG1-CT-2002-00896]; Stockholm County Council; Academy of Finland [110413]; British Heart Foundation [RG2008/08, RG2008/014]; Italian Ministry of Health (Ricerca Corrente); Stockholm County Council [20130053]; Swedish Heart-Lung Foundation [20130220]; British Heart Foundation [RG/08/008/25291] Funding Source: researchfish	European Community Sixth Framework Program(European Commission); AstraZeneca(AstraZeneca); British Heart Foundation(British Heart Foundation); Oxford British Heart Foundation Centre of Research Excellence; Wellcome Trust(Wellcome TrustEuropean Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Torsten and Ragnar Soderberg Foundation; Strategic Cardiovascular and Diabetes Program of Karolinska Institutet; Strategic Cardiovascular and Diabetes Program of Stockholm County Council; Foundation for Strategic Research; European Commission(European CommissionEuropean Commission Joint Research Centre); Stockholm County Council(Stockholm County Council); Academy of Finland(Academy of Finland); British Heart Foundation(British Heart Foundation); Italian Ministry of Health (Ricerca Corrente)(Ministry of Health, Italy); Stockholm County Council(Stockholm County Council); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); British Heart Foundation(British Heart Foundation)	The PROCARDIS was supported by the European Community Sixth Framework Program (LSHM-CT-2007-037273), AstraZeneca, the British Heart Foundation, the Oxford British Heart Foundation Centre of Research Excellence, the Wellcome Trust (075491/Z/04), the Swedish Research Council, the Knut and Alice Wallenberg Foundation, the Swedish Heart-Lung Foundation, the Torsten and Ragnar Soderberg Foundation, the Strategic Cardiovascular and Diabetes Programs of Karolinska Institutet and Stockholm County Council, the Foundation for Strategic Research and the Stockholm County Council (560283) The IMPROVE study was supported by the European Commission (Contract number: QLG1-CT-2002-00896), the Swedish Heart-Lung Foundation, the Swedish Research Council (projects 8691 and 0593), the Knut and Alice Wallenberg Foundation, the Foundation for Strategic Research, the Stockholm County Council (project 592229), the Strategic Cardiovascular and Diabetes Programmes of Karolinska Institutet and Stockholm County Council, the European Union Framework Programme 7 (FP7/2007-2013) for the Innovative Medicine Initiative under grant agreement no IMI/115006 (the SUMMIT consortium), the Academy of Finland (Grant #110413), the British Heart Foundation (RG2008/08, RG2008/014) and the Italian Ministry of Health (Ricerca Corrente). The present study was funded by a research grant from Stockholm County Council (grant n. 20130053 to BG) and a research grant from the the Swedish Heart-Lung Foundation (grant 20130220 to UdF). The funding organizations and/or sponsors have not had any role in the design or conduct of the study, the collection, management, analysis or interpretation of the data, writing and/or approving the manuscript.	Baldassarre D, 2010, EUR HEART J, V31, P614, DOI 10.1093/eurheartj/ehp496; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bland JM, 1996, BRIT MED J, V312, P1079; Crawford DC, 2005, ANNU REV MED, V56, P303, DOI 10.1146/annurev.med.56.082103.104540; Danik JS, 2009, CIRC-CARDIOVASC GENE, V2, P134, DOI 10.1161/CIRCGENETICS.108.825273; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; Elliott P, 2009, JAMA-J AM MED ASSOC, V302, P37, DOI 10.1001/jama.2009.954; Farrall M, 2006, PLOS GENET, V2, P755, DOI 10.1371/journal.pgen.0020072; Ferreira RC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003444; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Garbers C, 2014, BBA-MOL BASIS DIS, V1842, P1485, DOI 10.1016/j.bbadis.2014.05.018; Gigante B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011300; Gigante B, 2009, THROMB HAEMOSTASIS, V101, P943, DOI 10.1160/TH08-09-0612; Horiuchi S, 1998, IMMUNOLOGY, V95, P360, DOI 10.1046/j.1365-2567.1998.00622.x; Jurinke C, 2004, MOL BIOTECHNOL, V26, P147, DOI 10.1385/MB:26:2:147; Leander K, 2012, CLIN CHIM ACTA, V413, P727, DOI 10.1016/j.cca.2012.01.002; Marin V, 2001, J IMMUNOL, V167, P3435, DOI 10.4049/jimmunol.167.6.3435; McKellar GE, 2009, NAT REV CARDIOL, V6, P410, DOI 10.1038/nrcardio.2009.57; Pickard BS, 2009, MOL PSYCHIATR, V14, P874, DOI 10.1038/mp.2008.24; Qi L, 2009, DIABETES, V58, P275, DOI 10.2337/db08-0968; Rafiq S, 2007, GENES IMMUN, V8, P552, DOI 10.1038/sj.gene.6364414; Reuterwall C, 1999, J INTERN MED, V246, P161, DOI 10.1046/j.1365-2796.1999.00554.x; Revez JA, 2013, GENES IMMUN, V14, P441, DOI 10.1038/gene.2013.38; Sarwar N, 2012, LANCET, V379, P1205, DOI 10.1016/S0140-6736(11)61931-4; Schaid DJ, 2004, GENET EPIDEMIOL, V27, P348, DOI 10.1002/gepi.20037; Small KM, 2008, J CARDIOVASC PHARM, V51, P106, DOI 10.1097/FJC.0b013e31815a958f; Swerdlow DI, 2012, LANCET, V379, P1214, DOI 10.1016/S0140-6736(12)60110-X; Tregouet DA, 2007, BIOINFORMATICS, V23, P1038, DOI 10.1093/bioinformatics/btm058; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793	30	17	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119980	10.1371/journal.pone.0119980	http://dx.doi.org/10.1371/journal.pone.0119980			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781951	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000351284600114
J	Goldstein, JA; Prasad, V				Goldstein, Jeffery A.; Prasad, Vinay			Disease Specific Productivity of American Cancer Hospitals	PLOS ONE			English	Article							II CLINICAL-TRIALS; RESEARCH PERFORMANCE; H INDEX; ONCOLOGY; QUALITY; SURVIVAL; BENEFITS; OUTCOMES; TRENDS; RISKS	Context Research-oriented cancer hospitals in the United States treat and study patients with a range of diseases. Measures of disease specific research productivity, and comparison to overall productivity, are currently lacking. Hypothesis Different institutions are specialized in research of particular diseases. Objective To report disease specific productivity of American cancer hospitals, and propose a summary measure. Method We conducted a retrospective observational survey of the 50 highest ranked cancer hospitals in the 2013 US News and World Report rankings. We performed an automated search of PubMed and Clinicaltrials.gov for published reports and registrations of clinical trials (respectively) addressing specific cancers between 2008 and 2013. We calculated the summed impact factor for the publications. We generated a summary measure of productivity based on the number of Phase II clinical trials registered and the impact factor of Phase II clinical trials published for each institution and disease pair. We generated rankings based on this summary measure. Results We identified 6076 registered trials and 6516 published trials with a combined impact factor of 44280.4, involving 32 different diseases over the 50 institutions. Using a summary measure based on registered and published clinical trails, we ranked institutions in specific diseases. As expected, different institutions were highly ranked in disease-specific productivity for different diseases. 43 institutions appeared in the top 10 ranks for at least 1 disease (vs 10 in the overall list), while 6 different institutions were ranked number 1 in at least 1 disease (vs 1 in the overall list). Conclusion Research productivity varies considerably among the sample. Overall cancer productivity conceals great variation between diseases. Disease specific rankings identify sites of high academic productivity, which may be of interest to physicians, patients and researchers.	[Goldstein, Jeffery A.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37235 USA; [Prasad, Vinay] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Vanderbilt University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Goldstein, JA (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37235 USA.	jeffery.a.goldstein@vanderbilt.edu		Goldstein, Jeffery/0000-0002-4086-057X; Prasad, Vinayak/0000-0002-6110-8221				Aoun SG, 2013, WORLD NEUROSURG, V80, pE85, DOI 10.1016/j.wneu.2012.01.052; Bornmann L, 2009, EMBO REP, V10, P2, DOI 10.1038/embor.2008.233; Decullier E, 2009, PLOS MED, V6, P202, DOI 10.1371/journal.pmed.1000034; Eckhouse S, 2008, MOL ONCOL, V2, P20, DOI 10.1016/j.molonc.2008.03.007; El-Maraghi RH, 2008, J CLIN ONCOL, V26, P1346, DOI 10.1200/JCO.2007.13.5913; Green J, 1997, JAMA-J AM MED ASSOC, V277, P1152, DOI 10.1001/jama.277.14.1152; Hillner BE, 2000, J CLIN ONCOL, V18, P2327, DOI 10.1200/JCO.2000.18.11.2327; Horstmann E, 2005, NEW ENGL J MED, V352, P895, DOI 10.1056/NEJMsa042220; Huang MH, 2011, AM SOC INF SCI ANN M, V48, P1; Lamont EB, 2003, JNCI-J NATL CANCER I, V95, P1370, DOI 10.1093/jnci/djg035; Lane J, 2010, NATURE, V464, P488, DOI 10.1038/464488a; Munoz A, 2004, JNCI-J NATL CANCER I, V96, P411, DOI 10.1093/jnci/djh065; Onega T, 2009, MED CARE RES REV, V66, P542, DOI 10.1177/1077558709335536; Onega T, 2009, J GEN INTERN MED, V24, P205, DOI 10.1007/s11606-008-0863-y; Patel VM, 2011, J ROY SOC MED, V104, P251, DOI 10.1258/jrsm.2011.110005; Ponce FA, 2010, J NEUROSURG, V113, P447, DOI 10.3171/2010.3.JNS1032; Pope DG, 2009, J HEALTH ECON, V28, P1154, DOI 10.1016/j.jhealeco.2009.08.006; Prasad V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107803; Roberts TG, 2004, JAMA-J AM MED ASSOC, V292, P2130, DOI 10.1001/jama.292.17.2130; Rothberg MB, 2008, HEALTH AFFAIR, V27, P1680, DOI 10.1377/hlthaff.27.6.1680; Sharma B, 2013, SURGERY, V153, P493, DOI 10.1016/j.surg.2012.09.006	21	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0121233	10.1371/journal.pone.0121233	http://dx.doi.org/10.1371/journal.pone.0121233			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781329	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600199
J	Jokinen, J; Rinta-Kokko, H; Siira, L; Palmu, AA; Virtanen, MJ; Nohynek, H; Virolainen-Julkunen, A; Toropainen, M; Nuorti, JP				Jokinen, Jukka; Rinta-Kokko, Hanna; Siira, Lotta; Palmu, Arto A.; Virtanen, Mikko J.; Nohynek, Hanna; Virolainen-Julkunen, Anni; Toropainen, Maija; Nuorti, J. Pekka			Impact of Ten-Valent Pneumococcal Conjugate Vaccination on Invasive Pneumococcal Disease in Finnish Children - A Population-Based Study	PLOS ONE			English	Article							CLUSTER-RANDOMIZED-TRIAL; STREPTOCOCCUS-PNEUMONIAE; SEROTYPE REPLACEMENT; COLONIZATION; PHID-CV10; PROVINCE; ENGLAND; FINLAND; CANADA; TRENDS	Background The ten-valent pneumococcal conjugate vaccine (PCV10) was introduced into the Finnish National Vaccination Program (NVP) in September 2010 with a 2+1 schedule (3, 5, 12 months) without catch-up vaccinations. We evaluated the direct and indirect effects of PCV10 on invasive pneumococcal disease (IPD) among children <= 5 years of age during the first three years after NVP introduction. Methods We conducted a population-based, observational follow-up study. The cohort of vaccine-eligible children (all children born June 1, 2010 or later) was followed from 3 months of age until the end of 2013. For the indirect effect, another cohort of older children ineligible for PCV10 vaccination was followed from 2011 through 2013. Both cohorts were compared with season-and age-matched reference cohorts before NVP introduction. National, population-based laboratory surveillance data were used to compare culture-confirmed serotype-specific IPD rates in the vaccine target and reference cohorts by using Poisson regression models. Results The overall IPD rate among vaccine-eligible children was reduced by 80% (95% CI 72 to 85); the reduction in vaccine-type IPD was 92% (95% CI 86 to 95). However, a non-significant increase in non-vaccine type IPD was observed. During 2012-2013, we also observed a 48% (95% CI 18 to 69) reduction in IPD among unvaccinated children 2 to 5 years of age, which was mostly attributable to the ten vaccine serotypes. Conclusions This is the first population-based study investigating the impact of PCV10 introduction without prior PCV7 use. A substantial decrease in IPD rates among vaccine-eligible children was observed. A smaller and temporally delayed reduction among older, unvaccinated children suggests that PCV10 also provides indirect protection against vaccine-type IPD. Changes in serotype distribution warrant continuous monitoring of potential increases in non-vaccine serotypes.	[Jokinen, Jukka; Rinta-Kokko, Hanna; Palmu, Arto A.; Nohynek, Hanna] Natl Inst Hlth & Welf, Dept Vaccinat & Immune Protect, Helsinki, Finland; [Siira, Lotta; Virtanen, Mikko J.; Toropainen, Maija; Nuorti, J. Pekka] Natl Inst Hlth & Welf, Dept Infect Dis Surveillance & Control, Helsinki, Finland; [Virolainen-Julkunen, Anni] Minist Social Affairs & Hlth, Dept Promot Welf & Hlth, Helsinki, Finland; [Nuorti, J. Pekka] Univ Tampere, Sch Hlth Sci, Dept Epidemiol, FIN-33101 Tampere, Finland	Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; Tampere University	Jokinen, J (corresponding author), Natl Inst Hlth & Welf, Dept Vaccinat & Immune Protect, Helsinki, Finland.	jukka.jokinen@thl.fi		Siira, Lotta/0000-0002-0330-7396; Palmu, Arto A./0000-0001-8071-8896	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	The authors are or have been employees of the National Institute for Health and Welfare, which has received research funding from GlaxoSmithKline for a Nationwide effectiveness trial of the ten-valent pneumococcal conjugate vaccine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRESTI A, 2004, CATEGORICAL DATA ANA; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Darenberg J, 2014, 9TH INTERNATIONAL SY; De Wals P, 2014, VACCINE, V32, P1501, DOI 10.1016/j.vaccine.2013.11.028; De Wals P, 2012, VACCINE, V30, P6416, DOI 10.1016/j.vaccine.2012.08.017; Domingues CMAS, 2014, LANCET RESP MED, V2, P464, DOI 10.1016/S2213-2600(14)70060-8; GRAY BM, 1982, AM J EPIDEMIOL, V116, P692, DOI 10.1093/oxfordjournals.aje.a113452; Hanage WP, 2010, EPIDEMICS-NETH, V2, P80, DOI 10.1016/j.epidem.2010.03.005; Harboe ZB, 2014, CLIN INFECT DIS, V59, P1066, DOI 10.1093/cid/ciu524; Jokinen J, 2014, NORDIC VACCINE MEETI; Jokinen J, THL REPORT 34 2012; Jokinen J, 2014, 9TH INTERNATIONAL SY; Kayhty H, 2006, EXPERT REV VACCINES, V5, P651, DOI 10.1586/14760584.5.5.651; Klemets P, 2008, SCAND J INFECT DIS, V40, P621, DOI 10.1080/00365540801938931; Klemets P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-96; Ladhani SN, 2013, EMERG INFECT DIS, V19, P61, DOI 10.3201/eid1901.120741; Lim GH, 2013, VACCINE, V31, P2680, DOI 10.1016/j.vaccine.2013.04.007; Lucero MG, 2009, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD004977.PUB2; Martinelli D, 2014, HUM VACC IMMUNOTHER, V10, P33, DOI 10.4161/hv.26650; McCullagh P, 2002, GENERALIZED LINEAR M; Mereckiene J, 2014, INVASIVE PNEUMOCOCCA; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Nuorti P, 2002, LASTEN PNEUMOKOKKITA; Palmu AA, 2014, LANCET RESP MED, V2, P717, DOI 10.1016/S2213-2600(14)70139-0; Palmu AA, 2013, LANCET, V381, P214, DOI 10.1016/S0140-6736(12)61854-6; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Siira L, 2012, J CLIN MICROBIOL, V50, P2727, DOI 10.1128/JCM.00689-12; Siira L, 2009, ANTIMICROB AGENTS CH, V53, P2066, DOI 10.1128/AAC.01464-08; Tregnaghi MW, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001657	29	117	118	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120290	10.1371/journal.pone.0120290	http://dx.doi.org/10.1371/journal.pone.0120290			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781031	Green Published, gold, Green Submitted			2022-12-27	WOS:000351284600147
J	Kim, EH; Kim, S; Lee, JH; Kim, J; Han, Y; Kim, YM; Kim, GB; Jung, K; Cheong, HK; Ahn, K				Kim, Eun-Hye; Kim, Soyeon; Lee, Jung Hyun; Kim, Jihyun; Han, Youngshin; Kim, Young-Min; Kim, Gyo-Boong; Jung, Kweon; Cheong, Hae-Kwan; Ahn, Kangmo			Indoor Air Pollution Aggravates Symptoms of Atopic Dermatitis in Children	PLOS ONE			English	Article							SICK BUILDING SYNDROME; BARRIER FUNCTION; SKIN BARRIER; RISK-FACTORS; FORMALDEHYDE; ASSOCIATION; EXPOSURE; ECZEMA; POLLUTANTS; EMISSIONS	Most of researches on the impact of indoor air pollutants on atopic dermatitis (AD) have been based upon animal models, in vitro experiments and case-control studies. However, human data to elucidate the role of indoor air pollution on worsening symptoms of preexisting AD from a longitudinal study are scarce. The objective of this prospective study was to evaluate the effect of indoor air pollution on AD symptoms in children. We surveyed 30 children with AD in a day-care centre, which moved to a new building during the study. These children stayed there for 8 hours a day Monday through Friday, and their daily symptom scores were recorded. Indoor and outdoor air pollutant levels were continuously measured 24 hours a day for 12 months (Period 1 to 4). Data were analyzed using a generalized linear mixed model. Compared to the period before moving (Period 1), concentrations of indoor air pollutants mostly increased after moving (Period 2) and decreased by natural ventilation and bake-out (Periods 3 and 4). The rate of positive AD symptom increased from 32.8% (Period 1) up to 43.8%(Period 2) and 50.5% (Period 3), then decreased to 35.4% in Period 4 (P < 0.0001). When the delayed effects of indoor air pollutants on AD symptoms 2 days later were evaluated, AD symptoms significantly increased by 12.7% (95% CI: -0.01 to 27.1) as toluene levels increased by 1 ppb (P = 0.05). In conclusion, indoor air pollutants increase the risk of AD aggravation in children and toluene in the indoor environment might act as an aggravating factor.	[Kim, Eun-Hye; Kim, Soyeon; Cheong, Hae-Kwan] Sungkyunkwan Univ, Sch Med, Dept Social & Prevent Med, Suwon, South Korea; [Kim, Eun-Hye; Cheong, Hae-Kwan] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Seoul, South Korea; [Lee, Jung Hyun; Kim, Jihyun; Ahn, Kangmo] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, Seoul, South Korea; [Kim, Jihyun; Han, Youngshin; Kim, Young-Min; Ahn, Kangmo] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Environm Hlth Ctr Atop Dis, Seoul, South Korea; [Kim, Gyo-Boong; Jung, Kweon] Seoul Res Inst Publ Hlth & Environm, Seoul, South Korea	Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Cheong, HK (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Social & Prevent Med, Suwon, South Korea.	hkcheong@skku.edu; kmaped@gmail.com	Ahn, Kangmo/F-4609-2014	Cheong, Hae-Kwan/0000-0003-2758-9399	Ministry of Environment (MOE), Republic of Korea	Ministry of Environment (MOE), Republic of Korea	This study was financially supported by the Ministry of Environment (MOE), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 2014, J ALLERGY CLIN IMMUN, V134, P993, DOI 10.1016/j.jaci.2014.09.023; APTER A, 1994, J ALLERGY CLIN IMMUN, V94, P277, DOI 10.1016/0091-6749(94)90087-6; Arshad SH, 2005, CHEST, V127, P502, DOI 10.1378/chest.127.2.502; Bisgaard H, 2009, J ALLERGY CLIN IMMUN, V123, P651, DOI 10.1016/j.jaci.2008.11.036; Bornehag CG, 2004, ENVIRON HEALTH PERSP, V112, P1393, DOI 10.1289/ehp.7187; Ciencewicki J, 2008, J ALLERGY CLIN IMMUN, V122, P456, DOI 10.1016/j.jaci.2008.08.004; Eberlein-Konig B, 1998, J ALLERGY CLIN IMMUN, V101, P141, DOI 10.1016/S0091-6749(98)70212-X; Flamant-Hulin M, 2010, J TOXICOL ENV HEAL A, V73, P272, DOI 10.1080/15287390903249206; Futamura M, 2009, TOXICOLOGY, V255, P100, DOI 10.1016/j.tox.2008.10.012; Giusti F, 2001, PEDIATR DERMATOL, V18, P93, DOI 10.1046/j.1525-1470.2001.018002093.x; GUZELIAN PS, 1992, PEDIATRICS, V89, P353; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; Herbarth O, 2006, INT J HYG ENVIR HEAL, V209, P241, DOI 10.1016/j.ijheh.2006.01.003; Hodgson AT, 2002, INDOOR AIR, V12, P235, DOI 10.1034/j.1600-0668.2002.01129.x; Hulin M, 2012, EUR RESPIR J, V40, P1033, DOI 10.1183/09031936.00159011; Huss-Marp J, 2006, CLIN EXP ALLERGY, V36, P338, DOI 10.1111/j.1365-2222.2006.02448.x; Kang DH, 2010, BUILD ENVIRON, V45, P1816, DOI 10.1016/j.buildenv.2010.02.010; Kim J, 2013, J ALLERGY CLIN IMMUN, V132, P495, DOI 10.1016/j.jaci.2013.04.019; Kolarik B, 2008, ENVIRON HEALTH PERSP, V116, P98, DOI 10.1289/ehp.10498; Landrigan P J, 1998, Int J Occup Med Environ Health, V11, P189; Mann JK, 2010, ENVIRON HEALTH PERSP, V118, P1497, DOI 10.1289/ehp.0901292; Mendell MJ, 2007, INDOOR AIR, V17, P259, DOI 10.1111/j.1600-0668.2007.00478.x; MONTGOMERY MR, 1994, J ALLERGY CLIN IMMUN, V94, P371; Nakayama K, 2007, Int J Immunopathol Pharmacol, V20, P35; Nikolovski J, 2008, J INVEST DERMATOL, V128, P1728, DOI 10.1038/sj.jid.5701239; Norback D, 2009, CURR OPIN ALLERGY CL, V9, P55, DOI 10.1097/ACI.0b013e32831f8f08; Saito A, 2011, ENVIRON TOXICOL, V26, P224, DOI 10.1002/tox.20547; STALDER JF, 1993, DERMATOLOGY, V186, P23, DOI 10.1159/000247298; Xu BH, 2002, IMMUNOL LETT, V84, P49, DOI 10.1016/S0165-2478(02)00126-8	29	51	54	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119501	10.1371/journal.pone.0119501	http://dx.doi.org/10.1371/journal.pone.0119501			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781186	gold, Green Published, Green Submitted			2022-12-27	WOS:000351284600068
J	Lauriola, M; Iani, L				Lauriola, Marco; Iani, Luca			Does Positivity Mediate the Relation of Extraversion and Neuroticism with Subjective Happiness?	PLOS ONE			English	Article							GENERAL SELF-EFFICACY; CROSS-SECTIONAL ANALYSES; LIFE SATISFACTION; PERSONALITY-TRAITS; ESTEEM; BELIEFS; CONSTRUCT; GENETICS; BENEFITS; OPTIMISM	Recent theories suggest an important role of neuroticism, extraversion, attitudes, and global positive orientations as predictors of subjective happiness. We examined whether positivity mediates the hypothesized relations in a community sample of 504 adults between the ages of 20 and 60 years old (females = 50%). A model with significant paths from neuroticism to subjective happiness, from extraversion and neuroticism to positivity, and from positivity to subjective happiness fitted the data (Satorra-Bentler scaled chi-square (38) = 105.91; Comparative Fit Index =.96; Non-Normed Fit Index =.95; Root Mean Square Error of Approximation =.060; 90% confidence interval =.046, .073). The percentage of subjective happiness variance accounted for by personality traits was only about 48%, whereas adding positivity as a mediating factor increased the explained amount of subjective happiness to 78%. The mediation model was invariant by age and gender. The results show that the effect of extraversion on happiness was fully mediated by positivity, whereas the effect of neuroticism was only partially mediated. Implications for happiness studies are also discussed.	[Lauriola, Marco] Univ Roma La Sapienza, Dept Social & Dev Psychol, I-00185 Rome, Italy; [Iani, Luca] European Univ Rome, Dept Human Sci, Rome, Italy	Sapienza University Rome; European University of Rome	Iani, L (corresponding author), European Univ Rome, Dept Human Sci, Rome, Italy.	luca.iani@unier.it	Iani, Luca/C-9144-2018					Albuquerque I, 2012, SOC INDIC RES, V105, P447, DOI 10.1007/s11205-010-9780-7; ARGYLE M, 1990, PERS INDIV DIFFER, V11, P1011, DOI 10.1016/0191-8869(90)90128-E; Armor DJ, 1974, SOCIOLOGICAL METHODS, P17; Baumeister RF, 2003, PSYCHOL SCI, P1, DOI 10.1111/1529-1006.01431; Bentler P.M., 2005, EQS STRUCTURAL EQUAT; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bleidorn W, 2014, EUR J PERSONALITY, V28, P244, DOI 10.1002/per.1957; Boehm J. K., 2020, OXFORD HDB POSITIVE, V3rd, P667, DOI DOI 10.1093/OXFORDHB/9780195187243.013.0063; Browne M. W., 1993, TESTING STRUCTURAL E, P136, DOI DOI 10.1177/0049124192021002005; Brunwasser SM, 2009, J CONSULT CLIN PSYCH, V77, P1042, DOI 10.1037/a0017671; Byrne B.M., 2010, STRUCTURAL EQUATION, DOI DOI 10.4324/9781410600219; Caprara, 2009, EUROPEAN HLTH PSYCHO, V11, P46; Caprara GV, 2012, PSYCHOL ASSESSMENT, V24, P701, DOI 10.1037/a0026681; Cohen J.E., 1988, STAT POWER ANAL BEHA; Del Giudice M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029265; DeNeve KM, 1998, PSYCHOL BULL, V124, P197, DOI 10.1037/0033-2909.124.2.197; DIENER E, 1995, J PERS SOC PSYCHOL, V68, P653, DOI 10.1037/0022-3514.68.4.653; Diener E, 1999, PSYCHOL BULL, V125, P276, DOI 10.1037//0033-2909.125.2.276; Diener E., 1999, WELL BEING FDN HEDON, P213, DOI DOI 10.1037/0003-066X.61.4.305; Donnellan AB, 2008, PSYCHOL AGING, V23, P558, DOI 10.1037/a0012897; Duncan E, 2013, J HAPPINESS STUD, V14, P1145, DOI 10.1007/s10902-012-9372-0; Dweck CS, 2008, CURR DIR PSYCHOL SCI, V17, P391, DOI 10.1111/j.1467-8721.2008.00612.x; Furnham A, 2000, SOC PSYCH PSYCH EPID, V35, P463, DOI 10.1007/s001270050265; Gale CR, 2013, J RES PERS, V47, P687, DOI 10.1016/j.jrp.2013.06.005; Gallagher MW, 2009, J PERS, V77, P1025, DOI 10.1111/j.1467-6494.2009.00573.x; Gillham J.E., 2001, OPTIMISM PESSIMISM I, P53, DOI [https://doi.org/10.1037/10385-003, DOI 10.1037/10385-003, DOI 10.1037/10385-000]; Hampson SE, 2012, ANNU REV PSYCHOL, V63, P315, DOI 10.1146/annurev-psych-120710-100419; HATTIE J, 1985, APPL PSYCH MEAS, V9, P139, DOI 10.1177/014662168500900204; Hills P, 2001, PERS INDIV DIFFER, V30, P595, DOI 10.1016/S0191-8869(00)00058-1; Hills P, 2001, PERS INDIV DIFFER, V31, P1357, DOI 10.1016/S0191-8869(00)00229-4; Hoffart A, 2002, BEHAV RES THER, V40, P611, DOI 10.1016/S0005-7967(01)00027-4; Howell RT, 2010, BEHAV RES METHODS, V42, P775, DOI 10.3758/BRM.42.3.775; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Iani L, 2014, SOC INDIC RES, V118, P953, DOI 10.1007/s11205-013-0468-7; ISTAT, LAB FORC SURV; John O.P., 1999, HDB PERSONALITY THEO, V1999, P102, DOI DOI 10.1037/A0019265; Kashdan TB, 2007, MOTIV EMOTION, V31, P159, DOI [10.1007/s11031-007-9068-7, 10.1007/s11031-007-9074-9]; Kline R.B., 2011, PRINCIPLES PRACTICE; Lattriola M, 2000, PSYCHOL HEALTH, V15, P539; Lightsey OR, 2013, J HAPPINESS STUD, V14, P115, DOI 10.1007/s10902-011-9319-x; Little TD, 2002, STRUCT EQU MODELING, V9, P151, DOI 10.1207/S15328007SEM0902_1; Lu L, 1997, PERS INDIV DIFFER, V22, P249, DOI 10.1016/S0191-8869(96)00187-0; Lucas RE, 2008, J PERS, V76, P385, DOI 10.1111/j.1467-6494.2008.00490.x; Luhmann M, 2012, J PERS SOC PSYCHOL, V102, P592, DOI 10.1037/a0025948; Lykken D, 1996, PSYCHOL SCI, V7, P186, DOI 10.1111/j.1467-9280.1996.tb00355.x; Lyubomirsky S, 2005, PSYCHOL BULL, V131, P803, DOI 10.1037/0033-2909.131.6.803; Lyubomirsky S, 2005, REV GEN PSYCHOL, V9, P111, DOI 10.1037/1089-2680.9.2.111; Lyubomirsky S, 1999, SOC INDIC RES, V46, P137, DOI 10.1023/A:1006824100041; Lyubomirsky S., 2006, J HAPPINESS STUD, V7, P183, DOI [DOI 10.1007/S10902-005-4754-1, 10.1007/s10902-005-4754-1]; Lyubomirsky S, 2006, SOC INDIC RES, V78, P363, DOI 10.1007/s11205-005-0213-y; Lyubomirsky S, 2013, CURR DIR PSYCHOL SCI, V22, P57, DOI 10.1177/0963721412469809; MacKinnon DP, 2002, PSYCHOL METHODS, V7, P83, DOI 10.1037/1082-989X.7.1.83; MacKinnon DP., 2008, INTRO STAT MEDIATION; Quevedo RJM, 2011, PERS INDIV DIFFER, V50, P206, DOI 10.1016/j.paid.2010.09.030; Maxwell SE, 2007, PSYCHOL METHODS, V12, P23, DOI 10.1037/1082-989X.12.1.23; Maxwell SE, 2011, MULTIVAR BEHAV RES, V46, P816, DOI 10.1080/00273171.2011.606716; McConnell AR, 2011, J PERS SOC PSYCHOL, V101, P1239, DOI 10.1037/a0024506; McCrae RR, 2009, CAMBRIDGE HANDBOOK OF PERSONALITY PSYCHOLOGY, P148; McCrae RR, 2000, J PERS SOC PSYCHOL, V78, P173, DOI 10.1037/0022-3514.78.1.173; McMahan EA, 2012, J HAPPINESS STUD, V13, P79, DOI 10.1007/s10902-011-9251-0; Myers JE, 2011, J COUNS DEV, V89, P28, DOI 10.1002/j.1556-6678.2011.tb00058.x; Neff KD, 2007, J RES PERS, V41, P908, DOI 10.1016/j.jrp.2006.08.002; Pepping CA, 2013, J POSIT PSYCHOL, V8, P376, DOI 10.1080/17439760.2013.807353; Purvis A, 2011, PERS INDIV DIFFER, V50, P370, DOI 10.1016/j.paid.2010.10.023; Rosenberg M., 1965, SOC ADOLESCENT SELF, DOI 10.1515/9781400876136; Samson AC, 2011, SWISS J PSYCHOL, V70, P53, DOI 10.1024/1421-0185/a000039; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Schimmack U, 2004, PERS SOC PSYCHOL B, V30, P1062, DOI 10.1177/0146167204264292; Scholz U, 2002, EUR J PSYCHOL ASSESS, V18, P242, DOI 10.1027//1015-5759.18.3.242; Schwartz B, 2002, J PERS SOC PSYCHOL, V83, P1178, DOI 10.1037//0022-3514.83.5.1178; Schwarzer R, 1997, APPL PSYCHOL-INT REV, V46, P69, DOI 10.1111/j.1464-0597.1997.tb01096.x; Sporrle M, 2010, PSICOTHEMA, V22, P543; Steel P, 2008, PSYCHOL BULL, V134, P138, DOI 10.1037/0033-2909.134.1.138; Strobel M, 2011, SCAND J PSYCHOL, V52, P43, DOI 10.1111/j.1467-9450.2010.00826.x; Taylor AB, 2008, ORGAN RES METHODS, V11, P241, DOI 10.1177/1094428107300344; Warner RM, 2011, J HAPPINESS STUD, V12, P1063, DOI 10.1007/s10902-010-9245-3; Weber M, 2013, PERS INDIV DIFFER, V55, P322, DOI 10.1016/j.paid.2013.03.006; Weiss A, 2008, PSYCHOL SCI, V19, P205, DOI 10.1111/j.1467-9280.2008.02068.x; Zentner M., 2008, EUROPEAN J DEV SCI, V2, P7, DOI [DOI 10.3233/DEV-2008-21203, 10.3233/DEV-2008-21203]; Zhang JW, 2013, J HAPPINESS STUD, V14, P169, DOI 10.1007/s10902-012-9322-x; Zweig JS, J HAPPINESS IN PRESS	81	25	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0121991	10.1371/journal.pone.0121991	http://dx.doi.org/10.1371/journal.pone.0121991			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7QC	25781887	Green Submitted, Green Published, gold			2022-12-27	WOS:000351284600212
J	Valpione, S; Moser, JC; Parrozzani, R; Bazzi, M; Mansfield, AS; Mocellin, S; Pigozzo, J; Midena, E; Markovic, SN; Aliberti, C; Campana, LG; Chiarion-Sileni, V				Valpione, Sara; Moser, Justin C.; Parrozzani, Raffaele; Bazzi, Marco; Mansfield, Aaron S.; Mocellin, Simone; Pigozzo, Jacopo; Midena, Edoardo; Markovic, Svetomir N.; Aliberti, Camillo; Campana, Luca G.; Chiarion-Sileni, Vanna			Development and External Validation of a Prognostic Nomogram for Metastatic Uveal Melanoma	PLOS ONE			English	Article							NEEDLE-ASPIRATION BIOPSY; OCULAR MELANOMA; LIVER METASTASES; CHOROIDAL MELANOMA; FREE SURVIVAL; IV MELANOMA; STAGE-III; FOLLOW-UP; EXPERIENCE; INTRAARTERIAL	Background Approximately 50% of patients with uveal melanoma (UM) will develop metastatic disease, usually involving the liver. The outcome of metastatic UM (mUM) is generally poor and no standard therapy has been established. Additionally, clinicians lack a validated prognostic tool to evaluate these patients. The aim of this work was to develop a reliable prognostic nomogram for clinicians. Patients and Methods Two cohorts of mUM patients, from Veneto Oncology Institute (IOV) (N=152) and Mayo Clinic (MC) (N=102), were analyzed to develop and externally validate, a prognostic nomogram. Results The median survival of mUM was 17.2 months in the IOV cohort and 19.7 in the MC cohort. Percentage of liver involvement (HR 1.6), elevated levels of serum LDH (HR 1.6), and a WHO performance status=1 (HR 1.5) or 2-3 (HR 4.6) were associated with worse prognosis. Longer disease-free interval from diagnosis of UM to that of mUM conferred a survival advantage (HR 0.9). The nomogram had a concordance probability of 0.75 (SE.006) in the development dataset (IOV), and 0.80 (SE.009) in the external validation (MC). Nomogram predictions were well calibrated. Conclusions The nomogram, which includes percentage of liver involvement, LDH levels, WHO performance status and disease free-interval accurately predicts the prognosis of mUM and could be useful for decision-making and risk stratification for clinical trials.	[Valpione, Sara; Pigozzo, Jacopo; Chiarion-Sileni, Vanna] Veneto Reg Oncol Res Inst IOV IRCCS, Melanoma Oncol Unit, Padua, Italy; [Valpione, Sara; Mocellin, Simone] Dept Surg Oncol & Gastroenterol, Padua, Italy; [Moser, Justin C.] Mayo Clin, Dept Internal Med, Rochester, MN USA; [Parrozzani, Raffaele] GB Bietti Fdn IRCCS, Rome, Italy; [Bazzi, Marco; Midena, Edoardo] Univ Padua, Dept Stat Sci, Padua, Italy; [Mansfield, Aaron S.; Markovic, Svetomir N.] Mayo Clin, Div Med Oncol, Rochester, MN USA; [Midena, Edoardo] Univ Padua, Dept Ophthalmol, Padua, Italy; [Aliberti, Camillo] Veneto Reg Oncol Res Inst IOV IRCCS, Intervent Radiol, Padua, Italy; [Campana, Luca G.] Veneto Reg Oncol Res Inst IOV IRCCS, Sarcoma & Melanoma Unit, Padua, Italy	IRCCS Istituto Oncologico Veneto (IOV); Mayo Clinic; IRCCS - Fondazione "G.B. Bietti" per lo Studio e la Ricerca in Oftalmologia; University of Padua; Mayo Clinic; University of Padua; IRCCS Istituto Oncologico Veneto (IOV); IRCCS Istituto Oncologico Veneto (IOV)	Valpione, S (corresponding author), Veneto Reg Oncol Res Inst IOV IRCCS, Melanoma Oncol Unit, Padua, Italy.	sara.valpione@ioveneto.it	parrozzani, raffaele/K-2034-2016; Pigozzo, Jacopo/K-2503-2016; Midena, Edoardo/AAB-6010-2020; sileni, vanna chiarion/B-9042-2018; Valpione, Sara/C-4051-2014; Campana, Luca/R-4799-2016; Parrozzani, Raffaele/W-3341-2017; Mansfield, Aaron/AAQ-8298-2021; Pigozzo, Jacopo/AAD-5994-2021; MOCELLIN, SIMONE/AID-6338-2022	parrozzani, raffaele/0000-0003-0216-727X; Pigozzo, Jacopo/0000-0003-2427-8915; sileni, vanna chiarion/0000-0001-9191-9124; Valpione, Sara/0000-0002-1699-2548; Parrozzani, Raffaele/0000-0003-0216-727X; Mansfield, Aaron/0000-0002-9483-6903; Pigozzo, Jacopo/0000-0003-2427-8915; MOCELLIN, SIMONE/0000-0002-9433-8445; Valpione, Sara/0000-0001-9641-3819; CAMPANA, LUCA GIOVANNI/0000-0002-8466-8459	Ministry of Health; Fondazione Roma	Ministry of Health; Fondazione Roma(Fondazione RomaEuropean Commission)	Partial results were presented at the EORTC Melanoma Group spring meeting 2014. The ophthalmological part of the research for this paper was supported by Ministry of Health and Fondazione Roma.	Augsburger James J, 2007, Trans Am Ophthalmol Soc, V105, P54; Augsburger JJ, 2009, AM J OPHTHALMOL, V148, P119, DOI 10.1016/j.ajo.2009.01.023; Augsburger JJ, 2007, T AM OPHTHAL SOC, V105, P9; BEDIKIAN AY, 1995, CANCER, V76, P1665, DOI 10.1002/1097-0142(19951101)76:9<1665::AID-CNCR2820760925>3.0.CO;2-J; BEDIKIAN AY, 1981, SOUTHERN MED J, V74, P574, DOI 10.1097/00007611-198105000-00017; Bonaldi L, 2008, J CANCER RES CLIN, V134, P1123, DOI 10.1007/s00432-008-0382-6; Brozyna AA, 2008, INT J CANCER, V123, P1448, DOI 10.1002/ijc.23664; Brozyna AA, 2013, HUM PATHOL, V44, P2071, DOI 10.1016/j.humpath.2013.02.022; Carvajal RD, 2014, JAMA-J AM MED ASSOC, V311, P2397, DOI 10.1001/jama.2014.6096; Cruz F, 2003, CANCER RES, V63, P5761; Diener-West M, 2005, ARCH OPHTHALMOL-CHIC, V123, P1639; Diener-West M, 2004, J CLIN ONCOL, V22, P2438, DOI 10.1200/jco.2004.08.194; DORVAL T, 1992, EUR J CANCER, V28A, P2087, DOI 10.1016/0959-8049(92)90266-5; Eskelin S, 2003, CANCER-AM CANCER SOC, V97, P465, DOI 10.1002/cncr.11113; Ewens KG, 2013, INVEST OPHTH VIS SCI, V54, P5721, DOI 10.1167/iovs.13-12195; Falchook GS, 2012, LANCET ONCOL, V13, P782, DOI 10.1016/S1470-2045(12)70269-3; Feldman ED, 2004, ANN SURG ONCOL, V11, P290, DOI 10.1245/ASO.2004.07.004; Fiorentini G, 2009, IN VIVO, V23, P131; Gold JS, 2009, LANCET ONCOL, V10, P1045, DOI 10.1016/S1470-2045(09)70242-6; Gonsalves CF, 2011, AM J ROENTGENOL, V196, P468, DOI 10.2214/AJR.10.4881; GRAGOUDAS ES, 1991, OPHTHALMOLOGY, V98, P383; Hsueh EC, 2004, CANCER, V100, P122, DOI 10.1002/cncr.11872; KATH R, 1993, CANCER, V72, P2219, DOI 10.1002/1097-0142(19931001)72:7<2219::AID-CNCR2820720725>3.0.CO;2-J; Kivela T, 2003, EUR J CANCER, V39, P1115, DOI 10.1016/S0959-8049(03)00132-1; Kodjikian L, 2005, GRAEF ARCH CLIN EXP, V243, P985, DOI 10.1007/s00417-005-1188-8; Leyvraz S, 2014, ANN ONCOL, V25, P742, DOI 10.1093/annonc/mdt585; Leyvraz S, 2012, CURR OPIN ONCOL, V24, P162, DOI 10.1097/CCO.0b013e32834ff069; Maio M, 2013, ANN ONCOL, V24, P2911, DOI 10.1093/annonc/mdt376; Mallone S, 2012, EUR J CANCER, V48, P1167, DOI 10.1016/j.ejca.2011.10.004; Mariani P, 2012, DEV OPHTHALMOL, V49, P166, DOI 10.1159/000328333; Midena E, 2006, EUR J OPHTHALMOL, V16, P422, DOI 10.1177/112067210601600310; Midena E, 2008, GRAEF ARCH CLIN EXP, V246, P609, DOI 10.1007/s00417-007-0692-4; Moser JC, 2015, MELANOMA RES, V25, P59, DOI 10.1097/CMR.0000000000000125; Olofsson R, 2013, ANN SURG ONCOL; Onken MD, 2004, CANCER RES, V64, P7205, DOI 10.1158/0008-5472.CAN-04-1750; Peters S, 2006, ANN ONCOL, V17, P578, DOI 10.1093/annonc/mdl009; RAJPAL S, 1983, CANCER, V52, P334, DOI 10.1002/1097-0142(19830715)52:2<334::AID-CNCR2820520225>3.0.CO;2-E; Rietschel P, 2005, J CLIN ONCOL, V23, P8076, DOI 10.1200/JCO.2005.02.6534; Sato T, 2008, J CLIN ONCOL, V26, P5436, DOI 10.1200/JCO.2008.16.0705; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Slominski A, 2009, INT J CANCER, V124, P1470, DOI 10.1002/ijc.24005; Slominski AT, 2014, MAYO CLIN PROC, V89, P429, DOI 10.1016/j.mayocp.2014.02.009; Tarhini AA, 2011, CLIN CANCER RES, V17, P6574, DOI 10.1158/1078-0432.CCR-11-1463; Thomas S, 2012, BRIT J CANCER, V106, P1171, DOI 10.1038/bjc.2012.54; Valpione S, 2015, MELANOMA RES; Valsecchi ME, 2013, EXPERT OPIN INV DRUG, V22, P1473, DOI 10.1517/13543784.2013.837449	46	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120181	10.1371/journal.pone.0120181	http://dx.doi.org/10.1371/journal.pone.0120181			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25780931	gold, Green Submitted, Green Published			2022-12-27	WOS:000351284600136
J	Ebneter, A; Agca, C; Dysli, C; Zinkernagel, MS				Ebneter, Andreas; Agca, Cavit; Dysli, Chantal; Zinkernagel, Martin S.			Investigation of Retinal Morphology Alterations Using Spectral Domain Optical Coherence Tomography in a Mouse Model of Retinal Branch and Central Retinal Vein Occlusion	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CYSTOID MACULAR EDEMA; RISK-FACTORS; RAT MODEL; NEOVASCULARIZATION; INTERLEUKIN-6; PATHOGENESIS; MICE	Retinal vein occlusion is a leading cause of visual impairment. Experimental models of this condition based on laser photocoagulation of retinal veins have been described and extensively exploited in mammals and larger rodents such as the rat. However, few reports exist on the use of this paradigm in the mouse. The objective of this study was to investigate a model of branch and central retinal vein occlusion in the mouse and characterize in vivo longitudinal retinal morphology alterations using spectral domain optical coherence tomography. Retinal veins were experimentally occluded using laser photocoagulation after intravenous application of Rose Bengal, a photo-activator dye enhancing thrombus formation. Depending on the number of veins occluded, variable amounts of capillary dropout were seen on fluorescein angiography. Vascular endothelial growth factor levels were markedly elevated early and peaked at day one. Retinal thickness measurements with spectral domain optical coherence tomography showed significant swelling (p<0.001) compared to baseline, followed by gradual thinning plateauing two weeks after the experimental intervention (p<0.001). Histological findings at day seven correlated with spectral domain optical coherence tomography imaging. The inner layers were predominantly affected by degeneration with the outer nuclear layer and the photoreceptor outer segments largely preserved. The application of this retinal vein occlusion model in the mouse carries several advantages over its use in other larger species, such as access to a vast range of genetically modified animals. Retinal changes after experimental retinal vein occlusion in this mouse model can be non-invasively quantified by spectral domain optical coherence tomography, and may be used to monitor effects of potential therapeutic interventions.	[Zinkernagel, Martin S.] Univ Hosp Bern, Dept Ophthalmol, Inselspital, CH-3010 Bern, Switzerland; Univ Bern, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern	Zinkernagel, MS (corresponding author), Univ Hosp Bern, Dept Ophthalmol, Inselspital, CH-3010 Bern, Switzerland.	martin.zinkernagel@insel.ch	Zinkernagel, Martin/C-3799-2017; Agca, Cavit/AAY-9574-2020; Ebneter, Andreas/C-5226-2017	Zinkernagel, Martin/0000-0002-5622-114X; Agca, Cavit/0000-0001-8472-7052; Ebneter, Andreas/0000-0001-6666-2558; Zinkernagel, Martin S./0000-0003-3447-2359	Inselspital Bern; OPOS foundation	Inselspital Bern; OPOS foundation	These studies were supported by grants from the Inselspital Bern and the OPOS foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameri H, 2008, GRAEF ARCH CLIN EXP, V246, P1429, DOI 10.1007/s00417-008-0878-4; Bek T, 2009, ACTA OPHTHALMOL, V87, P362, DOI 10.1111/j.1755-3768.2008.01429.x; Berger A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096494; Bringmann A, 2004, OPHTHALMIC RES, V36, P241, DOI 10.1159/000081203; CAMPBELL FP, 1961, ARCH OPHTHALMOL-CHIC, V65, P2, DOI 10.1001/archopht.1961.01840020004002; Campochiaro PA, 2012, OPHTHALMOLOGICA, V227, P30, DOI 10.1159/000337157; Chidlow G, 2006, INVEST OPHTH VIS SCI, V54, P2319, DOI DOI 10.1167/IOVS.12-11204; Chuang LH, 2011, OPHTHALMIC RES, V45, P31, DOI 10.1159/000315617; Comyn O, 2013, CURR OPIN OPHTHALMOL, V24, P248, DOI 10.1097/ICU.0b013e32835fab27; Ehlers JP, 2011, SURV OPHTHALMOL, V56, P281, DOI 10.1016/j.survophthal.2010.11.006; Fischer M Dominik, 2013, Methods Mol Biol, V935, P79, DOI 10.1007/978-1-62703-080-9_5; Fischer MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007507; Genevois O, 2004, INVEST OPHTH VIS SCI, V45, P594, DOI 10.1167/iovs.03-0764; Grant MB, 2002, NAT MED, V8, P607, DOI 10.1038/nm0602-607; Jaulim A, 2013, RETINA-J RET VIT DIS, V33, P901, DOI 10.1097/IAE.0b013e3182870c15; Karia N, 2010, CLIN OPHTHALMOL, V4, P809; Lozano DC, 2013, INVEST OPHTH VIS SCI, V54, P6446, DOI 10.1167/iovs.13-12575; Maier R, 2011, OPHTHALMOLOGY, V118, P1125, DOI 10.1016/j.ophtha.2010.10.014; McAllister IL, 2013, INVEST OPHTH VIS SCI, V54, P4910, DOI 10.1167/iovs.13-11967; McAllister IL, 2012, CLIN EXP OPHTHALMOL, V40, P48, DOI 10.1111/j.1442-9071.2011.02713.x; McAllister IL, 2010, OPHTHALMOLOGY, V117, P954, DOI 10.1016/j.ophtha.2009.10.026; Mendrinos E, 2011, INVEST OPHTH VIS SCI, V52, P3215, DOI 10.1167/iovs.10-6888; Nakao S, 2013, INVEST OPHTH VIS SCI, V54, P5288, DOI 10.1167/iovs.13-11946; Noma H, 2005, AM J OPHTHALMOL, V140, P256, DOI 10.1016/j.ajo.2005.03.003; Noma H, 2013, JAMA OPHTHALMOL, V131, P160, DOI 10.1001/2013.jamaophthalmol.228; Noma H, 2009, OPHTHALMOLOGY, V116, P87, DOI 10.1016/j.ophtha.2008.09.034; O'Mahoney PRA, 2008, ARCH OPHTHALMOL-CHIC, V126, P692, DOI 10.1001/archopht.126.5.692; Paques M, 2003, INVEST OPHTH VIS SCI, V44, P4960, DOI 10.1167/iovs.02-0738; Park SP, 2010, RETINA-J RET VIT DIS, V30, P281, DOI 10.1097/IAE.0b013e3181b9f153; Rehak M, 2011, GRAEF ARCH CLIN EXP, V249, P1175, DOI 10.1007/s00417-011-1683-z; Rogers S, 2010, OPHTHALMOLOGY, V117, P313, DOI [10.1016/j.ophtha.2009.07.017, 10.1016/j.ophtha.2010.01.060]; Scheppke L, 2008, J CLIN INVEST, V118, P2337, DOI [10.1172/JC133361, 10.1172/JCI33361]; Scholl S, 2010, OPHTHALMOLOGICA, V224, P8, DOI 10.1159/000315155; Shen LJ, 2009, CURR EYE RES, V34, P415, DOI 10.1080/02713680902862989; Tameesh MK, 2004, AM J OPHTHALMOL, V138, P829, DOI 10.1016/j.ajo.2004.06.083; Weinberg DV, 2013, RETINA-J RET VIT DIS, V33, P287, DOI 10.1097/IAE.0b013e318263d106; WILSON CA, 1991, INVEST OPHTH VIS SCI, V32, P2357; WOLF S, 1994, GRAEF ARCH CLIN EXP, V232, P33, DOI 10.1007/BF00176435; YANOFF M, 1984, SURV OPHTHALMOL, V28, P505, DOI 10.1016/0039-6257(84)90233-9; Zhang H, 2007, JPN J OPHTHALMOL, V51, P251, DOI 10.1007/s10384-007-0445-2; Zhang Y, 2008, CURR EYE RES, V33, P365, DOI 10.1080/02713680801939318	41	36	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119046	10.1371/journal.pone.0119046	http://dx.doi.org/10.1371/journal.pone.0119046			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775456	Green Submitted, Green Published, gold			2022-12-27	WOS:000351183500065
J	Lee, IH; Song, SH; Cook, DI; Dinudom, A				Lee, Il-Ha; Song, Sung-Hee; Cook, David I.; Dinudom, Anuwat			H-Ras Mediates the Inhibitory Effect of Epidermal Growth Factor on the Epithelial Na+ Channel	PLOS ONE			English	Article							PHOSPHOINOSITIDE 3-OH KINASE; SODIUM-CHANNEL; ENAC REGULATION; DOWN-REGULATION; ALPHA-SUBUNIT; LIPID RAFTS; PROTEIN; EGF; CELLS; CAVEOLIN-1	The present study investigates the role of small G-proteins of the Ras family in the epidermal growth factor (EGF)-activated cellular signalling pathway that downregulates activity of the epithelial Na+ channel (ENaC). We found that H-Ras is a key component of this EGF-activated cellular signalling mechanism in M1 mouse collecting duct cells. Expression of a constitutively active H-Ras mutant inhibited the amiloride-sensitive current. The H-Ras-mediated signalling pathway that inhibits activity of ENaC involves c-Raf, and that the inhibitory effect of H-Ras on ENaC is abolished by the MEK1/2 inhibitor, PD98059. The inhibitory effect of H-Ras is not mediated by Nedd4-2, a ubiquitin protein ligase that regulates the abundance of ENaC at the cell surface membrane, or by a negative effect of H-Ras on proteolytic activation of the channel. The inhibitory effects of EGF and H-Ras on ENaC, however, were not observed in cells in which expression of caveolin-1 (Cav-1) had been knocked down by siRNA. These findings suggest that the inhibitory effect of EGF on ENaC-dependent Na+ absorption is mediated via the H-Ras/c-Raf, MEK/ERK signalling pathway, and that Cav-1 is an essential component of this EGF-activated signalling mechanism. Taken together with reports that mice expressing a constitutive mutant of H-Ras develop renal cysts, our findings suggest that H-Ras may play a key role in the regulation of renal ion transport and renal development.	[Lee, Il-Ha; Song, Sung-Hee; Cook, David I.; Dinudom, Anuwat] Univ Sydney, Sch Med Sci, Bosch Inst, Discipline Physiol, Sydney, NSW 2006, Australia	University of Sydney	Dinudom, A (corresponding author), Univ Sydney, Sch Med Sci, Bosch Inst, Discipline Physiol, Sydney, NSW 2006, Australia.	anuwat@physiol.usyd.edu.au			National Health and Medical Research Council of Australia [10027447]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Funding provided by National Health and Medical Research Council of Australia, grant number 10027447, https://www.nhmrc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agelaki S, 2009, CANCER BIOL THER, V8, P1470, DOI 10.4161/cbt.8.15.8939; Ambesi-Impiombato F S, 1979, Int Rev Cytol Suppl, P163; Baines DL, 2010, PFLUG ARCH EUR J PHY, V459, P451, DOI 10.1007/s00424-009-0717-4; Cao LS, 2005, BIOCHEM BIOPH RES CO, V331, P503, DOI 10.1016/j.bbrc.2005.03.201; Carattino MD, 2008, J BIOL CHEM, V283, P25290, DOI 10.1074/jbc.M803931200; Castellano Esther, 2011, Genes Cancer, V2, P216, DOI 10.1177/1947601911408081; DHAND R, 1994, EMBO J, V13, P511, DOI 10.1002/j.1460-2075.1994.tb06289.x; Eaton DC, 2001, J MEMBRANE BIOL, V184, P313, DOI 10.1007/s00232-001-0098-x; Falin R, 2005, AM J PHYSIOL-CELL PH, V288, pC1003, DOI 10.1152/ajpcell.00213.2004; Falin RA, 2007, J GEN PHYSIOL, V130, P313, DOI 10.1085/jgp.200709775; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; Galbiati F, 1998, EMBO J, V17, P6633, DOI 10.1093/emboj/17.22.6633; Gesualdo L, 1996, KIDNEY INT, V49, P656, DOI 10.1038/ki.1996.94; Gilbert E, 1997, INT J CANCER, V73, P749, DOI 10.1002/(SICI)1097-0215(19971127)73:5<749::AID-IJC23>3.0.CO;2-#; Giovannardi S, 2002, J BIOL CHEM, V277, P12158, DOI 10.1074/jbc.M110466200; Grossmann C, 2004, AM J PHYSIOL-RENAL, V286, pF1226, DOI 10.1152/ajprenal.00378.2003; HAHNEL C, 1992, EUR J NEUROSCI, V4, P361, DOI 10.1111/j.1460-9568.1992.tb00883.x; Hendron E, 2002, MOL BIOL CELL, V13, P3042, DOI 10.1091/mbc.E02-05-0260; Hill WG, 2002, J BIOL CHEM, V277, P33541, DOI 10.1074/jbc.C200309200; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Hummler E, 1999, AM J PHYSIOL-GASTR L, V276, pG567, DOI 10.1152/ajpgi.1999.276.3.G567; Hummler E, 1997, P NATL ACAD SCI USA, V94, P11710, DOI 10.1073/pnas.94.21.11710; Ilatovskaya DV, 2013, AM J PHYSIOL-CELL PH, V304, pC102, DOI 10.1152/ajpcell.00231.2012; Je HD, 2004, AM J PHYSIOL-HEART C, V286, pH91, DOI 10.1152/ajpheart.00472.2003; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Ko B, 2007, P NATL ACAD SCI USA, V104, P20120, DOI 10.1073/pnas.0709506104; Kocher HM, 2003, NEPHROL DIAL TRANSPL, V18, P2284, DOI 10.1093/ndt/gfg375; Lee IH, 2007, J BIOL CHEM, V282, P29866, DOI 10.1074/jbc.M701923200; Lee IH, 2011, J BIOL CHEM, V286, P19259, DOI 10.1074/jbc.M111.239772; Lee IH, 2009, J BIOL CHEM, V284, P12663, DOI 10.1074/jbc.M809737200; Levchenko V, 2010, J CELL PHYSIOL, V223, P252, DOI 10.1002/jcp.22033; Liu L, 2009, AM J PHYSIOL-RENAL, V296, pF1417, DOI 10.1152/ajprenal.90337.2008; Markadieu N, 2005, AM J PHYSIOL-RENAL, V288, pF1201, DOI 10.1152/ajprenal.00383.2004; Matalon S, 1999, ANNU REV PHYSIOL, V61, P627, DOI 10.1146/annurev.physiol.61.1.627; Michlig S, 2005, J BIOL CHEM, V280, P38264, DOI 10.1074/jbc.M506308200; Mineo C, 1996, J BIOL CHEM, V271, P11930, DOI 10.1074/jbc.271.20.11930; MUTO S, 1991, AM J PHYSIOL, V260, pF163, DOI 10.1152/ajprenal.1991.260.2.F163; Nassar N, 2010, BIOCHEMISTRY-US, V49, P1970, DOI 10.1021/bi9020742; Nicod M, 2002, EMBO J, V21, P5109, DOI 10.1093/emboj/cdf509; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Omerovic J, 2008, ONCOGENE, V27, P2754, DOI 10.1038/sj.onc.1210925; Omerovic J, 2007, CELL MOL LIFE SCI, V64, P2575, DOI 10.1007/s00018-007-7133-8; Park JH, 2009, AM J PHYSIOL-CELL PH, V297, pC935, DOI 10.1152/ajpcell.00121.2009; Pike LJ, 2005, J BIOL CHEM, V280, P26796, DOI 10.1074/jbc.M503805200; PRadervand S, 1999, P NATL ACAD SCI USA, V96, P1732, DOI 10.1073/pnas.96.4.1732; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; SEEBURG PH, 1984, NATURE, V312, P71, DOI 10.1038/312071a0; Shen J-P, 2003, AM J PHYSIOL-RENAL, V284, P57; Shi HK, 2002, J BIOL CHEM, V277, P13539, DOI 10.1074/jbc.M111717200; Silvius JR, 2002, J MEMBRANE BIOL, V190, P83, DOI 10.1007/s00232-002-1026-4; Snyder PM, 2004, J BIOL CHEM, V279, P5042, DOI 10.1074/jbc.M312477200; SNYDER PM, 1995, CELL, V83, P969, DOI 10.1016/0092-8674(95)90212-0; Spindler B, 1997, PFLUG ARCH EUR J PHY, V434, P323, DOI 10.1007/s004240050403; Spindler B, 1999, AM J PHYSIOL-CELL PH, V276, pC1154, DOI 10.1152/ajpcell.1999.276.5.C1154; Staruschenko A, 2005, BBA-BIOMEMBRANES, V1669, P108, DOI 10.1016/j.bbamem.2005.01.005; Staruschenko A, 2004, J BIOL CHEM, V279, P37771, DOI 10.1074/jbc.M402176200; Stockand JD, 1999, J BIOL CHEM, V274, P35449, DOI 10.1074/jbc.274.50.35449; STOOS BA, 1991, KIDNEY INT, V39, P1168, DOI 10.1038/ki.1991.148; Sweeney WE, 2000, KIDNEY INT, V57, P33, DOI 10.1046/j.1523-1755.2000.00829.x; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tong QS, 2005, AM J PHYSIOL-RENAL, V288, pF150, DOI 10.1152/ajprenal.00261.2004; TURNHEIM K, 1991, PHYSIOL REV, V71, P429, DOI 10.1152/physrev.1991.71.2.429; VEHASKARI VM, 1991, AM J PHYSIOL, V261, pF896, DOI 10.1152/ajprenal.1991.261.5.F896; Veizis IE, 2005, AM J PHYSIOL-RENAL, V288, pF474, DOI 10.1152/ajprenal.00227.2004; Wilson PD, 2004, KIDNEY INT, V65, P2441, DOI 10.1111/j.1523-1755.2004.00667.x; Yan J, 1998, J BIOL CHEM, V273, P24052, DOI 10.1074/jbc.273.37.24052; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zabner J, 1998, MOL CELL, V2, P397, DOI 10.1016/S1097-2765(00)80284-1; Zeng FH, 2009, EXP CELL RES, V315, P602, DOI 10.1016/j.yexcr.2008.08.005; Zentner MD, 1998, J BIOL CHEM, V273, P30770, DOI 10.1074/jbc.273.46.30770; Zheleznova NN, 2011, BBA-MOL BASIS DIS, V1812, P1301, DOI 10.1016/j.bbadis.2010.10.004; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	75	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0116938	10.1371/journal.pone.0116938	http://dx.doi.org/10.1371/journal.pone.0116938			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774517	gold, Green Published, Green Submitted			2022-12-27	WOS:000351183500012
J	Lian, F; Cui, Y; Zhou, CL; Gao, KW; Wu, LW				Lian, Feng; Cui, Yong; Zhou, Chenliang; Gao, Kewei; Wu, Liwen			Identification of a Plasma Four-microRNA Panel as Potential Noninvasive Biomarker for Osteosarcoma	PLOS ONE			English	Article							PROGNOSTIC-FACTORS; MICRORNAS; SERUM; CANCER	Background Circulating microRNAs (miRNAs) are emerging as promising biomarkers for human cancer. Osteosarcoma is the most common human primary malignant bone tumor in children and young adults. The objective of this study was to investigate whether circulating miRNAs in plasma could be a useful biomarker for detecting osteosarcoma and monitoring tumor removal dynamics. Methods Plasma samples were obtained from 90 patients before surgery, 50 patients after one month of surgery, and 90 healthy individuals. The study was divided into three steps: First, initial screening of the profiles of circulating miRNAs in pooled plasma samples from healthy controls and pre-operative osteosarcoma patients using a TaqMan low density array (TLDA). Second, evaluation of miRNA concentration in individual plasma samples from 90 pre-operative osteosarcoma patients and 90 healthy controls by a quantitative real time PCR (qRT-PCR) assay. Third, evaluation of miRNA concentration in paired plasma samples from 50 pre- and post-operative osteosarcoma patients by qRT-PCR assay. Results Four plasma miRNAs including miR-195-5p, miR-199a-3p, miR-320a, and miR-374a-5p were significantly increased in the osteosarcoma patients. Receiver operating characteristics curve analysis of the combined populations demonstrated that the four-miRNA signature could discriminate cases from controls with an area under the curve of 0.9608 (95% CI 0.9307-0.9912). These 4 miRNAs were markedly decreased in the plasma after operation. In addition, circulating miR-195-5p and miR-199a-3p were correlated with metastasis status, while miR-199a-3p and miR-320a were correlated with histological subtype. Conclusions Our data suggest that altered levels of circulating miRNAs might have great potential to serve as novel, non-invasive biomarkers for osteosarcoma.	[Lian, Feng; Cui, Yong; Zhou, Chenliang; Gao, Kewei; Wu, Liwen] Harbin Med Univ, Affiliated Hosp 4, Dept Orthoped, Harbin 150001, Heilongjiang, Peoples R China	Harbin Medical University	Lian, F (corresponding author), Harbin Med Univ, Affiliated Hosp 4, Dept Orthoped, Harbin 150001, Heilongjiang, Peoples R China.	lian_fenghum@163.com; wu_liwen@yeah.net	聂, 宏光/GYJ-8253-2022	聂, 宏光/0000-0002-9973-6354				Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bacci G, 2006, CANCER-AM CANCER SOC, V106, P1154, DOI 10.1002/cncr.21724; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bielack SS, 2002, J CLIN ONCOL, V20, P776, DOI 10.1200/JCO.20.3.776; Bielack SS, 2008, J CLIN ONCOL, V26, P3102, DOI 10.1200/JCO.2008.17.1108; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chen X, 2012, INT J CANCER, V130, P1620, DOI 10.1002/ijc.26177; Duan ZF, 2011, MOL CANCER THER, V10, P1337, DOI 10.1158/1535-7163.MCT-11-0096; Jones KB, 2012, CANCER RES, V72, P1865, DOI 10.1158/0008-5472.CAN-11-2663; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu R, 2011, EUR J CANCER, V47, P784, DOI 10.1016/j.ejca.2010.10.025; Mao JH, 2012, ONCOL LETT, V4, P1125, DOI 10.3892/ol.2012.863; Marina N, 2004, ONCOLOGIST, V9, P422, DOI 10.1634/theoncologist.9-4-422; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Ouyang L, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0340-7; Tian Q, 2014, EJSO-EUR J SURG ONC, V40, P67, DOI 10.1016/j.ejso.2013.08.024; Tian Y, 2014, BIOSCI REP; Yang JL, 2013, CURR OPIN ONCOL, V25, P398, DOI 10.1097/CCO.0b013e3283622c1b; Yuan J, 2012, J INT MED RES, V40, P2090, DOI 10.1177/030006051204000606; Zen K, 2012, MED RES REV, V32, P326, DOI 10.1002/med.20215	22	66	69	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0121499	10.1371/journal.pone.0121499	http://dx.doi.org/10.1371/journal.pone.0121499			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775010	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500214
J	Ogawa, H; Fujikura, D; Ohnuma, M; Ohnishi, N; Hang'ombe, BM; Mimuro, H; Ezaki, T; Mweene, AS; Higashi, H				Ogawa, Hirohito; Fujikura, Daisuke; Ohnuma, Miyuki; Ohnishi, Naomi; Hang'ombe, Bernard M.; Mimuro, Hitomi; Ezaki, Takayuki; Mweene, Aaron S.; Higashi, Hideaki			A Novel Multiplex PCR Discriminates Bacillus anthracis and Its Genetically Related Strains from Other Bacillus cereus Group Species	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; CHROMOSOMAL DNA; THURINGIENSIS; SEQUENCES; IDENTIFICATION; GENES; POPULATION; INFECTION; BACTERIA	Anthrax is an important zoonotic disease worldwide that is caused by Bacillus anthracis, a spore-forming pathogenic bacterium. A rapid and sensitive method to detect B. anthracis is important for anthrax risk management and control in animal cases to address public health issues. However, it has recently become difficult to identify B. anthracis by using previously reported molecular-based methods because of the emergence of B. cereus, which causes severe extra-intestinal infection, as well as the human pathogenic B. thuringiensis, both of which are genetically related to B. anthracis. The close genetic relation of chromosomal backgrounds has led to complexity of molecular-based diagnosis. In this study, we established a B. anthracis multiplex PCR that can screen for the presence of B. anthracis virulent plasmids and differentiate B. anthracis and its genetically related strains from other B. cereus group species. Six sets of primers targeting a chromosome of B. anthracis and B. anthracis-like strains, two virulent plasmids, pXO1 and pXO2, a bacterial gene, 16S rRNA gene, and a mammalian gene, actin-beta gene, were designed. The multiplex PCR detected approximately 3.0 CFU of B. anthracis DNA per PCR reaction and was sensitive to B. anthracis. The internal control primers also detected all bacterial and mammalian DNAs examined, indicating the practical applicability of this assay as it enables monitoring of appropriate amplification. The assay was also applied for detection of clinical strains genetically related to B. anthracis, which were B. cereus strains isolated from outbreaks of hospital infections in Japan, and field strains isolated in Zambia, and the assay differentiated B. anthracis and its genetically related strains from other B. cereus group strains. Taken together, the results indicate that the newly developed multiplex PCR is a sensitive and practical method for detecting B. anthracis.	[Ogawa, Hirohito; Higashi, Hideaki] Univ Zambia, Sch Vet Med, Hokudai Ctr Zoonosis Control Zambia, Lusaka, Zambia; [Ogawa, Hirohito; Mweene, Aaron S.; Higashi, Hideaki] Univ Zambia, Sch Vet Med, Dept Dis Control, Lusaka, Zambia; [Fujikura, Daisuke; Ohnuma, Miyuki; Ohnishi, Naomi; Higashi, Hideaki] Hokkaido Univ, Res Ctr Zoonosis Control, Div Infect & Immun, Sapporo, Hokkaido, Japan; [Hang'ombe, Bernard M.] Univ Zambia, Sch Vet Med, Dept Paraclin Studies, Lusaka, Zambia; [Mimuro, Hitomi] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Div Bacteriol,Dept Infect Dis Control, Tokyo, Japan; [Mimuro, Hitomi] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Pathogen Microbes Repository Unit, Tokyo, Japan; [Ezaki, Takayuki] Gifu Univ, Grad Sch Med, Dept Microbiol Regenerat & Adv Med Sci, Gifu, Japan; [Higashi, Hideaki] Hokkaido Univ, Global Inst Collaborat Res & Educ, Global Stn Zoonosis Control, Sapporo, Hokkaido, Japan	University of Zambia; University of Zambia; Hokkaido University; University of Zambia; University of Tokyo; University of Tokyo; Gifu University; Hokkaido University	Higashi, H (corresponding author), Univ Zambia, Sch Vet Med, Hokudai Ctr Zoonosis Control Zambia, Lusaka, Zambia.	hidea-hi@czc.hokudai.ac.jp	Higashi, Hideaki/F-6872-2012; Ogawa, Hirohito/F-6918-2012; OHNISHI, Naomi/F-6914-2012	Ogawa, Hirohito/0000-0001-5738-4816; OHNISHI, Naomi/0000-0002-2382-3152	Government of the Republic of Zambia; Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	Government of the Republic of Zambia; Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	This work was supported by the Government of the Republic of Zambia and the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren J, 2013, VIRULENCE, V4, P671, DOI 10.4161/viru.26288; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; BEYER W, 1995, MICROBIOL RES, V150, P179, DOI 10.1016/S0944-5013(11)80054-6; Brightwell C, 1998, MOL CELL PROBE, V12, P367, DOI 10.1006/mcpr.1998.0195; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Fasanella A, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-167; Franz DR, 1997, JAMA-J AM MED ASSOC, V278, P399, DOI 10.1001/jama.278.5.399; Granum PE, 1997, FEMS MICROBIOL LETT, V157, P223, DOI 10.1016/S0378-1097(97)00438-2; Han CS, 2006, J BACTERIOL, V188, P3382, DOI 10.1128/JB.188.9.3382-3390.2006; Hang'ombe MB, 2012, TROP DOCT, V42, P136, DOI 10.1258/td.2012.110454; Helgason E, 2000, J CLIN MICROBIOL, V38, P1615, DOI 10.1128/JCM.38.4.1615-1622.2000; Helgason E, 2000, APPL ENVIRON MICROB, V66, P2627, DOI 10.1128/AEM.66.6.2627-2630.2000; Hernandez E, 1998, J CLIN MICROBIOL, V36, P2138, DOI 10.1128/JCM.36.7.2138-2139.1998; Hicks CW, 2012, INTENS CARE MED, V38, P1092, DOI 10.1007/s00134-012-2541-0; Hoffmaster AR, 2006, J CLIN MICROBIOL, V44, P3352, DOI 10.1128/JCM.00561-06; Hoffmaster AR, 2004, P NATL ACAD SCI USA, V101, P8449, DOI 10.1073/pnas.0402414101; HUTSON RA, 1993, J APPL BACTERIOL, V75, P463, DOI 10.1111/j.1365-2672.1993.tb02803.x; Jernigan DB, 2002, EMERG INFECT DIS, V8, P1019, DOI 10.3201/eid0810.020353; Klee SR, 2006, J BACTERIOL, V188, P5333, DOI 10.1128/JB.00303-06; Klee SR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010986; Kurosaki Y, 2009, J APPL MICROBIOL, V107, P1947, DOI 10.1111/j.1365-2672.2009.04379.x; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Makino SI, 2001, LETT APPL MICROBIOL, V33, P237, DOI 10.1046/j.1472-765x.2001.00989.x; Marchesi JR, 1998, APPL ENVIRON MICROB, V64, P795; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Ohnishi N, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00116-14; Priest FG, 2004, J BACTERIOL, V186, P7959, DOI 10.1128/JB.186.23.7959-7970.2004; Ramisse V, 1996, FEMS MICROBIOL LETT, V145, P9, DOI 10.1016/0378-1097(96)00358-8; Ramisse V, 1999, J APPL MICROBIOL, V87, P224, DOI 10.1046/j.1365-2672.1999.00874.x; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Sue D, 2006, J CLIN MICROBIOL, V44, P3426, DOI 10.1128/JCM.00873-06; TURNBULL PCB, 1979, J CLIN PATHOL, V32, P289, DOI 10.1136/jcp.32.3.289; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; WHO, 1998, GUID SURV CONTR ANTH; Winsley T, 2012, APPL ENVIRON MICROB, V78, P5938, DOI 10.1128/AEM.01299-12; Zhang JW, 2011, DIAGN MICR INFEC DIS, V70, P307, DOI 10.1016/j.diagmicrobio.2011.02.012	37	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0122004	10.1371/journal.pone.0122004	http://dx.doi.org/10.1371/journal.pone.0122004			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774512	Green Published, gold, Green Submitted			2022-12-27	WOS:000351183500219
J	Ouyang, X; Chen, KW; Yao, L; Wu, X; Zhang, JC; Li, K; Jin, Z; Guo, XJ				Ouyang, Xin; Chen, Kewei; Yao, Li; Wu, Xia; Zhang, Jiacai; Li, Ke; Jin, Zhen; Guo, Xiaojuan		Alzheimer's Dis Neuroimaging	Independent Component Analysis-Based Identification of Covariance Patterns of Microstructural White Matter Damage in Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; STRUCTURAL CONNECTIVITY; FRACTIONAL ANISOTROPY; VOXELWISE ANALYSIS; DTI; ARCHITECTURE; GREY; AD	The existing DTI studies have suggested that white matter damage constitutes an important part of the neurodegenerative changes in Alzheimer's disease (AD). The present study aimed to identify the regional covariance patterns of microstructural white matter changes associated with AD. In this study, we applied a multivariate analysis approach, independent component analysis (ICA), to identify covariance patterns of microstructural white matter damage based on fractional anisotropy (FA) skeletonised images from DTI data in 39 AD patients and 41 healthy controls (HCs) from the Alzheimer's Disease Neuroimaging Initiative database. The multivariate ICA decomposed the subject-dimension concatenated FA data into a mixing coefficient matrix and a source matrix. Twenty-eight independent components (ICs) were extracted, and a two sample t-test on each column of the corresponding mixing coefficient matrix revealed significant AD/HC differences in ICA weights for 7 ICs. The covariant FA changes primarily involved the bilateral corona radiata, the superior longitudinal fasciculus, the cingulum, the hippocampal commissure, and the corpus callosum in AD patients compared to HCs. Our findings identified covariant white matter damage associated with AD based on DTI in combination with multivariate ICA, potentially expanding our understanding of the neuropathological mechanisms of AD.	[Ouyang, Xin; Yao, Li; Wu, Xia; Zhang, Jiacai; Guo, Xiaojuan] Beijing Normal Univ, Coll Informat Sci & Technol, Beijing 100875, Peoples R China; [Chen, Kewei] Banner Alzheimers Inst, Phoenix, AZ USA; [Chen, Kewei] Banner Good Samaritan PET Ctr, Phoenix, AZ USA; [Yao, Li; Wu, Xia; Guo, Xiaojuan] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Li, Ke; Jin, Zhen] Beijing 306 Hosp, Lab Magnet Resonance Imaging, Beijing, Peoples R China	Beijing Normal University; Banner Research; Banner Health; Banner Alzheimer's Institute; Banner Research; Banner Health; Beijing Normal University	Guo, XJ (corresponding author), Beijing Normal Univ, Coll Informat Sci & Technol, Beijing 100875, Peoples R China.	gxj@bnu.edu.cn			National Key Basic Research Program (973 Program), China [2012CB720704]; National Natural Science Foundation (NNSF), China [81000603]; Funds for International Cooperation and Exchange of NNSF, China [61210001]; Key Program of NNSF, China [91320201]; National Institute of Mental Health, US [RO1 MH57899]; National Institute on Aging, US [9R01AG031581-10, P30 AG19610, k23 AG24062]; State of Arizona; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant) [U01 AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]; National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031581, P30AG019610, K23AG024062] Funding Source: NIH RePORTER	National Key Basic Research Program (973 Program), China; National Natural Science Foundation (NNSF), China(National Natural Science Foundation of China (NSFC)); Funds for International Cooperation and Exchange of NNSF, China; Key Program of NNSF, China; National Institute of Mental Health, US(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Aging, US(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); State of Arizona; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD ADNI (Department of Defense); National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Key Basic Research Program (973 Program), China (2012CB720704), the National Natural Science Foundation (NNSF), China (81000603), the Funds for International Cooperation and Exchange of NNSF, China (61210001), Key Program of NNSF, China (91320201), the National Institute of Mental Health, US (RO1 MH57899), the National Institute on Aging, US (9R01AG031581-10, P30 AG19610, k23 AG24062), and the State of Arizona. Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Alzheimer's Association; Alzheimer's Drug Discovery Foundation; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bosch B, 2012, NEUROBIOL AGING, V33, P61, DOI 10.1016/j.neurobiolaging.2010.02.004; Bozzali M, 2002, J NEUROL NEUROSUR PS, V72, P742, DOI 10.1136/jnnp.72.6.742; Calhoun VD, 2009, NEUROIMAGE, V45, pS163, DOI 10.1016/j.neuroimage.2008.10.057; Caprihan A, 2011, BRAIN CONNECT, V1, P133, DOI 10.1089/brain.2011.0015; Damoiseaux JS, 2009, HUM BRAIN MAPP, V30, P1051, DOI 10.1002/hbm.20563; Dickerson BC, 2004, ANN NEUROL, V56, P27, DOI 10.1002/ana.20163; Fayed N, 2012, J ALZHEIMERS DIS, V31, pS5, DOI 10.3233/JAD-2011-111292; Frisoni GB, 2002, J NEUROL NEUROSUR PS, V73, P657, DOI 10.1136/jnnp.73.6.657; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Guo XJ, 2012, NEUROSCI LETT, V531, P136, DOI 10.1016/j.neulet.2012.10.038; Guo XJ, 2010, NEUROSCI LETT, V468, P146, DOI 10.1016/j.neulet.2009.10.086; Habeck C, 2010, CELL BIOCHEM BIOPHYS, V58, P53, DOI 10.1007/s12013-010-9093-0; Jack CR, 2011, NEUROBIOL AGING, V32, pS48, DOI 10.1016/j.neurobiolaging.2011.09.011; Kincses ZT, 2013, J ALZHEIMERS DIS, V36, P119, DOI 10.3233/JAD-122431; Koch W, 2012, NEUROBIOL AGING, V33, P466, DOI 10.1016/j.neurobiolaging.2010.04.013; Li YO, 2012, HUM BRAIN MAPP, V33, P1431, DOI 10.1002/hbm.21292; Liu YW, 2011, NEUROBIOL AGING, V32, P1558, DOI 10.1016/j.neurobiolaging.2009.10.006; Luo L, 2012, BRAIN CONNECT, V2, P33, DOI 10.1089/brain.2011.0026; Medina D, 2006, NEUROBIOL AGING, V27, P663, DOI 10.1016/j.neurobiolaging.2005.03.026; Naggara O, 2006, PSYCHIAT RES-NEUROIM, V146, P243, DOI 10.1016/j.pscychresns.2006.01.005; Oishi K, 2011, J ALZHEIMERS DIS, V26, P287, DOI 10.3233/JAD-2011-0007; Salat DH, 2009, NEUROIMAGE, V44, P1247, DOI 10.1016/j.neuroimage.2008.10.030; Shu N, 2011, J ALZHEIMERS DIS, V26, P275, DOI 10.3233/JAD-2011-0024; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Teipel SJ, 2014, J ALZHEIMERS DIS, V41, P69, DOI 10.3233/JAD-131829; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; Wu X, 2013, IEEE ACM T COMPUT BI, V10, P173, DOI 10.1109/TCBB.2012.141; Xie S, 2006, NEUROLOGY, V66, P1845, DOI 10.1212/01.wnl.0000219625.77625.aa; Xu L, 2009, NEUROIMAGE, V44, P777, DOI 10.1016/j.neuroimage.2008.09.051; Zhang Y, 2007, NEUROLOGY, V68, P13, DOI 10.1212/01.wnl.0000250326.77323.01; Zhang Y, 2009, BRAIN, V132, P2579, DOI 10.1093/brain/awp071; Zhou YX, 2008, ALZHEIMERS DEMENT, V4, P265, DOI 10.1016/j.jalz.2008.04.006	35	9	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119714	10.1371/journal.pone.0119714	http://dx.doi.org/10.1371/journal.pone.0119714			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775003	gold, Green Submitted, Green Published			2022-12-27	WOS:000351183500114
J	Wang, XB; Lou, MN; Li, YJ; Ye, WJ; Zhang, ZY; Jia, XF; Shi, HY; Zhu, XC; Wang, LX				Wang, XiaoBing; Lou, MeiNa; Li, Yongji; Ye, WenJing; Zhang, ZhiYong; Jia, Xiufen; Shi, HongYing; Zhu, XiaoChun; Wang, LiangXing			Cardiovascular Involvement in Connective Tissue Disease: The Role of Interstitial Lung Disease	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; CORONARY-ARTERY-DISEASE; RHEUMATOID-ARTHRITIS; AUTOIMMUNE-DISEASES; ENDOTHELIAL FUNCTION; COMPUTED-TOMOGRAPHY; CARDIAC INVOLVEMENT; PULMONARY-FIBROSIS; RISK; ATHEROSCLEROSIS	Objective The aim of this study was to assess cardiovascular involvement in patients with connective tissue disease (CTD), and determine whether interstitial lung disease (ILD) in these patients is associated with elevated cardiovascular risk. Methods This study evaluated a retrospective cohort of 436 CTD patients admitted to a large teaching hospital in Zhejiang province, China, along with an additional 436 participants of an annual community health screening conducted in the physical examination center who served as age-and gender-matched controls. Demographic, clinical, serologic and imaging characteristics, as well as medications used by each participant were recorded. Cardiovascular involvement was defined by uniform criteria. Correlations between clinical/serologic factors and cardiovascular involvement were determined by univariate and multivariate analyses. Results CTD patients had a significantly higher cardiovascular involvement rate than controls (64.7% vs 23.4%), with higher rates of diabetes, hypertension, and hyperlipidemia, elevated systolic and diastolic pressures, C-reactive protein, total cholesterol, and low-density lipoprotein cholesterol, and lower albumin and high-density lipoprotein cholesterol (all p < 0.05). Furthermore, CTP patients with cardiovascular involvement were significantly older, had higher systolic and diastolic pressures, C-reactive protein, glucose, and uric acid, higher rates of diabetes, hypertension, and use of moderate-to high-dose glucocorticoids, and longer disease duration compared to patients without involvement (all p < 0.05). Moreover, CTD in patients with cardiovascular involvement was more likely to be complicated by ILD (p < 0.01), which manifested as a higher alveolar inflammation score (p < 0.05). In the multivariate analysis, cardiovascular involvement in CTD patients was associated with age, systolic pressure, body mass index, uric acid, disease duration > 2 years, use of moderate-to high-dose glucocorticoids, and ILD with a high alveolar inflammation score. Conclusion Cardiovascular involvement is increased in CTD patients, and is associated with ILD with a higher alveolar inflammation score. Thus, early-stage echocardiography and CT scans should be used to detect potential cardiovascular complications in these patients.	[Wang, XiaoBing; Li, Yongji; Ye, WenJing; Zhang, ZhiYong; Zhu, XiaoChun] Wenzhou Med Univ, Affiliated Hosp 1, Dept Rheumal, Wenzhou, Zhejiang, Peoples R China; [Lou, MeiNa] Wenzhou Med Univ, Affiliated Hosp 1, Dept Cardiol, Wenzhou, Zhejiang, Peoples R China; [Jia, Xiufen] Wenzhou Med Univ, Affiliated Hosp 1, Dept Radiol, Wenzhou, Zhejiang, Peoples R China; [Shi, HongYing] Wenzhou Med Univ, Sch Environm Sci & Publ, Dept Prevent Med, Wenzhou, Zhejiang, Peoples R China; [Wang, LiangXing] Wenzhou Med Univ, Affiliated Hosp 1, Dept Pneumol, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Wang, LX (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Pneumol, Wenzhou, Zhejiang, Peoples R China.	wzyxywlx@163.com		Ye, Wenjing/0000-0003-0754-0643				[Anonymous], 1980, ARTHRITIS RHEUMATISM, V23, P581; Antoniou KM, 2009, EUR RESPIR J, V33, P882, DOI 10.1183/09031936.00152607; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Arosio E, 2007, J HYPERTENS, V25, P1273, DOI 10.1097/HJH.0b013e3280b0157e; Bartoloni E, 2013, CLIN REV ALLERG IMMU, V44, P14, DOI 10.1007/s12016-010-8251-x; Bassi N, 2007, AUTOIMMUN REV, V7, P52, DOI 10.1016/j.autrev.2007.06.003; Belizna CC, 2007, AUTOIMMUN REV, V7, P46, DOI 10.1016/j.autrev.2007.06.002; Boueiz A, 2010, CURR OPIN RHEUMATOL, V22, P696, DOI 10.1097/BOR.0b013e32833dfbd8; Budoff MJ, 1996, CIRCULATION, V93, P898, DOI 10.1161/01.CIR.93.5.898; del Rincon I, 2001, ARTHRITIS RHEUM-US, V44, P2737, DOI 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#; DeMarco P, 2006, CURR RHEUMATOL REP, V8, P114; Doyle TJ, 2012, AM J RESP CRIT CARE, V185, P1147, DOI 10.1164/rccm.201108-1420PP; Fimognari Filippo Luca, 2008, Int J Chron Obstruct Pulmon Dis, V3, P89; Flaherty KR, 2003, THORAX, V58, P143, DOI 10.1136/thorax.58.2.143; Gay SE, 1998, AM J RESP CRIT CARE, V157, P1063, DOI 10.1164/ajrccm.157.4.9703022; Gochuico BR, 2008, ARCH INTERN MED, V168, P159, DOI 10.1001/archinternmed.2007.59; Haque S, 2005, NAT CLIN PRACT CARD, V2, P423, DOI 10.1038/ncpcardio0270; HEJTMANCIK MR, 1964, AM HEART J, V68, P119, DOI 10.1016/0002-8703(64)90248-0; Hurlimann D, 2002, CIRCULATION, V106, P2184, DOI 10.1161/01.CIR.0000037521.71373.44; Kizer JR, 2004, ARCH INTERN MED, V164, P551, DOI 10.1001/archinte.164.5.551; Kocheril SV, 2005, ARTHRIT RHEUM-ARTHR, V53, P549, DOI 10.1002/art.21322; Launay D, 2006, J RHEUMATOL, V33, P1789; Maki-Petaja KM, 2007, J AM COLL CARDIOL, V50, P852, DOI 10.1016/j.jacc.2007.04.076; Meune C, 2008, ARTHRITIS RHEUM-US, V58, P1803, DOI 10.1002/art.23463; Mosca M, 2012, BEST PRACT RES CL RH, V26, P73, DOI 10.1016/j.berh.2012.01.005; Nurmohamed MT, 2009, AUTOIMMUN REV, V8, P663, DOI 10.1016/j.autrev.2009.02.015; Peters MJL, 2010, ANN RHEUM DIS, V69, P325, DOI 10.1136/ard.2009.113696; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sarzi-Puttini P, 2010, AUTOIMMUN REV, V9, P849, DOI 10.1016/j.autrev.2010.08.002; Sattar N, 2003, CIRCULATION, V108, P2957, DOI 10.1161/01.CIR.0000099844.31524.05; SHARP GC, 1972, AM J MED, V52, P148, DOI 10.1016/0002-9343(72)90064-2; Sitia S, 2009, AUTOIMMUN REV, V8, P281, DOI 10.1016/j.autrev.2008.08.004; TAN EM, 1982, ARTHRITIS RHEUM, V25, P753, DOI 10.1002/art.1780250707; Turiel M, 2005, LUPUS, V14, P727, DOI 10.1191/0961203305lu2209oa; Turiel M, 2010, AUTOIMMUN REV, V9, P414, DOI 10.1016/j.autrev.2009.11.002; Vij R, 2013, CHEST, V143, P814, DOI 10.1378/chest.12-0741; VITALI C, 1993, ARTHRITIS RHEUM, V36, P340, DOI 10.1002/art.1780360309	37	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0121976	10.1371/journal.pone.0121976	http://dx.doi.org/10.1371/journal.pone.0121976			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775471	gold, Green Published, Green Submitted			2022-12-27	WOS:000351183500218
J	Fang, YF; Hsieh, MH; Chung, FT; Huang, YK; Chen, GY; Lin, SM; Lin, HC; Wang, CH; Kuo, HP				Fang, Yueh-Fu; Hsieh, Meng-Heng; Chung, Fu-Tsai; Huang, Yao-Kuang; Chen, Guan-Yuan; Lin, Shu-Min; Lin, Horng-Chyuan; Wang, Chin-Hwa; Kuo, Han-Pin			Flexible Bronchoscopy with Multiple Modalities for Foreign Body Removal in Adults	PLOS ONE			English	Article							ASPIRATION; EXPERIENCE; BODIES; AIRWAY; CRYOTHERAPY; CHILDREN; LUNG	Objectives Aspiration of the lower airways due to foreign body is rare in adults. This study aimed to determine the outcome of patients who received flexible bronchoscopy with different modalities for foreign body removal in the lower airways. Patients and Methods Between January 2003 and January 2014, 94 patients diagnosed with foreign body in the lower airways underwent flexible bronchoscopy with different modalities, which included forceps, loop, basket, knife, electromagnet, and cryotherapy. The clinical presentation, foreign body location and characteristics, and applications of flexible bronchoscopy were analyzed. Results Forty (43%) patients had acute aspiration, which developed within one week of foreign body entry and 54 (57%) had chronic aspiration. The most common foreign bodies were teeth or bone. More patients with chronic aspiration than those with acute aspiration were referred from the out-patient clinic (48% vs. 28%), but more patients with acute aspiration were referred from the emergency room (35% vs. 6%) and intensive care unit (18% vs. 2%). Flexible bronchoscopy with different modalities was used to remove the foreign bodies (85/94, 90%). Electromagnet or cryotherapy was used in nine patients to eliminate the surrounding granulation tissue before foreign body removal. In the nine patients with failed flexible bronchoscopy, eight underwent rigid bronchoscopy instead and one had right lower lung lobectomy for lung abscess. Conclusions Flexible bronchoscopy with multiple modalities is effective for diagnosing and removing foreign bodies in the lower respiratory airways in adults, with a high success rate (90%) and no difference between acute and chronic aspirations.	[Fang, Yueh-Fu; Hsieh, Meng-Heng; Chung, Fu-Tsai; Chen, Guan-Yuan; Lin, Shu-Min; Lin, Horng-Chyuan; Wang, Chin-Hwa; Kuo, Han-Pin] Chang Gung Mem Hosp, Chang Gung Fdn, Dept Thorac Med, Taoyuan, Taiwan; [Fang, Yueh-Fu; Hsieh, Meng-Heng; Chung, Fu-Tsai; Huang, Yao-Kuang; Chen, Guan-Yuan; Lin, Shu-Min; Lin, Horng-Chyuan; Wang, Chin-Hwa; Kuo, Han-Pin] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Huang, Yao-Kuang] Chang Gung Mem Hosp, Div Thorac & Cardiovasc Surg, Chiayi, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Kuo, HP (corresponding author), Chang Gung Mem Hosp, Chang Gung Fdn, Dept Thorac Med, Taoyuan, Taiwan.	q8828@ms11.hinet.net	Wang, Chun-Hua/C-1488-2016; Wang, Chun-Hua/V-9861-2019; Huang, Yao-Kuang/AAK-5137-2021	Wang, Chun-Hua/0000-0002-3514-9353; Huang, Yao-Kuang/0000-0003-2699-2207				Boufersaoui A, 2013, INT J PEDIATR OTORHI, V77, P1683, DOI 10.1016/j.ijporl.2013.07.026; Casalini AG, 2013, J BRONCHOL INTERN PU, V20, P313, DOI 10.1097/LBR.0000000000000024; CASSON AG, 1987, CAN J SURG, V30, P193; Chen CH, 1997, CHEST, V112, P129, DOI 10.1378/chest.112.1.129; Chou CL, 2013, ANN THORAC SURG, V95, P982, DOI 10.1016/j.athoracsur.2012.11.044; Dikensoy O, 2002, POSTGRAD MED J, V78, P399, DOI 10.1136/pmj.78.921.399; ELHASSANI NB, 1988, J THORAC CARDIOV SUR, V96, P621; Hetzel J, 2012, EUR RESPIR J, V39, P685, DOI 10.1183/09031936.00033011; Hui H, 2008, J PEDIATR SURG, V43, P718, DOI 10.1016/j.jpedsurg.2007.10.010; Khan A, 2011, RESPIRATION, V81, P129, DOI 10.1159/000320262; LAN RS, 1989, AM REV RESPIR DIS, V140, P1734, DOI 10.1164/ajrccm/140.6.1734; Lee Seon-Heui, 2011, Korean Journal of Internal Medicine, V26, P137, DOI 10.3904/kjim.2011.26.2.137; LIMPER AH, 1990, ANN INTERN MED, V112, P604, DOI 10.7326/0003-4819-112-8-604; Tang LF, 2009, WORLD J PEDIATR, V5, P191, DOI 10.1007/s12519-009-0036-z; Vergnon JM, 2006, EUR RESPIR J, V28, P200, DOI 10.1183/09031936.06.00014006; Weber SM, 2005, LARYNGOSCOPE, V115, P687, DOI 10.1097/01.mlg.0000161353.45999.dd	16	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118993	10.1371/journal.pone.0118993	http://dx.doi.org/10.1371/journal.pone.0118993			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768933	gold, Green Published, Green Submitted			2022-12-27	WOS:000351277500058
J	Choudhary, S; Canalis, E; Estus, T; Adams, D; Pilbeam, C				Choudhary, Shilpa; Canalis, Ernesto; Estus, Thomas; Adams, Douglas; Pilbeam, Carol			Cyclooxygenase-2 Suppresses the Anabolic Response to PTH Infusion in Mice	PLOS ONE			English	Article							PARATHYROID-HORMONE; BONE-FORMATION; SIGNALING PATHWAYS; PROSTAGLANDIN E-2; T-CELLS; DIFFERENTIATION; EXPRESSION; INTERMITTENT; STIMULATION; OSTEOCLASTOGENESIS	We previously reported that the ability of continuously elevated PTH to stimulate osteoblastic differentiation in bone marrow stromal cell cultures was abrogated by an osteoclastic factor secreted in response to cyclooxygenase-2 (Cox2)-produced prostaglandin E-2. We now examine the impact of Cox2 (Ptgs2) knockout (KO) on the anabolic response to continuously elevated PTH in vivo. PTH (40 mu g/kg/d) or vehicle was infused for 12 or 21 days in 3-mo-old male wild type (WT) and KO mice in the outbred CD-1 background. Changes in bone phenotype were assessed by bone mineral density (BMD), mu CT and histomorphometry. PTH infusion for both 12 and 21 days increased femoral BMD in Cox2 KO mice and decreased BMD in WT mice. Femoral and vertebral trabecular bone volume fractions were increased in KO mice, but not in WT mice, by PTH infusion. In the femoral diaphysis, PTH infusion increased cortical area in Cox2 KO, but not WT, femurs. PTH infusion markedly increased trabecular bone formation rate in the femur, serum markers of bone formation, and expression of bone formation-related genes, growth factors, and Wnt target genes in KO mice relative to WT mice, and decreased gene expression of Wnt antagonists only in KO mice. In contrast to the differential effects of PTH on anabolic factors in WT and KO mice, PTH infusion increased serum markers of resorption, expression of resorption-related genes, and the percent bone surface covered by osteoclasts similarly in both WT and KO mice. We conclude that Cox2 inhibits the anabolic, but not the catabolic, effects of continuous PTH. These data suggest that the bone loss with continuously infused PTH in mice is due largely to suppression of bone formation and that this suppression is mediated by Cox2.	[Choudhary, Shilpa; Canalis, Ernesto; Estus, Thomas; Adams, Douglas; Pilbeam, Carol] Univ Connecticut, Ctr Hlth, New England Musculoskeletal Inst, Farmington, CT 06030 USA; [Choudhary, Shilpa; Pilbeam, Carol] Univ Connecticut, Ctr Hlth, Dept Med, Farmington, CT USA	University of Connecticut; University of Connecticut	Pilbeam, C (corresponding author), Univ Connecticut, Ctr Hlth, New England Musculoskeletal Inst, Farmington, CT 06030 USA.	pilbeam@nso.uchc.edu			National Institute of Health from the National Institute of Arthritis and Musculoskeletal Research [AR060286, AR63049]; National Institute of Digestive and Diabetes and Kidney Research [DK045227]; National Institute of Dental and Craniofacial Research [T90DE021]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060286, R01AR063049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045227] Funding Source: NIH RePORTER	National Institute of Health from the National Institute of Arthritis and Musculoskeletal Research; National Institute of Digestive and Diabetes and Kidney Research; National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institute of Health awards from the National Institute of Arthritis and Musculoskeletal Research, AR060286 (CP) and AR63049 (EC), from the National Institute of Digestive and Diabetes and Kidney Research, DK045227 (EC), and from the National Institute of Dental and Craniofacial Research, T90DE021 (TE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedi B, 2012, P NATL ACAD SCI USA, V109, pE725, DOI 10.1073/pnas.1120735109; BELLOWS CG, 1990, ENDOCRINOLOGY, V127, P3111, DOI 10.1210/endo-127-6-3111; Bennett CN, 2007, J BONE MINER RES, V22, P1924, DOI 10.1359/JBMR.070810; Bergenstock MK, 2007, ANN NY ACAD SCI, V1116, P354, DOI 10.1196/annals.1402.047; Blackwell KA, 2010, TRENDS ENDOCRIN MET, V21, P294, DOI 10.1016/j.tem.2009.12.004; Cho YD, 2012, J CELL PHYSIOL, V227, P2287, DOI 10.1002/jcp.24038; Choudhary S, 2008, BIOCHEM BIOPH RES CO, V372, P536, DOI 10.1016/j.bbrc.2008.05.050; Choudhary S, 2013, BONE, V56, P31, DOI 10.1016/j.bone.2013.04.017; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Fei YR, 2012, J CELL PHYSIOL, V227, P3539, DOI 10.1002/jcp.24075; Greenfield Edward M, 2012, Curr Mol Pharmacol, V5, P127; Hackett JA, 2006, J RHEUMATOL, V33, P1320; Horwitz MJ, 2011, J BONE MINER RES, V26, P2287, DOI 10.1002/jbmr.415; Iida-Klein A, 2005, J ENDOCRINOL, V186, P549, DOI 10.1677/joe.1.06270; Ishizuya T, 1997, J CLIN INVEST, V99, P2961, DOI 10.1172/JCI119491; Jee WSS, 1997, BONE, V21, P297, DOI 10.1016/S8756-3282(97)00147-6; Jilka RL, 2010, J BONE MINER RES, V25, P2427, DOI 10.1002/jbmr.145; Kaneko H, 2007, PROSTAG LEUKOTR ESS, V77, P181, DOI 10.1016/j.plefa.2007.09.002; Kang YJ, 2006, J IMMUNOL, V177, P8111, DOI 10.4049/jimmunol.177.11.8111; Kim SW, 2012, J BONE MINER RES, V27, P2075, DOI 10.1002/jbmr.1665; KLEIN DC, 1970, ENDOCRINOLOGY, V86, P1436, DOI 10.1210/endo-86-6-1436; Kondo H, 2002, J BONE MINER RES, V17, P1667, DOI 10.1359/jbmr.2002.17.9.1667; Lane Nancy E, 2010, Curr Osteoporos Rep, V8, P23, DOI 10.1007/s11914-010-0005-4; Lee SK, 2002, BONE, V31, P252, DOI 10.1016/S8756-3282(02)00804-9; Li X, 2007, J BIOL CHEM, V282, P33098, DOI 10.1074/jbc.M611781200; Locklin RM, 2003, J CELL BIOCHEM, V89, P180, DOI 10.1002/jcb.10490; MORHAM SG, 1995, CELL, V83, P473, DOI 10.1016/0092-8674(95)90125-6; O'Brien CA, 2013, BONE, V54, P258, DOI 10.1016/j.bone.2012.08.121; Okada Y, 2000, J CLIN INVEST, V105, P823, DOI 10.1172/JCI8195; Ono M, 2011, J BONE MINER RES, V26, P193, DOI 10.1002/jbmr.205; Pacifici R, 2013, ENDOCRINE, V44, P576, DOI 10.1007/s12020-013-9960-8; Pilbeam CC, 2008, PRINCIPLES OF BONE BIOLOGY, VOL 2, 3RD EDITION, P1235, DOI 10.1016/B978-0-12-373884-4.00072-0; Potts JT, 2007, ANN NY ACAD SCI, V1117, P196, DOI 10.1196/annals.1402.088; Rhee Y, 2011, J BONE MINER RES, V26, P1035, DOI 10.1002/jbmr.304; Richards JB, 2006, OSTEOPOROSIS INT, V17, P1410, DOI 10.1007/s00198-006-0142-x; Robling AG, 2011, ENDOCRINOLOGY, V152, P2963, DOI 10.1210/en.2011-0049; Siddappa R, 2008, P NATL ACAD SCI USA, V105, P7281, DOI 10.1073/pnas.0711190105; Suponitzky I, 1998, J ENDOCRINOL, V156, P51, DOI 10.1677/joe.0.1560051; Swarthout JT, 2002, GENE, V282, P1, DOI 10.1016/S0378-1119(01)00798-3; Tahimic CG, 2013, FRONT ENDOCRINOL LAU, V6, P2; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; ten Dijke P, 2006, CURR MED RES OPIN, V22, pS7, DOI 10.1185/030079906X80576; Tian XY, 2008, BONE, V42, P914, DOI 10.1016/j.bone.2007.12.228; Wan M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001464; Wang YH, 2005, J BONE MINER RES, V20, P5, DOI 10.1359/JBMR.041016; Xu MS, 2010, BONE, V47, P341, DOI 10.1016/j.bone.2010.05.006; Xu MS, 2005, ENDOCRINOLOGY, V146, P1843, DOI 10.1210/en.2004-0734; Yang D, 2007, BONE, V40, P1453, DOI 10.1016/j.bone.2007.02.001; Yuan Q, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002726	49	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120164	10.1371/journal.pone.0120164	http://dx.doi.org/10.1371/journal.pone.0120164			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781979	Green Published, gold, Green Submitted			2022-12-27	WOS:000351284600135
J	Henriksson, PJG; Heijungs, R; Dao, HM; Phan, LT; de Snoo, GR; Guinee, JB				Henriksson, Patrik J. G.; Heijungs, Reinout; Dao, Hai M.; Phan, Lam T.; de Snoo, Geert R.; Guinee, Jeroen B.			Product Carbon Footprints and Their Uncertainties in Comparative Decision Contexts	PLOS ONE			English	Article							LIFE-CYCLE ASSESSMENT; VARIABILITY; SENSITIVITY; METHODOLOGY; PARAMETER	In response to growing awareness of climate change, requests to establish product carbon footprints have been increasing. Product carbon footprints are life cycle assessments restricted to just one impact category, global warming. Product carbon footprint studies generate life cycle inventory results, listing the environmental emissions of greenhouse gases from a product's lifecycle, and characterize these by their global warming potentials, producing product carbon footprints that are commonly communicated as point values. In the present research we show that the uncertainties surrounding these point values necessitate more sophisticated ways of communicating product carbon footprints, using different sizes of catfish (Pangasius spp.) farms in Vietnam as a case study. As most product carbon footprint studies only have a comparative meaning, we used dependent sampling to produce relative results in order to increase the power for identifying environmentally superior products. We therefore argue that product carbon footprints, supported by quantitative uncertainty estimates, should be used to test hypotheses, rather than to provide point value estimates or plain confidence intervals of products' environmental performance.	[Henriksson, Patrik J. G.; de Snoo, Geert R.; Guinee, Jeroen B.] Leiden Univ, Inst Environm Sci CML, Leiden, Netherlands; [Heijungs, Reinout] Vrije Univ Amsterdam, Fac Econ & Business Adm, Dept Econometr & Operat Res, Amsterdam, Netherlands; [Dao, Hai M.] Can Tho Univ, Coll Aquaculture & Fisheries, Dept Coastal Aquaculture, Can Tho, Vietnam; [Phan, Lam T.] Res Inst Aquaculture 2, Dept Inland Resources & Fisheries Capture, Ho Chi Minh City, Vietnam	Leiden University; Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; Can Tho University	Henriksson, PJG (corresponding author), Leiden Univ, Inst Environm Sci CML, Leiden, Netherlands.	henriksson@cml.leidenuniv.nl	Guinée, Jeroen/K-7931-2013; Heijungs, Reinout/K-7855-2013	Guinée, Jeroen/0000-0003-2558-6493; Heijungs, Reinout/0000-0002-0724-5962; Henriksson, Patrik JG/0000-0002-3439-623X	European Union [222889]	European Union(European Commission)	This research has been done as part of the Sustaining Ethical Aquaculture Trade (SEAT; www.seatglobal.eu) project, which is financed by the European Union within the Seventh Framework (http://cordis.europa.eu/fp7/home_en.html) Programme-Sustainable Development Global Change and Ecosystem (project no. 222889). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. PJGH, DHM, PLT, JB all received their funding through the SEAT project. RH and GRS received their funding from Leiden University.	[Anonymous], 2006, 140402006 ISO; Basset-Mens C, 2009, INT J LIFE CYCLE ASS, V14, P630, DOI 10.1007/s11367-009-0108-2; Beattie G, 2012, NAT CLIM CHANGE, V2, P214, DOI 10.1038/nclimate1468; BSI, 2008, 2050 BSI PAS; Chen XB, 2014, J CLEAN PROD, V81, P150, DOI 10.1016/j.jclepro.2014.06.046; Ciroth A, 2016, INT J LIFE CYCLE ASS, V21, P1338, DOI 10.1007/s11367-013-0670-5; de Koning A, 2010, INT J LIFE CYCLE ASS, V15, P79, DOI 10.1007/s11367-009-0123-3; Finnveden G, 1998, INT J LCA, V3, P65, DOI DOI 10.1007/BF02978486; Frischknecht R, 2007, 1 EC DBEND; HANSSEN OJ, 1996, J CLEAN PROD, V4, P149; Hauck M, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/7/074005; Heijungs R, 2005, INT J LIFE CYCLE ASS, V10, P103, DOI 10.1065/lca2004.06.161; Heijungs R, 2001, INT J LIFE CYCLE ASS, V6, P141, DOI 10.1007/BF02978732; Heijungs R., 2002, COMPUTATIONAL STRUCT, DOI [DOI 10.1007/978-94-015-9900-9, 10.1007/978-94-015-9900-9]; Heijungs R, 2014, INT J LIFE CYCLE ASS, V19, P1445, DOI 10.1007/s11367-014-0751-0; Henriksson P.J.G., 2014, FINAL LCA CASE STUDY; Henriksson PJG, 2014, INT J LIFE CYCLE ASS, V19, P429, DOI 10.1007/s11367-013-0647-4; Hertwich EG., 2000, J IND ECOL, V4, P13, DOI [10.1162/108819800569267, DOI 10.1162/108819800569267]; Hoekstra AY, THE WATER FOOTPRINT; Hong JL, 2010, INT J LIFE CYCLE ASS, V15, P499, DOI 10.1007/s11367-010-0175-4; Huijbregts M.A., 1998, INT J LIFE CYCLE ASS, V3, P273, DOI [10.1007/BF0297983519983:5, DOI 10.1007/BF02979835, 10.1007/BF02979835]; Huijbregts MAJ, 2003, ENVIRON SCI TECHNOL, V37, P2600, DOI 10.1021/es020971+; Huijbregts MAJ, 2001, INT J LIFE CYCLE ASS, V6, P127, DOI 10.1007/BF02978728; Huijbregts MAJ, 1998, INT J LIFE CYCLE ASS, V3, P343, DOI DOI 10.1007/BF02979345; IPCC, 2013, INT PAN CLIM WORK GR; ISO, 2012, 14067 ISO; ISO, 2006, 14044 ISO; JRC, 2010, ILCD HDB GEN GUID LC; Kennedy DJ, 1996, INT J LIFE CYCLE ASS, V1, P199, DOI DOI 10.1007/BF02978693; Linkov I, 2011, ENVIRON SCI TECHNOL, V45, P5068, DOI 10.1021/es100959q; Liu G, 2012, J CLEAN PROD, V35, P108, DOI 10.1016/j.jclepro.2012.05.030; Lloyd SM, 2007, J IND ECOL, V11, P161, DOI 10.1162/jiec.2007.1136; Lo SC, 2005, SCI TOTAL ENVIRON, V340, P23, DOI 10.1016/j.scitotenv.2004.08.020; Malca J, 2010, J IND ECOL, V14, P322, DOI 10.1111/j.1530-9290.2010.00227.x; Mattila T, 2011, J IND ECOL, V15, P217, DOI 10.1111/j.1530-9290.2010.00326.x; Maurice B., 2000, J CLEAN PROD, V8, P95, DOI [10.1016/S0959-6526(99)00324-8, DOI 10.1016/S0959-6526(99)00324-8]; Mutel CL, 2013, ENVIRON SCI TECHNOL, V47, P5660, DOI 10.1021/es3050949; Myhre G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P659; Prado-Lopez V, 2014, INT J LIFE CYCLE ASS, V19, P405, DOI 10.1007/s11367-013-0641-x; Ravetz JR, 1999, FUTURES, V31, P647; Bojaca CR, 2010, INT J LIFE CYCLE ASS, V15, P238, DOI 10.1007/s11367-010-0150-0; Roos E, 2011, INT J LIFE CYCLE ASS, V16, P338, DOI 10.1007/s11367-011-0270-1; Roos E, 2010, INT J LIFE CYCLE ASS, V15, P478, DOI 10.1007/s11367-010-0171-8; Sonnemann GW, 2003, J CLEAN PROD, V11, P279, DOI 10.1016/S0959-6526(02)00028-8; Steinmann ZJN, 2014, INT J LIFE CYCLE ASS, V19, P1146, DOI 10.1007/s11367-014-0717-2; Swarr TE, 2011, INT J LIFE CYCLE ASS, V16, P389, DOI 10.1007/s11367-011-0287-5; Upham P, 2011, J CLEAN PROD, V19, P348, DOI 10.1016/j.jclepro.2010.05.014; van der Harst E, 2014, ENVIRON MODELL SOFTW, V51, P123, DOI 10.1016/j.envsoft.2013.09.014; van Zelm R, 2013, ENVIRON SCI TECHNOL, V47, P9274, DOI 10.1021/es305107s; Vandenbergh MP, 2011, NAT CLIM CHANGE, V1, P4, DOI 10.1038/nclimate1071; Weber CL, 2012, J IND ECOL, V16, P203, DOI 10.1111/j.1530-9290.2011.00407.x; Weidema B.P., 1996, J CLEAN PROD, V4, P167, DOI [10.1016/S0959-6526(96)00043-1, DOI 10.1016/S0959-6526(96)00043-1]; Yoshida H, 2014, WATER RES, V56, P292, DOI 10.1016/j.watres.2014.03.014	53	78	79	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0121221	10.1371/journal.pone.0121221	http://dx.doi.org/10.1371/journal.pone.0121221			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781175	gold, Green Published, Green Submitted			2022-12-27	WOS:000351284600198
J	Kweon, HJ; Yu, SY; Kim, DI; Suh, BC				Kweon, Hae-Jin; Yu, Soo-Young; Kim, Dong-Il; Suh, Byung-Chang			Differential Regulation of Proton-Sensitive Ion Channels by Phospholipids: A Comparative Study between ASICs and TRPV1	PLOS ONE			English	Article							EPITHELIAL NA+ CHANNEL; TUMOR-SUPPRESSOR PTEN; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; CAPSAICIN RECEPTOR; PLASMA-MEMBRANE; NOCICEPTIVE NEURONS; ARACHIDONIC-ACID; SENSORY NEURONS; LOW PH; PHOSPHOINOSITIDES	Protons are released in pain-generating pathological conditions such as inflammation, ischemic stroke, infection, and cancer. During normal synaptic activities, protons are thought to play a role in neurotransmission processes. Acid-sensing ion channels (ASICs) are typical proton sensors in the central nervous system (CNS) and the peripheral nervous system (PNS). In addition to ASICs, capsaicin-and heat-activated transient receptor potential vanilloid 1 (TRPV1) channels can also mediate proton-mediated pain signaling. In spite of their importance in perception of pH fluctuations, the regulatory mechanisms of these protonsensitive ion channels still need to be further investigated. Here, we compared regulation of ASICs and TRPV1 by membrane phosphoinositides, which are general cofactors of many receptors and ion channels. We observed that ASICs do not require membrane phosphatidylinositol 4-phosphate (PI(4)P) or phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2) for their function. However, TRPV1 currents were inhibited by simultaneous breakdown of PI (4) P and PI(4,5)P-2. By using a novel chimeric protein, CF-PTEN, that can specifically dephosphorylate at the D3 position of phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P-3), we also observed that neither ASICs nor TRPV1 activities were altered by depletion of PI (3,4,5)P-3 in intact cells. Finally, we compared the effects of arachidonic acid (AA) on two proton-sensitive ion channels. We observed that AA potentiates the currents of both ASICs and TRPV1, but that they have different recovery aspects. In conclusion, ASICs and TRPV1 have different sensitivities toward membrane phospholipids, such as PI(4)P, PI(4,5) P-2, and AA, although they have common roles as proton sensors. Further investigation about the complementary roles and respective contributions of ASICs and TRPV1 in proton-mediated signaling is necessary.	[Kweon, Hae-Jin; Yu, Soo-Young; Kim, Dong-Il; Suh, Byung-Chang] DGIST, Dept Brain Sci, Daegu, South Korea	Daegu Gyeongbuk Institute of Science & Technology (DGIST)	Suh, BC (corresponding author), DGIST, Dept Brain Sci, Daegu, South Korea.	bcsuh@dgist.ac.kr	Kweon, Hae-Jin/AAP-9842-2021		Ministry of Education, Science Technology [2012R1A1A2044699]; DGIST R&D Program of the Ministry of Science, ICTFuture Planning [14-BD-06]	Ministry of Education, Science Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); DGIST R&D Program of the Ministry of Science, ICTFuture Planning	This work was supported by the Ministry of Education, Science & Technology (No. 2012R1A1A2044699) and the DGIST R&D Program of the Ministry of Science, ICT&Future Planning (No. 14-BD-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NJ, 2002, J PHYSIOL-LONDON, V543, P521, DOI 10.1113/jphysiol.2002.020297; Aneiros E, 2011, EMBO J, V30, P994, DOI 10.1038/emboj.2011.19; Askwith CC, 2004, J BIOL CHEM, V279, P18296, DOI 10.1074/jbc.M312145200; Balla A, 2008, MOL BIOL CELL, V19, P711, DOI 10.1091/mbc.E07-07-0713; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; Cao E, 2013, NEURON, V77, P667, DOI 10.1016/j.neuron.2012.12.016; Chai SH, 2007, J BIOL CHEM, V282, P22668, DOI 10.1074/jbc.M703624200; Chen XM, 2007, J PHYSIOL-LONDON, V579, P657, DOI 10.1113/jphysiol.2006.120733; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Chyb S, 1999, NATURE, V397, P255, DOI 10.1038/16703; Das S, 2003, P NATL ACAD SCI USA, V100, P7491, DOI 10.1073/pnas.0932835100; DeRose R, 2013, PFLUG ARCH EUR J PHY, V465, P409, DOI 10.1007/s00424-012-1208-6; Deval E, 2010, PHARMACOL THERAPEUT, V128, P549, DOI 10.1016/j.pharmthera.2010.08.006; Donier E, 2008, EUR J NEUROSCI, V28, P74, DOI 10.1111/j.1460-9568.2008.06282.x; Dorofeeva NA, 2009, NEUROREPORT, V20, P1386, DOI 10.1097/WNR.0b013e3283318912; Du JY, 2014, P NATL ACAD SCI USA, V111, P8961, DOI 10.1073/pnas.1407018111; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Falkenburger BH, 2010, J PHYSIOL-LONDON, V588, P3179, DOI 10.1113/jphysiol.2010.192153; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Hardie RC, 2007, J PHYSIOL-LONDON, V578, P9, DOI 10.1113/jphysiol.2006.118372; Hattori T, 2009, CIRC RES, V105, P279, DOI 10.1161/CIRCRESAHA.109.202036; Hesselager M, 2004, J BIOL CHEM, V279, P11006, DOI 10.1074/jbc.M313507200; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; Horowitz LF, 2005, J GEN PHYSIOL, V126, P243, DOI 10.1085/jgp.200509309; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; Iwasaki H, 2008, P NATL ACAD SCI USA, V105, P7970, DOI 10.1073/pnas.0803936105; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Klein RM, 2008, J BIOL CHEM, V283, P26208, DOI 10.1074/jbc.M801912200; Kweon HJ, 2013, BMB REP, V46, P295, DOI 10.5483/BMBRep.2013.46.6.121; Lacroix J, 2011, J BIOL CHEM, V286, P17945, DOI 10.1074/jbc.M110.201749; Leffler A, 2006, NEUROSCIENCE, V139, P699, DOI 10.1016/j.neuroscience.2005.12.020; Li TB, 2012, J BIOL CHEM, V287, P40680, DOI 10.1074/jbc.M112.418400; Liu BY, 2005, J NEUROSCI, V25, P4835, DOI 10.1523/JNEUROSCI.1296-05.2005; Lukacs V, 2007, J NEUROSCI, V27, P7070, DOI 10.1523/JNEUROSCI.1866-07.2007; Lukacs V, 2013, J BIOL CHEM, V288, P35003, DOI 10.1074/jbc.M113.520288; Lukacs V, 2013, J NEUROSCI, V33, P11451, DOI 10.1523/JNEUROSCI.5637-12.2013; Magnotta VA, 2012, P NATL ACAD SCI USA, V109, P8270, DOI 10.1073/pnas.1205902109; Meves H, 2008, BRIT J PHARMACOL, V155, P4, DOI 10.1038/bjp.2008.216; Pochynyuk O, 2006, AM J PHYSIOL-RENAL, V290, pF949, DOI 10.1152/ajprenal.00386.2005; Pochynyuk O, 2007, J GEN PHYSIOL, V130, P399, DOI 10.1085/jgp.200709800; Rahdar M, 2009, P NATL ACAD SCI USA, V106, P480, DOI 10.1073/pnas.0811212106; Ryu SJ, 2003, J GEN PHYSIOL, V122, P45, DOI 10.1085/jgp.200308847; Senning EN, 2014, J BIOL CHEM, V289, P10999, DOI 10.1074/jbc.M114.553180; Sherwood TW, 2011, J NEUROSCI, V31, P9723, DOI 10.1523/JNEUROSCI.1665-11.2011; Shin J, 2002, P NATL ACAD SCI USA, V99, P10150, DOI 10.1073/pnas.152002699; Smith ES, 2007, NEUROSCIENCE, V145, P686, DOI 10.1016/j.neuroscience.2006.12.024; SMITH ML, 1986, J CEREBR BLOOD F MET, V6, P574, DOI 10.1038/jcbfm.1986.104; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Suh BC, 2010, NEURON, V67, P224, DOI 10.1016/j.neuron.2010.07.001; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Ugawa S, 2005, MOL BRAIN RES, V136, P125, DOI 10.1016/j.molbrainres.2005.01.010; Vazquez F, 2006, P NATL ACAD SCI USA, V103, P3633, DOI 10.1073/pnas.0510570103; Wemmie JA, 2013, NAT REV NEUROSCI, V14, P461, DOI 10.1038/nrn3529; Yue G, 2002, J BIOL CHEM, V277, P11965, DOI 10.1074/jbc.M108951200; Zhang Z, 2005, J BIOL CHEM, V280, P39185, DOI 10.1074/jbc.M506965200	61	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0122014	10.1371/journal.pone.0122014	http://dx.doi.org/10.1371/journal.pone.0122014			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781982	Green Submitted, Green Published, gold			2022-12-27	WOS:000351284600214
J	Mascuch, SJ; Moree, WJ; Hsu, CC; Turner, GG; Cheng, TL; Blehert, DS; Kilpatrick, AM; Frick, WF; Meehan, MJ; Dorrestein, PC; Gerwick, L				Mascuch, Samantha J.; Moree, Wilna J.; Hsu, Cheng-Chih; Turner, Gregory G.; Cheng, Tina L.; Blehert, David S.; Kilpatrick, A. Marm; Frick, Winifred F.; Meehan, Michael J.; Dorrestein, Pieter C.; Gerwick, Lena			Direct Detection of Fungal Siderophores on Bats with White-Nose Syndrome via Fluorescence Microscopy-Guided Ambient Ionization Mass Spectrometry	PLOS ONE			English	Article							MOLECULAR NETWORKING; IRON ASSIMILATION; EMERGING DISEASE; DESTRUCTANS; GEOMYCES; ECOLOGY	White-nose syndrome (WNS) caused by the pathogenic fungus Pseudogymnoascus destructans is decimating the populations of several hibernating North American bat species. Little is known about the molecular interplay between pathogen and host in this disease. Fluorescence microscopy ambient ionization mass spectrometry was used to generate metabolic profiles from the wings of both healthy and diseased bats of the genus Myotis. Fungal siderophores, molecules that scavenge iron from the environment, were detected on the wings of bats with WNS, but not on healthy bats. This work is among the first examples in which microbial molecules are directly detected from an infected host and highlights the ability of atmospheric ionization methodologies to provide direct molecular insight into infection.	[Mascuch, Samantha J.; Dorrestein, Pieter C.; Gerwick, Lena] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, La Jolla, CA 92093 USA; [Hsu, Cheng-Chih; Meehan, Michael J.; Dorrestein, Pieter C.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Moree, Wilna J.; Hsu, Cheng-Chih; Meehan, Michael J.; Dorrestein, Pieter C.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Turner, Gregory G.] Penn Game Commiss, Harrisburg, PA 17110 USA; [Cheng, Tina L.; Kilpatrick, A. Marm; Frick, Winifred F.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Blehert, David S.] US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI 53711 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Santa Cruz; United States Department of the Interior; United States Geological Survey	Gerwick, L (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, La Jolla, CA 92093 USA.	lgerwick@ucsd.edu	Frick, Winifred/ABA-3519-2020; Dorrestein, Pieter/ABF-2930-2020	Frick, Winifred/0000-0002-9469-1839; Hsu, Cheng-Chih/0000-0002-2892-5326; Blehert, David/0000-0002-1065-9760	National Institutes of Health Grant [GM094802]; National Science Foundation [DEB-1115895]; P.E.O. fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067550, R01GM094802] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); P.E.O. fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research in the laboratory of PCD for the development of real-time MS was supported by National Institutes of Health Grant GM094802 (http://www.nih.gov/). Research in the laboratory of AMK was supported by National Science Foundation grant DEB-1115895 (http://www.nsf.gov/). Work by SJM was partially supported by a P.E.O. fellowship (http://www.peointernational.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Boonen J, 2012, TOXICOLOGY, V301, P21, DOI 10.1016/j.tox.2012.06.012; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Cryan PM, 2013, J WILDLIFE DIS, V49, P398, DOI 10.7589/2012-04-121; Eisendle M, 2006, EUKARYOT CELL, V5, P1596, DOI 10.1128/EC.00057-06; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Flajs D, 2009, ARH HIG RADA TOKSIKO, V60, P457, DOI 10.2478/10004-1254-60-2009-1992; Fluckinger M, 2004, ANTIMICROB AGENTS CH, V48, P3367, DOI 10.1128/AAC.48.9.3367-3372.2004; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Gargas A, 2009, MYCOTAXON, V108, P147, DOI 10.5248/108.147; Haas H, 2008, ANNU REV PHYTOPATHOL, V46, P149, DOI 10.1146/annurev.phyto.45.062806.094338; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Heymann P, 2002, INFECT IMMUN, V70, P5246, DOI 10.1128/IAI.70.9.5246-5255.2002; Hissen AHT, 2005, INFECT IMMUN, V73, P5493, DOI 10.1128/IAI.73.9.5493-5503.2005; Holdich DM, 2009, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2009025; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Hsu CC, 2013, P NATL ACAD SCI USA, V110, P14855, DOI 10.1073/pnas.1310618110; Johnson L, 2008, MYCOL RES, V112, P170, DOI 10.1016/j.mycres.2007.11.012; Kim K, 2004, AM NAT, V164, pS52, DOI 10.1086/424609; Langwig KE, 2012, ECOL LETT, V15, P1050, DOI 10.1111/j.1461-0248.2012.01829.x; Lorch JM, 2011, NATURE, V480, P376, DOI 10.1038/nature10590; Meteyer CU, 2009, J VET DIAGN INVEST, V21, P411, DOI 10.1177/104063870902100401; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Miller M, 2009, BIOMETALS, V22, P61, DOI 10.1007/s10534-008-9185-0; Minnis AM, 2013, FUNGAL BIOL-UK, V117, P638, DOI 10.1016/j.funbio.2013.07.001; MOR H, 1992, BIOMETALS, V5, P213, DOI 10.1007/BF01061220; Parrow NL, 2013, INFECT IMMUN, V81, P3503, DOI 10.1128/IAI.00602-13; Puechmaille SJ, 2011, TRENDS ECOL EVOL, V26, P570, DOI 10.1016/j.tree.2011.06.013; Puechmaille SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019167; Reeder DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038920; Sarmiento-Ramirez JM, 2010, FEMS MICROBIOL LETT, V312, P192, DOI 10.1111/j.1574-6968.2010.02116.x; Schrettl M, 2004, J EXP MED, V200, P1213, DOI 10.1084/jem.20041242; Schrettl M, 2007, PLOS PATHOG, V3, P1195, DOI 10.1371/journal.ppat.0030128; Schrettl M, 2011, CURR OPIN MICROBIOL, V14, P400, DOI 10.1016/j.mib.2011.06.002; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Theurl I, 2005, BIOMETALS, V18, P359, DOI 10.1007/s10534-005-3710-1; Turner GG, 2014, J WILDL DIS, V50; Warnecke L, 2012, P NATL ACAD SCI USA, V109, P6999, DOI 10.1073/pnas.1200374109; Watrous J, 2012, P NATL ACAD SCI USA, V109, pE1743, DOI 10.1073/pnas.1203689109; Winkelmann G, 2007, BIOMETALS, V20, P379, DOI 10.1007/s10534-006-9076-1; Yang JY, 2013, J NAT PROD, V76, P1686, DOI 10.1021/np400413s	41	22	22	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119668	10.1371/journal.pone.0119668	http://dx.doi.org/10.1371/journal.pone.0119668			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781976	Green Submitted, gold, Green Published			2022-12-27	WOS:000351284600084
J	Monroe, AE; Reeder, GD; James, L				Monroe, Andrew E.; Reeder, Glenn D.; James, Lauren			Perceptions of Intentionality for Goal-Related Action: Behavioral Description Matters	PLOS ONE			English	Article							ACTION IDENTIFICATION; MORAL RESPONSIBILITY; OTHERS INTENTIONS; MIND PERCEPTION; INFANTS; JUDGMENTS; BLAME; ATTRIBUTION; BELIEFS; BIAS	Perceptions of intentionality critically guide everyday social interactions, though the literature provides diverging portraits of how such judgments are made. One view suggests that people have an "intentionality bias," predisposing them toward labeling behaviors as intentional. A second view focuses on a more complex pattern of reasoning whereby judgments of intentionality are shaped by information about social context and mental states. Drawing on the theory of action-identification, we attempt to integrate these two perspectives. We propose that people parse intentionality into two categories: judgments about concrete, low-level behaviors and judgments about relatively more abstract, high-level behaviors. Evidence from five studies supports this distinction. Low-level behaviors were perceived as intentional regardless of mental state information, supporting the " intentionality bias" view. In contrast, judgments about the intentionality of high-level behaviors varied depending on social context and mental states, supporting the systematic view of intentionality.	[Monroe, Andrew E.] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA; [Reeder, Glenn D.] Illinois State Univ, Dept Psychol, Normal, IL 61761 USA; [James, Lauren] Depaul Univ, Dept Psychol, Chicago, IL 60604 USA	State University System of Florida; Florida State University; Illinois State University; DePaul University	Monroe, AE (corresponding author), Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA.	Monroe@psy.fsu.edu		Monroe, Andrew/0000-0002-9755-8726				Begue L, 2010, PERS SOC PSYCHOL B, V36, P1301, DOI 10.1177/0146167210383044; Buttelmann D, 2009, COGNITION, V112, P337, DOI 10.1016/j.cognition.2009.05.006; DARLEY JM, 1990, ANNU REV PSYCHOL, V41, P525, DOI 10.1146/annurev.ps.41.020190.002521; Decety J, 2012, J NEUROPHYSIOL, V108, P3068, DOI 10.1152/jn.00473.2012; GERGELY G, 1995, COGNITION, V56, P165, DOI 10.1016/0010-0277(95)00661-H; GILBERT DT, 1995, PSYCHOL BULL, V117, P21, DOI 10.1037/0033-2909.117.1.21; Grafton ST, 2007, HUM MOVEMENT SCI, V26, P590, DOI 10.1016/j.humov.2007.05.009; Gray HM, 2007, SCIENCE, V315, P619, DOI 10.1126/science.1134475; Gray K, 2012, PSYCHOL INQ, V23, P101, DOI 10.1080/1047840X.2012.651387; Gray K, 2008, PSYCHOL SCI, V19, P1260, DOI 10.1111/j.1467-9280.2008.02208.x; Guglielmo S, 2010, PERS SOC PSYCHOL B, V36, P1635, DOI 10.1177/0146167210386733; Heider F, 1944, AM J PSYCHOL, V57, P243, DOI 10.2307/1416950; Hughes JS, 2012, J SOC PSYCHOL, V152, P1, DOI 10.1080/00224545.2011.565383; Knobe J, 2003, ANALYSIS, V63, P190, DOI 10.1111/1467-8284.00419; Knobe J., 2004, J THEOR PHILOS PSYCH, V24, P252, DOI [DOI 10.1037/H0091246, 10.1037/h0091246]; Knobe J, 2010, BEHAV BRAIN SCI, V33, P315, DOI 10.1017/S0140525X10000907; Kozak MN, 2006, J PERS SOC PSYCHOL, V90, P543, DOI 10.1037/0022-3514.90.4.543; Lagnado DA, 2008, COGNITION, V108, P754, DOI 10.1016/j.cognition.2008.06.009; Malle B F, 1999, Pers Soc Psychol Rev, V3, P23, DOI 10.1207/s15327957pspr0301_2; malle b. f., 2001, INTENTIONS INTENTION, P265; Malle BF, 2014, PSYCHOL INQ, V25, P147, DOI 10.1080/1047840X.2014.877340; Malle BF, 2012, SYD SYM SOC PSYCHOL, P313; Malle BF, 2012, J PERS SOC PSYCHOL, V102, P661, DOI 10.1037/a0026790; Malle BF, 1997, J EXP SOC PSYCHOL, V33, P101, DOI 10.1006/jesp.1996.1314; Marsh AA, 2010, SOC COGN AFFECT NEUR, V5, P392, DOI 10.1093/scan/nsq004; Molden DC, 2009, PSYCHOL INQ, V20, P37, DOI 10.1080/10478400902744295; Monroe AE, 2011, J EXP SOC PSYCHOL, V47, P1255, DOI 10.1016/j.jesp.2011.05.012; Nichols S, 2007, MIND LANG, V22, P346, DOI 10.1111/j.1468-0017.2007.00312.x; Onishi KH, 2005, SCIENCE, V308, P255, DOI 10.1126/science.1107621; Pacherie E, 2008, COGNITION, V107, P179, DOI 10.1016/j.cognition.2007.09.003; Pettit D, 2009, MIND LANG, V24, P586, DOI 10.1111/j.1468-0017.2009.01375.x; Pizarro D, 2003, PSYCHOL SCI, V14, P267, DOI 10.1111/1467-9280.03433; Plaks JE, 2009, PERS SOC PSYCHOL B, V35, P1687, DOI 10.1177/0146167209345529; PREMACK D, 1990, COGNITION, V36, P1, DOI 10.1016/0010-0277(90)90051-K; Reeder GD, 2009, PSYCHOL INQ, V20, P1, DOI 10.1080/10478400802615744; Ross L., 1977, ADV EXP SOC PSYCHOL, V10, P173, DOI https://doi.org/10.1016/S0065-2601(08)60357-3; Rosset E, 2008, COGNITION, V108, P771, DOI 10.1016/j.cognition.2008.07.001; Rosset E, 2014, J COGN CULT, V14, P27, DOI 10.1163/15685373-12342108; Saxe R, 2004, ANNU REV PSYCHOL, V55, P87, DOI 10.1146/annurev.psych.55.090902.142044; Schachner A, 2013, COGNITION, V129, P309, DOI 10.1016/j.cognition.2013.07.006; Schank RC., 1977, SCRIPTS PLANS GOALS; Scholl BJ, 2000, TRENDS COGN SCI, V4, P299, DOI 10.1016/S1364-6613(00)01506-0; Surian L, 2007, PSYCHOL SCI, V18, P580, DOI 10.1111/j.1467-9280.2007.01943.x; Uttich K, 2010, COGNITION, V116, P87, DOI 10.1016/j.cognition.2010.04.003; Vallacher R.R., 2012, HDB THEORIES SOCIAL, V1, P327, DOI [DOI 10.4135/9781446249215.N17, 10.4135/9781446249215]; VALLACHER RR, 1989, J PERS SOC PSYCHOL, V57, P660, DOI 10.1037/0022-3514.57.4.660; WELLMAN HM, 1990, COGNITION, V35, P245, DOI 10.1016/0010-0277(90)90024-E; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304; Woodward AL, 1999, INFANT BEHAV DEV, V22, P145, DOI 10.1016/S0163-6383(99)00007-7; Woodward AL, 2009, CURR DIR PSYCHOL SCI, V18, P53, DOI 10.1111/j.1467-8721.2009.01605.x; Woolfolk RL, 2006, COGNITION, V100, P283, DOI 10.1016/j.cognition.2005.05.002; Young L, 2009, NEUROPSYCHOLOGIA, V47, P2065, DOI 10.1016/j.neuropsychologia.2009.03.020	52	5	5	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119841	10.1371/journal.pone.0119841	http://dx.doi.org/10.1371/journal.pone.0119841			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7QC	25781315	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600099
J	Roscher, C; Schumacher, J; Schmid, B; Schulze, ED				Roscher, Christiane; Schumacher, Jens; Schmid, Bernhard; Schulze, Ernst-Detlef			Contrasting Effects of Intraspecific Trait Variation on Trait-Based Niches and Performance of Legumes in Plant Mixtures	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; SPECIES RICHNESS; GRASSLAND COMMUNITIES; BIODIVERSITY; MECHANISMS; DIVERSITY; GROWTH; VARIABILITY; PATTERNS; SHADE	Niche differentiation, assumed to be a key mechanism of species coexistence, requires that species differ in their functional traits. So far it remains unclear to which extent trait plasticity leads to niche shifts of species at higher plant diversity, thereby increasing or decreasing niche overlap between species. To analyse this question it is convenient to measure niches indirectly via the variation in resource-uptake traits rather than directly via the resources used. We provisionally call these indirectly measured niches trait-based niches. We studied shoot- and leaf-morphological characteristics in seven legume species in monoculture and multi-species mixture in experimental grassland. Legume species varied in the extent of trait variation in response to plant diversity. Trait plasticity led to significant shifts in species niches in multiple dimensions. Single-species niches in several traits associated with height growth and filling of canopy space were expanded, while other niche dimensions were compressed or did not change with plant diversity. Niche separation among legumes decreased in dimensions related to height growth and space filling, but increased in dimensions related to leaf size and morphology. The total extent of occupied niche space was larger in mixture than in the combined monocultures for dimensions related to leaf morphology and smaller for dimensions related to whole-plant architecture. Taller growth, greater space filling and greater plasticity in shoot height were positively, while larger values and greater plasticity in specific leaf area were negatively related with increased performance of species in mixture. Our study shows that trait variation in response to plant diversity shifts species niches along trait axes. Plastically increased niche differentiation is restricted to niche dimensions that are apparently not related to size-dependent differences between species, but functional equivalence (convergence in height growth) rather than complementarity (divergence in traits associated with light acquisition) explains increased performance of legumes in mixture.	[Roscher, Christiane] UFZ, Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany; [Schumacher, Jens] Univ Jena, Inst Stochast, Jena, Germany; [Schmid, Bernhard] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Schmid, Bernhard] Univ Zurich, Zurich Basel Plant Sci Ctr, Zurich, Switzerland; [Schulze, Ernst-Detlef] Max Planck Inst Biogeochem, D-07745 Jena, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Friedrich Schiller University of Jena; University of Zurich; University of Zurich; Max Planck Society	Roscher, C (corresponding author), UFZ, Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany.	christiane.roscher@ufz.de	Schulze, Ernst-Detlef/K-9627-2014; Schmid, Bernhard/C-8625-2009	Schmid, Bernhard/0000-0002-8430-3214	German Science Foundation [FOR456/1451, RO2397/3]; University of Jena; Max Planck Institute for Biogeochemistry, Jena; Swiss National Science Foundation [147092]	German Science Foundation(German Research Foundation (DFG)); University of Jena; Max Planck Institute for Biogeochemistry, Jena; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The Jena Experiment is funded by the German Science Foundation (FOR456/1451) with additional support by the University of Jena and the Max Planck Institute for Biogeochemistry, Jena. This specific research project was further supported by the German Science Foundation (RO2397/3 to CR). Additional support was provided by the Swiss National Science Foundation (grant no. 147092 to BS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert CH, 2011, PERSPECT PLANT ECOL, V13, P217, DOI 10.1016/j.ppees.2011.04.003; [Anonymous], 2001, PLANT STRATEGIES VEG; [Anonymous], 2014, R LANG ENV STAT COMP; Anten NPR, 1999, J ECOL, V87, P583, DOI 10.1046/j.1365-2745.1999.00365.x; Bates Douglas, 2014, LME4 LINEAR MIXED EF; Bolnick DI, 2011, TRENDS ECOL EVOL, V26, P183, DOI 10.1016/j.tree.2011.01.009; Boucher FC, 2013, FUNCT ECOL, V27, P382, DOI 10.1111/1365-2435.12034; Callaway RM, 2003, ECOLOGY, V84, P1115, DOI 10.1890/0012-9658(2003)084[1115:PPAIAP]2.0.CO;2; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; COLEMAN JS, 1994, TRENDS ECOL EVOL, V9, P187, DOI 10.1016/0169-5347(94)90087-6; CORRE WJ, 1983, ACTA BOT NEERL, V32, P49, DOI 10.1111/j.1438-8677.1983.tb01677.x; Dassler A, 2008, PLANT BIOLOGY, V10, P573, DOI 10.1111/j.1438-8677.2008.00073.x; Dimitrakopoulos PG, 2004, ECOL LETT, V7, P574, DOI 10.1111/j.1461-0248.2004.00607.x; Ellenberg H., 1988, VEGETATION ECOLOGY C; Evans JR, 2001, PLANT CELL ENVIRON, V24, P755, DOI 10.1046/j.1365-3040.2001.00724.x; Falster DS, 2003, TRENDS ECOL EVOL, V18, P337, DOI 10.1016/S0169-5347(03)00061-2; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Gianoli E, 2009, OIKOS, V118, P1924, DOI 10.1111/j.1600-0706.2009.17884.x; GIVNISH TJ, 1988, AUST J PLANT PHYSIOL, V15, P63, DOI 10.1071/PP9880063; Grime JP, 2006, J VEG SCI, V17, P255, DOI 10.1111/j.1654-1103.2006.tb02444.x; Gubsch M, 2011, ANN BOT-LONDON, V107, P157, DOI 10.1093/aob/mcq220; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jones, 1992, PLANTS MICROCLIMATES; Kluge G, 2000, BER DTSCH WETTERDIEN, V213, P1; Laughlin DC, 2012, ECOL LETT, V15, P1291, DOI 10.1111/j.1461-0248.2012.01852.x; Le Bagousse-Pinguet Y, 2014, J ECOL, V102, P466, DOI 10.1111/1365-2745.12201; Levine JM, 2009, NATURE, V461, P254, DOI 10.1038/nature08251; Lipowsky A, 2011, BASIC APPL ECOL, V12, P360, DOI 10.1016/j.baae.2011.03.005; Loreau M, 1998, OIKOS, V82, P600, DOI 10.2307/3546381; Lorentzen S, 2008, PERSPECT PLANT ECOL, V10, P73, DOI 10.1016/j.ppees.2007.12.001; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Maire V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077372; Maire V, 2012, NEW PHYTOL, V196, P497, DOI 10.1111/j.1469-8137.2012.04287.x; Marquard E, 2009, ECOLOGY, V90, P3290, DOI 10.1890/09-0069.1; Mason NWH, 2011, J ECOL, V99, P788, DOI 10.1111/j.1365-2745.2011.01801.x; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; Pigliucci M., 2004, PHENOTYPIC INTEGRATI; Price JN, 2014, FUNCT ECOL, V28, P509, DOI 10.1111/1365-2435.12186; Roscher C, 2005, ECOL LETT, V8, P419, DOI 10.1111/j.1461-0248.2005.00736.x; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Roscher C, 2011, OECOLOGIA, V165, P437, DOI 10.1007/s00442-010-1735-9; ROUGHGARDEN J, 1972, AM NAT, V106, P683, DOI 10.1086/282807; ROUGHGARDEN J, 1974, AM NAT, V108, P429, DOI 10.1086/282924; Salles JF, 2009, ECOLOGY, V90, P3324, DOI 10.1890/09-0188.1; SCHLICHTING CD, 1989, OECOLOGIA, V78, P496, DOI 10.1007/BF00378740; SCHLICHTING CD, 1989, BIOSCIENCE, V39, P460, DOI 10.2307/1311138; SCHMID B, 1992, EVOL TREND PLANT, V6, P45; SCHMID B, 1984, OECOLOGIA, V63, P1, DOI 10.1007/BF00379777; Silvertown J, 2004, TRENDS ECOL EVOL, V19, P605, DOI 10.1016/j.tree.2004.09.003; Spasojevic MJ, 2012, J ECOL, V100, P652, DOI 10.1111/j.1365-2745.2011.01945.x; Spehn EM, 2005, ECOL MONOGR, V75, P37, DOI 10.1890/03-4101; Thein S, 2008, BASIC APPL ECOL, V9, P475, DOI 10.1016/j.baae.2007.08.004; Valladares F, 2008, ANNU REV ECOL EVOL S, V39, P237, DOI 10.1146/annurev.ecolsys.39.110707.173506; Valladares F, 2007, NEW PHYTOL, V176, P749, DOI 10.1111/j.1469-8137.2007.02275.x; van Kleunen M, 2005, NEW PHYTOL, V166, P49, DOI 10.1111/j.1469-8137.2004.01296.x; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Violle C, 2012, TRENDS ECOL EVOL, V27, P244, DOI 10.1016/j.tree.2011.11.014; Violle C, 2009, J PLANT ECOL-UK, V2, P87, DOI 10.1093/jpe/rtp007; Werger MJA, 2002, J VEG SCI, V13, P615, DOI 10.1111/j.1654-1103.2002.tb02089.x; Zuppinger-Dingley D, 2014, NATURE, V515, P108, DOI 10.1038/nature13869	60	28	28	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119786	10.1371/journal.pone.0119786	http://dx.doi.org/10.1371/journal.pone.0119786			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781938	Green Accepted, Green Published, gold			2022-12-27	WOS:000351284600093
J	Schreiber, T; Sorgatz, A; List, F; Bluher, D; Thieme, S; Wilmanns, M; Bonas, U				Schreiber, Tom; Sorgatz, Anika; List, Felix; Blueher, Doreen; Thieme, Sabine; Wilmanns, Matthias; Bonas, Ulla			Refined Requirements for Protein Regions Important for Activity of the TALE AvrBs3	PLOS ONE			English	Article							III EFFECTORS; EFFICIENT CONSTRUCTION; CRYSTAL-STRUCTURE; DNA RECOGNITION; NUCLEAR IMPORT; XANTHOMONAS; TRANSCRIPTION; CLONING; GENE; VESICATORIA	AvrBs3, the archetype of the family of transcription activator-like (TAL) effectors from phytopathogenic Xanthomonas bacteria, is translocated by the type III secretion system into the plant cell. AvrBs3 localizes to the plant cell nucleus and activates the transcription of target genes. Crucial for this is the central AvrBs3 region of 17.5 34-amino acid repeats that functions as a DNA-binding domain mediating recognition in a "one-repeat-to-one base pair" manner. Although AvrBs3 forms homodimers in the plant cell cytosol prior to nuclear import, it binds DNA as a monomer. Here, we show that complex formation of AvrBs3 proteins negatively affects their DNA-binding affinity in vitro. The conserved cysteine residues at position 30 of each repeat facilitate AvrBs3 complexes via disulfide bonds in vitro but are also required for the gene-inducing activity of the AvrBs3 monomer, i.e., activation of plant gene promoters. Our data suggest that the latter is due to a contribution to protein plasticity and that cysteine substitutions to alanine or serine result in a different DNA-binding mode. In addition, our studies revealed that extended parts of both the N-terminal and C-terminal regions of AvrBs3 contribute to DNA binding and, hence, gene-inducing activity in planta.	[Schreiber, Tom; Sorgatz, Anika; List, Felix; Blueher, Doreen; Thieme, Sabine; Bonas, Ulla] Univ Halle Wittenberg, Dept Genet, Inst Biol, D-06108 Halle, Saale, Germany; [List, Felix; Wilmanns, Matthias] DESY, European Mol Biol Lab, Hamburg Unit, Hamburg, Germany	Martin Luther University Halle Wittenberg; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Bonas, U (corresponding author), Univ Halle Wittenberg, Dept Genet, Inst Biol, D-06108 Halle, Saale, Germany.	ulla.bonas@genetik.uni-halle.de		Wilmanns, Matthias/0000-0002-4643-5435	Deutsche Forschungsgemeinschaft [SFB 648]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (SFB 648) to U.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alber T, 1992, CURR OPIN GENET DEV, V2, P205, DOI 10.1016/S0959-437X(05)80275-8; Ansai S, 2013, GENETICS, V193, P739, DOI 10.1534/genetics.112.147645; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; BONAS U, 1989, MOL GEN GENET, V218, P127, DOI 10.1007/BF00330575; Buttner D, 2004, MOL MICROBIOL, V54, P755, DOI 10.1111/j.1365-2958.2004.04302.x; DANIELS MJ, 1984, EMBO J, V3, P3323, DOI 10.1002/j.1460-2075.1984.tb02298.x; de Lange O, 2014, NUCLEIC ACIDS RES, V199, P773; de Lange O, 2014, PLANT J, V78, P753, DOI 10.1111/tpj.12431; de Lange O, 2013, NEW PHYTOL, V199, P773, DOI 10.1111/nph.12324; de Souza TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032305; Deng D, 2014, PROTEIN CELL, V5, P297, DOI 10.1007/s13238-014-0035-2; Deng D, 2012, SCIENCE, V335, P720, DOI 10.1126/science.1215670; Domingues MN, 2010, MOL PLANT PATHOL, V11, P663, DOI [10.1111/J.1364-3703.2010.00636.X, 10.1111/j.1364-3703.2010.00636.x]; Doyle EL, 2013, TRENDS CELL BIOL, V23, P390, DOI 10.1016/j.tcb.2013.04.003; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Gabriel DW, 1997, TRENDS PLANT SCI, V2, P204, DOI 10.1016/S1360-1385(97)89544-1; Gao HS, 2012, CELL RES, V22, P1716, DOI 10.1038/cr.2012.156; Geissler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019509; Gurlebeck D, 2005, PLANT J, V42, P175, DOI 10.1111/j.1365-313X.2005.02370.x; Juillerat A, 2014, SCI REP-UK, V4, DOI 10.1038/srep03831; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; Karimi M, 2005, TRENDS PLANT SCI, V10, P103, DOI 10.1016/j.tplants.2005.01.008; Kay S, 2005, MOL PLANT MICROBE IN, V18, P838, DOI 10.1094/MPMI-18-0838; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; Kay S, 2009, PLANT J, V59, P859, DOI 10.1111/j.1365-313X.2009.03922.x; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Marois E, 2002, MOL PLANT MICROBE IN, V15, P637, DOI 10.1094/MPMI.2002.15.7.637; Meckler JF, 2013, NUCLEIC ACIDS RES, V41, P4118, DOI 10.1093/nar/gkt085; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Romer P, 2007, SCIENCE, V318, P645, DOI 10.1126/science.1144958; Scholze H, 2011, THESIS M LUTHER U HA; Schreiber T, 2014, NUCLEIC ACIDS RES, V42, P7160, DOI 10.1093/nar/gku341; Schulze S, 2012, NEW PHYTOL, V195, P894, DOI 10.1111/j.1469-8137.2012.04210.x; Stella S, 2013, ACTA CRYSTALLOGR D, V69, P1707, DOI 10.1107/S0907444913016429; Sun N, 2013, BIOTECHNOL BIOENG, V110, P1811, DOI 10.1002/bit.24890; Szurek B, 2001, PLANT J, V26, P523, DOI 10.1046/j.0960-7412.2001.01046.x; Taggart AKP, 1996, SCIENCE, V272, P1331, DOI 10.1126/science.272.5266.1331; Tartof K. E., 1987, BRL FOCUS, V9, P2; Thieme F, 2005, J BACTERIOL, V187, P7254, DOI 10.1128/JB.187.21.7254-7266.2005; VAN LAREBEKE N, 1974, NATURE, V252, P169, DOI 10.1038/252169a0; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	48	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120214	10.1371/journal.pone.0120214	http://dx.doi.org/10.1371/journal.pone.0120214			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781334	gold, Green Published, Green Submitted			2022-12-27	WOS:000351284600139
J	Furuya-Kanamori, L; McKenzie, SJ; Yakob, L; Clark, J; Paterson, DL; Riley, TV; Clements, AC				Furuya-Kanamori, Luis; McKenzie, Samantha J.; Yakob, Laith; Clark, Justin; Paterson, David L.; Riley, Thomas V.; Clements, Archie C.			Clostridium difficile Infection Seasonality: Patterns across Hemispheres and Continents - A Systematic Review	PLOS ONE			English	Review							TIME-SERIES ANALYSIS; UNITED-STATES; ANTIBIOTIC CONSUMPTION; DISEASE; RISK; INFLUENZA; EPIDEMIOLOGY; SURVEILLANCE; AUSTRALIA; EXPOSURE	Background Studies have demonstrated seasonal variability in rates of Clostridium difficile infection (CDI). Synthesising all available information on seasonality is a necessary step in identifying large-scale epidemiological patterns and elucidating underlying causes. Methods Three medical and life sciences publication databases were searched from inception to October 2014 for longitudinal epidemiological studies written in English, Spanish or Portuguese that reported the incidence of CDI. The monthly frequency of CDI were extracted, standardized and weighted according to the number of follow-up months. Cross correlation coefficients (XCORR) were calculated to examine the correlation and lag between the year-month frequencies of reported CDI across hemispheres and continents. Results The search identified 13, 5 and 2 studies from North America, Europe, and Oceania, respectively that met the inclusion criteria. CDI had a similar seasonal pattern in the Northern and Southern Hemisphere characterized by a peak in spring and lower frequencies of CDI in summer/ autumn with a lag of 8 months (XCORR = 0.60) between hemispheres. There was no difference between the seasonal patterns across European and North American countries. Conclusion CDI demonstrates a distinct seasonal pattern that is consistent across North America, Europe and Oceania. Further studies are required to identify the driving factors of the observed seasonality.	[Furuya-Kanamori, Luis; Clements, Archie C.] Australian Natl Univ, Res Sch Populat Hlth, Canberra, ACT, Australia; [McKenzie, Samantha J.] Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia; [Yakob, Laith] Univ London London Sch Hyg & Trop Med, Dept Dis Control, London WC1E 7HT, England; [Clark, Justin] Drug ARM Australasia, Annerley, Qld, Australia; [Paterson, David L.] Univ Queensland, UQ Ctr Clin Res, Herston, Qld, Australia; [Riley, Thomas V.] Univ Western Australia, Microbiol & Immunol, Nedlands, WA 6009, Australia; [Riley, Thomas V.] Univ Western Australia, Queen Elizabeth II Med Ctr, Dept Microbiol, PathWest Lab Med, Nedlands, WA 6009, Australia	Australian National University; University of Queensland; University of London; London School of Hygiene & Tropical Medicine; University of Queensland; University of Western Australia; University of Western Australia	Furuya-Kanamori, L (corresponding author), Australian Natl Univ, Res Sch Populat Hlth, Canberra, ACT, Australia.	Luis.Furuya-Kanamori@anu.edu.au	Clements, Archie/ABD-1615-2020; Clark, Justin M/P-8173-2018; Yakob, Laith/AAD-4521-2019; Clark, Justin/AAL-8513-2021	Yakob, Laith/0000-0001-8639-4511; Clark, Justin/0000-0003-0133-1613; Paterson, David/0000-0003-2079-4437; Furuya-Kanamori, Luis/0000-0002-4337-9757	Endeavour Postgraduate Scholarship [3781 2014]; Australia National University Higher Degree Scholarship; Australian National Health and Medical Research Council Senior Research Fellowship [1058878]; Fondo para la Innovacion, Ciencia y Tecnologia Scholarship [095-FINCyT-BDE-2014]	Endeavour Postgraduate Scholarship; Australia National University Higher Degree Scholarship; Australian National Health and Medical Research Council Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Fondo para la Innovacion, Ciencia y Tecnologia Scholarship	LFK is funded by an Endeavour Postgraduate Scholarship (# 3781 2014), an Australia National University Higher Degree Scholarship, and a Fondo para la Innovacion, Ciencia y Tecnologia Scholarship (# 095-FINCyT-BDE-2014). ACC is funded by an Australian National Health and Medical Research Council Senior Research Fellowship (# 1058878). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; Archibald LK, 2004, J INFECT DIS, V189, P1585, DOI 10.1086/383045; Bartlett JG, 2002, NEW ENGL J MED, V346, P334, DOI 10.1056/NEJMcp011603; Brown KA, 2013, AM J EPIDEMIOL, V178, P118, DOI 10.1093/aje/kws463; Brown KA, 2013, ANTIMICROB AGENTS CH, V57, P2326, DOI 10.1128/AAC.02176-12; Burckhardt F, 2008, EMERG INFECT DIS, V14, P691, DOI 10.3201/eid1404.071023; Camacho-Ortiz A, 2009, REV INVEST CLIN, V61, P371; Clements ACA, 2010, LANCET INFECT DIS, V10, P395, DOI 10.1016/S1473-3099(10)70080-3; Codella J, 2014, MED DECIS MAKING; Cunningham R, 2003, J HOSP INFECT, V54, P243, DOI 10.1016/S0195-6701(03)00088-4; Damani N, 2011, BMC PROC S6, V5, pP186; Deorari S, 1999, Can J Infect Dis, V10, P421; Deshpande A, 2013, J ANTIMICROB CHEMOTH, V68, P1951, DOI 10.1093/jac/dkt129; Dubberke ER, 2009, INFECT CONT HOSP EP, V30, P518, DOI 10.1086/597380; Faires MC, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-254; Fleming DM, 2003, BRIT J GEN PRACT, V53, P778; Freeman J, 2010, CLIN MICROBIOL REV, V23, P529, DOI 10.1128/CMR.00082-09; Furuya-Kanamori L, 2015, INFECT CONT HOSP EP, V36, P132, DOI 10.1017/ice.2014.39; Furuya-Kanamori L, 2014, J INFECTION, V69, P447, DOI 10.1016/j.jinf.2014.06.014; Gilca R, 2012, ANTIMICROB AGENTS CH, V56, P639, DOI 10.1128/AAC.05411-11; Gilca R, 2010, INFECT CONT HOSP EP, V31, P939, DOI 10.1086/655463; Grassly NC, 2006, P ROY SOC B-BIOL SCI, V273, P2541, DOI 10.1098/rspb.2006.3604; Hensgens MPM, 2012, J ANTIMICROB CHEMOTH, V67, P742, DOI 10.1093/jac/dkr508; Jagai J, 2009, EMERG INFECT DIS, V15, P343, DOI 10.3201/eid1502.080785; Khanna S, 2013, CLIN INFECT DIS, V56, P1401, DOI 10.1093/cid/cit075; Kuntz JL, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-194; Lanzas C, 2014, INFECT CONT HOSP EP, V35, P1043, DOI 10.1086/677162; MacDonald K S, 1993, Can J Infect Control, V8, P37; Marra F, 2007, ANN PHARMACOTHER, V41, P659, DOI 10.1345/aph.1H293; McFarland LV, 2007, CLIN INFECT DIS, V45, P1141, DOI 10.1086/522187; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Pascual M, 2005, PLOS MED, V2, P18, DOI 10.1371/journal.pmed.0020005; Patrick DM, 2004, CLIN INFECT DIS, V39, P11, DOI 10.1086/420825; Pituch H, 2009, INT J ANTIMICROB AG, V33, pS42, DOI 10.1016/S0924-8579(09)70016-0; Polgreen PM, 2010, INFECT CONT HOSP EP, V31, P382, DOI 10.1086/651095; Reil M, 2012, EPIDEMIOL INFECT, V140, P1787, DOI 10.1017/S0950268811002627; Reveles KR, 2014, VALUE HEALTH, V17, pA267, DOI 10.1016/j.jval.2014.03.1555; Riley TV, 2013, CLOSTRIDIUM DIFFICIL; Rodriguez-Palacios A, 2009, EMERG INFECT DIS, V15, P802, DOI 10.3201/eid1505.081084; Slimings C, 2014, MED J AUSTRALIA, V200, P272, DOI 10.5694/mja13.11153; Slimings C, 2014, J ANTIMICROB CHEMOTH, V69, P881, DOI 10.1093/jac/dkt477; Sonnenberg A, 2008, INFLAMM BOWEL DIS, V14, P955, DOI 10.1002/ibd.20408; Tamerius J, 2011, ENVIRON HEALTH PERSP, V119, P439, DOI 10.1289/ehp.1002383; Thomas C, 2003, J ANTIMICROB CHEMOTH, V51, P1339, DOI 10.1093/jac/dkg254; Van Boeckel TP, 2014, LANCET INFECT DIS, V14, P742, DOI 10.1016/S1473-3099(14)70780-7; Von Muller L, 2011, CLIN MICROBIOL INFEC, V17, pS577; Wells G.A., NEWCASTLE OTTAWA SCA; Wong-McClure RA, 2012, REV PANAM SALUD PUBL, V32, P413, DOI 10.1590/S1020-49892012001400004; Yakob L, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.43; Yakob L, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-376	50	30	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120730	10.1371/journal.pone.0120730	http://dx.doi.org/10.1371/journal.pone.0120730			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775463	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000351183500191
J	George, A; Blankenship, KM				George, Annie; Blankenship, Kim M.			Peer Outreach Work as Economic Activity: Implications for HIV Prevention Interventions among Female Sex Workers	PLOS ONE			English	Article							COMMUNITY-HEALTH WORKERS; ANDHRA-PRADESH; PROGRAM; RISK; HIV/AIDS; INDIA; AIDS; VOLUNTEERISM; MOBILIZATION; KARNATAKA	Female sex workers (FSWs) who work as peer outreach workers in HIV prevention programs are drawn from poor socio-economic groups and consider outreach work, among other things, as an economic activity. Yet, while successful HIV prevention outcomes by such programs are attributed in part to the work of peers who have dense relations with FSW communities, there is scant discussion of the economic implications for FSWs of their work as peers. Using observational data obtained from an HIV prevention intervention for FSWs in south India, we examined the economic benefits and costs to peers of doing outreach work and their implications for sex workers' economic security. We found that peers considered their payment incommensurate with their workload, experienced long delays receiving compensation, and at times had to advance money from their pockets to do their assigned peer outreach work. For the intervention these conditions resulted in peer attrition and difficulties in recruitment of new peer workers. We discuss the implications of these findings for uptake of services, and the possibility of reaching desired HIV outcomes. Inadequate and irregular compensation to peers and inadequate budgetary outlays to perform their community-based outreach work could weaken peers' relationships with FSW community members, undermine the effectiveness of peer-mediated HIV prevention programs and invalidate arguments for the use of peers.	[Blankenship, Kim M.] Amer Univ, Dept Sociol, Washington, DC 20016 USA; [Blankenship, Kim M.] Amer Univ, Ctr Hlth Risk & Soc, Washington, DC 20016 USA	American University; American University	George, A (corresponding author), 206 Sun City B,NIBM Rd, Pune, Maharashtra, India.	anngeor@gmail.com			Bill & Melinda Gates Foundation [OPP30183_01]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the Bill & Melinda Gates Foundation, Grant No OPP30183_01. The views expressed herein are those of the authors and do not necessarily reflect the official policy or position of the Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam K, 2012, SOC SCI MED, V75, P511, DOI 10.1016/j.socscimed.2012.03.039; Avahan, 2009, PEER LED OUTREACH SC; Banerjea N, 2011, CULT DYN, V23, P197, DOI 10.1177/0921374011430565; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Barker RD, 2002, SAMJ S AFR MED J, V92, P291; Beattie TSH, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-476; Bhattacharjee P, 2013, AIDS CARE, V25, pS46, DOI 10.1080/09540121.2012.736607; Bhattacharya K, 2001, COMMUNITY HLTH WORKE; Blankenship KA, 2008, AIDS, V22, pS109, DOI 10.1097/01.aids.0000343769.92949.dd; Bowen KJ, 2011, ASIA-PAC J PUBLIC HE, V23, P843, DOI 10.1177/1010539509355190; Campbell C, 2011, GLOB PUBLIC HEALTH, V6, P125, DOI 10.1080/17441690903334232; Chakravarthy JBR, 2012, J EPIDEMIOL COMMUN H, V66, pII78, DOI 10.1136/jech-2011-200487; Chen Martha Alter, 2008, 4 WIEGO; Cornwall A, 2003, WORLD DEV, V31, P1325, DOI 10.1016/S0305-750X(03)00086-X; Dandona R, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-87; Dil Y, 2012, J COMMUN HEALTH, V37, P1192, DOI 10.1007/s10900-012-9569-5; Evans C, 2008, SOC SCI MED, V66, P467, DOI 10.1016/j.socscimed.2007.08.030; Gaikwad SS, 2013, J EPIDEMIOLOGY COMMU, V66, pii69; Gilmore B, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-847; Glenton C, 2010, SOC SCI MED, V70, P1920, DOI 10.1016/j.socscimed.2010.02.034; Government of India, 2011, WAG RAT RUR IND 2009; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Gurnani V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-755; Halli SS, 2006, AIDS CARE, V18, P739, DOI 10.1080/09540120500466937; Hanefeld J, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-8; Karnataka Health Promotion Trust (KHPT) and Population Council, 2008, PATTERNS OF MIGRATIO; Maes K, 2012, HUM ORGAN, V71, P54, DOI 10.17730/humo.71.1.axm39467485m22w4; Maes KC, 2010, SOC SCI MED, V71, P1375, DOI 10.1016/j.socscimed.2010.06.020; Maupin JN, 2011, HUM ORGAN, V70, P44, DOI 10.17730/humo.70.1.lw033538861270u6; Medhanyie A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-352; Mukanga D, 2011, TROP MED INT HEALTH, V16, P1234, DOI 10.1111/j.1365-3156.2011.02831.x; Muula AS, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-208; Mwai GW, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18586; NACO, 2007, TARG INT NACP 3 OP G, V1; Nkonki L, 2011, B WORLD HEALTH ORGAN, V89, P919, DOI 10.2471/BLT.11.087825; Nyamathi AM, 2011, HEALTH CARE WOMEN IN, V32, P300, DOI 10.1080/07399332.2010.536282; Population Council, 2008, PATT MOB HIV RISK FE; Rahman SM, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-12; Rao PJVR, 2010, SEX TRANSM INFECT, V86, pI7, DOI 10.1136/sti.2009.039297; Reed E, 2010, PUBLIC HEALTH REP, V125, P81, DOI 10.1177/00333549101250S412; Reza-Paul S, 2008, AIDS, V22, pS91, DOI 10.1097/01.aids.0000343767.08197.18; Schneider H, 2008, HEALTH POLICY PLANN, V23, P179, DOI 10.1093/heapol/czn006; Sgaier SK, 2013, HEALTH AFFAIR, V32, P1265, DOI 10.1377/hlthaff.2012.0646; Shahmanesh M, 2008, TROP MED INT HEALTH, V13, P659, DOI 10.1111/j.1365-3156.2008.02040.x; Sundararaman T, 2011, B WORLD HEALTH ORGAN, V89, P73, DOI 10.2471/BLT.09.070862; Swendeman D, 2009, SOC SCI MED, V69, P1157, DOI 10.1016/j.socscimed.2009.07.035; Swidler A, 2009, WORLD DEV, V37, P1182, DOI 10.1016/j.worlddev.2008.11.002; Task shifting: rational redistribution of tasks among health workforce teams, 2008, GLOB REC GUID; Torri MC, 2013, INT Q COMMUNITY HEAL, V33, P3, DOI 10.2190/IQ.33.1.b; Tucker Saroj, 2012, Indian J Sex Transm Dis AIDS, V33, P9, DOI 10.4103/0253-7184.93787; Urada LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033282; World Health Organization (WHO), 2007, COMMUNITY HLTH WORKE; Zachariah R, 2009, T ROY SOC TROP MED H, V103, P549, DOI 10.1016/j.trstmh.2008.09.019	53	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119729	10.1371/journal.pone.0119729	http://dx.doi.org/10.1371/journal.pone.0119729			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD6EY	25775122	gold, Green Published, Green Submitted			2022-12-27	WOS:000351183500115
J	Karaminis, T; Turi, M; Neil, L; Badcock, NA; Burr, D; Pellicano, E				Karaminis, Themelis; Turi, Marco; Neil, Louise; Badcock, Nicholas A.; Burr, David; Pellicano, Elizabeth			Atypicalities in Perceptual Adaptation in Autism Do Not Extend to Perceptual Causality	PLOS ONE			English	Article							BIOLOGICAL MOTION; VISUAL-ADAPTATION; CHILDREN; MECHANISMS; NUMEROSITY; RECOGNITION; CAUSATION; GENDER	A recent study showed that adaptation to causal events (collisions) in adults caused subsequent events to be less likely perceived as causal. In this study, we examined if a similar negative adaptation effect for perceptual causality occurs in children, both typically developing and with autism. Previous studies have reported diminished adaptation for face identity, facial configuration and gaze direction in children with autism. To test whether diminished adaptive coding extends beyond high-level social stimuli (such as faces) and could be a general property of autistic perception, we developed a child-friendly paradigm for adaptation of perceptual causality. We compared the performance of 22 children with autism with 22 typically developing children, individually matched on age and ability (IQ scores). We found significant and equally robust adaptation aftereffects for perceptual causality in both groups. There were also no differences between the two groups in their attention, as revealed by reaction times and accuracy in a change-detection task. These findings suggest that adaptation to perceptual causality in autism is largely similar to typical development and, further, that diminished adaptive coding might not be a general characteristic of autism at low levels of the perceptual hierarchy, constraining existing theories of adaptation in autism.	[Karaminis, Themelis; Neil, Louise; Pellicano, Elizabeth] Univ London, Inst Educ, Ctr Res Autism & Educ CRAE, London WC1N 1AZ, England; [Turi, Marco; Burr, David] Univ Florence, Dept Psychol, Florence, Italy; [Badcock, Nicholas A.] Macquarie Univ, Dept Cognit Sci, Australian Res Council ARC, Ctr Excellence Cognit & Its Disorders, Sydney, NSW 2109, Australia; [Burr, David; Pellicano, Elizabeth] Univ Western Australia, Sch Psychol, Perth, WA 6009, Australia	University of London; University College London; UCL Institute of Education; University of Florence; Macquarie University; University of Western Australia	Karaminis, T (corresponding author), Univ London, Inst Educ, Ctr Res Autism & Educ CRAE, London WC1N 1AZ, England.	t.karaminis@ioe.ac.uk	TURI, MARCO/K-3680-2018; Pellicano, Liz/I-5749-2019; Badcock, Nicholas/O-7227-2015	TURI, MARCO/0000-0002-4495-0804; Pellicano, Liz/0000-0002-7246-8003; Badcock, Nicholas/0000-0001-6862-4694; Burr, David/0000-0003-1541-8832	UK's Medical Research Council [MR/J013145/1]; European Science Council (ERC); Medical Research Council [MR/J013145/1] Funding Source: researchfish; MRC [MR/J013145/1] Funding Source: UKRI	UK's Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Science Council (ERC)(European Research Council (ERC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was generously supported by a grant from the UK's Medical Research Council awarded to EP and DB (MR/J013145/1) and also by the European Science Council (ERC advanced grant "STANIB"). Research at the Centre for Research in Autism and Education (CRAE) is also supported by The Clothworkers' Foundation and Pears Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 1999, NAT NEUROSCI, V2, P1015, DOI 10.1038/14814; Allen G, 2001, FRONT BIOSCI-LANDMRK, V6, pD105, DOI 10.2741/allen; American Psychiatric Association, 2013, DIAGNOSTIC AND STATI; Anobile G, 2014, PSYCHOL SCI, V25, P265, DOI 10.1177/0956797613501520; Arnold D, J VIS IN PRESS; BARLOW H, 1990, VISION RES, V30, P1561, DOI 10.1016/0042-6989(90)90144-A; Blake R, 2003, PSYCHOL SCI, V14, P151, DOI 10.1111/1467-9280.01434; Boynton GM, 2004, NAT NEUROSCI, V7, P8, DOI 10.1038/nn0104-8; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brooks A, 2008, CURR BIOL, V18, pR728, DOI 10.1016/j.cub.2008.06.054; Burr D, 2008, CURR BIOL, V18, P425, DOI 10.1016/j.cub.2008.02.052; Clifford CWG, 2007, VISION RES, V47, P3125, DOI 10.1016/j.visres.2007.08.023; Congiu S, 2010, J AUTISM DEV DISORD, V40, P39, DOI 10.1007/s10803-009-0824-2; Cook R, 2014, AUTISM RES, V7, P481, DOI 10.1002/aur.1381; Corsello C, 2007, J CHILD PSYCHOL PSYC, V48, P932, DOI 10.1111/j.1469-7610.2007.01762.x; Dennett HW, 2012, PSYCHOL SCI, V23, P1279, DOI 10.1177/0956797612446350; Ewing L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081353; Ewing L, 2013, DEVELOPMENTAL SCI, V16, P116, DOI 10.1111/desc.12007; Fiorentini C, 2012, NEUROPSYCHOLOGIA, V50, P2926, DOI 10.1016/j.neuropsychologia.2012.08.019; Freitag CM, 2008, NEUROPSYCHOLOGIA, V46, P1480, DOI 10.1016/j.neuropsychologia.2007.12.025; Grossman E, 2000, J COGNITIVE NEUROSCI, V12, P711, DOI 10.1162/089892900562417; Happe F, 2006, J AUTISM DEV DISORD, V36, P5, DOI 10.1007/s10803-005-0039-0; Harvey BM, 2013, SCIENCE, V341, P1123, DOI 10.1126/science.1239052; Jastorff J, 2009, J NEUROSCI, V29, P7315, DOI 10.1523/JNEUROSCI.4870-08.2009; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Jordan H, 2006, NAT NEUROSCI, V9, P738, DOI 10.1038/nn1710; Kleiner M, 2007, PERCEPTION, V36, P14; Knapen T, 2009, J VISION, V9, DOI [10.1167/9.13.16, 10.1167/9.5.16]; Kohn A, 2007, J NEUROPHYSIOL, V97, P3155, DOI 10.1152/jn.00086.2007; Koldewyn K, 2010, BRAIN, V133, P599, DOI 10.1093/brain/awp272; Lord C., 1999, AUTISM DIAGNOSTIC OB; Meaux E, 2014, HUM BRAIN MAPP, V35, P4362, DOI 10.1002/hbm.22480; Mottron L, 2006, J AUTISM DEV DISORD, V36, P27, DOI 10.1007/s10803-005-0040-7; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pellicano E, 2007, CURR BIOL, V17, P1508, DOI 10.1016/j.cub.2007.07.065; Pellicano E, 2013, CHILD DEV PERSPECT, V7, P143, DOI 10.1111/cdep.12031; Pellicano E, 2013, NEUROPSYCHOLOGIA, V51, P1504, DOI 10.1016/j.neuropsychologia.2013.03.021; Pellicano E, 2012, TRENDS COGN SCI, V16, P504, DOI 10.1016/j.tics.2012.08.009; Ray E, 2007, RES AUTISM SPECT DIS, V1, P266, DOI 10.1016/j.rasd.2006.11.002; Rhodes G, 2011, VISION RES, V51, P1811, DOI 10.1016/j.visres.2011.06.008; Rips LJ, 2011, PERSPECT PSYCHOL SCI, V6, P77, DOI 10.1177/1745691610393525; Rolfs M, 2013, CURR BIOL, V23, P250, DOI 10.1016/j.cub.2012.12.017; Rutherford MD, 2012, J AUTISM DEV DISORD, V42, P221, DOI 10.1007/s10803-011-1233-x; Rutter M., 2003, SOCIAL COMMUNICATION; Schlottmann A, 1999, PERCEPTION, V28, P1105, DOI 10.1068/p2767; Schlottmann A, 2002, CHILD DEV, V73, P1656, DOI 10.1111/1467-8624.00497; Schlottmann A, 2006, ACTA PSYCHOL, V123, P112, DOI 10.1016/j.actpsy.2006.05.006; Troje NF, 2006, J VISION, V6, P850, DOI 10.1167/6.8.7; Tschacher W, 2006, SCHIZOPHRENIA BULL, V32, pS106, DOI 10.1093/schbul/sbl018; Turi M, 2014, POSTER PRESENTED AT; Webster M. A., 2005, ADV VISUAL COGNITION, V2, P241, DOI DOI 10.1093/ACPROF:OSO/9780198529699.003.0010; Wechsler D., 2011, WASI 2 WECHSLER ABBR; White PA, 2009, PSYCHOL REV, V116, P580, DOI 10.1037/a0016337	53	22	22	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120439	10.1371/journal.pone.0120439	http://dx.doi.org/10.1371/journal.pone.0120439			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD6EY	25774507	Green Published, gold			2022-12-27	WOS:000351183500174
J	Salazar, KA; Joffe, NR; Dinguirard, N; Houde, P; Castillo, MG				Salazar, Karla A.; Joffe, Nina R.; Dinguirard, Nathalie; Houde, Peter; Castillo, Maria G.			Transcriptome Analysis of the White Body of the Squid Euprymna tasmanica with Emphasis on Immune and Hematopoietic Gene Discovery	PLOS ONE			English	Article							PEPTIDOGLYCAN RECOGNITION PROTEIN; THIOESTER-CONTAINING PROTEINS; HAWAIIAN BOBTAIL SQUID; KAPPA-B ACTIVATION; VIBRIO-FISCHERI; LIGHT-ORGAN; LINEAGE COMMITMENT; OCTOPUS-VULGARIS; BACTERIA-BINDING; INNATE IMMUNITY	In the mutualistic relationship between the squid Euprymna tasmanica and the bioluminescent bacterium Vibrio fischeri, several host factors, including immune-related proteins, are known to interact and respond specifically and exclusively to the presence of the symbiont. In squid and octopus, the white body is considered to be an immune organ mainly due to the fact that blood cells, or hemocytes, are known to be present in high numbers and in different developmental stages. Hence, the white body has been described as the site of hematopoiesis' in cephalopods. However, to our knowledge, there are no studies showing any molecular evidence of such functions. In this study, we performed a transcriptomic analysis of white body tissue of the Southern dumpling squid, Euprymna tasmanica. Our primary goal was to gain insights into the functions of this tissue and to test for the presence of gene transcripts associated with hematopoietic and immune processes. Several hematopoiesis genes including CPSF1, GATA 2, TFIID, and FGFR2 were found to be expressed in the white body. In addition, transcripts associated with immune-related signal transduction pathways, such as the toll-like receptor/NF-kappa beta, and MAPK pathways were also found, as well as other immune genes previously identified in Euprymna tasmanica's sister species, E. scolopes. This study is the first to analyze an immune organ within cephalopods, and to provide gene expression data supporting the white body as a hematopoietic tissue.	[Salazar, Karla A.; Joffe, Nina R.; Dinguirard, Nathalie; Houde, Peter; Castillo, Maria G.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA	New Mexico State University	Castillo, MG (corresponding author), New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.	mcastill@nmsu.edu		Dinguirard, Nathalie/0000-0001-5843-2584	CONACyT PhD fellowship [216017/311449]; New Mexico State University Start-up fund	CONACyT PhD fellowship(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); New Mexico State University Start-up fund	This work was supported by the CONACyT PhD fellowship 216017/311449 (http://www.conacyt.gob.mx/) to KAS and the New Mexico State University Start-up fund to MGC. The funders had no role in the study design, data collection and analysis, decision to publish or preparation in the manuscript.	Altura MA, 2013, ENVIRON MICROBIOL, V15, P2937, DOI 10.1111/1462-2920.12179; Altura MA, 2011, CELL MICROBIOL, V13, P527, DOI 10.1111/j.1462-5822.2010.01552.x; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bikker FJ, 2004, J BIOL CHEM, V279, P47699, DOI 10.1074/jbc.M406095200; Bikker FJ, 2002, J BIOL CHEM, V277, P32109, DOI 10.1074/jbc.M203788200; Bolli N, 2011, BLOOD, V117, P3996, DOI 10.1182/blood-2010-08-304030; Carnaud C, 1999, J IMMUNOL, V163, P4647; Carter CG, 2009, COMP BIOCHEM PHYS A, V153, P185, DOI 10.1016/j.cbpa.2009.02.015; Castellanos-Martinez S, 2014, DEV COMP IMMUNOL, V44, P50, DOI 10.1016/j.dci.2013.11.013; Castellanos-Martinez S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107873; Castillo MG, 2009, DEV COMP IMMUNOL, V33, P69, DOI 10.1016/j.dci.2008.07.013; CHOU CC, 1986, MOL CELL BIOL, V6, P566, DOI 10.1128/MCB.6.2.566; Chun CK, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-154; Claes MF, 1996, ACTA ZOOL-STOCKHOLM, V77, P173, DOI 10.1111/j.1463-6395.1996.tb01262.x; Collins Andrew J, 2010, J Vis Exp, DOI 10.3791/1714; Collins AJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00091; COWDEN RR, 1972, J INVERTEBR PATHOL, V19, P113, DOI 10.1016/0022-2011(72)90196-6; Currie CR, 2007, NATURE, V98, P701; Davidson SK, 2004, CELL MICROBIOL, V6, P1139, DOI 10.1111/j.1462-5822.2004.00429.x; De Arras L, 2014, GENETICS, V197, P485, DOI 10.1534/genetics.113.160499; Detournay O, 2012, DEV COMP IMMUNOL, V38, P525, DOI 10.1016/j.dci.2012.08.008; DIPIETRO LA, 1995, SHOCK, V4, P233, DOI 10.1097/00024382-199510000-00001; Dishaw LJ, 2005, IMMUNOGENETICS, V57, P535, DOI 10.1007/s00251-005-0005-1; Dodds AW, 1998, IMMUNOL REV, V166, P15; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Drew BA, 2012, BBA-REV CANCER, V1825, P37, DOI 10.1016/j.bbcan.2011.10.002; Estevez-Calvar N, 2011, DEV COMP IMMUNOL, V35, P1015, DOI 10.1016/j.dci.2011.03.023; Franche C, 2007, PLANT SOIL, V321, P335; Franklin AM, 2012, BIOL LETTERS, V8, P754, DOI 10.1098/rsbl.2012.0556; Fujito NT, 2010, DEV COMP IMMUNOL, V34, P775, DOI 10.1016/j.dci.2010.02.011; Giesert C, 2003, ANN NY ACAD SCI, V996, P227, DOI 10.1111/j.1749-6632.2003.tb03250.x; Gil J, 2004, MOL CELL BIOL, V24, P4502, DOI 10.1128/MCB.24.10.4502-4512.2004; Goodson MS, 2005, APPL ENVIRON MICROB, V71, P6934, DOI 10.1128/AEM.71.11.6934-6946.2005; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Guan RJ, 2004, P NATL ACAD SCI USA, V101, P17168, DOI 10.1073/pnas.0407856101; Hart DO, 2009, DEV DYNAM, V238, P2540, DOI 10.1002/dvdy.22083; Heath-Heckman EAC, 2011, ZOOLOGY, V114, P191, DOI 10.1016/j.zool.2011.02.002; Hernandez-Campo PM, 2007, CYTOM PART B-CLIN CY, V72B, P34, DOI 10.1002/cyto.b.20143; Iwasaki H, 2007, ONCOGENE, V26, P6687, DOI 10.1038/sj.onc.1210754; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jones BW, 2004, MAR BIOL, V144, P1151, DOI 10.1007/s00227-003-1285-3; Jurica MS, 2002, RNA, V8, P426, DOI 10.1017/S1355838202021088; Kaufman DS, 2001, P NATL ACAD SCI USA, V98, P10716, DOI 10.1073/pnas.191362598; Keeney KM, 2014, ANNU REV MICROBIOL, V68, P217, DOI 10.1146/annurev-micro-091313-103456; Koropatnick TA, 2007, BIOL BULL-US, V212, P29, DOI 10.2307/25066578; Kraus ZJ, 2008, J IMMUNOL, V181, P7800, DOI 10.4049/jimmunol.181.11.7800; Kremer N, 2013, CELL HOST MICROBE, V14, P183, DOI 10.1016/j.chom.2013.07.006; Kremer N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000630; Kvennefors ECE, 2010, DEV COMP IMMUNOL, V34, P1219, DOI 10.1016/j.dci.2010.06.016; Law SKA, 1997, PROTEIN SCI, V6, P263; Lazzaro BP, 2008, CURR OPIN MICROBIOL, V11, P284, DOI 10.1016/j.mib.2008.05.001; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Lin M, 2002, BLOOD, V99, P1683, DOI 10.1182/blood.V99.5.1683; Liu SB, 2006, RNA, V12, P1418, DOI 10.1261/rna.55406; Liu Z, 2011, CELL, V146, P720, DOI 10.1016/j.cell.2011.08.005; Madsen J, 2003, EUR J IMMUNOL, V33, P2327, DOI 10.1002/eji.200323972; Mandel MJ, 2012, APPL ENVIRON MICROB, V78, P4620, DOI 10.1128/AEM.00377-12; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; McFall-Ngai M, 2010, SEMIN IMMUNOL, V22, P48, DOI 10.1016/j.smim.2009.11.003; MCFALLNGAI M, 1990, BIOL BULL, V179, P332, DOI 10.2307/1542325; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Mellroth P, 2003, J BIOL CHEM, V278, P7059, DOI 10.1074/jbc.M208900200; Mills KHG, 2004, NAT REV IMMUNOL, V4, P841, DOI 10.1038/nri1485; Moltschaniwskyj NA, 2007, REV FISH BIOL FISHER, V17, P455, DOI 10.1007/s11160-007-9056-8; Nonaka M, 2004, MOL IMMUNOL, V40, P897, DOI 10.1016/j.molimm.2003.10.009; Nyholm SV, 2009, ENVIRON MICROBIOL, V11, P483, DOI 10.1111/j.1462-2920.2008.01788.x; Nyholm SV, 1998, BIOL BULL, V195, P89, DOI 10.2307/1542815; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026; Portela J, 2013, J INNATE IMMUN, V5, P261, DOI 10.1159/000345909; Rodriguez-Lanetty M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-23; Rosado CJ, 2008, CELL MICROBIOL, V10, P1765, DOI 10.1111/j.1462-5822.2008.01191.x; Rosenstiel P, 2007, J IMMUNOL, V178, P8203, DOI 10.4049/jimmunol.178.12.8203; Sahu A, 2001, IMMUNOL REV, V180, P35, DOI 10.1034/j.1600-065X.2001.1800103.x; Scaccabarozzi A, 2000, BRIT J HAEMATOL, V110, P978, DOI 10.1046/j.1365-2141.2000.02280.x; Schleicher TR, 2014, MOL CELL PROTEOMICS, V13, P2673, DOI 10.1074/mcp.M113.037259; Schleicher TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025649; Dreon MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063782; Septer AN, 2011, ENVIRON MICROBIOL, V13, P2855, DOI 10.1111/j.1462-2920.2011.02558.x; Sinn DL, 2005, J COMP PSYCHOL, V119, P99, DOI 10.1037/0735-7036.119.1.99; SOTTRUPJENSEN L, 1985, P NATL ACAD SCI USA, V82, P9, DOI 10.1073/pnas.82.1.9; Squires ZE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037074; SUTHERLAND DR, 1991, BLOOD, V77, P84; Tada K, 2001, J BIOL CHEM, V276, P36530, DOI 10.1074/jbc.M104837200; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; Troll JV, 2010, ENVIRON MICROBIOL, V12, P2190, DOI 10.1111/j.1462-2920.2009.02121.x; Troll JV, 2009, CELL MICROBIOL, V11, P1114, DOI 10.1111/j.1462-5822.2009.01315.x; Tsai FY, 1997, BLOOD, V89, P3636, DOI 10.1182/blood.V89.10.3636.3636_3636_3643; VISVADER JE, 1995, MOL CELL BIOL, V15, P634; Wang YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061213; Wang ZM, 2003, J BIOL CHEM, V278, P49044, DOI 10.1074/jbc.M307758200; WEI SL, 1989, MAR BIOL, V103, P541, DOI 10.1007/BF00399586; Wier AM, 2010, P NATL ACAD SCI USA, V107, P2259, DOI 10.1073/pnas.0909712107; Williams MJ, 2007, J IMMUNOL, V178, P4711, DOI 10.4049/jimmunol.178.8.4711; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang T, 2014, DEV COMP IMMUNOL, V45, P141, DOI 10.1016/j.dci.2014.02.015; Zhu J, 2002, ONCOGENE, V21, P3295, DOI 10.1038/sj.onc.1205318; Zouari I, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-221	100	18	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119949	10.1371/journal.pone.0119949	http://dx.doi.org/10.1371/journal.pone.0119949			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775132	Green Submitted, gold, Green Published			2022-12-27	WOS:000351183500143
J	Tarpy, DR; Delaney, DA; Seeley, TD				Tarpy, David R.; Delaney, Deborah A.; Seeley, Thomas D.			Mating Frequencies of Honey Bee Queens (Apis mellifera L.) in a Population of Feral Colonies in the Northeastern United States	PLOS ONE			English	Article							VARROA-JACOBSONI OUD; GENETIC DIVERSITY; SCIENTIFIC NOTE; POLYANDRY; EVOLUTION; PROMISCUITY; HYMENOPTERA; CLIMATES; DISEASE; GROWTH	Across their introduced range in North America, populations of feral honey bee (Apis mellifera L.) colonies have supposedly declined in recent decades as a result of exotic parasites, most notably the ectoparasitic mite Varroa destructor. Nonetheless, recent studies have documented several wild populations of colonies that have persisted. The extreme polyandry of honey bee queens-and the increased intracolony genetic diversity it confers-has been attributed, in part, to improved disease resistance and may be a factor in the survival of these populations of feral colonies. We estimated the mating frequencies of queens in feral colonies in the Arnot Forest in New York State to determine if the level of polyandry of these queens is especially high and so might contribute to their survival success. We geno-typed the worker offspring from 10 feral colonies in the Arnot Forest of upstate New York, as well as those from 20 managed colonies closest to this forest. We found no significant differences in mean mating frequency between the feral and managed queens, suggesting that queens in the remote, low-density population of colonies in the Arnot Forest are neither mate-limited nor adapted to mate at an especially high frequency. These findings support the hypothesis that the hyperpolyandry of honey bees has been shaped on an evolutionary timescale rather than on an ecological one.	[Tarpy, David R.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Tarpy, David R.] N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA; [Delaney, Deborah A.] Univ Delaware, Dept Entomol & Wildlife Biol, Newark, DE USA; [Seeley, Thomas D.] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of Delaware; Cornell University	Tarpy, DR (corresponding author), N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA.	david_tarpy@ncsu.edu		Tarpy, David/0000-0001-8601-6094	North American Pollinator Protection Campaign; USDA grant [2008-02404]	North American Pollinator Protection Campaign; USDA grant(United States Department of Agriculture (USDA))	This research was funded by a grant from the North American Pollinator Protection Campaign (to TDS, DAD and DRT), and by USDA grant number 2008-02404 (to DAD and DRT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arundel J, 2012, ECOL MODEL, V247, P48, DOI 10.1016/j.ecolmodel.2012.08.001; Boomsma JJ, 1996, PHILOS T R SOC B, V351, P947, DOI 10.1098/rstb.1996.0087; Chauzat MP, 2006, J ECON ENTOMOL, V99, P253, DOI 10.1603/0022-0493-99.2.253; Chen Y, 2008, J INVERTEBR PATHOL, V97, P186, DOI 10.1016/j.jip.2007.07.010; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Cremer S, 2007, CURR BIOL, V17, pR693, DOI 10.1016/j.cub.2007.06.008; Crozier RH, 1997, ELECTROPHORESIS, V18, P1672, DOI 10.1002/elps.1150180934; Delaney DA, 2009, ANN ENTOMOL SOC AM, V102, P666, DOI 10.1603/008.102.0411; Delaney DA, 2011, APIDOLOGIE, V42, P1, DOI 10.1051/apido/2010027; Engel Michael S., 2009, Proceedings of the California Academy of Sciences, V60, P23; Franck P, 2000, INSECT SOC, V47, P364, DOI 10.1007/PL00001732; Hamilton W.D., 1987, P81; Hamilton WD, 1975, Q REV BIOL, V50, P175, DOI [DOI 10.1086/408439, 10.1086/408439]; KORPELA S, 1992, J APICULT RES, V31, P157, DOI 10.1080/00218839.1992.11101278; KRAUS B, 1995, APIDOLOGIE, V26, P149, DOI 10.1051/apido:19950208; LOPER GM, 1992, J KANSAS ENTOMOL SOC, V65, P223; Magnus R, 2010, SOCIOBIOLOGY, V55, P285; Mattila HR, 2007, SCIENCE, V317, P362, DOI 10.1126/science.1143046; Moritz RFA, 2008, J INSECT CONSERV, V12, P455, DOI 10.1007/s10841-007-9078-5; Neumann P, 2000, INSECT SOC, V47, P271, DOI 10.1007/PL00001714; Neumann P, 1999, J APICULT RES, V38, P11, DOI 10.1080/00218839.1999.11100990; Nielsen DI, 2000, THESIS U CALIFORNIA; Nielsen R, 2003, MOL ECOL, V12, P3157, DOI 10.1046/j.1365-294X.2003.01994.x; Oldroyd BP, 1999, TRENDS ECOL EVOL, V14, P312, DOI 10.1016/S0169-5347(99)01613-4; OLDROYD BP, 1994, BEHAV ECOL SOCIOBIOL, V34, P169, DOI 10.1007/BF00167741; Palmer KA, 2000, APIDOLOGIE, V31, P235, DOI 10.1051/apido:2000119; Park S, 2008, EXCEL MICROSATELLITE; Ruttner F., 1988, BIOGEOGRAPHY TAXONOM, DOI [10.1007/978-3-642-72649-1, DOI 10.1007/978-3-642-72649-1]; Sammataro D, 2000, ANNU REV ENTOMOL, V45, P519, DOI 10.1146/annurev.ento.45.1.519; Schmid-Hempel P., 1998, Parasites in social insects.; Seeley TD, 2002, APIDOLOGIE, V33, P75, DOI 10.1051/apido:2001008; Seeley TD, 2007, APIDOLOGIE, V38, P19, DOI 10.1051/apido:2006055; Seeley TD, 2007, P ROY SOC B-BIOL SCI, V274, P67, DOI 10.1098/rspb.2006.3702; SHERMAN PW, 1988, AM NAT, V131, P602, DOI 10.1086/284809; Strassmann J, 2001, INSECT SOC, V48, P1, DOI 10.1007/PL00001737; Tarpy DR, 2013, NATURWISSENSCHAFTEN, V100, P723, DOI 10.1007/s00114-013-1065-y; Tarpy DR, 2012, J ECON ENTOMOL, V105, P20, DOI 10.1603/EC11276; Tarpy DR, 2010, J APICULT RES, V49, P302, DOI 10.3896/IBRA.1.49.4.02; Tarpy DR, 2003, P ROY SOC B-BIOL SCI, V270, P99, DOI 10.1098/rspb.2002.2199; Tarpy DR, 2004, INSECT SOC, V51, P203, DOI 10.1007/s00040-004-0734-4; Tarpy DR, 2001, ANN ZOOL FENN, V38, P255; Tilley CA, 1997, ANIM BEHAV, V54, P1483, DOI 10.1006/anbe.1997.0546; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; VISSCHER PK, 1982, ECOLOGY, V63, P1790, DOI 10.2307/1940121; VISSCHER PK, 1989, AM BEE J, V129, P536; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Wattanachaiyingcharoen W, 2003, APIDOLOGIE, V34, P85, DOI 10.1051/apido:2002044; Williams GR, 2010, BIOESSAYS, V32, P845, DOI 10.1002/bies.201000075; Wilson-Rich N, 2009, ANNU REV ENTOMOL, V54, P405, DOI 10.1146/annurev.ento.53.103106.093301	49	31	31	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118734	10.1371/journal.pone.0118734	http://dx.doi.org/10.1371/journal.pone.0118734			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775410	Green Submitted, Green Published, gold			2022-12-27	WOS:000351183500037
J	Xavier, C; Builes, JJ; Gomes, V; Ospino, JM; Aquino, J; Parson, W; Amorim, A; Gusmao, L; Goios, A				Xavier, Catarina; Builes, Juan Jose; Gomes, Veronica; Ospino, Jose Miguel; Aquino, Juliana; Parson, Walther; Amorim, Antonio; Gusmao, Leonor; Goios, Ana			Admixture and Genetic Diversity Distribution Patterns of Non-Recombining Lineages of Native American Ancestry in Colombian Populations	PLOS ONE			English	Article							AUTOSOMAL MICROSATELLITE DATA; MULTILOCUS GENOTYPE DATA; HUMAN MITOCHONDRIAL-DNA; COLUMBIAN BONE REMAINS; SOUTH-AMERICA; AMERINDIAN POPULATIONS; NORTHWESTERN COLOMBIA; INTERNATIONAL SOCIETY; ANTIOQUIA COLOMBIA; MTDNA HAPLOGROUPS	Genetic diversity of present American populations results from very complex demographic events involving different types and degrees of admixture. Through the analysis of lineage markers such as mtDNA and Y chromosome it is possible to recover the original Native American haplotypes, which remained identical since the admixture events due to the absence of recombination. However, the decrease in the effective population sizes and the consequent genetic drift effects suffered by these populations during the European colonization resulted in the loss or under-representation of a substantial fraction of the Native American lineages. In this study, we aim to clarify how the diversity and distribution of uniparental lineages vary with the different demographic characteristics (size, degree of isolation) and the different levels of admixture of extant Native groups in Colombia. We present new data resulting from the analyses of mtDNA whole control region, Y chromosome SNP haplogroups and STR haplotypes, and autosomal ancestry informative insertion-deletion polymorphisms in Colombian individuals from different ethnic and linguistic groups. The results demonstrate that populations presenting a high proportion of non-Native American ancestry have preserved nevertheless a substantial diversity of Native American lineages, for both mtDNA and Y chromosome. We suggest that, by maintaining the effective population sizes high, admixture allowed for a decrease in the effects of genetic drift due to Native population size reduction and thus resulting in an effective preservation of the Native American non-recombining lineages.	[Xavier, Catarina; Gomes, Veronica; Amorim, Antonio; Gusmao, Leonor; Goios, Ana] Univ Porto, Inst Invest & Inovacao Saude, P-4100 Oporto, Portugal; [Xavier, Catarina; Gomes, Veronica; Amorim, Antonio; Gusmao, Leonor; Goios, Ana] Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Oporto, Portugal; [Xavier, Catarina; Parson, Walther] Med Univ Innsbruck, Inst Legal Med, A-6020 Innsbruck, Austria; [Builes, Juan Jose] Univ Antioquia, Inst Biol, Medellin, Colombia; [Builes, Juan Jose; Ospino, Jose Miguel] Lab Genes Ltda, Medellin, Colombia; [Aquino, Juliana; Gusmao, Leonor] State Univ Rio de Janeiro UERJ, LDD, Rio De Janeiro, Brazil; [Parson, Walther] Penn State Univ, Eberly Coll Sci, University Pk, PA 16802 USA; [Amorim, Antonio] Univ Porto, Fac Ciencias, P-4100 Oporto, Portugal	Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Medical University of Innsbruck; Universidad de Antioquia; Universidade do Estado do Rio de Janeiro; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Universidade do Porto	Goios, A (corresponding author), Univ Porto, Inst Invest & Inovacao Saude, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	aalmeida@ipatimup.pt	Parson, Walther/AAD-6845-2020; Gusmão, Leonor/L-8931-2019; Gusmao, Leonor/B-3122-2013; Amorim, Antonio/A-7938-2008; Goios, Ana/J-6012-2013	Gusmão, Leonor/0000-0003-0432-6481; Gusmao, Leonor/0000-0003-0432-6481; Amorim, Antonio/0000-0002-7518-6247; Goios, Ana/0000-0002-3297-8420; Xavier, Catarina/0000-0003-3522-1631; Builes Gomez, Juan Jose/0000-0001-8403-6809; Gomes, Veronica/0000-0003-2815-6376; Parson, Walther/0000-0002-5692-2392	FCT; FCT, the Portuguese Foundation for Science and Technology; European Social Fund (Human Potential Thematic Operational Programme) [SFRH/BD/90873/2012, SFRH/BPD/76207/2011, SFRH/BPD/43646/2008]	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT, the Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); European Social Fund (Human Potential Thematic Operational Programme)(European Social Fund (ESF))	Ipatimup is an Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education, and is partially supported by FCT, the Portuguese Foundation for Science and Technology. CX, VG and AG are also supported by FCT fellowships co-financed by the European Social Fund (Human Potential Thematic Operational Programme; grants SFRH/BD/90873/2012, SFRH/BPD/76207/2011 and SFRH/BPD/43646/2008, respectively). The funders had no role in study	Aceituno FJ, 2013, QUATERN INT, V301, P23, DOI 10.1016/j.quaint.2012.05.017; Achilli A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001764; Adelaar W., 2004, LANGUAGES ANDES; Alonso A, 2003, INT CONGR SER, V1239, P585, DOI 10.1016/S0531-5131(02)00401-6; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Arango R, 2004, PUEBLOS INDIGENAS CO; Arango Raul, 1998, PUEBLOS INDIGENAS CO; Bandelt HJ, 2008, INT J LEGAL MED, V122, P11, DOI 10.1007/s00414-006-0151-5; Bedoya G, 2006, P NATL ACAD SCI USA, V103, P7234, DOI 10.1073/pnas.0508716103; Brion M, 2005, INT J LEGAL MED, V119, P10, DOI 10.1007/s00414-004-0439-2; Builes JJ, 2007, FORENSIC SCI INT, V167, P62, DOI 10.1016/j.forsciint.2005.12.015; Builes JJ, 2006, FORENSIC SCI INT, V164, P79, DOI 10.1016/j.forsciint.2005.10.005; Campbell Lyle, 2000, AM INDIAN LANGUAGES, P396; Carracedo A, 2000, FORENSIC SCI INT, V110, P79, DOI 10.1016/S0379-0738(00)00161-4; Carvajal-Carmona LG, 2000, AM J HUM GENET, V67, P1287, DOI 10.1016/S0002-9297(07)62956-5; Casas-Vargas A, 2011, AM J PHYS ANTHROPOL, V146, P637, DOI 10.1002/ajpa.21626; Noguera MC, 2014, ANN HUM BIOL, V41, P453, DOI 10.3109/03014460.2013.852244; Constenla Umana A., 1991, FILOLOGIA LINGUISTIC, V17, P137, DOI [10.15517/rfl.v17i1-2.20972, DOI 10.15517/RFL.V17I1-2.20972]; Curnow T.J., 1998, INT J AM LINGUIST, V64, P338, DOI [10.1086/466365, DOI 10.1086/466365]; Curtin Philip D., 1972, ATLANTIC SLAVE TRADE; DANE, 2007, COL NAC MULT DIV ETN; Palacio OD, 2006, FORENSIC SCI INT, V160, P217, DOI 10.1016/j.forsciint.2005.05.034; Drummond A., 2011, GENEIOUS V5 5; Dulik Matthew C, 2012, Proc Natl Acad Sci U S A, V109, P8471, DOI 10.1073/pnas.1118760109; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Gaviria A, 2004, FORENSIC SCI INT, V143, P69, DOI 10.1016/j.forsciint.2004.01.007; Gaviria AA, 2005, FORENSIC SCI INT, V151, P85, DOI 10.1016/j.forsciint.2004.07.006; Gomes V, 2010, HUM GENET, V127, P603, DOI 10.1007/s00439-010-0808-5; Gomez-Perez L, 2010, ANN HUM BIOL, V37, P488, DOI 10.3109/03014460903433810; Greenberg J. H, 1987, LANGUAGE AM; Gusmao L, 2006, INT J LEGAL MED, V120, P191, DOI 10.1007/s00414-005-0026-1; Ibarra A, 2014, INT J LEGAL MED, V128, P19, DOI 10.1007/s00414-013-0858-z; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Keyeux G, 2002, HUM BIOL, V74, P211, DOI 10.1353/hub.2002.0022; Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382; Kolman CJ, 1997, GENETICS, V147, P1289; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Melton PE, 2007, AM J PHYS ANTHROPOL, V133, P753, DOI 10.1002/ajpa.20581; Mesa NR, 2000, AM J HUM GENET, V67, P1277, DOI 10.1016/S0002-9297(07)62955-3; Parson W, 2004, INT CONGR SER, V1261, P106, DOI 10.1016/S0531-5131(03)01629-7; Parson W, 2007, FORENSIC SCI INT-GEN, V1, P88, DOI 10.1016/j.fsigen.2007.01.018; Parson W, 2007, FORENSIC SCI INT-GEN, V1, P13, DOI 10.1016/j.fsigen.2006.11.003; Pereira R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029684; Pritchard JK, 2000, GENETICS, V155, P945; Qamar R, 2002, AM J HUM GENET, V70, P1107, DOI 10.1086/339929; Rock AW, 2013, FORENSIC SCI INT-GEN, V7, P601, DOI 10.1016/j.fsigen.2013.07.005; Roewer L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003460; Rojas W, 2010, AM J PHYS ANTHROPOL, V143, P13, DOI 10.1002/ajpa.21270; Rothhammer F, 2009, ANN HUM GENET, V73, P540, DOI 10.1111/j.1469-1809.2009.00537.x; S?nchez-Albornoz N., 2014, POBLACION AM LATINA; Salas A, 2008, AM J HUM BIOL, V20, P584, DOI 10.1002/ajhb.20783; Salas A, 2004, AM J HUM GENET, V74, P454, DOI 10.1086/382194; Silva A, 2008, BIOMEDICA, V28, P569, DOI 10.7705/biomedica.v28i4.62; Torres MM, 2006, AM J HUM BIOL, V18, P59, DOI 10.1002/ajhb.20461; Trombetta B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016073; Usme-Romero S, 2013, GENET MOL BIOL, V36, P149, DOI 10.1590/S1415-47572013005000011; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Willuweit S, 2007, FORENSIC SCI INT-GEN, V1, P83, DOI 10.1016/j.fsigen.2007.01.017; Yang NN, 2010, ANN HUM GENET, V74, P525, DOI 10.1111/j.1469-1809.2010.00608.x; Yunis JJ, 2005, J FORENSIC SCI, V50, P682; Yunis JJ, 2001, HUM IMMUNOL, V62, P970, DOI 10.1016/S0198-8859(01)00295-6	62	18	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120155	10.1371/journal.pone.0120155	http://dx.doi.org/10.1371/journal.pone.0120155			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CD6EY	25775361	gold, Green Published, Green Submitted			2022-12-27	WOS:000351183500153
J	Zhu, LX; Shen, DX; Zhou, QM; Li, ZX; Fang, XD; Li, QZ				Zhu, Lingxiang; Shen, Dingxia; Zhou, Qiming; Li, Zexia; Fang, Xiangdong; Li, Quan-Zhen			A Locked Nucleic Acid (LNA)-Based Real-Time PCR Assay for the Rapid Detection of Multiple Bacterial Antibiotic Resistance Genes Directly from Positive Blood Culture	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; SPECTRUM BETA-LACTAMASES; STAPHYLOCOCCUS-AUREUS; KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; METHICILLIN-RESISTANT; CARBAPENEMASE GENES; DNA MICROARRAY; IDENTIFICATION; PREVALENCE	Bacterial strains resistant to various antibiotic drugs are frequently encountered in clinical infections, and the rapid identification of drug-resistant strains is highly essential for clinical treatment. We developed a locked nucleic acid (LNA)-based quantitative real-time PCR (LNA-qPCR) method for the rapid detection of 13 antibiotic resistance genes and successfully used it to distinguish drug-resistant bacterial strains from positive blood culture samples. A sequence-specific primer-probe set was designed, and the specificity of the assays was assessed using 27 ATCC bacterial strains and 77 negative blood culture samples. No cross-reaction was identified among bacterial strains and in negative samples, indicating 100% specificity. The sensitivity of the assays was determined by spiking each bacterial strain into negative blood samples, and the detection limit was 1-10 colony forming units (CFU) per reaction. The LNA-qPCR assays were first applied to 72 clinical bacterial isolates for the identification of known drug resistance genes, and the results were verified by the direct sequencing of PCR products. Finally, the LNA-qPCR assays were used for the detection in 47 positive blood culture samples, 19 of which (40.4%) were positive for antibiotic resistance genes, showing 91.5% consistency with phenotypic susceptibility results. In conclusion, LNA-qPCR is a reliable method for the rapid detection of bacterial antibiotic resistance genes and can be used as a supplement to phenotypic susceptibility testing for the early detection of antimicrobial resistance to allow the selection of appropriate antimicrobial treatment and to prevent the spread of resistant isolates.	[Zhu, Lingxiang; Fang, Xiangdong] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Zhu, Lingxiang; Li, Zexia; Li, Quan-Zhen] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Shen, Dingxia] Peoples Liberat Army, Gen Hosp, Dept Clin Microbiol, Beijing, Peoples R China; [Zhou, Qiming] Chinese Acad Sci, State Key Lab Mycol, Inst Microbiol, Beijing, Peoples R China	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; University of Texas System; University of Texas Southwestern Medical Center Dallas; Chinese People's Liberation Army General Hospital; Chinese Academy of Sciences; Institute of Microbiology, CAS	Li, QZ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA.	quan.li@utsouthwestern.edu			National Institutes of Health [R03 AR055778]; Nature Science Foundation of China [81270852]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR055778] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by the National Institutes of Health grant R03 AR055778 (http://grants.nih.gov/grants/funding/r03.htm) and the Nature Science Foundation of China (81270852) (http://www.nsfc.gov.cn/nsfc/cen/00/kxb/hxb/images/1000.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beal SG, 2013, J CLIN MICROBIOL, V51, P3988, DOI 10.1128/JCM.01889-13; Bogaerts P, 2011, ANTIMICROB AGENTS CH, V55, P4457, DOI 10.1128/AAC.00353-11; Brolund A, 2010, J MICROBIOL METH, V82, P229, DOI 10.1016/j.mimet.2010.06.006; Alvargonzalez JJC, 2014, J MED MICROBIOL, V63, P1093, DOI 10.1099/jmm.0.067280-0; Chaudhary M, 2014, IOSR J PHARM BIOL SC, V9, P155; Choi J, 2013, LAB CHIP, V13, P280, DOI 10.1039/c2lc41055a; Clinical and Laboratory Standards Institute (CLSI), 2012, CLSI DOCUMENT M07 A9; CLSI, 2012, M02A11 CLSI, V7th; Dallenne C, 2010, J ANTIMICROB CHEMOTH, V65, P490, DOI 10.1093/jac/dkp498; DUTKAMALEN S, 1990, MOL GEN GENET, V224, P364, DOI 10.1007/BF00262430; Ellem J, 2011, J CLIN MICROBIOL, V49, P3074, DOI 10.1128/JCM.02647-10; Foster AGW, 2013, J CLIN MICROBIOL, V51, P3717, DOI 10.1128/JCM.01679-13; Fothergill A, 2013, J CLIN MICROBIOL, V51, P805, DOI 10.1128/JCM.02326-12; Grobner S, 2009, J CLIN MICROBIOL, V47, P1689, DOI 10.1128/JCM.02179-08; Gupta Gunjan, 2014, J Lab Physicians, V6, P1, DOI 10.4103/0974-2727.129082; HARTMAN BJ, 1984, J BACTERIOL, V158, P513, DOI 10.1128/JB.158.2.513-516.1984; He WQ, 2013, DIAGN MICR INFEC DIS, V77, P267, DOI 10.1016/j.diagmicrobio.2013.07.001; Hindiyeh M, 2011, J CLIN MICROBIOL, V49, P2480, DOI 10.1128/JCM.00149-11; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Ji S, 2014, EUR J CLIN MICROBIOL, V33, P989, DOI 10.1007/s10096-013-2037-z; Li B, 2014, CAN J MICROBIOL, V60, P691, DOI 10.1139/cjm-2014-0291; Li Y, 2014, J MICROBIOL IMMUNOL; Livermore DM, 2002, CLIN INFECT DIS, V34, P634, DOI 10.1086/338782; Ma L, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-599; Machen A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087870; McWilliams CS, 2014, J CLIN MICROBIOL, V52, P2653, DOI 10.1128/JCM.03613-13; Morrissey I, 2014, J MED MICROBIOL, V63, P556, DOI 10.1099/jmm.0.068981-0; Naas T, 2011, ANTIMICROB AGENTS CH, V55, P4038, DOI 10.1128/AAC.01734-10; Naas T, 2011, J CLIN MICROBIOL, V49, P1608, DOI 10.1128/JCM.02607-10; Nordmann P, 2011, J CLIN MICROBIOL, V49, P718, DOI 10.1128/JCM.01773-10; Ong DCT, 2011, J ANTIMICROB CHEMOTH, V66, P1647, DOI 10.1093/jac/dkr184; Oxacelay C, 2009, J ANTIMICROB CHEMOTH, V64, P986, DOI 10.1093/jac/dkp336; Palladino S, 2003, J CLIN MICROBIOL, V41, P2483, DOI 10.1128/JCM.41.6.2483-2486.2003; Pasteran F, 2011, J CLIN MICROBIOL, V49, P697, DOI 10.1128/JCM.01178-10; Pu WX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088134; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Roschanski N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100956; Rossolini GM, 2008, CLIN MICROBIOL INFEC, V14, P33, DOI 10.1111/j.1469-0691.2007.01867.x; Saeed K, 2014, INFECTION, V42, P843, DOI 10.1007/s15010-014-0641-1; Steindor M, 2012, J CLIN MICROBIOL, V50, P157, DOI 10.1128/JCM.06086-11; Tojo M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094064; Walsh TR, 2010, INT J ANTIMICROB AG, V36, pS8, DOI 10.1016/S0924-8579(10)70004-2; Wielders CLC, 2002, J CLIN MICROBIOL, V40, P3970, DOI 10.1128/JCM.40.11.3970-3975.2002; Yang J, 2013, CLIN MICROBIOL INFEC, V19, pE509, DOI 10.1111/1469-0691.12275; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09; Zhang CM, 2014, INFECT GENET EVOL, V27, P271, DOI 10.1016/j.meegid.2014.07.031; Zhou G, 2014, EMERG INFECT DIS, V20, P340, DOI 10.3201/eid2002.121263; Zhu LX, 2007, J CLIN MICROBIOL, V45, P3514, DOI 10.1128/JCM.02340-06; Zhu LX, 2007, ANTIMICROB AGENTS CH, V51, P3707, DOI 10.1128/AAC.01461-06; Zhu LX, 2014, WORLD J MICROB BIOT, V30, P967, DOI 10.1007/s11274-013-1515-x; Zhu LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066584	51	5	6	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120464	10.1371/journal.pone.0120464	http://dx.doi.org/10.1371/journal.pone.0120464			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775001	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500178
J	Becker, NI; Encarnacao, JA				Becker, Nina I.; Encarnacao, Jorge A.			Silvicolous on a Small Scale: Possibilities and Limitations of Habitat Suitability Models for Small, Elusive Mammals in Conservation Management and Landscape Planning	PLOS ONE			English	Article							DORMICE MUSCARDINUS-AVELLANARIUS; SPECIES DISTRIBUTION MODELS; NESTING-BEHAVIOR; PRESENCE-ABSENCE; COMMON DORMICE; SAMPLE-SIZE; WIND FARMS; ACCURACY; DORMOUSE; CHALLENGES	Species distribution and endangerment can be assessed by habitat-suitability modelling. This study addresses methodical aspects of habitat suitability modelling and includes an application example in actual species conservation and landscape planning. Models using species presence-absence data are preferable to presence-only models. In contrast to species presence data, absences are rarely recorded. Therefore, many studies generate pseudo- absence data for modelling. However, in this study model quality was higher with null samples collected in the field. Next to species data the choice of landscape data is crucial for suitability modelling. Landscape data with high resolution and ecological relevance for the study species improve model reliability and quality for small elusive mammals like Muscardinus avellanarius. For large scale assessment of species distribution, models with lowdetailed data are sufficient. For regional site-specific conservation issues like a conflict-free site for new wind turbines, high-detailed regional models are needed. Even though the overlap with optimally suitable habitat for M. avellanarius was low, the installation of wind plants can pose a threat due to habitat loss and fragmentation. To conclude, modellers should clearly state the purpose of their models and choose the according level of detail for species and environmental data.	[Becker, Nina I.; Encarnacao, Jorge A.] Univ Giessen, Mammalian Ecol Grp, Dept Anim Ecol & Systemat, D-35390 Giessen, Germany	Justus Liebig University Giessen	Becker, NI (corresponding author), Univ Giessen, Mammalian Ecol Grp, Dept Anim Ecol & Systemat, D-35390 Giessen, Germany.	Nina.I.Becker@allzool.bio.uni-giessen.de; J.Encarnacao@bio.uni-giessen.de	Encarnação, Jorge A./I-8644-2018	Encarnação, Jorge A./0000-0001-8766-0607				Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Amori G, 2008, MUSCARDINUS AVELLANA; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Barry S, 2006, J APPL ECOL, V43, P413, DOI 10.1111/j.1365-2664.2006.01136.x; Bauschmann G, 1989, LEBENSRAM WALDRAND W; Becker NI, 2012, EUR J WILDLIFE RES, V58, P945, DOI 10.1007/s10344-012-0637-z; Belaire JA, 2014, CONSERV BIOL, V28, P541, DOI 10.1111/cobi.12199; Bell S, 2008, BIODIVERS CONSERV, V17, P3443, DOI 10.1007/s10531-008-9357-9; Beyer HL, 2004, HAWTHS ANAL TOOLS AR; Bosso L, 2013, J NAT CONSERV, V21, P72, DOI 10.1016/j.jnc.2012.10.003; Brambilla M, 2009, BIOL CONSERV, V142, P2033, DOI 10.1016/j.biocon.2009.03.033; Bright P.W., 2006, DORMOUSE CONSERVATIO; BRIGHT PW, 1992, J ZOOL, V226, P589, DOI 10.1111/j.1469-7998.1992.tb07502.x; Bright PW, 1996, MAMMAL REV, V26, P157, DOI 10.1111/j.1365-2907.1996.tb00151.x; BRIGHT PW, 1991, J ZOOL, V224, P177, DOI 10.1111/j.1469-7998.1991.tb04797.x; BRIGHT PW, 1990, BIOL CONSERV, V54, P307, DOI 10.1016/0006-3207(90)90143-D; Bright PW, 1998, ANIM BEHAV, V56, P1485, DOI 10.1006/anbe.1998.0921; Brotons L, 2004, ECOGRAPHY, V27, P437, DOI 10.1111/j.0906-7590.2004.03764.x; Buchner S, 2010, NUL, V8; Buchner S, 2012, FENA HESSEN FORST, P34; Buchner S, 2008, ACTA THERIOL, V53, P259, DOI 10.1007/BF03193122; Chefaoui RM, 2008, ECOL MODEL, V210, P478, DOI 10.1016/j.ecolmodel.2007.08.010; Dormann CF, 2011, MODELLING COMPLEX ECOLOGICAL DYNAMICS: AN INTRODUCTION INTO ECOLOGICAL MODELLING FOR STUDENTS, TEACHERS & SCIENTISTS, P179, DOI 10.1007/978-3-642-05029-9_13; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Encarnacao JA, 2013, J WILDLIFE DIS, V49, P860, DOI 10.7589/2012-10-262; Engler R, 2004, J APPL ECOL, V41, P263, DOI 10.1111/j.0021-8901.2004.00881.x; FENA HF, 2004, ART EUR BIB CAST FIB; Gottschalk TK, 2007, J ORNITHOL, V148, P427, DOI 10.1007/s10336-007-0155-z; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Inman RD, 2013, ENDANGER SPECIES RES, V20, P1, DOI 10.3354/esr00487; Jiang DF, 2013, STAT METHODS MED RES, V22, P505, DOI 10.1177/0962280211428385; Juskaitis R, 2008, BIODIVERS CONSERV, V17, P3559, DOI 10.1007/s10531-008-9470-9; Katzner T, 2013, ANIM CONSERV, V16, P367, DOI 10.1111/acv.12067; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lawrence A., 2010, TAKING STOCK NATURE, P251; Liechti F, 2013, BIOL CONSERV, V162, P24, DOI 10.1016/j.biocon.2013.03.018; Lindenmayer DB, 1999, BIOL CONSERV, V89, P83, DOI 10.1016/S0006-3207(98)00116-5; Loe L, 2011, EUR J WILDLIFE RES, P1; MacKenzie DI, 2005, J WILDLIFE MANAGE, V69, P849, DOI 10.2193/0022-541X(2005)069[0849:WATIWP]2.0.CO;2; Maclean N, 2010, SILENT SUMMER STATE, P768; McPherson JM, 2004, J APPL ECOL, V41, P811, DOI 10.1111/j.0021-8901.2004.00943.x; Meddins C, 2013, CLOCAENOG FOREST WIN, P49; Meinig H, 2009, ROTE LISTE GAFAHRDET, V1, P115; Morris P, 2004, DORMICE; Mortelliti A, 2013, MAMM BIOL, V78, P309, DOI 10.1016/j.mambio.2012.09.006; Naim DM, 2014, GENET MOL RES, V13, P167, DOI 10.4238/2014.January.10.8; Osborne PE, 2001, J APPL ECOL, V38, P458, DOI 10.1046/j.1365-2664.2001.00604.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Reiners T. E., 2012, Peckiana, P87; Ridgeway G., 2006, GEN BOOSTED REGRESSI; Roscioni F, 2013, BIODIVERS CONSERV, V22, P1821, DOI 10.1007/s10531-013-0515-3; Roscioni F, 2014, LANDSCAPE ECOL, V29, P891, DOI 10.1007/s10980-014-0030-2; Rota CT, 2011, ECOGRAPHY, V34, P659, DOI 10.1111/j.1600-0587.2010.06433.x; Russo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110894; Santos H, 2013, BIOL CONSERV, V157, P178, DOI 10.1016/j.biocon.2012.06.017; Schmeller DS, 2009, CONSERV BIOL, V23, P307, DOI 10.1111/j.1523-1739.2008.01125.x; Stockwell DRB, 2002, ECOL MODEL, V148, P1, DOI 10.1016/S0304-3800(01)00388-X; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tabassum-Abbasi, 2014, RENEW SUST ENERG REV, V31, P270, DOI 10.1016/j.rser.2013.11.019; Temple H., 2007, STATUS DISTRIBUTION; Temple HJ, 2009, FOLIA ZOOL, V58, P248; TRFfS Computing, 2011, R LANG ENV STAT COMP, DOI [10.1016/j.neuroimage.2011.01.013, DOI 10.1016/J.NEUROIMAGE.2011.01.013]; Williams GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009264; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Yackulic CB, 2013, METHODS ECOL EVOL, V4, P236, DOI 10.1111/2041-210x.12004; Zabala J, 2005, EUR J WILDLIFE RES, V51, P157, DOI 10.1007/s10344-005-0094-z	70	5	5	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120562	10.1371/journal.pone.0120562	http://dx.doi.org/10.1371/journal.pone.0120562			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781894	Green Submitted, gold, Green Published			2022-12-27	WOS:000351284600172
J	Chen, Q; Zhang, F; Wang, YB; Liu, ZY; Sun, AY; Zen, K; Zhang, CY; Zhang, QP				Chen, Qun; Zhang, Fan; Wang, Yanbo; Liu, Zhengya; Sun, Anyang; Zen, Ke; Zhang, Chen-yu; Zhang, Qipeng			The Transcription Factor C-Myc Suppresses MiR-23b and MiR-27b Transcription during Fetal Distress and Increases the Sensitivity of Neurons to Hypoxia-Induced Apoptosis	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; ACTIVATING FACTOR-I; BIRTH ASPHYXIA; MESSENGER-RNA; EXPRESSION; MICRORNAS; MITOCHONDRIAL; PROTEIN; MECHANISMS; MICROGLIA	Previous studies reported that the expression of miR-23b-27b cluster was downregulated in embryonic brain cortices during hypoxia-induced neuronal apoptosis. However, the mechanism underlying this downregulation is not completely understood. Here, we report that the transcription factor c-Myc plays an important role in regulating the expression of miR-23b-27b cluster during hypoxia. First, the c-Myc protein level was significantly elevated in embryonic brain cortices in a mouse model of fetal distress. Second, forced overexpression or knockdown of c-Myc could suppress or increase the expression of miR-23b-27b cluster polynucleotides. Third, we identified 2 conserved c-Myc binding sites (E-boxes) in the enhancer and promoter regions of miR-23b-27b cluster in the mouse genome. Finally, we showed that elevated c-Myc expression led to an increase in the Apaf-1 level by suppressing miR-23b-27b cluster expression and that this enhanced neuronal sensitivity to apoptosis. In summary, our study demonstrates that c-Myc may suppress the expression of the miR-23b-27b cluster, resulting in additional neuronal apoptosis during hypoxia.	[Chen, Qun; Zhang, Fan; Wang, Yanbo; Liu, Zhengya; Zen, Ke; Zhang, Chen-yu; Zhang, Qipeng] Nanjing Univ, Sch Life Sci, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China; [Sun, Anyang] Yancheng Inst Hlth Sci, Lab Neurodegenerat Dis & Repair, Yancheng, Peoples R China	Nanjing University	Sun, AY (corresponding author), Yancheng Inst Hlth Sci, Lab Neurodegenerat Dis & Repair, Yancheng, Peoples R China.	anyangsun@hotmail.com; kzen@nju.edu.cn; cyzhang@nju.edu.cn; qpzhang@nju.edu.cn	Liu, Zhengya/AAA-2559-2020		National Natural Science Foundation of China [31100777, 30988003, 90608010]; Natural Science Foundation of Jiangsu Province [BK2011013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by grants from the National Natural Science Foundation of China (31100777, 30988003 and 90608010) and the Natural Science Foundation of Jiangsu Province (BK2011013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIELTISON C, 1986, DEV MED CHILD NEUROL, V28, P671; An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Ashraf QM, 2007, NEUROSCI LETT, V415, P253, DOI 10.1016/j.neulet.2007.01.023; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Banasiak KJ, 2000, PROG NEUROBIOL, V62, P215, DOI 10.1016/S0301-0082(00)00011-3; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chen Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.92; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Fleiss B, 2012, BRAIN RES, V1433, P9, DOI 10.1016/j.brainres.2011.11.035; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; GIBSON AW, 1995, EXP CELL RES, V218, P351, DOI 10.1006/excr.1995.1166; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Greenway SC, 2000, J EXP ZOOL, V287, P477, DOI 10.1002/1097-010X(20001201)287:7<477::AID-JEZ3>3.0.CO;2-4; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Hung AC, 2000, J CELL BIOCHEM, V77, P323, DOI 10.1002/(SICI)1097-4644(20000501)77:2<323::AID-JCB14>3.0.CO;2-W; Hutton LC, 2009, DEV NEUROSCI-BASEL, V31, P523, DOI 10.1159/000251907; Ireland Z, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.10.790; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kuida K, 2000, INT J BIOCHEM CELL B, V32, P121, DOI 10.1016/S1357-2725(99)00024-2; Lesuisse C, 2002, J NEUROBIOL, V51, P9, DOI 10.1002/neu.10037; Li XN, 2013, J BIOL CHEM, V288, P18121, DOI 10.1074/jbc.M113.478560; Lin Q, 2011, MOL CANCER RES, V9, P757, DOI 10.1158/1541-7786.MCR-11-0053; Northington FJ, 2007, NEUROSCIENCE, V149, P822, DOI 10.1016/j.neuroscience.2007.06.060; Pietras A, 2008, J PATHOL, V214, P482, DOI 10.1002/path.2304; Ratcliffe PJ, 2007, J CLIN INVEST, V117, P862, DOI 10.1172/JCI31750; Saikumar P, 1998, ONCOGENE, V17, P3401, DOI 10.1038/sj.onc.1202590; Seidel S, 2010, BRAIN, V133, P983, DOI 10.1093/brain/awq042; Trollmann R, 2008, AM J PHYSIOL-REG I, V295, pR1973, DOI 10.1152/ajpregu.00053.2008; Volpe JJ, 2001, MENT RETARD DEV D R, V7, P56, DOI 10.1002/1098-2779(200102)7:1<56::AID-MRDD1008>3.0.CO;2-A; Wang XW, 2013, SCI REP-UK, V3, DOI 10.1038/srep01942; Xue G., 2014, ONCOGENE; Yakovlev AG, 2001, J NEUROSCI, V21, P7439, DOI 10.1523/JNEUROSCI.21-19-07439.2001; Yoshida H, 2002, CELL DEATH DIFFER, V9, P1273, DOI 10.1038/sj.cdd.4401128; Zhang L, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-211; Zhang L, 2012, GLIA, V60, P1888, DOI 10.1002/glia.22404	38	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120217	10.1371/journal.pone.0120217	http://dx.doi.org/10.1371/journal.pone.0120217			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781629	Green Published, gold, Green Submitted			2022-12-27	WOS:000351284600141
J	Clive, AO; Hooper, CE; Edey, AJ; Morley, AJ; Zahan-Evans, N; Hall, D; Lyburn, I; White, P; Braybrooke, JP; Sequeiros, I; Lyen, SM; Milton, T; Kahan, BC; Maskell, NA				Clive, Amelia O.; Hooper, Clare E.; Edey, Anthony J.; Morley, Anna J.; Zahan-Evans, Natalie; Hall, David; Lyburn, Iain; White, Paul; Braybrooke, Jeremy P.; Sequeiros, Iara; Lyen, Stephen M.; Milton, Tim; Kahan, Brennan C.; Maskell, Nick A.			A Randomised Controlled Trial of Intravenous Zoledronic Acid in Malignant Pleural Disease: A Proof of Principle Pilot Study	PLOS ONE			English	Article							CELLS IN-VITRO; BREAST-CANCER; PHASE-III; MESOTHELIOMA; BISPHOSPHONATES; GROWTH; COMBINATION; CISPLATIN; CRITERIA	Introduction Animal studies have shown Zoledronic Acid (ZA) may diminish pleural fluid accumulation and tumour bulk in malignant pleural disease (MPD). We performed a pilot study to evaluate its effects in humans. Methods We undertook a single centre, double-blind, placebo-controlled trial in adults with MPD. Patients were randomised (1: 1) to receive 2 doses of intravenous ZA or placebo, 3 weeks apart and were followed-up for 6 weeks. The co-primary outcomes were change in Visual Analogue Scale (VAS) score measured breathlessness during trial follow-up and change in the initial area under the curve (iAUC) on thoracic Dynamic Contrast Enhanced Magnetic Resonance Imaging (DCE-MRI) from randomisation to week 5. Multiple secondary end-points were also evaluated. Results Between January 2010 and May 2013, 30 patients were enrolled, 24 randomised and 4 withdrew after randomisation (1 withdrew consent; 3 had a clinical decline). At baseline, the ZA group were more breathless, had more advanced disease on radiology and worse quality of life than the placebo group. There was no significant difference between the groups with regards change in breathlessness (Adjusted mean difference (AMD) 4.16 (95% CI -4.7 to 13.0)) or change in DCE-MRI iAUC (AMD -15.4 (95% CI -58.1 to 27.3). Two of nine (22%) in the ZA arm had a >10% improvement by modified RECIST (vs 0/11 who received placebo). There was no significant difference in quality of life measured by the QLQ-C30 score (global QOL: AMD -4.1 (-13.0 to 4.9)), side effects or serious adverse event rates. Conclusions This is the first human study to evaluate ZA in MPD. The study is limited by small numbers and imbalanced baseline characteristics. Although no convincing treatment effect was identified, potential benefits for specific subgroups of patients cannot be excluded. This study provides important information regarding the feasibility of future trials to evaluate the effects of ZA further.	[Clive, Amelia O.; Hooper, Clare E.; Maskell, Nick A.] Univ Bristol, Acad Resp Unit, Bristol, Avon, England; [Clive, Amelia O.; Hooper, Clare E.; Edey, Anthony J.; Morley, Anna J.; Zahan-Evans, Natalie; Sequeiros, Iara; Lyen, Stephen M.; Maskell, Nick A.] North Bristol NHS Trust, North Bristol Lung Ctr, Southmead Hosp, Bristol, Avon, England; [Hall, David; Lyburn, Iain] Cobalt Hlth, Cheltenham, Glos, England; [White, Paul] Univ W England, Dept Stat, Bristol BS16 1QY, Avon, England; [Braybrooke, Jeremy P.] Univ Hosp Bristol NHS Fdn Trust, Bristol Canc Inst, Bristol, Avon, England; [Milton, Tim] Univ Hosp Bristol NHS Fdn Trust, Dept Oral & Maxillofacial Surg, Bristol, Avon, England; [Kahan, Brennan C.] Queen Mary Univ London, Pragmat Clin Trials Unit, London, England	University of Bristol; North Bristol NHS Trust; Southmead Hospital; University of West England; University of Bristol; University of Bristol; University of London; Queen Mary University London	Maskell, NA (corresponding author), Univ Bristol, Acad Resp Unit, Bristol, Avon, England.	nick.maskell@bristol.ac.uk		Braybrooke, Jeremy/0000-0003-1943-7360; White, Paul/0000-0002-7503-9896; maskell, nick/0000-0002-1276-6500	North Bristol NHS Trust; Novartis; United Kingdom Medical	North Bristol NHS Trust; Novartis(Novartis); United Kingdom Medical	This trial was supported by unrestricted research grants from North Bristol NHS Trust (small grants scheme), Novartis and United Kingdom Medical. The study was sponsored by North Bristol NHS Trust. The IPCs and drainage bottles were provided by United Kingdom Medical. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Armato SG, 2014, J THORAC ONCOL, V9, P1187, DOI 10.1097/JTO.0000000000000211; Bushunow P, ZOMETA ADJUVANT TREA; Byrne MJ, 2004, ANN ONCOL, V15, P257, DOI 10.1093/annonc/mdh059; Clezardin P, 2011, BONE, V48, P71, DOI 10.1016/j.bone.2010.07.016; Coolen J, 2012, RADIOLOGY, V263, P884, DOI 10.1148/radiol.12110872; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; EORTC, 2001, EORTC QLQ C30 SCORIN; Giesel FL, 2006, CHEST, V129, P1570, DOI 10.1378/chest.129.6.1570; Gnant M, 2012, CANCER TREAT REV, V38, P407, DOI 10.1016/j.ctrv.2011.09.003; Gnant M, 2009, NEW ENGL J MED, V360, P679, DOI 10.1056/NEJMoa0806285; Kahan BC, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-139; Kahan BC, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5840; Kahan BC, 2012, STAT MED, V31, P328, DOI 10.1002/sim.4431; Kao SCH, 2012, LUNG CANCER, V75, P248, DOI 10.1016/j.lungcan.2011.06.007; Kawata E, 2010, CANCER LETT, V294, P245, DOI 10.1016/j.canlet.2010.02.008; Lawson A, 2010, ONCOLOGY TIMES, V32, P44; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; Novartis Pharmaceuticals UK Ltd, 2012, SUMM PROD CHAR ZOL A; Okamoto S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060297; Okamoto S, 2012, J THORAC ONCOL, V7, P873, DOI 10.1097/JTO.0b013e31824c7d43; Robert F, 2014, PILOT STUDY BISPHOSP; Santini D, 2003, CLIN CANCER RES, V9, P2893; Stathopoulos GT, 2008, AM J RESP CRIT CARE, V178, P50, DOI 10.1164/rccm.200710-1513OC; Tsao AS, 2011, J THORAC ONCOL, V6, P598, DOI 10.1097/JTO.0b013e318208c83d; van Meerbeeck JP, 2005, J CLIN ONCOL, V23, P6881, DOI 10.1200/JCO.20005.14.589; Veltman JD, 2010, BRIT J CANCER, V103, P629, DOI 10.1038/sj.bjc.6605814; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Wakchoure S, 2006, CLIN CANCER RES, V12, P2862, DOI 10.1158/1078-0432.CCR-05-2766; White IR, 2005, STAT MED, V24, P993, DOI 10.1002/sim.1981; Winter MC, 2013, CLIN CANCER RES, V19, P2755, DOI 10.1158/1078-0432.CCR-12-3235; Yasumitsu A, 2010, J THORAC ONCOL, V5, P479, DOI 10.1097/JTO.0b013e3181d2f008	31	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0118569	10.1371/journal.pone.0118569	http://dx.doi.org/10.1371/journal.pone.0118569			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781025	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600027
J	Jones, CA; Ross, L; Surani, N; Dharamshi, N; Karmali, K				Jones, Charlotte A.; Ross, Leanne; Surani, Nadia; Dharamshi, Narissa; Karmali, Karima			Framingham Ten-Year General Cardiovascular Disease Risk: Agreement between BMI-Based and Cholesterol-Based Estimates in a South Asian Convenience Sample	PLOS ONE			English	Article							CARE; PREVENTION; MANAGEMENT; DIAGNOSIS; BARRIERS; SCORE	The goal of this analysis was to determine the agreement between body mass index-based and cholesterol-based ten-year Framingham general cardiovascular disease risk scores among a convenience sample of 773 South Asian Canadian adults attending community-based screening clinics. Scores were calculated using age, systolic blood pressure, antihypertensive use, current smoking, diabetes, and total cholesterol and high density lipoprotein (for cholesterol-based risk) or height and weight (for body mass index-based risk). Mean risk score differences (body mass index-based risk minus cholesterol-based risk) were estimated using paired t-tests. Bland-Altman plots were used to assess agreement between scores. Finally, agreement across risk categories (low [< 10%], moderate [10% to < 20%], high [> = 20%]) was examined using the kappa statistic. Average agreement between the two risk scores was quite good overall (mean differences of 0.6% for men and 0.5% for women), but increased to about 3% among participants 60-74 years of age. However, Bland-Altman plots revealed that the differences between the two scores and the variability of the differences increased with increasing average 10-year risk. In terms of clinical importance, the limits of agreement were reasonable for women < 60 years (95% confidence interval: -3.2% to 3.1%), but of concern for women 60-74 years (95% confidence interval: -6.0% to 12.3%), men < 60 years (95% confidence interval: -7.1% to 7.3%) and men 6-074 years (95% confidence interval: -13.8% to 18.8%). Agreement across categories was moderate for most sex and age groups examined (kappa values: 0.51 for women < 60 years, 0.50 for women 60-74 years, 0.65 for men < 60 years), except for men 60-74 years, where agreement was only fair (kappa = 0.26). In light of these disagreements, evaluation of a participant's change in cardiovascular disease risk over time will necessitate use of the same risk score (i.e., either body mass index-based or cholesterol-based) at all screening sessions.	[Jones, Charlotte A.; Ross, Leanne] Univ Calgary, Dept Med, Libin Cardiovasc Inst, Calgary, AB, Canada; [Jones, Charlotte A.; Ross, Leanne] Univ British Columbia Okanagan, Fac Med, Southern Med Program, Kelowna, BC, Canada	Libin Cardiovascular Institute Of Alberta; University of Calgary; University of British Columbia; University of British Columbia Okanagan	Jones, CA (corresponding author), Univ Calgary, Dept Med, Libin Cardiovasc Inst, Calgary, AB, Canada.	charlotte.jones@ubc.ca			Public Health Agency of Canada's Canadian Diabetes Strategy Community-Based Funding Program [6262-15-2010/8041049]	Public Health Agency of Canada's Canadian Diabetes Strategy Community-Based Funding Program	CJ received funding for this work from the Public Health Agency of Canada's (http://www.phacaspc. gc.ca/index-eng.php) Canadian Diabetes Strategy Community-Based Funding Program (Project Number: 6262-15-2010/8041049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarabi M, 2005, EUR J CARDIOV PREV R, V12, P46, DOI 10.1097/00149831-200502000-00007; Allison C, 2006, Issues Emerg Health Technol, P1; Altman D.G., 1991, PRACTICAL STATISTIC; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brindle P, 2006, HEART, V92, P1595, DOI 10.1136/hrt.2006.092346; Bryan Shirley, 2010, Health Rep, V21, P71; Canada Statistics, 2009, LEAD CAUS DEATH CAN; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; CYR L, 1992, COMPUT BIOL MED, V22, P239, DOI 10.1016/0010-4825(92)90063-S; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Davachi S, 2005, CAN J DIABETES, V29, P87; Gaziano TA, 2008, LANCET, V371, P923, DOI 10.1016/S0140-6736(08)60418-3; Genest J, 2009, CAN J CARDIOL, V25, P567, DOI 10.1016/S0828-282X(09)70715-9; Green BB, 2012, AM J PREV MED, V42, P342, DOI 10.1016/j.amepre.2011.12.009; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Jain A, 2011, ANN CLIN BIOCHEM, V48, P159, DOI 10.1258/acb.2010.010195; Jones C, 2008, CAN J CARDIOL, V24, P561, DOI 10.1016/S0828-282X(08)70634-2; Jones CA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-160; Jones CA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-24; Lai DWL, 2010, CAN J AGING, V29, P249, DOI 10.1017/S0714980810000188; Myers MG, 2009, BLOOD PRESS MONIT, V14, P108, DOI 10.1097/MBP.0b013e32832c5167; Nijjar APK, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-38; Pandya A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020416; Parikh P, 2009, AM J HEALTH PROMOT, V23, P279, DOI 10.4278/ajhp.071221140; Patel JV, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-192; Patel M, 2012, J IMMIGR MINOR HEALT, V14, P774, DOI 10.1007/s10903-011-9550-x; Quinn RR, 2010, CAN J CARDIOL, V26, P241, DOI 10.1016/S0828-282X(10)70378-0; Ramaraj R, 2008, POSTGRAD MED J, V84, P518, DOI 10.1136/pgmj.2007.066381; Rao N, 2012, INT J CLIN PRACT, V66, P262, DOI 10.1111/j.1742-1241.2011.02773.x; Robinson Vollman A, 2008, CANADIAN COMMUNITY P, DOI [10.3109/01612840.2012.714054, DOI 10.3109/01612840.2012.714054]; Sheth T, 1999, CAN MED ASSOC J, V161, P132; Wood D, 2005, HEART, V91, P1, DOI 10.1136/hrt.2005.079988	33	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119183	10.1371/journal.pone.0119183	http://dx.doi.org/10.1371/journal.pone.0119183			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781949	Green Published, gold, Green Submitted			2022-12-27	WOS:000351284600054
J	Ohuchi, SJ; Sagawa, F; Ohno, H; Inoue, T				Ohuchi, Shoji J.; Sagawa, Fumihiko; Ohno, Hirohisa; Inoue, Tan			A Purification Method for a Molecular Complex in Which a Scaffold Molecule Is Fully Loaded with Heterogeneous Molecules	PLOS ONE			English	Article							PROTEIN; AFFINITY; PEPTIDE	An affinity resin-based pull-down method is convenient for the purification of biochemical materials. However, its use is difficult for the isolation of a molecular complex fully loaded with multiple components from a reaction mixture containing the starting materials and intermediate products. To overcome this problem, we have developed a new purification procedure that depends on sequential elimination of the residues. In practice, two affinity resins were used for purifying a triangular-shaped RNP (RNA-protein complex) consisting of three ribosomal proteins (L7Ae) bound to an RNA scaffold. First, a resin with immobilized L7Ae protein captured the incomplete RNP complexes and the free RNA scaffold. Next, another resin with an immobilized chemically modified RNA of a derivative of Box C/ D motif, the binding partner of L7Ae, was used to capture free protein. The complete triangular RNP was successfully purified from the mixture by these two steps. Obviously, the purified triangular RNP displaying three protein-binding peptides exhibited an improved performance when compared with the unrefined product. Conceptually, this purification procedure should be applicable for the purification of a variety of complexes consisting of multiple components other than RNP.	[Ohuchi, Shoji J.; Sagawa, Fumihiko; Ohno, Hirohisa; Inoue, Tan] Kyoto Univ, Grad Sch Biostudies, Lab Gene Biodynam, Kyoto, Japan	Kyoto University	Inoue, T (corresponding author), Kyoto Univ, Grad Sch Biostudies, Lab Gene Biodynam, Kyoto, Japan.	tan@kuchem.kyoto-u.ac.jp			Japan Society for the Promotion of Science [23221011, 23119005]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from Japan Society for the Promotion of Science (23221011 and 23119005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Frey S, 2014, J CHROMATOGR A, V1337, P106, DOI 10.1016/j.chroma.2014.02.030; Fujita Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06422; Grabow WW, 2014, ACCOUNTS CHEM RES, V47, P1871, DOI 10.1021/ar500076k; Hara T, 2013, CHEM COMMUN, V49, P3833, DOI 10.1039/c3cc38688k; Koyfman AY, 2009, J AM CHEM SOC, V131, P14237, DOI 10.1021/ja9015638; Kuhn JF, 2002, NUCLEIC ACIDS RES, V30, P931, DOI 10.1093/nar/30.4.931; Lai YT, 2012, TRENDS CELL BIOL, V22, P653, DOI 10.1016/j.tcb.2012.08.004; MILLIGAN JF, 1989, METHOD ENZYMOL, V180, P51; Moore T, 2004, STRUCTURE, V12, P807, DOI 10.1016/j.str.2004.02.033; Ohno H, 2011, NAT NANOTECHNOL, V6, P115, DOI 10.1038/nnano.2010.268; Patra A, 2012, ANGEW CHEM INT EDIT, V51, P11863, DOI 10.1002/anie.201204946; PIEKEN WA, 1991, SCIENCE, V253, P314, DOI 10.1126/science.1857967; Schmidt TGM, 1996, J MOL BIOL, V255, P753, DOI 10.1006/jmbi.1996.0061; Tintore M, 2014, CHEMBIOCHEM, V15, P1374, DOI 10.1002/cbic.201402014; Voss S, 1997, PROTEIN ENG, V10, P975, DOI 10.1093/protein/10.8.975	15	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120576	10.1371/journal.pone.0120576	http://dx.doi.org/10.1371/journal.pone.0120576			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781936	Green Published, gold, Green Submitted			2022-12-27	WOS:000351284600173
J	Romo-Gonzalez, T; Esquivel-Velazquez, M; Ostoa-Saloma, P; Lara, C; Zentella, A; Leon-Diaz, R; Lamoyi, E; Larralde, C				Romo-Gonzalez, Tania; Esquivel-Velazquez, Marcela; Ostoa-Saloma, Pedro; Lara, Carlos; Zentella, Alejandro; Leon-Diaz, Rosalba; Lamoyi, Edmundo; Larralde, Carlos			The Network of Antigen-Antibody Reactions in Adult Women with Breast Cancer or Benign Breast Pathology or without Breast Pathology	PLOS ONE			English	Article							TUMOR-ASSOCIATED ANTIGENS; SERUM AUTOANTIBODIES; EARLY-DIAGNOSIS; IMMUNE; BIOMARKERS; PROGRESSION; SYSTEM	The Immunoglobulin G (IgG) antibody response to different protein antigens of the mammary ductal carcinoma by adult women affected by Breast Cancer (BC) distinguishes at least 103 proteins that differ in their molecular weights (MW). The IgG producing cell clones (nodes) coexist with each other in each individual organism and share energy resources among themselves, as well as factors that control the level of expression and Specificity of their IgG antibodies. So, it can be proposed that among them there is a Network of interconnections (links) unveiled by the antigens, which specifically react with the IgG antibodies produced by the clones. This Network possibly regulates IgG antibodies' activity and effectiveness. We describe the Network of nodes and links that exists between the different antigens and their respective IgG producing cell clones against the extracted protein antigens from the cells of the T47D Cell-Line, in 50 women with BC, 50 women with Benign Breast Pathology (BBP) and 50 women without breast pathology (H). We have found that women with BBP have the highest number of Links, followed by the H group and, lastly, the women with BC, a finding which suggests that cancer interferes with the Connectivity between the IgG producing cell clones and blocks the expression of 322 links in women with BBP and 32 links in women with H. It is also plausible that the largest number of links in the women with BBP indicates the Network's state of arousal that provides protection against BC. On the other hand, there were manymissing links in the BC group of women; the clone which lost more links in the BC group was the hub 24, which point to some of the antigens of T47D as potentially useful as vaccines, as the immune system of women with BBP is well aware of them.	[Romo-Gonzalez, Tania; Leon-Diaz, Rosalba] Univ Veracruzana, Inst Invest Biol, Xalapa 91000, Veracruz, Mexico; [Esquivel-Velazquez, Marcela; Ostoa-Saloma, Pedro; Zentella, Alejandro; Lamoyi, Edmundo; Larralde, Carlos] Univ Nacl Autonoma Mexico, Programa Invest Canc Mama, Inst Invest Biomed, Mexico City 04510, DF, Mexico; [Lara, Carlos] Hosp Gen Mexico City, Secretaria Salubridad & Asistencia, Mexico City, DF, Mexico	Universidad Veracruzana; Universidad Nacional Autonoma de Mexico; Hospital General de Mexico	Larralde, C (corresponding author), Univ Nacl Autonoma Mexico, Programa Invest Canc Mama, Inst Invest Biomed, Mexico City 04510, DF, Mexico.	tromogonzalez@uv.mx; okumichu@gmail.com	Romo-Gonzalez, Tania/F-3694-2019; Esquivel-Velazquez, Marcela/AAS-3232-2021; Ostoa-Saloma, Pedro/V-3226-2019; Lara-Gutiérrez, Carlos Alberto/G-6915-2019; Leon, Rosalba/B-7989-2014; Romo-Gonzalez, Tania/AHC-8125-2022	Romo-Gonzalez, Tania/0000-0003-0097-4780; Lara-Gutiérrez, Carlos Alberto/0000-0001-5079-8194; Romo-Gonzalez, Tania/0000-0003-0097-4780; Esquivel-Velazquez, Marcela/0000-0002-2975-8603; Ostoa-Saloma, Pedro/0000-0003-2066-8019	Consejo Nacional de Ciencia y Tecnologia, Mexico [SALUD-2011-C01-162020]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPITT) [IT203014]; DGAPA; Universidad Nacional Autonoma de Mexico; ICYTDF	Consejo Nacional de Ciencia y Tecnologia, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPITT)(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); DGAPA; Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); ICYTDF	This project was funded by grant SALUD-2011-C01-162020 (EL) from the Consejo Nacional de Ciencia y Tecnologia, Mexico and by grant #IT203014 (C. Larralde) from Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPITT), DGAPA, Universidad Nacional Autonoma de Mexico. MEV was recipient of a postdoctoral fellowship from ICYTDF and is recipient of a postdoctoral fellowship from DGAPA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal A, 2006, CANCER RES, V66, P232, DOI 10.1158/0008-5472.CAN-05-2232; Albert R, 2000, PHYS REV LETT, V85, P5234, DOI 10.1103/PhysRevLett.85.5234; Aldana M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.095702; Allavena P, 2008, IMMUNOL REV, V222, P155, DOI 10.1111/j.1600-065X.2008.00607.x; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Benta M., AGNA 2 1; Blalock JE, 2005, J INTERN MED, V257, P126, DOI 10.1111/j.1365-2796.2004.01441.x; Brandan ME, 2006, CANCEROL, V1, P147; Brom S, 2000, PLASMID, V44, P34, DOI 10.1006/plas.2000.1469; Chapman C, 2007, ANN ONCOL, V18, P868, DOI 10.1093/annonc/mdm007; Chen LL, 2009, BRIT J CANCER, V101, P749, DOI 10.1038/sj.bjc.6605214; Desmetz C, 2011, J CELL MOL MED, V15, P2013, DOI 10.1111/j.1582-4934.2011.01355.x; Desmetz C, 2009, CLIN CANCER RES, V15, P4733, DOI 10.1158/1078-0432.CCR-08-3307; Tabernero MD, 2010, CANCER BIOMARK, V6, P247, DOI 10.3233/CBM-2009-0139; Dorogovtsev SN, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.066130; Esquivel-Velazquez M, DIFFERENTIAL UNIDIME; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Dantes OG, 2011, SALUD PUBLICA MEXICO, V53, pS220; IBM, MANUAL DEL USUARIO D; INEGI, 2011, STATISTICS ABOUT THE; International Agency for Research on Cancer WHO, GLOBOCAN 2008 CANCER; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; JERNE NK, 1974, ANN INST PASTEUR IMM, VC125, P373; Lu HL, 2008, J PROTEOME RES, V7, P1388, DOI 10.1021/pr700818f; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Knaul FM, 2008, REPROD HEALTH MATTER, V16, P113, DOI 10.1016/S0968-8080(08)32414-8; Michaelson J., 2003, J WOMENS IMAGING, V5, P3, DOI DOI 10.1097/00130747-200302000-00002; Morales-Montor J, 2004, J PARASITOL, V90, P531, DOI 10.1645/GE-113R3; Nigenda G, 2009, SALUD PUBLICA MEXICO, V51, pS254; Ostoa-Saloma P, 2009, J IMMUNOL METHODS, V351, P46, DOI 10.1016/j.jim.2009.09.006; Piura E, 2011, J ONCOL, V2011, DOI 10.1155/2011/982425; Porta C, 2011, CANCER LETT, V305, P250, DOI 10.1016/j.canlet.2010.10.012; Ravasz E, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026112; Secretaria de Salud, 2008, BREAST CANCER SPECIF; Stewart J, 2004, ARTIF LIFE, V10, P261, DOI 10.1162/1064546041255593; STEWART J, 1989, IMMUNOL REV, V110, P37, DOI 10.1111/j.1600-065X.1989.tb00026.x; STEWART J, 1992, IMMUNOL TODAY, V13, P396, DOI 10.1016/0167-5699(92)90088-O; Tan EM, 2008, IMMUNOL REV, V222, P328, DOI 10.1111/j.1600-065X.2008.00611.x; Tan HT, 2009, FEBS J, V276, P6880, DOI 10.1111/j.1742-4658.2009.07396.x; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zhong L, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2091	45	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119014	10.1371/journal.pone.0119014	http://dx.doi.org/10.1371/journal.pone.0119014			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781932	Green Submitted, gold, Green Published			2022-12-27	WOS:000351284600043
J	Song, G; Dickins, BJA; Demeter, J; Engel, S; Dunn, B; Cherry, JM				Song, Giltae; Dickins, Benjamin J. A.; Demeter, Janos; Engel, Stacia; Dunn, Barbara; Cherry, J. Michael			AGAPE (Automated Genome Analysis PipelinE) for Pan-Genome Analysis of Saccharomyces cerevisiae	PLOS ONE			English	Article							GENETIC-VARIATION; SAKE YEASTS; STRAINS; DELETION; MUTANTS; S288C; IDENTIFICATION; BIOSYNTHESIS; FERMENTATION; ALIGNMENT	The characterization and public release of genome sequences from thousands of organisms is expanding the scope for genetic variation studies. However, understanding the phenotypic consequences of genetic variation remains a challenge in eukaryotes due to the complexity of the genotype-phenotype map. One approach to this is the intensive study of model systems for which diverse sources of information can be accumulated and integrated. Saccharomyces cerevisiae is an extensively studied model organism, with well-known protein functions and thoroughly curated phenotype data. To develop and expand the available resources linking genomic variation with function in yeast, we aim to model the pan-genome of S. cerevisiae. To initiate the yeast pan-genome, we newly sequenced or resequenced the genomes of 25 strains that are commonly used in the yeast research community using advanced sequencing technology at high quality. We also developed a pipeline for automated pan-genome analysis, which integrates the steps of assembly, annotation, and variation calling. To assign strain-specific functional annotations, we identified genes that were not present in the reference genome. We classified these according to their presence or absence across strains and characterized each group of genes with known functional and phenotypic features. The functional roles of novel genes not found in the reference genome and associated with strains or groups of strains appear to be consistent with anticipated adaptations in specific lineages. As more S. cerevisiae strain genomes are released, our analysis can be used to collate genome data and relate it to lineage-specific patterns of genome evolution. Our new tool set will enhance our understanding of genomic and functional evolution in S. cerevisiae, and will be available to the yeast genetics and molecular biology community.	[Song, Giltae; Demeter, Janos; Engel, Stacia; Dunn, Barbara; Cherry, J. Michael] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Dickins, Benjamin J. A.] Nottingham Trent Univ, Sch Sci & Technol, Nottingham, England	Stanford University; Nottingham Trent University	Song, G (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.	gsong@stanford.edu	Song, Giltae/ABG-7799-2020	Song, Giltae/0000-0001-8796-4678; Engel, Stacia/0000-0001-5472-917X; Cherry, J. Michael/0000-0001-9163-5180; Snyder, Michael/0000-0003-0784-7987; Dunn, Barbara/0000-0002-7041-0035; Choe, Kisurb/0000-0002-6396-8452; Dickins, Benjamin/0000-0002-0866-6232	National Human Genome Research Institute at the United States National Institutes of Health [U41, HG001315]	National Human Genome Research Institute at the United States National Institutes of Health	This work is funded by a U41 grant from the National Human Genome Research Institute at the United States National Institutes of Health (HG001315). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Human Genome Research Institute or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao T, 2011, DNA RES, V18, P423, DOI 10.1093/dnares/dsr029; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Argueso JL, 2009, GENOME RES, V19, P2258, DOI 10.1101/gr.091777.109; Asano T, 2001, J BIOSCI BIOENG, V92, P429, DOI 10.1263/jbb.92.429; Atkinson R. W., 1881, P ROY SOC, V32, P299; Bedoya-Reina OC, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-17; Bentley S, 2009, NAT REV MICROBIOL, V7, P258, DOI 10.1038/nrmicro2123; Bergstrom A, 2014, MOL BIOL EVOL, V31, P872, DOI 10.1093/molbev/msu037; Borneman AR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001287; BORTS RH, 1984, COLD SPRING HARB SYM, V49, P67, DOI 10.1101/SQB.1984.049.01.010; Botstein D, 2011, GENETICS, V189, P695, DOI 10.1534/genetics.111.130765; Brachmann CB, 1998, YEAST, V14, P115; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Doniger SW, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000183; DUBIN RA, 1986, MOL CELL BIOL, V6, P2757, DOI 10.1128/MCB.6.8.2757; Dunn B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003366; Engel SR, 2010, NUCLEIC ACIDS RES, V38, pD433, DOI 10.1093/nar/gkp917; Fay JC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r26; Fisk DG, 2006, YEAST, V23, P857, DOI 10.1002/yea.1400; Gibson AW, 1997, GENETICS, V146, P1287; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Harris R, 2007, THESIS PENNSYLBANIA; Heck JA, 2006, P NATL ACAD SCI USA, V103, P3256, DOI 10.1073/pnas.0510998103; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; KANE SM, 1974, J BACTERIOL, V118, P8, DOI 10.1128/JB.118.1.8-14.1974; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Kobayashi T, 2007, BIOSCI BIOTECH BIOCH, V71, P646, DOI 10.1271/bbb.60550; Kumar C, 2003, YEAST, V20, P857, DOI 10.1002/yea.1012; LACROUTE F, 1968, J BACTERIOL, V95, P824, DOI 10.1128/JB.95.3.824-832.1968; Lam HYK, 2012, NAT BIOTECHNOL, V30, P226, DOI 10.1038/nbt.2134; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li YD, 2014, GENOME BIOL EVOL, V6, P2516, DOI 10.1093/gbe/evu201; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Meyrial V, 2001, EUR J BIOCHEM, V268, P334, DOI 10.1046/j.1432-1327.2001.01882.x; MORTIMER RK, 1986, GENETICS, V113, P35; MORTIMER RK, 1994, YEAST, V10, P1543, DOI 10.1002/yea.320101203; Nitta A, 2000, SEIBUTSU-KOGAKU KAIS, V78, P77; Novo M, 2009, P NATL ACAD SCI USA, V106, P16333, DOI 10.1073/pnas.0904673106; Perez-Ortin JE, 2002, GENOME RES, V12, P1533, DOI 10.1101/gr.436602; Read BA, 2013, NATURE, V499, P209, DOI 10.1038/nature12221; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Salzberg SL, 2012, GENOME RES, V22, P557, DOI 10.1101/gr.131383.111; Schacherer J, 2009, NATURE, V458, P342, DOI 10.1038/nature07670; SHERMAN F, 1963, GENETICS, V48, P375; SIKORSKI RS, 1989, GENETICS, V122, P19; Simpson JT, 2012, GENOME RES, V22, P549, DOI 10.1101/gr.126953.111; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Sniegowski Paul D., 2002, FEMS Yeast Research, V1, P299, DOI 10.1016/S1567-1356(01)00043-5; Song G, 2012, GENOME BIOL EVOL, V4, P586, DOI 10.1093/gbe/evs032; Spingola M, 1999, RNA, V5, P221, DOI 10.1017/S1355838299981682; van Dijken JP, 2000, ENZYME MICROB TECH, V26, P706, DOI 10.1016/S0141-0229(00)00162-9; Voth WP, 2005, EUKARYOT CELL, V4, P1018, DOI 10.1128/EC.4.6.1018-1028.2005; Warringer J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002111; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wu H, 2005, APPL ENVIRON MICROB, V71, P6845, DOI 10.1128/AEM.71.11.6845-6855.2005; Zhao YB, 2012, BIOINFORMATICS, V28, P416, DOI 10.1093/bioinformatics/btr655	60	36	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120671	10.1371/journal.pone.0120671	http://dx.doi.org/10.1371/journal.pone.0120671			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781462	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600180
J	Wu, SG; Lai, YQ; He, ZY; Zhou, Y; Chen, SY; Dai, MM; Zhou, J; Lin, Q; Chi, F				Wu, Sangang; Lai, Youqun; He, Zhenyu; Zhou, Yuan; Chen, Shanyu; Dai, Mingming; Zhou, Juan; Lin, Qin; Chi, Feng			Dosimetric Comparison of the Simultaneous Integrated Boost in Whole-Breast Irradiation after Breast-Conserving Surgery: IMRT, IMRT plus an Electron Boost and VMAT	PLOS ONE			English	Article							HEART-DISEASE; LOCAL-CONTROL; EORTC BOOST; RADIOTHERAPY; CANCER; THERAPY; WOMEN	Objectives To compare the target volume coverage and doses to organs at risks (OARs) using three techniques that simultaneous integrated boost (SIB) in whole-breast irradiation (WBI) after breast-conserving surgery, including intensity-modulated radiation therapy (IMRT), IMRT plus an electron boost (IMRT-EB), and volumetric-modulated arc therapy (VMAT). Methods A total of 10 patients with early-stage left-sided breast cancer after breast-conserving surgery were included in this study. IMRT, IMRT-EB and VMAT plans were generated for each patient. Results The conformity index (CI) of the planning target volumes evaluation (PTV-Eval) of VMAT was significantly superior to those of IMRT and IMRT-EB (P < 0.05). The CI of the PTV Eval-boost of VMAT was better than that of IMRT (P = 0.018) and IMRT-EB (P < 0.001), while the CI of the PTV Eval-boost of IMRT was better than that of IMRT-EB (P = 0.002). The V5, V10 and Dmean in ipsilateral lung with VMAT were significantly higher than IMRT (P < 0.05) and IMRT-EB (P < 0.05). The Dmean, V5 and V10 in heart with VMAT were significantly greater than those of IMRT and IMRT-EB (P < 0.05). There was no significant difference in the OARs between IMRT and IMRT-EB (P > 0.05). Conclusions Considered the target volume coverage and radiation dose delivered to the OARs (especially the heart and lung), IMRT may be more suitable for the SIB in WBI than IMRT-EB and VMAT. Additional clinical studies with a larger sample size will be needed to assess the long-term feasibility and efficacy of SIB using different radiotherapy techniques.	[Wu, Sangang; Lai, Youqun; Zhou, Yuan; Chen, Shanyu; Dai, Mingming; Lin, Qin] Xiamen Univ, Affiliated Hosp 1, Dept Radiat Oncol, Xiamen Canc Ctr, Xiamen, Peoples R China; [He, Zhenyu; Chi, Feng] Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Ctr Canc,Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Zhou, Juan] Xiamen Univ, Affiliated Hosp 1, Xiamen Canc Ctr, Dept Obstet & Gynecol, Xiamen, Peoples R China	Xiamen University; State Key Lab Oncology South China; Sun Yat Sen University; Xiamen University	Lin, Q (corresponding author), Xiamen Univ, Affiliated Hosp 1, Dept Radiat Oncol, Xiamen Canc Ctr, Xiamen, Peoples R China.	linqin05@163.com; chif@sysucc.edu.cn	Wu, San-Gang/AAA-8959-2022		Sci-Tech Office of Guangdong Province [2008B060600019]; Youth Foundation of the First Affiliated Hospital of Xiamen University [XYY2012005]; Education Scientific Research Project of Young Teachers in Fujian Province [JB13131]	Sci-Tech Office of Guangdong Province; Youth Foundation of the First Affiliated Hospital of Xiamen University; Education Scientific Research Project of Young Teachers in Fujian Province	This study was supported by a grant from the Sci-Tech Office of Guangdong Province (No. 2008B060600019), the Youth Foundation of the First Affiliated Hospital of Xiamen University (No. XYY2012005) and the Education Scientific Research Project of Young Teachers in Fujian Province (No. JB13131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V366, P2087; Abo-Madyan Y, 2014, RADIOTHER O IN PRESS; Alford SL, 2013, J MED IMAG RADIAT ON, V57, P222, DOI 10.1111/j.1754-9485.2012.02473.x; [Anonymous], 2007, J AM COLL SURGEONS, V205, P362, DOI 10.1016/j.jamcollurg.2007.02.057; Askoxylakis V, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-249; Bartelink H, 2007, J CLIN ONCOL, V25, P3259, DOI 10.1200/JCO.2007.11.4991; Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825; Henson KE, 2013, BRIT J CANCER, V108, P179, DOI 10.1038/bjc.2012.575; Immink JM, 2012, ANN ONCOL, V23, P2591, DOI 10.1093/annonc/mds066; International Commission on Radiation Units and Measurements, 2010, J ICRU, V10, P1; Jin GH, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-89; Kodama Kazunori, 1996, World Health Statistics Quarterly, V49, P7; Liem X, 2014, CANCER RADIOTHER, V18, P15, DOI 10.1016/j.canrad.2013.07.149; McGale P, 2011, RADIOTHER ONCOL, V100, P167, DOI 10.1016/j.radonc.2011.06.016; National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology, 2014, BREAST CANC VERSION; Otto K, 2008, MED PHYS, V35, P310, DOI 10.1118/1.2818738; Park SH, 2013, J BREAST CANCER, V16, P300, DOI 10.4048/jbc.2013.16.3.300; Patt DA, 2005, J CLIN ONCOL, V23, P7475, DOI 10.1200/JCO.2005.13.755; Poortman PM, 2009, RADIOTHER ONCOL, V90, P80, DOI 10.1016/j.radonc.2008.07.011; Poortmans P, 2004, RADIOTHER ONCOL, V72, P25, DOI 10.1016/j.radonc.2004.03.007; Remouchamps VM, 2003, INT J RADIAT ONCOL, V55, P392, DOI 10.1016/S0360-3016(02)04143-3; Scorsetti M, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-145; Sedlmayer F, 2013, STRAHLENTHER ONKOL, V189, P193, DOI 10.1007/s00066-012-0300-3; Senkus E, 2013, ANN ONCOL, V24, P7, DOI 10.1093/annonc/mdt284; Thilmann C, 2001, INT J CANCER, V96, P341, DOI 10.1002/ijc.1042; Van Parijs H, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-36; Zhang Q, 2003, MED PHYS, V34, P4772	27	13	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120811	10.1371/journal.pone.0120811	http://dx.doi.org/10.1371/journal.pone.0120811			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781183	Green Published, gold, Green Submitted			2022-12-27	WOS:000351284600188
J	Ejaz, AA; Pourafshar, N; Mohandas, R; Smallwood, BA; Johnson, RJ; Hsu, JW				Ejaz, A. Ahsan; Pourafshar, Negiin; Mohandas, Rajesh; Smallwood, Bryan A.; Johnson, Richard J.; Hsu, Jack W.			Uric Acid and the Prediction Models of Tumor Lysis Syndrome in AML	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; ACUTE MYELOID-LEUKEMIA; RISK; CANCER	We investigated the ability of serum uric acid (SUA) to predict laboratory tumor lysis syndrome (LTLS) and compared it to common laboratory variables, cytogenetic profiles, tumor markers and prediction models in acute myeloid leukemia patients. In this retrospective study patients were risk-stratified for LTLS based on SUA cut-off values and the discrimination ability was compared to current prediction models. The incidences of LTLS were 17.8%, 21% and 62.5% in the low, intermediate and high-risk groups, respectively. SUA was an independent predictor of LTLS (adjusted OR 1.12, CI95% 1.0-1.3, p = 0.048). The discriminatory ability of SUA, per ROC curves, to predict LTLS was superior to LDH, cytogenetic profile, tumor markers and the combined model but not to WBC (AUCWBC 0.679). However, in comparisons between high-risk SUA and high-risk WBC, SUA had superior discriminatory capability than WBC (AUCSUA 0.664 vs. AUCWBC 0.520; p < 0.001). SUA also demonstrated better performance than the prediction models (high-risk SUAAUC 0.695, p < 0.001). In direct comparison of high-risk groups, SUA again demonstrated superior performance than the prediction models (high-risk SUAAUC 0.668, p = 0.001) in predicting LTLS, approaching that of the combined model (AUC 0.685, p < 0.001). In conclusion, SUA alone is comparable and highly predictive for LTLS than other prediction models.	[Ejaz, A. Ahsan; Pourafshar, Negiin; Mohandas, Rajesh] North Florida South Georgia Vet Hlth Syst, Div Nephrol Hypertens & Transplantat, Gainesville, FL 32608 USA; [Mohandas, Rajesh] North Florida South Georgia Vet Hlth Syst, Nephrol & Hypertens Sect, Dept Vet Affairs Med Ctr, Gainesville, FL USA; [Smallwood, Bryan A.] Univ Florida, Dept Epidemiol, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA; [Smallwood, Bryan A.] Univ Florida, Coll Med, Gainesville, FL USA; [Johnson, Richard J.] Univ Colorado, Hlth Sci Ctr, Div Renal Dis & Hypertens, Gainesville, FL USA; [Hsu, Jack W.] Univ Florida, Div Hematol & Oncol, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Colorado System; University of Colorado Anschutz Medical Campus; State University System of Florida; University of Florida	Ejaz, AA (corresponding author), North Florida South Georgia Vet Hlth Syst, Div Nephrol Hypertens & Transplantat, Gainesville, FL 32608 USA.	ejazaa@medicine.ufl.edu	Mohandas, Rajesh/CAA-6727-2022	Mohandas, Rajesh/0000-0002-4430-8678	BLRD VA [I01 BX002586] Funding Source: Medline	BLRD VA		Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; Cairo MS, 2010, BRIT J HAEMATOL, V149, P578, DOI 10.1111/j.1365-2141.2010.08143.x; Cairo MS, 2004, BRIT J HAEMATOL, V127, P3, DOI 10.1111/j.1365-2141.2004.05094.x; Chawla LS, 2014, NEW ENGL J MED, V371, P58, DOI 10.1056/NEJMra1214243; Ejaz AA, 2007, CLIN J AM SOC NEPHRO, V2, P16, DOI 10.2215/CJN.00350106; Ejaz AA, 2009, AM J NEPHROL, V30, P425, DOI 10.1159/000238824; Feig DI, 2004, KIDNEY INT, V66, P281, DOI 10.1111/j.1523-1755.2004.00729.x; Kang DH, 2005, J AM SOC NEPHROL, V16, P3553, DOI 10.1681/ASN.2005050572; Khosla UM, 2005, KIDNEY INT, V67, P1739, DOI 10.1111/j.1523-1755.2005.00273.x; Lam AQ, 2012, CLIN J AM SOC NEPHRO, V7, P1692, DOI 10.2215/CJN.03140312; Lapsia V, 2012, AM J MED, V125, DOI 10.1016/j.amjmed.2011.06.021; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Montesinos P, 2007, HAEMATOLOGICA, V93, P67, DOI 10.3324/haematol.11575; Roncal CA, 2007, AM J PHYSIOL-RENAL, V292, pF116, DOI 10.1152/ajprenal.00160.2006; Sanchez-Lozada LG, 2007, AM J PHYSIOL-RENAL, V292, pF1238, DOI 10.1152/ajprenal.00164.2006; Sanchez-Lozada LG, 2005, KIDNEY INT, V67, P237, DOI 10.1111/j.1523-1755.2005.00074.x; Shimada M, 2011, SEMIN NEPHROL, V31, P453, DOI 10.1016/j.semnephrol.2011.08.010; Shimada M, 2009, NEPHROL DIAL TRANSPL, V24, P2960, DOI 10.1093/ndt/gfp330; Surrey West Sussex and Hampshire Cancer Network NHS, GUID MAN TUM LYS SYN	19	16	18	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119497	10.1371/journal.pone.0119497	http://dx.doi.org/10.1371/journal.pone.0119497			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775138	gold, Green Submitted, Green Published			2022-12-27	WOS:000351183500098
J	Heo, SC; Shin, WC; Lee, MJ; Kim, BR; Jang, IH; Choi, EJ; Lee, JS; Kim, JH				Heo, Soon Chul; Shin, Won Chul; Lee, Mi Jeong; Kim, Ba Reun; Jang, Il Ho; Choi, Eun-Jung; Lee, Jung Sub; Kim, Jae Ho			Periostin Accelerates Bone Healing Mediated by Human Mesenchymal Stem Cell-Embedded Hydroxyapatite/Tricalcium Phosphate Scaffold	PLOS ONE			English	Article							HUMAN ADIPOSE-TISSUE; STROMAL CELLS; EXTRACELLULAR-MATRIX; IN-VITRO; GROWTH; DEFECTS; ANGIOGENESIS; PROGENITORS; EXPRESSION; MODEL	Background Periostin, an extracellular matrix protein, is expressed in bone, more specifically, the periosteum and periodontal ligaments, and plays a key role in formation and metabolism of bone tissues. Human adipose tissue-derived mesenchymal stem cells (hASCs) have been reported to differentiate into osteoblasts and stimulate bone repair. However, the role of periostin in hASC-mediated bone healing has not been clarified. In the current study, we examined the effect of periostin on bone healing capacity of hASCs in a critical size calvarial defect model. Methods and Results Recombinant periostin protein stimulated migration, adhesion, and proliferation of hASCs in vitro. Implantation of either hASCs or periostin resulted in slight, but not significant, stimulation of bone healing, whereas co-implantation of hASCs together with periostin further potentiated bone healing. In addition, the number of Ki67-positive proliferating cells was significantly increased in calvarial defects by co-implantation of both hASCs and periostin. Consistently, proliferation of administered hASCs was stimulated by co-implantation with periostin in vivo. In addition, co-delivery of hASCs with periostin resulted in markedly increased numbers of CD31-positive endothelial cells and alpha-SMA-positive arterioles in calvarial defects. Conclusions These results suggest that recombinant periostin potentiates hASC-mediated bone healing by stimulating proliferation of transplanted hASCs and angiogenesis in calvarial defects.	[Heo, Soon Chul; Lee, Mi Jeong; Kim, Ba Reun; Jang, Il Ho; Choi, Eun-Jung; Kim, Jae Ho] Pusan Natl Univ, Sch Med, Dept Physiol, Yangsan 626870, Gyeongsangnam D, South Korea; [Shin, Won Chul; Lee, Jung Sub] Pusan Natl Univ, Sch Med, Dept Orthopaed Surg, Yangsan 626870, Gyeongsangnam D, South Korea; [Kim, Jae Ho] Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Yangsan 626770, Gyeongsangnam D, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital	Lee, JS (corresponding author), Pusan Natl Univ, Sch Med, Dept Orthopaed Surg, Yangsan 626870, Gyeongsangnam D, South Korea.	jungsublee@pusan.ac.kr; jhkimst@pusan.ac.kr		Jang, Il Ho/0000-0002-0820-3035; Kim, Jae Ho/0000-0003-4323-4790	programs of the National Research Foundation of Korea - Ministry of Education, Science and Technology [NRF-2012R1A1A4A01011953, 2010-0020274]	programs of the National Research Foundation of Korea - Ministry of Education, Science and Technology	This research was supported by the programs of the National Research Foundation of Korea (www.nrf.re.kr) funded by the Ministry of Education, Science and Technology (NRF-2012R1A1A4A01011953; 2010-0020274). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnet N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078347; Bonnet N, 2012, P NATL ACAD SCI USA, V109, P15048, DOI 10.1073/pnas.1203085109; Cho YH, 2012, BIOMATERIALS, V33, P1376, DOI 10.1016/j.biomaterials.2011.10.078; DeCoster TA, 2004, J AM ACAD ORTHOP SUR, V12, P28, DOI 10.5435/00124635-200401000-00005; Geiger F, 2005, J BONE MINER RES, V20, P2028, DOI 10.1359/JBMR.050701; Gillan L, 2002, CANCER RES, V62, P5358; Guven S, 2011, BIOMATERIALS, V32, P5801, DOI 10.1016/j.biomaterials.2011.04.064; Heo SC, 2011, BBA-MOL CELL RES, V1813, P2061, DOI 10.1016/j.bbamcr.2011.08.004; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Janicki P, 2011, INJURY, V42, pS77, DOI 10.1016/j.injury.2011.06.014; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Jurgens WJFM, 2009, CYTOTHERAPY, V11, P1052, DOI 10.3109/14653240903219122; Keramaris NC, 2012, CURR STEM CELL RES T, V7, P293; Kii I, 2010, J BIOL CHEM, V285, P2028, DOI 10.1074/jbc.M109.051961; Kim BR, 2014, BBA-MOL BASIS DIS, V1842, P1324, DOI 10.1016/j.bbadis.2014.05.004; Kim HP, 2012, CURR STEM CELL RES T, V7, P165; Koob S, 2011, TISSUE ENG PT A, V17, P311, DOI [10.1089/ten.tea.2010.0338, 10.1089/ten.TEA.2010.0338]; Kruzynska-Frejtag A, 2004, DEV DYNAM, V229, P857, DOI 10.1002/dvdy.10453; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; Kuznetsov SA, 2011, STEM CELLS DEV, V20, P269, DOI 10.1089/scd.2009.0501; Kwon YW, 2013, BBA-MOL BASIS DIS, V1832, P2136, DOI 10.1016/j.bbadis.2013.08.002; Lee HC, 2012, CIRC J, V76, P1750, DOI 10.1253/circj.CJ-11-1135; Lee MJ, 2010, J PROTEOME RES, V9, P1754, DOI 10.1021/pr900898n; Levi B, 2011, PLAST RECONSTR SURG, V128, P373, DOI 10.1097/PRS.0b013e31821e6e49; Levi B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011177; Lindroos B, 2011, STEM CELL REV REP, V7, P269, DOI 10.1007/s12015-010-9193-7; Litvin J, 2004, J CELL BIOCHEM, V92, P1044, DOI 10.1002/jcb.20115; Mankani MH, 2006, AM J PATHOL, V168, P542, DOI 10.2353/ajpath.2006.050407; Merle B, 2012, OSTEOPOROSIS INT, V23, P1199, DOI 10.1007/s00198-011-1892-7; Morra L, 2011, VIRCHOWS ARCH, V459, P465, DOI 10.1007/s00428-011-1151-5; Niemeyer P, 2010, BIOMATERIALS, V31, P3572, DOI 10.1016/j.biomaterials.2010.01.085; Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224; Ogita M, 2008, ENDOCRINOLOGY, V149, P5713, DOI 10.1210/en.2008-0369; Rios H, 2005, MOL CELL BIOL, V25, P11131, DOI 10.1128/MCB.25.24.11131-11144.2005; Romanos GE, 2014, J CELL PHYSIOL, V229, P1, DOI 10.1002/jcp.24407; Ruan K, 2009, J CELL BIOCHEM, V107, P1053, DOI 10.1002/jcb.22214; Scherberich A, 2007, STEM CELLS, V25, P1823, DOI 10.1634/stemcells.2007-0124; Shimazaki M, 2008, J EXP MED, V205, P295, DOI 10.1084/jem.20071297; Supronowicz P, 2011, TISSUE ENG PT A, V17, P789, DOI [10.1089/ten.tea.2010.0357, 10.1089/ten.TEA.2010.0357]; Szoke K, 2012, STEM CELL TRANSL MED, V1, P658, DOI 10.5966/sctm.2012-0069; Tai IT, 2005, CARCINOGENESIS, V26, P908, DOI 10.1093/carcin/bgi034; Vahabi Surena, 2012, Chang Gung Med J, V35, P28; Yoshiba N, 2007, CELL TISSUE RES, V330, P133, DOI 10.1007/s00441-007-0439-x; Zhu SM, 2009, J CELL PHYSIOL, V218, P584, DOI 10.1002/jcp.21633; Zomorodian E, 2012, STEM CELLS INT, V2012, P1, DOI DOI 10.1155/2012/980353	45	28	30	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0116698	10.1371/journal.pone.0116698	http://dx.doi.org/10.1371/journal.pone.0116698			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775460	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500011
J	Meli, R; Weisova, P; Propst, F				Meli, Rajeshwari; Weisova, Petronela; Propst, Friedrich			Repulsive Axon Guidance by Draxin Is Mediated by Protein Kinase B (Akt), Glycogen Synthase Kinase-3 beta (GSK-3 beta) and Microtubule-Associated Protein 1B	PLOS ONE			English	Article							GROWTH-CONE COLLAPSE; NETRIN RECEPTOR DCC; NEURONAL MIGRATION; PHOSPHATIDYLINOSITOL 3-KINASE; MAP1B; PHOSPHORYLATION; MECHANISM; OUTGROWTH; INHIBITION; INSULIN	Draxin is an important axon guidance cue necessary for the formation of forebrain commissures including the corpus callosum, but the molecular details of draxin signaling are unknown. To unravel how draxin signals are propagated we used murine cortical neurons and genetic and pharmacological approaches. We found that draxin-induced growth cone collapse critically depends on draxin receptors (deleted in colorectal cancer, DCC), inhibition of protein kinase B/Akt, activation of GSK-3 beta (glycogen synthase kinase-3 beta) and the presence of microtubule-associated protein MAP1B. This study, for the first time elucidates molecular events in draxin repulsion, links draxin and DCC to MAP1B and identifies a novel MAP1B-depenent GSK-3 beta pathway essential for chemo-repulsive axon guidance cue signaling.	[Meli, Rajeshwari; Weisova, Petronela; Propst, Friedrich] Univ Vienna, Vienna Bioctr VBC, Dept Biochem & Cell Biol, MFPL, A-1030 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Propst, F (corresponding author), Univ Vienna, Vienna Bioctr VBC, Dept Biochem & Cell Biol, MFPL, Waehringer Guertel 18, A-1030 Vienna, Austria.	friedrich.propst@univie.ac.at	Weisova, Petronela/AAM-5989-2020		Doktoratskolleg 'Molecular Mechanisms of Cell Signaling' [P20839-B09, W1220-B09]	Doktoratskolleg 'Molecular Mechanisms of Cell Signaling'	This research was supported by grants P20839-B09 and W1220-B09 (Doktoratskolleg 'Molecular Mechanisms of Cell Signaling') from the Austrian Science Fund (FWF) to F.P.P.W. is funded by the Max F. Perutz Laboratories' Vienna International Postdoctoral Program for Molecular Life Sciences (Austrian Ministry of Science and Research and City of Vienna, Cultural Department-Science and Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Ahmed G, 2011, J NEUROSCI, V31, P14018, DOI 10.1523/JNEUROSCI.0943-11.2011; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Anilkumar U, 2013, J NEUROCHEM, V124, P721, DOI 10.1111/jnc.12108; Atwal JK, 2003, J NEUROSCI, V23, P7602; Bouquet C, 2004, J NEUROSCI, V24, P7204, DOI 10.1523/JNEUROSCI.2254-04.2004; Bouquet C, 2007, MOL CELL NEUROSCI, V36, P235, DOI 10.1016/j.mcn.2007.07.002; Brown M, 2004, J NEUROSCI, V24, P8994, DOI 10.1523/JNEUROSCI.3184-04.2004; Chadborn NH, 2006, J CELL SCI, V119, P951, DOI 10.1242/jcs.02801; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; de la Torre JR, 1997, NEURON, V19, P1211, DOI 10.1016/S0896-6273(00)80413-4; Del Rio JA, 2004, CURR BIOL, V14, P840, DOI 10.1016/j.cub.2004.04.046; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Edstrorn A, 2003, J NEUROSCI RES, V74, P726, DOI 10.1002/jnr.10686; Eickholt BJ, 2002, J CELL BIOL, V157, P211, DOI 10.1083/jcb.200201098; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Gonzalez-Billault C, 2000, MOL CELL NEUROSCI, V16, P408, DOI 10.1006/mcne.2000.0880; Gonzalez-Billault C, 2005, CEREB CORTEX, V15, P1134, DOI 10.1093/cercor/bhh213; Goold RG, 1999, J CELL SCI, V112, P3373; Gordon-Weeks PR, 2000, MICROSC RES TECHNIQ, V48, P63, DOI 10.1002/(SICI)1097-0029(20000115)48:2<63::AID-JEMT2>3.0.CO;2-1; Halpain S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-224; Henle SJ, 2013, J BIOL CHEM, V288, P20837, DOI 10.1074/jbc.C113.487066; Hur EM, 2011, GENE DEV, V25, P1968, DOI 10.1101/gad.17015911; Islam SM, 2009, SCIENCE, V323, P388, DOI 10.1126/science.1165187; Kapfhammer JP, 2007, NAT PROTOC, V2, P2005, DOI 10.1038/nprot.2007.295; Kawauchi T, 2003, EMBO J, V22, P4190, DOI 10.1093/emboj/cdg413; Kim SR, 2011, ANN NEUROL, V70, P110, DOI 10.1002/ana.22383; Kolsch V, 2008, J CELL SCI, V121, P551, DOI 10.1242/jcs.023333; Li L, 2009, J NEUROSCI, V29, P5873, DOI 10.1523/JNEUROSCI.0183-09.2009; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Lucas FR, 1998, J CELL SCI, V111, P1351; Meixner A, 2000, J CELL BIOL, V151, P1169, DOI 10.1083/jcb.151.6.1169; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Mukai F, 2002, J NEUROCHEM, V81, P1073, DOI 10.1046/j.1471-4159.2002.00918.x; Naser IB, 2009, DEV BIOL, V332, P351, DOI 10.1016/j.ydbio.2009.06.004; Negishi M, 2005, CELL MOL LIFE SCI, V62, P1363, DOI 10.1007/s00018-005-5018-2; Oinuma I, 2010, J BIOL CHEM, V285, P28200, DOI 10.1074/jbc.M110.147546; Riyadh MA, 2014, BIOCHEM BIOPH RES CO, V449, P169, DOI 10.1016/j.bbrc.2014.05.013; Round J, 2007, CURR OPIN NEUROBIOL, V17, P15, DOI 10.1016/j.conb.2007.01.003; SAITO Y, 1994, BIOCHEM J, V303, P27, DOI 10.1042/bj3030027; Sanchez S, 2001, J NEUROCHEM, V78, P468, DOI 10.1046/j.1471-4159.2001.00453.x; Schmidt EF, 2007, ADV EXP MED BIOL, V600, P1; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; Stroissnigg H, 2007, NAT CELL BIOL, V9, P1035, DOI 10.1038/ncb1625; Tortosa E, 2013, EMBO J, V32, P1293, DOI 10.1038/emboj.2013.76; Trivedi N, 2005, J CELL SCI, V118, P993, DOI 10.1242/jcs.01697; Tymanskyj SR, 2012, MOL CELL NEUROSCI, V49, P110, DOI 10.1016/j.mcn.2011.10.003; Uchida Y, 2005, GENES CELLS, V10, P165, DOI 10.1111/j.1365-2443.2005.00827.x; von Philipsborn A, 2007, INT REV CYTOL, V263, P1, DOI 10.1016/S0074-7696(07)63001-0; Waite K, 2010, CURR TOP MICROBIOL, V346, P245, DOI 10.1007/82_2010_82; Wang QH, 1999, MOL CELL BIOL, V19, P4008; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011	55	16	16	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119524	10.1371/journal.pone.0119524	http://dx.doi.org/10.1371/journal.pone.0119524			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775433	Green Submitted, gold, Green Published			2022-12-27	WOS:000351183500100
J	Shen, SX; Li, J; Guo, Q; Zhang, W; Wang, XY; Fu, LY; Li, LK; An, YF; Liu, WX; Li, HY; Huang, T; Zhang, ZD; Niu, KJ				Shen, Suxing; Li, Jing; Guo, Qi; Zhang, Wen; Wang, Xiuyang; Fu, Liyuan; Li, Linke; An, Yufang; Liu, Weixi; Li, Hongyun; Huang, Tao; Zhang, Zedan; Niu, Kaijun			Body Mass Index Is Associated with Physical Performance in Suburb-Dwelling Older Chinese: A Cross-Sectional Study	PLOS ONE			English	Article							NUTRITIONAL-STATUS; HANDGRIP STRENGTH; GRIP STRENGTH; AGE; MEN; MOBILITY; HEALTHY; WOMEN; RELIABILITY; POPULATION	Background Physical performance is reported to have various beneficial effects on human health, especially in older individuals. Although such effects are associated with body mass index (BMI), the relationship between BMI and physical performance has not been clarified. Design We conducted a cross-sectional study of 966 suburb-dwelling Tianjin individuals aged >= 60 years (average age 67.5 +/- 6.02, men 435, women 531). Mobility, balance, and muscle strength were assessed by walking speed, timed up-and-go test (TUGT), and grip strength, respectively. The subjects were categorized into three groups based on BMI (kg/m(2)) as follows: normal weight, 18.5 <= BMI <= 23.9; overweight, 24.0 <= BMI <= 27.9; and obese, BMI >= 28.0. Result After adjusting for all other variables, relative grip strength decreased when BMI increased in both men and women (P for trend < 0.001 and < 0.001, respectively). BMI may be negatively associated with TUGT performance in the women only. There was no apparent association between walking speed and BMI in either sex, but after adjusting for age, walking speed was faster when BMI increased in women (P for trend=0.0162). Conclusion This study suggests that in older individuals, higher BMI is associated with poor muscle strength in both sexes.	[Shen, Suxing; Guo, Qi; Zhang, Wen] Tianjin Med Univ, TEDA Int Cardiovasc Hosp, Cardiovasc Clin Coll, Dept Rehabil Med, Tianjin, Peoples R China; [Shen, Suxing; Guo, Qi; Zhang, Wen; Wang, Xiuyang; Fu, Liyuan; Li, Linke; An, Yufang; Liu, Weixi; Li, Hongyun; Huang, Tao; Zhang, Zedan] Tianjin Med Univ, Dept Rehabil & Sports Med, Tianjin, Peoples R China; [Li, Jing] Tianjin Med Univ, Metab Dis Hosp, Minist Hlth, Key Lab Hormones & Dev, Tianjin, Peoples R China; [Li, Jing] Tianjin Med Univ, Tianjin Inst Endocrinol, Tianjin, Peoples R China; [Niu, Kaijun] Tianjin Med Univ, Nutr Epidemiol Inst, Tianjin, Peoples R China; [Niu, Kaijun] Tianjin Med Univ, Sch Publ Hlth, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Guo, Q (corresponding author), Tianjin Med Univ, TEDA Int Cardiovasc Hosp, Cardiovasc Clin Coll, Dept Rehabil Med, Tianjin, Peoples R China.	guoqijp@gmail.com	Linong, Ji/AAB-6543-2020	Niu, Kaijun/0000-0002-8772-2481	National Natural Science Foundation of China [81372118]; Tianjin City High School Science & Technology Fund Planning Project [20120130]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin City High School Science & Technology Fund Planning Project	This work was supported by grant (81372118) from the National Natural Science Foundation of China, and grant (20120130) from the Tianjin City High School Science & Technology Fund Planning Project. The funders had an important role in study design, data collection and analysis, and decision to publish.	BASSEY EJ, 1993, CLIN SCI, V84, P331, DOI 10.1042/cs0840331; Brach JS, 2004, PREV MED, V39, P74, DOI 10.1016/j.ypmed.2004.02.044; Chen Chunming, 2004, Biomed Environ Sci, V17 Suppl, P1; Corcoran MP, 2007, AM J CLIN NUTR, V85, P662; Couillard C, 2000, J CLIN ENDOCR METAB, V85, P1026, DOI 10.1210/jc.85.3.1026; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Coqueiro RD, 2010, J NUTR HEALTH AGING, V14, P803, DOI 10.1007/s12603-010-0126-6; Daly RM, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-71; Davison KK, 2002, J AM GERIATR SOC, V50, P1802, DOI 10.1046/j.1532-5415.2002.50508.x; den Ouden MEM, 2011, MATURITAS, V69, P208, DOI 10.1016/j.maturitas.2011.04.008; Ding JZ, 2007, AM J CLIN NUTR, V85, P405; Fares D, 2012, REV ASSOC MED BRAS, V58, P434, DOI 10.1590/S0104-42302012000400013; Ferreira RS, 2013, GERIATR NURS, V34, P465, DOI 10.1016/j.gerinurse.2013.07.013; Gunther CM, 2008, J HAND SURG-AM, V33A, P558, DOI 10.1016/j.jhsa.2008.01.008; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Hardy R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056483; Himes CL, 2000, DEMOGRAPHY, V37, P73, DOI 10.2307/2648097; Huang C, 2014, NUTR METAB CARDIOVAS, V24, P648, DOI 10.1016/j.numecd.2013.12.013; Jimenez-Pavon D, 2012, EUR J APPL PHYSIOL, V112, P2455, DOI 10.1007/s00421-011-2216-5; Koster A, 2007, OBESITY, V15, P3122, DOI 10.1038/oby.2007.372; Lauretani F, 2003, J APPL PHYSIOL, V95, P1851, DOI 10.1152/japplphysiol.00246.2003; Li M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079955; Liu N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-313; Macfarlane DJ, 2007, J SCI MED SPORT, V10, P45, DOI 10.1016/j.jsams.2006.05.003; Rodrigues-Barbosa Aline, 2011, Rev. salud pública, V13, P54; Sergi G, 2007, J AM GERIATR SOC, V55, P2023, DOI 10.1111/j.1532-5415.2007.01460.x; Shimada H, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002424; Shin H, 2011, J AGING RES, DOI DOI 10.4061/2011/191896; Shin H, 2014, J GERIATR PHYS THER, V37, P7, DOI 10.1519/JPT.0b013e31828af203; Sinha I, 2014, CELL TISSUE RES; Sinha-Hikim I, 2006, J CLIN ENDOCR METAB, V91, P3024, DOI 10.1210/jc.2006-0357; Stenholm S, 2012, J GERONTOL A-BIOL, V67, P1068, DOI 10.1093/gerona/gls064; Veronese N, 2013, J AM MED DIR ASSOC, V14, P53, DOI 10.1016/j.jamda.2012.09.014; Visser M, 1998, J GERONTOL A-BIOL, V53, pM214, DOI 10.1093/gerona/53A.3.M214; Wells JCK, 2007, BEST PRACT RES CL EN, V21, P415, DOI 10.1016/j.beem.2007.04.007; Woo J, 2007, OBESITY, V15, P1886, DOI 10.1038/oby.2007.223	36	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119914	10.1371/journal.pone.0119914	http://dx.doi.org/10.1371/journal.pone.0119914			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774797	gold, Green Submitted, Green Published			2022-12-27	WOS:000351183500140
J	Staples, KJ; Nicholas, B; McKendry, RT; Spalluto, CM; Wallington, JC; Bragg, CW; Robinson, EC; Martin, K; Djukanovic, R; Wilkinson, TMA				Staples, Karl J.; Nicholas, Ben; McKendry, Richard T.; Spalluto, C. Mirella; Wallington, Joshua C.; Bragg, Craig W.; Robinson, Emily C.; Martin, Kirstin; Djukanovic, Ratko; Wilkinson, Tom M. A.			Viral Infection of Human Lung Macrophages Increases PDL1 Expression via IFN beta	PLOS ONE			English	Article							CD8(+) T-CELLS; UP-REGULATION; VIRUS-REPLICATION; INTERFERON-GAMMA; DENDRITIC CELLS; PD-1 EXPRESSION; DEFICIENT; DEFENSE; B7-H1; HIV	Lung macrophages are an important defence against respiratory viral infection and recent work has demonstrated that influenza-induced macrophage PDL1 expression in the murine lung leads to rapid modulation of CD8+ T cell responses via the PD1 receptor. This PD1/PDL1 pathway may downregulate acute inflammatory responses to prevent tissue damage. The aim of this study was to investigate the mechanisms of PDL1 regulation by human macrophages in response to viral infection. Ex-vivo viral infection models using influenza and RSV were established in human lung explants, isolated lung macrophages and monocyte-derived macrophages (MDM) and analysed by flow cytometry and RT-PCR. Incubation of lung explants, lung macrophages and MDM with X31 resulted in mean cellular infection rates of 18%, 18% and 29% respectively. Viral infection significantly increased cell surface expression of PDL1 on explant macrophages, lung macrophages and MDM but not explant epithelial cells. Infected MDM induced IFN beta release from autologous CD8+ T cells, an effect enhanced by PDL1 blockade. We observed increases in PDL1 mRNA and IFN beta mRNA and protein release by MDM in response to influenza infection. Knockdown of IFN beta by siRNA, resulted in a 37.5% reduction in IFN beta gene expression in response to infection, and a significant decrease in PDL1 mRNA. Furthermore, when MDM were incubated with IFN beta, this cytokine caused increased expression of PDL1 mRNA. These data indicate that human macrophage PDL1 expression modulates CD8+ cell IFN gamma. release in response to virus and that this expression is regulated by autologous IFN beta production.	[Staples, Karl J.; Nicholas, Ben; McKendry, Richard T.; Spalluto, C. Mirella; Wallington, Joshua C.; Bragg, Craig W.; Robinson, Emily C.; Martin, Kirstin; Djukanovic, Ratko; Wilkinson, Tom M. A.] Univ Southampton, Fac Med, Acad Unit Clin & Expt Sci, Sir Henry Wellcome Labs,Southampton Gen Hosp, Southampton SO9 5NH, Hants, England; [Djukanovic, Ratko; Wilkinson, Tom M. A.] Southampton Gen Hosp, Southampton NIHR Resp Biomed Res Unit, Southampton SO9 4XY, Hants, England	University of Southampton; University of Southampton	Staples, KJ (corresponding author), Univ Southampton, Fac Med, Acad Unit Clin & Expt Sci, Sir Henry Wellcome Labs,Southampton Gen Hosp, Southampton SO9 5NH, Hants, England.	k.staples@southampton.ac.uk		Nicholas, Benjamin/0000-0003-1467-9643; Staples, Karl/0000-0003-3844-6457; Wilkinson, Tom/0000-0003-1771-3851; Djukanovic, Ratko/0000-0001-6039-5612	Asthma UK [08/026]; British Medical Association HC Roscoe Award; Medical Research Council 4-year studentship	Asthma UK; British Medical Association HC Roscoe Award; Medical Research Council 4-year studentship	This work was part funded by a project grant from Asthma UK (08/026) and the British Medical Association HC Roscoe Award 2013 to KJS. RTM was funded by a Medical Research Council 4-year studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarnath S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003130; Boasso A, 2008, CLIN IMMUNOL, V129, P132, DOI 10.1016/j.clim.2008.05.009; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Do TTH, 2011, MICROBIOL IMMUNOL, V55, P751, DOI 10.1111/j.1348-0421.2011.00383.x; Erickson JJ, 2012, J CLIN INVEST, V122, P2967, DOI 10.1172/JCI62860; Golden-Mason L, 2007, J VIROL, V81, P9249, DOI 10.1128/JVI.00409-07; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; JAKAB GJ, 1982, AM REV RESPIR DIS, V126, P778; Keir ME, 2007, CURR OPIN IMMUNOL, V19, P309, DOI 10.1016/j.coi.2007.04.012; Khan N, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002676; Message SD, 2008, P NATL ACAD SCI USA, V105, P13562, DOI 10.1073/pnas.0804181105; Muhlbauer M, 2006, J HEPATOL, V45, P520, DOI 10.1016/j.jhep.2006.05.007; Nicholas B, 2012, AM J RESP CRIT CARE, V185, pA5716; Nicod LP, 1999, RESPIRATION, V66, P2, DOI 10.1159/000029329; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; RODGERS BC, 1982, J MED VIROL, V9, P177, DOI 10.1002/jmv.1890090304; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schreiner B, 2004, J NEUROIMMUNOL, V155, P172, DOI 10.1016/j.jneuroim.2004.06.013; SCHWARTZ RH, 1992, CELL, V71, P1065, DOI 10.1016/S0092-8674(05)80055-8; Selenko-Gebauer N, 2003, J IMMUNOL, V170, P3637, DOI 10.4049/jimmunol.170.7.3637; Sheng ZM, 2011, P NATL ACAD SCI USA, V108, P16416, DOI 10.1073/pnas.1111179108; SIBILLE Y, 1990, AM REV RESPIR DIS, V141, P471, DOI 10.1164/ajrccm/141.2.471; Staples KJ, 2012, J ALLERGY CLIN IMMUN, V130, P1404, DOI 10.1016/j.jaci.2012.07.023; Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765; Sundberg EJ, 2007, SEMIN IMMUNOL, V19, P262, DOI 10.1016/j.smim.2007.04.006; Sykes A, 2012, J ALLERGY CLIN IMMUN, V129, P1506, DOI 10.1016/j.jaci.2012.03.044; Taylor AE, 2010, EUR RESPIR J, V35, P1039, DOI 10.1183/09031936.00036709; Trabattoni D, 2003, BLOOD, V101, P2514, DOI 10.1182/blood-2002-10-3065; Tudhope SJ, 2008, J PHARMACOL EXP THER, V324, P306, DOI 10.1124/jpet.107.127670; van der Sluijs KF, 2004, J IMMUNOL, V172, P7603, DOI 10.4049/jimmunol.172.12.7603; Wang JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029879; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; WARSHAUER D, 1977, AM REV RESPIR DIS, V115, P269; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Xie ZY, 2009, IMMUNOL INVEST, V38, P624, DOI 10.1080/08820130903062210	38	37	38	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0121527	10.1371/journal.pone.0121527	http://dx.doi.org/10.1371/journal.pone.0121527			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775126	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000351183500215
J	Williams, M; Summers, BJ; Baxter, RHG				Williams, Marni; Summers, Brady J.; Baxter, Richard H. G.			Biophysical Analysis of Anopheles gambiae Leucine-Rich Repeat Proteins APL1A(1), APLB and APL1C and Their Interaction with LRIM1	PLOS ONE			English	Article							HUMAN MALARIA PARASITE; CRYSTAL-STRUCTURE; MOSQUITO; COMPLEMENT; RESISTANCE; VECTOR; MACROMOLECULES; SCATTERING; IMMUNITY; PROGRAM	Natural infection of Anopheles gambiae by malaria-causing Plasmodium parasites is significantly influenced by the APL1 genetic locus. The locus contains three closely related leucine-rich repeat (LRR) genes, APL1A, APL1B and APL1C. Multiple studies have reported the participation of APL1A-C in the immune response of A. gambiae to invasion by both rodent and human Plasmodium isolates. APL1C forms a heterodimer with the related LRR protein LRIM1 via a C-terminal coiled-coil domain that is also present in APL1A and APL1B. The LRIM1/APL1C heterodimer protects A. gambiae from infection by binding the complement-like protein TEP1 to form a stable and active immune complex. Here we report solution x-ray scatting data for the LRIM1/APL1C heterodimer, the oligomeric state of LRIM1/APL1 LRR domains in solution and the crystal structure of the APL1B LRR domain. The LRIM1/APL1C heterodimeric complex has a flexible and extended structure in solution. In contrast to the APL1A, APL1C and LRIM1 LRR domains, the APL1B LRR domain is a homodimer. The crystal structure of APL1B-LRR shows that the homodimer is formed by an N-terminal helix that complements for the absence of an N-terminal capping motif in APL1B, which is a unique distinction within the LRIM1/APL1 protein family. Full-length APL1A(1) and APL1B form a stable complex with LRIM1. These results support a model in which APL1A(1), APL1B and APL1C can all form an extended, flexible heterodimer with LRIM1, providing a repertoire of functional innate immune complexes to protect A. gambiae from a diverse array of pathogens.	[Williams, Marni; Summers, Brady J.; Baxter, Richard H. G.] Yale Univ, Dept Chem & Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Baxter, RHG (corresponding author), Yale Univ, Dept Chem & Mol Biophys & Biochem, New Haven, CT 06520 USA.	richard.baxter@yale.edu	Baxter, Richard/F-3027-2013	Baxter, Richard/0000-0001-5140-1726	DOE Office of Biological and Environmental Research; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98CH10886]; National Institute of Health project MINOS [R01GM105404]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105404] Funding Source: NIH RePORTER	DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Institute of Health project MINOS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Prof. Kenneth Vernick for helpful discussions as well as originally supplying sequences for G3 alleles of APL1A<SUP>1</SUP>, APL1A<SUP>2</SUP> and APL1B. The authors would also like to thank Michael J. Robertson for helping with the initial studies on the APL1A<SUP>1</SUP> protein and Bill Eliason for the SEC-MALLS experiments. SAXS experiments were conducted at the Advanced Light Source (ALS), a national user facility operated by Lawrence Berkeley National Laboratory on behalf of the Department of Energy, Office of Basic Energy Sciences, through the Integrated Diffraction Analysis Technologies (IDAT) program, supported by DOE Office of Biological and Environmental Research. Diffraction data of APL1B-LRR were collected at National Synchrotron Light Source (NSLS) beam line X25C (Brookhaven National Laboratory). Use of the NSLS was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-98CH10886. Additional support comes from the National Institute of Health project MINOS (R01GM105404).	Andrews RK, 2004, THROMB RES, V114, P447, DOI 10.1016/j.thromres.2004.07.020; [Anonymous], 2014, WHO WORLD MAL REP 20; Baxter RHG, 2007, P NATL ACAD SCI USA, V104, P11615, DOI 10.1073/pnas.0704967104; Baxter RHG, 2010, P NATL ACAD SCI USA, V107, P16817, DOI 10.1073/pnas.1010575107; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; BENNETT MJ, 1995, PROTEIN SCI, V4, P2455, DOI 10.1002/pro.5560041202; Bierne H, 2007, MICROBES INFECT, V9, P1156, DOI 10.1016/j.micinf.2007.05.003; Blandin SA, 2009, SCIENCE, V326, P147, DOI 10.1126/science.1175241; Blandin Stephanie A., 2008, V415, P365, DOI 10.1007/978-1-59745-570-1_21; Botos I, 2011, STRUCTURE, V19, P447, DOI 10.1016/j.str.2011.02.004; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fraiture M, 2009, CELL HOST MICROBE, V5, P273, DOI 10.1016/j.chom.2009.01.005; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Frolet C, 2006, IMMUNITY, V25, P677, DOI 10.1016/j.immuni.2006.08.019; Garver LS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002737; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guttman M, 2013, STRUCTURE, V21, P321, DOI 10.1016/j.str.2013.02.004; Harris C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001112; Hohenester E, 2006, BIOCHEM SOC T, V34, P418, DOI 10.1042/BST0340418; Holm I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052684; Hurd H, 2005, EVOLUTION, V59, P2560, DOI 10.1111/j.0014-3820.2005.tb00969.x; Kajander T, 2011, J MOL BIOL, V413, P1001, DOI 10.1016/j.jmb.2011.09.032; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; Kresse H, 2001, J CELL PHYSIOL, V189, P266, DOI 10.1002/jcp.10030; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Le BV, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002958; Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7; Matilla A, 2005, CEREBELLUM, V4, P7, DOI 10.1080/14734220410019020; Mitri C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000576; Molina-Cruz A, 2013, SCIENCE, V340, P984, DOI 10.1126/science.1235264; Molina-Cruz A, 2012, P NATL ACAD SCI USA, V109, pE1957, DOI 10.1073/pnas.1121183109; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niare O, 2002, SCIENCE, V298, P213, DOI 10.1126/science.1073420; Niemann HH, 2004, MICROBES INFECT, V6, P101, DOI 10.1016/j.micinf.2003.11.001; Osta MA, 2004, SCIENCE, V303, P2030, DOI 10.1126/science.1091789; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Povelones M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002023; Povelones M, 2009, SCIENCE, V324, P258, DOI 10.1126/science.1171400; Rebsamen M, 2013, TRENDS IMMUNOL, V34, P610, DOI 10.1016/j.it.2013.05.002; Riehle MM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003672; Riehle MM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-87; Riehle MM, 2006, SCIENCE, V312, P577, DOI 10.1126/science.1124153; Rottschaefer SM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000600; Rousseau F, 2012, ADV EXP MED BIOL, V747, P137, DOI 10.1007/978-1-4614-3229-6_9; Schlunegger MP, 1997, ADV PROTEIN CHEM, V50, P61, DOI 10.1016/S0065-3233(08)60319-8; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Scott PG, 2004, P NATL ACAD SCI USA, V101, P15633, DOI 10.1073/pnas.0402976101; Seiradake E, 2009, EMBO REP, V10, P736, DOI 10.1038/embor.2009.95; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Waterhouse RM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-531; West AP, 2006, ANNU REV CELL DEV BI, V22, P409, DOI 10.1146/annurev.cellbio.21.122303.115827; White BJ, 2011, P NATL ACAD SCI USA, V108, P244, DOI 10.1073/pnas.1013648108	58	8	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118911	10.1371/journal.pone.0118911	http://dx.doi.org/10.1371/journal.pone.0118911			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775123	Green Published, gold, Green Submitted			2022-12-27	WOS:000351183500053
J	Atyame, CM; Cattel, J; Lebon, C; Flores, O; Dehecq, JS; Weill, M; Gouagna, LC; Tortosa, P				Atyame, Celestine M.; Cattel, Julien; Lebon, Cyrille; Flores, Olivier; Dehecq, Jean-Sebastien; Weill, Mylene; Gouagna, Louis Clement; Tortosa, Pablo			Wolbachia-Based Population Control Strategy Targeting Culex quinquefasciatus Mosquitoes Proves Efficient under Semi-Field Conditions	PLOS ONE			English	Article							CYTOPLASMIC INCOMPATIBILITY; AEDES-ALBOPICTUS; PIPIENS-QUINQUEFASCIATUS; INSECTICIDE RESISTANCE; SPECIES COMPLEX; BLOCKS DENGUE; INFECTION; STRAIN; DENSITY; MALES	In mosquitoes, the maternally inherited bacterial Wolbachia induce a form of embryonic lethality called cytoplasmic incompatibility (CI). This property can be used to reduce the density of mosquito field populations through inundative releases of incompatible males in order to sterilize females (Incompatible Insect Technique, or IIT, strategy). We have previously constructed the LR[wPip(Is)] line representing a good candidate for controlling field populations of the Culex quinquefasciatus mosquito in the islands of the south-western Indian Ocean. The main purpose of the present study was to fill the gap between laboratory experiments and field implementation, i.e. assessing mating competitiveness of these incompatible males under semi-field conditions. In a first set of experiments, we analyzed crossing relationships between LR[wPip(Is)] males and La Reunion field females collected as larvae in 19 distinct localities throughout the island. This investigation revealed total embryonic mortality, confirming the strong sterilizing capacity of LR[wPip(Is)] males. Subsequently, mating competitiveness of LR[wPip(Is)] males was assessed under semi-field conditions in the presence of field males and females from La Reunion. Confrontations were carried out in April and December using different ratios of LR[wPip(Is)] to field males. The results indicated that the LR[wPip(Is)] males successfully compete with field males in mating with field females, displaying even higher competitiveness than field males in April. Our results support the implementation of small-scale field tests in order to assess the feasibility of IIT against Cx. quinquefasciatus in the islands of southwestern Indian Ocean where this mosquito species is a proven competent vector for human pathogens.	[Atyame, Celestine M.; Cattel, Julien; Lebon, Cyrille; Gouagna, Louis Clement; Tortosa, Pablo] CRVOI, Reunion Isl, France; [Atyame, Celestine M.; Cattel, Julien; Tortosa, Pablo] Univ Reunion, Reunion Isl, France; [Lebon, Cyrille] CNRS, IRD UM1 UM2, MIVEGEC, UMR 5290 224, Montpellier, France; [Flores, Olivier] UMR PVBMT, CIRAD, Reunion Isl, France; [Dehecq, Jean-Sebastien] ARS OI, St Denis, Reunion, France; [Weill, Mylene] CNRS, ISEM UMR 5554, UM2, Montpellier, France	University of La Reunion; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; CIRAD; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Atyame, CM (corresponding author), CRVOI, Ste Clotilde, Reunion Isl, France.	celestine.atyame-nten@univ-reunion.fr		Flores, Olivier/0000-0002-1416-0449; Weill, Mylene/0000-0002-4043-1601; Tortosa, Pablo/0000-0002-7928-7264; Gouagna, Louis Clement/0000-0003-0957-4484	European Union's Seventh Framework Programme ([FP7]) [263958]; French Ministry of Health; European Regional Development Fund (FEDER-Reunion)	European Union's Seventh Framework Programme ([FP7]); French Ministry of Health; European Regional Development Fund (FEDER-Reunion)	Celestine M. Atyame Post-Doctoral position was funded by the European Union's Seventh Framework Programme ([FP7/2007-2013]) under grant agreement no 263958 (RUN-Emerge project). This investigation had received the joint financial supports from the French Ministry of Health and the European Regional Development Fund (FEDER-Reunion) under the Convergence 2007-2013 Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alto BW, 2012, MED VET ENTOMOL, V26, P396, DOI 10.1111/j.1365-2915.2012.01010.x; Apostolaki A, 2011, J APPL ENTOMOL, V135, P546, DOI 10.1111/j.1439-0418.2011.01614.x; Atyame CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087336; Atyame CM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001440; Atyame CM, 2011, MOL BIOL EVOL, V28, P2761, DOI 10.1093/molbev/msr083; Atyame CM, 2011, MOL ECOL, V20, P286, DOI 10.1111/j.1365-294X.2010.04937.x; Balenghien T, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-78; BARR AR, 1980, NATURE, V283, P71, DOI 10.1038/283071a0; Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192; Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108; Bourtzis K, 2008, ADV EXP MED BIOL, V627, P104, DOI 10.1007/978-0-387-78225-6_9; Bourtzis K, 2014, ACTA TROP, V132, pS150, DOI 10.1016/j.actatropica.2013.11.004; Calvitti M, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-254; Chambers EW, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001271; Clark ME, 2003, MECH DEVELOP, V120, P185, DOI 10.1016/S0925-4773(02)00424-0; Crawley M.J., 2007, R BOOK; CURTIS CF, 1982, ENTOMOL EXP APPL, V31, P181, DOI 10.1111/j.1570-7458.1982.tb03133.x; Dodson BL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002965; Dumas E, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-181; Duron O, 2006, P ROY SOC B-BIOL SCI, V273, P495, DOI 10.1098/rspb.2005.3336; Duron O, 2006, HEREDITY, V96, P493, DOI 10.1038/sj.hdy.6800831; Duron O, 2005, MOL ECOL, V14, P1561, DOI 10.1111/j.1365-294X.2005.02495.x; Duron O, 2011, HEREDITY, V106, P986, DOI 10.1038/hdy.2010.146; Duron O, 2007, J BACTERIOL, V189, P4442, DOI 10.1128/JB.00142-07; Duron O, 2012, P ROY SOC B-BIOL SCI, V279, P4473, DOI 10.1098/rspb.2012.1368; Enayati A, 2010, ANNU REV ENTOMOL, V55, P569, DOI 10.1146/annurev-ento-112408-085423; Facchinelli L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002001; Fonseca DM, 2004, SCIENCE, V303, P1535, DOI 10.1126/science.1094247; Gilles JRL, 2014, ACTA TROP, V132, pS178, DOI 10.1016/j.actatropica.2013.08.015; Harbach RE, 2012, J AM MOSQUITO CONTR, V28, P10, DOI 10.2987/8756-971X-28.4.10; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Hoffmann AA, 2005, NATURE, V436, P189, DOI 10.1038/436189a; Jannat KNE, 2013, J VECTOR ECOL, V38, P120, DOI 10.1111/j.1948-7134.2013.12017.x; Kambris Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001143; Kittayapong P, 2002, AM J TROP MED HYG, V66, P108, DOI 10.4269/ajtmh.2002.66.108; Kriesner P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003607; LAVEN H, 1967, NATURE, V216, P383, DOI 10.1038/216383a0; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Moretti R, 2013, MED VET ENTOMOL, V27, P377, DOI 10.1111/j.1365-2915.2012.01061.x; O'Connor L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001797; Oliva CF, 2013, ACTA TROP, V125, P287, DOI 10.1016/j.actatropica.2012.11.010; Papathanos PA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S5; Pocquet N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077855; R Core Team, 2021, R LANGUAGE ENV STAT; Rasgon JL, 2003, GENETICS, V165, P2029; Rivero A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001000; Takken W, 1998, J MED ENTOMOL, V35, P639, DOI 10.1093/jmedent/35.5.639; Tantely ML, 2010, INSECT BIOCHEM MOLEC, V40, P317, DOI 10.1016/j.ibmb.2010.02.005; Tortosa P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009700; TURELLI M, 1991, NATURE, V353, P440, DOI 10.1038/353440a0; Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; YEN JH, 1971, NATURE, V232, P657, DOI 10.1038/232657a0; Zabalou S, 2004, P NATL ACAD SCI USA, V101, P15042, DOI 10.1073/pnas.0403853101; Zabalou S, 2009, ENTOMOL EXP APPL, V132, P232, DOI 10.1111/j.1570-7458.2009.00886.x; Zele F, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2837	57	33	35	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119288	10.1371/journal.pone.0119288	http://dx.doi.org/10.1371/journal.pone.0119288			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768841	Green Published, gold, Green Submitted			2022-12-27	WOS:000351277500073
J	Fernandes, GHC; de Carvalho, PDC; Serra, AJ; Crespilho, AM; Peron, JPS; Rossato, C; Leal, ECP; Albertini, R				Fernandes, Guilherme Henrique C.; Camillo de Carvalho, Paulo de Tarso; Serra, Andrey Jorge; Crespilho, Andre Maciel; Schatzman Peron, Jean Pierre; Rossato, Cristiano; Pinto Leal-Junior, Ernesto Cesar; Albertini, Regiane			The Effect of Low-Level Laser Irradiation on Sperm Motility, and Integrity of the Plasma Membrane and Acrosome in Cryopreserved Bovine Sperm	PLOS ONE			English	Article							CALCIUM-TRANSPORT; SPERMATOZOA; THERAPY; MITOCHONDRIA; FERTILITY; QUALITY; CELLS; LIGHT	Background and Objective Freezing changes sperm integrity remarkably. Cryopreservation involves cooling, freezing, and thawing and all these contribute to structural damage in sperm, resulting in reduced fertility potential. Low-level laser irradiation (LLLI) could increase energy supply to the cell and cause reactive oxygen species reduction (ROS), contributing to the restoration of oxygen consumption and adenosine triphosphate synthesis (ATP) in the mitochondria. Our goal was to analyze the effects of low-level laser irradiation on sperm motility and integrity of the plasma membrane and acrosome in cryopreserved bovine sperm. Study Design/Materials and Methods We analyzed 09 samples of bull semen (Bos taurus indicus), divided into three groups: a control group without laser irradiation, a 4J group subjected to a laser irradiation dose of 4 joules, and a 6J group subjected to dose of 6 joules. Samples were divided for the analysis of cell viability and acrosomal membrane integrity using flow cytometry; another portion was used for motion analysis. Irradiation was performed in petri dishes of 30 mm containing 3 ml of semen by an aluminum gallium indium phosphide laser diode with a wavelength of 660 nm, 30mW power, and energy of 4 and 6 joules for 80 and 120 seconds respectively. Subsequently, the irradiated and control semen samples were subjected to cryopreservation and analyzed by flow cytometry (7AAD and FITC-PSA) using the ISAS - Integrated Semen Analysis System. Results Flow cytometry showed an increase in the percentage of live sperm cells and acrosome integrity in relation to control cells when subjected to irradiation of low-power laser in two different doses of 4 and 6 joules (p < 0.05). In the analysis of straightness, percentage of cell movement, and motility, a dose of 4 joules was more effective (p < 0.05). Conclusion We conclude that LLLI may exert beneficial effects in the preservation of live sperm. A dose of 4 joules prior to cryopreservation was more effective than a dose of 6 joules in preserving sperm motility.	[Fernandes, Guilherme Henrique C.; Camillo de Carvalho, Paulo de Tarso; Serra, Andrey Jorge; Pinto Leal-Junior, Ernesto Cesar; Albertini, Regiane] Univ Nove Julho UNINOVE, Postgrad Program Rehabil Sci, Sao Paulo, SP, Brazil; [Camillo de Carvalho, Paulo de Tarso; Albertini, Regiane] Univ Nove Julho UNINOVE, Postgrad Program Biophoton, Sao Paulo, SP, Brazil; [Crespilho, Andre Maciel] Univ Santo Amaro UNISA, Postgrad Program Vet Med, Sao Paulo, SP, Brazil; [Schatzman Peron, Jean Pierre; Rossato, Cristiano] Univ Sao Paulo, Inst Ciencias Biomed, Sao Paulo, SP, Brazil	Universidade Nove de Julho; Universidade Nove de Julho; Universidade de Santo Amaro (UNISA); Universidade de Sao Paulo	de Carvalho, PDC (corresponding author), Univ Nove Julho UNINOVE, Postgrad Program Rehabil Sci, Sao Paulo, SP, Brazil.	paulo.tarso@uninove.br	Leal-Junior, Ernesto Cesar/H-8920-2016; Fernandes, Guilherme/HHT-1055-2022; Peron, Jean Pierre S/F-9248-2012; Albertini, Regiane/AAL-7940-2020; de Tarso C de Carvalho, Paulo/G-5333-2011; Crespilho, André Maciel/L-5447-2013; Serra, Andrey Jorge/E-7460-2015	Leal-Junior, Ernesto Cesar/0000-0001-6393-7616; Albertini, Regiane/0000-0002-4143-0387; de Tarso C de Carvalho, Paulo/0000-0001-9624-4103; Crespilho, André Maciel/0000-0003-4594-3961; Serra, Andrey Jorge/0000-0002-5407-8183; Rossato, Cristiano/0000-0003-1124-0520	CAPES; UNINOVE	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); UNINOVE	The authors would like to thank Tairana Central de Congelamento de Semen Ltda., represented by Dr. Vet. Tatiana Isaa Uherara Berton, for the donation of semen samples and technical support and suggestions. The authors would also like to thank the CAPES scholarship of Guilherme H. C. Fernandes, and UNINOVE, for all support.	Albuquerque-Pontes GM, 2015, LASER MED SCI, V30, P59, DOI 10.1007/s10103-014-1616-2; Alves ACA, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4296; Awda BJ, 2009, BIOL REPROD, V81, P553, DOI 10.1095/biolreprod.109.076471; Barbas JP, 2009, CELL TISSUE BANK, V10, P49, DOI 10.1007/s10561-008-9081-4; Breitbart H, 1996, J PHOTOCH PHOTOBIO B, V34, P117, DOI 10.1016/1011-1344(95)07281-0; Buyukleblebici S, 2014, ANIM REPROD SCI, V150, P77, DOI 10.1016/j.anireprosci.2014.09.006; Celeghini ECC, 2008, ANIM REPROD SCI, V104, P119, DOI 10.1016/j.anireprosci.2007.02.001; Corral-Baques MI, 2009, LASER MED SCI, V24, P703, DOI 10.1007/s10103-008-0606-7; Da Silva AA, 2013, J COSMET LASER THER, V15, P210, DOI 10.3109/14764172.2012.761345; Dahlen C, 2014, ADV EXP MED BIOL, V752, P97, DOI 10.1007/978-1-4614-8887-3_5; Denadai AS, 2009, LASER MED SCI, V24, P689, DOI 10.1007/s10103-008-0595-6; Forero-Gonzalez RA, 2012, ANDROLOGIA, V44, P154, DOI 10.1111/j.1439-0272.2010.01154.x; Gadella BM, 2014, THERIOGENOLOGY, V81, P74, DOI 10.1016/j.theriogenology.2013.09.005; Gillan L, 2005, THERIOGENOLOGY, V63, P445, DOI 10.1016/j.theriogenology.2004.09.024; Graham JK, 2001, ANIM REPROD SCI, V68, P239, DOI 10.1016/S0378-4320(01)00160-9; Huang YY, 2011, DOSE-RESPONSE, V9, P602, DOI 10.2203/dose-response.11-009.Hamblin; Iaffaldano N, 2005, ANIM REPROD SCI, V85, P317, DOI 10.1016/j.anireprosci.2004.04.043; Iaffaldano N, 2010, ANIM REPROD SCI, V119, P123, DOI 10.1016/j.anireprosci.2009.10.005; Karu TI, 2012, PHOTOMED LASER SURG, V30, P239, DOI 10.1089/pho.2012.9888; Kathiravan P, 2008, ANIM REPROD SCI, V104, P9, DOI 10.1016/j.anireprosci.2007.01.002; Lubart R, 1997, LASER SURG MED, V21, P493, DOI 10.1002/(SICI)1096-9101(1997)21:5<493::AID-LSM12>3.0.CO;2-A; LUBART R, 1992, J PHOTOCH PHOTOBIO B, V15, P337, DOI 10.1016/1011-1344(92)85139-L; Lubart R, 1996, LASER IN DER MED, P449, DOI DOI 10.1007/978-3-642-80264-5_107; Manchini MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101270; Motta JPR, 2014, CRYOBIOLOGY, V68, P343, DOI 10.1016/j.cryobiol.2014.04.007; RodriguezMartinez H, 1997, REPROD FERT DEVELOP, V9, P297, DOI 10.1071/R96081; Romon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059189; Shahverdi A, 2014, CELL J, V16, P279; Simoes R, 2013, REPRODUCTION, V146, P433, DOI 10.1530/REP-13-0123; Thibier M, 2005, REPROD NUTR DEV, V45, P235, DOI 10.1051/rnd:2005016; Torres-Junior JR, 2014, ANIM REPROD SCI; Verstegen J, 2002, THERIOGENOLOGY, V57, P149, DOI 10.1016/S0093-691X(01)00664-1; Yazdi RS, 2014, LASER MED SCI, V29, P97, DOI 10.1007/s10103-013-1276-7; Zeng CG, 2014, CRYOBIOLOGY, V69, P119, DOI 10.1016/j.cryobiol.2014.06.003	34	30	32	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0121487	10.1371/journal.pone.0121487	http://dx.doi.org/10.1371/journal.pone.0121487			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781016	gold, Green Published, Green Submitted			2022-12-27	WOS:000351284600207
J	Jayaratne, YSN; Zwahlen, RA				Jayaratne, Yasas Shri Nalaka; Zwahlen, Roger Arthur			The Evolution of Dental Journals from 2003 to 2012: A Bibliometric Analysis	PLOS ONE			English	Article							IMPACT-FACTOR GAME; RADIOLOGY; TRENDS	Bibliometrics are a set of methods, which can be used to analyze academic literature quantitatively and its changes over time. The objectives of this study were 1) to evaluate trends related to academic performance of dental journals from 2003 to 2012 using bibliometric indices, and 2) monitor the changes of the five dental journals with the highest and lowest impact factor (IF) published in 2003. Data for the subject category "Dentistry, Oral Surgery & Medicine" was retrieved from the Journal Citation Reports (JCR) published from 2003 to 2012. Linear regressions analysis was used to determine statistical trends over the years with each bibliometric indicator as the dependent variable and the JCR year as the predictor variable. Statistically significant rise in the total number of dental journals, the number of all articles with the steepest rise observed for research articles, the number of citations and the aggregate IF was observed from 2003 to 2012. The analysis of the five top and five bottom-tire dental journals revealed a rise in IF however, with a wide variation in relation to the magnitude of this rise. Although the IF of the top five journals remained relatively constant, the percentile ranks of the four lowest ranking journals in 2003 increased significantly with the sharpest rise being noted for the British Journal of Oral & Maxillofacial Surgery. This study revealed significant growth of dental literature in absolute terms, as well as upward trends for most of the citation-based bibliometric indices from 2003 to 2012.	[Jayaratne, Yasas Shri Nalaka] Univ Connecticut, Sch Dent Med, Dept Craniofacial Sci, Div Orthodont, Farmington, CT 06030 USA; [Jayaratne, Yasas Shri Nalaka; Zwahlen, Roger Arthur] Univ Hong Kong, Fac Dent, Discipline Oral & Maxillofacial Surg, Pokfulam, Hong Kong, Peoples R China	University of Connecticut; University of Hong Kong	Zwahlen, RA (corresponding author), Univ Hong Kong, Fac Dent, Discipline Oral & Maxillofacial Surg, Pokfulam, Hong Kong, Peoples R China.	zwahlen@hku.hk		Jayaratne, Yasas/0000-0002-4813-648X				[Anonymous], 2006, PLOS MED, V3, P707, DOI 10.1371/journal.pmed.0030291; Brody T, 2006, J AM SOC INF SCI TEC, V57, P1060, DOI 10.1002/asi.20373; Coronado RA, 2011, PHYS THER, V91, P642, DOI 10.2522/ptj.20100267; De Bellis N., 2009, BIBLIOMETRICS CITATI; Falagas ME, 2008, ARCH IMMUNOL THER EX, V56, P223, DOI 10.1007/s00005-008-0024-5; Garfield E., 1994, CURRENT CONTENTS, V20; Goldreich O., 2003, CURRENT ROLE J; Jackson A, 2010, BRIT J RADIOL, V83, P93, DOI 10.1259/bjr/18689409; Kurmis AP, 2006, ACAD RADIOL, V13, P77, DOI 10.1016/j.acra.2005.08.016; Lee CH, 2011, ACAD EMERG MED, V18, P898, DOI 10.1111/j.1553-2712.2011.01137.x; Lim KJ, 2012, RADIOLOGY, V264, P796, DOI 10.1148/radiol.12111976; Lopez-Abente G, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-24; Loria A, 2000, Matern Child Health J, V4, P59, DOI 10.1023/A:1009535003338; Olk P, 2004, ORGAN SCI, V15, P120, DOI 10.1287/orsc.1030.0055; Ring M E, 1986, Compend Contin Educ Dent, V7, P648; Rogers LF, 2002, AM J ROENTGENOL, V178, P541, DOI 10.2214/ajr.178.3.1780541; Saha S, 2003, J MED LIBR ASSOC, V91, P42; Seglen PO, 1997, BRIT MED J, V314, P498; de Araujo CGS, 2012, J APPL PHYSIOL, V112, P1434, DOI 10.1152/japplphysiol.01491.2011; Thompson Reuters, 2012, SCOP NOT; Thompson Reuters, 2008, US BIBL GUID EV RES; Thomson Reuters, 2012, J CITATION REPORTS; Tse H, 2008, NATURE, V454, P938, DOI 10.1038/454938c; Wilbur KC, 2009, MARKET SCI, V28, P293, DOI 10.1287/mksc.1080.0397	24	45	47	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119503	10.1371/journal.pone.0119503	http://dx.doi.org/10.1371/journal.pone.0119503			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781486	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600070
J	Kittaka, H; Yagi, Y; Zushi, R; Hazui, H; Akimoto, H				Kittaka, Hirotada; Yagi, Yoshiki; Zushi, Ryosuke; Hazui, Hiroshi; Akimoto, Hiroshi			The Investigation of Posttraumatic Pseudoaneurysms in Patients Treated with Nonoperative Management for Blunt Abdominal Solid Organ Injuries	PLOS ONE			English	Article							SPLENIC INJURY; FOLLOW-UP; ARTERY PSEUDOANEURYSM; ANGIOGRAPHIC EMBOLIZATION; EASTERN ASSOCIATION; TRAUMATIC INJURIES; HEPATIC-INJURY; LIVER-INJURY; CHILDREN; COMPLICATIONS	Background Posttraumatic pseudoaneurysms (PAs) have been recognized as the cause of delayed hemorrhage complicated with nonoperative management (NOM), although the need for intervention in patients with small-sized PAs and the relationship between the occurrence of PAs and bed-rest has been also unclear. Objectives The purpose of this study was to investigate the clinical history of small-sized PAs (less than 10 mm in diameter) which occurred in abdominal solid organs, and to analyze the relationship between the occurrence of PAs and early mobilization from bed. Methods Sixty-two patients who were successfully managed with NOM were investigated. Mobilization within three days post-injury was defined as "early mobilization" and bed-rest lasting over three days was defined as "late mobilization." A comparison of the clinical factors, including the duration of bed-rest between patients with and without PAs detected by followup CT was performed. Furthermore, a multiple logistic regression model analysis on the occurrence of PAs was performed. Results PAs were detected in 7 of the 62 patients. The One patient with PAs measuring larger than 10 mm received trans-arterial embolization, and the remaining six patients with PAs smaller than 10 mm were managed conservatively. Consequently, no delayed hemorrhage occurred, and the PAs spontaneously disappeared in all of the six patients managed without intervention. The multiple regression model analysis revealed that early mobilization was not a significant factor predicting new-onset PAs. Conclusions Small PAs can be expected to disappear spontaneously. Moreover, early mobilization is not a significant risk factor for the occurrence of PAs.	[Kittaka, Hirotada; Yagi, Yoshiki; Zushi, Ryosuke; Hazui, Hiroshi; Akimoto, Hiroshi] Osaka Misihima Emergency Crit Care Ctr, Dept Emergency, Takatsuki, Osaka, Japan		Kittaka, H (corresponding author), Osaka Misihima Emergency Crit Care Ctr, Dept Emergency, 11-1 Minami Akutagawa Cho, Takatsuki, Osaka, Japan.	kittaka142@osaka-mishima.jp						Archer LP, 1996, ARCH SURG-CHICAGO, V131, P309; Bhullar IS, 2012, J TRAUMA ACUTE CARE, V72, P1127, DOI 10.1097/TA.0b013e3182569849; Cho YP, 2003, J TRAUMA, V54, P1006, DOI 10.1097/01.TA.0000061493.80633.EC; Cocanour CS, 2000, J TRAUMA, V48, P606, DOI 10.1097/00005373-200004000-00005; Cox JC, 2005, J TRAUMA, V59, P1175, DOI 10.1097/01.ta.0000189003.01375.71; Crawford RS, 2007, SURGERY, V142, P337, DOI 10.1016/j.surg.2007.05.003; CROCE MA, 1994, AM J SURG, V168, P235, DOI 10.1016/S0002-9610(05)80193-X; Davis KA, 1998, J TRAUMA, V44, P1008, DOI 10.1097/00005373-199806000-00013; Dobremez E, 2006, EUR J PEDIATR SURG, V16, P166, DOI 10.1055/s-2006-924197; Francisco LE, 2010, WORLD J HEPATOL, V2, P87, DOI 10.4254/wjh.v2.i2.87; Farrell TM, 1996, J TRAUMA, V41, P1067, DOI 10.1097/00005373-199612000-00025; Frumiento C, 2000, J PEDIATR SURG, V35, P788, DOI 10.1053/jpsu.2000.6082; Galvan DA, 2006, CURR OPIN CRIT CARE, V12, P590, DOI 10.1097/MCC.0b013e328010d4ad; Goffette PP, 2002, EUR RADIOL, V12, P994, DOI 10.1007/s00330-002-1396-0; Gow KW, 1996, J PEDIATR SURG, V31, P812, DOI 10.1016/S0022-3468(96)90140-2; Haan JM, 2007, AM SURGEON, V73, P13; Hardcastle TC, 2010, J PEDIATR SURG, V45, pE1, DOI 10.1016/j.jpedsurg.2010.02.119; HUSMANN DA, 1990, J UROLOGY, V143, P682, DOI 10.1016/S0022-5347(17)40057-7; Kennedy JA, 1999, INJURY, V30, P535, DOI 10.1016/S0020-1383(99)00144-8; Kozar RA, 2005, J TRAUMA, V59, P1066, DOI 10.1097/01.ta.0000188937.75879.ab; London JA, 2008, ARCH SURG-CHICAGO, V143, P972, DOI 10.1001/archsurg.143.10.972; Madhusudhan KS, 2009, J POSTGRAD MED, V55, P124, DOI 10.4103/0022-3859.52844; Martin K, 2011, J PEDIATR SURG, V46, P933, DOI 10.1016/j.jpedsurg.2011.02.031; Mayglothling JA, 2011, J EMERG MED, V41, P21, DOI 10.1016/j.jemermed.2008.10.012; McCray VW, 2008, J TRAUMA, V65, P1354, DOI 10.1097/TA.0b013e31818e8fde; Minarik L, 2002, PEDIATR SURG INT, V18, P429, DOI 10.1007/s00383-002-0820-5; Moreno RD, 2007, J TRAUMA, V62, P1048, DOI 10.1097/01.ta.0000235295.02414.d7; Muroya T, 2013, J TRAUMA ACUTE CARE, V75, P417, DOI 10.1097/TA.0b013e31829fda77; Safavi A, 2011, J PEDIATR SURG, V46, P938, DOI 10.1016/j.jpedsurg.2011.02.035; Sartorelli KH, 2000, J TRAUMA, V49, P56, DOI 10.1097/00005373-200007000-00008; Sasaki H, 2009, EMERG MED J, V26, P223, DOI 10.1136/emj.2008.064766; Savage SA, 2008, J TRAUMA, V64, P1085, DOI 10.1097/TA.0b013e31816920f1; SCHURR MJ, 1995, J TRAUMA, V39, P507; Sidhu MK, 1999, PEDIATR RADIOL, V29, P46, DOI 10.1007/s002470050532; Skattum J, 2013, J TRAUMA ACUTE CARE, V74, P100, DOI 10.1097/TA.0b013e31827890b2; Stassen NA, 2012, J TRAUMA ACUTE CARE, V73, pS294, DOI 10.1097/TA.0b013e3182702afc; Stassen NA, 2012, J TRAUMA ACUTE CARE, V73, pS288, DOI 10.1097/TA.0b013e318270160d; Stylianos S, 2000, J PEDIATR SURG, V35, P164, DOI 10.1016/S0022-3468(00)90003-4; SUGG SL, 1995, J TRAUMA, V39, P593; Velmahos GC, 2003, ARCH SURG-CHICAGO, V138, P844, DOI 10.1001/archsurg.138.8.844; Von Rueden K T, 1995, AACN Clin Issues, V6, P212, DOI 10.1097/00044067-199505000-00005; Wahl WL, 2005, SURGERY, V138, P742, DOI 10.1016/j.surg.2005.07.021; Watson GA, 2006, J TRAUMA, V61, P1113, DOI 10.1097/01.ta.0000241363.97619.d6; Weinberg JA, 2007, J TRAUMA, V62, P1143, DOI 10.1097/TA.0b013e318047b7c2; Yardeni D, 2004, J TRAUMA, V57, P404, DOI 10.1097/01.TA.0000044633.53328.F0	45	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0121078	10.1371/journal.pone.0121078	http://dx.doi.org/10.1371/journal.pone.0121078			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781957	Green Submitted, Green Published, gold			2022-12-27	WOS:000351284600194
J	Sakurai-Yageta, M; Maruyama, T; Suzuki, T; Ichikawa, K; Murakami, Y				Sakurai-Yageta, Mika; Maruyama, Tomoko; Suzuki, Takashi; Ichikawa, Kazuhisa; Murakami, Yoshinori			Dynamic Regulation of a Cell Adhesion Protein Complex Including CADM1 by Combinatorial Analysis of FRAP with Exponential Curve-Fitting	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; LUNG-CANCER; E-CADHERIN; FLUORESCENCE RECOVERY; ADHERENS JUNCTIONS; EPITHELIAL-CELLS; TSLC1; MEMBRANE; ASSOCIATION; DIFFUSION	Protein components of cell adhesion machinery show continuous renewal even in the static state of epithelial cells and participate in the formation and maintenance of normal epithelial architecture and tumor suppression. CADM1 is a tumor suppressor belonging to the immunoglobulin superfamily of cell adhesion molecule and forms a cell adhesion complex with an actin-binding protein, 4.1B, and a scaffold protein, MPP3, in the cytoplasm. Here, we investigate dynamic regulation of the CADM1-4.1B-MPP3 complex in mature cell adhesion by fluorescence recovery after photobleaching (FRAP) analysis. Traditional FRAP analysis were performed for relatively short period of around 10min. Here, thanks to recent advances in the sensitive laser detector systems, we examine FRAP of CADM1 complex for longer period of 60 min and analyze the recovery with exponential curve-fitting to distinguish the fractions with different diffusion constants. This approach reveals that the fluorescence recovery of CADM1 is fitted to a single exponential function with a time constant (tau) of approximately 16 min, whereas 4.1B and MPP3 are fitted to a double exponential function with two tau s of approximately 40-60 sec and 16 min. The longer t is similar to that of CADM1, suggesting that 4.1B and MPP3 have two distinct fractions, one forming a complex with CADM1 and the other present as a free pool. Fluorescence loss in photobleaching analysis supports the presence of a free pool of these proteins near the plasma membrane. Furthermore, double exponential fitting makes it possible to estimate the ratio of 4.1B and MPP3 present as a free pool and as a complex with CADM1 as approximately 3: 2 and 3: 1, respectively. Our analyses reveal a central role of CADM1 in stabilizing the complex with 4.1B and MPP3 and provide insight in the dynamics of adhesion complex formation.	[Sakurai-Yageta, Mika; Maruyama, Tomoko; Murakami, Yoshinori] Univ Tokyo, Inst Med Sci, Div Mol Pathol, Minato Ku, Tokyo 1088639, Japan; [Ichikawa, Kazuhisa] Univ Tokyo, Inst Med Sci, Div Math Oncol, Minato Ku, Tokyo 1088639, Japan; [Suzuki, Takashi; Ichikawa, Kazuhisa; Murakami, Yoshinori] CREST, Japan Sci & Technol Agcy, Chiyoda Ku, Tokyo 1028666, Japan; [Suzuki, Takashi] Osaka Univ, Grad Sch Engn Sci, Div Math Sci, Toyonaka, Osaka 5608531, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Osaka University	Murakami, Y (corresponding author), Univ Tokyo, Inst Med Sci, Div Mol Pathol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	ymurakam@ims.u-tokyo.ac.jp	Sakurai-Yageta, Mika/U-1842-2019	Sakurai-Yageta, Mika/0000-0001-5606-3324	Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science, and Technology, Japan [25290051, 24790310]; Ministry of Health, Labor, and Welfare, Japan [22090601, 23120701]; Grants-in-Aid for Scientific Research [24790310, 22117008] Funding Source: KAKEN	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	A CREST project from Japan Science and Technology Agency [M. S. -Y., T. S., K. I., Y. M.]; a Grant-in-Aid for Scientific Research (B) [25290051 for Y. M.] and a Grant-in-Aid for Young Scientists (B) [24790310 for M. S. -Y.] from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; a Grant-in-Aid for the Third Term Comprehensive Control Research for Cancer from the Ministry of Health, Labor, and Welfare, Japan [22090601 and 23120701 for Y. M.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Cavey M, 2008, NATURE, V453, P751, DOI 10.1038/nature06953; de Beco S, 2009, P NATL ACAD SCI USA, V106, P7010, DOI 10.1073/pnas.0811253106; Feder TJ, 1996, BIOPHYS J, V70, P2767, DOI 10.1016/S0006-3495(96)79846-6; Fogel AI, 2011, EMBO J, V30, P4728, DOI 10.1038/emboj.2011.336; Fukuhara H, 2003, ONCOGENE, V22, P6160, DOI 10.1038/sj.onc.1206744; Giangreco A, 2009, DEVELOPMENT, V136, P3505, DOI 10.1242/dev.038232; Hanada T, 2003, J BIOL CHEM, V278, P34445, DOI 10.1074/jbc.M305209200; Hong S, 2010, P NATL ACAD SCI USA, V107, P3528, DOI 10.1073/pnas.0911027107; Hoover KB, 2000, CURR OPIN CELL BIOL, V12, P229, DOI 10.1016/S0955-0674(99)00080-0; Hoshino D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002479; Huang J, 2011, J CELL SCI, V124, P4001, DOI 10.1242/jcs.086694; Kang M, 2008, BIOPHYS J, V95, pL13, DOI 10.1529/biophysj.108.135913; Kuramochi M, 2001, NAT GENET, V27, P427, DOI 10.1038/86934; Mao XL, 2003, CANCER RES, V63, P7979; Masuda M, 2005, J BIOL CHEM, V280, P42164, DOI 10.1074/jbc.M507136200; Masuda M, 2002, J BIOL CHEM, V277, P31014, DOI 10.1074/jbc.M203620200; Mauceri D, 2007, J NEUROCHEM, V100, P1032, DOI 10.1111/j.1471-4159.2006.04267.x; Murakami S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082894; Murakami Y, 2005, CANCER SCI, V96, P543, DOI 10.1111/j.1349-7006.2005.00089.x; Noda K, 2010, MOL BIOL CELL, V21, P584, DOI 10.1091/mbc.E09-07-0580; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Raleigh DR, 2010, MOL BIOL CELL, V21, P1200, DOI 10.1091/mbc.E09-08-0734; Sakurai-Yageta M, 2009, BIOCHEM BIOPH RES CO, V390, P977, DOI 10.1016/j.bbrc.2009.10.088; Shen L, 2008, J CELL BIOL, V181, P683, DOI 10.1083/jcb.200711165; Shewan AM, 2005, MOL BIOL CELL, V16, P4531, DOI 10.1091/mbc.E05-04-0330; Shingai T, 2003, J BIOL CHEM, V278, P35421, DOI 10.1074/jbc.M305387200; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; Takahashi Y, 2012, BREAST CANCER-TOKYO, V19, P242, DOI 10.1007/s12282-011-0272-7; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tran YK, 1999, CANCER RES, V59, P35; Yageta M, 2002, CANCER RES, V62, P5129; Yamada D, 2006, INT J CANCER, V118, P916, DOI 10.1002/ijc.21450; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; YGUERABIDE J, 1982, BIOPHYS J, V40, P69, DOI 10.1016/S0006-3495(82)84459-7; Zhang SB, 2003, J BIOL CHEM, V278, P4048, DOI 10.1074/jbc.M209960200	36	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0116637	10.1371/journal.pone.0116637	http://dx.doi.org/10.1371/journal.pone.0116637			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25780926	gold, Green Published, Green Submitted			2022-12-27	WOS:000351284600006
J	Ud-Din, AI; Liu, YC; Roujeinikova, A				Ud-Din, Abu I.; Liu, Yu C.; Roujeinikova, Anna			Crystal Structure of Helicobacter pylori Pseudaminic Acid Biosynthesis N-Acetyltransferase PseH: Implications for Substrate Specificity and Catalysis	PLOS ONE			English	Article							PROVIDES RESISTANCE; GNAT SUPERFAMILY; MECHANISM; ACETYLGLUCOSAMINE; PHENIX	Helicobacter pylori infection is the common cause of gastroduodenal diseases linked to a higher risk of the development of gastric cancer. Persistent infection requires functional flagella that are heavily glycosylated with 5,7-diacetamido-3,5,7,9-tetradeoxy-L-glycero-L-manno-nonulosonic acid (pseudaminic acid). Pseudaminic acid biosynthesis protein H (PseH) catalyzes the third step in its biosynthetic pathway, producing UDP-2,4-diacetamido-2,4,6-trideoxy-beta-L-altropyranose. It belongs to the GCN5-related N-acetyltransferase (GNAT) superfamily. The crystal structure of the PseH complex with cofactor acetyl-CoA has been determined at 2.3 angstrom resolution. This is the first crystal structure of the GNAT superfamily member with specificity to UDP-4-amino-4,6-dideoxy-beta-L-AltNAc. PseH is a homodimer in the crystal, each subunit of which has a central twisted beta-sheet flanked by five alpha-helices and is structurally homologous to those of other GNAT superfamily enzymes. Interestingly, PseH is more similar to the GNAT enzymes that utilize amino acid sulfamoyl adenosine or protein as a substrate than a different GNAT-superfamily bacterial nucleotide-sugar N-acetyltransferase of the known structure, WecD. Analysis of the complex of PseH with acetyl-CoA revealed the location of the cofactor-binding site between the splayed strands beta 4 and beta 5. The structure of PseH, together with the conservation of the active-site general acid among GNAT superfamily transferases, are consistent with a common catalytic mechanism for this enzyme that involves direct acetyl transfer from AcCoA without an acetylated enzyme intermediate. Based on structural homology with microcin C7 acetyltransferase MccE and WecD, the Michaelis complex can be modeled. The model suggests that the nucleotide-and 4-amino-4,6-dideoxy-beta-L-AltNAc-binding pockets form extensive interactions with the substrate and are thus the most significant determinants of substrate specificity. A hydrophobic pocket accommodating the 6'-methyl group of the altrose dictates preference to the methyl over the hydroxyl group and thus to contributes to substrate specificity of PseH.	[Ud-Din, Abu I.; Liu, Yu C.; Roujeinikova, Anna] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia; [Roujeinikova, Anna] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia	Monash University; Monash University	Roujeinikova, A (corresponding author), Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia.	anna.roujeinikova@monash.edu		Roujeinikova, Anna/0000-0001-8478-4751	Australian Research Council [DP1094619]	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council Fellowship to AR (DP1094619). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agarwal V, 2011, J BIOL CHEM, V286, P21295, DOI 10.1074/jbc.M111.226282; [Anonymous], 2011, J DIGEST DIS, V12, P319, DOI 10.1111/j.1751-2980.2011.00529.x; [Anonymous], PYMOL MOL GRAPH SYST; Baldwin DN, 2007, INFECT IMMUN, V75, P1005, DOI 10.1128/IAI.01176-06; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bauer B., 2011, ULCERS, V2011, DOI [DOI 10.1155/2011/340157, 10.1155/2011/340157]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Guerry P, 2006, MOL MICROBIOL, V60, P299, DOI 10.1111/j.1365-2958.2006.05100.x; Hegde SS, 2007, BIOCHEMISTRY-US, V46, P7187, DOI 10.1021/bi700256z; Hung MN, 2006, J BACTERIOL, V188, P5606, DOI 10.1128/JB.00306-06; International Agency for Research on Cancer, 1994, IARC MON EV CARC RIS, V61, P177; Ishiyama N, 2006, J BIOL CHEM, V281, P24489, DOI 10.1074/jbc.M602393200; Josenhans C, 2002, FEMS MICROBIOL LETT, V210, P165, DOI 10.1016/S0378-1097(02)00638-9; Kazakov T, 2014, J BACTERIOL, V196, P3377, DOI 10.1128/JB.01584-14; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Liu YC, 2014, ACTA CRYSTALLOGR F, V70, P1276, DOI 10.1107/S2053230X14015398; Majorek KA, 2013, J BIOL CHEM, V288, P30223, DOI 10.1074/jbc.M113.501353; Mio T, 1999, J BIOL CHEM, V274, P424, DOI 10.1074/jbc.274.1.424; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Novikova M, 2010, J BIOL CHEM, V285, P12662, DOI 10.1074/jbc.M109.080192; Olivier NB, 2008, J BIOL CHEM, V283, P27937, DOI 10.1074/jbc.M801207200; Ottemann KM, 2002, INFECT IMMUN, V70, P1984, DOI 10.1128/IAI.70.4.1984-1990.2002; Peneff C, 2001, J BIOL CHEM, V276, P16328, DOI 10.1074/jbc.M009988200; Scheibner KA, 2002, J BIOL CHEM, V277, P18118, DOI 10.1074/jbc.M200595200; Schirm M, 2003, MOL MICROBIOL, V48, P1579, DOI 10.1046/j.1365-2958.2003.03527.x; Schoenhofen IC, 2006, GLYCOBIOLOGY, V16, p8C, DOI 10.1093/glycob/cwl010; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Vetting MW, 2005, J BIOL CHEM, V280, P22108, DOI 10.1074/jbc.M502401200; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yoshiyama H, 2000, MICROBES INFECT, V2, P55, DOI 10.1016/S1286-4579(00)00285-9	37	14	14	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0115634	10.1371/journal.pone.0115634	http://dx.doi.org/10.1371/journal.pone.0115634			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781966	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600004
J	Yang, L; Shi, TY; Liu, F; Ren, CX; Wang, ZL; Li, YY; Tu, XY; Yang, G; Cheng, X				Yang, Li; Shi, Tingyan; Liu, Fei; Ren, Chunxia; Wang, Ziliang; Li, Yingyi; Tu, Xiaoyu; Yang, Gong; Cheng, Xi			REV3L, a Promising Target in Regulating the Chemosensitivity of Cervical Cancer Cells	PLOS ONE			English	Article							DNA-POLYMERASE-ZETA; MAINTAINING GENOME STABILITY; CATALYTIC SUBUNIT; TRANSLESION SYNTHESIS; POL-ZETA; OVARIAN TUMORIGENESIS; CISPLATIN RESISTANCE; EMBRYONIC LETHALITY; CARCINOMA CELLS; MISMATCH REPAIR	REV3L, the catalytic subunit of DNA Polymerase zeta (Pol zeta), plays a significant role in the DNA damage tolerance mechanism of translesion synthesis (TLS). The role of REV3L in chemosensitivity of cervical cancer needs exploration. In the present study, we evaluated the expression of the Pol zeta protein in paraffin-embedded tissues using immunohistochemistry and found that the expression of Pol zeta in cervical cancer tissues was higher than that in normal tissues. We then established some cervical cancer cell lines with REV3L suppression or overexpression. Depletion of REV3L suppresses cell proliferation and colony formation of cervical cancer cells through G1 arrest, and REV3L promotes cell proliferation and colony formation of cervical cancer cells by promoting G(1) phase to S phase transition. The suppression of REV3L expression enhanced the sensitivity of cervical cancer cells to cisplatin, and the overexpression of REV3L conferred resistance to cisplatin as evidenced by the alteration of apoptosis rates, and significantly expression level changes of anti-apoptotic proteins B-cell lymphoma 2 (Bcl-2), myeloid cell leukemia sequence 1 (Mcl-1) and B-cell lymphoma-extra large (Bcl-xl) and proapoptotic Bcl-2-associated x protein (Bax). Our data suggest that REV3L plays an important role in regulating cervical cancer cellular response to cisplatin, and thus targeting REV3L may be a promising way to alter chemosensitivity in cervical cancer patients.	[Yang, Li; Liu, Fei; Cheng, Xi] Fudan Univ, Shanghai Canc Ctr, Dept Gynecol Oncol, Shanghai 200433, Peoples R China; [Yang, Li] Zhejiang Canc Hosp, Dept Gynecol Oncol, Hangzhou, Zhejiang, Peoples R China; [Shi, Tingyan; Liu, Fei; Ren, Chunxia; Wang, Ziliang; Li, Yingyi; Tu, Xiaoyu; Yang, Gong] Fudan Univ, Shanghai Canc Ctr, Inst Canc, Shanghai 200433, Peoples R China; [Shi, Tingyan] Fudan Univ, Zhongshan Hosp, Dept Obstet & Gynecol, Shanghai 200433, Peoples R China; [Liu, Fei; Ren, Chunxia; Wang, Ziliang; Li, Yingyi; Tu, Xiaoyu; Yang, Gong; Cheng, Xi] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Ren, Chunxia] Peoples Hosp Wuxi, Dept Gynecol & Obstet, Wuxi, Jiangsu, Peoples R China; [Tu, Xiaoyu] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200433, Peoples R China	Fudan University; Zhejiang Cancer Hospital; Fudan University; Fudan University; Fudan University; Fudan University	Yang, G (corresponding author), Fudan Univ, Shanghai Canc Ctr, Inst Canc, Shanghai 200433, Peoples R China.	yanggong@fudan.edu.cn; cheng_xi1@hotmail.com	Wang, Zhiquan/HHS-6768-2022	Shi, Tingyan/0000-0002-5356-0365	National Natural Science Foundation of China [81202050]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Support was provided by the National Natural Science Foundation of China (grant no. 81202050; http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertella MR, 2005, DNA REPAIR, V4, P583, DOI 10.1016/j.dnarep.2005.01.005; Bemark M, 2000, CURR BIOL, V10, P1213, DOI 10.1016/S0960-9822(00)00724-7; Bhat A, 2013, NUCLEIC ACIDS RES, V41, P2328, DOI 10.1093/nar/gks1442; Brondello JM, 2008, ONCOGENE, V27, P6093, DOI 10.1038/onc.2008.212; Burger H, 2011, DRUG RESIST UPDATE, V14, P22, DOI 10.1016/j.drup.2010.12.002; Cheng X, 2011, GYNECOL ONCOL, V121, P323, DOI 10.1016/j.ygyno.2010.12.360; Doles J, 2010, P NATL ACAD SCI USA, V107, P20786, DOI 10.1073/pnas.1011409107; Ferlay J, 2012, GLOBOCAN 2012 V1 0 C, V11, DOI [10.1097/QAI.0000000000000279, DOI 10.1097/QAI.0000000000000279]; Gibbs PEM, 1998, P NATL ACAD SCI USA, V95, P6876, DOI 10.1073/pnas.95.12.6876; Gueranger Q, 2008, DNA REPAIR, V7, P1551, DOI 10.1016/j.dnarep.2008.05.012; Hara K, 2010, J BIOL CHEM, V285, P12299, DOI 10.1074/jbc.M109.092403; Hicks JK, 2010, MOL CELL BIOL, V30, P1217, DOI 10.1128/MCB.00993-09; Ho V, 2010, ENVIRON MOL MUTAGEN, V51, P552, DOI 10.1002/em.20573; Jansen JG, 2009, DNA REPAIR, V8, P1444, DOI 10.1016/j.dnarep.2009.09.006; Kawamura K, 2001, INT J ONCOL, V18, P97; Kikuchi S, 2012, J BIOL CHEM, V287, P33847, DOI 10.1074/jbc.M112.396838; Knobel PA, 2011, NEOPLASIA, V13, P961, DOI 10.1593/neo.11828; Lange SS, 2013, P NATL ACAD SCI USA, V110, pE687, DOI 10.1073/pnas.1217425110; Lange SS, 2011, NAT REV CANCER, V11, P96, DOI 10.1038/nrc2998; Lehmann AR, 2007, DNA REPAIR, V6, P891, DOI 10.1016/j.dnarep.2007.02.003; Li ZQ, 2002, MUTAT RES-FUND MOL M, V510, P71, DOI 10.1016/S0027-5107(02)00253-1; Lin XJ, 2006, MOL CANCER THER, V5, P1239, DOI 10.1158/1535-7163.MCT-05-0491; Lin XJ, 2006, CLIN CANCER RES, V12, P563, DOI 10.1158/1078-0432.CCR-05-1380; McCulloch SD, 2008, CELL RES, V18, P148, DOI 10.1038/cr.2008.4; Murakumo Y, 2000, J BIOL CHEM, V275, P4391, DOI 10.1074/jbc.275.6.4391; Murakumo Y, 2001, J BIOL CHEM, V276, P35644, DOI 10.1074/jbc.M102051200; Nelson JR, 1996, SCIENCE, V272, P1646, DOI 10.1126/science.272.5268.1646; Nojima K, 2005, CANCER RES, V65, P11704, DOI 10.1158/0008-5472.CAN-05-1214; Okada T, 2005, MOL CELL BIOL, V25, P6103, DOI 10.1128/MCB.25.14.6103-6111.2005; Okuda T, 2005, MOL PHARMACOL, V67, P1852, DOI 10.1124/mol.104.010579; Pan QR, 2005, CANCER LETT, V217, P139, DOI 10.1016/j.canlet.2004.07.021; Schenten D, 2009, J EXP MED, V206, P477, DOI 10.1084/jem.20080669; Shachar S, 2009, EMBO J, V28, P383, DOI 10.1038/emboj.2008.281; Sharma S, 2012, MOL PHARMACOL, V81, P778, DOI 10.1124/mol.111.076828; Sharma S, 2012, NUCLEIC ACIDS RES, V40, P682, DOI 10.1093/nar/gkr769; Shi TY, 2013, MED ONCOL, V30, DOI [10.1007/s12032-013-0500-4, 10.1007/s12032-013-0697-2]; Shi TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050461; Sonoda E, 2003, EMBO J, V22, P3188, DOI 10.1093/emboj/cdg308; Varadi V, 2011, BREAST CANCER RES TR, V129, P235, DOI 10.1007/s10549-011-1460-z; Wang HB, 2009, NEURO-ONCOLOGY, V11, P790, DOI 10.1215/15228517-2009-015; Wang YM, 2012, CANCER RES, V72, P4037, DOI 10.1158/0008-5472.CAN-12-0103; Wittschieben J, 2000, CURR BIOL, V10, P1217, DOI 10.1016/S0960-9822(00)00725-9; Wittschieben JP, 2010, CANCER RES, V70, P2770, DOI 10.1158/0008-5472.CAN-09-4267; Wittschieben JP, 2006, CANCER RES, V66, P134, DOI 10.1158/0008-5472.CAN-05-2982; Wu F, 2004, CANCER RES, V64, P8029, DOI 10.1158/0008-5472.CAN-03-3942; Xie K, 2010, P NATL ACAD SCI USA, V107, P20792, DOI 10.1073/pnas.1011412107; Yang G, 2006, P NATL ACAD SCI USA, V103, P16472, DOI 10.1073/pnas.0605752103; Yang G, 2010, CLIN CANCER RES, V16, P3875, DOI 10.1158/1078-0432.CCR-10-0483; Yang G, 2010, CLIN CANCER RES, V16, P3171, DOI 10.1158/1078-0432.CCR-09-3171; Zhang S, 2013, ONCOGENE, V32, P242, DOI 10.1038/onc.2012.32	50	33	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120334	10.1371/journal.pone.0120334	http://dx.doi.org/10.1371/journal.pone.0120334			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781640	Green Submitted, gold, Green Published			2022-12-27	WOS:000351284600151
J	Bester, M; Forkert, ND; Stellmann, JP; Aly, L; Drabik, A; Young, KL; Heesen, C; Fiehler, J; Siemonsen, S				Bester, Maxim; Forkert, Nils Daniel; Stellmann, Jan Patrick; Aly, Lilian; Drabik, Anna; Young, Kim Lea; Heesen, Christoph; Fiehler, Jens; Siemonsen, Susanne			Increased Perfusion in Normal Appearing White Matter in High Inflammatory Multiple Sclerosis Patients	PLOS ONE			English	Article							CLINICALLY ISOLATED SYNDROME; HEMODYNAMIC IMPAIRMENT; CEREBRAL PERFUSION; BRAIN; QUANTIFICATION; ABNORMALITIES; ANGIOGENESIS; PERMEABILITY; COMPONENT; ACCURATE	Purpose Although cerebral perfusion alterations have long been acknowledged in multiple sclerosis (MS), the relationship between measurable perfusion changes and the status of highly active MS has not been examined. We hypothesized that alteration of perfusion can be detected in normal appearing white matter and is increased in high inflammatory patients. Materials and Methods Thirty-three patients with relapsing-remitting MS underwent four monthly 3T MRI scans including dynamic susceptibility contrast perfusion-weighted MRI. Cerebral blood flow (CBF) and cerebral blood volume (CBV) were measured in normal appearing white matter. Patients were stratified in a high- and low-inflammatory group according to the number of new contrast enhancing lesions. Results Thirteen patients were classified as high-inflammatory. Compared to low-inflammatory patients, the high-inflammatory group demonstrated significantly higher CBV (p = 0.001) and CBF (p = 0.014) values. A mixed model analysis to assess independent variables associated with CBV and CBF revealed that white matter lesion load and atrophy measurements had no significant influence on CBF and CBV. Conclusion This work provides evidence that high inflammatory lesion load is associated with increased CBV and CBF, underlining the role of global modified microcirculation prior to leakage of the blood-brain barrier in the pathophysiology of MS. Perfusion changes might therefore be sensitive to active inflammation apart from lesion development without local blood-brain barrier breakdown, and could be utilized to further assess the metabolic aspect of current inflammation.	[Bester, Maxim; Forkert, Nils Daniel; Fiehler, Jens; Siemonsen, Susanne] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany; [Forkert, Nils Daniel] Univ Calgary, Dept Radiol, Calgary, AB, Canada; [Forkert, Nils Daniel] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Stellmann, Jan Patrick; Young, Kim Lea; Heesen, Christoph] Univ Med Ctr Hamburg Eppendorf, Inst Neuroimmunol & Clin MS Res, Dept Neurol, Hamburg, Germany; [Aly, Lilian] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, D-80290 Munich, Germany; [Drabik, Anna] Univ Med Ctr Hamburg Eppendorf, Dept Med Biometry & Epidemiol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Calgary; University of Calgary; University of Hamburg; University Medical Center Hamburg-Eppendorf; Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf	Bester, M (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany.	mbester@uke.de	Stellmann, Jan-Patrick/ABA-7132-2020; Forkert, Nils Daniel/K-6273-2012	Stellmann, Jan-Patrick/0000-0003-2565-2833; Forkert, Nils Daniel/0000-0003-2556-3224; Sturner, Klarissa Hanja/0000-0003-2199-3315; Aly, Lilian/0000-0002-7051-124X; Gellissen, Susanne/0000-0002-7444-7265				ADAMS CWM, 1985, J NEUROL SCI, V69, P269, DOI 10.1016/0022-510X(85)90139-X; Adhya S, 2006, NEUROIMAGE, V33, P1029, DOI 10.1016/j.neuroimage.2006.08.008; Banati RB, 2000, BRAIN, V123, P2321, DOI 10.1093/brain/123.11.2321; Barkhof F, 1999, MULT SCLER J, V5, P283, DOI 10.1177/135245859900500415; Battaglini M, 2012, HUM BRAIN MAPP, V33, P2062, DOI 10.1002/hbm.21344; Cramer SP, 2014, NEUROIMAGE-CLIN, V4, P182, DOI 10.1016/j.nicl.2013.12.001; Filippi M, 2010, NEUROLOGY, V75, P2121, DOI 10.1212/WNL.0b013e318200d768; Forkert ND, 2014, METHOD INFORM MED, V53, P469, DOI 10.3414/ME14-01-0007; Ge YL, 2005, AM J NEURORADIOL, V26, P1539; Giovannoni G, 2014, J NEUROL, V261, P316, DOI 10.1007/s00415-013-7196-4; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Haider L, 2011, BRAIN, V134, P1914, DOI 10.1093/brain/awr128; Hartung T, 1996, DEV BIOL STAND, V86, P85; Haselhorst R, 2000, JMRI-J MAGN RESON IM, V11, P495, DOI 10.1002/(SICI)1522-2586(200005)11:5<495::AID-JMRI5>3.0.CO;2-S; Heales SJR, 1999, BBA-BIOENERGETICS, V1410, P215, DOI 10.1016/S0005-2728(98)00168-6; Holley JE, 2010, NEUROSCI LETT, V470, P65, DOI 10.1016/j.neulet.2009.12.059; Inglese M, 2008, J CEREBR BLOOD F MET, V28, P164, DOI 10.1038/sj.jcbfm.9600504; Inglese M, 2007, ARCH NEUROL-CHICAGO, V64, P196, DOI 10.1001/archneur.64.2.196; Ingrisch M, 2012, INVEST RADIOL, V47, P252, DOI 10.1097/RLI.0b013e31823bfc97; Jain RK, 2002, SEMIN ONCOL, V29, P3, DOI 10.1053/sonc.2002.37265; Juurlink BHJ, 2013, MULT SCLER INT, V2013, DOI 10.1155/2013/598093; Kalman B, 2003, NEUROMOL MED, V3, P147, DOI 10.1385/NMM:3:3:147; Khan O, 2010, ANN NEUROL, V67, P286, DOI 10.1002/ana.22001; KOSTYK SK, 1989, BRAIN RES, V504, P284, DOI 10.1016/0006-8993(89)91369-3; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lassmann H, 2003, J NEUROL SCI, V206, P187, DOI 10.1016/S0022-510X(02)00421-5; Law M, 2004, RADIOLOGY, V231, P645, DOI 10.1148/radiol.2313030996; Li XF, 2003, MAGN RESON IMAGING, V21, P1095, DOI 10.1016/S0730-725X(03)00205-4; Lucchinetti CF, 2005, NEUROL CLIN, V23, P77, DOI 10.1016/j.ncl.2004.09.002; Paling D, 2014, J CEREBR BLOOD F MET, V34, P34, DOI 10.1038/jcbfm.2013.161; Papadaki EZ, 2014, EUR J NEUROL, V21, P499, DOI 10.1111/ene.12338; Papadaki EZ, 2012, MAGN RESON MED, V68, P1932, DOI 10.1002/mrm.24194; Pathak AP, 2001, MAGNET RESON MED, V46, P735, DOI 10.1002/mrm.1252; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Putnam TJ, 1933, NEW ENGLAND J MED; Rashid W, 2004, J NEUROL NEUROSUR PS, V75, P1288, DOI 10.1136/jnnp.2003.026021; Raz E, 2010, RADIOLOGY, V254, P227, DOI 10.1148/radiol.2541090817; Roscoe WA, 2009, J NEUROIMMUNOL, V209, P6, DOI 10.1016/j.jneuroim.2009.01.009; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Soon D, 2007, MULT SCLER J, V13, P884, DOI 10.1177/1352458507076970; Varga AW, 2009, J NEUROL SCI, V282, P28, DOI 10.1016/j.jns.2008.12.036; WAKEFIELD AJ, 1994, J CLIN PATHOL, V47, P129, DOI 10.1136/jcp.47.2.129; Wuerfel J, 2004, BRAIN, V127, P111, DOI 10.1093/brain/awh007; Zeis T, 2008, BRAIN, V131, P288, DOI 10.1093/brain/awm291	44	32	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119356	10.1371/journal.pone.0119356	http://dx.doi.org/10.1371/journal.pone.0119356			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774497	Green Published, gold, Green Submitted			2022-12-27	WOS:000351183500084
J	Bixby, H; Hodgson, S; Fortunato, L; Hansell, A; Fecht, D				Bixby, Honor; Hodgson, Susan; Fortunato, Lea; Hansell, Anna; Fecht, Daniela			Associations between Green Space and Health in English Cities: An Ecological, Cross-Sectional Study	PLOS ONE			English	Article							NATURAL-ENVIRONMENT; PHYSICAL-ACTIVITY; DEPRIVATION; URBANITY	Green space has been identified as a modifiable feature of the urban environment and associations with physiological and psychological health have been reported at the local level. This study aims to assess whether these associations between health and green space are transferable to a larger scale, with English cities as the unit of analysis. We used an ecological, cross-sectional study design. We classified satellite-based land cover data to quantify green space coverage for the 50 largest cities in England. We assessed associations between city green space coverage with risk of death from all causes, cardiovascular disease, lung cancer and suicide between 2002 and 2009 using Poisson regression with random effect. After adjustment for age, income deprivation and air pollution, we found that at the city level the risk of death from all causes and a priori selected causes, for men and women, did not significantly differ between the greenest and least green cities. These findings suggest that the local health effects of urban green space observed at the neighbourhood level in some studies do not transfer to the city level. Further work is needed to establish how urban residents interact with local green space, in order to ascertain the most relevant measures of green space.	[Bixby, Honor; Hodgson, Susan; Fortunato, Lea; Hansell, Anna; Fecht, Daniela] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, MRC PHE Ctr Environm & Hlth, UK Small Area Hlth Stat Unit, London, England; [Hansell, Anna] Imperial Coll Healthcare NHS Trust, Publ Hlth & Primary Care, London, England	Imperial College London; Imperial College London	Fecht, D (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, MRC PHE Ctr Environm & Hlth, UK Small Area Hlth Stat Unit, London, England.	d.fecht@imperial.ac.uk		Hansell, Anna/0000-0001-9904-7447; Hodgson, Susan/0000-0001-8519-8586; Fecht, Daniela/0000-0002-0738-0013	Public Health England, MRC-PHE Centre for Environment and Health; United Kingdom Medical Research Council; MRC [MR/L01341X/1] Funding Source: UKRI; Medical Research Council [MR/L01341X/1] Funding Source: researchfish	Public Health England, MRC-PHE Centre for Environment and Health; United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors received no specific funding for this work. The work of the United Kingdom Small Area Health Statistics Unit is funded by Public Health England https://www.gov.uk/government/organisations/public-health-england as part of the MRC-PHE Centre for Environment and Health, funded also by the United Kingdom Medical Research Council http://www.mrc.ac.uk/. The funders had no involvement in the study design, analysis and interpretation of data, writing of the article or the decision to submit the article for publication.	Allender S, 2011, J URBAN HEALTH, V88, P906, DOI 10.1007/s11524-011-9586-1; Astell-Burt T, 2014, DIABETES CARE, V37, P197, DOI 10.2337/dc13-1325; Bunker SJ, 2003, MED J AUSTRALIA, V178, P272, DOI 10.5694/j.1326-5377.2003.tb05193.x; Christian WJ, 2012, SPAT SPATIO-TEMPORAL, V3, P287, DOI 10.1016/j.sste.2012.09.001; Dadvand P, 2012, ENVIRON INT, V40, P110, DOI 10.1016/j.envint.2011.07.004; de Vries S, 2003, ENVIRON PLANN A, V35, P1717, DOI 10.1068/a35111; Department of Health, 2011, PUBL HLTH RESP DEAL; Department of Health, 2004, CHOOS HLTH MAK HLTH; Duncan M, 2005, PREV MED, V40, P363, DOI 10.1016/j.ypmed.2004.06.017; Erskine S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-99; Hartig T, 2003, J ENVIRON PSYCHOL, V23, P109, DOI 10.1016/S0272-4944(02)00109-3; HARTIG T, 1991, ENVIRON BEHAV, V23, P3, DOI 10.1177/0013916591231001; Hilisdon M, 2006, PUBLIC HEALTH, V120, P1127, DOI 10.1016/j.puhe.2006.10.007; Hu ZY, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-20; Kavanagh AM, 2006, J EPIDEMIOL COMMUN H, V60, P490, DOI 10.1136/jech.2005.043562; Lloyd, 2004, ENGLISH INDICES DEPR; Maas J, 2009, J EPIDEMIOL COMMUN H, V63, P967, DOI 10.1136/jech.2008.079038; Maas J, 2006, J EPIDEMIOL COMMUN H, V60, P587, DOI 10.1136/jech.2005.043125; Mitchell R, 2008, LANCET, V372, P1655, DOI 10.1016/S0140-6736(08)61689-X; Mitchell R, 2007, J EPIDEMIOL COMMUN H, V61, P681, DOI 10.1136/jech.2006.053553; Mitchell R, 2011, J EPIDEMIOL COMMUN H, V65, P853, DOI 10.1136/jech.2010.119172; Molinari C, 1998, SOC SCI MED, V47, P1113, DOI 10.1016/S0277-9536(98)00114-2; Morton D., 2011, 1107 NERC CTR EC HYD; Nielsen TS, 2007, HEALTH PLACE, V13, P839, DOI 10.1016/j.healthplace.2007.02.001; Office for National Statistics, 2004, CENS 2001 KEY STAT 1; Richardson E, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-240; Richardson EA, 2012, J EPIDEMIOL COMMUN H, V66, P160, DOI 10.1136/jech.2011.137240; Richardson EA, 2010, SOC SCI MED, V71, P568, DOI 10.1016/j.socscimed.2010.04.015; Stafford M, 2003, INT J EPIDEMIOL, V32, P357, DOI 10.1093/ije/dyg084; ULRICH RS, 1984, SCIENCE, V224, P420, DOI 10.1126/science.6143402; Verheij RA, 1996, SOC SCI MED, V42, P923, DOI 10.1016/0277-9536(95)00190-5; Vienneau D, 2010, ATMOS ENVIRON, V44, P688, DOI 10.1016/j.atmosenv.2009.11.016; Wendel-Vos GCW, 2004, MED SCI SPORT EXER, V36, P725, DOI 10.1249/01.MSS.0000121955.03461.0A; Wise J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2184; Zenk SN, 2011, HEALTH PLACE, V17, P1150, DOI 10.1016/j.healthplace.2011.05.001	35	49	51	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119495	10.1371/journal.pone.0119495	http://dx.doi.org/10.1371/journal.pone.0119495			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD6EY	25775020	Green Submitted, Green Published, gold			2022-12-27	WOS:000351183500097
J	Caligiore, D; Mustile, M; Cipriani, D; Redgrave, P; Triesch, J; De Marsico, M; Baldassarre, G				Caligiore, Daniele; Mustile, Magda; Cipriani, Daniele; Redgrave, Peter; Triesch, Jochen; De Marsico, Maria; Baldassarre, Gianluca			Intrinsic Motivations Drive Learning of Eye Movements: An Experiment with Human Adults	PLOS ONE			English	Article							SUBCORTICAL LOOPS; EXPLORATION; INFORMATION; ACQUISITION; MECHANISMS; DOPAMINE; INFANTS; SIGNAL	Intrinsic motivations drive the acquisition of knowledge and skills on the basis of novel or surprising stimuli or the pleasure to learn new skills. In so doing, they are different from extrinsic motivations that are mainly linked to drives that promote survival and reproduction. Intrinsic motivations have been implicitly exploited in several psychological experiments but, due to the lack of proper paradigms, they are rarely a direct subject of investigation. This article investigates how different intrinsic motivation mechanisms can support the learning of visual skills, such as "foveate a particular object in space", using a gaze contingency paradigm. In the experiment participants could freely foveate objects shown in a computer screen. Foveating each of two "button" pictures caused different effects: one caused the appearance of a simple image (blue rectangle) in unexpected positions, while the other evoked the appearance of an always-novel picture (objects or animals). The experiment studied how two possible intrinsic motivation mechanisms might guide learning to foveate one or the other button picture. One mechanism is based on the sudden, surprising appearance of a familiar image at unpredicted locations, and a second one is based on the content novelty of the images. The results show the comparative effectiveness of the mechanism based on image novelty, whereas they do not support the operation of the mechanism based on the surprising location of the image appearance. Interestingly, these results were also obtained with participants that, according to a post experiment questionnaire, had not understood the functions of the different buttons suggesting that novelty-based intrinsic motivation mechanisms might operate even at an unconscious level.	[Caligiore, Daniele; Mustile, Magda; Baldassarre, Gianluca] Consiglio Nazl Ric LOCEN ISTC CNR, Ist Sci & Tecnol Cogniz, Lab Computat Embodied Neurosci, Rome, Italy; [Cipriani, Daniele; De Marsico, Maria] Univ Roma La Sapienza, Dipartimento Informat, I-00185 Rome, Italy; [Redgrave, Peter] Univ Sheffield, Dept Psychol, Sheffield S10 2TN, S Yorkshire, England; [Triesch, Jochen] Frankfurt Inst Adv Studies, Frankfurt, Germany	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); Sapienza University Rome; University of Sheffield	Caligiore, D (corresponding author), Consiglio Nazl Ric LOCEN ISTC CNR, Ist Sci & Tecnol Cogniz, Lab Computat Embodied Neurosci, Rome, Italy.	daniele.caligiore@istc.cnr.it	Caligiore, Daniele/AAX-1887-2020; Baldassarre, Gianluca/AAY-1081-2020; De Marsico, Maria/K-6684-2015	Baldassarre, Gianluca/0000-0002-1277-4447; De Marsico, Maria/0000-0002-1391-8502	European Commission [ICT-IP-231722]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This research was funded by the European Commission 7th Framework Programme (FP7/2007-2013), "Challenge 2-Cognitive Systems, Interaction, Robotics", grant agreement No. ICT-IP-231722, project "IM-CLeVeR-Intrinsically Motivated Cumulative Learning Versatile Robots" (www.imclever.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslin RN, 2009, OPTOMETRY VISION SCI, V86, P561, DOI 10.1097/OPX.0b013e3181a76e96; Baldacchino G, 2013, INT POLIT ECON SER, P1; Baldassarre G., 2011, P INT C DEV LEARN EP, pE1; Baldassarre G., 2013, INTRINSICALLY MOTIVA; Baldassarre G, 2013, NEURAL NETWORKS, V41, P168, DOI 10.1016/j.neunet.2012.09.015; BALOTA DA, 1985, COGNITIVE PSYCHOL, V17, P364, DOI 10.1016/0010-0285(85)90013-1; Baranes A, 2013, ROBOT AUTON SYST, V61, P49, DOI 10.1016/j.robot.2012.05.008; Barto A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00907; Berlyne D.E., 1960, CONFLICT AROUSAL CUR, DOI [10.1037/11164-000, DOI 10.1037/11164-000]; BERLYNE DE, 1966, SCIENCE, V153, P25, DOI 10.1126/science.153.3731.25; Boehnke SE, 2008, CURR OPIN NEUROBIOL, V18, P544, DOI 10.1016/j.conb.2008.11.004; Caligiore D, 2013, NEUROSCI BIOBEHAV R, V37, P2504, DOI 10.1016/j.neubiorev.2013.07.016; Chentanez, 2005, ADV NEURAL INFORM PR, P1281, DOI DOI 10.21236/ADA440280; Cipriani D, 2013, EUR C EYE MOV ECEM 2, pE1; Deci EL, 1985, INTRINSIC MOTIVATION; Devore J.L, 2000, PROBABILITY STAT ENG; Frank MC, 2012, INFANCY, V17, P355, DOI 10.1111/j.1532-7078.2011.00086.x; FREEMAN GH, 1979, J ROY STAT SOC B MET, V41, P253; Gerken L, 2014, DEV SCI; Gerken L, 2011, DEVELOPMENTAL SCI, V14, P972, DOI 10.1111/j.1467-7687.2011.01046.x; GRANT DA, 1948, PSYCHOL BULL, V45, P427, DOI 10.1037/h0053912; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; Himmelbach M, 2006, NEUROIMAGE, V32, P1747, DOI 10.1016/j.neuroimage.2006.04.221; Johnson SP, 2003, P NATL ACAD SCI USA, V100, P10568, DOI 10.1073/pnas.1630655100; Kidd C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036399; Kumaran D, 2007, HIPPOCAMPUS, V17, P735, DOI 10.1002/hipo.20326; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Marraffa R., 2012, IEEE INT C DEV LEARN, pe1; McHaffie JG, 2005, TRENDS NEUROSCI, V28, P401, DOI 10.1016/j.tins.2005.06.006; Mirolli M., 2013, INTRINSICALLY MOTIVA, P49, DOI DOI 10.1007/978-3-642-32375-1_3; Mirolli M, 2013, NEURAL NETWORKS, V39, P40, DOI 10.1016/j.neunet.2012.12.012; Nehmzow U., 2013, INTRINSICALLY MOTIVA, P185, DOI DOI 10.1007/978-3-642-32375-1_8; Otero-Millan J, 2008, J VISION, V8, DOI 10.1167/8.14.21; Oudeyer Pierre-Yves, 2007, Front Neurorobot, V1, P6, DOI 10.3389/neuro.12.006.2007; Pannasch S, 2009, VIS COGN, V17, P1109, DOI 10.1080/13506280902764422; Power T. G., 2000, PLAY EXPLORATION CHI; Ranganath C, 2003, NAT REV NEUROSCI, V4, P193, DOI 10.1038/nrn1052; REDER SM, 1973, BEHAV RES METH INSTR, V5, P218, DOI 10.3758/BF03200168; Redgrave P, 2011, NEUROSCIENCE, V198, P138, DOI 10.1016/j.neuroscience.2011.07.060; Redgrave P, 2006, NAT REV NEUROSCI, V7, P967, DOI 10.1038/nrn2022; Ryan RM, 2000, CONTEMP EDUC PSYCHOL, V25, P54, DOI 10.1006/ceps.1999.1020; Ryan RM, 2001, ANNU REV PSYCHOL, V52, P141, DOI 10.1146/annurev.psych.52.1.141; Santucci VG, 2013, FRONT NEUROROBOTICS, V7, DOI 10.3389/fnbot.2013.00022; Schembri M., 2007, P 6 INT C DEV LEARN, pE1, DOI DOI 10.1109/DEVLRN.2007.4354052; Schlesinger M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00802; SCHMIDHUBER J, 1991, IEEE IJCNN, P1458, DOI 10.1109/IJCNN.1991.170605; Schmidhuber J., 1991, P INT C SIM AD BEH A, P222; Singh S, 2010, IEEE T AUTON MENT DE, V2, P70, DOI 10.1109/TAMD.2010.2051031; von Hofsten C, 2007, DEVELOPMENTAL SCI, V10, P54, DOI 10.1111/j.1467-7687.2007.00564.x; Wang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030884; WHITE RW, 1959, PSYCHOL REV, V66, P297, DOI 10.1037/h0040934; WURTZ RH, 1980, ANNU REV NEUROSCI, V3, P189, DOI 10.1146/annurev.ne.03.030180.001201	53	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118705	10.1371/journal.pone.0118705	http://dx.doi.org/10.1371/journal.pone.0118705			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD6EY	25775248	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000351183500036
J	Catala, S; Perez-Sierra, A; Abad-Campos, P				Catala, Santiago; Perez-Sierra, Ana; Abad-Campos, Paloma			The Use of Genus-Specific Amplicon Pyrosequencing to Assess Phytophthora Species Diversity Using eDNA from Soil and Water in Northern Spain	PLOS ONE			English	Article							FUNGAL COMMUNITIES; SEQUENCE ALIGNMENT; MULTIPLE; QUANTIFICATION; IDENTIFICATION; INTRODUCTIONS; ECOSYSTEMS; CITRICOLA; PATHOGEN; DATABASE	Phytophthora is one of the most important and aggressive plant pathogenic genera in agriculture and forestry. Early detection and identification of its pathways of infection and spread are of high importance to minimize the threat they pose to natural ecosystems. eDNA was extracted from soil and water from forests and plantations in the north of Spain. Phytophthora-specific primers were adapted for use in high-throughput Sequencing (HTS). Primers were tested in a control reaction containing eight Phytophthora species and applied to water and soil eDNA samples from northern Spain. Different score coverage threshold values were tested for optimal Phytophthora species separation in a custom-curated database and in the control reaction. Clustering at 99% was the optimal criteria to separate most of the Phytophthora species. Multiple Molecular Operational Taxonomic Units (MOTUs) corresponding to 36 distinct Phytophthora species were amplified in the environmental samples. Pyrosequencing of amplicons from soil samples revealed low Phytophthora diversity (13 species) in comparison with the 35 species detected in water samples. Thirteen of the MOTUs detected in rivers and streams showed no close match to sequences in international sequence databases, revealing that eDNA pyrosequencing is a useful strategy to assess Phytophthora species diversity in natural ecosystems.	[Catala, Santiago; Perez-Sierra, Ana; Abad-Campos, Paloma] Univ Politecn Valencia, Inst Agroforestal Mediterraneo, E-46022 Valencia, Spain; [Perez-Sierra, Ana] Forest Res, Alice Holt Lodge, Farnham, Surrey, England	Universitat Politecnica de Valencia	Catala, S (corresponding author), Univ Politecn Valencia, Inst Agroforestal Mediterraneo, Camino Vera S-N, E-46022 Valencia, Spain.	sangarca@upv.es	Perez-Sierra, Ana/AAE-9414-2021	Perez-Sierra, Ana/0000-0001-5403-1433; Abad-Campos, Paloma/0000-0002-5979-4349	Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (EUPHRESCO-CEP: "Current and Emerging Phytophthoras: Research Supporting Risk Assessment And Risk Management")	Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (EUPHRESCO-CEP: "Current and Emerging Phytophthoras: Research Supporting Risk Assessment And Risk Management")	This project has been supported by the Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (EUPHRESCO-CEP: "Current and Emerging Phytophthoras: Research Supporting Risk Assessment And Risk Management"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrews S, FASTQC QUALITY CONTR; Bergmark L, 2012, FEMS MICROBIOL LETT, V333, P77, DOI 10.1111/j.1574-6968.2012.02601.x; Brasier CM, 2008, PLANT PATHOL, V57, P792, DOI 10.1111/j.1365-3059.2008.01886.x; Brasier CM, 2003, MYCOL RES, V107, P277, DOI 10.1017/S095375620300738X; Brasier CM, 2003, MYCOL RES, V107, P477, DOI 10.1017/S0953756203007548; Catala S, 2012, PHYT FOR NAT EC 6 IN, P34; Chen W, 2013, PHYTOPATHOLOGY, V103, P43, DOI 10.1094/PHYTO-04-12-0092-R; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Coince A, 2013, FUNGAL ECOL, V6, P223, DOI 10.1016/j.funeco.2013.01.002; Cooke DEL, 2000, FUNGAL GENET BIOL, V30, P17, DOI 10.1006/fgbi.2000.1202; Creer S, 2012, MOL ECOL, V21, P1033, DOI 10.1111/j.1365-294X.2012.05437.x; Davey ML, 2013, MOL ECOL, V22, P368, DOI 10.1111/mec.12122; Deagle Bruce E, 2006, Front Zool, V3, P11, DOI 10.1186/1742-9994-3-11; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guha Roy S, 2014, REV PLANT P IN PRESS, V6; Hansen EM, 2012, ANNU REV PHYTOPATHOL, V50, P359, DOI 10.1146/annurev-phyto-081211-172946; Huai WX, 2013, FOREST PATHOL, V43, P87, DOI 10.1111/efp.12015; Huberli D, 2013, AUSTRALAS PLANT PATH, V42, P251, DOI 10.1007/s13313-012-0195-6; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Jobard M, 2012, ENVIRON MICROBIOL, V14, P2480, DOI 10.1111/j.1462-2920.2012.02771.x; Jones DR, 2007, PLANT PATHOL, V56, P891, DOI 10.1111/j.1365-3059.2007.01619.x; Jumpponen A, 2009, NEW PHYTOL, V184, P438, DOI 10.1111/j.1469-8137.2009.02990.x; Jung T, 2011, PERSOONIA, V26, P13, DOI 10.3767/003158511X557577; Jung T, 2009, PERSOONIA, V22, P95, DOI 10.3767/003158509X442612; Li LL, 2013, CURR MICROBIOL, V67, P423, DOI 10.1007/s00284-013-0382-x; Livermore JA, 2013, ENVIRON MICROBIOL, V15, P2333, DOI 10.1111/1462-2920.12106; Monchy S, 2011, ENVIRON MICROBIOL, V13, P1433, DOI 10.1111/j.1462-2920.2011.02444.x; Nakayama Jiro, 2013, Biosci Microbiota Food Health, V32, P69, DOI 10.12938/bmfh.32.69; Nechwatal J, 2013, PLANT PATHOL, V62, P355, DOI 10.1111/j.1365-3059.2012.02638.x; Nilsson RH, 2009, FEMS MICROBIOL LETT, V296, P97, DOI 10.1111/j.1574-6968.2009.01618.x; Oh E, 2013, IMA FUNGUS, V4, P123, DOI 10.5598/imafungus.2013.04.01.12; Park J, 2008, PLANT DIS, V92, P966, DOI 10.1094/PDIS-92-6-0966; Pavon CF, 2008, PLANT DIS, V92, P143, DOI 10.1094/PDIS-92-1-0143; Reeser P, 2011, NZ J FORESTRY SCI, V41, P65; Reeser PW, 2011, MYCOLOGIA, V103, P22, DOI 10.3852/10-013; Reichard SH, 2001, BIOSCIENCE, V51, P103, DOI 10.1641/0006-3568(2001)051[0103:HAAPOI]2.0.CO;2; Roche, 2010, GUID AMPL EXP DES; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Schena L, 2006, MOL PLANT PATHOL, V7, P365, DOI 10.1111/j.1364-3703.2006.00345.x; Scibetta S, 2012, J MICROBIOL METH, V88, P356, DOI 10.1016/j.mimet.2011.12.012; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; Than DJ, 2013, FOREST PATHOL, V43, P324, DOI 10.1111/efp.12034; Tooley PW, 2006, PHYTOPATHOLOGY, V96, P336, DOI 10.1094/PHYTO-96-0336; Vannini A, 2013, FEMS MICROBIOL ECOL, V85, P433, DOI 10.1111/1574-6941.12132; Vettraino AM, 2012, LETT APPL MICROBIOL, V55, P390, DOI 10.1111/j.1472-765x.2012.03310.x; Weber CF, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00078; White TJ., 1990, PCR PROTOCOLS GUIDE, P315	52	50	52	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119311	10.1371/journal.pone.0119311	http://dx.doi.org/10.1371/journal.pone.0119311			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775250	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500081
J	Harteveld, AA; De Cocker, LJL; Dieleman, N; van der Kolk, AG; Zwanenburg, JJM; Robe, PA; Luijten, PR; Hendrikse, J				Harteveld, Anita A.; De Cocker, Laurens J. L.; Dieleman, Nikki; van der Kolk, Anja G.; Zwanenburg, Jaco J. M.; Robe, Pierre A.; Luijten, Peter R.; Hendrikse, Jeroen			High-Resolution Postcontrast Time-of-Flight MR Angiography of Intracranial Perforators at 7.0 Tesla	PLOS ONE			English	Article							MAGNETIC-RESONANCE ANGIOGRAPHY; LENTICULOSTRIATE ARTERIES; 7 T; HEAD COIL; CONTRAST; STROKE; OPTIMIZATION; ACQUISITION; INFARCTION; OCCLUSION	Background and Purpose Different studies already demonstrated the benefits of 7T for precontrast TOF-MRA in the visualization of intracranial small vessels. The aim of this study was to assess the performance of high-resolution 7T TOF-MRA after the administration of a gadolinium-based contrast agent in visualizing intracranial perforating arteries. Materials and Methods Ten consecutive patients (7 male; mean age, 50.4 +/- 9.9 years) who received TOF-MRA at 7T after contrast administration were retrospectively included in this study. Intracranial perforating arteries, branching from the parent arteries of the circle of Willis, were identified on all TOF-MRA images. Provided a TOF-MRA before contrast administration was present, a direct comparison between pre- and postcontrast TOF-MRA was made. Results It was possible to visualize intracranial perforating arteries branching off from the entire circle of Willis, and their proximal branches. The posterior cerebral artery (P1 and proximal segment of P2) appeared to have the largest number of visible perforating branches (mean of 5.1 in each patient, with a range of 2-7). The basilar artery and middle cerebral artery (M1 and proximal segment M2) followed with a mean number of 5.0 and 3.5 visible perforating branches (range of 1-9 and 1-8, respectively). Venous contamination in the postcontrast scans sometimes made it difficult to discern the arterial or venous nature of a vessel. Conclusion High-resolution postcontrast TOF-MRA at 7T was able to visualize multiple intracranial perforators branching off from various parts of the circle of Willis and proximal intracranial arteries. Although confirmation in a larger study is needed, the administration of a contrast agent for high-resolution TOF-MRA at 7T seems to enable a better visualization of the distal segment of certain intracranial perforators.	[Harteveld, Anita A.; De Cocker, Laurens J. L.; Dieleman, Nikki; van der Kolk, Anja G.; Zwanenburg, Jaco J. M.; Luijten, Peter R.; Hendrikse, Jeroen] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Zwanenburg, Jaco J. M.] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands; [Robe, Pierre A.] Univ Med Ctr Utrecht, Dept Neurosurg, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Harteveld, AA (corresponding author), Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands.	a.a.harteveld-2@umcutrecht.nl	Zwanenburg, Jaco J.M./B-3857-2009	Zwanenburg, Jaco J.M./0000-0002-4282-5719; van der Kolk, Anja/0000-0002-8267-8848				Boeckh-Behrens T, 2012, EUR J RADIOL, V81, P1238, DOI 10.1016/j.ejrad.2011.02.057; Cho ZH, 2008, STROKE, V39, P1604, DOI 10.1161/STROKEAHA.107.508002; Conijn MMA, 2009, EUR RADIOL, V19, P2986, DOI 10.1007/s00330-009-1485-4; DAVIS WL, 1993, J COMPUT ASSIST TOMO, V17, P15, DOI 10.1097/00004728-199301000-00002; FISHER CM, 1971, NEUROLOGY, V21, P900, DOI 10.1212/WNL.21.9.900; FISHER CM, 1965, NEUROLOGY, V15, P774, DOI 10.1212/WNL.15.8.774; FISHER CM, 1969, ACTA NEUROPATHOL, V12, P1, DOI 10.1007/BF00685305; Greenberg SM, 2006, NEW ENGL J MED, V354, P1451, DOI 10.1056/NEJMp068043; Hendrikse J, 2008, CEREBROVASC DIS, V26, P624, DOI 10.1159/000166838; Heverhagen JT, 2008, INVEST RADIOL, V43, P568, DOI 10.1097/RLI.0b013e31817e9b2c; Kang CK, 2010, INT J STROKE, V5, P374, DOI 10.1111/j.1747-4949.2010.00464.x; Kang CK, 2010, J MAGN RESON IMAGING, V32, P544, DOI 10.1002/jmri.22250; Kang CK, 2009, HYPERTENSION, V54, P1050, DOI 10.1161/HYPERTENSIONAHA.109.140350; Kang CK, 2009, MAGN RESON MED, V61, P136, DOI 10.1002/mrm.21786; Kang HS, 2005, AM J NEURORADIOL, V26, P306; Kumral E, 2004, NEUROLOGY, V63, P2429, DOI 10.1212/01.WNL.0000147261.22630.F8; Lang FF, 2001, J NEUROSURG, V95, P638, DOI 10.3171/jns.2001.95.4.0638; Liem MK, 2010, STROKE, V41, P2812, DOI 10.1161/STROKEAHA.110.586883; Marinkovic S, 1996, NEUROSURGERY, V39, P72, DOI 10.1097/00006123-199607000-00016; Moshel YA, 2008, J NEUROSURG, V109, P825, DOI 10.3171/JNS/2008/109/11/0825; Nowinski WL, 2013, J NEUROIMAGING, V23, P86, DOI 10.1111/j.1552-6569.2011.00597.x; Ozsarlak O, 2004, EUR RADIOL, V14, P2067, DOI 10.1007/s00330-004-2411-4; Schmitter S, 2012, MAGN RESON MED, V68, P188, DOI 10.1002/mrm.23226; Seo SW, 2012, J NEUROL SCI, V322, P200, DOI 10.1016/j.jns.2012.05.032; Stamm AC, 2013, MAGN RESON IMAGING, V31, P545, DOI 10.1016/j.mri.2012.10.023; Umutlu L, 2013, ACAD RADIOL, V20, P628, DOI 10.1016/j.acra.2012.12.012; van der Kolk AG, 2013, EUR J RADIOL, V82, P708, DOI 10.1016/j.ejrad.2011.07.007; von Morze C, 2007, J MAGN RESON IMAGING, V26, P900, DOI 10.1002/jmri.21097; Wardlaw JM, 2001, ANN NEUROL, V50, P208, DOI 10.1002/ana.1082; Wiggins GC, 2009, MAGN RESON MED, V62, P754, DOI 10.1002/mrm.22028; Yang JJ, 2002, AM J NEURORADIOL, V23, P557; Yano T, 1997, ACTA RADIOL, V38, P47; Zhou Q, 2011, ACTA RADIOL, V52, P894, DOI 10.1258/ar.2011.110195	33	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0121051	10.1371/journal.pone.0121051	http://dx.doi.org/10.1371/journal.pone.0121051			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774881	Green Published, gold, Green Submitted			2022-12-27	WOS:000351183500204
J	Hohn, R; Kottler, U; Peto, T; Blettner, M; Munzel, T; Blankenberg, S; Lackner, KJ; Beutel, M; Wild, PS; Pfeiffer, N				Hoehn, Rene; Kottler, Ulrike; Peto, Tunde; Blettner, Maria; Muenzel, Thomas; Blankenberg, Stefan; Lackner, Karl J.; Beutel, Manfred; Wild, Philipp S.; Pfeiffer, Norbert			The Ophthalmic Branch of the Gutenberg Health Study: Study Design, Cohort Profile and Self-Reported Diseases	PLOS ONE			English	Article							MACULAR DEGENERATION; DIABETIC-RETINOPATHY; EYE DISEASES; RISK-FACTORS; PREVALENCE; POPULATION; CHILDREN; CLASSIFICATION; ASSOCIATION; NYSTAGMUS	Purpose This paper describes the study design, methodology, cohort profile and self-reported diseases in the ophthalmological branch of the Gutenberg Health Study (GHS). Methods The GHS is an ongoing, prospective, interdisciplinary, single-center, population-based cohort study in Germany. The main goals of the ophthalmological section are to assess the prevalence and incidence of ocular diseases and to explore risk factors, genetic determinants and associations with systemic diseases and conditions. The eye examination at baseline included a medical history, self-reported eye diseases, visual acuity, refractive errors, intraocular pressure, visual field, pachymetry, keratometry, fundus photography and tear sampling. The 5-year follow-up visit additionally encompassed optical coherence tomography, anterior segment imaging and optical biometry. The general examination included anthropometry; blood pressure measurement; carotid artery ultrasound; electrocardiogram; echocardiography; spirometry; cognitive tests; questionnaires; assessment of mental conditions; and DNA, RNA, blood and urine sampling. Results Of 15,010 participants (aged 35-74 years at the time of inclusion), ocular data are available for 14,700 subjects (97.9%). The mean visual acuity (standard deviation), mean spherical equivalent, median decimal visual acuity, and mean intraocular pressure were 0.08 (0.17) logMar, -0.42 (2.43) diopters, 0.9 and 14.24 (2.79) mm Hg, respectively. The frequencies of self-reported strabismus, glaucoma, surgery for retinal detachment and retinal vascular occlusions were 2.7%, 2.3%, 0.2% and 0.4%, respectively. Conclusions The GHS is the most extensive dataset of ophthalmic diseases and conditions and their risk factors in Germany and one of the largest cohorts worldwide. This dataset will provide new insight in the epidemiology of ophthalmic diseases and related medical specialties.	[Hoehn, Rene; Kottler, Ulrike; Pfeiffer, Norbert] Univ Med Ctr Mainz, Dept Ophthalmol, Mainz, Germany; [Hoehn, Rene] Klin Pallas, Olten, Switzerland; [Peto, Tunde] NHS Fdn Trust, Moorfields Eye Hosp, NIHR Biomed Res Ctr, London, England; [Peto, Tunde] UCL Inst Ophthalmol, London, England; [Blettner, Maria] Univ Med Ctr Mainz, Inst Med Biostat Epidemiol & Informat, Mainz, Germany; [Muenzel, Thomas; Wild, Philipp S.] Univ Med Ctr Mainz, Prevent Cardiol & Prevent Med Dept Med 2, Mainz, Germany; [Blankenberg, Stefan] Univ Med Ctr Hamburg Eppendorf, Clin Gen & Intervent Cardiol, Hamburg, Germany; [Lackner, Karl J.] Univ Med Ctr Mainz, Inst Clin Chem & Lab Med, Mainz, Germany; [Beutel, Manfred] Univ Med Ctr Mainz, Dept Psychosomat Med & Psychotherapy, Mainz, Germany; [Wild, Philipp S.] Univ Med Ctr Mainz, Ctr Thrombosis & Hemostasis, Mainz, Germany; [Wild, Philipp S.] German Ctr Cardiovasc Res DZHK, Mainz, Germany	Johannes Gutenberg University of Mainz; Oxford University Hospitals NHS Foundation Trust; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; University of Hamburg; University Medical Center Hamburg-Eppendorf; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; German Centre for Cardiovascular Research	Hohn, R (corresponding author), Univ Med Ctr Mainz, Dept Ophthalmol, Mainz, Germany.	rhoehn@gmx.de	Peto, Tunde/G-8812-2018; Wild, Philipp S./M-2106-2019; Pfeiffer, Norbert/AAO-7586-2020; Munzel, Thomas/A-2912-2014	Peto, Tunde/0000-0001-6265-0381; Munzel, Thomas/0000-0001-5503-4150; Hohn, Rene/0000-0003-2870-1469; Wild, Philipp/0000-0003-4413-9752	government of Rheinland-Pfalz [AZ 961-386261/733]; research program "Wissen schafft Zukunft" of the Johannes Gutenberg-University of Mainz; research program "Center for Translational Vascular Biology (CTVB)" of the Johannes Gutenberg-University of Mainz; Boehringer Ingelheim; PHILIPS Medical Systems; Novartis Pharma; Federal Ministry of Education and Research (BMBF) [01EO1003]; NIHR Biomedical Research Centerat Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology	government of Rheinland-Pfalz; research program "Wissen schafft Zukunft" of the Johannes Gutenberg-University of Mainz; research program "Center for Translational Vascular Biology (CTVB)" of the Johannes Gutenberg-University of Mainz; Boehringer Ingelheim(Boehringer Ingelheim); PHILIPS Medical Systems; Novartis Pharma; Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); NIHR Biomedical Research Centerat Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology	The Gutenberg Health Study is funded through the government of Rheinland-Pfalz ("Stiftung Rheinland-Pfalz fur Innovation", contract AZ 961-386261/733), the research programs "Wissen schafft Zukunft" and "Center for Translational Vascular Biology (CTVB)" of the Johannes Gutenberg-University of Mainz, and its contract with Boehringer Ingelheim, PHILIPS Medical Systems and Novartis Pharma, including an unrestricted grant for the Gutenberg Health Study. PSW is funded by the Federal Ministry of Education and Research (BMBF 01EO1003). TP was supported by the NIHR Biomedical Research Centerat Moorfields Eye Hospital NHS Foundation Trust and the UCL Institute of Ophthalmology. Funders were involved in the development of the study design as scientific consultants. However, they played no role in data collection, analysis, decision to publish, or preparation of the manuscript. Klinik Pallas provided support in the form of a salary for author RH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the author contributions section.	[Anonymous], 1991, Ophthalmology, V98, P786; Barry JC, 2003, BRIT J OPHTHALMOL, V87, P909, DOI 10.1136/bjo.87.7.909; Bertelsen G, 2013, ACTA OPHTHALMOL, V91, P635, DOI 10.1111/j.1755-3768.2012.02511.x; Ehrt O, 2012, EUR J PAEDIATR NEURO, V16, P567, DOI 10.1016/j.ejpn.2012.02.010; Ferris FL, 2013, OPHTHALMOLOGY, V120, P844, DOI 10.1016/j.ophtha.2012.10.036; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Friedman DS, 2009, OPHTHALMOLOGY, V116, P2128, DOI 10.1016/j.ophtha.2009.04.034; Gao Z, 2012, OPHTHAL EPIDEMIOL, V19, P16, DOI 10.3109/09286586.2011.632703; GRAHAM PA, 1974, BRIT J OPHTHALMOL, V58, P224, DOI 10.1136/bjo.58.3.224; Graw J, 2011, INVEST OPHTH VIS SCI, V52, P7778, DOI 10.1167/iovs.10-7113; Hoehn R, 2013, OPHTHALMOLOGY, V120, P961, DOI 10.1016/j.ophtha.2012.10.031; KEITH NM, 1974, AM J MED SCI, V268, P336, DOI 10.1097/00000441-197412000-00004; Korb CA, 2014, GRAEF ARCH CLIN EXP, V252, P1403, DOI 10.1007/s00417-014-2591-9; Kvarnstrom G, 2001, ACTA OPHTHALMOL SCAN, V79, P240, DOI 10.1034/j.1600-0420.2001.790306.x; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; MacLennan PA, 2013, CURR EYE RES, V38, P1, DOI 10.3109/02713683.2012.733054; Mangione CM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1050, DOI 10.1001/archopht.119.7.1050; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mirshahi A, 2013, OPHTHALMOLOGE, V110, P210, DOI 10.1007/s00347-012-2666-0; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Rogers S, 2010, OPHTHALMOLOGY, V117, P313, DOI [10.1016/j.ophtha.2009.07.017, 10.1016/j.ophtha.2010.01.060]; Ruta LM, 2013, DIABETIC MED, V30, P387, DOI 10.1111/dme.12119; Sarvananthan N, 2009, INVEST OPHTH VIS SCI, V50, P5201, DOI 10.1167/iovs.09-3486; Sawaguchi S, 2012, OPHTHALMOLOGY, V119, P1134, DOI 10.1016/j.ophtha.2011.12.038; Takeda Y, 2011, J CARD FAIL, V17, P556, DOI 10.1016/j.cardfail.2011.03.007; Tham YC, 2013, CLIN EXP OPHTHALMOL, V41, P842, DOI 10.1111/ceo.12112; Volzke H, 2012, BUNDESGESUNDHEITSBLA, V55, P790, DOI 10.1007/s00103-012-1483-6; Wild PS, 2012, BUNDESGESUNDHEITSBLA, V55, P824, DOI 10.1007/s00103-012-1502-7; Wild PS, 2011, CIRC-CARDIOVASC GENE, V4, P403, DOI 10.1161/CIRCGENETICS.110.958728; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; Zobor D, 2012, OPHTHALMOLOGE, V109, P501, DOI 10.1007/s00347-012-2555-6	32	72	72	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120476	10.1371/journal.pone.0120476	http://dx.doi.org/10.1371/journal.pone.0120476			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775251	Green Published, gold, Green Submitted			2022-12-27	WOS:000351183500180
J	Kirsten, TB; Galvao, MC; Reis-Silva, TM; Queiroz-Hazarbassanov, N; Bernardi, MM				Kirsten, Thiago B.; Galvao, Marcella C.; Reis-Silva, Thiago M.; Queiroz-Hazarbassanov, Nicolle; Bernardi, Maria M.			Zinc Prevents Sickness Behavior Induced by Lipopolysaccharides after a Stress Challenge in Rats	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; NEUROTROPHIC FACTOR; INDUCED TERATOGENICITY; PRENATAL EXPOSURE; RESTRAINT STRESS; SPATIAL MEMORY; MICE; BRAIN; SUPPLEMENTATION; HIPPOCAMPUS	Sickness behavior is considered part of the specific beneficial adaptive behavioral and neuroimmune changes that occur in individuals in response to infectious/inflammatory processes. However, in dangerous and stressful situations, sickness behavior should be momentarily abrogated to prioritize survival behaviors, such as fight or flight. Taking this assumption into account, we experimentally induced sickness behavior in rats using lipopolysaccharides (LPS), an endotoxin that mimics infection by gram-negative bacteria, and then exposed these rats to a restraint stress challenge. Zinc has been shown to play a regulatory role in the immune and nervous systems. Therefore, the objective of this study was to examine the effects of zinc treatment on the sickness response of stress-challenged rats. We evaluated 22-kHz ultrasonic vocalizations, open-field behavior, tumor necrosis factor a (TNF-alpha), corticosterone, and brain-derived neurotrophic factor (BDNF) plasma levels. LPS administration induced sickness behavior in rats compared to controls, i.e., decreases in the distance traveled, average velocity, rearing frequency, self-grooming, and number of vocalizations, as well as an increase in the plasma levels of TNF-alpha, compared with controls after a stressor challenge. LPS also decreased BDNF expression but did not influence anxiety parameters. Zinc treatment was able to prevent sickness behavior in LPS-exposed rats after the stress challenge, restoring exploratory/motor behaviors, communication, and TNF-alpha levels similar to those of the control group. Thus, zinc treatment appears to be beneficial for sick animals when they are facing risky/stressful situations.	[Kirsten, Thiago B.; Galvao, Marcella C.; Reis-Silva, Thiago M.; Queiroz-Hazarbassanov, Nicolle] Univ Sao Paulo, Sch Vet Med, Dept Pathol, Sao Paulo, Brazil; [Kirsten, Thiago B.; Bernardi, Maria M.] Univ Estadual Paulista, Environm & Expt Pathol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual Paulista	Kirsten, TB (corresponding author), Univ Sao Paulo, Sch Vet Med, Dept Pathol, Sao Paulo, Brazil.	thik@hotmail.com	Kirsten, Thiago Berti/AAS-2166-2021; Queiroz-Hazarbassanov, Nicolle/P-4333-2014; Bernardi, M. M./H-8418-2012; Reis-Silva, Thiago M./E-6318-2013; Bernardi, Maria/T-6813-2019; Queiroz-Hazarbassanov, Nicolle/Q-6901-2019; Reis-Silva, Thiago Moirinho/AAE-6346-2019	Kirsten, Thiago Berti/0000-0002-4032-4355; Queiroz-Hazarbassanov, Nicolle/0000-0002-5692-0565; Bernardi, M. M./0000-0002-6860-9416; Queiroz-Hazarbassanov, Nicolle/0000-0002-5692-0565; Reis-Silva, Thiago Moirinho/0000-0002-4134-4307	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Sao Paulo Research Foundation (FAPESP) [2012/07007-8, 2009/51886-3]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/Premio); Paulista University (UNIP) [7-02-908/2014]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/Premio); Paulista University (UNIP)	This research was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), the Sao Paulo Research Foundation (FAPESP grant no. 2012/07007-8 and thematic grant no. 2009/51886-3), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/Premio), and Paulista University (UNIP grant no. 7-02-908/2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Antoniadis EA, 1999, BEHAV BRAIN RES, V101, P1, DOI 10.1016/S0166-4328(98)00056-4; Aubert A, 1999, NEUROSCI BIOBEHAV R, V23, P1029, DOI 10.1016/S0149-7634(99)00034-2; Aubert A, 1997, BRAIN BEHAV IMMUN, V11, P107, DOI 10.1006/brbi.1997.0485; Barrientos RM, 2004, J NEUROIMMUNOL, V155, P119, DOI 10.1016/j.jneuroim.2004.06.009; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; BLUTHE RM, 1994, CR ACAD SCI III-VIE, V317, P499; BLUTHE RM, 1992, BRAIN RES, V573, P318, DOI 10.1016/0006-8993(92)90779-9; Buynitsky T, 2009, NEUROSCI BIOBEHAV R, V33, P1089, DOI 10.1016/j.neubiorev.2009.05.004; Carey LC, 2003, BIRTH DEFECTS RES A, V67, P240, DOI 10.1002/bdra.10035; Chua JSC, 2012, BRAIN BEHAV IMMUN, V26, P326, DOI 10.1016/j.bbi.2011.10.002; Chua JSC, 2006, PEDIATR RES, V59, P355, DOI 10.1203/01.pdr.0000199906.37619.9c; Connor TJ, 2002, NEUROIMMUNOMODULAT, V10, P367, DOI 10.1159/000071478; Corona C, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.73; Coyle P, 2009, BEHAV BRAIN RES, V197, P210, DOI 10.1016/j.bbr.2008.08.022; Dantzer R, 2007, BRAIN BEHAV IMMUN, V21, P153, DOI 10.1016/j.bbi.2006.09.006; Dhabhar FS, 1996, J IMMUNOL, V156, P2608; Echeverry MB, 2004, NEUROSCIENCE, V125, P981, DOI 10.1016/j.neuroscience.2003.12.046; Engeland CG, 2003, PSYCHONEUROENDOCRINO, V28, P970, DOI 10.1016/S0306-4530(02)00118-X; Guan ZW, 2006, BRAIN BEHAV IMMUN, V20, P64, DOI 10.1016/j.bbi.2005.04.005; Haase H, 2008, EXP GERONTOL, V43, P394, DOI 10.1016/j.exger.2007.12.002; HART BL, 1988, NEUROSCI BIOBEHAV R, V12, P123, DOI 10.1016/S0149-7634(88)80004-6; Hritcu L, 2014, PROG NEURO-PSYCHOPH, V51, P126, DOI 10.1016/j.pnpbp.2014.01.016; Je HS, 2012, P NATL ACAD SCI USA, V109, P15924, DOI 10.1073/pnas.1207767109; KENT S, 1992, TRENDS PHARMACOL SCI, V13, P24, DOI 10.1016/0165-6147(92)90012-U; Kirsten TB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082244; Kirsten TB, 2012, J NEUROSCI RES, V90, P1903, DOI 10.1002/jnr.23089; Kirsten TB, 2010, NEUROIMMUNOMODULAT, V17, P240, DOI 10.1159/000290040; Larson SJ, 2001, BRAIN BEHAV IMMUN, V15, P371, DOI 10.1006/brbi.2001.0643; Lenczowski MJP, 1997, AM J PHYSIOL-REG I, V273, pR1870, DOI 10.1152/ajpregu.1997.273.6.R1870; Maret W, 2006, J TRACE ELEM MED BIO, V20, P3, DOI 10.1016/j.jtemb.2006.01.006; Maywald M, 2014, J TRACE ELE IN PRESS; McEwen BS, 2000, BRAIN RES, V886, P172, DOI 10.1016/S0006-8993(00)02950-4; Miyake K, 2003, INT IMMUNOPHARMACOL, V3, P119, DOI 10.1016/S1567-5769(02)00258-8; Nowak G, 2004, EUR J PHARMACOL, V492, P57, DOI 10.1016/j.ejphar.2004.03.038; Patti CL, 2005, PHARMACOL BIOCHEM BE, V81, P923, DOI 10.1016/j.pbb.2005.07.004; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Railey AM, 2011, J ALZHEIMERS DIS, V24, P375, DOI 10.3233/JAD-2011-101452; SALES GD, 1972, ANIM BEHAV, V20, P88, DOI 10.1016/S0003-3472(72)80177-5; Schnydrig S, 2007, NEUROSCI LETT, V429, P69, DOI 10.1016/j.neulet.2007.09.067; Summers BL, 2006, PEDIATR RES, V59, P66, DOI 10.1203/01.pdr.0000190573.23893.13; Takahashi N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014115; Tuerk MJ, 2009, CURR OPIN GASTROEN, V25, P136, DOI 10.1097/MOG.0b013e328321b395; Wohr M, 2013, BEHAV BRAIN RES, V251, P5, DOI 10.1016/j.bbr.2013.05.047; Yirmiya R, 1999, BRAIN RES, V829, P28, DOI 10.1016/S0006-8993(99)01274-3	45	15	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120263	10.1371/journal.pone.0120263	http://dx.doi.org/10.1371/journal.pone.0120263			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775356	gold, Green Published, Green Submitted			2022-12-27	WOS:000351183500162
J	Liu, Y; Duan, CH; Zhang, CX; Yang, XM; Zhao, Y; Dong, R; Zhou, JJ; Gai, ZT				Liu, Yi; Duan, Chunhong; Zhang, Chunxiu; Yang, Xiaomeng; Zhao, Yan; Dong, Rui; Zhou, Jiajing; Gai, Zhongtao			Evaluation of a Viral Microarray Based on Simultaneous Extraction and Amplification of Viral Nucleotide Acid for Detecting Human Herpesviruses and Enteroviruses	PLOS ONE			English	Article							MULTIPLEX-PCR; DNA; ENCEPHALITIS; IDENTIFICATION; EPIDEMIOLOGY; MENINGITIS; INFECTIONS	In this study, a viral microarray based assay was developed to detect the human herpesviruses and enteroviruses associated with central nervous system infections, including herpes simplex virus type 1, type 2 (HSV1 and HSV2), Epstein-Barr virus (EBV), cytomegalovirus (CMV), enterovirus 71 (EV71), coxsackievirus A 16 (CA16) and B 5(CB5). The DNA polymerase gene of human herpesviruses and 5'-untranslated region of enteroviruses were selected as the targets to design primers and probes. Human herpesviruses DNA and enteroviruses RNA were extracted simultaneously by using a guanidinium thiocyanate acid buffer, and were subsequently amplified through a biotinylated asymmetry multiplex RT-PCR with the specific primer of enteroviruses. In total, 90 blood samples and 49 cerebrospinal fluids samples with suspected systemic or neurological virus infections were investigated. Out of 139 samples, 66 were identified as positive. The specificities of this multiplex RT-PCR microarray assay were over 96% but the sensitivities were various from 100% for HSV1, HSV2, EV71 and CB5, 95.83% for CMV, 80% for EBV to 71.43% for CA16 in comparison with reference standards of TaqMan qPCR/qRT-PCR. The high Kappa values (> 0.90) from HSV1, HSV2, CMV, EV71 and CB5 were obtained, indicating almost perfect agreement in term of the 5 viruses detection. But lower Kappa values for EBV (0.63) and CA16 (0.74) displayed a moderate to substantial agreement. This study provides an innovation of simultaneous extraction, amplification, hybridization and detection of DNA viruses and RNA viruses with simplicity and specificity, and demonstrates a potential clinical utility for a variety of viruses' detection.	[Liu, Yi; Yang, Xiaomeng; Dong, Rui; Gai, Zhongtao] Shandong Univ, Qilu Childrens Hosp, Pediat Res Inst, Jinan 250100, Peoples R China; [Duan, Chunhong; Gai, Zhongtao] Shandong Univ, Qilu Childrens Hosp, Dept Pediat, Jinan 250100, Peoples R China; [Zhang, Chunxiu; Zhou, Jiajing] Shanghai Biochip Natl Engn Res Ctr, Shanghai, Peoples R China; [Zhao, Yan] Maternal & Childrens Hlth Care Inst Jinan, Clin Cent Lab, Jinan, Peoples R China	Shandong University; Shandong University	Gai, ZT (corresponding author), Shandong Univ, Qilu Childrens Hosp, Pediat Res Inst, Jinan 250100, Peoples R China.	gaizhongtao@sina.com			Natural Science Foundation of Shandong Province [Y2007C072]; Jinan Health Science and Technology Project [201327]	Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Jinan Health Science and Technology Project	This study was funded by Natural Science Foundation of Shandong Province (Y2007C072) and Jinan Health Science and Technology Project (201327). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archimbaud C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068571; Boriskin YS, 2004, J CLIN MICROBIOL, V42, P5811, DOI 10.1128/JCM.42.12.5811-5818.2004; Casaroto E, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-487; CASAS I, 1995, J VIROL METHODS, V53, P25, DOI 10.1016/0166-0934(94)00173-E; Chen P, 2013, J MED VIROL, V85, P483, DOI 10.1002/jmv.23478; Chen TC, 2006, J CLIN MICROBIOL, V44, P2212, DOI 10.1128/JCM.02393-05; Dupuis M, 2011, J MED VIROL, V83, P2172, DOI 10.1002/jmv.22169; Engelmann I, 2013, DIAGN MICR INFEC DIS, V76, P232, DOI 10.1016/j.diagmicrobio.2013.02.024; Florescu Diana F., 2011, Infectious Disorders - Drug Targets, V11, P354; Foldes-Papp Zeno, 2004, Mol Diagn, V8, P1; He J, 2009, VIRUSES-BASEL, V1, P441, DOI 10.3390/v1030441; Jaaskelainen AJ, 2006, J CLIN VIROL, V37, P83, DOI 10.1016/j.jcv.2006.05.010; Korimbocus J, 2005, J CLIN MICROBIOL, V43, P3779, DOI 10.1128/JCM.43.8.3779-3787.2005; Lee MKP, 2013, J MED VIROL, V85, P1811, DOI 10.1002/jmv.23663; Leveque N, 2014, J CLIN MICROBIOL, V52, P212, DOI 10.1128/JCM.02270-13; Mao Q, 2013, HUM VACCIN IMMUNOTHE, V10; Mathew AG, 2013, INDIAN PEDIATR, V50, P418, DOI 10.1007/s13312-013-0101-5; Miller MB, 2009, CLIN MICROBIOL REV, V22, P611, DOI 10.1128/CMR.00019-09; Rao AN, 2012, ANAL CHEM, V84, P9379, DOI 10.1021/ac302165h; Shi JR, 2010, EUR J PEDIATR, V169, P421, DOI 10.1007/s00431-009-1038-5; Singh DD, 2012, CURR MICROBIOL, V65, P290, DOI 10.1007/s00284-012-0154-z; Stahl JP, 2011, MED MALADIES INFECT, V41, P453, DOI 10.1016/j.medmal.2011.05.015; Sun Y, 2012, ANAL BIOANAL CHEM, V402, P741, DOI 10.1007/s00216-011-5459-4; Wang Z, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-577; Xu XL, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-87; Zhao HB, 2014, INDIAN J MICROBIOL, V54, P80, DOI 10.1007/s12088-013-0399-7; Zheng ZB, 2008, J MED VIROL, V80, P1042, DOI 10.1002/jmv.21131	27	4	6	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0117626	10.1371/journal.pone.0117626	http://dx.doi.org/10.1371/journal.pone.0117626			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774509	gold, Green Submitted, Green Published			2022-12-27	WOS:000351183500021
J	Picado, M; Carmona, S; Hoekzema, E; Pailhez, G; Berge, D; Mane, A; Fauquet, J; Hilferty, J; Moreno, A; Cortizo, R; Vilarroya, O; Bulbena, A				Picado, Marisol; Carmona, Susanna; Hoekzema, Elseline; Pailhez, Guillem; Berge, Daniel; Mane, Anna; Fauquet, Jordi; Hilferty, Joseph; Moreno, Ana; Cortizo, Romina; Vilarroya, Oscar; Bulbena, Antoni			The Neuroanatomical Basis of Panic Disorder and Social Phobia in Schizophrenia: A Voxel Based Morphometric Study	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; ANXIETY DISORDERS; 1ST-EPISODE SCHIZOPHRENIA; FUNCTIONAL CONNECTIVITY; LIKELIHOOD ESTIMATION; CORTICAL THICKNESS; SPECTRUM DISORDERS; NEGATIVE SYMPTOMS; VOLUME REDUCTION; BRAIN MORPHOLOGY	Objective It is known that there is a high prevalence of certain anxiety disorders among schizophrenic patients, especially panic disorder and social phobia. However, the neural underpinnings of the comorbidity of such anxiety disorders and schizophrenia remain unclear. Our study aims to determine the neuroanatomical basis of the co-occurrence of schizophrenia with panic disorder and social phobia. Methods Voxel-based morphometry was used in order to examine brain structure and to measure between-group differences, comparing magnetic resonance images of 20 anxious patients, 20 schizophrenic patients, 20 schizophrenic patients with comorbid anxiety, and 20 healthy control subjects. Results Compared to the schizophrenic patients, we observed smaller grey-matter volume (GMV) decreases in the dorsolateral prefrontal cortex and precentral gyrus in the schizophrenic-anxiety group. Additionally, the schizophrenic group showed significantly reduced GMV in the dorsolateral prefrontal cortex, precentral gyrus, orbitofrontal cortex, temporal gyrus and angular/inferior parietal gyrus when compared to the control group. Conclusions Our findings suggest that the comorbidity of schizophrenia with panic disorder and social phobia might be characterized by specific neuroanatomical and clinical alterations that may be related to maladaptive emotion regulation related to anxiety. Even thought our findings need to be replicated, our study suggests that the identification of neural abnormalities involved in anxiety, schizophrenia and schizophrenia-anxiety may lead to an improved diagnosis and management of these conditions.	[Picado, Marisol; Carmona, Susanna; Hoekzema, Elseline; Berge, Daniel; Mane, Anna; Fauquet, Jordi; Vilarroya, Oscar] Fundacio IMIM, Grp Recerca Neuroimatge, Barcelona, Spain; [Pailhez, Guillem; Berge, Daniel; Mane, Anna; Cortizo, Romina; Bulbena, Antoni] Inst Neuropsiquiatria & Addicc, Barcelona, Spain; [Carmona, Susanna] Univ Carlos III Madrid, Dept Bioingn & Ingn Aeroespacial, Madrid, Spain; [Fauquet, Jordi] Univ Autonoma Barcelona, Dept Psicobiol & Metodol Ciencies Salut, E-08193 Barcelona, Spain; [Hilferty, Joseph] Univ Barcelona, Fac Filol, Dept Filol Anglesa & Alemanya, Barcelona, Spain; [Moreno, Ana] Germanes Hosp, Fdn Invest & Docencia Maria Angustias Gimenez, Barcelona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Universidad Carlos III de Madrid; Autonomous University of Barcelona; University of Barcelona	Picado, M (corresponding author), Fundacio IMIM, Grp Recerca Neuroimatge, Barcelona, Spain.	marisol.picado@gmail.com	Bulbena, Antonio/AAG-5411-2019; Vilarroya, Oscar/AAH-3283-2021; Berge, Daniel/J-8783-2017; Fauquet Ars, Jordi/C-3961-2008	Bulbena, Antonio/0000-0003-2404-2478; Vilarroya, Oscar/0000-0001-8285-5624; Berge, Daniel/0000-0003-2544-1016; Fauquet Ars, Jordi/0000-0003-4546-6317; mane santacana, anna/0000-0003-2127-349X; Pailhez, Guillem/0000-0002-0648-5112; Hilferty, Joseph/0000-0003-2473-4562; Hoekzema, Elseline/0000-0001-5814-8647; Carmona, Susanna/0000-0001-5853-6527	Fondo de Investigacion Sanitaria [Pi052381]; FI grant of the Agencia de Gestio d' Ajuts Universitaris i de Recerca	Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); FI grant of the Agencia de Gestio d' Ajuts Universitaris i de Recerca	Funding was provided by the Fondo de Investigacion Sanitaria (Pi052381). MP is supported by a FI grant of the Agencia de Gestio d' Ajuts Universitaris i de Recerca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achim AM, 2011, SCHIZOPHRENIA BULL, V37, P811, DOI 10.1093/schbul/sbp148; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Anderson JE, 2002, SCHIZOPHR RES, V58, P123, DOI 10.1016/S0920-9964(01)00372-3; Asami T, 2008, PSYCHIAT CLIN NEUROS, V62, P322, DOI 10.1111/j.1440-1819.2008.01800.x; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Barch DM, 2001, ARCH GEN PSYCHIAT, V58, P280, DOI 10.1001/archpsyc.58.3.280; Bigler ED, 2007, DEV NEUROPSYCHOL, V31, P217, DOI 10.1080/87565640701190841; Bishop SJ, 2008, ANN NY ACAD SCI, V1129, P141, DOI 10.1196/annals.1417.016; Bremner J Douglas, 2004, Expert Rev Neurother, V4, P275, DOI 10.1586/14737175.4.2.275; Bruhl AB, 2014, HUM BRAIN MAPP, V35, P2966, DOI 10.1002/hbm.22378; Buckley P, 2011, SCHIZOPHR B, V35, P383; Bulbena A, 2005, NEUROL PSYCHIAT BR, V12, P95; Chan RCK, 2011, SCHIZOPHRENIA BULL, V37, P177, DOI 10.1093/schbul/sbp073; DELISI LE, 1995, BIOL PSYCHIAT, V38, P349, DOI 10.1016/0006-3223(94)00376-E; Diekhof EK, 2011, NEUROIMAGE, V58, P275, DOI 10.1016/j.neuroimage.2011.05.073; Eisenberg DP, 2010, NEUROPSYCHOPHARMACOL, V35, P258, DOI 10.1038/npp.2009.111; Ellison-Wright I, 2008, AM J PSYCHIAT, V165, P1015, DOI 10.1176/appi.ajp.2008.07101562; Etkin A, 2009, ARCH GEN PSYCHIAT, V66, P1361, DOI 10.1001/archgenpsychiatry.2009.104; Fornito A, 2009, SCHIZOPHR RES, V108, P104, DOI 10.1016/j.schres.2008.12.011; Frick A, 2013, NEUROSCI LETT, V536, P52, DOI 10.1016/j.neulet.2012.12.060; Glahn DC, 2008, BIOL PSYCHIAT, V64, P774, DOI 10.1016/j.biopsych.2008.03.031; Goldberg II, 2006, NEURON, V50, P329, DOI 10.1016/j.neuron.2006.03.015; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Griez E. J. L., 2001, ANXIETY DISORDERS IN; Hayano F, 2009, PSYCHIAT CLIN NEUROS, V63, P266, DOI 10.1111/j.1440-1819.2009.01960.x; Herwig U, 2007, NEUROIMAGE, V37, P652, DOI 10.1016/j.neuroimage.2007.05.023; Honea R, 2005, AM J PSYCHIAT, V162, P2233, DOI 10.1176/appi.ajp.162.12.2233; Hyman SE, 2007, NAT REV NEUROSCI, V8, P725, DOI 10.1038/nrn2218; John John P, 2009, Indian J Psychiatry, V51, P180, DOI 10.4103/0019-5545.55084; Kalisch R, 2009, NEUROSCI BIOBEHAV R, V33, P1215, DOI 10.1016/j.neubiorev.2009.06.003; Kasai K, 2003, ARCH GEN PSYCHIAT, V60, P766, DOI 10.1001/archpsyc.60.8.766; Kaufman A.S., 1990, KAUFMAN BRIEF INTELL; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Klumpp H, 2012, BIOL PSYCHOL, V89, P273, DOI 10.1016/j.biopsycho.2011.10.010; Koike S, 2011, CLIN NEUROPHYSIOL, V122, P1533, DOI 10.1016/j.clinph.2010.12.056; Lopez-Garcia P, 2006, PSYCHIAT RES-NEUROIM, V147, P153, DOI 10.1016/j.pscychresns.2006.04.007; Lysaker PH, 2007, ACTA PSYCHIAT SCAND, V116, P290, DOI 10.1111/j.1600-0447.2007.01067.x; MacDonald AW, 2005, AM J PSYCHIAT, V162, P475, DOI 10.1176/appi.ajp.162.3.475; Massana G, 2003, AM J PSYCHIAT, V160, P566, DOI 10.1176/appi.ajp.160.3.566; Meyer-Lindenberg AS, 2005, ARCH GEN PSYCHIAT, V62, P379, DOI 10.1001/archpsyc.62.4.379; Mukherjee P, 2014, SCHIZOPHRENIA BULL, V40, P152, DOI 10.1093/schbul/sbt086; Nitschke JB, 2006, NEUROIMAGE, V29, P106, DOI 10.1016/j.neuroimage.2005.06.068; O'Carroll R., 2000, ADV PSYCHIAT TREAT, V6, P161, DOI [10.1192/apt.6.3.161, DOI 10.1192/APT.6.3.161]; Ochsner KN, 2012, ANN NY ACAD SCI, V1251, pE1, DOI 10.1111/j.1749-6632.2012.06751.x; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Petrowski K, 2014, J AFFECT DISORDERS, V152, P454, DOI 10.1016/j.jad.2013.10.016; Phan KL, 2005, BIOL PSYCHIAT, V57, P210, DOI 10.1016/j.biopsych.2004.10.030; Pokos V, 2006, CURR PSYCHIATRY REV, V2, P285, DOI 10.2174/157340006778018193; Pol HEH, 2001, ARCH GEN PSYCHIAT, V58, P1118; Protopopescu X, 2006, NEUROREPORT, V17, P361, DOI 10.1097/01.wnr.0000203354.80438.1; Rametti G, 2010, SCHIZOPHR RES, V121, P66, DOI 10.1016/j.schres.2010.05.016; Rusch N, 2007, SCHIZOPHR RES, V93, P79, DOI 10.1016/j.schres.2007.01.029; Schultz CC, 2010, SCHIZOPHR RES, V116, P204, DOI 10.1016/j.schres.2009.11.001; Sobanski T, 2010, PSYCHOL MED, V40, P1879, DOI 10.1017/S0033291709991930; Spampinato MV, 2009, J NEUROPSYCH CLIN N, V21, P199, DOI 10.1176/appi.neuropsych.21.2.199; Spielberg C, 1970, STATE TRAIT ANXIETY; Sylvester CM, 2012, TRENDS NEUROSCI, V35, P527, DOI 10.1016/j.tins.2012.04.012; Takayanagi Y, 2010, SCHIZOPHR RES, V121, P55, DOI 10.1016/j.schres.2010.05.006; Talati A, 2013, BIOL PSYCHIAT, V73, P75, DOI 10.1016/j.biopsych.2012.05.022; Tang JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040247; Tibbo P, 2003, DEPRESS ANXIETY, V17, P65, DOI 10.1002/da.10083; Turnbull G, 2001, SOC PSYCH PSYCH EPID, V36, P235, DOI 10.1007/s001270170054; Uchida RR, 2008, PSYCHIAT RES-NEUROIM, V163, P21, DOI 10.1016/j.pscychresns.2007.04.015; Vita A, 2006, SCHIZOPHR RES, V82, P75, DOI 10.1016/j.schres.2005.11.004; WALDROP MF, 1968, CHILD DEV, V39, P391, DOI 10.1111/j.1467-8624.1968.tb04433.x; Wright IC, 2000, AM J PSYCHIAT, V157, P16, DOI 10.1176/ajp.157.1.16	66	6	6	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119847	10.1371/journal.pone.0119847	http://dx.doi.org/10.1371/journal.pone.0119847			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774979	Green Published, gold, Green Submitted			2022-12-27	WOS:000351183500133
J	Samad, MA; Kim, UK; Kang, JJ; Ke, QG; Kang, PM				Samad, Mohammed A.; Kim, Ui Kyoung; Kang, Joshua J.; Ke, Qingen; Kang, Peter M.			Endothelin A Receptor Antagonist, Atrasentan, Attenuates Renal and Cardiac Dysfunction in Dahl Salt-Hypertensive Rats in a Blood Pressure Independent Manner	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CONVERTING-ENZYME-INHIBITOR; CARDIOVASCULAR EVENTS; HEART-FAILURE; SELECTIVE ENDOTHELIN; EMERGING ROLE; RISK-FACTOR; BLOCKADE; ALBUMINURIA; HYPERTROPHY	Proteinuria is a hallmark of chronic kidney disease (CKD) and cardiovascular disease (CVD), and a good predictor of clinical outcome. Selective endothelin A (ETA) receptor antagonist used with renin-angiotensin system (RAS) inhibitors prevents development of proteinuria in CKD. However, whether the improvement in proteinuria would have beneficial effects on CVD, independent of RAS inhibition, is not well understood. In this study, we investigated whether atrasentan, an ETA receptor antagonist, has renal and cardiovascular effects independent of RAS inhibition. Male Dahl salt sensitive (DSS) rats, at six weeks of age, received water with or without different doses of atrasentan and/or enalapril under high salt (HS) diet or normal diet (ND) for 6 weeks. At the end of 12th week, atrasentan at a moderate dose significantly attenuated proteinuria and serum creatinine without reducing mean arterial pressure (MAP), thereby preventing cardiac hypertrophy and improving cardiac function. ACE inhibitor enalapril at a dose that did not significantly lowered BP, attenuated cardiac hypertrophy while moderately improving cardiac function without reducing proteinuria and serum creatinine level. Nonetheless, combined therapy of atrasentan and enalapril that does not altering BP exerted additional cardioprotective effect. Based on these findings, we conclude that BP independent monotherapy of ETA receptor antagonist attenuates the progression of CKD and significantly mitigates CVD independent of RAS inhibition.	[Samad, Mohammed A.; Kim, Ui Kyoung; Kang, Joshua J.; Ke, Qingen; Kang, Peter M.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Cardiovasc Inst, Boston, MA 02215 USA; [Samad, Mohammed A.; Kang, Peter M.] Chonbuk Natl Univ, Dept BIN Fus Technol, Jeonju 561756, South Korea	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Jeonbuk National University	Kang, PM (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Cardiovasc Inst, Boston, MA 02215 USA.	pkang@bidmc.harvard.edu		SAMAD, MOHAMMED/0000-0001-7329-7325	AbbVie; Brain Korea 21 Plus program from Ministry of Education, Science and Technology, South Korea	AbbVie(AbbVie); Brain Korea 21 Plus program from Ministry of Education, Science and Technology, South Korea	This study was supported in part by research support from AbbVie (PMK) and Brain Korea 21 Plus program from Ministry of Education, Science and Technology, South Korea (MAS, PMK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan A, 2005, BRIT J PHARMACOL, V146, P846, DOI 10.1038/sj.bjp.0706384; Ammarguellat FZ, 2002, HYPERTENSION, V39, P679, DOI 10.1161/hy0202.103481; Andress DL, 2012, LIFE SCI, V91, P739, DOI 10.1016/j.lfs.2012.01.011; Bae S, 2013, J APPL PHYSIOL, V114, P979, DOI 10.1152/japplphysiol.01506.2012; Bae S, 2011, CARDIOVASC RES, V91, P632, DOI 10.1093/cvr/cvr133; Barton M, 2008, NAT CLIN PRACT NEPHR, V4, P490, DOI 10.1038/ncpneph0891; Barton M, 2010, BBA-MOL BASIS DIS, V1802, P1203, DOI 10.1016/j.bbadis.2010.03.012; Bodyak N, 2007, P NATL ACAD SCI USA, V104, P16810, DOI 10.1073/pnas.0611202104; Bruzzi I, 1997, J NEPHROL, V10, P179; Callera GE, 2004, HYPERTENSION, V43, P872, DOI 10.1161/01.HYP.0000117296.30296.14; Chade AR, 2006, J AM SOC NEPHROL, V17, P3394, DOI 10.1681/ASN.2006060635; Chade AR, 2014, KIDNEY INT, V85, P833, DOI 10.1038/ki.2013.477; Chandrashekar K, 2014, J AM SOC NEPHROL, V25, P869, DOI 10.1681/ASN.2014020174; Channick RN, 2004, J AM COLL CARDIOL, V43, p62S, DOI 10.1016/j.jacc.2004.02.042; Chen SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060008; CODY RJ, 1992, CIRCULATION, V85, P504, DOI 10.1161/01.CIR.85.2.504; de Zeeuw D, 2004, CIRCULATION, V110, P921, DOI 10.1161/01.CIR.0000139860.33974.28; de Zeeuw D, 2004, KIDNEY INT, V65, P2309, DOI 10.1111/j.1523-1755.2004.00653.x; Demuth K, 1998, NEPHROL DIAL TRANSPL, V13, P375, DOI 10.1093/oxfordjournals.ndt.a027833; Dhaun N, 2009, HYPERTENSION, V54, P113, DOI 10.1161/HYPERTENSIONAHA.109.132670; El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7; Ergul A, 2000, HYPERTENSION, V36, P62, DOI 10.1161/01.HYP.36.1.62; Gagliardini E, 2009, AM J PHYSIOL-RENAL, V297, pF1448, DOI 10.1152/ajprenal.00340.2009; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Griffin KA, 2003, HYPERTENSION, V41, P201, DOI 10.1161/01.HYP.0000049881.25304.73; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Hong HM, 2011, PROTEOMICS, V11, P283, DOI 10.1002/pmic.201000018; HOSODA K, 1991, FEBS LETT, V287, P23, DOI 10.1016/0014-5793(91)80007-P; Hynynen Meri M, 2006, Recent Pat Cardiovasc Drug Discov, V1, P95; Ibsen H, 2005, HYPERTENSION, V45, P198, DOI 10.1161/01.HYP.0000154082.72286.2a; Ideishi M, 1994, Blood Press Suppl, V5, P99; INOUE A, 1989, P NATL ACAD SCI USA, V86, P2863, DOI 10.1073/pnas.86.8.2863; Jafar TH, 2003, ANN INTERN MED, V139, P244, DOI 10.7326/0003-4819-139-4-200308190-00006; Kakarla SK, 2010, BASIC RES CARDIOL, V105, P535, DOI 10.1007/s00395-010-0094-3; Kang PM, 2000, CIRC RES, V87, P118, DOI 10.1161/01.RES.87.2.118; Kang PM, 2004, AM J PHYSIOL-HEART C, V287, pH72, DOI 10.1152/ajpheart.00556.2003; Kedzierski RM, 2001, ANNU REV PHARMACOL, V41, P851, DOI 10.1146/annurev.pharmtox.41.1.851; Kelsen S, 2011, AM J PHYSIOL-RENAL, V301, pF218, DOI 10.1152/ajprenal.00089.2011; Kohan DE, 2014, KIDNEY INT, V86, P896, DOI 10.1038/ki.2014.143; Kohan DE, 2011, J AM SOC NEPHROL, V22, P763, DOI 10.1681/ASN.2010080869; Luscher TF, 2000, CIRCULATION, V102, P2434, DOI 10.1161/01.CIR.102.19.2434; Nagase M, 2006, HYPERTENSION, V47, P1084, DOI 10.1161/01.HYP.0000222003.28517.99; Nishikimi T, 2004, J HYPERTENS, V22, P1787, DOI 10.1097/00004872-200409000-00024; Opgenorth TJ, 1996, J PHARMACOL EXP THER, V276, P473; Parfrey PS, 1996, NEPHROL DIAL TRANSPL, V11, P1277; Parvanova A, 2013, LANCET DIABETES ENDO, V1, P19, DOI 10.1016/S2213-8587(13)70029-9; Parving HH, 2008, NEW ENGL J MED, V358, P2433, DOI 10.1056/NEJMoa0708379; Pieske B, 1999, CIRCULATION, V99, P1802, DOI 10.1161/01.CIR.99.14.1802; Piotrkowski B, 2009, FREE RADICAL RES, V43, P390, DOI 10.1080/10715760902801517; Plante E, 2004, CAN J PHYSIOL PHARM, V82, P191, DOI 10.1139/Y04-005; Raichlin E, 2008, HYPERTENSION, V52, P522, DOI 10.1161/HYPERTENSIONAHA.108.113068; Rich S, 2003, CIRCULATION, V108, P2184, DOI 10.1161/01.CIR.0000094397.19932.78; Ruggenenti P, 2008, J AM SOC NEPHROL, V19, P1213, DOI 10.1681/ASN.2007090970; Saleh MA, 2011, DIABETOLOGIA, V54, P979, DOI 10.1007/s00125-010-2021-4; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; Sato A, 2005, AM J HYPERTENS, V18, P44, DOI 10.1016/j.amjhyper.2004.06.029; Sharma J N, 1983, J Hypertens, V1, P251, DOI 10.1097/00004872-198310000-00009; SILBERBERG JS, 1989, KIDNEY INT, V36, P286, DOI 10.1038/ki.1989.192; Sugden PH, 2003, J MOL CELL CARDIOL, V35, P871, DOI 10.1016/S0022-2828(03)00153-6; Tanaka Ryou, 2012, Vet Med Int, V2012, P105316, DOI 10.1155/2012/105316; Turner JM, 2012, KIDNEY INT, V81, P351, DOI 10.1038/ki.2011.380; Varagic J, 2002, J MOL CELL CARDIOL, V34, P1435, DOI 10.1006/jmcc.2002.2075; Vuurmans TJL, 2003, HYPERTENSION, V41, P1253, DOI 10.1161/01.HYP.0000072982.70666.E8; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2; Wenzel RR, 2009, J AM SOC NEPHROL, V20, P655, DOI 10.1681/ASN.2008050482; Wessale JL, 2002, CLIN SCI, V103, p112S, DOI 10.1042/CS103S112S; Williams JM, 2012, HYPERTENSION, V60, P1157, DOI 10.1161/HYPERTENSIONAHA.112.199240; Xia QG, 2006, ACTA PHARMACOL SIN, V27, P1417, DOI 10.1111/j.1745-7254.2006.00447.x; Yamamoto S, 2005, CIRCULATION, V111, P302, DOI 10.1161/01.CIR.0000153351.86708.F7; Yan LD, 2010, J CARDIOVASC PHARM, V56, P246, DOI 10.1097/FJC.0b013e3181e89f36; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Yu M, 2003, J HYPERTENS, V21, P1125, DOI 10.1097/00004872-200306000-00012; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Zhang YM, 2012, J MOL CELL BIOL, V4, P97, DOI 10.1093/jmcb/mjs002	75	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0121664	10.1371/journal.pone.0121664	http://dx.doi.org/10.1371/journal.pone.0121664			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775254	Green Published, gold, Green Submitted			2022-12-27	WOS:000351183500216
J	Shi, XW; Zhang, F; Lv, AL; Wen, Y; Guo, X				Shi, Xiaowei; Zhang, Feng; Lv, Aili; Wen, Yan; Guo, Xiong			COL9A1 Gene Polymorphism Is Associated with Kashin-Beck Disease in a Northwest Chinese Han Population	PLOS ONE			English	Article							MULTIPLE EPIPHYSEAL DYSPLASIA; TANDEM REPEAT LOCI; ENDEMIC OSTEOARTHRITIS; LINKAGE ANALYSIS; CANDIDATE GENES; COLLAGEN-IX; RISK; HIP; MUTATIONS; ETIOLOGY	Objective We sought to determine whether genomic polymorphism in collagen IX genes (COL9A) was associated with Kashin-Beck disease (KBD). Methods Twenty seven single nucleotide polymorphisms (SNPs) in COL9A1, COL9A2 and COL9A3 were genotyped in 274 KBD cases and 248 healthy controls using the Sequenom MassARRAY system. Associations between the COL9A polymorphism and KBD risk were detected using an unconditional logistic regression model. Linkage disequilibrium (LD) and haplotypes analysis were performed with the Haploview software. Results After Bonferroni correction, the frequency distribution of genotypes in rs6910140 in COL9A1 was significantly different between the KBD and the control groups (X-2 = 16.74, df = 2, P = 0.0002). Regression analysis showed that the allele "C" in SNP rs6910140 had a significant protective effect on KBD [odds ratio (OR) = 0.49, 95% confidence interval (CI) = 0.34-0.70, P = 0.0001]. The frequencies of alleles and genotypes in rs6910140 were significantly different among subjects of different KBD stages (allele: X-2 = 7.82, df = 2, P = 0.02, genotype: X-2 = 14.81, df = 4, P = 0.005). However, haplotype analysis did not detect any significant association between KBD and COL9A1, COL9A2 and COL9A3. Conclusions We observed a significant association between rs6910140 of COL9A1 and KBD, suggesting a role of COL9A1 in the development of KBD.	[Shi, Xiaowei] Xi An Jiao Tong Univ, Ctr Maternal & Child Hlth Care, Affiliated Hosp 1, Med Collage, Xian 710049, Shannxi, Peoples R China; [Zhang, Feng; Lv, Aili; Wen, Yan; Guo, Xiong] Xi An Jiao Tong Univ, Key Lab Environm & Gene Related Dis, Key Lab Trace Elements & Endem Dis, Sch Publ Hlth,Hlth Sci Ctr,Minist Educ,Minist Hlt, Xian 710049, Shannxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Guo, X (corresponding author), Xi An Jiao Tong Univ, Key Lab Environm & Gene Related Dis, Key Lab Trace Elements & Endem Dis, Sch Publ Hlth,Hlth Sci Ctr,Minist Educ,Minist Hlt, Xian 710049, Shannxi, Peoples R China.	guox@mail.xjtu.edu.cn			National Natural Science Foundation of China [81273007]; Foundation of Shaanxi Province of China [2011K15-06-05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Shaanxi Province of China	This research was supported by grants from the National Natural Science Foundation of China (No. 81273007); The Foundation of Shaanxi Province of China (2011K15-06-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annunen S, 1999, SCIENCE, V285, P409, DOI 10.1126/science.285.5426.409; Bonnemann CG, 2000, P NATL ACAD SCI USA, V97, P1212, DOI 10.1073/pnas.97.3.1212; Cao J, 2008, OSTEOARTHR CARTILAGE, V16, P680, DOI 10.1016/j.joca.2007.09.002; Carlsen S, 2006, IEEE SPECTRUM, V43, P8; Chasseur C, 2001, INT ORTHOP, V25, P154, DOI 10.1007/s002640000218; Czarny-Ratajczak M, 2001, AM J HUM GENET, V69, P969, DOI 10.1086/324023; FASSLER R, 1994, P NATL ACAD SCI USA, V91, P5070, DOI 10.1073/pnas.91.11.5070; Guo X, 2014, OSTEOARTHR CARTILAGE, V22, P1774, DOI 10.1016/j.joca.2014.07.023; Ikeda T, 2002, J BONE MINER RES, V17, P1290, DOI 10.1359/jbmr.2002.17.7.1290; Jackson GC, 2010, AM J MED GENET A, V152A, P863, DOI 10.1002/ajmg.a.33240; Jakkula E, 2005, OSTEOARTHR CARTILAGE, V13, P497, DOI 10.1016/j.joca.2005.02.005; Lohiniva J, 2000, AM J MED GENET, V90, P216, DOI 10.1002/(SICI)1096-8628(20000131)90:3<216::AID-AJMG6>3.0.CO;2-1; Mathieu F, 1997, INT ORTHOP, V21, P151, DOI 10.1007/s002640050139; MENDLER M, 1989, J CELL BIOL, V108, P191, DOI 10.1083/jcb.108.1.191; Moreno-Reyes R, 1998, NEW ENGL J MED, V339, P1112, DOI 10.1056/NEJM199810153391604; Mustafa Z, 2000, RHEUMATOLOGY, V39, P299, DOI 10.1093/rheumatology/39.3.299; Paassilta P, 2001, JAMA-J AM MED ASSOC, V285, P1843, DOI 10.1001/jama.285.14.1843; Rouault K, 2009, OSTEOARTHR CARTILAGE, V17, P1099, DOI 10.1016/j.joca.2008.12.012; Seki S, 2006, J HUM GENET, V51, P1063, DOI 10.1007/s10038-006-0062-9; SHAM PC, 1995, ANN HUM GENET, V59, P97, DOI 10.1111/j.1469-1809.1995.tb01608.x; Shi XW, 2010, SCAND J RHEUMATOL, V39, P259, DOI 10.3109/03009740903270599; Shi XW, 2010, J BONE JOINT SURG AM, V92A, P72, DOI 10.2106/JBJS.H.00502; Sudre P, 2001, INT ORTHOP, V25, P175, DOI 10.1007/s002640000179; Suetens C, 2001, INT ORTHOP, V25, P180, DOI 10.1007/s002640100247; Sun T, 2006, CLIN CANCER RES, V12, P7009, DOI 10.1158/1078-0432.CCR-06-0464; Videman T, 2009, ARTHRITIS RHEUM-US, V60, P470, DOI 10.1002/art.24268; Wang S, 2013, GENE, V512, P89, DOI 10.1016/j.gene.2012.10.006; Zhang F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022983; Zhang GQ, 1989, CHIN J ENDEMIOL, V8, P27; Zhao QM, 2012, CLIN RHEUMATOL, V31, P1051, DOI 10.1007/s10067-012-1975-7; Zhou JQ, 2012, THROMB RES, V130, P602, DOI 10.1016/j.thromres.2012.05.023	31	13	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120365	10.1371/journal.pone.0120365	http://dx.doi.org/10.1371/journal.pone.0120365			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774918	Green Published, gold, Green Submitted			2022-12-27	WOS:000351183500168
J	Tsujioka, H; Kunieda, T; Katou, Y; Shirahige, K; Kubo, T				Tsujioka, Hiroshi; Kunieda, Takekazu; Katou, Yuki; Shirahige, Katsuhiko; Kubo, Takeo			Unique Gene Expression Profile of the Proliferating Xenopus Tadpole Tail Blastema Cells Deciphered by RNA-Sequencing Analysis	PLOS ONE			English	Article							LYSYL OXIDASE; REGENERATION; PLANARIAN; IDENTIFICATION; TRANSCRIPTION; CYTOKINE; BREVICAN; PROTEIN; LIMBS	Organ regenerative ability depends on the animal species and the developmental stage. The molecular bases for variable organ regenerative ability, however, remain unknown. Previous studies have identified genes preferentially expressed in the blastema tissues in various animals, but transcriptome analysis of the isolated proliferating blastema cells has not yet been reported. In the present study, we used RNA-sequencing analysis to analyze the gene expression profile of isolated proliferating blastema cells of regenerating Xenopus laevis tadpole tails. We used flow cytometry to isolate proliferating cells, and non-proliferating blastema cells, from regenerating tadpole tails as well as proliferating tail bud cells from tail bud embryos, the latter two of which were used as control cells, based on their DNA content. Among the 28 candidate genes identified by RNA-sequencing analysis, quantitative reverse transcription-polymerase chain reaction identified 10 genes whose expression was enriched in regenerating tadpole tails compared with non-regenerating tadpole tails or tails from the tail bud embryos. Among them, whole mount in situ hybridization revealed that chromosome segregation 1-like and interleukin 11 were expressed in the broad area of the tail blastema, while brevican, lysyl oxidase, and keratin 18 were mainly expressed in the notochord bud in regenerating tails. We further combined whole mount in situ hybridization with immunohistochemistry for the incorporated 5-bromo-2-deoxyuridine to confirm that keratin 18 and interleukin 11 were expressed in the proliferating tail blastema cells. Based on the proposed functions of their homologs in other animal species, these genes might have roles in the extracellular matrix formation in the notochord bud ( brevican and lysyl oxidase), cell proliferation (chromosome segregation 1-like and keratin 18), and in the maintenance of the differentiation ability of proliferating blastema cells (interleukin 11) in regenerating tadpole tails.	[Tsujioka, Hiroshi; Kunieda, Takekazu; Kubo, Takeo] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan; [Katou, Yuki; Shirahige, Katsuhiko] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 113, Japan	University of Tokyo; University of Tokyo	Kubo, T (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.	stkubo@bs.s.u-tokyo.ac.jp	KUBO, TAKEO/G-4951-2014; Tsujioka, Hiroshi/M-1343-2014; Kunieda, Takekazu/G-4946-2014	Tsujioka, Hiroshi/0000-0001-7484-4191; Kubo, Takeo/0000-0002-5914-5269; Kunieda, Takekazu/0000-0002-6256-1335	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Grant-in-Aid for Scientific Research on Innovative Areas 'Homeostatic Inflammation' from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TA, 2004, NAT STRUCT MOL BIOL, V11, P816, DOI 10.1038/nsmb813; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bamba S, 2003, AM J PHYSIOL-GASTR L, V285, pG529, DOI 10.1152/ajpgi.00050.2003; Bartz H, 2002, CLIN EXP IMMUNOL, V129, P438, DOI 10.1046/j.1365-2249.2002.01927.x; Beck CW, 2003, DEV CELL, V5, P429, DOI 10.1016/S1534-5807(03)00233-8; Chen ZQ, 2008, TRANSPLANTATION, V86, P1116, DOI 10.1097/TP.0b013e318186fec2; Corcoran JP, 1997, DEV DYNAM, V210, P355; Fang Y, 2013, P NATL ACAD SCI USA, V110, P13416, DOI 10.1073/pnas.1309810110; Frischknecht R, 2012, INT J BIOCHEM CELL B, V44, P1051, DOI 10.1016/j.biocel.2012.03.022; Fukazawa T, 2009, DEVELOPMENT, V136, P2323, DOI 10.1242/dev.033985; Gargioli C, 2004, DEVELOPMENT, V131, P2669, DOI 10.1242/dev.01155; Geach TJ, 2005, DIFFERENTIATION, V73, P414, DOI 10.1111/j.1432-0436.2005.00041.x; Grow M, 2006, DEV DYNAM, V235, P2667, DOI 10.1002/dvdy.20897; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; Isoe Y, 2012, BIOCHEM BIOPH RES CO, V423, P627, DOI 10.1016/j.bbrc.2012.05.125; James-Zorn C, 2013, NUCLEIC ACIDS RES, V41, pD865, DOI 10.1093/nar/gks1025; Kernacki KA, 1998, INFECT IMMUN, V66, P376, DOI 10.1128/IAI.66.1.376-379.1998; King MW, 2003, DEV DYNAM, V226, P398, DOI 10.1002/dvdy.10250; Kiya T, 2008, INSECT MOL BIOL, V17, P531, DOI 10.1111/j.1365-2583.2008.00821.x; Knapp D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061352; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lin GF, 2013, DEV CELL, V24, P41, DOI 10.1016/j.devcel.2012.11.017; Lin KK, 2006, METHOD ENZYMOL, V420, P255, DOI 10.1016/S0076-6879(06)20011-9; Liu SY, 2013, NATURE, V500, P81, DOI 10.1038/nature12414; Love NR, 2014, BIOESSAYS, V36, P27, DOI 10.1002/bies.201300110; Love NR, 2013, NAT CELL BIOL, V15, P222, DOI 10.1038/ncb2659; Love NR, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-70; MCGOWAN CH, 1990, MOL CELL BIOL, V10, P3847, DOI 10.1128/MCB.10.7.3847; Monaghan JR, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-1; Mukaigasa K, 2009, P NATL ACAD SCI USA, V106, P18309, DOI 10.1073/pnas.0708837106; Naora Y, 2013, BIOCHEM BIOPH RES CO, V431, P152, DOI 10.1016/j.bbrc.2013.01.005; Narva E, 2012, STEM CELLS, V30, P452, DOI 10.1002/stem.1013; Nieuwkoop DP, 1967, NORMAL TABLE OF XENO; Nishioka T, 2012, CELL STRUCT FUNCT, V37, P75, DOI 10.1247/csf.11015; Ogryzko VV, 1997, BIOCHEMISTRY-US, V36, P9493, DOI 10.1021/bi970236o; Okada N, 1991, CURR OPIN GENET DEV, V1, P498, DOI 10.1016/S0959-437X(05)80198-4; Pearl EJ, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-66; Peterson H, 2013, FRONT PHYSIOL, V4, P1, DOI [10.3389/fphys.2013.00001, DOI 10.3389/FPHYS.2013.00001]; Sander V, 2001, MECH DEVELOP, V102, P251, DOI 10.1016/S0925-4773(01)00302-1; Sikes JM, 2013, NATURE, V500, P77, DOI 10.1038/nature12403; Stefan H, 2012, XENOPUS PROTOCOLS PO; Stoick-Cooper CL, 2007, GENE DEV, V21, P1292, DOI 10.1101/gad.1540507; Tazaki A, 2005, DEV DYNAM, V233, P1394, DOI 10.1002/dvdy.20472; TERAMURA M, 1992, BLOOD, V79, P327; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trepicchio WL, 1996, J IMMUNOL, V157, P3627; Umesono Y, 2013, NATURE, V500, P73, DOI 10.1038/nature12359; WAKEFIELD L, 1983, DEV BIOL, V95, P468, DOI 10.1016/0012-1606(83)90048-9; Wasner M, 2003, GENE, V312, P225, DOI 10.1016/S0378-1119(03)00618-8; Wellmann A, 1997, AM J PATHOL, V150, P25; Whitehead GG, 2005, SCIENCE, V310, P1957, DOI 10.1126/science.1117637; Wu CH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-434	54	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0111655	10.1371/journal.pone.0111655	http://dx.doi.org/10.1371/journal.pone.0111655			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775398	gold, Green Submitted, Green Published			2022-12-27	WOS:000351183500001
J	Zhang, JQ; Meng, SY; Wen, J; Rao, GY				Zhang, Jian-Qiang; Meng, Shi-Yong; Wen, Jun; Rao, Guang-Yuan			DNA Barcoding of Rhodiola (Crassulaceae): A Case Study on a Group of Recently Diversified Medicinal Plants from the Qinghai-Tibetan Plateau	PLOS ONE			English	Article							SPECIES IDENTIFICATION; TRNL-F; CHLOROPLAST; PHYLOGENY; IDENTIFY; MATK; EVOLUTION; SELECTION; PRIMERS; REGIONS	DNA barcoding, the identification of species using one or a few short standardized DNA sequences, is an important complement to traditional taxonomy. However, there are particular challenges for barcoding plants, especially for species with complex evolutionary histories. We herein evaluated the utility of five candidate sequences-rbcL, matK, trnH-psbA, trnL-F and the internal transcribed spacer (ITS) - for barcoding Rhodiola species, a group of high-altitude plants frequently used as adaptogens, hemostatics and tonics in traditional Tibetan medicine. Rhodiola was suggested to have diversified rapidly recently. The genus is thus a good model for testing DNA barcoding strategies for recently diversified medicinal plants. This study analyzed 189 accessions, representing 47 of the 55 recognized Rhodiola species in the Flora of China treatment. Based on intraspecific and interspecific divergence and degree of monophyly statistics, ITS was the best single-locus barcode, resolving 66% of the Rhodiola species. The core combination rbcL+matK resolved only 40.4% of them. Unsurprisingly, the combined use of all five loci provided the highest discrimination power, resolving 80.9% of the species. However, this is weaker than the discrimination power generally reported in barcoding studies of other plant taxa. The observed complications may be due to the recent diversification, incomplete lineage sorting and reticulate evolution of the genus. These processes are common features of numerous plant groups in the high-altitude regions of the Qinghai-Tibetan Plateau.	[Zhang, Jian-Qiang; Meng, Shi-Yong; Rao, Guang-Yuan] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Wen, Jun] Smithsonian Inst, Natl Museum Nat Hist, Dept Bot, Washington, DC 20560 USA	Peking University; Smithsonian Institution; Smithsonian National Museum of Natural History	Wen, J (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Bot, MRC 166, Washington, DC 20560 USA.	wenj@si.edu; rao@pku.edu.cn		Meng, Shiyong/0000-0002-6855-2990	National Natural Science Foundation of China [31470313]; China Scholarship Council [201206010113]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council)	This research was supported by National Natural Science Foundation of China (Grant no. 31470313). JQZ has been supported by a scholarship for exchanging Ph.D. candidates from the China Scholarship Council (No. 201206010113) for his studies at the Smithsonian Institution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, PHARMACOPOEIA PEOPLE; Asmussen CB, 2001, AM J BOT, V88, P1103, DOI 10.2307/2657094; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Bock DG, 2014, NEW PHYTOL, V201, P1021, DOI 10.1111/nph.12560; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Chen CW, 2013, ANN BOT-LONDON, V111, P663, DOI 10.1093/aob/mct004; Cowan RS, 2006, TAXON, V55, P611, DOI 10.2307/25065638; de Groot GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016371; Dong LN, 2011, J SYST EVOL, V49, P189, DOI 10.1111/j.1759-6831.2011.00124.x; Doyle J. J., 1991, Molecular techniques in taxonomy., P283; Drummond A, 2011, GENEIOUS VERSION 7 1; Du ZY, 2011, J SYST EVOL, V49, P246, DOI 10.1111/j.1759-6831.2011.00131.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Fu K. T., 2001, FLORA CHINA, V8, P202, DOI DOI 10.11646/PHYTOTAXA.292.2.5; Fu S.H., 1984, FLORA REIPUBLICAE PO, V34, P33; Fu YM, 2011, J SYST EVOL, V49, P237, DOI 10.1111/j.1759-6831.2011.00126.x; Gu J, 2011, J SYST EVOL, V49, P213, DOI 10.1111/j.1759-6831.2011.00136.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guo X, 2011, J SYST EVOL, V49, P203, DOI 10.1111/j.1759-6831.2011.00130.x; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Ipek M, 2014, TURK J BOT, V38, P203, DOI 10.3906/bot-1308-46; JOHNSON LA, 1994, SYST BOT, V19, P143, DOI 10.2307/2419718; Joly S, 2009, AM NAT, V174, pE54, DOI 10.1086/600082; Kelly G S, 2001, Altern Med Rev, V6, P293; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2008, P NATL ACAD SCI USA, V105, P2761, DOI 10.1073/pnas.0800476105; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lei YD, 2006, GENET MOL BIOL, V29, P339, DOI 10.1590/S1415-47572006000200023; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Li DZ, 2011, J SYST EVOL, V49, P165, DOI 10.1111/j.1759-6831.2011.00137.x; Maddison WP, 2006, SYST BIOL, V55, P21, DOI 10.1080/10635150500354928; Mattioli L, 2012, PSYCHOPHARMACOLOGY, V221, P183, DOI 10.1007/s00213-012-2686-0; Mayuzumi S, 2004, SYST BOT, V29, P587, DOI 10.1600/0363644041744329; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Miller SE, 2007, P NATL ACAD SCI USA, V104, P4775, DOI 10.1073/pnas.0700466104; Nitta JH, 2008, TAXON, V57, P725, DOI 10.1002/tax.573006; OHBA H, 1978, Journal of the Faculty of Science University of Tokyo Section III Botany, V12, P139; Ohba H, 1981, J FS U TOKYO, V3, P65; Ohba H, 1982, J FS U TOKYO, V3, P121; Ohba H, 1981, J FS U TOKYO, V3, P337; Ohba H, 1993, 15 INT BOT C; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 2006, NUCLEIC ACIDS RES, V34, pW700, DOI 10.1093/nar/gkl042; RIESEBERG LH, 1994, TAXON, V43, P21, DOI 10.2307/1223457; Rohloff J, 2002, PHYTOCHEMISTRY, V59, P655, DOI 10.1016/S0031-9422(02)00004-3; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Shi LC, 2011, J SYST EVOL, V49, P261, DOI 10.1111/j.1759-6831.2011.00133.x; Spooner DM, 2009, AM J BOT, V96, P1177, DOI 10.3732/ajb.0800246; Swofford DL., 2003, PAUP PHYLOGENETIC AN; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wen J, 2007, CAN J BOT, V85, P731, DOI 10.1139/B07-071; Xiang XG, 2011, J SYST EVOL, V49, P252, DOI 10.1111/j.1759-6831.2011.00116.x; Xue CY, 2011, J SYST EVOL, V49, P267, DOI 10.1111/j.1759-6831.2011.00127.x; Yan HF, 2011, J SYST EVOL, V49, P225, DOI 10.1111/j.1759-6831.2011.00115.x; Yan TF, 2003, CONSERV GENET, V4, P213, DOI 10.1023/A:1023342723814; Yang YC, 1991, TIBET MED; Yu J, 2011, J SYST EVOL, V49, P176, DOI 10.1111/j.1759-6831.2011.00134.x; Zhang DQ, 2014, BIOCHEM SYST ECOL, V52, P14, DOI 10.1016/j.bse.2013.10.004; Zhang JQ, 2014, MOL PHYLOGENET EVOL, V77, P147, DOI 10.1016/j.ympev.2014.04.013; Zhang JQ, 2014, SYST BOT, V39, P441, DOI 10.1600/036364414X680753; Zuo YJ, 2011, PLANTA MED, V77, P182, DOI 10.1055/s-0030-1250166	70	24	28	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119921	10.1371/journal.pone.0119921	http://dx.doi.org/10.1371/journal.pone.0119921			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774915	Green Published, gold, Green Submitted			2022-12-27	WOS:000351183500141
J	Allagh, KP; Shamanna, BR; Murthy, GVS; Ness, AR; Doyle, P; Neogi, SB; Pant, HB				Allagh, Komal Preet; Shamanna, B. R.; Murthy, Gudlavalleti V. S.; Ness, Andy R.; Doyle, Pat; Neogi, Sutapa B.; Pant, Hira B.		Wellcome Trust-PHFI Folic Acid Pro	Birth Prevalence of Neural Tube Defects and Orofacial Clefts in India: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article								Background In the last two decades, India has witnessed a substantial decrease in infant mortality attributed to infectious disease and malnutrition. However, the mortality attributed to birth defects remains constant. Studies on the prevalence of birth defects such as neural tube defects and orofacial clefts in India have reported inconsistent results. Therefore, we conducted a systematic review of observational studies to document the birth prevalence of neural tube defects and orofacial clefts. Methods A comprehensive literature search for observational studies was conducted in MEDLINE and EMBASE databases using key MeSH terms (neural tube defects OR cleft lip OR cleft palate AND Prevalence AND India). Two reviewers independently reviewed the retrieved studies, and studies satisfying the eligibility were included. The quality of included studies was assessed using selected criteria from STROBE statement. Results The overall pooled birth prevalence (random effect) of neural tube defects in India is 4.5 per 1000 total births (95% CI 4.2 to 4.9). The overall pooled birth prevalence (random effect) of orofacial clefts is 1.3 per 1000 total births (95% CI 1.1 to 1.5). Subgroup analyses were performed by region, time period, consanguinity, and gender of newborn. Conclusion The overall prevalence of neural tube defects from India is high compared to other regions of the world, while that of orofacial clefts is similar to other countries. The majority of studies included in the review were hospital based. The quality of these studies ranged from low to moderate. Further well-designed, high quality community-based observational studies are needed to accurately estimate the burden of neural tube defects and orofacial clefts in India.	[Allagh, Komal Preet; Murthy, Gudlavalleti V. S.; Pant, Hira B.] Indian Inst Publ Hlth Hyderabad, Publ Hlth Fdn India, South Asia Ctr Disabil Inclus Dev & Res, Hyderabad, Andhra Pradesh, India; [Shamanna, B. R.] Univ Hyderabad, Hyderabad 500134, Andhra Pradesh, India; [Ness, Andy R.] Univ Hosp Bristol NHS Fdn Trust, Natl Inst Hlth Res, Bristol Nutr Biomed Res Unit, Bristol, Avon, England; [Ness, Andy R.] Univ Bristol, Bristol, Avon, England; [Ness, Andy R.] Univ Hosp Bristol NHS Fdn Trust, UK Natl Inst Hlth Res, Bristol Nutr Biomed Res Unit Nutr Diet & Lifestyl, Bristol, Avon, England; [Ness, Andy R.] Univ Bristol, Sch Oral & Dent Sci, Bristol, Avon, England; [Doyle, Pat] London Sch Hyg & Trop Med, London WC1, England; [Neogi, Sutapa B.] Indian Inst Publ Hlth Delhi, Publ Hlth Fdn India, Delhi, India	Public Health Foundation of India; University of Hyderabad; University of Bristol; University of Bristol; University of Bristol; University of Bristol; University of London; London School of Hygiene & Tropical Medicine; Public Health Foundation of India	Allagh, KP (corresponding author), Indian Inst Publ Hlth Hyderabad, Publ Hlth Fdn India, South Asia Ctr Disabil Inclus Dev & Res, Hyderabad, Andhra Pradesh, India.	komal.allagh@iiphh.org	Neogi, Sutapa B/AAH-9252-2020; Ness, Andy R/M-7612-2013	Ness, Andy R/0000-0003-3548-9523	Wellcome Trust- Public Health Foundation of India (PHFI) consortium; National Institute for Health Research [NF-SI-0513-10083] Funding Source: researchfish	Wellcome Trust- Public Health Foundation of India (PHFI) consortium; National Institute for Health Research(National Institute for Health Research (NIHR))	This work has been funded by the Wellcome Trust- Public Health Foundation of India (PHFI) consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S S, 1999, Indian Pediatr, V36, P643; Agbenorku P., 2013, OROFACIAL CLEFTS WOR; [Anonymous], BIRTH DEF RISK FACT; [Anonymous], 2012, CONGENITAL ANOMALIES; [Anonymous], 2013, BIRTH DEF S E AS PUB; [Anonymous], BIRTH DEF COUNT; [Anonymous], 2013, PREV CONTR BIRTH DEF; Bhat B. Vishnu, 1998, Indian Journal of Pediatrics, V65, P873, DOI 10.1007/BF02831352; Bhide P, 2013, BIRTH DEFECTS RES A, V97, P437, DOI 10.1002/bdra.23153; CHATURVEDI P, 1989, Indian Journal of Pediatrics, V56, P501, DOI 10.1007/BF02722424; Cherian A, 2005, LANCET, V366, P930, DOI 10.1016/S0140-6736(05)67319-9; CHOUDHURY A R, 1989, Indian Journal of Pediatrics, V56, P493, DOI 10.1007/BF02722422; Christianson A., 2006, GLOBAL REPORT BIRTH; Dash Sharma P, 1970, Indian J Pediatr, V37, P618; Dutta V, 2000, Indian Pediatr, V37, P998; Grover Neelam, 2000, Indian Journal of Pediatrics, V67, P249, DOI 10.1007/BF02758158; Gupta S, 2009, INDIAN J CLIN BIOCHE, V24, P150, DOI 10.1007/s12291-009-0027-9; Jaikrishan G, 2013, J COMMUN GENET, V4, P21, DOI 10.1007/s12687-012-0113-1; Khattak ST, 2008, GOMAL J MED SCI, V6; KULKARNI ML, 1987, LANCET, V1, P1260; Little J, 2008, B WORLD HEALTH ORGAN, V82, P213; Mahadevan B., 2005, Indian Journal of Pediatrics, V72, P557, DOI 10.1007/BF02724177; Master Nootani P, 1968, ACTA GENETICA STAT M, V18, P97; Mossey P, 2009, INDIAN J PLAST SURG, V42, pS9, DOI 10.4103/0970-0358.57182; Ram U, 2013, LANCET GLOB HEALTH, V1, pE219, DOI 10.1016/S2214-109X(13)70073-1; Saiyad SS, 2012, NATL J MED RES, V2, P121; SHARMA JB, 1992, INT J GYNECOL OBSTET, V39, P291, DOI 10.1016/0020-7292(92)90260-P; SOOD M, 1991, Indian Journal of Pediatrics, V58, P363, DOI 10.1007/BF02754968; Sridhar K, 2009, INDIAN J PLAST SURG, V42, pS184, DOI 10.4103/0970-0358.57191; Swain S, 1994, Indian Pediatr, V31, P1187; Taksande Amar, 2010, Indian J Hum Genet, V16, P159, DOI 10.4103/0971-6866.73412; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Verma I C, 2002, Community Genet, V5, P192, DOI 10.1159/000066335; Verma IC, 1998, INDIAN J HUMAN GENET, V4, P84; VERMA M, 1991, Indian Journal of Pediatrics, V58, P245, DOI 10.1007/BF02751129	35	33	36	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118961	10.1371/journal.pone.0118961	http://dx.doi.org/10.1371/journal.pone.0118961			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768737	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000351277500057
J	da Silva, R; Veneza, I; Sampaio, I; Araripe, J; Schneider, H; Gomes, G				da Silva, Raimundo; Veneza, Ivana; Sampaio, Iracilda; Araripe, Juliana; Schneider, Horacio; Gomes, Grazielle			High Levels of Genetic Connectivity among Populations of Yellowtail Snapper, Ocyurus chrysurus (Lutjanidae - Perciformes), in the Western South Atlantic Revealed through Multilocus Analysis	PLOS ONE			English	Article							RED SNAPPER; STATISTICAL-METHOD; DNA; MARINE; PHYLOGEOGRAPHY; SPECIATION; DIVERSITY; INFERENCE; PATTERNS; FISHES	In the present study, five loci (mitochondrial and nuclear) were sequenced to determine the genetic diversity, population structure, and demographic history of populations of the yellowtail snapper, Ocyurus chrysurus, found along the coast of the western South Atlantic. O. chrysurus is a lutjanid species that is commonly associated with coral reefs and exhibits an ample geographic distribution, and it can therefore be considered a good model for the investigation of phylogeographic patterns and genetic connectivity in marine environments. The results reflected a marked congruence between the mitochondrial and nuclear markers as well as intense gene flow among the analyzed populations, which represent a single genetic stock along the entire coast of Brazil between the states of Para and Espirito Santo. Our data also showed high levels of genetic diversity in the species (mainly mtDNA), as well a major historic population expansion, which most likely coincided with the sea level oscillations at the end of the Pleistocene. In addition, this species is intensively exploited by commercial fisheries, and data on the genetic structure of its populations will be essential for the development of effective conservation and management plans.	[da Silva, Raimundo; Veneza, Ivana; Gomes, Grazielle] Fed Univ Para, Inst Estudos Costeiros, Lab Genet Aplicada, Braganca, Para, Brazil; [Sampaio, Iracilda; Araripe, Juliana; Schneider, Horacio; Gomes, Grazielle] Fed Univ Para, Inst Estudos Costeiros, Lab Genet & Biol Mol, Braganca, Para, Brazil	Universidade Federal do Para; Universidade Federal do Para	Gomes, G (corresponding author), Fed Univ Para, Inst Estudos Costeiros, Lab Genet Aplicada, Campus Braganca, Braganca, Para, Brazil.	grazielle@ufpa.br	Gomes, Grazielle/G-9326-2019; Araripe, Juliana/U-4665-2018; Schneider, Horacio/J-7131-2012; VENEZA, IVANA/AAX-2762-2021; VENEZA, IVANA B/P-3883-2018; Araripe, Juliana/N-9071-2019; SAMPAIO, IRACILDA/J-6514-2012	Gomes, Grazielle/0000-0001-8898-0311; Araripe, Juliana/0000-0002-8014-3081; Schneider, Horacio/0000-0002-5987-6395; VENEZA, IVANA/0000-0002-3528-1290; VENEZA, IVANA B/0000-0002-3528-1290; Araripe, Juliana/0000-0002-8014-3081; SAMPAIO, IRACILDA/0000-0002-2137-4656	CNPq [306233/2009-6]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding for this research was provided by CNPq (grants 306233/2009-6 to IS, 306233/2009-6 to HS and a young scientist scholarship to RS). The funders had no role in study design, data collection and analysis.	ALLEN G.R., 1985, FAO SPECIES CATALOGU, V6; [Anonymous], PECES MARINHOS VENEZ; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Barreto AMF, 2002, PALAEOGEOGR PALAEOCL, V179, P57, DOI 10.1016/S0031-0182(01)00408-4; Bellwood David R., 2002, P5, DOI 10.1016/B978-012615185-5/50003-7; Benjamini Y, 2001, ANN STAT, V29, P1165; Bernardi G, 2013, MOL ECOL, V22, P5487, DOI 10.1111/mec.12494; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Craig MT, 2006, J BIOGEOGR, V33, P969, DOI 10.1111/j.1365-2699.2006.01467.x; de Oliveira JN, 2014, MOL PHYLOGENET EVOL, V77, P275, DOI 10.1016/j.ympev.2014.04.019; DeWoody JA, 2000, J FISH BIOL, V56, P461, DOI 10.1111/j.1095-8649.2000.tb00748.x; Dmitriev DA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000113; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Eytan RI, 2010, EVOLUTION, V64, P3380, DOI 10.1111/j.1558-5646.2010.01071.x; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Iriarte PJF, 2011, SCI MAR, V75, P701, DOI 10.3989/scimar.2011.75n4701; Floeter SR, 2008, J BIOGEOGR, V35, P22, DOI 10.1111/j.1365-2699.2007.01790.x; Freitas MO, 2011, SCI MAR, V75, P135, DOI 10.3989/scimar.2011.75n1135; Fu YX, 1997, GENETICS, V147, P915; Gaither MR, 2012, P ROY SOC B-BIOL SCI, V279, P3948, DOI 10.1098/rspb.2012.1481; Gaither MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028913; Gaither MR, 2010, J BIOGEOGR, V37, P133, DOI 10.1111/j.1365-2699.2009.02188.x; Garber AF, 2004, MAR BIOTECHNOL, V6, P175, DOI 10.1007/s10126-003-0023-7; Gold JR, 2011, N AM J FISH MANAGE, V31, P209, DOI 10.1080/02755947.2011.568864; Gomes G, 2008, GENET MOL BIOL, V31, P372, DOI 10.1590/S1415-47572008000200035; Gomes G, 2012, AN ACAD BRAS CIENC, V84, P979, DOI 10.1590/S0001-37652012000400013; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hassan M, 2002, MOL ECOL NOTES, V2, P334, DOI 10.1046/j.1471-8286.2002.00236.x; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hoarau G, 2005, P ROY SOC B-BIOL SCI, V272, P497, DOI 10.1098/rspb.2004.2963; Hoareau TB, 2012, MOL PHYLOGENET EVOL, V62, P566, DOI 10.1016/j.ympev.2011.10.004; Hogan JD, 2007, B MAR SCI, V80, P219; HUDSON RR, 1985, GENETICS, V111, P147; Huelsenbeck JP, 2011, EVOL BIOINFORM, V7, P55, DOI 10.4137/EBO.S6761; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jarman SN, 2002, MAR BIOTECHNOL, V4, P347, DOI 10.1007/s10126-002-0029-6; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Karlsson S, 2009, MAR BIOL, V156, P1841, DOI 10.1007/s00227-009-1217-y; Khodri M, 2001, NATURE, V410, P570, DOI 10.1038/35069044; LEE WJ, 1995, J MOL EVOL, V41, P54; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lindeman Kenneth C., 2001, Proceedings of the Gulf and Caribbean Fisheries Institute, V52, P732; Lindholm J., 2005, MOVEMENT YELLOWTAIL; Luiz OJ, 2012, P ROY SOC B-BIOL SCI, V279, P1033, DOI 10.1098/rspb.2011.1525; Menezes NA, 1980, MANUAL PEIXES MARINH, VIV; Nei M., 1987, MOL EVOLUTIONARY GEN; Ovenden JR, 2015, FISH FISH, V16, P125, DOI 10.1111/faf.12052; PAITHANKAR KR, 1991, NUCLEIC ACIDS RES, V19, P1346, DOI 10.1093/nar/19.6.1346; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; PETERSON RG, 1991, PROG OCEANOGR, V26, P1, DOI 10.1016/0079-6611(91)90006-8; Phillips NM, 2011, MAR BIOL, V158, P903, DOI 10.1007/s00227-010-1617-z; Pinsky ML, 2014, MOL ECOL, V23, P29, DOI 10.1111/mec.12509; Planes Serge, 2002, P201, DOI 10.1016/B978-012615185-5/50012-8; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A., 2007, TRACER V1 4; Ray N, 2003, MOL BIOL EVOL, V20, P76, DOI 10.1093/molbev/msg009; Rocha LA, 2003, J BIOGEOGR, V30, P1161, DOI 10.1046/j.1365-2699.2003.00900.x; Rocha LA, 2005, P ROY SOC B-BIOL SCI, V272, P573, DOI 10.1098/2004.3005; Rocha LA, 2002, MOL ECOL, V11, P243, DOI 10.1046/j.0962-1083.2001.01431.x; Rocha LA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-157; Rodrigues-Filho LFS, 2011, THESIS U FEDERAL; Rodriguez-Rey GT, 2014, MAR FRESHWATER RES, V65, P59, DOI 10.1071/MF12359; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rousset F, 1997, GENETICS, V145, P1219; Sachs JP, 2001, SCIENCE, V293, P2077, DOI 10.1126/science.1063584; Saillant EA, 2012, FISHERIES MANAG ECOL, V19, P301, DOI 10.1111/j.1365-2400.2011.00840.x; Salzburger W, 2011, MOL ECOL, V20, P1952, DOI 10.1111/j.1365-294X.2011.05066.x; Sambrook J, 1989, MOL CLONING; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Selkoe KA, 2014, MOL ECOL, V23, P3064, DOI 10.1111/mec.12804; Sevilla RG, 2007, MOL ECOL NOTES, V7, P730, DOI 10.1111/j.1471-8286.2007.01863.x; SHULMAN MJ, 1995, EVOLUTION, V49, P897, DOI 10.1111/j.1558-5646.1995.tb02325.x; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Varela AI, 2012, MAR BIOL, V159, P1049, DOI 10.1007/s00227-012-1885-x; Vasconcellos AV, 2008, GENET MOL BIOL, V31, P308, DOI 10.1590/S1415-47572008000200026; WALLACE RK, 1977, B MAR SCI, V27, P292; Watson M, 2002, MAR ECOL PROG SER, V237, P247, DOI 10.3354/meps237247; Weir BS, 2002, ANNU REV GENET, V36, P721, DOI 10.1146/annurev.genet.36.050802.093940; Wieman AC, 2014, MAR BIOL, V161, P173, DOI 10.1007/s00227-013-2327-0; Zhang JB, 2006, ICES J MAR SCI, V63, P693, DOI 10.1016/j.icesjms.2006.01.004	87	13	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0122173	10.1371/journal.pone.0122173	http://dx.doi.org/10.1371/journal.pone.0122173			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25769032	Green Submitted, Green Published, gold			2022-12-27	WOS:000351277500147
J	Tropea, C; Stumpf, L; Greco, LSL				Tropea, Carolina; Stumpf, Liane; Lopez Greco, Laura Susana			Effect of Temperature on Biochemical Composition, Growth and Reproduction of the Ornamental Red Cherry Shrimp Neocaridina heteropoda heteropoda (Decapoda, Caridea)	PLOS ONE			English	Article							LOBSTER JASUS-EDWARDSII; SEASONAL-VARIATIONS; LARVAL DEVELOPMENT; EMBRYONIC-DEVELOPMENT; CANCER-SETOSUS; CRUSTACEA; SURVIVAL; INCUBATION; SALINITY; CRAB	The effect of water temperature on biochemical composition, growth and reproduction of the ornamental shrimp, Neocaridina heteropoda heteropoda, was investigated to determine the optimum temperature for its culture. The effect of embryo incubation temperature on the subsequent performance of juveniles was also evaluated. Ovigerous females and recently hatched juveniles (JI) were maintained during egg incubation and for a 90-day period, respectively, at three temperatures (24, 28 and 32 degrees C). Incubation period increased with decreasing water temperature, but the number and size of JI were similar among treatments. At day 30 of the 90-day period, body weight and growth increment (GI) at 24 degrees C were lower than those at 28 and 32 degrees C. On subsequent days, GI at 24 degrees C exceeded that at 28 and 32 degrees C, leading to a similar body weight among treatments. These results suggest growth was delayed at 24 degrees C, but only for 30 days after hatching. The lipid concentration tended to be lowest, intermediate and highest at 28, 32 and 24 degrees C, respectively, possibly as a consequence of the metabolic processes involved in growth and ovarian maturation. Protein and glycogen concentrations were similar among treatments. Both the growth trajectory and biochemical composition of shrimps were affected by the temperature experienced during the 90-day growth period independently of the embryo incubation temperature. During the growth period, shrimps reached sexual maturity and mated, with the highest proportion of ovigerous females occurring at 28 degrees C. All the females that matured and mated at 32 degrees C lost their eggs, indicating a potentially stressful effect of high temperature on ovarian maturation. Based on high survival and good growth performance of shrimps at the three temperatures tested over the 90-day period it is concluded that N. heteropoda heteropoda is tolerant to a wide range of water temperatures, with 28 degrees C being the optimum temperature for its culture.	[Tropea, Carolina; Stumpf, Liane; Lopez Greco, Laura Susana] Univ Buenos Aires, FCEyN, Dept Biodivers & Expt Biol, Biol Reprod & Growth Crustaceans, Buenos Aires, DF, Argentina; [Tropea, Carolina; Stumpf, Liane; Lopez Greco, Laura Susana] CONICET UBA, IBBEA, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Greco, LSL (corresponding author), Univ Buenos Aires, FCEyN, Dept Biodivers & Expt Biol, Biol Reprod & Growth Crustaceans, Cdad Univ C1428EHA, Buenos Aires, DF, Argentina.	laura@bg.fcen.uba.ar			(CT LS LLG) Agencia Nacional de Promocion Cientifica y Tecnologica (PICT) [01187, 1333]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP) [112-201101-00212]; Universidad de Buenos Aires Ciencia y Tecnica [20020100100003]; Ministerio de Ciencia, Tecnologia e Innovacion Producitiva-Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [BR/11/21]	(CT LS LLG) Agencia Nacional de Promocion Cientifica y Tecnologica (PICT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires Ciencia y Tecnica; Ministerio de Ciencia, Tecnologia e Innovacion Producitiva-Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Funding provided by (CT LS LLG) Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 2007, project 01187 and PICT 2012, project 1333), Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP 2012-2014, number 112-201101-00212), Universidad de Buenos Aires Ciencia y Tecnica (project 20020100100003) and Ministerio de Ciencia, Tecnologia e Innovacion Producitiva-Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)BR/11/21. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSLER MO, 1984, J CRUSTACEAN BIOL, V4, P546, DOI 10.2307/1548068; Anger K, 2004, J EXP MAR BIOL ECOL, V306, P217, DOI 10.1016/j.jembe.2004.01.010; Arnberg M, 2013, MAR BIOL, V160, P2037, DOI 10.1007/s00227-012-2072-9; Bergstrom BI, 2000, ADV MAR BIOL, V38, P55, DOI 10.1016/S0065-2881(00)38003-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brillon S, 2005, MAR BIOL, V147, P895, DOI 10.1007/s00227-005-1633-6; Buckup L, 2008, COMP BIOCHEM PHYS A, V149, P59, DOI 10.1016/j.cbpa.2007.10.008; Cai Yi-xiong, 1996, Acta Zootaxonomica Sinica, V21, P129; Calado R, 2005, AQUACULTURE, V245, P221, DOI 10.1016/j.aquaculture.2004.11.034; Calado R., 2009, MARINE ORNAMENTAL SH; CHILDRESS JJ, 1990, DEEP-SEA RES, V37, P929, DOI 10.1016/0198-0149(90)90104-4; da Silva-Castiglioni D, 2007, COMP BIOCHEM PHYS A, V148, P204, DOI 10.1016/j.cbpa.2007.04.005; Dahlhoff EP, 2004, ANNU REV PHYSIOL, V66, P183, DOI 10.1146/annurev.physiol.66.032102.114509; Dutra BK, 2006, IHERINGIA SER ZOOL, V98, P355; Fischer S, 2009, J EXP MAR BIOL ECOL, V374, P160, DOI 10.1016/j.jembe.2009.04.019; Fischer S, 2009, MAR ECOL PROG SER, V377, P193, DOI 10.3354/meps07845; FOLCH J, 1957, J BIOL CHEM, V226, P497; Garcia-Guerrero M, 2003, COMP BIOCHEM PHYS A, V135, P147, DOI 10.1016/S1095-6433(02)00354-9; Garcia-Guerrero MU, 2010, J WORLD AQUACULT SOC, V41, P84, DOI 10.1111/j.1749-7345.2009.00336.x; Hamasaki K, 2003, AQUACULTURE, V219, P561, DOI 10.1016/S0044-8486(02)00662-2; Hartnoll RG, 2001, HYDROBIOLOGIA, V449, P111, DOI 10.1023/A:1017597104367; Heerbrandt TC, 2006, J WORLD AQUACULT SOC, V37, P186, DOI 10.1111/j.1749-7345.2006.00025.x; Holland D.L., 1978, Biochemical and Biophysical Perspectives in Marine Biology, V4, P85; Kumlu M, 2000, AQUACULTURE, V188, P167, DOI 10.1016/S0044-8486(00)00330-6; Lemos D, 2001, AQUACULTURE, V199, P131, DOI 10.1016/S0044-8486(01)00523-3; Morris S, 1998, S AFR J ZOOL, V33, P87; MOURENTE G, 1991, MAR BIOL, V110, P21, DOI 10.1007/BF01313088; Nelson K., 1991, Crustacean Issues, V7, P77; Nur F.A.H., 2013, Asian Journal of Animal and Veterinary Advances, V8, P108; Oliveira GT, 2004, COMP BIOCHEM PHYS A, V137, P383, DOI 10.1016/j.cbpb.2003.10.017; Palacios E, 2000, AQUACULTURE, V185, P353, DOI 10.1016/S0044-8486(99)00362-2; Parado-Estepa FD, 1998, ISR J AQUACULT-BAMID, V50, P174; Paula J, 2001, HYDROBIOLOGIA, V449, P141, DOI 10.1023/A:1017505506184; Perez-Velazquez M, 2003, AQUAC RES, V34, P1205, DOI 10.1046/j.1365-2109.2003.00931.x; Portner HO, 2005, SCI MAR, V69, P271; Ritar AJ, 2003, COMP BIOCHEM PHYS A, V136, P353, DOI 10.1016/S1095-6433(03)00167-3; SHIRLEY SM, 1987, MAR BIOL, V95, P371, DOI 10.1007/BF00409567; Smith GG, 2002, AQUACULTURE, V209, P157, DOI 10.1016/S0044-8486(01)00758-X; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Tong LJ, 2000, MAR FRESHWATER RES, V51, P243, DOI 10.1071/MF99049; Tropea C, 2012, J CRUSTACEAN BIOL, V32, P883, DOI 10.1163/1937240X-00002103; Urzua A, 2013, HELGOLAND MAR RES, V67, P267, DOI 10.1007/s10152-012-0321-4; VANHANDEL E, 1965, ANAL BIOCHEM, V11, P256, DOI 10.1016/0003-2697(65)90013-8; Wang WN, 2006, AQUACULTURE, V256, P624, DOI 10.1016/j.aquaculture.2006.02.009; WEAR RG, 1974, J MAR BIOL ASSOC UK, V54, P745, DOI 10.1017/S0025315400022918; Wehrtmann IS, 2003, J NAT HIST, V37, P2165, DOI 10.1080/00222930210133291; Weiss M, 2009, J EXP MAR BIOL ECOL, V376, P48, DOI 10.1016/j.jembe.2009.06.002	47	50	50	4	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119468	10.1371/journal.pone.0119468	http://dx.doi.org/10.1371/journal.pone.0119468			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768918	Green Published, gold, Green Submitted			2022-12-27	WOS:000351277500082
J	Akanda, ZZ; Naeem, A; Russell, E; Belrose, J; Si, FF; Hodge, WG				Akanda, Zarique Z.; Naeem, Abdul; Russell, Elizabeth; Belrose, Jillian; Si, Francie F.; Hodge, William G.			Graft Rejection Rate and Graft Failure Rate of Penetrating Keratoplasty (PKP) vs Lamellar Procedures: A Systematic Review	PLOS ONE			English	Article							DEEP ANTERIOR LAMELLAR; AUTOMATED ENDOTHELIAL KERATOPLASTY; KERATOCONUS; OUTCOMES; RISK; EYES	Purpose The aim of our investigation was to conduct a quantitative meta-analysis of the present world literature comparing the major surgical outcomes of penetrating keratoplasty (PKP) to lamellar procedures. Our goal is that clinicians, eye bank administrators, and health policy makers will be able to utilize this study in implementing decisions in regards to corneal transplantation. Methods Pooled measures of association were with odds ratios and because of study heterogeneity, the pooled effects were assumed to follow a random effects model (DerSimonian-Laird). The comparisons were between 1) PKP's and all lamellar procedures (anterior AND posterior) and then 2) between PKP's and all anterior lamellar procedures and 3) PKP and all posterior lamellar procedures. Results For PKP vs anterior lamellar procedures, the pooled odds ratio for rejection of PKP over lamellar keratoplasty (LK) was 3.56 (95% CI: 1.76-7.20) and for outright failure, the pooled odds ratio of PKP failure vs LK was 2.85 (95% CI: 0.84-9.66). For posterior lamellar procedures, the pooled odds ratio for rejection of PKP over LK was 1.52 (95% CI: 1.00-2.32). The pooled odds ratio for outright failure of PKP over posterior lamellar procedures was 2.09 (95% CI: 0.57-7.59). The follow up time was significantly longer for full transplants than for lamellar procedures. Conclusions For both anterior and posterior lamellar procedures, the odds ratios comparing rejection of full transplants to lamellar procedures (both anterior and posterior individually) were significantly higher in the PKP group. For outright failure, the PKP group also had a higher risk of failure than the lamellar groups but this was not statistically significant in either instance ( anterior or posterior). Some of the clinical differences benefitting lamellar procedures may at least be partly explained by follow up time differences between groups and this needs to be accounted for more rigorously in future studies.	[Akanda, Zarique Z.; Naeem, Abdul; Belrose, Jillian] Univ Western Ontario, London, ON, Canada; [Russell, Elizabeth] St Joseph Hlth Care, London, ON, Canada; [Si, Francie F.; Hodge, William G.] Univ Western Ontario, Ivey Eye Inst, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Hodge, WG (corresponding author), Univ Western Ontario, Ivey Eye Inst, London, ON, Canada.	William.Hodge@sjhc.london.on.ca		Akanda, Zarique/0000-0001-9383-4255	Academic Medical Organization of Southwestern Ontario (AMOSO) AFP Innovation Fund (Ontario, Canada) [INN12-010]	Academic Medical Organization of Southwestern Ontario (AMOSO) AFP Innovation Fund (Ontario, Canada)	Academic Medical Organization of Southwestern Ontario (AMOSO) AFP Innovation Fund (Ontario, Canada) (INN12-010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan BDS, 2007, CORNEA, V26, P1039, DOI 10.1097/ICO.0b013e31812f66e5; Anshu A, 2012, OPHTHALMOLOGY, V119, P536, DOI 10.1016/j.ophtha.2011.09.019; Anshu A, 2009, OPHTHALMOLOGY, V116, P615, DOI 10.1016/j.ophtha.2008.12.043; Borderie VM, 2008, ARCH OPHTHALMOL-CHIC, V126, P31, DOI 10.1001/archophthalmol.2007.12; Borderie VM, 2012, OPHTHALMOLOGY, V119, P249, DOI 10.1016/j.ophtha.2011.07.057; Borderie VM, 2009, OPHTHALMOLOGY, V116, P2354, DOI 10.1016/j.ophtha.2009.05.009; Cassidy D, 2013, CLIN EXP OPTOM, V96, P165, DOI 10.1111/cxo.12047; Ceccuzzi R, 2010, OPHTHALMOLOGICA, V224, P247, DOI 10.1159/000277615; Cheng YYY, 2011, AM J OPHTHALMOL, V152, P556, DOI 10.1016/j.ajo.2011.03.012; Cheng YYY, 2011, OPHTHALMOLOGY, V118, P302, DOI 10.1016/j.ophtha.2010.06.005; Cheng YYY, 2009, TRANSPLANTATION, V88, P1294, DOI 10.1097/TP.0b013e3181bc419c; Croasdale CR, 2013, CORNEA, V32, P280, DOI 10.1097/ICO.0b013e3182561305; Fasolo A, 2011, CORNEA, V30, P1328, DOI 10.1097/ICO.0b013e318206895a; Funnell CL, 2006, EYE, V20, P527, DOI 10.1038/sj.eye.6701903; Gorovoy MS, 2014, CORNEA, V33, P101, DOI 10.1097/ICO.0000000000000023; Han DCY, 2009, AM J OPHTHALMOL, V148, P744, DOI 10.1016/j.ajo.2009.05.028; Heidemann DG, 2008, CORNEA, V27, P161, DOI 10.1097/ICO.0b013e31815b8304; Hjortdal J, 2009, ACTA OPHTHALMOL, V87, P310, DOI 10.1111/j.1755-3768.2008.01492.x; Jones MNA, 2009, INVEST OPHTH VIS SCI, V50, P5625, DOI 10.1167/iovs.09-3994; Kawashima M, 2006, AM J OPHTHALMOL, V142, P304, DOI 10.1016/j.ajo.2006.03.057; Krurneich JH, 2008, KLIN MONATSBL AUGENH, V225, P637, DOI 10.1055/s-2008-1027485; Lass JH, 2008, OPHTHALMOLOGY, V115, P627, DOI [10.1016/j.ophtha.2008,01.004, 10.1016/j.ophtha.2008.01.004]; MacIntyre R, 2014, CORNEA, V33, P6, DOI 10.1097/ICO.0b013e3182a9fbfd; Price FW, 2006, J CATARACT REFR SURG, V32, P411, DOI 10.1016/j.jcrs.2005.12.078; Price MO, 2013, OPHTHALMOLOGY, V120, P246, DOI 10.1016/j.ophtha.2012.08.007; Price MO, 2010, OPHTHALMOLOGY, V117, P438, DOI 10.1016/j.ophtha.2009.07.036; Rudolph M, 2012, OPHTHALMOLOGY, V119, P528, DOI 10.1016/j.ophtha.2011.08.034; Shimazaki J, 2002, AM J OPHTHALMOL, V134, P159, DOI 10.1016/S0002-9394(02)01523-4; Tan DTH, 2010, BRIT J OPHTHALMOL, V94, P1295, DOI 10.1136/bjo.2009.167528; Tan DTH, 2008, OPHTHALMOLOGY, V115, P975, DOI 10.1016/j.ophtha.2007.08.049; Tan DTH, 2012, LANCET, V379, P1749, DOI 10.1016/S0140-6736(12)60437-1; Thompson RW, 2003, OPHTHALMOLOGY, V110, P1396, DOI 10.1016/S0161-6420(03)00463-9; Trimarchi F, 2001, OPHTHALMOLOGICA, V215, P389, DOI 10.1159/000050894; Watson SL, 2004, OPHTHALMOLOGY, V111, P1676, DOI 10.1016/j.ophtha.2004.02.010; Wu SQ, 2012, AM J OPHTHALMOL, V153, P291, DOI 10.1016/j.ajo.2011.07.020	35	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119934	10.1371/journal.pone.0119934	http://dx.doi.org/10.1371/journal.pone.0119934			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781319	gold, Green Published, Green Submitted			2022-12-27	WOS:000351284600109
J	Asamitsu, K; Hirokawa, T; Hibi, Y; Okamoto, T				Asamitsu, Kaori; Hirokawa, Takatsugu; Hibi, Yurina; Okamoto, Takashi			Molecular Dynamics Simulation and Experimental Verification of the Interaction between Cyclin T1 and HIV-1 Tat Proteins	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN P-TEFB; TRANSCRIPTIONAL ACTIVATION; IN-VITRO; KINASE; TRANSACTIVATION; ELONGATION; COMPLEX; RNA; REPLICATION	The viral encoded Tat protein is essential for the transcriptional activation of HIV proviral DNA. Interaction of Tat with a cellular transcription elongation factor P-TEFb containing CycT1 is critically required for its action. In this study, we performed MD simulation using the 3D data for wild-type and 4CycT1mutants3D data. We found that the dynamic structural change of CycT1 H2' helix is indispensable for its activity for the Tat action. Moreover, we detected flexible structural changes of the Tat-recognition cavity in the WT CycT1 comprising of ten AAs that are in contact with Tat. These structural fluctuations in WT were lost in the CycT1 mutants. We also found the critical importance of the hydrogen bond network involving H1, H1' and H2 helices of CycT1. Since similar AA substitutions of the Tat-CycT1 chimera retained the Tat-supporting activity, these interactions are considered primarily involved in interaction with Tat. These findings described in this paper should provide vital information for the development of effective anti-Tat compound.	[Asamitsu, Kaori; Hibi, Yurina; Okamoto, Takashi] Nagoya City Univ, Grad Sch Med Sci, Dept Mol & Cellular Biol, Nagoya, Aichi, Japan; [Hirokawa, Takatsugu] Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery Molprof, Tokyo, Japan	Nagoya City University; National Institute of Advanced Industrial Science & Technology (AIST)	Okamoto, T (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Mol & Cellular Biol, Nagoya, Aichi, Japan.	tokamoto@med.nagoya-cu.ac.jp		Asamitsu, Kaori/0000-0001-5333-8011	Research on HIV/AIDS; Ministry of Health, Labour and Welfare of Japan, JSPS KAKENHI [21390142]; IMAI MEMORIAL TRUST FOR AIDS RESEARCH; Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan	Research on HIV/AIDS; Ministry of Health, Labour and Welfare of Japan, JSPS KAKENHI; IMAI MEMORIAL TRUST FOR AIDS RESEARCH; Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was partially supported by grants form Grants-in-Aid from Research on HIV/AIDS, the Ministry of Health, Labour and Welfare of Japan, JSPS KAKENHI Grant Number 21390142, The IMAI MEMORIAL TRUST FOR AIDS RESEARCH, Grant-in-Aid for Research in Nagoya City University, and Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Asamitsu K, 2011, J MOL BIOL, V410, P887, DOI 10.1016/j.jmb.2011.04.061; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bieniasz PD, 1998, EMBO J, V17, P7056, DOI 10.1093/emboj/17.23.7056; Chao SH, 2000, J BIOL CHEM, V275, P28345, DOI 10.1074/jbc.C000446200; Clavel F, 2004, NEW ENGL J MED, V350, P1023, DOI 10.1056/NEJM2ra025195; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Fujinaga K, 2002, J VIROL, V76, P12934, DOI 10.1128/JVI.76.24.12934-12939.2002; Fujinaga K, 2002, J VIROL, V76, P10873, DOI 10.1128/JVI.76.21.10873-10881.2002; Fujinaga K, 1999, P NATL ACAD SCI USA, V96, P1285, DOI 10.1073/pnas.96.4.1285; Fujinaga K, 1998, J VIROL, V72, P7154, DOI 10.1128/JVI.72.9.7154-7159.1998; Garber ME, 1998, COLD SPRING HARB SYM, V63, P371, DOI 10.1101/sqb.1998.63.371; Garber ME, 1998, GENE DEV, V12, P3512, DOI 10.1101/gad.12.22.3512; GARCIA AE, 1992, PHYS REV LETT, V68, P2696, DOI 10.1103/PhysRevLett.68.2696; Goh CS, 2004, CURR OPIN STRUC BIOL, V14, P104, DOI 10.1016/j.sbi.2004.01.005; Hamasaki T, 2013, ANTIMICROB AGENTS CH, V57, P1323, DOI 10.1128/AAC.01711-12; Hornak V, 2006, J AM CHEM SOC, V128, P2812, DOI 10.1021/ja058211x; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Ivanov D, 1999, J MOL BIOL, V288, P41, DOI 10.1006/jmbi.1999.2663; Jadlowsky JK, 2008, J GEN VIROL, V89, P2783, DOI 10.1099/vir.0.2008/002857-0; Karn J, 1999, J MOL BIOL, V293, P235, DOI 10.1006/jmbi.1999.3060; Kuzmina A, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-51; Mancebo HSY, 1997, GENE DEV, V11, P2633, DOI 10.1101/gad.11.20.2633; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; Mbonye UR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003338; Miller F, 2005, J BIOL CHEM, V280, P7985, DOI 10.1074/jbc.M413160200; Miteva MA, 2004, BIOPHYS J, V86, P488, DOI 10.1016/S0006-3495(04)74127-2; MUNOZ V, 1994, NAT STRUCT BIOL, V1, P399, DOI 10.1038/nsb0694-399; Okamoto H, 2000, VIROLOGY, V272, P402, DOI 10.1006/viro.2000.0396; Peng JM, 1998, GENE DEV, V12, P755, DOI 10.1101/gad.12.5.755; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Petukhov M, 1999, PROTEIN SCI, V8, P2144, DOI 10.1110/ps.8.10.2144; Petukhov M, 2002, PROTEIN SCI, V11, P766, DOI 10.1110/ps.2610102; Sarol LC, 2002, BIOCHEM BIOPH RES CO, V291, P890, DOI 10.1006/bbrc.2002.6532; STICKLE DF, 1992, J MOL BIOL, V226, P1143, DOI 10.1016/0022-2836(92)91058-W; Tahirov TH, 2010, NATURE, V465, P747, DOI 10.1038/nature09131; Takada N, 2002, J VIROL, V76, P8019, DOI 10.1128/JVI.76.16.8019-8030.2002; Taube R, 1999, VIROLOGY, V264, P245, DOI 10.1006/viro.1999.9944; Toth G, 2006, BIOCHEMISTRY-US, V45, P6606, DOI 10.1021/bi060188k; Verstraete N, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-50; Wang D, 2001, J VIROL, V75, P7266, DOI 10.1128/JVI.75.16.7266-7279.2001; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	44	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119451	10.1371/journal.pone.0119451	http://dx.doi.org/10.1371/journal.pone.0119451			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781978	Green Published, gold, Green Submitted			2022-12-27	WOS:000351284600064
J	Dunlop, A; Welsh, L; McQuaid, D; Dean, J; Gulliford, S; Hansen, V; Bhide, S; Nutting, C; Harrington, K; Newbold, K				Dunlop, Alex; Welsh, Liam; McQuaid, Dualta; Dean, Jamie; Gulliford, Sarah; Hansen, Vibeke; Bhide, Shreerang; Nutting, Chris; Harrington, Kevin; Newbold, Kate			Brain-Sparing Methods for IMRT of Head and Neck Cancer	PLOS ONE			English	Article							NASOPHARYNGEAL CARCINOMA; COGNITIVE DECLINE; RADIATION-THERAPY; RADIOTHERAPY; CISPLATIN; TUMORS	Purpose Radical radiotherapy for head and neck cancer (HNC) may deliver significant doses to brain structures. There is evidence that this may cause a decline in neurocognitive function (NCF). Radiation dose to the medial temporal lobes, and particularly to the hippocampi, seems to be critical in determining NCF outcomes. We evaluated the feasibility of two alternative intensity-modulated radiotherapy (IMRT) techniques to generate hippocampus-and brain-sparing HNC treatment plans to preserve NCF. Methods and Materials A planning study was undertaken for ten patients with HNC whose planning target volume (PTV) included the nasopharynx. Patients had been previously treated using standard (chemo)-IMRT techniques. Bilateral hippocampi were delineated according to the RTOG atlas, on T1w MRI co-registered to the RT planning CT. Hippocampus-sparing plans (HSRT), and whole-brain/hippocampus-sparing fixed-field non-coplanar IMRT (BSRT) plans, were generated. DVHs and dose difference maps were used to compare plans. NTCP calculations for NCF impairment, based on hippocampal dosimetry, were performed for all plans. Results Significant reductions in hippocampal doses relative to standard plans were achieved in eight of ten cases for both HSRT and BSRT. EQD2 D40% to bilateral hippocampi was significantly reduced from a mean of 23.5 Gy (range 14.5-35.0) in the standard plans to a mean of 8.6 Gy (4.2-24.7) for HSRT (p = 0.001) and a mean of 9.0 Gy (4.3-17.3) for BSRT (p < 0.001). Both HSRT and BSRT resulted in a significant reduction in doses to the whole brain, brain stem, and cerebellum. Conclusion We demonstrate that IMRT plans for HNC involving the nasopharynx can be successfully optimised to significantly reduce dose to the bilateral hippocampi and whole brain. The magnitude of the achievable dose reductions results in significant reductions in the probability of radiation-induced NCF decline. These results could readily be translated into a future clinical trial.	[Dunlop, Alex; McQuaid, Dualta; Gulliford, Sarah; Hansen, Vibeke] Inst Canc Res, Joint Dept Phys, London SW3 6JB, England; [Dunlop, Alex; McQuaid, Dualta; Gulliford, Sarah; Hansen, Vibeke] Royal Marsden NHS Fdn Trust, London, England; [Welsh, Liam; Bhide, Shreerang; Nutting, Chris; Harrington, Kevin; Newbold, Kate] Royal Marsden Hosp, London SW3 6JJ, England; [Welsh, Liam; Dean, Jamie; Bhide, Shreerang; Harrington, Kevin] Inst Canc Res, London SW3 6JB, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Dunlop, A (corresponding author), Inst Canc Res, Joint Dept Phys, London SW3 6JB, England.	Alex.Dunlop@rmh.nhs.uk	Dean, Jamie/H-4618-2019; Newbold, Kate/AAA-9176-2022	Dean, Jamie/0000-0002-5434-8032; Harrington, Kevin/0000-0002-6014-348X; Gulliford, Sarah/0000-0002-1768-2904	NHS Executive; Cancer Research UK [C46/A10588, C7224/A13407]; National Institute for Health Research Royal Marsden; Institute of Cancer Research Biomedical Research Centre; Cancer Research UK [13407] Funding Source: researchfish; Engineering and Physical Sciences Research Council [1240077] Funding Source: researchfish	NHS Executive; Cancer Research UK(Cancer Research UK); National Institute for Health Research Royal Marsden; Institute of Cancer Research Biomedical Research Centre; Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was undertaken in The Royal Marsden NHS Foundation Trust which received a proportion of its funding from the NHS Executive; the views expressed in this publication are those of the authors and not necessarily those of the NHS Executive. This work was supported by Cancer Research UK Programme Grants C46/A10588 and C7224/A13407. The authors also acknowledge the support of the National Institute for Health Research Royal Marsden and Institute of Cancer Research Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abayomi OK, 2002, ACTA ONCOL, V41, P346, DOI 10.1080/028418602760169389; Bhide SA, 2008, BRIT J CANCER, V99, P57, DOI 10.1038/sj.bjc.6604444; Bhide SA, 2012, BRIT J RADIOL, V85, P487, DOI 10.1259/bjr/85942136; Cao Y, 2009, CLIN CANCER RES, V15, P1747, DOI 10.1158/1078-0432.CCR-08-1420; Chapman CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057768; Cheung MC, 2000, ARCH NEUROL-CHICAGO, V57, P1347, DOI 10.1001/archneur.57.9.1347; Corvo R, 2007, RADIOTHER ONCOL, V85, P156, DOI 10.1016/j.radonc.2007.04.002; Dirix P, 2010, LANCET ONCOL, V11, P85, DOI 10.1016/S1470-2045(09)70231-1; Gan HK, 2011, INT J RADIAT ONCOL, V81, P126, DOI 10.1016/j.ijrobp.2010.05.004; Gondi V, 2013, INT J RADIAT ONCOL, V87, P1186, DOI DOI 10.1016/J.IJR0BP.2013.10.005; Gondi V, 2013, INT J RADIAT ONCOL, V85, P348, DOI 10.1016/j.ijrobp.2012.11.031; Gondi V, 2010, RADIOTHER ONCOL, V97, P370, DOI 10.1016/j.radonc.2010.09.013; Gondi V, 2010, INT J RADIAT ONCOL, V78, P1244, DOI 10.1016/j.ijrobp.2010.01.039; Greene-Schloesser D, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00073; Gulliford SL, 2012, RADIOTHER ONCOL, V104, P205, DOI 10.1016/j.radonc.2012.07.005; Holliday EB, 2014, INT J RADIAT ONCOL, V89, P292, DOI 10.1016/j.ijrobp.2014.02.029; Hsiao KY, 2010, INT J RADIAT ONCOL, V77, P722, DOI 10.1016/j.ijrobp.2009.06.080; International Commission on Radiation Units and Measurements, 2010, J ICRU, V10, P1; LEE PWH, 1989, J NEUROL NEUROSUR PS, V52, P488, DOI 10.1136/jnnp.52.4.488; Li YQ, 2003, CANCER RES, V63, P5950; Miah AB, 2012, INT J RADIAT ONCOL, V82, P539, DOI 10.1016/j.ijrobp.2010.09.055; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Namikawa K, 2000, BIOL TRACE ELEM RES, V74, P223, DOI 10.1385/BTER:74:3:223; Nutting CM, 2011, LANCET ONCOL, V12, P127, DOI 10.1016/S1470-2045(10)70290-4; Paddick I, 2000, J NEUROSURG, V93, P219, DOI 10.3171/jns.2000.93.supplement_3.0219; Peiffer AM, 2013, NEUROLOGY, V80, P747, DOI 10.1212/WNL.0b013e318283bb0a; Powell C., 2013, RADIOTHER ONCOL; Troy L, 2000, PSYCHO-ONCOL, V9, P29, DOI 10.1002/(SICI)1099-1611(200001/02)9:1<29::AID-PON428>3.0.CO;2-Z; Welsh L, 2014, CLIN ONCOLOGY	29	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120141	10.1371/journal.pone.0120141	http://dx.doi.org/10.1371/journal.pone.0120141			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781636	gold, Green Published, Green Submitted			2022-12-27	WOS:000351284600131
J	Heurich, M; Brand, TTG; Kaandorp, MY; Sustr, P; Muller, J; Reineking, B				Heurich, Marco; Brand, Tom T. G.; Kaandorp, Manon Y.; Sustr, Pavel; Mueller, Joerg; Reineking, Bjoern			Country, Cover or Protection: What Shapes the Distribution of Red Deer and Roe Deer in the Bohemian Forest Ecosystem?	PLOS ONE			English	Article							CAPREOLUS-CAPREOLUS DEER; LYNX LYNX-LYNX; CERVUS-ELAPHUS; ALTITUDINAL GRADIENT; HABITAT SELECTION; HOME-RANGE; WILDLIFE MANAGEMENT; POPULATION-DENSITY; PARTIAL MIGRATION; NATIONAL-PARK	The Bohemian Forest Ecosystem encompasses various wildlife management systems. Two large, contiguous national parks (one in Germany and one in the Czech Republic) form the centre of the area, are surrounded by private hunting grounds, and hunting regulations in each country differ. Here we aimed at unravelling the influence of management-related and environmental factors on the distribution of red deer (Cervus elaphus) and roe deer (Capreolus capreolus) in this ecosystem. We used the standing crop method based on counts of pellet groups, with point counts every 100 m along 218 randomly distributed transects. Our analysis, which accounted for overdispersion as well as zero inflation and spatial autocorrelation, corroborated the view that both human management and the physical and biological environment drive ungulate distribution in mountainous areas in Central Europe. In contrast to our expectations, protection by national parks was the least important variable for red deer and the third important out of four variables for roe deer; protection negatively influenced roe deer distribution in both parks and positively influenced red deer distribution in Germany. Country was the most influential variable for both red and roe deer, with higher counts of pellet groups in the Czech Republic than in Germany. Elevation, which indicates increasing environmental harshness, was the second most important variable for both species. Forest cover was the least important variable for roe deer and the third important variable for red deer; the relationship for roe deer was positive and linear, and optimal forest cover for red deer was about 70% within a 500 m radius. Our results have direct implications for the future conservation management of deer in protected areas in Central Europe and show in particular that large non-intervention zones may not cause agglomerations of deer that could lead to conflicts along the border of protected, mountainous areas.	[Heurich, Marco; Mueller, Joerg] Bavarian Forest Natl Pk, Dept Conservat & Res, Grafenau, Germany; [Heurich, Marco] Univ Freiburg, Fac Environm & Nat Resources, Chair Wildlife Ecol & Management, D-79106 Freiburg, Germany; [Brand, Tom T. G.; Kaandorp, Manon Y.] Univ Appl Sci, Van Hall Larenstein, Leeuwarden, Netherlands; [Sustr, Pavel] Acad Sci Czech Republ, Global Change Res Ctr, Dept Biodivers Res, Brno, Czech Republic; [Sustr, Pavel] Sumava Natl Pk, Vimperk, Czech Republic; [Mueller, Joerg] Tech Univ Munich, Dept Ecol & Ecosyst Management, Chair Terr Ecol, Freising Weihenstephan, Germany; [Reineking, Bjoern] Univ Bayreuth, Bayreuth Ctr Ecol & Environm Res BayCEER, Biogeog Modelling, Bayreuth, Germany; [Reineking, Bjoern] UR EMGR Ecosyst Montagnards, St Martin Dheres, France	University of Freiburg; Czech Academy of Sciences; Global Change Research Centre of the Czech Academy of Sciences; Technical University of Munich; University of Bayreuth	Heurich, M (corresponding author), Bavarian Forest Natl Pk, Dept Conservat & Res, Grafenau, Germany.	marco.heurich@npv-bw.bayern.de	Heurich, Marco/O-4653-2014; Šustr, Pavel/G-9876-2014	Heurich, Marco/0000-0003-0051-2930; Reineking, Bjorn/0000-0001-5277-9181; Muller, Jorg/0000-0002-1409-1586	project "Modelluntersuchungen zum Wildtiermanagement in Schutzgebieten am Beispiel des Nationalparks Bayerischer Wald" of the German Federal Environmental Foundation (Deutsche Bundesstiftung Umwelt); EU programme INTERREG IV (EFRE Ziel 3); Bavarian Forest National Park Administration; GA CR [14-36098G]; MSMT [CZ.1.05/1.1.00/02.0073]	project "Modelluntersuchungen zum Wildtiermanagement in Schutzgebieten am Beispiel des Nationalparks Bayerischer Wald" of the German Federal Environmental Foundation (Deutsche Bundesstiftung Umwelt); EU programme INTERREG IV (EFRE Ziel 3); Bavarian Forest National Park Administration; GA CR(Grant Agency of the Czech Republic); MSMT(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported by the project "Modelluntersuchungen zum Wildtiermanagement in Schutzgebieten am Beispiel des Nationalparks Bayerischer Wald" of the German Federal Environmental Foundation (Deutsche Bundesstiftung Umwelt). This study was part of a project on the predator-prey relationship of the Eurasian lynx, roe deer and red deer carried out by the Bavarian Forest National Park Administration, Department of Research. Financial support was provided by the EU programme INTERREG IV (EFRE Ziel 3), and the Bavarian Forest National Park Administration. Pavel Sustr's contribution was funded by the grants No. 14-36098G of the GA CR and No. CZ.1.05/1.1.00/02.0073 of the MSMT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apollonio M., 2010, EUROPEAN UNGULATES T; AULAK W, 1990, ACTA THERIOL, V35, P111, DOI 10.4098/AT.arch.90-12; Barancekova M, 2010, EUR J WILDLIFE RES, V56, P327, DOI 10.1007/s10344-009-0321-0; Bartos L., 2010, EUROPEAN UNGULATES T; Belotti E, 2014, EUR J WILDLIFE RES, V60, P441, DOI 10.1007/s10344-014-0801-8; BOBEK B, 1984, J APPL ECOL, V21, P881, DOI 10.2307/2405053; Borkowski J, 2008, FOREST ECOL MANAG, V255, P468, DOI 10.1016/j.foreco.2007.09.013; BOYCE MS, 1991, GREATER YELLOWSTONE ECOSYSTEM, P183; Bradford JB, 2008, J ENVIRON MANAGE, V86, P520, DOI 10.1016/j.jenvman.2006.12.005; Cagnacci F, 2011, OIKOS, V120, P1790, DOI 10.1111/j.1600-0706.2011.19441.x; Campbell D, 2004, J APPL ECOL, V41, P1185, DOI 10.1111/j.0021-8901.2004.00964.x; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Conover MR, 2001, WILDLIFE SOC B, V29, P521; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Farr T.G., 2000, EOS T AM GEOPHYS UN, V81, P583, DOI [DOI 10.1029/EO081I048P00583, 10.1029/EO081i048p00583]; Forsyth DM, 2007, J WILDLIFE MANAGE, V71, P964, DOI 10.2193/2005-695; GARNER DL, 1995, ENVIRON MANAGE, V19, P233, DOI 10.1007/BF02471993; Gerner J, 2011, J NAT CONSERV, V19, P319, DOI 10.1016/j.jnc.2011.06.002; Gill R. M. A., 1990, GEMS INFORM SERIES, V8; Gill RMA, 1996, FOREST ECOLOGY; Gordon IJ, 2004, J APPL ECOL, V41, P1021, DOI 10.1111/j.0021-8901.2004.00985.x; Hagen R, 2014, SCI TOTAL ENVIRON, V468, P140, DOI 10.1016/j.scitotenv.2013.08.022; Heinze E, 2011, FOREST ECOL MANAG, V261, P288, DOI 10.1016/j.foreco.2010.10.022; Hemami MR, 2005, FOREST ECOL MANAG, V215, P224, DOI 10.1016/j.foreco.2005.05.013; Heurich M, 2012, EUR J WILDLIFE RES, V58, P567, DOI 10.1007/s10344-011-0606-y; Hothorn T, 2010, FOREST ECOL MANAG, V260, P1416, DOI 10.1016/j.foreco.2010.07.019; Huff DE, 1999, ECOL APPL, V9, P17; Hurley PM, 2012, BIOL CONSERV, V146, P62, DOI 10.1016/j.biocon.2011.10.034; IUCN, 1994, GUID PROT AR MAN CAT; JANZEN DH, 1983, OIKOS, V41, P402, DOI 10.2307/3544100; JEDRZEJEWSKA B, 1994, J APPL ECOL, V31, P664, DOI 10.2307/2404157; Jiang GS, 2008, WILDLIFE BIOL, V14, P92, DOI 10.2981/0909-6396(2008)14[92:HUASBR]2.0.CO;2; Karanth KK, 2013, ENVIRON MANAGE, V52, P1320, DOI 10.1007/s00267-013-0162-1; Kramer K, 2006, FOREST ECOL MANAG, V226, P238, DOI 10.1016/j.foreco.2006.01.037; Krojerova-Prokesova J, 2010, WILDLIFE BIOL, V16, P173, DOI 10.2981/09-004; Latham J, 1996, J ZOOL, V240, P285, DOI 10.1111/j.1469-7998.1996.tb05285.x; Latham J, 2009, J ZOOL, V240, P285; Lovari S, 1997, BEHAV PROCESS, V40, P239, DOI 10.1016/S0376-6357(97)00019-3; Ludwig M, 2012, ERDKUNDE, V66, P143, DOI 10.3112/erdkunde.2012.02.04; MACARTHUR RH, 1964, P NATL ACAD SCI USA, V51, P1207, DOI 10.1073/pnas.51.6.1207; Milner JM, 2006, J APPL ECOL, V43, P721, DOI 10.1111/j.1365-2664.2006.01183.x; MITCHELL B, 1985, J ZOOL, V207, P1; Most L, 2015, FOREST ECOL MANAG, V338, P46, DOI 10.1016/j.foreco.2014.11.015; Muller J, 2014, BIOL CONSERV, V177, P210, DOI 10.1016/j.biocon.2014.07.007; Mysterud A, 2001, NATURE, V410, P1096, DOI 10.1038/35074099; Mysterud A, 1999, J ZOOL, V247, P479, DOI 10.1111/j.1469-7998.1999.tb01011.x; Mysterud A, 1999, WILDLIFE SOC B, V27, P385; Mysterud A, 1997, WILDLIFE BIOL, V3, P27, DOI 10.2981/wlb.1997.004; Mysterud A, 2011, OIKOS, V120, P1817, DOI 10.1111/j.1600-0706.2010.19439.x; Nahlik A., 2005, Wildlife Biology in Practice, V1, P47; Podolski I, 2013, WILDLIFE BIOL, V19, P69, DOI 10.2981/12-049; Porter WF, 1999, ECOL APPL, V9, P3, DOI 10.2307/2641162; Prokesova J, 2006, FOLIA ZOOL, V55, P1; R Core Team, 2013, R LANG ENV STAT COMP, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; Richardson L, 2009, ECOL ECON, V68, P1535, DOI 10.1016/j.ecolecon.2008.10.016; Roever CL, 2013, BIOL CONSERV, V157, P128, DOI 10.1016/j.biocon.2012.06.025; Ronnegard L, 2008, WILDLIFE BIOL, V14, P358, DOI 10.2981/0909-6396(2008)14[358:EOFMUT]2.0.CO;2; Said S, 2005, LANDSCAPE ECOL, V20, P1003, DOI 10.1007/s10980-005-7518-8; Smart JCR, 2004, MAMMAL REV, V34, P99, DOI 10.1046/j.0305-1838.2003.00026.x; STAINES BW, 1984, P ROY SOC EDINB B, V82, P303, DOI 10.1017/S026972700000381X; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Treves A, 2005, CONSERV BIOL SER, V9, P86; Weingarth K, 2012, ANIM BIODIV CONSERV, V35, P197; WELCH D, 1990, J ZOOL, V221, P453, DOI 10.1111/j.1469-7998.1990.tb04013.x; Williams SC, 2013, WILDLIFE SOC B, V37, P137, DOI 10.1002/wsb.236; Wilmers CC, 2012, FRONT ECOL ENVIRON, V10, P409, DOI 10.1890/110176; WILSON E O, 1992; Wolfl M, 2001, ACTA THERIOL, V46, P181, DOI 10.1007/BF03192427; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wotschikowsky U, 1981, ROT UND REHWILD NATI	72	32	32	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120960	10.1371/journal.pone.0120960	http://dx.doi.org/10.1371/journal.pone.0120960			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781942	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600193
J	Makanae, K; Kintaka, R; Ishikawa, K; Moriya, H				Makanae, Koji; Kintaka, Reiko; Ishikawa, Koji; Moriya, Hisao			Small Toxic Protein Encoded on Chromosome VII of Saccharomyces cerevisiae	PLOS ONE			English	Article							PLASMA-MEMBRANE FUSION; GENE DISRUPTION; IDENTIFICATION; EXPRESSION; CASSETTES; AZOLE	In a previous study, we found an unknown element that caused growth inhibition after its copy number increased in the 30 region of DIE2 in Saccharomyces cerevisiae. In this study, we further identified this element and observed that overexpression of a small protein (sORF2) of 57 amino acids encoded in this region caused growth inhibition. The transcriptional response and multicopy suppression of the growth inhibition caused by sORF2 overexpression suggest that sORF2 overexpression inhibits the ergosterol biosynthetic pathway. sORF2 was not required in the normal growth of S. cerevisiae, and not conserved in related yeast species including S. paradoxus. Thus, sORF2 (designated as OTO1) is an orphan ORF that determines the specificity of this species.	[Makanae, Koji; Moriya, Hisao] Okayama Univ, Res Core Interdisciplinary Sci, Kita Ku, Okayama 7008530, Japan; [Kintaka, Reiko; Ishikawa, Koji] Okayama Univ, Grad Sch Sci & Technol, Kita Ku, Okayama 7008530, Japan	Okayama University; Okayama University	Moriya, H (corresponding author), Okayama Univ, Res Core Interdisciplinary Sci, Kita Ku, Okayama 7008530, Japan.	hisaom@cc.okayama-u.ac.jp	Moriya, Hisao/B-2424-2011	Moriya, Hisao/0000-0001-7638-3640; Makanae, Koji/0000-0002-8560-4561; Ishikawa, Koji/0000-0001-8241-9523	MEXT KAKENHI [221S0002]; Asahi Glass Foundation; Okayama University	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Asahi Glass Foundation; Okayama University	This research was supported partly by MEXT KAKENHI (B, Challenging Exploratory Research, and 221S0002), the Asahi Glass Foundation, and grants-in-aid for strategic research promotion from Okayama University. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal AK, 2003, J BIOL CHEM, V278, P34998, DOI 10.1074/jbc.M306291200; Aguilar PS, 2010, P NATL ACAD SCI USA, V107, P4170, DOI 10.1073/pnas.0914094107; Amberg DC., 2005, METHODS YEAST GENETI; Amerik AY, 2000, BIOL CHEM, V381, P981, DOI 10.1515/BC.2000.121; Brachmann CB, 1998, YEAST, V14, P115; DINGWALL C, 1988, J CELL BIOL, V107, P841, DOI 10.1083/jcb.107.3.841; Fischer D, 1999, BIOINFORMATICS, V15, P759, DOI 10.1093/bioinformatics/15.9.759; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Heiman MG, 2000, J CELL BIOL, V151, P719, DOI 10.1083/jcb.151.3.719; Jin H, 2008, J CELL BIOL, V180, P813, DOI 10.1083/jcb.200705076; Kastenmayer JP, 2006, GENOME RES, V16, P365, DOI 10.1101/gr.4355406; KELLY SL, 1993, BIOCHEM SOC T, V21, P1034, DOI 10.1042/bst0211034; Kessler MM, 2003, GENOME RES, V13, P264, DOI 10.1101/gr.232903; KOHRER K, 1991, METHOD ENZYMOL, V194, P398; Kumar A, 2002, NAT BIOTECHNOL, V20, P58, DOI 10.1038/nbt0102-58; Li QR, 2008, GENOME RES, V18, P1294, DOI 10.1101/gr.076661.108; Makanae K, 2013, GENOME RES, V23, P300, DOI 10.1101/gr.146662.112; Moriya H, 2012, MOL BIOSYST, V8, P2513, DOI 10.1039/c2mb25100k; Moriya H, 2006, PLOS GENET, V2, P2176, DOI 10.1371/journal.pgen.0020218; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; Oshiro G, 2002, GENOME RES, V12, P1210, DOI 10.1101/gr.226802; Sasabe M, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-2; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130	24	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120678	10.1371/journal.pone.0120678	http://dx.doi.org/10.1371/journal.pone.0120678			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781884	Green Submitted, Green Published, gold			2022-12-27	WOS:000351284600182
J	Rotherham, M; El Haj, AJ				Rotherham, Michael; El Haj, Alicia J.			Remote Activation of the Wnt/beta-Catenin Signalling Pathway Using Functionalised Magnetic Particles	PLOS ONE			English	Article							SUPPRESSES OSTEOGENIC DIFFERENTIATION; BETA-CATENIN; PROMOTES PROLIFERATION; UP-REGULATION; WNT SIGNALS; MECHANISM; CELLS; NANOPARTICLES; INSIGHTS; COMPLEX	Wnt signalling pathways play crucial roles in developmental biology, stem cell fate and tissue patterning and have become an attractive therapeutic target in the fields of tissue engineering and regenerative medicine. Wnt signalling has also been shown to play a role in human Mesenchymal Stem Cell (hMSC) fate, which have shown potential as a cell therapy in bone and cartilage tissue engineering. Previous work has shown that biocompatible magnetic nanoparticles (MNP) can be used to stimulate specific mechanosensitive membrane receptors and ion channels in vitro and in vivo. Using this strategy, we determined the effects of mechano-stimulation of the Wnt Frizzled receptor on Wnt pathway activation in hMSC. Frizzled receptors were tagged using anti-Frizzled functionalised MNP (Fz-MNP). A commercially available oscillating magnetic bioreactor (MICA Biosystems) was used to mechanically stimulate Frizzled receptors remotely. Our results demonstrate that Fz-MNP can activate Wnt/beta-catenin signalling at key checkpoints in the signalling pathway. Immunocytochemistry indicated nuclear localisation of the Wnt intracellular messenger beta-catenin after treatment with Fz-MNP. A Wnt signalling TCF/LEF responsive luciferase reporter transfected into hMSC was used to assess terminal signal activation at the nucleus. We observed an increase in reporter activity after treatment with Fz-MNP and this effect was enhanced after mechano-stimulation using the magnetic array. Western blot analysis was used to probe the mechanism of signalling activation and indicated that Fz-MNP signal through an LRP independent mechanism. Finally, the gene expression profiles of stress response genes were found to be similar when cells were treated with recombinant Wnt-3A or Fz-MNP. This study provides proof of principle that Wnt signalling and Frizzled receptors are mechanosensitive and can be remotely activated in vitro. Using magnetic nanoparticle technology it may be possible to modulate Wnt signalling pathways and thus control stem cell fate for therapeutic purposes.	[Rotherham, Michael; El Haj, Alicia J.] Keele Univ, Inst Sci & Technol Med, Stoke On Trent, Staffs, England	Keele University	Rotherham, M (corresponding author), Keele Univ, Inst Sci & Technol Med, Stoke On Trent, Staffs, England.	m.rotherham@keele.ac.uk	Rotherham, Michael/K-7275-2019	Rotherham, Michael/0000-0002-9297-7681; El Haj, Alicia/0000-0003-3544-5678	Biotechnology and Biological Sciences Research Council [BB/G010560/1]; BBSRC [BB/G010560/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnology and Biological Sciences Research Council (Grant number BB/G010560/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnsdorf EJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005388; Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104; Boland GM, 2004, J CELL BIOCHEM, V93, P1210, DOI 10.1002/jcb.20284; Brown SD, 1998, BIOCHEM BIOPH RES CO, V248, P879, DOI 10.1006/bbrc.1998.9061; Carron C, 2003, J CELL SCI, V116, P2541, DOI 10.1242/jcs.00451; Carthy JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019809; Cho HH, 2006, TISSUE ENG, V12, P111, DOI 10.1089/ten.2006.12.111; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Cong F, 2003, MOL CELL BIOL, V23, P8462, DOI 10.1128/MCB.23.23.8462-8470.2003; Coudreuse D, 2007, DEVELOPMENT, V134, P3, DOI 10.1242/dev.02699; de Boer J, 2004, BONE, V34, P818, DOI 10.1016/j.bone.2004.01.016; De Boer J, 2004, TISSUE ENG, V10, P393, DOI 10.1089/107632704323061753; Ehrlich D, 2010, PEDIATR DEVEL PATHOL, V13, P1, DOI 10.2350/08-03-0443.1; Etheridge SL, 2004, STEM CELLS, V22, P849, DOI 10.1634/stemcells.22-5-849; FENG L, 1995, J CLIN INVEST, V95, P1669, DOI 10.1172/JCI117842; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; Gujral TS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010024; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Henstock JR, 2014, REMOTELY ACTIVATED M; Holmen SL, 2005, BIOCHEM BIOPH RES CO, V328, P533, DOI 10.1016/j.bbrc.2005.01.009; Hu B, 2014, NANOMED-NANOTECHNOL, V10, P45, DOI 10.1016/j.nano.2013.06.014; Hughes S, 2005, MED ENG PHYS, V27, P754, DOI 10.1016/j.medengphy.2005.04.006; Javaheri B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035726; Kanczler JM, 2010, TISSUE ENG PT A, V16, P3241, DOI [10.1089/ten.tea.2009.0638, 10.1089/ten.TEA.2009.0638]; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Kumar A, 2003, FASEB J, V17, P386, DOI 10.1096/fj.02-0542com; Ling L, 2009, GENE, V433, P1, DOI 10.1016/j.gene.2008.12.008; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; McBain SC, 2008, INT J NANOMED, V3, P169; Mercurio F, 1999, ONCOGENE, V18, P6163, DOI 10.1038/sj.onc.1203174; Nunez F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018562; Nusse R, 1999, TRENDS GENET, V15, P1, DOI 10.1016/S0168-9525(98)01634-5; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Oreffo ROC, 2005, STEM CELL REV, V1, P169, DOI 10.1385/SCR:1:2:169; Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201; Perobner I, 2012, INT J BIOCHEM CELL B, V44, P1970, DOI 10.1016/j.biocel.2012.07.025; Qiu WM, 2007, J BONE MINER RES, V22, P1720, DOI 10.1359/JBMR.070721; Quarto N, 2010, TISSUE ENG PT A, V16, P3185, DOI 10.1089/ten.tea.2010.0133; Schuijers J, 2014, EMBO J, V33, P146, DOI 10.1002/embj.201385358; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Steinauer KK, 2000, INT J RADIAT ONCOL, V48, P325, DOI 10.1016/S0360-3016(00)00671-4; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tolwinski NS, 2003, DEV CELL, V4, P407, DOI 10.1016/S1534-5807(03)00063-7; Wang HY, 2006, CELL SIGNAL, V18, P934, DOI 10.1016/j.cellsig.2005.12.008; Willert K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007864; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Yiu HHP, 2011, NANOMEDICINE-UK, V6, P1429, DOI [10.2217/NNM.11.132, 10.2217/nnm.11.132]; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185	51	47	48	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0121761	10.1371/journal.pone.0121761	http://dx.doi.org/10.1371/journal.pone.0121761			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781466	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000351284600210
J	Sanada-Morimura, S; Otuka, A; Matsumura, M; Etoh, T; Zhu, YQ; Zhou, YJ; Zhang, GF				Sanada-Morimura, Sachiyo; Otuka, Akira; Matsumura, Masaya; Etoh, Tomoki; Zhu, Yeqin; Zhou, Yijun; Zhang, Gufeng			Take-Off Time of the First Generation of the Overwintering Small Brown Planthopper, Laodelphax striatellus in the Temperate Zone in East Asia	PLOS ONE			English	Article							NILAPARVATA-LUGENS STAL; SOGATELLA-FURCIFERA HORVATH; LONG-DISTANCE MIGRATION; LEVEL JET-STREAM; RICE PLANTHOPPERS; DELPHACIDAE; POPULATION; CHINA; IMMIGRATION; PREDICTION	Overseas migration of the small brown planthopper, Laodelphax striatellus (Fallen), occurs during the winter wheat harvest season in East Asia. Knowing the take-off time of emigrating L. striatellus is crucial for predicting such migrations with a simulation technique because winds, carriers of migratory insects, change continuously. Several methods were used in China and Japan from late May to early June 2012 and again in 2013 to identify the precise timing of take-off. These methods included: a tow net trap mounted to a pole at 10 m above the ground, a helicopter-towed net trap, and a canopy trap (which also had video monitoring) set over wheat plants. Laodelphax striatellus emigrated from wheat fields mainly in the early evening, before dusk. The insects also emigrated during the daytime but rarely emigrated at dawn, showing a pattern that is unlike the bimodal emigration at dusk and dawn of two other rice planthoppers, the brown planthopper, Nilaparvata lugens (Stal), and the white-backed planthopper, Sogatella furcifera (Horvath). There was no significant difference in the temporal pattern of take-off behavior between females and males of Japanese L. striatellus populations.	[Sanada-Morimura, Sachiyo; Otuka, Akira; Matsumura, Masaya] Kyushu Okinawa Agr Res Ctr, Kumamoto, Japan; [Etoh, Tomoki] Saga Prefectural Agr Res Ctr, Saga, Japan; [Zhu, Yeqin] Plant Protect Stn Jiangsu Prov, Nanjing, Jiangsu, Peoples R China; [Zhou, Yijun; Zhang, Gufeng] Jiangsu Acad Agr Sci, Inst Plant Protect, Nanjing, Jiangsu, Peoples R China	Jiangsu Academy of Agricultural Sciences	Otuka, A (corresponding author), Kyushu Okinawa Agr Res Ctr, Kumamoto, Japan.	atouka@affrc.go.jp			science and technology research promotion program for agriculture, forestry, fisheries and food industry from the Ministry of Agriculture, Forestry and Fisheries of Japan [24018]; research project entitled "Development of technologies for mitigation and adaptation to climate change in Agriculture, Forestry and Fisheries" from the Ministry of Agriculture, Forestry and Fisheries of Japan	science and technology research promotion program for agriculture, forestry, fisheries and food industry from the Ministry of Agriculture, Forestry and Fisheries of Japan; research project entitled "Development of technologies for mitigation and adaptation to climate change in Agriculture, Forestry and Fisheries" from the Ministry of Agriculture, Forestry and Fisheries of Japan	This work was funded by the science and technology research promotion program for agriculture, forestry, fisheries and food industry, No. 24018 (2012-2013), and a research project entitled "Development of technologies for mitigation and adaptation to climate change in Agriculture, Forestry and Fisheries" (2012-2013). Both funds were from the Ministry of Agriculture, Forestry and Fisheries of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT CH, 1951, ECOLOGY, V32, P155, DOI 10.2307/1930414; Beerwinkle KR, 1990, TRANSACTIONS OF THE, V32, P1847, DOI 10.13031/2013.31233; Chapman JW, 2011, ANNU REV ENTOMOL, V56, P337, DOI 10.1146/annurev-ento-120709-144820; Cheng ZhaoBang, 2013, Chinese Journal of Applied Entomology, V50, P706; Falk BW, 1998, ANNU REV PHYTOPATHOL, V36, P139, DOI 10.1146/annurev.phyto.36.1.139; He Yuan, 2012, Chinese Journal of Rice Science, V26, P109, DOI 10.3969/j.issn.1001-7216.2012.01.0.17; IRWIN ME, 1988, PHILOS T R SOC B, V321, P421, DOI 10.1098/rstb.1988.0101; Johnson CG, 1955, ANN APPL BIOL, V43, P51, DOI 10.1111/j.1744-7348.1955.tb02452.x; KISIMOTO R, 1976, ECOL ENTOMOL, V1, P95, DOI 10.1111/j.1365-2311.1976.tb01210.x; KISIMOTO R, 1968, Applied Entomology and Zoology, V3, P37; LAI ZL, 1982, ACTA ENTOMOL SINICA, V25, P397; Liu XD, 2013, INSECT SCI, V20, P385, DOI 10.1111/j.1744-7917.2012.01533.x; Ohkubo N, 1971, Japanese Journal of Applied Entomology and Zoology, V15, P8; Osborne J, 2002, DISPERSAL ECOLOGY, P24; Otuka A, 2005, AGR FOREST ENTOMOL, V7, P1, DOI 10.1111/j.1461-9555.2005.00236.x; Otuka A, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00309; Otuka A, 2012, APPL ENTOMOL ZOOL, V47, P379, DOI 10.1007/s13355-012-0130-x; Otuka A, 2010, APPL ENTOMOL ZOOL, V45, P259, DOI 10.1303/aez.2010.259; RILEY JR, 1994, B ENTOMOL RES, V84, P389, DOI 10.1017/S0007485300032521; RILEY JR, 1991, ECOL ENTOMOL, V16, P471, DOI 10.1111/j.1365-2311.1991.tb00240.x; Sanada-Morimura S., 2014, MONTHLY JOURNAL OF A, V51, P44; Seino Hiroshi, 1987, Journal of Agricultural Meteorology, V43, P203; Stefanescu C, 2007, J ANIM ECOL, V76, P888, DOI 10.1111/j.1365-2656.2007.01262.x; Tochigi Prefectural Sustainable Agriculture Extension Center, 2014, DISEASE AND INSECT P; Wang HD, 2008, PLANT DIS, V92, P1190, DOI 10.1094/PDIS-92-8-1190; WATANABE T, 1991, APPL ENTOMOL ZOOL, V26, P457, DOI 10.1303/aez.26.457; Zera AJ, 1997, ANNU REV ENTOMOL, V42, P207, DOI 10.1146/annurev.ento.42.1.207; Zhang Ai-Min, 2008, Acta Entomologica Sinica, V51, P640; Zhang Gu-Feng, 2012, Chinese Journal of Applied Entomology, V49, P1716; Zhang Hai-Yan, 2011, Chinese Journal of Applied Entomology, V48, P1298; Zhou Y., 2010, RICE STRIPE VIRUS DI; Zhou YJ, 2009, APEC WORKSHOP ON THE, V2, P27	32	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120271	10.1371/journal.pone.0120271	http://dx.doi.org/10.1371/journal.pone.0120271			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25780936	gold, Green Published, Green Submitted			2022-12-27	WOS:000351284600146
J	Ho, LM; Wang, MP; Ho, SY; Lam, TH				Ho, Lai Ming; Wang, Man Ping; Ho, Sai Yin; Lam, Tai Hing			Changes in Individual Weight Status Based on Body Mass Index and Waist Circumference in Hong Kong Chinese	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; CENTRAL OBESITY; RISK-FACTORS; ADULTS; OVERWEIGHT; PREVALENCE; TRENDS; TRAJECTORIES; DISEASE; COHORT	Background Weight change predicted diseases and mortality. We investigate 3-year changes in individual body mass index (BMI) and waist circumference in Hong Kong Chinese adults. Methods In the Population Health Survey, 7084 adults in 2003 (baseline) were followed up in 2006. Longitudinal anthropometric data were available in 2941 (41.5%) for BMI and 2956 for waist circumference. Weight status and central obesity were based on objectively measured BMI and waist circumference using Asian standards. Results Mean BMI (SD) increased from 22.8 (3.62) to 23.1 (3.95) (p<0.001) with 1.3 percentage point increase in prevalence of overweight and obesity (from 44.3% to 45.6%). One in 5 (22.0%) normal or underweight baseline respondents became overweight or obese and a similar proportion (24.8%) of overweight and obese respondents became normal or underweight. Prevalence of central obesity increased from 28.3% to 32.4% (p<0.001) with a non-significantly greater increase in women (30.0% to 38.1%) than men (23.0% to 26.1%) (p=0.63). A higher proportion of centrally obese respondents returned to normal (29.4%) than normal respondents developing central obesity (17.4%). Conclusions This is one of the few studies in Chinese, which found dynamic longitudinal changes (increase/stable/decrease) in individual weight status and waist circumference. Future studies with better follow-up and investigating the causes of such changes are warranted.	[Ho, Lai Ming; Ho, Sai Yin; Lam, Tai Hing] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Wang, Man Ping] Univ Hong Kong, Sch Nursing, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Wang, MP (corresponding author), Univ Hong Kong, Sch Nursing, Hong Kong, Hong Kong, Peoples R China.	mpwang@hku.hk	; Ho, Daniel Sai Yin/C-4307-2009; Lam, Tai Hing/C-4317-2009	Wang, Man Ping/0000-0003-4000-2388; Ho, Daniel Sai Yin/0000-0001-9485-0273; ho, lm/0000-0002-2709-927X; Lam, Tai Hing/0000-0002-2033-9971	Department of Health (HKSAR) & Health and Health Services Research Fund [04060571]	Department of Health (HKSAR) & Health and Health Services Research Fund	The project was funded by Department of Health (HKSAR) & Health and Health Services Research Fund (#04060571). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KF, 2014, AM J EPIDEMIOL, V179, P135, DOI 10.1093/aje/kwt254; BLAIR SN, 1993, ANN INTERN MED, V119, P749, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00024; BROWNELL KD, 1994, ARCH INTERN MED, V154, P1325, DOI 10.1001/archinte.154.12.1325; Centre for Health Protection, 2013, STAT BEHAV RISK FACT; Chang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063690; Cohen J.E., 1988, STAT POWER ANAL BEHA; Department of Health & Department of Community Medicine at University of Hong Kong, 2006, POP HLTH SURV REP; Droyvold WB, 2006, INT J OBESITY, V30, P935, DOI 10.1038/sj.ijo.0803178; Du TT, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-327; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; GOLDSTEIN DJ, 1992, INT J OBESITY, V16, P397; Hou XH, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1064; Iribarren C, N ENG J MED, V333, P686; Jacobsen BK, 2001, ARCH INTERN MED, V161, P466, DOI 10.1001/archinte.161.3.466; Kataja-Tuomola M, 2010, EUR J EPIDEMIOL, V25, P333, DOI 10.1007/s10654-010-9444-6; Ko GT, 2010, EUR J CLIN NUTR, V64, P549, DOI 10.1038/ejcn.2010.49; Lo WS, 2011, INT J PEDIATR OBES, V6, pE381, DOI 10.3109/17477166.2010.514342; Malhotra R, 2013, OBESITY, V21, P1923, DOI 10.1002/oby.20318; Matsushita Y, 2008, INT J OBESITY, V32, P1861, DOI 10.1038/ijo.2008.188; Nafziger AN, 2006, EUR J EPIDEMIOL; Nanri A, 2010, INT J OBESITY, V34, P348, DOI 10.1038/ijo.2009.234; Ostbye T, 2011, INT J EPIDEMIOL, V40, P240, DOI 10.1093/ije/dyq142; PAMUK ER, 1992, AM J EPIDEMIOL, V136, P686, DOI 10.1093/oxfordjournals.aje.a116548; Reynolds K, 2007, OBESITY, V15, P10, DOI 10.1038/oby.2007.527; Rothman KJ, 2008, VALIDITY EPIDEMIOLOG, P128; Sauvaget C, 2008, INT J EPIDEMIOL, V37, P990, DOI 10.1093/ije/dyn059; Stevens J, 2013, AM J EPIDEMIOL, V178, P239, DOI 10.1093/aje/kws461; Stevens VL, 2012, AM J EPIDEMIOL, V175, P785, DOI 10.1093/aje/kwr378; Tanamas SK, 2014, OBESITY, V22, P1538, DOI 10.1002/oby.20704; Thomas GN, 2008, ATHEROSCLEROSIS, V196, P682, DOI 10.1016/j.atherosclerosis.2007.07.024; Thomas GN, 2004, OBES RES, V12, P1805, DOI 10.1038/oby.2004.224; Tian HG, 2009, PREV MED, V48, P59, DOI 10.1016/j.ypmed.2008.10.020; Wang H, 2007, INT J OBESITY, V31, P272, DOI 10.1038/sj.ijo.0803416; Wannamethee SG, 2002, ARCH INTERN MED, V162, P2575, DOI 10.1001/archinte.162.22.2575; Wat NMS, 2001, INT J OBESITY, V25, P1789, DOI 10.1038/sj.ijo.0801834; World Health Organization, 2000, AS PAC PERSP REDF OB; Xi B, 2012, OBES REV, V13, P287, DOI 10.1111/j.1467-789X.2011.00944.x; Zhang XG, 2008, OBESITY, V16, P168, DOI 10.1038/oby.2007.43; Zheng H, 2013, AM J EPIDEMIOL, V178, P1591, DOI 10.1093/aje/kwt179	39	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119827	10.1371/journal.pone.0119827	http://dx.doi.org/10.1371/journal.pone.0119827			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775476	gold, Green Published, Green Submitted			2022-12-27	WOS:000351183500128
J	Kluger, B; Bueschl, C; Lemmens, M; Michlmayr, H; Malachova, A; Koutnik, A; Maloku, I; Berthiller, F; Adam, G; Krska, R; Schuhmacher, R				Kluger, Bernhard; Bueschl, Christoph; Lemmens, Marc; Michlmayr, Herbert; Malachova, Alexandra; Koutnik, Andrea; Maloku, Imer; Berthiller, Franz; Adam, Gerhard; Krska, Rudolf; Schuhmacher, Rainer			Biotransformation of the Mycotoxin Deoxynivalenol in Fusarium Resistant and Susceptible Near Isogenic Wheat Lines	PLOS ONE			English	Article							HEAD BLIGHT RESISTANCE; MASKED MYCOTOXINS; STRUCTURE ELUCIDATION; SPRING WHEAT; PLANT; DETOXIFICATION; QTLS; ARABIDOPSIS; GLUTATHIONE; METABOLISM	In this study, a total of nine different biotransformation products of the Fusarium mycotoxin deoxynivalenol (DON) formed in wheat during detoxification of the toxin are characterized by liquid chromatography-high resolution mass spectrometry (LC-HRMS). The detected metabolites suggest that DON is conjugated to endogenous metabolites via two major metabolism routes, namely 1) glucosylation (DON-3-glucoside, DON-di-hexoside, 15-acetyl-DON-3-glucoside, DON-malonylglucoside) and 2) glutathione conjugation (DON-S-glutathione, "DON-2H"-S-glutathione, DON-S-cysteinyl-glycine and DON-S-cysteine). Furthermore, conjugation of DON to a putative sugar alcohol (hexitol) was found. A molar mass balance for the cultivar 'Remus' treated with 1 mg DON revealed that under the test conditions approximately 15% of the added DON were transformed into DON-3-glucoside and another 19% were transformed to the remaining eight biotransformation products or irreversibly bound to the plant matrix. Additionally, metabolite abundance was monitored as a function of time for each DON derivative and was established for six DON treated wheat lines (1 mg/ear) differing in resistance quantitative trait loci (QTL) Fhb1 and/or Qfhs.ifa-5A. All cultivars carrying QTL Fhb1 showed similar metabolism kinetics: Formation of DON-Glc was faster, while DON-GSH production was less efficient compared to cultivars which lacked the resistance QTL Fhb1. Moreover, all wheat lines harboring Fhb1 showed significantly elevated D3G/DON abundance ratios.	[Kluger, Bernhard; Bueschl, Christoph; Malachova, Alexandra; Berthiller, Franz; Krska, Rudolf; Schuhmacher, Rainer] Univ Nat Resources & Life Sci, Dept Agrobiotechnol IFA Tulln, Ctr Analyt Chem, Vienna BOKU, Tulln, Austria; [Lemmens, Marc; Koutnik, Andrea; Maloku, Imer] Univ Nat Resources & Life Sci, Dept Agrobiotechnol IFA Tulln, Inst Biotechnol Plant Prod, Vienna BOKU, Tulln, Austria; [Michlmayr, Herbert; Adam, Gerhard] Univ Nat Resources & Life Sci, Dept Appl Genet & Cell Biol, Vienna BOKU, Tulln, Austria	University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna	Schuhmacher, R (corresponding author), Univ Nat Resources & Life Sci, Dept Agrobiotechnol IFA Tulln, Ctr Analyt Chem, Vienna BOKU, Tulln, Austria.	rainer.schuhmacher@boku.ac.at	Schuhmacher, Rainer/U-5174-2019	Schuhmacher, Rainer/0000-0002-7520-4943; Krska, Rudolf/0000-0001-6843-9755; Berthiller, Franz/0000-0001-5883-2879; Michlmayr, Herbert/0000-0001-7998-1494; bueschl, christoph/0000-0003-1729-9785; Adam, Gerhard/0000-0002-3008-3797	Austrian Science Fund (projects SFB Fusarium) [3706-B11, F3702-B11]; Federal Country Lower Austria; European Regional Development Fund (ERDF) of the European Union [GZ WST3-T-95/001-2006]	Austrian Science Fund (projects SFB Fusarium)(Austrian Science Fund (FWF)); Federal Country Lower Austria; European Regional Development Fund (ERDF) of the European Union	The Austrian Science Fund (projects SFB Fusarium #3706-B11 and #F3702-B11), the Federal Country Lower Austria and the European Regional Development Fund (ERDF) of the European Union (Grant Number GZ WST3-T-95/001-2006) are greatly acknowledged for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JA, 2001, THEOR APPL GENET, V102, P1164, DOI 10.1007/s001220000509; [Anonymous], 2014, R LANG ENV STAT COMP; Armstrong RN, 1999, COMP NAT PROD CHEM, P51; BAILLIE TA, 1981, PHARMACOL REV, V33, P81; Berthiller F, 2005, J AGR FOOD CHEM, V53, P3421, DOI 10.1021/jf047798g; Berthiller F, 2013, MOL NUTR FOOD RES, V57, P165, DOI 10.1002/mnfr.201100764; Berthiller F, 2011, TOXICOL LETT, V206, P264, DOI 10.1016/j.toxlet.2011.08.006; Berthiller F, 2009, ANAL BIOANAL CHEM, V395, P1243, DOI 10.1007/s00216-009-2874-x; Boutigny AL, 2008, EUR J PLANT PATHOL, V121, P411, DOI 10.1007/s10658-007-9266-x; Buerstmayr H, 2002, THEOR APPL GENET, V104, P84, DOI 10.1007/s001220200009; Buerstmayr H, 2003, THEOR APPL GENET, V107, P503, DOI 10.1007/s00122-003-1272-6; Buerstmayr H, 2009, PLANT BREEDING, V128, P1, DOI 10.1111/j.1439-0523.2008.01550.x; Bueschl C, 2013, METABOLOMICS, P1; Bueschl C, 2012, BIOINFORMATICS, V28, P736, DOI 10.1093/bioinformatics/bts012; Chakraborty S, 2011, PLANT PATHOL, V60, P2, DOI 10.1111/j.1365-3059.2010.02411.x; Coleman JOD, 1997, TRENDS PLANT SCI, V2, P144, DOI 10.1016/S1360-1385(97)01019-4; Dall'asta C, 2005, Mycotoxin Res, V21, P123, DOI 10.1007/BF02954435; Dall'Erta A, 2013, CHEM RES TOXICOL, V26, P305, DOI 10.1021/tx300438c; Day B, 2007, ANN NY ACAD SCI, V1113, P123, DOI 10.1196/annals.1391.029; De Vos RCH, 2007, NAT PROTOC, V2, P778, DOI 10.1038/nprot.2007.95; Engelhardt Gabriele, 1999, Advances in Food Sciences, V21, P71; Fruhmann P, 2014, ORG BIOMOL CHEM, V12, P5144, DOI 10.1039/c4ob00458b; Fruhmann P, 2014, TOXINS, V6, P325, DOI 10.3390/toxins6010325; Gardiner SA, 2010, MOL PLANT MICROBE IN, V23, P962, DOI 10.1094/MPMI-23-7-0962; Gunnaiah R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040695; Hirayama T, 2010, PLANT J, V61, P1041, DOI 10.1111/j.1365-313X.2010.04124.x; Horbach R, 2011, J PLANT PHYSIOL, V168, P51, DOI 10.1016/j.jplph.2010.06.014; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Kazan K, 2012, MOL PLANT PATHOL, V13, P399, DOI 10.1111/j.1364-3703.2011.00762.x; Kluger B, 2013, ANAL BIOANAL CHEM, V405, P5031, DOI 10.1007/s00216-012-6483-8; Laurent F, 2007, ENVIRON TOXICOL CHEM, V26, P2299, DOI 10.1897/07-036R.1; Lemmens M, 2005, MOL PLANT MICROBE IN, V18, P1318, DOI 10.1094/MPMI-18-1318; Levsen K, 2005, J CHROMATOGR A, V1067, P55, DOI 10.1016/j.chroma.2004.08.165; McCormick SP, 2011, TOXINS, V3, P802, DOI 10.3390/toxins3070802; Nagl V, 2014, TOXICOL LETT, V229, P190, DOI 10.1016/j.toxlet.2014.06.032; Pestka JJ, 2010, ARCH TOXICOL, V84, P663, DOI 10.1007/s00204-010-0579-8; Poppenberger B, 2003, J BIOL CHEM, V278, P47905, DOI 10.1074/jbc.M307552200; Rocco CJ, 2008, PLASMID, V59, P231, DOI 10.1016/j.plasmid.2008.01.001; Rychlik M, 2014, MYCOTOXIN RES, P1; Schweiger W, 2013, MOL PLANT PATHOL, V14, P772, DOI 10.1111/mpp.12048; Schweiger W, 2013, MOL PLANT MICROBE IN, V26, P781, DOI 10.1094/MPMI-08-12-0205-R; SEWALD N, 1992, TETRAHEDRON-ASYMMETR, V3, P953, DOI 10.1016/S0957-4166(00)82193-X; Shima J, 1997, APPL ENVIRON MICROB, V63, P3825, DOI 10.1128/AEM.63.10.3825-3830.1997; Skidmore MW, 1998, PURE APPL CHEM, V70, P1423, DOI 10.1351/pac199870071423; Stobiecki M, 2010, J NAT PROD, V73, P1254, DOI 10.1021/np100139d; Taguchi G, 2010, PLANT J, V63, P1031, DOI 10.1111/j.1365-313X.2010.04298.x; Walter Stephanie, 2011, Mycotoxin Res, V27, P221, DOI 10.1007/s12550-011-0099-2; Walter S, 2010, NEW PHYTOL, V185, P54, DOI 10.1111/j.1469-8137.2009.03041.x; Warth B, 2014, METABOLOMICS, P1, DOI [10.5339/gcsp.2014.4, DOI 10.5339/GCSP.2014.4]; Wolf AE, 1996, FEBS LETT, V384, P31, DOI 10.1016/0014-5793(96)00272-4; Xiao J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-197; Zachariasova M, 2012, J AGR FOOD CHEM, V60, P9280, DOI 10.1021/jf302069z	52	67	73	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119656	10.1371/journal.pone.0119656	http://dx.doi.org/10.1371/journal.pone.0119656			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775425	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500109
J	Lugenbiel, P; Wenz, F; Govorov, K; Schweizer, PA; Katus, HA; Thomas, D				Lugenbiel, Patrick; Wenz, Fabian; Govorov, Katharina; Schweizer, Patrick A.; Katus, Hugo A.; Thomas, Dierk			Atrial Fibrillation Complicated by Heart Failure Induces Distinct Remodeling of Calcium Cycling Proteins	PLOS ONE			English	Article							TACHYCARDIA; CONTRACTILE; DYSFUNCTION; MECHANISMS; MODEL; ARRHYTHMOGENESIS; SUPPRESSION; CHANNELS; DOGS	Atrial fibrillation (AF) and heart failure (HF) are two of the most common cardiovascular diseases. They often coexist and account for significant morbidity and mortality. Alterations in cellular Ca2+ homeostasis play a critical role in AF initiation and maintenance. This study was designed to specifically elucidate AF-associated remodeling of atrial Ca2+ cycling in the presence of mild HF. AF was induced in domestic pigs by atrial burst pacing. The animals underwent electrophysiologic and echocardiographic examinations. Ca2+ handling proteins were analyzed in right atrial tissue obtained from pigs with AF (day 7; n = 5) and compared to sinus rhythm (SR) controls (n = 5). During AF, animals exhibited reduction of left ventricular ejection fraction (from 73% to 58%) and prolonged atrial refractory periods. AF and HF were associated with suppression of protein kinase A (PKA)R-II (-62%) and Ca2+-calmodulin-dependent kinase II (CaMKII) delta by 37%, without changes in CaMKII delta autophosphorylation. We further detected downregulation of L-type calcium channel (LTCC) subunit alpha(2) (-75%), sarcoplasmic reticulum Ca2+-ATPase (Serca) 2a (-29%), phosphorylated phospholamban (Ser16, -92%; Thr17, -70%), and phospho-ryanodine receptor 2 (RyR2) (Ser2808, -62%). Na+-Ca2+ exchanger (NCX) levels were upregulated (+ 473%), whereas expression of Ser2814-phosphorylated RyR2 and LTCCa1c subunits was not significantly altered. In conclusion, AF produced distinct arrhythmogenic remodeling of Ca2+ handling in the presence of tachycardia-induced mild HF that is different from AF without structural alterations. The changes may provide a starting point for personalized approaches to AF treatment.	[Lugenbiel, Patrick; Wenz, Fabian; Govorov, Katharina; Schweizer, Patrick A.; Katus, Hugo A.; Thomas, Dierk] Med Univ Hosp, Dept Cardiol, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Thomas, D (corresponding author), Med Univ Hosp, Dept Cardiol, Neuenheimer Feld 410, D-69120 Heidelberg, Germany.	dierk.thomas@med.uni-heidelberg.de	Thomas, Dierk/ABA-4706-2021; Thomas, Dierk/V-3940-2017	Thomas, Dierk/0000-0002-5687-7843; 	University of Heidelberg, Faculty of Medicine; DZHK (Deutsches Zentrum fur Herz-Kreislauf-Forschung-German Centre for Cardiovascular Research); BMBF (German Ministry of Education and Research); German Cardiac Society; Hengstberger Foundation; Joachim Siebeneicher Foundation; Cardiology Career Program of the Department of Cardiology, University of Heidelberg	University of Heidelberg, Faculty of Medicine; DZHK (Deutsches Zentrum fur Herz-Kreislauf-Forschung-German Centre for Cardiovascular Research); BMBF (German Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF)); German Cardiac Society; Hengstberger Foundation; Joachim Siebeneicher Foundation; Cardiology Career Program of the Department of Cardiology, University of Heidelberg	This study was supported in part by research grants from the University of Heidelberg, Faculty of Medicine (Postdoc Fellowship to P.L.), from the DZHK (Deutsches Zentrum fur Herz-Kreislauf-Forschung-German Centre for Cardiovascular Research) and from the BMBF (German Ministry of Education and Research) (to H.A.K. and D.T.), from the German Cardiac Society and the Hengstberger Foundation (Klaus-Georg and Sigrid Hengstberger Scholarship to D.T.), and from the Joachim Siebeneicher Foundation (to D.T.). F.W. was supported by the Cardiology Career Program of the Department of Cardiology, University of Heidelberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allessie M, 2002, CARDIOVASC RES, V54, P230, DOI 10.1016/S0008-6363(02)00258-4; Bauer A, 2004, CARDIOVASC RES, V61, P764, DOI 10.1016/j.cardiores.2003.12.013; Bikou O, 2011, CARDIOVASC RES, V92, P218, DOI 10.1093/cvr/cvr209; Cha TJ, 2004, CIRCULATION, V110, P1520, DOI 10.1161/01.CIR.0000142052.03565.87; Dobrev D, 2010, N-S ARCH PHARMACOL, V381, P195, DOI 10.1007/s00210-009-0457-1; Duhme N, 2013, EUR HEART J, V34, P2768, DOI 10.1093/eurheartj/ehs391; Elvan A, 1996, CIRCULATION, V94, P2953, DOI 10.1161/01.CIR.94.11.2953; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Greiser M, 2009, J MOL CELL CARDIOL, V46, P385, DOI 10.1016/j.yjmcc.2008.11.012; Heijman J, 2014, CIRC RES, V114, P1483, DOI 10.1161/CIRCRESAHA.114.302226; Iwasaki YK, 2011, CIRCULATION, V124, P2264, DOI 10.1161/CIRCULATIONAHA.111.019893; Joung B, 2010, HEART RHYTHM, V7, P88, DOI 10.1016/j.hrthm.2009.09.018; Kato T, 2004, CIRC J, V68, P568, DOI 10.1253/circj.68.568; Kerr CR, 2005, AM HEART J, V149, P489, DOI 10.1016/j.ahj.2004.09.053; Li DS, 2000, CIRCULATION, V101, P2631, DOI 10.1161/01.CIR.101.22.2631; Lugenbiel P, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.111.000372; Lugenbiel P, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0265-5; Nattel S, 2005, PROG CARDIOVASC DIS, V48, P9, DOI 10.1016/j.pcad.2005.06.002; Nattel S, 2007, PHYSIOL REV, V87, P425, DOI 10.1152/physrev.00014.2006; Schmidt C, 2014, HEART RHYTHM, V11, P1798, DOI 10.1016/j.hrthm.2014.06.020; Schmidt C, 2014, LIFE SCI, V97, P107, DOI 10.1016/j.lfs.2013.12.006; Schotten U, 2011, PHYSIOL REV, V91, P265, DOI 10.1152/physrev.00031.2009; Schweizer PA, 2014, J AM COLL CARDIOL, V64, P757, DOI 10.1016/j.jacc.2014.06.1155; Soucek R, 2012, HEART RHYTHM, V9, P265, DOI 10.1016/j.hrthm.2011.09.008; Stambler BS, 2008, CIRC-ARRHYTHMIA ELEC, V1, P77, DOI 10.1161/CIRCEP.108.785071; Stambler BS, 2004, J CARDIOVASC ELECTR, V15, P933, DOI 10.1046/j.1540-8167.2004.04336.x; Trappe K, 2013, EUR HEART J, V34, P147, DOI 10.1093/eurheartj/ehr269; Voigt N, 2014, CIRCULATION, V129, P145, DOI 10.1161/CIRCULATIONAHA.113.006641; Voigt N, 2012, CIRCULATION, V125, P2059, DOI 10.1161/CIRCULATIONAHA.111.067306; Wakili R, 2010, CIRC-ARRHYTHMIA ELEC, V3, P530, DOI 10.1161/CIRCEP.109.933036; Wang TJ, 2003, CIRCULATION, V107, P2920, DOI 10.1161/01.CIR.0000072767.89944.6E; WIJFFELS MCEF, 1995, CIRCULATION, V92, P1954, DOI 10.1161/01.CIR.92.7.1954; Yeh YH, 2008, CIRC-ARRHYTHMIA ELEC, V1, P93, DOI 10.1161/CIRCEP.107.754788; Yue LX, 1997, CIRC RES, V81, P512, DOI 10.1161/01.RES.81.4.512	34	30	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0116395	10.1371/journal.pone.0116395	http://dx.doi.org/10.1371/journal.pone.0116395			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775120	gold, Green Published, Green Submitted			2022-12-27	WOS:000351183500008
J	Ogawa, T; Kawashima, N; Obata, H; Kanosue, K; Nakazawa, K				Ogawa, Tetsuya; Kawashima, Noritaka; Obata, Hiroki; Kanosue, Kazuyuki; Nakazawa, Kimitaka			Distinct Motor Strategies Underlying Split-Belt Adaptation in Human Walking and Running	PLOS ONE			English	Article							LOCOMOTOR ADAPTATION; INTERLIMB COORDINATION; ELECTRICAL-STIMULATION; TREADMILL ADAPTATION; MUSCLE CONTRIBUTIONS; NETWORKS; SUPPORT; TRANSITIONS; MOVEMENT; FEEDBACK	The aim of the present study was to elucidate the adaptive and de-adaptive nature of human running on a split-belt treadmill. The degree of adaptation and de-adaptation was compared with those in walking by calculating the antero-posterior component of the ground reaction force (GRF). Adaptation to walking and running on a split-belt resulted in a prominent asymmetry in the movement pattern upon return to the normal belt condition, while the two components of the GRF showed different behaviors depending on the gaits. The anterior braking component showed prominent adaptive and de-adaptive behaviors in both gaits. The posterior propulsive component, on the other hand, exhibited such behavior only in running, while that in walking showed only short-term aftereffect (lasting less than 10 seconds) accompanied by largely reactive responses. These results demonstrate a possible difference in motor strategies (that is, the use of reactive feedback and adaptive feedforward control) by the central nervous system (CNS) for split-belt locomotor adaptation between walking and running. The present results provide basic knowledge on neural control of human walking and running as well as possible strategies for gait training in athletic and rehabilitation scenes.	[Ogawa, Tetsuya; Kanosue, Kazuyuki] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan; [Ogawa, Tetsuya] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan; [Ogawa, Tetsuya; Kawashima, Noritaka] Natl Rehabil Ctr Persons Disabil, Res Inst, Dept Rehabil Movement Funct, Tokorozawa, Saitama, Japan; [Obata, Hiroki; Nakazawa, Kimitaka] Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan	Waseda University; Japan Society for the Promotion of Science; University of Tokyo	Ogawa, T (corresponding author), Waseda Univ, Fac Sport Sci, 2-579-15 Mikajima, Tokorozawa, Saitama, Japan.	t.ogawa@aoni.waseda.jp						Bastian AJ, 2006, CURR OPIN NEUROBIOL, V16, P645, DOI 10.1016/j.conb.2006.08.016; Blanchette A, 2009, J NEUROPHYSIOL, V102, P568, DOI 10.1152/jn.91096.2008; Cabelguen JM, 2003, J NEUROSCI, V23, P2434; CAPADAY C, 1987, J PHYSIOL-LONDON, V392, P513, DOI 10.1113/jphysiol.1987.sp016794; Cappellini G, 2006, J NEUROPHYSIOL, V95, P3426, DOI 10.1152/jn.00081.2006; CAVAGNA GA, 1976, J PHYSIOL-LONDON, V262, P639, DOI 10.1113/jphysiol.1976.sp011613; Choi JT, 2007, NAT NEUROSCI, V10, P1055, DOI 10.1038/nn1930; Choi JT, 2009, BRAIN, V132, P722, DOI 10.1093/brain/awn333; Dietz V, 2002, NAT REV NEUROSCI, V3, P781, DOI 10.1038/nrn939; Earhart GM, 2001, J NEUROPHYSIOL, V86, P1666, DOI 10.1152/jn.2001.86.4.1666; FORSSBERG H, 1980, ACTA PHYSIOL SCAND, V108, P283, DOI 10.1111/j.1748-1716.1980.tb06534.x; GRILLNER S, 1985, SCIENCE, V228, P143, DOI 10.1126/science.3975635; Hamner SR, 2010, J BIOMECH, V43, P2709, DOI 10.1016/j.jbiomech.2010.06.025; Ivanenko YP, 2008, EUR J NEUROSCI, V27, P3351, DOI 10.1111/j.1460-9568.2008.06289.x; Jayaram G, 2011, CEREB CORTEX, V21, P1901, DOI 10.1093/cercor/bhq263; KAWATO M, 1987, BIOL CYBERN, V57, P169, DOI 10.1007/BF00364149; Lam T, 2006, J NEUROPHYSIOL, V95, P766, DOI 10.1152/jn.00473.2005; Liu MQ, 2008, J BIOMECH, V41, P3243, DOI 10.1016/j.jbiomech.2008.07.031; Malone LA, 2010, J NEUROPHYSIOL, V103, P1954, DOI 10.1152/jn.00832.2009; Mawase F, 2013, J NEUROPHYSIOL, V109, P2216, DOI 10.1152/jn.00938.2012; McLean DL, 2008, NAT NEUROSCI, V11, P1419, DOI 10.1038/nn.2225; MORI S, 1989, BRAIN RES, V505, P66, DOI 10.1016/0006-8993(89)90116-9; Morton SM, 2006, J NEUROSCI, V26, P9107, DOI 10.1523/JNEUROSCI.2622-06.2006; Musselman KE, 2011, J NEUROPHYSIOL, V105, P2195, DOI 10.1152/jn.01002.2010; Ogawa T, 2014, J NEUROPHYSIOL, V111, P722, DOI 10.1152/jn.00497.2012; Ogawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046349; Prilutsky BI, 2001, J EXP BIOL, V204, P2277; Reisman DS, 2007, BRAIN, V130, P1861, DOI 10.1093/brain/awm035; Reisman DS, 2005, J NEUROPHYSIOL, V94, P2403, DOI 10.1152/jn.00089.2005; Sasaki K, 2006, J BIOMECH, V39, P2005, DOI 10.1016/j.jbiomech.2005.06.019; SHIK ML, 1966, BIOPHYS-USSR, V11, P756; Talpalar AE, 2013, NATURE, V500, P85, DOI 10.1038/nature12286; Torres-Oviedo G, 2010, J NEUROSCI, V30, P17015, DOI 10.1523/JNEUROSCI.4205-10.2010; Vasudevan EVL, 2010, J NEUROPHYSIOL, V103, P183, DOI 10.1152/jn.00501.2009; Yanagihara D, 1996, P NATL ACAD SCI USA, V93, P13292, DOI 10.1073/pnas.93.23.13292	35	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0121951	10.1371/journal.pone.0121951	http://dx.doi.org/10.1371/journal.pone.0121951			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775426	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500217
J	Panneerselvam, J; Jin, JK; Shanker, M; Lauderdale, J; Bates, J; Wang, Q; Zhao, YD; Archibald, SJ; Hubin, TJ; Ramesh, R				Panneerselvam, Janani; Jin, Jiankang; Shanker, Manish; Lauderdale, Jason; Bates, Jonathan; Wang, Qi; Zhao, Yan D.; Archibald, Stephen J.; Hubin, Timothy J.; Ramesh, Rajagopal			IL-24 Inhibits Lung Cancer Cell Migration and Invasion by Disrupting The SDF-1/CXCR4 Signaling Axis	PLOS ONE			English	Article							DIFFERENTIATION-ASSOCIATED GENE-7; CHEMOKINE RECEPTOR; TUMOR-GROWTH; CXCR4 ANTAGONIST; EXPRESSION; METASTASIS; MDA-7/IL-24; MDA-7; KINASES; PATHWAY	Background The stromal cell derived factor (SDF)-1/chemokine receptor (CXCR)-4 signaling pathway plays a key role in lung cancer metastasis and is molecular target for therapy. In the present study we investigated whether interleukin (IL)-24 can inhibit the SDF-1/CXCR4 axis and suppress lung cancer cell migration and invasion in vitro. Further, the efficacy of IL-24 in combination with CXCR4 antagonists was investigated. Methods Human H1299, A549, H460 and HCC827 lung cancer cell lines were used in the present study. The H1299 lung cancer cell line was stably transfected with doxycycline-inducible plasmid expression vector carrying the human IL-24 cDNA and used in the present study to determine the inhibitory effects of IL-24 on SDF-1/CXCR4 axis. H1299 and A549 cell lines were used in transient transfection studies. The inhibitory effects of IL-24 on SDF1/CXCR4 and its downstream targets were analyzed by quantitative RT-PCR, western blot, luciferase reporter assay, flow cytometry and immunocytochemistry. Functional studies included cell migration and invasion assays. Principal Findings Endogenous CXCR4 protein expression levels varied among the four human lung cancer cell lines. Doxycycline-induced IL-24 expression in the H1299-IL24 cell line resulted in reduced CXCR4 mRNA and protein expression. IL-24 post-transcriptionally regulated CXCR4 mRNA expression by decreasing the half-life of CXCR4 mRNA (>40%). Functional studies showed IL-24 inhibited tumor cell migration and invasion concomitant with reduction in CXCR4 and its downstream targets (pAKT(S473), pmTOR(S2448), pPRAS40(T246) and HIF-1 alpha). Additionally, IL-24 inhibited tumor cell migration both in the presence and absence of the CXCR4 agonist, SDF-1. Finally, IL-24 when combined with CXCR4 inhibitors (AMD3100, SJA5) or with CXCR4 siRNA demonstrated enhanced inhibitory activity on tumor cell migration. Conclusions IL-24 disrupts the SDF-1/CXCR4 signaling pathway and inhibits lung tumor cell migration and invasion. Additionally, IL-24, when combined with CXCR4 inhibitors exhibited enhanced anti-metastatic activity and is an attractive therapeutic strategy for lung metastasis.	[Panneerselvam, Janani; Lauderdale, Jason; Bates, Jonathan; Wang, Qi; Zhao, Yan D.; Ramesh, Rajagopal] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73106 USA; [Panneerselvam, Janani; Lauderdale, Jason; Bates, Jonathan; Wang, Qi; Hubin, Timothy J.; Ramesh, Rajagopal] Univ Oklahoma, Hlth Sci Ctr, Stephenson Canc Ctr, Oklahoma City, OK USA; [Shanker, Manish] Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA; [Zhao, Yan D.] Univ Oklahoma, Hlth Sci Ctr, Dept Biostat & Epidemiol, Oklahoma City, OK USA; [Archibald, Stephen J.] Univ Hull, Dept Chem, Kingston Upon Hull HU6 7RX, N Humberside, England; [Hubin, Timothy J.] Southwestern Oklahoma State Univ, Dept Chem, Weatherford, OK USA; [Ramesh, Rajagopal] Grad Program Biomed Sci, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Texas System; UTMD Anderson Cancer Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Hull	Ramesh, R (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73106 USA.	rajagopal-ramesh@ouhsc.edu	Archibald, Steve/I-8723-2012; Hubin, Timothy J/A-9399-2009	Archibald, Steve/0000-0001-7581-8817; Hubin, Timothy J/0000-0003-2277-1191	Jim and Christy Everest Endowed Chair in Cancer Developmental Therapeutics; Experimental Therapeutics Program; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [P20 GM103639]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103639] Funding Source: NIH RePORTER	Jim and Christy Everest Endowed Chair in Cancer Developmental Therapeutics; Experimental Therapeutics Program; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health(General Electric); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was supported in part by funds received from the Jim and Christy Everest Endowed Chair in Cancer Developmental Therapeutics (RR); seed grant from the Experimental Therapeutics Program (TJH, RR). The authors thank the Stephenson Cancer Center at the University of Oklahoma, Oklahoma City, OK and an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20 GM103639 for the use of Cancer Functional Genomic Core, which provided real-time PCR service. Assistance received from the molecular imaging core facility for conducting flow cytometric studies is appreciated. RR is an Oklahoma TSET Research Scholar and holds the Jim and Christy Everest Endowed Chair in Cancer Developmental Therapeutics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MM, 2013, TRANSL ONCOL, V6, P660, DOI 10.1593/tlo.13559; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Busillo JM, 2010, J BIOL CHEM, V285, P7805, DOI 10.1074/jbc.M109.091173; Caudell EG, 2002, J IMMUNOL, V168, P6041, DOI 10.4049/jimmunol.168.12.6041; Chada S, 2004, MOL THER, V10, P1085, DOI 10.1016/j.ymthe.2004.08.020; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chen G, 2012, J BIOL CHEM, V287, P12132, DOI 10.1074/jbc.M111.302299; Chinni SR, 2006, PROSTATE, V66, P32, DOI 10.1002/pros.20318; Chu HY, 2007, INT J BIOCHEM CELL B, V39, P197, DOI 10.1016/j.biocel.2006.07.008; Clift IC, 2014, MOL PHARMACOL, V85, P542, DOI 10.1124/mol.113.089714; COHEN P, 1992, TRENDS BIOCHEM SCI, V17, P408, DOI 10.1016/0968-0004(92)90010-7; Cojoc Monica, 2013, Onco Targets Ther, V6, P1347, DOI 10.2147/OTT.S36109; D'Alterio C, 2012, CANCER IMMUNOL IMMUN, V61, P1713, DOI 10.1007/s00262-012-1223-7; Darash-Yahana M, 2004, FASEB J, V18, P1240, DOI 10.1096/fj.03-0935fje; Domanska UM, 2013, EUR J CANCER, V49, P219, DOI 10.1016/j.ejca.2012.05.005; Ellerhorst JA, 2002, J CLIN ONCOL, V20, P1069, DOI 10.1200/JCO.2002.20.4.1069; FIFE RS, 1995, J LAB CLIN MED, V125, P407; Florio T, 2006, MOL PHARMACOL, V69, P539, DOI 10.1124/mol.105.015255; Fumarola C, 2014, BIOCHEM PHARMACOL, V90, P197, DOI 10.1016/j.bcp.2014.05.011; Furusato B, 2010, PATHOL INT, V60, P497, DOI 10.1111/j.1440-1827.2010.02548.x; Ierano C, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.269; Inoue S, 2006, CURR GENE THER, V6, P73, DOI 10.2174/156652306775515574; Ishikawa S, 2005, CLIN CANCER RES, V11, P1198; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Khan A, 2009, J AM CHEM SOC, V131, P3416, DOI 10.1021/ja807921k; Koizumi K, 2007, CANCER SCI, V98, P1652, DOI 10.1111/j.1349-7006.2007.00606.x; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Kunz S, 2006, EXP DERMATOL, V15, P991, DOI 10.1111/j.1600-0625.2006.00516.x; Lam WK, 2007, RESPIROLOGY, V12, P471, DOI 10.1111/j.1440-1843.2007.01105.x; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Liu L, 2013, CANCER EPIDEMIOL, V37, P71, DOI 10.1016/j.canep.2012.08.005; Mhashilkar AM, 2001, MOL MED, V7, P271, DOI 10.1007/BF03401847; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Minamiya Y, 2010, LUNG CANCER, V68, P466, DOI 10.1016/j.lungcan.2009.07.015; Monterrubio M, 2009, BIOCHEM BIOPH RES CO, V388, P199, DOI 10.1016/j.bbrc.2009.07.153; Na IK, 2008, HUM PATHOL, V39, P1751, DOI 10.1016/j.humpath.2008.04.017; Nervi B, 2009, BLOOD, V113, P6206, DOI 10.1182/blood-2008-06-162123; Oonakahara K, 2004, AM J RESP CELL MOL, V30, P671, DOI 10.1165/rcmb.2003-0340OC; Otsuka S, 2011, J THORAC ONCOL, V6, P1169, DOI 10.1097/JTO.0b013e3182199a99; Panneerselvam J, 2013, P 104 ANN M AM ASS C, P542; Panneerselvam Janani, 2013, J Mol Signal, V8, P15, DOI 10.1186/1750-2187-8-15; Paschoud S, 2006, MOL CELL BIOL, V26, P8228, DOI 10.1128/MCB.01155-06; Peled A, 2012, EXPERT OPIN INV DRUG, V21, P341, DOI 10.1517/13543784.2012.656197; Phillips RJ, 2003, AM J RESP CRIT CARE, V167, P1676, DOI 10.1164/rccm.200301-071OC; Phillips RJ, 2005, J BIOL CHEM, V280, P22473, DOI 10.1074/jbc.M500963200; Porta C, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00064; Ramesh R, 2004, DNA CELL BIOL, V23, P850, DOI 10.1089/dna.2004.23.850; Ramesh R, 2004, MOL THER, V9, P510, DOI 10.1016/j.ymthe.2004.01.019; Ramesh R, 2003, CANCER RES, V63, P5105; Ramsey DM, 2013, BIOORG MED CHEM LETT, V23, P20, DOI 10.1016/j.bmcl.2012.10.138; Redjal N, 2006, CLIN CANCER RES, V12, P6765, DOI 10.1158/1078-0432.CCR-06-1372; Saeki T, 2000, GENE THER, V7, P2051, DOI 10.1038/sj.gt.3301330; Sauane M, 2003, J CELL PHYSIOL, V196, P334, DOI 10.1002/jcp.10309; Stewart AL, 2002, MOL MED, V8, P451, DOI 10.1007/BF03402025; Su LP, 2005, CLIN CANCER RES, V11, P8273, DOI 10.1158/1078-0432.CCR-05-0537; Sun XJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-17; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Tong AW, 2005, MOL THER, V11, P160, DOI 10.1016/j.ymthe.2004.09.021; Uchida D, 2011, EUR J CANCER, V47, P452, DOI 10.1016/j.ejca.2010.09.028; Uy GL, 2012, BLOOD, V119, P3917, DOI 10.1182/blood-2011-10-383406; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Vila-Coro AJ, 1999, FASEB J, V13, P1699, DOI 10.1096/fasebj.13.13.1699; Wagner PL, 2009, J THORAC CARDIOV SUR, V137, P615, DOI 10.1016/j.jtcvs.2008.07.039; Wang JH, 2008, J BIOL CHEM, V283, P4283, DOI 10.1074/jbc.M707465200; Wolk K, 2002, J IMMUNOL, V168, P5397, DOI 10.4049/jimmunol.168.11.5397; Wurth R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00144; Zlotnik A, 2008, J PATHOL, V215, P211, DOI 10.1002/path.2350	69	51	56	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0122439	10.1371/journal.pone.0122439	http://dx.doi.org/10.1371/journal.pone.0122439			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775124	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500224
J	Pezzolla, D; Lopez-Beas, J; Lachaud, CC; Dominguez-Rodriguez, A; Smani, T; Hmadcha, A; Soria, B				Pezzolla, Daniela; Lopez-Beas, Javier; Lachaud, Christian C.; Dominguez-Rodriguez, Alejandro; Smani, Tarik; Hmadcha, Abdelkrim; Soria, Bernat			Resveratrol Ameliorates the Maturation Process of beta- Cell-Like Cells Obtained from an Optimized Differentiation Protocol of Human Embryonic Stem Cells	PLOS ONE			English	Article							INSULIN-PRODUCING CELLS; HIGHLY EFFICIENT DIFFERENTIATION; PANCREATIC DUODENAL HOMEOBOX-1; CONCENTRATION-DEPENDENT MANNER; IN-VITRO; UNCOUPLING PROTEIN-2; SECRETING CELLS; DIRECTED DIFFERENTIATION; DEFINITIVE ENDODERM; GENERATION	Human embryonic stem cells (hESCs) retain the extraordinary capacity to differentiate into different cell types of an adult organism, including pancreatic beta-cells. For this particular lineage, although a lot of effort has been made in the last ten years to achieve an efficient and reproducible differentiation protocol, it was not until recently that this aim was roughly accomplished. Besides, several studies evidenced the impact of resveratrol (RSV) on insulin secretion, even though the mechanism by which this polyphenol potentiates glucose-stimulated insulin secretion (GSIS) is still not clear. The aim of this study was to optimize an efficient differentiation protocol that mimics in vivo pancreatic organogenesis and to investigate whether RSV may improve the final maturation step to obtain functional insulin-secreting cells. Our results indicate that treatment of hESCs (HS-181) with activin-A induced definitive endoderm differentiation as detected by the expression of SOX17 and FOXA2. Addition of retinoic acid (RA), Noggin and Cyclopamine promoted pancreatic differentiation as indicated by the expression of the early pancreatic progenitor markers ISL1, NGN3 and PDX1. Moreover, during maturation in suspension culture, differentiating cells assembled in islet-like clusters, which expressed specific endocrine markers such as PDX1, SST, GCG and INS. Similar results were confirmed with the human induced Pluripotent Stem Cell (hiPSC) line MSUH-001. Finally, differentiation protocols incorporating RSV treatment yielded numerous insulin-positive cells, induced significantly higher PDX1 expression and were able to transiently normalize glycaemia when transplanted in streptozotocin (STZ) induced diabetic mice thus promoting its survival. In conclusion, our strategy allows the efficient differentiation of hESCs into pancreatic endoderm capable of generating beta-cell-like cells and demonstrates that RSV improves the maturation process.	[Pezzolla, Daniela; Lopez-Beas, Javier; Lachaud, Christian C.; Hmadcha, Abdelkrim; Soria, Bernat] FPS, Andalusian Ctr Mol Biol & Regenerat Med CABIMER, Dept Stem Cells, Seville, Spain; [Dominguez-Rodriguez, Alejandro; Smani, Tarik] Inst Biomed Seville IBIS, Cardiovasc Pathophysiol, Seville, Spain; [Pezzolla, Daniela; Lopez-Beas, Javier; Hmadcha, Abdelkrim; Soria, Bernat] Spanish Biomed Res Ctr Diabet & Associated Metab, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS)	Hmadcha, A (corresponding author), FPS, Andalusian Ctr Mol Biol & Regenerat Med CABIMER, Dept Stem Cells, Seville, Spain.	karim.hmadcha@cabimer.es	Hmadcha, Abdelkrim/T-1173-2019; Hajami, Tarik Smani/D-5372-2016; , Bernat/AAL-6470-2021; López-Beas, Javier/Q-3935-2018; Lachaud, Christian Claude/C-2036-2017; IBIS, CARDIOVASCULAR/P-3910-2015	Hmadcha, Abdelkrim/0000-0002-4105-3702; Hajami, Tarik Smani/0000-0002-1877-7438; López-Beas, Javier/0000-0002-2463-947X; Lachaud, Christian Claude/0000-0001-8698-4589; Soria, Bernat/0000-0002-2356-0380; Dominguez Rodriguez, Alejandro/0000-0002-3508-8538	(Fundacion Progreso y Salud) Consejeria de Salud, Junta de Andalucia [PI-0022/2008]; Consejeria de Innovacion Ciencia y Empresa, Junta de Andalucia [CTS-6505, INP-2011-1615-900000, P10-CVI-6095]; Instituto de Salud Carlos III (Red TerCel-Grant) [RD06/0010/0025, RD12/0019/0028, RD12/0042/0041, PI10/00964, PI14/01015, PI10/00871]; Ministry of Health and Consumer Affairs (Advanced Therapies Program Grant) [TRA-120]; FEDER	(Fundacion Progreso y Salud) Consejeria de Salud, Junta de Andalucia(Junta de Andalucia); Consejeria de Innovacion Ciencia y Empresa, Junta de Andalucia(Junta de Andalucia); Instituto de Salud Carlos III (Red TerCel-Grant)(Instituto de Salud Carlos III); Ministry of Health and Consumer Affairs (Advanced Therapies Program Grant); FEDER(European Commission)	Authors are supported by the nonprofit Foundation (Fundacion Progreso y Salud) Consejeria de Salud, Junta de Andalucia (Grant PI-0022/2008); FEDER co-funded grants from Consejeria de Innovacion Ciencia y Empresa, Junta de Andalucia (Grant CTS-6505; INP-2011-1615-900000 and P10-CVI-6095); FEDER co-funded grants from Instituto de Salud Carlos III (Red TerCel-Grant RD06/0010/0025, RD12/0019/0028 and RD12/0042/0041; PI10/00964, PI14/01015 and PI10/00871) and the Ministry of Health and Consumer Affairs (Advanced Therapies Program Grant TRA-120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkrim H, 2009, J CELL MOL MED, V13, P1464, DOI 10.1111/j.1582-4934.2009.00837.x; Affourtit C, 2008, BBA-BIOENERGETICS, V1777, P973, DOI 10.1016/j.bbabio.2008.03.022; Affourtit C, 2008, BIOCHEM J, V409, P199, DOI 10.1042/BJ20070954; Ameri J, 2010, STEM CELLS, V28, P45, DOI 10.1002/stem.249; Azzu V, 2008, BBA-BIOENERGETICS, V1777, P1378, DOI 10.1016/j.bbabio.2008.07.001; Baetge EE, 2008, DIABETES OBES METAB, V10, P186, DOI 10.1111/j.1463-1326.2008.00956.x; Basford CL, 2012, DIABETOLOGIA, V55, P358, DOI 10.1007/s00125-011-2335-x; Bashmakov Yuriy K, 2014, ISRN Endocrinol, V2014, P816307, DOI 10.1155/2014/816307; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bonal C, 2008, INT J DEV BIOL, V52, P823, DOI 10.1387/ijdb.072444cb; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Borriello A, 2010, NUTR METAB CARDIOVAS, V20, P618, DOI 10.1016/j.numecd.2010.07.004; Brand MD, 2010, DIABETES OBES METAB, V12, P134, DOI 10.1111/j.1463-1326.2010.01264.x; Brasnyo P, 2011, BRIT J NUTR, V106, P383, DOI 10.1017/S0007114511000316; Bruin JE, 2014, STEM CELL RES, V12, P194, DOI 10.1016/j.scr.2013.10.003; Calvanese V, 2010, P NATL ACAD SCI USA, V107, P13736, DOI 10.1073/pnas.1001399107; Cano DA, 2014, CELL MOL LIFE SCI, V71, P2383, DOI 10.1007/s00018-013-1510-2; Chen WP, 2007, EUR J PHARMACOL, V568, P269, DOI 10.1016/j.ejphar.2007.04.062; Lachaud CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055181; Crandall JP, 2013, DIABETES, V62, P1022, DOI 10.2337/db12-1788; Crandall JP, 2012, J GERONTOL A-BIOL, V67, P1307, DOI 10.1093/gerona/glr235; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Elrick LJ, 2001, DIABETES, V50, P2244, DOI 10.2337/diabetes.50.10.2244; Fiori JL, 2013, DIABETES, V62, P3500, DOI 10.2337/db13-0266; Guo SR, 2014, CELL BIOL INT, V38, P849, DOI 10.1002/cbin.10274; Hay DC, 2008, P NATL ACAD SCI USA, V105, P12301, DOI 10.1073/pnas.0806522105; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Hovatta O, 2003, HUM REPROD, V18, P1404, DOI 10.1093/humrep/deg290; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hrvatin S, 2014, P NATL ACAD SCI USA, V111, P3038, DOI 10.1073/pnas.1400709111; Jiang JJ, 2007, STEM CELLS, V25, P1940, DOI 10.1634/stemcells.2006-0761; Jiang W, 2007, CELL RES, V17, P333, DOI 10.1038/cr.2007.28; Johannesson M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004794; Kim SK, 1998, P NATL ACAD SCI USA, V95, P13036, DOI 10.1073/pnas.95.22.13036; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Leon-Quinto T, 2004, DIABETOLOGIA, V47, P1442, DOI 10.1007/s00125-004-1458-8; Loh KM, 2014, CELL STEM CELL, V14, P237, DOI 10.1016/j.stem.2013.12.007; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Nostro MC, 2012, SEMIN CELL DEV BIOL, V23, P701, DOI 10.1016/j.semcdb.2012.06.010; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Patel KR, 2011, ANN NY ACAD SCI, V1215, P161, DOI 10.1111/j.1749-6632.2010.05853.x; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Rajagopal J, 2003, SCIENCE, V299, P363; Rezania A, 2014, NAT BIOTECHNOL, V32, P1121, DOI 10.1038/nbt.3033; Rezania A, 2013, STEM CELLS, V31, P2432, DOI 10.1002/stem.1489; Rezania A, 2012, DIABETES, V61, P2016, DOI 10.2337/db11-1711; Schiesser JV, 2014, ANN NY ACAD SCI, V1311, P124, DOI 10.1111/nyas.12369; Schulz TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037004; Segev H, 2004, STEM CELLS, V22, P265, DOI 10.1634/stemcells.22-3-265; Shim JH, 2007, DIABETOLOGIA, V50, P1228, DOI 10.1007/s00125-007-0634-z; Shiroi A, 2002, STEM CELLS, V20, P284, DOI 10.1634/stemcells.20-4-284; Soria B, 2001, DIFFERENTIATION, V68, P205, DOI 10.1046/j.1432-0436.2001.680408.x; Soria B, 2000, DIABETES, V49, P157, DOI 10.2337/diabetes.49.2.157; Soria B, 2014, PRINCIPLES OF TISSUE ENGINEERING, 4TH EDITION, P837, DOI 10.1016/B978-0-12-398358-9.00041-0; Sulzbacher S, 2009, STEM CELL REV REP, V5, P159, DOI 10.1007/s12015-009-9061-5; Szkudelski T, 2011, ANN NY ACAD SCI, V1215, P34, DOI 10.1111/j.1749-6632.2010.05844.x; Tsaniras SC, 2011, VITAM HORM, V87, P79, DOI 10.1016/B978-0-12-386015-6.00025-1; Tsaniras SC, 2010, J ENDOCRINOL, V206, P13, DOI 10.1677/JOE-10-0073; Vaca P, 2006, STEM CELLS, V24, P258, DOI 10.1634/stemcells.2005-0058; Vetterli L, 2011, J BIOL CHEM, V286, P6049, DOI 10.1074/jbc.M110.176842; Watanabe H, 2008, PANCREAS, V36, P153, DOI 10.1097/MPA.0b013e318157753e; Xie S, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-47; Zhang DH, 2009, CELL RES, V19, P429, DOI 10.1038/cr.2009.28; Zhang YJ, 2004, J AGR FOOD CHEM, V52, P228, DOI 10.1021/jf034616u	67	27	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119904	10.1371/journal.pone.0119904	http://dx.doi.org/10.1371/journal.pone.0119904			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774684	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500139
J	Signorelli, S; Dans, PD; Coitino, EL; Borsani, O; Monza, J				Signorelli, Santiago; Dans, Pablo D.; Laura Coitino, E.; Borsani, Omar; Monza, Jorge			Connecting Proline and gamma-Aminobutyric Acid in Stressed Plants through Non-Enzymatic Reactions	PLOS ONE			English	Article							POLARIZABLE CONTINUUM MODEL; SIMPLE COMPUTATIONAL MODEL; FREE-RADICAL INTERVENTION; CATALYZED OXIDATION; MOLECULAR-MECHANISMS; SOLVATION ENERGY; OXYGEN RADICALS; WATER-DEFICIT; GABA; ACCUMULATION	The accumulation of proline (Pro) in plants exposed to biotic/abiotic stress is a well-documented and conserved response in most vegetal species. Stress conditions induce the overproduction of reactive oxygen species which can lead to cellular damage. In vitro assays have shown that enzyme inactivation by hydroxyl radicals ((OH)-O-center dot) can be avoided in presence of Pro, suggesting that this amino acid could act as an (OH)-O-center dot scavenger. We applied Density Functional Theory coupled with a polarizable continuum model to elucidate how Pro reacts with (OH)-O-center dot. In this work we suggest that Pro reacts favourably with (OH)-O-center dot by H-abstraction on the amine group. This reaction produces the spontaneous decarboxylation of Pro leading to the formation of pyrrolidin-1-yl. In turn, pyrrolidin-1-yl can easily be converted to Delta(1)-pyrroline, the substrate of the enzyme Delta(1)-pyrroline dehydrogenase, which produces gamma-aminobutyric acid (GABA). GABA and Pro are frequently accumulated in stressed plants and several protective roles have been assigned to these molecules. Thereby we present an alternative non-enzymatic way to synthetize GABA under oxidative stress. Finally this work sheds light on a new beneficial role of Pro accumulation in the maintenance of photosynthetic activity.	[Signorelli, Santiago; Borsani, Omar; Monza, Jorge] Univ Republica, Fac Agron, Dept Biol Vegetal, Lab Bioquim, Montevideo, Uruguay; [Dans, Pablo D.] Inst Res Biomed IRB Barcelona, Joint BSC CRG IRB Res Program Computat Biol, Barcelona, Spain; [Laura Coitino, E.] Univ Republica, Fac Ciencias, Inst Quim Biol, Lab Quim Teor & Computac, Montevideo, Uruguay	Universidad de la Republica, Uruguay; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Universidad de la Republica, Uruguay	Signorelli, S (corresponding author), Univ Republica, Fac Agron, Dept Biol Vegetal, Lab Bioquim, Montevideo, Uruguay.	ssignorelli@fagro.edu.uy	Signorelli, Santiago/AGL-8124-2022; Signorelli, Santiago/AAV-7069-2020; Coitiño Izaguirre, Elena Laura/A-8101-2016; Dans, Pablo D./K-6330-2019	Signorelli, Santiago/0000-0002-1854-3164; Coitiño Izaguirre, Elena Laura/0000-0002-6214-2413; Dans, Pablo D./0000-0002-5927-372X; Borsani, Omar/0000-0002-9111-5801	Fondo Clemente Estable 6662 Agencia Nacional de Investigacion e Innovacion (FCE 6662 ANII); Programa de desarrollo de las ciencias basicas (PEDECIBA); Comision Academica de Posgrado (CAP); Sistema Nacional de Investigadores (SNI)	Fondo Clemente Estable 6662 Agencia Nacional de Investigacion e Innovacion (FCE 6662 ANII); Programa de desarrollo de las ciencias basicas (PEDECIBA); Comision Academica de Posgrado (CAP); Sistema Nacional de Investigadores (SNI)	Fondo Clemente Estable 6662 Agencia Nacional de Investigacion e Innovacion (FCE 6662 ANII), Programa de desarrollo de las ciencias basicas (PEDECIBA), http://www.pedeciba. edu.uy/indice.php, SS. Comision Academica de Posgrado (CAP), http://www.posgrados.udelar.edu.uy/, SS. Sistema Nacional de Investigadores (SNI): http://www.sni.org.uy/, SS PDD ELC OB JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcay N, 2012, J PLANT PHYSIOL, V169, P452, DOI 10.1016/j.jplph.2011.11.006; ALIA, 1991, BIOCHEM BIOPH RES CO, V181, P1238, DOI 10.1016/0006-291X(91)92071-Q; Alia, 2001, AMINO ACIDS, V21, P195; AMICI A, 1989, J BIOL CHEM, V264, P3341; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; Bader R. F. W., 1990, ATOMS MOL QUANTUM TH; BARNETT NM, 1966, PLANT PHYSIOL, V41, P1222, DOI 10.1104/pp.41.7.1222; BONDI A, 1964, J PHYS CHEM-US, V68, P441, DOI 10.1021/j100785a001; Bonifacic M, 1998, J AM CHEM SOC, V120, P9930, DOI 10.1021/ja9815428; Bouche N, 2004, TRENDS PLANT SCI, V9, P110, DOI 10.1016/j.tplants.2004.01.006; Bussis D, 1998, J EXP BOT, V49, P1361, DOI 10.1093/jexbot/49.325.1361; Cances E, 1997, J CHEM PHYS, V107, P3032, DOI 10.1063/1.474659; Chen CB, 2005, P NATL ACAD SCI USA, V102, P3459, DOI 10.1073/pnas.0407960102; CHIANG HH, 1995, PLANT CELL ENVIRON, V18, P1280, DOI 10.1111/j.1365-3040.1995.tb00187.x; Dat J, 2000, CELL MOL LIFE SCI, V57, P779, DOI 10.1007/s000180050041; Demidchik V, 2010, J CELL SCI, V123, P1468, DOI 10.1242/jcs.064352; Diaz P, 2014, PLANT ADAPTATION TO ENVIRONMENTAL CHANGE: SIGNIFICANCE OF AMINO ACIDS AND THEIR DERIVATIVES, P53, DOI 10.1079/9781780642734.0053; DOVER S, 1972, J BACTERIOL, V110, P165, DOI 10.1128/JB.110.1.165-170.1972; DOVER S, 1972, J BACTERIOL, V109, P835, DOI 10.1128/JB.109.2.835-843.1972; Fait A, 2008, TRENDS PLANT SCI, V13, P14, DOI 10.1016/j.tplants.2007.10.005; Fait A, 2006, PLANT PHYSIOL, V142, P839, DOI 10.1104/pp.106.086694; Feng Z, 2004, ACTA PHYSIOL PLANT, V26, P345; FLORES HE, 1985, PLANT GROWTH REGUL, V3, P277, DOI 10.1007/BF00117586; FLORIS F, 1989, J COMPUT CHEM, V10, P616, DOI 10.1002/jcc.540100504; FLORIS FM, 1991, J COMPUT CHEM, V12, P784, DOI 10.1002/jcc.540120703; FOYER CH, 1994, PLANT CELL ENVIRON, V17, P507, DOI 10.1111/j.1365-3040.1994.tb00146.x; Frisch M. J., 2009, GAUSSIAN 16 REVISION; FUKUI K, 1981, ACCOUNTS CHEM RES, V14, P363, DOI 10.1021/ar00072a001; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1; Halliwell B, 2006, PLANT PHYSIOL, V141, P312, DOI 10.1104/pp.106.077073; Hiremath MI, 2006, RUSS J PHYS CHEM+, V80, P1029, DOI 10.1134/S0036024406070053; Hong ZL, 2000, PLANT PHYSIOL, V122, P1129, DOI 10.1104/pp.122.4.1129; Hratchian HP, 2005, J PHYS CHEM A, V109, P8579, DOI 10.1021/jp052616m; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kapitan J, 2006, J AM CHEM SOC, V128, P2438, DOI 10.1021/ja057337r; Matysik J, 2002, CURR SCI INDIA, V82, P525; Mayer I, 2007, J COMPUT CHEM, V28, P204, DOI 10.1002/jcc.20494; Miertus S, 1997, INT J BIOL MACROMOL, V20, P85, DOI 10.1016/S0141-8130(96)01143-9; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Nanjo T, 1999, FEBS LETT, V461, P205, DOI 10.1016/S0014-5793(99)01451-9; Neill S, 2002, CURR OPIN PLANT BIOL, V5, P388, DOI 10.1016/S1369-5266(02)00282-0; Polle A, 1997, OXIDATIVE STRESS MOL; Poole P, 2000, ADV MICROB PHYSIOL, V43, P117, DOI 10.1016/S0065-2911(00)43004-3; REED AE, 1988, CHEM REV, V88, P899, DOI 10.1016/0030-4018(75)90085-1; REED AE, 1983, J CHEM PHYS, V78, P4066, DOI 10.1063/1.445134; Renew S, 2005, PLANT J, V44, P342, DOI 10.1111/j.1365-313X.2005.02528.x; Scheiner S, 2010, J AM CHEM SOC, V132, P16450, DOI 10.1021/ja105204v; Seregar VC, 2006, TRANSIT METAL CHEM, V31, P541, DOI 10.1007/s11243-006-0029-x; Sharma S, 2011, PLANT PHYS, V157; Shelp BJ, 2012, PLANT SCI, V193, P130, DOI 10.1016/j.plantsci.2012.06.001; Shelp BJ, 1999, TRENDS PLANT SCI, V4, P446, DOI 10.1016/S1360-1385(99)01486-7; Signorelli S, 2014, J PHYS CHEM B, V118, P37, DOI 10.1021/jp407773u; Signorelli S, 2013, PLANT PHYSIOL BIOCH, V64, P80, DOI 10.1016/j.plaphy.2012.12.017; SMIRNOFF N, 1989, PHYTOCHEMISTRY, V28, P1057, DOI 10.1016/0031-9422(89)80182-7; Sweetlove LJ, 2002, PLANT J, V32, P891, DOI 10.1046/j.1365-313X.2002.01474.x; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Tomasi J, 2011, WIRES COMPUT MOL SCI, V1, P855, DOI 10.1002/wcms.54; Vega D, 2014, J COMPUT METHODS SCI, V14, P131, DOI 10.3233/JCM-140491; Wheeler SE, 2010, J CHEM THEORY COMPUT, V6, P395, DOI 10.1021/ct900639j; WIBERG KB, 1968, TETRAHEDRON, V24, P1083, DOI 10.1016/0040-4020(68)88057-3; Zhao Y, 2008, ACCOUNTS CHEM RES, V41, P157, DOI 10.1021/ar700111a	62	91	91	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0115349	10.1371/journal.pone.0115349	http://dx.doi.org/10.1371/journal.pone.0115349			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775459	Green Submitted, Green Published, gold			2022-12-27	WOS:000351183500002
J	Takahashi, M; Miyazaki, S; Myojo, M; Sawaki, D; Iwata, H; Kiyosue, A; Higashikuni, Y; Tanaka, T; Fujita, D; Ando, J; Fujita, H; Hirata, Y; Komuro, I				Takahashi, Masao; Miyazaki, Susumu; Myojo, Masahiro; Sawaki, Daigo; Iwata, Hiroshi; Kiyosue, Arihiro; Higashikuni, Yasutomi; Tanaka, Tomofumi; Fujita, Daishi; Ando, Jiro; Fujita, Hideo; Hirata, Yasunobu; Komuro, Issei			Impact of the Distance from the Stent Edge to the Residual Plaque on Edge Restenosis following Everolimus-Eluting Stent Implantation	PLOS ONE			English	Article							INTRAVASCULAR ULTRASOUND ASSESSMENT; OPTICAL COHERENCE TOMOGRAPHY; CORONARY; PREDICTORS; LESIONS; INTERVENTION; DEPLOYMENT; INJURY	Objectives This study aimed to assess the relation between stent edge restenosis (SER) and the distance from the stent edge to the residual plaque using quantitative intravascular ultrasound. Background Although percutaneous coronary intervention with drug-eluting stents has improved SER rates, determining an appropriate stent edge landing zone can be challenging in cases of diffuse plaque lesions. It is known that edge vascular response can occur within 2 mm from the edge of a bare metal stent, but the distance to the adjacent plaque has not been evaluated for drug-eluting stents. Methods A total of 97 proximal residual plaque lesions (plaque burden [PB] > 40%) treated with ever-olimus- eluting stents were retrospectively evaluated to determine the distance from the stent edge to the residual plaque. Results The SER group had significantly higher PB (59.1 +/- 6.1% vs. 51.9 +/- 9.1% for non-SER; P = 0.04). Higher PB was associated with SER, with the cutoff value of 54.74% determined using receiver operating characteristic (ROC) curve analysis. At this cutoff value of PB, the distance from the stent edge to the lesion was significantly associated with SER (odds ratio = 2.05, P = 0.035). The corresponding area under the ROC curve was 0.725, and the cutoff distance value for predicting SER was 1.0 mm. Conclusion An interval less than 1 mm from the proximal stent edge to the nearest point with the determined PB cutoff value of 54.74% was significantly associated with SER in patients with residual plaque lesions.	[Takahashi, Masao; Myojo, Masahiro; Sawaki, Daigo; Iwata, Hiroshi; Kiyosue, Arihiro; Higashikuni, Yasutomi; Tanaka, Tomofumi; Fujita, Daishi; Ando, Jiro; Fujita, Hideo; Komuro, Issei] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan; [Miyazaki, Susumu] Univ Tokyo, Dept Med Engn, Tokyo, Japan; [Hirata, Yasunobu] Tokyo Teishin Hosp, Tokyo, Japan	University of Tokyo; University of Tokyo	Takahashi, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan.	masaotakahashi-gi@umin.org	SAWAKI, Daigo/T-6871-2018; FUJITA, HIDEO/AHC-6839-2022	SAWAKI, Daigo/0000-0003-1417-2033; HIGASHIKUNI, YASUTOMI/0000-0002-2232-567X; Fujita, Hideo/0000-0002-4901-3502; Takahashi, Masao/0000-0002-3799-2256	Ministry of Education, Culture, Sports, Science, and Technology of Japan [17659229]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Grants-in-Aid #17659229 (to YH), Core Research for Evolutional Science and Technology from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Claessen BE, 2009, CIRC-CARDIOVASC INTE, V2, P339, DOI 10.1161/CIRCINTERVENTIONS.108.831800.108.831800; Colombo A, 2007, CIRCULATION, V116, P1424, DOI 10.1161/CIRCULATIONAHA.106.621359; Costa MA, 2008, AM J CARDIOL, V101, P1704, DOI 10.1016/j.amjcard.2008.02.053; Gada H, 2013, JACC-CARDIOVASC INTE, V6, P1263, DOI 10.1016/j.jcin.2013.07.009; Genest J, 2009, CAN J CARDIOL, V25, P567, DOI 10.1016/S0828-282X(09)70715-9; Gillett Melissa J, 2009, Clin Biochem Rev, V30, P197; Gillett MJ, 2009, CLIN BIOCH REV AUSTR, V32, P1327; Gogas BD, 2013, JACC-CARDIOVASC INTE, V6, P211, DOI 10.1016/j.jcin.2013.01.132; Kang SJ, 2013, AM J CARDIOL, V111, P1401, DOI 10.1016/j.amjcard.2013.01.291; Kang SJ, 2013, AM J CARDIOL, V111, P1408, DOI 10.1016/j.amjcard.2013.01.288; Kaple RK, 2009, ULTRASOUND MED BIOL, V35, P550, DOI 10.1016/j.ultrasmedbio.2008.09.024; Kawamori H, 2013, EUR HEART J-CARD IMG, V14, P865, DOI 10.1093/ehjci/jes299; Liu XB, 2009, JACC-CARDIOVASC INTE, V2, P997, DOI 10.1016/j.jcin.2009.07.012; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Mehran R, 1999, CIRCULATION, V100, P1872, DOI 10.1161/01.CIR.100.18.1872; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Mudra H, 2001, CIRCULATION, V104, P1343, DOI 10.1161/hc3701.096064; Sakurai R, 2005, AM J CARDIOL, V96, P1251, DOI 10.1016/j.amjcard.2005.06.066; Schofer J, 2003, LANCET, V362, P1093, DOI 10.1016/S0140-6736(03)14462-5; Serruys PW, 2002, J AM COLL CARDIOL, V39, P393, DOI 10.1016/S0735-1097(01)01760-0; Shimohama T, 2010, AM J CARDIOL, V106, P13, DOI 10.1016/j.amjcard.2010.02.008; van der Giessen WJ, 2001, CIRCULATION, V104, P2236, DOI 10.1161/hc4301.097873; Waksman R, 1997, CIRCULATION, V96, P1944, DOI 10.1161/01.CIR.96.6.1944; Weissman NJ, 2007, EUR HEART J, V28, P1574, DOI 10.1093/eurheartj/ehm174; Weissman NJ, 2001, AM J CARDIOL, V88, P248, DOI 10.1016/S0002-9149(01)01635-6; Zhang QY, 2012, CHINESE MED J-PEKING, V125, P1547, DOI 10.3760/cma.j.issn.0366-6999.2012.09.005	26	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0121079	10.1371/journal.pone.0121079	http://dx.doi.org/10.1371/journal.pone.0121079			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775115	Green Published, gold, Green Submitted			2022-12-27	WOS:000351183500206
J	Taubert, J; Hou, B; Risselada, HJ; Mehner, D; Lunsdorf, H; Grubmuller, H; Bruser, T				Taubert, Johannes; Hou, Bo; Risselada, H. Jelger; Mehner, Denise; Luensdorf, Heinrich; Grubmueller, Helmut; Brueser, Thomas			TatBC-Independent TatA/Tat Substrate Interactions Contribute to Transport Efficiency	PLOS ONE			English	Article							TWIN-ARGININE TRANSLOCATION; DEPENDENT PROTEIN-TRANSPORT; COLI PLASMA-MEMBRANE; ESCHERICHIA-COLI; SIGNAL PEPTIDE; STREPTOMYCES-LIVIDANS; PATHWAY SPECIFICITY; PRECURSOR PROTEINS; BACILLUS-SUBTILIS; BINDING-SITE	The Tat system can transport folded, signal peptide-containing proteins (Tat substrates) across energized membranes of prokaryotes and plant plastids. A twin-arginine motif in the signal peptide of Tat substrates is recognized by TatC-containing complexes, and TatA permits the membrane passage. Often, as in the model Tat systems of Escherichia coli and plant plastids, a third component-TatB-is involved that resembles TatA but has a higher affinity to TatC. It is not known why most TatA dissociates from TatBC complexes in vivo and distributes more evenly in the membrane. Here we show a TatBC-independent substrate-binding to TatA from Escherichia coli, and we provide evidence that this binding enhances Tat transport. First hints came from in vivo cross-linking data, which could be confirmed by affinity co-purification of TatA with the natural Tat substrates HiPIP and NrfC. Two positions on the surface of HiPIP could be identified that are important for the TatA interaction and transport efficiency, indicating physiological relevance of the interaction. Distributed TatA thus may serve to accompany membrane-interacting Tat substrates to the few TatBC spots in the cells.	[Taubert, Johannes; Hou, Bo; Mehner, Denise; Brueser, Thomas] Leibniz Univ Hannover, Inst Microbiol, D-30167 Hannover, Germany; [Risselada, H. Jelger; Grubmueller, Helmut] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Luensdorf, Heinrich] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany	Leibniz University Hannover; Max Planck Society; Helmholtz Association; Helmholtz-Center for Infection Research	Bruser, T (corresponding author), Leibniz Univ Hannover, Inst Microbiol, Schneiderberg 50, D-30167 Hannover, Germany.	brueser@ifmb.uni-hannover.de		Mehner-Breitfeld, Denise/0000-0002-6785-898X; Bruser, Thomas/0000-0002-5889-8306	Deutsche Forschungsgemeinschaft [GRK 1026]; Open Access Publishing Fund of the Leibniz Universitat Hannover; Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of the Leibniz Universitat Hannover; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (GRK 1026). The authors acknowledge support by the Open Access Publishing Fund of the Leibniz Universitat Hannover and the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Aldridge C, 2014, J CELL BIOL, V205, P51, DOI 10.1083/jcb.201311057; Bageshwar UK, 2009, MOL MICROBIOL, V74, P209, DOI 10.1111/j.1365-2958.2009.06862.x; Behrendt J, 2014, BIOCHEMISTRY-US, V53, P2344, DOI 10.1021/bi500169s; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berthelmann F, 2004, FEBS LETT, V569, P82, DOI 10.1016/j.febslet.2004.05.054; Berthelmann F, 2008, J BIOL CHEM, V283, P25281, DOI 10.1074/jbc.M707757200; Blaudeck N, 2003, J BACTERIOL, V185, P2811, DOI 10.1128/JB.185.9.2811-2819.2003; Bogsch E, 1997, EMBO J, V16, P3851, DOI 10.1093/emboj/16.13.3851; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; Bolhuis A, 2000, FEBS LETT, V472, P88, DOI 10.1016/S0014-5793(00)01428-9; Brehmer T, 2012, LANGMUIR, V28, P3534, DOI 10.1021/la204473t; Bruser T, 1998, FEMS MICROBIOL LETT, V164, P329; Bruser T, 2003, EUR J BIOCHEM, V270, P1211, DOI 10.1046/j.1432-1033.2003.03481.x; Bruser T, 2003, MICROBIOL RES, V158, P7, DOI 10.1078/0944-5013-00176; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; Cristobal S, 1999, EMBO J, V18, P2982, DOI 10.1093/emboj/18.11.2982; Dabney-Smith C, 2006, J BIOL CHEM, V281, P5476, DOI 10.1074/jbc.M512453200; Dabney-Smith C, 2009, MOL BIOL CELL; Dahlberg M, 2010, J CHEM THEORY COMPUT, V6, P1638, DOI 10.1021/ct900654e; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Keersmaeker S, 2005, BIOCHEM BIOPH RES CO, V335, P973, DOI 10.1016/j.bbrc.2005.07.165; De Keersmaeker S, 2005, FEBS LETT, V579, P797, DOI 10.1016/j.febslet.2004.12.059; De Keersmaeker S, 2007, MICROBIOL-SGM, V153, P1087, DOI 10.1099/mic.0.2006/003053-0; Dilks M, 2005, J BACTERIOL, V187, P8104, DOI 10.1128/JB.187.23.8104-8113.2005; Frielingsdorf S, 2008, J BIOL CHEM, V283, P33838, DOI 10.1074/jbc.M806334200; Frobel J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2308; Frobel J, 2011, J BIOL CHEM, V286, P43679, DOI 10.1074/jbc.M111.292565; Gerard F, 2006, J BIOL CHEM, V281, P6130, DOI 10.1074/jbc.M512733200; Gerard F, 2007, J BIOL CHEM, V282, P5263, DOI 10.1074/jbc.M610337200; Halbig D, 1999, EUR J BIOCHEM, V263, P543, DOI 10.1046/j.1432-1327.1999.00536.x; Haldimann A, 2001, J BACTERIOL, V183, P6384, DOI 10.1128/JB.183.21.6384-6393.2001; Heikkila MP, 2001, J BACTERIOL, V183, P1663, DOI 10.1128/JB.183.5.1663-1671.2001; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hinsley AP, 2001, FEBS LETT, V497, P45, DOI 10.1016/S0014-5793(01)02428-0; Holzapfel E, 2007, BIOCHEMISTRY-US, V46, P2892, DOI 10.1021/bi062205b; Hou B, 2006, J MOL BIOL, V355, P957, DOI 10.1016/j.jmb.2005.11.029; Hou Bo, 2011, Biomol Concepts, V2, P507, DOI 10.1515/BMC.2011.040; Huber D, 2011, MOL CELL, V41, P343, DOI 10.1016/j.molcel.2010.12.028; Ize B, 2002, J MOL BIOL, V317, P327, DOI 10.1006/jmbi.2002.5431; Jack RL, 2001, J BACTERIOL, V183, P1801, DOI 10.1128/JB.183.5.1801-1804.2001; Jongbloed JDH, 2006, TRENDS MICROBIOL, V14, P2, DOI 10.1016/j.tim.2005.11.001; Karamyshev AL, 2005, J BIOL CHEM, V280, P37930, DOI 10.1074/jbc.M509100200; Kerth A, 2012, CHEMBIOCHEM, V13, P231, DOI 10.1002/cbic.201100458; Kreutzenbeck P, 2007, J BIOL CHEM, V282, P7903, DOI 10.1074/jbc.M610126200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lausberg F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039867; Leake MC, 2008, P NATL ACAD SCI USA, V105, P15376, DOI 10.1073/pnas.0806338105; Lindenstrauss U, 2009, FEMS MICROBIOL LETT, V295, P135, DOI 10.1111/j.1574-6968.2009.01600.x; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Maurer C, 2010, MOL BIOL CELL, V21, P4151, DOI 10.1091/mbc.E10-07-0585; Mehner D, 2012, J BIOL CHEM; Molik S, 2001, J BIOL CHEM, V276, P42761, DOI 10.1074/jbc.M106690200; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Pal D, 2012, PLANT PHYSL; Palmer T, 2012, NAT REV MICROBIOL, V10, P483, DOI 10.1038/nrmicro2814; Panahandeh S, 2008, J BIOL CHEM, V283, P33267, DOI 10.1074/jbc.M804225200; Pop OI, 2003, J BIOL CHEM, V278, P38428, DOI 10.1074/jbc.M306516200; Ray N, 2005, J BIOL CHEM, V280, P17961, DOI 10.1074/jbc.M413521200; Richter S, 2005, J BIOL CHEM, V280, P42723, DOI 10.1074/jbc.M509570200; Rodriguez F, 2013, P NATL ACAD SCI USA, V110, pE1092, DOI 10.1073/pnas.1219486110; Rollauer SE, 2012, NATURE, V492, P210, DOI 10.1038/nature11683; Rose P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069488; Ryu YH, 2006, NAT METHODS, V3, P263, DOI 10.1038/NMETH864; Sargent F, 2001, EUR J BIOCHEM, V268, P3361, DOI 10.1046/j.1432-1327.2001.02263.x; Schreiber S, 2006, J BIOL CHEM, V281, P19977, DOI 10.1074/jbc.M513900200; SCOTTI PD, 1985, J VIROL METHODS, V12, P149, DOI 10.1016/0166-0934(85)90015-1; Shanmugham A, 2006, BIOCHEMISTRY-US, V45, P2243, DOI 10.1021/bi052188a; Stanley NR, 2000, J BIOL CHEM, V275, P11591, DOI 10.1074/jbc.275.16.11591; Taubert J, 2014, BIOL CHEM, V395, P827, DOI 10.1515/hsz-2014-0170; Tullman-Ercek D, 2007, J BIOL CHEM; VALENTINE RC, 1968, BIOCHEMISTRY-US, V7, P2143, DOI 10.1021/bi00846a017; Wexler M, 2000, J BIOL CHEM, V275, P16717, DOI 10.1074/jbc.M000800200; Wilms B, 2001, BIOTECHNOL BIOENG, V73, P95, DOI 10.1002/bit.1041; Xie K, 2008, NAT REV MICROBIOL, V6, P234, DOI 10.1038/nrmicro3595; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030	77	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119761	10.1371/journal.pone.0119761	http://dx.doi.org/10.1371/journal.pone.0119761			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774531	gold, Green Published, Green Submitted			2022-12-27	WOS:000351183500120
J	Tigner, J; Bayne, EM; Boutin, S				Tigner, Jesse; Bayne, Erin M.; Boutin, Stan			American Marten Respond to Seismic Lines in Northern Canada at Two Spatial Scales	PLOS ONE			English	Article							WINTER HABITAT SELECTION; RESIDUAL FOREST STANDS; LOGGED BOREAL FORESTS; HOME-RANGE SIZE; ENERGY DEVELOPMENT; DETECTION PROBABILITIES; LANDSCAPE PATTERN; WOODLAND CARIBOU; OCCUPANCY RATES; SOUTHERN FRINGE	Development of hydrocarbon resources across northwest Canada has spurred economic prosperity and generated concerns over impacts to biodiversity. To balance these interests, numerous jurisdictions have adopted management thresholds that allow for limited energy development but minimize undesirable impacts to wildlife. Used for exploration, seismic lines are the most abundant linear feature in the boreal forest and exist at a variety of widths and recovery states. We used American marten (Martes americana) as a model species to measure how line attributes influence species' response to seismic lines, and asked whether responses to individual lines trigger population impacts. Marten response to seismic lines was strongly influenced by line width and recovery state. Compared to forest interiors, marten used open seismic lines >= 3 m wide less often, but used open lines <= 2 m wide and partially recovered lines >= 6 m wide similarly. Marten response to individual line types appeared to trigger population impacts. The probability of occurrence at the home range scale declined with increasing seismic line density, and the inclusion of behavioral response to line density calculations improved model fit. In our top performing model, we excluded seismic lines <= 2 m from our calculation of line density, and the probability of occurrence declined > 80% between home ranges with the lowest and highest line densities. Models that excluded seismic lines did not strongly explain occurrence. We show how wildlife-derived metrics can inform regulatory guidelines to increase the likelihood those guidelines meet intended management objectives. With respect to marten, not all seismic lines constitute disturbances, but avoidance of certain line types scales to population impacts. This approach provides the ecological context required to understand cause and effect relationships among socio-economic and ecological conservation goals.	[Tigner, Jesse; Bayne, Erin M.; Boutin, Stan] Univ Alberta, Dept Biol Sci, Integrated Landscape Management Grp, Edmonton, AB T6G 2E9, Canada	University of Alberta	Tigner, J (corresponding author), Explor, Suite 1500,630 6th Ave SW, Calgary, AB T2P 0S8, Canada.	tigner@explor.net	; Boutin, Stan/A-2619-2014	Bayne, Erin/0000-0002-0679-4521; Boutin, Stan/0000-0001-6317-038X	Environmental Studies Research Fund; National Science and Engineering Research Council (NSERC) Integrated Landscape Management Chair, Alberta Sports, Recreation, Parks; Wildlife Foundation DIP Program; Canadian Circumpolar Institute C/Bar Program; Canadian Association of Geophysical Contractors; British Columbia Ministry of Environment; Government of the Northwest Territories; IHS Energy; Ducks Unlimited Canada; Canadian Wildlife Service; Aboriginal Affairs and Northern Development Canada; Acho Dene Koe; Dehcho First Nations; Apache Canada; Canadian Natural; EOG Canada; Nexen; Nabors International; University of Alberta	Environmental Studies Research Fund; National Science and Engineering Research Council (NSERC) Integrated Landscape Management Chair, Alberta Sports, Recreation, Parks; Wildlife Foundation DIP Program; Canadian Circumpolar Institute C/Bar Program; Canadian Association of Geophysical Contractors; British Columbia Ministry of Environment; Government of the Northwest Territories; IHS Energy; Ducks Unlimited Canada; Canadian Wildlife Service; Aboriginal Affairs and Northern Development Canada; Acho Dene Koe; Dehcho First Nations; Apache Canada; Canadian Natural; EOG Canada; Nexen; Nabors International; University of Alberta(University of Alberta)	Funding from Environmental Studies Research Fund, National Science and Engineering Research Council (NSERC) Integrated Landscape Management Chair, Alberta Sports, Recreation, Parks, and Wildlife Foundation DIP Program, Canadian Circumpolar Institute C/Bar Program, Canadian Association of Geophysical Contractors, British Columbia Ministry of Environment, Government of the Northwest Territories, IHS Energy, Ducks Unlimited Canada, Canadian Wildlife Service, Aboriginal Affairs and Northern Development Canada, Acho Dene Koe and the Dehcho First Nations, Apache Canada, Canadian Natural, EOG Canada, Nexen, Nabors International, and the University of Alberta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts G, 2008, ECOGRAPHY, V31, P140, DOI 10.1111/j.2007.0906-7590.05236.x; Andruskiw M, 2008, ECOLOGY, V89, P2273, DOI 10.1890/07-1428.1; Ashenhurst AR, 2008, ARCTIC, V61, P190; Baldwin RA, 2008, J MAMMAL, V89, P419, DOI 10.1644/07-MAMM-A-053R1.1; Bayne E., 2011, ECOLOGICALLY BASED C; Bayne EM, 2005, LANDSCAPE ECOL, V20, P203, DOI 10.1007/s10980-004-2265-9; Bayne EM, 2005, ECOSCIENCE, V12, P216, DOI 10.2980/i1195-6860-12-2-216.1; Bayne EM, 2008, CONSERV BIOL, V22, P1186, DOI 10.1111/j.1523-1739.2008.00973.x; BenDavid M, 1997, OECOLOGIA, V111, P280, DOI 10.1007/s004420050236; Beyer HL, 2010, PHILOS T R SOC B, V365, P2245, DOI 10.1098/rstb.2010.0083; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; BUSKIRK SW, 1989, J WILDLIFE MANAGE, V53, P997, DOI 10.2307/3809601; Caro T, 1999, TRENDS ECOL EVOL, V14, P366, DOI 10.1016/S0169-5347(99)01663-8; Chapin TG, 1997, J WILDLIFE MANAGE, V61, P707, DOI 10.2307/3802178; Chapin TG, 1998, CONSERV BIOL, V12, P1327, DOI 10.1046/j.1523-1739.1998.96227.x; Chen Han Y. H., 2002, Environmental Reviews, V10, P137, DOI 10.1139/a02-007; Cheveau M, 2013, J WILDLIFE MANAGE, V77, P749, DOI 10.1002/jwmg.511; Cushman SA, 2011, LANDSCAPE ECOL, V26, P1137, DOI 10.1007/s10980-011-9645-8; Darling AF, 2009, THESIS U ALBERTA; Dehcho Land Use Planning Committee, 2006, RESP LAND DEHCH LAND; Doherty KE, 2008, J WILDLIFE MANAGE, V72, P187, DOI 10.2193/2006-454; DOUGLASS RJ, 1983, CAN FIELD NAT, V97, P71; Dyer SJ, 2002, CAN J ZOOL, V80, P839, DOI [10.1139/z02-060, 10.1139/Z02-060]; Dyer SJ, 2001, J WILDLIFE MANAGE, V65, P531, DOI 10.2307/3803106; Ecosystem Classification Group, 2007, EC REG NW TERR TAIG; Environment and Climate Change Canada, 2021, REC STR BARN OWL TYT; Flynn RW, 2009, J WILDLIFE MANAGE, V73, P1269, DOI 10.2193/2008-169; Fortin Clement, 1994, P179; Francis CD, 2011, LANDSCAPE ECOL, V26, P1269, DOI 10.1007/s10980-011-9609-z; Fuller AK, 2005, J WILDLIFE MANAGE, V69, P710, DOI 10.2193/0022-541X(2005)069[0710:IOPTHO]2.0.CO;2; Gilbert MM, 2011, J WILDLIFE MANAGE, V75, P816, DOI 10.1002/jwmg.123; Gill JA, 2001, BIOL CONSERV, V97, P265, DOI 10.1016/S0006-3207(00)00002-1; GILL JA, 2000, BEHAV CONSERVATION, P51; Godbout G, 2008, ECOSCIENCE, V15, P332, DOI 10.2980/15-3-3091; Godbout G, 2010, ECOSCIENCE, V17, P175, DOI 10.2980/17-2-3288; Griffin SC, 2007, CONSERV BIOL, V21, P1070, DOI 10.1111/j.1523-1739.2007.00688.x; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; Habib L, 2007, J APPL ECOL, V44, P176, DOI 10.1111/j.1365-2664.2006.01234.x; Hardin JW, 2012, GEN ESTIMATING EQUAT; Hargis CD, 1999, J APPL ECOL, V36, P157, DOI 10.1046/j.1365-2664.1999.00377.x; Harju SM, 2010, J WILDLIFE MANAGE, V74, P437, DOI 10.2193/2008-289; Hearn BJ, 2010, J WILDLIFE MANAGE, V74, P719, DOI 10.2193/2009-138; HODGMAN TP, 1994, J WILDLIFE MANAGE, V58, P593, DOI 10.2307/3809671; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Indian and Northern Affairs Canada, 2007, PREL STAT KNOWL REP; James ARC, 2000, J WILDLIFE MANAGE, V64, P154, DOI 10.2307/3802985; Johnson CA, 2009, P R SOC B, V276, P3361, DOI 10.1098/rspb.2008.1958; Jorgenson JC, 2010, ECOL APPL, V20, P205, DOI 10.1890/08-1856.1; Kemper JT, 2009, J VEG SCI, V20, P557, DOI 10.1111/j.1654-1103.2009.01069.x; Kennett S., 2006, SCI BASED THRESHOLDS; Kirk TA, 2009, LANDSCAPE ECOL, V24, P759, DOI 10.1007/s10980-009-9349-5; Komers PE, 2013, GLOBAL CHANGE BIOL, V19, P2916, DOI 10.1111/gcb.12266; Lankau HE, 2013, AVIAN CONSERV ECOL, V8, DOI 10.5751/ACE-00596-080105; Latham ADM, 2011, ECOL APPL, V21, P2854, DOI 10.1890/11-0666.1; Lee P, 2006, J ENVIRON MANAGE, V78, P240, DOI 10.1016/j.jenvman.2005.03.016; MacFarlane A, 2003, THESIS U ALBERTA; Machtans CS, 2006, CAN J ZOOL, V84, P1421, DOI 10.1139/Z06-134; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; McCann NP, 2010, J WILDLIFE MANAGE, V74, P1502, DOI 10.2193/2009-297; Moriarty KM, 2011, J WILDLIFE MANAGE, V75, P1774, DOI 10.1002/jwmg.228; Neufeld L, 2006, THESIS U ALBERTA; Nielsen SE, 2007, BIOL CONSERV, V137, P403, DOI 10.1016/j.biocon.2007.02.024; Northrup JM, 2013, ECOL LETT, V16, P112, DOI 10.1111/ele.12009; Oberg PR, 2001, THESIS U ALBERTA; Otis DL, 1987, WILDLIFE MONOGR, P62; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Payer DC, 2000, CAN J FOREST RES, V30, P1965, DOI 10.1139/cjfr-30-12-1965; Payer DC, 2003, FOREST ECOL MANAG, V179, P145, DOI 10.1016/S0378-1127(02)00517-0; PAYER DC, 1999, THESIS U MAINE; Poole KG, 2004, CAN J ZOOL, V82, P423, DOI [10.1139/z04-006, 10.1139/Z04-006]; Porter AD, 2005, CAN J FOREST RES, V35, P901, DOI 10.1139/X05-014; Potvin F, 2000, CONSERV BIOL, V14, P844, DOI 10.1046/j.1523-1739.2000.99036.x; Potvin Francois, 1997, P452; Powell Roger A., 1994, P101; REVEL RD, 1984, FOREST GROWTH REGENE; Robitaille JF, 2000, ACTA THERIOL, V45, P137, DOI 10.4098/AT.arch.00-15; ROUGHTON RD, 1982, J WILDLIFE MANAGE, V46, P217, DOI 10.2307/3808424; Ruggiero LF, 1994, SCI BASIS CONSERVING; [Salmo Consulting Axys Environmental Consulting Forem Technologies Wildlife & Company], 2004, DEH CHO CUM EFF STUD; Salmo Consulting Diversified Environmental Services Gaia Consultants Forem Technologies Axys Environmental Consulting, 2003, CUM EFF IND THRESH C; Sawyer H, 2006, J WILDLIFE MANAGE, V70, P396, DOI 10.2193/0022-541X(2006)70[396:WHSOMD]2.0.CO;2; Sawyer H, 2009, J WILDLIFE MANAGE, V73, P1052, DOI 10.2193/2008-478; Schmiegelow FKA, 2002, ECOL APPL, V12, P375; Schneider RR, 2003, CONSERV ECOL, V7; Schneider RR, 2002, ALTERNATIVE FUTURES, DOI [10.2527/jas.2014-7375, DOI 10.2527/JAS.2014-7375]; Slauson KM, 2007, J WILDLIFE MANAGE, V71, P458, DOI 10.2193/2004-332; Smith AC, 2002, CAN J ZOOL, V80, P1602, DOI 10.1139/Z02-166; Smith JB, 2007, J WILDLIFE MANAGE, V71, P2412, DOI 10.2193/2007-091; SNYDER JE, 1987, CAN J ZOOL, V65, P169, DOI 10.1139/z87-024; Sorensen T, 2008, J WILDLIFE MANAGE, V72, P900, DOI 10.2193/2007-079; SOUTIERE EC, 1979, J WILDLIFE MANAGE, V43, P850, DOI 10.2307/3808268; St-Laurent MH, 2008, FOREST ECOL MANAG, V254, P261, DOI 10.1016/j.foreco.2007.08.006; Strimbu B, 2011, J ENVIRON MANAGE, V92, P1740, DOI 10.1016/j.jenvman.2011.02.007; Thompson ID, 2008, FOREST CHRON, V84, P741, DOI 10.5558/tfc84741-5; THOMPSON ID, 1994, J WILDLIFE MANAGE, V58, P280, DOI 10.2307/3809392; THOMPSON ID, 1994, J WILDLIFE MANAGE, V58, P272, DOI 10.2307/3809391; Tigner J, 2014, J WILDLIFE MANAGE, V78, P282, DOI 10.1002/jwmg.664; Vanderwel MC, 2010, J WILDLIFE MANAGE, V74, P1492, DOI 10.2193/2009-426; Vigeant-Langlois C, 2011, CAN J FOREST RES, V41, P2202, DOI [10.1139/X11-133, 10.1139/x11-133]; Walker BL, 2007, J WILDLIFE MANAGE, V71, P2644, DOI 10.2193/2006-529; Wasser SK, 2011, FRONT ECOL ENVIRON, V9, P546, DOI 10.1890/100071; Weclaw P, 2004, ECOL MODEL, V177, P75, DOI 10.1016/j.ecolmodel.2003.12.052; Wiebe PA, 2013, J WILDLIFE MANAGE, V77, P379, DOI 10.1002/jwmg.471; Wulder MA, 2003, FOREST CHRON, V79, P1075, DOI 10.5558/tfc791075-6; Zielinski WJ, 2008, J WILDLIFE MANAGE, V72, P1558, DOI 10.2193/2007-397; Zielinski WJ, 1996, ECOL APPL, V6, P1254, DOI 10.2307/2269605; Zwolak R, 2009, FOREST ECOL MANAG, V258, P539, DOI 10.1016/j.foreco.2009.05.033	108	26	27	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118720	10.1371/journal.pone.0118720	http://dx.doi.org/10.1371/journal.pone.0118720			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768848	Green Published, Green Submitted, gold			2022-12-27	WOS:000351277500041
J	Avong, YK; Isaakidis, P; Hinderaker, SG; Van den Bergh, R; Ali, E; Obembe, BO; Ekong, E; Adebamowo, C; Ndembi, N; Okuma, J; Osakwe, A; Oladimeji, O; Akang, G; Obasanya, JO; Eltayeb, O; Agbaje, AV; Abimiku, A; Mensah, CO; Dakum, PS				Avong, Yohanna Kamabi; Isaakidis, Petros; Hinderaker, Sven Gudmund; Van den Bergh, Rafael; Ali, Engy; Obembe, Bolajoko Oladunni; Ekong, Ernest; Adebamowo, Clement; Ndembi, Nicaise; Okuma, James; Osakwe, Adeline; Oladimeji, Olanrewaju; Akang, Gabriel; Obasanya, Joshua Olusegun; Eltayeb, Osman; Agbaje, Aderonke Vivian; Abimiku, Alash'le; Mensah, Charles Olalekan; Dakum, Patrick Sunday			Doing No Harm? Adverse Events in a Nation-Wide Cohort of Patients with Multidrug-Resistant Tuberculosis in Nigeria	PLOS ONE			English	Article							DRUG-REACTIONS; PHARMACOVIGILANCE; DETERMINANTS; FREQUENCY; KNOWLEDGE	Background Adverse events (AEs) of second line anti-tuberculosis drugs (SLDs) are relatively well documented. However, the actual burden has rarely been described in detail in programmatic settings. We investigated the occurrence of these events in the national cohort of multidrug-resistant tuberculosis (MDR-TB) patients in Nigeria. Method This was a retrospective, observational cohort study, using pharmacovigilance data systematically collected at all MDR-TB treatment centers in Nigeria. Characteristics of AEs during the intensive phase treatment were documented, and risk factors for development of AEs were assessed. Results Four hundred and sixty patients were included in the analysis: 62% were male; median age was 33 years [Interquartile Range (IQR): 28-42] and median weight was 51 kg (IQR: 45-59). Two hundred and three (44%) patients experienced AEs; four died of conditions associated with SLD AEs. Gastro-intestinal (n = 100), neurological (n = 75), ototoxic (n = 72) and psychiatric (n = 60) AEs were the most commonly reported, whereas ototoxic and psychiatric AEs were the most debilitating. Majority of AEs developed after 1-2 months of therapy, and resolved in less than a month after treatment. Some treatment centers were twice as likely to report AEs compared with others, highlighting significant inconsistencies in reporting at different treatment centers. Patients with a higher body weight had an increased risk of experiencing AEs. No differences were observed in risk of AEs between HIV-infected and uninfected patients. Similarly, age was not significantly associated with AEs. Conclusion Patients in the Nigerian MDR-TB cohort experienced a wide range of AEs, some of which were disabling and fatal. Early identification and prompt management as well as standardized reporting of AEs at all levels of healthcare, including the community is urgently needed. Safer regimens for drug-resistant TB with the shortest duration are advocated.	[Avong, Yohanna Kamabi; Obembe, Bolajoko Oladunni; Ekong, Ernest; Adebamowo, Clement; Ndembi, Nicaise; Okuma, James; Agbaje, Aderonke Vivian; Abimiku, Alash'le; Mensah, Charles Olalekan; Dakum, Patrick Sunday] Inst Human Virol, Abuja, Nigeria; [Isaakidis, Petros; Van den Bergh, Rafael; Ali, Engy] Med Sans Frontieres, Operat Res Unit, Luxembourg, Luxembourg; [Hinderaker, Sven Gudmund] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Adebamowo, Clement] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Osakwe, Adeline] Natl Agcy Food & Drug Adm Control, Abuja, Nigeria; [Oladimeji, Olanrewaju] Zankli Med Ctr, Abuja, Nigeria; [Oladimeji, Olanrewaju] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Akang, Gabriel; Obasanya, Joshua Olusegun] Natl TB & Leprosy Control Program, Abuja, Nigeria; [Eltayeb, Osman] Damien Fdn Belgium, Nigeria Project, Ibadan, Nigeria	Doctors Without Borders; University of Bergen; University System of Maryland; University of Maryland Baltimore; Liverpool School of Tropical Medicine; University of Liverpool	Avong, YK (corresponding author), Inst Human Virol, Abuja, Nigeria.	yavong@gmail.com	Avong, Yohanna/AAS-4891-2020; Adebamowo, Clement/C-8778-2011; Oladimeji, Olanrewaju/AAE-9633-2019; NDEMBI, Nicaise/AAE-4383-2020	Avong, Yohanna/0000-0001-6798-8576; Adebamowo, Clement/0000-0002-6571-2880; Oladimeji, Olanrewaju/0000-0002-5356-901X; Van den Bergh, Rafael/0000-0001-6277-8713; Isaakidis, Petros/0000-0002-7881-1554	MSF; Union; Department for International Development (DFID); WHO	MSF; Union; Department for International Development (DFID); WHO(World Health Organization)	The programme was funded by MSF, The Union, the Department for International Development (DFID) and WHO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews JR, 2007, J INFECT DIS, V196, pS482, DOI 10.1086/521121; [Anonymous], 2014, PROD INF; Awofeso Niyi, 2008, Bull World Health Organ, V86, pB; Biovision Incorporated, 2014, DEL ANT AG; Carroll MW, 2012, INT J TUBERC LUNG D, V16, P961, DOI 10.5588/ijtld.11.0574; Central Intelligence Agency (CIA) World Factbook, 2014, NIG DEM PROF 2014; Chinenye JUMO, 2012, NIGERAN J PHARM SCI, V11; Diacon AH, 2012, LANCET, V380, P986, DOI 10.1016/S0140-6736(12)61080-0; Edwards I, 2002, PHARMACOVIGILANCE, P169; Fadare JO, 2011, TROP J PHARM RES, V10, P235, DOI 10.4314/tjpr.v10i3.4; Fry RS, 2005, INT J TUBERC LUNG D, V9, P1027; Gler MT, 2012, NEW ENGL J MED, V366, P2151, DOI 10.1056/NEJMoa1112433; GRIFFIN JP, 1986, BRIT J CLIN PHARMACO, V22, pS83, DOI 10.1111/j.1365-2125.1986.tb02988.x; Isaakidis P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040781; Kehinde AO, 2007, J NATL MED ASSOC, V99, P1185; Kennedy D, 2000, PHARMACOEPIDEM DR S, P151; Langendam MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053599; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; Leimane V, 2005, LANCET, V365, P318, DOI 10.1016/S0140-6736(05)17786-1; Lopez-Gonzalez E, 2009, DRUG SAFETY, V32, P19, DOI 10.2165/00002018-200932010-00002; Moore N, 1998, BRIT J CLIN PHARMACO, V45, P301, DOI 10.1046/j.1365-2125.1998.00667.x; Nigeria Federal Ministry of Health, 2011, GUID CONTR CLIN MAN; Nigeria Federal Ministry of Health, 2012, NAT DRUG RES TB PREV; Nigeria Federal Ministry of Health, 2010, NAT TUB LEPR CONTR W; Ohaju-Obodo JO, 2010, PHARMACOEPIDEM DR S, V19, P191, DOI 10.1002/pds.1724; Oladimeji O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094393; Oreagba IA, 2011, PHARMACOEPIDEM DR S, V20, P30, DOI 10.1002/pds.2021; Osakwe Adeline, 2013, Int J Risk Saf Med, V25, P219, DOI 10.3233/JRS-130605; Rosenbaum DDM, 2001, CLIN RES COORDINATOR; Rosenbaum DSF, 2002, PHYS INVESTIGATOR HD; Rosenbaum DSF, 1998, CLIN RES MONITOR HDB; Sagwa Evans, 2012, South Med Rev, V5, P6; Shean K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063057; Tekle B, 2002, INT J TUBERC LUNG D, V6, P573; Torun T, 2005, INT J TUBERC LUNG D, V9, P1373; US Department of Health Services, 2012, SELF STUD MOD TUB PA; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Waller PCBP, 2002, PHARMACOVIGILANCE, P183; White TJ, 1999, PHARMACOECONOMICS, V15, P445, DOI 10.2165/00019053-199915050-00003; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; World Health Organization, 2011, GLOB PLAN STOP TB 20, DOI [10.1371/journal.pone.0108591, DOI 10.1371/JOURNAL.PONE.0108591]; World Health Organization, 2012, MULT EXT DRUG RES TB	42	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120161	10.1371/journal.pone.0120161	http://dx.doi.org/10.1371/journal.pone.0120161			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781958	Green Submitted, Green Published, gold			2022-12-27	WOS:000351284600134
J	Fan, ZD; Wang, FF; Huang, H; Huang, N; Ma, HH; Guo, YH; Zhang, YY; Qian, XQ; Yu, HG				Fan, Zhi-Dan; Wang, Fei-Fei; Huang, Hui; Huang, Na; Ma, Hui-Hui; Guo, Yi-Hong; Zhang, Ya-Yuan; Qian, Xiao-Qing; Yu, Hai-Guo			STAT4 rs7574865 G/T and PTPN22 rs2488457 G/C Polymorphisms Influence the Risk of Developing Juvenile Idiopathic Arthritis in Han Chinese Patients	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; PROMOTER POLYMORPHISM; SUSCEPTIBILITY LOCI; GENE; ASSOCIATION; CLASSIFICATION; POPULATION; HAPLOTYPE; SUPPORT; VARIANT	Juvenile idiopathic arthritis (JIA) is a common autoimmune disease characterized by environmental influences along with several predisposing genes in the pathogenesis. The protein tyrosine phosphatase nonreceptor 22 (PTPN22) and signal transducer and activator of transcription factor 4 (STAT4) have been recognized as susceptibility genes for numerous autoimmune diseases. Associations of STAT4 rs7574865 G/T and PTPN22 (rs2488457 G/C and rs2476601 C/T) polymorphisms with JIA have repeatedly been replicated in several Caucasian populations. The aim of this study was to investigate the influence of three polymorphisms mentioned above on the risk of developing JIA in Han Chinese patients. Genotyping was performed on a total of 137 Chinese patients with JIA (JIA group) and 150 sex and age frequency-matched healthy volunteers (Control group). The single-nucleotide polymorphisms (SNP) were determined by using direct sequencing of PCR-amplified products. There were significant differences of PTPN22 rs2488457 G/C and STAT4 rs7574865 G/T polymorphisms between both groups. However, no significant difference was observed in distribution frequencies of PTPN22 rs2476601 polymorphism. The association with the PTPN22 rs2488457 G/C polymorphism remained significant in the stratifications by age at onset, ANA status, splenomegaly, lymphadenectasis and involvement joints. As with the STAT4 rs7574865 G/T polymorphisms, the enthesitis-related arthritis and presence of hepatomegaly had strong effect on the association. Our data strengthen STAT4 rs7574865 G/T and PTPN22 rs2488457 G/C polymorphisms as susceptibility factors for JIA.	[Fan, Zhi-Dan; Wang, Fei-Fei; Huang, Hui; Huang, Na; Ma, Hui-Hui; Guo, Yi-Hong; Zhang, Ya-Yuan; Qian, Xiao-Qing; Yu, Hai-Guo] Nanjing Med Univ, Nanjing Childrens Hosp, Dept Rheumatol & Immunol, Nanjing 210008, Jiangsu, Peoples R China		Yu, HG (corresponding author), Nanjing Med Univ, Nanjing Childrens Hosp, Dept Rheumatol & Immunol, 72 Guangzhou Rd, Nanjing 210008, Jiangsu, Peoples R China.	yuhaiguo73@126.com	ma, huihui/HDM-4386-2022	ma, huihui/0000-0002-3463-1842	Chinese National Natural Science Fund [81202345, 81102256]	Chinese National Natural Science Fund(National Natural Science Foundation of China (NSFC))	This work was supported by Chinese National Natural Science Fund (No. 81202345, 81102256). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Burn GL, 2011, FEBS LETT, V585, P3689, DOI 10.1016/j.febslet.2011.04.032; Chinoy H, 2008, ARTHRITIS RHEUM-US, V58, P3247, DOI 10.1002/art.23900; Clark A, 2013, INFECT GENET EVOL, V18, P257, DOI 10.1016/j.meegid.2013.05.025; Cloutier JF, 1999, J EXP MED, V189, P111, DOI 10.1084/jem.189.1.111; Dimopoulou DG, 2013, HUM IMMUNOL, V74, P1194, DOI 10.1016/j.humimm.2013.06.018; El-Zawahry BM, 2013, GENE, V523, P147, DOI 10.1016/j.gene.2013.03.070; Hinks A, 2005, ARTHRITIS RHEUM-US, V52, P1694, DOI 10.1002/art.21049; Hinks A, 2013, NAT GENET, V45, P664, DOI 10.1038/ng.2614; Hinks A, 2010, ANN RHEUM DIS, V69, P1049, DOI 10.1136/ard.2009.110650; Huang H, 2013, CLIN RHEUMATOL, V32, P1021, DOI 10.1007/s10067-013-2232-4; Kang M, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1953; Kawasaki E, 2006, AM J MED GENET A, V140A, P586, DOI 10.1002/ajmg.a.31124; Lee YH, 2007, RHEUMATOLOGY, V46, P49, DOI 10.1093/rheumatology/kel170; Lee YH, 2010, RHEUMATOL INT, V30, P661, DOI 10.1007/s00296-009-1051-z; Liu F, 2012, CELL BIOCHEM BIOPHYS, V62, P273, DOI 10.1007/s12013-011-9291-4; Martini A, 2012, ANN RHEUM DIS, V71, P1437, DOI 10.1136/annrheumdis-2012-201388; Mathur AN, 2007, J IMMUNOL, V178, P4901, DOI 10.4049/jimmunol.178.8.4901; Mori M, 2005, J HUM GENET, V50, P264, DOI 10.1007/s10038-005-0246-8; Pazar B, 2008, CLIN EXP RHEUMATOL, V26, P1146; Petty RE, 2004, J RHEUMATOL, V31, P390; Ravelli A, 2007, LANCET, V369, P767, DOI 10.1016/S0140-6736(07)60363-8; Seldin MF, 2005, GENES IMMUN, V6, P720, DOI 10.1038/sj.gene.6364255; Sugiura T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1930; Velaga MR, 2004, J CLIN ENDOCR METAB, V89, P5862, DOI 10.1210/jc.2004-1108; Viken MK, 2007, TISSUE ANTIGENS, V70, P190, DOI 10.1111/j.1399-0039.2007.00871.x; Viola S, 2005, ARTHRITIS RHEUM-US, V52, P2092, DOI 10.1002/art.21119; Watford WT, 2004, IMMUNOL REV, V202, P139, DOI 10.1111/j.0105-2896.2004.00211.x; Woo P, 2006, NAT CLIN PRACT RHEUM, V2, P28, DOI 10.1038/ncprheum0084	29	19	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0117389	10.1371/journal.pone.0117389	http://dx.doi.org/10.1371/journal.pone.0117389			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781893	Green Submitted, Green Published, gold			2022-12-27	WOS:000351284600012
J	Lynn, GE; Oliver, JD; Nelson, CM; Felsheim, RF; Kurtti, TJ; Munderloh, UG				Lynn, Geoffrey E.; Oliver, Jonathan D.; Nelson, Curtis M.; Felsheim, Roderick F.; Kurtti, Timothy J.; Munderloh, Ulrike G.			Tissue Distribution of the Ehrlichia muris-Like Agent in a Tick Vector	PLOS ONE			English	Article							HUMAN GRANULOCYTIC EHRLICHIOSIS; IN-SITU HYBRIDIZATION; LYME-DISEASE; ANAPLASMA-MARGINALE; DERMACENTOR-ANDERSONI; IXODES-SCAPULARIS; SALIVARY-GLANDS; CAUSATIVE AGENT; CLIMATE-CHANGE; RICKETTSIA	Human pathogens transmitted by ticks undergo complex life cycles alternating between the arthropod vector and a mammalian host. While the latter has been investigated to a greater extent, examination of the biological interactions between microbes and the ticks that carry them presents an equally important opportunity for disruption of the disease cycle. In this study, we used in situ hybridization to demonstrate infection by the Ehrlichia muris-like organism, a newly recognized human pathogen, of Ixodes scapularis ticks, a primary vector for several important human disease agents. This allowed us to assess whole sectioned ticks for the patterns of tissue invasion, and demonstrate generalized dissemination of ehrlichiae in a variety of cell types and organs within ticks infected naturally via blood feeding. Electron microscopy was used to confirm these results. Here we describe a strong ehrlichial affinity for epithelial cells, neuronal cells of the synganglion, salivary glands, and male accessory glands.	[Lynn, Geoffrey E.; Oliver, Jonathan D.; Nelson, Curtis M.; Felsheim, Roderick F.; Kurtti, Timothy J.; Munderloh, Ulrike G.] Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Lynn, GE (corresponding author), Univ Minnesota, Dept Entomol, 219 Hodson Hall,1980 Folwell Ave, St Paul, MN 55108 USA.	lynnx044@umn.edu		Lynn, Geoffrey/0000-0002-7095-0912	National Institutes of Health (USA) [R01AI042792]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI117173, R01AI042792] Funding Source: NIH RePORTER	National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was funded under grant number R01AI042792, which was generously provided by the National Institutes of Health (USA) and awarded to UGM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnes JT, 2010, INFECT IMMUN, V78, P2446, DOI 10.1128/IAI.00108-10; [Anonymous], 2011, GUIDE CARE USE LAB A; Balashov YS, 1983, ATLAS IXODID TICK UL; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; BARBOUR AG, 1993, SCIENCE, V260, P1610, DOI 10.1126/science.8503006; Burgdorfer W., 1981, RICKETTSIAE RICKETTS, P585; Chavez ASO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036012; Cortinas MR, 2006, J MED ENTOMOL, V43, P810, DOI 10.1603/0022-2585(2006)43[810:CSOWDI]2.0.CO;2; Dawson JE, 2001, AM J TROP MED HYG, V65, P603, DOI 10.4269/ajtmh.2001.65.603; DUMLER JS, 1995, J CLIN MICROBIOL, V33, P1704, DOI 10.1128/JCM.33.7.1704-1711.1995; Felek S, 2004, INFECT IMMUN, V72, P659, DOI 10.1128/IAI.72.2.659-666.2004; Ge NL, 1996, J MED ENTOMOL, V33, P911, DOI 10.1093/jmedent/33.6.911; GOFF W, 1988, P NATL ACAD SCI USA, V85, P919, DOI 10.1073/pnas.85.3.919; Goodman JL, 1996, NEW ENGL J MED, V334, P209, DOI 10.1056/NEJM199601253340401; Hammac GK, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-193; Harrus S, 2005, INT J PARASITOL, V35, P1309, DOI 10.1016/j.ijpara.2005.06.005; ITO S, 1975, ANN NY ACAD SCI, V266, P35, DOI 10.1111/j.1749-6632.1975.tb35087.x; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9; Kocan K.M., 1986, P472; KOCAN KM, 1983, AM J VET RES, V44, P798; KOCAN KM, 1992, AM J VET RES, V53, P499; KOCAN KM, 1987, ONDERSTEPOORT J VET, V54, P87; Kuriakose JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024136; Kurtti TJ, 2015, INT J SYST EVOL MICR, V65, P965, DOI 10.1099/ijs.0.000047; Kurtti TJ, 1996, INFECT IMMUN, V64, P4148, DOI 10.1128/IAI.64.10.4148-4153.1996; KURTTI TJ, 1994, CAN J ZOOL, V72, P977, DOI 10.1139/z94-134; Levi T, 2012, P NATL ACAD SCI USA, V109, P10942, DOI 10.1073/pnas.1204536109; Liu L, 2011, EMBO REP, V12, P1196, DOI 10.1038/embor.2011.177; Logiudice K, 2008, ECOLOGY, V89, P2841, DOI 10.1890/07-1047.1; Long SW, 2003, J MED ENTOMOL, V40, P1000, DOI 10.1603/0022-2585-40.6.1000; Lynn GE, 2012, 25 ANN AM SOC RICK M; Massung RF, 2007, J CLIN MICROBIOL, V45, P2138, DOI 10.1128/JCM.00478-07; Munderloh UG, 2009, ANN NY ACAD SCI, V1166, P112, DOI 10.1111/j.1749-6632.2009.04520.x; Nelson CM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-364; Niebylski ML, 1997, INT J SYST BACTERIOL, V47, P446, DOI 10.1099/00207713-47-2-446; Noh SM, 2006, INFECT IMMUN, V74, P3471, DOI 10.1128/IAI.01843-05; Ogden NH, 2006, INT J PARASITOL, V36, P63, DOI 10.1016/j.ijpara.2005.08.016; Ogden NH, 2014, ENVIRON HEALTH PERSP, V122, P631, DOI 10.1289/ehp.1307799; Oliver JD, 2014, APPL ENVIRON MICROB, V80, P1170, DOI 10.1128/AEM.03352-13; Popov VL, 2007, VECTOR-BORNE ZOONOT, V7, P699, DOI 10.1089/vbz.2007.0148; Pritt BS, 2011, NEW ENGL J MED, V365, P422, DOI 10.1056/NEJMoa1010493; Ramabu SS, 2010, INFECT IMMUN, V78, P3047, DOI 10.1128/IAI.00300-10; Reichard MV, 2009, VECTOR-BORNE ZOONOT, V9, P565, DOI 10.1089/vbz.2008.0106; Saito TB, 2015, J INFECT DIS, V211, P452, DOI 10.1093/infdis/jiu372; Sauer J. R., 1986, MORPHOLOGY PHYSL BEH; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; SMITH RD, 1976, AM J VET RES, V37, P119; Sonenshine DE, 1991, BIOL TICKS, V1; Telford Iii Sam R, 2011, Open Microbiol J, V5, P18, DOI 10.2174/1874285801105010018; Telford SR, 1996, P NATL ACAD SCI USA, V93, P6209, DOI 10.1073/pnas.93.12.6209; Thepparit C, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-149; Walker David H, 2004, Trans Am Clin Climatol Assoc, V115, P375; Walker DH, 2004, T AM CLIN CLIMAT ASS, V115, P382	54	19	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0122007	10.1371/journal.pone.0122007	http://dx.doi.org/10.1371/journal.pone.0122007			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781930	Green Published, gold, Green Submitted			2022-12-27	WOS:000351284600213
J	Rawson, KS; Dixon, D; Nowotny, P; Ricci, WM; Binder, EF; Rodebaugh, TL; Wendleton, L; Dore, P; Lenze, EJ				Rawson, Kerri S.; Dixon, David; Nowotny, Petra; Ricci, William M.; Binder, Ellen F.; Rodebaugh, Thomas L.; Wendleton, Leah; Dore, Peter; Lenze, Eric J.			Association of Functional Polymorphisms from Brain-Derived Neurotrophic Factor and Serotonin-Related Genes with Depressive Symptoms after a Medical Stressor in Older Adults	PLOS ONE			English	Article							ACTIVITY-DEPENDENT SECRETION; BDNF VAL66MET POLYMORPHISM; HIP FRACTURE; MAJOR DEPRESSION; COGNITIVE IMPAIRMENT; PSYCHIATRIC-ILLNESS; ELDERLY PERSONS; HUMAN-MEMORY; RISK-FACTORS; RECOVERY	Depressive symptoms are common in older adults after a disabling medical event and interfere with rehabilitation and recovery from the disability. This prospective study examined the role of genetic polymorphisms implicated in synaptic integrity and stress-associated depression as predictors of depressive symptoms after hip fracture. We recruited healthy comparisons from the community and participants with hip fracture after surgical fixation from Saint Louis, Missouri hospitals. We examined the valine (Val) to methionine (Met) polymorphism in brain-derived neurotrophic factor (BDNF), serotonin 1A receptor (5HT1a-rs6295) polymorphism, and the serotonin transporter-linked polymorphic region (5HTTLPR) interaction with the rs25531 A to G single nucleotide polymorphism (5HTTLPR-rs25531) as predictors of depressive symptoms. We also examined whether depressive symptoms mediate the influence of BDNF genotype on functional recovery. Among 429 participants with hip fracture, BDNF Met/Met carriers developed significantly more depressive symptoms than Val/Val carriers during a four-week period after the fracture (p =.012). BDNF genotype also predicted functional recovery over the ensuing year, mediated by its effects on depressive symptoms (CI: 0.07-3.37). Unlike prior studies of stressful life events, the S0 5HTTLPR-rs25531 variant did not predict higher levels of depressive symptoms; instead, we report an exploratory finding of an epistatic effect between BDNF and 5HTTLPR-rs25531 whereby the compounded effects of two LA alleles and BDNF Met/Met genotype elevate risk of depressive symptoms after hip fracture (p =.006). No differences between 5HT1a genotypes were found. Our findings suggest plasticity-related genetic factors contribute to the neural mechanisms of mental and functional well-being after a disabling medical stressor.	[Rawson, Kerri S.; Dixon, David; Nowotny, Petra; Wendleton, Leah; Dore, Peter; Lenze, Eric J.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Ricci, William M.] Washington Univ, Sch Med, Barnes Jewish Hosp, Orthopaed Trauma Serv, St Louis, MO USA; [Binder, Ellen F.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Rodebaugh, Thomas L.] Washington Univ, Dept Psychol, St Louis, MO 63130 USA	Washington University (WUSTL); Barnes-Jewish Hospital; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Rawson, KS (corresponding author), Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA.	rawsonk@psychiatry.wustl.edu	Rodebaugh, Thomas/A-6475-2008; Lenze, Eric J/AAW-8652-2021	Rodebaugh, Thomas/0000-0001-6814-7795; Lenze, Eric/0000-0002-0471-9368	National Institutes of Mental Health (NIMH) [R01 MH074596, T32 MH014677-36]; Washington University Institute of Clinical and Translational Sciences from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) [UL1TR000448]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH014677, R01MH074596] Funding Source: NIH RePORTER	National Institutes of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Washington University Institute of Clinical and Translational Sciences from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding was provided by the National Institutes of Mental Health (NIMH; R01 MH074596 (EJL) and T32 MH014677-36 (KSR)) and Washington University Institute of Clinical and Translational Sciences grant UL1TR000448 (EJL) from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Albert PR, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-21; Bisschop MI, 2004, J CLIN EPIDEMIOL, V57, P187, DOI 10.1016/j.jclinepi.2003.01.001; Bogdan R, 2013, MOL PSYCHIATR, V18, P288, DOI 10.1038/mp.2012.35; Bueller JA, 2006, BIOL PSYCHIAT, V59, P812, DOI 10.1016/j.biopsych.2005.09.022; Campbell S, 2004, J PSYCHIATR NEUROSCI, V29, P417; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Chen Zhe-Yu, 2008, Novartis Found Symp, V289, P180; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Cree M, 2000, J AM GERIATR SOC, V48, P283, DOI 10.1111/j.1532-5415.2000.tb02647.x; Dougherty LR, 2010, BIOL PSYCHOL, V83, P93, DOI 10.1016/j.biopsycho.2009.10.009; Duman Ronald S, 2009, Dialogues Clin Neurosci, V11, P239; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; First M.B., 2012, STRUCTURED CLIN INTE; Givens JL, 2008, J AM GERIATR SOC, V56, P1075, DOI 10.1111/j.1532-5415.2008.01711.x; Hannan EL, 2001, JAMA-J AM MED ASSOC, V285, P2736, DOI 10.1001/jama.285.21.2736; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Hayley S, 2013, J PSYCHIATR NEUROSCI, V38, P291, DOI 10.1503/jpn.130146; Heils A, 1996, J NEUROCHEM, V66, P2621; Heils A, 1995, J NEURAL TRANSM-GEN, V102, P247, DOI 10.1007/BF01281159; Hershkovitz A, 2007, ARCH PHYS MED REHAB, V88, P916, DOI 10.1016/j.apmr.2007.03.029; Holmes J, 2000, PSYCHOL MED, V30, P921, DOI 10.1017/S0033291799002548; Kain H B, 2000, Holist Nurs Pract, V14, P24; Karg K, 2011, ARCH GEN PSYCHIAT, V68, P444, DOI 10.1001/archgenpsychiatry.2010.189; Katon Wayne J, 2011, Dialogues Clin Neurosci, V13, P7; KATZMAN R, 1983, AM J PSYCHIAT, V140, P734; Kaufman J, 2006, BIOL PSYCHIAT, V59, P673, DOI 10.1016/j.biopsych.2005.10.026; Kendler KS, 2013, MOL PSYCHIATR, V18, P1058, DOI 10.1038/mp.2013.50; Kennedy G J, 1990, J Community Health, V15, P93, DOI 10.1007/BF01321314; Kim JM, 2007, BIOL PSYCHIAT, V62, P423, DOI 10.1016/j.biopsych.2006.11.020; Kishi T, 2013, EUR ARCH PSY CLIN N, V263, P105, DOI 10.1007/s00406-012-0337-4; Kohen R, 2008, ARCH GEN PSYCHIAT, V65, P1296, DOI 10.1001/archpsyc.65.11.1296; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; Lemonde S, 2003, J NEUROSCI, V23, P8788; Lenze EJ, 2005, AM J GERIAT PSYCHIAT, V13, P428; Lenze EJ, 2004, INT J GERIATR PSYCH, V19, P472, DOI 10.1002/gps.1116; Lenze EJ, 2008, J AFFECT DISORDERS, V111, P61, DOI 10.1016/j.jad.2008.02.005; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lesch KP, 1998, BIOL PSYCHIAT, V44, P179, DOI 10.1016/S0006-3223(98)00121-8; Lipsky RH, 2007, ANN NY ACAD SCI, V1122, P130, DOI 10.1196/annals.1403.009; MacQueen G, 2011, MOL PSYCHIATR, V16, P252, DOI 10.1038/mp.2010.80; Magaziner J, 1997, AM J PUBLIC HEALTH, V87, P1630, DOI 10.2105/AJPH.87.10.1630; MAGAZINER J, 1990, J GERONTOL, V45, pM101, DOI 10.1093/geronj/45.3.M101; Marks R, 2003, AGEING RES REV, V2, P57, DOI 10.1016/S1568-1637(02)00045-4; MAROTTOLI RA, 1992, J AM GERIATR SOC, V40, P861, DOI 10.1111/j.1532-5415.1992.tb01980.x; Martinowich K, 2008, NEUROPSYCHOPHARMACOL, V33, P73, DOI 10.1038/sj.npp.1301571; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; Mattson MP, 2004, TRENDS NEUROSCI, V27, P589, DOI 10.1016/j.tins.2004.08.001; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; MOSSEY JM, 1989, AM J PUBLIC HEALTH, V79, P279, DOI 10.2105/AJPH.79.3.279; Munafo MR, 2009, BIOL PSYCHIAT, V65, P211, DOI 10.1016/j.biopsych.2008.06.009; Murdoch JD, 2013, BIOL PSYCHIAT, V74, P879, DOI 10.1016/j.biopsych.2013.02.006; Nakatani D, 2005, AM HEART J, V150, P652, DOI 10.1016/j.ahj.2005.03.062; Otte C, 2007, AM J PSYCHIAT, V164, P1379, DOI 10.1176/appi.ajp.2007.06101617; Parker M, 2006, BMJ-BRIT MED J, V333, P27, DOI 10.1136/bmj.333.7557.27; Pei Y, 2012, AM J MED GENET B, V159B, P560, DOI 10.1002/ajmg.b.32062; Petryshen TL, 2010, MOL PSYCHIATR, V15, P810, DOI 10.1038/mp.2009.24; Porcelli S, 2011, J PSYCHIATR NEUROSCI, V36, P87, DOI 10.1503/jpn.100059; Prina AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034821; Prince MJ, 1997, PSYCHOL MED, V27, P311, DOI 10.1017/S0033291796004473; Pritchard JK, 2000, GENETICS, V155, P945; Risch N, 2009, JAMA-J AM MED ASSOC, V301, P2462, DOI 10.1001/jama.2009.878; Shimizu E, 2004, AM J MED GENET B, V126B, P122, DOI 10.1002/ajmg.b.20118; Tapia-Arancibia L, 2008, BRAIN RES REV, V59, P201, DOI 10.1016/j.brainresrev.2008.07.007; Taylor WD, 2011, PHARMACOGENOMICS J, V11, P146, DOI 10.1038/tpj.2010.12; Taylor WD, 2007, AM J GERIAT PSYCHIAT, V15, P850, DOI 10.1097/JGP.0b013e318050c9d5; Taylor WD, 2005, ARCH GEN PSYCHIAT, V62, P537, DOI 10.1001/archpsyc.62.5.537; Terracciano A, 2010, NEUROPSYCHOPHARMACOL, V35, P1083, DOI 10.1038/npp.2009.213; Wendland JR, 2006, MOL PSYCHIATR, V11, P224, DOI 10.1038/sj.mp.4001789; Williams CS, 2006, J AGING HEALTH, V18, P743, DOI 10.1177/0898264306293268; Yu H, 2011, ACTA PHARMACOL SIN, V32, P3, DOI 10.1038/aps.2010.184; Zuckerman JD, 1996, NEW ENGL J MED, V334, P1519, DOI 10.1056/NEJM199606063342307; Zuckerman JD, 2000, J ORTHOP TRAUMA, V14, P20, DOI 10.1097/00005131-200001000-00005	76	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120685	10.1371/journal.pone.0120685	http://dx.doi.org/10.1371/journal.pone.0120685			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781924	Green Submitted, Green Published, gold			2022-12-27	WOS:000351284600183
J	Tarasov, S; Genier, F				Tarasov, Sergei; Genier, Francois			Innovative Bayesian and Parsimony Phylogeny of Dung Beetles (Coleoptera, Scarabaeidae, Scarabaeinae) Enhanced by Ontology-Based Partitioning of Morphological Characters	PLOS ONE			English	Article							EVOLUTION; DIVERSITY; INFERENCE; LIGHT	Scarabaeine dung beetles are the dominant dung feeding group of insects and are widely used as model organisms in conservation, ecology and developmental biology. Due to the conflicts among 13 recently published phylogenies dealing with the higher-level relationships of dung beetles, the phylogeny of this lineage remains largely unresolved. In this study, we conduct rigorous phylogenetic analyses of dung beetles, based on an unprecedented taxon sample (110 taxa) and detailed investigation of morphology (205 characters). We provide the description of morphology and thoroughly illustrate the used characters. Along with parsimony, traditionally used in the analysis of morphological data, we also apply the Bayesian method with a novel approach that uses anatomy ontology for matrix partitioning. This approach allows for heterogeneity in evolutionary rates among characters from different anatomical regions. Anatomy ontology generates a number of parameter-partition schemes which we compare using Bayes factor. We also test the effect of inclusion of autapomorphies in the morphological analysis, which hitherto has not been examined. Generally, schemes with more parameters were favored in the Bayesian comparison suggesting that characters located on different body regions evolve at different rates and that partitioning of the data matrix using anatomy ontology is reasonable; however, trees from the parsimony and all the Bayesian analyses were quite consistent. The hypothesized phylogeny reveals many novel clades and provides additional support for some clades recovered in previous analyses. Our results provide a solid basis for a new classification of dung beetles, in which the taxonomic limits of the tribes Dichotomiini, Deltochilini and Coprini are restricted and many new tribes must be described. Based on the consistency of the phylogeny with biogeography, we speculate that dung beetles may have originated in the Mesozoic contrary to the traditional view pointing to a Cenozoic origin.	[Tarasov, Sergei] Univ Oslo, Nat Hist Museum, Natl Ctr Biosystemat, Dept Res & Collect, NO-0318 Oslo, Norway; [Genier, Francois] Agr & Agri Food Canada, Canadian Natl Collect Insects Arachnids & Nematod, Coleoptera Sect, Ottawa, ON K1A 0C6, Canada	University of Oslo; Agriculture & Agri Food Canada	Tarasov, S (corresponding author), Univ Oslo, Nat Hist Museum, Natl Ctr Biosystemat, Dept Res & Collect, POB 1172 Blindern, NO-0318 Oslo, Norway.	sergxf@yandex.ru			SYNTHESYS grant	SYNTHESYS grant	Visits of Sergei Tarasov to the MNHN in Paris received support from the SYNTHESYS grant (http://www.synthesys.info). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens D, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1470; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bai M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021600; Baillie JEM, 2008, CONSERV LETT, V1, P18, DOI 10.1111/j.1755-263X.2008.00009.x; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; Browne J, 1998, SYST ENTOMOL, V23, P307, DOI 10.1046/j.1365-3113.1998.00059.x; Chin K, 1996, PALAIOS, V11, P280, DOI 10.2307/3515235; Clarke JA, 2008, SYST BIOL, V57, P185, DOI 10.1080/10635150802022231; Clements JF, 2007, CLEMENTS CHECKLIST B; Davis ALV, 2002, J BIOGEOGR, V29, P1217, DOI 10.1046/j.1365-2699.2002.00776.x; DOBZHANSKY T, 1973, AM BIOL TEACH, V35, P125, DOI 10.2307/4444260; Donitz J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070695; Edmonds WD, 1972, KANS U SCI B, V49, P731; Emlen DJ, 2005, EVOLUTION, V59, P1060; Goloboff P, 2008, CLADISTICS, V24, P91; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kukalova-Peck J, 2004, EUR J ENTOMOL, V101, P95, DOI 10.14411/eje.2004.018; KUKALOVAPECK J, 1993, CAN ENTOMOL, V125, P181, DOI 10.4039/Ent125181-2; Lawrence JF, 2011, ANN ZOOL, V61, P1, DOI 10.3161/000345411X576725; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Losos JB, 2012, SCIENCE, V338, P1428, DOI 10.1126/science.1232455; Maddison WP, 2019, MESQUITE MODULAR SYS; Mlambo S, 2013, ORG DIVERS EVOL, P1; Moczek Armin, 2011, P126; Monaghan MT, 2007, MOL PHYLOGENET EVOL, V45, P674, DOI 10.1016/j.ympev.2007.06.009; Montreuil O, 1998, ANN SOC ENTOMOL FR, V34, P135; Muller J, 2006, SYSTEMATIC BIOL, V55, P503, DOI 10.1080/10635150600755396; NEWTON MA, 1994, J R STAT SOC B, V56, P3; Nichols E, 2008, BIOL CONSERV, V141, P1461, DOI 10.1016/j.biocon.2008.04.011; Nichols Elizabeth S., 2011, P267; Nikolajev G. V., 2007, MESOZOIC STAGE EVOLU; Nixon K.C., 2002, WINCLADA VER 1 00 08; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Ocampo FC, 2006, INVERTEBR SYST, V20, P557, DOI 10.1071/IS05031; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Philips T. Keith, 2011, P21; Philips TK, 2004, INVERTEBR SYST, V18, P53, DOI 10.1071/IS03030; Pol D, 2009, CLADISTICS, V25, P515, DOI 10.1111/j.1096-0031.2009.00258.x; Pretorius Resia, 2000, Elytron (Barcelona), V14, P125; Rambaut A, 2013, TRACER V1 6; Rannala B, 2012, MOL BIOL EVOL, V29, P325, DOI 10.1093/molbev/msr210; Regier JC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-280; Remane A., 1961, Zoologischer Anzeiger, V166, P447; Remane A, 1952, TEORETISCHE MORPHOLO, VI; Scholtz C., 2009, EVOLUTIONARY BIOL CO; SHAFER G, 1982, J AM STAT ASSOC, V77, P325, DOI 10.2307/2287244; Smith ABT, 2006, COLEOPTS BULL, V60, P35, DOI 10.1649/0010-065X(2006)60[35:AOOTCA]2.0.CO;2; Sole CL, 2010, MOL PHYLOGENET EVOL, V56, P631, DOI 10.1016/j.ympev.2010.04.023; Solodovnikov A, 2013, CLADISTICS, V29, P360, DOI 10.1111/j.1096-0031.2012.00433.x; Spector S, 2006, COLEOPTS BULL, V60, P71, DOI 10.1649/0010-065X(2006)60[71:SDBCSS]2.0.CO;2; Tarasov SI, 2011, CLADISTICS, V27, P490, DOI 10.1111/j.1096-0031.2011.00351.x; Team RDC, 2012, R LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; Vaz-de-Mello FZ, 2007, ANN SOC ENTOMOL FR, V43, P231, DOI 10.1080/00379271.2007.10697516; Vaz-De-Mello FZ, 2008, ZOOTAXA, P1; Vaz-de-Mello FZ, 2007, REVISION TAXANOMICA; Villalba S, 2002, J MOL EVOL, V55, P116, DOI 10.1007/s00239-002-2314-4; Wagele JW, 2005, FDN PHYLOGENETIC SYS, V1st; Wirta H, 2008, MOL PHYLOGENET EVOL, V47, P1076, DOI 10.1016/j.ympev.2008.03.010; Wirta H, 2010, MOL PHYLOGENET EVOL, V57, P710, DOI 10.1016/j.ympev.2010.08.013; Xie WG, 2011, SYST BIOL, V60, P150, DOI 10.1093/sysbio/syq085; Yoder MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015991; Zunino M., 1984, Bulletin de la Societe Entomologique de France, V88, P531	63	104	114	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0116671	10.1371/journal.pone.0116671	http://dx.doi.org/10.1371/journal.pone.0116671			86	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781019	Green Published, gold, Green Submitted			2022-12-27	WOS:000351284600007
J	Wex, E; Bouyssou, T				Wex, Eva; Bouyssou, Thierry			Olodaterol Attenuates Citric Acid-Induced Cough in Naive and Ovalbumin-Sensitized and Challenged Guinea Pigs	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; PHARMACOLOGICAL CHARACTERIZATION; RECEPTOR SENSITIVITY; ALLERGIC COUGH; INDACATEROL; CAPSAICIN; AGONIST; NEURONS; COPD; BRONCHODILATORS	Excessive coughing is a common feature of airway diseases. Different G-protein coupled receptors, including beta 2-adrenergic receptors (beta 2-AR), have been implicated in the molecular mechanisms underlying the cough reflex. However, the potential antitussive property of beta 2-AR agonists in patients with respiratory disease is a matter of ongoing debate. The aim of our study was to test the efficacy of the long-acting beta 2-AR agonist olodaterol with regard to its antitussive property in a pre-clinical model of citric acid-induced cough in guinea pigs and to compare the results to different clinically relevant beta 2-AR agonists. In our study beta 2-AR agonists were intratracheally administered, as dry powder, into the lungs of naive or ovalbumin-sensitized guinea pigs 15 minutes prior to induction of cough by exposure to citric acid. Cough events were counted over 15 minutes during the citric acid exposure. Olodaterol dose-dependently inhibited the number of cough events in naive and even more potently and with a greater maximal efficacy in ovalbumin-sensitized guinea pigs (p < 0.01). Formoterol and salmeterol showed a trend towards reducing cough. On the contrary, indacaterol demonstrated pro-tussive properties as it significantly increased the number of coughs, both in naive and ovalbumin-sensitized animals (p < 0.001). In conclusion, olodaterol, at doses eliciting bronchodilation, showed antitussive properties in a model of citric acid-induced cough in naive and ovalbumin-sensitized guinea pigs. This is in agreement with pre-clinical and clinical studies showing antitussive efficacy of beta 2-AR agonists. Indacaterol increased the number of coughs in this model, which concurs with clinical data where a transient cough has been observed after indacaterol inhalation. While the antitussive properties of beta 2-AR agonists can be explained by their ability to lead to the cAMP-induced hyperpolarization of the neuron membrane thereby inhibiting sensory nerve activation and the cough reflex, the mechanism underlying the pro-tussive property of indacaterol is not known.	[Wex, Eva; Bouyssou, Thierry] Boehringer Ingelheim Pharma GmbH & Co KG, Resp Dis Res, Biberach, Germany	Boehringer Ingelheim	Bouyssou, T (corresponding author), Boehringer Ingelheim Pharma GmbH & Co KG, Resp Dis Res, Biberach, Germany.	thierry.bouyssou@boehringer-ingelheim.com		Wex, Eva/0000-0002-4643-1899	Boehringer Ingelheim Pharma GmbH Co. KG	Boehringer Ingelheim Pharma GmbH Co. KG(Boehringer Ingelheim)	This study was funded by Boehringer Ingelheim Pharma GmbH & Co. KG. The funder provided support in the form of salaries for authors EW and TB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Akopian AN, 2007, J PHYSIOL-LONDON, V583, P175, DOI 10.1113/jphysiol.2007.133231; [Anonymous], 2010, AUSTR PUBL ASS REP I; [Anonymous], 2009, ASS REP HIR BREEZH; Battram C, 2006, J PHARMACOL EXP THER, V317, P762, DOI 10.1124/jpet.105.098251; Becker LA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001726.pub4; Beier J, 2007, PULM PHARMACOL THER, V20, P740, DOI 10.1016/j.pupt.2006.09.001; BOLSER DC, 1995, EUR J PHARMACOL, V277, P159, DOI 10.1016/0014-2999(95)00076-W; Bouyssou T, 2010, J PHARMACOL EXP THER, V334, P53, DOI 10.1124/jpet.110.167007; Burgel PR, 2009, CHEST, V135, P975, DOI 10.1378/chest.08-2062; Campbell M, 2005, RESP MED, V99, P1511, DOI 10.1016/j.rmed.2005.08.016; Canning BJ, 2011, AM J PHYSIOL-REG I, V300, pR369, DOI 10.1152/ajpregu.00044.2010; Cazzola M, 2013, J THORAC DIS, V5, P559, DOI 10.3978/j.issn.2072-1439.2013.07.35; Chang AB, 1998, ARCH DIS CHILD, V79, P6, DOI 10.1136/adc.79.1.6; Chong CF, 2005, EMERG MED J, V22, P429, DOI 10.1136/emj.2004.015719; Chung KF, 2008, LANCET, V371, P1364, DOI 10.1016/S0140-6736(08)60595-4; Dicpinigaitis Peter V, 2012, Cough, V8, P10, DOI 10.1186/1745-9974-8-10; Doherty MJ, 2000, THORAX, V55, P643, DOI 10.1136/thorax.55.8.643; ELLULMICALLEF R, 1983, BRIT MED J, V287, P940, DOI 10.1136/bmj.287.6397.940; Feldman G, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-11; Freund-Michel VC, 2010, EUR RESPIR J, V35, P647, DOI 10.1183/09031936.00034009; FUJIMURA M, 1993, THORAX, V48, P615, DOI 10.1136/thx.48.6.615; FUJIMURA M, 1992, THORAX, V47, P441, DOI 10.1136/thx.47.6.441; Gibb A, 2013, DRUGS, V73, P1841, DOI 10.1007/s40265-013-0137-9; Gu QH, 2007, J APPL PHYSIOL, V102, P1545, DOI 10.1152/japplphysiol.01010.2006; Lewis CA, 2007, PULM PHARMACOL THER, V20, P325, DOI 10.1016/j.pupt.2006.12.001; Lieu TM, 2012, AM J PHYSIOL-LUNG C, V302, pL941, DOI 10.1152/ajplung.00366.2011; LOWRY R, 1987, BRIT J CLIN PHARMACO, V24, P503, DOI 10.1111/j.1365-2125.1987.tb03204.x; Maher SA, 2011, CURR OPIN PHARMACOL, V11, P248, DOI 10.1016/j.coph.2011.06.005; Morice AH, 2006, THORAX, V61, pI1, DOI 10.1136/thx.2006.065144; Morice AH, 2004, EUR RESPIR J, V24, P481, DOI 10.1183/09031936.04.00027804; Mulrennan S, 2004, PULM PHARMACOL THER, V17, P127, DOI 10.1016/j.pupt.2004.01.002; Niimi A, 2011, PULM PHARMACOL THER, V24, P328, DOI 10.1016/j.pupt.2011.01.011; Ohkura N, 2010, EUR RESPIR J, V36, P459, DOI 10.1183/09031936.00057410; POUNSFORD JC, 1985, THORAX, V40, P662, DOI 10.1136/thx.40.9.662; Prudon B, 2005, CHEST, V127, P550, DOI 10.1378/chest.127.2.550; Ray SM, 2012, PHARMACOTHERAPY, V32, P456, DOI 10.1002/j.1875-9114.2012.01025.x; SMITH CA, 1991, EUR RESPIR J, V4, P1076; Tamaoki J, 2010, ALLERGY ASTHMA PROC, V31, pE78, DOI 10.2500/aap.2010.31.3366; Terada K, 2009, RESPIROLOGY, V14, P1151, DOI 10.1111/j.1440-1843.2009.01620.x; Walland A, 1997, EUR J PHARMACOL, V330, P213, DOI 10.1016/S0014-2999(97)01011-X; Watanabe N, 2005, PULM PHARMACOL THER, V18, P187, DOI 10.1016/j.pupt.2004.12.002	41	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119953	10.1371/journal.pone.0119953	http://dx.doi.org/10.1371/journal.pone.0119953			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781609	Green Submitted, Green Published, gold			2022-12-27	WOS:000351284600111
J	Zheng, MG; Chen, XA				Zheng, Mingguo; Chen, Xiaoan			Statistical Determination of Rainfall-Runoff Erosivity Indices for Single Storms in the Chinese Loess Plateau	PLOS ONE			English	Article							FLOW-SEDIMENT RELATIONSHIP; HILLY AREAS; HYPERCONCENTRATED FLOW; INTERRILL EROSION; SOIL-EROSION; RIVER	Correlation analysis is popular in erosion-or earth-related studies, however, few studies compare correlations on a basis of statistical testing, which should be conducted to determine the statistical significance of the observed sample difference. This study aims to statistically determine the erosivity index of single storms, which requires comparison of a large number of dependent correlations between rainfall-runoff factors and soil loss, in the Chinese Loess Plateau. Data observed at four gauging stations and five runoff experimental plots were presented. Based on the Meng's tests, which is widely used for comparing correlations between a dependent variable and a set of independent variables, two methods were proposed. The first method removes factors that are poorly correlated with soil loss from consideration in a stepwise way, while the second method performs pairwise comparisons that are adjusted using the Bonferroni correction. Among 12 rainfall factors, I-30 (the maximum 30-minute rainfall intensity) has been suggested for use as the rainfall erosivity index, although I-30 is equally correlated with soil loss as factors of I-20, EI10 (the product of the rainfall kinetic energy, E, and I-10), EI20 and EI30 are. Runoff depth (total runoff volume normalized to drainage area) is more correlated with soil loss than all other examined rain-fall-runoff factors, including I-30, peak discharge and many combined factors. Moreover, sediment concentrations of major sediment-producing events are independent of all examined rainfall-runoff factors. As a result, introducing additional factors adds little to the prediction accuracy of the single factor of runoff depth. Hence, runoff depth should be the best erosivity index at scales from plots to watersheds. Our findings can facilitate predictions of soil erosion in the Loess Plateau. Our methods provide a valuable tool while determining the predictor among a number of variables in terms of correlations.	[Zheng, Mingguo] Chinese Acad Sci, Key Lab Water Cycle & Related Land Surface Proc, Inst Geog Sci & Nat Resources Res, Beijing 100101, Peoples R China; [Chen, Xiaoan] Jiangxi Inst Soil & Water Conservat, Nanchang 330029, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Zheng, MG (corresponding author), Chinese Acad Sci, Key Lab Water Cycle & Related Land Surface Proc, Inst Geog Sci & Nat Resources Res, Beijing 100101, Peoples R China.	zhengmg.04b@igsnrr.ac.cn			National Natural Science Foundation of China [41271306]; Non-profit Industry Financial Program of MWR [201201083]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Non-profit Industry Financial Program of MWR	The research is funded by the National Natural Science Foundation of China (41271306; http://www.nsfc.gov.cn/) and the Non-profit Industry Financial Program of MWR (201201083; http://www.mwr.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Hammad AH, 2006, SOIL TILL RES, V87, P39, DOI 10.1016/j.still.2005.02.037; Angulo-Martinez M, 2009, J HYDROL, V379, P111, DOI 10.1016/j.jhydrol.2009.09.051; [Anonymous], J SOIL WATER CONSERV; [蔡强国 Cai Qiangguo], 2004, [地理研究, Geographical Research], V23, P433; Chaplot VAM, 2003, SOIL SCI SOC AM J, V67, P844, DOI 10.2136/sssaj2003.0844; Chen XA, 2010, J SEDIMENT RES, P5; Diodato N, 2007, J HYDROL, V345, P224, DOI 10.1016/j.jhydrol.2007.08.008; DRAGOUN FJ, 1962, J GEOPHYS RES, V67, P1495, DOI 10.1029/JZ067i004p01495; FOSTER GR, 1982, T ASAE, V25, P124, DOI 10.13031/2013.33490; Goyal JK, 2009, MATH STAT; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Hudson N., 1971, SOIL CONSERVATION; HUSSEIN MH, 1994, HYDROLOG SCI J, V39, P535, DOI 10.1080/02626669409492773; Jia Z, 1990, MEMOIR NISWC ACAD SI, V12, P9; Jia ZJ, 1987, SOIL WATER CONSERV C, P18; Jiang ZS, 1983, SOIL WATER CONSERVAT, P32; Kiassari EM, 2012, TURK J AGRIC FOR, V36, P365, DOI 10.3906/tar-1103-9; Kinnell PIA, 2010, J HYDROL, V385, P384, DOI 10.1016/j.jhydrol.2010.01.024; Kinnell PIA, 1998, SOIL SCI SOC AM J, V62, P1667, DOI 10.2136/sssaj1998.03615995006200060026x; KINNELL PIA, 1995, J SOIL WATER CONSERV, V50, P507; LAL R, 1976, GEODERMA, V16, P389, DOI 10.1016/0016-7061(76)90003-3; Lee JH, 2011, J HYDROL, V409, P30, DOI 10.1016/j.jhydrol.2011.07.031; Liu QJ, 2013, GEOMORPHOLOGY, V186, P181, DOI 10.1016/j.geomorph.2013.01.012; MENG XL, 1992, PSYCHOL BULL, V111, P172, DOI 10.1037/0033-2909.111.1.172; Mou JZ, 1980, P 1 INT S RIV SED, P73; Pierson TC, 2005, S-P BKS GEOPHYS SCI, P159; Renard KG, 1997, AGR HDB, V384, P703; Rice TK, 2008, ADV GENET, V60, P293, DOI 10.1016/S0065-2660(07)00412-9; SALAKO F K, 1991, Soil Technology, V4, P93, DOI 10.1016/0933-3630(91)90042-L; Sharifah Mastura SA, 2003, GEOGRAFIA, V4, P44; Shi ZH, 2013, SOIL SCI SOC AM J, V77, P257, DOI 10.2136/sssaj2012.0273; Shi ZH, 2012, J HYDROL, V454, P123, DOI 10.1016/j.jhydrol.2012.06.004; Shi ZH, 2004, CATENA, V55, P33, DOI 10.1016/S0341-8162(03)00088-2; Silver NC, 2006, APPL PSYCH MEAS, V30, P152, DOI 10.1177/0146621605277132; SINZOT A, 1989, EARTH SURF PROCESSES, V14, P509; Sukhanovski YP, 2002, J PLANT NUTR SOIL SC, V165, P51, DOI 10.1002/1522-2624(200202)165:1<51::AID-JPLN51>3.0.CO;2-3; Uson A, 2001, CATENA, V43, P293, DOI 10.1016/S0341-8162(00)00150-8; Wang WZ., 1996, B SOIL WATER CONSERV, V16, P1; Wang WZ, 1987, SOIL WATER CONSERV C, P34; Wang WZ, 1996, B SOIL WATER CONSERV, V16, P12; Wang WZ, 1983, B SOIL WATER CONSERV, P62; Williams J.R., 1975, PRESENT PROSPECTIVE, P244; Williams JW, 2008, 200817 BRC; Wischmeier W.H., 1978, USDA AGR HDB, P537; WISCHMEIER WALTER H., 1958, TRANS AMER GEOPHYS UNION, V39, P285; WISCHMEIER WALTER H., 1959, SOIL SCI SOC AMER PROC, V23, P246; Wischmeier WH., 1958, AGR ENG, V39, P458; WRIGHT SP, 1992, BIOMETRICS, V48, P1005, DOI 10.2307/2532694; Xu JX, 1999, CATENA, V36, P1, DOI 10.1016/S0341-8162(99)00009-0; Yu GQ, 2014, HYDROL PROCESS, V28, P5322, DOI 10.1002/hyp.10020; Yue BJ, 2014, NAT HAZARDS, V74, P585, DOI 10.1007/s11069-014-1199-z; Zheng MG, 2008, GEOMORPHOLOGY, V93, P288, DOI 10.1016/j.geomorph.2007.03.001; Zheng MG, 2013, CATENA, V109, P164, DOI 10.1016/j.catena.2013.03.017; Zheng MG, 2012, CATENA, V98, P29, DOI 10.1016/j.catena.2012.05.013; Zheng MG, 2011, EARTH SURF PROC LAND, V36, P1499, DOI 10.1002/esp.2176	55	16	21	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0117989	10.1371/journal.pone.0117989	http://dx.doi.org/10.1371/journal.pone.0117989			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781173	Green Published, gold, Green Submitted			2022-12-27	WOS:000351284600018
J	Gonzalez-Foruria, I; Santulli, P; Chouzenoux, S; Carmona, F; Batteux, F; Chapron, C				Gonzalez-Foruria, Inaki; Santulli, Pietro; Chouzenoux, Sandrine; Carmona, Francisco; Batteux, Frederic; Chapron, Charles			Soluble Ligands for the NKG2D Receptor Are Released during Endometriosis and Correlate with Disease Severity	PLOS ONE			English	Article							NATURAL-KILLER-CELL; DEEPLY INFILTRATING ENDOMETRIOSIS; PERITONEAL-FLUID; BLADDER ENDOMETRIOSIS; WOMEN; EXPRESSION; CYTOTOXICITY; MANAGEMENT; SERUM; PATHOGENESIS	Background Endometriosis is a benign gynaecological disease. Abundant bulk of evidence suggests that patients with endometriosis have an immunity dysfunction that enables ectopic endometrial cells to implant and proliferate. Previous studies show that natural killer cells have a pivotal role in the immune control of endometriosis. Methods and Findings This is a prospective laboratory study conducted in a tertiary-care university hospital between January 2011 and April 2013. We investigated non-pregnant, younger than 42-year-old patients (n = 202) during surgery for benign gynaecological conditions. After complete surgical exploration of the abdominopelvic cavity, 121 women with histologically proven endometriosis and 81 endometriosis-free controls women were enrolled. Patients with endometriosis were classified according to a surgical classification in three different types of endometriosis: superficial peritoneal endometriosis (SUP), ovarian endometrioma (OMA) and deep infiltrating endometriosis (DIE). Peritoneal fluid samples were obtained from all study participants during the surgery in order to detect soluble NKG2D ligands (MICA, MICB and ULBP-2). When samples with undetectable peritoneal fluid levels of MICA, MICB and ULBP-2 were excluded, MICA ratio levels were significantly higher in endometriosis patients than in controls (median, 1.1 pg/mg; range, 0.1-143.5 versus median, 0.6 pg/mg; range, 0.1-3.5; p=0.003). In a similar manner peritoneal fluid MICB levels were also increased in endometriosis-affected patients compared with disease-free women (median, 4.6 pg/mg; range, 1.2-4702 versus median, 3.4 pg/mg; range, 0.7-20.1; p=0.001). According to the surgical classification, peritoneal fluid soluble MICA, MICB and ULBP-2 ratio levels were significantly increased in DIE as compared to controls (p=0.015, p=0.003 and p=0.045 respectively). MICA ratio levels also correlated with dysmenorrhea (r=0.232; p=0.029), total rAFS score (r=0.221; p=0.031) and adhesions rAFS score (r=0.221; p=0.031). Conclusions We demonstrate a significant increase of peritoneal fluid NKG2D ligands in women with endometriosis especially in those cases presenting DIE. This study suggests that NKG2D ligands shedding is a novel pathway in endometriosis complex pathogenesis that impairs NK cell function.	[Gonzalez-Foruria, Inaki; Santulli, Pietro; Chouzenoux, Sandrine; Batteux, Frederic; Chapron, Charles] INSERM, Inst Cochin, Dept Dev Reprod & Canc, Paris, France; [Gonzalez-Foruria, Inaki; Santulli, Pietro; Chapron, Charles] Univ Paris 05, Dept Gynecol Obstet & Reprod Med 2, Grp Hosp Univ GHU Ouest,Ctr Hosp Univ CHU Cochin, AP HP,Sorbone Paris Cite,Fac Med, Paris, France; [Gonzalez-Foruria, Inaki; Carmona, Francisco] Univ Barcelona, Hosp Clin, IDIBAPS, Inst Clin Gynecol Obstet & Neonatol,Fac Med, Barcelona, Spain; [Batteux, Frederic] Hop Cochin, Serv Immunol Biol, F-75674 Paris 14, France; [Batteux, Frederic; Chapron, Charles] Hop Cochin, DHU Risque & Grossesse, F-75674 Paris 14, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP	Batteux, F (corresponding author), INSERM, Inst Cochin, Dept Dev Reprod & Canc, Paris, France.	frederic.batteux@cch.aphp.fr	Batteux, Frederic/O-7889-2017; Santulli, Pietro/T-5201-2019; Santulli, Pi/O-8756-2017; Chapron, Charles/O-8567-2017; Carmona, Francisco/AAT-1363-2020	Batteux, Frederic/0000-0002-1265-7996; Gonzalez-Foruria, Inaki/0000-0003-4846-0578	University Paris Descartes; INSERM; Fundacion Alfonso Martin Escudero	University Paris Descartes; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fundacion Alfonso Martin Escudero	This work was supported by grants from University Paris Descartes, INSERM, and Fundacion Alfonso Martin Escudero. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews WC, 1985, FERTIL STERIL, V44, P7, DOI DOI 10.1016/S0015-0282(16)48797-2; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Berkkanoglu M, 2003, AM J REPROD IMMUNOL, V50, P48, DOI 10.1034/j.1600-0897.2003.00042.x; Borghese B, 2008, MOL ENDOCRINOL, V22, P2557, DOI 10.1210/me.2008-0322; Borghese B, 2010, MOL ENDOCRINOL, V24, P1872, DOI 10.1210/me.2010-0160; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Chapron C, 2004, ANN NY ACAD SCI, V1034, P326, DOI 10.1196/annals.1335.035; Chapron C, 2006, HUM REPROD, V21, P1839, DOI 10.1093/humrep/del079; Chapron C, 2011, HUM REPROD, V26, P2028, DOI 10.1093/humrep/der156; Chapron C, 2011, FERTIL STERIL, V95, P877, DOI 10.1016/j.fertnstert.2010.10.027; Chapron C, 2010, FERTIL STERIL, V94, P2353, DOI 10.1016/j.fertnstert.2010.04.020; Chapron C, 2010, HUM REPROD, V25, P884, DOI 10.1093/humrep/deq017; Chapron C, 2009, FERTIL STERIL, V92, P453, DOI 10.1016/j.fertnstert.2008.06.003; Chitadze G, 2013, SCAND J IMMUNOL, V78, P120, DOI 10.1111/sji.12072; de Ziegler D, 2010, LANCET, V376, P730, DOI 10.1016/S0140-6736(10)60490-4; Donnez J, 1996, FERTIL STERIL, V66, P362, DOI 10.1016/S0015-0282(16)58501-X; Dousset B, 2010, ANN SURG, V251, P887, DOI 10.1097/SLA.0b013e3181d9722d; Fauconnier A, 2005, HUM REPROD UPDATE, V11, P595, DOI 10.1093/humupd/dmi029; Fauconnier A, 2002, FERTIL STERIL, V78, P719, DOI 10.1016/S0015-0282(02)03331-9; Funamizu A, 2014, AM J REPROD IMMUNOL, V71, P359, DOI 10.1111/aji.12206; Garzetti GG, 1996, OBSTET GYNECOL, V88, P234; GARZETTI GG, 1993, OBSTET GYNECOL, V81, P665; Giudice LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5; HALME J, 1983, AM J OBSTET GYNECOL, V145, P333, DOI 10.1016/0002-9378(83)90720-2; Huergo-Zapico L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00106; HUSKISSON EC, 1974, LANCET, V2, P1127, DOI 10.1016/S0140-6736(74)90884-8; KANZAKI H, 1992, AM J OBSTET GYNECOL, V167, P257, DOI 10.1016/S0002-9378(11)91670-6; Katsuki Y, 1998, EUR J ENDOCRINOL, V138, P216, DOI 10.1530/eje.0.1380216; KhoshdelRad N, 2014, ARCH GYNECOL OBSTET, V289, P1107, DOI 10.1007/s00404-013-3082-7; Knapp VJ, 1999, FERTIL STERIL, V72, P10; Laschke MW, 2011, HUM REPROD UPDATE, V17, P628, DOI 10.1093/humupd/dmr023; Leconte M, 2014, J REPROD IMMUNOL, V103, P45, DOI 10.1016/j.jri.2013.12.121; Lopez-Soto A, 2014, INT J CANC; Maeda N, 2002, FERTIL STERIL, V77, P297, DOI 10.1016/S0015-0282(01)02964-8; Matarese G, 2003, TRENDS MOL MED, V9, P223, DOI 10.1016/S1471-4914(03)00051-0; Mistry AR, 2007, IMMUNOLOGY, V121, P439, DOI 10.1111/j.1365-2567.2007.02652.x; Ngo C, 2009, AM J PATHOL, V175, P225, DOI 10.2353/ajpath.2009.080804; OOSTERLYNCK DJ, 1991, FERTIL STERIL, V56, P45; OOSTERLYNCK DJ, 1992, FERTIL STERIL, V58, P290; OOSTERLYNCK DJ, 1994, ACTA OBSTET GYN SCAN, V73, P333, DOI 10.3109/00016349409015774; OOSTERLYNCK DJ, 1993, OBSTET GYNECOL, V82, P206; Paschen A, 2009, CLIN CANCER RES, V15, P5208, DOI 10.1158/1078-0432.CCR-09-0886; Salih HR, 2008, FRONT BIOSCI, V13, P3448; Salih HR, 2006, HUM IMMUNOL, V67, P188, DOI 10.1016/j.humimm.2006.02.008; Salih HR, 2002, J IMMUNOL, V169, P4098, DOI 10.4049/jimmunol.169.8.4098; Sampson JA, 1927, AM J PATHOL, V3, P93; Santulli P, 2014, J CLIN ENDOCR METAB, V99, P881, DOI 10.1210/jc.2013-2950; Santulli P, 2013, HUM REPROD, V28, P2126, DOI 10.1093/humrep/det238; Santulli P, 2013, FERTIL STERIL, V99, P219, DOI 10.1016/j.fertnstert.2012.08.055; Senturk LM, 1999, J REPROD IMMUNOL, V43, P67, DOI 10.1016/S0165-0378(98)00079-5; Somigliana E, 2007, FERTIL STERIL, V87, P1287, DOI 10.1016/j.fertnstert.2006.11.090; Streuli I, 2013, EXPERT OPIN PHARMACO, V14, P291, DOI 10.1517/14656566.2013.767334; Umesaki N, 1999, GYNECOL OBSTET INVES, V48, P66, DOI 10.1159/000010137; Vinatier D, 1996, HUM REPROD UPDATE, V2, P371, DOI 10.1093/humupd/2.5.371; Waldhauer I, 2008, CANCER RES, V68, P6368, DOI 10.1158/0008-5472.CAN-07-6768; WILSON TJ, 1994, FERTIL STERIL, V62, P1086; Wu MH, 2005, J CLIN ENDOCR METAB, V90, P286, DOI 10.1210/jc.2004-1612; Wu MY, 2000, FERTIL STERIL, V74, P1187, DOI 10.1016/S0015-0282(00)01592-2; Yuge A, 2007, HUM REPROD, V22, P938, DOI 10.1093/humrep/del485	59	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119961	10.1371/journal.pone.0119961	http://dx.doi.org/10.1371/journal.pone.0119961			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775242	Green Submitted, Green Published, gold			2022-12-27	WOS:000351183500144
J	Hou, CL; Liu, H; Zhang, J; Zhang, SH; Yang, FJ; Zeng, XF; Thacker, PA; Zhang, GL; Qiao, SY				Hou, Chengli; Liu, Hong; Zhang, Jiang; Zhang, Shihai; Yang, Fengjuan; Zeng, Xiangfang; Thacker, Philip A.; Zhang, Guolong; Qiao, Shiyan			Intestinal Microbiota Succession and Immunomodulatory Consequences after Introduction of Lactobacillus reuteri I5007 in Neonatal Piglets	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; GUT MICROBIOTA; GASTROINTESTINAL-TRACT; IMMUNE-SYSTEM; HYGIENE HYPOTHESIS; FERMENTUM I5007; MUCOSAL DEFENSE; HOST; BACTERIA; COMPLEX	Seventy-two, suckling piglets, obtained from 9 litters standardized to 8 piglets, were assigned to 1 of 3 treatments (n = 24) to compare short-term, early administration with intermittent, longer-term administration of Lactobacillus reuteri I5007. The treatments were a control (given a placebo of 0.1% peptone water from day 1 to 5) or treatments in which 1.7 x 10 (10) CFU Lactobacillus reuteri was administrated either daily for 4 days starting on day 1 or every 4th day from day 1 to 17. Five piglets per treatment were killed at 3 time points (day 7, 14 and 21). Denaturing Gradient Electrophoresis of ileal digesta revealed an increase in the presence of Lactobacillus reuteri I5007 and Clostridium lentocellum (on day 14 and 21) in the every 4th-day treatment and Actinobacillus porcinus (on day 7 and 14) in both Lactobacillus reuteri treatments, while reducing the abundance of E. coli on day 21 in the every 4th-day treatment. Real-time qPCR of ileal digesta showed an increase in Bifidobacterium spp. on day 14 for both Lactobacillus reuteri I5007 treatments. An increase in the concentration of lactic acid and a lower pH was observed in the first 4-day treatment on day 7 and the every 4th day treatment on day 14. The relative abundance of mRNA for TGF-beta was increased while that for IFN-gamma was decreased in the mesenteric lymph nodes of piglets treated with Lactobacillus reuteri every 4th day. In conclusion, early intervention with Lactobacillus reuteri increases the presence of beneficial bacteria and decreases the presence of undesirable microbes in the lower gastrointestinal tract. The changes appear to be mediated by altering the intestinal pH through lactic acid production resulting in favorable bacterial species colonization. A prolonged duration of treatment (i.e. every 4th day) would appear to be superior to treatment only during the first 4 days.	[Hou, Chengli; Liu, Hong; Zhang, Jiang; Zhang, Shihai; Yang, Fengjuan; Zeng, Xiangfang; Qiao, Shiyan] China Agr Univ, State Key Lab Anim Nutr, Beijing 100193, Peoples R China; [Thacker, Philip A.] Univ Saskatchewan, Dept Anim & Poultry Sci, Saskatoon, SK S7N 0W0, Canada; [Zhang, Guolong] Oklahoma State Univ, Dept Anim Sci, Stillwater, OK 74078 USA	China Agricultural University; University of Saskatchewan; Oklahoma State University System; Oklahoma State University - Stillwater	Qiao, SY (corresponding author), China Agr Univ, State Key Lab Anim Nutr, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China.	qiaoshy@mafic.ac.cn	Zhang, Guolong/HCI-5587-2022; Hou, Chengli/AGY-1396-2022; chengli, Hou/AGZ-4530-2022; Zhang, Guolong/AAU-8197-2020	chengli, Hou/0000-0002-5617-8655; Zhang, Guolong/0000-0003-4781-5816	National Natural Science Foundation of China [31420103908]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was financially supported by the National Natural Science Foundation of China (Grant Number 31420103908). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda PS, 2012, ELECTROPHORESIS, V33, P366, DOI 10.1002/elps.201100335; Ashida H, 2012, NAT CHEM BIOL, V8, P36, DOI 10.1038/nchembio.741; Bailey M, 2005, P NUTR SOC, V64, P451, DOI 10.1079/PNS2005452; Bauer Eva, 2006, Current Issues in Intestinal Microbiology, V7, P35; Bezkorovainy A, 2001, AM J CLIN NUTR, V73, p399S, DOI 10.1093/ajcn/73.2.399s; Bjorksten B, 2006, CLIN EXP ALLERGY, V36, P1215, DOI 10.1111/j.1365-2222.2006.02579.x; Bjorksten B, 2009, NESTLE NUTR WORKS SE, V64, P11, DOI 10.1159/000235780; Boyle RJ, 2006, AM J CLIN NUTR, V83, P1256, DOI 10.1093/ajcn/83.6.1256; Brandt K, 2012, CLINICS, V67, P113, DOI 10.6061/clinics/2012(02)05; Bron PA, 2012, NAT REV MICROBIOL, V10, P66, DOI 10.1038/nrmicro2690; Claud EC, 2011, ANAEROBE, V17, P180, DOI 10.1016/j.anaerobe.2011.02.004; Collado-Romero M, 2010, VET RES, V41, DOI 10.1051/vetres/2009072; Delzenne NM, 2011, ANNU REV NUTR, V31, P15, DOI 10.1146/annurev-nutr-072610-145146; dos Santos VM, 2010, CURR OPIN BIOTECH, V21, P539, DOI 10.1016/j.copbio.2010.08.003; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Duncker SC, 2006, VET IMMUNOL IMMUNOP, V111, P239, DOI 10.1016/j.vetimm.2006.01.017; Forchielli ML, 2005, BRIT J NUTR, V93, pS41, DOI 10.1079/BJN20041356; Franklin MA, 2002, J ANIM SCI, V80, P2904; Gaskins HR, 2008, CLIN INFECT DIS, V46, pS80, DOI 10.1086/523336; Hansen CHF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034043; Hou CL, 2014, J BIOTECHNOL, V179, P63, DOI 10.1016/j.jbiotec.2014.03.019; Isolauri E., 2004, CURR PAEDIAT, V14, P104, DOI DOI 10.1016/J.CUPE.2003.11.002; Kelly D, 2007, MUTAT RES-FUND MOL M, V622, P58, DOI 10.1016/j.mrfmmm.2007.03.011; Kok RG, 1996, APPL ENVIRON MICROB, V62, P3668, DOI 10.1128/AEM.62.10.3668-3672.1996; Konstantinov SR, 2004, APPL ENVIRON MICROB, V70, P3821, DOI 10.1128/AEM.70.7.3821-3830.2004; Leser TD, 2002, APPL ENVIRON MICROB, V68, P673, DOI 10.1128/AEM.68.2.673-690.2002; Levast B, 2010, VET IMMUNOL IMMUNOP, V137, P261, DOI 10.1016/j.vetimm.2010.06.004; Li XJ, 2008, J APPL MICROBIOL, V104, P1082, DOI 10.1111/j.1365-2672.2007.03636.x; Liu H, 2014, J AGR FOOD CHEM, V62, P860, DOI 10.1021/jf403288r; Livingston M, 2010, IMMUNOL CELL BIOL, V88, P99, DOI 10.1038/icb.2009.71; Mackie RI, 1999, AM J CLIN NUTR, V69, p1035S, DOI 10.1093/ajcn/69.5.1035s; Marzotto M, 2006, RES MICROBIOL, V157, P857, DOI 10.1016/j.resmic.2006.06.007; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Moue M, 2008, BBA-GEN SUBJECTS, V1780, P134, DOI 10.1016/j.bbagen.2007.11.006; Musso G, 2010, DIABETES CARE, V33, P2277, DOI 10.2337/dc10-0556; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nubel U, 1996, J BACTERIOL, V178, P5636; Paulin SM, 2007, INFECT IMMUN, V75, P3950, DOI 10.1128/IAI.00366-07; Rakoff-Nahoum S, 2008, MUCOSAL IMMUNOL, V1, pS10, DOI 10.1038/mi.2008.49; Rauch M, 2010, GUT MICROBES, V1, P335, DOI 10.4161/gmic.1.5.13169; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Schmidt B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028284; SWORDS WE, 1993, BIOL NEONATE, V63, P191, DOI 10.1159/000243931; Walter J, 2001, APPL ENVIRON MICROB, V67, P2578, DOI 10.1128/AEM.67.6.2578-2585.2001; Walter J, 2011, P NATL ACAD SCI USA, V108, P4645, DOI 10.1073/pnas.1000099107; Wang XQ, 2012, J NUTR, V142, P7, DOI 10.3945/jn.111.147074; Ye LL, 2008, DEV COMP IMMUNOL, V32, P966, DOI 10.1016/j.dci.2008.01.008; Yi JQ, 2013, ASIAN AUSTRAL J ANIM, V26, P1181, DOI 10.5713/ajas.2013.13129; Zoetendal EG, 1998, APPL ENVIRON MICROB, V64, P3854	51	27	31	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119505	10.1371/journal.pone.0119505	http://dx.doi.org/10.1371/journal.pone.0119505			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775260	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500099
J	Meunier, CNJ; Callebert, J; Cancela, JM; Fossier, P				Meunier, Claire Nicole Jeanne; Callebert, Jacques; Cancela, Jose-Manuel; Fossier, Philippe			Effect of Dopaminergic D1 Receptors on Plasticity Is Dependent of Serotoninergic 5-HT1A Receptors in L5-Pyramidal Neurons of the Prefrontal Cortex	PLOS ONE			English	Article							LONG-TERM POTENTIATION; EXCITATION-INHIBITION BALANCE; SYNAPTIC PLASTICITY; PYRAMIDAL NEURONS; CELLULAR-LOCALIZATION; GABAERGIC INHIBITION; AREA CA1; MODULATION; DEPRESSION; MECHANISMS	Major depression and schizophrenia are associated with dysfunctions of serotoninergic and dopaminergic systems mainly in the prefrontal cortex (PFC). Both serotonin and dopamine are known to modulate synaptic plasticity. 5-HT1A receptors (5-HT(1A)Rs) and dopaminergic type D1 receptors are highly represented on dendritic spines of layer 5 pyramidal neurons (L5PyNs) in PFC. How these receptors interact to tune plasticity is poorly understood. Here we show that D1-like receptors (D1Rs) activation requires functional 5HT(1A)Rs to facilitate LTP induction at the expense of LTD. Using 129/Sv and 5-HT1AR-KO mice, we recorded post-synaptic currents evoked by electrical stimulation in layer 2/3 after activation or inhibition of D1Rs. High frequency stimulation resulted in the induction of LTP, LTD or no plasticity. The D1 agonist markedly enhanced the NMDA current in 129/Sv mice and the percentage of L5PyNs displaying LTP was enhanced whereas LTD was reduced. In 5HT(1A)R-KO mice, the D1 agonist failed to increase the NMDA current and orientated the plasticity towards L5PyNs displaying LTD, thus revealing a prominent role of 5-HT(1A)Rs in dopamine-induced modulation of plasticity. Our data suggest that in pathological situation where 5-HT(1A)Rs expression varies, dopaminergic treatment used for its ability to increase LTP could turn to be less and less effective.	[Meunier, Claire Nicole Jeanne; Cancela, Jose-Manuel; Fossier, Philippe] Univ Paris 11, Neurosci Paris Saclay Inst NeuroPSI, CNRS, UMR 8197, F-91405 Orsay, France; [Callebert, Jacques] Univ Paris 05, Lab Neuropharmacol Addict, INSERM, CNRS,U705,UMR 7157, F-75006 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Fossier, P (corresponding author), Univ Paris 11, Neurosci Paris Saclay Inst NeuroPSI, CNRS, UMR 8197, Batiment 446, F-91405 Orsay, France.	philippe.fossier@u-psud.fr	callebert, jacques/L-4569-2017	Cancela, Jose-Manuel/0000-0002-6234-1500	CNRS; SANOFI-AVENTIS R.D. Exploratory Unit	CNRS(Centre National de la Recherche Scientifique (CNRS)); SANOFI-AVENTIS R.D. Exploratory Unit	This research has been supported by grants from CNRS. C.N.J Meunier is the recipient of a fellowship from CNRS and SANOFI-AVENTIS R.D. Exploratory Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnsten AFT, 2011, PHARMACOL BIOCHEM BE, V99, P211, DOI 10.1016/j.pbb.2011.01.020; Ashpole NM, 2012, J BIOL CHEM, V287, P8495, DOI 10.1074/jbc.M111.323915; Azmitia EC, 1996, NEUROPSYCHOPHARMACOL, V14, P35, DOI 10.1016/S0893-133X(96)80057-1; Bai J, 2014, CEREB CORTEX, V24, P945, DOI 10.1093/cercor/bhs376; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Bhagwagar Z, 2004, MOL PSYCHIATR, V9, P386, DOI 10.1038/sj.mp.4001401; Boureau YL, 2011, NEUROPSYCHOPHARMACOL, V36, P74, DOI 10.1038/npp.2010.151; CEPEDA C, 1992, SYNAPSE, V11, P330, DOI 10.1002/syn.890110408; Chen GJ, 2004, P NATL ACAD SCI USA, V101, P2596, DOI 10.1073/pnas.0308618100; Chen L, 2007, J NEUROPHYSIOL, V97, P2448, DOI 10.1152/jn.00317.2006; Choi SY, 2005, J NEUROSCI, V25, P11433, DOI 10.1523/JNEUROSCI.4084-05.2005; CORMIER RJ, 1993, NEURON, V10, P907, DOI 10.1016/0896-6273(93)90206-7; Coultrap SJ, 2014, CELL REP, V6, P431, DOI 10.1016/j.celrep.2014.01.005; DESCARRIES L, 1987, NEUROSCIENCE, V21, P807, DOI 10.1016/0306-4522(87)90038-8; Diaz-Mataix L, 2005, J NEUROSCI, V25, P10831, DOI 10.1523/JNEUROSCI.2999-05.2005; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Dupuis JP, 2014, EMBO J, V33, P842, DOI 10.1002/embj.201386356; Fries P, 2001, NAT NEUROSCI, V4, P194, DOI 10.1038/84032; Gamo NJ, 2011, BEHAV NEUROSCI, V125, P282, DOI 10.1037/a0023165; Garcia-Garcia AL, 2014, PSYCHOPHARMACOLOGY, V231, P623, DOI 10.1007/s00213-013-3389-x; GASPAR P, 1995, EUR J NEUROSCI, V7, P1050, DOI 10.1111/j.1460-9568.1995.tb01092.x; Gonzalez-Islas C, 2003, J NEUROSCI, V23, P867; Goto Y, 2010, BIOL PSYCHIAT, V67, P199, DOI 10.1016/j.biopsych.2009.08.026; Granon S, 2012, BEHAV BRAIN RES, V229, P419, DOI 10.1016/j.bbr.2011.11.011; Grenier FO, 2001, J NEUROPHYSIOL, V86, P1884, DOI 10.1152/jn.2001.86.4.1884; Gurden H, 1999, NEUROSCIENCE, V94, P1019, DOI 10.1016/S0306-4522(99)00395-4; Gurden H, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0003.2000; Hanley JG, 2005, EMBO J, V24, P3266, DOI 10.1038/sj.emboj.7600801; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; Hayama T, 2013, NAT NEUROSCI, V16, P1409, DOI 10.1038/nn.3496; Hensch TK, 2005, PROG BRAIN RES, V147, P115, DOI 10.1016/S0079-6123(04)47009-5; Huang F-S, 2004, PNAS, V101, P3236; Huang FS, 2010, NEUROSCI RES, V67, P108, DOI 10.1016/j.neures.2010.02.005; KEMA IP, 1993, CLIN CHIM ACTA, V221, P143, DOI 10.1016/0009-8981(93)90029-4; Koch G, 2011, CLIN NEUROPHYSIOL, V122, P703, DOI 10.1016/j.clinph.2010.10.033; Kolomiets B, 2009, CEREB CORTEX, V19, P2708, DOI 10.1093/cercor/bhp047; Kruse MS, 2009, EUR NEUROPSYCHOPHARM, V19, P296, DOI 10.1016/j.euroneuro.2008.12.006; Ladepeche L, 2014, SEMIN CELL DEV BIOL, V27, P3, DOI 10.1016/j.semcdb.2013.10.005; Le Roux N, 2006, EUR J NEUROSCI, V24, P3507, DOI 10.1111/j.1460-9568.2006.05203.x; LIDOW MS, 1991, NEUROSCIENCE, V40, P657, DOI 10.1016/0306-4522(91)90003-7; Liu XY, 2006, NEURON, V52, P897, DOI 10.1016/j.neuron.2006.10.011; Lucas-Meunier E, 2009, CEREB CORTEX, V19, P2411, DOI 10.1093/cercor/bhn258; Meunier CNJ, 2013, NEUROPHARMACOLOGY, V71, P37, DOI 10.1016/j.neuropharm.2013.03.003; Moreau AW, 2013, NEUROSCIENCE, V238, P148, DOI 10.1016/j.neuroscience.2013.02.013; Moreau AW, 2010, CEREB CORTEX, V20, P456, DOI 10.1093/cercor/bhp114; Morice E, 2007, NEUROPSYCHOPHARMACOL, V32, P2108, DOI 10.1038/sj.npp.1301354; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; Nakayama H, 2012, NEURON, V74, P384, DOI 10.1016/j.neuron.2012.02.032; Oda S, 2010, BRAIN RES, V1329, P89, DOI 10.1016/j.brainres.2010.03.011; Otani S, 1998, NEUROSCIENCE, V85, P669, DOI 10.1016/S0306-4522(97)00677-5; Otani S, 2003, CEREB CORTEX, V13, P1251, DOI 10.1093/cercor/bhg092; Polter AM, 2010, CELL SIGNAL, V22, P1406, DOI 10.1016/j.cellsig.2010.03.019; Ramboz S, 1998, P NATL ACAD SCI USA, V95, P14476, DOI 10.1073/pnas.95.24.14476; SAKAI N, 1993, BRAIN RES, V613, P326, DOI 10.1016/0006-8993(93)90921-9; Santana N, 2004, CEREB CORTEX, V14, P1100, DOI 10.1093/cercor/bhh070; Santana N, 2009, CEREB CORTEX, V19, P849, DOI 10.1093/cercor/bhn134; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Seamans JK, 2001, J NEUROSCI, V21, P3628, DOI 10.1523/JNEUROSCI.21-10-03628.2001; Sheynikhovich D, 2011, J PHYSIOL-PARIS, V105, P45, DOI 10.1016/j.jphysparis.2011.08.001; Shively CA, 2006, ARCH GEN PSYCHIAT, V63, P396, DOI 10.1001/archpsyc.63.4.396; Steriade M, 2000, NEUROSCIENCE, V101, P243, DOI 10.1016/S0306-4522(00)00353-5; Steriade M, 1999, TRENDS NEUROSCI, V22, P337, DOI 10.1016/S0166-2236(99)01407-1; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P252, DOI 10.1016/S1364-6613(99)01345-5; Trantham-Davidson H, 2004, J NEUROSCI, V24, P10652, DOI 10.1523/JNEUROSCI.3179-04.2004; Tritsch NX, 2012, NEURON, V76, P33, DOI 10.1016/j.neuron.2012.09.023; Van den Oever MC, 2010, NEUROSCI BIOBEHAV R, V35, P276, DOI 10.1016/j.neubiorev.2009.11.016; Varela JA, 2009, J NEUROSCI, V29, P3109, DOI 10.1523/JNEUROSCI.4746-08.2009; Vargas R, 2011, SYNAPSE, V65, P441, DOI 10.1002/syn.20862; Wirkner K, 2004, NEUROSCI LETT, V372, P89, DOI 10.1016/j.neulet.2004.09.015; Witkowski G, 2008, NEUROSCIENCE, V155, P53, DOI 10.1016/j.neuroscience.2008.05.021; Wolf ME, 2010, NEUROTOX RES, V18, P393, DOI 10.1007/s12640-010-9176-0; Yang YL, 2009, PSYCHIAT RES-NEUROIM, V174, P81, DOI 10.1016/j.pscychresns.2009.03.012	74	8	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120286	10.1371/journal.pone.0120286	http://dx.doi.org/10.1371/journal.pone.0120286			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775449	Green Published, gold, Green Submitted			2022-12-27	WOS:000351183500163
J	Shankar, V; Hori, H; Kihira, K; Lei, Q; Toyoda, H; Iwamoto, S; Komada, Y				Shankar, Vipin; Hori, Hiroki; Kihira, Kentaro; Lei, Qi; Toyoda, Hidemi; Iwamoto, Shotaro; Komada, Yoshihiro			Mesenchymal Stromal Cell Secretome Up-Regulates 47 kDa CXCR4 Expression, and Induce Invasiveness in Neuroblastoma Cell Lines	PLOS ONE			English	Article							MINIMAL RESIDUAL DISEASE; CHEMOKINE RECEPTOR CXCR4; BONE-MARROW; CANCER-CELLS; TUMOR-CELLS; MICROENVIRONMENT; METASTASIS; GROWTH; HETEROGENEITY; SENSITIVITY	Neuroblastoma accounts for 15% of childhood cancer deaths and presents with metastatic disease of the bone and the bone marrow at diagnosis in 70% of the cases. Previous studies have shown that the Mesenchymal Stromal Cell (MSC) secretome, triggers metastases in several cancer types such as breast and prostate cancer, but the specific role of the MSC factors in neuroblastoma metastasis is unclear. To better understand the effect of MSC secretome on chemokine receptors in neuroblastoma, and its role in metastasis, we studied a panel of 20 neuroblastoma cell lines, and compared their invasive potential towards MSC-conditioned-RPMI (mRPMI) and their cytokine receptor expression profiles. Western blot analysis revealed the expression of multiple CXCR4 isoforms in neuroblastoma cells. Among the five major isoforms, the expression of the 47 kDa isoform showed significant correlation with high invasiveness. Pretreatment with mRPMI up-regulated the expression of the 47 kDa CXCR4 isoform and also increased MMP-9 secretion, expression of integrin alpha 3 and integrin beta 1, and the invasive potential of the cell; while blocking CXCR4 either with AMD 3100, a CXCR4 antagonist, or with an anti-47 kDa CXCR4 neutralizing antibody decreased the secretion of MMP-9, the expression of integrin alpha 3 and integrin beta 1, and the invasive potential of the cell. Pretreatment with mRPMI also protected the 47 kDa CXCR4 isoform from ubiquitination and subsequent degradation. Our data suggest a modulatory role of the MSC secretome on the expression of the 47 kDa CXCR4 isoform and invasion potential of the neuroblastoma cells to the bone marrow.	[Shankar, Vipin; Hori, Hiroki; Kihira, Kentaro; Lei, Qi; Toyoda, Hidemi; Iwamoto, Shotaro; Komada, Yoshihiro] Mie Univ, Grad Sch Med, Dept Pediat, Tsu, Mie 514, Japan	Mie University	Hori, H (corresponding author), Mie Univ, Grad Sch Med, Dept Pediat, 2-174 Edobashi, Tsu, Mie 514, Japan.	hhori@clin.medic.mie-u.ac.jp	Chelakkot, Vipin Shankar/GPX-2558-2022	Chelakkot, Vipin Shankar/0000-0002-2385-9489				Airoldi I, 2006, CLIN CANCER RES, V12, P77, DOI 10.1158/1078-0432.CCR-05-1376; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Carlisle AJ, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-126; Chantrain CF, 2008, CANCER MICROENVIRON, V1, P23, DOI 10.1007/s12307-008-0010-7; Chinni SR, 2006, PROSTATE, V66, P32, DOI 10.1002/pros.20318; Domanska UM, 2013, EUR J CANCER, V49, P219, DOI 10.1016/j.ejca.2012.05.005; Fukuda M, 2001, J PEDIAT HEMATOL ONC, V23, P10, DOI 10.1097/00043426-200101000-00004; Furusato B, 2009, CANCER DRUG DISCOV D, P31, DOI 10.1007/978-1-60327-267-4_2; Gout S, 2008, CANCER MICROENVIRON, V1, P69, DOI 10.1007/s12307-008-0007-2; Granchi D, 2011, BONE, V48, P152, DOI 10.1016/j.bone.2010.06.028; Hiraiwa H, 1997, CANCER, V79, P2036, DOI 10.1002/(SICI)1097-0142(19970515)79:10<2036::AID-CNCR27>3.3.CO;2-M; Hu M, 2008, EUR J CANCER, V44, P2760, DOI 10.1016/j.ejca.2008.09.038; Iwamoto S, 2007, J CLIN INVEST, V117, P1049, DOI 10.1172/JCI30235; Jacobson O, 2009, BIOORGAN MED CHEM, V17, P1486, DOI 10.1016/j.bmc.2009.01.014; Kisenge RR, 2003, CANCER SCI, V94, P598, DOI 10.1111/j.1349-7006.2003.tb01489.x; Kollar Katarina, 2009, Int J Cell Biol, V2009, P904682, DOI 10.1155/2009/904682; Kollmar O, 2007, NEOPLASIA, V9, P862, DOI 10.1593/neo.07559; Komada Y, 1998, CANCER, V82, P591, DOI 10.1002/(SICI)1097-0142(19980201)82:3<591::AID-CNCR23>3.3.CO;2-E; Kukreja P, 2005, CANCER RES, V65, P9891, DOI 10.1158/0008-5472.CAN-05-1293; Lapham CK, 2002, J LEUKOCYTE BIOL, V72, P1206; Lee S, 2012, ONCOTARGET, V3, P1576; Liberman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043665; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Maris JM, 1999, J CLIN ONCOL, V17, P2264, DOI 10.1200/JCO.1999.17.7.2264; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Matthay KK, 2008, LANCET ONCOL, V9, P195, DOI 10.1016/S1470-2045(08)70046-9; Meier R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001016; Mishra A, 2011, CANCER MICROENVIRON, V4, P221, DOI 10.1007/s12307-011-0083-6; Ogawa M, 2005, CLIN CANCER RES, V11, P3485, DOI 10.1158/1078-0432.CCR-04-1781; Ootsuka S, 2008, BIOL PHARM BULL, V31, P1071, DOI 10.1248/bpb.31.1071; Polyak K, 2009, TRENDS GENET, V25, P30, DOI 10.1016/j.tig.2008.10.012; Qi L, 2013, CANCER SCI, V104, P1162, DOI 10.1111/cas.12204; Raffaghello L, 2009, SEMIN CANCER BIOL, V19, P97, DOI 10.1016/j.semcancer.2008.10.003; Reynolds CP, 2004, PEDIATR TRANSPLANT, V8, P56, DOI 10.1111/j.1398-2265.2004.00216.x; Rosenkilde MM, 2004, J BIOL CHEM, V279, P3033, DOI 10.1074/jbc.M309546200; Russell HV, 2004, J PEDIATR SURG, V39, P1506, DOI 10.1016/j.jpedsurg.2004.06.019; Skalnikova HK, 2013, BIOCHIMIE, V95, P2196, DOI 10.1016/j.biochi.2013.07.015; Slagsvold T, 2006, EMBO J, V25, P3738, DOI 10.1038/sj.emboj.7601267; Sloane AJ, 2005, IMMUNOL CELL BIOL, V83, P129, DOI 10.1111/j.1440-1711.2004.01304.x; Sohara Y, 2005, CANCER LETT, V228, P203, DOI 10.1016/j.canlet.2005.01.059; Somasundaram R, 2009, SEMIN CANCER BIOL, V19, P92, DOI 10.1016/j.semcancer.2008.11.002; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Ura H, 1998, SURG TODAY, V28, P1001, DOI 10.1007/BF02483952; van Golen CM, 2006, CANCER RES, V66, P6570, DOI 10.1158/0008-5472.CAN-05-1448; Zhang LB, 2007, NEOPLASIA, V9, P36, DOI 10.1593/neo.06670; Zhao HY, 2013, CHILD NERV SYST, V29, P1097, DOI 10.1007/s00381-013-2086-8	49	16	16	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120069	10.1371/journal.pone.0120069	http://dx.doi.org/10.1371/journal.pone.0120069			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774696	Green Submitted, gold, Green Published			2022-12-27	WOS:000351183500148
J	DiVall, SA; Herrera, D; Sklar, B; Wu, S; Wondisford, F; Radovick, S; Wolfe, A				DiVall, Sara A.; Herrera, Danny; Sklar, Bonnie; Wu, Sheng; Wondisford, Fredric; Radovick, Sally; Wolfe, Andrew			Insulin Receptor Signaling in the GnRH Neuron Plays a Role in the Abnormal GnRH Pulsatility of Obese Female Mice	PLOS ONE			English	Article							POLYCYSTIC OVARIAN SYNDROME; BODY-MASS INDEX; LUTEINIZING-HORMONE; NEUROPEPTIDE SECRETION; HYPOTHALAMIC NEURONS; INVERSE RELATIONSHIP; METABOLIC SYNDROME; DEPENDENT PATHWAY; MALE RATS; EXPRESSION	Infertility associated with obesity is characterized by abnormal hormone release from reproductive tissues in the hypothalamus, pituitary, and ovary. These tissues maintain insulin sensitivity upon peripheral insulin resistance. Insulin receptor signaling may play a role in the dysregulation of gonadotropin-releasing hormone (GnRH) secretion in obesity, but the interdependence of hormone secretion in the reproductive axis and the multi-hormone and tissue dysfunction in obesity hinders investigations of putative contributing factors to the disrupted GnRH secretion. To determine the role of GnRH insulin receptor signaling in the dysregulation of GnRH secretion in obesity, we created murine models of diet-induced obesity (DIO) with and without intact insulin signaling in the GnRH neuron. Obese control female mice were infertile with higher luteinizing hormone levels and higher GnRH pulse amplitude and total pulsatile secretion compared to lean control mice. In contrast, DIO mice with a GnRH specific knockout of insulin receptor had improved fertility, luteinizing hormone levels approaching lean mice, and GnRH pulse amplitude and total secretion similar to lean mice. Pituitary responsiveness was similar between genotypes. These results suggest that in the obese state, insulin receptor signaling in GnRH neurons increases GnRH pulsatile secretion and consequent LH secretion, contributing to reproductive dysfunction.	[DiVall, Sara A.; Herrera, Danny; Sklar, Bonnie; Wu, Sheng; Wondisford, Fredric; Radovick, Sally; Wolfe, Andrew] Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21218 USA	Johns Hopkins University	DiVall, SA (corresponding author), Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21218 USA.	sara.divall@seattlechildrens.org			National Institutes of Health [K08 HD056139, UO1-HD-066432]; Eunice Kennedy Shriver NICHD/NIH (SCCPIR) [U54-HD28934]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD056139, U54HD028934, P50HD028934, R00HD068130, U01HD066432] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD044608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK079637, P30DK079637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver NICHD/NIH (SCCPIR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding provided by National Institutes of Health Grants K08 HD056139 to SD and UO1-HD-066432 to AW and SR. Technical support was provided by the Integrated Physiology Core of the Baltimore Diabetes Research Training Center (P60-DK-079637). The University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core is supported by the Eunice Kennedy Shriver NICHD/NIH (SCCPIR) Grant U54-HD28934. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RA, 1999, NEUROENDOCRINOLOGY, V70, P353, DOI 10.1159/000054496; BOURGUIGNON JP, 1984, ENDOCRINOLOGY, V114, P1941, DOI 10.1210/endo-114-5-1941; Brothers KJ, 2010, CELL METAB, V12, P295, DOI 10.1016/j.cmet.2010.06.010; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Burcelin R, 2003, ENDOCRINOLOGY, V144, P4484, DOI 10.1210/en.2003-0457; Castellano JM, 2006, DIABETES, V55, P2602, DOI 10.2337/db05-1584; Castellano JM, 2011, ENDOCRINOLOGY, V152, P3396, DOI 10.1210/en.2010-1415; Diamanti-Kandarakis E, 2012, ENDOCR REV, V33, P981, DOI 10.1210/er.2011-1034; DiVall SA, 2007, MOL CELL ENDOCRINOL, V270, P64, DOI 10.1016/j.mce.2007.02.007; DiVall SA, 2010, J CLIN INVEST, V120, P2900, DOI 10.1172/JCI41069; Heger S, 2003, ENDOCRINOLOGY, V144, P2566, DOI 10.1210/en.2002-221107; Hill JW, 2010, CELL METAB, V11, P286, DOI 10.1016/j.cmet.2010.03.002; Jain A, 2007, J CLIN ENDOCR METAB, V92, P2468, DOI 10.1210/jc.2006-2274; Jonas EA, 1997, NATURE, V385, P343, DOI 10.1038/385343a0; Kisfalvi K, 2007, ENDOCRINOLOGY, V148, P3246, DOI 10.1210/en.2006-1711; Konner AC, 2012, CELL METAB, V16, P144, DOI 10.1016/j.cmet.2012.07.004; Kovacs P, 2002, NEUROENDOCRINOLOGY, V76, P357, DOI 10.1159/000067585; Krsmanovic LZ, 2003, P NATL ACAD SCI USA, V100, P2969, DOI 10.1073/pnas.0535708100; Liu XH, 2008, ENDOCRINOLOGY, V149, P4605, DOI 10.1210/en.2008-0321; Michalakis K, 2013, METABOLISM, V62, P457, DOI 10.1016/j.metabol.2012.08.012; Nelson JF, LONGITUDINAL STUDY E; Novaira HJ, 2011, J NEUROSCI, V31, P3336, DOI 10.1523/JNEUROSCI.5419-10.2011; Pagan YL, 2006, J CLIN ENDOCR METAB, V91, P1309, DOI 10.1210/jc.2005-2099; Qiu XL, 2013, ENDOCRINOLOGY, V154, P1337, DOI 10.1210/en.2012-2056; Quennell JH, 2011, ENDOCRINOLOGY, V152, P1541, DOI 10.1210/en.2010-1100; RISMA KA, 1995, P NATL ACAD SCI USA, V92, P1322, DOI 10.1073/pnas.92.5.1322; Simpson HL, 1998, GROWTH HORM IGF RES, V8, P83, DOI 10.1016/S1096-6374(98)80098-1; Srouji SS, 2007, J CLIN ENDOCR METAB, V92, P1347, DOI 10.1210/jc.2006-2716; Suter KJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE130, DOI 10.1152/ajpendo.90300.2008; Tanaka T, 2000, BIOL REPROD, V62, P1256, DOI 10.1095/biolreprod62.5.1256; VELDHUIS JD, 1986, AM J PHYSIOL, V250, pE486, DOI 10.1152/ajpendo.1986.250.4.E486; Wolfe A, 2008, J NEUROENDOCRINOL, V20, P909, DOI 10.1111/j.1365-2826.2008.01746.x; Woller MJ, 2010, AM J PHYSIOL-REG I, V298, pR70, DOI 10.1152/ajpregu.00193.2009; Wu S, 2011, DIABETES; Wu S., 2013, DIABETES; Xu Y, 2011, CELL METAB, V14, P453, DOI 10.1016/j.cmet.2011.08.009; Yang JL, 2010, ENDOCRINOLOGY, V151, P774, DOI 10.1210/en.2009-0751	38	41	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119995	10.1371/journal.pone.0119995	http://dx.doi.org/10.1371/journal.pone.0119995			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25780937	gold, Green Published, Green Submitted			2022-12-27	WOS:000351284600116
J	Harris, ML; Byles, JE; Sibbritt, D; Loxton, D				Harris, Melissa L.; Byles, Julie E.; Sibbritt, David; Loxton, Deborah			"Just Get on with It": Qualitative Insights of Coming to Terms with a Deteriorating Body for Older Women with Osteoarthritis	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; PSYCHOLOGICAL ADJUSTMENT; MIDDLE-AGE; DEPRESSION; IMPACT; ILLNESS; LIFE; PERSPECTIVE; PREDICTORS; DISTRESS	Objective To qualify the psychosocial burden of osteoarthritis for older women and identify factors perceived to assist with psychological adjustment to the disease. Methods Women who indicated being diagnosed/treated for osteoarthritis in the previous three years in the fifth survey of the Australian Longitudinal Study on Women's Health provided the sampling frame. Participants were randomly sampled until saturation was reached using a systematic process. Thematic content analysis was applied to the 19 semi-structured telephone interviews using a realist framework. Results The findings indicate that the emotional burden of osteoarthritis is considerable, and the process of psychological adjustment complex. Older women with osteoarthritis have psychological difficulties associated with increasing pain and functional impairment. Psychological adjustment over time was attributed primarily to cognitive and attitudinal factors (e.g. stoicism, making downward comparisons and possessing specific notions about the cause of arthritis). This was a dynamic 'day to day' process involving a constant struggle between grieving physical losses and increasing dependence amidst symptom management. Conclusion The findings of this study add to the current understanding of the complex processes involved in psychological adjustment over time. Targeted interventions focused on assisting women with arthritis redefine self-concepts outside the confines of caring responsibilities, coupled with public health education programs around understanding the destructive nature of arthritis are required. Understanding the destructive and (potentially) preventable nature of arthritis may facilitate early detection and increased uptake of appropriate treatment options for osteoarthritis that have the ability to modify disease trajectories.	[Harris, Melissa L.; Byles, Julie E.; Sibbritt, David; Loxton, Deborah] Univ Newcastle, Fac Hlth & Med, Prior Res Ctr Gender Hlth & Ageing, Callaghan, NSW 2308, Australia; [Sibbritt, David] Univ Technol Sydney, Fac Hlth, Broadway, NSW, Australia	University of Newcastle; University of Technology Sydney	Harris, ML (corresponding author), Univ Newcastle, Fac Hlth & Med, Prior Res Ctr Gender Hlth & Ageing, Callaghan, NSW 2308, Australia.	Melissa.Harris@newcastle.edu.au	Byles, Julie E/C-5062-2008; Sibbritt, David W/F-8070-2017	Byles, Julie E/0000-0002-3984-6877; Sibbritt, David W/0000-0003-3561-9447	Australian Government Department of Health [G0189875]	Australian Government Department of Health(Australian GovernmentDepartment of Health & Ageing)	The Australian Longitudinal Study on Women's Health was funded by the Australian Government Department of Health (G0189875), http://www.health.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlmen M, 2005, RHEUMATOLOGY, V44, P105, DOI 10.1093/rheumatology/keh412; Ailinger R L, 1993, West J Nurs Res, V15, P340, DOI 10.1177/019394599301500306; Andrianakos AA, 2005, RHEUMATOLOGY, V44, P932, DOI 10.1093/rheumatology/keh650; Avci Dilek, 2004, Menopause, V11, P615, DOI 10.1097/01.GME.0000119985.45613.7E; Axford J, 2010, CLIN RHEUMATOL, V29, P1277, DOI 10.1007/s10067-010-1547-7; Badley Elizabeth M, 2004, BMC Womens Health, V4 Suppl 1, pS18, DOI 10.1186/1472-6874-4-S1-S18; Baird C L, 2000, Clin Excell Nurse Pract, V4, P231; Barlow JH, 1998, BRIT J RHEUMATOL, V37, P985; Bolen J., 2005, Morbidity and Mortality Weekly Report, V54, P119; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; BROWN GK, 1989, J CONSULT CLIN PSYCH, V57, P652, DOI 10.1037/0022-006X.57.5.652; Brown WJ, 1998, WOMEN HEALTH, V28, P23; Buckwalter JA, 2000, CLIN ORTHOP RELAT R, P159; Buckwalter JA, 2004, CLIN ORTHOP RELAT R, pS6, DOI 10.1097/01.blo.0000143938.30681.9d; Covic T, 2000, RHEUMATOLOGY, V39, P1027, DOI 10.1093/rheumatology/39.9.1027; Covinsky KE, 2008, J AM GERIATR SOC, V56, P23, DOI 10.1111/j.1532-5415.2007.01511.x; de Ridder D, 2008, LANCET, V372, P246, DOI 10.1016/S0140-6736(08)61078-8; Dickens C, 2002, PSYCHOSOM MED, V64, P52, DOI 10.1097/00006842-200201000-00008; Evers AWM, 2002, J RHEUMATOL, V29, P2327; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Francis JJ, 2010, PSYCHOL HEALTH, V25, P1229, DOI 10.1080/08870440903194015; Gignac MAM, 2006, ARTHRIT RHEUM-ARTHR, V55, P905, DOI 10.1002/art.22338; Gorevic PD, 2004, GERIATRICS-US, V59, P28; Gronning K, 2011, CLIN RHEUMATOL, V30, P1425, DOI 10.1007/s10067-011-1836-9; Harris ML, 2012, J PSYCHOSOM RES, V73, P251, DOI 10.1016/j.jpsychores.2012.06.009; HAWLEY DJ, 1993, J RHEUMATOL, V20, P2025; Iaquinta ML, 2004, J NURS CARE QUAL, V19, P280, DOI 10.1097/00001786-200407000-00016; KATZ PP, 1995, ARTHRITIS RHEUM, V38, P49, DOI 10.1002/art.1780380108; Kee CC, 1998, APPL NURS RES, V11, P19, DOI 10.1016/S0897-1897(98)80041-4; Kitto SC, 2008, MED J AUSTRALIA, V188, P243, DOI 10.5694/j.1326-5377.2008.tb01595.x; Lee C, 2005, INT J EPIDEMIOL, V34, P987, DOI 10.1093/ije/dyi098; Lincoln Y.S., 1985, NATURALISTIC ENQUIRY; Ling SM, 1998, J AM GERIATR SOC, V46, P216, DOI 10.1111/j.1532-5415.1998.tb02543.x; Lutze U, 2007, SCAND J CARING SCI, V21, P64, DOI 10.1111/j.1471-6712.2007.00443.x; Marks R., 2013, AM J MED STUD SCI ED, V1, P11, DOI [10.12691/ajms-1-3-1], DOI 10.12691/AJMS-1-3-1]; Martel-Pelletier J, 1999, OSTEOARTHR CARTILAGE, V7, P371, DOI 10.1053/joca.1998.0214; Melanson PM, 2003, J ADV NURS, V42, P125, DOI 10.1046/j.1365-2648.2003.02595.x; Melanson PM, 1995, ACT ADAPT AGING, V19, P33; Mengshoel AM, 2008, ARTHRIT RHEUM-ARTHR, V59, P1439, DOI 10.1002/art.24103; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Patton M, 2015, UTILIZATION FOCUSED, VFourth; Persson LO, 2005, SCAND J RHEUMATOL, V34, P191, DOI 10.1080/03009740510017698; Plach SK, 2004, J FAMILY NURS, V10, P33; Ramjeet J, 2005, RHEUMATOLOGY, V44, P1166, DOI 10.1093/rheumatology/keh699; Rosemann Thomas, 2007, J Orthop Surg Res, V2, P12, DOI 10.1186/1749-799X-2-12; Sharma L, 2006, CURR OPIN RHEUMATOL, V18, P147, DOI 10.1097/01.bor.0000209426.84775.f8; Sharpe L, 2001, J PSYCHOSOM RES, V51, P713, DOI 10.1016/S0022-3999(01)00266-5; Shih M, 2006, J GEN INTERN MED, V21, P1160, DOI 10.1111/j.1525-1497.2006.00573.x; Stamm T, 2008, QUAL HEALTH RES, V18, P658, DOI 10.1177/1049732308316348; Strauss A, 1990, BASICS QUALITATIVE R, DOI [10.1111/j.1365-2702.2009.02908.x, DOI 10.1111/J.1365-2702.2009.02908.X]; Sturgeon JA, 2010, CURR PAIN HEADACHE R, V14, P105, DOI 10.1007/s11916-010-0095-9; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Trivedi Madhukar H, 2004, Prim Care Companion J Clin Psychiatry, V6, P12; Turner AP, 2007, ARTHRIT RHEUM-ARTHR, V57, P267, DOI 10.1002/art.22537; Uhlig T, 2000, RHEUMATOLOGY, V39, P732, DOI 10.1093/rheumatology/39.7.732; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; *WHO SCI GROUP, 2003, WHO TECHN REP SER, V919; WILLIAMS G, 1984, SOCIOL HEALTH ILL, V6, P175, DOI 10.1111/1467-9566.ep10778250; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646; Yelin E, 1989, GERIATR MED TODAY, V8, P103	60	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120507	10.1371/journal.pone.0120507	http://dx.doi.org/10.1371/journal.pone.0120507			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7QC	25781471	gold, Green Published, Green Submitted			2022-12-27	WOS:000351284600170
J	Hung, N; Shen, CC; Hu, YW; Hu, LY; Yeh, CM; Teng, CJ; Kuan, AS; Chen, SC; Chen, TJ; Liu, CJ				Hung, Ning; Shen, Cheng-Che; Hu, Yu-Wen; Hu, Li-Yu; Yeh, Chiu-Mei; Teng, Chung-Jen; Kuan, Ai-Seon; Chen, San-Chi; Chen, Tzeng-Ji; Liu, Chia-Jen			Risk of Cancer in Patients with Iron Deficiency Anemia: A Nationwide Population-Based Study	PLOS ONE			English	Article							COLORECTAL-CANCER; GASTRIC ADENOCARCINOMA; SERUM FERRITIN; PREVALENCE; CARCINOGENICITY; ESOPHAGUS; OUTCOMES; STORES; CARDIA; WOMEN	Objective This study evaluated the risk of cancer among patients with iron deficiency anemia (IDA) by using a nationwide population-based data set. Method Patients newly diagnosed with IDA and without antecedent cancer between 2000 and 2010 were recruited from the Taiwan National Health Insurance Research Database. The standardized incidence ratios (SIRs) of cancer types among patients with IDA were calculated. Results Patients with IDA exhibited an increased overall cancer risk (SIR: 2.15). Subgroup analysis showed that patients of both sexes and in all age groups had an increased SIR. After we excluded patients diagnosed with cancer within the first and first 5 years of IDA diagnosis, the SIRs remained significantly elevated at 1.43 and 1.30, respectively. In addition, the risks of pancreatic (SIR: 2.31), kidney (SIR: 2.23), liver (SIR: 1.94), and bladder cancers (SIR: 1.74) remained significantly increased after exclusion of patients diagnosed with cancer within 5 years after IDA diagnosis. Conclusion The overall cancer risk was significantly elevated among patients with IDA. After we excluded patients diagnosed with IDA and cancer within 1 and 5 years, the SIRs remained significantly elevated compared with those of the general population. The increased risk of cancer was not confined to gastrointestinal cancer when the SIRs of pancreatic, kidney, liver, and bladder cancers significantly increased after exclusion of patients diagnosed with IDA and cancer within the first 5 years. This finding may be caused by immune activities altered by IDA. Further study is necessary to determine the association between IDA and cancer risk.	[Hung, Ning; Hu, Yu-Wen; Teng, Chung-Jen; Kuan, Ai-Seon; Liu, Chia-Jen] Kaohsiung Vet Gen Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Shen, Cheng-Che] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Shen, Cheng-Che] Taichung Vet Gen Hosp, Chiayi Branch, Dept Psychiat, Chiayi, Taiwan; [Hu, Yu-Wen] Natl Chung Cheng Univ, Dept Informat Magagement, Chiayi, Taiwan; [Hu, Yu-Wen; Teng, Chung-Jen; Chen, Tzeng-Ji; Liu, Chia-Jen] Taipei Vet Gen Hosp, Ctr Canc, Taipei, Taiwan; [Hu, Li-Yu] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Yeh, Chiu-Mei; Chen, Tzeng-Ji] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Teng, Chung-Jen] Far Eastern Mem Hosp, Dept Med, Div Hematol & Oncol, New Taipei City, Taiwan; [Chen, San-Chi; Liu, Chia-Jen] Taipei Vet Gen Hosp, Dept Med, Div Hematol & Oncol, Taipei, Taiwan	Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; National Chung Cheng University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Far Eastern Memorial Hospital; Taipei Veterans General Hospital	Liu, CJ (corresponding author), Kaohsiung Vet Gen Hosp, Dept Psychiat, Kaohsiung, Taiwan.	pures1000@yahoo.com.tw	Chen, TJ/AAH-8430-2021	Hu, Yu-Wen/0000-0002-7983-415X; Shen, Cheng-Che/0000-0003-1587-5590				AKIBA S, 1991, CANCER-AM CANCER SOC, V67, P1707, DOI 10.1002/1097-0142(19910315)67:6<1707::AID-CNCR2820670638>3.0.CO;2-C; Aslan M, 2006, MUTAT RES-FUND MOL M, V601, P144, DOI 10.1016/j.mrfmmm.2006.06.013; Atamna H, 2001, J BIOL CHEM, V276, P48410, DOI 10.1074/jbc.M108362200; Attia MA, 2009, INDIAN J HEMATOL BLO, V25, P70, DOI 10.1007/s12288-009-0017-3; Baan R, 2007, LANCET ONCOL, V8, P292, DOI 10.1016/S1470-2045(07)70099-2; Baker F, 2000, JAMA-J AM MED ASSOC, V284, P735, DOI 10.1001/jama.284.6.735; Beguin Y, 2014, CRIT REV ONCOL HEMAT, V89, P1, DOI 10.1016/j.critrevonc.2013.10.008; Bird CL, 1996, AM J EPIDEMIOL, V144, P34, DOI 10.1093/oxfordjournals.aje.a008852; Boffetta P, 2003, BRIT MED BULL, V68, P71, DOI 10.1093/bmp/ldg023; Cross AJ, 2006, INT J CANCER, V118, P3147, DOI 10.1002/ijc.21780; Das Indranil, 2014, J Nat Sci Biol Med, V5, P158, DOI 10.4103/0976-9668.127317; deBenoist B, 2008, WORLDWIDE PREVALENCE; Ekiz C, 2005, HEMATOL J, V5, P579, DOI 10.1038/sj.thj.6200574; Guralnik JM, 2004, BLOOD, V104, P2263, DOI 10.1182/blood-2004-05-1812; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harhaji L, 2004, CLIN EXP IMMUNOL, V137, P109, DOI 10.1111/j.1365-2249.2004.02515.x; Harrison LE, 1997, CANCER-AM CANCER SOC, V80, P1021; Haut ER, 2011, JAMA-J AM MED ASSOC, V305, P2462, DOI 10.1001/jama.2011.822; HERRINTON LJ, 1995, AM J EPIDEMIOL, V142, P692, DOI 10.1093/oxfordjournals.aje.a117698; Ioannou GN, 2002, AM J MED, V113, P276, DOI 10.1016/S0002-9343(02)01214-7; JAGADEESAN V, 1994, NUTR CANCER, V22, P285, DOI 10.1080/01635589409514354; Kabat GC, 2007, CANCER CAUSE CONTROL, V18, P1047, DOI 10.1007/s10552-007-9058-9; Kato I, 1999, INT J CANCER, V80, P693, DOI 10.1002/(SICI)1097-0215(19990301)80:5&lt;693::AID-IJC11&gt;3.0.CO;2-G; KNEKT P, 1994, INT J CANCER, V56, P379, DOI 10.1002/ijc.2910560315; Knight K, 2004, AM J MED, V116, P11, DOI 10.1016/j.amjmed.2003.12.008; Looker AC, 1997, JAMA-J AM MED ASSOC, V277, P973, DOI 10.1001/jama.277.12.973; Nakama H, 2000, INT J COLORECTAL DIS, V15, P271; Nelson RL, 2001, NUTR REV, V59, P140, DOI 10.1111/j.1753-4887.2001.tb07002.x; NOMURA A, 1992, CANCER EPIDEM BIOMAR, V1, P547; Payne CM, 2005, CANCER EPIDEM BIOMAR, V14, P2066, DOI 10.1158/1055-9965.EPI-05-0180; PRIME SS, 1983, BRIT J CANCER, V47, P413, DOI 10.1038/bjc.1983.62; Shirai T, 1997, CANCER RES, V57, P195; Stratton JF, 1998, BRIT J OBSTET GYNAEC, V105, P493, DOI 10.1111/j.1471-0528.1998.tb10148.x; Tang Yong-Mei, 2006, Wei Sheng Yan Jiu, V35, P79; Tatemichi M, 2005, CANCER LETT, V217, P197, DOI 10.1016/j.canlet.2004.09.002; Torti SV, 2013, NAT REV CANCER, V13, P342, DOI 10.1038/nrc3495; Ullman TA, 2011, GASTROENTEROLOGY, V140, P1807, DOI 10.1053/j.gastro.2011.01.057; Umbreit J, 2005, AM J HEMATOL, V78, P225, DOI 10.1002/ajh.20249; Vitale J J, 1977, Adv Exp Med Biol, V91, P229; Wang YP, 2012, CAN MED ASSOC J, V184, pE804, DOI 10.1503/cmaj.120518; Zhang ZF, 1997, NUTR CANCER, V27, P298, DOI 10.1080/01635589709514541; Zhang ZF, 1996, CANCER EPIDEM BIOMAR, V5, P761; Ziech D, 2011, MUTAT RES-FUND MOL M, V711, P167, DOI 10.1016/j.mrfmmm.2011.02.015	43	34	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119647	10.1371/journal.pone.0119647	http://dx.doi.org/10.1371/journal.pone.0119647			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781632	Green Submitted, Green Published, gold			2022-12-27	WOS:000351284600081
J	Lamikanra, AA; Merryweather-Clarke, AT; Tipping, AJ; Roberts, DJ				Lamikanra, Abigail A.; Merryweather-Clarke, Alison T.; Tipping, Alex J.; Roberts, David J.			Distinct Mechanisms of Inadequate Erythropoiesis Induced by Tumor Necrosis Factor Alpha or Malarial Pigment	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; MOLECULAR-MECHANISM; ANEMIA; EXPRESSION; CELLS; INTERLEUKIN-10; PROLIFERATION; TRANSCRIPTION; APOPTOSIS; SURVIVAL	The role of infection in erythropoietic dysfunction is poorly understood. In children with P. falciparum malaria, the by-product of hemoglobin digestion in infected red cells (hemozoin) is associated with the severity of anemia which is independent of circulating levels of the inflammatory cytokine tumor necrosis alpha (TNF-alpha). To gain insight into the common and specific effects of TNF-alpha and hemozoin on erythropoiesis, we studied the gene expression profile of purified primary erythroid cultures exposed to either TNF-alpha (10ng/ml) or to hemozoin (12.5 mu g/ml heme units) for 24 hours. Perturbed gene function was assessed using co-annotation of associated gene ontologies and expression of selected genes representative of the profile observed was confirmed by real time PCR (rtPCR). The changes in gene expression induced by each agent were largely distinct; many of the genes significantly modulated by TNF-alpha were not affected by hemozoin. The genes modulated by TNF-alpha were significantly enriched for those encoding proteins involved in the control of type 1 interferon signalling and the immune response to viral infection. In contrast, genes induced by hemozoin were significantly enriched for functional roles in regulation of transcription and apoptosis. Further analyses by rtPCR revealed that hemozoin increases expression of transcription factors that form part of the integrated stress response which is accompanied by reduced expression of genes involved in DNA repair. This study confirms that hemozoin induces cellular stress on erythroblasts that is additional to and distinct from responses to inflammatory cytokines and identifies new genes that may be involved in the pathogenesis of severe malarial anemia. More generally the respective transcription profiles highlight the varied mechanisms through which erythropoiesis may be disrupted during infectious disease.	[Lamikanra, Abigail A.; Merryweather-Clarke, Alison T.; Tipping, Alex J.; Roberts, David J.] Univ Oxford, Nuffield Div Clin Lab Sci, Oxford OX3 9BQ, England; [Lamikanra, Abigail A.; Merryweather-Clarke, Alison T.; Tipping, Alex J.; Roberts, David J.] John Radcliffe Hosp, Natl Hlth Serv Blood & Transplant, Oxford OX3 9BQ, England	University of Oxford; NHS Blood & Transplant (NHSBT); University of Oxford	Lamikanra, AA (corresponding author), Univ Oxford, Nuffield Div Clin Lab Sci, Oxford OX3 9BQ, England.	abigail.lamikanra@ndcls.ox.ac.uk	Lamikanra, Abigail/AAD-9603-2019		National Institute for Health Research (NIHR) [RP-PG-0310-1004]; National Institute for Health Research [RP-PG-0310-1004] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This article summarizes independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme (Grant Reference Number RP-PG-0310-1004). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.	ABDALLA S, 1980, BRIT J HAEMATOL, V46, P171, DOI 10.1111/j.1365-2141.1980.tb05956.x; ABDALLA SH, 1984, T ROY SOC TROP MED H, V78, P60, DOI 10.1016/0035-9203(84)90173-1; Aguilar R, 2014, BLOOD, V123, P959, DOI 10.1182/blood-2013-08-520767; [Anonymous], 2011, HUMAN ERYTHROBLAST M; Awandare GA, 2011, AM J HEMATOL, V86, P155, DOI 10.1002/ajh.21933; Bailis JM, 2004, CURR OPIN GENET DEV, V14, P17, DOI 10.1016/j.gde.2003.11.002; Betin VMS, 2013, AUTOPHAGY, V9, P881, DOI 10.4161/auto.24172; Blencowe BJ, 2003, CURR BIOL, V13, pR149, DOI 10.1016/S0960-9822(03)00079-4; Bohmer RM, 2004, STEM CELLS, V22, P216, DOI 10.1634/stemcells.22-2-216; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Bulinski JC, 2001, J CELL SCI, V114, P3885; Casals-Pascual C, 2006, BLOOD; Casals-Pascual C, 2012, HAEMATOL-HEMATOL J, V97, P1695, DOI 10.3324/haematol.2012.065854; DORMER P, 1983, BLUT, V46, P279, DOI 10.1007/BF00319868; Douglas NM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001575; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; FIBACH E, 1989, BLOOD, V73, P100; Giribaldi G, 2010, INFECT IMMUN, V78, P4912, DOI 10.1128/IAI.00455-10; GOLDIE P, 1990, AM J TROP MED HYG, V43, P584, DOI 10.4269/ajtmh.1990.43.584; GOODMAN JW, 1985, P NATL ACAD SCI USA, V82, P3291, DOI 10.1073/pnas.82.10.3291; Gordillo M, 2008, HUM MOL GENET, V17, P2172, DOI 10.1093/hmg/ddn116; Griffiths MJ, 2005, J INFECT DIS, V191, P1599, DOI 10.1086/429297; Grigorakaki C, 2011, BIOCHEM PHARMACOL, V82, P156, DOI 10.1016/j.bcp.2011.03.030; Hercus TR, 2009, BLOOD, V114, P1289, DOI 10.1182/blood-2008-12-164004; Inger L, 2004, METHODS MALARIA RES; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jesnowski R, 2002, PANCREATOLOGY, V2, P421, DOI 10.1159/000065091; Kim R, 2006, APOPTOSIS, V11, P5, DOI 10.1007/s10495-005-3088-0; Kurtzhals JAL, 1998, LANCET, V351, P1768, DOI 10.1016/S0140-6736(97)09439-7; Lamikanra AA, 2007, BLOOD, V110, P18, DOI 10.1182/blood-2006-09-018069; Lamikanra AA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008446; Lin MH, 2014, TOXICOLOGY, V315, P24, DOI 10.1016/j.tox.2013.11.007; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Menendez C, 2000, PARASITOL TODAY, V16, P469, DOI 10.1016/S0169-4758(00)01774-9; Merryweather-Clarke AT, 2011, BLOOD, V117, pE96, DOI 10.1182/blood-2010-07-290825; Monnich M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020051; Morceau F, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/405016; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; Okiro EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062214; Othoro C, 1999, J INFECT DIS, V179, P279, DOI 10.1086/314548; Pagola S, 2000, NATURE, V404, P307, DOI 10.1038/35005132; Papadaki HA, 2002, BLOOD, V100, P474, DOI 10.1182/blood-2002-01-0136; PHILLIPS RE, 1992, BAILLIERE CLIN HAEM, V5, P315, DOI 10.1016/S0950-3536(11)80022-3; Portugal S, 2011, NAT MED, V17, P732, DOI 10.1038/nm.2368; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; RUSTEN LS, 1995, BLOOD, V85, P989, DOI 10.1182/blood.V85.4.989.bloodjournal854989; Schrimpe AC, 2009, CHEM RES TOXICOL, V22, P433, DOI 10.1021/tx8002752; Schwarzer E, 2003, BLOOD, V101, P722, DOI 10.1182/blood-2002-03-0979; Scian MJ, 2008, ONCOGENE, V27, P2583, DOI 10.1038/sj.onc.1210898; Sexton AC, 2004, J INFECT DIS, V189, P1245, DOI 10.1086/382596; Skorokhod OA, 2010, BLOOD, V116, P4328, DOI 10.1182/blood-2010-03-272781; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Sullivan DJ, 1996, P NATL ACAD SCI USA, V93, P11865, DOI 10.1073/pnas.93.21.11865; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; Tamez PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019307; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Ubeda M, 1999, MOL CELL BIOL, V19, P7589; Unal E, 2007, SCIENCE, V317, P245, DOI 10.1126/science.1140637; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Weatherall David J, 2002, Hematology Am Soc Hematol Educ Program, P35; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Zhang L, 2003, NAT BIOTECHNOL, V21, P818, DOI 10.1038/nbt836; Zhou YD, 2012, HUM MOL GENET, V21, P196, DOI 10.1093/hmg/ddr454	63	15	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119836	10.1371/journal.pone.0119836	http://dx.doi.org/10.1371/journal.pone.0119836			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781011	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600097
J	Ptak, A; Bedford, MR; Swiatkiewicz, S; Zyla, K; Jozefiak, D				Ptak, Anna; Bedford, Michael R.; Swiatkiewicz, Sylwester; Zyla, Krzysztof; Jozefiak, Damian			Phytase Modulates Ileal Microbiota and Enhances Growth Performance of the Broiler Chickens	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; RNA-TARGETED PROBES; ORGANIC-ACID BLEND; DIETARY CALCIUM; OLIGONUCLEOTIDE PROBES; GASTROINTESTINAL-TRACT; PHOSPHORUS HYDROLYSIS; BINDING CAPACITY; BACTERIA; PIGS	Phytase is well studied and explored, however, little is known about its effects on the microbial ecology of the gastrointestinal tract. In total, 400 one-day-old female Ross 308 chicks were randomly distributed to four experimental groups. The dietary treatments were arranged as a 2 x 2 complete factorial design, with the factors being adequate (PC) or insufficient calcium (Ca) and digestible phosphor (dP)(NC) and with or without 5000 phytase units (FTU)/kg of Escherichia coli 6-phytase. The gastrointestinal tract pH values, ileal microbial communities and short-chain fatty acid concentrations in the digesta were determined. The reduction in Ca and dP concentration significantly affected pH in the crop and caeca, and addition of phytase to the NC resulted in a pH increase in the ileum. The reduction in Ca and dP concentration significantly lowered, while phytase supplementation increased ileal total bacterial counts. Additionally, the deficient diet reduced butyrate-but increased lactate-producing bacteria. The addition of phytase increased Lactobacillus sp./Enterococcus sp. whereas in case of Clostridium leptum subgroup, Clostridium coccoides -Eubacterium rectale cluster, Bifidobacterium sp. and Streptococcus/Lactococcus counts, a significant Ca and dP level x phytase interaction was found. However, the recorded interactions indicated that the effects of phytase and Ca and dP levels were not consistent. Furthermore, the reduction of Ca and dP level lowered Clostridium perfringens and Enterobacteriaceae counts. The analysis of fermentation products showed that reducing the Ca and dP content in the diet reduced total SCFA, DL-lactate, and acetic acid in the ileum whereas phytase increased concentrations of these acids in the NC group. This suggests that P is a factor which limits fermentation in the ileum. It may be concluded that phytase plays a role in modulating the gut microbiota of chicken, however, this is clearly linked with the levels of P and Ca in a diet.	[Ptak, Anna] PIAST GRP Res & Dev Ctr, Ostrow Wielkopolski, Poland; [Bedford, Michael R.] AB Vista Feed Ingredients, Marlborough, MA USA; [Swiatkiewicz, Sylwester] Natl Res Inst Anim Prod, Dept Anim Nutr & Feed Sci, Balice, Poland; [Zyla, Krzysztof] Univ Agr, Dept Food Biotechnol, Krakow, Poland; [Jozefiak, Damian] Poznan Univ Life Sci, Dept Anim Nutr & Feed Management, Poznan, Poland	National Research Institute of Animal Production; Agricultural University Krakow; Poznan University of Life Sciences	Jozefiak, D (corresponding author), Poznan Univ Life Sci, Dept Anim Nutr & Feed Management, Poznan, Poland.	damjo@up.poznan.pl	Swiatkiewicz, Sylwester/H-4807-2011; Swiatkiewicz, Sylwester/O-9967-2019; Bedford, Michael/AAV-8204-2020; Swiatkiewicz, Sylwester/K-1623-2019	Swiatkiewicz, Sylwester/0000-0001-8330-2159; Bedford, Michael/0000-0002-5308-4290; Swiatkiewicz, Sylwester/0000-0001-8330-2159; Jozefiak, Damian/0000-0002-6606-7975	AB Vista Feed Ingredients	AB Vista Feed Ingredients	AB Vista Feed Ingredients provided support in the form of a salary for author MRB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Akyurek H, 2011, AFR J AGR RES, V6, P642; BoveeOudenhoven IMJ, 1997, GUT, V40, P497, DOI 10.1136/gut.40.4.497; Cowieson AJ, 2013, POULTRY SCI, V92, P2124, DOI 10.3382/ps.2013-03140; Cowieson AJ, 2009, WORLD POULTRY SCI J, V65, P401, DOI 10.1017/S0043933909000294; De Kort E, 2009, DAIRY SCI TECHNOL, V89, P283, DOI 10.1051/dst/2009008; DURAND M, 1988, J NUTR, V118, P249, DOI 10.1093/jn/118.2.249; Fallani M, 2006, J MICROBIOL METH, V67, P150, DOI 10.1016/j.mimet.2006.03.010; FLOOR MK, 1991, J NUTR, V121, P863, DOI 10.1093/jn/121.6.863; Franks AH, 1998, APPL ENVIRON MICROB, V64, P3336; Geesey GG, 2000, BIOFOULING, V15, P195, DOI 10.1080/08927010009386310; Ghorbani M. R., 2009, Research Journal of Biological Sciences, V4, P258; Giannenas I, 2014, ASIAN AUSTRAL J ANIM, V27, P225, DOI 10.5713/ajas.2013.13376; Griminger P., 1976, Avian physiology,, P233; GUINOTTE F, 1995, BRIT J NUTR, V73, P125, DOI 10.1079/BJN19950014; Harmsen HJM, 1999, MICROB ECOL HEALTH D, V11, P3, DOI DOI 10.1080/089106099435862; Jozefiak D, 2010, POULTRY SCI, V89, P1939, DOI 10.3382/ps.2010-00694; Jozefiak D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085347; KOMISARCZUK S, 1987, BRIT J NUTR, V57, P279, DOI 10.1079/BJN19870033; Lan Y, 2005, WORLD POULTRY SCI J, V61, P95, DOI 10.1079/WPS200445; LANGENDIJK PS, 1995, APPL ENVIRON MICROB, V61, P3069, DOI 10.1128/AEM.61.8.3069-3075.1995; Larsen N, 2007, INT J FOOD MICROBIOL, V114, P113, DOI 10.1016/j.ijfoodmicro.2006.10.033; Lawlor PG, 2005, IRISH VET J, V58, P447, DOI 10.1186/2046-0481-58-8-447; MANZ W, 1993, APPL ENVIRON MICROB, V59, P2293, DOI 10.1128/AEM.59.7.2293-2298.1993; Manz W, 1996, MICROBIOL-SGM, V142, P1097, DOI 10.1099/13500872-142-5-1097; McDonald M. W., 1964, P AUSTR POULR SCI CO, P112; Metzler BU, 2008, J ANIM SCI, V86, P1544, DOI 10.2527/jas.2007-0267; Metzler-Zebeli BU, 2010, J ANIM SCI, V88, P147, DOI 10.2527/jas.2008-1560; Metzler-Zebeli BU, 2011, FEMS MICROBIOL ECOL, V75, P402, DOI 10.1111/j.1574-6941.2010.01017.x; Mroz Z., 2006, Biology of nutrition in growing animals, P81, DOI 10.1016/S1877-1823(09)70091-8; Nourmohammadi R., 2011, AM J ANIM VET SCI, V6, P1, DOI DOI 10.3844/AJAYSP.2011.1.6; Perry GC, 2006, AVIAN GUT FUNCTION H, P124, DOI [10.3389/fimmu.2014.00482, DOI 10.3389/FIMMU.2014.00482]; Ptak A, 2013, ARCH TIERZUCHT, V56, P1028, DOI 10.7482/0003-9438-56-104; Radcliffe JS, 1998, J ANIM SCI, V76, P1880; SAS Institute, 1990, SAS US GUID STAT VER; Selle PH, 2008, LIVEST SCI, V113, P99, DOI 10.1016/j.livsci.2007.05.014; Selle PH, 2007, ANIM FEED SCI TECH, V135, P1, DOI 10.1016/j.anifeedsci.2006.06.010; Sghir A, 2000, APPL ENVIRON MICROB, V66, P2263, DOI 10.1128/AEM.66.5.2263-2266.2000; Sghir A, 1998, SYST APPL MICROBIOL, V21, P291, DOI 10.1016/S0723-2020(98)80036-2; SHAFEY TM, 1991, BRIT POULTRY SCI, V32, P185, DOI 10.1080/00071669108417339; Slominski B.A., 1991, P 8 INT RAP C SASK S, P1402; Smulikowska S, 2006, J ANIM FEED SCI, V15, P237, DOI 10.22358/jafs/66896/2006; Smulikowska S, 2010, J ANIM PHYSIOL AN N, V94, P15, DOI 10.1111/j.1439-0396.2008.00876.x; Tamim NM, 2004, POULTRY SCI, V83, P1358, DOI 10.1093/ps/83.8.1358; Tamim NM, 2003, J AGR FOOD CHEM, V51, P4687, DOI 10.1021/jf034122x; Ten Bruggencate SJM, 2004, GUT, V53, P530, DOI 10.1136/gut.2003.023499; Walk CL, 2013, POULTRY SCI, V92, P719, DOI 10.3382/ps.2012-02727; Walk CL, 2012, POULTRY SCI, V91, P1371, DOI 10.3382/ps.2011-01928	47	58	63	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119770	10.1371/journal.pone.0119770	http://dx.doi.org/10.1371/journal.pone.0119770			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781608	Green Submitted, Green Published, gold			2022-12-27	WOS:000351284600091
J	Rose, NH; Halitschke, R; Morse, DH				Rose, Noah H.; Halitschke, Rayko; Morse, Douglass H.			Tri-Trophic Effects of Seasonally Variable Induced Plant Defenses Vary across the Development of a Shelter Building Moth Larva and Its Parasitoid	PLOS ONE			English	Article							HOST; STRATEGIES; HERBIVORES; ECOLOGY; WASPS; MANIPULATION; MECHANISMS; COMPLEXITY; HYPOTHESIS; BEHAVIOR	Plant chemical defenses can negatively affect insect herbivore fitness, but they can also decrease herbivore palatability to predators or decrease parasitoid fitness, potentially changing selective pressures on both plant investment in production of chemical defenses and host feeding behavior. Larvae of the fern moth Herpetogramma theseusalis live in and feed upon leaf shelters of their own construction, and their most abundant parasitoid Alabagrus texanus oviposits in early instar larvae, where parasitoid larvae lay dormant for most of host development before rapidly developing and emerging just prior to host pupation. As such, both might be expected to live in a relatively constant chemical environment. Instead, we find that a correlated set of phenolic compounds shows strong seasonal variation both within shelters and in undamaged fern tissue, and the relative level of these compounds in these two different fern tissue types switches across the summer. Using experimental feeding treatments, in which we exposed fern moth larvae to different chemical trajectories across their development, we show that exposure to this set of phenolic compounds reduces the survival of larvae in early development. However, exposure to this set of compounds just before the beginning of explosive parasitoid growth increased parasitoid survival. Exposure during the period of rapid parasitoid growth and feeding decreased parasitoid survival. These results highlight the spatial and temporal complexity of leaf shelter chemistry, and demonstrate the developmental contingency of associated effects on both host and parasitoid, implying the existence of complex selective pressures on plant investment in chemical defenses, host feeding behavior, and parasitoid life history.	[Rose, Noah H.; Morse, Douglass H.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Halitschke, Rayko] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA	Brown University; Cornell University	Morse, DH (corresponding author), Brown Univ, Dept Ecol & Evolutionary Biol, Box G-W, Providence, RI 02912 USA.	d_morse@brown.edu	Halitschke, Rayko/AAY-2365-2020	Halitschke, Rayko/0000-0002-1109-8782; Rose, Noah/0000-0001-7129-4753	Undergraduate Teaching and Research Assistantship (UTRA) fellowship from Brown University	Undergraduate Teaching and Research Assistantship (UTRA) fellowship from Brown University	NHR was supported by an Undergraduate Teaching and Research Assistantship (UTRA) fellowship from Brown University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2000, CURR OPIN PLANT BIOL, V3, P329, DOI 10.1016/S1369-5266(00)00089-3; Agrawal AA, 2011, FUNCT ECOL, V25, P420, DOI 10.1111/j.1365-2435.2010.01796.x; Baldwin IT, 1999, PLANTA, V208, P137, DOI 10.1007/s004250050543; Ballhorn DJ, 2011, J ECOL, V99, P313, DOI 10.1111/j.1365-2745.2010.01747.x; BENNETT RN, 1994, NEW PHYTOL, V127, P617, DOI 10.1111/j.1469-8137.1994.tb02968.x; Benrey B, 1997, ECOLOGY, V78, P987, DOI 10.2307/2265852; Bukovinszky T, 2009, OECOLOGIA, V160, P299, DOI 10.1007/s00442-009-1308-y; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Fukui Akiko, 2002, Entomological Science, V5, P263; Harvey JA, 2005, ENTOMOL EXP APPL, V117, P1, DOI 10.1111/j.1570-7458.2005.00348.x; Harvey JA, 2000, OIKOS, V88, P621, DOI 10.1034/j.1600-0706.2000.880319.x; Harvey JA, 2002, ECOLOGY, V83, P2439, DOI 10.1890/0012-9658(2002)083[2439:TDSOEW]2.0.CO;2; HARVEY JA, 1995, ENTOMOL EXP APPL, V75, P213, DOI 10.1007/BF02382255; Hunter MD, 2003, AGR FOREST ENTOMOL, V5, P1, DOI 10.1046/j.1461-9563.2003.00168.x; Jervis MA, 2008, ANNU REV ENTOMOL, V53, P361, DOI 10.1146/annurev.ento.53.103106.093433; Kaplan I, 2007, OECOLOGIA, V152, P665, DOI 10.1007/s00442-007-0692-4; Keinanen M, 2001, J AGR FOOD CHEM, V49, P3553, DOI 10.1021/jf010200+; Libersat F, 2009, ANNU REV ENTOMOL, V54, P189, DOI 10.1146/annurev.ento.54.110807.090556; Lind JT, 2007, ENTOMOLOGIA EXPT APP, V124, P45; Malcolm SB, 1996, ENTOMOL EXP APPL, V80, P193, DOI 10.1007/BF00194755; Matsuki S, 2004, ANN BOT-LONDON, V93, P141, DOI 10.1093/aob/mch022; Mithofer A, 2012, ANNU REV PLANT BIOL, V63, P431, DOI 10.1146/annurev-arplant-042110-103854; Morse DH, 2011, AM MIDL NAT, V166, P252, DOI 10.1674/0003-0031-166.2.252; Morse DH, 2009, ECOL ENTOMOL, V34, P246, DOI 10.1111/j.1365-2311.2008.01073.x; Ode PJ, 2006, ANNU REV ENTOMOL, V51, P163, DOI 10.1146/annurev.ento.51.110104.151110; R Development Core Team, 2012, R LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; SAGERS CL, 1992, FUNCT ECOL, V6, P741, DOI 10.2307/2389971; SEQUEIRA R, 1994, ENTOMOL EXP APPL, V71, P15, DOI 10.1007/BF02380565	28	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120769	10.1371/journal.pone.0120769	http://dx.doi.org/10.1371/journal.pone.0120769			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781029	gold, Green Published, Green Submitted			2022-12-27	WOS:000351284600187
J	Wang, L; Jiang, YL; Zhang, JR; Zhou, CZ; Chen, YX				Wang, Lei; Jiang, Yong-Liang; Zhang, Jing-Ren; Zhou, Cong-Zhao; Chen, Yuxing			Structural and Enzymatic Characterization of the Choline Kinase LicA from Streptococcus pneumoniae	PLOS ONE			English	Article							NUTRITIONAL-REQUIREMENTS; LIPOTEICHOIC ACID; PHOSPHOCHOLINE; SEQUENCE; GENE; PROTEINS	LicA plays a key role in the cell-wall phosphorylcholine biosynthesis of Streptococcus pneumonia. Here we determined the crystal structures of apo-form LicA at 1.94 angstrom and two complex forms LicA-choline and LicA-AMP-MES, at 2.01 and 1.45 angstrom resolution, respectively. The overall structure adopts a canonical protein kinase-like fold, with the active site located in the crevice of the N-and C-terminal domains. The three structures present distinct poses of the active site, which undergoes an open-closed-open conformational change upon substrate binding and product release. The structure analyses combined with mutageneses and enzymatic assays enabled us to figure out the key residues for the choline kinase activity of LicA. In addition, structural comparison revealed the loop between helices alpha 7 and alpha 8 might modulate the substrate specificity and catalytic activity. These findings shed light on the structure and mechanism of the prokaryotic choline kinase LicA, and might direct the rational design of novel anti-pneumococcal drugs.	[Wang, Lei; Jiang, Yong-Liang; Zhou, Cong-Zhao; Chen, Yuxing] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Wang, Lei; Jiang, Yong-Liang; Zhou, Cong-Zhao; Chen, Yuxing] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Zhang, Jing-Ren] Tsinghua Univ, Ctr Infect Dis Res, Sch Med, Beijing 100084, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Tsinghua University	Jiang, YL (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China.	jyl@mail.ustc.edu.cn; cyxing@ustc.edu.cn	Chen, Yuxing/P-4156-2014; Zhou, Cong-Zhao/E-9174-2011; Wang, Lei/AAA-1917-2020	Chen, Yuxing/0000-0002-7560-1922; Zhou, Cong-Zhao/0000-0002-6881-7151; Wang, Lei/0000-0002-3024-8627; Jiang, YongLiang/0000-0001-5441-4936	National Natural Science Foundation of China [31470739, 31270781, 31400628, U1332114]; Research Fund for the Doctoral Program of Higher Education [20123402110004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP))	This work was supported by the National Natural Science Foundation of China (Grant No. 31470739, 31270781, 31400628 and U1332114: http://www.nsfc.gov.cn/) and the Research Fund for the Doctoral Program of Higher Education (Grant No. 20123402110004: http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Badger E, 1944, J BACTERIOL, V47, P509, DOI 10.1128/JB.47.6.509-518.1944; Baur S, 2009, J BACTERIOL, V191, P1200, DOI 10.1128/JB.01120-08; BRENNER S, 1987, NATURE, V329, P21, DOI 10.1038/329021a0; BRIESE T, 1985, EUR J BIOCHEM, V146, P417, DOI 10.1111/j.1432-1033.1985.tb08668.x; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Damjanovic M, 2007, J BACTERIOL, V189, P7105, DOI 10.1128/JB.00681-07; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Eberhardt A, 2009, MOL MICROBIOL, V74, P395, DOI 10.1111/j.1365-2958.2009.06872.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fagone P, 2013, BBA-MOL CELL BIOL L, V1831, P523, DOI 10.1016/j.bbalip.2012.09.009; Fischer W, 2000, RES MICROBIOL, V151, P421, DOI 10.1016/S0923-2508(00)00174-1; Gibellini F, 2008, BIOCHEM J, V415, P135, DOI 10.1042/BJ20080435; Gisch N, 2013, J BIOL CHEM, V288, P15654, DOI 10.1074/jbc.M112.446963; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Hao Q, 2000, J APPL CRYSTALLOGR, V33, P980, DOI 10.1107/S0021889800001424; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hong BS, 2010, J BIOL CHEM, V285, P16330, DOI 10.1074/jbc.M109.039024; Hudson CS, 2013, BBA-PROTEINS PROTEOM, V1834, P1107, DOI 10.1016/j.bbapap.2013.02.008; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kim KH, 1998, J BIOL CHEM, V273, P6844, DOI 10.1074/jbc.273.12.6844; Kinoshita K, 1999, PROTEIN ENG, V12, P11, DOI 10.1093/protein/12.1.11; Kwak BY, 2002, J BIOL CHEM, V277, P4343, DOI 10.1074/jbc.M109163200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liao HN, 2006, BBA-MOL CELL BIOL L, V1761, P111, DOI 10.1016/j.bbalip.2006.01.005; Lu L, 2008, J IMMUNOL, V181, P7138, DOI 10.4049/jimmunol.181.10.7138; Malito E, 2006, J MOL BIOL, V364, P136, DOI 10.1016/j.jmb.2006.08.084; Mellroth P, 2014, MBIO, V5, DOI 10.1128/mBio.01120-13; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peisach D, 2003, STRUCTURE, V11, P703, DOI 10.1016/S0969-2126(03)00094-7; Qiu W, 2010, CRYSTAL STRUCTURE CH; Rane L, 1940, J BACTERIOL, V40, P695, DOI 10.1128/JB.40.5.695-704.1940; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Scott JAG, 2008, J CLIN INVEST, V118, P1291, DOI 10.1172/JCI33947; Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6; Serino L, 2002, MOL MICROBIOL, V43, P437, DOI 10.1046/j.1365-2958.2002.02755.x; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Wernimont AK, 2009, CRYSTAL STRUCTURE CH; Wernimont AK, 2008, CRYSTAL STRUCTURE PL; Young NM, 2013, MOL IMMUNOL, V56, P563, DOI 10.1016/j.molimm.2013.05.237; Yuan C, 2004, J BIOL CHEM, V279, P17801, DOI 10.1074/jbc.M401382200; Zhang JR, 1999, MOL MICROBIOL, V31, P1477, DOI 10.1046/j.1365-2958.1999.01291.x	46	7	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120467	10.1371/journal.pone.0120467	http://dx.doi.org/10.1371/journal.pone.0120467			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781969	gold, Green Published, Green Submitted			2022-12-27	WOS:000351284600164
J	Zheng, X; Li, AS; Zheng, HY; Zhao, DM; Guan, DG; Zou, HW				Zheng, Xu; Li, Allison S.; Zheng, Huanyu; Zhao, Dongmei; Guan, Dagang; Zou, Huawei			Different Associations of CD45 Isoforms with STAT3, PKC and ERK Regulate IL-6-Induced Proliferation in Myeloma	PLOS ONE			English	Article							TYROSINE-PHOSPHATASE CD45; CELL ANTIGEN RECEPTOR; NF-KAPPA-B; MULTIPLE-MYELOMA; LIPID RAFTS; IN-VITRO; LYMPHOCYTE-ACTIVATION; SIGNAL-TRANSDUCTION; MEMBRANE RAFTS; T-LYMPHOCYTES	In response to interleukin 6 (IL-6) stimulation, both CD45RO and CD45RB, but not CD45RA, translocate to lipid rafts. However, the significance of this distinct translocation and the downstream signals in CD45 isoforms-participated IL-6 signal are not well understood. Using sucrose fractionation, we found that phosphorylated signal transducer and activator of transcription (STAT) 3 and STAT1 were mainly localized in lipid rafts in response to IL-6 stimulation, despite both STAT3 and STAT1 localizing in raft and non-raft fractions in the presence or absence of IL-6. On the other hand, extracellular signal-regulated kinase (ERK), and phosphorylated ERK were localized in non-raft fractions regardless of the existence of IL-6. The rafts inhibitor significantly impeded the phosphorylation of STAT3 and STAT1 and nuclear translocation, but had little effect on (and only postponing) the phosphorylation of ERK. This data suggests that lipid raft-dependent STAT3 and STAT1 pathways are dominant pathways of IL-6 signal in myeloma cells. Interestingly, the phosphorylation level of STAT3 but not STAT1 in CD45(+) cells was significantly higher compared to that of CD45-cells, while the phosphorylation level of ERK in CD45(+) myeloma cells was relatively low. Furthermore, exogenously expressed CD45RO/RB significantly enhanced STAT3, protein kinase C (PKC) and downstream NF-kappa B activation; however, CD45RA/RB inhibited IL-6-induced ERK phosphorylation. CD45 also enhanced the nuclear localization of STAT3 but not that of STAT1. In response to IL-6 stimulation, CD45RO moved into raft compartments and formed a complex with STAT3 and PKC in raft fraction, while CD45RA remained outside of lipid rafts and formed a complex with ERK in non-raft fraction. This data suggests a different role of CD45 isoforms in IL-6-induced signaling, indicating that while CD45RA/RB seems inhibit the rafts-unrelated ERK pathway, CD45RO/RB may actually work to enhance the rafts-related STAT3 and PKC/NF-kappa B pathways.	[Zheng, Xu; Zhao, Dongmei; Guan, Dagang; Zou, Huawei] China Med Univ, ShengJing Hosp, Dept Oncol, Shenyang 110001, Liaoning, Peoples R China; [Li, Allison S.] Harvard Univ, Cambridge, MA 02138 USA; [Zheng, Huanyu] He Univ, Shenyang, Liaoning, Peoples R China	China Medical University; Harvard University	Zheng, X (corresponding author), China Med Univ, ShengJing Hosp, Dept Oncol, Shenyang 110001, Liaoning, Peoples R China.	zhengx@sj-hospital.org		Zheng, Xu/0000-0002-4185-9765	National Natural Science Foundation of China (NSFC) [81101487]; Specialized Research Fund for the Doctoral Program of Higher Education of China (SRFDP) [20102104120014]; Scientific Research Foundation for the Returned Overseas Chinese Scholars; State Education Ministry [2011508]; Scientific Research Fund of Liaoning Provincial Education Department [L2010640]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China (SRFDP)(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Scientific Research Foundation for the Returned Overseas Chinese Scholars(Scientific Research Foundation for the Returned Overseas Chinese Scholars); State Education Ministry; Scientific Research Fund of Liaoning Provincial Education Department	This work was supported by National Natural Science Foundation of China (NSFC) (Grants 81101487; X. Z.), Specialized Research Fund for the Doctoral Program of Higher Education of China (SRFDP) (Grants 20102104120014; X. Z.), Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (Grants 2011508; X. Z.). A Project Supported by Scientific Research Fund of Liaoning Provincial Education Department (Grants L2010640; X. Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abroun S, 2008, BRIT J HAEMATOL, V142, P754, DOI 10.1111/j.1365-2141.2008.07252.x; Blank N, 2001, J IMMUNOL, V166, P6034, DOI 10.4049/jimmunol.166.10.6034; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Chatterjee M, 2004, BLOOD, V104, P3712, DOI 10.1182/blood-2004-04-1670; CONLON K, 1995, EUR J IMMUNOL, V25, P644, DOI 10.1002/eji.1830250303; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; DIANZANI U, 1992, EUR J IMMUNOL, V22, P365, DOI 10.1002/eji.1830220212; Dornan S, 2002, J BIOL CHEM, V277, P1912, DOI 10.1074/jbc.M108386200; Edmonds SD, 2002, J IMMUNOL, V169, P5036, DOI 10.4049/jimmunol.169.9.5036; FERRER JM, 1992, CELL IMMUNOL, V141, P10, DOI 10.1016/0008-8749(92)90123-7; Fischer C, 2005, J BIOL CHEM, V280, P37266, DOI 10.1074/jbc.M411580200; Freiberg BA, 2002, NAT IMMUNOL, V3, P911, DOI 10.1038/ni836; Fujii R, 1999, BRIT J HAEMATOL, V105, P131, DOI 10.1046/j.1365-2141.1999.01281.x; Galbiati F, 2001, CELL, V106, P403, DOI 10.1016/S0092-8674(01)00472-X; Galliher AJ, 2007, CANCER RES, V67, P3752, DOI 10.1158/0008-5472.CAN-06-3851; Giancotti FG, 2003, ANNU REV CELL DEV BI, V19, P173, DOI 10.1146/annurev.cellbio.19.031103.133334; Grotzinger J, 1999, BIOL CHEM, V380, P803, DOI 10.1515/BC.1999.100; Gupta N, 2003, MOL BIOL CELL, V14, P432, DOI 10.1091/mbc.02-05-0078; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Hallek M, 1998, BLOOD, V91, P3, DOI 10.1182/blood.V91.1.3.3_3_21; HATA H, 1994, LEUKEMIA, V8, P1768; Hayashi T, 2002, MOL CANCER THER, V1, P851; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Hideshima T, 2004, BLOOD, V104, P607, DOI 10.1182/blood-2004-01-0037; Hryniewicz-Jankowska A, 2014, BBA-REV CANCER, V1845, P155, DOI 10.1016/j.bbcan.2014.01.006; Hsia CY, 2002, INT IMMUNOL, V14, P905, DOI 10.1093/intimm/dxf055; IHLE JN, 1994, TRENDS BIOCHEM SCI, V19, P222, DOI 10.1016/0968-0004(94)90026-4; Irie-Sasaki J, 2001, NATURE, V409, P349, DOI 10.1038/35053086; Ishikawa H, 2002, BLOOD, V99, P2172, DOI 10.1182/blood.V99.6.2172; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; KAWANO M, 1988, NATURE, V332, P83, DOI 10.1038/332083a0; KLEIN B, 1989, BLOOD, V73, P517; Kretzschmar AK, 2004, BIOCHEM J, V377, P289, DOI 10.1042/BJ20030708; Kucharczak J, 2003, ONCOGENE, V22, P8961, DOI 10.1038/sj.onc.1207230; Li FJ, 2005, BLOOD, V105, P3295, DOI 10.1182/blood-2004-10-4083; Liu S, 2006, ONCOGENE, V25, P419, DOI 10.1038/sj.onc.1208982; Mahmoud MS, 1998, BLOOD, V92, P3887, DOI 10.1182/blood.V92.10.3887.422a48_3887_3897; Mitani Y, 2001, GENES CELLS, V6, P631, DOI 10.1046/j.1365-2443.2001.00448.x; Mollinedo F, 2010, ONCOGENE, V29, P3748, DOI 10.1038/onc.2010.131; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Nam HJ, 2005, J EXP MED, V201, P441, DOI 10.1084/jem.20041890; NOVAK TJ, 1994, IMMUNITY, V1, P109, DOI 10.1016/1074-7613(94)90104-X; Ogata A, 1997, J IMMUNOL, V159, P2212; Patra SK, 2008, BBA-REV CANCER, V1785, P182, DOI 10.1016/j.bbcan.2007.11.002; Penninger JM, 2001, NAT IMMUNOL, V2, P389, DOI 10.1038/87687; Petricoin EF, 1997, NATURE, V390, P629, DOI 10.1038/37648; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Ramakrishnan V, 2010, AM J HEMATOL, V85, P675, DOI 10.1002/ajh.21785; ROBINSON AT, 1993, EUR J IMMUNOL, V23, P61, DOI 10.1002/eji.1830230111; Santos SCR, 2007, EXP CELL RES, V313, P1561, DOI 10.1016/j.yexcr.2007.02.020; Rowley M, 2002, ONCOGENE, V21, P8769, DOI 10.1038/sj.onc.1205387; Sadahira K, 2014, INT J ONCOL, V45, P2278, DOI 10.3892/ijo.2014.2652; Schneider U, 1997, BRIT J HAEMATOL, V97, P56, DOI 10.1046/j.1365-2141.1997.d01-2115.x; Sehgal PB, 2002, J BIOL CHEM, V277, P12067, DOI 10.1074/jbc.M200018200; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Siveen KS, 2014, BBA-REV CANCER, V1845, P136, DOI 10.1016/j.bbcan.2013.12.005; TORIMOTO Y, 1992, CELL IMMUNOL, V145, P111, DOI 10.1016/0008-8749(92)90317-I; TROWBRIDGE IS, 1994, ANNU REV IMMUNOL, V12, P85, DOI 10.1146/annurev.iy.12.040194.000505; Weintraub BC, 2000, J EXP MED, V191, P1443, DOI 10.1084/jem.191.8.1443	59	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119780	10.1371/journal.pone.0119780	http://dx.doi.org/10.1371/journal.pone.0119780			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781885	Green Submitted, gold, Green Published			2022-12-27	WOS:000351284600092
J	Arevalo-Herrera, M; Vallejo, AF; Rubiano, K; Solarte, Y; Marin, C; Castellanos, A; Cespedes, N; Herrera, S				Arevalo-Herrera, Myriam; Vallejo, Andres F.; Rubiano, Kelly; Solarte, Yezid; Marin, Catherin; Castellanos, Angelica; Cespedes, Nora; Herrera, Socrates			Recombinant Pvs48/45 Antigen Expressed in E-coli Generates Antibodies that Block Malaria Transmission in Anopheles albimanus Mosquitoes	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM TRANSMISSION; MONOCLONAL-ANTIBODIES; VIVAX; VACCINE; PROTEIN; IMMUNITY; PVS25; GALLINACEUM; CANDIDATE; GENOMICS	Transmission of malaria parasites from humans to Anopheles mosquitoes can be inhibited by specific antibodies elicited during malaria infection, which target surface Plasmodium gametocyte/gamete proteins. Some of these proteins may have potential for vaccine development. Pvs48/45 is a P. vivax gametocyte surface antigen orthologous to Pfs48/45, which may play a role during parasite fertilization and thus has potential for transmission blocking (TB) activity. Here we describe the expression of a recombinant Pvs48/45 protein expressed in Escherichia coli as a similar to 60kDa construct which we tested for antigenicity using human sera and for its immunogenicity and transmission blocking activity of specific anti-mouse and anti-monkey Pvs48/45 antibodies. The protein reacted with sera of individuals from malaria-endemic areas and in addition induced specific IgG antibody responses in BALB/c mice and Aotus l. griseimembra monkeys. Sera from both immunized animal species recognized native P. vivax protein in Western blot (WB) and immunofluorescence assays. Moreover, sera from immunized mice and monkeys produced significant inhibition of parasite transmission to Anopheles Albimanus mosquitoes as shown by membrane feeding assays. Results indicate the presence of reactive epitopes in the Pvs48/45 recombinant product that induce antibodies with TB activity. Further testing of this protein is ongoing to determine its vaccine potential.	[Arevalo-Herrera, Myriam; Rubiano, Kelly; Cespedes, Nora; Herrera, Socrates] Malaria Vaccine & Drug Dev Ctr, Cali, Colombia; [Vallejo, Andres F.; Rubiano, Kelly; Herrera, Socrates] Caucaseco Sci Res Ctr, Cali, Colombia; [Arevalo-Herrera, Myriam; Solarte, Yezid] Univ Valle, Sch Hlth, Cali, Colombia; [Marin, Catherin; Castellanos, Angelica; Herrera, Socrates] Primates Ctr Fdn, Cali, Colombia	Universidad del Valle	Arevalo-Herrera, M (corresponding author), Malaria Vaccine & Drug Dev Ctr, Cali, Colombia.	marevalo@inmuno.org	Solarte, Yezid A/C-1196-2013; Solarte, Yezid/ABG-5392-2020	Solarte, Yezid A/0000-0003-4173-0256; Solarte, Yezid/0000-0003-4173-0256; Castellanos Sanchez, Angelica Maria/0000-0002-6602-9696; Vallejo, Andres Felipe/0000-0002-4688-0598; Rubiano, Kely/0000-0002-4149-4030; Arevalo, Myriam/0000-0002-3434-9425	Colciencias [360-2011, 685-2013, 719-2013]; National Institutes of Health (NIH) [5U19AI089702]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089702] Funding Source: NIH RePORTER	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by Colciencias (Contracts 360-2011, 685-2013 and 719-2013) and by the National Institutes of Health (NIH) (Grant number 5U19AI089702). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcala P, 2003, FEBS LETT, V533, P115, DOI 10.1016/S0014-5793(02)03775-4; Arevalo-Herrera M, 2005, AM J TROP MED HYG, V73, P25; Arevalo-Herrera M, 2005, AM J TROP MED HYG, V73, P38; AVMA, 2013, AVMA GUID EUTH AN, P102; Baird JK, 1998, ANN TROP MED PARASIT, V92, P367, DOI 10.1080/00034989859366; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; BARR PJ, 1991, J EXP MED, V174, P1203, DOI 10.1084/jem.174.5.1203; Birkholtz LM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-197; Blagborough AM, 2010, VACCINE, V28, P6014, DOI 10.1016/j.vaccine.2010.06.100; BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; Bousema T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014114; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; CARTER R, 1990, PARASITE IMMUNOL, V12, P587, DOI 10.1111/j.1365-3024.1990.tb00990.x; CARTER R, 1995, MOL BIOCHEM PARASIT, V71, P203, DOI 10.1016/0166-6851(94)00054-Q; Chowdhury DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006352; Chung DWD, 2009, MOL BIOCHEM PARASIT, V168, P123, DOI 10.1016/j.molbiopara.2009.08.001; Collins WE, 2006, AM J TROP MED HYG, V74, P215, DOI 10.4269/ajtmh.2006.74.215; Collins WE, 1994, AOTUS THE OWL MONKEY; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; GAMAGEMENDIS AC, 1992, PARASITE IMMUNOL, V14, P385, DOI 10.1111/j.1365-3024.1992.tb00013.x; Gaspar P, 2012, BIOINFORMATICS, V28, P2683, DOI 10.1093/bioinformatics/bts465; GROTENDORST CA, 1984, INFECT IMMUN, V45, P775, DOI 10.1128/IAI.45.3.775-777.1984; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Herrera S, 2005, AM J TROP MED HYG, V73, P44, DOI 10.4269/ajtmh.2005.73.44; Hisaeda H, 2000, INFECT IMMUN, V68, P6618, DOI 10.1128/IAI.68.12.6618-6623.2000; KASLOW DC, 1994, INFECT IMMUN, V62, P5576, DOI 10.1128/IAI.62.12.5576-5580.1994; KASLOW DC, 1994, BIO-TECHNOL, V12, P494, DOI 10.1038/nbt0594-494; KAUSHAL DC, 1983, J IMMUNOL, V131, P2557; Kubler-Kielb J, 2007, P NATL ACAD SCI USA, V104, P293, DOI 10.1073/pnas.0609885104; Malkin EM, 2005, VACCINE, V23, P3131, DOI 10.1016/j.vaccine.2004.12.019; MENDIS KN, 1987, INFECT IMMUN, V55, P369, DOI 10.1128/IAI.55.2.369-372.1987; Mulder B, 1999, EXP PARASITOL, V92, P81, DOI 10.1006/expr.1999.4398; Outchkourov NS, 2008, P NATL ACAD SCI USA, V105, P4301, DOI 10.1073/pnas.0800459105; Pain A, 2009, NAT REV MICROBIOL, V7, P180, DOI 10.1038/nrmicro2096; Pradel G, 2007, PARASITOLOGY, V134, P1911, DOI 10.1017/S0031182007003381; Resources IoLA, 1985, GUIDE CARE USE LAB A; Roeffen W, 1996, PARASITE IMMUNOL, V18, P103, DOI 10.1046/j.1365-3024.1996.d01-54.x; Sahdev S, 2008, MOL CELL BIOCHEM, V307, P249, DOI 10.1007/s11010-007-9603-6; Shevchenko A, 2001, ANAL BIOCHEM, V296, P279, DOI 10.1006/abio.2001.5321; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Tachibana M, 2012, VACCINE, V30, P1807, DOI 10.1016/j.vaccine.2012.01.003; Terpe K, 2006, APPL MICROBIOL BIOT, V72, P211, DOI 10.1007/s00253-006-0465-8; van Dijk MR, 2001, CELL, V104, P153, DOI 10.1016/S0092-8674(01)00199-4; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wu Yu-Huan, 2008, P3	45	27	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119335	10.1371/journal.pone.0119335	http://dx.doi.org/10.1371/journal.pone.0119335			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775466	Green Submitted, Green Published, gold			2022-12-27	WOS:000351183500083
J	Fu, J; Hu, XH; Velroyen, A; Bech, M; Jiang, M; Pfeiffer, F				Fu, Jian; Hu, Xinhua; Velroyen, Astrid; Bech, Martin; Jiang, Ming; Pfeiffer, Franz			3D Algebraic Iterative Reconstruction for Cone-Beam X-Ray Differential Phase-Contrast Computed Tomography	PLOS ONE			English	Article							IMAGE-RECONSTRUCTION; ALGORITHMS; TOPOGRAPHY	Due to the potential of compact imaging systems with magnified spatial resolution and contrast, cone-beam x-ray differential phase-contrast computed tomography (DPC-CT) has attracted significant interest. The current proposed FDK reconstruction algorithm with the Hilbert imaginary filter will induce severe cone-beam artifacts when the cone-beam angle becomes large. In this paper, we propose an algebraic iterative reconstruction (AIR) method for cone-beam DPC-CT and report its experiment results. This approach considers the reconstruction process as the optimization of a discrete representation of the object function to satisfy a system of equations that describes the cone-beam DPC-CT imaging modality. Unlike the conventional iterative algorithms for absorption-based CT, it involves the derivative operation to the forward projections of the reconstructed intermediate image to take into account the differential nature of the DPC projections. This method is based on the algebraic reconstruction technique, reconstructs the image ray by ray, and is expected to provide better derivative estimates in iterations. This work comprises a numerical study of the algorithm and its experimental verification using a dataset measured with a three-grating interferometer and a mini-focus x-ray tube source. It is shown that the proposed method can reduce the cone-beam artifacts and performs better than FDK under large cone-beam angles. This algorithm is of interest for future cone-beam DPC-CT applications.	[Fu, Jian; Hu, Xinhua] Beijing Univ Aeronaut & Astronaut, Res Ctr Digital Radiat Imaging & Biomed Imaging, Beijing 100191, Peoples R China; [Velroyen, Astrid; Bech, Martin; Pfeiffer, Franz] Tech Univ Munich, Dept Phys, Lehrstuhl Biomed Phys, D-85748 Garching, Germany; [Velroyen, Astrid; Bech, Martin; Pfeiffer, Franz] Tech Univ Munich, Inst Med Tech, D-85748 Garching, Germany; [Bech, Martin] Lund Univ, S-22185 Lund, Sweden; [Jiang, Ming] Peking Univ, Sch Math Sci, Beijing 100871, Peoples R China	Beihang University; Technical University of Munich; Technical University of Munich; Lund University; Peking University	Fu, J (corresponding author), Beijing Univ Aeronaut & Astronaut, Res Ctr Digital Radiat Imaging & Biomed Imaging, Beijing 100191, Peoples R China.	fujian706@buaa.edu.cn	Bech, Martin/K-4331-2012; Jiang, Ming/A-9840-2008	Bech, Martin/0000-0001-9109-7175; Jiang, Ming/0000-0002-1661-0538	National Basic Research Program of China (973 Program) [2011CB809105]; National Science Foundation of China [11179009, 61121002, 10990013]; Program for New Century Excellent Talents in University (NCET) from Ministry of Education of P.R. China; Beijing NOVA program [2009A09]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University (NCET) from Ministry of Education of P.R. China(Program for New Century Excellent Talents in University (NCET)); Beijing NOVA program(Beijing Municipal Science & Technology Commission)	This work was partially supported by the National Basic Research Program of China (973 Program) (2011CB809105) and the National Science Foundation of China (11179009, 61121002, 10990013), Program for New Century Excellent Talents in University (NCET) from Ministry of Education of P.R. China and Beijing NOVA program (2009A09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bech M, 2009, PHYS MED BIOL, V54, P2747, DOI 10.1088/0031-9155/54/9/010; Beckmann F, 1997, J COMPUT ASSIST TOMO, V21, P539, DOI 10.1097/00004728-199707000-00006; BONSE U, 1965, APPL PHYS LETT, V6, P155, DOI 10.1063/1.1754212; Chapman D, 1997, PHYS MED BIOL, V42, P2015, DOI 10.1088/0031-9155/42/11/001; Cloetens P, 1999, APPL PHYS LETT, V75, P2912, DOI 10.1063/1.125225; David C, 2002, APPL PHYS LETT, V81, P3287, DOI 10.1063/1.1516611; DAVIS TJ, 1995, NATURE, V373, P595, DOI 10.1038/373595a0; Donath T, 2010, INVEST RADIOL, V45, P445, DOI 10.1097/RLI.0b013e3181e21866; FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612; Fessler J., 2000, HDB MED IMAGING, V2, P1, DOI DOI 10.1117/3.831079; Fu J, 2013, Z MED PHYS, V23, P186, DOI 10.1016/j.zemedi.2012.11.002; Fu J, 2012, OPT EXPRESS, V20, P21512, DOI 10.1364/OE.20.021512; GORDON R, 1970, J THEOR BIOL, V29, P471, DOI 10.1016/0022-5193(70)90109-8; Hahn D, 2013, BONE ARTIFACT REDUCT, P416; Herman GT, 2009, ADV PATTERN RECOGNIT, P1, DOI 10.1007/978-1-84628-723-7; HERMAN GT, 1993, IEEE T MED IMAGING, V12, P600, DOI 10.1109/42.241889; Huang ZF, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.013815; INGAL VN, 1995, J PHYS D APPL PHYS, V28, P2314, DOI 10.1088/0022-3727/28/11/012; Jerjen I, 2010, AIP CONF PROC, V1236, P227, DOI 10.1063/1.3426118; Jiang M, 2003, IEEE T MED IMAGING, V22, P569, DOI 10.1109/TMI.2003.812253; Jiang M, 2001, J X-RAY SCI TECHNOL, V10, P77; Jonas P, 2004, INVERSE PROBL, V20, P75, DOI 10.1088/0266-5611/20/1/005; Kaczmarz S., 1937, B INT ACAD POL SCI L, V35, P355; Kohler T, 2011, MED PHYS, V38, P4542, DOI 10.1118/1.3608906; Kudo H, 1998, PHYS MED BIOL, V43, P2885, DOI 10.1088/0031-9155/43/10/016; Momose A, 2003, OPT EXPRESS, V11, P2303, DOI 10.1364/OE.11.002303; Momose A, 2003, JPN J APPL PHYS 2, V42, pL866, DOI 10.1143/JJAP.42.L866; Momose A, 1996, NAT MED, V2, P473, DOI 10.1038/nm0496-473; Natterer F, 2001, THE MATHEMATICS OF C; Natterer F, 2001, MATHEMATICAL METHODS; Pfeiffer F, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108105; Pfeiffer F, 2006, NAT PHYS, V2, P258, DOI 10.1038/nphys265; Shimura T, 2013, OPT LETT, V38, P157, DOI 10.1364/OL.38.000157; Sidky EY, 2008, PHYS MED BIOL, V53, P4777, DOI 10.1088/0031-9155/53/17/021; Sidky EY, 2009, MED PHYS, V36, P4920, DOI 10.1118/1.3232211; SMITH BD, 1983, COMPUT BIOL MED, V13, P81, DOI 10.1016/S0010-4825(83)80001-8; Snigirev A, 1995, REV SCI INSTRUM, V66, P5486, DOI 10.1063/1.1146073; TAKEDA M, 1982, J OPT SOC AM, V72, P156, DOI 10.1364/JOSA.72.000156; Tang J, 2009, PHYS MED BIOL, V54, P5781, DOI 10.1088/0031-9155/54/19/008; Tapfer A, 2012, P NATL ACAD SCI USA, V109, P15691, DOI 10.1073/pnas.1207503109; Thibault JB, 2007, MED PHYS, V34, P4526, DOI 10.1118/1.2789499; TUY HK, 1983, SIAM J APPL MATH, V43, P546, DOI 10.1137/0143035; Wang J, 2009, MED PHYS, V36, P252, DOI 10.1118/1.3036112; Wang ZT, 2011, J X-RAY SCI TECHNOL, V19, P403, DOI 10.3233/XST-2011-0303; Weitkamp T, 2005, OPT EXPRESS, V13, P6296, DOI 10.1364/OPEX.13.006296; Wilkins SW, 1996, NATURE, V384, P335, DOI 10.1038/384335a0; Wu T, 2003, MED PHYS, V30, P365, DOI 10.1118/1.1543934; Xu F, 2005, IEEE T NUCL SCI, V52, P654, DOI 10.1109/TNS.2005.851398; Xu QF, 2012, OPT EXPRESS, V20, P10724, DOI 10.1364/OE.20.010724; Zhang K, 2011, ANAL BIOANAL CHEM, V401, P837, DOI 10.1007/s00216-011-5080-6; Zhang L, 2008, IEEE NUCL SCI S M06, P4193; Zhu PP, 2010, P NATL ACAD SCI USA, V107, P13576, DOI 10.1073/pnas.1003198107	52	11	12	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0117502	10.1371/journal.pone.0117502	http://dx.doi.org/10.1371/journal.pone.0117502			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775480	gold, Green Published			2022-12-27	WOS:000351183500020
J	Guo, J; Yao, HW; Lin, X; Xu, HD; Dean, D; Zhu, Z; Liu, G; Sime, P				Guo, Jia; Yao, Hongwei; Lin, Xin; Xu, Haodong; Dean, David; Zhu, Zhou; Liu, Gang; Sime, Patricia			IL-13 Induces YY1 through the AKT Pathway in Lung Fibroblasts	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; GROWTH-FACTOR; MYOFIBROBLAST DIFFERENTIATION; 3-KINASE/AKT PATHWAY; FIBROGENIC FACTORS; TISSUE FIBROSIS; GENE-EXPRESSION; INTERLEUKIN-13; CELLS; ACTIVATION	A key feature of lung fibrosis is the accumulation of myofibroblasts. Interleukin 13 (IL-13) is a pro-fibrotic mediator that directly and indirectly influences the activation of myofibroblasts. Transforming growth factor beta (TGF-beta) promotes the differentiation of fibroblasts into myofibroblasts, and can be regulated by IL-13. However, IL-13's downstream signaling pathways are not completely understood. We previously reported that the transcription factor Yin Yang 1 (YY1) is upregulated in fibroblasts treated with TGF-beta and in the lungs of mice and patients with pulmonary fibrosis. Moreover, YY1 directly regulates collagen and alpha smooth muscle actin (alpha-SMA) expression in fibroblasts. However, it is not known if IL-13 regulates fibroblast activation through YY1 expression. We hypothesize that IL-13 upregulates YY1 expression through regulation of AKT activation, leading to fibroblast activation. In this study we found that YY1 was upregulated by IL-13 in lung fibroblasts in a dose- and time-dependent manner, resulting in increased alpha-SMA. Conversely, knockdown of YY1 blocked IL-13-induced alpha-SMA expression in fibroblasts. Furthermore, AKT phosphorylation was increased in fibroblasts treated with IL-13, and AKT overexpression upregulated YY1, whereas blockade of AKT phosphorylation suppressed the induction of YY1 by IL-13 in vitro. In vivo YY1 was upregulated in fibrotic lungs from CC10-IL-13 transgenic mice compared to that from wild-type littermates, which was associated with increased AKT phosphorylation. Taken together, these findings demonstrate that IL-13 is a potent stimulator and activator of fibroblasts, at least in part, through AKT-mediated YY1 activation.	[Guo, Jia; Sime, Patricia] Univ Rochester, Sch Med, Dept Med, Rochester, NY 14620 USA; [Yao, Hongwei] Univ Rochester, Med Ctr, Dept Environm Med, Rochester, NY 14642 USA; [Lin, Xin; Dean, David; Sime, Patricia] Univ Rochester, Dept Pediat, Rochester, NY USA; [Xu, Haodong] Univ Calif Los Angeles, David Geffen Sch Med, Pathol & Lab Med, Los Angeles, CA 90095 USA; [Zhu, Zhou] Yale Univ, Dept Allergy & Clin Immunol, New Haven, CT USA; [Liu, Gang] Univ Alabama Birmingham, Dept Med Pulm & Crit Care, Birmingham, AL USA	University of Rochester; University of Rochester; University of Rochester; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Yale University; University of Alabama System; University of Alabama Birmingham	Guo, J (corresponding author), Univ Rochester, Sch Med, Dept Med, Rochester, NY 14620 USA.	jia_guo@urmc.rochester.edu	Yao, Hongwei/G-6444-2010; xu, hao/GWQ-7394-2022	, Gang/0000-0002-6999-7633; Liu, Gang/0000-0003-2615-131X	American Lung Associate and American Thoracic Society [RG-10327-N, 214017]; American Heart Associate [11SDG560007]; US National Institutes of Health [HL75432]; URMC Department of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075432] Funding Source: NIH RePORTER	American Lung Associate and American Thoracic Society; American Heart Associate; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); URMC Department of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project was supported by the grants from the American Lung Associate and American Thoracic Society (RG-10327-N and Award #214017 to J.G.), (http://www.pulmonaryfibrosis.org/), the American Heart Associate (11SDG560007), (http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/@rsch/documents/downloadable/ucm_432230.pdf); US National Institutes of Health (HL75432 to P.S), and support from the URMC Department of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonavida B, 2007, ONCOGENE, V26, P3629, DOI 10.1038/sj.onc.1210365; Borowski A, 2008, CLIN EXP ALLERGY, V38, P619, DOI 10.1111/j.1365-2222.2008.02944.x; Chiaramonte MG, 1999, J CLIN INVEST, V104, P777, DOI 10.1172/JCI7325; Chiaramonte MG, 1999, J IMMUNOL, V162, P920; Elias JA, 2003, CHEST, V123, p339S, DOI 10.1378/chest.123.3_suppl.339S-a; Fallon PG, 2000, J IMMUNOL, V164, P2585, DOI 10.4049/jimmunol.164.5.2585; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Fichtner-Feigl S, 2008, GASTROENTEROLOGY, V135, P2003, DOI 10.1053/j.gastro.2008.08.055; Garneau-Tsodikova S, 2008, CURR MED CHEM, V15, P2632, DOI 10.2174/092986708785908969; Gharaee-Kermani M, 2007, EXPERT OPIN EMERG DR, V12, P627, DOI 10.1517/14728214.12.4.627; Grehan JF, 2005, J IMMUNOL, V175, P1903, DOI 10.4049/jimmunol.175.3.1903; Guo JA, 1997, GENOMICS, V42, P141, DOI 10.1006/geno.1997.4628; Han EKH, 2007, ONCOGENE, V26, P5655, DOI 10.1038/sj.onc.1210343; Hancock A, 1998, AM J RESP CELL MOL, V18, P60, DOI 10.1165/ajrcmb.18.1.2627; Hasegawa M, 1997, J RHEUMATOL, V24, P328; He ZY, 2009, J RECEPT SIG TRANSD, V29, P119, DOI 10.1080/10799890902845690; Horowitz JC, 2004, J BIOL CHEM, V279, P1359, DOI 10.1074/jbc.M306248200; Horowitz JC, 2007, CELL SIGNAL, V19, P761, DOI 10.1016/j.cellsig.2006.10.001; Jakubzick C, 2003, J IMMUNOL, V171, P2684, DOI 10.4049/jimmunol.171.5.2684; Kang HR, 2007, J EXP MED, V204, P1083, DOI 10.1084/jem.20061273; Kaviratne M, 2004, J IMMUNOL, V173, P4020, DOI 10.4049/jimmunol.173.6.4020; Khalil N, 2004, CAN MED ASSOC J, V171, P153, DOI 10.1503/cmaj.1030055; Kulkarni AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015909; Lee CG, 2001, J EXP MED, V194, P809, DOI 10.1084/jem.194.6.809; Lin X, 2011, AM J RESP CRIT CARE, V183, P1689, DOI 10.1164/rccm.201002-0232OC; Moriya C, 2011, J INVEST DERMATOL, V131, P655, DOI 10.1038/jid.2010.361; Rosada RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008721; Roy SG, 2001, INT J BIOCHEM CELL B, V33, P723, DOI 10.1016/S1357-2725(01)00041-3; Russo RC, 2011, J LEUKOCYTE BIOL, V89, P269, DOI 10.1189/jlb.0610346; Saito A, 2003, INT ARCH ALLERGY IMM, V132, P168, DOI 10.1159/000073718; Shegogue D, 2004, J BIOL CHEM, V279, P23166, DOI 10.1074/jbc.M401238200; Sheppard Dean, 2006, Proc Am Thorac Soc, V3, P413, DOI 10.1513/pats.200601-008AW; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; Vittal R, 2005, AM J PATHOL, V166, P367, DOI 10.1016/S0002-9440(10)62260-2; Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909	39	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119039	10.1371/journal.pone.0119039	http://dx.doi.org/10.1371/journal.pone.0119039			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775215	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500063
J	Pereira, RC; Juppner, H; Gales, B; Salusky, IB; Wesseling-Perry, K				Pereira, Renata C.; Jueppner, Harald; Gales, Barbara; Salusky, Isidro B.; Wesseling-Perry, Katherine			Osteocytic Protein Expression Response to Doxercalciferol Therapy in Pediatric Dialysis Patients	PLOS ONE			English	Article							GROWTH-FACTOR 23; DENTIN MATRIX PROTEIN-1; CHRONIC KIDNEY-DISEASE; C-TERMINAL FRAGMENT; PARATHYROID-HORMONE; SECONDARY HYPERPARATHYROIDISM; PHOSPHATE HOMEOSTASIS; RENAL OSTEODYSTROPHY; BREAST-CARCINOMA; GENE-EXPRESSION	Background Osteocytic protein expression is dysregulated in CKD and is affected by changes in mineral metabolism; however the effects of active vitamin D sterol therapy on osteocyte protein expression in advanced CKD is unknown. Methods Eleven pediatric patients with end stage kidney disease underwent bone biopsy, were treated for 8 months with doxercalciferol, and then underwent a second bone biopsy. Bone expression of fibroblast growth factor 23 (FGF23), dentin matrix protein 1 (DMP1), and sclerostin were determined by immunohistochemistry and quantified by Ariol Scanning. Western blot analysis and qRT-PCR was performed on bone abstracts of a subset of study subjects to determine the nature (i.e. size) of FGF23 and DMP1 in bone before and after therapy. Results As assessed by immunohistochemistry, bone FGF23, DMP1 and sclerostin protein all increased with therapy. In the case of FGF23, this increase was due to an increase in the full-length molecule without the appearance of FGF23 fragments. DMP1 was present primarily in its full-length formin healthy controls while 57kDa and 37kDa fragments of DMP1 were apparent in bone of dialysis patients at baseline and the 57 kDa appeared to decrease with therapy. Conclusion Marked changes in osteocytic protein expression accompany doxercalciferol therapy, potentially impacting bone mineralization and the skeletal response to PTH. The effects of these bone changes on long-term outcomes remain to be determined.	[Pereira, Renata C.; Gales, Barbara; Salusky, Isidro B.; Wesseling-Perry, Katherine] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Jueppner, Harald] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Jueppner, Harald] Massachusetts Gen Hosp, Pediat Nephrol Unit, Boston, MA 02114 USA; [Jueppner, Harald] Harvard Univ, Sch Med, Boston, MA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Wesseling-Perry, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA.	kwesseling@mednet.ucla.edu			USPHS [DK-67563, DK-35423, DK-080984, PO-1DK11794]; CTSI [UL1 TR-000124]; Casey Lee Ball Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK011794, R01DK035423, K23DK080984, R01DK067563] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); CTSI; Casey Lee Ball Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by USPHS grants DK-67563, DK-35423, DK-080984, PO-1DK11794, and CTSI grant UL1 TR-000124 and funds from the Casey Lee Ball Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacchetta J, 2013, CLIN J AM SOC NEPHRO, V8, P824, DOI 10.2215/CJN.00330112; Bellido T, 2005, ENDOCRINOLOGY, V146, P4577, DOI 10.1210/en.2005-0239; Bhattacharyya N, 2012, TRENDS ENDOCRIN MET, V23, P610, DOI 10.1016/j.tem.2012.07.002; Bhattacharyya N, 2012, J BONE MINER RES, V27, P1132, DOI 10.1002/jbmr.1546; Cejka D, 2011, CLIN J AM SOC NEPHRO, V6, P877, DOI 10.2215/CJN.06550810; Chaussain C, 2009, EUR CELLS MATER, V18, P84, DOI 10.22203/eCM.v018a08; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Gokhale S, 2007, APPL IMMUNOHISTO M M, V15, P451, DOI 10.1097/PAI.0b013e31802ee998; Gomes SA, 2008, J BONE MINER METAB, V26, P110, DOI 10.1007/s00774-007-0788-2; GOODMAN WG, 1994, KIDNEY INT, V46, P1160, DOI 10.1038/ki.1994.380; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Hollis BW, 1996, CLIN CHEM, V42, P586; Huang BZ, 2008, CALCIFIED TISSUE INT, V82, P401, DOI 10.1007/s00223-008-9140-7; Isakova T, 2011, KIDNEY INT, V79, P1370, DOI 10.1038/ki.2011.47; Jiang Z, 2004, HISTOPATHOLOGY, V45, P218, DOI 10.1111/j.1365-2559.2004.01930.x; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Larsson T, 2004, ENDOCRINOLOGY, V145, P3087, DOI 10.1210/en.2003-1768; Lavi-Moshayoff V, 2010, AM J PHYSIOL-RENAL, V299, pF882, DOI 10.1152/ajprenal.00360.2010; Leys CM, 2007, SURGERY, V141, P41, DOI 10.1016/j.surg.2006.05.009; Liu SG, 2008, AM J PHYSIOL-ENDOC M, V295, pE254, DOI 10.1152/ajpendo.90201.2008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenz-Depiereux B, 2006, NAT GENET, V38, P1248, DOI 10.1038/ng1868; Lu YB, 2011, J BONE MINER RES, V26, P331, DOI 10.1002/jbmr.226; Martin A, 2012, MOL ENDOCRINOL, V26, P1883, DOI 10.1210/me.2012-1062; Meir T, 2014, KIDNEY INT, V86, P1106, DOI 10.1038/ki.2014.215; Moe S, 2006, KIDNEY INT, V69, P1945, DOI 10.1038/sj.ki.5000414; Nociti FH, 2014, J DENT RES, V93, P148, DOI 10.1177/0022034513516344; Pereira RC, 2009, BONE, V45, P1161, DOI 10.1016/j.bone.2009.08.008; Rhee Y, 2011, BONE, V49, P636, DOI 10.1016/j.bone.2011.06.025; Sabbagh Y, 2012, J BONE MINER RES, V27, P1757, DOI 10.1002/jbmr.1630; Sanchez CP, 1998, KIDNEY INT, V53, P1358, DOI 10.1046/j.1523-1755.1998.00866.x; Shimada T, 2010, J CLIN ENDOCR METAB, V95, P578, DOI 10.1210/jc.2009-1603; Smith ER, 2012, J CLIN ENDOCR METAB, V97, P3357, DOI 10.1210/jc.2012-1811; Turbin DA, 2008, BREAST CANCER RES TR, V110, P417, DOI 10.1007/s10549-007-9736-z; von Marschall Z, 2008, J BIOL CHEM, V283, P32730, DOI 10.1074/jbc.M804283200; Wesseling-Perry K, 2012, CLIN J AM SOC NEPHRO, V7, P146, DOI 10.2215/CJN.05940611; Wesseling-Perry K, 2011, KIDNEY INT, V79, P112, DOI 10.1038/ki.2010.352	37	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120856	10.1371/journal.pone.0120856	http://dx.doi.org/10.1371/journal.pone.0120856			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774916	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500195
J	Polo, G; Acosta, CM; Ferreira, F; Dias, RA				Polo, Gina; Mera Acosta, C.; Ferreira, Fernando; Dias, Ricardo Augusto			Location-Allocation and Accessibility Models for Improving the Spatial Planning of Public Health Services	PLOS ONE			English	Article							CARE; ACCESS	This study integrated accessibility and location-allocation models in geographic information systems as a proposed strategy to improve the spatial planning of public health services. To estimate the spatial accessibility, we modified the two-step floating catchment area (2SFCA) model with a different impedance function, a Gaussian weight for competition among service sites, a friction coefficient, distances along a street network based on the Dijkstra's algorithm and by performing a vectorial analysis. To check the accuracy of the strategy, we used the data from the public sterilization program for the dogs and cats of Bogot'a, Colombia. Since the proposed strategy is independent of the service, it could also be applied to any other public intervention when the capacity of the service is known. The results of the accessibility model were consistent with the sterilization program data, revealing that the western, central and northern zones are the most isolated areas under the sterilization program. Spatial accessibility improvement was sought by relocating the sterilization sites using the maximum coverage with finite demand and the p-median models. The relocation proposed by the maximum coverage model more effectively maximized the spatial accessibility to the sterilization service given the non-uniform distribution of the populations of dogs and cats throughout the city. The implementation of the proposed strategy would provide direct benefits by improving the effectiveness of different public health interventions and the use of financial and human resources.	[Polo, Gina; Ferreira, Fernando; Dias, Ricardo Augusto] Univ Sao Paulo, Epidemiol & Biostat Lab, Dept Prevent Vet Med & Anim Hlth, Sao Paulo, Brazil; [Mera Acosta, C.] Univ Sao Paulo, Inst Phys, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Polo, G (corresponding author), Univ Sao Paulo, Epidemiol & Biostat Lab, Dept Prevent Vet Med & Anim Hlth, Sao Paulo, Brazil.	gina@vps.fmvz.usp.br; dias@vps.fmvz.usp.br	Ferreira, Fernando/C-9038-2013; Dias, Ricardo A/D-5977-2013	Ferreira, Fernando/0000-0002-9160-7355; Polo, Gina/0000-0001-5569-7392; Dias, Ricardo Augusto/0000-0002-8241-7699	Programa de Estudantes - Convenio de Posgraduacao [190590/2011-4]	Programa de Estudantes - Convenio de Posgraduacao	This work had the following sources of funding: Programa de Estudantes - Convenio de Posgraduacao (Grant number 190590/2011-4) [URL: http://www.capes.gov.br/cooperacao-internacional/multinacional/pec-pg] to GP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell S, 2013, ANN ASSOC AM GEOGR, V103, P85, DOI 10.1080/00045608.2012.685050; Bell S, 2012, SPAT SPATIO-TEMPORAL, V3, P17, DOI 10.1016/j.sste.2012.02.003; Bergmann G, 2001, J BIOMECH, V34, P859, DOI 10.1016/S0021-9290(01)00040-9; Bogota DC, 2012, MOVILIDAD CIFRAS 201; Clifton M, 2001, STERILIZATION VACCIN; Dai DJ, 2010, HEALTH PLACE, V16, P1038, DOI 10.1016/j.healthplace.2010.06.012; Daskin M. S., 2004, HDB OR MS HLTH CARE; Eaton D, 1982, STUDIES MANAGEMENT S, V17, P331; EATON DJ, 1986, J OPER RES SOC, V37, P113, DOI 10.1057/jors.1986.21; Ferreira F, 2010, THESIS U SAO PAULO; Guagliardo Mark F, 2004, Int J Health Geogr, V3, P3; JOSEPH AE, 1982, SOC SCI MED, V16, P85, DOI 10.1016/0277-9536(82)90428-2; KHAN AA, 1992, SOCIO ECON PLAN SCI, V26, P275, DOI 10.1016/0038-0121(92)90004-O; Langford M, 2006, PROF GEOGR, V58, P294, DOI 10.1111/j.1467-9272.2006.00569.x; Luo W, 2003, ENVIRON PLANN B, V30, P865, DOI 10.1068/b29120; Luo W, 2012, HEALTH PLACE, V18, P789, DOI 10.1016/j.healthplace.2012.04.002; Luo W, 2009, HEALTH PLACE, V15, P1100, DOI 10.1016/j.healthplace.2009.06.002; Marpet MI, 1996, J FORENSIC SCI, V41, P747; Murawski L., 2009, SOCIOECONOMIC PLANNI, V43, P101, DOI [10.1016/j.seps.2008.02.012, DOI 10.1016/J.SEPS.2008.02.012]; Polo G, 2013, THESIS U SAO PAULO; Polo G, 2013, PREV VET MED, V111, P10, DOI 10.1016/j.prevetmed.2013.03.010; Radke J., 2000, GEOGRAPHIC INFORM SC, V6, P105, DOI [10.1080/10824000009480538, DOI 10.1080/10824000009480538]; Rahman SU, 2000, EUR J OPER RES, V123, P437, DOI 10.1016/S0377-2217(99)00289-1; Vega R, 2007, INVESTIGACIONES SEGU, V9, P203; Wan N, 2012, APPL GEOGR, V32, P291, DOI 10.1016/j.apgeog.2011.05.001; Wang FH, 2008, PROF GEOGR, V60, P54, DOI 10.1080/00330120701724087; Wang L, 2007, HEALTH PLACE, V13, P656, DOI 10.1016/j.healthplace.2006.10.001	27	39	42	5	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119190	10.1371/journal.pone.0119190	http://dx.doi.org/10.1371/journal.pone.0119190			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD6EY	25775411	Green Submitted, Green Published, gold			2022-12-27	WOS:000351183500073
J	Steiner, J; Wu, WC; Jankowich, M; Maron, BA; Sharma, S; Choudhary, G				Steiner, Johannes; Wu, Wen-Chih; Jankowich, Matthew; Maron, Bradley A.; Sharma, Satish; Choudhary, Gaurav			Echocardiographic Predictors of Mortality in Patients with Pulmonary Hypertension and Cardiopulmonary Comorbidities	PLOS ONE			English	Article							VENTRICULAR SYSTOLIC FUNCTION; HEART-FAILURE; ARTERY PRESSURE; PROGNOSTIC IMPORTANCE; OXYGEN-THERAPY; DIAGNOSIS; ACCURACY; DISEASE; TERM; DYSFUNCTION	Objective We aimed to identify the echocardiographic measures associated with survival in a patient population with a high prevalence of co-morbid cardiovascular and pulmonary disease that have significantly elevated estimated pulmonary artery systolic pressures (ePASP). Background Pulmonary hypertension (PH) is a clinical feature of several cardiopulmonary diseases that are prevalent among elderly. While certain echocardiographic parameters have been shown to be important in the prognosis in specific PH groups, the prognostic relevance of echocardiographic characteristics in a cohort with multiple cardiopulmonary comorbidities is unclear. Methods We retrospectively identified 152 patients with ePASP > 60 mmHg by echocardiography over a five year period (6/2006-11/2011) and followed until 4/2013. Candidate clinical and echocardiographic characteristics suggestive of PH severity were compared between deceased and surviving subpopulations. Cox proportional hazard modeling was used to identify echocardiographic predictors of death adjusted for age and clinical characteristics. Results This was a predominantly elderly (age 78.8 +/- 10.2 years), male (98.7%) cohort with several cardiopulmonary comorbidities. Overall mortality was high (69.7%, median survival 129 days). After adjusting for age and clinical characteristics, decreased right ventricular (RV) systolic function assessed by tricuspid annular plane systolic excursion (HR 0.56, 95% CI 0.33-0.96, p = 0.034) and increased RV thickness (HR: 4.34, 95% CI: 1.49-12.59, p = 0.007) were independently associated with mortality. In contrast, left ventricular systolic function, left ventricular diastolic parameters, ePASP, or echo-derived pulmonary vascular resistance (PVR) were not associated with increased mortality. Conclusion In a cohort of patients with PH and high prevalence of cardio-pulmonary comorbidities, RV systolic function and hypertrophy are associated with mortality and may be the most relevant echocardiographic markers for prognosis.	[Steiner, Johannes; Wu, Wen-Chih; Jankowich, Matthew; Sharma, Satish; Choudhary, Gaurav] Providence VA Med Ctr, Vasc Res Lab, Providence, RI 02908 USA; [Steiner, Johannes; Wu, Wen-Chih; Jankowich, Matthew; Sharma, Satish; Choudhary, Gaurav] Brown Univ, Dept Med, Warren Alpert Med Sch, Providence, RI 02912 USA; [Maron, Bradley A.] Vet Affairs Boston Healthcare Syst, Dept Cardiol, Boston, MA USA; [Maron, Bradley A.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Maron, Bradley A.] Harvard Univ, Sch Med, Dept Internal Med, Div Cardiovasc Med, Boston, MA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; Brown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Choudhary, G (corresponding author), Providence VA Med Ctr, Vasc Res Lab, Providence, RI 02908 USA.	Gaurav_Choudhary@brown.edu	Choudhary, Gaurav/M-1643-2019	Choudhary, Gaurav/0000-0001-9343-5481	Department of Veterans Affairs; MERIT Review Award [IBX000711A]; Research Enhancement Award Program grant [REA 08-263]; American Heart Association [11POST6720000]; United States National Institutes of Health [1K08HL111207-01A1]; Lerner and Klarman Foundation at Brigham and Women's Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL139613, K08HL111207] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); MERIT Review Award(US Department of Veterans Affairs); Research Enhancement Award Program grant; American Heart Association(American Heart Association); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lerner and Klarman Foundation at Brigham and Women's Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Department of Veterans Affairs; MERIT Review Award to GC (IBX000711A) Research Enhancement Award Program grant (REA 08-263) to W-CW, and awards from American Heart Association (11POST6720000), United States National Institutes of Health (1K08HL111207-01A1) and the Lerner and Klarman Foundation at Brigham and Women's Hospital to BAM. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AE, 2003, J AM COLL CARDIOL, V41, P1021, DOI 10.1016/S0735-1097(02)02973-X; Agarwal R, 2012, NEPHROL DIAL TRANSPL, V27, P310, DOI 10.1093/ndt/gfr320; Almagro P, 2006, RESPIRATION, V73, P311, DOI 10.1159/000088092; Burke MA, 2014, CIRC-HEART FAIL, V7, P288, DOI 10.1161/CIRCHEARTFAILURE.113.000854; Cogswell R, 2013, J HEART LUNG TRANSPL, V32, P293, DOI 10.1016/j.healun.2012.11.012; Dadfarmay Sina, 2010, Congest Heart Fail, V16, P287, DOI 10.1111/j.1751-7133.2010.00192.x; Fisher MR, 2009, AM J RESP CRIT CARE, V179, P615, DOI 10.1164/rccm.200811-1691OC; Forfia PR, 2006, AM J RESP CRIT CARE, V174, P1034, DOI 10.1164/rccm.200604-547OC; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Ghio S, 2001, J AM COLL CARDIOL, V37, P183, DOI 10.1016/S0735-1097(00)01102-5; Ghio S, 2013, EUR J HEART FAIL, V15, P408, DOI 10.1093/eurjhf/hfs208; Guazzi M, 2012, EUR RESPIR REV, V21, P338, DOI 10.1183/09059180.00004612; Guglin M, 2010, J CARD FAIL, V16, P461, DOI 10.1016/j.cardfail.2010.01.003; Haddad F, 2008, CIRCULATION, V117, P1717, DOI 10.1161/CIRCULATIONAHA.107.653584; Hoeper MM, 2009, J AM COLL CARDIOL, V54, pS85, DOI 10.1016/j.jacc.2009.04.008; Kjaergaard J, 2007, EUR J HEART FAIL, V9, P610, DOI 10.1016/j.ejheart.2007.03.001; Lam CSP, 2009, CIRCULATION, V119, P2663, DOI 10.1161/CIRCULATIONAHA.108.838698; Maron BA, 2013, CIRC-HEART FAIL, V6, P906, DOI 10.1161/CIRCHEARTFAILURE.112.000091; Marti S, 2006, EUR RESPIR J, V27, P689, DOI 10.1183/09031936.06.00076405; McClanahan A, 2011, J CARD FAIL, V17, P1023, DOI 10.1016/j.cardfail.2011.08.011; Meluzin J, 2005, J AM SOC ECHOCARDIOG, V18, P435, DOI 10.1016/j.echo.2005.02.004; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Opotowsky AR, 2012, CIRC-CARDIOVASC IMAG, V5, P765, DOI 10.1161/CIRCIMAGING.112.976654; OSWALDMAMMOSSER M, 1995, CHEST, V107, P1193, DOI 10.1378/chest.107.5.1193; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; SAITO H, 1992, AM REV RESPIR DIS, V146, P1576, DOI 10.1164/ajrccm/146.6.1576; Sato T, 2012, J AM SOC ECHOCARDIOG, V25, P280, DOI 10.1016/j.echo.2011.12.012; Shah SJ, 2012, JAMA-J AM MED ASSOC, V308, P1366, DOI 10.1001/jama.2012.12347; Steckelberg RC, 2013, J AM SOC ECHOCARDIOG, V26, P464, DOI 10.1016/j.echo.2013.01.006; Strange G, 2012, HEART, V98, P1805, DOI 10.1136/heartjnl-2012-301992; van de Veerdonk MC, 2011, J AM COLL CARDIOL, V58, P2511, DOI 10.1016/j.jacc.2011.06.068; WilhelmBurger MJB, 2008, DIGITAL IMAGE PROCES; Yu W, 2003, MED CARE RES REV, V60, p146S, DOI 10.1177/1077558703257000	33	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119277	10.1371/journal.pone.0119277	http://dx.doi.org/10.1371/journal.pone.0119277			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774911	Green Published, gold, Green Submitted			2022-12-27	WOS:000351183500078
J	van der Torren, CR; van Hensbergen, Y; Luther, S; Aghai, Z; Rychnavska, ZS; Slot, M; Scherjon, S; Kroger, N; Ganser, A; Weissinger, EM; Goulmy, E; Hambach, L				van der Torren, Cornelis R.; van Hensbergen, Yvette; Luther, Susanne; Aghai, Zohara; Rychnavska, Zuzana Stachova; Slot, Manon; Scherjon, Sicco; Kroeger, Nicolaus; Ganser, Arnold; Weissinger, Eva M.; Goulmy, Els; Hambach, Lothar			Possible Role of Minor H Antigens in the Persistence of Donor Chimerism after Stem Cell Transplantation; Relevance for Sustained Leukemia Remission	PLOS ONE			English	Article							CYTOTOXIC T-LYMPHOCYTES; VERSUS-HOST-DISEASE; 1ST INTERNATIONAL WORKSHOP; ACUTE MYELOID-LEUKEMIA; HISTOCOMPATIBILITY ANTIGENS; PROGNOSTIC-FACTORS; GRAFT; MARROW; IMMUNOTHERAPY; RELAPSE	Persistent complete donor chimerism is an important clinical indicator for remissions of hematological malignancies after HLA-matched allogeneic stem cell transplantation (SCT). However, the mechanisms mediating the persistence of complete donor chimerism are poorly understood. The frequent coincidence of complete donor chimerism with graft-versus- leukemia effects and graft-versus-host disease suggests that immune responses against minor histocompatibility antigens (mHags) are playing an important role in suppressing the host hematopoiesis after allogeneic SCT. Here, we investigated a possible relationship between donor immune responses against the hematopoiesis-restricted mHag HA-1 and the long-term kinetics of host hematopoietic chimerism in a cohort of 10 patients after allogeneic HLA-matched, HA-1 mismatched SCT. Functional HA-1 specific CTLs (HA1 CTLs) were detectable in 6/10 patients lysing host-type hematopoietic cells in vitro. Presence of HA-1 CTLs in the peripheral blood coincided with low host hematopoiesis levels quantified by highly sensitive mHag specific PCR. Additionally, co-incubation of host type CD34(+) cells with HA-1 CTLs isolated after allogeneic SCT prevented progenitor and cobblestone area forming cell growth in vitro and human hematopoietic engraftment in immunodeficient mice. Conversely, absence or loss of HA-1 CTLs mostly coincided with high host hematopoiesis levels and/or relapse. In summary, in this first study, presence of HA-1 CTLs paralleled low host hematopoiesis levels. This coincidence might be supported by the capacity of HA-1 CTLs isolated after allogeneic SCT to specifically eliminate host type hematopoietic stem/progenitor cells. Additional studies involving multiple mismatched mHags in more patients are required to confirm this novel characteristic of mHag CTLs as factor for the persistence of complete donor chimerism and leukemia remission after allogeneic SCT.	[van der Torren, Cornelis R.; Aghai, Zohara; Rychnavska, Zuzana Stachova; Goulmy, Els; Hambach, Lothar] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; [van Hensbergen, Yvette; Slot, Manon] Sanquin Blood Supply Fdn, Div Res, Dept Transfus Med, Leiden, Netherlands; [Luther, Susanne; Ganser, Arnold; Weissinger, Eva M.; Hambach, Lothar] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany; [Scherjon, Sicco] Leiden Univ, Med Ctr, Dept Obstet, Leiden, Netherlands; [Kroeger, Nicolaus] Univ Med Ctr Hamburg Eppendorf, Dept Bone Marrow Transplantat, Hamburg, Germany	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Hannover Medical School; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Hamburg; University Medical Center Hamburg-Eppendorf	Hambach, L (corresponding author), Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands.	hambach.lothar@mh-hannover.de			Sander foundation (Munich, Germany) [2005.111.1]; Integrated Research and Treatment Center Transplantation (IFB-Tx) - German Federal Ministry of Education and Research [01EO0802, 01EO1302]; Dutch Cancer Society (Koningin Wilhelmina Fonds, Amsterdam, The Netherlands) [UL2006-3482]; Netherlands Organization for Scientific Research (NWO) Den Haag, The Netherlands	Sander foundation (Munich, Germany); Integrated Research and Treatment Center Transplantation (IFB-Tx) - German Federal Ministry of Education and Research; Dutch Cancer Society (Koningin Wilhelmina Fonds, Amsterdam, The Netherlands)(KWF KankerbestrijdingNetherlands Government); Netherlands Organization for Scientific Research (NWO) Den Haag, The Netherlands(Netherlands Organization for Scientific Research (NWO)Netherlands Government)	This work is supported in part by funding from: Sander foundation (Munich, Germany, project code 2005.111.1); [http://www.wilhelm-sanderstiftung. de/]; the Integrated Research and Treatment Center Transplantation (IFB-Tx) funded by the German Federal Ministry of Education and Research (reference number: 01EO0802 and 01EO1302); [http://www.ifb-tx.de/]; the Dutch Cancer Society (Koningin Wilhelmina Fonds, Amsterdam, The Netherlands, project code UL2006-3482); [http://www. kwf.nl/]; the Netherlands Organization for Scientific Research (NWO; Den Haag, The Netherlands); [http://www.nwo.nl/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen MH, 2014, LEUKEMIA, V28, P1784, DOI 10.1038/leu.2014.108; Bethge WA, 2004, BLOOD, V103, P790, DOI 10.1182/blood-2003-07-2344; Bijker MS, 2008, EUR J IMMUNOL, V38, P1033, DOI 10.1002/eji.200737995; Boeck S, 2006, BONE MARROW TRANSPL, V37, P57, DOI 10.1038/sj.bmt.1705217; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Bonnet D, 2001, P NATL ACAD SCI USA, V96, P8639; Borchers S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050248; BRETAGNE S, 1987, BLOOD, V70, P1692; DEBUEGER M, 1992, J IMMUNOL, V149, P1788; Dey BR, 2003, BIOL BLOOD MARROW TR, V9, P320, DOI 10.1016/S1083-8791(03)00077-6; Diaconescu R, 2004, BLOOD, V104, P1550, DOI 10.1182/blood-2004-03-0804; Dickinson AM, 2002, NAT MED, V8, P410, DOI 10.1038/nm0402-410; Dierselhuis MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091274; Dupriez B, 1996, BLOOD, V88, P1013; FALKENBURG JHF, 1991, J EXP MED, V174, P27, DOI 10.1084/jem.174.1.27; GLUCKSBERG H, 1974, TRANSPLANTATION, V18, P295, DOI 10.1097/00007890-197410000-00001; GOULMY E, 1983, NATURE, V302, P159, DOI 10.1038/302159a0; Hambach L, 2005, CURR OPIN IMMUNOL, V17, P202, DOI 10.1016/j.coi.2005.01.010; Hambach L, 2006, LEUKEMIA, V20, P371, DOI 10.1038/sj.leu.2404056; Hobo W, 2013, BIOL BLOOD MARROW TR, V19, P274, DOI 10.1016/j.bbmt.2012.09.008; Holloway PA, 2004, LEUKEMIA, V18, P1543, DOI 10.1038/sj.leu.2403445; HOROWITZ MM, 1990, BLOOD, V75, P555; Kroger N, 2010, BIOL BLOOD MARROW TR, V16, P1325, DOI 10.1016/j.bbmt.2010.07.001; Kroger N, 2010, BIOL BLOOD MARROW TR, V16, P1187, DOI 10.1016/j.bbmt.2010.06.008; Marijt WAE, 2003, P NATL ACAD SCI USA, V100, P2742, DOI 10.1073/pnas.0530192100; MARIJT WAF, 1993, BLOOD, V82, P3778; Martinez-Climent JA, 2010, HAEMATOL-HEMATOL J, V95, P293, DOI 10.3324/haematol.2009.013318; Matsui W, 2008, CANCER RES, V68, P190, DOI 10.1158/0008-5472.CAN-07-3096; Mutis T, 2010, LEUKEMIA, V24, P1388, DOI 10.1038/leu.2010.115; Mutis T, 1999, BLOOD, V93, P2336, DOI 10.1182/blood.V93.7.2336.407k26_2336_2341; Mutis T, 1999, NAT MED, V5, P839, DOI 10.1038/10563; Riches JC, 2013, BLOOD, V121, P1612, DOI 10.1182/blood-2012-09-457531; Rosinski KV, 2008, BLOOD, V111, P4817, DOI 10.1182/blood-2007-06-096313; Rufer N, 1998, BONE MARROW TRANSPL, V22, P895, DOI 10.1038/sj.bmt.1701466; SHULMAN HM, 1980, AM J MED, V69, P204, DOI 10.1016/0002-9343(80)90380-0; Spierings E, 2003, LANCET, V362, P610, DOI 10.1016/S0140-6736(03)14191-8; Spierings E, 2007, PLOS GENET, V3, P1108, DOI 10.1371/journal.pgen.0030103; Spierings E, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000042; Spierings E, 2013, BIOL BLOOD MARROW TR, V19, P1244, DOI 10.1016/j.bbmt.2013.06.001; Spierings E, 2009, J IMMUNOL, V182, P4809, DOI 10.4049/jimmunol.0803911; Stern M, 2008, BLOOD, V112, P2990, DOI 10.1182/blood-2008-01-135285; Toes REM, 1998, J IMMUNOL, V160, P4449; van Halteren AGS, 2009, BLOOD, V114, P2263, DOI 10.1182/blood-2009-01-200410; VANDERHARST D, 1994, BLOOD, V83, P1060; Verdijk RM, 2004, BLOOD, V103, P1961, DOI 10.1182/blood-2003-05-1625; Vogt MHJ, 2002, BLOOD, V99, P3027, DOI 10.1182/blood.V99.8.3027; Wagner K, 2011, HAEMATOL-HEMATOL J, V96, P681, DOI 10.3324/haematol.2010.034074; Wiedemann B, 2010, EXP HEMATOL, V38, P1261, DOI 10.1016/j.exphem.2010.08.006; Wilke Martina, 2003, Hematol J, V4, P315, DOI 10.1038/sj.thj.6200318	49	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119595	10.1371/journal.pone.0119595	http://dx.doi.org/10.1371/journal.pone.0119595			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774796	gold, Green Submitted, Green Published			2022-12-27	WOS:000351183500104
J	Bersten, DC; Sullivan, AE; Li, D; Bhakti, V; Bent, SJ; Whitelaw, ML				Bersten, David C.; Sullivan, Adrienne E.; Li, Dian; Bhakti, Veronica; Bent, Stephen J.; Whitelaw, Murray L.			Inducible and Reversible Lentiviral and Recombination Mediated Cassette Exchange (RMCE) Systems for Controlling Gene Expression	PLOS ONE			English	Article							RNA INTERFERENCE; IN-VITRO; MICE; RESOURCE; MOUSE; PURIFICATION; INTEGRATION; GENERATION; PROTEINS; DESIGN	Manipulation of gene expression to invoke loss of function (LoF) or gain of function (GoF) phenotypes is important for interrogating complex biological questions both in vitro and in vivo. Doxycycline (Dox)-inducible gene expression systems are commonly used although success is often limited by high background and insufficient sensitivity to Dox. Here we develop broadly applicable platforms for reliable, tightly controlled and reversible Dox-inducible systems for lentiviral mediated generation of cell lines or FLP Recombination-Mediated Cassette Exchange (RMCE) into the Collagen 1a1 (Col1a1) locus (FLP-In Col1a1) in mouse embryonic stem cells. We significantly improve the flexibility, usefulness and robustness of the Dox-inducible system by using Tetracycline (Tet) activator (Tet-On) variants which are more sensitive to Dox, have no background activity and are expressed from single Gateway-compatible constructs. We demonstrate the usefulness of these platforms in ectopic gene expression or gene knockdown in multiple cell lines, primary neurons and in FLP-In Col1a1 mouse embryonic stem cells. We also improve the flexibility of RMCE Dox-inducible systems by generating constructs that allow for tissue or cell type-specific Dox-inducible expression and generate a shRNA selection algorithm that can effectively predict potent shRNA sequences able to knockdown gene expression from single integrant constructs. These platforms provide flexible, reliable and broadly applicable inducible expression systems for studying gene function.	[Bersten, David C.; Sullivan, Adrienne E.; Li, Dian; Bhakti, Veronica; Whitelaw, Murray L.] Univ Adelaide, Sch Mol & Biomed Sci Biochem, Adelaide, SA, Australia; [Bersten, David C.; Sullivan, Adrienne E.; Li, Dian; Bhakti, Veronica; Whitelaw, Murray L.] Univ Adelaide, Inst Mol Pathol, Adelaide, SA, Australia; [Bent, Stephen J.] Univ Adelaide, Sch Mol & Biomed Sci Genet, Adelaide, SA, Australia; [Bent, Stephen J.] Univ Adelaide, Robinson Res Inst, Adelaide, SA, Australia	University of Adelaide; University of Adelaide; University of Adelaide; Robinson Research Institute; University of Adelaide	Bersten, DC (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci Biochem, Adelaide, SA, Australia.	david.bersten@adelaide.edu.au; murray.whitelaw@adelaide.edu.au	Bent, Stephen/A-7094-2011	Bent, Stephen/0000-0003-1563-2855; Sullivan, Adrienne/0000-0003-3967-892X	Australian Research Council; National Health and Medical Research Council of Australia	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by the Australian Research Council and the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Bersten DC, 2014, BBA-GENE REGUL MECH, V1839, P13, DOI 10.1016/j.bbagrm.2013.11.004; Bersten DC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085768; Bersten DC, 2013, NAT REV CANCER, V13, P827, DOI 10.1038/nrc3621; Brown CY, 2010, HUM GENE THER, V21, P1005, DOI 10.1089/hum.2009.107; Burckstummer T, 2006, NAT METHODS, V3, P1013, DOI 10.1038/nmeth968; Carey BW, 2010, NAT METHODS, V7, P56, DOI [10.1038/NMETH.1410, 10.1038/nmeth.1410]; Ding Y, 2004, NUCLEIC ACIDS RES, V32, pW135, DOI 10.1093/nar/gkh449; Do CB, 2006, BIOINFORMATICS, V22, pE90, DOI 10.1093/bioinformatics/btl246; Dow LE, 2012, NAT PROTOC, V7, P374, DOI 10.1038/nprot.2011.446; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; Farrall AL, 2009, ONCOGENE, V28, P3671, DOI 10.1038/onc.2009.228; Fellmann C, 2013, CELL REP, V5, P1704, DOI 10.1016/j.celrep.2013.11.020; Fellmann C, 2011, MOL CELL, V41, P733, DOI 10.1016/j.molcel.2011.02.008; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Goshima N, 2008, NAT METHODS, V5, P1011, DOI 10.1038/nmeth.1273; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Haenebalcke L, 2013, CELL REP, V3, P335, DOI 10.1016/j.celrep.2013.01.016; Hao N, 2013, NUCLEIC ACIDS RES, V41, P5626, DOI 10.1093/nar/gkt206; Heinz N, 2011, HUM GENE THER, V22, P166, DOI 10.1089/hum.2010.099; Herold MJ, 2008, P NATL ACAD SCI USA, V105, P18507, DOI 10.1073/pnas.0806213105; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Kakinuma H, 2003, CANCER RES, V63, P7840; Kleibeuker W, 2009, HUM GENE THER, V20, P524, DOI 10.1089/hum.2008.182; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Loew R, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-81; Matveeva Olga V., 2012, Frontiers in Genetics, V3, P163, DOI 10.3389/fgene.2012.00163; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Moser M, 2004, MOL BRAIN RES, V128, P141, DOI 10.1016/j.molbrainres.2004.06.023; Premsrirut PK, 2011, CELL, V145, P145, DOI 10.1016/j.cell.2011.03.012; Ramachandrappa S, 2013, J CLIN INVEST, V123, P3042, DOI 10.1172/JCI68016; Raymond CS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000162; Sciabola S, 2013, NUCLEIC ACIDS RES, V41, P1383, DOI 10.1093/nar/gks1191; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Tan X, 2012, P NATL ACAD SCI USA, V109, P869, DOI 10.1073/pnas.1119873109; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tasic B, 2011, P NATL ACAD SCI USA, V108, P7902, DOI 10.1073/pnas.1019507108; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Wefers B, 2013, P NATL ACAD SCI USA, V110, P3782, DOI 10.1073/pnas.1218721110; Wu S, 2008, NAT PROTOC, V3, P1056, DOI 10.1038/nprot.2008.70; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Zhou X, 2006, GENE THER, V13, P1382, DOI 10.1038/sj.gt.3302780; Zuber J, 2011, NAT BIOTECHNOL, V29, P79, DOI 10.1038/nbt.1720	46	3	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0116373	10.1371/journal.pone.0116373	http://dx.doi.org/10.1371/journal.pone.0116373			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768837	Green Published, Green Submitted, gold			2022-12-27	WOS:000351277500009
J	Angeletti, S; Dicuonzo, G; Avola, A; Crea, F; Dedej, E; Vailati, F; Farina, C; De Florio, L				Angeletti, Silvia; Dicuonzo, Giordano; Avola, Alessandra; Crea, Francesca; Dedej, Etleva; Vailati, Francesca; Farina, Claudio; De Florio, Lucia			Viridans Group Streptococci Clinical Isolates: MALDI-TOF Mass Spectrometry versus Gene Sequence-Based Identification	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; PNEUMONIAE; PSEUDOPNEUMONIAE; BACTEREMIA	Viridans Group Streptococci (VGS) species-level identification is fundamental for patients management. Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) has been used for VGS identification but discrimination within the Mitis group resulted difficult. In this study, VGS identifications with two MALDI-TOF instruments, the Biotyper (Bruker) and the VITEK MS (bioMerieux) have been compared to those derived from tuf, soda and rpoB genes sequencing. VGS isolates were clustered and a dendrogram constructed using the Biotyper 3.0 software (Bruker). RpoB gene sequencing resulted the most sensitive and specific molecular method for S. pneumonia identification and was used as reference method. The sensitivity and the specificity of the VITEK MS in S. pneumonia identification were 100%, while the Biotyper resulted less specific (92.4%). In non pneumococcal VGS strains, the group-level correlation between rpoB and the Biotyper was 100%, while the species-level correlation was 61% after database upgrading (than 37% before upgrading). The group-level correlation between rpoB and the VITEK MS was 100%, while the species-level correlation was 36% and increases at 69% if isolates identified as S. mitis/S. oralis are included. The less accurate performance of the VITEK MS in VGS identification within the Mitis group was due to the inability to discriminate between S. mitis and S. oralis. Conversely, the Biotyper, after the release of the upgraded database, was able to discriminate between the two species. In the dendrogram, VGS strains from the same group were grouped into the same cluster and had a good correspondence with the gene-based clustering reported by other authors, thus confirming the validity of the upgraded version of the database. Data from this study demonstrated that MALDI-TOF technique can represent a rapid and cost saving method for VGS identification even within the Mitis group but improvements of spectra database are still recommended.	[Angeletti, Silvia; Dicuonzo, Giordano; Avola, Alessandra; Crea, Francesca; Dedej, Etleva; De Florio, Lucia] Univ Hosp Campus Biomed Rome, Clin Pathol & Microbiol Lab, Rome, Italy; [Vailati, Francesca; Farina, Claudio] AO Papa Giovanni XXIII, Inst Microbiol, Bergamo, Italy	University Campus Bio-Medico - Rome Italy; ASST Papa Giovanni XXIII	Angeletti, S (corresponding author), Univ Hosp Campus Biomed Rome, Clin Pathol & Microbiol Lab, Rome, Italy.	s.angeletti@unicampus.it	Farina, Claudio/U-7175-2017	Farina, Claudio/0000-0003-2298-4293				Arbique JC, 2004, J CLIN MICROBIOL, V42, P4686, DOI 10.1128/JCM.42.10.4686-4696.2004; Bizzini A, 2010, J CLIN MICROBIOL, V48, P1549, DOI 10.1128/JCM.01794-09; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; DeSimone DC, 2012, CIRCULATION, V126, P60, DOI 10.1161/CIRCULATIONAHA.112.095281; Doern CD, 2010, J CLIN MICROBIOL, V48, P3829, DOI 10.1128/JCM.01563-10; Drancourt M, 2004, J CLIN MICROBIOL, V42, P497, DOI 10.1128/JCM.42.2.497-504.2004; Facklam R, 2002, CLIN MICROBIOL REV, V15, P613, DOI 10.1128/CMR.15.4.613-630.2002; Friedrichs C, 2007, J CLIN MICROBIOL, V45, P2392, DOI 10.1128/JCM.00556-07; Galloway-Pena J, 2014, J CLIN MICROBIOL, V52, P2905, DOI 10.1128/JCM.01068-14; Hoshino T, 2005, J CLIN MICROBIOL, V43, P6073, DOI 10.1128/JCM.43.12.6073-6085.2005; Husain E, 2005, PEDIATR INFECT DIS J, V24, P563, DOI 10.1097/01.inf.0000164708.21464.03; Karpanoja P, 2014, EUR J CLIN MICROBIOL, V33, P779, DOI 10.1007/s10096-013-2012-8; Kawamura Y, 1999, MICROBIOL-UK, V145, P2605, DOI 10.1099/00221287-145-9-2605; Kellogg JA, 2001, J CLIN MICROBIOL, V39, P3373, DOI 10.1128/JCM.39.9.3373-3375.2001; Kitten T, 2012, J CLIN MICROBIOL, V50, P1039, DOI 10.1128/JCM.06438-11; Roa PL, 2013, CLIN MICROBIOL INFEC, V19, P438, DOI 10.1111/j.1469-0691.2012.03837.x; Matsumura Y, 2014, J CLIN MICROBIOL, V52, P1034, DOI 10.1128/JCM.03196-13; Messmer TO, 2004, DIAGN MICR INFEC DIS, V49, P249, DOI 10.1016/j.diagmicrobio.2004.04.013; Neville SA, 2011, J CLIN MICROBIOL, V49, P2980, DOI 10.1128/JCM.00431-11; Picard FJ, 2004, J CLIN MICROBIOL, V42, P3686, DOI 10.1128/jcm.42.8.3686-3695.2004; Sasaki E, 2004, J CLIN MICROBIOL, V42, P1360, DOI 10.1128/JCM.42.3.1360-1362.2004; Shelburne SA, 2014, EMERG INFECT DIS, V20, P762, DOI 10.3201/eid2005.130953; Song JH, 2009, INT J ANTIMICROB AG, V33, P93, DOI 10.1016/j.ijantimicag.2008.06.023; Teles C, 2011, EUR J CLIN MICROBIOL, V30, P243, DOI 10.1007/s10096-010-1076-y; Thompson Cristiane C, 2013, F1000Res, V2, P67, DOI 10.12688/f1000research.2-67.v1; Wessels E, 2012, J CLIN MICROBIOL, V50, P1171, DOI 10.1128/JCM.06609-11; Wolters M, 2011, INT J MED MICROBIOL, V301, P64, DOI 10.1016/j.ijmm.2010.06.002	27	45	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120502	10.1371/journal.pone.0120502	http://dx.doi.org/10.1371/journal.pone.0120502			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781023	Green Submitted, gold, Green Published			2022-12-27	WOS:000351284600167
J	Chen, P; Liu, Z; Wang, XJ; Peng, JH; Sun, QQ; Li, JZ; Wang, MX; Niu, LW; Zhang, ZY; Cai, G; Teng, MK; Li, X				Chen, Peng; Liu, Zheng; Wang, Xuejuan; Peng, Junhui; Sun, Qianqian; Li, Jianzhong; Wang, Mingxing; Niu, Liwen; Zhang, Zhiyong; Cai, Gang; Teng, Maikun; Li, Xu			Crystal and EM Structures of Human Phosphoribosyl Pyrophosphate Synthase I (PRS1) Provide Novel Insights into the Disease-Associated Mutations	PLOS ONE			English	Article							OF-FUNCTION MUTATIONS; DIPHOSPHATE SYNTHASE; SYNTHETASE; PRPS1; VISUALIZATION; SUPERACTIVITY; DYNAMICS; PROTEIN; CLONING; ENZYME	Human PRS1, which is indispensable for the biosynthesis of nucleotides, deoxynucleotides and their derivatives, is associated directly with multiple human diseases because of single base mutation. However, a molecular understanding of the effect of these mutations is hampered by the lack of understanding of its catalytic mechanism. Here, we reconstruct the 3D EM structure of the PRS1 apo state. Together with the native stain EM structures of AMPNPP, AMPNPP and R5P, ADP and the apo states with distinct conformations, we suggest the hexamer is the enzymatically active form. Based on crystal structures, sequence analysis, mutagenesis, enzyme kinetics assays, and MD simulations, we reveal the conserved substrates binding motifs and make further analysis of all pathogenic mutants.	[Chen, Peng; Liu, Zheng; Wang, Xuejuan; Peng, Junhui; Sun, Qianqian; Wang, Mingxing; Niu, Liwen; Zhang, Zhiyong; Cai, Gang; Teng, Maikun; Li, Xu] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Chen, Peng; Liu, Zheng; Wang, Xuejuan; Peng, Junhui; Sun, Qianqian; Wang, Mingxing; Niu, Liwen; Zhang, Zhiyong; Cai, Gang; Teng, Maikun; Li, Xu] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Chen, Peng; Liu, Zheng; Wang, Xuejuan; Peng, Junhui; Sun, Qianqian; Wang, Mingxing; Niu, Liwen; Zhang, Zhiyong; Cai, Gang; Teng, Maikun; Li, Xu] Chinese Acad Sci, Key Lab Struct Biol, Hefei 230026, Anhui, Peoples R China; [Li, Jianzhong] PLA, Nanjing Command, Fuzhou Gen Hosp, Dept Otolaryngol Head & Neck Surg, Fuzhou 350025, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences	Cai, G (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China.	gcai@ustc.edu.cn; mkteng@ustc.edu.cn; sachem@ustc.edu.cn	Cai, Gang/AAA-4439-2020; Peng, Junhui/ABH-7078-2020; Wang, Xuejuan/G-5093-2018; Cai, Gang/B-1103-2012	Cai, Gang/0000-0001-8622-3907; Peng, Junhui/0000-0003-2855-2299; Wang, Xuejuan/0000-0001-6493-9971; Cai, Gang/0000-0001-8622-3907; Li, Xu/0000-0001-5221-0817	Chinese Ministry of Science and Technology [2012CB917200]; Chinese National Natural Science Foundation [31130018, 31370732, 31270014, 31270760, U1432107]; Scientific Research Grant of Hefei Science Center of CAS [2015SRG-HSC042]; Science and Technological Fund of Anhui Province for Outstanding Youth [1308085JGD08]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Scientific Research Grant of Hefei Science Center of CAS; Science and Technological Fund of Anhui Province for Outstanding Youth	Financial support for this project was provided by the Chinese Ministry of Science and Technology (Grant Nos. 2012CB917200), Chinese National Natural Science Foundation (Grant Nos. 31130018, 31370732, 31270014, 31270760 and U1432107), the Scientific Research Grant of Hefei Science Center of CAS (Grant No. 2015SRG-HSC042) and the Science and Technological Fund of Anhui Province for Outstanding Youth (Grant No. 1308085JGD08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECKER MA, 1995, J CLIN INVEST, V96, P2133, DOI 10.1172/JCI118267; Becker MA, 1996, J BIOL CHEM, V271, P19894, DOI 10.1074/jbc.271.33.19894; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cai G, 2010, NAT STRUCT MOL BIOL, V17, P273, DOI 10.1038/nsmb.1757; Chen P, 2013, IUBMB LIFE; Cherney MM, 2011, J MOL BIOL, V413, P844, DOI 10.1016/j.jmb.2011.09.007; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Brouwer APM, 2007, AM J HUM GENET, V81, P507, DOI 10.1086/520706; de Brouwer APM, 2010, AM J HUM GENET, V86, P506, DOI 10.1016/j.ajhg.2010.02.024; Eriksen TA, 2000, NAT STRUCT BIOL, P24; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fisher D, 2002, EWEEK, V19, P1; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Getz G, 2007, SCIENCE, V317, DOI 10.1126/science.1138764; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Hove-Jensen B, 2005, FEBS J, V272, P3631, DOI 10.1111/j.1742-4658.2005.04785.x; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kadziola A, 2005, J MOL BIOL, V354, P815, DOI 10.1016/j.jmb.2005.10.001; Kamal MA, 2004, INT J BIOCHEM CELL B, V36, P545, DOI 10.1016/j.biocel.2003.08.014; Katashima R, 1998, BBA-GENE STRUCT EXPR, V1396, P245, DOI 10.1016/S0167-4781(97)00217-0; Kim HJ, 2007, AM J HUM GENET, V81, P552, DOI 10.1086/519529; KITA K, 1994, J BIOL CHEM, V269, P8334; Krath BN, 2001, J BIOL CHEM, V276, P17851, DOI 10.1074/jbc.M010172200; Li S, 2007, BIOCHEM J, V401, P39, DOI 10.1042/BJ20061066; Liu HL, 2009, BIOCHEM BIOPH RES CO, V379, P1120, DOI 10.1016/j.bbrc.2009.01.034; Liu XZ, 2010, AM J HUM GENET, V86, P65, DOI 10.1016/j.ajhg.2009.11.015; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Moran R, 2012, AM J MED GENET A, V158A, P455, DOI 10.1002/ajmg.a.34428; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; VERLET L, 1967, PHYS REV, V159, P98, DOI 10.1103/PhysRev.159.98; Voss NR, 2010, J STRUCT BIOL, V169, P389, DOI 10.1016/j.jsb.2009.12.005	37	7	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120304	10.1371/journal.pone.0120304	http://dx.doi.org/10.1371/journal.pone.0120304			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781187	Green Submitted, Green Published, gold			2022-12-27	WOS:000351284600148
J	Ebadi, A; Schiffauerova, A				Ebadi, Ashkan; Schiffauerova, Andrea			On the Relation between the Small World Structure and Scientific Activities	PLOS ONE			English	Article							CO-AUTHORSHIP NETWORKS; COLLABORATION NETWORKS; STATISTICAL-MECHANICS; SOCIAL NETWORK; SCIENCE; IMPACT; PERFORMANCE; CREATIVITY; MALAYSIA; LIBRARY	The modern science has become more complex and interdisciplinary in its nature which might encourage researchers to be more collaborative and get engaged in larger collaboration networks. Various aspects of collaboration networks have been examined so far to detect the most determinant factors in knowledge creation and scientific production. One of the network structures that recently attracted much theoretical attention is called small world. It has been suggested that small world can improve the information transmission among the network actors. In this paper, using the data on 12 periods of journal publications of Canadian researchers in natural sciences and engineering, the co-authorship networks of the researchers are created. Through measuring small world indicators, the small worldiness of the mentioned network and its relation with researchers' productivity, quality of their publications, and scientific team size are assessed. Our results show that the examined co-authorship network strictly exhibits the small world properties. In addition, it is suggested that in a small world network researchers expand their team size through getting connected to other experts of the field. This team size expansion may result in higher productivity of the whole team as a result of getting access to new resources, benefitting from the internal referring, and exchanging ideas among the team members. Moreover, although small world network is positively correlated with the quality of the articles in terms of both citation count and journal impact factor, it is negatively related with the average productivity of researchers in terms of the number of their publications.	[Ebadi, Ashkan; Schiffauerova, Andrea] Concordia Univ, CIISE, Montreal, PQ, Canada; [Schiffauerova, Andrea] Masdar Inst, Dept Engn Syst & Management, Masdar City, Abu Dhabi, U Arab Emirates	Concordia University - Canada; Khalifa University of Science & Technology	Ebadi, A (corresponding author), Concordia Univ, CIISE, Montreal, PQ, Canada.	a_ebad@encs.concordia.ca	Ebadi, Ashkan/AAI-5123-2020; Ebadi, Ashkan/GWZ-9018-2022	Ebadi, Ashkan/0000-0002-4542-9105; 				Abbasi A, 2011, J INFORMETR, V5, P594, DOI 10.1016/j.joi.2011.05.007; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; [Anonymous], 6 DEGREES SEPARATION; Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; Baum JAC, 2004, CAN J ADM SCI, V21, P307; Baum JAC, 2003, IND CORP CHANGE, V12, P697, DOI 10.1093/icc/12.4.697; Beaudry C, 2012, RES POLICY, V41, P1589, DOI 10.1016/j.respol.2012.03.022; BEAVER DD, 1979, SCIENTOMETRICS, V1, P231, DOI 10.1007/BF02016308; CENTRA JA, 1983, RES HIGH EDUC, V18, P379, DOI 10.1007/BF00974804; Chen ZF, 2010, J INFORMETR, V4, P97, DOI 10.1016/j.joi.2009.09.003; Coleman J., 1981, LONGITUDINAL DATA AN; Couto FM, 2009, HANDLING SELF CITATI; Cowan R, 2004, J ECON DYN CONTROL, V28, P1557, DOI 10.1016/j.jedc.2003.04.002; Davis G. F., 2003, Strategic Organization, V1, P301, DOI 10.1177/14761270030013002; De Nooy W., 2005, EXPLORATORY SOCIAL N; EISENHARDT KM, 1995, ADMIN SCI QUART, V40, P84, DOI 10.2307/2393701; ERDOS P, 1960, B INT STATIST INST, V38, P343; Eslami H, 2013, SCIENTOMETRICS, V97, P99, DOI 10.1007/s11192-013-1069-6; Fatt CK, 2010, SCIENTOMETRICS, V85, P849, DOI 10.1007/s11192-010-0254-0; Fleming L, 2007, ORGAN SCI, V18, P938, DOI 10.1287/orsc.1070.0289; Fleming L, 2006, CALIF MANAGE REV, V48, P6, DOI 10.2307/41166358; Fowler J., 2005, TURNOUT SMALL WORLD, P269; Gingras Y, 1996, BIBLIMETRIC ANAL FUN; Glanzel W, 2001, SCIENTOMETRICS, V51, P69, DOI 10.1023/A:1010512628145; Godin B, 2003, IMPACT RES GRANTS PR; Goyal S, 2006, J POLIT ECON, V114, P403, DOI 10.1086/500990; Guimera R, 2005, SCIENCE, V308, P697, DOI 10.1126/science.1106340; Gulati R, 2012, ORGAN SCI, V23, P449, DOI 10.1287/orsc.1100.0592; Hanneman RobertA., 2011, SAGE HDB SOCIAL NETW, P340, DOI DOI 10.4135/9781446294413.N24; HAUSMAN J, 1984, ECONOMETRICA, V52, P909, DOI 10.2307/1911191; He J, 2009, TECHNOL FORECAST SOC, V76, P91, DOI 10.1016/j.techfore.2008.03.020; Katz JS, 1997, RES POLICY, V26, P1, DOI 10.1016/S0048-7333(96)00917-1; Kogut B, 2001, AM SOCIOL REV, V66, P317, DOI 10.2307/3088882; Kostoff RN, 2002, SCIENTOMETRICS, V53, P49, DOI 10.1023/A:1014831920172; Kumar S, 2014, SCIENTOMETRICS, V98, P387, DOI 10.1007/s11192-013-1059-8; Kumar S, 2013, SCIENTOMETRICS, V97, P491, DOI 10.1007/s11192-013-0994-8; Lariviere V, 2006, SCIENTOMETRICS, V68, P519, DOI 10.1007/s11192-006-0127-8; Lazer D, 2007, ADMIN SCI QUART, V52, P667, DOI 10.2189/asqu.52.4.667; Lin N., 2002, SOCIAL CAPITAL THEOR, V19; Lissoni F, 2013, IND INNOV, V20, P195, DOI 10.1080/13662716.2013.791128; Liu XM, 2005, INFORM PROCESS MANAG, V41, P1462, DOI 10.1016/j.ipm.2005.03.012; MILGRAM S, 1967, PSYCHOL TODAY, V1, P61; Moody J, 2004, AM SOCIOL REV, V69, P213, DOI 10.1177/000312240406900204; Nascimento MA, 2003, SIGMOD RECORD, V32, P8; Newman MEJ, 2000, J STAT PHYS, V101, P819, DOI 10.1023/A:1026485807148; Newman MEJ, 2004, LECT NOTES PHYS, V650, P337; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Okubo Y., 1997, BIBLIOMETRIC INDICAT; Rosenzweig JS, 2008, AM J EMERG MED, V26, P5, DOI 10.1016/j.ajem.2007.02.028; Savanur K, 2010, SCIENTOMETRICS, V84, P365, DOI 10.1007/s11192-009-0100-4; Schilling MA, 2007, MANAGE SCI, V53, P1113, DOI 10.1287/mnsc.1060.0624; SEGLEN PO, 1992, J AM SOC INFORM SCI, V43, P628, DOI 10.1002/(SICI)1097-4571(199210)43:9<628::AID-ASI5>3.0.CO;2-0; Sullivan Bilian Ni, 2012, International Journal of Strategic Change Management, V4, P149, DOI 10.1504/IJSCM.2012.046509; Tijssen RJW, 2004, RES POLICY, V33, P709, DOI 10.1016/j.respol.2003.11.002; TRAVERS J, 1969, SOCIOMETRY, V32, P425, DOI 10.2307/2786545; Uzzi B, 2005, AM J SOCIOL, V111, P447, DOI 10.1086/432782; Uzzi B, 2007, EUR MANAG REV, V4, P77, DOI 10.1057/palgrave.emr.1500078; van Raan AFJ, 2006, J AM SOC INF SCI TEC, V57, P1919, DOI 10.1002/asi.20389; WASSERMAN S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099; Yan EJ, 2010, SCIENTOMETRICS, V83, P115, DOI 10.1007/s11192-009-0027-9; Yan EJ, 2009, J AM SOC INF SCI TEC, V60, P2107, DOI 10.1002/asi.21128	63	17	19	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0121129	10.1371/journal.pone.0121129	http://dx.doi.org/10.1371/journal.pone.0121129			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7QC	25780922	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600196
J	Kishabongo, AS; Katchunga, P; Van Aken, EH; Speeckaert, R; Lagniau, S; Coopman, R; Speeckaert, MM; Delanghe, JR				Kishabongo, Antoine Sadiki; Katchunga, Philippe; Van Aken, Elisabeth H.; Speeckaert, Reinhart; Lagniau, Sabrina; Coopman, Renaat; Speeckaert, Marijn M.; Delanghe, Joris R.			Glycation of Nail Proteins: From Basic Biochemical Findings to a Representative Marker for Diabetic Glycation-Associated Target Organ Damage	PLOS ONE			English	Article							DISSOCIATION MASS-SPECTROMETRY; NONENZYMATIC GLYCATION; AFFINITY-CHROMATOGRAPHY; MAILLARD REACTION; STRATUM-CORNEUM; HAIR FOLLICLE; HUMAN PLASMA; EYE LENS; PEPTIDES; COMPLICATIONS	Background Although assessment of glycated nail proteins may be a useful marker for monitoring of diabetes, their nature and formation are still poorly understood. Besides a detailed anatomical analysis of keratin glycation, the usefulness of glycated nail protein assessment for monitoring diabetic complications was investigated. Methods 216 patients (94 males, 122 females; mean age +/- standard deviation: 75.0 +/- 8.7 years) were enrolled. Glycation of nail and eye lens proteins was assessed using a photometric nitroblue tetrazolium-based assay. Following chromatographic separation of extracted nail proteins, binding and nonbinding fractions were analyzed using one-dimensional gel electrophoresis. Using a hand piece containing a latch-type-bur, a meticulous cutting of the nail plate into superficial and deep layers was performed, followed by a differential analysis of fructosamine. Results Using SDS PAGE, four and two bands were identified among the nonglycated and glycated nail fraction respectively. Significantly lower fructosamine concentrations were found in the superficial nail layer (mean: 2.16 +/- 1.37 mu mol/g nails) in comparison with the deep layer (mean: 4.36 +/- 2.55 mu mol/g nails) (P<0.05). A significant higher amount of glycated eye lens proteins was found in diabetes mellitus patients (mean: 3.80 +/- 1.57 mu mol/g eye lens) in comparison with nondiabetics (mean: 3.35 +/- 1.34 mu mol/g eye lens) (P<0.05). A marked correlation was found between glycated nail and glycated eye lens proteins [y (glycated nail proteins) = 0.39 + 0.99 x (eye lens glycated proteins); r(2) = 0.58, P<0.001]. The concentration of glycated eye lens proteins and the HbA1c level were found to be predictors of the concentration of glycated nail proteins. Conclusions Glycation of nail proteins takes place in the deep layer of finger nails, which is in close contact with blood vessels and interstitial fluid. Glycation of nail proteins can be regarded as a representative marker for diabetic glycation-associated target organ damage.	[Kishabongo, Antoine Sadiki] Catholic Univ Bukavu, Dept Lab Med, Bukavu, DEM REP CONGO; [Katchunga, Philippe] Catholic Univ Bukavu, Dept Internal Med, Bukavu, DEM REP CONGO; [Van Aken, Elisabeth H.] Sint Elisabeth Ziekenhuis, Dept Ophthalmol, Zottegem, Belgium; [Speeckaert, Reinhart] Ghent Univ Hosp, Dept Dermatol, Ghent, Belgium; [Lagniau, Sabrina; Delanghe, Joris R.] Ghent Univ Hosp, Dept Clin Chem, Ghent, Belgium; [Coopman, Renaat] Ghent Univ Hosp, Dept Dent, Ghent, Belgium; [Speeckaert, Marijn M.] Ghent Univ Hosp, Dept Nephrol, Ghent, Belgium	Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital	Delanghe, JR (corresponding author), Ghent Univ Hosp, Dept Clin Chem, Ghent, Belgium.	joris.delanghe@ugent.be			Ghent University	Ghent University(Ghent University)	Antoine Sadiki Kishabongo received a PhD scholarship from Ghent University.	Abraham EC, 2008, MOL CELL BIOCHEM, V310, P235, DOI 10.1007/s11010-007-9685-1; Adler FH, 2003, ADLERS PHYSL EYE CLI; Anguizola J, 2013, CLIN CHIM ACTA, V425, P64, DOI 10.1016/j.cca.2013.07.013; Ansari NA, 2011, DIS MARKERS, V30, P317, DOI [10.3233/DMA-2011-0791, 10.1155/2011/718694]; ARAKI N, 1992, J BIOL CHEM, V267, P10211; ARMBRUSTER DA, 1987, CLIN CHEM, V33, P2153; BAKAN E, 1985, CLIN CHIM ACTA, V147, P1, DOI 10.1016/0009-8981(85)90003-8; BROWNLEE M, 1992, DIABETES CARE, V15, P1835, DOI 10.2337/diacare.15.12.1835; Burns T, 2010, ROOKS TXB DERMATOLOG, V4; Cashman MW, 2010, CLIN DERMATOL, V28, P420, DOI 10.1016/j.clindermatol.2010.03.037; Costello MJ, 2013, EXP EYE RES, V116, P411, DOI 10.1016/j.exer.2013.10.015; de Berker D, 2000, BRIT J DERMATOL, V142, P89, DOI 10.1046/j.1365-2133.2000.03246.x; de Berker D. A. R., 2007, International Journal of Cosmetic Science, V29, P241, DOI 10.1111/j.1467-2494.2007.00372.x; de Berker D, 2013, CLIN DERMATOL, V31, P509, DOI 10.1016/j.clindermatol.2013.06.006; DeGroot J, 2004, CURR OPIN PHARMACOL, V4, P301, DOI 10.1016/j.coph.2004.01.007; GARLICK RL, 1984, J CLIN INVEST, V74, P1742, DOI 10.1172/JCI111592; Goldsmith L.A., 1991, PHYSL BIOCH MOL BIOL, V2nd; Hage DS, 1999, CLIN CHEM, V45, P593; HEID HW, 1988, DIFFERENTIATION, V37, P215, DOI 10.1111/j.1432-0436.1988.tb00724.x; Horvat S, 2004, J PEPT SCI, V10, P119, DOI 10.1002/psc.519; Inoue T, 2001, BIOSCI BIOTECH BIOCH, V65, P895, DOI 10.1271/bbb.65.895; Jansirani, 2004, Indian J Clin Biochem, V19, P110, DOI 10.1007/BF02872403; Jeffcoate SL, 2004, DIABETIC MED, V21, P657, DOI 10.1046/j.1464-5491.2003.01065.x; JOHNSON RN, 1983, CLIN CHIM ACTA, V127, P87, DOI 10.1016/0009-8981(83)90078-5; Kim KJ, 2012, DIABETES METAB J, V36, P98, DOI 10.4093/dmj.2012.36.2.98; Kishabongo AS, 2014, TROP MED INT HEALTH, V19, P58, DOI 10.1111/tmi.12218; KITAHARA T, 1991, Journal of Dermatological Science, V2, P402, DOI 10.1016/0923-1811(91)90003-G; LYNCH MH, 1986, J CELL BIOL, V103, P2593, DOI 10.1083/jcb.103.6.2593; Machan CM, 2012, OPTOMETRY VISION SCI, V89, P1165, DOI 10.1097/OPX.0b013e3182644cd1; MAROVA I, 1995, ACTA DIABETOL, V32, P38, DOI 10.1007/BF00581043; Mennella C, 2006, J PEPT SCI, V12, P291, DOI 10.1002/psc.722; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Nagaraj RH, 2012, AMINO ACIDS, V42, P1205, DOI 10.1007/s00726-010-0778-x; Nakamura A, 2002, BIOL PHARM BULL, V25, P569, DOI 10.1248/bpb.25.569; Nawale RB, 2006, INDIAN J BIOCHEM BIO, V43, P337; OIMOMI M, 1986, HORM METAB RES, V18, P827, DOI 10.1055/s-2007-1012449; ORSONNEAU JL, 1989, CLIN CHEM, V35, P2233; Pepaj M, 2015, J LIQ CHROMATOGR R T, V38, P20, DOI 10.1080/10826076.2013.864980; Priego-Capote F, 2010, MOL CELL PROTEOMICS, V9, P579, DOI 10.1074/mcp.M900439-MCP200; Raguz M, 2014, EXP EYE RES, V120, P138, DOI 10.1016/j.exer.2014.01.018; Rogers MA, 2006, INT REV CYTOL, V251, P209, DOI 10.1016/S0074-7696(06)51006-X; Slingsby C, 2013, PROTEIN SCI, V22, P367, DOI 10.1002/pro.2229; Speeckaert M, 2014, NEPHROL DIAL TRANSPL, V29, P2167, DOI 10.1093/ndt/gfu006; Tessier FJ, 2010, PATHOL BIOL, V58, P214, DOI 10.1016/j.patbio.2009.09.014; Wiley LA, 2010, MOL VIS, V16, P1253; Zhang Q, 2008, RAPID COMMUN MASS SP, V22, P3027, DOI 10.1002/rcm.3703; Zhang QB, 2008, J PROTEOME RES, V7, P2025, DOI 10.1021/pr700763r; Zhang QB, 2007, J PROTEOME RES, V6, P2323, DOI 10.1021/pr070112q; Zhang QB, 2007, RAPID COMMUN MASS SP, V21, P661, DOI 10.1002/rcm.2884; Zhang Q, 2008, ANAL CHEM, V80, P9822, DOI 10.1021/ac801704j	50	18	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120112	10.1371/journal.pone.0120112	http://dx.doi.org/10.1371/journal.pone.0120112			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781337	Green Published, gold, Green Submitted			2022-12-27	WOS:000351284600129
J	Peregrin, LS; Butcher, PA; Broadhurst, MK; Millar, RB				Peregrin, Laura S.; Butcher, Paul A.; Broadhurst, Matt K.; Millar, Russell B.			Angling-Induced Barotrauma in Snapper Chrysophrys auratus: Are There Consequences for Reproduction?	PLOS ONE			English	Article							PAGRUS-AURATUS; FISH REPRODUCTION; RELEASE SURVIVAL; HANDLING STRESS; CAPTURE DEPTH; SEX STEROIDS; MORTALITY; CAUGHT; CATCH; QUALITY	In response to concerns regarding the potential for sub-lethal impacts of barotrauma on reproductively active Chrysophrys auratus during catch and release, 90 males and 90 females representing five reproductive stages (immature or resting-28%, developing-8%, developed-7%, ripe or spawning-23% and spent-34%) were angled from 8-70 m and macroscopically assessed (on-board and then in a laboratory). Irrespective of sex, all fish exhibited various clinical signs of barotrauma, including a prolapsed cloaca (60% of fish); gastric herniation (46%); ruptured swim bladder (73%); organ displacement (48%); and kidney (3%), liver (73%) and coloemic-cavity haemorrhaging (33%); with the frequency of nearly all positively associated with capture depth. Reproductive stage was also an important barotrauma predictor (reflecting related morphological changes) with a general trend towards spent fish least likely to incur the various clinical signs-especially for a prolapsed cloaca (also common among immature or resting fish and significantly affected by food in the digestive tract) and a ruptured swim bladder (common among ripe or spawning fish). The only macroscopically visible gonad damage was haemorrhaging, which was least common among immature or resting and spent fish and, irrespective of reproductive stage, temporally reduced in frequency, and more quickly among males than females. While further research is required to accurately describe the effects of angling at each stage of the reproductive cycle and the physiological consequences of barotrauma on the gonads of C. auratus, given the observed influences of reproductive stage and depth on barotrauma found in this study, any adverse effects might be partially managed by regulating either temporal or spatial fishing effort.	[Peregrin, Laura S.; Butcher, Paul A.] So Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia; [Butcher, Paul A.; Broadhurst, Matt K.] NSW Dept Primary Ind, Fisheries Conservat Technol Unit, Coffs Harbour, NSW, Australia; [Millar, Russell B.] Univ Auckland, Dept Stat, Auckland 1, New Zealand	Southern Cross University; NSW Department of Primary Industries; University of Auckland	Butcher, PA (corresponding author), So Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia.	Paul.Butcher@dpi.nsw.gov.au	Broadhurst, Matt K/I-6783-2015; Butcher, Paul/T-4367-2019	Broadhurst, Matt K/0000-0003-0184-7249; Butcher, Paul/0000-0001-7338-6037; Peregrin, Laura/0000-0002-2555-7257	NSW Recreational Fishing Trusts; NSW Department of Primary Industries	NSW Recreational Fishing Trusts; NSW Department of Primary Industries	This research was funded by the NSW Recreational Fishing Trusts and the NSW Department of Primary Industries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamini Y, 2001, ANN STAT, V29, P1165; Bettinger JM, 2005, N AM J FISH MANAGE, V25, P1273, DOI 10.1577/M04-156.1; Broadhurst MK, 2012, J FISH BIOL, V80, P638, DOI 10.1111/j.1095-8649.2011.03202.x; Broadhurst MK, 2005, J EXP MAR BIOL ECOL, V321, P171, DOI 10.1016/j.jembe.2005.02.001; Butcher PA, 2012, FISH RES, V127, P49, DOI 10.1016/j.fishres.2012.04.013; Campbell MD, 2010, ICES J MAR SCI, V67, P513, DOI 10.1093/icesjms/fsp255; CAMPBELL PM, 1992, BIOL REPROD, V47, P1140, DOI 10.1095/biolreprod47.6.1140; Carragher J.F., 1991, P253; CARRAGHER JF, 1993, AQUACULTURE, V109, P375, DOI 10.1016/0044-8486(93)90176-Y; Clearwater SJ, 1997, J FISH BIOL, V50, P429, DOI 10.1006/jfbi.1996.0311; Cleary JJ, 2002, AQUAC RES, V33, P829, DOI 10.1046/j.1365-2109.2002.00718.x; Cleary JJ, 2000, J WORLD AQUACULT SOC, V31, P558, DOI 10.1111/j.1749-7345.2000.tb00905.x; Ferrell D, 1995, ASSESSMENT FISHERY S; Grixti D, 2010, FISHERIES MANAG ECOL, V17, P1, DOI 10.1111/j.1365-2400.2009.00704.x; Hall KC, 2014, J FISH DIS, V37, P251, DOI 10.1111/jfd.12103; Hall KC, 2009, J FISH BIOL, V75, P2737, DOI 10.1111/j.1095-8649.2009.02474.x; Hannah RW, 2007, T AM FISH SOC, V136, P24, DOI 10.1577/T06-022.1; Henry GW, 2003, NATL RECREATIONAL IN; Jarvis ET, 2008, CAN J FISH AQUAT SCI, V65, P1286, DOI 10.1139/F08-071; Lenanton R, 2009, MAXIMISING SURVIVAL; Lucy JA, 2002, AM FISHERIES SOC S, V30, P114; McGrath SP, 2011, ICES J MAR SCI, V68, P2114, DOI 10.1093/icesjms/fsr151; McLennan MF, 2014, FISHERIES MANAG ECOL, V21, P330, DOI 10.1111/fme.12083; Nguyen V, 2009, FISH RES, V96, P313, DOI 10.1016/j.fishres.2008.12.003; Pankhurst NW, 1997, FISH STRESS HLTH AQU, P74; Phelan M., 2008, 91 NO TERR DEP PRIM; R Core Team, 2012, R LANG ENV STAT COMP; Roach JP, 2011, J FISH BIOL, V79, P1130, DOI 10.1111/j.1095-8649.2011.03096.x; Rummer JL, 2005, T AM FISH SOC, V134, P1457, DOI 10.1577/T04-235.1; Schreck CB, 2010, GEN COMP ENDOCR, V165, P549, DOI 10.1016/j.ygcen.2009.07.004; Schreck CB, 2001, AQUACULTURE, V197, P3, DOI 10.1016/S0044-8486(01)00580-4; St John J, 2005, FISH RES, V76, P106, DOI 10.1016/j.fishres.2005.05.014; Stewart J, 2010, FISHERIES REPORT SER, V27; Stewart J, 2008, FISH RES, V90, P289, DOI 10.1016/j.fishres.2007.11.003; Wakefield CB, 2011, J FISH BIOL, V77, P1359	35	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119158	10.1371/journal.pone.0119158	http://dx.doi.org/10.1371/journal.pone.0119158			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781929	gold, Green Published			2022-12-27	WOS:000351284600053
J	Ueda, K; Yoshimura, K; Yamashita, O; Harada, T; Morikage, N; Hamano, K				Ueda, Koshiro; Yoshimura, Koichi; Yamashita, Osamu; Harada, Takasuke; Morikage, Noriyasu; Hamano, Kimikazu			Possible Dual Role of Decorin in Abdominal Aortic Aneurysm	PLOS ONE			English	Article							LEUCINE-RICH PROTEOGLYCANS; N-TERMINAL KINASE; INHIBITION; EXPRESSION; BIGLYCAN; MATRIX-METALLOPROTEINASE-9; ACTIVATION; REGRESSION; PATHWAY; DISEASE	Abdominal aortic aneurysm (AAA) is characterized by chronic inflammation, which leads to pathological remodeling of the extracellular matrix. Decorin, a small leucine-rich repeat proteoglycan, has been suggested to regulate inflammation and stabilize the extracellular matrix. Therefore, the present study investigated the role of decorin in the pathogenesis of AAA. Decorin was localized in the aortic adventitia under normal conditions in both mice and humans. AAA was induced in mice using CaCl2 treatment. Initially, decorin protein levels decreased, but as AAA progressed decorin levels increased in all layers. Local administration of exogenous decorin prevented the development of CaCl2-induced AAA. However, decorin was highly expressed in the degenerative lesions of human AAA walls, and this expression positively correlated with matrix metalloproteinase (MMP)-9 expression. In cell culture experiments, the addition of decorin inhibited secretion of MMP-9 in vascular smooth muscle cells, but had the opposite effect in macrophages. The results suggest that decorin plays a dual role in AAA. Adventitial decorin in normal aorta may protect against the development of AAA, but macrophages expressing decorin in AAA walls may facilitate the progression of AAA by up-regulating MMP-9 secretion.	[Ueda, Koshiro; Yoshimura, Koichi; Yamashita, Osamu; Harada, Takasuke; Morikage, Noriyasu; Hamano, Kimikazu] Yamaguchi Univ, Grad Sch Med, Dept Surg & Clin Sci, Ube, Yamaguchi 7558505, Japan; [Yoshimura, Koichi] Yamaguchi Prefectural Univ, Grad Sch Hlth & Welf, Yamaguchi 7538502, Japan	Yamaguchi University	Yoshimura, K (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Surg & Clin Sci, Ube, Yamaguchi 7558505, Japan.	yoshimko@yamaguchi-u.ac.jp			Japan Society for the Promotion of Science [KAKENHI 24390302, 26670618]; Takeda Science Foundation; Uehara Memorial Foundation; Grants-in-Aid for Scientific Research [24390302] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (KAKENHI 24390302 and 26670618 to KY), the Takeda Science Foundation (to KY), and the Uehara Memorial Foundation (to KY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Zen AA, 2006, ATHEROSCLEROSIS, V187, P31, DOI 10.1016/j.atherosclerosis.2005.08.023; Ang LS, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.88; Dil N, 2012, HEAD NECK ONCOL, V4, DOI 10.1186/1758-3284-4-11; Frey H, 2013, FEBS J, V280, P2165, DOI 10.1111/febs.12145; Geng YQ, 2006, MATRIX BIOL, V25, P484, DOI 10.1016/j.matbio.2006.08.259; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Golledge J, 2006, ARTERIOSCL THROM VAS, V26, P2605, DOI 10.1161/01.ATV.0000245819.32762.cb; Golledge J, 2011, CARDIOVASC RES, V92, P19, DOI 10.1093/cvr/cvr183; Golledge J, 2011, ATHEROSCLEROSIS, V217, P57, DOI 10.1016/j.atherosclerosis.2011.03.006; Gomez D, 2009, J PATHOL, V218, P131, DOI 10.1002/path.2516; Hamblin M, 2010, J VASC SURG, V52, P984, DOI 10.1016/j.jvs.2010.05.089; Hellenthal FAMVI, 2009, NAT REV CARDIOL, V6, P464, DOI 10.1038/nrcardio.2009.80; Humphrey JD, 2013, J VASC RES, V50, P1, DOI 10.1159/000342436; Kadirvel R, 2010, NEUROSURGERY, V66, P578, DOI 10.1227/01.NEU.0000365769.78334.8C; Kimura T, 2011, PATHOL INT, V61, P559, DOI 10.1111/j.1440-1827.2011.02699.x; Kochanek Kenneth D, 2011, Natl Vital Stat Rep, V60, P1; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; Marchica CL, 2011, AM J PHYSIOL-LUNG C, V300, pL863, DOI 10.1152/ajplung.00300.2009; Marzoll A, 2011, J CELL MOL MED, V15, P232, DOI 10.1111/j.1582-4934.2009.00986.x; Merline R, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001868; Mohamed SA, 2009, BIOMARK INSIGHTS, V4, P81; Moll FL, 2011, EUR J VASC ENDOVASC, V41, pS1, DOI 10.1016/j.ejvs.2010.09.011; Moreth K, 2012, CELL CYCLE, V11, P2084, DOI 10.4161/cc.20316; Nagasawa A, 2013, J SURG RES, V183, P472, DOI 10.1016/j.jss.2012.12.012; Neill T, 2012, AM J PATHOL, V181, P380, DOI 10.1016/j.ajpath.2012.04.029; Neill T, 2012, J BIOL CHEM, V287, P5492, DOI 10.1074/jbc.M111.283499; Nomura S, 2005, EUR SURG RES, V37, P370, DOI 10.1159/000090339; NORDSTROM T, 1994, FEBS LETT, V350, P82, DOI 10.1016/0014-5793(94)00738-1; PULKKINEN L, 1990, J BIOL CHEM, V265, P17780; Reinboth B, 2002, J BIOL CHEM, V277, P3950, DOI 10.1074/jbc.M109540200; Ricci R, 2004, SCIENCE, V306, P1558, DOI 10.1126/science.1101909; Rooke TW, 2011, J AM COLL CARDIOL, V58, P2020, DOI 10.1016/j.jacc.2011.08.023; Sakalihasan N, 2005, LANCET, V365, P1577, DOI 10.1016/S0140-6736(05)66459-8; Seidler DG, 2011, J IMMUNOL, V187, P6108, DOI 10.4049/jimmunol.1100373; Singla Sandeep, 2011, Ther Adv Cardiovasc Dis, V5, P305, DOI 10.1177/1753944711429715; Tedesco MM, 2010, VASCULAR SURG, P117; Theocharis AD, 2002, ATHEROSCLEROSIS, V165, P221, DOI 10.1016/S0021-9150(02)00231-9; Wang YT, 2013, CARDIOVASC PATHOL, V22, P126, DOI 10.1016/j.carpath.2012.07.005; Wu IC, 2010, INT J CANCER, V127, P2138, DOI 10.1002/ijc.25239; Wu Z, 2014, MATRIX BIOL, V35, P266, DOI 10.1016/j.matbio.2013.12.006; Xu YZ, 2012, NEUROCHEM RES, V37, P1843, DOI 10.1007/s11064-012-0787-0; Yamashita O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079753; Yoshimura K, 2005, NAT MED, V11, P1330, DOI 10.1038/nm1335; Yoshimura K, 2006, ANN NY ACAD SCI, V1085, P403, DOI 10.1196/annals.1383.049; Yoshimura K, 2006, ANN NY ACAD SCI, V1085, P74, DOI 10.1196/annals.1383.031; Yoshimura K, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/648167; Zhang K, 2014, EUR J CARDIO-THORAC	47	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120689	10.1371/journal.pone.0120689	http://dx.doi.org/10.1371/journal.pone.0120689			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781946	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600184
J	Wu, WS; Zhang, CY; Lin, WJ; Chen, Q; Guo, XD; Qian, Y; Zhang, LJ				Wu, Wensheng; Zhang, Canyang; Lin, Wenjing; Chen, Quan; Guo, Xindong; Qian, Yu; Zhang, Lijuan			Quantitative Structure-Property Relationship (QSPR) Modeling of Drug-Loaded Polymeric Micelles via Genetic Function Approximation	PLOS ONE			English	Article							BLOCK-COPOLYMER MICELLES; PH-SENSITIVE MICELLES; TRIBLOCK COPOLYMERS; EXTERNAL VALIDATION; DELIVERY; METHACRYLATE); PREDICTION; RELEASE; LENGTH	Self-assembled nano-micelles of amphiphilic polymers represent a novel anticancer drug delivery system. However, their full clinical utilization remains challenging because the quantitative structure-property relationship (QSPR) between the polymer structure and the efficacy of micelles as a drug carrier is poorly understood. Here, we developed a series of QSPR models to account for the drug loading capacity of polymeric micelles using the genetic function approximation (GFA) algorithm. These models were further evaluated by internal and external validation and a Y-randomization test in terms of stability and generalization, yielding an optimization model that is applicable to an expanded materials regime. As confirmed by experimental data, the relationship between microstructure and drug loading capacity can be well-simulated, suggesting that our models are readily applicable to the quantitative evaluation of the drug-loading capacity of polymeric micelles. Our work may offer a pathway to the design of formulation experiments.	[Wu, Wensheng; Zhang, Canyang; Lin, Wenjing; Chen, Quan; Guo, Xindong; Qian, Yu; Zhang, Lijuan] S China Univ Technol, Sch Chem & Chem Engn, Guangzhou 510641, Guangdong, Peoples R China; [Wu, Wensheng] Zhaoqing Univ, Sch Chem & Chem Engn, Zhaoqing, Peoples R China	South China University of Technology; Zhaoqing University	Zhang, LJ (corresponding author), S China Univ Technol, Sch Chem & Chem Engn, Guangzhou 510641, Guangdong, Peoples R China.	celjzh@scut.edu.cn	Zhang, Can Yang/G-7104-2015; ZHANG, Can Yang/AAK-2267-2021; ZHANG, CANYANG/O-8171-2016	ZHANG, CANYANG/0000-0002-6975-5781; Zhang, Lijuan/0000-0002-9765-1875	National Natural Science Foundation of China [21176090]; Team Project of Natural Science Foundation of Guangdong Province, China [S2011030001366]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20130172110009]; Fundamental Research Funds for the Central Universities, China [2013ZP0010, 2013ZZ0059, 2014ZP0020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Team Project of Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities, China(Fundamental Research Funds for the Central Universities)	This work was financially supported by National Natural Science Foundation of China (No. 21176090), Team Project of Natural Science Foundation of Guangdong Province, China (No. S2011030001366), Specialized Research Fund for the Doctoral Program of Higher Education of China (No. 20130172110009), and Fundamental Research Funds for the Central Universities, China (No. 2013ZP0010, 2013ZZ0059, 2014ZP0020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson A.C., 1985, PLOTS TRANSFORMATION; Babel MS, 2007, WATER RESOUR MANAG, V21, P573, DOI 10.1007/s11269-006-9030-6; Bahl J, 2012, J CHEMOMETR, V26, P85, DOI 10.1002/cem.2415; Bauhuber S, 2012, J CONTROL RELEASE, V162, P446, DOI 10.1016/j.jconrel.2012.07.017; Bouton F, 2010, LANGMUIR, V26, P7962, DOI 10.1021/la904836m; Dearden JC, 2009, SAR QSAR ENVIRON RES, V20, P241, DOI 10.1080/10629360902949567; Fagerberg T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065590; Feng C, 2013, LANGMUIR, V29, P10922, DOI 10.1021/la402335d; Feng ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100732; Friedman J, 1990, 102 LAB COMP STAT; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Gharagheizi F, 2012, CHEM ENG SCI, V76, P99, DOI 10.1016/j.ces.2012.03.033; Golbraikh A, 2002, J MOL GRAPH MODEL, V20, P269, DOI 10.1016/S1093-3263(01)00123-1; Gramatica P, 2004, EVALUATION DIFFERENT, P177; Gramatica P, 2007, QSAR COMB SCI, V26, P694, DOI 10.1002/qsar.200610151; Guo XD, 2012, IND ENG CHEM RES, V51, P4719, DOI 10.1021/ie2014668; Hira SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094309; Holland J.H., 1975, ADAPTATION NATURAL A; Kataoka K, 2001, ADV DRUG DELIVER REV, V47, P113, DOI 10.1016/S0169-409X(00)00124-1; Kim SW, 2011, J CONTROL RELEASE, V155, P116, DOI 10.1016/j.jconrel.2011.03.023; Kim S, 2008, J CONTROL RELEASE, V132, P222, DOI 10.1016/j.jconrel.2008.07.004; Lavasanifar A, 2002, ADV DRUG DELIVER REV, V54, P169, DOI 10.1016/S0169-409X(02)00015-7; Lei BL, 2009, ANAL CHIM ACTA, V644, P17, DOI 10.1016/j.aca.2009.04.019; Lin WJ, 2014, J MATER CHEM B, V2, P4008, DOI 10.1039/c3tb21694b; Lin WJ, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-243; Luo YL, 2013, IND ENG CHEM RES, V52, P1571, DOI 10.1021/ie3024164; Luo ZL, 2012, J CONTROL RELEASE, V162, P185, DOI 10.1016/j.jconrel.2012.06.027; Mehra R, 2013, MED CHEM RES, V22, P2303, DOI 10.1007/s00044-012-0225-5; Mhlanga P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053367; Oerlemans C, 2010, PHARM RES-DORDR, V27, P2569, DOI 10.1007/s11095-010-0233-4; Poon Z, 2011, NANOMED-NANOTECHNOL, V7, P201, DOI 10.1016/j.nano.2010.07.008; ROGERS D, 1994, J CHEM INF COMP SCI, V34, P854, DOI 10.1021/ci00020a020; Roy K, 2013, CHEM ENG SCI, V87, P141, DOI 10.1016/j.ces.2012.10.002; Roy K, 2012, CHEM ENG SCI, V73, P86, DOI 10.1016/j.ces.2012.01.005; Roy K, 2012, J CHEM INF MODEL, V52, P396, DOI 10.1021/ci200520g; Schuurmann G, 2008, J CHEM INF MODEL, V48, P2140, DOI 10.1021/ci800253u; Shahlaei M, 2013, CHEM REV, V113, P8093, DOI 10.1021/cr3004339; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Siepmann J, 2004, J CONTROL RELEASE, V96, P123, DOI 10.1016/j.jconrel.2004.01.011; Tatiya PD, 2013, IND ENG CHEM RES, V52, P1562, DOI 10.1021/ie301813a; Torchilin VP, 2004, CELL MOL LIFE SCI, V61, P2549, DOI 10.1007/s00018-004-4153-5; Tyrrell ZL, 2010, PROG POLYM SCI, V35, P1128, DOI 10.1016/j.progpolymsci.2010.06.003; Xiong XB, 2011, J CONTROL RELEASE, V155, P248, DOI 10.1016/j.jconrel.2011.04.028; Xu Y, 2014, IND ENG CHEM RES, V53, P4718, DOI 10.1021/ie4043196; Yang XL, 2014, PHARM RES-DORDR, V31, P291, DOI 10.1007/s11095-013-1160-y; Yang YQ, 2013, ACTA BIOMATER, V9, P7679, DOI 10.1016/j.actbio.2013.05.006; Yang YQ, 2012, LANGMUIR, V28, P8251, DOI 10.1021/la301099q; Zhang CY, 2014, J CONTROL RELEASE, V180, P42, DOI 10.1016/j.jconrel.2014.02.015; Zhang CY, 2012, BIOMATERIALS, V33, P6273, DOI 10.1016/j.biomaterials.2012.05.025; Zhang YH, 2010, NANOSCALE RES LETT, V5, P917, DOI 10.1007/s11671-010-9583-4; Zheng LS, 2011, J COLLOID INTERF SCI, V363, P114, DOI 10.1016/j.jcis.2011.07.040	51	36	38	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119575	10.1371/journal.pone.0119575	http://dx.doi.org/10.1371/journal.pone.0119575			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25780923	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600076
J	Yadav, MK; Chae, SW; Im, GJ; Chung, JW; Song, JJ				Yadav, Mukesh Kumar; Chae, Sung-Won; Im, Gi Jung; Chung, Jae-Woo; Song, Jae-Jun			Eugenol: A Phyto-Compound Effective against Methicillin-Resistant and Methicillin-Sensitive Staphylococcus aureus Clinical Strain Biofilms	PLOS ONE			English	Article							ESSENTIAL OILS; GENE-EXPRESSION; IN-VIVO; EPIDERMIDIS; CARVACROL; SARA; MECHANISMS; DISCOVERY; MODEL	Background Inhibition and eradication of Staphylococcus aureus biofilms with conventional antibiotic is difficult, and the treatment is further complicated by the rise of antibiotic resistance among staphylococci. Consequently, there is a need for novel antimicrobials that can treat biofilm-related infections and decrease antibiotics burden. Natural compounds such as eugenol with anti-microbial properties are attractive agents that could reduce the use of conventional antibiotics. In this study we evaluated the effect of eugenol on MRSA and MSSA biofilms in vitro and bacterial colonization in vivo. Methods and Results Effect of eugenol on in vitro biofilm and in vivo colonization were studied using microtiter plate assay and otitis media-rat model respectively. The architecture of in vitro biofilms and in vivo colonization of bacteria was viewed with SEM. Real-time RT-PCR was used to study gene expression. Check board method was used to study the synergistic effects of eugenol and carvacrol on established biofilms. Eugenol significantly inhibited biofilms growth of MRSA and MSSA in vitro in a concentration-dependent manner. Eugenol at MIC or 2xMIC effectively eradicated the pre-established biofilms of MRSA and MSSA clinical strains. In vivo, sub-MIC of eugenol significantly decreased 88% S. aureus colonization in rat middle ear. Eugenol was observed to damage the cell-membrane and cause a leakage of the cell contents. At sub-inhibitory concentration, it decreases the expression of biofilm- and enterotoxin-related genes. Eugenol showed a synergistic effect with carvacrol on the eradication of pre-established biofilms. Conclusion/Major Finding This study demonstrated that eugenol exhibits notable activity against MRSA and MSSA clinical strains biofilms. Eugenol inhibited biofilm formation, disrupted the cell-to-cell connections, detached the existing biofilms, and killed the bacteria in biofilms of both MRSA and MSSA with equal effectiveness. Therefore, eugenol may be used to control or eradicate S. aureus biofilm-related infections.	[Yadav, Mukesh Kumar] Korea Univ, Coll Med, Inst Med Device Clin Trials, Seoul 136705, South Korea; [Yadav, Mukesh Kumar; Chae, Sung-Won; Im, Gi Jung; Song, Jae-Jun] Korea Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul 136705, South Korea; [Chung, Jae-Woo] Dongguk Univ, Ilsan Hosp, Lab Med, Goyang, Gyeonggi, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Dongguk University; NHIS Ilsan Hospital	Song, JJ (corresponding author), Korea Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul 136705, South Korea.	jjsong23@gmail.com	Yadav, Mukesh Kumar/M-9154-2015; IM, GI JUNG/AAI-9755-2020	Yadav, Mukesh Kumar/0000-0002-4703-8554; IM, GI JUNG/0000-0002-9457-4253	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of education [2013R1A1A2A10004451]; Korea government (MSIP) [2012M2A2A6035679]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of education; Korea government (MSIP)	The research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of education (2013R1A1A2A10004451). And NRF grant funded by the Korea government (MSIP) No2012M2A2A6035679. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2010, FEMS IMMUNOL MED MIC, V58, P147, DOI 10.1111/j.1574-695X.2009.00601.x; Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106; Beenken KE, 2004, J BACTERIOL, V186, P4665, DOI 10.1128/JB.186.14.4665-4684.2004; Beenken KE, 2003, INFECT IMMUN, V71, P4206, DOI 10.1128/IAI.71.7.4206-4211.2003; Burt S, 2004, INT J FOOD MICROBIOL, V94, P223, DOI 10.1016/j.ijfoodmicro.2004.03.022; Chopra I, 2002, J APPL MICROBIOL, V92, p4S, DOI 10.1046/j.1365-2672.92.5s1.13.x; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; Clinical Laboratory Standards Institute, 2015, M100S15 CLSINCCLS M100S15 CLSINCCLS; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Cramton SE, 1999, INFECT IMMUN, V67, P5427, DOI 10.1128/IAI.67.10.5427-5433.1999; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Devi KP, 2010, J ETHNOPHARMACOL, V130, P107, DOI 10.1016/j.jep.2010.04.025; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Gill AO, 2004, APPL ENVIRON MICROB, V70, P5750, DOI 10.1128/AEM.70.10.5750-5755.2004; Guskey MT, 2010, PHARMACOTHERAPY, V30, P80, DOI 10.1592/phco.30.1.80; Hammer KA, 2012, INT J ANTIMICROB AG, V40, P239, DOI 10.1016/j.ijantimicag.2012.05.015; HASHIMOTO S, 1988, J DENT RES, V67, P1092, DOI 10.1177/00220345880670080601; Helander IM, 1998, J AGR FOOD CHEM, V46, P3590, DOI 10.1021/jf980154m; Hemaiswarya S, 2009, PHYTOMEDICINE, V16, P997, DOI 10.1016/j.phymed.2009.04.006; Hurdle JG, 2011, NAT REV MICROBIOL, V9, P62, DOI 10.1038/nrmicro2474; Hyldgaard M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00012; Inouye Shigeharu, 2001, Journal of Antimicrobial Chemotherapy, V47, P565, DOI 10.1093/jac/47.5.565; Kristinsson KG, 2005, J INFECT DIS, V191, P1876, DOI 10.1086/430003; Kwiecinski J, 2009, INT J ANTIMICROB AG, V33, P343, DOI 10.1016/j.ijantimicag.2008.08.028; La Storia A, 2011, RES MICROBIOL, V162, P164, DOI 10.1016/j.resmic.2010.11.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Ma YB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047255; Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996; Maki DG, 2006, MAYO CLIN PROC, V81, P1159, DOI 10.4065/81.9.1159; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Mohammed MJ, 2009, PHYTOMEDICINE, V16, P632, DOI 10.1016/j.phymed.2008.12.026; Moon SE, 2011, ARCH ORAL BIOL, V56, P907, DOI 10.1016/j.archoralbio.2011.02.005; Nostro A, 2007, J MED MICROBIOL, V56, P519, DOI 10.1099/jmm.0.46804-0; Nostro A, 2012, APMIS, V120, P967, DOI 10.1111/j.1600-0463.2012.02928.x; O'Neill E, 2007, J CLIN MICROBIOL, V45, P1379, DOI 10.1128/JCM.02280-06; Otto M, 2010, MED RES REV, V30, P1, DOI 10.1002/med.20160; Petersen PJ, 2006, J ANTIMICROB CHEMOTH, V57, P573, DOI 10.1093/jac/dki477; Qiu JZ, 2010, APPL ENVIRON MICROB, V76, P5846, DOI 10.1128/AEM.00704-10; Quave CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028737; Snowden JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084089; Thomas JG, 2005, BIOFILMS, INFECTION, AND ANTIMICROBIAL THERAPY, P21; Thornton RB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053837; Tsang LH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003361; Ultee A, 1999, APPL ENVIRON MICROB, V65, P4606; Valle J, 2003, MOL MICROBIOL, V48, P1075, DOI 10.1046/j.1365-2958.2003.03493.x; van Alphen LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045343; Vergara-Irigaray M, 2009, INFECT IMMUN, V77, P3978, DOI 10.1128/IAI.00616-09; Weiss EC, 2009, ANTIMICROB AGENTS CH, V53, P4096, DOI 10.1128/AAC.00484-09; Yadav MK, 2013, APMIS, V121, P1198, DOI 10.1111/apm.12067; Yadav MK, 2012, CLIN EXP OTORHINOLAR, V5, P139, DOI 10.3342/ceo.2012.5.3.139	51	119	123	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119564	10.1371/journal.pone.0119564	http://dx.doi.org/10.1371/journal.pone.0119564			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781975	Green Submitted, Green Published, gold			2022-12-27	WOS:000351284600074
J	Zhong, WY; Xiong, GZ; Wang, B; Lu, C; Dai, ZH; Lv, GH				Zhong, Weiye; Xiong, Guangzhong; Wang, Bing; Lu, Chang; Dai, Zhihui; Lv, Guohua			Surgical Management for Thoracic Spinal Tuberculosis Posterior Only versus Anterior Video-Assisted Thoracoscopic Surgery	PLOS ONE			English	Article							LUMBAR INTERBODY FUSION; DEBRIDEMENT; INSTRUMENTATION; DECOMPRESSION; THORACOLUMBAR; RECONSTRUCTION	Study Design A comparable retrospective study. Object To compare the clinical outcomes of surgical treatment by posterior only and anterior videoassisted thoracoscopic surgery for thoracic spinal tuberculosis (TSTB). Method 145 patients with TSTB treated by two different surgical procedures in our institution from June 2001 to June 2014 were studied. All cases were retrospectively analyzed and divided into two groups according to the given treatments: 75 cases (32F/43M) in group A performed single- stage posterior debridement, transforaminal thoracic interbody fusion and instrumentation, and 70 cases (30F/40M) in group B underwent anterior video- assisted thoracoscopic surgery (VATS). Clinical and radiographic results in the two groups were analyzed and compared. Results Patients in group A and B were followed up for an average of 4.6 +/- 1.8, 4.4 +/- 1.2 years, respectively. There was no statistically significant difference between groups in terms of the operation time, blood loss, bony fusion, neurological recovery and the correction angle of kyphotic deformity (P>0.05). Fewer pulmonary complications were observed in group A. Good clinical outcomes were achieved in both groups. Conclusions Both the anterior VATS and posterior approaches can effectively treat thoracic tuberculosis. Nevertheless, the posterior approach procedure obtained less morbidity and complications than the other.	[Zhong, Weiye; Wang, Bing; Lu, Chang; Dai, Zhihui; Lv, Guohua] Second Xiangya Hosp, Dept Spinal Surg, Changsha, Hunan, Peoples R China; [Zhong, Weiye; Xiong, Guangzhong; Wang, Bing; Lu, Chang; Dai, Zhihui; Lv, Guohua] Cent South Univ, Changsha, Hunan, Peoples R China; [Xiong, Guangzhong] Second Xiangya Hosp, Dept Neurosurg, Changsha, Hunan, Peoples R China	Central South University	Lu, C (corresponding author), Second Xiangya Hosp, Dept Spinal Surg, Changsha, Hunan, Peoples R China.	luchang001@126.com; spinelv@qq.com						Currie S, 2011, CLIN RADIOL, V66, P778, DOI 10.1016/j.crad.2011.02.016; DAVIS LA, 1993, SPINE, V18, P257, DOI 10.1097/00007632-199302000-00014; Garg B, 2012, INDIAN J ORTHOP, V46, P165, DOI 10.4103/0019-5413.93682; Garg N, 2014, CLIN ORTHOP RELAT R, V472, P1855, DOI 10.1007/s11999-014-3472-6; He B, 2012, ARCH ORTHOP TRAUM SU, V132, P1407, DOI 10.1007/s00402-012-1565-9; Huang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093648; Huang TJ, 2000, CLIN ORTHOP RELAT R, P143; Jayaswal A, 2007, CLIN ORTHOP RELAT R, P100, DOI 10.1097/BLO.0b013e318065b6e4; Kim SJ, 2007, J KOREAN NEUROSURG S, V42, P293, DOI 10.3340/jkns.2007.42.4.293; Levin Rafael, 2005, Spine J, V5, P632, DOI 10.1016/j.spinee.2005.03.013; Li M, 2011, SPINE J, V11, P726, DOI 10.1016/j.spinee.2011.06.009; Lu GH, 2012, EUR SPINE J, V21, P463, DOI 10.1007/s00586-011-2038-5; Machino M, 2010, SPINE, V35, pE1000, DOI 10.1097/BRS.0b013e3181dc9153; Maeng DH, 2013, ENDOSCOPIC SPINAL SU, P87; MOON MS, 1995, SPINE, V20, P1910, DOI 10.1097/00007632-199509000-00013; Moore SL, 2001, RADIOL CLIN N AM, V39, P329, DOI 10.1016/S0033-8389(05)70280-3; Pu XB, 2012, INT ORTHOP, V36, P307, DOI 10.1007/s00264-011-1329-0; Talu U, 2006, J SPINAL DISORD TECH, V19, P554, DOI 10.1097/01.bsd.0000211202.93125.c7; Zaveri GR, 2009, J SPINAL DISORD TECH, V22, P257, DOI 10.1097/BSD.0b013e31818859d0; Zhang HQ, 2014, EUR SPINE J, V23, P234, DOI 10.1007/s00586-013-2867-5; Zhang HQ, 2012, ARCH ORTHOP TRAUM SU, V132, P1717, DOI 10.1007/s00402-012-1618-0; Zhang HQ, 2007, J SPINAL DISORD TECH, V20, P263, DOI 10.1097/01.bsd.0000211281.68400.1b; Zhang HQ, 2013, ARCH ORTHOP TRAUM SU, V133, P333, DOI 10.1007/s00402-012-1669-2; Zhang HQ, 2013, EUR SPINE J, V22, P616, DOI 10.1007/s00586-012-2470-1	24	17	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119759	10.1371/journal.pone.0119759	http://dx.doi.org/10.1371/journal.pone.0119759			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781165	Green Published, gold, Green Submitted			2022-12-27	WOS:000351284600088
J	Assent, D; Bourgot, I; Hennuy, B; Geurts, P; Noel, A; Foidart, JM; Maquoi, E				Assent, Delphine; Bourgot, Isabelle; Hennuy, Benoit; Geurts, Pierre; Noel, Agnes; Foidart, Jean-Michel; Maquoi, Erik			A Membrane-Type-1 Matrix Metalloproteinase (MT1-MMP) - Discoidin Domain Receptor 1 Axis Regulates Collagen-Induced Apoptosis in Breast Cancer Cells	PLOS ONE			English	Article							TYROSINE KINASES; GENE-EXPRESSION; ACTIVATION; INVASION; PROTEIN; METASTASIS; INHIBITION; DIVERSITY; SURVIVAL; ROLES	During tumour dissemination, invading breast carcinoma cells become confronted with a reactive stroma, a type I collagen-rich environment endowed with anti-proliferative and proapoptotic properties. To develop metastatic capabilities, tumour cells must acquire the capacity to cope with this novel microenvironment. How cells interact with and respond to their microenvironment during cancer dissemination remains poorly understood. To address the impact of type I collagen on the fate of tumour cells, human breast carcinoma MCF-7 cells were cultured within three-dimensional type I collagen gels (3D COL1). Using this experimental model, we have previously demonstrated that membrane type-1 matrix metalloproteinase (MT1-MMP), a proteinase overexpressed in many aggressive tumours, promotes tumour progression by circumventing the collagen-induced up-regulation of BIK, a pro-apoptotic tumour suppressor, and hence apoptosis. Here we performed a transcriptomic analysis to decipher the molecular mechanisms regulating 3D COL1-induced apoptosis in human breast cancer cells. Control and MT1-MMP expressing MCF-7 cells were cultured on two-dimensional plastic plates or within 3D COL1 and a global transcriptional time-course analysis was performed. Shifting the cells from plastic plates to 3D COL1 activated a complex reprogramming of genes implicated in various biological processes. Bioinformatic analysis revealed a 3D COL1-mediated alteration of key cellular functions including apoptosis, cell proliferation, RNA processing and cytoskeleton remodelling. By using a panel of pharmacological inhibitors, we identified discoidin domain receptor 1 (DDR1), a receptor tyrosine kinase specifically activated by collagen, as the initiator of 3D COL1-induced apoptosis. Our data support the concept that MT1-MMP contributes to the inactivation of the DDR1-BIK signalling axis through the cleavage of collagen fibres and/or the alteration of DDR1 receptor signalling unit, without triggering a drastic remodelling of the transcriptome of MCF-7 cells.	[Assent, Delphine; Bourgot, Isabelle; Noel, Agnes; Foidart, Jean-Michel; Maquoi, Erik] Univ Liege, Unit Canc, Grp Interdisciplinaire Genoproteom Appl, Lab Tumour & Dev Biol, Liege, Belgium; [Hennuy, Benoit] Univ Liege, GIGA Genom Platform, Liege, Belgium; [Geurts, Pierre] Univ Liege, Dept Elect Engn & Comp Sci, Syst & Modelling, Liege, Belgium; [Geurts, Pierre] Univ Liege, GIGA R, Liege, Belgium	University of Liege; University of Liege; University of Liege; University of Liege	Maquoi, E (corresponding author), Univ Liege, Unit Canc, Grp Interdisciplinaire Genoproteom Appl, Lab Tumour & Dev Biol, Liege, Belgium.	erik.maquoi@ulg.ac.be		Noel, Agnes/0000-0002-7670-6179	Fonds de la Recherche Scientifique - FNRS (F.R.S.- FNRS, Belgium); Fondation contre le Cancer (foundation of public interest, Belgium); Fonds speciaux de la Recherche (University of Liege); Centre Anticancereux pres l'Universite de Liege; Fonds Leon Fredericq (University of Liege); Direction Generale Operationnelle de l'Economie, de l'Emploi et de la Recherche from the Service Public de Wallonie (SPW, Belgium); Interuniversity Attraction Poles Programme - Belgian Science Policy (Brussels, Belgium); Plan National Cancer (Service Public Federal)	Fonds de la Recherche Scientifique - FNRS (F.R.S.- FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS); Fondation contre le Cancer (foundation of public interest, Belgium); Fonds speciaux de la Recherche (University of Liege)(University of Liege); Centre Anticancereux pres l'Universite de Liege; Fonds Leon Fredericq (University of Liege)(University of Liege); Direction Generale Operationnelle de l'Economie, de l'Emploi et de la Recherche from the Service Public de Wallonie (SPW, Belgium); Interuniversity Attraction Poles Programme - Belgian Science Policy (Brussels, Belgium)(Belgian Federal Science Policy Office); Plan National Cancer (Service Public Federal)	This work was supported by grants from the Fonds de la Recherche Scientifique - FNRS (F.R.S.- FNRS, Belgium), the Fondation contre le Cancer (foundation of public interest, Belgium), the Fonds speciaux de la Recherche (University of Liege), the Centre Anticancereux pres l'Universite de Liege, the Fonds Leon Fredericq (University of Liege), the Direction Generale Operationnelle de l'Economie, de l'Emploi et de la Recherche from the Service Public de Wallonie (SPW, Belgium), the Interuniversity Attraction Poles Programme - Belgian Science Policy (Brussels, Belgium), the Plan National Cancer (Service Public Federal). The Actions de Recherche Concertees (University of Liege, Belgium). DA is a recipient of a Televie fellowship from the Fonds de la Recherche Scientifique - FNRS (F.R.S.-FNRS, Belgium). EM is a Research Associate from the Fonds de la Recherche Scientifique - FNRS (F.R.S.-FNRS, Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao WJ, 2004, J CELL BIOL, V167, P745, DOI 10.1083/jcb.200404018; Barbolina MV, 2008, SEMIN CELL DEV BIOL, V19, P24, DOI 10.1016/j.semcdb.2007.06.008; Barbosa-Morais NL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp942; Barkan D, 2010, CANCER RES, V70, P5706, DOI 10.1158/0008-5472.CAN-09-2356; Barone FC, 2001, J PHARMACOL EXP THER, V296, P312; Belyantseva IA, 2009, P NATL ACAD SCI USA, V106, P9703, DOI 10.1073/pnas.0900221106; Bhamidipati A, 2000, J CELL BIOL, V149, P1087, DOI 10.1083/jcb.149.5.1087; BIRKEDALHANSEN H, 1987, METHOD ENZYMOL, V144, P140; Bissell MJ, 2003, CURR OPIN CELL BIOL, V15, P753, DOI 10.1016/j.ceb.2003.10.016; Blencowe BJ, 2002, CURR BIOL, V12, pR147, DOI 10.1016/S0960-9822(02)00711-X; Bonnomet A, 2010, J MAMMARY GLAND BIOL, V15, P261, DOI 10.1007/s10911-010-9174-0; Brandvold KR, 2012, ACS CHEM BIOL, V7, P1393, DOI 10.1021/cb300172e; Cader FZ, 2013, BLOOD, V122, P4237, DOI 10.1182/blood-2013-04-499004; Montero JC, 2011, CLIN CANCER RES, V17, P5546, DOI 10.1158/1078-0432.CCR-10-2616; Chen LC, 2010, CELL DEATH DIFFER, V17, P1463, DOI 10.1038/cdd.2010.24; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Chen ZY, 2011, CARCINOGENESIS, V32, P1419, DOI 10.1093/carcin/bgr088; Cheng J, 2011, CANCER LETT, V310, P35, DOI 10.1016/j.canlet.2011.06.001; Cui H, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00134; Day E, 2008, EUR J PHARMACOL, V599, P44, DOI 10.1016/j.ejphar.2008.10.014; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Emanuele MJ, 2011, P NATL ACAD SCI USA, V108, P9845, DOI 10.1073/pnas.1106136108; Figueira RCS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-20; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Fu HL, 2013, J BIOL CHEM, V288, P12114, DOI 10.1074/jbc.M112.409599; Fujisaki H, 2002, EXP CELL RES, V280, P255, DOI 10.1006/excr.2002.5639; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Germain M, 2002, J BIOL CHEM, V277, P18053, DOI 10.1074/jbc.M201235200; Gilles C, 1997, LAB INVEST, V76, P651; Han SP, 2010, BIOCHEM J, V430, P379, DOI 10.1042/BJ20100396; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harunaga JS, 2011, MATRIX BIOL, V30, P363, DOI 10.1016/j.matbio.2011.06.001; Henriet P, 2000, P NATL ACAD SCI USA, V97, P10026, DOI 10.1073/pnas.170290997; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Huang XF, 2012, ONCOL REP, V27, P1541, DOI 10.3892/or.2012.1672; Huelga SC, 2012, CELL REP, V1, P167, DOI 10.1016/j.celrep.2012.02.001; Jaskiewicz L, 2008, CURR TOP MICROBIOL, V320, P77; Kallio MA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-507; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim HG, 2013, ACS CHEM BIOL, V8, P2145, DOI 10.1021/cb400430t; Kim HG, 2011, J BIOL CHEM, V286, P17672, DOI 10.1074/jbc.M111.236612; Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004; Kubow Kristopher E, 2011, Nat Cell Biol, V13, P3, DOI 10.1038/ncb0111-3; Liao SH, 2009, PROTEOMICS, V9, P3901, DOI 10.1002/pmic.200800922; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Lopez-Otin C, 2010, NAT REV CANCER, V10, P278, DOI 10.1038/nrc2823; Maquoi E, 2000, J BIOL CHEM, V275, P11368, DOI 10.1074/jbc.275.15.11368; Maquoi E, 2012, ONCOGENE, V31, P480, DOI 10.1038/onc.2011.249; Marko M, 2010, EXP CELL RES, V316, P390, DOI 10.1016/j.yexcr.2009.10.021; McDonald PC, 2012, ONCOTARGET, V3, P84, DOI 10.18632/oncotarget.422; McGowan PM, 2008, ANN ONCOL, V19, P1566, DOI 10.1093/annonc/mdn180; Millerot-Serrurot E, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-26; Mizushima H, 2009, J CELL SCI, V122, P4277, DOI 10.1242/jcs.054551; MONTGOMERY AMP, 1994, P NATL ACAD SCI USA, V91, P8856, DOI 10.1073/pnas.91.19.8856; Mori H, 2002, EMBO J, V21, P3949, DOI 10.1093/emboj/cdf411; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Noel A, 1999, CURR TOPICS PATHOL, V93, P183; Noel A, 2008, SEMIN CELL DEV BIOL, V19, P52, DOI 10.1016/j.semcdb.2007.05.011; Noel A, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00140; O'Reilly D, 2013, GENOME RES, V23, P281, DOI 10.1101/gr.142968.112; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; OKADA A, 1995, P NATL ACAD SCI USA, V92, P2730, DOI 10.1073/pnas.92.7.2730; Ongusaha PP, 2003, EMBO J, V22, P1289, DOI 10.1093/emboj/cdg129; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Perumal S, 2008, P NATL ACAD SCI USA, V105, P2824, DOI 10.1073/pnas.0710588105; Poincloux R, 2009, J CELL SCI, V122, P3015, DOI 10.1242/jcs.034561; Prasanth KV, 2010, MOL BIOL CELL, V21, P4184, DOI 10.1091/mbc.E10-02-0105; Rauch J, 2010, CANCER RES, V70, P1679, DOI 10.1158/0008-5472.CAN-09-2740; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; Rowe RG, 2008, TRENDS CELL BIOL, V18, P560, DOI 10.1016/j.tcb.2008.08.007; Sabeh F, 2009, J BIOL CHEM, V284, P23001, DOI 10.1074/jbc.M109.002808; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sakamoto T, 2014, MOL CELL BIOL, V34, P30, DOI 10.1128/MCB.01169-13; Sakamoto T, 2011, J BIOL CHEM, V286, P14691, DOI 10.1074/jbc.M110.188714; Schofield AV, 2013, CRIT REV BIOCHEM MOL, V48, P301, DOI 10.3109/10409238.2013.786671; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Sen Banibrata, 2011, J Signal Transduct, V2011, P865819, DOI 10.1155/2011/865819; Sodek KL, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-223; Sun J, 2013, CARCINOGENESIS, V34, P1943, DOI 10.1093/carcin/bgt163; Tanoue T, 2004, J CELL BIOL, V165, P517, DOI 10.1083/jcb.200403006; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Tracy K, 2007, AUTOPHAGY, V3, P616, DOI 10.4161/auto.4892; UEHARA Y, 1988, VIROLOGY, V164, P294, DOI 10.1016/0042-6822(88)90649-6; Ureshino H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041312; Valiathan RR, 2012, CANCER METAST REV, V31, P295, DOI 10.1007/s10555-012-9346-z; Vijayalingam S, 2010, Genes Cancer, V1, P964, DOI 10.1177/1947601910386110; Vogel W, 2000, J BIOL CHEM, V275, P5779, DOI 10.1074/jbc.275.8.5779; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang Q, 2013, MOL BIOL REP, V40, P3723, DOI 10.1007/s11033-012-2448-4; Xu NH, 2001, MOL CELL BIOL, V21, P6960, DOI 10.1128/MCB.21.20.6960-6971.2001; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhu PC, 2011, CANCER CELL, V19, P401, DOI 10.1016/j.ccr.2011.01.018	100	30	32	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0116006	10.1371/journal.pone.0116006	http://dx.doi.org/10.1371/journal.pone.0116006			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774665	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500004
J	Pescador, DS; de Bello, F; Valladares, F; Escudero, A				Pescador, David S.; de Bello, Francesco; Valladares, Fernando; Escudero, Adrian			Plant Trait Variation along an Altitudinal Gradient in Mediterranean High Mountain Grasslands: Controlling the Species Turnover Effect	PLOS ONE			English	Article							INTRASPECIFIC VARIABILITY; FUNCTIONAL DIVERSITY; LEAF-AREA; ENVIRONMENTAL FILTERS; POSITIVE INTERACTIONS; ALPINE PLANTS; COMMUNITY; GROWTH; INCREASE; PATTERNS	Assessing changes in plant functional traits along gradients is useful for understanding the assembly of communities and their response to global and local environmental drivers. However, these changes may reflect the effects of species composition (i.e. composition turnover), species abundance (i.e. species interaction), and intra-specific trait variability (i.e. species plasticity). In order to determine the relevance of the latter, trait variation can be assessed under minimal effects of composition turnover. Nine sampling sites were established along an altitudinal gradient in a Mediterranean high mountain grassland community with low composition turnover (Madrid, Spain; 1940 m-2419 m). Nine functional traits were also measured for ten individuals of around ten plant species at each site, for a total of eleven species across all sites. The relative importance of different sources of variability (within/between site and intra-/inter-specific functional diversity) and trait variation at species and community level along the considered gradients were explored. We found a weak individual species response to altitude and other environmental variables although in some cases, individuals were smaller and leaves were thicker at higher elevations. This lack of species response was most likely due to greater within-than between-site species variation. At the community level, inter-specific functional diversity was generally greater than the intra-specific component except for traits linked to leaf element content (leaf carbon content, leaf nitrogen content, delta C-13 and delta N-15). Inter-specific functional diversity decreased with lower altitude for four leaf traits (specific leaf area, leaf dry matter content, delta C-13 and delta N-15), suggesting trait convergence between species at lower elevations, where water shortage may have a stronger environmental filtering effect than colder temperatures at higher altitudes. Our results suggest that, within a vegetation type encompassing various environmental gradients, both, changes in species abundance and intra-specific trait variability adjust for the community functional response to environmental changes.	[Pescador, David S.; Valladares, Fernando; Escudero, Adrian] Univ Rey Juan Carlos, Dept Biol & Geol, Madrid, Spain; [de Bello, Francesco] Acad Sci Czech Republ, Inst Bot, Trebon, Czech Republic; [de Bello, Francesco] Univ South Bohemia, Dept Bot, Ceske Budejovice, Czech Republic; [Valladares, Fernando] CSIC, Museo Nacl Ciencias Nat, E-28006 Madrid, Spain	Universidad Rey Juan Carlos; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Pescador, DS (corresponding author), Univ Rey Juan Carlos, Dept Biol & Geol, Madrid, Spain.	david.sanchez@urjc.es	de Bello, Francesco/AFQ-8650-2022; Escudero, Adrián/H-5046-2015; de Bello, Francesco/HCI-1196-2022; Pescador, David Sánchez/F-2672-2015; de Bello, Francesco/H-1582-2014	Escudero, Adrián/0000-0002-1427-5465; de Bello, Francesco/0000-0001-9202-8198; Pescador, David Sánchez/0000-0003-0395-9543; de Bello, Francesco/0000-0001-9202-8198	Comunidad de Madrid [CM-S2009/AMB-1783]; Spanish Ministry of Science and Innovation [CGL2012-38427]	Comunidad de Madrid(Comunidad de Madrid); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The research was supported by the Comunidad de Madrid under the project REMEDINAL 2 [CM-S2009/AMB-1783] and by Spanish Ministry of Science and Innovation, under the project MOUNTAINS [CGL2012-38427]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2007, ECOL LETT, V10, P135, DOI 10.1111/j.1461-0248.2006.01006.x; Albert CH, 2011, PERSPECT PLANT ECOL, V13, P217, DOI 10.1016/j.ppees.2011.04.003; Albert CH, 2010, FUNCT ECOL, V24, P1192, DOI 10.1111/j.1365-2435.2010.01727.x; Albert CH, 2010, J ECOL, V98, P604, DOI 10.1111/j.1365-2745.2010.01651.x; Anderson J. M., 1993, TROPICAL SOIL BIOL F; Angert AL, 2006, OECOLOGIA, V148, P183, DOI 10.1007/s00442-006-0361-z; [Anonymous], 2010, R LANG ENV STAT COMP; Auger S, 2013, J VEG SCI, V24, P419, DOI 10.1111/j.1654-1103.2012.01473.x; Callaway RM, 2002, NATURE, V417, P844, DOI 10.1038/nature00812; Cavieres LA, 2006, NEW PHYTOL, V169, P59, DOI 10.1111/j.1469-8137.2005.01573.x; Chambers J., 1992, STAT MODELS S WADSWO, DOI 10.1201/9780203738535-4; CODIGNOLA A, 1987, NORD J BOT, V7, P673, DOI 10.1111/j.1756-1051.1987.tb02036.x; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Cornwell WK, 2009, ECOL MONOGR, V79, P109, DOI 10.1890/07-1134.1; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; Dawson TE, 2002, ANNU REV ECOL SYST, V33, P507, DOI 10.1146/annurev.ecolsys.33.020602.095451; de Bello F, 2013, ECOGRAPHY, V36, P393, DOI 10.1111/j.1600-0587.2012.07438.x; de Bello F, 2011, METHODS ECOL EVOL, V2, P163, DOI 10.1111/j.2041-210X.2010.00071.x; Diaz S, 1998, J VEG SCI, V9, P113, DOI 10.2307/3237229; Fajardo A, 2011, NEW PHYTOL, V189, P259, DOI 10.1111/j.1469-8137.2010.03468.x; Gandullo J, 1974, I NAC INVESTIG AGRAR, V1, P95; Garcia-Fernandez A, 2013, AM J BOT, V100, P1641, DOI 10.3732/ajb.1200653; Garcia-Fernandez A, 2012, ANN BOT-LONDON, V110, P1221, DOI 10.1093/aob/mcs195; Gottfried M, 1998, ARCTIC ALPINE RES, V30, P207, DOI 10.2307/1551968; Grassein F, 2010, ANN BOT-LONDON, V106, P637, DOI 10.1093/aob/mcq154; Gross N, 2013, J ECOL, V101, P637, DOI 10.1111/1365-2745.12063; Gutierrez-Giron A, 2015, GEODERMA, V237, P1, DOI 10.1016/j.geoderma.2014.08.005; Gutierrez-Giron A, 2013, PLANT ECOL DIVERS, V6, P435, DOI 10.1080/17550874.2013.783641; HilleRisLambers J, 2012, ANNU REV ECOL EVOL S, V43, P227, DOI 10.1146/annurev-ecolsys-110411-160411; Hogberg P, 1997, NEW PHYTOL, V137, P179, DOI 10.1046/j.1469-8137.1997.00808.x; Hsiao TC, 1985, SOC EXP BIOL SEMINAR, P239; Huber E, 2007, PLANT SOIL, V301, P65, DOI 10.1007/s11104-007-9422-2; Jung V, 2014, J ECOL, V102, P45, DOI 10.1111/1365-2745.12177; Jung V, 2010, J ECOL, V98, P1134, DOI 10.1111/j.1365-2745.2010.01687.x; Kahmen A, 2008, OECOLOGIA, V156, P861, DOI 10.1007/s00442-008-1028-8; KEDDY PA, 1992, J VEG SCI, V3, P157, DOI 10.2307/3235676; Kichenin E, 2013, FUNCT ECOL, V27, P1254, DOI 10.1111/1365-2435.12116; Korner C, 1987, FUNCT ECOL, V1, P179, DOI 10.2307/2389420; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Korner C, 1998, OECOLOGIA, V115, P445, DOI 10.1007/s004420050540; Korner C, 2003, ALPINE PLANT LIFE FU, DOI DOI 10.1007/978-3-030-59538-8; Leps J, 2011, ECOGRAPHY, V34, P856, DOI 10.1111/j.1600-0587.2010.06904.x; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; Messier J, 2010, ECOL LETT, V13, P838, DOI 10.1111/j.1461-0248.2010.01476.x; Milla R, 2009, FUNCT ECOL, V23, P111, DOI 10.1111/j.1365-2435.2008.01484.x; Perez RSA, 1997, ERIA, V43, P227; Perez-Ramos IM, 2012, J ECOL, V100, P1315, DOI 10.1111/1365-2745.12000; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Poorter H, 2012, NEW PHYTOL, V193, P30, DOI 10.1111/j.1469-8137.2011.03952.x; Prentice IC, 2011, NEW PHYTOL, V190, P169, DOI 10.1111/j.1469-8137.2010.03579.x; RAO CR, 1982, THEOR POPUL BIOL, V21, P24, DOI 10.1016/0040-5809(82)90004-1; Robinson D, 2001, TRENDS ECOL EVOL, V16, P153, DOI 10.1016/S0169-5347(00)02098-X; Roche P, 2004, PLANT ECOL, V174, P37, DOI 10.1023/B:VEGE.0000046056.94523.57; Rodrigo A, 1997, ECOL MODEL, V102, P325, DOI 10.1016/S0304-3800(97)00067-7; Scheepens JF, 2010, OECOLOGIA, V164, P141, DOI 10.1007/s00442-010-1650-0; Shi PL, 2006, BASIC APPL ECOL, V7, P370, DOI 10.1016/j.baae.2005.06.005; Spasojevic MJ, 2012, J ECOL, V100, P652, DOI 10.1111/j.1365-2745.2011.01945.x; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Turunen M, 2005, ENVIRON POLLUT, V137, P390, DOI 10.1016/j.envpol.2005.01.030; Vile D, 2005, ANN BOT-LONDON, V96, P1129, DOI 10.1093/aob/mci264; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Violle C, 2012, TRENDS ECOL EVOL, V27, P244, DOI 10.1016/j.tree.2011.11.014; WHITTAKER RH, 1960, ECOL MONOGR, V30, P280, DOI 10.2307/1943563; WOODWARD FI, 1983, NEW PHYTOL, V95, P313, DOI 10.1111/j.1469-8137.1983.tb03498.x; Wright IJ, 2001, FUNCT ECOL, V15, P423, DOI 10.1046/j.0269-8463.2001.00542.x	65	63	69	6	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118876	10.1371/journal.pone.0118876	http://dx.doi.org/10.1371/journal.pone.0118876			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774532	gold, Green Submitted, Green Published			2022-12-27	WOS:000351183500048
J	Shimizu-Motohashi, Y; Asakura, Y; Motohashi, N; Belur, NR; Baumrucker, MG; Asakura, A				Shimizu-Motohashi, Yuko; Asakura, Yoko; Motohashi, Norio; Belur, Nandkishore R.; Baumrucker, Michael G.; Asakura, Atsushi			Pregnancy-Induced Amelioration of Muscular Dystrophy Phenotype in mdx Mice via Muscle Membrane Stabilization Effect of Glucocorticoid	PLOS ONE			English	Article							ANNEXIN A1; EVANS BLUE; PREDNISONE; MOUSE; PATHOLOGY; ESTROGEN; CALCIUM; CELLS; CORTICOSTERONE; INACTIVATION	Duchenne muscular dystrophy (DMD), the most common and severe type of dystrophinopathy, is an X-linked recessive genetic disease caused by the absence of dystrophin, which leads to fragility and vulnerability of the sarcolemma to mechanical stretching with increased membrane permeability. Currently, glucocorticoids such as prednisolone are the only medication available for DMD. However, molecular pathways responsible for this effect are still unclear. In addition, it remains unclear whether sex-related factors, including pregnancy and the postpartum period, affect the phenotype of dystrophinopathy. Here, we report the amelioration of muscle membrane permeability in the diaphragm muscle of pregnant and postpartum, but not in nulliparous, mdx mice, an animal model for DMD, during the physiological surge of corticosterone, the most abundant glucocorticoid in rodents. Cultures of single muscle fibers and myotubes isolated from mdx mouse diaphragm demonstrate resistance to hypo-osmotic shock when treated with corticosterone but not with estradiol or progesterone. This corticosterone-mediated resistance was diminished by an antagonist of corticosterone, indicating that the glucocorticoid-glucocorticoid receptor axis plays a role in this membrane stabilization effect on muscle. Moreover, subcutaneous injection of corticosterone into mdx mice showed decreased membrane permeability. This is the first report to demonstrate that pregnancy-related resistance to muscle fiber damage in mdx mice due to the membrane stabilization effect of corticosterone. We also propose that this membrane stabilization effect is exerted through annexin A1 up-regulation as the molecular mechanisms of glucocorticoid effects on DMD muscle. Furthermore, single muscle fiber culture studies provide a sensitive chemical screening platform for muscular dystrophies.	[Shimizu-Motohashi, Yuko; Asakura, Yoko; Motohashi, Norio; Belur, Nandkishore R.; Baumrucker, Michael G.; Asakura, Atsushi] Univ Minnesota, Sch Med, Dept Neurol, Stem Cell Inst,Paul & Sheila Wellstone Muscular D, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Asakura, A (corresponding author), Univ Minnesota, Sch Med, Dept Neurol, Stem Cell Inst,Paul & Sheila Wellstone Muscular D, Minneapolis, MN 55455 USA.	asakura@umn.edu	Motohashi, Norio/AGE-8809-2022; Asakura, Atsushi/H-2745-2019	Motohashi, Norio/0000-0002-8172-4339; Asakura, Atsushi/0000-0001-8078-1027; BELUR, NANDKISHORE/0000-0003-2229-8007	NIH [R01AR62142, R03AR61545]; Muscular Dystrophy Association [MDA 241600]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR061545, R01AR062142] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIH (R01AR62142), NIH (R03AR61545), and Muscular Dystrophy Association (MDA 241600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DG, 2011, INT J BIOCHEM CELL B, V43, P290, DOI 10.1016/j.biocel.2010.11.005; ATKINSON HC, 1995, ENDOCRINOLOGY, V136, P512, DOI 10.1210/en.136.2.512; Barros RPA, 2011, CELL METAB, V14, P289, DOI 10.1016/j.cmet.2011.08.005; Besedovsky L, 2014, FASEB J, V28, P67, DOI 10.1096/fj.13-237958; Bizzarro V, 2012, J CELL PHYSIOL, V227, P3007, DOI 10.1002/jcp.24032; Brioschi S, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-73; Bushby K, 2010, LANCET NEUROL, V9, P177, DOI 10.1016/S1474-4422(09)70272-8; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Choi CI, 2008, J NEUROL SCI, V268, P40, DOI 10.1016/j.jns.2007.10.024; Dorchies OM, 2013, AM J PATHOL, V182, P485, DOI 10.1016/j.ajpath.2012.10.018; Ennen JP, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-9; Fairclough RJ, 2013, NAT REV GENET, V14, P373, DOI 10.1038/nrg3460; Figueiredo HF, 2007, AM J PHYSIOL-ENDOC M, V292, pE1173, DOI 10.1152/ajpendo.00102.2006; Fisher I, 2005, FASEB J, V19, P834, DOI 10.1096/fj.04-2511fje; Gaud A, 2004, NEUROMUSCULAR DISORD, V14, P365, DOI 10.1016/j.nmd.2004.02.011; Givertz MM, 2013, CIRCULATION, V127, pE622, DOI 10.1161/CIRCULATIONAHA.113.001851; Goonasekera SA, 2011, J CLIN INVEST, V121, P1044, DOI 10.1172/JCI43844; GUERRIERO V, 1980, ENDOCRINOLOGY, V106, P1198, DOI 10.1210/endo-106-4-1198; Hartel JV, 2001, MUSCLE NERVE, V24, P428, DOI 10.1002/1097-4598(200103)24:3<428::AID-MUS1018>3.3.CO;2-5; Heier CR, 2013, EMBO MOL MED, V5, P1569, DOI 10.1002/emmm.201302621; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Houtchens M, 2013, CLIN OBSTET GYNECOL, V56, P342, DOI 10.1097/GRF.0b013e31828f272b; Huynh T, 2013, J PATHOL, V231, P223, DOI 10.1002/path.4231; Jacobs SCJM, 1996, J NEUROL, V243, P410, DOI 10.1007/BF00869001; KISSEL JT, 1991, NEUROLOGY, V41, P667, DOI 10.1212/WNL.41.5.667; Leijendekker WJ, 1996, BRIT J PHARMACOL, V118, P611, DOI 10.1111/j.1476-5381.1996.tb15445.x; Leung DG, 2013, ANN NEUROL, V74, P404, DOI 10.1002/ana.23989; Matsuda C., 2012, PLOS CURR, V4, DOI DOI 10.1371/5035ADD8CAFF4; MATSUDA R, 1995, J BIOCHEM-TOKYO, V118, P959, DOI 10.1093/jb/118.5.959; McNeil AK, 2006, J BIOL CHEM, V281, P35202, DOI 10.1074/jbc.M606406200; MENKE A, 1991, NATURE, V349, P69, DOI 10.1038/349069a0; MENKE A, 1995, J CELL SCI, V108, P727; METZINGER L, 1995, BRIT J PHARMACOL, V116, P2811, DOI 10.1111/j.1476-5381.1995.tb15930.x; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; Montanaro F, 1999, J CELL BIOL, V145, P1325, DOI 10.1083/jcb.145.6.1325; Motohashi N, 2014, JOVE-J VIS EXP, DOI 10.3791/50846; PASQUINI F, 1995, NEUROMUSCULAR DISORD, V5, P105, DOI 10.1016/0960-8966(94)00042-8; Passaquin AC, 1998, BRIT J PHARMACOL, V124, P1751, DOI 10.1038/sj.bjp.0702036; PASTERNAK C, 1995, J CELL BIOL, V128, P355, DOI 10.1083/jcb.128.3.355; Pasut A, 2013, JOVE-J VIS EXP, DOI 10.3791/50074; Pawluski JL, 2009, PHYSIOL BEHAV, V96, P108, DOI 10.1016/j.physbeh.2008.09.004; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; RIFAI Z, 1995, AM J PHYSIOL-ENDOC M, V268, pE67, DOI 10.1152/ajpendo.1995.268.1.E67; Rooney JE, 2006, J CELL SCI, V119, P2185, DOI 10.1242/jcs.02952; ROSENBLATT JS, 1988, PSYCHONEUROENDOCRINO, V13, P29, DOI 10.1016/0306-4530(88)90005-4; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seppanen E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062662; Shimizu-Motohashi Y, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00050; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647; Shors TJ, 2007, BIOL PSYCHIAT, V62, P487, DOI 10.1016/j.biopsych.2006.10.033; SKLAR RM, 1991, J NEUROL SCI, V101, P73, DOI 10.1016/0022-510X(91)90019-4; Spencer MJ, 2001, CLIN IMMUNOL, V98, P235, DOI 10.1006/clim.2000.4966; St-Pierre SJG, 2004, FASEB J, V18, P1937, DOI 10.1096/fj.04-1859fje; Swaggart KA, 2014, P NATL ACAD SCI USA, V111, P6004, DOI 10.1073/pnas.1324242111; Verma M, 2010, J HISTOCHEM CYTOCHEM; Verma M, 2010, HUM MOL GENET, V19, P4145, DOI 10.1093/hmg/ddq334; Viggiano E, 2013, CLIN GENET, V84, P265, DOI 10.1111/cge.12048; von Maltzahn J, 2012, P NATL ACAD SCI USA, V109, P20614, DOI 10.1073/pnas.1215765109; VOOGT JL, 1969, AM J PHYSIOL, V216, P655, DOI 10.1152/ajplegacy.1969.216.3.655; Watanabe S, 2011, STEM CELLS, V29, P505, DOI 10.1002/stem.598; WEBSTER C, 1988, CELL, V52, P503, DOI 10.1016/0092-8674(88)90463-1; Wehling-Henricks M, 2004, NEUROMUSCULAR DISORD, V14, P483, DOI 10.1016/j.nmd.2004.04.008; Wooddell CI, 2010, MUSCLE NERVE, V41, P487, DOI 10.1002/mus.21527; Wuebbles RD, 2013, DIS MODEL MECH, V6, P1175, DOI 10.1242/dmm.012211	65	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120325	10.1371/journal.pone.0120325	http://dx.doi.org/10.1371/journal.pone.0120325			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775477	Green Submitted, gold, Green Published			2022-12-27	WOS:000351183500164
J	Vu, LT; Keschrumrus, V; Zhang, X; Zhong, JF; Su, QN; Kabeer, MH; Loudon, WG; Li, SC				Vu, Long T.; Keschrumrus, Vic; Zhang, Xi; Zhong, Jiang F.; Su, Qingning; Kabeer, Mustafa H.; Loudon, William G.; Li, Shengwen Calvin			Tissue Elasticity Regulated Tumor Gene Expression: Implication for Diagnostic Biomarkers of Primitive Neuroectodermal Tumor	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; MMP9 EXPRESSION; BREAST-CANCER; WEB SERVER; CELLS; CAVEOLIN; ACTIVATION; INDUCTION; INVASION	Background The tumor microenvironment consists of both physical and chemical factors. Tissue elasticity is one physical factor contributing to the microenvironment of tumor cells. To test the importance of tissue elasticity in cell culture, primitive neuroectodermal tumor (PNET) stem cells were cultured on soft polyacrylamide (PAA) hydrogel plates that mimics the elasticity of brain tissue compared with PNET on standard polystyrene (PS) plates. We report the molecular profiles of PNET grown on either PAA or PS. Methodology/Principal Findings A whole-genome microarray profile of transcriptional expression between the two culture conditions was performed as a way to probe effects of substrate on cell behavior in culture. The results showed more genes downregulated on PAA compared to PS. This led us to propose microRNA (miRNA) silencing as a potential mechanism for downregulation. Bioinformatic analysis predicted a greater number of miRNA binding sites from the 3' UTR of downregulated genes and identified as specific miRNA binding sites that were enriched when cells were grown on PAA-this supports the hypothesis that tissue elasticity plays a role in influencing miRNA expression. Thus, Dicer was examined to determine if miRNA processing was affected by tissue elasticity. Dicer genes were downregulated on PAA and had multiple predicted miRNA binding sites in its 3' UTR that matched the miRNA binding sites found enriched on PAA. Many differentially regulated genes were found to be present on PS but downregulated on PAA were mapped onto intron sequences. This suggests expression of alternative polyadenylation sites within intron regions that provide alternative 3' UTRs and alternative miRNA binding sites. This results in tissue specific transcriptional downregulation of mRNA in humans by miRNA. We propose a mechanism, driven by the physical characteristics of the microenvironment by which downregulation of genes occur. We found that tissue elasticity-mediated cytokines (TGF beta 2 and TNF alpha) signaling affect expression of ECM proteins. Conclusions Our results suggest that tissue elasticity plays important roles in miRNA expression, which, in turn, regulate tumor growth or tumorigenicity.	[Vu, Long T.; Keschrumrus, Vic; Kabeer, Mustafa H.; Loudon, William G.; Li, Shengwen Calvin] Univ Calif Irvine, Neurooncol & Stem Cell Res Lab, Ctr Neurosci Res, CHOC Childrens Hosp Res Inst, Orange, CA 92868 USA; [Loudon, William G.] St Joseph Hosp, Dept Neurol Surg, Orange, CA 92868 USA; [Loudon, William G.] Univ Calif Irvine, Sch Med, Dept Neurol Surg, Orange, CA 92862 USA; [Li, Shengwen Calvin] Univ Calif Irvine, Dept Neurol, Sch Med, Orange, CA 92697 USA; [Vu, Long T.; Li, Shengwen Calvin] Calif State Univ Fullerton, Dept Biol Sci, Fullerton, CA 92834 USA; [Zhang, Xi; Zhong, Jiang F.] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Kabeer, Mustafa H.] CHOC Childrens Hosp, Dept Pediat Surg, Orange, CA 92868 USA; [Su, Qingning] Shenzhen Univ, Bioengn Res Ctr, Sch Med, Shenzhen 518057, Guangdong, Peoples R China; [Kabeer, Mustafa H.] Univ Calif Irvine, Sch Med, Dept Surg, Orange, CA 92868 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; California State University System; California State University Fullerton; University of Southern California; Shenzhen University; University of California System; University of California Irvine	Zhong, JF (corresponding author), Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA.	jzhong@usc.edu; shengwel@uci.edu	li, wj/HGD-7322-2022; Li, Shengwen Calvin/H-1725-2012	Li, Shengwen Calvin/0000-0002-9699-9204	Children's Hospital of Orange County (CHOC) Children's Foundation; CHOC Neuroscience Institute; Austin Ford Tribute Fund; W. M. Keck Foundation; National Institutes of Health [R21CA134391]; National Science Foundation [AW 0852720]; NATIONAL CANCER INSTITUTE [R21CA134391] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001414] Funding Source: NIH RePORTER	Children's Hospital of Orange County (CHOC) Children's Foundation; CHOC Neuroscience Institute; Austin Ford Tribute Fund; W. M. Keck Foundation(W.M. Keck Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by the Children's Hospital of Orange County (CHOC) Children's Foundation, CHOC Neuroscience Institute, Austin Ford Tribute Fund, W. M. Keck Foundation, Grant R21CA134391 from the National Institutes of Health, and Grant AW 0852720 from the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agus DB, 2013, SCI REP-UK, V3, DOI 10.1038/srep01449; Alexiou P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009171; Baumann F, 2009, NEURO-ONCOLOGY, V11, P368, DOI 10.1215/15228517-2008-106; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Charles N, 2010, CELL CYCLE, V9, P3012, DOI 10.4161/cc.9.15.12710; Chellaiah MA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/302392; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Cheng G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004632; Chou YC, 2010, CHEM-BIOL INTERACT, V184, P403, DOI 10.1016/j.cbi.2010.01.010; Cobaleda C, 2008, STEM CELL REV, V4, P67, DOI 10.1007/s12015-008-9012-6; Deb S, 1999, J NEUROSCI RES, V55, P44, DOI 10.1002/(SICI)1097-4547(19990101)55:1<44::AID-JNR6>3.0.CO;2-G; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Favre G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043435; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Gantier MP, 2011, NUCLEIC ACIDS RES, V39, P5692, DOI 10.1093/nar/gkr148; Gonzalez-Sarmiento R, 2008, CURR STEM CELL RES T, V3, P55; Han YP, 2001, J BIOL CHEM, V276, P22341, DOI 10.1074/jbc.M010839200; Han YP, 2007, J BIOL CHEM, V282, P12928, DOI 10.1074/jbc.M700554200; Hsieh WP, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-222; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Keklikoglou I, 2012, ONCOGENE, V31, P4150, DOI 10.1038/onc.2011.571; Li C, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-8-RESEARCH0032; Li MH, 2009, CANCER CELL, V16, P533, DOI 10.1016/j.ccr.2009.10.025; Li SW, 2007, HUMAN STEM CELL MANUAL: A LABORATORY GUIDE, P127, DOI 10.1016/B978-012370465-8/50015-6; Li SC, 2012, CANCER CELL INT, V12, DOI 10.1186/1475-2867-12-41; Li SC, 2012, STEM CELLS DEV, V21, P503, DOI 10.1089/scd.2011.0267; Li SC, 2011, P NATL ACAD SCI USA, V108, P12793, DOI 10.1073/pnas.1100509108; Li SC, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-9; Li SW, 1996, J BIOL CHEM, V271, P568, DOI 10.1074/jbc.271.1.568; Li SW, 1998, FEBS LETT, V434, P127, DOI 10.1016/S0014-5793(98)00945-4; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; Li SW, 1996, J BIOL CHEM, V271, P3863; Liu P, 2012, J CELL PHYSIOL, V227, P867, DOI 10.1002/jcp.22993; Liu ZG, 2014, NEURO-ONCOLOGY, V16, P787, DOI 10.1093/neuonc/not244; Lockwood CJ, 2008, BIOL REPROD, V78, P1064, DOI 10.1095/biolreprod.107.063743; Lovett DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034177; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Munchar MJJ, 2003, PATHOLOGY, V35, P125, DOI 10.1080/0031302031000082214; Noguer-Dance M, 2010, HUM MOL GENET, V19, P3566, DOI 10.1093/hmg/ddq272; Pelz CR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-520; Port M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-52; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rippe V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009485; Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Seguin CA, 2008, SPINE, V33, P356, DOI 10.1097/BRS.0b013e3181642a5e; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Sunyer R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046107; Tse J.R., 2010, CURR PROTOC CELL BIO, V10, pUnit, DOI [DOI 10.1002/0471143030.CB1016S47, 10.1002/0471143030.cb1016s47]; Tu SM, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-40; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Yang K, 2009, INT J CLIN EXP PATHO, V2, P361	60	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120336	10.1371/journal.pone.0120336	http://dx.doi.org/10.1371/journal.pone.0120336			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774514	Green Published, gold			2022-12-27	WOS:000351183500165
J	Yeh, CH; Kuo, PL; Wang, YY; Wu, YY; Chen, MF; Lin, DY; Lai, TH; Chiang, HS; Lin, YH				Yeh, Chung-Hsin; Kuo, Pao-Lin; Wang, Ya-Yun; Wu, Ying-Yu; Chen, Mei-Feng; Lin, Ding-Yen; Lai, Tsung-Hsuan; Chiang, Han-Sun; Lin, Ying-Hung			SEPT12/SPAG4/LAMINB1 Complexes Are Required for Maintaining the Integrity of the Nuclear Envelope in Postmeiotic Male Germ Cells	PLOS ONE			English	Article							SUN-DOMAIN PROTEINS; SEPTIN GENE FAMILY; HUMAN ASTHENOZOOSPERMIA; MAMMALIAN SEPTINS; MALE-INFERTILITY; CYTOSKELETON; EXPRESSION; MICE; ORGANIZATION; IDENTIFICATION	Male infertility affects approximately 50% of all infertile couples. The male-related causes of intracytoplasmic sperm injection failure include the absence of sperm, immotile or immature sperm, and sperm with structural defects such as those caused by premature chromosomal condensation and DNA damage. Our previous studies based on a knockout mice model indicated that SEPT12 proteins are critical for the terminal morphological formation of sperm. SEPT12 mutations in men result in teratozospermia and oligozospermia. In addition, the spermatozoa exhibit morphological defects of the head and tail, premature chromosomal condensation, and nuclear damage. However, the molecular functions of SEPT12 during spermatogenesis remain unclear. To determine the molecular functions of SEPT12, we applied a yeast 2-hybrid system to identify SEPT12 interactors. Seven proteins that interact with SEPT12 were identified: SEPT family proteins (SEPT4 and SEPT6), nuclear or nuclear membrane proteins (protamine 2, sperm-associated antigen 4, and NDC1 transmembrane nucleoproine), and sperm-related structural proteins (pericentriolar material 1 and obscurinlike 1). Sperm-associated antigen 4 (SPAG4; also known as SUN4) belongs to the SUN family of proteins and acts as a linker protein between nucleoskeleton and cytoskeleton proteins and localizes in the nuclear membrane. We determined that SEPT12 interacts with SPAG4 in a male germ cell line through coimmunoprecipitation. During human spermiogenesis, SEPT12 is colocalized with SPAG4 near the nuclear periphery in round spermatids and in the centrosome region in elongating spermatids. Furthermore, we observed that SEPT12/SPAG4/LAMINB1 formed complexes and were coexpressed in the nuclear periphery of round spermatids. In addition, mutated SEPT12, which was screened from an infertile man, affected the integration of these nuclear envelope complexes through coimmunoprecipitation. This was the first study that suggested that SEPT proteins link to the SUN/LAMIN complexes during the formation of nuclear envelopes and are involved in the development of postmeiotic germ cells.	[Yeh, Chung-Hsin] Shin Kong Wu Ho Su Mem Hosp, Dept Surg, Div Urol, Taipei, Taiwan; [Yeh, Chung-Hsin; Lai, Tsung-Hsuan; Chiang, Han-Sun] Fu Jen Catholic Univ, Sch Med, New Taipei City, Taiwan; [Kuo, Pao-Lin; Wang, Ya-Yun] Natl Cheng Kung Univ, Coll Med, Dept Obstet & Gynecol, Tainan 70101, Taiwan; [Wu, Ying-Yu; Chiang, Han-Sun; Lin, Ying-Hung] Fu Jen Catholic Univ, Coll Med, Grad Inst Basic Med, New Taipei City, Taiwan; [Chen, Mei-Feng] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan; [Lin, Ding-Yen] Natl Cheng Kung Univ, Inst Bioinformat & Biosignal Transduct, Coll Biosci & Biotechnol, Tainan 70101, Taiwan; [Lai, Tsung-Hsuan] Cathay Gen Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Lai, Tsung-Hsuan] Natl Cent Univ, Inst Syst Biol & Bioinformat, Zhongli City, Taoyuan County, Taiwan	Shin Kong Wu Ho Su Memorial Hospital; Fu Jen Catholic University; National Cheng Kung University; Fu Jen Catholic University; Chang Gung University; National Cheng Kung University; Cathay General Hospital; National Central University	Lin, YH (corresponding author), Fu Jen Catholic Univ, Coll Med, Grad Inst Basic Med, New Taipei City, Taiwan.	084952@mail.fju.edu.tw	Chen, Mei Feng/I-2763-2016; Lin, Ying-Hung/AAC-6327-2019	Chen, Mei Feng/0000-0002-7170-0843; Lin, Ying-Hung/0000-0002-1574-1579	Ministry of Science and Technology of the Republic of China [NSC 101-2320-B-030-012-MY2, NSC 102-2320-B-030- 006-MY3, MOST 103-2314-B-030-002-]; Shin-Kong Wu Ho-Su Memorial Hospital [101-SKH-FJU-06]; Cathay General Hospital [102-CGH-FJU-03]	Ministry of Science and Technology of the Republic of China(Ministry of Science and Technology, Taiwan); Shin-Kong Wu Ho-Su Memorial Hospital; Cathay General Hospital	This study was supported by grants from the Ministry of Science and Technology of the Republic of China (YHL: NSC 101-2320-B-030-012-MY2, NSC 102-2320-B-030- 006-MY3 and MOST 103-2314-B-030-002-), Shin-Kong Wu Ho-Su Memorial Hospital (YHL: 101-SKH-FJU-06), and Cathay General Hospital (YHL: 102-CGH-FJU-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chao HCA, 2010, J ASSIST REPROD GEN, V27, P299, DOI 10.1007/s10815-010-9409-4; Chi YH, 2009, DEVELOPMENT, V136, P965, DOI 10.1242/dev.029868; Cho C, 2001, NAT GENET, V28, P82, DOI 10.1038/ng0501-82; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; Ding X, 2007, DEV CELL, V12, P863, DOI 10.1016/j.devcel.2007.03.018; Frohnert C, 2011, MOL HUM REPROD, V17, P207, DOI 10.1093/molehr/gaq099; Geisler SB, 2007, GENOMICS, V89, P521, DOI 10.1016/j.ygeno.2006.12.004; Gob E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012072; Hall PA, 2005, J PATHOL, V206, P269, DOI 10.1002/path.1789; Hall PA, 2004, J PATHOL, V204, P489, DOI 10.1002/path.1654; Haque F, 2006, MOL CELL BIOL, V26, P3738, DOI 10.1128/MCB.26.10.3738-3751.2006; Hasan S, 2006, FEBS LETT, V580, P1263, DOI 10.1016/j.febslet.2006.01.039; Hsu CC, 2012, J BIOL CHEM, V287, P22533, DOI 10.1074/jbc.M111.335331; Ihara M, 2005, DEV CELL, V8, P343, DOI 10.1016/j.devcel.2004.12.005; Javed M, 2010, REPROD BIOMED ONLINE, V20, P56, DOI 10.1016/j.rbmo.2009.10.010; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Kinoshita M, 2007, CELL, V130, P777, DOI 10.1016/j.cell.2007.08.022; Kissel H, 2005, DEV CELL, V8, P353, DOI 10.1016/j.devcel.2005.01.021; Kracklauer MP, 2010, J CELL SCI, V123, P2763, DOI 10.1242/jcs.066589; Kremer BE, 2007, CELL, V130, P837, DOI 10.1016/j.cell.2007.06.053; Kuo PL, 2013, INT J MOL SCI, V14, P22102, DOI 10.3390/ijms141122102; Kuo YC, 2012, HUM MUTAT, V33, P710, DOI 10.1002/humu.22028; Lhuillier P, 2009, HUM REPROD, V24, P1296, DOI 10.1093/humrep/dep020; Lin YH, 2011, INT J ANDROL, V34, pE358, DOI 10.1111/j.1365-2605.2010.01126.x; Lin YH, 2006, FERTIL STERIL, V86, P1650, DOI 10.1016/j.fertnstert.2006.04.039; Lin Ying-Hung, 2011, Spermatogenesis, V1, P298; Lin YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034011; Lin YH, 2011, FERTIL STERIL, V95, P363, DOI 10.1016/j.fertnstert.2010.07.1064; Lin YH, 2009, AM J PATHOL, V174, P1857, DOI 10.2353/ajpath.2009.080955; Mansfeld J, 2006, MOL CELL, V22, P93, DOI 10.1016/j.molcel.2006.02.015; Martinez C, 2004, BIOCHEM J, V382, P783, DOI 10.1042/BJ20040372; Mostowy S, 2012, NAT REV MOL CELL BIO, V13, P183, DOI 10.1038/nrm3284; Nagata K, 2004, J BIOL CHEM, V279, P55895, DOI 10.1074/jbc.M406153200; Padmakumar VC, 2005, J CELL SCI, V118, P3419, DOI 10.1242/jcs.02471; PALERMO G, 1992, LANCET, V340, P17, DOI 10.1016/0140-6736(92)92425-F; Shao XP, 1999, DEV BIOL, V211, P109, DOI 10.1006/dbio.1999.9297; Silber SJ, 2000, CLIN OBSTET GYNECOL, V43, P854, DOI 10.1097/00003081-200012000-00017; Sirajuddin M, 2007, NATURE, V449, P311, DOI 10.1038/nature06052; Spiliotis ET, 2005, SCIENCE, V307, P1781, DOI 10.1126/science.1106823; Sugino Y, 2008, J UROLOGY, V180, P2706, DOI 10.1016/j.juro.2008.08.005; Tasi YC, 2013, J ASSIST REPROD GEN, V30, P505, DOI 10.1007/s10815-013-9954-8; Turgay Y, 2010, EMBO J, V29, P2262, DOI 10.1038/emboj.2010.119; Tzur YB, 2006, NAT REV MOL CELL BIO, V7, P782, DOI 10.1038/nrm2003; World Health Organization, 1992, WHO LAB MAN EX HUM S; Zhang XC, 2009, NEURON, V64, P173, DOI 10.1016/j.neuron.2009.08.018; Zhu M, 2008, J BIOL CHEM, V283, P18916, DOI 10.1074/jbc.M710591200	47	31	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120722	10.1371/journal.pone.0120722	http://dx.doi.org/10.1371/journal.pone.0120722			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775403	Green Submitted, Green Published, gold			2022-12-27	WOS:000351183500190
J	Schwartz, AJ; Sarver, DC; Sugg, KB; Dzierzawski, JT; Gumucio, JP; Mendias, CL				Schwartz, Andrew J.; Sarver, Dylan C.; Sugg, Kristoffer B.; Dzierzawski, Justin T.; Gumucio, Jonathan P.; Mendias, Christopher L.			p38 MAPK Signaling in Postnatal Tendon Growth and Remodeling	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE; COLLAGEN-SYNTHESIS; TISSUE; DIFFERENTIATION; HYALURONAN; INHIBITION; EXPRESSION; CELLS; HYPERTROPHY	Tendon is a dynamic tissue whose structure and function is influenced by mechanical loading, but little is known about the fundamental mechanisms that regulate tendon growth and remodeling in vivo. Data from cultured tendon fibroblasts indicated that the p38 MAPK pathway plays an important role in tendon fibroblast proliferation and collagen synthesis in vitro. To gain greater insight into the mechanisms of tendon growth, and explore the role of p38 MAPK signaling in this process, we tested the hypotheses that inducing plantaris tendon growth through the ablation of the synergist Achilles tendon would result in rapid expansion of a neotendon matrix surrounding the original tendon, and that treatment with the p38 MAPK inhibitor SB203580 would prevent this growth. Rats were treated with vehicle or SB203580, and subjected to synergist ablation by bilateral tenectomy of the Achilles tendon. Changes in histological and biochemical properties of plantaris tendons were analyzed 3, 7, or 28 days after overload, and comparisons were made to non-overloaded animals. By 28 days after overload, tendon mass had increased by 30% compared to non-overloaded samples, and cross-sectional area (CSA) increased by around 50%, with most of the change occurring in the neotendon. The expansion in CSA initially occurred through the synthesis of a hyaluronic acid rich matrix that was progressively replaced with mature collagen. Pericytes were present in areas of active tendon growth, but never in the original tendon ECM. Inhibition of p38 MAPK resulted in a profound decrease in IL6 expression, and had a modest effect on the expression of other ECM and cell proliferation genes, but had a negligible impact on overall tendon growth. The combined results from this study provided novel insights into tendon mechanobiology, and suggest that p38 MAPK signaling does not appear to be necessary for tendon growth in vivo.	[Schwartz, Andrew J.; Sarver, Dylan C.; Sugg, Kristoffer B.; Dzierzawski, Justin T.; Gumucio, Jonathan P.; Mendias, Christopher L.] Univ Michigan, Sch Med, Dept Orthopaed Surg, Ann Arbor, MI 48109 USA; [Schwartz, Andrew J.; Sarver, Dylan C.; Sugg, Kristoffer B.; Gumucio, Jonathan P.; Mendias, Christopher L.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI USA; [Sugg, Kristoffer B.] Univ Michigan, Sch Med, Dept Surg, Sect Plast Surg, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Mendias, CL (corresponding author), Univ Michigan, Sch Med, Dept Orthopaed Surg, Ann Arbor, MI 48109 USA.	cmendias@umich.edu	Mendias, Christopher/C-5557-2018	Mendias, Christopher/0000-0002-2384-0171	NIH/NIAMS [R01-AR063649, F31-AR065931, F32-AR067086]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR067086, R01AR063649, F31AR065931] Funding Source: NIH RePORTER	NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Support for this study was provided by NIH/NIAMS grants R01-AR063649, F31-AR065931, and F32-AR067086. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/783632; Acharya A, 2012, DEVELOPMENT, V139, P2139, DOI 10.1242/dev.079970; Andersen MB, 2011, J APPL PHYSIOL, V110, P1549, DOI 10.1152/japplphysiol.00037.2010; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Baeza-Raja B, 2004, MOL BIOL CELL, V15, P2013, DOI 10.1091/mbc.E03-08-0585; Baud A, 2013, NAT GENET, V45, P767, DOI 10.1038/ng.2644; Bernet JD, 2014, NAT MED, V20, P265, DOI 10.1038/nm.3465; Birbrair A, 2013, AM J PHYSIOL-CELL PH, V305, pC1098, DOI 10.1152/ajpcell.00171.2013; Calve S, 2012, AM J PHYSIOL-CELL PH, V303, pC577, DOI 10.1152/ajpcell.00057.2012; Calve S, 2010, DEV BIOL, V344, P259, DOI 10.1016/j.ydbio.2010.05.007; Chiquet M, 2009, BBA-MOL CELL RES, V1793, P911, DOI 10.1016/j.bbamcr.2009.01.012; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Davis ME, 2013, J APPL PHYSIOL, V115, P884, DOI 10.1152/japplphysiol.00137.2013; Eliasson P, 2013, J APPL PHYSIOL, V114, P1519, DOI 10.1152/japplphysiol.01500.2012; ESSER KA, 1995, J APPL PHYSIOL, V78, P30, DOI 10.1152/jappl.1995.78.1.30; Ettema GJC, 1996, J EXP BIOL, V199, P1277; Fry CS, 2014, FASEB J, V28, P1654, DOI 10.1096/fj.13-239426; Girish KS, 2007, LIFE SCI, V80, P1921, DOI 10.1016/j.lfs.2007.02.037; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Guerquin MJ, 2013, J CLIN INVEST, V123, P3564, DOI 10.1172/JCI67521; Gumucio JP, 2014, J APPL PHYSIOL, V117, P1287, DOI 10.1152/japplphysiol.00720.2014; Hamilton DL, 2014, AM J PHYSIOL-ENDOC M, V307, pE365, DOI 10.1152/ajpendo.00674.2013; Havis E, 2014, DEVELOPMENT, V141, P3683, DOI 10.1242/dev.108654; Heinemeier K, 2003, J APPL PHYSIOL, V95, P2390, DOI 10.1152/japplphysiol.00403.2003; Heinemeier KM, 2013, FASEB J, V27, P2074, DOI 10.1096/fj.12-225599; Itano N, 2002, P NATL ACAD SCI USA, V99, P3609, DOI 10.1073/pnas.052026799; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kjaer M, 2009, SCAND J MED SCI SPOR, V19, P500, DOI 10.1111/j.1600-0838.2009.00986.x; Langberg H, 2002, J PHYSIOL-LONDON, V542, P985, DOI 10.1113/jphysiol.2002.019141; Ledford H, 2011, NATURE, V472, P273, DOI 10.1038/472273a; Lee JC, 1999, PHARMACOL THERAPEUT, V82, P389, DOI 10.1016/S0163-7258(99)00008-X; Lejard V, 2011, J BIOL CHEM, V286, P5855, DOI 10.1074/jbc.M110.153106; Li JH, 2006, AM J PATHOL, V169, P1527, DOI 10.2353/ajpath.2006.060169; Lin SL, 2008, AM J PATHOL, V173, P1617, DOI 10.2353/ajpath.2008.080433; Lorda-Diez CI, 2009, J BIOL CHEM, V284, P29988, DOI 10.1074/jbc.M109.014811; Maeda T, 2011, CURR BIOL, V21, P933, DOI 10.1016/j.cub.2011.04.007; McCarthy JJ, 2011, DEVELOPMENT, V138, P3657, DOI 10.1242/dev.068858; Mendias CL, 2008, P NATL ACAD SCI USA, V105, P388, DOI 10.1073/pnas.0707069105; Mendias CL, 2006, J APPL PHYSIOL, V101, P898, DOI 10.1152/japplphysiol.00126.2006; Mendias CL, 2012, J APPL PHYSIOL, V113, P56, DOI 10.1152/japplphysiol.00301.2012; Mendias CL, 2012, J ORTHOP RES, V30, P606, DOI 10.1002/jor.21550; Meran S, 2011, J BIOL CHEM, V286, P17618, DOI 10.1074/jbc.M111.226563; MICHNA H, 1989, INT ORTHOP, V13, P161, DOI 10.1007/BF00268040; Millar NL, 2012, ANN RHEUM DIS, V71, P302, DOI 10.1136/ard.2011.154229; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Munoz-Canoves P, 2013, FEBS J, V280, P4131, DOI 10.1111/febs.12338; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; Perdiguero E, 2011, J CELL BIOL, V195, P307, DOI 10.1083/jcb.201104053; Perez-Schindler J, 2013, P NATL ACAD SCI USA, V110, P20314, DOI 10.1073/pnas.1312039110; Pryce BA, 2009, DEVELOPMENT, V136, P1351, DOI 10.1242/dev.027342; Rowe RG, 2011, AM J PHYSIOL-LUNG C, V301, pL683, DOI 10.1152/ajplung.00187.2011; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sugg KB, 2014, J ORTHOP RES, V32, P944, DOI 10.1002/jor.22624; Tan Q, 2013, STEM CELLS DEV, V22, P3128, DOI 10.1089/scd.2013.0073; Taylor SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016337; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0	56	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120044	10.1371/journal.pone.0120044	http://dx.doi.org/10.1371/journal.pone.0120044			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768932	Green Published, Green Submitted, gold			2022-12-27	WOS:000351277500106
J	Dong, G; Wei, DD; Wang, JS; Guo, PP; Li, MH; Yang, MH; Kong, LY				Dong, Ge; Wei, Dandan; Wang, Junsong; Guo, Pingping; Li, Minghui; Yang, Minghua; Kong, Lingyi			Study of the Cardiotoxicity of Venenum Bufonis in Rats using an 1H NMR-Based Metabolomics Approach	PLOS ONE			English	Article							TRADITIONAL CHINESE MEDICINE; TOAD VENOM; MASS-SPECTROMETRY; TOXICITY; BUFADIENOLIDES; METABONOMICS; SERUM; CHROMATOGRAPHY; THIOACETAMIDE; SPECTROSCOPY	Venenum Bufonis, a well-known traditional Chinese medicine, has been widely used in Asia and has gained popularity in Western countries over the last decade. Venenum Bufonis has obvious side effects that have been observed in clinical settings, but few studies have reported on its cardiotoxicity. In this work, the cardiotoxicity of Venenum Bufonis was investigated using a H-11 NMR-based metabolomics approach. The H-1 NMR profiles of the serum, myocardial extracts and liver extracts of specific-pathogen-free rats showed that Venenum Bufonis produced significant metabolic perturbations dose-dependently with a distinct time effect, peaking at 2 hr after dosing and attenuating gradually. Clinical chemistry, electrocardiographic recordings, and histopathological evaluation provided additional evidence of Venenum Bufonis-induced cardiac damage that complemented and supported the metabolomics findings. The combined results demonstrated that oxidative stress, mitochondrial dysfunction, and energy metabolism perturbations were associated with the cardiac damage that results from Venenum Bufonis.	[Dong, Ge; Wei, Dandan; Guo, Pingping; Yang, Minghua; Kong, Lingyi] China Pharmaceut Univ, Dept Nat Med Chem, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China; [Wang, Junsong; Li, Minghui] Nanjing Univ Sci & Technol, Ctr Mol Metab, Sch Environm & Biol Engn, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University; Nanjing University of Science & Technology	Wang, JS (corresponding author), Nanjing Univ Sci & Technol, Ctr Mol Metab, Sch Environm & Biol Engn, Nanjing, Jiangsu, Peoples R China.	wang.junsong@gmail.com; cpu_lykong@126.com	WANG, JS/C-8780-2013	WANG, JS/0000-0002-8935-4969	National Science Foundation of China [81430092, 81173526]; Program for New Century Excellent Talents in University (Ministry of Education, China) [NCET-11-0738]; Fundamental Research Funds for the Central Universities (Ministry of Education, China) [30920130112014]; Program for Changjiang Scholars and Innovative Research Team in University (Ministry of Education) [PCSIRT-IRT1193]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University (Ministry of Education, China)(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities (Ministry of Education, China); Program for Changjiang Scholars and Innovative Research Team in University (Ministry of Education)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was funded by National Science Foundation of China (81430092; 81173526; National Science Foundation of China; http://www.nsfc.gov.cn/), the Program for New Century Excellent Talents in University (NCET-11-0738; Ministry of Education, China; http://www.moe.gov.cn/), the Fundamental Research Funds for the Central Universities (No. 30920130112014; Ministry of Education, China; http://www.moe.gov.cn/) granted to Prof. Wang, and the Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT-IRT1193; Ministry of Education, China; http://www.moe.gov.cn/) granted to Prof. Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreadou I, 2009, NMR BIOMED, V22, P585, DOI 10.1002/nbm.1370; Arica V, 2013, HUM EXP TOXICOL, V32, P655, DOI 10.1177/0960327112467043; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Cai YM, 2013, J ETHNOPHARMACOL, V147, P349, DOI 10.1016/j.jep.2013.03.017; CHEN KK, 1967, J PHARM SCI-US, V56, P1535, DOI 10.1002/jps.2600561202; China TPCotPsRo, 2010, PHARMACOPOEIA OF THE, VI, P360; Constantinou MA, 2007, TOXICOL APPL PHARM, V218, P11, DOI 10.1016/j.taap.2006.10.007; Gaude E, 2013, CURR METABOL, V1, P180, DOI 10.2174/2213235X11301020005; Gowda R M, 2003, Heart, V89, pe14, DOI 10.1136/heart.89.4.e14; Hu YM, 2011, J PHARMACEUT BIOMED, V56, P210, DOI 10.1016/j.jpba.2011.05.014; Jiang CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066786; Jiang P, 2011, MOL BIOSYST, V7, P824, DOI 10.1039/c0mb00110d; Kim JS, 2003, BIOCHEM BIOPH RES CO, V304, P463, DOI 10.1016/S0006-291X(03)00618-1; KWAN T, 1992, CHEST, V102, P949, DOI 10.1378/chest.102.3.949; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048872; Li JA, 2011, J PROTEOME RES, V10, P1073, DOI 10.1021/pr100862t; Li L, 2008, J ETHNOPHARMACOL, V116, P561, DOI 10.1016/j.jep.2008.01.014; Luo XP, 2006, ANAL BIOANAL CHEM, V384, P1254, DOI 10.1007/s00216-005-0251-y; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; Oorni K, 1997, J BIOL CHEM, V272, P21303, DOI 10.1074/jbc.272.34.21303; Pan ZZ, 2007, ANAL BIOANAL CHEM, V387, P525, DOI 10.1007/s00216-006-0687-8; Schaffer SW, 2014, AMINO ACIDS, V46, P21, DOI 10.1007/s00726-012-1378-8; Schoner W, 2007, AM J PHYSIOL-CELL PH, V293, pC509, DOI 10.1152/ajpcell.00098.2007; SHIMADA K, 1977, CHEM PHARM BULL, V25, P714; Steyn PS, 1998, NAT PROD REP, V15, P397; Taniyama Y, 2003, HYPERTENSION, V42, P1075, DOI 10.1161/01.HYP.0000100443.09293.4F; Tian N, 2013, METABOLOMICS, V9, P1228, DOI 10.1007/s11306-013-0535-8; Trushina E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063644; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Wang LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065675; Wang XJ, 2012, J PROTEOME RES, V11, P1284, DOI 10.1021/pr200963e; Waters NJ, 2005, CHEM RES TOXICOL, V18, P639, DOI 10.1021/tx049869b; Wei L, 2008, TOXICOL APPL PHARM, V227, P417, DOI 10.1016/j.taap.2007.11.015; Ye M, 2006, J CHROMATOGR B, V838, P86, DOI 10.1016/j.jchromb.2006.04.042; Yen HC, 1996, J CLIN INVEST, V98, P1253, DOI 10.1172/JCI118909; Zhang AH, 2012, ANAL BIOANAL CHEM, V404, P1239, DOI 10.1007/s00216-012-6117-1; Zhang ZH, 2013, J ETHNOPHARMACOL, V149, P303, DOI 10.1016/j.jep.2013.06.039; Zhao YF, 2006, J PHARMACEUT BIOMED, V41, P124, DOI 10.1016/j.jpba.2005.10.046	41	88	95	2	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119515	10.1371/journal.pone.0119515	http://dx.doi.org/10.1371/journal.pone.0119515			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781638	Green Published, gold, Green Submitted			2022-12-27	WOS:000351284600071
J	Fagan, KJ; Rogers, GB; Melino, M; Arthur, DM; Costello, ME; Morrison, M; Powell, EE; Irvine, KM				Fagan, Kevin J.; Rogers, Geraint B.; Melino, Michelle; Arthur, Dionne M.; Costello, Mary-Ellen; Morrison, Mark; Powell, Elizabeth E.; Irvine, Katharine M.			Ascites Bacterial Burden and Immune Cell Profile Are Associated with Poor Clinical Outcomes in the Absence of Overt Infection	PLOS ONE			English	Article							IFN-GAMMA; LIVER; DNA; EXPRESSION; DIVERSITY; CIRRHOSIS; SERUM	Bacterial infections, most commonly spontaneous bacterial peritonitis in patients with ascites, occur in one third of admitted patients with cirrhosis, and account for a 4-fold increase in mortality. Bacteria are isolated from less than 40% of ascites infections by culture, necessitating empirical antibiotic treatment, but culture-independent studies suggest bacteria are commonly present, even in the absence of overt infection. Widespread detection of low levels of bacteria in ascites, in the absence of peritonitis, suggests immune impairment may contribute to higher susceptibility to infection in cirrhotic patients. However, little is known about the role of ascites leukocyte composition and function in this context. We determined ascites bacterial composition by quantitative PCR and 16S rRNA gene sequencing in 25 patients with culture-negative, non- neutrocytic ascites, and compared microbiological data with ascites and peripheral blood leukocyte composition and phenotype. Bacterial DNA was detected in ascitic fluid from 23 of 25 patients, with significant positive correlations between bacterial DNA levels and poor 6-month clinical outcomes (death, readmission). Ascites leukocyte composition was variable, but dominated by macrophages or T lymphocytes, with lower numbers of B lymphocytes and natural killer cells. Consistent with the hypothesis that impaired innate immunity contributes to susceptibility to infection, high bacterial DNA burden was associated with reduced major histocompatibility complex class II expression on ascites (but not peripheral blood) monocytes/macrophages. These data indicate an association between the presence of ascites bacterial DNA and early death and readmission in patients with decompensated cirrhosis. They further suggest that impairment of innate immunity contributes to increased bacterial translocation, risk of peritonitis, or both.	[Fagan, Kevin J.; Melino, Michelle; Arthur, Dionne M.; Powell, Elizabeth E.; Irvine, Katharine M.] Univ Queensland, Translat Res Inst, Sch Med, Ctr Liver Dis Res, Brisbane, Qld, Australia; [Fagan, Kevin J.; Powell, Elizabeth E.] Princess Alexandra Hosp, Dept Gastroenterol & Hepatol, Brisbane, Qld 4102, Australia; [Rogers, Geraint B.] Flinders Univ S Australia, Sch Med, SAHMRI Infect & Immun Theme, Adelaide, SA 5001, Australia; [Costello, Mary-Ellen; Morrison, Mark] Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld, Australia	University of Queensland; Flinders University South Australia; South Australian Health & Medical Research Institute (SAHMRI); University of Queensland	Irvine, KM (corresponding author), Univ Queensland, Translat Res Inst, Sch Med, Ctr Liver Dis Res, Brisbane, Qld, Australia.	Katharine.irvine@uq.edu.au	Rogers, Geraint/AAD-1011-2020; Morrison, Mark/C-9707-2013; Irvine, Katharine M/A-5559-2011; Powell, Elizabeth/B-4455-2011; Rogers, Geraint/N-1957-2013	Morrison, Mark/0000-0001-9257-9133; Irvine, Katharine M/0000-0002-6716-1605; Powell, Elizabeth/0000-0001-5008-8061; Rogers, Geraint/0000-0003-4054-1947; Melino, Michelle/0000-0001-6962-9016	PA Hospital Foundation; Australian Liver Foundation; Australian National Health and Medical Research Council	PA Hospital Foundation; Australian Liver Foundation; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by the PA Hospital Foundation (www.pafoundation.org.au) and the Australian Liver Foundation (www.liver.org.au) Pauline Hall Fellowship (to KMI) and the Australian National Health and Medical Research Council (www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniades CG, 2006, HEPATOLOGY, V44, P34, DOI 10.1002/hep.21240; Arroyo V, 2014, J HEPATOL, V61, P396, DOI 10.1016/j.jhep.2014.04.012; Arvaniti V, 2010, GASTROENTEROLOGY, V139, P1246, DOI 10.1053/j.gastro.2010.06.019; Balkhy HH, 1999, J IMMUNOL, V162, P3633; Bellentani S, 1997, GUT, V41, P845, DOI 10.1136/gut.41.6.845; Bellot P, 2010, HEPATOLOGY, V52, P2044, DOI 10.1002/hep.23918; Berry PA, 2011, INTENS CARE MED, V37, P453, DOI 10.1007/s00134-010-2099-7; Brandl K, 2008, NATURE, V455, P804, DOI 10.1038/nature07250; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen YF, 2011, HEPATOLOGY, V54, P562, DOI 10.1002/hep.24423; Cholongitas E, 2005, LIVER INT, V25, P57, DOI 10.1111/j.1478-3231.2004.0985.x; Docke WD, 1997, NAT MED, V3, P678, DOI 10.1038/nm0697-678; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fagan KJ, 2014, INTERN MED J; GARCIAGONZALEZ M, 1993, GASTROENTEROLOGY, V105, P527, DOI 10.1016/0016-5085(93)90730-Z; Leber B, 2012, SEMIN RESP CRIT CARE, V33, P80, DOI 10.1055/s-0032-1301737; LEBRUN L, 1992, J HEPATOL, V16, P98, DOI 10.1016/S0168-8278(05)80100-X; Leentjens J, 2012, AM J RESP CRIT CARE, V186, P838, DOI 10.1164/rccm.201204-0645OC; Lu MF, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003339; Neuberger J, 2008, GUT, V57, P252, DOI 10.1136/gut.2007.131730; O'Brien AJ, 2014, NAT MED, V20, P522, DOI 10.1038/nm.3516; Philippart F, 2012, CRIT CARE MED, V40, P2987, DOI 10.1097/CCM.0b013e31825b8d57; Pievani A, 2011, BLOOD, V118, P3301, DOI 10.1182/blood-2011-02-336321; Poli A, 2009, IMMUNOLOGY, V126, P458, DOI 10.1111/j.1365-2567.2008.03027.x; Qin N, 2014, NATURE, V513, P59, DOI 10.1038/nature13568; Quigley EM, 2013, EXPERT REV GASTROENT, V7, P723, DOI 10.1586/17474124.2013.848167; Rogers GB, 2010, EUR J CLIN MICROBIOL, V29, P533, DOI 10.1007/s10096-010-0891-5; Rogers GB, 2014, LANCET RESPIRATORY M; Rogers GB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074884; Such J, 2002, HEPATOLOGY, V36, P135, DOI 10.1053/jhep.2002.33715; Wasmuth HE, 2005, J HEPATOL, V42, P195, DOI 10.1016/j.jhep.2004.10.019; Wolk K, 2000, BLOOD, V96, P218, DOI 10.1182/blood.V96.1.218.013k04_218_223; Wolk K, 2003, J BIOL CHEM, V278, P18030, DOI 10.1074/jbc.M207714200; Zapater P, 2008, HEPATOLOGY, V48, P1924, DOI 10.1002/hep.22564	37	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120642	10.1371/journal.pone.0120642	http://dx.doi.org/10.1371/journal.pone.0120642			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781164	Green Published, gold, Green Submitted			2022-12-27	WOS:000351284600178
J	Kalyani, D; Tiwari, MK; Li, JL; Kim, SC; Kalia, VC; Kang, YC; Lee, JK				Kalyani, Dayanand; Tiwari, Manish Kumar; Li, Jinglin; Kim, Sun Chang; Kalia, Vipin C.; Kang, Yun Chan; Lee, Jung-Kul			A Highly Efficient Recombinant Laccase from the Yeast Yarrowia lipolytica and Its Application in the Hydrolysis of Biomass	PLOS ONE			English	Article							ENZYMATIC-HYDROLYSIS; MULTICOPPER OXIDASE; PHENOLIC-COMPOUNDS; MOLECULAR-CLONING; RICE STRAW; PURIFICATION; TECHNOLOGIES; PRETREATMENT; SUBSTRATE	A modified thermal asymmetric interlaced polymerase chain reaction was performed to obtain the first yeast laccase gene (YlLac) from the isolated yeast Yarrowia lipolytica. The 1557-bp full-length cDNA of YlLac encoded a mature laccase protein containing 519 amino acids preceded by a signal peptide of 19 amino acids, and the YlLac gene was expressed in the yeast Pichia pastoris. YlLac is a monomeric glycoprotein with a molecular mass of similar to 55 kDa as determined by polyacrylamide-gel electrophoresis. It showed a higher catalytic efficiency towards 2,2-azino-bis(3-ethylbenzothiazoline-6-sulfonate) (k(cat)/K-m = 17.5 s(-1) mu M-1) and 2,6-dimethoxyphenol (k(cat)/K-m = 16.1 s(-1) mu M-1) than other reported laccases. The standard redox potential of the T1 site of the enzyme was found to be 772 mV. The highest catalytic efficiency of the yeast recombinant laccase, YlLac, makes it a good candidate for industrial applications: it removes phenolic compounds in acid-pretreated woody biomass (Populus balsamifera) and enhanced saccharification.	[Kalyani, Dayanand; Tiwari, Manish Kumar; Li, Jinglin; Lee, Jung-Kul] Konkuk Univ, Dept Chem Engn, Seoul, South Korea; [Kim, Sun Chang] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Kalia, Vipin C.] CSIR, Inst Genom & Integrat Biol, Microbial Biotechnol & Genom, Delhi, India; [Kang, Yun Chan] Korea Univ, Dept Mat Sci & Engn, Seoul, South Korea	Konkuk University; Korea Advanced Institute of Science & Technology (KAIST); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Korea University	Kang, YC (corresponding author), Korea Univ, Dept Mat Sci & Engn, Seoul, South Korea.	yckang@korea.ac.kr; jkrhee@konkuk.ac.kr	Tiwari, Manish K./D-9034-2011; Kalyani, Dayanand/AAF-3120-2020; Lee, Jungkukl/D-9104-2011; Kim, Sun/GSN-4867-2022; Kim, Sun Chang/C-2026-2011; Kang, Yun Chan/H-2457-2015	Tiwari, Manish K./0000-0002-4667-1112; Kalyani, Dayanand/0000-0001-5829-9357; Kang, Yun Chan/0000-0001-5769-5761	Energy Efficiency & Resources Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) from the Ministry of Trade, Industry & Energy, Republic of Korea [201320200000420]; Intelligent Synthetic Biology Center of Global Frontier Project - Ministry of Science, ICT and Future Planning, Republic of Korea [2011-0031955]; KU Brain Pool fellowship of Konkuk University	Energy Efficiency & Resources Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) from the Ministry of Trade, Industry & Energy, Republic of Korea; Intelligent Synthetic Biology Center of Global Frontier Project - Ministry of Science, ICT and Future Planning, Republic of Korea; KU Brain Pool fellowship of Konkuk University	This work was supported by the Energy Efficiency & Resources Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP), granted financial resource from the Ministry of Trade, Industry & Energy, Republic of Korea (201320200000420). This research was also supported by a grant from the Intelligent Synthetic Biology Center of Global Frontier Project (2011-0031955) funded by the Ministry of Science, ICT and Future Planning, Republic of Korea. This work was supported by 2013 KU Brain Pool fellowship of Konkuk University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvira P, 2010, BIORESOURCE TECHNOL, V101, P4851, DOI 10.1016/j.biortech.2009.11.093; Arora DS, 2010, APPL BIOCHEM BIOTECH, V160, P1760, DOI 10.1007/s12010-009-8676-y; Baldrian P, 2004, FEMS MICROBIOL ECOL, V50, P245, DOI 10.1016/j.femsec.2004.07.005; Couto SR, 2006, BIOTECHNOL ADV, V24, P500, DOI 10.1016/j.biotechadv.2006.04.003; Dedeyan B, 2000, APPL ENVIRON MICROB, V66, P925, DOI 10.1128/AEM.66.3.925-929.2000; Fernandez-Sanchez C, 2002, BIOELECTROCHEMISTRY, V58, P149, DOI 10.1016/S1567-5394(02)00119-6; Frasconi M, 2010, BBA-PROTEINS PROTEOM, V1804, P899, DOI 10.1016/j.bbapap.2009.12.018; Giardina P, 2010, CELL MOL LIFE SCI, V67, P369, DOI 10.1007/s00018-009-0169-1; Gu CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093912; Hoegger PJ, 2006, FEBS J, V273, P2308, DOI 10.1111/j.1742-4658.2006.05247.x; Huang WT, 2011, PROCESS BIOCHEM, V46, P1469, DOI 10.1016/j.procbio.2011.03.020; Jeya M, 2010, APPL MICROBIOL BIOT, V86, P1473, DOI 10.1007/s00253-009-2395-8; Jin SY, 2006, PROCESS BIOCHEM, V41, P1261, DOI 10.1016/j.procbio.2005.12.022; Kallio JP, 2009, J MOL BIOL, V392, P895, DOI 10.1016/j.jmb.2009.06.053; Kalyani D, 2012, PROCESS BIOCHEM, V47, P671, DOI 10.1016/j.procbio.2012.01.013; Kataoka K, 2007, J MOL BIOL, V373, P141, DOI 10.1016/j.jmb.2007.07.041; Kudanga T, 2014, APPL MICROBIOL BIOT, V98, P6525, DOI 10.1007/s00253-014-5810-8; Kunamneni A, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-32; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee KM, 2012, BIORESOURCE TECHNOL, V123, P636, DOI 10.1016/j.biortech.2012.07.066; Litthauer D, 2007, ENZYME MICROB TECH, V40, P563, DOI 10.1016/j.enzmictec.2006.05.011; Mate D, 2010, CHEM BIOL, V17, P1030, DOI 10.1016/j.chembiol.2010.07.010; Matera I, 2008, INORG CHIM ACTA, V361, P4129, DOI 10.1016/j.ica.2008.03.091; Parawira W, 2011, CRIT REV BIOTECHNOL, V31, P20, DOI 10.3109/07388551003757816; Patel SKS, 2014, J MICROBIOL BIOTECHN, V24, P639, DOI 10.4014/jmb.1401.01025; Piscitelli Alessandra, 2010, Bioeng Bugs, V1, P252, DOI 10.4161/bbug.1.4.11438; Sanchez-Amat A, 2001, BBA-PROTEIN STRUCT M, V1547, P104, DOI 10.1016/S0167-4838(01)00174-1; Singer T, 2003, METH MOL B, V236, P241; SINGLETON VL, 1978, J SCI FOOD AGR, V29, P403, DOI 10.1002/jsfa.2740290416; Tiwari M, 2010, J MOL GRAPH MODEL, V28, P707, DOI 10.1016/j.jmgm.2010.01.004; Tiwari MK, 2012, J BIOL CHEM, V287, P19429, DOI 10.1074/jbc.M111.335752; Wong KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066426; Xiao YZ, 2004, MYCOLOGIA, V96, P26, DOI 10.2307/3761984; Xu F, 1997, J BIOL CHEM, V272, P924, DOI 10.1074/jbc.272.2.924; Yaver DS, 1996, APPL ENVIRON MICROB, V62, P834, DOI 10.1128/AEM.62.3.834-841.1996; Zhu JY, 2010, APPL MICROBIOL BIOT, V87, P847, DOI 10.1007/s00253-010-2654-8	36	36	39	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120156	10.1371/journal.pone.0120156	http://dx.doi.org/10.1371/journal.pone.0120156			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781945	Green Submitted, Green Published, gold			2022-12-27	WOS:000351284600133
J	Linn, DE; Bronson, RT; Li, Z				Linn, Douglas E.; Bronson, Roderick T.; Li, Zhe			Genetic Interaction between Tmprss2-ERG Gene Fusion and Nkx3.1-Loss Does Not Enhance Prostate Tumorigenesis in Mouse Models	PLOS ONE			English	Article							PATHOLOGY COMMITTEE; CANCER PROGRESSION; CONSENSUS REPORT; ENGINEERED MICE; ERG EXPRESSION; PTEN LOSS; CARCINOGENESIS; COOPERATIVITY; ACTIVATION; PATHWAYS	Gene fusions involving ETS family transcription factors (mainly TMPRSS2-ERG and TMPRSS2-ETV1 fusions) have been found in similar to 50% of human prostate cancer cases. Although expression of TMPRSS2-ERG or TMPRSS2-ETV1 fusion alone is insufficient to initiate prostate tumorigenesis, they appear to sensitize prostate epithelial cells for cooperation with additional oncogenic mutations to drive frank prostate adenocarcinoma. To search for such ETS-cooperating oncogenic events, we focused on a well-studied prostate tumor suppressor NKX3.1, as loss of NKX3.1 is another common genetic alteration in human prostate cancer. Previous studies have shown that deletions at 8p21 (harboring NKX3.1) and 21q22 (resulting in TMPRSS2-ERG fusion) were both present in a subtype of prostate cancer cases, and that ERG can lead to epigenetic silencing of NKX3.1 in prostate cancer cells, whereas NKX3.1 can in turn negatively regulate TMPRSS2-ERG fusion expression via suppression of the TMPRSS2 promoter activity. We recently generated knockin mouse models for TMPRSS2-ERG and TMPRSS2-ETV1 fusions, utilizing the endogenous Tmprss2 promoter. We crossed these knockin models to an Nkx3.1 knockout mouse model. In Tmprss2-ERG; Nkx3.1(+/-)(or (-/-)) male mice, although we observed a slight but significant upregulation of Tmprss2-ERG fusion expression upon Nkx3.1 loss, we did not detect any significant cooperation between these two genetic events to enhance prostate tumorigenesis in vivo. Furthermore, retrospective analysis of a previously published human prostate cancer dataset revealed that within ERG-overexpressing prostate cancer cases, NKX3.1 loss or deletion did not predict biochemical relapse after radical prostatectomy. Collectively, these data suggest that although TMPRSS2-ERG fusion and loss of NKX3.1 are among the most common mutational events found in prostate cancer, and although each of them can sensitize prostate epithelial cells for cooperating with other oncogenic events, these two events themselves do not appear to cooperate at a significant level in vivo to enhance prostate tumorigenesis.	[Linn, Douglas E.; Li, Zhe] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Linn, Douglas E.; Li, Zhe] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Bronson, Roderick T.] Harvard Univ, Sch Med, Rodent Histopathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Li, Z (corresponding author), Brigham & Womens Hosp, Div Genet, 75 Francis St, Boston, MA 02115 USA.	zli4@rics.bwh.harvard.edu			Career Development Award from Dana-Farber/Harvard Cancer Center Prostate Cancer SPORE [P50CA090381]; Idea Development Award from Department of Defense [PC100704]; NATIONAL CANCER INSTITUTE [P50CA090381] Funding Source: NIH RePORTER	Career Development Award from Dana-Farber/Harvard Cancer Center Prostate Cancer SPORE; Idea Development Award from Department of Defense; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Career Development Award from Dana-Farber/Harvard Cancer Center Prostate Cancer SPORE (P50CA090381) and an Idea Development Award from Department of Defense (PC100704) to Z.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate-Shen C, 2003, CANCER RES, V63, P3886; Abate-Shen C, 2008, DIFFERENTIATION, V76, P717, DOI 10.1111/j.1432-0436.2008.00292.x; Baena E, 2013, GENE DEV, V27, P683, DOI 10.1101/gad.211011.112; Bhatia-Gaur R, 1999, GENE DEV, V13, P966, DOI 10.1101/gad.13.8.966; Carver BS, 2009, NATURE, V457, pE1, DOI 10.1038/nature07738; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Casey OM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041668; Chinnaiyan AM, 2008, NEOPLASIA, V10, P177, DOI 10.1593/neo.07822; Demichelis F, 2009, GENE CHROMOSOME CANC, V48, P366, DOI 10.1002/gcc.20647; DETRE S, 1995, J CLIN PATHOL, V48, P876, DOI 10.1136/jcp.48.9.876; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Ittmann M, 2013, CANCER RES, V73, P2718, DOI 10.1158/0008-5472.CAN-12-4213; Kim MJ, 2002, P NATL ACAD SCI USA, V99, P2884, DOI 10.1073/pnas.042688999; King JC, 2009, NAT GENET, V41, P524, DOI 10.1038/ng.371; Klezovitch O, 2008, P NATL ACAD SCI USA, V105, P2105, DOI 10.1073/pnas.0711711105; Kumar-Sinha C, 2008, NAT REV CANCER, V8, P497, DOI 10.1038/nrc2402; Kunderfranco P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010547; Lapointe J, 2007, CANCER RES, V67, P8504, DOI 10.1158/0008-5472.CAN-07-0673; Lei QY, 2006, CANCER CELL, V9, P367, DOI 10.1016/j.ccr.2006.03.031; Park JH, 2002, AM J PATHOL, V161, P727, DOI 10.1016/S0002-9440(10)64228-9; Pettersson A, 2012, CANCER EPIDEM BIOMAR, V21, P1497, DOI 10.1158/1055-9965.EPI-12-0042; Setlur SR, 2008, JNCI-J NATL CANCER I, V100, P815, DOI 10.1093/jnci/djn150; Shappell SB, 2004, CANCER RES, V64, P2270, DOI 10.1158/0008-5472.CAN-03-0946; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Shin S, 2009, CANCER RES, V69, P8102, DOI 10.1158/0008-5472.CAN-09-0941; Simmons SO, 2006, BIOCHEM J, V393, P397, DOI 10.1042/BJ20051030; Tanaka M, 2000, DEV DYNAM, V219, P248, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1054>3.3.CO;2-5; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thangapazham R, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-16; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Yang Chih-Cheng, 2014, F1000Res, V3, P115, DOI 10.12688/f1000research.3818.2; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Zong Y, 2009, P NATL ACAD SCI USA, V106, P12465, DOI 10.1073/pnas.0905931106	34	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120628	10.1371/journal.pone.0120628	http://dx.doi.org/10.1371/journal.pone.0120628			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25780911	Green Submitted, Green Published, gold			2022-12-27	WOS:000351284600176
J	Nygaard, H; Slettalokken, G; Vegge, G; Hollan, I; Whist, JE; Strand, T; Ronnestad, BR; Ellefsen, S				Nygaard, Havard; Slettalokken, Gunnar; Vegge, Geir; Hollan, Ivana; Whist, Jon Elling; Strand, Tor; Ronnestad, Bent R.; Ellefsen, Stian			Irisin in Blood Increases Transiently after Single Sessions of Intense Endurance Exercise and Heavy Strength Training	PLOS ONE			English	Article							CIRCULATING IRISIN; ADIPOSE-TISSUE; WHITE FAT; PGC-1-ALPHA; COACTIVATOR; EXPRESSION; PLASMA; FNDC5	Purpose Irisin is a recently identified exercise-induced hormone that increases energy expenditure, at least in rodents. The main purpose of this study was to test the hypothesis that Irisin increases acutely in blood after singular sessions of intense endurance exercise (END) and heavy strength training (STR). Secondary, we wanted to explore the relationship between body composition and exercise-induced effects on irisin, and the effect of END and STR on muscular expression of the irisin gene FNDC5. Methods Nine moderately trained healthy subjects performed three test days using a randomized and standardized crossover design: one day with 60 minutes of END, one day with 60 minutes of STR, and one day without exercise (CON). Venous blood was sampled over a period of 24h on the exercise days. Results Both END and STR led to transient increases in irisin concentrations in blood, peaking immediately after END and one hour after STR, before gradually returning to baseline. Irisin responses to STR, but not END, showed a consistently strong negative correlation with proportions of lean body mass. Neither END nor STR affected expression of FNDC5, measured 4h after training sessions, though both protocols led to pronounced increases in PGC-1 alpha expression, which is involved in transcriptional control of FNDC5. Conclusion The results strongly suggest that single sessions of intense endurance exercise and heavy strength training lead to transient increases in irisin concentrations in blood. This was not accompanied by increased FNDC5 expression, measured 4h post-exercise. The results suggest that irisin responses to resistance exercise are higher in individuals with lower proportions of lean body mass.	[Nygaard, Havard; Slettalokken, Gunnar; Vegge, Geir; Ronnestad, Bent R.; Ellefsen, Stian] Lillehammer Univ Coll, Lillehammer, Norway; [Hollan, Ivana] Hosp Rheumat Dis, Lillehammer, Norway; [Whist, Jon Elling; Strand, Tor] Innlandet Hosp Trust, Lillehammer, Norway	Inland Norway University of Applied Sciences; Innlandet Hospital Trust	Nygaard, H (corresponding author), Lillehammer Univ Coll, Lillehammer, Norway.	havard.nygaard@hil.no	Nygaard, Havard/AAA-1344-2019; Strand, Tor/D-9836-2016	Strand, Tor/0000-0002-4038-151X; Nygaard, Havard/0000-0002-7401-5323; Ronnestad, Bent/0000-0002-6907-1347				Anastasilakis AD, 2014, J CLIN ENDOCR METAB; Andreoli A, 2009, RADIOL MED, V114, P286, DOI 10.1007/s11547-009-0369-7; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Daskalopoulou SS, 2014, EUROPEAN J ENDOCRINO; Ellefsen S, 2014, SCANDINAVIAN J MED S, DOI [10.1111/j.1600-0838.2012.01507.x, DOI 10.1111/J.1600-0838.2012.01507.X]; Ellefsen S, 2014, EUROPEAN J APPL PHYS; Elsen M, 2014, J ENDOCRINOL, V222, pR25, DOI 10.1530/JOE-14-0189; Emanuele E., 2014, AM J MED; Erickson HP, 2013, ADIPOCYTE, V2, P289, DOI 10.4161/adip.26082; Gibala MJ, 2012, J PHYSIOL-LONDON, V590, P1077, DOI 10.1113/jphysiol.2011.224725; Hecksteden A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-235; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Huh J.Y., 2014, J CLIN ENDOCR METAB; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Huh JY, 2012, METABOLISM; Kraemer RR, 2014, HORM METAB RES, V46, P150, DOI 10.1055/s-0033-1355381; Lee P, 2014, CELL METAB, V19, P302, DOI 10.1016/j.cmet.2013.12.017; Liu JJ, 2013, J DIABETES COMPLICAT, V27, P365, DOI 10.1016/j.jdiacomp.2013.03.002; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Norheim F, 2014, FEBS J, V281, P739, DOI 10.1111/febs.12619; Norrbom J, 2011, AM J PHYSIOL-ENDOC M, V301, pE1092, DOI 10.1152/ajpendo.00119.2011; Novelle MG, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/746281; Pardo M, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/857270; Park KH, 2013, J CLIN ENDOCR METAB, V98, P4899, DOI 10.1210/jc.2013-2373; Pekkala S., 2013, J PHYSL; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rana KS, 2014, AGE, V36, P995, DOI 10.1007/s11357-014-9620-9; Raschke S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073680; Ravussin E, 2011, ANNU REV NUTR, V31, P33, DOI 10.1146/annurev-nutr-072610-145209; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Singhal V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100218; Timmons JA, 2012, NATURE, V488, pE9, DOI 10.1038/nature11364; Tsuchiya Y, 2014, TOHOKU J EXP MED, V233, P135, DOI 10.1620/tjem.233.135; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; World health organization, 2013, WORLD HLTH STAT 2013; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xiang L, 2014, ATHEROSCLEROSIS, V235, P328, DOI 10.1016/j.atherosclerosis.2014.04.036; Yan B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094235	42	76	81	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0121367	10.1371/journal.pone.0121367	http://dx.doi.org/10.1371/journal.pone.0121367			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781950	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600204
J	Pelc, RS; McClure, JC; Kaur, SJ; Sears, KT; Rahman, MS; Ceraul, SM				Pelc, Rebecca S.; McClure, Jennifer C.; Kaur, Simran J.; Sears, Khandra T.; Rahman, M. Sayeedur; Ceraul, Shane M.			Disrupting Protein Expression with Peptide Nucleic Acids Reduces Infection by Obligate Intracellular Rickettsia	PLOS ONE			English	Article							ACTIN-BASED MOTILITY; GREEN FLUORESCENT PROTEIN; MARINER-BASED TRANSPOSON; OUTER-MEMBRANE PROTEIN; DERMACENTOR-VARIABILIS; ANTISENSE INHIBITION; GENE-EXPRESSION; ARP2/3 COMPLEX; TRANSFORMATION; CONORII	Peptide Nucleic Acids (PNAs) are single-stranded synthetic nucleic acids with a pseudopeptide backbone in lieu of the phosphodiester linked sugar and phosphate found in traditional oligos. PNA designed complementary to the bacterial Shine-Dalgarno or start codon regions of mRNA disrupts translation resulting in the transient reduction in protein expression. This study examines the use of PNA technology to interrupt protein expression in obligate intracellular Rickettsia sp. Their historically intractable genetic system limits characterization of protein function. We designed PNA targeting mRNA for rOmpB from Rickettsia typhi and rickA from Rickettsia montanensis, ubiquitous factors important for infection. Using an in vitro translation system and competitive binding assays, we determined that our PNAs bind target regions. Electroporation of R. typhi and R. montanensis with PNA specific to rOmpB and rickA, respectively, reduced the bacteria's ability to infect host cells. These studies open the possibility of using PNA to suppress protein synthesis in obligate intracellular bacteria.	[Pelc, Rebecca S.; McClure, Jennifer C.; Kaur, Simran J.; Sears, Khandra T.; Rahman, M. Sayeedur; Ceraul, Shane M.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Ceraul, SM (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA.	scera001@umaryland.edu	Sears, Khandra T/AAI-2485-2020	Sears, Khandra T/0000-0001-9400-8262; Pelc, Rebecca/0000-0001-5080-4945	National Institutes of Health/National Institute of Allergy and Infectious Diseases [1K22AI08040-01A1, R01AI043006, R01AI017828]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI017828, R37AI017828, R01AI043006] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Work for this manuscript was supported by funds from the National Institutes of Health/National Institute of Allergy and Infectious Diseases 1K22AI08040-01A1 to Shane M. Ceraul and R01AI043006 and R01AI017828 to Abdu F. Azad. The content is solely the responsibility of the authors and does not represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. http://www.niaid.nih.gov. National Institutes of Health/National Institute of Allergy and Infectious Diseases R01AI043006 and R01AI017828 to Abdu F. Azad provided partial support to personnel who authored this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldridge GD, 2005, APPL ENVIRON MICROB, V71, P2095, DOI 10.1128/AEM.71.4.2095-2105.2005; Baldridge GD, 2007, J INVERTEBR PATHOL, V94, P163, DOI 10.1016/j.jip.2006.10.003; Burkhardt NY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029511; Ceraul SM, 2011, INFECT IMMUN, V79, P321, DOI 10.1128/IAI.00362-10; Chan YGY, 2009, CELL MICROBIOL, V11, P629, DOI 10.1111/j.1462-5822.2008.01279.x; Clark TR, 2011, J BACTERIOL, V193, P4993, DOI 10.1128/JB.05279-11; Clark TR, 2011, INFECT IMMUN, V79, P1631, DOI 10.1128/IAI.00048-11; Good L, 1998, NAT BIOTECHNOL, V16, P355, DOI 10.1038/nbt0498-355; Good L, 2001, NAT BIOTECHNOL, V19, P360, DOI 10.1038/86753; Good L, 1999, Curr Issues Mol Biol, V1, P111; Gouin E, 2004, NATURE, V427, P457, DOI 10.1038/nature02318; HACKSTADT T, 1992, INFECT IMMUN, V60, P159, DOI 10.1128/IAI.60.1.159-165.1992; Jeng RL, 2004, CELL MICROBIOL, V6, P761, DOI 10.1111/j.1462-5822.2004.00402.x; Kaur SJ, 2012, J BACTERIOL, V194, P4920, DOI 10.1128/JB.00793-12; Kleba B, 2010, INFECT IMMUN, V78, P2240, DOI 10.1128/IAI.00100-10; Liu ZM, 2007, APPL ENVIRON MICROB, V73, P6644, DOI 10.1128/AEM.01727-07; Ma S, 2014, INTEGR BIOL-UK, V6, P973, DOI 10.1039/c4ib00172a; Martinez JJ, 2005, CELL, V123, P1013, DOI 10.1016/j.cell.2005.08.046; Martinez JJ, 2004, J CELL SCI, V117, P5097, DOI 10.1242/jcs.01382; Nekhotiaeva N, 2004, MOL THER, V10, P652, DOI 10.1016/j.ymthe.2004.07.006; NIELSEN PE, 1991, SCIENCE, V254, P1497, DOI 10.1126/science.1962210; Oliver JD, 2014, APPL ENVIRON MICROB, V80, P1170, DOI 10.1128/AEM.03352-13; Pelc RS, 2014, INSECT MOL BIOL, V23, P457, DOI 10.1111/imb.12094; Petchampai N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093768; Rachek LI, 1998, J BACTERIOL, V180, P2118, DOI 10.1128/JB.180.8.2118-2124.1998; Rajasekaran P, 2013, INT J ANTIMICROB AG, V41, P358, DOI 10.1016/j.ijantimicag.2012.11.017; Reed SCO, 2014, CURR BIOL, V24, P98, DOI 10.1016/j.cub.2013.11.025; Troyer JM, 1999, INFECT IMMUN, V67, P3308, DOI 10.1128/IAI.67.7.3308-3311.1999	28	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119283	10.1371/journal.pone.0119283	http://dx.doi.org/10.1371/journal.pone.0119283			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781160	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600058
J	Penarrubia, L; Sanz, N; Pla, C; Vidal, O; Vinas, J				Penarrubia, Luis; Sanz, Nuria; Pla, Carles; Vidal, Oriol; Vinas, Jordi			Using Massive Parallel Sequencing for the Development, Validation, and Application of Population Genetics Markers in the Invasive Bivalve Zebra Mussel (Dreissena polymorpha)	PLOS ONE			English	Article							MICROSATELLITE LOCI; NORTH-AMERICA; FRESH-WATER; GENOME SIZE; EUROPE; DIFFERENTIATION; PALLAS; SOFTWARE; DYNAMICS; PATTERNS	The zebra mussel (Dreissena polymorpha, Pallas, 1771) is one of the most invasive species of freshwater bivalves, due to a combination of biological and anthropogenic factors. Once this species has been introduced to a new area, individuals form dense aggregations that are very difficult to remove, leading to many adverse socioeconomic and ecological consequences. In this study, we identified, tested, and validated a new set of polymorphic microsatellite loci (also known as SSRs, Single Sequence Repeats) using a Massive Parallel Sequencing (MPS) platform. After several pruning steps, 93 SSRs could potentially be amplified. Out of these SSRs, 14 were polymorphic, producing a polymorphic yield of 15.05%. These 14 polymorphic microsatellites were fully validated in a first approximation of the genetic population structure of D. polymorpha in the Iberian Peninsula. Based on this polymorphic yield, we propose a criterion for establishing the number of SSRs that require validation in similar species, depending on the final use of the markers. These results could be used to optimize MPS approaches in the development of microsatellites as genetic markers, which would reduce the cost of this process.	[Penarrubia, Luis; Sanz, Nuria; Pla, Carles; Vidal, Oriol; Vinas, Jordi] Univ Girona, Dept Biol, Lab Ictiol Genet, Girona, Spain	Universitat de Girona	Vinas, J (corresponding author), Univ Girona, Dept Biol, Lab Ictiol Genet, Campus Montilivi, Girona, Spain.	jordi.vinas@udg.edu	Pla, Carles/L-5765-2014; Sanz, Nuria/L-3074-2014; Vidal, Oriol/C-8973-2009; Vinas, Jordi/A-5397-2010	Pla, Carles/0000-0002-3749-4740; Sanz, Nuria/0000-0001-5274-1917; Vidal, Oriol/0000-0002-8197-1567; Penarrubia, Luis/0000-0001-6024-1832; Vinas, Jordi/0000-0003-0193-1141	Spanish MICINN (Ministerio de Ciencia e Innovacion) [CGL200909407]	Spanish MICINN (Ministerio de Ciencia e Innovacion)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This research was carried out within the objectives of the research project CGL200909407 of the Spanish MICINN (Ministerio de Ciencia e Innovacion), http://www.idi.mineco.gob.es/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Astanei I, 2005, MOL ECOL, V14, P1655, DOI 10.1111/j.1365-294X.2005.02530.x; Benjamini Y, 2001, ANN STAT, V29, P1165; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; bij de Vaate A, 2002, CAN J FISH AQUAT SCI, V59, P1159, DOI 10.1139/F02-098; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Brown JE, 2010, BIOL INVASIONS, V12, P3687, DOI 10.1007/s10530-010-9763-2; Chistiakov DA, 2006, AQUACULTURE, V255, P1, DOI 10.1016/j.aquaculture.2005.11.031; DeWoody JA, 2000, J FISH BIOL, V56, P461, DOI 10.1111/j.1095-8649.2000.tb00748.x; Diez-del-Molino D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082501; Dolezel J, 2003, CYTOM PART A, V51A, P127, DOI 10.1002/cyto.a.10013; Duran C, 2012, LIMNETICA, V31, P213; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Feldheim KA, 2011, MOL ECOL RESOUR, V11, P725, DOI 10.1111/j.1755-0998.2011.03012.x; Gardner MG, 2011, MOL ECOL RESOUR, V11, P1093, DOI 10.1111/j.1755-0998.2011.03037.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gregory TR, 2003, GENOME, V46, P841, DOI [10.1139/g03-069, 10.1139/G03-069]; Guichoux E, 2011, MOL ECOL RESOUR, V11, P591, DOI 10.1111/j.1755-0998.2011.03014.x; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hoshino AA, 2012, GENETIC DIVERSITY IN MICROORGANISMS, P149; Johnson LE, 2001, ECOL APPL, V11, P1789, DOI 10.1890/1051-0761(2001)011[1789:ODOAIS]2.0.CO;2; Karatayev AY, 2015, HYDROBIOLOGIA, V746, P97, DOI 10.1007/s10750-014-1901-x; KINZELBACH R, 1992, LIMNOL AKTUELL, V4, P5; Lewis KM, 2000, CAN J FISH AQUAT SCI, V57, P637, DOI 10.1139/cjfas-57-3-637; Lopes-Lima M, 2014, HYDROBIOLOGIA, V735, P1, DOI 10.1007/s10750-014-1902-9; Lowe S., 2000, 100 WORLDS WORST INV, DOI DOI 10.1525/9780520948433-159; Luo CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030087; MARSDEN JE, 1995, CAN J FISH AQUAT SCI, V52, P836, DOI 10.1139/f95-083; May GE, 2006, MOL ECOL, V15, P1021, DOI 10.1111/j.1365-294X.2006.02814.x; McInerney CE, 2011, HEREDITY, V106, P78, DOI 10.1038/hdy.2010.36; Naish KA, 2001, MOL ECOL NOTES, V1, P286, DOI 10.1046/j.1471-8278 .2001.00111.x; Navarro A, 2013, ECOTOXICOLOGY, V22, P915, DOI 10.1007/s10646-013-1084-7; Penarrubia L, 2014, CONSERV GENET RESOUR; Pritchard JK, 2000, GENETICS, V155, P945; Rajagopal S, 2009, BIOL INVASIONS, V11, P2147, DOI 10.1007/s10530-009-9495-3; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Richard GF, 2008, MICROBIOL MOL BIOL R, V72, P686, DOI 10.1128/MMBR.00011-08; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruiz-Altaba C., 2001, QUERCUS, V188, P50; Saavedra C, 2006, AQUACULTURE, V256, P1, DOI 10.1016/j.aquaculture.2006.02.023; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Sanz N, 2013, BIOL INVASIONS, V15, P2333, DOI 10.1007/s10530-013-0456-5; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; TAUTZ D, 1994, CURR OPIN GENET DEV, V4, P832, DOI 10.1016/0959-437X(94)90067-1; Therriault TW, 2005, HEREDITY, V95, P16, DOI 10.1038/sj.hdy.6800691; Thomas G, 2011, J SHELLFISH RES, V30, P123, DOI 10.2983/035.030.0118; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vidal O, 2012, ECOL FRESHW FISH, V21, P100, DOI 10.1111/j.1600-0633.2011.00527.x; Vinas J, 2004, MAR BIOL, V145, P225, DOI 10.1007/s00227-004-1319-5; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Zane L, 2002, MOL ECOL, V11, P1, DOI 10.1046/j.0962-1083.2001.01418.x; Zhan Aibin, 2009, Journal of Ocean University of China, V8, P161, DOI 10.1007/s11802-009-0161-2	52	11	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120732	10.1371/journal.pone.0120732	http://dx.doi.org/10.1371/journal.pone.0120732			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25780924	Green Published, gold, Green Submitted			2022-12-27	WOS:000351284600186
J	Wu, CL; Fu, TF; Chou, YY; Yeh, SR				Wu, Chia-Lin; Fu, Tsai-Feng; Chou, Yen-Yun; Yeh, Sheng-Rong			A Single Pair of Neurons Modulates Egg-Laying Decisions in Drosophila	PLOS ONE			English	Article							ANESTHESIA-RESISTANT MEMORY; MUSHROOM BODY; BODIES; SLEEP; CIRCUITS; PATHWAY; ETHANOL; BRAIN	Animals have to judge environmental cues and choose the most suitable option for them from many different options. Female fruit flies selecting an optimum site to deposit their eggs is a biologically important reproductive behavior. When given the direct choice between ovipositing their eggs in a sucrose-containing medium or a caffeine-containing medium, female flies prefer the latter. However, the neural circuits and molecules that regulate this decision-making processes during egg-laying site selection remain poorly understood. In the present study, we found that amnesiac (amn) mutant flies show significant defects in egg-laying decisions, and such defects can be reversed by expressing the wild-type amn transgene in two dorsal paired medial (DPM) neurons in the brain. Silencing neuronal activity with an inward rectifier potassium channel (Kir2.1) in DPM neurons also impairs egg-laying decisions. Finally, the activity in mushroom body alpha beta neurons is required for the egg-laying behavior, suggesting a possible "DPM-alpha beta neurons" brain circuit modulating egg-laying decisions. Our results highlight the brain circuits and molecular mechanisms of egg-laying decisions in Drosophila.	[Wu, Chia-Lin; Chou, Yen-Yun] Chang Gung Univ, Dept Biochem, Coll Med, Taoyuan, Taiwan; [Wu, Chia-Lin] Chang Gung Univ, Grad Inst Biomed Sci, Coll Med, Taoyuan, Taiwan; [Wu, Chia-Lin] Chang Gung Mem Hosp, Dept Med Res, Taoyuan, Taiwan; [Fu, Tsai-Feng] Natl Chi Nan Univ, Dept Appl Chem, Nantou, Taiwan; [Yeh, Sheng-Rong] Chang Gung Univ, Dept Biomed Sci, Coll Med, Taoyuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; National Chi Nan University; Chang Gung University	Wu, CL (corresponding author), Chang Gung Univ, Dept Biochem, Coll Med, Taoyuan, Taiwan.	clwu@mail.cgu.edu.tw		Wu, Chia-Lin/0000-0002-7906-2364; Fu, Tsai-Feng/0000-0002-0343-3018	Ministry of Science and Technology [101-2221-E-182-080-MY3, 102-2321-B-182-010, 101-2221-E-007-071-MY3, 101-2311-M-260-002, 103-2633-B-260 -001]; Chang Gung Memorial Hospital [CMRPD1B0323]; Taichung Veterans General Hospital/National Chi Nan University Joint Research Program [TCVGH-NCNU1037905]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Taichung Veterans General Hospital/National Chi Nan University Joint Research Program	This work was supported by grants from the Ministry of Science and Technology 101-2221-E-182-080-MY3, 102-2321-B-182-010, 101-2221-E-007-071-MY3 (to C.-L.W), 101-2311-M-260-002, 103-2633-B-260 -001 (to T.-F.F), a grant from the Chang Gung Memorial Hospital CMRPD1B0323 (to C.-L.W), and a grant from the Taichung Veterans General Hospital/National Chi Nan University Joint Research Program TCVGH-NCNU1037905 (to T.-F.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aso Y, 2009, J NEUROGENET, V23, P156, DOI 10.1080/01677060802471718; Azanchi R, 2013, P NATL ACAD SCI USA, V110, P21153, DOI 10.1073/pnas.1320208110; Bang S, 2011, J KOREAN MED ASSOC, V54, P10, DOI 10.5124/jkma.2011.54.1.10; Bhattacharya A, 2004, J BIOL CHEM, V279, P37291, DOI 10.1074/jbc.M403819200; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; DeZazzo J, 1999, J NEUROSCI, V19, P8740, DOI 10.1523/JNEUROSCI.19-20-08740.1999; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; FEANY MB, 1995, SCIENCE, V268, P869, DOI 10.1126/science.7754370; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Hong ST, 2008, NATURE, V454, P771, DOI 10.1038/nature07090; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Kacsoh BZ, 2013, SCIENCE, V339, P947, DOI 10.1126/science.1229625; Keene AC, 2006, CURR BIOL, V16, P1524, DOI 10.1016/j.cub.2006.06.022; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; Lee PT, 2011, P NATL ACAD SCI USA, V108, P13794, DOI 10.1073/pnas.1019483108; Liu WJ, 2008, BIOCHEM BIOPH RES CO, V372, P798, DOI 10.1016/j.bbrc.2008.05.119; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2; Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739; QUINN WG, 1979, NATURE, V277, P212, DOI 10.1038/277212a0; Schwartz NU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037910; Sebastiao AM, 2013, NEUROPHARMACOLOGY, V64, P97, DOI 10.1016/j.neuropharm.2012.06.053; Tamura T, 2003, NEURON, V40, P1003, DOI 10.1016/S0896-6273(03)00732-3; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Wang XJ, 2008, NEURON, V60, P215, DOI 10.1016/j.neuron.2008.09.034; Wu CL, 2013, CURR BIOL, V23, P2346, DOI 10.1016/j.cub.2013.09.056; Wu CL, 2011, CURR BIOL, V21, P848, DOI 10.1016/j.cub.2011.02.041; Wu CL, 2008, J NEUROGENET, V22, P257, DOI 10.1080/01677060802307755; Yang CH, 2008, SCIENCE, V319, P1679, DOI 10.1126/science.1151842	30	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0121335	10.1371/journal.pone.0121335	http://dx.doi.org/10.1371/journal.pone.0121335			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781933	gold, Green Published, Green Submitted			2022-12-27	WOS:000351284600203
J	Gong, SW; Guo, R; Zhang, T; Guo, JX				Gong, Shiwei; Guo, Rui; Zhang, Tao; Guo, Jixun			Warming and Nitrogen Addition Increase Litter Decomposition in a Temperate Meadow Ecosystem	PLOS ONE			English	Article							LEAF-LITTER; NUTRIENT DYNAMICS; INNER-MONGOLIA; CLIMATE-CHANGE; FOREST LITTER; CARBON; GRASSLAND; QUALITY; AVAILABILITY; BIODIVERSITY	Background Litter decomposition greatly influences soil structure, nutrient content and carbon sequestration, but how litter decomposition is affected by climate change is still not well understood. Methodology/Principal Findings A field experiment with increased temperature and nitrogen (N) addition was established in April 2007 to examine the effects of experimental warming, N addition and their interaction on litter decomposition in a temperate meadow steppe in northeastern China. Warming, N addition and warming plus N addition reduced the residual mass of L. chinensis litter by 3.78%, 7.51% and 4.53%, respectively, in 2008 and 2009, and by 4.73%, 24.08% and 16.1%, respectively, in 2010. Warming, N addition and warming plus N addition had no effect on the decomposition of P. communis litter in 2008 or 2009, but reduced the residual litter mass by 5.58%, 15.53% and 5.17%, respectively, in 2010. Warming and N addition reduced the cellulose percentage of L. chinensis and P. communis, specifically in 2010. The lignin percentage of L. chinensis and P. communis was reduced by warming but increased by N addition. The C, N and P contents of L. chinensis and P. communis litter increased with time. Warming and N addition reduced the C content and C: N ratios of L. chinensisand P. communis litter, but increased the N and P contents. Significant interactive effects of warming and N addition on litter decomposition were observed (P<0.01). Conclusion/Significance The litter decomposition rate was highly correlated with soil temperature, soil water content and litter quality. Warming and N addition significantly impacted the litter decomposition rate in the Songnen meadow ecosystem, and the effects of warming and N addition on litter decomposition were also influenced by the quality of litter. These results highlight how climate change could alter grassland ecosystem carbon, nitrogen and phosphorus contents in soil by influencing litter decomposition.	[Gong, Shiwei; Zhang, Tao; Guo, Jixun] NE Normal Univ, Minist Educ, Inst Grassland Sci, Key Lab Vegetat Ecol, Changchun 130024, Peoples R China; [Guo, Rui] Chinese Acad Agr Sci, Inst Environm & Sustainable Dev Agr, Key Lab Dryland Agr, Minist Agr, Beijing 100081, Peoples R China	Northeast Normal University - China; Chinese Academy of Agricultural Sciences; Institute of Environment & Sustainable Development in Agriculture, CAAS; Ministry of Agriculture & Rural Affairs	Zhang, T (corresponding author), NE Normal Univ, Minist Educ, Inst Grassland Sci, Key Lab Vegetat Ecol, Changchun 130024, Peoples R China.	zhangt946@nenu.edu.cn; gjixun@nenu.edu.cn			National Natural Science Foundation of China [31170303, 31300097, 31100332]; Fundamental Research Funds for the Central Universities [12QNJJ017]; State Key Laboratory of Desert and Oasis Ecology, Xinjiang Institute of Ecology and Geography, ChineseAcademy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); State Key Laboratory of Desert and Oasis Ecology, Xinjiang Institute of Ecology and Geography, ChineseAcademy of Sciences	This research was supported by the National Natural Science Foundation of China (No. 31170303, 31300097 and 31100332), the Fundamental Research Funds for the Central Universities (No. 12QNJJ017), and State Key Laboratory of Desert and Oasis Ecology, Xinjiang Institute of Ecology and Geography, ChineseAcademy of Sciences.	Aerts R, 2006, J ECOL, V94, P713, DOI 10.1111/j.1365-2745.2006.01142.x; Bai YF, 2010, GLOBAL CHANGE BIOL, V16, P358, DOI 10.1111/j.1365-2486.2009.01950.x; Berg Bjorn, 1997, Environmental Reviews, V5, P1, DOI 10.1139/er-5-1-1; Bontti EE, 2009, GLOBAL CHANGE BIOL, V15, P1356, DOI 10.1111/j.1365-2486.2008.01815.x; Bragazza L, 2012, GLOBAL CHANGE BIOL, V18, P1163, DOI 10.1111/j.1365-2486.2011.02585.x; Butenschoen O, 2011, SOIL BIOL BIOCHEM, V43, P1902, DOI 10.1016/j.soilbio.2011.05.011; Cantarel AAM, 2013, J VEG SCI, V24, P113, DOI 10.1111/j.1654-1103.2012.01452.x; Cheng XL, 2010, AGR ECOSYST ENVIRON, V138, P206, DOI 10.1016/j.agee.2010.04.019; Cornelissen JHC, 2007, ECOL LETT, V10, P619, DOI 10.1111/j.1461-0248.2007.01051.x; COUTEAUX MM, 1995, TRENDS ECOL EVOL, V10, P63, DOI 10.1016/S0169-5347(00)88978-8; Deng Xiao-wen, 2009, Journal of Forestry Research (Harbin), V20, P111, DOI 10.1007/s11676-009-0020-4; Dias T, 2013, SOIL BIOL BIOCHEM, V58, P163, DOI 10.1016/j.soilbio.2012.10.027; Fang H, 2007, PLANT SOIL, V297, P233, DOI 10.1007/s11104-007-9339-9; Flury S, 2014, BASIC APPL ECOL, V15, P219, DOI 10.1016/j.baae.2014.04.002; FOG K, 1988, BIOL REV, V63, P433, DOI 10.1111/j.1469-185X.1988.tb00725.x; GALLARDO A, 1992, BIOGEOCHEMISTRY, V15, P213; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; He CE, 2007, AGR ECOSYST ENVIRON, V121, P395, DOI 10.1016/j.agee.2006.12.016; Henry HAL, 2005, OECOLOGIA, V142, P465, DOI 10.1007/s00442-004-1713-1; Hobbie SE, 2005, ECOSYSTEMS, V8, P644, DOI 10.1007/s10021-003-0110-7; Johansson O, 2012, GLOBAL CHANGE BIOL, V18, P2626, DOI 10.1111/j.1365-2486.2012.02723.x; Keeler BL, 2009, ECOSYSTEMS, V12, P1, DOI 10.1007/s10021-008-9199-z; Knops JMH, 2007, GLOBAL CHANGE BIOL, V13, P1960, DOI 10.1111/j.1365-2486.2007.01405.x; Knorr M, 2005, ECOLOGY, V86, P3252, DOI 10.1890/05-0150; Kuperman RG, 1999, SOIL BIOL BIOCHEM, V31, P237, DOI 10.1016/S0038-0717(98)00105-9; Li LJ, 2011, J ARID ENVIRON, V75, P787, DOI 10.1016/j.jaridenv.2011.04.009; Liu P, 2006, APPL SOIL ECOL, V34, P266, DOI 10.1016/j.apsoil.2005.12.009; Magill AH, 2000, SOIL BIOL BIOCHEM, V32, P603, DOI 10.1016/S0038-0717(99)00187-X; Milchunas DG, 2001, ECOSYSTEMS, V4, P139, DOI 10.1007/s100210000064; Nadelhoffer K.J., 1992, ARCTIC ECOSYSTEMS CH, P281, DOI DOI 10.1016/B978-0-12-168250-7.50019-5; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; PARKINSON JA, 1975, COMMUN SOIL SCI PLAN, V6, P1, DOI 10.1080/00103627509366539; Pregitzer KS, 2004, BIOGEOCHEMISTRY, V68, P179, DOI 10.1023/B:BIOG.0000025737.29546.fd; Qu GuoHui, 2003, Acta Prataculturae Sinica, V12, P18; ROWLAND AP, 1994, COMMUN SOIL SCI PLAN, V25, P269, DOI 10.1080/00103629409369035; Salah YMS, 2011, PROCEDIA ENVIRON SCI, V6, P180, DOI 10.1016/j.proenv.2011.05.019; Sanchez FG, 2001, FOREST ECOL MANAG, V152, P85, DOI 10.1016/S0378-1127(00)00592-2; Sardans J, 2008, APPL SOIL ECOL, V39, P223, DOI 10.1016/j.apsoil.2007.12.011; Saura-Mas S, 2012, ENVIRON EXP BOT, V77, P274, DOI 10.1016/j.envexpbot.2011.11.014; Shaw MR, 2001, ECOL APPL, V11, P1206, DOI 10.2307/3061022; Sjoberg G, 2004, SOIL BIOL BIOCHEM, V36, P1761, DOI 10.1016/j.soilbio.2004.03.010; Sjoberg G, 2003, SOIL BIOL BIOCHEM, V35, P1305, DOI 10.1016/S0038-0717(03)00201-3; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Song CC, 2011, ECOL ENG, V37, P1578, DOI 10.1016/j.ecoleng.2011.03.036; van Meeteren MM, 2008, APPL SOIL ECOL, V38, P119, DOI 10.1016/j.apsoil.2007.09.006; Waldrop MP, 2004, ECOL APPL, V14, P1172, DOI 10.1890/03-5120; Wang Z, 2006, CHINESE AGR SCI B, V22, P241; Xu GP, 2010, PLANT ECOL, V209, P257, DOI 10.1007/s11258-009-9714-0; Xu GP, 2010, NUTR CYCL AGROECOSYS, V87, P49, DOI 10.1007/s10705-009-9311-6; Zhang CaiHong, 2013, Journal of Resources and Ecology, V4, P20	50	14	16	18	153	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0116013	10.1371/journal.pone.0116013	http://dx.doi.org/10.1371/journal.pone.0116013			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774776	Green Submitted, Green Published, gold			2022-12-27	WOS:000351183500005
J	Maes, E; Valkenborg, D; Baggerman, G; Willems, H; Landuyt, B; Schoofs, L; Mertens, I				Maes, Evelyne; Valkenborg, Dirk; Baggerman, Geert; Willems, Hanny; Landuyt, Bart; Schoofs, Liliane; Mertens, Inge			Determination of Variation Parameters as a Crucial Step in Designing TMT-Based Clinical Proteomics Experiments	PLOS ONE			English	Article							DIFFERENCE GEL-ELECTROPHORESIS; BLOOD MONONUCLEAR-CELLS; QUANTITATIVE PROTEOMICS; BIOMARKER DISCOVERY; ISOBARIC TAGS; MASS-SPECTROMETRY; HUMAN PLASMA; PIPELINE; QUANTIFICATION; VERIFICATION	In quantitative shotgun proteomic analyses by liquid chromatography and mass spectrometry, a rigid study design is necessary in order to obtain statistically relevant results. Hypothesis testing, sample size calculation and power estimation are fundamental concepts that require consideration upon designing an experiment. For this reason, the reproducibility and variability of the proteomic platform needs to be assessed. In this study, we evaluate the technical (sample preparation), labeling (isobaric labels), and total (biological + technical + labeling + experimental) variability and reproducibility of a workflow that employs a shotgun LC-MS/MS approach in combination with TMT peptide labeling for the quantification of peripheral blood mononuclear cell (PBMC) proteome. We illustrate that the variability induced by TMT labeling is small when compared to the technical variation. The latter is also responsible for a substantial part of the total variation. Prior knowledge about the experimental variability allows for a correct design, a prerequisite for the detection of biologically significant disease-specific differential proteins in clinical proteomics experiments.	[Maes, Evelyne; Valkenborg, Dirk; Baggerman, Geert; Willems, Hanny; Mertens, Inge] Flemish Inst Technol Res VITO, Mol, Belgium; [Maes, Evelyne; Valkenborg, Dirk; Baggerman, Geert; Willems, Hanny; Mertens, Inge] Univ Antwerp, CFP CeProMa, B-2020 Antwerp, Belgium; [Maes, Evelyne; Landuyt, Bart; Schoofs, Liliane] Katholieke Univ Leuven, Res Grp Funct Genom & Prote, Leuven, Belgium; [Valkenborg, Dirk] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat, Diepenbeek, Belgium	VITO; University of Antwerp; KU Leuven; Hasselt University	Maes, E (corresponding author), Flemish Inst Technol Res VITO, Mol, Belgium.	evelyne.maes@vito.be	schoofs, liliane/ABD-2943-2020; Maes, Evelyne/ABI-1790-2020; Mertens, Inge/N-9787-2018; Schoofs, Liliane/F-2815-2010	Mertens, Inge/0000-0002-4888-3485; Willems, Hanny/0000-0001-9848-1997; Schoofs, Liliane/0000-0002-1673-432X; Baggerman, Geert/0000-0002-0661-931X; Maes, Evelyne/0000-0002-1461-6039; VALKENBORG, Dirk/0000-0002-1877-3496	Emmanuel Van der Schueren grant of the Vlaamse Liga tegen Kanker (VLK)	Emmanuel Van der Schueren grant of the Vlaamse Liga tegen Kanker (VLK)	Evelyne Maes is funded by an Emmanuel Van der Schueren grant of the Vlaamse Liga tegen Kanker (VLK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Christoforou AL, 2012, ANAL BIOANAL CHEM, V404, P1029, DOI 10.1007/s00216-012-6012-9; Cigna D, 2013, MOL BIOSYST, V9, P1162, DOI 10.1039/c3mb25402j; Corzett TH, 2006, J PROTEOME RES, V5, P2611, DOI 10.1021/pr060100p; Dayon L, 2008, ANAL CHEM, V80, P2921, DOI 10.1021/ac702422x; Dayon L, 2010, J PROTEOMICS, V73, P769, DOI 10.1016/j.jprot.2009.10.015; Dotzlaw H, 2004, BBA-PROTEINS PROTEOM, V1696, P121, DOI 10.1016/j.bbapap.2003.09.015; Ejigu BA, 2013, OMICS, V17, P473, DOI 10.1089/omi.2013.0010; Gan CS, 2007, J PROTEOME RES, V6, P821, DOI 10.1021/pr060474i; Karp NA, 2010, MOL CELL PROTEOMICS, V9, P1885, DOI 10.1074/mcp.M900628-MCP200; Kocher T, 2009, J PROTEOME RES, V8, P4743, DOI 10.1021/pr900451u; Levin Y, 2011, PROTEOMICS, V11, P2565, DOI 10.1002/pmic.201100033; Li Z, 2012, J PROTEOME RES, V11, P1582, DOI 10.1021/pr200748h; Maes E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061933; Mesko B, 2011, TRENDS MOL MED, V17, P223, DOI 10.1016/j.molmed.2010.12.004; Nagaraj N, 2011, J PROTEOME RES, V10, P637, DOI 10.1021/pr100835s; Nesvizhskii AI, 2007, NAT METHODS, V4, P787, DOI 10.1038/NMETH1088; Ow SY, 2009, J PROTEOME RES, V8, P5347, DOI 10.1021/pr900634c; Paulovich AG, 2008, PROTEOM CLIN APPL, V2, P1386, DOI 10.1002/prca.200780174; Perrin RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064314; Piehowski PD, 2013, J PROTEOME RES, V12, P2128, DOI 10.1021/pr301146m; Russell MR, 2012, J PROTEOMICS, V77, P441, DOI 10.1016/j.jprot.2012.09.020; Skates SJ, 2013, J PROTEOME RES, V12, P5383, DOI 10.1021/pr400132j; Song XM, 2008, J PROTEOME RES, V7, P2952, DOI 10.1021/pr800072x; Ting L, 2011, NAT METHODS, V8, P937, DOI [10.1038/NMETH.1714, 10.1038/nmeth.1714]; Vergara D, 2008, PROTEOMICS, V8, P2045, DOI 10.1002/pmic.200700726; Wang LQ, 2012, RHEUMATOL INT, V32, P585, DOI 10.1007/s00296-010-1625-9; Wei CM, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-87; Whiteaker JR, 2011, NAT BIOTECHNOL, V29, P625, DOI 10.1038/nbt.1900; Winkler W, 2008, MOL CELL PROTEOMICS, V7, P193, DOI 10.1074/mcp.M700137-MCP200; Wu LF, 2013, NATURE, V499, P79, DOI 10.1038/nature12223; Wu Q, 2012, ANAL CHIM ACTA, V731, P1, DOI 10.1016/j.aca.2012.04.010; Zhang XQ, 2006, PROTEOMICS, V6, P5260, DOI 10.1002/pmic.200600006; Zhang YY, 2013, CHEM REV, V113, P2343, DOI 10.1021/cr3003533; Zhou C, 2012, J PROTEOME RES, V11, P2103, DOI 10.1021/pr200636x; Zolg JW, 2004, MOL CELL PROTEOMICS, V3, P345, DOI 10.1074/mcp.M400007-MCP200	35	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120115	10.1371/journal.pone.0120115	http://dx.doi.org/10.1371/journal.pone.0120115			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775046	Green Published, gold			2022-12-27	WOS:000351183500151
J	Olsvik, PA; Berntssen, MHG; Softeland, L				Olsvik, Pal A.; Berntssen, Marc H. G.; Softeland, Liv			Modifying Effects of Vitamin E on Chlorpyrifos Toxicity in Atlantic Salmon	PLOS ONE			English	Article							ACETYLCHOLINESTERASE INHIBITION; LIPID-PEROXIDATION; PLANT INGREDIENTS; OXIDATIVE STRESS; FISH; ORGANOPHOSPHATE; INSECTICIDE; PARATHION; CYTOCHROME-P450; GLUTATHIONE	The aim of this study was to elucidate how vitamin E (alpha tocopherol) may ameliorate the toxicity of the pesticide chlorpyrifos in Atlantic salmon. Freshly isolated hepatocytes were exposed to vitamin E, chlorpyrifos or a combination of vitamin E and chlorpyrifos (all 100 mu M). Transcriptomics (RNA-seq) and metabolomics were used to screen for effects of vitamin E and chlorpyrifos. By introducing vitamin E, the number of upregulated transcripts induced by chlorpyrifos exposure was reduced from 941 to 626, while the number of downregulated transcripts was reduced from 901 to 742 compared to the control. Adding only vitamin E had no effect on the transcriptome. Jak-STAT signaling was the most significantly affected pathway by chlorpyrifos treatment according to the transcriptomics data. The metabolomics data showed that accumulation of multiple long chain fatty acids and dipeptides and amino acids in chlorpyrifos treated cells was partially alleviated by vitamin E treatment. Significant interaction effects between chlorpyrifos and vitamin E were seen for 15 metabolites, including 12 dipeptides. The antioxidant had relatively modest effects on chlorpyrifosinduced oxidative stress. By combining the two data sets, the study suggests that vitamin E supplementation prevents uptake and accumulation of fatty acids, and counteracts inhibited carbohydrate metabolism. Overall, this study shows that vitamin E only to a moderate degree modifies chlorpyrifos toxicity in Atlantic salmon liver cells.	[Olsvik, Pal A.; Berntssen, Marc H. G.; Softeland, Liv] Natl Inst Nutr & Seafood Res, Bergen, Norway		Olsvik, PA (corresponding author), Natl Inst Nutr & Seafood Res, Bergen, Norway.	pal.olsvik@nifes.no	Olsvik, Pål A/B-8232-2012; Berntssen, Marc/O-9406-2018	Olsvik, Pål A/0000-0002-5641-9420; 	Norwegian Research Council [200506/I30]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	Norwegian Research Council Grant 200506/I30 http://www.forskningsradet.no/en/Home_page/1177315753906. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abassi YA, 2009, CHEM BIOL, V16, P712, DOI 10.1016/j.chembiol.2009.05.011; Alavanja MCR, 2013, CA-CANCER J CLIN, V63, P120, DOI 10.3322/caac.21170; Almeida JR, 2010, ECOTOXICOLOGY, V19, P1369, DOI 10.1007/s10646-010-0523-y; Ambali SF, 2010, FOOD CHEM TOXICOL, V48, P3477, DOI 10.1016/j.fct.2010.09.026; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 2008, STAT WORLD FISH AQ 2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Elskus AA, 2005, BIOCH MOLEC, V6, P119; EPA, 2006, INT RER EL DEC CHLOR; Fulton MH, 2014, FISH PHYSIOL, V33, P309, DOI 10.1016/B978-0-12-398254-4.00006-6; Fulton MH, 2001, ENVIRON TOXICOL CHEM, V20, P37, DOI [10.1897/1551-5028(2001)020&lt;0037:AIIEFA&gt;2.0.CO;2, 10.1002/etc.5620200104]; GALGANI F, 1992, MAR ECOL PROG SER, V91, P77, DOI 10.3354/meps091077; Giesy John P., 1999, Reviews of Environmental Contamination and Toxicology, V160, P1; Goel A, 2005, CHEM-BIOL INTERACT, V156, P131, DOI 10.1016/j.cbi.2005.08.004; GRINBERGFUNES RA, 1994, CARCINOGENESIS, V15, P2449, DOI 10.1093/carcin/15.11.2449; Gunduz F, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-143; Hodgson E, 2008, PEST MANAG SCI, V64, P617, DOI 10.1002/ps.1563; ISO, 1099352009 ISO; Jacobson SM, 2010, AQUAT TOXICOL, V100, P101, DOI 10.1016/j.aquatox.2010.07.015; Gomez-Lechon MJ, 2009, CURR DRUG METAB, V10, P692, DOI 10.2174/138920009789895543; Jouvet P, 2000, MOL BIOL CELL, V11, P1919, DOI 10.1091/mbc.11.5.1919; Kaiser JP, 2012, INT J TOXICOL, V31, P551, DOI 10.1177/1091581812466418; Karami-Mohajeri S, 2011, HUM EXP TOXICOL, V30, P1119, DOI 10.1177/0960327110388959; Kaur R, 2008, ENVIRON TOXICOL PHAR, V26, P45, DOI 10.1016/j.etap.2008.01.004; Kelley EE, 2010, FREE RADICAL BIO MED, V48, P493, DOI 10.1016/j.freeradbiomed.2009.11.012; Kristal BS, 1999, ARCH BIOCHEM BIOPHYS, V370, P22, DOI 10.1006/abbi.1999.1387; Krovel AV, 2010, COMP BIOCHEM PHYS C, V151, P175, DOI 10.1016/j.cbpc.2009.10.003; Lavado R, 2011, AQUAT TOXICOL, V101, P57, DOI 10.1016/j.aquatox.2010.09.002; Lukaszewicz-Hussain A, 2004, POL J ENVIRON STUD, V13, P397; Magnarelli G, 2013, ADV BIOL CHEM, V03, P460, DOI [10.4236/abc.2013.35050, DOI 10.4236/ABC.2013.35050]; Mansour SA, 2009, PESTIC BIOCHEM PHYS, V93, P34, DOI 10.1016/j.pestbp.2008.09.004; Moon YJ, 2006, TOXICOL IN VITRO, V20, P187, DOI 10.1016/j.tiv.2005.06.048; Moreira EG, 2010, TOXICOL APPL PHARM, V245, P310, DOI 10.1016/j.taap.2010.03.015; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MOUSHUMI L, 1994, PHYTOTHER RES, V8, P237, DOI 10.1002/ptr.2650080410; Nacher-Mestre J, 2014, J AGR FOOD CHEM, V62, P2165, DOI 10.1021/jf405366n; Olsvik PA, 2011, FOOD CHEM TOXICOL, V49, P3258, DOI 10.1016/j.fct.2011.09.025; Oruc E, 2012, B ENVIRON CONTAM TOX, V88, P678, DOI 10.1007/s00128-012-0548-4; Richard AJ, 2014, BBA-MOL BASIS DIS, V1842, P431, DOI 10.1016/j.bbadis.2013.05.030; Salyha YT, 2013, NEUROPHYSIOLOGY+, V45, P193, DOI 10.1007/s11062-013-9356-7; Saxena Ronika, 2011, Toxicol Int, V18, P73, DOI 10.4103/0971-6580.75871; SCHIMMEL SC, 1983, J AGR FOOD CHEM, V31, P104, DOI 10.1021/jf00115a027; Softeland L, 2014, FOOD CHEM TOXICOL, V73, P157, DOI 10.1016/j.fct.2014.08.008; Softeland L, 2009, TOXICOL IN VITRO, V23, P1455, DOI 10.1016/j.tiv.2009.07.014; Sun LB, 2013, AQUAT TOXICOL, V126, P148, DOI 10.1016/j.aquatox.2012.11.002; Torstensen BE, 2004, AQUACULT NUTR, V10, P175, DOI 10.1111/j.1365-2095.2004.00289.x; Verma RS, 2009, PESTIC BIOCHEM PHYS, V95, P152, DOI 10.1016/j.pestbp.2009.08.004; Waagbo R, 2013, AQUACULT NUTR, V19, P598, DOI 10.1111/anu.12010; Xing HJ, 2014, CHEMOSPHERE, V104, P244, DOI 10.1016/j.chemosphere.2014.01.002; Xing HJ, 2013, ENVIRON TOXICOL PHAR, V35, P47, DOI 10.1016/j.etap.2012.11.004; Xu WN, 2012, J AQUAT ANIM HEALTH, V24, P185, DOI 10.1080/08997659.2012.675937; Yeh ST, 2006, FISH SHELLFISH IMMUN, V20, P332, DOI 10.1016/j.fsi.2005.05.008; Yen J, 2011, NEUROTOXICOL TERATOL, V33, P735, DOI 10.1016/j.ntt.2011.10.004	53	37	40	4	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119250	10.1371/journal.pone.0119250	http://dx.doi.org/10.1371/journal.pone.0119250			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774794	gold, Green Submitted, Green Published			2022-12-27	WOS:000351183500077
J	Pauwels, K; Simoens, S; Casteels, M; Huys, I				Pauwels, Kim; Simoens, Steven; Casteels, Minne; Huys, Isabelle			Insights into European Drug Shortages: A Survey of Hospital Pharmacists	PLOS ONE			English	Article							NATIONAL-SURVEY; UNITED-STATES; PHARMACEUTICALS; STRATEGIES; IMPACT; CARE	Drug shortages are a complex and global phenomenon. When a drug cannot be delivered at the moment of patient demand, every stakeholder in the health care system is affected. The aim of this study was to investigate the characteristics, clinical impact, financial impact and management of drug shortages in European hospital pharmacies and identify opportunities for prevention and mitigation of drug shortages in Europe. An online survey was designed based on a review of the literature and interviews and was sent to subscribers of Hospital Pharmacy Europe between June and September 2013. Forty-five percent of respondents (n = 161) indicated that life sustaining or life preserving drugs such as oncology drugs were affected by drug shortages. More than 30% of respondents indicated that drug shortages in Europe were always or often associated with increased costs for hospitals, increased personnel costs and more expensive alternative drugs (n = 161). On the question when information about a drug shortage was obtained, 42% of respondents answered that information from the pharmaceutical company was obtained at the time of no delivery, 50% indicated that information from the wholesaler was obtained at the time of no delivery, while 40% of respondents indicated that information was never or rarely received from the government (n = 161). Fifty seven percent of respondents strongly agreed that an obligation to the producer to notify further shortages could help to solve the problem (n = 161). These results showed that pharmaceutical companies and wholesalers are already involved in the management of drug shortages, while a role is still reserved for the government. Mandatory notification in advance and centralized information can help to reduce workload for hospital pharmacists, will allow early anticipation of drug shortages and will facilitate mitigation of the clinical impact on patients.	[Pauwels, Kim; Simoens, Steven; Casteels, Minne; Huys, Isabelle] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, B-3000 Leuven, Belgium	KU Leuven	Pauwels, K (corresponding author), Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, B-3000 Leuven, Belgium.	Kim.Pauwels@pharm.kuleuven.be	Huys, Isabelle/M-8673-2016	Simoens, Steven/0000-0002-9512-2005	Agency for Innovation by Science and Technology; Research Foundation Flanders; TEVA	Agency for Innovation by Science and Technology; Research Foundation Flanders(FWO); TEVA(Teva Pharmaceutical Industries)	KP is funded by the Agency for Innovation by Science and Technology (http://www.iwt.be/english/welcome). The study is included in a project supported by Research Foundation Flanders (http://www.fwo.be/en/). The study is included in a project supported by TEVA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alspach JG, 2012, CRIT CARE NURSE, V32, P11, DOI 10.4037/ccn2012818; American Hospital Association, 2011, AHA SURV DRUG SHORT; [Anonymous], 2013, COMP MACR GEOGR CONT; Bart TN, 2008, VALUE HEALTH, V11, P996, DOI 10.1111/j.1524-4733.2008.00339.x; Birgli ag, 2013, EV MED SHORT EUR MOR; Capstick TGD, 2011, INT J TUBERC LUNG D, V15, P754, DOI 10.5588/ijtld.10.0568; Chabner BA, 2011, NEW ENGL J MED, V365, P2147, DOI 10.1056/NEJMp1112633; Cherici C, 2013, NAVIGATING DRUG SHOR; Dal MF, 2013, PREV MED, V57, P146; Dylst P, 2011, HEALTH POLICY, V101, P146, DOI 10.1016/j.healthpol.2011.03.004; European Association of Hospital Pharmacists, 2013, MED SHORT EUR HOSP; European Association of Pharmaceutical Full-line Wholesalers, 2012, MED SHORT EUR THEIR; European Generic medicines Association (EGA), 2013, EGA POS PAP TEND UNS; Gatesman ML, 2011, NEW ENGL J MED, V365, P1653, DOI 10.1056/NEJMp1109772; Generics and Biosimilarrs Initiative, 2012, UK DRUG SHORT AR FAR; Generics and Biosimilarrs Initiative, 2012, APPG REP DRUG SHORT; Generics and Biosimilarrs Initiative, 2011, BIOS CANC DRUG SHORT; Generics and Biosimilarrs Initiative, 2012, DRUG SHORT WOES CONT; Gray A, 2012, B WORLD HEALTH ORGAN, V154-154A; Hall R, 2013, CAN J ANESTH, V60, P539, DOI 10.1007/s12630-013-9920-z; IHS Healthcare and Pharma Blog, 2013, DRUG SHORT RES PRIC; IHS Healthcare and Pharma Blog, 2012, PAR EXP LEAD DRUG SH; IHS Healthcare and Pharma Blog, 2012, COST CONT POL IMP DR; IMS institute, 2011, DRUG SHORT CLOS LOOK; Institute for Safe Medication Practices, 2010, DRUG SHORT NAT SURV; ISPE, 2013, REP ISPE DRUG SHORT; Kaakeh R, 2011, AM J HEALTH-SYST PH, V68, P1811, DOI 10.2146/ajhp110210; Mayer DK, 2012, CLIN J ONCOL NURS, V16, P107, DOI 10.1188/12.CJON.107-108; McBride A, 2013, AM J HEALTH-SYST PH, V70, P609, DOI 10.2146/ajhp120563; Morrissey John, 2012, Hosp Health Netw, V86, P46; Pharmaceutical Service Negotiating Committee (PSNC), 2013, BRAND MED SHORT; Rider Anne Elise, 2013, J Pharm Pract, V26, P183, DOI 10.1177/0897190013482332; Tirelli U, 2012, EUR REV MED PHARMACO, V16, P138; Ventola C Lee, 2011, P T, V36, P740; Woodcock J, 2013, CLIN PHARMACOL THER, V93, P170, DOI 10.1038/clpt.2012.220	35	58	61	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119322	10.1371/journal.pone.0119322	http://dx.doi.org/10.1371/journal.pone.0119322			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775406	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000351183500082
J	Zhang, YC; Zhai, WJ; Zhao, MF; Li, DG; Chai, X; Cao, XL; Meng, JX; Chen, J; Xiao, X; Li, Q; Mu, J; Shen, JC; Meng, AM				Zhang, Yuchen; Zhai, Wenjing; Zhao, Mingfeng; Li, Deguan; Chai, Xiao; Cao, Xiaoli; Meng, Juanxia; Chen, Jie; Xiao, Xia; Li, Qing; Mu, Juan; Shen, Jichun; Meng, Aimin			Effects of Iron Overload on the Bone Marrow Microenvironment in Mice	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; OXIDATIVE STRESS; HEMATOPOIETIC MICROENVIRONMENT; OSTEOGENIC DIFFERENTIATION; CHELATION-THERAPY; STROMAL CELLS; LOW-LEVEL; MAINTENANCE; CULTURE; COMBINATION	Objective Using a mouse model, Iron Overload (IO) induced bone marrow microenvironment injury was investigated, focusing on the involvement of reactive oxygen species (ROS). Methods Mice were intraperitoneally injected with iron dextran (12.5, 25, or 50mg) every three days for two, four, and six week durations. Deferasirox(DFX) 125mg/ml and N-acetyl-L-cysteine (NAC) 40mM were co-administered. Then, bone marrow derived mesenchymal stem cells (BM-MSCs) were isolated and assessed for proliferation and differentiation ability, as well as related gene changes. Immunohistochemical analysis assessed the expression of haematopoietic chemokines. Supporting functions of BM-MSCs were studied by co-culture system. Results In IO condition (25mg/ml for 4 weeks), BM-MSCs exhibited proliferation deficiencies and un-balanced osteogenic/adipogenic differentiation. The IO BM-MSCs showed a longer double time (2.07 +/- 0.14 days) than control (1.03 +/- 0.07 days) (P<0.05). The immunohistochemical analysis demonstrated that chemokine stromal cell-derived factor-1, stem cell factor-1, and vascular endothelial growth factor-1 expression were decreased. The co-cultured system demonstrated that bone marrow mononuclear cells (BM-MNCs) co-cultured with IO BM-MSCs had decreased colony forming unit (CFU) count (p<0.01), which indicates IO could lead to decreased hematopoietic supporting functions of BM-MSCs. This effect was associated with elevated phosphatidylinositol 3 kinase (PI3K) and reduced of Forkhead box protein O3 (FOXO3) mRNA expression, which could induce the generation of ROS. Results also demonstrated that NAC or DFX treatment could partially attenuate cell injury and inhibit signaling pathway striggered by IO. Conclusion These results demonstrated that IO can impair the bone marrow microenvironment, including the quantity and quality of BM-MSCs.	[Zhang, Yuchen; Zhao, Mingfeng; Chai, Xiao; Cao, Xiaoli; Meng, Juanxia; Chen, Jie; Xiao, Xia; Li, Qing; Mu, Juan] Tianjin First Cent Hosp, Dept Hematol, Tianjin, Peoples R China; [Zhai, Wenjing] Chinese Acad Med Sci, Blood Dis Hosp, Dept Stem Cells Transplantat, Tianjin, Peoples R China; [Li, Deguan; Meng, Aimin] Chinese Acad Med Sci, Inst Radiat Med, Key Lab Radiat Med & Mol Nucl Med, Tianjin, Peoples R China; [Li, Deguan; Meng, Aimin] Peking Union Med Coll, Tianjin, Peoples R China; [Shen, Jichun] Logist Univ Peoples Armed Police Force, Affiliated Hosp, Dept Hematol, Tianjin, Peoples R China	Tianjin Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Radiation Medicine - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zhao, MF (corresponding author), Tianjin First Cent Hosp, Dept Hematol, Tianjin, Peoples R China.	zmfzmf@hotmail.com	Zhang, Yuchen/GYI-8858-2022	Zhao, Mingfeng/0000-0002-5995-7558	National Natural Science Foundation of China [81041043]; National Natural Science Foundation of Tianjin [13JCYBJC23400]; Science and Technique Foundation of Tianjin [13KG106, 2013KR07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Tianjin; Science and Technique Foundation of Tianjin	This study was supported by the National Natural Science Foundation of China (81041043), the National Natural Science Foundation of Tianjin (13JCYBJC23400), and Science and Technique Foundation of Tianjin (13KG106,2013KR07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baghaban Eslaminejad Mohamadreza, 2014, World J Stem Cells, V6, P344, DOI 10.4252/wjsc.v6.i3.344; Bakhshi T, 2008, TRANSFUSION, V48, P2638, DOI 10.1111/j.1537-2995.2008.01926.x; Bird RJ, 2012, INTERN MED J, V42, P450, DOI 10.1111/j.1445-5994.2012.02734.x; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; CLOPTON DA, 1995, BIOCHEM BIOPH RES CO, V210, P189, DOI 10.1006/bbrc.1995.1645; Cornejo P, 2005, NITRIC OXIDE-BIOL CH, V13, P54, DOI 10.1016/j.niox.2005.04.009; Danjou F, 2013, BLOOD CELL MOL DIS, V51, P142, DOI 10.1016/j.bcmd.2013.06.001; Dar A, 2005, NAT IMMUNOL, V6, P1038, DOI 10.1038/ni1251; Dolado I, 2008, CANCER CELL, V14, P427, DOI 10.1016/j.ccr.2008.11.006; Fei CM, 2014, TUMOR BIOL, V35, P4307, DOI 10.1007/s13277-013-1565-6; Gattermann N, 2012, HAEMATOL-HEMATOL J, V97, P1364, DOI 10.3324/haematol.2011.048546; Guariglia R, 2011, LEUKEMIA RES, V35, P566, DOI 10.1016/j.leukres.2010.11.027; Habermann TM, 2008, BLOOD, V112, P2694, DOI 10.1182/blood-2007-09-111658; Haidar R, 2012, SPINE, V37, P334, DOI 10.1097/BRS.0b013e31821bd095; Hamada Y, 2009, BONE, V44, P936, DOI 10.1016/j.bone.2008.12.011; Hammoud M, 2012, J CELL PHYSIOL, V227, P2750, DOI 10.1002/jcp.23019; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Jin HT, 2012, INT ORTHOP, V36, P2589, DOI 10.1007/s00264-012-1674-7; Lee SE, 2013, ACTA HAEMATOL-BASEL, V129, P72, DOI 10.1159/000342772; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu WY, 2013, EUR J HAEMATOL, V91, P249, DOI 10.1111/ejh.12159; Mayack SR, 2008, BLOOD, V112, P519, DOI 10.1182/blood-2008-01-133710; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Muguruma Y, 2006, BLOOD, V107, P1878, DOI 10.1182/blood-2005-06-2211; Okabe H, 2014, EUR J HAEMATOL, V93, P118, DOI 10.1111/ejh.12309; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prus E, 2008, CYTOM PART A, V73A, P22, DOI 10.1002/cyto.a.20491; Rahal A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/761264; Ren HY, 2006, BIOCHEM BIOPH RES CO, V347, P12, DOI 10.1016/j.bbrc.2006.05.169; Reyes M, 2001, BLOOD, V98, P2615, DOI 10.1182/blood.V98.9.2615; Saigo K, 2011, J INT MED RES, V39, P1941, DOI 10.1177/147323001103900539; Shao LJ, 2011, INT J HEMATOL, V94, P24, DOI 10.1007/s12185-011-0872-1; Suzuki T, 2008, INT J HEMATOL, V88, P30, DOI 10.1007/s12185-008-0119-y; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Wang Y, 2010, FREE RADICAL BIO MED, V48, P348, DOI 10.1016/j.freeradbiomed.2009.11.005; WHYTE MP, 1995, J CLIN INVEST, V95, P1440, DOI 10.1172/JCI117814; Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453; Xie Fang, 2011, Zhonghua Yi Xue Za Zhi, V91, P3284; Zhang DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021397; Zhang Y, 2013, J CELL BIOCHEM, V114, P2595, DOI 10.1002/jcb.24607; Zhao MF, 2010, BLOOD, V116, P1724, DOI 10.1182/blood.V116.21.4247.4247; Zhu H, 2010, NAT PROTOC, V5, P550, DOI 10.1038/nprot.2009.238	46	50	57	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120219	10.1371/journal.pone.0120219	http://dx.doi.org/10.1371/journal.pone.0120219			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774923	Green Submitted, Green Published, gold			2022-12-27	WOS:000351183500159
J	Bian, C; Zhao, ZQ; Zhang, YQ; Lu, N				Bian, Chao; Zhao, Zhi-Qi; Zhang, Yu-Qiu; Lu, Ning			Involvement of CX3CL1/CX3CR1 Signaling in Spinal Long Term Potentiation	PLOS ONE			English	Article							EVOKED FIELD POTENTIALS; NF-KAPPA-B; IL-23 P19 EXPRESSION; DORSAL-HORN; NERVE INJURY; TNF-ALPHA; P38 MAPK; PAIN; FRACTALKINE; INDUCTION	The long-term potentiation (LTP) of spinal C-fiber-evoked field potentials is considered as a fundamental mechanism of central sensitization in the spinal cord. Accumulating evidence has showed the contribution of spinal microglia to spinal LTP and pathological pain. As a key signaling of neurons-microglia interactions, the involvement of CX3CL1/CX3CR1 signaling in pathological pain has also been investigated extensively. The present study examined whether CX3CL1/CX3CR1 signaling plays a role in spinal LTP. The results showed that 10-trains tetanic stimulation (100 Hz, 2s) of the sciatic nerve (TSS) produced a significant LTP of C-fiber-evoked field potentials lasting for over 3 h in the rat spinal dorsal horn. Blockade of CX3CL1/CX3CR1 signaling with an anti-CX3CR1 neutralizing antibody (CX3CR1 AB) markedly suppressed TSS-induced LTP. Exogenous CX3CL1 significantly potentiated 3-trains TSS-induced LTP in rats. Consistently, spinal LTP of C-fiber-evoked field potentials was also induced by TSS (100 Hz, 1s, 4 trains) in all C57BL/6 wild type (WT) mice. However, in CX3CR1(-/-) mice, TSS failed to induce LTP and behavioral hypersensitivity, confirming an essential role of CX3CR1 in spinal LTP induction. Furthermore, blockade of IL-18 or IL-23, the potential downstream factors of CX3CL1/CX3CR1 signaling, with IL-18 BP or anti-IL-23 neutralizing antibody (IL-23 AB), obviously suppressed spinal LTP in rats. These results suggest that CX3CL1/CX3CR1 signaling is involved in LTP of C-fiber-evoked field potentials in the rodent spinal dorsal horn.	[Zhang, Yu-Qiu] Fudan Univ, Inst Brain Sci, Inst Neurobiol, Shanghai 200032, Peoples R China; Fudan Univ, Collaborat Innovat Ctr Brain Sci, State Key Lab Med Neurobiol, Shanghai 200032, Peoples R China	Fudan University; Fudan University	Zhang, YQ (corresponding author), Fudan Univ, Inst Brain Sci, Inst Neurobiol, Shanghai 200032, Peoples R China.	yuqiuzhang@fudan.edu.cn; ninglu@fudan.edu.cn	Zhang, Yu-Qiu/CAF-6295-2022; Zhang, Yu-Qiu/AAS-2516-2020		National Basic Research Program of China [2013CB531900]; National Natural Science Foundation of China [31420103903, 31421091, 81471130, 31271183]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2013CB531900, www.973.gov.cn/English/Index.aspx) and the National Natural Science Foundation of China (31420103903, 31421091, 81471130, and 31271183: www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azkue JJ, 2003, PAIN, V106, P373, DOI 10.1016/j.pain.2003.08.007; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Bertollini C, 2006, NEUROPHARMACOLOGY, V51, P816, DOI 10.1016/j.neuropharm.2006.05.027; Bian C, 2013, BRAIN BEHAV IMMUN; Bian C, 2014, BRAIN BEHAV IMMUN, V37, P220, DOI 10.1016/j.bbi.2013.12.011; Cao H, 2008, NEUROSCI BIOBEHAV R, V32, P972, DOI 10.1016/j.neubiorev.2008.03.009; Chapman GA, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-15-j0004.2000; Chen SZ, 2002, J NEUROIMMUNOL, V133, P46, DOI 10.1016/S0165-5728(02)00354-5; Chu YX, 2012, NEUROSCI BULL, V28, P49, DOI 10.1007/s12264-012-1058-4; Chu YX, 2010, BRAIN BEHAV IMMUN, V24, P1176, DOI 10.1016/j.bbi.2010.06.001; Clark AK, 2007, P NATL ACAD SCI USA, V104, P10655, DOI 10.1073/pnas.0610811104; Clark AK, 2012, ARTHRITIS RHEUM-US, V64, P2038, DOI 10.1002/art.34351; Clark AK, 2012, EXP NEUROL, V234, P283, DOI 10.1016/j.expneurol.2011.09.012; Clark AK, 2011, CURR PHARM BIOTECHNO, V12, P1707; Clark AK, 2009, J NEUROSCI, V29, P6945, DOI 10.1523/JNEUROSCI.0828-09.2009; Combadiere C, 2003, CIRCULATION, V107, P1009, DOI 10.1161/01.CIR.0000057548.68243.42; Cook A, 2010, J BIOL CHEM, V285, P10563, DOI 10.1074/jbc.M109.035477; Garton KJ, 2001, J BIOL CHEM, V276, P37993; Gong QJ, 2009, GLIA, V57, P583, DOI 10.1002/glia.20786; Gruber-Schoffnegger D, 2013, J NEUROSCI, V33, P6540, DOI 10.1523/JNEUROSCI.5087-12.2013; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Hughes PM, 2002, GLIA, V37, P314, DOI 10.1002/glia.10037; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Ji RR, 2003, TRENDS NEUROSCI, V26, P696, DOI 10.1016/j.tins.2003.09.017; Ji RR, 2013, PAIN; Kleinschnitz C, 2006, EXP NEUROL, V200, P480, DOI 10.1016/j.expneurol.2006.03.014; Lee KM, 2010, EUR J PAIN, V14, DOI 10.1016/j.ejpain.2009.10.017; Li YH, 2008, EXP MOL PATHOL, V84, P1, DOI 10.1016/j.yexmp.2007.09.004; Li YH, 2007, BRAIN, V130, P490, DOI 10.1093/brain/awl273; Liang LL, 2010, J NEUROSCI RES, V88, P2899, DOI 10.1002/jnr.22439; Limatola C, 2005, J NEUROIMMUNOL, V166, P19, DOI 10.1016/j.jneuroim.2005.03.023; Lindia JA, 2005, J PAIN, V6, P434, DOI 10.1016/j.jpain.2005.02.001; LIU XG, 1995, NEUROSCI LETT, V191, P43, DOI 10.1016/0304-3940(95)11553-0; Liu XG, 1997, J NEUROPHYSIOL, V78, P1973, DOI 10.1152/jn.1997.78.4.1973; Liu Xian-Guo, 2008, Shengli Xuebao, V60, P653; Liu YL, 2007, NEUROPHARMACOLOGY, V52, P708, DOI 10.1016/j.neuropharm.2006.09.011; Lyons A, 2009, J NEUROCHEM, V110, P1547, DOI 10.1111/j.1471-4159.2009.06253.x; Ma JY, 2002, NEUROREPORT, V13, P1781, DOI 10.1097/00001756-200210070-00017; Ma JY, 2001, BRAIN RES BULL, V56, P575, DOI 10.1016/S0361-9230(01)00728-6; Maggi L, 2009, J NEUROIMMUNOL, V215, P36, DOI 10.1016/j.jneuroim.2009.07.016; Milligan ED, 2004, EUR J NEUROSCI, V20, P2294, DOI 10.1111/j.1460-9568.2004.03709.x; Mise-Omata S, 2007, J IMMUNOL, V179, P6596, DOI 10.4049/jimmunol.179.10.6596; Miyoshi K, 2008, J NEUROSCI, V28, P12775, DOI 10.1523/JNEUROSCI.3512-08.2008; Mizuno T, 2003, BRAIN RES, V979, P65, DOI 10.1016/S0006-8993(03)02867-1; Mizutani N, 2007, J IMMUNOL, V179, P7478, DOI 10.4049/jimmunol.179.11.7478; Niimi N, 2013, J NEUROIMMUNOL, V254, P39, DOI 10.1016/j.jneuroim.2012.08.015; Ossipov MH, 1999, PAIN, V79, P127, DOI 10.1016/S0304-3959(98)00187-0; Park CK, 2011, J NEUROSCI, V31, P15072, DOI 10.1523/JNEUROSCI.2443-11.2011; Piccinin S, 2010, J NEUROIMMUNOL, V224, P85, DOI 10.1016/j.jneuroim.2010.05.012; Ruscheweyh R, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-20; Rygh LJ, 2005, PSYCHONEUROENDOCRINO, V30, P959, DOI 10.1016/j.psyneuen.2005.04.007; Sandkuhler J, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-9; Sasaki A, 2013, NEUROREPORT, V24, P137, DOI 10.1097/WNR.0b013e32835df4d9; Shan S, 2007, PAIN, V129, P64, DOI 10.1016/j.pain.2006.09.035; Shan S, 2011, NEUROBIOL AGING, V32, P443, DOI 10.1016/j.neurobiolaging.2009.03.004; Smith AK, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-61; Sun JL, 2013, J NEUROSCI RES, V91, P545, DOI 10.1002/jnr.23168; Thakker P, 2007, J IMMUNOL, V178, P2589, DOI 10.4049/jimmunol.178.4.2589; Utsugi M, 2006, J IMMUNOL, V177, P4550, DOI 10.4049/jimmunol.177.7.4550; Verge GM, 2004, EUR J NEUROSCI, V20, P1150, DOI 10.1111/j.1460-9568.2004.03593.x; Verri WA, 2007, BRAIN BEHAV IMMUN, V21, P535, DOI 10.1016/j.bbi.2006.11.005; Yang HW, 2004, J NEUROPHYSIOL, V91, P1122, DOI 10.1152/jn.00735.2003; Ying B, 2006, BIOCHEM BIOPH RES CO, V340, P1264, DOI 10.1016/j.bbrc.2005.12.139; Zhang Hong-Mei, 2004, Shengli Xuebao, V56, P591; Zhang XC, 2006, NEUROPHARMACOLOGY, V50, P748, DOI 10.1016/j.neuropharm.2005.11.021; Zhao J, 2010, LIFE SCI, V87, P120, DOI 10.1016/j.lfs.2010.05.015; Zhu LX, 2012, CYTOKINE, V60, P171, DOI 10.1016/j.cyto.2012.05.016; Zhuang ZY, 2007, BRAIN BEHAV IMMUN, V21, P642, DOI 10.1016/j.bbi.2006.11.003; Zujovic V, 2000, GLIA, V29, P305, DOI 10.1002/(SICI)1098-1136(20000215)29:4<305::AID-GLIA2>3.0.CO;2-V	69	13	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118842	10.1371/journal.pone.0118842	http://dx.doi.org/10.1371/journal.pone.0118842			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768734	Green Published, gold, Green Submitted			2022-12-27	WOS:000351277500049
J	Gao, MM; Ma, YJ; Liu, DX				Gao, Mingming; Ma, Yongjie; Liu, Dexi			High-Fat Diet-Induced Adiposity, Adipose Inflammation, Hepatic Steatosis and Hyperinsulinemia in Outbred CD-1 Mice	PLOS ONE			English	Article							INSULIN-RESISTANCE; INDUCED OBESITY; GLUCOSE-INTOLERANCE; HYDRODYNAMIC DELIVERY; C57BL/6J MICE; PROTECTS MICE; WEIGHT-GAIN; TISSUE; LIVER; MOUSE	High-fat diet (HFD) has been applied to a variety of inbred mouse strains to induce obesity and obesity related metabolic complications. In this study, we determined HFD induced development of metabolic disorders on outbred female CD-1 mice in a time dependent manner. Compared to mice on regular chow, HFD-fed CD-1 mice gradually gained more fat mass and consequently exhibited accelerated body weight gain, which was associated with adipocyte hypertrophy and up-regulated expression of adipose inflammatory chemokines and cytokines such as Mcp-1 and Tnf-alpha. Increased fat accumulation in white adipose tissue subsequently led to ectopic fat deposition in brown adipose tissue, giving rise to whitening of brown adipose tissue without altering plasma level of triglyceride. Ectopic fat deposition was also observed in the liver, which was associated with elevated expression of key genes involved in hepatic lipid sequestration, including Ppar-gamma 2, Cd36 and Mgat1. Notably, adipose chronic inflammation and ectopic lipid deposition in the liver and brown fat were accompanied by glucose intolerance and insulin resistance, which was correlated with hyperinsulinemia and pancreatic islet hypertrophy. Collectively, these results demonstrate sequentially the events that HFD induces physiological changes leading to metabolic disorders in an outbred mouse model more closely resembling heterogeneity of the human population.	[Gao, Mingming; Ma, Yongjie; Liu, Dexi] Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Liu, DX (corresponding author), Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA.	dliu@uga.edu	MA, YONGJIE/O-3861-2015; Gao, Mingming/F-4317-2016		NIH [RO1EB007357, RO1HL098295]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007357] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The study was supported in part by grants from NIH (RO1EB007357 and RO1HL098295). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asarian L, 2013, AM J PHYSIOL-REG I, V305, pR1215, DOI 10.1152/ajpregu.00446.2012; Barron AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078554; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Breslin WL, 2010, LAB ANIM-UK, V44, P231, DOI 10.1258/la.2010.009114; Bu L, 2013, AAPS J, V15, P1001, DOI 10.1208/s12248-013-9501-7; Chen HC, 2002, J LIPID RES, V43, P986; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Collins S, 2004, PHYSIOL BEHAV, V81, P243, DOI 10.1016/j.physbeh.2004.02.006; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Gao MM, 2014, DISCOV MED, V17, P319; Gao MM, 2014, J CONTROL RELEASE, V185, P1, DOI 10.1016/j.jconrel.2014.03.047; Gao MM, 2013, PHARM RES-DORDR, V30, P2940, DOI 10.1007/s11095-013-1125-1; Gao MM, 2013, MOL THER, V21, P1852, DOI 10.1038/mt.2013.125; Gao MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065641; Gao MM, 2013, AAPS J, V15, P744, DOI 10.1208/s12248-013-9473-7; Gao MM, 2013, AAPS J, V15, P258, DOI 10.1208/s12248-012-9429-3; Garg N, 2011, BIOCHEM BIOPH RES CO, V413, P476, DOI 10.1016/j.bbrc.2011.08.123; Gerner RR, 2013, CAN J PHYSIOL PHARM, V91, P867, DOI 10.1139/cjpp-2013-0050; Gunawardana SC, 2012, DIABETES, V61, P674, DOI 10.2337/db11-0510; Guyenet SJ, 2012, J CLIN ENDOCR METAB, V97, P745, DOI 10.1210/jc.2011-2525; Iossa S, 2003, BRIT J NUTR, V90, P953, DOI 10.1079/BJN2003000968; James P T, 2001, Obes Res, V9 Suppl 4, p228S, DOI 10.1038/oby.2001.123; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Kanter R, 2012, ADV NUTR, V3, P491, DOI 10.3945/an.112.002063; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9; Malik VS, 2013, NAT REV ENDOCRINOL, V9, P13, DOI 10.1038/nrendo.2012.199; Mayes J S, 2004, Obes Rev, V5, P197, DOI 10.1111/j.1467-789X.2004.00152.x; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; Montgomery MK, 2013, DIABETOLOGIA, V56, P1129, DOI 10.1007/s00125-013-2846-8; Nov O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053626; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Podrini C, 2013, MAMM GENOME, V24, P240, DOI 10.1007/s00335-013-9456-0; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Verschuren L, 2009, CIRC RES, V105, P99, DOI 10.1161/CIRCRESAHA.109.199166; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wells JCK, 2012, SOC SCI MED, V75, P482, DOI 10.1016/j.socscimed.2012.03.029; WEST DB, 1992, AM J PHYSIOL, V262, pR1025, DOI 10.1152/ajpregu.1992.262.6.R1025; Wiedemann MSF, 2013, AM J PHYSIOL-ENDOC M, V305, pE388, DOI 10.1152/ajpendo.00179.2013; Wu Y, 2013, J ENDOCRINOL, V219, P195, DOI 10.1530/JOE-13-0160; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200	52	94	96	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119784	10.1371/journal.pone.0119784	http://dx.doi.org/10.1371/journal.pone.0119784			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768847	Green Published, Green Submitted, gold			2022-12-27	WOS:000351277500097
J	Roswall, N; Hogh, V; Envold-Bidstrup, P; Raaschou-Nielsen, O; Ketzel, M; Overvad, K; Olsen, A; Sorensen, M				Roswall, Nina; Hogh, Vibeke; Envold-Bidstrup, Pernille; Raaschou-Nielsen, Ole; Ketzel, Matthias; Overvad, Kim; Olsen, Anja; Sorensen, Mette			Residential Exposure to Traffic Noise and Health-Related Quality of Life-A Population-Based Study	PLOS ONE			English	Article							LONG-TERM EXPOSURE; OF-LIFE; TRANSPORTATION NOISE; ENVIRONMENTAL NOISE; AIRCRAFT NOISE; MENTAL-HEALTH; ANNOYANCE; NEIGHBORHOOD; SATISFACTION; POLLUTION	Background Few studies have investigated the association between objectively measured traffic noise and health-related quality of life. However, as traffic noise has been associated with both cardiovascular disease and diabetes, and health-issues including sleeping problems, annoyance, and stress, it seems plausible that traffic noise is associated with health-related quality of life. Methods Between 1999 and 2002, a cohort of 38,964 Danes filled in the short form-36 (SF-36) questionnaire. Residential exposure to road traffic and railway noise was calculated for all historical addresses for 10 years preceding the SF-36, using the Nordic prediction method. Associations between noise exposure and SF-36 summary scales and the eight sub-scales were calculated using general linear models, adjusted for age, sex, socioeconomic status, and lifestyle. Results Models adjusted for age, sex and socioeconomic factors showed that a 10 dB higher road traffic noise 1 year preceding SF-36 assessment was associated with a 0.14 lower mental component summary (MCS) score (95% confidence interval (CI) -0.26, -0.01). However, further adjustment for lifestyle factors (smoking, alcohol, and waist circumference) attenuated the association: (-0.08 (95% CI: -0.20, 0.04)). Exposure to more than 55 dB of railway noise in the same time period was borderline significantly associated with lower MCS. The physical component summary was not associated with traffic noise. Conclusion The present study suggests a weak association between traffic noise exposure and the mental health component score of SF-36, which may operate through lifestyle. The magnitude of effect was, however, not clinically relevant.	[Roswall, Nina; Envold-Bidstrup, Pernille; Raaschou-Nielsen, Ole; Olsen, Anja; Sorensen, Mette] Danish Canc Soc Res Ctr, Copenhagen, Denmark; [Hogh, Vibeke] Aalborg Univ Hosp, Dept Cardiol, Aalborg AF Study Grp, Aalborg, Denmark; [Ketzel, Matthias] Aarhus Univ, Dept Environm Sci, Roskilde, Denmark; [Overvad, Kim] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark	Danish Cancer Society; Aalborg University; Aalborg University Hospital; Aarhus University; Aarhus University	Roswall, N (corresponding author), Danish Canc Soc Res Ctr, Copenhagen, Denmark.	roswall@cancer.dk	Ketzel, Matthias/K-4246-2015; Roswall, Nina/AAJ-6700-2020; Raaschou-Nielsen, Ole/GOK-0338-2022	Ketzel, Matthias/0000-0001-9519-1935; Roswall, Nina/0000-0003-3071-1658; Raaschou-Nielsen, Ole/0000-0002-1223-0909; Overvad, Kim/0000-0001-6429-7921; Sorensen, Mette/0000-0002-7302-4789; Bidstrup, Pernille/0000-0002-9704-6800; Olsen, Anja/0000-0003-4788-503X	European Research Council, EU [281760]	European Research Council, EU(European Research Council (ERC))	Funding: The research presented in this paper was funded by The European Research Council, EU 7th Research Framework Programme (http://ec.europa.eu/research/fp7/index_en.cfm); Grant Number 281760. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babisch W, 2014, NOISE HEALTH, V16, P1, DOI 10.4103/1463-1741.127847; Basner M, 2014, LANCET, V383, P1325, DOI 10.1016/S0140-6736(13)61613-X; Bendtsen H, 1999, SCI TOTAL ENVIRON, V235, P331, DOI 10.1016/S0048-9697(99)00216-8; Bodin T, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-14; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Dratva J, 2010, QUAL LIFE RES, V19, P37, DOI 10.1007/s11136-009-9571-2; Eriksson C, 2014, ENVIRON HEALTH PERSP, V122, P687, DOI 10.1289/ehp.1307115; Fontaine K R, 2001, Obes Rev, V2, P173, DOI 10.1046/j.1467-789x.2001.00032.x; Frei P, 2014, INT J HYG ENVIR HEAL, V217, P188, DOI 10.1016/j.ijheh.2013.04.003; Goines L, 2007, SOUTH MED J, V100, P287, DOI 10.1097/SMJ.0b013e3180318be5; Guite HF, 2006, PUBLIC HEALTH, V120, P1117, DOI 10.1016/j.puhe.2006.10.005; Gundersen H, 2013, ARCH ENVIRON OCCUP H, V68, P153, DOI 10.1080/19338244.2012.676103; LERCHER P, 1996, SCI TOTAL ENVIRON, V190, P85; Leslie E, 2008, PREV MED, V47, P273, DOI 10.1016/j.ypmed.2008.01.014; Maruish ME., 2011, USERS MANUAL SF 36V2, V3rd ed.; Matheson M P, 2003, Noise Health, V5, P31; Miedema Henk M E, 2007, Behav Sleep Med, V5, P1, DOI 10.1207/s15402010bsm0501_1; Miedema HME, 2007, J SOC ISSUES, V63, P41, DOI 10.1111/j.1540-4560.2007.00495.x; Miedema HME, 1998, J ACOUST SOC AM, V104, P3432, DOI 10.1121/1.423927; Miedema HME, 2001, ENVIRON HEALTH PERSP, V109, P409, DOI 10.2307/3454901; Nitschke M, 2014, NOISE HEALTH, V16, P137, DOI 10.4103/1463-1741.134913; Ohrstrom E, 2004, J ACOUST SOC AM, V115, P719, DOI 10.1121/1.1639333; OHRSTROM E, 1991, J SOUND VIB, V151, P513, DOI 10.1016/0022-460X(91)90551-T; Ouis Djamel, 2002, Noise Health, V4, P69; Parra DC, 2010, SOC SCI MED, V70, P1070, DOI 10.1016/j.socscimed.2009.12.024; Passchier-Vermeer W, 2000, ENVIRON HEALTH PERSP, V108, P123, DOI 10.1289/ehp.00108s1123; REVICKI DA, 1989, J FAM PRACTICE, V29, P377; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; Schreckenberg D, 2010, INT J ENV RES PUB HE, V7, P3382, DOI 10.3390/ijerph7093382; Selander J, 2009, EPIDEMIOLOGY, V20, P272, DOI 10.1097/EDE.0b013e31819463bd; Shepherd D, 2013, INT J ENV RES PUB HE, V10, P1284, DOI 10.3390/ijerph10041284; Shepherd D, 2010, INT J ENV RES PUB HE, V7, P3579, DOI 10.3390/ijerph7103580; Sorensen M, 2014, ENVIRON RES, V133, P49, DOI 10.1016/j.envres.2014.05.011; Sorensen M, 2013, ENVIRON HEALTH PERSP, V121, P217, DOI 10.1289/ehp.1205503; Stansfeld SA, 2009, NOISE HEALTH, V11, P169, DOI 10.4103/1463-1741.53364; Tjonneland A, 2007, SCAND J PUBLIC HEALT, V35, P432, DOI 10.1080/14034940601047986; Urban J, 2013, INT J ENV RES PUB HE, V10, P1895, DOI 10.3390/ijerph10051895; US Department of Health and Human Services, 2000, MEAS HLTH DAYS POP A; van Lenthe FJ, 2006, J EPIDEMIOL COMMUN H, V60, P699, DOI 10.1136/jech.2005.043851; Welch D, 2013, NOISE HEALTH, V15, P224, DOI 10.4103/1463-1741.113513; WHO (WorldHealthOrganization), 2009, NIGHT NOIS GUID EUR; Yamazaki S, 2005, INT J ENVIRON HEAL R, V15, P1, DOI 10.1080/09603120400018709	42	24	25	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120199	10.1371/journal.pone.0120199	http://dx.doi.org/10.1371/journal.pone.0120199			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7NO	25768919	Green Published, Green Submitted, gold			2022-12-27	WOS:000351277500114
J	Steiner, M; Volkheimer, D; Meyers, N; Wehner, T; Wilke, HJ; Claes, L; Ignatius, A				Steiner, Malte; Volkheimer, David; Meyers, Nicholaus; Wehner, Tim; Wilke, Hans-Joachim; Claes, Lutz; Ignatius, Anita			Comparison between Different Methods for Biomechanical Assessment of Ex Vivo Fracture Callus Stiffness in Small Animal Bone Healing Studies	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; EXTERNAL FIXATOR; FEMUR FRACTURE; MOUSE FEMUR; RAT FEMORA; MODEL; MICE; STRENGTH; TRAUMA; TIBIA	For ex vivo measurements of fracture callus stiffness in small animals, different test methods, such as torsion or bending tests, are established. Each method provides advantages and disadvantages, and it is still debated which of those is most sensitive to experimental conditions (i.e. specimen alignment, directional dependency, asymmetric behavior). The aim of this study was to experimentally compare six different testing methods regarding their robustness against experimental errors. Therefore, standardized specimens were created by selective laser sintering (SLS), mimicking size, directional behavior, and embedding variations of respective rat long bone specimens. For the latter, five different geometries were created which show shifted or tilted specimen alignments. The mechanical tests included three-point bending, four-point bending, cantilever bending, axial compression, constrained torsion, and unconstrained torsion. All three different bending tests showed the same principal behavior. They were highly dependent on the rotational direction of the maximum fracture callus expansion relative to the loading direction (creating experimental errors of more than 60%), however small angular deviations (< 15 degrees) were negligible. Differences in the experimental results between the bending tests originate in their respective location of maximal bending moment induction. Compared to four-point bending, three-point bending is easier to apply on small rat and mouse bones under realistic testing conditions and yields robust measurements, provided low variation of the callus shape among the tested specimens. Axial compressive testing was highly sensitive to embedding variations, and therefore cannot be recommended. Although it is experimentally difficult to realize, unconstrained torsion testing was found to be the most robust method, since it was independent of both rotational alignment and embedding uncertainties. Constrained torsional testing showed small errors (up to 16.8%, compared to corresponding alignment under unconstrained torsion) due to a parallel offset between the specimens' axis of gravity and the torsional axis of rotation.	[Steiner, Malte; Volkheimer, David; Meyers, Nicholaus; Wehner, Tim; Wilke, Hans-Joachim; Claes, Lutz; Ignatius, Anita] Univ Hosp Ulm, Ctr Musculoskeletal Res Ulm, Inst Orthoped Res & Biomech, Ulm, Germany	Ulm University	Steiner, M (corresponding author), Univ Hosp Ulm, Ctr Musculoskeletal Res Ulm, Inst Orthoped Res & Biomech, Ulm, Germany.	malte.steiner@uni-ulm.de	Meyers, Nicholaus/R-7482-2016; Wilke, Hans-Joachim/M-6440-2014; Claes, Lutz/O-4697-2014; Ignatius, Anita/M-6012-2013	Meyers, Nicholaus/0000-0001-7614-1203; Wilke, Hans-Joachim/0000-0001-6007-8844; Ignatius, Anita/0000-0002-4782-1979	Center of Musculoskeletal Research Ulm, University of Ulm, Germany	Center of Musculoskeletal Research Ulm, University of Ulm, Germany	This study was intramurally funded by the Center of Musculoskeletal Research Ulm, University of Ulm, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augat P, 2003, J ORTHOP RES, V21, P1011, DOI 10.1016/S0736-0266(03)00098-6; Bosemark P, 2014, J ORTHOP RES, V32, P721, DOI 10.1002/jor.22599; Cheung KMC, 2003, J ORTHOP RES, V21, P685, DOI 10.1016/S0736-0266(03)00026-3; Claes L, 2009, CALCIFIED TISSUE INT, V85, P17, DOI 10.1007/s00223-009-9262-6; Claes L, 2009, J ORTHOP RES, V27, P22, DOI 10.1002/jor.20712; Ehrnthaller C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081341; EKELAND A, 1981, ACTA ORTHOP SCAND, V52, P605, DOI 10.3109/17453678108992155; ENGESAETER LB, 1978, ACTA ORTHOP SCAND, V49, P512, DOI 10.3109/17453677808993231; Gandhi A, 2005, BONE, V37, P482, DOI 10.1016/j.bone.2005.04.039; Heilmann A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084232; HENRY AN, 1968, P ROY SOC MED, V61, P902, DOI 10.1177/003591576806100921; Histing T, 2011, BONE, V49, P591, DOI 10.1016/j.bone.2011.07.007; Histing T, 2013, J INVEST SURG, V26, P30, DOI 10.3109/08941939.2012.687435; Histing T, 2009, J ORTHOP RES, V27, P1152, DOI 10.1002/jor.20849; Jamsa T, 1998, BONE, V23, P155, DOI 10.1016/S8756-3282(98)00076-3; KELLER TS, 1986, J ORTHOP RES, V4, P57, DOI 10.1002/jor.1100040107; Manigrasso MB, 2004, J ORTHOP TRAUMA, V18, P687, DOI 10.1097/00005131-200411000-00006; Meganck JA, 2013, BONE, V56, P204, DOI 10.1016/j.bone.2013.06.003; Park AG, 2013, J ORTHOP RES, V31, P776, DOI 10.1002/jor.22287; Recknagel S, 2013, J ORTHOP RES, V31, P465, DOI 10.1002/jor.22242; Recknagel S, 2012, J ORTHOP RES, V30, P581, DOI 10.1002/jor.21561; Recknagel S, 2011, J ORTHOP RES, V29, P734, DOI 10.1002/jor.21299; RICHARDSON JB, 1994, J BONE JOINT SURG BR, V76B, P389, DOI 10.1302/0301-620X.76B3.8175839; Rontgen V, 2010, J ORTHOP RES, V28, P1456, DOI 10.1002/jor.21148; Sisask G, 2013, BONE, V54, P126, DOI 10.1016/j.bone.2013.01.019; Steck R, 2011, J ORTHOP RES, V29, P1245, DOI 10.1002/jor.21341; Strube P, 2008, BONE, V42, P758, DOI 10.1016/S0021-9290(08)70350-6; Strube P, 2009, BONE, V45, P1065, DOI 10.1016/j.bone.2009.08.005; Wallace A, 2011, J ORTHOP RES, V29, P1437, DOI 10.1002/jor.21367; Wehner T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115695; Wehner T, 2014, J ORTHOP RES, V32, P1589, DOI 10.1002/jor.22721; Wehner T, 2010, J BIOMECH, V43, P2473, DOI 10.1016/j.jbiomech.2010.05.028; Wehrle E, 2014, J ORTHOP RES, V32, P1006, DOI 10.1002/jor.22629; WIDMANN RF, 1993, J ORTHOP RES, V11, P422, DOI 10.1002/jor.1100110315; Wilke H J, 1994, Eur Spine J, V3, P91, DOI 10.1007/BF02221446; Wright DA, 2012, J BIOMECH, V45, P2236, DOI 10.1016/j.jbiomech.2012.06.016	36	21	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119603	10.1371/journal.pone.0119603	http://dx.doi.org/10.1371/journal.pone.0119603			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781027	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600077
J	Syka, M; Keller, J; Klempir, J; Rulseh, AM; Roth, J; Jech, R; Vorisek, I; Vymazal, J				Syka, Michael; Keller, Jiri; Klempir, Jiri; Rulseh, Aaron M.; Roth, Jan; Jech, Robert; Vorisek, Ivan; Vymazal, Josef			Correlation between Relaxometry and Diffusion Tensor Imaging in the Globus Pallidus of Huntington's Disease Patients	PLOS ONE			English	Article							BASAL GANGLIA; GRAY-MATTER; MR RELAXOMETRY; BRAIN-TISSUE; IRON; AGE; RELAXATION; TIME; PARKINSON; PATHOLOGY	Huntington's disease (HD) is an inherited neurodegenerative disorder with progressive impairment of motor, behavioral and cognitive functions. The clinical features of HD are closely related to the degeneration of the basal ganglia, predominantly the striatum. The main striatal output structure, the globus pallidus, strongly accumulates metalloprotein-bound iron, which was recently shown to influence the diffusion tensor scalar values. To test the hypothesis that this effect dominates in the iron-rich basal ganglia of HD patients, we examined the globus pallidus using DTI and T2 relaxometry sequences. Quantitative magnetic resonance (MR), clinical and genetic data (number of CAG repeats) were obtained from 14 HD patients. MR parameters such as the T2 relaxation rate (RR), fractional anisotropy (FA) and mean diffusivity (MD) were analysed. A positive correlation was found between RR and FA (R2=0.84), between CAG and RR (R2=0.59) and between CAG and FA (R2=0.44). A negative correlation was observed between RR and MD (R2=0.66). A trend towards correlation between CAG and MD was noted. No correlation between MR and clinical parameters was found. Our results indicate that especially magnetic resonance FA measurements in the globus pallidus of HD patients may be strongly affected by metalloprotein-bound iron accumulation.	[Syka, Michael; Keller, Jiri; Rulseh, Aaron M.; Vymazal, Josef] Na Homolce Hosp, Dept Radiol, Prague, Czech Republic; [Syka, Michael] St Annes Univ Hosp, Int Clin Res Ctr, Brno, Czech Republic; [Keller, Jiri] Charles Univ Prague, Dept Neurol, Fac Med 3, Prague, Czech Republic; [Klempir, Jiri; Roth, Jan; Jech, Robert] Charles Univ Prague, Dept Neurol, Fac Med 1, Prague, Czech Republic; [Klempir, Jiri; Roth, Jan; Jech, Robert] Charles Univ Prague, Ctr Clin Neurosci, Fac Med 1, Prague, Czech Republic; [Klempir, Jiri; Rulseh, Aaron M.; Roth, Jan; Jech, Robert] Charles Univ Prague, Gen Univ Hosp Prague, Prague, Czech Republic; [Klempir, Jiri] Charles Univ Prague, Inst Anat, Fac Med 1, Prague, Czech Republic; [Rulseh, Aaron M.] Charles Univ Prague, Dept Radiol, Fac Med 1, Prague, Czech Republic; [Syka, Michael; Vorisek, Ivan] Acad Sci Czech Republ, Inst Expt Med, Vvi, Prague, Czech Republic	Na Homolce Hospital; St Anne's University Hospital Brno (FNUSA-ICRC); Charles University Prague; Charles University Prague; Charles University Prague; Charles University Prague; General University Hospital Prague; Charles University Prague; Charles University Prague; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences	Syka, M (corresponding author), Na Homolce Hosp, Dept Radiol, Prague, Czech Republic.	msyka@email.cz	Klempir, Jiri/P-3897-2017; Keller, Jiří/AAE-4791-2019; Jech, Robert/HHY-7342-2022; Roth, Jan/O-1817-2017; Klempir, Jiri/AAI-7300-2021; Rulseh, Aaron/D-3924-2015	Klempir, Jiri/0000-0002-0735-7155; Keller, Jiří/0000-0002-6799-7840; Jech, Robert/0000-0002-9732-8947; Roth, Jan/0000-0002-5247-7746; Rulseh, Aaron/0000-0002-8332-4419	Ministry of Health, Czech Republic - conceptual development of research organization (Nemocnice Na Homolce - NNH) [00023884]; project FNUSA-ICRC from the European Regional Development Fund [CZ.1.05/1.1.00/02.0123]; Research Projects of Charles University in Prague [PRVOUK P34, PRVOUK P26]; IGA of Ministry of Health, Czech Republic [NT12094/2011]; Grant Agency of the Czech Republic [P303/11/2378]	Ministry of Health, Czech Republic - conceptual development of research organization (Nemocnice Na Homolce - NNH); project FNUSA-ICRC from the European Regional Development Fund; Research Projects of Charles University in Prague; IGA of Ministry of Health, Czech Republic; Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	This work was supported by the Ministry of Health, Czech Republic - conceptual development of research organization (Nemocnice Na Homolce - NNH, 00023884), the project FNUSA-ICRC (no. CZ.1.05/1.1.00/02.0123) from the European Regional Development Fund, the Research Projects of Charles University in Prague (PRVOUK P34 and PRVOUK P26), and the grants from IGA of Ministry of Health, Czech Republic (NT12094/2011) and from Grant Agency of the Czech Republic (P303/11/2378). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albin RL, 1995, ANN NEUROL, V38, P835, DOI 10.1002/ana.410380602; Aquino D, 2009, RADIOLOGY, V252, P165, DOI 10.1148/radiol.2522081399; Bartzokis G, 2000, CELL MOL BIOL, V46, P821; Bartzokis G, 1999, ARCH NEUROL-CHICAGO, V56, P569, DOI 10.1001/archneur.56.5.569; BARTZOKIS G, 1994, AM J NEURORADIOL, V15, P1129; BARTZOKIS G, 1993, MAGN RESON MED, V29, P459, DOI 10.1002/mrm.1910290406; Bartzokis G, 2007, NEUROCHEM RES, V32, P1655, DOI 10.1007/s11064-007-9352-7; Bastin ME, 1998, MAGN RESON IMAGING, V16, P773, DOI 10.1016/S0730-725X(98)00098-8; Cattaneo E, 2001, TRENDS NEUROSCI, V24, P182, DOI 10.1016/S0166-2236(00)01721-5; CHEN JC, 1993, AM J NEURORADIOL, V14, P275; Dezortova M, 2012, CONTRAST MEDIA MOL I, V7, P509, DOI 10.1002/cmmi.1482; Douaud G, 2009, NEUROIMAGE, V46, P958, DOI 10.1016/j.neuroimage.2009.03.044; DRAYER B, 1986, AM J ROENTGENOL, V147, P103, DOI 10.2214/ajr.147.1.103; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; Gusella JF, 1998, CURR OPIN NEUROBIOL, V8, P425, DOI 10.1016/S0959-4388(98)80071-8; Hajek M, 2005, EUR RADIOL, V15, P1060, DOI 10.1007/s00330-004-2553-4; HALLGREN B, 1958, J NEUROCHEM, V3, P41, DOI 10.1111/j.1471-4159.1958.tb12607.x; Hasan KM, 2009, J MAGN RESON IMAGING, V29, P70, DOI 10.1002/jmri.21648; Herynek V, 2012, J MAGN RESON IMAGING, V35, P1332, DOI 10.1002/jmri.23599; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mascalchi M, 2004, RADIOLOGY, V232, P867, DOI 10.1148/radiol.2322030820; McGahan MC, 2005, AM J PHYSIOL-CELL PH, V288, pC1117, DOI 10.1152/ajpcell.00444.2004; ORDIDGE RJ, 1994, MAGNET RESON MED, V32, P335, DOI 10.1002/mrm.1910320309; Penney JB, 1997, ANN NEUROL, V41, P689, DOI 10.1002/ana.410410521; Peran P, 2009, HUM BRAIN MAPP, V30, P2667, DOI 10.1002/hbm.20698; Pfefferbaum A, 2010, NEUROBIOL AGING, V31, P482, DOI 10.1016/j.neurobiolaging.2008.04.013; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Rosas HD, 2006, MOVEMENT DISORD, V21, P1317, DOI 10.1002/mds.20979; Rosas HD, 2012, ARCH NEUROL-CHICAGO, V69, P887, DOI 10.1001/archneurol.2011.2945; Rosas HD, 2003, NEUROLOGY, V60, P1615, DOI 10.1212/01.WNL.0000065888.88988.6E; Rulseh AM, 2013, J MAGN RESON IMAGING, V38, P1103, DOI 10.1002/jmri.24065; Sanchez-Castaneda C, 2013, HUM BRAIN MAPP, V34, P1625, DOI 10.1002/hbm.22019; SCHENKER C, 1993, NEURORADIOLOGY, V35, P119, DOI 10.1007/BF00593967; Seppi K, 2006, MOVEMENT DISORD, V21, P1043, DOI 10.1002/mds.20868; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Vorisek I, 2009, ACTA PHYSIOL, V195, P101, DOI 10.1111/j.1748-1716.2008.01924.x; Vymazal J, 1999, RADIOLOGY, V211, P489, DOI 10.1148/radiology.211.2.r99ma53489; VYMAZAL J, 1995, JMRI-J MAGN RESON IM, V5, P554; Vymazal J, 2007, J NEUROL SCI, V263, P20, DOI 10.1016/j.jns.2007.05.018; Walimuni IS, 2011, NEUROIMAGE, V57, P1402, DOI 10.1016/j.neuroimage.2011.05.063; WARNER JP, 1993, MOL CELL PROBE, V7, P235, DOI 10.1006/mcpr.1993.1034; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537	47	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0118907	10.1371/journal.pone.0118907	http://dx.doi.org/10.1371/journal.pone.0118907			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781024	gold, Green Published, Green Submitted			2022-12-27	WOS:000351284600037
J	Tsai, YC; Grimm, S; Chao, JL; Wang, SC; Hofmeyer, K; Shen, J; Eichinger, F; Michalopoulou, T; Yao, CK; Chang, CH; Lin, SH; Sun, YH; Pflugfelder, GO				Tsai, Yu-Chen; Grimm, Stefan; Chao, Ju-Lan; Wang, Shih-Chin; Hofmeyer, Kerstin; Shen, Jie; Eichinger, Fred; Michalopoulou, Theoni; Yao, Chi-Kuang; Chang, Chih-Hsuan; Lin, Shih-Han; Sun, Y. Henry; Pflugfelder, Gert O.			Optomotor-Blind Negatively Regulates Drosophila Eye Development by Blocking Jak/STAT Signaling	PLOS ONE			English	Article							MORPHOGENETIC FURROW PROGRESSION; GENE-EXPRESSION; CELL FATE; RETINAL DIFFERENTIATION; COMPARTMENT BOUNDARY; ACTS DOWNSTREAM; REPORTER GENE; IMAGINAL DISK; COMPOUND EYE; GLIAL-CELLS	Organ formation requires a delicate balance of positive and negative regulators. In Drosophila eye development, wingless (wg) is expressed at the lateral margins of the eye disc and serves to block retinal development. The T-box gene optomotor-blind (omb) is expressed in a similar pattern and is regulated by Wg. Omb mediates part of Wg activity in blocking eye development. Omb exerts its function primarily by blocking cell proliferation. These effects occur predominantly in the ventral margin. Our results suggest that the primary effect of Omb is the blocking of Jak/STAT signaling by repressing transcription of upd which encodes the Jak receptor ligand Unpaired.	[Tsai, Yu-Chen; Chao, Ju-Lan; Yao, Chi-Kuang; Sun, Y. Henry] Natl Yang Ming Univ, Inst Genet, Taipei 112, Taiwan; [Tsai, Yu-Chen; Chao, Ju-Lan; Yao, Chi-Kuang; Sun, Y. Henry] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Tsai, Yu-Chen; Wang, Shih-Chin; Chang, Chih-Hsuan; Lin, Shih-Han] Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan; [Tsai, Yu-Chen; Wang, Shih-Chin; Chang, Chih-Hsuan; Lin, Shih-Han] Tunghai Univ, Life Sci Ctr, Taichung 40704, Taiwan; [Grimm, Stefan; Hofmeyer, Kerstin; Pflugfelder, Gert O.] Univ Wurzburg, Lehrstuhl Genet & Neurobiol, Biozentrum, Theodor Boveri Inst, D-97070 Wurzburg, Germany; [Shen, Jie; Eichinger, Fred; Michalopoulou, Theoni; Pflugfelder, Gert O.] Johannes Gutenberg Univ Mainz, Inst Genet, D-55122 Mainz, Germany; [Shen, Jie] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Tunghai University; Tunghai University; University of Wurzburg; Johannes Gutenberg University of Mainz; China Agricultural University	Sun, YH (corresponding author), Natl Yang Ming Univ, Inst Genet, Taipei 112, Taiwan.	mbyhsun@gate.sinica.edu.tw; pflugfel@uni-mainz.de	shen, jie/H-9087-2016; Pflugfelder, Gert/ABG-9562-2021; Yao, Chi-Kuang/Y-9325-2019; Sun, Y. Henry/ABC-4614-2021; shen, jie/W-9807-2019; Sun, Y. Henry/AAZ-7966-2021	Yao, Chi-Kuang/0000-0003-0977-4347; Sun, Y. Henry/0000-0001-8279-5270; shen, jie/0000-0002-6021-7151; 	National Science Council of the Republic of China [NSC 88-2312-B-001-016, NSC 90-2312-B-001-006, NSC 91-2312-B-001-006, NSC 99-2311-B-029-002-MY3, NSC-102-2633-B-029-002]; Deutsche Forschungsgemeinschaft [Pf 163/11-1]; ROC-Germany exchange program [PPP 87-I-2911-01]	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ROC-Germany exchange program	This study was supported by grants to Y.H. S. (NSC 88-2312-B-001-016, NSC 90-2312-B-001-006, NSC 91-2312-B-001-006) to Y.C.T. (NSC 99-2311-B-029-002-MY3, NSC-102-2633-B-029-002) from the National Science Council (http://www.most.gov.tw/mp.aspx?mp=7) of the Republic of China, to G.O.P. (Pf 163/11-1) from Deutsche Forschungsgemeinschaft (http://www.dfg.de/en/index.jsp) and a ROC-Germany exchange program (PPP 87-I-2911-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach EA, 2003, GENETICS, V165, P1149; Bach EA, 2007, GENE EXPR PATTERNS, V7, P323, DOI 10.1016/j.modgep.2006.08.003; Barolo S, 2000, BIOTECHNIQUES, V29, P726, DOI 10.2144/00294bm10; BASLER K, 1988, CELL, V54, P299; Behesti H, 2009, DEV BIOL, V333, P360, DOI 10.1016/j.ydbio.2009.06.026; Bessa J, 2002, GENE DEV, V16, P2415, DOI 10.1101/gad.1009002; BLACKMAN RK, 1991, DEVELOPMENT, V111, P657; Bonini NM, 1999, BIOESSAYS, V21, P991, DOI 10.1002/(SICI)1521-1878(199912)22:1&lt;991::AID-BIES3&gt;3.0.CO;2-3; Borod ER, 1998, DEV BIOL, V197, P187, DOI 10.1006/dbio.1998.8888; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROWN NL, 1995, CELL, V80, P879, DOI 10.1016/0092-8674(95)90291-0; Burke R, 1996, DEV BIOL, V179, P360, DOI 10.1006/dbio.1996.0267; Cadigan KM, 2002, SEMIN CELL DEV BIOL, V13, P83, DOI 10.1016/S1084-9521(02)00014-9; Cadigan KM, 2002, DEVELOPMENT, V129, P3393; Calleja M, 1996, SCIENCE, V274, P252, DOI 10.1126/science.274.5285.252; Chanut F, 1997, DEV GENET, V20, P197; Chanut F, 1997, DEVELOPMENT, V124, P559; Chao JL, 2004, DEVELOPMENT, V131, P3839, DOI 10.1242/dev.01258; Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; Cho KO, 1998, NATURE, V396, P272, DOI 10.1038/24394; Cook O, 2004, DEVELOPMENT, V131, P2113, DOI 10.1242/dev.01100; Dominguez M, 2005, DEV DYNAM, V232, P673, DOI 10.1002/dvdy.20311; Dominguez M, 1998, NATURE, V396, P276, DOI 10.1038/24402; Ekas LA, 2006, DEVELOPMENT, V133, P4721, DOI 10.1242/dev.02675; Ekas LA, 2010, DEV BIOL, V344, P621, DOI 10.1016/j.ydbio.2010.05.497; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Freeman M, 1997, DEVELOPMENT, V124, P261; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; Gorfinkiel N, 1999, MECH DEVELOP, V86, P113, DOI 10.1016/S0925-4773(99)00122-7; Grimm S, 1996, SCIENCE, V271, P1601, DOI 10.1126/science.271.5255.1601; Gross JM, 2005, P NATL ACAD SCI USA, V102, P4371, DOI 10.1073/pnas.0501061102; Gruenauer-Kloevekorn Claudia, 2005, Ophthalmic Genet, V26, P1, DOI 10.1080/13816810590918073; HAYNIE JL, 1986, J EXP ZOOL, V237, P293, DOI 10.1002/jez.1402370302; Hazelett DJ, 1998, DEVELOPMENT, V125, P3741; HEBERLEIN U, 1993, CELL, V75, P913, DOI 10.1016/0092-8674(93)90535-X; HIGASHIJIMA SI, 1992, GENE DEV, V6, P50, DOI 10.1101/gad.6.1.50; Hou XS, 1996, CELL, V84, P411, DOI 10.1016/S0092-8674(00)81286-6; Ito K, 1997, DEVELOPMENT, V124, P761; Jang CC, 2003, DEVELOPMENT, V130, P2939, DOI 10.1242/dev.00522; Gutierrez-Avino FJ, 2009, EMBO REP, V10, P1051, DOI 10.1038/embor.2009.140; KASSIS JA, 1992, P NATL ACAD SCI USA, V89, P1919, DOI 10.1073/pnas.89.5.1919; Kopp A, 1997, DEVELOPMENT, V124, P3715; Kumar JP, 2011, DEV NEUROBIOL, V71, P1133, DOI 10.1002/dneu.20921; Kumar JP, 2010, CURR TOP DEV BIOL, V93, P1, DOI [10.1016/B978-0-12-385044-7.00001-1, 10.1016/S0070-2153(10)93001-9]; Leconte L, 2004, J BIOL CHEM, V279, P47272, DOI 10.1074/jbc.M406624200; Lee JD, 2001, DEVELOPMENT, V128, P1519; Lopes CS, 2010, DEV BIOL, V339, P78, DOI 10.1016/j.ydbio.2009.12.020; Luo H, 1999, DEV BIOL, V213, P432, DOI 10.1006/dbio.1999.9390; MA CY, 1995, DEVELOPMENT, V121, P2279; Mayer LR, 2013, FLY, V7, P118, DOI 10.4161/fly.23657; NewburyEcob RA, 1996, J MED GENET, V33, P300, DOI 10.1136/jmg.33.4.300; Oros SM, 2010, DEV BIOL, V346, P258, DOI 10.1016/j.ydbio.2010.07.030; Pai CY, 1998, GENE DEV, V12, P435, DOI 10.1101/gad.12.3.435; PAN DJ, 1995, CELL, V80, P543, DOI 10.1016/0092-8674(95)90508-1; Peng HW, 2009, GENE DEV, V23, P2307, DOI 10.1101/gad.1820009; Pflugfelder GO, 2009, J NEUROGENET, V23, P15, DOI 10.1080/01677060802471619; PFLUGFELDER GO, 1995, COMP BIOCHEM PHYS A, V110, P185, DOI 10.1016/0300-9629(94)00159-Q; Pignoni F, 1997, DEVELOPMENT, V124, P271; POECK B, 1993, DEVELOPMENT, V117, P1017; POECK B, 1993, MOL GEN GENET, V238, P325, DOI 10.1007/BF00291990; Porsch M, 2005, MECH DEVELOP, V122, P81, DOI 10.1016/j.mod.2004.08.007; Rangarajan R, 1999, DEVELOPMENT, V126, P3285; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; Rodriguez DD, 2004, DEV BIOL, V268, P481, DOI 10.1016/j.ydbio.2004.01.005; Roignant JY, 2010, DEVELOPMENT, V137, P273, DOI 10.1242/dev.041244; Sen A, 2014, J NEUROGENET, V28, P250, DOI 10.3109/01677063.2014.917645; Sen A, 2010, MOL GENET GENOMICS, V283, P147, DOI 10.1007/s00438-009-0505-z; Shen J, 2005, DEV BIOL, V279, P31, DOI 10.1016/j.ydbio.2004.11.033; Shen J, 2008, MECH DEVELOP, V125, P233, DOI 10.1016/j.mod.2007.11.006; Shen J, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-23; Silver SJ, 2005, DEVELOPMENT, V132, P3, DOI 10.1242/dev.01539; Singh A, 2003, DEVELOPMENT, V130, P6351, DOI 10.1242/dev.00864; Singh A, 2012, DEV DYNAM, V241, P69, DOI 10.1002/dvdy.22764; Sowden JC, 2001, INVEST OPHTH VIS SCI, V42, P3095; STAEHLINGHAMPTON K, 1994, CELL GROWTH DIFFER, V5, P585; Strutt DI, 1995, DEVELOPMENT, V121, P4247; SUN YH, 1995, GENETICS, V141, P1075; Tang CY, 2002, GENESIS, V34, P39, DOI 10.1002/gene.10135; Tomlinson A, 2003, DEV CELL, V5, P799, DOI 10.1016/S1534-5807(03)00326-5; Treisman JE, 1999, BIOESSAYS, V21, P843, DOI 10.1002/(SICI)1521-1878(199910)21:10<843::AID-BIES6>3.3.CO;2-A; TREISMAN JE, 1995, DEVELOPMENT, V121, P3519; Treisman JE, 2013, WIRES DEV BIOL, V2, P545, DOI 10.1002/wdev.100; Tsai YC, 2004, GENESIS, V39, P141, DOI 10.1002/gene.20035; Tsai YC, 2007, DEV BIOL, V306, P760, DOI 10.1016/j.ydbio.2007.04.011; Wernet MF, 2014, DEVELOPMENT, V141, P918, DOI 10.1242/dev.103127; Wiersdorff V, 1996, DEVELOPMENT, V122, P2153; WOLFF T, 1991, DEVELOPMENT, V113, P841; Wolff TaR DN, 1993, THE DEVELOPMENT OF D, P1277; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; Zeidler MP, 1999, GENE DEV, V13, P1342, DOI 10.1101/gad.13.10.1342; Zhang XB, 2013, DEVELOPMENT, V140, P2917, DOI 10.1242/dev.094300	91	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120236	10.1371/journal.pone.0120236	http://dx.doi.org/10.1371/journal.pone.0120236			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781970	Green Submitted, Green Published, gold			2022-12-27	WOS:000351284600144
J	Zhang, Z; Zheng, XL; Zeng, DDJ; Leischow, SJ				Zhang, Zhu; Zheng, Xiaolong; Zeng, Daniel Dajun; Leischow, Scott J.			Information Seeking Regarding Tobacco and Lung Cancer: Effects of Seasonality	PLOS ONE			English	Article							ELECTRONIC CIGARETTES; SMOKING; PATTERNS; SALES	This paper conducted one of the first comprehensive international Internet analyses of seasonal patterns in information seeking concerning tobacco and lung cancer. Search query data for the terms "tobacco" and "lung cancer" from January 2004 to January 2014 was collected from Google Trends. The relevant countries included the USA, Canada, the UK, Australia, and China. Two statistical approaches including periodogram and cross-correlation were applied to analyze seasonal patterns in the collected search trends and their associations. For these countries except China, four out of six cross-correlations of seasonal components of the search trends regarding tobacco were above 0.600. For these English-speaking countries, similar patterns existed in the data concerning lung cancer, and all cross-correlations between seasonal components of the search trends regarding tobacco and that regarding lung cancer were also above 0.700. Seasonal patterns widely exist in information seeking concerning tobacco and lung cancer on an international scale. The findings provide a piece of novel Internet-based evidence for the seasonality and health effects of tobacco use.	[Zhang, Zhu; Zheng, Xiaolong; Zeng, Daniel Dajun] Chinese Acad Sci, State Key Lab Management & Control Complex Syst, Inst Automat, Beijing, Peoples R China; [Zeng, Daniel Dajun] Univ Arizona, Dept Management Informat Syst, Tucson, AZ 85721 USA; [Leischow, Scott J.] Mayo Clin, Scottsdale, AZ USA	Chinese Academy of Sciences; Institute of Automation, CAS; University of Arizona; Mayo Clinic; Mayo Clinic Phoenix	Zeng, DDJ (corresponding author), Chinese Acad Sci, State Key Lab Management & Control Complex Syst, Inst Automat, Beijing, Peoples R China.	dajun.zeng@ia.ac.cn			National Natural Science Foundation of China [71103180, 71472175, 71025001, 91224008]; National Institutes of Health (NIH) of USA [1R01DA037378-01]; Ministry of Health of China [2012ZX10004801, 2013ZX10004218];  [2013A127]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA037378] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health (NIH) of USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Health of China; ; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research is partially supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) under Grant No. 71103180 (PI: XZ), 71472175 (PI: XZ), 71025001 (PI: DDZ), 91224008 (PI: DDZ), and 61175040 (PI: WM); National Institutes of Health (NIH) of USA (http://www.nih.gov/) under Grant No. 1R01DA037378-01 (PI: DDZ); the Ministry of Health of China (http://www.nhfpc.gov.cn/) under Grant No. 2012ZX10004801 (PI: DDZ) and 2013ZX10004218 (PI: DDZ); and by the Grant No. 2013A127 (PI: DDZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, MATHWORKS MATLAB 7 1; Ayers JW, 2012, J MED INTERNET RES, V14, P288, DOI 10.2196/jmir.2148; Ayers JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016777; Ayers JW, 2011, AM J PREV MED, V40, P448, DOI 10.1016/j.amepre.2010.12.007; Boland M, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-208; Carr LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048158; Cavazos-Rehg PA, 2015, TOB CONTROL, V24, P249, DOI 10.1136/tobaccocontrol-2013-051276; Chandra S, 2003, TOB CONTROL, V12, P105, DOI 10.1136/tc.12.1.105; Chandra S, 2011, NICOTINE TOB RES, V13, P395, DOI 10.1093/ntr/ntq258; Chang W, 2005, 2005 IEEE INTELLIGENT TRANSPORTATION SYSTEMS CONFERENCE (ITSC), P1120; Choi HY, 2012, ECON REC, V88, P2, DOI 10.1111/j.1475-4932.2012.00809.x; Cobb NK, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1911; Cobb NK, 2010, AM J PREV MED, V38, pS429, DOI 10.1016/j.amepre.2009.12.001; Colwell B, 2006, NICOTINE TOB RES, V8, P239, DOI 10.1080/14622200600576503; Cui KN, 2014, LECT NOTES COMPUT SC, V8549, P44, DOI 10.1007/978-3-319-08416-9_5; Eysenbach Gunther, 2006, AMIA Annu Symp Proc, P244; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Li XC, 2008, LECT NOTES COMPUT SC, V5075, P401; Lu HM, 2010, IEEE T KNOWL DATA EN, V22, P565, DOI 10.1109/TKDE.2009.115; Luo CA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1028; Mai SK, 2007, HLTH CONS SMOK REP S, V2, P30; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Momperousse D, 2007, TOB CONTROL, V16, P69, DOI 10.1136/tc.2006.018135; Santillana M, 2014, AM J PREV MED, V47, P341, DOI 10.1016/j.amepre.2014.05.020; Sheffer MA, 2010, AM J PREV MED, V38, pS343, DOI 10.1016/j.amepre.2009.11.014; Wellman RJ, 2003, TOB CONTROL, V12, P339, DOI 10.1136/tc.12.3.339; World Health Organization, 2012, WHO GLOB REP MORT AT; Yang AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013728; Yuan Luo, 2010, 2010 IEEE International Conference on Service Operations and Logistics and Informatics (SOLI 2010), P76, DOI 10.1109/SOLI.2010.5551614; Zeng D, 2010, IEEE INTELL SYST, V25, P13, DOI 10.1109/MIS.2010.151; Zhang Z, 2013, 2013 IEEE INTERNATIONAL CONFERENCE ON INTELLIGENCE AND SECURITY INFORMATICS: BIG DATA, EMERGENT THREATS, AND DECISION-MAKING IN SECURITY INFORMATICS, P371, DOI 10.1109/ISI.2013.6578861; Zheng Min., 2011, LECT NOTES COMPUTER, P85, DOI [10.1007/978-3-642-22039-5_9, DOI 10.1007/978-3-642-22039-5_9]	32	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0117938	10.1371/journal.pone.0117938	http://dx.doi.org/10.1371/journal.pone.0117938			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781020	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600017
J	Zheng, H; Gao, JX; Teng, YG; Feng, CY; Tian, MR				Zheng, Hao; Gao, Jixi; Teng, Yanguo; Feng, Chaoyang; Tian, Meirong			Temporal Variations in Soil Moisture for Three Typical Vegetation Types in Inner Mongolia, Northern China	PLOS ONE			English	Article							LOESS-PLATEAU; VARIABILITY; INFILTRATION; HYDROLOGY; CATCHMENT	Drought and shortages of soil water are becoming extremely severe due to global climate change. A better understanding of the relationship between vegetation type and soil-moisture conditions is crucial for conserving soil water in forests and for maintaining a favorable hydrological balance in semiarid areas, such as the Saihanwula National Nature Reserve in Inner Mongolia, China. We investigated the temporal dynamics of soil moisture in this reserve to a depth of 40 cm under three types of vegetation during a period of rainwater recharge. Rainwater from most rainfalls recharged the soil water poorly below 40 cm, and the rainfall threshold for increasing the moisture content of surface soil for the three vegetations was in the order: artificial Larix spp. (AL) > Quercus mongolica (QM) > unused grassland (UG). QM had the highest mean soil moisture content (21.13%) during the monitoring period, followed by UG (16.52%) and AL (14.55%); and the lowest coefficient of variation (CV 9.6-12.5%), followed by UG (CV 10.9-18.7%) and AL (CV 13.9-21.0%). QM soil had a higher nutrient content and higher soil porosities, which were likely responsible for the higher ability of this cover to retain soil water. The relatively smaller QM trees were able to maintain soil moisture better in the study area.	[Zheng, Hao; Gao, Jixi; Teng, Yanguo] Beijing Normal Univ, Coll Water Sci, Beijing 100875, Peoples R China; [Zheng, Hao; Gao, Jixi; Tian, Meirong] Minist Environm Protect China, Nanjing Inst Environm Sci, Nanjing 210042, Jiangsu, Peoples R China; [Feng, Chaoyang] Chinese Res Inst Environm Sci, Beijing 100012, Peoples R China	Beijing Normal University; Chinese Research Academy of Environmental Sciences	Gao, JX (corresponding author), Beijing Normal Univ, Coll Water Sci, Beijing 100875, Peoples R China.	gaojx168@163.com			National Special Scientific Research of Environmental Protection Public Welfare Project [201209027]; National Science and Technology Support Project [2012BAC01B00]	National Special Scientific Research of Environmental Protection Public Welfare Project; National Science and Technology Support Project	This work was supported by the National Special Scientific Research of Environmental Protection Public Welfare Project (No. 201209027) and the National Science and Technology Support Project (No. 2012BAC01B00). The funders played a role in the data collection and analysis and in the decision to publish. The funders played no role in the study design nor in the preparation of the manuscript.	Baroni G, 2013, J HYDROL, V489, P148, DOI 10.1016/j.jhydrol.2013.03.007; Baskan O, 2013, ENVIRON MONIT ASSESS, V185, P10441, DOI 10.1007/s10661-013-3343-8; BELL KR, 1980, WATER RESOUR RES, V16, P796, DOI 10.1029/WR016i004p00796; Bharati L, 2002, AGROFOREST SYST, V56, P249, DOI 10.1023/A:1021344807285; Brooks SM, 1997, J ENVIRON MANAGE, V49, P297, DOI 10.1006/jema.1996.0091; Calder I.R., 2007, NEW UNDERSTANDING FO; CHARPENTIER MA, 1992, J GEOPHYS RES-ATMOS, V97, P18987, DOI 10.1029/92JD00882; Chen HS, 2010, ENVIRON EARTH SCI, V61, P1105, DOI 10.1007/s12665-009-0428-3; Daly E, 2005, ENVIRON ENG SCI, V22, P9, DOI 10.1089/ees.2005.22.9; Duan L, 2011, HYDROL EARTH SYST SC, V8, P1895; Famiglietti JS, 1998, J HYDROL, V210, P259, DOI 10.1016/S0022-1694(98)00187-5; [高磊 Gao Lei], 2010, [冰川冻土, Journal of Glaciology and Geocryology], V32, P964; Garcia-Estringana P, 2013, ECOHYDROLOGY, V6, P741, DOI 10.1002/eco.1295; Hagyo A, 2006, BIOLOGIA, V61, pS261, DOI 10.2478/s11756-006-0169-7; Hai APH, 2012, GEODERMA, V177, P8, DOI 10.1016/j.geoderma.2012.01.031; HAWLEY ME, 1983, J HYDROL, V62, P179, DOI 10.1016/0022-1694(83)90102-6; Lakshmi V, 2003, HYDROL PROCESS, V17, P3041, DOI 10.1002/hyp.1275; [李慧星 LI Huixing], 2007, [河海大学学报. 自然科学版, Journal of Hohai University. Natural Sciences], V35, P172; Lull HW, 1955, 140 USDA SO EXPSTA; Peng HH, 2013, THESIS LANZHOU U GAN; Qiu Y, 2001, J HYDROL, V240, P243, DOI 10.1016/S0022-1694(00)00362-0; REYNOLDS S G, 1970, Journal of Hydrology (Amsterdam), V11, P288, DOI 10.1016/0022-1694(70)90068-5; Santamarta-Cerezal JC, 2012, NOT BOT HORTI AGROBO, V40, P9; Sharda VN, 2006, INT WORKSH IMP REF D; SKLASH MG, 1979, J HYDROL, V43, P45, DOI 10.1016/0022-1694(79)90164-1; Tyagi J. V., 2011, Journal of Forestry Research (Harbin), V22, P543, DOI 10.1007/s11676-011-0197-1; Vereecken H, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031813; [王根绪 Wang Genxu], 2003, [冰川冻土, Journal of Glaciology and Geocryology], V25, P653; Wang XY, 2014, POL J ENVIRON STUD, V23, P511; Zhao HL, 2006, CATENA, V65, P71, DOI 10.1016/j.catena.2005.10.001; Zhu FR, 2013, HUBEI AGR SCI, V1, P39	31	25	26	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0118964	10.1371/journal.pone.0118964	http://dx.doi.org/10.1371/journal.pone.0118964			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781333	Green Submitted, Green Published, gold			2022-12-27	WOS:000351284600039
J	Burin, D; Livelli, A; Garbarini, F; Fossataro, C; Folegatti, A; Gindri, P; Pia, L				Burin, Dalila; Livelli, Alessandro; Garbarini, Francesca; Fossataro, Carlotta; Folegatti, Alessia; Gindri, Patrizia; Pia, Lorenzo			Are Movements Necessary for the Sense of Body Ownership? Evidence from the Rubber Hand Illusion in Pure Hemiplegic Patients	PLOS ONE			English	Article							AROUSAL RESPONSES; UNAFFECTED LIMBS; STROKE PATIENTS; BODILY SELF; ANOSOGNOSIA; INTEGRATION; EMBODIMENT; STIMULATION; SENSITIVITY; POSITION	A question still debated within cognitive neuroscience is whether signals present during actions significantly contribute to the emergence of human's body ownership. In the present study, we aimed at answer this question by means of a neuropsychological approach. We administered the classical rubber hand illusion paradigm to a group of healthy participants and to a group of neurological patients affected by a complete left upper limb hemiplegia, but without any propriceptive/tactile deficits. The illusion strength was measured both subjectively (i.e., by a self-report questionnaire) and behaviorally (i.e., the location of one's own hand is shifted towards the rubber hand). We aimed at examining whether, and to which extent, an enduring absence of movements related signals affects body ownership. Our results showed that patients displayed, respect to healthy participants, stronger illusory effects when the left (affected) hand was stimulated and no effects when the right (unaffected) hand was stimulated. In other words, hemiplegics had a weaker/more flexible sense of body ownership for the affected hand, but an enhanced/more rigid one for the healthy hand. Possible interpretations of such asymmetrical distribution of body ownership, as well as limits of our results, are discussed. Broadly speaking, our findings suggest that the alteration of the normal flow of signals present during movements impacts on human's body ownership. This in turn, means that movements have a role per se in developing and maintaining a coherent body ownership.	[Burin, Dalila; Livelli, Alessandro; Garbarini, Francesca; Fossataro, Carlotta; Folegatti, Alessia; Gindri, Patrizia; Pia, Lorenzo] Univ Turin, Dept Psychol, SAMBA SpAtial Motor & Bodily Awareness Res Grp, Turin, Italy; [Pia, Lorenzo] NIT Neurosci Inst Turin, Turin, Italy; [Gindri, Patrizia] San Camillo Hosp, Turin, Italy	University of Turin	Pia, L (corresponding author), Univ Turin, Dept Psychol, SAMBA SpAtial Motor & Bodily Awareness Res Grp, Turin, Italy.	lorenzo.pia@unito.it	Pia, Lorenzo/R-5263-2016; Garbarini, Francesca/L-9350-2019; Burin, Dalila/U-8108-2019	Pia, Lorenzo/0000-0002-0360-3152; Garbarini, Francesca/0000-0003-1210-0175; Burin, Dalila/0000-0002-9884-7650; Fossataro, Carlotta/0000-0001-8145-006X	MASTER DEI TALENTI Scholarship	MASTER DEI TALENTI Scholarship	This work was supported by MASTER DEI TALENTI 2013 Scholarship to DB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo D, 2009, EXP BRAIN RES, V192, P87, DOI 10.1007/s00221-008-1560-0; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Botvinick M, 2004, SCIENCE, V305, P782, DOI 10.1126/science.1101836; Cocchini G, 2001, NEUROPSYCHOL REHABIL, V11, P17, DOI 10.1080/09602010042000132; Costantini M, 2007, CONSCIOUS COGN, V16, P229, DOI 10.1016/j.concog.2007.01.001; Desaphy JF, 2001, BRAIN, V124, P1100, DOI 10.1093/brain/124.6.1100; Diller L, 1977, Adv Neurol, V18, P63; Dummer T, 2009, PERCEPTION, V38, P271, DOI 10.1068/p5921; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Farne A, 2000, BRAIN, V123, P2350, DOI 10.1093/brain/123.11.2350; Fiorio M, 2011, BRAIN, V134, P1428, DOI 10.1093/brain/awr026; Gallagher S, 2000, TRENDS COGN SCI, V4, P14, DOI 10.1016/S1364-6613(99)01417-5; Gallese V, 2010, NEUROPSYCHOLOGIA, V48, P746, DOI 10.1016/j.neuropsychologia.2009.09.038; Garbarini F, 2014, CURR BIOL, V24, pR738, DOI 10.1016/j.cub.2014.07.023; Garbarini F, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00737; Garbarini F, 2013, J NEUROL NEUROSUR PS, V84, P416, DOI 10.1136/jnnp-2012-302838; Garbarini F, 2013, CURR BIOL, V23, pR57, DOI 10.1016/j.cub.2012.12.003; GUIARD Y, 1987, J MOTOR BEHAV, V19, P486; Head H, 1911, BRAIN, V34, P102, DOI 10.1093/brain/34.2-3.102; James W., 1890, PRINCIPLES PSYCHOL, V2, P283; Kalckert A, 2014, CONSCIOUS COGN, V26, P117, DOI 10.1016/j.concog.2014.02.003; Kalckert A, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00040; Kammers MPM, 2009, NEUROPSYCHOLOGIA, V47, P204, DOI 10.1016/j.neuropsychologia.2008.07.028; Lenggenhager B, 2007, SCIENCE, V317, P1096, DOI 10.1126/science.1143439; Longo MR, 2008, COGNITION, V107, P978, DOI 10.1016/j.cognition.2007.12.004; Longo MR, 2009, PERCEPTION, V38, P69, DOI 10.1068/p6045; Makin TR, 2008, BEHAV BRAIN RES, V191, P1, DOI 10.1016/j.bbr.2008.02.041; MEASSO G, 1993, DEV NEUROPSYCHOL, V9, P77, DOI 10.1080/87565649109540545; Merleau-Ponty M., 1962, PHENOMENOLOGY OF PER; Newport R, 2010, EXP BRAIN RES, V204, P385, DOI 10.1007/s00221-009-2104-y; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pia L, 2014, TRANSLATIONAL NEUROS, V5, P1, DOI DOI 10.2478/S13380-014-0227-5; Pia L, 2014, CORTEX, V61, P158, DOI 10.1016/j.cortex.2014.08.006; Pia L, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00298; Pia L, 2013, CORTEX, V49, P1694, DOI 10.1016/j.cortex.2012.08.017; Pia L, 2013, J NEUROPSYCHOL, V7, P45, DOI 10.1111/j.1748-6653.2012.02034.x; Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011; Riemer M, 2013, EXP BRAIN RES, V229, P383, DOI 10.1007/s00221-012-3374-3; Rognini G, 2013, EUR J NEUROSCI, V37, P1120, DOI 10.1111/ejn.12128; Romano D, 2014, BEHAV BRAIN RES, V261, P275, DOI 10.1016/j.bbr.2013.12.049; Romano D, 2013, RESTOR NEUROL NEUROS, V31, P373, DOI 10.3233/RNN-120273; Sato Y, 2005, J NEUROL SCI, V231, P13, DOI 10.1016/j.jns.2004.12.005; Sato Y, 1999, STROKE, V30, P414, DOI 10.1161/01.STR.30.2.414; Scandola M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00404; Slater M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010564; Spinazzola L., 2014, APPL PSYCHOLOG B, V62, P37; Tidoni E, 2014, RESTORATIVE NEUROLOG; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; Tsakiris M, 2006, CONSCIOUS COGN, V15, P423, DOI 10.1016/j.concog.2005.09.004; Tsakiris M, 2011, P ROY SOC B-BIOL SCI, V278, P2470, DOI 10.1098/rspb.2010.2547; Walsh LD, 2011, J PHYSIOL-LONDON, V589, P3009, DOI 10.1113/jphysiol.2011.204941; Wilson B., 1987, THE BEHAVIOURAL INAT; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Zanette G, 2004, CLIN NEUROPHYSIOL, V115, P1264, DOI 10.1016/j.clinph.2003.12.033	54	75	76	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0117155	10.1371/journal.pone.0117155	http://dx.doi.org/10.1371/journal.pone.0117155			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD6EY	25775041	Green Published, gold			2022-12-27	WOS:000351183500016
J	Chou, CL; Pang, CY; Lee, TJF; Fang, TC				Chou, Chu-Lin; Pang, Cheng-Yoong; Lee, Tony J. F.; Fang, Te-Chao			Beneficial Effects of Calcitriol on Hypertension, Glucose Intolerance, Impairment of Endothelium-Dependent Vascular Relaxation, and Visceral Adiposity in Fructose-Fed Hypertensive Rats	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; HYPERINSULINEMIA-INDUCED HYPERTENSION; VITAMIN-D DEFICIENCY; BLOOD-PRESSURE; 1,25-DIHYDROXYVITAMIN D-3; INSULIN-RESISTANCE; METABOLIC SYNDROME; RECEPTOR; INCREASES; CALCIUM	Besides regulating calcium homeostasis, the effects of vitamin D on vascular tone and metabolic disturbances remain scarce in the literature despite an increase intake with high-fructose corn syrup worldwide. We investigated the effects of calcitriol, an active form of vitamin D, on vascular relaxation, glucose tolerance, and visceral fat pads in fructose-fed rats. Male Wistar-Kyoto rats were divided into 4 groups (n = 6 per group). Group Con: standard chow diet for 8 weeks; Group Fru: high-fructose diet (60% fructose) for 8 weeks; Group Fru-HVD: high-fructose diet as Group Fru, high-dose calcitriol treatment (20 ng/100 g body weight per day) 4 weeks after the beginning of fructose feeding; and Group Fru-LVD: high-fructose diet as Group Fru, low-dose calcitriol treatment (10 ng/100 g body weight per day) 4 weeks after the beginning of fructose feeding. Systolic blood pressure was measured twice a week by the tail-cuff method. Blood was examined for serum ionized calcium, phosphate, creatinine, glucose, triglycerides, and total cholesterol. Intra-peritoneal glucose intolerance test, aortic vascular reactivity, the weight of visceral fat pads, adipose size, and adipose angiotensin II levels were analyzed at the end of the study. The results showed that the fructose-fed rats significantly developed hypertension, impaired glucose tolerance, heavier weight and larger adipose size of visceral fat pads, and raised adipose angiotensin II expressions compared with the control rats. High-and low-dose calcitriol reduced modestly systolic blood pressure, increased endothelium-dependent aortic relaxation, ameliorated glucose intolerance, reduced the weight and adipose size of visceral fat pads, and lowered adipose angiotensin II expressions in the fructose-fed rats. However, high-dose calcitriol treatment mildly increased serum ionized calcium levels (1.44 +/- 0.05 mmol/L). These results suggest a protective role of calcitriol treatment on endothelial function, glucose tolerance, and visceral adiposity in fructose-fed rats.	[Chou, Chu-Lin; Pang, Cheng-Yoong] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Lee, Tony J. F.] Tzu Chi Univ, Inst Life Sci Pharmacol & Toxicol & Med Sci, Hualien, Taiwan; [Lee, Tony J. F.] So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA; [Fang, Te-Chao] Taipei Med Univ, Wan Fang Hosp, Dept Internal Med, Div Nephrol, Taipei, Taiwan; [Fang, Te-Chao] Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei, Taiwan	Tzu Chi University; Tzu Chi University; Southern Illinois University System; Southern Illinois University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University	Fang, TC (corresponding author), Taipei Med Univ, Wan Fang Hosp, Dept Internal Med, Div Nephrol, Taipei, Taiwan.	fangtechao@yahoo.com.tw	Pang, Cheng-Yoong/AFO-1562-2022; Pang, Cheng-Yoong/R-4990-2019	Pang, Cheng-Yoong/0000-0002-9063-2858; Chou, Chu-Lin/0000-0002-9695-1067	Tzu Chi General Hospital, Hualien, Taiwan [TCRD 102-50]	Tzu Chi General Hospital, Hualien, Taiwan	This study was supported by a grant from Tzu Chi General Hospital (TCRD 102-50), Hualien, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arunabh S, 2003, J CLIN ENDOCR METAB, V88, P157, DOI 10.1210/jc.2002-020978; Atchison DK, 2013, AM J PHYSIOL-RENAL, V305, pF1109, DOI 10.1152/ajprenal.00010.2013; Bas A, 2006, J BONE MINER RES, V21, P484, DOI 10.1359/JBMR.051211; Baz-Hecht M, 2010, CURR OPIN ENDOCRINOL, V17, P113, DOI 10.1097/MED.0b013e3283372859; Boucher BJ, 2011, CURR DRUG TARGETS, V12, P61; Cheng Q, 2011, DIABETOLOGIA, V54, P2077, DOI 10.1007/s00125-011-2100-1; Chou CL, 2013, HYPERTENS RES, V36, P123, DOI 10.1038/hr.2012.124; Chou CL, 2011, ARCH MED SCI, V7, P882, DOI 10.5114/aoms.2011.25566; de Boer IH, 2008, CURR OPIN NEPHROL HY, V17, P566, DOI 10.1097/MNH.0b013e32830fe377; Dong JH, 2012, EUR HEART J, V33, P2980, DOI 10.1093/eurheartj/ehr459; Douard V, 2013, AM J PHYSIOL-ENDOC M, V304, pE1303, DOI 10.1152/ajpendo.00582.2012; Fang TC, 1998, HYPERTENSION, V32, P235, DOI 10.1161/01.HYP.32.2.235; Fang TC, 1998, J HYPERTENS, V16, P1767, DOI 10.1097/00004872-199816120-00009; Freundlich M, 2008, KIDNEY INT, V74, P1394, DOI 10.1038/ki.2008.408; Frigolet ME, 2013, J NUTR BIOCHEM, V24, P2003, DOI 10.1016/j.jnutbio.2013.07.002; Furuhashi M, 2004, J HYPERTENS, V22, P1977, DOI 10.1097/00004872-200410000-00021; Ghiadoni L, 2012, CURR VASC PHARMACOL, V10, P42, DOI 10.2174/157016112798829823; Giacchetti G, 2000, J HYPERTENS, V18, P695, DOI 10.1097/00004872-200018060-00006; Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174; Goltzman D, 2010, ANN NY ACAD SCI, V1192, P145, DOI 10.1111/j.1749-6632.2009.05226.x; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Huang BW, 2004, DIABETES OBES METAB, V6, P120, DOI 10.1111/j.1462-8902.2004.00323.x; HWANG IS, 1989, AM J HYPERTENS, V2, P424, DOI 10.1093/ajh/2.6.424; HWANG IS, 1987, HYPERTENSION, V10, P512, DOI 10.1161/01.HYP.10.5.512; Ikeda A, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/863410; Johnson RJ, 2007, AM J CLIN NUTR, V86, P899; Kinzig KP, 2010, ENDOCRINOLOGY, V151, P3105, DOI 10.1210/en.2010-0175; KOBAYASHI R, 1993, HYPERTENSION, V21, P1051, DOI 10.1161/01.HYP.21.6.1051; Lastra G, 2008, AM J PHYSIOL-ENDOC M, V295, pE110, DOI 10.1152/ajpendo.00258.2007; Lin HW, 2008, P NATL ACAD SCI USA, V105, P19526, DOI 10.1073/pnas.0810262105; Maestro B, 2000, ENDOCR J, V47, P383, DOI 10.1507/endocrj.47.383; Mancuso P, 2008, J CARDIOVASC PHARM, V51, P559, DOI 10.1097/FJC.0b013e3181761906; Maurer AD, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-77; Mellanby E, 1919, LANCET, V1, P407; Min LJ, 2014, AM J HYPERTENS, V27, P1036, DOI 10.1093/ajh/hpu015; Mitri J, 2011, EUR J CLIN NUTR, V65, P1005, DOI 10.1038/ejcn.2011.118; MORTENSEN JT, 1993, PHARMACOL TOXICOL, V72, P124, DOI 10.1111/j.1600-0773.1993.tb00302.x; Nagai Y, 2009, EXP PHYSIOL, V94, P1016, DOI 10.1113/expphysiol.2009.048108; Nakagawa T, 2006, AM J PHYSIOL-RENAL, V290, pF625, DOI 10.1152/ajprenal.00140.2005; Osaki A, 2014, HYPERTENS RES, V37, P185, DOI 10.1038/hr.2013.122; Parikh SJ, 2004, J CLIN ENDOCR METAB, V89, P1196, DOI 10.1210/jc.2003-031398; Pilz S, 2009, NAT REV CARDIOL, V6, P621, DOI 10.1038/nrcardio.2009.135; Pittas AG, 2010, ANN INTERN MED, V152, P307, DOI 10.7326/0003-4819-152-5-201003020-00009; Reungjui S, 2007, J AM SOC NEPHROL, V18, P2724, DOI 10.1681/ASN.2007040416; Saito H, 2014, J STEROID BIOCHEM, V144, P189, DOI 10.1016/j.jsbmb.2013.11.013; Saito H, 2013, J STEROID BIOCHEM, V136, P178, DOI 10.1016/j.jsbmb.2012.10.004; Schulz E, 2011, HYPERTENS RES, V34, P665, DOI 10.1038/hr.2011.39; Sergeev IN, 2014, MOL NUTR FOOD RES, V58, P1342, DOI 10.1002/mnfr.201300503; Soares MJ, 2011, EUR J CLIN NUTR, V65, P994, DOI 10.1038/ejcn.2011.106; Strahorn P, 2005, J HYPERTENS, V23, P2179, DOI 10.1097/01.hjh.0000191904.26853.b8; Stucchi P, 2009, BRIT J PHARMACOL, V158, P771, DOI 10.1111/j.1476-5381.2009.00355.x; Takiishi T, 2010, ENDOCRIN METAB CLIN, V39, P419, DOI 10.1016/j.ecl.2010.02.013; Tamez H, 2012, CURR OPIN NEPHROL HY, V21, P492, DOI 10.1097/MNH.0b013e3283557bf0; Vieth R, 1999, AM J CLIN NUTR, V69, P842; Vieth R, 2007, J BONE MINER RES, V22, pV64, DOI 10.1359/JBMR.07S221; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Witham MD, 2009, J HYPERTENS, V27, P1948, DOI 10.1097/HJH.0b013e32832f075b; Wong MSK, 2008, AM J PHYSIOL-HEART C, V295, pH289, DOI 10.1152/ajpheart.00116.2008; Wong MSK, 2010, AM J PHYSIOL-HEART C, V299, pH1226, DOI 10.1152/ajpheart.00288.2010; Wu K, 2010, ENDOCRINOLOGY, V151, P3566, DOI 10.1210/en.2010-0204; Wu LY, 2004, EUR J NUTR, V43, P116, DOI 10.1007/s00394-004-0450-x; Yen TH, 2013, LUPUS, V22, P180, DOI 10.1177/0961203312471871; Yuan WH, 2007, J BIOL CHEM, V282, P29821, DOI 10.1074/jbc.M705495200; Zebger-Gong H, 2011, J HYPERTENS, V29, P339, DOI 10.1097/HJH.0b013e328340aa30; Zhou CL, 2008, KIDNEY INT, V74, P170, DOI 10.1038/ki.2008.101; Zittermann A, 2007, CURR OPIN LIPIDOL, V18, P41, DOI 10.1097/MOL.0b013e328011c6fc	67	9	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119843	10.1371/journal.pone.0119843	http://dx.doi.org/10.1371/journal.pone.0119843			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774877	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500132
J	Schreiner, B; Ingold-Heppner, B; Pehl, D; Locatelli, G; Berrit-SchNthaler, H; Becher, B				Schreiner, Bettina; Ingold-Heppner, Barbara; Pehl, Debora; Locatelli, Giuseppe; BerritSch Nthaler, Helia; Becher, Burkhard			Deletion of Jun Proteins in Adult Oligodendrocytes Does Not Perturb Cell Survival, or Myelin Maintenance In Vivo	PLOS ONE			English	Article							C-JUN; AXONAL REGENERATION; TRANSCRIPTION FACTORS; MULTIPLE-SCLEROSIS; MOUSE DEVELOPMENT; SCHWANN-CELLS; INDUCED DEATH; KAPPA-B; AP-1; ACTIVATION	Oligodendrocytes, the myelin-forming glial cells of the central nervous system (CNS), are fundamental players in rapid impulse conduction and normal axonal functions. JunB and c-Jun are DNA-binding components of the AP-1 transcription factor, which is known to regulate different processes such as proliferation, differentiation, stress responses and death in several cell types, including cultured oligodendrocyte/lineage cells. By selectively inactivating Jun B and c-Jun in myelinating oligodendrocytes in vivo, we generated mutant mice that developed normally, and within more than 12 months showed normal ageing and survival rates. In the adult CNS, absence of JunB and c-Jun from mature oligodendrocytes caused low-grade glial activation without overt signs of demyelination or secondary leukocyte infiltration into the brain. Even after exposure to toxic or autoimmune oligodendrocyte insults, signs of altered oligodendrocyte viability were mild and detectable only upon cuprizone treatment. We conclude that JunB and c-Jun expression in post-mitotic oligodendrocytes is mostly dispensable for the maintainance of white matter tracts throughout adult life, even under demyelinating conditions.	[Schreiner, Bettina; Locatelli, Giuseppe; Becher, Burkhard] Univ Zurich, Inst Expt Immunol, CH-8091 Zurich, Switzerland; [Schreiner, Bettina] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; [Ingold-Heppner, Barbara] Charite, Inst Pathol, D-13353 Berlin, Germany; [Pehl, Debora] Charite, Inst Neuropathol, D-13353 Berlin, Germany; [Locatelli, Giuseppe] LMU Univ Munchen, Inst Clin Neuroimmunol, Munich, Germany; [BerritSch Nthaler, Helia] Spanish Natl Canc Res Ctr, Madrid, Spain	University of Zurich; University of Zurich; University Zurich Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munich; Centro Nacional de Investigaciones Oncologicas (CNIO)	Becher, B (corresponding author), Univ Zurich, Inst Expt Immunol, Sternwartstr 2, CH-8091 Zurich, Switzerland.	becher@immunology.uzh.ch	Becher, Burkhard/ABE-4225-2020	Becher, Burkhard/0000-0002-1541-7867; Locatelli, Giuseppe/0000-0002-2179-4407	Swiss National Science Foundation [316030_150768, 310030_146130, CRSII3_136203, SPUM 33CM30-124111/1]; European Union; university research priority project translational cancer research; Stiftung fur Forschung an der Medizinischen Fakultat	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union(European Commission); university research priority project translational cancer research; Stiftung fur Forschung an der Medizinischen Fakultat	This study was supported by grants from the Swiss National Science Foundation (316030_150768 (BB), 310030_146130 (BB), CRSII3_136203 (BB) and SPUM 33CM30-124111/1 (BB, BS)), European Union FP7 project TargetBraIn, NeuroKine and ATECT (BB), the university research priority project translational cancer research (BB) and "Stiftung fur Forschung an der Medizinischen Fakultat" (BS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong RC, 2006, J NEUROPATH EXP NEUR, V65, P245, DOI 10.1097/01.jnen.0000205142.08716.7e; Arthur-Farraj PJ, 2012, NEURON, V75, P633, DOI 10.1016/j.neuron.2012.06.021; Barnett SC, 1995, DEVELOPMENT, V121, P3969; Behrens A, 2002, EMBO J, V21, P1782, DOI 10.1093/emboj/21.7.1782; Bonetti B, 1999, AM J PATHOL, V155, P1433, DOI 10.1016/S0002-9440(10)65456-9; Bradl M, 2010, ACTA NEUROPATHOL, V119, P37, DOI 10.1007/s00401-009-0601-5; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; FitzGerald UF, 2000, MOL CELL NEUROSCI, V16, P453, DOI 10.1006/mcne.2000.0886; FitzGerald UF, 2003, MOL CELL NEUROSCI, V22, P516, DOI 10.1016/S1044-7431(02)00040-4; Fontana X, 2012, J CELL BIOL, V198, P127, DOI 10.1083/jcb.201205025; HILBERG F, 1993, NATURE, V365, P179, DOI 10.1038/365179a0; Hiremath MM, 1998, J NEUROIMMUNOL, V92, P38, DOI 10.1016/S0165-5728(98)00168-4; Hovelmeyer N, 2005, J IMMUNOL, V175, P5875, DOI 10.4049/jimmunol.175.9.5875; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; JOHNSON RS, 1993, GENE DEV, V7, P1309, DOI 10.1101/gad.7.7b.1309; Jurewicz A, 2006, GLIA, V53, P158, DOI 10.1002/glia.20249; Jurewicz A, 2003, BRAIN, V126, P1358, DOI 10.1093/brain/awg146; KALLUNKI T, 1994, GENE DEV, V8, P2996, DOI 10.1101/gad.8.24.2996; Kenner L, 2004, J CELL BIOL, V164, P613, DOI 10.1083/jcb.200308155; Kipp M, 2009, ACTA NEUROPATHOL, V118, P723, DOI 10.1007/s00401-009-0591-3; Ladiwala U, 1998, J NEUROSCI, V18, P1297; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; MATTHIEU JM, 1990, DEV NEUROSCI-BASEL, V12, P293, DOI 10.1159/000111858; Mechta-Grigoriou F, 2001, ONCOGENE, V20, P2378, DOI 10.1038/sj.onc.1204381; PHAMDINH D, 1993, P NATL ACAD SCI USA, V90, P7990, DOI 10.1073/pnas.90.17.7990; Raivich G, 2004, NEURON, V43, P57, DOI 10.1016/j.neuron.2004.06.005; Ransohoff RM, 2012, NAT NEUROSCI, V15, P1074, DOI 10.1038/nn.3168; Ruff CA, 2012, J NEUROCHEM, V121, P607, DOI 10.1111/j.1471-4159.2012.07706.x; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Solly SK, 1996, GLIA, V18, P39, DOI 10.1002/(SICI)1098-1136(199609)18:1<39::AID-GLIA4>3.3.CO;2-T; Vollgraf U, 1999, J NEUROCHEM, V73, P2501, DOI 10.1046/j.1471-4159.1999.0732501.x; WAGNER T, 1977, EXP CELL RES, V107, P1, DOI 10.1016/0014-4827(77)90379-2; Yoon SO, 1998, J NEUROSCI, V18, P3273; Zenz R, 2005, NATURE, V437, P369, DOI 10.1038/nature03963; Zhang PS, 1996, J NEUROSCI RES, V46, P114, DOI 10.1002/(SICI)1097-4547(19961001)46:1<114::AID-JNR14>3.0.CO;2-5	35	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120454	10.1371/journal.pone.0120454	http://dx.doi.org/10.1371/journal.pone.0120454			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774663	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000351183500175
J	Singh, N; Mishra, RK				Singh, Niharika; Mishra, Ramesh Kumar			Unintentional Activation of Translation Equivalents in Bilinguals Leads to Attention Capture in a Cross-Modal Visual Task	PLOS ONE			English	Article							EYE-MOVEMENTS; IRRELEVANT SPEECH; DIFFERENT SCRIPTS; WORD RECOGNITION; TIME-COURSE; LANGUAGE; 2ND-LANGUAGE; REPRESENTATION; MECHANISMS; FIXATION	Using a variant of the visual world eye tracking paradigm, we examined if language non-selective activation of translation equivalents leads to attention capture and distraction in a visual task in bilinguals. High and low proficient Hindi-English speaking bilinguals were instructed to programme a saccade towards a line drawing which changed colour among other distractor objects. A spoken word, irrelevant to the main task, was presented before the colour change. On critical trials, one of the line drawings was a phonologically related word of the translation equivalent of the spoken word. Results showed that saccade latency was significantly higher towards the target in the presence of this cross-linguistic translation competitor compared to when the display contained completely unrelated objects. Participants were also slower when the display contained the referent of the spoken word among the distractors. However, the bilingual groups did not differ with regard to the interference effect observed. These findings suggest that spoken words activates translation equivalent which bias attention leading to interference in goal directed action in the visual domain.	[Singh, Niharika; Mishra, Ramesh Kumar] Univ Allahabad, Ctr Behav & Cognit Sci, Allahabad 211002, Uttar Pradesh, India; [Mishra, Ramesh Kumar] Univ Hyderabad, Ctr Neural & Cognit Sci, Hyderabad 500134, Andhra Pradesh, India	University of Allahabad; University of Hyderabad	Mishra, RK (corresponding author), Univ Allahabad, Ctr Behav & Cognit Sci, Allahabad 211002, Uttar Pradesh, India.	rkmishra@uohyd.ac.in	SINGH, NIHARIKA/GQH-0296-2022		Department of Science and Technology, Government of India	Department of Science and Technology, Government of India(Department of Science & Technology (India))	The study was funded by Department of Science and Technology, Government of India to RKM. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allopenna PD, 1998, J MEM LANG, V38, P419, DOI 10.1006/jmla.1997.2558; Altmann G. T. M., 2011, OXFORD HDB EYE MOVEM, P979; Bertels J, 2011, J COGN PSYCHOL, V23, P435, DOI 10.1080/20445911.2011.535513; Blumenfeld H. K., 2007, LANG COGNITIVE PROC, V22, P633, DOI 10.1080/01690960601000746; Blumenfeld HK, 2014, BILING-LANG COGN, V17, P610, DOI 10.1017/S1366728913000564; Cleland AA, 2012, LANG COGNITIVE PROC, V27, P572, DOI 10.1080/01690965.2011.564942; COOPER RM, 1974, COGNITIVE PSYCHOL, V6, P84, DOI 10.1016/0010-0285(74)90005-X; Costa A, 2000, J EXP PSYCHOL LEARN, V26, P1283, DOI 10.1037//0278-7393.26.5.1283; Costa A, 2006, J EXP PSYCHOL LEARN, V32, P1057, DOI 10.1037/0278-7393.32.5.1057; de Groot AMB, 2000, Q J EXP PSYCHOL-A, V53, P397, DOI 10.1080/713755891; DEGROOT AMB, 1991, J MEM LANG, V30, P90, DOI 10.1016/0749-596X(91)90012-9; Dijkstra T, 2000, J MEM LANG, V42, P445, DOI 10.1006/jmla.1999.2697; Dimitropoulou M, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00188; Duyck W, 2005, J EXP PSYCHOL LEARN, V31, P1340, DOI 10.1037/0278-7393.31.6.1340; Elliott EM, 2012, ACTA PSYCHOL, V140, P64, DOI 10.1016/j.actpsy.2012.02.009; Gollan TH, 1997, J EXP PSYCHOL LEARN, V23, P1122, DOI 10.1037/0278-7393.23.5.1122; Grainger J, 1998, LANG COGNITIVE PROC, V13, P601, DOI 10.1080/016909698386393; Guo TM, 2012, J EXP PSYCHOL LEARN, V38, P1165, DOI 10.1037/a0028076; Hermans D., 1998, BILING-LANG COGN, V1, P213, DOI [10.1017/S1366728998000364, DOI 10.1017/S1366728998000364]; Huettig F, 2005, COGNITION, V96, pB23, DOI 10.1016/j.cognition.2004.10.003; Huettig F, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2011.00394; Ju M, 2004, PSYCHOL SCI, V15, P314, DOI 10.1111/j.0956-7976.2004.00675.x; KROLL JF, 1994, J MEM LANG, V33, P149, DOI 10.1006/jmla.1994.1008; Kroll JF, 2010, BILING-LANG COGN, V13, P373, DOI 10.1017/S136672891000009X; Lagrou E, 2011, J EXP PSYCHOL LEARN, V37, P952, DOI 10.1037/a0023217; LeCompte DC, 1997, J EXP PSYCHOL LEARN, V23, P472, DOI 10.1037/0278-7393.23.2.472; Lemhofer K, 2012, BEHAV RES METHODS, V44, P325, DOI 10.3758/s13428-011-0146-0; Lupyan G, 2011, QUARTERLY JOURNAL OF, P1; Marian V, 2003, BRAIN LANG, V86, P70, DOI 10.1016/S0093-934X(02)00535-7; Marian V, 2003, APPL PSYCHOLINGUIST, V24, P173, DOI 10.1017/S0142716403000092; Marian V, DIFFERENTIAL RECRUIT; Marian V., 2003, BILING-LANG COGN, V6, P97, DOI DOI 10.1017/S1366728903001068; Marian V, 2008, J PSYCHOLINGUIST RES, V37, P141, DOI 10.1007/s10936-007-9064-9; Mishra RK, 2009, PROG BRAIN RES, V176, P277, DOI 10.1016/S0079-6123(09)17616-1; Mishra RK, 2012, PROGRESS IN BRAIN RE, V212; Mishra RK, 2013, READ WRIT, V27, P129; Salverda AP, 2011, J EXP PSYCHOL HUMAN, V37, P1122, DOI 10.1037/a0023101; Salverda AP, 2011, ACTA PSYCHOL, V137, P172, DOI 10.1016/j.actpsy.2010.09.010; Schoonbaert S, 2007, J MEM LANG, V56, P153, DOI 10.1016/j.jml.2006.10.002; Shook A, 2013, BILING-LANG COGN, V16, P304, DOI 10.1017/S1366728912000466; Sunderman G, 2006, STUD SECOND LANG ACQ, V28, P387, DOI 10.1017/S0272263106060177; Sunderman GL, 2012, LANG COGNITIVE PROC, V27, P1265, DOI 10.1080/01690965.2011.596420; Weber A, 2004, J MEM LANG, V50, P1, DOI 10.1016/S0749-596X(03)00105-0; Wu YJ, 2013, COGNITION, V129, P418, DOI 10.1016/j.cognition.2013.08.005; Wu YJ, 2012, J NEUROSCI, V32, P6485, DOI 10.1523/JNEUROSCI.6119-11.2012; Wu YJ, 2010, J NEUROSCI, V30, P7646, DOI 10.1523/JNEUROSCI.1602-10.2010; Yee E, 2006, J EXP PSYCHOL LEARN, V32, P1, DOI 10.1037/0278-7393.32.1.1; Zeelenberg R, 2010, COGNITION, V115, P202, DOI 10.1016/j.cognition.2009.12.004; Zhang TL, 2011, PSYCHOL SCI, V22, P1237, DOI 10.1177/0956797611421492	49	6	6	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120131	10.1371/journal.pone.0120131	http://dx.doi.org/10.1371/journal.pone.0120131			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD6EY	25775184	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500152
J	Hale, M; Itani, F; Buchta, CM; Wald, G; Bing, M; Norian, LA				Hale, Malika; Itani, Farah; Buchta, Claire M.; Wald, Gal; Bing, Megan; Norian, Lyse A.			Obesity Triggers Enhanced MDSC Accumulation in Murine Renal Tumors via Elevated Local Production of CCL2	PLOS ONE			English	Article							MYELOID SUPPRESSOR-CELLS; ADIPOSE-TISSUE; INSULIN-RESISTANCE; VISCERAL OBESITY; IMMUNE-RESPONSE; INFLAMMATION; CANCER; CARCINOMA; RISK; ARGINASE	Obesity is one of the leading risk factors for developing renal cell carcinoma, an immunogenic tumor that is treated clinically with immunostimulatory therapies. Currently, however, the mechanisms linking obesity with renal cancer incidence are unclear. Using a model of diet-induced obesity, we found that obese BALB/c mice with orthotopic renal tumors had increased total frequencies of myeloid-derived suppressor cells (MDSC) in renal tumors and spleens by d14 post-tumor challenge, relative to lean counterparts. Renal tumors from obese mice had elevated concentrations of the known myeloid cell chemoattractant CCL2, which was produced locally by increased percentages of dendritic cells, macrophages, B cells, and CD45(-) cells in tumors. MDSC expression of the CCL2 receptor, CCR2, was unaltered by obesity but greater percentages of CCR2(+) MDSCs were present in renal tumors from obese mice. Of note, the intracellular arginase levels and per-cell suppressive capacities of tumor-infiltrating and splenic MDSCs were unchanged in obese mice relative to lean controls. Thus, our findings suggest that obesity promotes renal tumor progression via development of a robust immunosuppressive environment that is characterized by heightened local and systemic MDSC prevalence. Targeted intervention of the CCL2/CCR2 pathway may facilitate immune-mediated renal tumor clearance in the obese.	[Hale, Malika; Buchta, Claire M.; Wald, Gal; Bing, Megan; Norian, Lyse A.] Univ Iowa, Dept Urol, Iowa City, IA 52242 USA; [Itani, Farah; Norian, Lyse A.] Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA USA; [Norian, Lyse A.] Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA; [Norian, Lyse A.] Univ Iowa, Fraternal Order Eagles Diabet Res Ctr, Iowa City, IA USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa	Norian, LA (corresponding author), Univ Iowa, Dept Urol, Iowa City, IA 52242 USA.	lyse-norian@uiowa.edu		Norian, Lyse/0000-0003-1016-313X; Hale, Malika/0000-0002-0822-7141	National Cancer Institute [1 R01 CA181088-01]; University of Iowa Flow Cytometry Core Facility: National Cancer Institute Award [P30CA086862]; American Cancer Society; NATIONAL CANCER INSTITUTE [R01CA181088, P30CA086862] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Iowa Flow Cytometry Core Facility: National Cancer Institute Award; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	LAN: American Cancer Society Seed Grant administered through the Holden Comprehensive Cancer Center at the University of Iowa (http://www.cancer.org/); National Cancer Institute #1 R01 CA181088-01 (www.cancer.gov/) and University of Iowa Flow Cytometry Core Facility: National Cancer Institute Award #P30CA086862 (www.cancer.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allavena P, 2008, CURR OPIN GENET DEV, V18, P3, DOI 10.1016/j.gde.2008.01.003; Arendt LM, 2013, CANCER RES, V73, P6080, DOI 10.1158/0008-5472.CAN-13-0926; Bunt SK, 2006, J IMMUNOL, V176, P284, DOI 10.4049/jimmunol.176.1.284; Catalan V, 2007, OBES SURG, V17, P1464, DOI 10.1007/s11695-008-9424-z; Chehval V, 2014, IMMUNOL RES, V59, P211, DOI 10.1007/s12026-014-8533-0; Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46; Colli JL, 2009, UROLOGY, V73, P431, DOI 10.1016/j.urology.2008.06.044; Daurkin I, 2011, CANCER RES, V71, P6400, DOI 10.1158/0008-5472.CAN-11-1261; Edwards BK, 2014, CANCER-AM CANCER SOC, V120, P1290, DOI 10.1002/cncr.28509; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gilbert CA, 2013, ANNU REV MED, V64, P45, DOI 10.1146/annurev-med-121211-091527; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hanson HL, 2000, IMMUNITY, V13, P265, DOI 10.1016/S1074-7613(00)00026-1; Huang B, 2007, CANCER LETT, V252, P86, DOI 10.1016/j.canlet.2006.12.012; Huber J, 2008, J CLIN ENDOCR METAB, V93, P3215, DOI 10.1210/jc.2007-2630; James BR, 2014, CANCER IMMUNOL IMMUN, V63, P1213, DOI 10.1007/s00262-014-1598-8; James BR, 2012, J IMMUNOL, V189, P1311, DOI 10.4049/jimmunol.1100587; Jensen HK, 2009, J CLIN ONCOL, V27, P4709, DOI 10.1200/JCO.2008.18.9498; Jung JI, 2015, INT J CANCER, V136, P258, DOI 10.1002/ijc.28983; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Ladoire S, 2011, ONCOLOGIST, V16, P71, DOI 10.1634/theoncologist.2010-0227; Lukesova S, 2008, FOLIA BIOL-PRAGUE, V54, P134; Naya Y, 2010, UROL INT, V85, P30, DOI 10.1159/000318988; Norian LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031085; Norian LA, 2009, CANCER RES, V69, P3086, DOI 10.1158/0008-5472.CAN-08-2826; Ochoa AC, 2007, CLIN CANCER RES, V13, p721S, DOI 10.1158/1078-0432.CCR-06-2197; Okwan-Duodu D, 2013, AM J CANCER RES, V3, P21; Panee J, 2012, CYTOKINE, V60, P1, DOI 10.1016/j.cyto.2012.06.018; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Rodriguez PC, 2009, CANCER RES, V69, P1553, DOI 10.1158/0008-5472.CAN-08-1921; SAYERS TJ, 1990, CANCER RES, V50, P5414; Schlecker E, 2012, J IMMUNOL, V189, P5602, DOI 10.4049/jimmunol.1201018; Sejima T, 2013, UROL ONCOL-SEMIN ORI, V31, P1343, DOI 10.1016/j.urolonc.2011.09.008; Steffens S, 2011, ONCOLOGIST, V16, P1565, DOI 10.1634/theoncologist.2011-0213; Tateya S, 2010, ENDOCRINOLOGY, V151, P971, DOI 10.1210/en.2009-0926; Tu S, 2008, CANCER CELL, V14, P408, DOI 10.1016/j.ccr.2008.10.011; Vincent J, 2010, CANCER RES, V70, P3052, DOI 10.1158/0008-5472.CAN-09-3690; Wald G, 2014, UROL ONCOL-SEMIN ORI, V32, P589, DOI 10.1016/j.urolonc.2014.01.023; Walter S, 2012, NAT MED, V18, P1254, DOI 10.1038/nm.2883; Wang FR, 2014, INT J CANCER, V135, P1673, DOI 10.1002/ijc.28813; Xia S, 2011, J BIOL CHEM, V286, P23591, DOI 10.1074/jbc.M111.237123; Youn JI, 2012, J LEUKOCYTE BIOL, V91, P167, DOI 10.1189/jlb.0311177; Zea AH, 2005, CANCER RES, V65, P3044, DOI 10.1158/0008-5472.CAN-04-4505; Zhu Y, 2013, J UROLOGY, V189, P447, DOI 10.1016/j.juro.2012.09.030	45	46	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118784	10.1371/journal.pone.0118784	http://dx.doi.org/10.1371/journal.pone.0118784			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25769110	Green Published, gold, Green Submitted			2022-12-27	WOS:000351277500043
J	Choi, YJ; Kim, SY; So, KS; Baek, IJ; Kim, WS; Choi, SH; Lee, JC; Bivona, TG; Rho, JK; Choi, CM				Choi, Yun Jung; Kim, Seon Ye; So, Kwang Sup; Baek, In-Jeoung; Kim, Woo Sung; Choi, Se Hoon; Lee, Jae Cheol; Bivona, Trever G.; Rho, Jin Kyung; Choi, Chang-Min			AUY922 Effectively Overcomes MET- and AXL-Mediated Resistance to EGFR-TKI in Lung Cancer Cells	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; PROTEIN 90 INHIBITOR; HSP90 INHIBITOR; ACQUIRED-RESISTANCE; TUMOR-GROWTH; CYCLE ARREST; MULTIPLE-MYELOMA; MUTATIONS; METASTASIS; GEFITINIB	The activation of bypass signals, such as MET and AXL, has been identified as a possible mechanism of EGFR-TKI resistance. Because various oncoproteins depend on HSP90 for maturation and stability, we investigated the effects of AUY922, a newly developed nongeldanamycin class HSP90 inhibitor, in lung cancer cells with MET-and AXL-mediated resistance. We established resistant cell lines with HCC827 cells harboring an exon 19-deletion mutation in of the EGFR gene via long-term exposure to increasing concentrations of gefitinib and erlotinib (HCC827/GR and HCC827/ER, respectively). HCC827/GR resistance was mediated by MET activation, whereas AXL activation caused resistance in HCC827/ER cells. AUY922 treatment effectively suppressed proliferation and induced cell death in both resistant cell lines. Accordingly, the downregulation of EGFR, MET, and AXL led to decreased Akt activation. The inhibitory effects of AUY922 on each receptor were confirmed in gene-transfected LK2 cells. AUY922 also effectively controlled tumor growth in xenograft mouse models containing HCC827/GR and HCC827/ER cells. In addition, AUY922 reduced invasion and migration by both types of resistant cells. Our study findings thus show that AUY922 is a promising therapeutic option for MET-and AXL-mediated resistance to EGFR-TKI in lung cancer.	[Choi, Yun Jung; Kim, Seon Ye; So, Kwang Sup; Kim, Woo Sung; Rho, Jin Kyung; Choi, Chang-Min] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pulmonol & Crit Care Med, Seoul, South Korea; [Choi, Yun Jung; Baek, In-Jeoung; Rho, Jin Kyung] Univ Ulsan, Coll Med, Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea; [Choi, Se Hoon] Univ Ulsan, Coll Med, Asan Med Ctr, Thorac & Cardiovasc Surg, Seoul, South Korea; [Lee, Jae Cheol; Choi, Chang-Min] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea; [Bivona, Trever G.] Univ Calif San Francisco, Helen Diller Comprehens Canc Ctr, Div Hematol Oncol, San Francisco, CA 94143 USA	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Rho, JK (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pulmonol & Crit Care Med, Seoul, South Korea.	jkrho@amc.seoul.kr; ccm@amc.seoul.kr	Lee, Jae Cheol/AAA-2678-2021	Baek, In-Jeoung/0000-0002-0641-7208	National Research Foundation of Korea (NRF) [2013R1A1A2005112]; Asan Institute for Life Sciences [2014-597]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Asan Institute for Life Sciences	J.K. Rho had been awarded a grant of the National Research Foundation of Korea (NRF, 2013R1A1A2005112) and S.H. Choi had been awarded a grant of the Asan Institute for Life Sciences (2014-597). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao RD, 2009, CLIN CANCER RES, V15, P4046, DOI 10.1158/1078-0432.CCR-09-0152; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; CARMICHAEL J, 1987, CANCER RES, V47, P943; Engelman JA, 2007, CANCER RES, V67, P11924, DOI 10.1158/0008-5472.CAN-07-1885; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Georgakis GV, 2006, BRIT J HAEMATOL, V135, P68, DOI 10.1111/j.1365-2141.2006.06247.x; Georgakis GV, 2006, CLIN CANCER RES, V12, P584, DOI 10.1158/1078-0432.CCR-05-1194; Graham B, 2012, CANCER SCI, V103, P522, DOI 10.1111/j.1349-7006.2011.02191.x; Grugan KD, 2010, P NATL ACAD SCI USA, V107, P11026, DOI 10.1073/pnas.0914295107; Kim HR, 2013, MOL ONCOL, V7, P1093, DOI 10.1016/j.molonc.2013.08.001; Kobayashi N, 2012, LUNG CANCER, V75, P161, DOI 10.1016/j.lungcan.2011.04.022; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Koizumi H, 2012, J THORAC ONCOL, V7, P1078, DOI 10.1097/JTO.0b013e3182519a2c; Krishnamoorthy GP, 2013, J BIOL CHEM, V288, P17481, DOI 10.1074/jbc.M112.439422; Lamottke B, 2012, EUR J HAEMATOL, V88, P406, DOI 10.1111/j.1600-0609.2012.01764.x; Li Y, 2009, ONCOGENE, V28, P3442, DOI 10.1038/onc.2009.212; Masuya D, 2004, BRIT J CANCER, V90, P1555, DOI 10.1038/sj.bjc.6601718; Okawa Y, 2009, BLOOD, V113, P846, DOI 10.1182/blood-2008-04-151928; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Paz-Ares L, 2010, J CELL MOL MED, V14, P51, DOI 10.1111/j.1582-4934.2009.00991.x; Perez-Soler R, 2004, J CLIN ONCOL, V22, P3238, DOI 10.1200/JCO.2004.11.057; Postel-Vinay S, 2012, NAT GENET, V44, P835, DOI 10.1038/ng.2362; Rho JK, 2014, CANCER RES, V74, P253, DOI 10.1158/0008-5472.CAN-13-1103; Rice JW, 2009, ONCOL RES, V18, P229, DOI 10.3727/096504009X12596189659240; Robinson KW, 2013, ONCOLOGIST, V18, P115, DOI 10.1634/theoncologist.2012-0262; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Shimamura T, 2005, CANCER RES, V65, P6401, DOI 10.1158/0008-5472.CAN-05-0933; Shimamura T, 2008, CANCER RES, V68, P5827, DOI 10.1158/0008-5472.CAN-07-5428; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Ueno T, 2012, LUNG CANCER, V76, P26, DOI 10.1016/j.lungcan.2011.09.011; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Webb CP, 1998, ONCOGENE, V17, P2019, DOI 10.1038/sj.onc.1202135; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Whitesell L, 2012, BBA-MOL CELL RES, V1823, P756, DOI 10.1016/j.bbamcr.2011.12.006; Wu WJ, 2013, CLIN CANCER RES, V19, P5699, DOI 10.1158/1078-0432.CCR-13-1758; Xu L, 2012, CANCER RES, V72, P3302, DOI 10.1158/0008-5472.CAN-11-3720; Zhang YX, 2008, CANCER RES, V68, P1905, DOI 10.1158/0008-5472.CAN-07-2661; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330	39	20	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119832	10.1371/journal.pone.0119832	http://dx.doi.org/10.1371/journal.pone.0119832			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25780909	Green Submitted, gold, Green Published			2022-12-27	WOS:000351284600096
J	Cicchitti, L; Martelli, M; Cerritelli, F				Cicchitti, Luca; Martelli, Marta; Cerritelli, Francesco			Chronic Inflammatory Disease and Osteopathy: A Systematic Review	PLOS ONE			English	Article							MANIPULATIVE TREATMENT; PUBLICATION BIAS; PREVENTION; MEDICINE; BURDEN	Background Chronic inflammatory diseases (CID) are globally highly prevalent and characterized by severe pathological medical conditions. Several trials were conducted aiming at measuring the effects of manipulative therapies on patients affected by CID. The purpose of this review was to explore the extent to which osteopathic manipulative treatment (OMT) can be beneficial in medical conditions also classified as CID. Methods This review included any type of experimental study which enrolled subjects with CID comparing OMT with any type of control procedure. The search was conducted on eight databases in January 2014 using a pragmatic literature search approach. Two independent reviewers conducted study selection and data extraction for each study. The risk of bias was evaluated according to the Cochrane methods. Heterogeneity was assessed and meta-analysis performed where possible. Results 10 studies met the inclusion criteria for this review enrolling 386 subjects. The search identified six RCTs, one laboratory study, one cross-over pilot studies, one observational study and one case control pilot study. Results suggest a potential effect of osteopathic medicine on patients with medical pathologies associated with CID (in particular Chronic Obstructive Pulmonary Disease (COPD), Irritable Bowel Syndrome, Asthma and Peripheral Arterial Disease) compared to no treatment or sham therapy although data remain elusive. Moreover one study showed possible effects on arthritis rat model. Meta-analysis was performed for COPD studies only showing no effect of any type of OMT applied versus control. No major side effects were reported by those receiving OMT. Conclusion The present systematic review showed inconsistent data on the effect of OMT in the treatment of medical conditions potentially associated with CID, however the OMT appears to be a safe approach. Further more robust trials are needed to determine the direction and magnitude of the effect of OMT and to generalize favorable results.	[Cicchitti, Luca; Martelli, Marta; Cerritelli, Francesco] COME Collaborat, Clin Based Human Res Dept, Pescara, Italy; [Cicchitti, Luca; Martelli, Marta] Accad Italiana Osteopatia Tradiz, Res Dept, Pescara, Italy; [Cerritelli, Francesco] G DAnnunzio Univ Chieti Pescara, Dept Neurosci Imaging & Clin Sci, Chieti, Italy; [Cerritelli, Francesco] G DAnnunzio Univ Chieti Pescara, ITAB, Chieti, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Cerritelli, F (corresponding author), COME Collaborat, Clin Based Human Res Dept, Pescara, Italy.	francesco.cerritelli@gmail.com	Cerritelli, Francesco/AAJ-5003-2020; Cerritelli, Francesco/O-8416-2015	Cerritelli, Francesco/0000-0002-2963-9620				Anderson G, 2004, PUBLIC HEALTH REP, V119, P263, DOI 10.1016/j.phr.2004.04.005; [Anonymous], 2007, DORLANDS MED DICT HL; Attali TV, 2013, J DIGEST DIS, V14, P654, DOI 10.1111/1751-2980.12098; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Bockenhauer Susan E., 2002, Journal of the American Osteopathic Association, V102, P371; Bosma-den Boer MM, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-32; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Cao TV, 2013, J MANIP PHYSIOL THER, V36, P513, DOI 10.1016/j.jmpt.2013.07.004; COOK DJ, 1993, JAMA-J AM MED ASSOC, V269, P2749, DOI 10.1001/jama.269.21.2749; DICKERSIN K, 1990, JAMA-J AM MED ASSOC, V263, P1385, DOI 10.1001/jama.263.10.1385; DICKERSIN K, 1987, CONTROL CLIN TRIALS, V8, P343, DOI 10.1016/0197-2456(87)90155-3; Ding RB, 2012, J ETHNOPHARMACOL, V144, P457, DOI 10.1016/j.jep.2012.09.044; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Florance BM, 2012, EUR J GASTROEN HEPAT, V24, P944, DOI 10.1097/MEG.0b013e3283543eb7; GREGOIRE G, 1995, J CLIN EPIDEMIOL, V48, P159, DOI 10.1016/0895-4356(94)00098-B; Guiney PA, 2005, J AM OSTEOPATH ASSOC, V105, P7; Hallas Brian, 1997, Journal of the American Osteopathic Association, V97, P207; Heap GA, 2009, HUM MOL GENET, V18, pR101, DOI [10.1093/hmg/ddp001, 10.1093/hmg/ddp473]; Henley Charles E, 2008, Osteopath Med Prim Care, V2, P7, DOI 10.1186/1750-4732-2-7; Hicks MR, 2012, J APPL PHYSIOL, V113, P465, DOI 10.1152/japplphysiol.01545.2011; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hopewell S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4145; Hundscheid HWC, 2007, J GASTROEN HEPATOL, V22, P1394, DOI 10.1111/j.1440-1746.2006.04741.x; Licciardone JC, 2012, J AM OSTEOPATH ASSOC, V112, P596, DOI 10.7556/jaoa.2012.112.9.596; Lombardini R, 2009, MANUAL THER, V14, P439, DOI 10.1016/j.math.2008.08.002; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Moher D, 1996, LANCET, V347, P363, DOI 10.1016/S0140-6736(96)90538-3; Noll Donald R, 2009, Osteopath Med Prim Care, V3, P9, DOI 10.1186/1750-4732-3-9; Noll DR, 2008, J AM OSTEOPATH ASSOC, V108, P251; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Saydah SH, 2006, J ALTERN COMPLEM MED, V12, P805, DOI 10.1089/acm.2006.12.805; Standley PR, 2008, J BODYW MOV THER, V12, P201, DOI 10.1016/j.jbmt.2008.05.006; Turner L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000030.pub2; Willoughby DA, 2000, LANCET, V355, P646, DOI 10.1016/S0140-6736(99)12031-2; Yach D, 2004, JAMA-J AM MED ASSOC, V291, P2616, DOI 10.1001/jama.291.21.2616; Zanotti E, 2012, COMPLEMENT THER MED, V20, P16, DOI 10.1016/j.ctim.2011.10.008; Zatalia St Rabiul, 2013, Acta Med Indones, V45, P141	38	35	35	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0121327	10.1371/journal.pone.0121327	http://dx.doi.org/10.1371/journal.pone.0121327			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781621	Green Published, gold, Green Submitted			2022-12-27	WOS:000351284600201
J	Hawro, T; Bogucki, A; Krupinska-Kun, M; Maurer, M; Wozniacka, A				Hawro, Tomasz; Bogucki, Andrzej; Krupinska-Kun, Maria; Maurer, Marcus; Wozniacka, Anna			Intractable Headaches, Ischemic Stroke, and Seizures Are Linked to the Presence of Anti-beta 2GPI Antibodies in Patients with Systemic Lupus Erythematosus	PLOS ONE			English	Article							13TH INTERNATIONAL-CONGRESS; NEUROPSYCHIATRIC MANIFESTATIONS; ANTIPHOSPHOLIPID ANTIBODIES; ANTICARDIOLIPIN ANTIBODIES; CLASSIFICATION CRITERIA; ANTINUCLEAR ANTIBODIES; PREVALENCE; ASSOCIATION; DIAGNOSIS; MIGRAINE	Background Neuropsychiatric systemic lupus erythematosus (NPSLE) is a common and potentially fatal manifestation of SLE. Antiphospholipid antibodies (aPL) such as lupus anticoagulant (LA), anticardiolipin (aCL) and antibodies to beta 2glycoprotein I (anti-beta 2GPI), the most important aPL antigen, are thought to play a role in some forms of NPSLE. As of yet, their specific roles in NPSLE manifestations remain to be elucidated. Methodology/Principal Findings 57 SLE patients (53 women) were assessed for LA, aCL and anti-beta(2)GPI twice, to determine persistent positivity. All patients were examined by neurology and psychiatry specialists. 69 healthy subjects were assessed as controls. NPSLE was diagnosed in 74% of patients. Headaches were the most prevalent manifestation of NPSLE (39%), followed by cerebrovascular disease (CVD) (23%), depressive disorders (19.0%), and seizures (14%). NPSLE and non-NPSLE patients showed comparable SLE activity and corticosteroid use. In 65% of patients neuropsychiatric manifestations preceded SLE diagnosis. aPL profiles of NPSLE patients and non-NPSLE patients were similar. Headaches and ischemic stroke were independently associated with anti-beta(2)GPI-IgM (OR=5.6; p<0.05), and seizures were linked to anti-beta(2)GPI-IgG (OR=11.3; p= 0.01). Conclusions In SLE patients, neuropsychiatric manifestations occur frequently and early, often before the disease is diagnosed. Autoantibodies to beta 2GPI are linked to non-specific headaches, ischemic stroke and seizures, and show a better predictive value than aCL and LA. These findings may help to improve the diagnosis of NPSLE and should prompt further studies to characterize the role of anti-beta 2GPI in the pathogenesis of this condition.	[Hawro, Tomasz; Maurer, Marcus] Charite, Dept Dermatol & Allergy, D-13353 Berlin, Germany; [Bogucki, Andrzej] Med Univ Lodz, Dept Extrapyramidal Dis, Lodz, Poland; [Krupinska-Kun, Maria] Med Univ Lodz, Dept Affect & Psychot Disorders, Lodz, Poland; [Wozniacka, Anna] Med Univ Lodz, Dept Dermatol & Venereol, Lodz, Poland	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Medical University Lodz; Medical University Lodz; Medical University Lodz	Maurer, M (corresponding author), Charite, Dept Dermatol & Allergy, D-13353 Berlin, Germany.	marcus.maurer@charite.de	Maurer, Marcus/ABG-2174-2020; Wozniacka, Anna Jolanta/S-9674-2016	Maurer, Marcus/0000-0002-4121-481X; Hawro, Tomasz/0000-0001-9990-1332	Medical University of Lodz [503/1-152-01/503-01]	Medical University of Lodz	This work was funded by the grant from the Medical University of Lodz nr. 503/1-152-01/503-01. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afeltra A, 2003, NEUROLOGY, V61, P108, DOI 10.1212/01.WNL.0000058904.94330.A7; Ainiala H, 2001, NEUROLOGY, V57, P496, DOI 10.1212/WNL.57.3.496; Ainiala H, 2001, ARTHRIT RHEUM-ARTHR, V45, P419, DOI 10.1002/1529-0131(200110)45:5<419::AID-ART360>3.0.CO;2-X; Amit M, 1999, CLIN EXP RHEUMATOL, V17, P467; ASHERSON RA, 1989, AM J MED, V86, P391, DOI 10.1016/0002-9343(89)90335-5; Avcin T, 2002, LUPUS, V11, P4, DOI 10.1191/0961203302lu146rr; Avcin T, 2008, ARTHRIT RHEUM-ARTHR, V59, P206, DOI 10.1002/art.23334; BRANDT JT, 1995, THROMB HAEMOSTASIS, V74, P1185; Brey RL, 2002, NEUROLOGY, V58, P1214, DOI 10.1212/WNL.58.8.1214; Cavestro C, 2011, J THROMB HAEMOST, V9, P1350, DOI 10.1111/j.1538-7836.2011.04348.x; Cervera R, 2002, ARTHRITIS RHEUM-US, V46, P1019, DOI 10.1002/art.10187; Chapman J, 1999, LUPUS, V8, P127, DOI 10.1191/096120399678847524; Chiewthanakul P, 2012, ASIAN PAC J ALLERGY, V30, P55; Cuadrado MJ, 2001, QJM-MON J ASSOC PHYS, V94, P114, DOI 10.1093/qjmed/94.2.114; de Carvalho JF, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/981519; FEINGLASS EJ, 1976, MEDICINE, V55, P323, DOI 10.1097/00005792-197607000-00004; Fernandez-Nebro A, 1999, LUPUS, V8, P151, DOI 10.1191/096120399678847443; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GALLI M, 1990, LANCET, V335, P1544, DOI 10.1016/0140-6736(90)91374-J; Hanly JG, 2008, ARTHRITIS RHEUM-US, V58, P843, DOI 10.1002/art.23218; Hanly JG, 2007, ARTHRITIS RHEUM-US, V56, P265, DOI 10.1002/art.22305; Hanly JG, 2011, ANN RHEUM DIS, V70, P1726, DOI 10.1136/ard.2010.148502; Hanly JG, 2013, ARTHRITIS RHEUM-US, V65, P2887, DOI 10.1002/art.38106; Hanly JG, 2012, ANN RHEUM DIS, V71, P1502, DOI 10.1136/annrheumdis-2011-201089; HARRIS EN, 1984, CLIN EXP RHEUMATOL, V2, P47; Hawro Tomasz, 2009, Pol Merkur Lekarski, V26, P43; HERRANZ MT, 1994, ARTHRITIS RHEUM, V37, P568, DOI 10.1002/art.1780370418; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Kozora E, 2012, LUPUS, V21, P402, DOI 10.1177/0961203311429116; Lakos G, 1999, CLIN EXP IMMUNOL, V117, P574; Lakos G, 2012, ARTHRITIS RHEUM-US, V64, P1, DOI 10.1002/art.33349; Liang MH, 1999, ARTHRITIS RHEUM-US, V42, P599; LIANG MH, 1988, ARTHRITIS RHEUM, V31, P817, DOI 10.1002/art.1780310701; MARKUS HS, 1992, J NEUROL, V239, P39, DOI 10.1007/BF00839210; Martincz-Berriotxoa A, 2007, LUPUS, V16, P810, DOI 10.1177/0961203307083316; Mevorach D, 1996, LUPUS, V5, P173, DOI 10.1177/096120339600500301; Mikdashi J, 2005, NEUROLOGY, V64, P2102, DOI 10.1212/01.WNL.0000165959.98370.D5; Mikdashi J, 2004, RHEUMATOLOGY, V43, P1555, DOI 10.1093/rheumatology/keh384; Mitsikostas DD, 2004, BRAIN, V127, P1200, DOI 10.1093/brain/awh146; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Mok CC, 2001, J RHEUMATOL, V28, P766; MONTALBAN J, 1992, NEUROLOGY, V42, P681, DOI 10.1212/WNL.42.3.681; Peltola JT, 2000, AM J MED, V109, P712, DOI 10.1016/S0002-9343(00)00617-3; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473; Pierangeli SS, 2012, CLIN CHIM ACTA, V413, P358, DOI 10.1016/j.cca.2011.09.048; Piette JC, 1998, CIRCULATION, V97, P2195, DOI 10.1161/01.CIR.97.22.2195; Rasmussen BK, 2001, CEPHALALGIA, V21, P774, DOI 10.1046/j.1468-2982.2001.00248.x; Robert M, 2006, NEUROL INDIA, V54, P75, DOI 10.4103/0028-3886.24713; Sabbadini MG, 1999, LUPUS, V8, P11, DOI 10.1191/096120399678847344; Sanna G, 2003, J RHEUMATOL, V30, P985; Sanna G, 2003, RHEUMATOLOGY, V42, P200, DOI 10.1093/rheumatology/keg080; Sastre-Garriga J, 2003, LUPUS, V12, P877, DOI 10.1191/0961203303lu496oa; Sciascia S, 2014, J NEUROL, V261, P1706, DOI 10.1007/s00415-014-7406-8; Sfikakis PP, 1998, BRIT J RHEUMATOL, V37, P300; SIBLEY JT, 1992, J RHEUMATOL, V19, P47; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Singh S, 2009, RHEUMATOL INT, V29, P1455, DOI 10.1007/s00296-009-0887-6; Tan EM, 1997, ARTHRITIS RHEUM-US, V40, P1601, DOI 10.1002/art.1780400909; Tietjen GE, 1998, NEUROLOGY, V50, P1433, DOI 10.1212/WNL.50.5.1433; Tincani A, 2004, THROMB RES, V114, P553, DOI 10.1016/j.thromres.2004.06.035; Tincani A, 2009, LUPUS, V18, P913, DOI 10.1177/0961203309106919; Unterman A, 2011, SEMIN ARTHRITIS RHEU, V41, P1, DOI 10.1016/j.semarthrit.2010.08.001; Verrot D, 1997, AM J MED, V103, P33, DOI 10.1016/S0002-9343(97)90046-2; von Scheven E, 2002, ARTHRIT RHEUM-ARTHR, V47, P414, DOI 10.1002/art.10510; Ward MM, 1996, ARCH INTERN MED, V156, P1337, DOI 10.1001/archinte.156.12.1337; Willis R, 2013, ANN NY ACAD SCI, V1285, P44, DOI 10.1111/nyas.12080	66	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119911	10.1371/journal.pone.0119911	http://dx.doi.org/10.1371/journal.pone.0119911			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781014	gold, Green Submitted, Green Published			2022-12-27	WOS:000351284600107
J	Huang, KK; Wang, T; Cheng, Y; Zheng, XP				Huang, Keke; Wang, Tao; Cheng, Yuan; Zheng, Xiaoping			Effect of Heterogeneous Investments on the Evolution of Cooperation in Spatial Public Goods Game	PLOS ONE			English	Article							DIVERSITY PROMOTES; REPUTATION; PUNISHMENT; TRAGEDY	Understanding the emergence of cooperation in spatial public goods game remains a grand challenge across disciplines. Inmost previous studies, it is assumed that the investments of all the cooperators are identical, and often equal to 1. However, it is worth mentioning that players are diverse and heterogeneous when choosing actions in the rapidly developing modern society and researchers have shown more interest to the heterogeneity of players recently. For modeling the heterogeneous players without loss of generality, it is assumed in this work that the investment of a cooperator is a random variable with uniform distribution, the mean value of which is equal to 1. The results of extensive numerical simulations convincingly indicate that heterogeneous investments can promote cooperation. Specifically, a large value of the variance of the random variable can decrease the two critical values for the result of behavioral evolution effectively. Moreover, the larger the variance is, the better the promotion effect will be. In addition, this article has discussed the impact of heterogeneous investments when the coevolution of both strategy and investment is taken into account. Comparing the promotion effect of coevolution of strategy and investment with that of strategy imitation only, we can conclude that the coevolution of strategy and investment decreases the asymptotic fraction of cooperators by weakening the heterogeneity of investments, which further demonstrates that heterogeneous investments can promote cooperation in spatial public goods game.	[Huang, Keke; Wang, Tao; Zheng, Xiaoping] Tsinghua Univ, Dept Automat, Beijing 100084, Peoples R China; [Cheng, Yuan] Beijing Univ Chem Technol, Sch Mech & Elect Engn, Beijing 100029, Peoples R China	Tsinghua University; Beijing University of Chemical Technology	Zheng, XP (corresponding author), Tsinghua Univ, Dept Automat, Beijing 100084, Peoples R China.	asean@mail.tsinghua.edu.cn			973 Program [2011CB706900]; National Natural Science Foundation of China [71225007]	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the 973 Program (Grant NO. 2011CB706900), and by the National Natural Science Foundation of China (Grants NO. 71225007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boccaletti S, 2014, PHYS REP, V544, P1, DOI 10.1016/j.physrep.2014.07.001; BORNSTEIN G, 1994, J EXP SOC PSYCHOL, V30, P52, DOI 10.1006/jesp.1994.1003; Brandt H, 2006, P NATL ACAD SCI USA, V103, P495, DOI 10.1073/pnas.0507229103; Brandt H, 2003, P ROY SOC B-BIOL SCI, V270, P1099, DOI 10.1098/rspb.2003.2336; Burlando RM, 2005, EXP ECON, V8, P35, DOI 10.1007/s10683-005-0436-4; Chen XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0043724, 10.1371/journal.pone.0036895]; Fehr E, 2004, TRENDS COGN SCI, V8, P185, DOI 10.1016/j.tics.2004.02.007; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Gaechter S., 2006, HETEROGENEOUS SOCIAL; Gomez-Gardenes J, 2011, CHAOS, V21, DOI 10.1063/1.3535579; Guan JY, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.056101; Helbing D, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/8/083005; Killingback Timothy, 2010, Biology Theory, V5, P3, DOI 10.1162/BIOT_a_00019; Kollock P, 1998, ANNU REV SOCIOL, V24, P183, DOI 10.1146/annurev.soc.24.1.183; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; Pennisi E, 2005, SCIENCE, V309, P93, DOI 10.1126/science.309.5731.93; Perc M, 2013, CHAOS SOLITON FRACT, V56, P1, DOI 10.1016/j.chaos.2013.06.002; Perc M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0997; Rong ZH, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/30001; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Semmann D, 2003, NATURE, V425, P390, DOI 10.1038/nature01986; Shi DM, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/58003; Szabo G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.118101; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/38003; Szolnoki A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056109; Wang L, 2013, SCI REPORTS, V3; Wang L, 2014, CHINESE SCI BULL, V59, P3511, DOI 10.1007/s11434-014-0499-8; Wang Z, 2013, SCI REPORTS, V3; Wang Z, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.052813; Wang Z, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/3/033041; Wang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040218; Wang Z, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/48001; Wang Z, 2011, J THEOR BIOL, V277, P19, DOI 10.1016/j.jtbi.2011.02.016; Wang Z, 2011, PHYSICA A, V390, P1234, DOI 10.1016/j.physa.2010.12.003; Wang Z, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.021115; Wang ZT, 2012, RADIOCARBON, V54, P195, DOI 10.2458/azu_js_rc.v54i2.15869; Yuan WJ, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.022818; Zhang GQ, 2013, CHAOS SOLITON FRACT, V51, P31, DOI 10.1016/j.chaos.2013.03.003; Zhao DW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112018	40	46	46	3	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120317	10.1371/journal.pone.0120317	http://dx.doi.org/10.1371/journal.pone.0120317			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7QC	25781345	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600149
J	Kuo, YM; Henry, RA; Huang, LQ; Chen, X; Stargell, LA; Andrews, AJ				Kuo, Yin-Ming; Henry, Ryan A.; Huang, Liangqun; Chen, Xu; Stargell, Laurie A.; Andrews, Andrew J.			Utilizing Targeted Mass Spectrometry to Demonstrate Asf1-Dependent Increases in Residue Specificity for Rtt109-Vps75 Mediated Histone Acetylation	PLOS ONE			English	Article							ACETYLTRANSFERASE-CHAPERONE COMPLEX; NUCLEOSOME CORE PARTICLE; RECOMBINANT HISTONES; H3; DNA; LYSINE-56; ASF1; H4; VPS75; TRANSCRIPTION	In Saccharomyces cerevisiae, Rtt109, a lysine acetyltransferase (KAT), associates with a histone chaperone, either Vps75 or Asf1. It has been proposed that these chaperones alter the selectivity of Rtt109 or which residues it preferentially acetylates. In the present study, we utilized a label-free quantitative mass spectrometry-based method to determine the steady-state kinetic parameters of acetylation catalyzed by Rtt109-Vps75 on H3 monomer, H3/H4 tetramer, and H3/H4-Asf1 complex. These results show that among these histone conformations, only H3K9 and H3K23 are significantly acetylated under steady-state conditions and that Asf1 promotes H3/H4 acetylation by Rtt109-Vps75. Asf1 equally increases the Rtt109-Vps75 specificity for both of these residues with a maximum stoichiometry of 1: 1 (Asf1 to H3/H4), but does not alter the selectivity between these two residues. These data suggest that the H3/H4-Asf1 complex is a substrate for Rtt109-Vps75 without altering selectivity between residues. The deletion of either Rtt109 or Asf1 in vivo results in the same reduction of H3K9 acetylation, suggesting that Asf1 is required for efficient H3K9 acetylation both in vitro and in vivo. Furthermore, we found that the acetylation preference of Rtt109-Vps75 could be directed to H3K56 when those histones already possess modifications, such as those found on histones purified from chicken erythrocytes. Taken together, Vps75 and Asf1 both enhance Rtt109 acetylation for H3/H4, although via different mechanisms, but have little impact on the residue selectivity. Importantly, these results provide evidence that histone chaperones can work together via interactions with either the enzyme or the substrate to more efficiently acetylate histones.	[Kuo, Yin-Ming; Henry, Ryan A.; Andrews, Andrew J.] Fox Chase Canc Ctr, Dept Canc Biol, Philadelphia, PA 19111 USA; [Huang, Liangqun; Chen, Xu; Stargell, Laurie A.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA	Fox Chase Cancer Center; Colorado State University	Andrews, AJ (corresponding author), Fox Chase Canc Ctr, Dept Canc Biol, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	Andrew.Andrews@fccc.edu	Stargell, Laurie/GWC-7423-2022		W. W. Smith Charitable Trust; Pennsylvania Department of Health; National Institute of General Medical Sciences of the National Institutes of Health [R01 GM102503, GM088409]; NATIONAL CANCER INSTITUTE [T32CA009035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102503, P01GM088409] Funding Source: NIH RePORTER	W. W. Smith Charitable Trust; Pennsylvania Department of Health; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by the W. W. Smith Charitable Trust, the Pennsylvania Department of Health, and the National Institute of General Medical Sciences of the National Institutes of Health under Award Number R01 GM102503 to AJA and GM088409 to LAS. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abshiru N, 2013, J PROTEOMICS, V81, P80, DOI 10.1016/j.jprot.2012.09.026; Albaugh BN, 2010, BIOCHEMISTRY-US, V49, P6375, DOI 10.1021/bi100381y; Berndsen CE, 2008, NAT STRUCT MOL BIOL, V15, P948, DOI 10.1038/nsmb.1459; Bowman A, 2011, MOL CELL, V41, P398, DOI 10.1016/j.molcel.2011.01.025; Cai L, 2011, COLD SH Q B, V76, P195, DOI 10.1101/sqb.2011.76.010769; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; Donham DC, 2011, NUCLEIC ACIDS RES, V39, P5449, DOI 10.1093/nar/gkr097; Downs JA, 2008, DNA REPAIR, V7, P2020, DOI 10.1016/j.dnarep.2008.08.016; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Edmondson DG, 1996, GENE DEV, V10, P1247, DOI 10.1101/gad.10.10.1247; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; English CM, 2005, BIOCHEMISTRY-US, V44, P13673, DOI 10.1021/bi051333h; Fillingham J, 2008, MOL CELL BIOL, V28, P4342, DOI 10.1128/MCB.00182-08; Galdieri L, 2012, J BIOL CHEM, V287, P23865, DOI 10.1074/jbc.M112.380519; Gilibili RR, 2011, BIOMED CHROMATOGR, V25, P1352, DOI 10.1002/bmc.1608; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Han JH, 2007, J BIOL CHEM, V282, P28587, DOI 10.1074/jbc.M702496200; Han JH, 2007, J BIOL CHEM, V282, P14158, DOI 10.1074/jbc.M700611200; Henry RA, 2013, BIOCHEMISTRY-US, V52, P5746, DOI 10.1021/bi400684q; Keck KM, 2011, TRAFFIC, V12, P826, DOI 10.1111/j.1600-0854.2011.01202.x; Kolonko EM, 2010, P NATL ACAD SCI USA, V107, P20275, DOI 10.1073/pnas.1009860107; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Kuo YM, 2014, METHODS, V70, P127, DOI 10.1016/j.ymeth.2014.08.003; Kuo YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054896; Lin CQ, 2008, STRUCTURE, V16, P1503, DOI 10.1016/j.str.2008.07.006; Liu B, 2009, J BIOL CHEM, V284, P32288, DOI 10.1074/jbc.M109.045856; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; North JA, 2012, NUCLEIC ACIDS RES, V40, P10215, DOI 10.1093/nar/gks747; Park YJ, 2008, NAT STRUCT MOL BIOL, V15, P957, DOI 10.1038/nsmb.1480; Park YJ, 2008, CURR OPIN STRUC BIOL, V18, P282, DOI 10.1016/j.sbi.2008.04.003; Pupaibool J, 2013, INFECT IMMUN, V81, P2268, DOI 10.1128/IAI.01173-12; Radovani E, 2013, EUKARYOT CELL, V12, P654, DOI 10.1128/EC.00291-12; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Schneider J, 2006, J BIOL CHEM, V281, P37270, DOI 10.1074/jbc.C600265200; Schneider TD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022548; Shimko JC, 2011, J MOL BIOL, V408, P187, DOI 10.1016/j.jmb.2011.01.003; Tang Y, 2008, P NATL ACAD SCI USA, V105, P12206, DOI 10.1073/pnas.0802393105; Tang Y, 2008, NAT STRUCT MOL BIOL, V15, P738, DOI 10.1038/nsmb.1448; Tang Y, 2006, NAT STRUCT MOL BIOL, V13, P921, DOI 10.1038/nsmb1147; Tang Y, 2011, STRUCTURE, V19, P221, DOI 10.1016/j.str.2010.12.012; Tropberger P, 2013, CELL, V152, P859, DOI 10.1016/j.cell.2013.01.032; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006	45	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0118516	10.1371/journal.pone.0118516	http://dx.doi.org/10.1371/journal.pone.0118516			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781956	Green Published, gold, Green Submitted			2022-12-27	WOS:000351284600024
J	Muhlenberg, T; Grunewald, S; Treckmann, J; Podleska, L; Schuler, M; Fletcher, JA; Bauer, S				Muehlenberg, Thomas; Grunewald, Susanne; Treckmann, Juergen; Podleska, Lars; Schuler, Martin; Fletcher, Jonathan A.; Bauer, Sebastian			Inhibition of KIT-Glycosylation by 2-Deoxyglucose Abrogates KIT-Signaling and Combination with ABT-263 Synergistically Induces Apoptosis in Gastrointestinal Stromal Tumor	PLOS ONE			English	Article							PHASE-II TRIAL; IMATINIB MESYLATE; CELL-DEATH; 2-DEOXY-D-GLUCOSE; CANCER; PET; ACTIVATION; MUTATIONS; AUTOPHAGY; BREAST	Positron emission tomography (PET) with F-18-fluorodeoxyglucose (FDG) is frequently used for visualizing gastrointestinal stromal tumors (GIST), which are highly glucose-avid tumors. Dramatic metabolic responses following imatinib treatment indicate a high, KIT-dependent glucose turnover which has been particularly helpful for predicting tumor response to imatinib. The glucose analogue 2-deoxyglucose (2DG) inhibits glucose metabolism in cancer cells that depend on aerobic glycolysis for ATP production. We show that 2DG inhibits proliferation in both imatinib-sensitive and imatinib-resistant GIST cell lines at levels that can be achieved clinically. KIT-negative GIST48B have 3-14-fold higher IC50 levels than KIT-positive GIST cells indicating that oncogenic KIT may sensitize cells to 2DG. GIST sensitivity to 2DG is increased in low-glucose media (110mg/dl). 2DG leads to dose- and glucose dependent inhibition of KIT glycosylation with resultant reduction of membrane-bound KIT, inhibition of KIT-phosphorylation and inactivation of KIT-dependent signaling intermediates. In contrast to imatinib, 2DG caused ER-stress and elicited the unfolded protein response (UPR). Mannose but not pyruvate rescued GIST cells from 2DG-induced growth arrest, suggesting that loss of KIT integrity is the predominant effect of 2DG in GIST. Additive anti-tumoral effects were seen with imatinib and BH3-mimetics. Our data provide the first evidence that modulation of the glucose-metabolism by 2DG may have a disease-specific effect and may be therapeutically useful in GIST.	[Muehlenberg, Thomas; Grunewald, Susanne; Schuler, Martin; Bauer, Sebastian] Univ Duisburg Essen, Univ Hosp Essen, Dept Med Oncol, Essen, Germany; [Muehlenberg, Thomas; Grunewald, Susanne; Treckmann, Juergen; Podleska, Lars; Bauer, Sebastian] Univ Duisburg Essen, Univ Hosp Essen, Sarcoma Ctr, Essen, Germany; [Treckmann, Juergen; Podleska, Lars] Univ Duisburg Essen, Univ Hosp Essen, Dept Visceral & Transplant Surg, Essen, Germany; [Muehlenberg, Thomas; Grunewald, Susanne; Treckmann, Juergen; Podleska, Lars; Schuler, Martin; Bauer, Sebastian] Univ Duisburg Essen, Univ Hosp Essen, West German Canc Ctr, Essen, Germany; [Schuler, Martin] German Canc Consortium DKTK, Heidelberg, Germany; [Fletcher, Jonathan A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ); Harvard University; Brigham & Women's Hospital; Harvard Medical School	Muhlenberg, T (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Dept Med Oncol, Essen, Germany.	thomas.muehlenberg@uni-due.de	Bauer, Sebastian/D-8120-2012; Mühlenberg, Thomas/J-8423-2019; Bauer, Sebastian/HHR-9319-2022	Bauer, Sebastian/0000-0001-5949-8120; Mühlenberg, Thomas/0000-0002-2078-8857; 	Deutsche Krebshilfe [109757]; National Institutes of Health [NIH 1P50CA127003, NIH 1P50CA168512-01]; Life Raft Group Research Initiative; NATIONAL CANCER INSTITUTE [P50CA127003, U54CA168512] Funding Source: NIH RePORTER	Deutsche Krebshilfe(Deutsche Krebshilfe); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Life Raft Group Research Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supportet by a Max Eder Fellowship (SB) of the Deutsche Krebshilfe (No. 109757), the National Institutes of Health (JF; NIH 1P50CA127003, NIH 1P50CA168512-01) and received funds from the Life Raft Group Research Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer S, 2005, INT J CANCER, V117, P316, DOI 10.1002/ijc.21164; Blanke CD, 2008, J CLIN ONCOL, V26, P620, DOI 10.1200/JCO.2007.13.4403; Blanke CD, 2008, J CLIN ONCOL, V26, P626, DOI 10.1200/JCO.2007.13.4452; Cheng G, 2012, CANCER RES, V72, P2634, DOI 10.1158/0008-5472.CAN-11-3928; Demetri GD, 2006, LANCET, V368, P1329, DOI 10.1016/S0140-6736(06)69446-4; Demetri GD, 2013, LANCET, V381, P295, DOI 10.1016/S0140-6736(12)61857-1; Duensing A, 2004, ONCOGENE, V23, P3999, DOI 10.1038/sj.onc.1207525; Fischer B, 2009, NEW ENGL J MED, V361, P32, DOI 10.1056/NEJMoa0900043; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Gupta A, 2010, P NATL ACAD SCI USA, V107, P14333, DOI 10.1073/pnas.1000248107; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Janeway KA, 2011, P NATL ACAD SCI USA, V108, P314, DOI 10.1073/pnas.1009199108; Kurtoglu M, 2007, MOL CANCER THER, V6, P3049, DOI 10.1158/1535-7163.MCT-07-0310; Letai AG, 2008, NAT REV CANCER, V8, P121, DOI 10.1038/nrc2297; Leung HJ, 2012, ANTIMICROB AGENTS CH, V56, P5794, DOI 10.1128/AAC.01126-12; Liu Y, 2008, CANCER RES, V68, P9015, DOI 10.1158/0008-5472.CAN-08-1935; Maschek G, 2004, CANCER RES, V64, P31, DOI 10.1158/0008-5472.CAN-03-3294; Muhlenberg T, 2010, EJC SUPPL, V8, P69, DOI 10.1016/S1359-6349(10)71916-9; Muhlenberg T, 2009, CANCER RES, V69, P6941, DOI 10.1158/0008-5472.CAN-08-4004; Nakatani H, 2006, INT J MOL MED, V17, P893; Raez LE, 2013, CANCER CHEMOTH PHARM, V71, P523, DOI 10.1007/s00280-012-2045-1; Rubin BP, 2001, CANCER RES, V61, P8118; Simon S, 2013, CANCER RES, V73, P3661, DOI 10.1158/0008-5472.CAN-12-3839; Simons AL, 2007, INT J RADIAT ONCOL, V69, P1222, DOI 10.1016/j.ijrobp.2007.07.2343; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Smeland Eivind, 2012, Sarcoma, V2012, P541650, DOI 10.1155/2012/541650; Stein M, 2010, PROSTATE, V70, P1388, DOI 10.1002/pros.21172; Steinert DM, 2006, CANCER-AM CANCER SOC, V106, P1617, DOI 10.1002/cncr.21781; Tagg SLC, 2008, BRIT J CANCER, V99, P1842, DOI 10.1038/sj.bjc.6604752; Tarn C, 2006, CANCER RES, V66, P5477, DOI 10.1158/0008-5472.CAN-05-3906; Van den Abbeele AID, 2012, J NUCL MED, V53, P567, DOI 10.2967/jnumed.111.094425; WARBURG O, 1956, SCIENCE, V124, P269; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Xi HB, 2011, CANCER CHEMOTH PHARM, V67, P899, DOI 10.1007/s00280-010-1391-0; Yamaguchi R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024102; Zagorodna O, 2012, ONCOGENE, V31, P2738, DOI 10.1038/onc.2011.454	37	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120531	10.1371/journal.pone.0120531	http://dx.doi.org/10.1371/journal.pone.0120531			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781619	gold, Green Submitted, Green Published			2022-12-27	WOS:000351284600171
J	Pajares, S; Souza, V; Eguiarte, LE				Pajares, Silvia; Souza, Valeria; Eguiarte, Luis E.			Multivariate and Phylogenetic Analyses Assessing the Response of Bacterial Mat Communities from an Ancient Oligotrophic Aquatic Ecosystem to Different Scenarios of Long-Term Environmental Disturbance	PLOS ONE			English	Article							CUATRO CIENEGAS BASIN; 16S RIBOSOMAL-RNA; 2 MICROBIAL MATS; COMPARATIVE METAGENOMICS; FUNCTIONAL-SIGNIFICANCE; ECOLOGICAL RESPONSES; DIVERSITY; BIODIVERSITY; TEMPERATURE; MODEL	Understanding the response of bacterial communities to environmental change is extremely important in predicting the effect of biogeochemical modifications in ecosystem functioning. The Cuatro Cienegas Basin is an ancient oasis in the Mexican Chihuahuan desert that hosts a wide diversity of microbial mats and stromatolites that have survived in extremely oligotrophic pools with nearly constant conditions. However, thus far, the response of these unique microbial communities to long- term environmental disturbances remains unexplored. We therefore studied the compositional stability of these bacterial mat communities by using a replicated (3x) mesocosm experiment: a) Control; b) Fluct: fluctuating temperature; c) 40C: increase to 40 degrees C; d) UVplus: artificial increase in UV radiation; and f) UVmin: UV radiation protection. In order to observe the changes in biodiversity, we obtained 16S rRNA gene clone libraries from microbial mats at the end of the experiment (eight months) and analyzed them using multivariate and phylogenetic tools. Sequences were assigned to 13 major lineages, among which Cyanobacteria (38.8%) and Alphaproteobacteria (25.5%) were the most abundant. The less extreme treatments (Control and UVmin) had a more similar composition and distribution of the phylogenetic groups with the natural pools than the most extreme treatments (Fluct, 40C, and UVplus), which showed drastic changes in the community composition and structure, indicating a different community response to each environmental disturbance. An increase in bacterial diversity was found in the UVmin treatment, suggesting that protected environments promote the establishment of complex bacterial communities, while stressful environments reduce diversity and increase the dominance of a few Cyanobacterial OTUs (mainly Leptolyngbya sp) through environmental filtering. Mesocosm experiments using complex bacterial communities, along with multivariate and phylogenetic analyses of molecular data, can assist in addressing questions about bacterial responses to long-term environmental stress.	[Pajares, Silvia; Souza, Valeria; Eguiarte, Luis E.] Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolut, CU, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Souza, V (corresponding author), Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolut, CU, Mexico City 04510, DF, Mexico.	souza@unam.mx		souza, valeria/0000-0002-2992-4229	office of APFF of Cuatro Cienegas; CBTA22	office of APFF of Cuatro Cienegas; CBTA22	We would like to thank the teachers CH Hernandez and PL Arizpe and the high school students from the CBTA22 of Cuatro Cienegas for technical assistance with the mesocosm experiment and L. Espinosa for logistic support. We specially thank PRONATURA Noreste for the access to the Pozas Azules ranch, the office of APFF of Cuatro Cienegas for their support, and above all the CBTA22 for providing housing and support for the experiment.	Abed RMM, 2006, AQUAT MICROB ECOL, V44, P21, DOI 10.3354/ame044021; Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2013, AR5 IPCC; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; Barberan A, 2010, AQUAT MICROB ECOL, V59, P1, DOI 10.3354/ame01389; Bonilla-Rosso G, 2012, ASTROBIOLOGY, V12, P659, DOI 10.1089/ast.2011.0724; Breitbart M, 2009, ENVIRON MICROBIOL, V11, P16, DOI 10.1111/j.1462-2920.2008.01725.x; Cardinale B.J., 2009, ECOLOGY, V90, P854, DOI DOI 10.1890/08-1584.1; Castenholz R.W., 2012, ECOLOGY CYANOBACTERI, P481, DOI [10.1007/978-94-007-3855-3_19, DOI 10.1007/978-94-007-3855-3_19]; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Des Marais DJ, 2003, BIOL BULL-US, V204, P160, DOI 10.2307/1543552; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Eiler A, 2004, ENVIRON MICROBIOL, V6, P1228, DOI 10.1111/j.1462-2920.2004.00657.x; Elser JJ, 2006, ECOL LETT, V9, P292, DOI 10.1111/j.1461-0248.2005.00873.x; Elser JJ, 2005, FRESHWATER BIOL, V50, P1808, DOI 10.1111/j.1365-2427.2005.01451.x; FUERST JA, 2004, WORLD FED CULT COLLE, V38, P1; Galand PE, 2009, P NATL ACAD SCI USA, V106, P22427, DOI 10.1073/pnas.0908284106; Gotelli NJ, 2001, OECOLOGIA, V129, P281, DOI 10.1007/s004420100717; Green J, 2006, TRENDS ECOL EVOL, V21, P501, DOI 10.1016/j.tree.2006.06.012; Guisan A, 2014, NAT CLIM CHANGE, V4, P175, DOI 10.1038/nclimate2157; Hader DP, 2011, PHOTOCH PHOTOBIO SCI, V10, P242, DOI 10.1039/c0pp90036b; Hall EK, 2008, ISME J, V2, P471, DOI 10.1038/ismej.2008.9; Harris JK, 2013, ISME J, V7, P50, DOI 10.1038/ismej.2012.79; Havemann SA, 2008, APPL ENVIRON MICROB, V74, P7410, DOI 10.1128/AEM.01710-08; Helmus MR, 2010, ECOL LETT, V13, P162, DOI 10.1111/j.1461-0248.2009.01411.x; Horner-Devine MC, 2006, ECOLOGY, V87, pS100, DOI 10.1890/0012-9658(2006)87[100:PCAOIB]2.0.CO;2; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Jessup CM, 2004, TRENDS ECOL EVOL, V19, P189, DOI 10.1016/j.tree.2004.01.008; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kircher M, 2010, BIOESSAYS, V32, P524, DOI 10.1002/bies.200900181; Lake PS, 2000, J N AM BENTHOL SOC, V19, P573, DOI 10.2307/1468118; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lavergne S, 2010, ANNU REV ECOL EVOL S, V41, P321, DOI 10.1146/annurev-ecolsys-102209-144628; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Liu ZF, 2011, ISME J, V5, P1279, DOI 10.1038/ismej.2011.37; Martin AP, 2002, APPL ENVIRON MICROB, V68, P3673, DOI 10.1128/AEM.68.8.3673-3682.2002; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; McCaig AE, 1999, APPL ENVIRON MICROB, V65, P1721; Miller AW, 2011, FEMS MICROBIOL ECOL, V75, P231, DOI 10.1111/j.1574-6941.2010.00991.x; Morlon H, 2011, ECOL LETT, V14, P141, DOI 10.1111/j.1461-0248.2010.01563.x; Nitti A, 2012, ASTROBIOLOGY, V12, P685, DOI 10.1089/ast.2011.0812; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Paerl H.W., 2010, MICROBIAL MATS MODER, P423; Pajares S, 2013, ANTON LEEUW INT J G, V104, P1159, DOI 10.1007/s10482-013-0038-7; Pajares S, 2012, MICROB ECOL, V64, P346, DOI 10.1007/s00248-012-0045-7; Peimbert M, 2012, ASTROBIOLOGY, V12, P648, DOI 10.1089/ast.2011.0694; Pizzetti I, 2011, APPL ENVIRON MICROB, V77, P5009, DOI 10.1128/AEM.02931-10; Pringault O, 2001, AQUAT MICROB ECOL, V26, P127, DOI 10.3354/ame026127; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Core Team, 2016, R FDN STAT COMP; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Rebollar EA, 2012, ENVIRON MICROBIOL, V14, P2323, DOI 10.1111/j.1462-2920.2012.02784.x; Reed HE, 2007, FEMS MICROBIOL ECOL, V62, P161, DOI 10.1111/j.1574-6941.2007.00386.x; Ross KA, 2012, MICROB ECOL, V64, P162, DOI 10.1007/s00248-012-0012-3; Schafer H, 2001, FEMS MICROBIOL ECOL, V34, P243, DOI 10.1016/S0168-6496(00)00102-1; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shade A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00417; Souza V, 2006, P NATL ACAD SCI USA, V103, P6565, DOI 10.1073/pnas.0601434103; Souza V, 2008, NAT REV MICROBIOL, V6, P559, DOI 10.1038/nrmicro1917; Souza V, 2012, ASTROBIOLOGY, V12, P641, DOI 10.1089/ast.2011.0675; Strickland MS, 2009, ECOLOGY, V90, P441, DOI 10.1890/08-0296.1; Taton A, 2003, APPL ENVIRON MICROB, V69, P5157, DOI 10.1128/AEM.69.9.5157-5169.2003; Varin T, 2012, APPL ENVIRON MICROB, V78, P549, DOI 10.1128/AEM.06354-11; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Warnes GR, 2012, J PHYCOL, DOI [10.1111/j.0022-3646.1997.00569.x, DOI 10.1111/J.0022-3646.1997.00569.X]; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Wolaver BD, 2013, GEOSPHERE, V9, P113, DOI 10.1130/GES00849.1; Yannarell AC, 2007, ENVIRON MICROBIOL, V9, P576, DOI 10.1111/j.1462-2920.2006.01173.x	72	11	11	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119741	10.1371/journal.pone.0119741	http://dx.doi.org/10.1371/journal.pone.0119741			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781013	Green Submitted, Green Published, gold			2022-12-27	WOS:000351284600087
J	Schicktanz, N; Fastenrath, M; Milnik, A; Spalek, K; Auschra, B; Nyffeler, T; Papassotiropoulos, A; de Quervain, DJF; Schwegler, K				Schicktanz, Nathalie; Fastenrath, Matthias; Milnik, Annette; Spalek, Klara; Auschra, Bianca; Nyffeler, Thomas; Papassotiropoulos, Andreas; de Quervain, Dominique J. -F.; Schwegler, Kyrill			Continuous Theta Burst Stimulation over the Left Dorsolateral Prefrontal Cortex Decreases Medium Load Working Memory Performance in Healthy Humans	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; COGNITIVE NEUROSCIENCE; EXCITABILITY; COMPONENT; FMRI; TMS	The dorsolateral prefrontal cortex (DLPFC) plays a key role in working memory. Evidence indicates that transcranial magnetic stimulation (TMS) over the DLPFC can interfere with working memory performance. Here we investigated for how long continuous theta-burst stimulation (cTBS) over the DLPFC decreases working memory performance and whether the effect of cTBS on performance depends on working memory load. Forty healthy young subjects received either cTBS over the left DLPFC or sham stimulation before performing a 2-, and 3-back working memory letter task. An additional 0-back condition served as a nonmemory- related control, measuring general attention. cTBS over the left DLPFC significantly impaired 2-back working memory performance for about 15 min, whereas 3-back and 0-back performances were not significantly affected. Our results indicate that the effect of left DLPFC cTBS on working memory performance lasts for roughly 15 min and depends on working memory load.	[Schicktanz, Nathalie; Fastenrath, Matthias; Spalek, Klara; de Quervain, Dominique J. -F.; Schwegler, Kyrill] Univ Basel, Dept Psychol, Div Cognit Neurosci, Basel, Switzerland; [Milnik, Annette; Auschra, Bianca; Papassotiropoulos, Andreas] Univ Basel, Dept Psychol, Div Mol Neurosci, Basel, Switzerland; [Papassotiropoulos, Andreas; de Quervain, Dominique J. -F.] Univ Basel, Life Sci Training Facil, Dept Biozentrum, Basel, Switzerland; [Schicktanz, Nathalie; Milnik, Annette; Papassotiropoulos, Andreas; de Quervain, Dominique J. -F.; Schwegler, Kyrill] Univ Basel, Psychiat Univ Clin, Basel, Switzerland; [Nyffeler, Thomas] Univ Hosp Bern, Inselspital, Dept Neurol, Percept & Eye Movement Lab, CH-3010 Bern, Switzerland; [Nyffeler, Thomas] Univ Hosp Bern, Inselspital, Dept Clin Res, Percept & Eye Movement Lab, CH-3010 Bern, Switzerland; [Nyffeler, Thomas] Univ Bern, Bern, Switzerland; [Nyffeler, Thomas] Luzerner Kantonsspital, Ctr Neurol & Neurorehabil, Luzern, Switzerland	University of Basel; University of Basel; University of Basel; University of Basel; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; Lucerne Cantonal Hospital	Schicktanz, N (corresponding author), Univ Basel, Dept Psychol, Div Cognit Neurosci, Basel, Switzerland.	nathalie.schicktanz@unibas.ch		Spalek, Klara/0000-0002-4244-6495; Papassotiropoulos, Andreas/0000-0002-2210-9651; Milnik, Annette/0000-0002-3933-3289; Nyffeler, Thomas/0000-0003-2504-8935; de Quervain, Dominique/0000-0001-7131-2464	Uniscientia Stiftung	Uniscientia Stiftung	Uniscientia Stiftung generously supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Balanza-Martinez V, 2008, NEUROSCI BIOBEHAV R, V32, P1426, DOI 10.1016/j.neubiorev.2008.05.019; Barch DM, 2005, ANNU REV CLIN PSYCHO, V1, P321, DOI 10.1146/annurev.clinpsy.1.102803.143959; D'Esposito M, 2007, PHILOS T R SOC B, V362, P761, DOI 10.1098/rstb.2007.2086; Doyle AE, 2006, J CLIN PSYCHIAT, V67, P21; Fitzgerald PB, 2006, CLIN NEUROPHYSIOL, V117, P2584, DOI 10.1016/j.clinph.2006.06.712; Gamboa OL, 2010, EXP BRAIN RES, V204, P181, DOI 10.1007/s00221-010-2293-4; GEVINS A, 1993, ELECTROEN CLIN NEURO, V87, P128, DOI 10.1016/0013-4694(93)90119-G; GoldmanRakic PS, 1996, P NATL ACAD SCI USA, V93, P13473, DOI 10.1073/pnas.93.24.13473; Goldsworthy MR, 2015, CEREB CORTEX, V25, P1724, DOI 10.1093/cercor/bht353; Goldsworthy MR, 2013, BRAIN STIMUL, V6, P340, DOI 10.1016/j.brs.2012.06.005; Heck A, 2014, NEURON, V81, P1203, DOI 10.1016/j.neuron.2014.01.010; Honey GD, 2002, NEUROIMAGE, V17, P573, DOI 10.1006/nimg.2002.1193; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Jonides J, 1997, J COGNITIVE NEUROSCI, V9, P462, DOI 10.1162/jocn.1997.9.4.462; Kaminski JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024836; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Laux L, 1981, STATE TRADIT ANGSTIN; Lee TG, 2012, J NEUROSCI, V32, P15458, DOI 10.1523/JNEUROSCI.0627-12.2012; Ma LS, 2012, HUM BRAIN MAPP, V33, P1850, DOI 10.1002/hbm.21329; Manelis A, 2015, CEREB CORTEX, V25, P726, DOI 10.1093/cercor/bht262; Morgan HM, 2013, BRAIN STIMUL, V6, P122, DOI 10.1016/j.brs.2012.03.001; Mottaghy FM, 2002, CEREB CORTEX, V12, P369, DOI 10.1093/cercor/12.4.369; Nyffeler T, 2006, EUR J NEUROSCI, V24, P2961, DOI 10.1111/j.1460-9568.2006.05154.x; Nyffeler T, 2006, NEUROSCI LETT, V409, P57, DOI 10.1016/j.neulet.2006.09.011; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Postle BR, 2006, NEUROSCIENCE, V139, P23, DOI 10.1016/j.neuroscience.2005.06.005; Robertson EM, 2003, J COGNITIVE NEUROSCI, V15, P948, DOI 10.1162/089892903770007344; Rottschy C, 2012, NEUROIMAGE, V60, P830, DOI 10.1016/j.neuroimage.2011.11.050; Sandrini M, 2011, NEUROSCI BIOBEHAV R, V35, P516, DOI 10.1016/j.neubiorev.2010.06.005; Schicktanz N, 2014, ANN CLIN TRANSL NEUR, V1, P69, DOI 10.1002/acn3.22; Silvanto J, 2008, TRENDS COGN SCI, V12, P447, DOI 10.1016/j.tics.2008.09.004; Sole-Padulles C, 2006, CEREB CORTEX, V16, P1487, DOI 10.1093/cercor/bhj083; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704	35	27	26	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120640	10.1371/journal.pone.0120640	http://dx.doi.org/10.1371/journal.pone.0120640			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781012	gold, Green Submitted, Green Published			2022-12-27	WOS:000351284600177
J	Cavanaugh, AR; Schwartz, GJ; Blouet, C				Cavanaugh, Althea R.; Schwartz, Gary J.; Blouet, Clemence			High-Fat Feeding Impairs Nutrient Sensing and Gut Brain Integration in the Caudomedial Nucleus of the Solitary Tract in Mice	PLOS ONE			English	Article							DIET-INDUCED OBESITY; EXTRACELLULAR AMINO-ACIDS; REGULATES FOOD-INTAKE; MEAL SIZE; MAMMALIAN TARGET; PARAVENTRICULAR NUCLEUS; HINDBRAIN NEURONS; SKELETAL-MUSCLE; ENERGY-BALANCE; RATS	Hyperphagic obesity is characterized in part by a specific increase in meal size that contributes to increased daily energy intake, but the mechanisms underlying impaired activity of meal size regulatory circuits, particularly those converging at the caudomedial nucleus of the solitary tract in the hindbrain (cmNTS), remain poorly understood. In this paper, we assessed the consequences ofhigh-fat (HF) feeding and diet-induced obesity (DIO) on cmNTS nutrient sensing and metabolic integration in the control of meal size. Mice maintained on a standard chow diet, low-fat (LF) diet or HF diet for 2 weeks or 6 months were implanted with a bilateral brain cannula targeting the cmNTS. Feeding behavior was assessed using behavioral chambers and meal-pattern analysis following cmNTS L-leucine injections alone or together with ip CCK. Molecular mechanisms implicated in the feeding responses were assessed using western blot, immunofluorescence and pharmacological inhibition of the amino acid sensing mTORC1 pathway (mammalian target of rapamycin complex 1). We found that HF feeding blunts the anorectic consequences of cmNTS L-leucine administration. Increased baseline activity of the L-leucine sensor P70 S6 kinase 1 and impaired L-leucine-induced activation of this pathway in the cmNTS of HF-fed mice indicate that HF feeding is associated with an impairment in cmNTS mTOR nutritional and hormonal sensing. Interestingly, the acute orexigenic effect of the mTORC1 inhibitor rapamycin was preserved in HF-fed mice, supporting the assertion that HF-induced increase in baseline cmNTS mTORC1 activity underlies the defect in L-leucine sensing. Last, the synergistic feeding-suppressive effect of CCK and cmNTS L-leucine was abrogated in DIO mice. These results indicate that HF feeding leads to an impairment in cmNTS nutrient sensing and metabolic integration in the regulation of meal size.	[Cavanaugh, Althea R.; Schwartz, Gary J.; Blouet, Clemence] Yeshiva Univ, Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Blouet, Clemence] Univ Cambridge, MRC, Inst Metab Sci, Metab Dis Unit, Cambridge, England	Yeshiva University; Albert Einstein College of Medicine; University of Cambridge	Schwartz, GJ (corresponding author), Yeshiva Univ, Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA.	gary.schwartz@einstein.yu.edu; csb69@medschl.cam.ac.uk		Blouet, Clemence/0000-0002-1752-1270	National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases [K99 DK 093724, R00 DK 020541]; Ajinomoto Amino Acid Research Program (3ARP); Medical Research Council [MC_UU_12012/5/B] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK093724, P30DK020541, R01DK105441, P30DK026687, P60DK020541] Funding Source: NIH RePORTER	National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Ajinomoto Amino Acid Research Program (3ARP); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases (K99 DK 093724 and R00 DK 020541) and the Ajinomoto Amino Acid Research Program (3ARP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthoud HR, 2006, PHYSIOL BEHAV, V89, P517, DOI 10.1016/j.physbeh.2006.08.018; Blevins JE, 2004, AM J PHYSIOL-REG I, V287, pR87, DOI 10.1152/ajpregu.00604.2003; Blouet C, 2012, CELL METAB, V16, P579, DOI 10.1016/j.cmet.2012.10.003; Blouet C, 2009, J NEUROSCI, V29, P8302, DOI 10.1523/JNEUROSCI.1668-09.2009; Choi YH, 2000, LIFE SCI, V66, P1105, DOI 10.1016/S0024-3205(00)00414-8; Choi YH, 2001, BRAIN RES, V892, P320, DOI 10.1016/S0006-8993(00)03267-4; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Cota D, 2008, J NEUROSCI, V28, P7202, DOI 10.1523/JNEUROSCI.1389-08.2008; Covasa M, 1998, PEPTIDES, V19, P1407, DOI 10.1016/S0196-9781(98)00096-5; Covasa M, 1999, AM J PHYSIOL-REG I, V277, pR279, DOI 10.1152/ajpregu.1999.277.1.R279; CURRIE PJ, 1995, LIFE SCI, V57, P1911, DOI 10.1016/0024-3205(95)02178-L; Cyr NE, 2014, ENDOCRINOLOGY, V155, P2423, DOI 10.1210/en.2013-1998; Donovan MJ, 2009, BRAIN RES, V1248, P136, DOI 10.1016/j.brainres.2008.10.042; Duca FA, 2013, INT J OBESITY, V37, P375, DOI 10.1038/ijo.2012.45; Farley C, 2003, OBES RES, V11, P845, DOI 10.1038/oby.2003.116; Fei W, 2012, PEPTIDES, P23, DOI [10.1016/j.peptides.2012.04.009, DOI 10.1016/J.PEPTIDES.2012.04.009]; Grill HJ, 2006, OBESITY, V14, P216, DOI 10.1038/oby.2006.312; Grill HJ, 2012, CELL METAB, V16, P296, DOI 10.1016/j.cmet.2012.06.015; Hawkins RA, 2006, J NUTR, V136, p218S, DOI 10.1093/jn/136.1.218S; Kageyama T, 2000, NEUROREPORT, V11, P3663, DOI 10.1097/00001756-200011270-00015; Kanoski SE, 2012, AM J PHYSIOL-ENDOC M, V303, pE496, DOI 10.1152/ajpendo.00205.2012; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Lutz TA, 2013, DIABETES OBES METAB, V15, P99, DOI 10.1111/j.1463-1326.2012.01670.x; Martin TL, 2006, J BIOL CHEM, V281, P18933, DOI 10.1074/jbc.M512831200; Orr ME, 2014, NEUROBIOL AGING, V35, P1233, DOI 10.1016/j.neurobiolaging.2013.12.006; Smith GP, 1996, NEUROSCI BIOBEHAV R, V20, P41, DOI 10.1016/0149-7634(95)00038-G; Treesukosol Y, 2014, APPETITE, V75, P21, DOI 10.1016/j.appet.2013.12.004; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Williams DL, 2011, PHYSIOL BEHAV, V103, P557, DOI 10.1016/j.physbeh.2011.04.005; Wu Q, 2012, NATURE, V483, P594, DOI 10.1038/nature10899; Zhao S, 2012, INT J OBESITY, V36, P1522, DOI 10.1038/ijo.2011.265	31	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118888	10.1371/journal.pone.0118888	http://dx.doi.org/10.1371/journal.pone.0118888			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774780	Green Published, gold, Green Submitted			2022-12-27	WOS:000351183500050
J	Ding, T; Hong, MH; Richards, AM; Wong, TI; Zhou, XD; Drum, CL				Ding, Tao; Hong, Minghui; Richards, A. Mark; Wong, Ten It; Zhou, Xiaodong; Drum, Chester Lee			Quantification of a Cardiac Biomarker in Human Serum Using Extraordinary Optical Transmission (EOT)	PLOS ONE			English	Article							SURFACE-PLASMON RESONANCE; SUBWAVELENGTH HOLE ARRAYS; CHEST-PAIN SYMPTOMS; TO-BALLOON TIME; MYOCARDIAL-INFARCTION; DIAGNOSTIC PROTOCOL; NANOHOLE ARRAYS; HIGH-THROUGHPUT; METAL-FILMS; REAL-TIME	Nanoimprinting lithography (NIL) is a manufacturing process that can produce macroscale surface areas with nanoscale features. In this paper, this technique is used to solve three fundamental issues for the application of localized surface plasmonic resonance (LSPR) in practical clinical measurements: assay sensitivity, chip-to-chip variance, and the ability to perform assays in human serum. Using NIL, arrays of 140 nm square features were fabricated on a sensing area of 1.5 mm x 1.5 mm with low cost. The high reproducibility of NIL allowed for the use of a one-chip, one-measurement approach with 12 individually manufactured surfaces with minimal chip-to-chip variations. To better approximate a real world setting, all chips were modified with a biocompatible, multi-component monolayer and interchip variability was assessed by measuring a bioanalyte standard (2.5-75 ng/ml) in the presence of a complex biofluid, human serum. In this setting, nanoimprinted LSPR chips were able to provide sufficient characteristics for a 'low-tech' approach to laboratory-based bioanalyte measurement, including: 1) sufficient size to interface with a common laboratory light source and detector without the need for a microscope, 2) high sensitivity in serum with a cardiac troponin limit of detection of 0.55 ng/ml, and 3) very low variability in chip manufacturing to produce a figure of merit (FOM) of 10.5. These findings drive LSPR closer to technical comparability with ELISA-based assays while preserving the unique particularities of a LSPR based sensor, suitability for multiplexing and miniaturization, and point-of-care detections.	[Ding, Tao; Richards, A. Mark; Drum, Chester Lee] Natl Univ Singapore, Yong Loo Lin Sch Med, Cardiovasc Res Inst, Singapore 117595, Singapore; [Hong, Minghui] Natl Univ Singapore, Dept Elect & Comp Engn, Singapore 117548, Singapore; [Wong, Ten It; Zhou, Xiaodong] ASTAR, Inst Mat Res Engn, Singapore, Singapore	National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Materials Research & Engineering (IMRE)	Drum, CL (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Cardiovasc Res Inst, Singapore 117595, Singapore.	mdccld@nus.edu.sg	Zhou, Xiao Dong/AAZ-3659-2020; Wong, Ten It/Q-1987-2016; Drum, Chester/A-6089-2015	Zhou, Xiao Dong/0000-0002-0195-4186; Wong, Ten It/0000-0002-5616-3365; Drum, Chester/0000-0001-6327-4584	Singapore Ministry of Health's National Medical Research Council [NMRC/CSA/035/2012]; National University of Singapore	Singapore Ministry of Health's National Medical Research Council(National Medical Research Council, Singapore); National University of Singapore(National University of Singapore)	This research is supported by the Singapore Ministry of Health's National Medical Research Council under its clinician scientist funding scheme, NMRC/CSA/035/2012 and the National University of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhagawati M, 2013, ANAL CHEM, V85, P9564, DOI 10.1021/ac401673e; Biswas A, 2012, ADV COLLOID INTERFAC, V170, P2, DOI 10.1016/j.cis.2011.11.001; Cannon CP, 2000, JAMA-J AM MED ASSOC, V283, P2941, DOI 10.1001/jama.283.22.2941; Chang TY, 2011, LAB CHIP, V11, P3596, DOI 10.1039/c1lc20475k; Coe JV, 2008, ANNU REV PHYS CHEM, V59, P179, DOI 10.1146/annurev.physchem.59.032607.093703; Dahlin AB, 2006, ANAL CHEM, V78, P4416, DOI 10.1021/ac0601967; Ebbesen TW, 1998, NATURE, V391, P667, DOI 10.1038/35570; Garcia-Vidal FJ, 2010, REV MOD PHYS, V82, P729, DOI 10.1103/RevModPhys.82.729; Gates BD, 2005, CHEM REV, V105, P1171, DOI 10.1021/cr030076o; Guo LJ, 2007, ADV MATER, V19, P495, DOI 10.1002/adma.200600882; Guo LH, 2012, BIOSENS BIOELECTRON, V31, P567, DOI 10.1016/j.bios.2011.10.047; Im H, 2012, ANAL CHEM, V84, P1941, DOI 10.1021/ac300070t; Ji J, 2008, ANAL CHEM, V80, P2491, DOI 10.1021/ac7023206; Kim JH, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2355468; Krishnan A, 2001, OPT COMMUN, V200, P1, DOI 10.1016/S0030-4018(01)01558-9; Lesuffleur A, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2747668; Lin EH, 2014, OPT EXPRESS, V22, P19621, DOI 10.1364/OE.22.019621; Liu HT, 2008, NATURE, V452, P728, DOI 10.1038/nature06762; Live LS, 2010, ANAL CHEM, V82, P3780, DOI 10.1021/ac100177j; McNamara RL, 2006, J AM COLL CARDIOL, V47, P2180, DOI 10.1016/j.jacc.2005.12.072; Nahshol O, 2008, ANAL BIOCHEM, V383, P52, DOI 10.1016/j.ab.2008.08.017; Nakamoto K, 2012, ANAL CHEM, V84, P3187, DOI 10.1021/ac203160r; Schwind M, 2013, NANO LETT, V13, P1743, DOI 10.1021/nl400328x; Sharpe JC, 2008, ANAL CHEM, V80, P2244, DOI 10.1021/ac702555r; Shon YS, 2009, PLASMONICS, V4, P95, DOI 10.1007/s11468-009-9079-1; Stark PRH, 2005, METHODS, V37, P37, DOI 10.1016/j.ymeth.2005.05.006; Stewart ME, 2006, P NATL ACAD SCI USA, V103, P17143, DOI 10.1073/pnas.0606216103; Than M, 2012, J AM COLL CARDIOL, V59, P2091, DOI 10.1016/j.jacc.2012.02.035; Than M, 2011, LANCET, V377, P1077, DOI 10.1016/S0140-6736(11)60310-3; Valsecchi C, 2013, LANGMUIR, V29, P5638, DOI 10.1021/la400085r; Wong TI, 2013, LAB CHIP, V13, P2405, DOI 10.1039/c3lc41396a; Wu L, 2012, IEEE PHOTONICS J, V4, P26, DOI 10.1109/JPHOT.2011.2177652; Wu L, 2012, J OPT SOC AM B, V29, P521, DOI 10.1364/JOSAB.29.000521; Xiang GS, 2010, NANOSCALE RES LETT, V5, P818, DOI 10.1007/s11671-010-9566-5; Yang J, 2014, LIGHT-SCI APPL, V3, DOI 10.1038/lsa.2014.66; Yang JC, 2010, NANO LETT, V10, P3173, DOI 10.1021/nl102078j	36	12	12	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120974	10.1371/journal.pone.0120974	http://dx.doi.org/10.1371/journal.pone.0120974			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774658	gold, Green Published, Green Submitted			2022-12-27	WOS:000351183500202
J	Geng, PL; Liao, YM; Ruan, ZH; Liang, HJ				Geng, Peiliang; Liao, Yunmei; Ruan, Zhihua; Liang, Houjie			Increased Risk of Cutaneous Melanoma Associated with p53 Arg72Pro Polymorphism	PLOS ONE			English	Article							TP53 ARG72PRO; SKIN-CANCER; CODON-72 POLYMORPHISM; MDM2 SNP309; PATHOGENESIS; METAANALYSIS	Objective The objective of this study was to test the hypothesis that p53 Arg72Pro polymorphism may contribute to an increased risk of cutaneous melanoma (CM). Methods By searching the databases of PubMed, EMBASE, and Web of Science, a total of 8 eligible case-control studies with 1,957 CM cases and 2,887 controls were included in this metaanalysis. Stata software was used to analyze all the statistical data. Results The pooled data by a fixed-effects model suggested an increased risk of CM associated with p53 Arg72Pro polymorphism under the genetic model of Arg/Pro vs. Pro/Pro without heterogeneity (ORArg/Pro vs. Pro/Pro = 1.76, 95% CI = 1.55-1.99, P-heterogeneity = 0.075). A similar trend was seen in subgroups of hospital-based studies and population-based studies. Conclusion Our meta-analysis based on all studies shows that the p53 Arg72Pro polymorphism may increase individual susceptibility to CM, particularly in Caucasians and could serve as a biomarker to predict the population at high risk of CM.	[Liang, Houjie] Third Mil Med Univ, Southwest Hosp, Dept Oncol, Chongqing, Peoples R China; Third Mil Med Univ, Southwest Hosp, Southwest Canc Ctr, Chongqing, Peoples R China	Army Medical University; Army Medical University	Liang, HJ (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Oncol, Chongqing, Peoples R China.	lianghoujie@sina.com			National Natural Science Foundation of China [81272364]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grant number 81272364 from the National Natural Science Foundation of China (to HJL). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastiaens MT, 2001, MOL CARCINOGEN, V30, P56, DOI 10.1002/1098-2744(200101)30:1<56::AID-MC1013>3.0.CO;2-2; Bcnjamin CL, 2008, ADV EXP MED BIOL, V624, P265, DOI 10.1007/978-0-387-77574-6_21; Benjamin CL, 2007, TOXICOL APPL PHARM, V224, P241, DOI 10.1016/j.taap.2006.12.006; Bray F, 2002, EUR J CANCER, V38, P99, DOI 10.1016/S0959-8049(01)00350-1; Capasso M, 2010, J HUM GENET, V55, P518, DOI 10.1038/jhg.2010.62; Cotignola J, 2012, J INVEST DERMATOL, V132, P1471, DOI 10.1038/jid.2012.15; de Gruijl FR, 2002, SKIN PHARMACOL APPL, V15, P316, DOI 10.1159/000064535; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Goldstein AM, 2001, ARCH DERMATOL, V137, P1493; Gwosdz C, 2006, INT J CANCER, V118, P577, DOI 10.1002/ijc.21366; Halachmi S, 2001, CURR OPIN ONCOL, V13, P129, DOI 10.1097/00001622-200103000-00008; Han JL, 2006, MOL CARCINOGEN, V45, P694, DOI 10.1002/mc.20190; Hussain S P, 2000, Ann N Y Acad Sci, V919, P79; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jiang DK, 2011, J INVEST DERMATOL, V131, P220, DOI 10.1038/jid.2010.270; Jiang WD, 1999, ONCOGENE, V18, P4247, DOI 10.1038/sj.onc.1202789; Kaelin WG, 1999, ONCOGENE, V18, P7701, DOI 10.1038/sj.onc.1202955; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Li CY, 2008, J INVEST DERMATOL, V128, P1585, DOI 10.1038/sj.jid.5701186; MANTEL N, 1959, J NATL CANCER I, V22, P719; Oliveira C, 2013, J CANCER RES CLIN, V139, P1199, DOI 10.1007/s00432-013-1430-4; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Ortonne JP, 2002, BRIT J DERMATOL, V146, P11, DOI 10.1046/j.1365-2133.146.s61.4.x; Robles AI, 2001, ACTA ONCOL, V40, P696; Shen HB, 2003, J INVEST DERMATOL, V121, P1510, DOI 10.1046/j.1523-1747.2003.12648.x; Spatz A, 2001, CANCER RES, V61, P2480; Stefanaki I, 2007, BRIT J DERMATOL, V156, P357, DOI 10.1111/j.1365-2133.2006.07645.x; Thurow HS, 2011, J BIOSCIENCES, V36, P823, DOI 10.1007/s12038-011-9147-5; Whibley C, 2009, NAT REV CANCER, V9, P95, DOI 10.1038/nrc2584; Zou YF, 2011, J INVEST DERMATOL, V131, P781, DOI 10.1038/jid.2010.367	32	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118112	10.1371/journal.pone.0118112	http://dx.doi.org/10.1371/journal.pone.0118112			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774791	Green Published, gold, Green Submitted			2022-12-27	WOS:000351183500023
J	Huang, Q; Wen, S; Wang, B; Wang, QD; Guo, CG; Wu, XY; Zhang, R; Yang, R; Chen, F; Xiao, WB				Huang, Qiang; Wen, Song; Wang, Bo; Wang, Qidong; Guo, Chuangen; Wu, Xinying; Zhang, Rui; Yang, Rong; Chen, Feng; Xiao, Wenbo			C5b-9-Targeted Molecular MR Imaging in Rats with Heymann Nephritis: A New Approach in the Evaluation of Nephrotic Syndrome	PLOS ONE			English	Article							GLOMERULAR MESANGIAL CELLS; IRON-OXIDE NANOPARTICLES; SUBLYTIC C5B-9 COMPLEXES; IN-VIVO; AFFIBODY MOLECULES; THY-1 NEPHRITIS; APOPTOSIS; INJURY; MODEL	Membranous nephropathy (MN) is the major cause of adult nephrotic syndrome, which severely affects patients' quality of life. Currently, percutaneous renal biopsy is required to definitively diagnose MN. However, this technique is invasive and may cause severe complications. Therefore, an urgent clinical need exists for dynamic noninvasive monitoring of the renal state. In-depth molecular imaging studies could assist in finding a solution. Membrane attack complex C5b-9 is the key factor in the development of MN, and this protein primarily deposits in the glomerulus. The present study bound polyclonal antibodies to C5b-9 with ultrasmall superparamagnetic iron oxide (USPIO) nanoparticles to obtain C5b-9-targeted magnetic resonance molecular imaging probes. The probes were injected intravenously into rats with Heymann nephritis, a classic disease model of MN. The signal intensity in the T2*-weighted imaging of kidneys in vivo using 7.0 Tesla magnetic resonance imaging decreased significantly 24 hours after injection compared to the untargeted and control groups. This signal change was consistent with the finding of nanoparticle deposits in pathological glomeruli. This study demonstrated a novel molecular imaging technique for the assessment of MN.	[Huang, Qiang; Wang, Qidong; Guo, Chuangen; Zhang, Rui; Yang, Rong; Chen, Feng; Xiao, Wenbo] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Radiol, Hangzhou 310003, Zhejiang, Peoples R China; [Wen, Song] Southeast Univ, Sch Med, Jiangsu Key Lab Mol & Funct Imaging, Nanjing, Jiangsu, Peoples R China; [Wang, Bo] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Pathol, Hangzhou 310003, Zhejiang, Peoples R China; [Wu, Xinying] Nanjing Med Univ, Nanjing Hosp 1, Dept Radiol, Nanjing, Jiangsu, Peoples R China	Zhejiang University; Southeast University - China; Zhejiang University; Nanjing Medical University	Xiao, WB (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Radiol, Hangzhou 310003, Zhejiang, Peoples R China.	chenfengbe@aliyun.com; xiaowb.111@163.com			National Natural Science Foundation of P.R. China [81171388, 81201128]; Ministry of Health Research Foundation of P.R. China [WKJ2011-2-004]; Medical Science and technology development Foundation, Nanjing Department of Health [YKK13102]	National Natural Science Foundation of P.R. China(National Natural Science Foundation of China (NSFC)); Ministry of Health Research Foundation of P.R. China; Medical Science and technology development Foundation, Nanjing Department of Health	This study was supported by grants from the National Natural Science Foundation of P.R. China (81171388), and partly from the Ministry of Health Research Foundation of P.R. China (WKJ2011-2-004), the National Natural Science Foundation of P.R. China (81201128), Key Project supported by Medical Science and technology development Foundation, Nanjing Department of Health (YKK13102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altai M, 2014, EUR J MED CHEM, V87, P519, DOI 10.1016/j.ejmech.2014.09.082; Altai M, 2013, CANCER BIOTHER RADIO, V28, P187, DOI 10.1089/cbr.2012.1304; Cai QY, 2012, NANOMED-NANOTECHNOL, V8, P365, DOI 10.1016/j.nano.2011.06.019; Cybulsky AV, 2005, AM J PHYSIOL-RENAL, V289, pF593, DOI 10.1152/ajprenal.00066.2005; Fei XN, 2010, MOLECULES, V15, P6983, DOI 10.3390/molecules15106983; Hauger O, 2006, RADIOLOGY, V238, P200, DOI 10.1148/radiol.2381041668; Hauger O, 1999, MAGNET RESON MED, V41, P156, DOI 10.1002/(SICI)1522-2594(199901)41:1<156::AID-MRM22>3.0.CO;2-C; He C, 2005, J IMMUNOL, V174, P5750, DOI 10.4049/jimmunol.174.9.5750; HEYMANN W, 1959, P SOC EXP BIOL MED, V100, P660; Honarvar H, 2013, NUCL MED BIOL, V40, P378, DOI 10.1016/j.nucmedbio.2012.12.009; Korbet SM, 2002, SEMIN NEPHROL, V22, P254, DOI 10.1053/snep.2002.31713; Liu LS, 2012, J BIOL CHEM, V287, P16410, DOI 10.1074/jbc.M111.319566; Liu SJ, 2009, MOL PHARMACEUT, V6, P1074, DOI 10.1021/mp900143a; LOTAN D, 1984, KIDNEY INT, V25, P778, DOI 10.1038/ki.1984.90; Madhav D, 2011, SAUDI J KIDNEY DIS T, V22, P544; MALATHI P, 1979, BIOCHIM BIOPHYS ACTA, V554, P259, DOI 10.1016/0005-2736(79)90023-3; NOMURA A, 1995, J CLIN INVEST, V96, P2348, DOI 10.1172/JCI118291; Qiao JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018103; Qiao RR, 2012, ACS NANO, V6, P3304, DOI 10.1021/nn300240p; Qiu W, 2009, EUR J IMMUNOL, V39, P3251, DOI 10.1002/eji.200939264; Ronco P, 2010, J AM SOC NEPHROL, V21, P564, DOI 10.1681/ASN.2009121220; Salzer R, 2007, ANAL BIOANAL CHEM, V389, P1101, DOI 10.1007/s00216-007-1529-z; Sargsyan SA, 2012, KIDNEY INT, V81, P152, DOI 10.1038/ki.2011.332; Serkova NJ, 2010, RADIOLOGY, V255, P517, DOI 10.1148/radiol.09091134; Thorek DLJ, 2006, ANN BIOMED ENG, V34, P23, DOI 10.1007/s10439-005-9002-7; Munoz AT, 2011, ARCH MED SCI, V7, P823, DOI 10.5114/aoms.2011.25557; Trivedi RA, 2004, STROKE, V35, P1631, DOI 10.1161/01.STR.0000131268.50418.b7; Wallberg H, 2011, PROTEIN EXPRES PURIF, V76, P127, DOI 10.1016/j.pep.2010.10.008; Wen S, 2012, J LIPID RES, V53, P829, DOI 10.1194/jlr.M018895; Zhang YQ, 2000, KIDNEY INT, V58, P1300, DOI 10.1046/j.1523-1755.2000.00286.x	30	7	7	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0121244	10.1371/journal.pone.0121244	http://dx.doi.org/10.1371/journal.pone.0121244			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774523	Green Published, gold, Green Submitted			2022-12-27	WOS:000351183500210
J	Nithya, R; Ahmed, SA; Hoe, CH; Gopinath, SCB; Citartan, M; Chinni, SV; Lee, LP; Rozhdestvensky, TS; Tang, TH				Nithya, Ravichantar; Ahmed, Siti Aminah; Hoe, Chee-Hock; Gopinath, Subash C. B.; Citartan, Marimuthu; Chinni, Suresh V.; Lee, Li Pin; Rozhdestvensky, Timofey S.; Tang, Thean-Hock			Non-Protein Coding RNA Genes as the Novel Diagnostic Markers for the Discrimination of Salmonella Species Using PCR	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; MULTIPLEX PCR; NONCODING RNAS; PARATYPHI-A; RAPID DETECTION; IDENTIFICATION; TYPHI; DIFFERENTIATION; AMPLIFICATION; METASTASIS	Salmonellosis, a communicable disease caused by members of the Salmonella species, transmitted to humans through contaminated food or water. It is of paramount importance, to generate accurate detection methods for discriminating the various Salmonella species that cause severe infection in humans, including S. Typhi and S. Paratyphi A. Here, we formulated a strategy of detection and differentiation of salmonellosis by a multiplex polymerase chain reaction assay using S. Typhi non-protein coding RNA (sRNA) genes. With the designed sequences that specifically detect sRNA genes from S. Typhi and S. Paratyphi A, a detection limit of up to 10 pg was achieved. Moreover, in a stool-seeding experiment with S. Typhi and S. Paratyphi A, we have attained a respective detection limit of 15 and 1.5 CFU/mL. The designed strategy using sRNA genes shown here is comparatively sensitive and specific, suitable for clinical diagnosis and disease surveillance, and sRNAs represent an excellent molecular target for infectious disease.	[Nithya, Ravichantar; Ahmed, Siti Aminah; Hoe, Chee-Hock; Gopinath, Subash C. B.; Citartan, Marimuthu; Lee, Li Pin; Tang, Thean-Hock] Univ Sains Malaysia, Adv Med & Dent Inst, Kepala Batas, Penang, Malaysia; [Gopinath, Subash C. B.] Univ Malaysia Perlis, Inst Nano Elect Engn, Kangar, Perlis, Malaysia; [Gopinath, Subash C. B.] Univ Malaysia Perlis, Sch Bioproc Engn, Kangar, Perlis, Malaysia; [Chinni, Suresh V.] AIMST Univ, Fac Sci Appl, Dept Biotechnol, Bedong, Malaysia; [Rozhdestvensky, Timofey S.] Univ Munster, Inst Expt Pathol, D-48149 Munster, Germany	Universiti Sains Malaysia; Universiti Malaysia Perlis; Universiti Malaysia Perlis; AIMST University; University of Munster	Gopinath, SCB (corresponding author), Univ Sains Malaysia, Adv Med & Dent Inst, Kepala Batas, Penang, Malaysia.	subash@unimap.edu.my; tangth@amdi.usm.edu.my	Nithya, Ravichantar/GZL-9537-2022; Chinni, Venkata Suresh/A-7313-2011; citartan, marimuthu/U-2392-2019; Rozhdestvensky, Timofey/R-2270-2019; Gopinath, Subash/D-2953-2015; citartan, marimuthu/K-7811-2013; Ahmed, Siti Aminah/B-7725-2014	Rozhdestvensky, Timofey/0000-0002-3384-925X; Gopinath, Subash/0000-0002-8347-4687; Ahmed, Siti Aminah/0000-0002-0626-175X; Suresh Chinni, Venkata/0000-0002-4697-2994	Advanced Medical and Dental Institute Postgraduate Research Grant Scheme; National Genome Research Network [NGFNIII 01GS0808]; Universiti Sains Malaysia Graduate Assistant Scheme	Advanced Medical and Dental Institute Postgraduate Research Grant Scheme; National Genome Research Network; Universiti Sains Malaysia Graduate Assistant Scheme	This work was funded by the Advanced Medical and Dental Institute Postgraduate Research Grant Scheme and by the National Genome Research Network (grant #NGFNIII 01GS0808). The authors would like to thank the Universiti Sains Malaysia Graduate Assistant Scheme for funding Nithya Ravichantar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SA, 2012, MALAYS J MED SCI, V19, P9; Aziah I, 2007, DIAGN MICR INFEC DIS, V59, P373, DOI 10.1016/j.diagmicrobio.2007.05.014; Baele M, 2004, J CLIN MICROBIOL, V42, P1115, DOI 10.1128/JCM.42.3.1115-1122.2004; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bronze M.S, 2005, BIODEFENCE PRINCIPLE; Buckle Geoffrey C, 2012, J Glob Health, V2, P010401, DOI 10.7189/jogh.02.010401; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Chang CC, 2012, SENSORS-BASEL, V12, P8319, DOI 10.3390/s120608319; Chinni SV, 2010, NUCLEIC ACIDS RES, V38, P5893, DOI 10.1093/nar/gkq281; Cocolin L, 1998, FEMS IMMUNOL MED MIC, V22, P233, DOI 10.1111/j.1574-695X.1998.tb01211.x; COMPTON J, 1991, NATURE, V350, P91, DOI 10.1038/350091a0; Connor BA, 2005, LANCET INFECT DIS, V5, P623, DOI 10.1016/S1473-3099(05)70239-5; Costa FF, 2005, GENE, V357, P83, DOI 10.1016/j.gene.2005.06.019; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; de Gruyter W, 2010, MOL DIAGNOSTICS INFE; Deng W, 2003, J BACTERIOL, V185, P2330, DOI 10.1128/JB.185.7.2330-2337.2003; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Gonzalez-Escalona N, 2009, APPL ENVIRON MICROB, V75, P3714, DOI 10.1128/AEM.02686-08; Gopinath SCB, 2014, BIOSENS BIOELECTRON, V60, P332, DOI 10.1016/j.bios.2014.04.014; Gopinath SCB, 2010, MOL CANCER RES, V8, P1536, DOI 10.1158/1541-7786.MCR-10-0242; Hall PA, 2005, HEMATOL ONCOL, V23, P49, DOI 10.1002/hon.748; Henegariu O, 1997, BIOTECHNIQUES, V23, P504, DOI 10.2144/97233rr01; Hirose K, 2002, J CLIN MICROBIOL, V40, P633, DOI 10.1128/JCM.40.02.633-636.2002; Ho CC, 2012, J CLIN MICROBIOL, V50, P1905, DOI 10.1128/JCM.06843-11; Huttenhofer A, 2005, TRENDS GENET, V21, P289, DOI 10.1016/j.tig.2005.03.007; Jay JM, 2010, MODERN FOOD MICROBIO, P511; Jeong ES, 2011, EXP ANIM TOKYO, V60, P65, DOI 10.1538/expanim.60.65; KONGMUANG U, 1994, J CLIN MICROBIOL, V32, P3072, DOI 10.1128/JCM.32.12.3072-3074.1994; Livny J, 2010, NUCLEIC ACIDS RES, V38, P1504, DOI 10.1093/nar/gkp1121; Maskey AP, 2008, T ROY SOC TROP MED H, V102, P91, DOI 10.1016/j.trstmh.2007.10.003; Massi Muhammad Nasrum, 2003, Journal of Infection and Chemotherapy, V9, P233, DOI 10.1007/s10156-003-0256-4; Meng XQ, 2013, GASTROENTEROLOGY, V145, P426, DOI 10.1053/j.gastro.2013.04.004; Ngan GJY, 2010, RES MICROBIOL, V161, P243, DOI 10.1016/j.resmic.2010.03.005; Ochiai RL, 2005, EMERG INFECT DIS, V11, P1764, DOI 10.3201/eid1111.050168; Pokharel BM, 2006, INT J INFECT DIS, V10, P434, DOI 10.1016/j.ijid.2006.07.001; Raabe CA, 2011, RNA, V17, P1357, DOI 10.1261/rna.2682311; Ren SC, 2013, EUR J CANCER, V49, P2949, DOI 10.1016/j.ejca.2013.04.026; Rozhdeswensky TS, 2007, RNA BIOL, V4, P11, DOI 10.4161/rna.4.1.4306; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Storz G, 2002, SCIENCE, V296, P1260, DOI 10.1126/science.1072249; Tang TH, 2005, MOL MICROBIOL, V55, P469, DOI 10.1111/j.1365-2958.2004.04428.x; Tang TH, 2013, WORLD J MICROB BIOT, V29, P2389, DOI 10.1007/s11274-013-1407-0; Tankhiwale SS, 2003, INDIAN J MED RES, V117, P10; Tantawiwat Suwalee, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P162; Teh CSJ, 2008, JPN J INFECT DIS, V61, P313; Thong KL, 2013, WIPO Patent, Patent No. [WO2013070060 A1, 2013070060]; Upadhyay BP, 2010, SE ASIAN J TROP MED, V41, P426; Valerio E, 2009, MICROBIOL-SGM, V155, P642, DOI 10.1099/mic.0.022848-0; Wang Jan-Yi, 2009, Taiwanese Journal of Agricultural Chemistry and Food Science, V47, P17; Washietl S, 2005, NAT BIOTECHNOL, V23, P1383, DOI 10.1038/nbt1144; Wei B, 2013, POULTRY SCI, V92, P1164, DOI 10.3382/ps.2012-02823; Yong FL, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-280; Zhou YX, 2011, J CELL PHYSIOL, V226, P968, DOI 10.1002/jcp.22483; Zhu Q, 1996, J APPL BACTERIOL, V80, P244, DOI 10.1111/j.1365-2672.1996.tb03216.x	54	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118668	10.1371/journal.pone.0118668	http://dx.doi.org/10.1371/journal.pone.0118668			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774907	gold, Green Submitted, Green Published			2022-12-27	WOS:000351183500033
J	Pandey, R; Botros, MA; Nacev, BA; Albig, AR				Pandey, Raghav; Botros, Mark A.; Nacev, Benjamin A.; Albig, Allan R.			Cyclosporin A Disrupts Notch Signaling and Vascular Lumen Maintenance	PLOS ONE			English	Article							VESSEL FORMATION; ANKYRIN DOMAIN; GROWTH-FACTOR; ZEBRAFISH; ANGIOGENESIS; CALCINEURIN; ACTIVATION; TARGET; MORPHOGENESIS; INHIBITION	Cyclosporin A (CSA) suppresses immune function by blocking the cyclophilin A and calcineurin/NFAT signaling pathways. In addition to immunosuppression, CSA has also been shown to have a wide range of effects in the cardiovascular system including disruption of heart valve development, smooth muscle cell proliferation, and angiogenesis inhibition. Circumstantial evidence has suggested that CSA might control Notch signaling which is also a potent regulator of cardiovascular function. Therefore, the goal of this project was to determine if CSA controls Notch and to dissect the molecular mechanism(s) by which CSA impacts cardiovascular homeostasis. We found that CSA blocked JAG1, but not DII4 mediated Notch1 NICD cleavage in transfected 293T cells and decreased Notch signaling in zebrafish embryos. CSA suppression of Notch was linked to cyclophilin A but not calcineurin/NFAT inhibition since N-MeVal-4-CsA but not FK506 decreased Notch1 NICD cleavage. To examine the effect of CSA on vascular development and function, double transgenic Fli1-GFP/Gata1-RFP zebrafish embryos were treated with CSA and monitored for vasculogenesis, angiogenesis, and overall cardiovascular function. Vascular patterning was not obviously impacted by CSA treatment and contrary to the anti-angiogenic activity ascribed to CSA, angiogenic sprouting of ISV vessels was normal in CSA treated embryos. Most strikingly, CSA treated embryos exhibited a progressive decline in blood flow that was associated with eventual collapse of vascular luminal structures. Vascular collapse in zebrafish embryos was partially rescued by global Notch inhibition with DAPT suggesting that disruption of normal Notch signaling by CSA may be linked to vascular collapse. However, multiple signaling pathways likely cause the vascular collapse phenotype since both cyclophilin A and calcineurin/NFAT were required for normal vascular function. Collectively, these results show that CSA is a novel inhibitor of Notch signaling and vascular function in zebrafish embryos.	[Pandey, Raghav] Univ Cincinnati, Dept Canc & Cell Biol, Cincinnati, OH USA; [Botros, Mark A.] Duke Univ, Dept Biol, Durham, NC USA; [Nacev, Benjamin A.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Nacev, Benjamin A.] Johns Hopkins Univ, Sch Med, Med Scientist Training Program, Baltimore, MD USA; [Albig, Allan R.] Boise State Univ, Dept Biol, Boise, ID 83725 USA	University System of Ohio; University of Cincinnati; Duke University; Johns Hopkins University; Johns Hopkins University; Idaho; Boise State University	Albig, AR (corresponding author), Boise State Univ, Dept Biol, Boise, ID 83725 USA.	allanalbig@boisestate.edu			National Institutes of Health (NIH) [3R15CA133829-01A1S1]; ISU College of Graduate and Professional Studies (CGPS, Student Research Fund); INBRE program (NIH) [P20 RR016454, GM103408]; NIH medical Scientist Training Program [T32GM07309]; NATIONAL CANCER INSTITUTE [R15CA133829] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103408, T32GM007309, P20GM109095] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ISU College of Graduate and Professional Studies (CGPS, Student Research Fund); INBRE program (NIH); NIH medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the National Institutes of Health (NIH) (Grant # 3R15CA133829-01A1S1 to ARA), ISU College of Graduate and Professional Studies (CGPS, Student Research Fund to RP), the INBRE program (NIH Grant # P20 RR016454 (National Center for Research Resources) and # P20 GM103408 (National Institute of General Medical Sciences), and the NIH medical Scientist Training Program Grant T32GM07309 (BAN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alva JA, 2004, CURR OPIN HEMATOL, V11, P278, DOI 10.1097/01.moh.0000130309.44976.ad; Alvarez-Arroyo MV, 2002, CIRC RES, V91, P202, DOI 10.1161/01.RES.0000027562.91075.56; Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Bradley CM, 2005, J MOL BIOL, V352, P253, DOI 10.1016/j.jmb.2005.06.041; Cannon JE, 2010, BRIT J PHARMACOL, V161, P140, DOI 10.1111/j.1476-5381.2010.00871.x; Chan J, 2002, CANCER CELL, V1, P257, DOI 10.1016/S1535-6108(02)00042-9; Chang CP, 2004, CELL, V118, P649, DOI 10.1016/j.cell.2004.08.010; CLIPSTONE NA, 1993, ANN NY ACAD SCI, V696, P20; Courtwright A, 2009, CANCER RES, V69, P4621, DOI 10.1158/0008-5472.CAN-08-3402; Iurlaro M, 1998, EXP HEMATOL, V26, P1215; Kadesch T, 2004, CURR OPIN GENET DEV, V14, P506, DOI 10.1016/j.gde.2004.07.007; Kim SH, 2004, AM J PATHOL, V164, P1567, DOI 10.1016/S0002-9440(10)63715-7; Leslie JD, 2007, DEVELOPMENT, V134, P839, DOI 10.1242/dev.003244; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Mammucari C, 2005, DEV CELL, V8, P665, DOI 10.1016/j.devcel.2005.02.016; Bradley CM, 2006, STRUCTURE, V14, P1303, DOI 10.1016/j.str.2006.06.013; Nacev BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024793; Nacev BA, 2011, J PHARMACOL EXP THER, V338, P466, DOI 10.1124/jpet.111.180851; Nasevicius A, 2000, YEAST, V17, P294, DOI 10.1002/1097-0061(200012)17:4<294::AID-YEA54>3.0.CO;2-5; NORRBY K, 1992, EXPERIENTIA, V48, P1135, DOI 10.1007/BF01948007; Parsons MJ, 2009, MECH DEVELOP, V126, P898, DOI 10.1016/j.mod.2009.07.002; Rafiee Parvaneh, 2004, Cell Commun Signal, V2, P3, DOI 10.1186/1478-811X-2-3; Ribatti D, 2000, INFLAMM RES, V49, P418, DOI 10.1007/s000110050610; Ruchoux MM, 2003, AM J PATHOL, V162, P329, DOI 10.1016/S0002-9440(10)63824-2; RUSCETTI FW, 1981, BLOOD, V57, P379; Rustighi A, 2009, NAT CELL BIOL, V11, P133, DOI 10.1038/ncb1822; Shah G, 2008, J SURG RES, V149, P171, DOI 10.1016/j.jss.2008.03.016; Shawber CJ, 2004, BIOESSAYS, V26, P225, DOI 10.1002/bies.20004; Siamakpour-Reihani S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020412; Vajkoczy P, 1999, J MOL MED, V77, P111, DOI 10.1007/s001090050314; Wang YY, 2014, DEVELOPMENT, V141, P307, DOI 10.1242/dev.096107; WELTE K, 1982, J EXP MED, V156, P454, DOI 10.1084/jem.156.2.454; Zanotti S, 2011, J BIOL CHEM, V286, P4576, DOI 10.1074/jbc.M110.161893; Zecchin E, 2007, DEV BIOL, V301, P192, DOI 10.1016/j.ydbio.2006.09.041; Zeini M, 2009, DEVELOPMENT, V136, P3335, DOI 10.1242/dev.037903	35	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119279	10.1371/journal.pone.0119279	http://dx.doi.org/10.1371/journal.pone.0119279			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775018	Green Published, gold, Green Submitted			2022-12-27	WOS:000351183500079
J	Peng, Q; Li, SP; Ma, KZ; Li, WR; Ma, Q; He, XG; He, YJ; He, T; Lu, XM				Peng, Qi; Li, Siping; Ma, Keze; Li, Wenrui; Ma, Qiang; He, Xiaoguang; He, Yuejing; He, Ting; Lu, Xiaomei			Large Cohort Screening of G6PD Deficiency and the Mutational Spectrum in the Dongguan District in Southern China	PLOS ONE			English	Article							DOT-BLOT ASSAY; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY; HAPLOTYPES	Background Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a common enzymatic disorder of the erythrocytes that affects 400 million people worldwide. We developed a PCR-reverse dot blot (RDB) assay to screen twenty genotypes of seventeen Chinese G6PD mutations and investigate the spectrum of G6PD deficiency mutations in Dongguan District, Guangdong Province, in southern China. Method The PCR-RDB assay consists of multiplex PCR amplification of seven fragments in the G6PD target sequence of wild-type and mutant genomic DNA samples followed by hybridization to a test strip containing allele-specific oligonucleotide probes. A total of 16,464 individuals were analyzed by a combination of phenotypic screening and genotypic detection using the PCR-RDB assay and DNA sequence analysis. Results The PCR-RDB assay had a detection rate of 98.1%, which was validated by direct sequencing in a blind study with 100% concordance. The G6PD deficiency incidence rate in Dongguan District is 4.08%. Thirty-two genotypes from 469 individuals were found. The two most common variants were c.1376G>T and c.1388G>A, followed by c.95A>G, c.871G>A, c.392G>T, and c.1024C>T. In addition, two rare mutations (c.703C>A and c.406C>T) were detected by DNA sequencing analysis. In our study, 65 cases harbored the C1311T/IVS polymorphism and 67 cases were homozygote. Conclusion The PCR-RDB assay we established is a reliable and effective method for screening G6PD mutations in the Chinese population. Data on the spectrum of mutations in the Dongguan District is beneficial to the clinical diagnosis and prevention of G6PD deficiency.	[Peng, Qi; Li, Siping; Ma, Keze; Li, Wenrui; Ma, Qiang; He, Xiaoguang; He, Yuejing; He, Ting; Lu, Xiaomei] Eighth Peoples Hosp Dongguan, Dongguan Inst Pediat, Dongguan, Guangdong, Peoples R China		Lu, XM (corresponding author), Eighth Peoples Hosp Dongguan, Dongguan Inst Pediat, Dongguan, Guangdong, Peoples R China.	lxm020@126.com			Dongguan Bureau of Science and Technology for the City Key Program of Science and Technology [2011105102017]	Dongguan Bureau of Science and Technology for the City Key Program of Science and Technology	This work was supported by the Dongguan Bureau of Science and Technology for the City Key Program of Science and Technology (Project Number:2011105102017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM A, 1961, NATURE, V189, P686, DOI 10.1038/189686a0; BEUTLER E, 1991, ACTA HAEMATOL-BASEL, V86, P179; BEUTLER E, 1994, BLOOD, V84, P3613, DOI 10.1182/blood.V84.11.3613.bloodjournal84113613; BEUTLER E, 1979, BRIT J HAEMATOL, V43, P465, DOI 10.1111/j.1365-2141.1979.tb03774.x; Beutler E, 2008, BLOOD, V111, P16, DOI 10.1182/blood-2007-04-077412; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; CHAN TK, 1964, BRIT MED J, V2, P102, DOI 10.1136/bmj.2.5401.102; Chen Y, 2006, INT J LAB MED, V27, P385; Chiang Szu-Hui, 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P72; CHIU DTY, 1993, BLOOD, V81, P2150, DOI 10.1182/blood.V81.8.2150.2150; DU CS, 1988, HUM GENET, V80, P385, DOI 10.1007/BF00273657; Hao Ying, 2011, Zhonghua Xue Ye Xue Za Zhi, V32, P245; HERZ F, 1970, BLOOD-J HEMATOL, V35, P90, DOI 10.1182/blood.V35.1.90.90; Jiang WY, 2006, HUM GENET, V119, P463, DOI 10.1007/s00439-005-0126-5; Li Jun, 2014, Zhonghua Yu Fang Yi Xue Za Zhi, V48, P192; Li L, 2008, BLOOD CELL MOL DIS, V41, P17, DOI 10.1016/j.bcmd.2008.01.007; Li Youqiong, 2014, Zhonghua Xue Ye Xue Za Zhi, V35, P724, DOI 10.3760/cma.j.issn.0253-2727.2014.08.012; Lu XM, 2013, CLIN CHIM ACTA, V418, P45, DOI 10.1016/j.cca.2012.12.023; Minucci A, 2012, BLOOD CELL MOL DIS, V48, P154, DOI 10.1016/j.bcmd.2012.01.001; Minucci A, 2009, IUBMB LIFE, V61, P27, DOI 10.1002/iub.137; Nkhoma ET, 2009, BLOOD CELL MOL DIS, V42, P267, DOI 10.1016/j.bcmd.2008.12.005; Pan SL, 2007, CHIN J HLTH BIRTH CH, V13, P42; TANG TK, 1995, BLOOD, V85, P3767, DOI 10.1182/blood.V85.12.3767.bloodjournal85123767; TANG TK, 1995, HUM GENET, V95, P630; XU WM, 1995, BLOOD, V85, P257, DOI 10.1182/blood.V85.1.257.bloodjournal851257; XU YK, 1985, HEREDITY DIS, V2, P67; Yan JB, 2010, J MOL DIAGN, V12, P305, DOI 10.2353/jmoldx.2010.090104; Yan TZ, 2006, HAEMATOLOGICA, V91, P1321; Yang Guang, 2004, Zhonghua Gan Zang Bing Za Zhi, V12, P677; Zaffanello M, 2004, EUR J EPIDEMIOL, V19, P255, DOI 10.1023/B:EJEP.0000020445.48298.3f	30	19	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120683	10.1371/journal.pone.0120683	http://dx.doi.org/10.1371/journal.pone.0120683			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775246	Green Published, gold, Green Submitted			2022-12-27	WOS:000351183500189
J	Tominaga, M; Kawai-Noma, S; Kawagishi, I; Sowa, Y; Saito, K; Umeno, D				Tominaga, Masahiro; Kawai-Noma, Shigeko; Kawagishi, Ikuro; Sowa, Yoshiyuki; Saito, Kyoichi; Umeno, Daisuke			Liquid-Based Iterative Recombineering Method Tolerant to Counter-Selection Escapes	PLOS ONE			English	Article							ESCHERICHIA-COLI; HOMOLOGOUS RECOMBINATION; SELECTABLE MARKER; GENOME; MUTATIONS; DEPENDENCE; EVOLUTION; MUTANTS; REPLICATION; POLYMERASE	Selection-based recombineering is a flexible and proven technology to precisely modify bacterial genomes at single base resolution. It consists of two steps of homologous recombination followed by selection/counter-selection. However, the shortage of efficient counter-selectable markers limits the throughput of this method. Additionally, the emergence of 'selection escapees' can affect recombinant pools generated through this method, and they must be manually removed at each step of selection-based recombineering. Here, we report a series of efforts to improve the throughput and robustness of selection-based recombineering and to achieve seamless and automatable genome engineering. Using the nucleoside kinase activity of herpes simplex virus thymidine kinase (hsvTK) on the non-natural nucleoside dP, a highly efficient, rapid, and liquid-based counter-selection system was established. By duplicating hsvtk gene, combined with careful control of the population size for the subsequent round, we effectively eliminated selection escapes, enabling seamless and multiple insertions/replacement of gene-size fragments in the chromosome. Four rounds of recombineering could thus be completed in 10 days, requiring only liquid handling and without any need for colony isolation or genotype confirmation. The simplicity and robustness of our method make it broadly accessible for multi-locus chromosomal modifications.	[Tominaga, Masahiro; Kawai-Noma, Shigeko; Saito, Kyoichi; Umeno, Daisuke] Chiba Univ, Fac Engn, Dept Appl Chem & Biotechnol, Inage Ku, Chiba 2638522, Japan; [Kawagishi, Ikuro; Sowa, Yoshiyuki] Hosei Univ, Dept Frontier Biosci, Tokyo 1848584, Japan; [Sowa, Yoshiyuki] Hosei Univ, Res Ctr Micronano Technol, Tokyo 1848584, Japan; [Umeno, Daisuke] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan	Chiba University; Hosei University; Hosei University; Japan Science & Technology Agency (JST)	Umeno, D (corresponding author), Chiba Univ, Fac Engn, Dept Appl Chem & Biotechnol, Inage Ku, 1-33 Yayoi Cyo, Chiba 2638522, Japan.	umeno@faculty.chiba-u.jp	Tominaga, Masahiro/GYJ-1256-2022	Tominaga, Masahiro/0000-0001-9691-0428; Sowa, Yoshiyuki/0000-0002-1691-2018	Commission for Development of Artificial Gene Synthesis Technology for Creating Innovative Biomaterial from the Ministry of Economy, Trade and Industry (METI, Japan); Precursory Research for Embryonic Science and Technology (PRESTO) program of the Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for Promotion of Science (JSPS) [23108507]; Grants-in-Aid for Scientific Research [25840054] Funding Source: KAKEN	Commission for Development of Artificial Gene Synthesis Technology for Creating Innovative Biomaterial from the Ministry of Economy, Trade and Industry (METI, Japan); Precursory Research for Embryonic Science and Technology (PRESTO) program of the Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for Promotion of Science (JSPS); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Commission for Development of Artificial Gene Synthesis Technology for Creating Innovative Biomaterial from the Ministry of Economy, Trade and Industry (METI, Japan), the Precursory Research for Embryonic Science and Technology (PRESTO) program of the Japan Science and Technology Agency (JST), and Grant-in-Aid for Scientific Research on Innovative Areas (23108507) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansho Y, 2012, CHEM BIOL, V19, P478, DOI 10.1016/j.chembiol.2012.01.019; Bershtein S, 2008, MOL BIOL EVOL, V25, P2311, DOI 10.1093/molbev/msn174; Bird AW, 2012, NAT METHODS, V9, P103, DOI [10.1038/NMETH.1803, 10.1038/nmeth.1803]; BLOMFIELD IC, 1991, MOL MICROBIOL, V5, P1447, DOI 10.1111/j.1365-2958.1991.tb00791.x; BREAKER RR, 1994, P NATL ACAD SCI USA, V91, P6093, DOI 10.1073/pnas.91.13.6093; BRESCH C, 1980, J THEOR BIOL, V85, P399, DOI 10.1016/0022-5193(80)90314-8; Cline J, 1996, NUCLEIC ACIDS RES, V24, P3546, DOI 10.1093/nar/24.18.3546; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; CUPPLES CG, 1989, P NATL ACAD SCI USA, V86, P5345, DOI 10.1073/pnas.86.14.5345; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DeVito JA, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1084; DRAKE JW, 1993, J MOL BIOL, V229, P8, DOI 10.1006/jmbi.1993.1002; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; DUBE DK, 1993, GENE, V137, P41, DOI 10.1016/0378-1119(93)90249-3; FUJITANI Y, 1995, GENETICS, V140, P797; Gregg CJ, 2014, NUCLEIC ACIDS RES, V42, P4779, DOI 10.1093/nar/gkt1374; Guo HH, 2004, P NATL ACAD SCI USA, V101, P9205, DOI 10.1073/pnas.0403255101; Hanczyc MM, 1998, RNA, V4, P268; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Kawate H, 2002, J BIOL CHEM, V277, P36304, DOI 10.1074/jbc.M204956200; Lajoie MJ, 2013, SCIENCE, V342, P361, DOI 10.1126/science.1241460; Lajoie MJ, 2013, SCIENCE, V342, P357, DOI 10.1126/science.1241459; Li XT, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt1075; LIN PKT, 1989, NUCLEIC ACIDS RES, V17, P10373, DOI 10.1093/nar/17.24.10373; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; LOVETT ST, 1988, GENETICS, V120, P37; Mizoguchi H, 2007, BIOSCI BIOTECH BIOCH, V71, P2905, DOI 10.1271/bbb.70274; Negishi K, 2002, GENETICS, V161, P1363; Pal C, 2014, NAT REV GENET, V15, P504, DOI 10.1038/nrg3746; Sawitzke JA, 2007, METHOD ENZYMOL, V421, P171, DOI 10.1016/S0076-6879(06)21015-2; SCHAAPER RM, 1987, P NATL ACAD SCI USA, V84, P6220, DOI 10.1073/pnas.84.17.6220; SEVERINOV K, 1993, J BIOL CHEM, V268, P14820; SHEN P, 1986, GENETICS, V112, P441; Stavropoulos TA, 2001, GENOMICS, V72, P99, DOI 10.1006/geno.2000.6481; SUMMERS WC, 1993, J BACTERIOL, V175, P6049, DOI 10.1128/JB.175.18.6049-6051.1993; SZATHMARY E, 1995, NATURE, V374, P227, DOI 10.1038/374227a0; Tashiro Y, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1070; VERROUST PJ, 1979, KIDNEY INT, V16, P9, DOI 10.1038/ki.1979.97; Vickers MF, 1999, BIOCHEM J, V339, P21, DOI 10.1042/0264-6021:3390021; Wang HH, 2012, ACS SYNTH BIOL, V1, P43, DOI 10.1021/sb3000029; Wang HH, 2012, NAT METHODS, V9, P591, DOI [10.1038/NMETH.1971, 10.1038/nmeth.1971]; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Wong QNY, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni059; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	47	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119818	10.1371/journal.pone.0119818	http://dx.doi.org/10.1371/journal.pone.0119818			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775434	Green Submitted, Green Published, gold			2022-12-27	WOS:000351183500127
J	van Oort, PAJ; de Vries, ME; Yoshida, H; Saito, K				van Oort, Pepijn A. J.; de Vries, Michiel E.; Yoshida, Hiroe; Saito, Kazuki			Improved Climate Risk Simulations for Rice in Arid Environments	PLOS ONE			English	Article							TEMPERATURE-INDUCED STERILITY; INDUCED SPIKELET STERILITY; IRRIGATED RICE; EXPLORING OPTIONS; MODELING APPROACH; SOLAR-RADIATION; AIR-TEMPERATURE; LOWLAND RICE; HEAT-STRESS; LESS WATER	We integrated recent research on cardinal temperatures for phenology and early leaf growth, spikelet formation, early morning flowering, transpirational cooling, and heat- and cold-induced sterility into an existing to crop growth model ORYZA2000. We compared for an arid environment observed potential yields with yields simulated with default ORYZA2000, with modified subversions of ORYZA2000 and with ORYZA_S, a model developed for the region of interest in the 1990s. Rice variety 'IR64' was sown monthly 15-times in a row in two locations in Senegal. The Senegal River Valley is located in the Sahel, near the Sahara desert with extreme temperatures during day and night. The existing subroutines underestimated cold stress and overestimated heat stress. Forcing the model to use observed spikelet number and phenology and replacing the existing heat and cold subroutines improved accuracy of yield simulation from EF = -0.32 to EF = 0.70 (EF is modelling efficiency). The main causes of improved accuracy were that the new model subversions take into account transpirational cooling (which is high in arid environments) and early morning flowering for heat sterility, and minimum rather than average temperature for cold sterility. Simulations were less accurate when also spikelet number and phenology were simulated. Model efficiency was 0.14 with new heat and cold routines and improved to 0.48 when using new cardinal temperatures for phenology and early leaf growth. The new adapted subversion of ORYZA2000 offers a powerful analytic tool for climate change impact assessment and cropping calendar optimisation in arid regions.	[van Oort, Pepijn A. J.; Saito, Kazuki] Africa Rice Ctr AfricaRice, Cotonou, Benin; [van Oort, Pepijn A. J.] Wageningen Univ, Ctr Crop Syst Anal, Crop & Weed Ecol Grp, NL-6700 AK Wageningen, Netherlands; [de Vries, Michiel E.] J Joordens Zaadhandel BV, NL-5995 ZG Kessel, Netherlands; [Yoshida, Hiroe] Natl Agr & Food Res Org, Tsukuba, Ibaraki 3058666, Japan	CGIAR; Africa Rice Center; Wageningen University & Research; National Agriculture & Food Research Organization - Japan	de Vries, ME (corresponding author), J Joordens Zaadhandel BV, NL-5995 ZG Kessel, Netherlands.	michielerikdevries@gmail.com; hiroey@affrc.go.jp; K.Saito@cgiar.org	Saito, Kazuki/ABE-5432-2021; van Oort, Pepijn/E-9903-2016	Saito, Kazuki/0000-0002-8609-2713; van Oort, Pepijn/0000-0001-7617-5382; De Vries, Michiel/0000-0002-1453-7672	CGIAR Consortium Research Program on Climate Change, Agriculture and Food Security (CCAFS); J. Joordens' Zaadhandel B.V.	CGIAR Consortium Research Program on Climate Change, Agriculture and Food Security (CCAFS); J. Joordens' Zaadhandel B.V.	This research was funded by the CGIAR Consortium Research Program on Climate Change, Agriculture and Food Security (CCAFS). J. Joordens' Zaadhandel B.V. provided support in the form of a salary for author M.E. de Vries, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Belder P, 2007, AGR SYST, V92, P91, DOI 10.1016/j.agsy.2006.03.001; Boling AA, 2007, AGR SYST, V92, P115, DOI 10.1016/j.agsy.2006.05.003; Boling AA, 2011, NJAS-WAGEN J LIFE SC, V58, P11, DOI 10.1016/j.njas.2010.05.001; Bouman B., 2001, ORYZA2000 MODELING L; Bouman BAM, 2007, AGR WATER MANAGE, V88, P23, DOI 10.1016/j.agwat.2006.10.005; Bouman BAM, 2006, AGR SYST, V87, P249, DOI 10.1016/j.agsy.2004.09.011; Confalonieri R, 2005, ECOL MODEL, V183, P269, DOI 10.1016/j.ecolmodel.2004.07.031; de Mey Y, 2012, J AGR ECON, V63, P175, DOI 10.1111/j.1477-9552.2011.00323.x; de Vries ME, 2010, FIELD CROP RES, V116, P154, DOI 10.1016/j.fcr.2009.12.006; Devries ME, 2011, EXP AGR, V47, P69, DOI 10.1017/S0014479710001328; Dingkuhn M, 1997, SYST APPR S, V6, P79; DINGKUHN M, 1995, AGR SYST, V48, P385, DOI 10.1016/0308-521X(94)00027-I; Dingkuhn M, 2012, CIRADIRRI07042012; DINGKUHN M, 1997, IRRIGATED RICE SAHEL, P361; Ephrath JE, 1996, AGR SYST, V51, P377, DOI 10.1016/0308-521X(95)00068-G; Farrell TC, 2006, FIELD CROP RES, V98, P178, DOI 10.1016/j.fcr.2006.01.003; Feng LP, 2007, AGR WATER MANAGE, V88, P1, DOI 10.1016/j.agwat.2006.10.006; Gaydon DS, 2012, AGR WATER MANAGE, V115, P1, DOI 10.1016/j.agwat.2012.08.007; Gourdji SM, ENV RES LETT, V8, P24; Haefele SM, 2002, FIELD CROP RES, V78, P119, DOI 10.1016/S0378-4290(02)00117-X; Heinemann AB, 2008, EUPHYTICA, V162, P395, DOI 10.1007/s10681-007-9579-z; Horie T., 1993, J AGR METEOROL, V48, P567, DOI DOI 10.2480/AGRMET.48.567; Horie T, 2001, RICE RES FOOD SECURI; Ishimaru T, 2010, ANN BOT-LONDON, V106, P515, DOI 10.1093/aob/mcq124; Jagadish KSV, 2011, FUNCT PLANT BIOL, V38, P261, DOI 10.1071/FP10224; Jagadish SVK, 2008, CROP SCI, V48, P1140, DOI 10.2135/cropsci2007.10.0559; Jagadish SVK, 2007, J EXP BOT, V58, P1627, DOI 10.1093/jxb/erm003; Jing Q, 2007, EUR J AGRON, V26, P166, DOI 10.1016/j.eja.2006.09.005; Jing Q, 2008, AGR SYST, V98, P177, DOI 10.1016/j.agsy.2008.06.005; Julia C, 2012, THESIS U MONTPELLIER; Julia C, 2013, EUR J AGRON, V49, P50, DOI 10.1016/j.eja.2013.03.006; Julia C, 2012, EUR J AGRON, V43, P166, DOI 10.1016/j.eja.2012.06.007; Kato Y, 2010, FIELD CROP RES, V117, P237, DOI 10.1016/j.fcr.2010.03.006; Kobata T, 2010, PLANT PROD SCI, V13, P289, DOI 10.1626/pps.13.289; Kobayasi K, 2010, PLANT PROD SCI, V13, P21, DOI 10.1626/pps.13.21; Kropff MJ, 1993, ORYZA1 BASIC MODEL I; Kuwagata T, 2008, AGR FOREST METEOROL, V148, P1754, DOI 10.1016/j.agrformet.2008.06.011; Li T, 2013, FIELD CROP RES, V149, P312, DOI 10.1016/j.fcr.2013.05.006; Matsui T, 1999, ANN BOT-LONDON, V84, P501, DOI 10.1006/anbo.1999.0943; Matsui T, 2002, ANN BOT-LONDON, V89, P683, DOI 10.1093/aob/mcf112; Matsui T, 1997, JPN J CROP SCI, V66, P449, DOI 10.1626/jcs.66.449; Matsui T, 2007, PLANT PROD SCI, V10, P57, DOI 10.1626/pps.10.57; Matsui Tsutomu, 2000, Plant Production Science, V3, P430, DOI 10.1626/pps.3.430; Matthews RB, 1997, AGR SYST, V54, P399, DOI 10.1016/S0308-521X(95)00060-I; Matthews Robin B., 1995, MODELING IMPACT CLIM; Nash J.E., 1970, J HYDROL, V370, P139, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; NISHIYAMA I, 1976, P159; Peng SB, 2008, FIELD CROP RES, V108, P32, DOI 10.1016/j.fcr.2008.04.001; Rebolledo MC, 2012, J AGRON CROP SCI, V198, P374, DOI 10.1111/j.1439-037X.2012.00528.x; Sanchez B, 2014, GLOBAL CHANGE BIOL, V20, P408, DOI 10.1111/gcb.12389; Sheehy JE, 2001, FIELD CROP RES, V71, P77, DOI 10.1016/S0378-4290(01)00145-9; Shimono H, 2007, FIELD CROP RES, V101, P221, DOI 10.1016/j.fcr.2006.11.010; Soundharajan B, 2009, PADDY WATER ENVIRON, V7, P135, DOI 10.1007/s10333-009-0156-z; Spitters CJT, 1995, SIMULATION MONOGRAPH; Teixeira EI, 2013, AGR FOREST METEOROL, V170, P206, DOI 10.1016/j.agrformet.2011.09.002; tenBerge HFM, 1997, FIELD CROP RES, V51, P29, DOI 10.1016/S0378-4290(96)01042-8; Uchijima, 1976, J AGROMETEOROL, V31, P199, DOI [10.2480/agrmet.31.199, DOI 10.2480/AGRMET.31.199]; van Laar H.H., 1997, QUANTITATIVE APPROAC, V14; van Oort PAJ, 2014, FIELD CROP RES, V156, P303, DOI 10.1016/j.fcr.2013.11.007; van Oort PAJ, 2011, AGR FOREST METEOROL, V151, P1545, DOI 10.1016/j.agrformet.2011.06.012; Wassmann R, 2009, ADV AGRON, V101, P59, DOI 10.1016/S0065-2113(08)00802-X; Weerakoon WMW, 2008, J AGRON CROP SCI, V194, P135, DOI 10.1111/j.1439-037X.2008.00293.x; White JW, 2011, AGRON J, V103, P1242, DOI 10.2134/agronj2011.0038; Yin XY, 1997, FIELD CROP RES, V51, P189, DOI 10.1016/S0378-4290(96)03456-9; YIN XY, 1995, AGR FOREST METEOROL, V77, P1, DOI 10.1016/0168-1923(95)02236-Q; Yoshida H, 2006, FIELD CROP RES, V97, P337, DOI 10.1016/j.fcr.2005.11.004; Yoshida S, 1981, FUNDAMENTALS RICE CR; Yoshimoto M., 2005, J AGRIC METEOROL, V60, P597, DOI [10.2480/agrmet.597, DOI 10.2480/AGRMET.597]; Yoshimoto Mayumi, 2011, Journal of Agricultural Meteorology, V67, P233, DOI 10.2480/agrmet.67.4.8; Zhang S, 2013, EUR J AGRON, V45, P165, DOI 10.1016/j.eja.2012.10.005	71	32	32	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118114	10.1371/journal.pone.0118114	http://dx.doi.org/10.1371/journal.pone.0118114			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774909	Green Published, gold, Green Submitted			2022-12-27	WOS:000351183500024
J	Atalla, H; Lysnyansky, I; Raviv, Y; Rottem, S				Atalla, Hazem; Lysnyansky, Inna; Raviv, Yossef; Rottem, Shlomo			Mycoplasma gallisepticum Inactivated by Targeting the Hydrophobic Domain of the Membrane Preserves Surface Lipoproteins and Induces a Strong Immune Response	PLOS ONE			English	Article							STRUCTURAL INTEGRITY; PROTEINS; HYOPNEUMONIAE; VACCINATION; INVASION; DISEASE; CULTURE; CELLS	An innovative approach for inactivation of Mycoplasma gallisepticum using the hydrophobic photoinduced alkylating probe 1, 5-iodonaphthylazide (INA) is described. Treatment of washed M. gallisepticum mid-exponential culture (0.2 mg cell protein / mL) with INA followed by irradiation with far-ultraviolet light (310-380 nm) completely abolished viability. Transmission electron microscopy showed that the majority of the inactivated M. gallisepticum were comparable in size to intact cells, but that part of the INA-treated M. gallisepticum preparation also contained low density cells and membrane vesicles. Confocal microscopy revealed that untreated M. gallisepticum cells were internalized by chicken red blood cells (c-RBCs), whereas the INA-inactivated cells remained attached to the outer surface of the c-RBCs. INA treatment of M. gallisepticum resulted in a complete inactivation of F0F1 - ATPase and of the L-arginine uptake system, but the cytoplasmatic soluble NADH2 dehydrogenase was only partially affected. Western blot analysis of the lipoprotein fraction showed that the INA-treated M. gallisepticum retained their lipoproteins. Following subcutaneous injection of M. gallisepticum INA-bacterin, 100% and 68.8% of chickens were positive by the rapid serum agglutination test and enzyme-linked immunosorbent assay respectively, 2 weeks post-injection. These data suggest that the photoinducible alkylating agent INA inactivates M. gallisepticum but preserves its surface lipoproteins and thus has the potential to be used as a general approach for the inactivation of mycoplasmas for vaccine development.	[Atalla, Hazem; Rottem, Shlomo] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Microbiol & Mol Genet, IL-91010 Jerusalem, Israel; [Lysnyansky, Inna] Kimron Vet Inst, Div Avian & Aquat Dis, Bet Dagan, Israel; [Raviv, Yossef] SAIC Frederick Inc, Natl Canc Inst, Frederick, MD USA	Hebrew University of Jerusalem; Kimron Veterinary Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Lysnyansky, I (corresponding author), Kimron Vet Inst, Div Avian & Aquat Dis, Bet Dagan, Israel.	innal@moag.gov.il			SAIC-Frederick	SAIC-Frederick	The authors received no specific funding for this work. SAIC-Frederick provided support in the form of salaries for Dr. Y. Raviv, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, MOL BIOL PATHOGENICI; Bearson SMD, 2003, AVIAN DIS, V47, P745, DOI 10.1637/6099; Belanger JM, 2010, PHOTOCHEM PHOTOBIOL, V86, P1099, DOI 10.1111/j.1751-1097.2010.00780.x; BORDIER C, 1981, J BIOL CHEM, V256, P1604; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Browning GF, 2011, VET MICROBIOL, V153, P44, DOI 10.1016/j.vetmic.2011.05.031; Chambaud I, 1999, TRENDS MICROBIOL, V7, P493, DOI 10.1016/S0966-842X(99)01641-8; El Gazzar M, 2011, AVIAN DIS, V55, P569, DOI 10.1637/9689-021711-Reg.1; FERGUSON M, 1993, J GEN VIROL, V74, P685, DOI 10.1099/0022-1317-74-4-685; Furuya Y, 2010, J GEN VIROL, V91, P1450, DOI 10.1099/vir.0.018168-0; GAISSER HD, 1987, BIOCHEM PHARMACOL, V36, P3237, DOI 10.1016/0006-2952(87)90639-3; Garcia M, 2005, AVIAN DIS, V49, P125, DOI 10.1637/7261-0812204R1; GEARY SJ, 1990, J RECEPTOR RES, V9, P465, DOI 10.3109/10799898909066071; Glew MD, 2000, INFECT IMMUN, V68, P6027, DOI 10.1128/IAI.68.10.6027-6033.2000; Haesebrouck F, 2004, VET MICROBIOL, V100, P255, DOI 10.1016/j.vetmic.2004.03.002; HAYFLICK L, 1960, ANN NY ACAD SCI, V79, P433, DOI 10.1111/j.1749-6632.1960.tb42709.x; Kleven SH, 2008, AVIAN DIS, V52, P367, DOI 10.1637/8323-041808-Review.1; Kleven SH, 2004, AVIAN DIS, V48, P562, DOI 10.1637/7148; Kornspan JD, 2010, INFECT IMMUN, V78, P611, DOI 10.1128/IAI.01017-09; Levisohn S, 2000, REV SCI TECH OIE, V19, P425, DOI 10.20506/rst.19.2.1232; Mateusen B, 2002, VET REC, V151, P135, DOI 10.1136/vr.151.5.135; Nicholas RA, 2008, J COMP PATHOL, V24, P24; Papazisi L, 2003, MICROBIOL-SGM, V149, P2307, DOI 10.1099/mic.0.26427-0; Raviv Y, 2005, J VIROL, V79, P12394, DOI 10.1128/JVI.79.19.12394-12400.2005; RAVIV Y, 1987, P NATL ACAD SCI USA, V84, P6103, DOI 10.1073/pnas.84.17.6103; Raviv Y, 2008, J VIROL, V82, P4612, DOI 10.1128/JVI.02233-07; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Rechnitzer H, 2006, CURR MICROBIOL, V53, P293, DOI 10.1007/s00284-006-0007-8; ROTTEM S, 1966, J BACTERIOL, V92, P714, DOI 10.1128/JB.92.3.714-722.1966; Rottem S, 2003, PHYSIOL REV, V83, P417, DOI 10.1152/physrev.00030.2002; SALMAN M, 1995, BBA-BIOMEMBRANES, V1235, P369, DOI 10.1016/0005-2736(95)80026-C; Shirvan M H, 1993, Subcell Biochem, V20, P261; Simionatto S, 2013, VET MICROBIOL, V165, P234, DOI 10.1016/j.vetmic.2013.04.019; Steinlage SJT, 2003, AVIAN DIS, V47, P499, DOI 10.1637/0005-2086(2003)047[0499:IACOAL]2.0.CO;2; Szczepanek SM, 2010, INFECT IMMUN, V78, P1760, DOI 10.1128/IAI.01172-09; Tola S, 1999, VACCINE, V17, P2764, DOI 10.1016/S0264-410X(99)00070-5; Viard M, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-21; Vogl G, 2008, INFECT IMMUN, V76, P71, DOI 10.1128/IAI.00871-07; Waites K. B., 2014, MOLLICUTES MOL BIOL, P289; Warfield KL, 2007, J INFECT DIS, V196, pS276, DOI 10.1086/520605; Winner F, 2000, INFECT IMMUN, V68, P4238, DOI 10.1128/IAI.68.7.4238-4244.2000; Yavlovich A, 2004, INFECT IMMUN, V72, P5004, DOI 10.1128/IAI.72.9.5004-5011.2004	42	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120462	10.1371/journal.pone.0120462	http://dx.doi.org/10.1371/journal.pone.0120462			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781939	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600163
J	He, ZY; Wu, SG; Zhou, J; Li, FY; Lin, Q; Lin, HX; Sun, JY				He, Zhen-Yu; Wu, San-Gang; Zhou, Juan; Li, Fang-Yan; Lin, Qin; Lin, Huan-Xin; Sun, Jia-Yuan			Postmastectomy Radiotherapy Improves Disease-Free Survival of High Risk of Locoregional Recurrence Breast Cancer Patients with T1-2 and 1 to 3 Positive Nodes	PLOS ONE			English	Article							SYSTEMIC THERAPY; LYMPH-NODES; MASTECTOMY; IRRADIATION; BENEFIT; TUMOR	Objectives The indications for post-mastectomy radiotherapy (PMRT) with T1-2 breast cancer and 1-3 positive axillary lymph nodes is still controversial. The purpose of this study was to investigate the role of PMRT in T1-2 breast cancer with 1-3 positive axillary lymph node. Methods We retrospectively reviewed the file records of 79 patients receiving PMRT and not receiving PMRT (618 patients). Results The median follow-up was 65 months. Multivariate analysis showed that PMRT was an independent prognostic factor of locoregional recurrence-free survival (LRFS) (P = 0.010). Subgroup analysis of patients who did not undergo PMRT showed that pT stage, number of positive axillary lymph nodes, and molecular subtype were independent prognostic factors of LRFS. PMRT improved LRFS in the entire group (P = 0.005), but did not affect distant metastasis- free survival (DMFS) (P = 0.494), disease-free survival (DFS) (P = 0.215), and overall survival (OS) (P = 0.645). For patients without PMRT, the 5-year LRFS of low-risk patients (0-1 risk factor for locoregional recurrence) of 94.5% was significantly higher than that of high-risk patients (2-3 risk factors for locoregional recurrence) (80.9%, P < 0.001). PMRT improved LRFS (P = 0.001) and DFS (P = 0.027) in high-risk patients, but did not improve LRFS, DMFS, DFS, and OS in low-risk patients. Conclusions PMRT is beneficial in patients with high risk of locoregional recurrence breast cancer patients with T1-2 and 1 to 3 positive nodes.	[He, Zhen-Yu; Li, Fang-Yan; Lin, Huan-Xin; Sun, Jia-Yuan] Sun Yat Sen Univ, State Key Lab Oncol South China, Dept Radiat Oncol, Canc Ctr,Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China; [Wu, San-Gang; Lin, Qin] Xiamen Univ, Xiamen Canc Ctr, Dept Radiat Oncol, Affiliated Hosp 1, Xiamen, Peoples R China; [Zhou, Juan] Xiamen Univ, Xiamen Canc Ctr, Dept Obstet & Gynecol, Affiliated Hosp 1, Xiamen, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Xiamen University; Xiamen University	Sun, JY (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol South China, Dept Radiat Oncol, Canc Ctr,Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China.	sunjy@sysucc.org.cn	Wu, San-Gang/AAA-8959-2022		Sci-Tech Office of Guangdong Province [2008B060600019, 2013B021800157]; Youth Foundation of the First Affiliated Hospital of Xiamen University [XYY2012005]; education scientific research project of young teachers in Fujian Province [JB13131]; National Natural Science Foundation of China [81402527]; Youth Foundation of Fujian Provincial Health and Family Planning Commission [2014-2-63]	Sci-Tech Office of Guangdong Province; Youth Foundation of the First Affiliated Hospital of Xiamen University; education scientific research project of young teachers in Fujian Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Foundation of Fujian Provincial Health and Family Planning Commission	This study was supported by the Sci-Tech Office of Guangdong Province (No. 2008B060600019 and No. 2013B021800157), the Youth Foundation of the First Affiliated Hospital of Xiamen University (No. XYY2012005), the education scientific research project of young teachers in Fujian Province (No. JB13131), the National Natural Science Foundation of China (No. 81402527), and the Youth Foundation of Fujian Provincial Health and Family Planning Commission (No. 2014-2-63).	Aebi S, 2011, ANN ONCOL, V22, pvi12, DOI 10.1093/annonc/mdr371; Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; Cosar R, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-28; Duraker N, 2012, JPN J CLIN ONCOL, V42, P601, DOI 10.1093/jjco/hys052; Fodor J, 2003, STRAHLENTHER ONKOL, V179, P197, DOI 10.1007/s00066-003-1010-7; Goldhirsch A, 1998, J NATL CANCER I, V90, P1601, DOI 10.1093/jnci/90.21.1601; Hamamoto Y, 2014, BREAST CANCER-TOKYO, V21, P177, DOI 10.1007/s12282-012-0369-7; Japan Comprehensive Cancer Network Breast, 2007, PRACT GUID SURG THER; Klinik Onkoloji Dernegi, 2013, GEOGR PROF COMP CONS; Kuo SH, 2008, INT J RADIAT ONCOL, V72, P1456, DOI 10.1016/j.ijrobp.2008.03.042; Matsunuma R, 2012, INT J RADIAT ONCOL, V83, P845, DOI 10.1016/j.ijrobp.2011.08.029; McBride A, 2014, INT J RADIAT ONCOL, V89, P392, DOI 10.1016/j.ijrobp.2014.02.013; McGale P, 2014, LANCET, V383, P2127, DOI 10.1016/S0140-6736(14)60488-8; Munshi A, 2012, ACTA ONCOL, V51, P547, DOI 10.3109/0284186X.2011.633929; Nagao T, 2013, INT J CLIN ONCOL, V18, P54, DOI 10.1007/s10147-011-0343-y; National Comprehensive Cancer Network (NCCN), 2012, CLIN PRACT GUID ONC; Offersen BV, 2011, BREAST CARE, V6, P347, DOI 10.1159/000333250; Overgaard M, 2007, RADIOTHER ONCOL, V82, P247, DOI 10.1016/j.radonc.2007.02.001; Pagani O, 2014, NEW ENGL J MED, V371, P107, DOI 10.1056/NEJMoa1404037; Panoff JE, 2011, BREAST CANCER RES TR, V128, P899, DOI 10.1007/s10549-011-1495-1; Recht A, 2001, J CLIN ONCOL, V19, P1539, DOI 10.1200/JCO.2001.19.5.1539; Schiavon G, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3636; Taylor ME, 2009, INT J RADIAT ONCOL, V73, P997, DOI 10.1016/j.ijrobp.2008.10.080; van der Hage JA, 2003, EUR J CANCER, V39, P2192, DOI 10.1016/S0959-8049(03)00572-0; Wu SG, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-119; Wu San-Gang, 2010, Chin J Cancer, V29, P668; Yang PS, 2010, INT J RADIAT ONCOL, V77, P516, DOI 10.1016/j.ijrobp.2009.05.016	27	23	23	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119105	10.1371/journal.pone.0119105	http://dx.doi.org/10.1371/journal.pone.0119105			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781605	gold, Green Submitted, Green Published			2022-12-27	WOS:000351284600051
J	Liu, X; Zhu, L; Liao, S; Xu, ZW; Zhou, YC				Liu, Xiao; Zhu, Ling; Liao, Shan; Xu, Zhiwen; Zhou, Yuancheng			The Porcine MicroRNA Transcriptome Response to Transmissible Gastroenteritis Virus Infection	PLOS ONE			English	Article							EXPRESSION; TARGETS; DIFFERENTIATION; PATHOGENESIS; RECOGNITION; DROSOPHILA; GENES; TGEV; RNAS	Transmissible gastroenteritis virus (TGEV; Coronaviridae family) causes huge economic losses to the swine industry. MicroRNAs (miRNAs) play a regulatory role in viral infection and may be involved in the mammalian immune response. Here, we report a comprehensive analysis of host miRNA expression in TGEV-infected swine testis (ST) cells. Deep sequencing generated 3,704,353 and 2,763,665 reads from uninfected ST cells and infected ST cells, respectively. The reads were aligned to known Sus scrofa pre-miRNAs in miR-Base 19, identifying 284 annotated miRNAs. Certain miRNAs were differentially regulated during TGEV infection. 59 unique miRNAs displayed significant differentially expression between the normal and TGEV-infected ST cell samples: 15 miRNAs were significantly up-regulated and 44 were significantly down-regulated. Stem-loop RT-PCR was carried out to determine the expression levels of specific miRNAs in the two samples, and the results were consistent with those of sequencing. Gene ontology enrichment analysis of host target genes demonstrated that the differentially expressed miRNAs are involved in regulatory networks, including cellular process, metabolic process, immune system process. This is the first report of the identification of ST cell miRNAs and the comprehensive analysis of the miRNA regulatory mechanism during TGEV infection, which revealed the miRNA molecular regulatory mechanisms for the viral infection, expression of viral genes and the expression of immune-related genes. The results presented here will aid research on the prevention and treatment of viral diseases.	[Liu, Xiao; Zhu, Ling; Liao, Shan; Xu, Zhiwen; Zhou, Yuancheng] Sichuan Agr Univ, Coll Vet Med, Anim Biotechnol Ctr, Yaan, Peoples R China; [Xu, Zhiwen] Sichuan Agr Univ, Coll Vet Med, Key Lab Anim Dis & Human Hlth, Yaan, Peoples R China; [Liu, Xiao] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Liver, Boston, MA USA; [Liu, Xiao] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Div,Dept Med, Boston, MA USA	Sichuan Agricultural University; Sichuan Agricultural University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Xu, ZW (corresponding author), Sichuan Agr Univ, Coll Vet Med, Anim Biotechnol Ctr, Yaan, Peoples R China.	abtcxzw@126.com		Zhou, Yuancheng/0000-0001-5295-826X	Program for New Century Excellent Talents in University of Ministry of Education of China [NCET-11-1059]; program for Changjiang Scholars and Innovative Research Team in University [IRT13083]; Sichuan Youth Waterfowl Disease Control and Prevention Science and Technology Innovative Research Team [2013TD0015]; Excellent Doctoral Dissertation Fostering Foundation of Sichuan Agricultural University	Program for New Century Excellent Talents in University of Ministry of Education of China(Program for New Century Excellent Talents in University (NCET)); program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Sichuan Youth Waterfowl Disease Control and Prevention Science and Technology Innovative Research Team; Excellent Doctoral Dissertation Fostering Foundation of Sichuan Agricultural University	This study was supported by the Program for New Century Excellent Talents in University of Ministry of Education of China (Project No: NCET-11-1059), program for Changjiang Scholars and Innovative Research Team in University (Project No: IRT13083), Sichuan Youth Waterfowl Disease Control and Prevention Science and Technology Innovative Research Team (Project No: 2013TD0015), and by the Excellent Doctoral Dissertation Fostering Foundation of Sichuan Agricultural University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Boss IW, 2009, TRENDS MICROBIOL, V17, P544, DOI 10.1016/j.tim.2009.09.002; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; CALLEBAUT P, 1989, VET MICROBIOL, V20, P9, DOI 10.1016/0378-1135(89)90003-5; Chae C, 2000, VET REC, V147, P606, DOI 10.1136/vr.147.21.606; Conrad KD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056272; Dolken L, 2009, VIRUS GENES, V38, P355, DOI 10.1007/s11262-009-0347-0; Enright AJ, 2004, GENOME BIOL, V5; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019; Grey F, 2007, PLOS PATHOG, V3, P1593, DOI 10.1371/journal.ppat.0030163; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Grundhoff A, 2011, VIROLOGY, V411, P325, DOI 10.1016/j.virol.2011.01.002; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Henke JI, 2008, EMBO J, V27, P3300, DOI 10.1038/emboj.2008.244; Hipfner DR, 2002, GENETICS, V161, P1527; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kim L, 2000, ARCH VIROL, V145, P1133, DOI 10.1007/s007050070114; Klase Z, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-63; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Li MT, 2011, INT J INNOV COMPUT I, V7, P1055; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Lin Z, 2011, CANCER LETT, V305, P186, DOI 10.1016/j.canlet.2010.08.018; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Murphy E, 2008, P NATL ACAD SCI USA, V105, P5453, DOI 10.1073/pnas.0711910105; Nair V, 2006, TRENDS MICROBIOL, V14, P169, DOI 10.1016/j.tim.2006.02.007; Norman KL, 2010, J VIROL, V84, P666, DOI 10.1128/JVI.01156-09; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Otsuka M, 2007, IMMUNITY, V27, P123, DOI 10.1016/j.immuni.2007.05.014; Ouellet DL, 2008, NUCLEIC ACIDS RES, V36, P2353, DOI 10.1093/nar/gkn076; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Riley KJL, 2010, J VIROL, V84, P5148, DOI 10.1128/JVI.00110-10; Samols MA, 2007, PLOS PATHOG, V3, P611, DOI 10.1371/journal.ppat.0030065; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tajima M, 1970, Arch Gesamte Virusforsch, V29, P105, DOI 10.1007/BF01253886; TUBOLY T, 1994, ARCH VIROL, V137, P55, DOI 10.1007/BF01311173; Valoczi A, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh171; Varkonyi-Gasic E, 2011, METHODS MOL BIOL, V744, P145, DOI 10.1007/978-1-61779-123-9_10; Williams AE, 2008, BIOCHEM SOC T, V36, P1211, DOI 10.1042/BST0361211; Wu YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030988	48	15	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120377	10.1371/journal.pone.0120377	http://dx.doi.org/10.1371/journal.pone.0120377			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781021	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600157
J	Murata, Y; Itoh, Y; Iwashita, T; Namba, K				Murata, Yoshiko; Itoh, Yoshiyuki; Iwashita, Takashi; Namba, Kosuke			Transgenic Petunia with the Iron(III)-Phytosiderophore Transporter Gene Acquires Tolerance to Iron Deficiency in Alkaline Environments	PLOS ONE			English	Article							FERRIC-CHELATE REDUCTASE; MUGINEIC ACID; GRAMINEOUS PLANTS; MASS-SPECTROMETRY; PHYTOSIDEROPHORE TRANSPORTER; 2'-DEOXYMUGINEIC ACID; YELLOW STRIPE1; NICOTIANAMINE; METAL; ACQUISITION	Iron is an essential nutrient for all plants. However, terrestrial plants often suffer from iron deficiency in alkaline soil due to its extremely low solubility. Alkaline soil accounts for about 30% of all cultivated ground in the world. Plants have evolved two distinct strategies, I and II, for iron uptake from the soil. Dicots and non-graminaceous monocots use Strategy I, which is primarily based on the reduction of iron(III) to iron(II) and the uptake of iron(II) by the iron-regulated transporter, IRT1. In contrast, graminaceous plants use Strategy II to efficiently acquire insoluble iron(III). Strategy II comprises the synthesis and secretion of iron-chelating phytosiderophores, such as mugineic acids and the Yellow Stripe 1 transporter proteins of the iron(III)-phytosiderophore complex. Barley, which exhibits the highest tolerance to iron deficiency in alkaline soil among graminaceous plants, utilizes mugineic acids and the specific iron(III)-mugineic acids transporter, HvYS1. In this study, we established the transgenic plant Petunia hybrida, which originally had only Strategy I, by introducing the HvYS1 transporter gene derived from barley. When the transgenic plants were grown hydroponically in media containing the iron(III)-20-deoxymugineic acid complex, free 2'-deoxymugineic acid and its iron(III) complex were detected in the root extract of the transgenic plant by electrospray ionization-Fourier transform-ion cyclotron resonance mass spectrometry. The growth of the transgenic petunia was significantly better than that of the control host in alkaline conditions. Consequently, the transgenic plant acquired a significantly enhanced tolerance to alkaline hydroponic media in the presence of the iron(III)-20-deoxymugineic acid complex. Furthermore, the flower color of the transgenic plant deepened. The results showed that iron-phytosiderophore complexes and their transporters can potentially be utilized to overcome the worldwide iron uptake problems to diverse plant species that are found in areas with alkaline conditions.	[Murata, Yoshiko; Itoh, Yoshiyuki; Iwashita, Takashi; Namba, Kosuke] Suntory Fdn Life Sci, Bioorgan Res Inst, Osaka, Japan	Suntory Holdings Ltd	Murata, Y (corresponding author), Suntory Fdn Life Sci, Bioorgan Res Inst, Osaka, Japan.	murata@sunbor.or.jp		Namba, Kosuke/0000-0003-1548-5656	MEXT Japan [18510200]; Suntory Holdings; Grants-in-Aid for Scientific Research [26102734] Funding Source: KAKEN	MEXT Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Suntory Holdings; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research Grant, MEXT Japan (No. 18510200 to YM) and the financial support of Suntory Holdings. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama T, 2009, PLANT MOL BIOL, V70, P681, DOI 10.1007/s11103-009-9500-3; Araki R, 2011, PLANT CELL PHYSIOL, V52, P1931, DOI 10.1093/pcp/pcr126; Bakkaus E, 2006, J CHROMATOGR A, V1129, P208, DOI 10.1016/j.chroma.2006.07.004; Briat JF, 2007, CURR OPIN PLANT BIOL, V10, P276, DOI 10.1016/j.pbi.2007.04.003; BRITSCH L, 1990, ARCH BIOCHEM BIOPHYS, V282, P152, DOI 10.1016/0003-9861(90)90099-K; BRUGLIERA F, 1994, PLANT J, V5, P81, DOI 10.1046/j.1365-313X.1994.5010081.x; CARLQUIST S, 1982, STAIN TECHNOL, V57, P311, DOI 10.3109/10520298209066729; Colangelo EP, 2006, CURR OPIN PLANT BIOL, V9, P322, DOI 10.1016/j.pbi.2006.03.015; COMAI L, 1990, PLANT MOL BIOL, V15, P373, DOI 10.1007/BF00019155; Connolly EL, 2003, PLANT PHYSIOL, V133, P1102, DOI 10.1104/pp.103.025122; Curie C, 2001, NATURE, V409, P346, DOI 10.1038/35053080; Curie C, 2009, ANN BOT-LONDON, V103, P1, DOI 10.1093/aob/mcn207; DECAROLIS E, 1994, PHYTOCHEMISTRY, V36, P1093, DOI 10.1016/S0031-9422(00)89621-1; Divol F, 2013, PLANT CELL, V25, P1040, DOI 10.1105/tpc.112.107672; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; FUJIWARA T, 1992, PLANT PHYSIOL, V99, P263, DOI 10.1104/pp.99.1.263; Gomez-Galera S, 2012, PLANT PHYSIOL BIOCH, V53, P46, DOI 10.1016/j.plaphy.2012.01.009; Inoue H, 2009, J BIOL CHEM, V284, P3470, DOI 10.1074/jbc.M806042200; Ishimaru Y, 2006, PLANT J, V45, P335, DOI 10.1111/j.1365-313X.2005.02624.x; Kakei Y, 2012, PLANT MOL BIOL, V79, P583, DOI 10.1007/s11103-012-9930-1; Katsumoto Y, 2007, PLANT CELL PHYSIOL, V48, P1589, DOI 10.1093/pcp/pcm131; KAWAI S, 1988, J PLANT NUTR, V11, P633, DOI 10.1080/01904168809363829; Koike S, 2004, PLANT J, V39, P415, DOI 10.1111/j.1365-313X.2004.02146.x; LAZO GR, 1991, BIO-TECHNOL, V9, P963, DOI 10.1038/nbt1091-963; Lee S, 2009, P NATL ACAD SCI USA, V106, P22014, DOI 10.1073/pnas.0910950106; MA JF, 1995, J BIOL CHEM, V270, P16549, DOI 10.1074/jbc.270.28.16549; MA JF, 1993, PLANT PHYSIOL, V102, P373, DOI 10.1104/pp.102.2.373; Ma JF, 1996, PHYSIOL PLANTARUM, V97, P609, DOI 10.1111/j.1399-3054.1996.tb00522.x; MARSCHNER H, 1986, J PLANT NUTR, V9, P695, DOI 10.1080/01904168609363475; Masuda H, 2013, RICE, V6, DOI 10.1186/1939-8433-6-40; Meda AR, 2007, PLANT PHYSIOL, V143, P1761, DOI 10.1104/pp.106.094474; Mori S, 1999, CURR OPIN PLANT BIOL, V2, P250, DOI 10.1016/S1369-5266(99)80043-0; MORI S, 1987, PLANT CELL PHYSIOL, V28, P1081; Murata Y, 2006, PLANT J, V46, P563, DOI 10.1111/j.1365-313X.2006.02714.x; Namba K, 2007, ANGEW CHEM INT EDIT, V46, P7060, DOI 10.1002/anie.200702403; Nozoye T, 2011, J BIOL CHEM, V286, P5446, DOI 10.1074/jbc.M110.180026; Quattrocchio F, 1998, PLANT J, V13, P475, DOI 10.1046/j.1365-313X.1998.00046.x; Roberts LA, 2004, PLANT PHYSIOL, V135, P112, DOI 10.1104/pp.103.037572; Robinson NJ, 1999, NATURE, V397, P694, DOI 10.1038/17800; ROMHELD V, 1986, PLANT PHYSIOL, V80, P175, DOI 10.1104/pp.80.1.175; Schaaf G, 2004, J BIOL CHEM, V279, P9091, DOI 10.1074/jbc.M311799200; Schroeder JI, 2013, NATURE, V497, P60, DOI 10.1038/nature11909; SHOJIMA S, 1990, PLANT PHYSIOL, V93, P1497, DOI 10.1104/pp.93.4.1497; SKINNER BJ, 1979, P NATL ACAD SCI USA, V76, P4212, DOI 10.1073/pnas.76.9.4212; SUGIURA Y, 1981, J AM CHEM SOC, V103, P6979, DOI 10.1021/ja00413a043; TAKAGI S, 1984, J PLANT NUTR, V7, P469, DOI 10.1080/01904168409363213; TAKAGI SI, 1976, SOIL SCI PLANT NUTR, V22, P423, DOI 10.1080/00380768.1976.10433004; Takahashi M, 1999, PLANT PHYSIOL, V121, P947, DOI 10.1104/pp.121.3.947; TAKEMOTO T, 1978, P JPN ACAD B-PHYS, V54, P469, DOI 10.2183/pjab.54.469; TANAKA Y, 1995, PLANT CELL PHYSIOL, V36, P1023, DOI 10.1093/oxfordjournals.pcp.a078844; VANENGELEN FA, 1995, TRANSGENIC RES, V4, P288, DOI 10.1007/BF01969123; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; Weber G, 2006, RAPID COMMUN MASS SP, V20, P973, DOI 10.1002/rcm.2402; Xiong HC, 2013, PLANT CELL ENVIRON, V36, P1888, DOI 10.1111/pce.12097; Xuan Y, 2006, J CHROMATOGR A, V1136, P73, DOI 10.1016/j.chroma.2006.09.060; Yen MR, 2001, MICROBIOL-SGM, V147, P2881, DOI 10.1099/00221287-147-11-2881; Zheng LQ, 2011, PLANT CELL PHYSIOL, V52, P765, DOI 10.1093/pcp/pcr009	57	9	11	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120227	10.1371/journal.pone.0120227	http://dx.doi.org/10.1371/journal.pone.0120227			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781941	gold, Green Published, Green Submitted			2022-12-27	WOS:000351284600143
J	Qian, Y; Li, XF; Zhang, DD; Cai, DS; Tian, HY; Liu, WB				Qian, Yu; Li, Xiang-Fei; Zhang, Ding-Dong; Cai, Dong-Sen; Tian, Hong-Yan; Liu, Wen-Bin			Effects of Dietary Pantothenic Acid on Growth, Intestinal Function, Anti-Oxidative Status and Fatty Acids Synthesis of Juvenile Blunt Snout Bream Megalobrama amblycephala	PLOS ONE			English	Article							DIGESTIVE ENZYME-ACTIVITIES; ACYL CARRIER PROTEIN; COENZYME-A; BODY-COMPOSITION; GENE-EXPRESSION; PRACTICAL DIETS; RAINBOW-TROUT; REQUIREMENT; PURIFICATION; BIOSYNTHESIS	Four groups of juvenile Megalobrama amblycephala were fed three times daily with six semi-purified diets containing 3.39 (PA unsupplied diet), 10.54, 19.28, 31.04, 48.38 and 59.72 mg kg(-1) calcium D-pantothenate. The results showed that survival rate, final weight, specific growth rate, protein efficiency ratio and nitrogen retention efficiency all increased significantly (P < 0.01) as dietary PA levels increased from 3.39 to 19.28 mg kg(-1), whereas the opposite was true for feed conversion ratio. Whole-body crude protein increased as dietary PA levels increased, while the opposite pattern was found for the crude lipid content. Intestinal alpha-amylase, lipase, protease, Na+-K+-ATPase, alkaline phosphatase and gamma-glutamyl transferase activities were all elevated in fish fed PA-supplemented diets. Hepatic catalase activities improved with increases in dietary PA, while the opposite was true for malondialdehyde contents. The liver PA concentration and coenzyme A content rose significantly (P < 0.01), up to 31.04 mg kg(-1), with increasing dietary PA levels and then plateaued. The percentage of hepatic saturated fatty acids increased significantly (P < 0.01) as dietary PA levels increased, while the percentages of monounsaturated fatty acids and polyunsaturated fatty acid (PUFA) decreased as dietary PA increased. Fish fed diets containing 19.28 and 31.04 mg kg(-1) PA exhibited higher (P < 0.01) docosahexaenoic acid and PUFA percentages in muscle than those fed with other diets. The expression of the gene encoding pantothenate kinase was significantly up-regulated (P < 0.01) in fish fed PA-supplemented diets. Hepatic Acetyl-CoA carboxylase a, fatty acid synthetase, stearoyl regulatory element-binding protein 1 and X receptor a genes all increased significantly (P < 0.01) as dietary PA levels increased from 3.39 to 31.04 mg kg(-1). Based on broken-line regression analyses of weight gain, liver CoA concentrations and PA contents against dietary PA levels, the optimal dietary PA requirements of juvenile blunt snout bream were estimated to be 24.08 mg kg(-1).	[Qian, Yu; Li, Xiang-Fei; Zhang, Ding-Dong; Cai, Dong-Sen; Tian, Hong-Yan; Liu, Wen-Bin] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Liu, WB (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China.	wbliu@njau.edu.cn	Tian, Hongyan/HII-4786-2022; Li, Xiang-Fei/I-2742-2019	Li, Xiang-Fei/0000-0003-0841-0584	Special Fund for Agro-scientific Research in the Public Interest of Ministry [201003020]; funds of the National Technology System for Conventional Freshwater Fish Industries of China [CARS-46-20]	Special Fund for Agro-scientific Research in the Public Interest of Ministry; funds of the National Technology System for Conventional Freshwater Fish Industries of China	Funding provided by Special Fund for Agro-scientific Research in the Public Interest of Ministry (201003020); the funds of the National Technology System for Conventional Freshwater Fish Industries of China (CARS-46-20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AOAC, 1995, OFF METH AN OFF AN C; BESSEY OA, 1946, J BIOL CHEM, V164, P321; BIRGE CH, 1972, J BIOL CHEM, V247, P4930; Cheng HL, 2011, GENE, V487, P46, DOI 10.1016/j.gene.2011.07.027; Cho C.Y., 1990, FASEB J, V4, P3747; CLARKE SD, 1993, J ANIM SCI, V71, P1957, DOI 10.2527/1993.7171957x; Feng L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069974; FOLCH J, 1957, J BIOL CHEM, V226, P497; Furne M, 2005, AQUACULTURE, V250, P391, DOI 10.1016/j.aquaculture.2005.05.017; Hakim Y, 2006, AQUACULTURE, V257, P420, DOI 10.1016/j.aquaculture.2006.02.034; Heath RJ, 1996, J BIOL CHEM, V271, P1833, DOI 10.1074/jbc.271.4.1833; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; HSU RY, 1965, J BIOL CHEM, V240, P3736; HUMMEL BCW, 1959, CAN J BIOCHEM PHYS, V37, P1393, DOI 10.1139/o59-157; Jiang GZ, 2013, AQUACULT NUTR, V19, P499, DOI 10.1111/anu.12001; KARGES RG, 1984, J FISH BIOL, V25, P57, DOI 10.1111/j.1095-8649.1984.tb04850.x; Kjaer MA, 2008, BBA-MOL CELL BIOL L, V1781, P112, DOI 10.1016/j.bbalip.2007.12.004; Krebs H A, 1970, Adv Enzyme Regul, V8, P335, DOI 10.1016/0065-2571(70)90028-2; Lazo JP, 1998, AQUACULTURE, V169, P225, DOI 10.1016/S0044-8486(98)00384-6; Li XF, 2010, AQUACULTURE, V303, P65, DOI 10.1016/j.aquaculture.2010.03.014; Li XF, 2012, FISH PHYSIOL BIOCHEM, V38, P529, DOI 10.1007/s10695-011-9533-9; Lin YH, 2012, AQUACULTURE, V324, P92, DOI 10.1016/j.aquaculture.2011.10.020; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093135; Lu KL, 2013, AQUACULTURE, V408, P160, DOI 10.1016/j.aquaculture.2013.06.003; Lygren B, 1999, J AQUAT ANIM HEALTH, V11, P211, DOI 10.1577/1548-8667(1999)011&lt;0211:EODPAA&gt;2.0.CO;2; MAGNUSON K, 1993, MICROBIOL REV, V57, P522, DOI 10.1128/MMBR.57.3.522-542.1993; MCCORMICK SD, 1993, CAN J FISH AQUAT SCI, V50, P656, DOI 10.1139/f93-075; Mommsen TP, 2001, COMP BIOCHEM PHYS B, V129, P207, DOI 10.1016/S1096-4959(01)00312-8; Moro GV, 2010, AQUAC RES, V41, P394, DOI 10.1111/j.1365-2109.2009.02352.x; MURAI T, 1979, J NUTR, V109, P1140, DOI 10.1093/jn/109.7.1140; NELSON RA, 1968, AM J CLIN NUTR, V21, P495, DOI 10.1093/ajcn/21.5.495; NRC (National Research Council), 2011, NUTR REQ FISH SHRIMP; Ogino C., 1967, B JPN SOC SCI FISH, V33, P351; Parvez S, 2005, ENVIRON TOXICOL PHAR, V20, P112, DOI 10.1016/j.etap.2004.11.002; REIBEL DK, 1982, J NUTR, V112, P1144, DOI 10.1093/jn/112.6.1144; ROBBINS KR, 1979, J NUTR, V109, P1710, DOI 10.1093/jn/109.10.1710; ROEM AJ, 1991, PROG FISH CULT, V53, P216, DOI 10.1577/1548-8640(1991)053&lt;0216:DPAROT&gt;2.3.CO;2; ROSALKI SB, 1970, LANCET, V2, P1139; SATOH K, 1978, CLIN CHIM ACTA, V90, P37; SERONDE J, 1963, YALE J BIOL MED, V36, P141; Sheikhzadeh N, 2012, FISH PHYSIOL BIOCHEM, V38, P413, DOI 10.1007/s10695-011-9519-7; Shiau SY, 1999, J NUTR, V129, P718, DOI 10.1093/jn/129.3.718; Shimeno S., 1991, HDB NUTR REQUIREMENT, P181, DOI 10.1201/9780203712146-20; SLYSHENKOV VS, 1995, FREE RADICAL BIO MED, V19, P767, DOI 10.1016/0891-5849(95)00084-B; SOLIMAN AK, 1992, AQUACULTURE, V104, P121, DOI 10.1016/0044-8486(92)90142-8; SONG WJ, 1992, J BACTERIOL, V174, P6411, DOI 10.1128/JB.174.20.6411-6417.1992; SWANK RL, 1948, J NEUROPATH EXP NEUR, V7, P274, DOI 10.1097/00005072-194807000-00003; VALLARI DS, 1988, J BACTERIOL, V170, P3961, DOI 10.1128/jb.170.9.3961-3966.1988; VALLARI DS, 1987, J BIOL CHEM, V262, P2468; WAKIL SJ, 1961, J LIPID RES, V2, P1; Wen ZP, 2009, AQUACULT NUTR, V15, P470, DOI 10.1111/j.1365-2095.2008.00612.x; WILSON RP, 1983, J NUTR, V113, P2124, DOI 10.1093/jn/113.10.2124; WINSTON GW, 1991, AQUAT TOXICOL, V19, P137, DOI 10.1016/0166-445X(91)90033-6; Woollard DC, 2000, FOOD CHEM, V69, P201, DOI 10.1016/S0308-8146(99)00255-1; Xu J, 1999, J BIOL CHEM, V274, P23577, DOI 10.1074/jbc.274.33.23577; ZAR JH, 1984, BIOSTAT ANAL, P236; Zhao S, 2012, AQUACULT NUTR, V18, P400, DOI 10.1111/j.1365-2095.2011.00905.x	59	54	58	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119518	10.1371/journal.pone.0119518	http://dx.doi.org/10.1371/journal.pone.0119518			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781913	Green Submitted, gold, Green Published			2022-12-27	WOS:000351284600072
J	Hadjiaghai, O; Ladich, F				Hadjiaghai, Oliwia; Ladich, Friedrich			Sex-Specific Differences in Agonistic Behaviour, Sound Production and Auditory Sensitivity in the Callichthyid Armoured Catfish Megalechis thoracata	PLOS ONE			English	Article							GOBIO L COTTIDAE; CICHLID FISH; SONIC MUSCLE; LATERAL-LINE; HEARING; VOCALIZATION; DIMORPHISM; DIVERSITY; TELEOSTEI; EVOLUTION	Background Data on sex-specific differences in sound production, acoustic behaviour and hearing abilities in fishes are rare. Representatives of numerous catfish families are known to produce sounds in agonistic contexts (intraspecific aggression and interspecific disturbance situations) using their pectoral fins. The present study investigates differences in agonistic behaviour, sound production and hearing abilities in males and females of a callichthyid catfish. Methodology/Principal Findings Eight males and nine females of the armoured catfish Megalechis thoracata were investigated. Agonistic behaviour displayed during male-male and female-female dyadic contests and sounds emitted were recorded, sound characteristics analysed and hearing thresholds measured using the auditory evoked potential (AEP) recording technique. Male pectoral spines were on average 1.7-fold longer than those of same-sized females. Visual and acoustic threat displays differed between sexes. Males produced low-frequency harmonic barks at longer distances and thumps at close distances, whereas females emitted broadband pulsed crackles when close to each other. Female aggressive sounds were significantly shorter than those of males (167 ms versus 219 to 240 ms) and of higher dominant frequency (562 Hz versus 132 to 403 Hz). Sound duration and sound level were positively correlated with body and pectoral spine length, but dominant frequency was inversely correlated only to spine length. Both sexes showed a similar U-shaped hearing curve with lowest thresholds between 0.2 and 1 kHz and a drop in sensitivity above 1 kHz. The main energies of sounds were located at the most sensitive frequencies. Conclusions/Significance Current data demonstrate that both male and female M. thoracata produce aggressive sounds, but the behavioural contexts and sound characteristics differ between sexes. Sexes do not differ in hearing, but it remains to be clarified if this is a general pattern among fish. This is the first study to describe sex-specific differences in agonistic behaviour in fishes.	[Hadjiaghai, Oliwia; Ladich, Friedrich] Univ Vienna, Dept Behav Biol, Vienna, Austria	University of Vienna	Ladich, F (corresponding author), Univ Vienna, Dept Behav Biol, Vienna, Austria.	friedrich.ladich@univie.ac.at			Open Access Publishing Fund of the University of Vienna	Open Access Publishing Fund of the University of Vienna	This article was supported by the Open Access Publishing Fund of the University of Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu T, 2002, J ACOUST SOC AM, V112, P3073, DOI 10.1121/1.1515799; Amorim Maria Clara P., 2006, P71; Bradbury Jack W., 1998, pi; BRANTLEY RK, 1993, BRAIN BEHAV EVOLUT, V42, P336, DOI 10.1159/000114170; BRANTLEY RK, 1994, ETHOLOGY, V96, P213, DOI 10.1111/j.1439-0310.1994.tb01011.x; BRAWN VIVIEN M., 1961, BEHAVIOUR, V18, P239, DOI 10.1163/156853961X00150; Burgess WE, 1998, ATLAS FRESHWATER MAR; COHEN MJ, 1967, J EXP ZOOL, V165, P355, DOI 10.1002/jez.1401650305; Connaughton MA, 2002, J EXP BIOL, V205, P2183; COURTENAY WR, 1971, COPEIA, P259, DOI 10.2307/1442826; Fay R. R., 1988, HEARING VERTEBRATES; Fine ML, 2003, CATFISHES, VOLS 1-2, P249; Fine ML, 1997, COPEIA, P777, DOI 10.2307/1447295; FINE ML, 1990, CAN J ZOOL, V68, P1374, DOI 10.1139/z90-205; Fine ML, 1981, HEARING SOUND COMMUN, P257; GEE JH, 1978, J EXP BIOL, V74, P1; GRAY GA, 1961, ECOLOGY, V42, P274, DOI 10.2307/1932079; Heyd A, 2000, REV SUISSE ZOOL, V107, P165, DOI 10.5962/bhl.part.80125; Higgs DM, 2013, J EXP BIOL, V216, P1484, DOI 10.1242/jeb.078816; HILL GL, 1987, COPEIA, P708; Kaatz IM, 1999, BIOL BULL, V197, P241, DOI 10.2307/1542626; Kaatz IM, 2010, CURR ZOOL, V56, P73, DOI 10.1093/czoolo/56.1.73; Kenyon TN, 1998, J COMP PHYSIOL A, V182, P307, DOI 10.1007/s003590050181; Kever L, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-34; KRATOCHVIL H, 1985, ZOOL JAHRB ALLG ZOOL, V89, P203; LADICH F, 1990, ETHOLOGY, V84, P193; LADICH F, 1989, ZOOL JAHRB ALLG ZOOL, V93, P501; Ladich F, 1999, BRAIN BEHAV EVOLUT, V53, P288, DOI 10.1159/000006600; Ladich F, 1998, J COMP PHYSIOL A, V182, P737, DOI 10.1007/s003590050218; LADICH F, 1989, J FISH BIOL, V35, P531, DOI 10.1111/j.1095-8649.1989.tb03004.x; Ladich F, 2004, SPR HDB AUD, V22, P95, DOI 10.1007/978-1-4419-8957-4_4; Ladich F., 2006, COMMUNICATION FISHES, V1, P3; Ladich F., SOUND COMMUNICATION; Ladich F, 2007, ANIM BEHAV, V73, P379, DOI 10.1016/j.anbehav.2006.04.014; Ladich F, 2014, SPRINGER HANDB AUDIT, V49, P289, DOI 10.1007/2506_2013_26; Ladich F, 2013, REV FISH BIOL FISHER, V23, P317, DOI 10.1007/s11160-012-9297-z; Ladich F, 2009, COMP BIOCHEM PHYS A, V154, P341, DOI 10.1016/j.cbpa.2009.07.004; Lagardere JP, 2007, J EXP ZOOL PART A, V303A, P1066; Lechner W, 2008, J EXP BIOL, V211, P1681, DOI 10.1242/jeb.016436; Lechner W, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-10; Maruska KP, 2007, J EXP BIOL, V210, P3990, DOI 10.1242/jeb.004390; Maruska KP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037612; Mayr M, 1987, THESIS U VIENNA; Myrberg A.A. Jr., 1972, Animal Behav Monogr, V5, P199, DOI 10.1016/0003-3472(72)90002-4; MYRBERG AA, 1965, SCIENCE, V149, P555, DOI 10.1126/science.149.3683.555; MYRBERG AA, 1980, J COMP PHYSIOL, V140, P135, DOI 10.1007/BF00606305; Myrberg Arthur A. Jr, 2006, P149; Oliveira TPR, 2014, J ZOOL, V294, P114, DOI 10.1111/jzo.12160; Parmentier E, 2005, MAR BIOL, V146, P455, DOI 10.1007/s00227-004-1467-7; Pruzsinszky I, 1998, ENVIRON BIOL FISH, V53, P183, DOI 10.1023/A:1007413108550; Rowe S, 2004, CAN J ZOOL, V82, P1391, DOI 10.1139/Z04-119; SATOU M, 1994, J COMP PHYSIOL A, V174, P539; Schulz-Mirbach T, 2010, HEARING RES, V267, P137, DOI 10.1016/j.heares.2010.04.001; SCHWARZ AL, 1980, ENVIRON BIOL FISH, V5, P335, DOI 10.1007/BF00005187; Simoes JM, 2008, J ACOUST SOC AM, V124, P1332, DOI 10.1121/1.2945712; STABENTHEINER A, 1988, J COMP PHYSIOL A, V162, P67, DOI 10.1007/BF01342704; TAKEMURA A, 1978, B JPN SOC SCI FISH, V44, P121; TEMPLEMAN W, 1958, J FISH RES BOARD CAN, V15, P355, DOI 10.1139/f58-019; Ueng JP, 2007, ZOOL STUD, V46, P103; Wysocki LE, 2005, JARO-J ASSOC RES OTO, V6, P28, DOI 10.1007/s10162-004-4043-4; Wysocki LE, 2005, HEARING RES, V201, P27, DOI 10.1016/j.heares.2004.08.015; Zeyl JN, 2013, J EXP BIOL, V216, P1075, DOI 10.1242/jeb.076935	62	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0121219	10.1371/journal.pone.0121219	http://dx.doi.org/10.1371/journal.pone.0121219			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775458	gold, Green Published			2022-12-27	WOS:000351183500209
J	Hotta, K; Kato, Y; Leighl, N; Takigawa, N; Gaafar, RM; Kayatani, H; Hirata, T; Ohashi, K; Kubo, T; Tabata, M; Tanimoto, M; Kiura, K				Hotta, Katsuyuki; Kato, Yuka; Leighl, Natasha; Takigawa, Nagio; Gaafar, Rabab Mohamed; Kayatani, Hiroe; Hirata, Taizo; Ohashi, Kadoaki; Kubo, Toshio; Tabata, Masahiro; Tanimoto, Mitsune; Kiura, Katsuyuki			Magnitude of the Benefit of Progression-Free Survival as a Potential Surrogate Marker in Phase 3 Trials Assessing Targeted Agents in Molecularly Selected Patients with Advanced Non-Small Cell Lung Cancer: Systematic Review	PLOS ONE			English	Article							1ST-LINE TREATMENT; III TRIALS; OPEN-LABEL; CHEMOTHERAPY; CISPLATIN; MULTICENTER; GEFITINIB; ERLOTINIB; AFATINIB; TIME	Background In evaluation of the clinical benefit of a new targeted agent in a phase 3 trial enrolling molecularly selected patients with advanced non-small cell lung cancer (NSCLC), overall survival (OS) as an endpoint seems to be of limited use because of a high level of treatment crossover for ethical reasons. A more efficient and useful indicator for assessing efficacy is needed. Methods and Findings We identified 18 phase 3 trials in the literature investigating EGFR-tyrosine kinase inhibitor (TKIs) or ALK-TKIs, now approved for use to treat NSCLC, compared with standard cytotoxic chemotherapy (eight trials were performed in molecularly selected patients and ten using an "all-comer" design). Receiver operating characteristic analysis was used to identify the best threshold by which to divide the groups. Although trials enrolling molecularly selected patients and all-comer trials had similar OS-hazard ratios (OS-HRs) (0.99 vs. 1.04), the former exhibited greater progression-free survival-hazard ratios (PFS-HR) (mean, 0.40 vs. 1.01; P < 0.01). A PFS-HR of 0.60 successfully distinguished between the two types of trials (sensitivity 100%, specificity 100%). The odds ratio for overall response was higher in trials with molecularly selected patients than in all-comer trials (mean: 6.10 vs. 1.64; P < 0.01). An odds ratio of 3.40 for response afforded a sensitivity of 88% and a specificity of 90%. Conclusion The notably enhanced PFS benefit was quite specific to trials with molecularly selected patients. A PFS-HR cutoff of similar to 0.6 may help detect clinical benefit of molecular targeted agents in which OS is of limited use, although desired threshold might differ in an individual trial.	[Hotta, Katsuyuki; Tanimoto, Mitsune] Okayama Univ Hosp, Dept Hematol & Oncol, Okayama, Japan; [Hotta, Katsuyuki; Kato, Yuka; Kayatani, Hiroe; Hirata, Taizo; Ohashi, Kadoaki; Kubo, Toshio; Tabata, Masahiro; Kiura, Katsuyuki] Okayama Univ Hosp, Dept Resp Med, Okayama, Japan; [Leighl, Natasha] Princess Margaret Hosp Div, Univ Hlth Network, Dept Med Oncol & Hematol, Toronto, ON, Canada; [Leighl, Natasha] Univ Toronto, Toronto, ON, Canada; [Takigawa, Nagio] Kawasaki Med Sch, Dept Gen Internal Med 4, Okayama, Japan; [Gaafar, Rabab Mohamed] Cairo Univ, Natl Canc Inst, Cairo, Egypt	Okayama University; Okayama University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Kawasaki Medical School; Egyptian Knowledge Bank (EKB); Cairo University; National Cancer Institute - Egypt	Hotta, K (corresponding author), Okayama Univ Hosp, Dept Hematol & Oncol, Okayama, Japan.	khotta@md.okayama-u.ac.jp	Ohashi, Kadoaki/AAX-2634-2021; KIURA, Katsuyuki/B-1991-2011	Ohashi, Kadoaki/0000-0002-5180-3933; Kiura, Katsuyuki/0000-0002-9172-9379				ALBERTI W, 1995, BRIT MED J, V311, P899; American Society of Clinical Oncology, CLINICALLY MEANINGFU; Blumenthal GM, 2014, J CLIN ONCOL SUPPL, V32, p5s; Chu TM, 2002, MATH BIOSCI, V176, P35, DOI 10.1016/S0025-5564(01)00107-9; Fujiwara Y, 2011, ANN ONCOL, V22, P376, DOI 10.1093/annonc/mdq360; Hotta K, 2004, J CLIN ONCOL, V22, P3852, DOI 10.1200/JCO.2004.02.109; Hotta K, 2009, ANN ONCOL, V20, P829, DOI 10.1093/annonc/mdp020; Hotta K, 2013, EDUCATIONAL BOOK IN, P219; Hotta K, 2007, CANCER-AM CANCER SOC, V109, P939, DOI 10.1002/cncr.22478; Hotta K, 2007, J THORAC ONCOL, V2, P96, DOI 10.1097/JTO.0b013e31802bb010; Hotta K, 2013, LUNG CANCER, V79, P20, DOI 10.1016/j.lungcan.2012.10.007; Hotta K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026646; Hotta K, 2009, J THORAC ONCOL, V4, P311, DOI 10.1097/JTO.0b013e3181989bd2; Inoue A, 2013, ANN ONCOL, V24, P54, DOI 10.1093/annonc/mds214; Laporte S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001802; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Matsuo K, 2005, J CLIN ONCOL, V23, P1334, DOI 10.1200/JCO.2005.05.273; Mitsudomi T, 2012, J CLIN ONCOL SUPPL, V30; Piedbois P, 2004, J CLIN ONCOL, V22, P3839, DOI 10.1200/JCO.2004.06.924; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Shepherd FA, 2000, J CLIN ONCOL, V18, P2095, DOI 10.1200/JCO.2000.18.10.2095; Solomon BD, 2014, NEW ENGL J MED, V370, P988, DOI 10.1056/NEJMp1310471; US Department of Health and Human Services US Food and Drug Administration Center for Drug Evaluation and Research, 2011, GUIDANCE FOR INDUSTR; Wu YL, 2014, LANCET ONCOL, V15, P213, DOI 10.1016/S1470-2045(13)70604-1; Yamanaka Takeharu, 2006, Int J Clin Oncol, V11, P167, DOI 10.1007/s10147-006-0580-7; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	28	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0121211	10.1371/journal.pone.0121211	http://dx.doi.org/10.1371/journal.pone.0121211			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775395	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500208
J	Lacerda-Queiroz, N; Brant, F; Rodrigues, DH; Vago, JP; Rachid, MA; Sousa, LP; Teixeira, MM; Teixeira, AL				Lacerda-Queiroz, Norinne; Brant, Fatima; Rodrigues, David Henrique; Vago, Juliana Priscila; Rachid, Milene Alvarenga; Sousa, Lirlandia Pires; Teixeira, Mauro Martins; Teixeira, Antonio Lucio			Phosphatidylinositol 3-Kinase gamma Is Required for the Development of Experimental Cerebral Malaria	PLOS ONE			English	Article							ACTIVATING-FACTOR RECEPTOR; CD8(+) T-CELLS; PATHOGENESIS; MODELS; INFLAMMATION; DYSFUNCTION; PARASITE; PLAYS	Experimental cerebral malaria (ECM) is characterized by a strong immune response, with leukocyte recruitment, blood-brain barrier breakdown and hemorrhage in the central nervous system. Phosphatidylinositol 3-kinase gamma (PI3K gamma) is central in signaling diverse cellular functions. Using PI3K gamma-deficient mice (PI3K gamma(-/-)) and a specific PI3K gamma inhibitor, we investigated the relevance of PI3K gamma for the outcome and the neuroinflammatory process triggered by Plasmodium berghei ANKA (PbA) infection. Infected PI3K gamma(-/-) mice had greater survival despite similar parasitemia levels in comparison with infected wild type mice. Histopathological analysis demonstrated reduced hemorrhage, leukocyte accumulation and vascular obstruction in the brain of infected PI3K gamma(-/-) mice. PI3K gamma deficiency also presented lower microglial activation (Iba-1+reactive microglia) and T cell cytotoxicity (Granzyme B expression) in the brain. Additionally, on day 6 post-infection, CD3(+)CD8(+) T cells were significantly reduced in the brain of infected PI3K gamma(-/-) mice when compared to infected wild type mice. Furthermore, expression of CD44 in CD8+ T cell population in the brain tissue and levels of phospho-IkB-alpha in the whole brain were also markedly lower in infected PI3K gamma(-/-) mice when compared with infected wild type mice. Finally, AS605240, a specific PI3K gamma inhibitor, significantly delayed lethality in infected wild type mice. In brief, our results indicate a pivotal role for PI3K gamma in the pathogenesis of ECM.	[Lacerda-Queiroz, Norinne; Brant, Fatima; Rodrigues, David Henrique; Rachid, Milene Alvarenga; Sousa, Lirlandia Pires; Teixeira, Mauro Martins; Teixeira, Antonio Lucio] Univ Fed Minas Gerais, Inst Biol Sci, Dept Biochem & Immunol, Lab Immunopharmacol, Belo Horizonte, MG, Brazil; [Vago, Juliana Priscila; Sousa, Lirlandia Pires] Univ Fed Minas Gerais, Fac Pharm, Dept Clin & Toxicol Anal, Belo Horizonte, MG, Brazil; [Teixeira, Mauro Martins; Teixeira, Antonio Lucio] Univ Fed Minas Gerais, Interdisciplinary Lab Med Invest, Sch Med, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Lacerda-Queiroz, N (corresponding author), Univ Fed Minas Gerais, Inst Biol Sci, Dept Biochem & Immunol, Lab Immunopharmacol, Belo Horizonte, MG, Brazil.	norinneq@yahoo.com.br; altexr@gmail.com	Rachid, Milene Alvarenga/C-3530-2017; DA SILVA, JULIANA PRISCILA VAGO/F-7386-2019; Teixeira, Antonio L/N-3315-2014	Rachid, Milene Alvarenga/0000-0002-3142-6552; DA SILVA, JULIANA PRISCILA VAGO/0000-0001-8188-3738; Teixeira, Antonio L/0000-0002-9621-5422	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Instituto Nacional de Ciencia e Tecnologia em Dengue (INCT/Dengue), Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Instituto Nacional de Ciencia e Tecnologia em Dengue (INCT/Dengue), Brazil	This work was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Instituto Nacional de Ciencia e Tecnologia em Dengue (INCT/Dengue), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzi J, 2012, DIABETES, V61, P1509, DOI 10.2337/db11-0134; Barber DF, 2005, NAT MED, V11, P933, DOI 10.1038/nm1291; Belnoue E, 2002, J IMMUNOL, V169, P6369, DOI 10.4049/jimmunol.169.11.6369; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Castor MGM, 2011, J LEUKOCYTE BIOL, V89, P955, DOI 10.1189/jlb.0810464; Chang WL, 2001, INFECT IMMUN, V69, P7341, DOI 10.1128/IAI.69.12.7341-7348.2001; Claser C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018720; de Souza JB, 2010, PARASITOLOGY, V137, P755, DOI 10.1017/S0031182009991715; de Souza JB, 2002, MICROBES INFECT, V4, P291, DOI 10.1016/S1286-4579(02)01541-1; Deb C, 2008, J NEUROVIROL, V14, P261, DOI 10.1080/13550280802105002; Desruisseaux MS, 2008, J INFECT DIS, V197, P1621, DOI 10.1086/587908; Fauconnier M, 2011, AM J PATHOL, V178, P212, DOI 10.1016/j.ajpath.2010.11.008; GRAU GE, 1986, J IMMUNOL, V137, P2348; Grau GER, 2012, FUTURE MICROBIOL, V7, P291, DOI [10.2217/FMB.11.155, 10.2217/fmb.11.155]; Haque A, 2011, J IMMUNOL, V186, P6148, DOI 10.4049/jimmunol.1003955; Hearn J, 2000, INFECT IMMUN, V68, P5364, DOI 10.1128/IAI.68.9.5364-5376.2000; Howland SW, 2013, EMBO MOL MED, V5, P984, DOI 10.1002/emmm.201202273; Hunt NH, 2006, INT J PARASITOL, V36, P569, DOI 10.1016/j.ijpara.2006.02.016; Jin R, 2011, STROKE, V42, P2033, DOI 10.1161/STROKEAHA.110.601369; Lacerda-Queiroz N, 2013, INT J PARASITOL, V43, P11, DOI 10.1016/j.ijpara.2012.11.008; Lacerda-Queiroz N, 2012, AM J PATHOL, V180, P246, DOI 10.1016/j.ajpath.2011.09.038; LaFrance-Corey RG, 2011, JOVE-J VIS EXP, DOI 10.3791/2747; Li H, 2013, NEUROSCIENCE, V253, P89, DOI 10.1016/j.neuroscience.2013.08.051; Machado FS, 2006, EXP BIOL MED, V231, P1176; Martin AL, 2008, J IMMUNOL, V180, P2081, DOI 10.4049/jimmunol.180.4.2081; Nitcheu J, 2003, J IMMUNOL, V170, P2221, DOI 10.4049/jimmunol.170.4.2221; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Renia L, 2006, INT J PARASITOL, V36, P547, DOI 10.1016/j.ijpara.2006.02.007; Rodrigues DH, 2010, J NEUROIMMUNOL, V222, P90, DOI 10.1016/j.jneuroim.2010.02.016; Russo RC, 2011, J LEUKOCYTE BIOL, V89, P269, DOI 10.1189/jlb.0610346; SENALDI G, 1994, INFECT IMMUN, V62, P1144, DOI 10.1128/IAI.62.4.1144-1149.1994; Van den Steen PE, 2013, TRENDS PARASITOL, V29, P346, DOI 10.1016/j.pt.2013.04.006	32	8	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119633	10.1371/journal.pone.0119633	http://dx.doi.org/10.1371/journal.pone.0119633			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775137	Green Submitted, Green Published, gold			2022-12-27	WOS:000351183500107
J	Liu, H; Ding, JX; Wang, JC; Wang, YA; Yang, MD; Zhang, YB; Chang, F; Chen, XS				Liu, He; Ding, Jianxun; Wang, Jincheng; Wang, Yinan; Yang, Modi; Zhang, Yanbo; Chang, Fei; Chen, Xuesi			Remission of Collagen-Induced Arthritis through Combination Therapy of Microfracture and Transplantation of Thermogel-Encapsulated Bone Marrow Mesenchymal Stem Cells	PLOS ONE			English	Article							CHRONIC INFLAMMATORY JOINT; ARTICULAR-CARTILAGE; SUBCHONDRAL BONE; IN-VITRO; HYDROGELS; OSTEOARTHRITIS; FIBROBLASTS; REVERSAL; REPAIR; ALPHA	The persistent inflammation of rheumatoid arthritis (RA) always leads to partial synovial hyperplasia and the destruction of articular cartilage. Bone marrow mesenchymal stem cells (BMMSCs) have been proven to possess immunosuppressive effects, and widely explored in the treatment of autoimmune diseases. However, poor inhibitory effect on local inflammatory state and limited capacity of preventing destruction of articular cartilage by systemic BMMSCs transplantation were observed. Herein, toward the classical type II collagen-induced arthritis in rats, the combination treatment of microfracture and in situ transplantation of thermogel-encapsulated BMMSCs was verified to obviously down-regulate the ratio of CD4(+) to CD8(+) T lymphocytes in peripheral blood. In addition, it resulted in the decreased levels of inflammatory cytokines, such as interleukin-1 beta, tumor necrosis factor-a and anti-collagen type II antibody, in the serum. Simultaneously, the combination therapy also could inhibit the proliferation of antigen specific lymphocytes and local joint inflammatory condition, and prevent the articular cartilage damage. The results indicated that the treatment programs could effectively stimulate the endogenous and exogenous BMMSCs to exhibit the immunosuppression and cartilage protection capability. This study provided a new therapeutic strategy for autoimmune inflammatory diseases, such as RA.	[Liu, He; Wang, Jincheng; Yang, Modi; Zhang, Yanbo; Chang, Fei] Jilin Univ, Dept Orthoped, Hosp 2, Changchun 130023, Peoples R China; [Ding, Jianxun; Chen, Xuesi] Chinese Acad Sci, Changchun Inst Appl Chem, Key Lab Polymer Ecomat, Changchun 130022, Peoples R China; [Wang, Yinan] Jilin Univ, Acad Translat Med, Bethune Hosp 1, Changchun 130023, Peoples R China	Jilin University; Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; Jilin University	Wang, YA (corresponding author), Jilin Univ, Acad Translat Med, Bethune Hosp 1, Changchun 130023, Peoples R China.	wyn7859@aliyun.com; ccfei_cn@hotmail.com	Ding, Jianxun/A-6155-2013; Chen, Xuesi/ABB-5039-2020	Ding, Jianxun/0000-0002-5232-8863; Wang, Jincheng/0000-0002-1217-5962	National Natural Science Foundation of China [81171681, 51303174]; National Science Foundation for Post-doctoral Scientists of China [2013M530990]; Jilin Provincial Research Foundation for Basic Research, China [201215055]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation for Post-doctoral Scientists of China(China Postdoctoral Science FoundationNational Natural Science Foundation of China (NSFC)); Jilin Provincial Research Foundation for Basic Research, China	This work was financially supported by the National Natural Science Foundation of China (No. 81171681 and 51303174), the National Science Foundation for Post-doctoral Scientists of China (No. 2013M530990), and the Jilin Provincial Research Foundation for Basic Research, China (No. 201215055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Armaka M, 2008, J EXP MED, V205, P331, DOI 10.1084/jem.20070906; Augello A, 2007, ARTHRITIS RHEUM-US, V56, P1175, DOI 10.1002/art.22511; Barkholt L, 2013, CYTOTHERAPY, V15, P753, DOI 10.1016/j.jcyt.2013.03.005; Beane OS, 2012, ANN BIOMED ENG, V40, P2079, DOI 10.1007/s10439-012-0639-8; Buckley CD, 2004, ANN RHEUM DIS, V63, P92, DOI 10.1136/ard.2004.028332; Cake MA, 2000, OSTEOARTHR CARTILAGE, V8, P404, DOI 10.1053/joca.1999.0315; Chang F, 2008, J ORTHOP RES, V26, P18, DOI 10.1002/jor.20470; Choi JJ, 2008, CLIN EXP IMMUNOL, V153, P269, DOI 10.1111/j.1365-2249.2008.03683.x; Cui HT, 2014, BIOMACROMOLECULES, V15, P1115, DOI 10.1021/bm4018963; Danoff JR, 2013, AUTOIMMUN DIS, V2013, DOI 10.1155/2013/185340; de Isla NG, 2008, BIORHEOLOGY, V45, P433, DOI 10.3233/BIR-2008-0503; del Rey MJ, 2009, ARTHRITIS RHEUM-US, V60, P2926, DOI 10.1002/art.24844; Djouad F, 2005, ARTHRITIS RHEUM-US, V52, P1595, DOI 10.1002/art.21012; Endres M, 2007, J ORTHOP RES, V25, P1299, DOI 10.1002/jor.20394; Gonzalez MA, 2009, ARTHRITIS RHEUM-US, V60, P1006, DOI 10.1002/art.24405; Gonzalez-Rey E, 2010, ANN RHEUM DIS, V69, P241, DOI 10.1136/ard.2008.101881; Granero-Molto F, 2009, STEM CELLS, V27, P1887, DOI 10.1002/stem.103; He CL, 2008, J CONTROL RELEASE, V127, P189, DOI 10.1016/j.jconrel.2008.01.005; Izquierdo E, 2011, ARTHRITIS RHEUM-US, V63, P2575, DOI 10.1002/art.30433; Jones S, 2007, J IMMUNOL, V179, P2824, DOI 10.4049/jimmunol.179.5.2824; Keerthi N, 2013, CURR STEM CELL RES T, V8, P444, DOI 10.2174/1574888X1130800062; Kehoe O, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-157; Kotake S, 2014, BBA-GEN SUBJECTS, V1840, P1209, DOI 10.1016/j.bbagen.2013.12.013; Krenn V, 2002, PATHOL RES PRACT, V198, P317, DOI 10.1078/0344-0338-5710261; Kyburz D, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13865; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Lequerre T, 2013, REV MED INTERNE, V34, P754, DOI 10.1016/j.revmed.2013.09.010; Liu YY, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3187; Liu Y, 2014, CLIN EXP MED, V14, P13, DOI 10.1007/s10238-012-0218-1; Liu ZZ, 2014, IN VITRO CELL DEV-AN, V50, P464, DOI 10.1007/s11626-013-9725-y; Ma HC, 2014, BIOMATERIALS, V35, P8723, DOI 10.1016/j.biomaterials.2014.06.045; Mao F, 2010, INFLAMM RES, V59, P219, DOI 10.1007/s00011-009-0090-y; Matheu V, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-25; Mohanty ST, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3098; Niranjan R, 2013, INT J BIOL MACROMOL, V54, P24, DOI 10.1016/j.ijbiomac.2012.11.026; OTTE P, 1991, Z RHEUMATOL, V50, P304; Poulet B, 2013, OSTEOARTHR CARTILAGE, V21, pS68, DOI 10.1016/j.joca.2013.02.148; Sanchez-Berna I, 2015, MED CLIN-BARCELONA, V144, P88, DOI 10.1016/j.medcli.2014.01.014; SEKI N, 1988, J IMMUNOL, V140, P1477; Singer NG, 2011, ANNU REV PATHOL-MECH, V6, P457, DOI 10.1146/annurev-pathol-011110-130230; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Spiller KL, 2011, TISSUE ENG PART B-RE, V17, P281, DOI [10.1089/ten.TEB.2011.0077, 10.1089/ten.teb.2011.0077]; Stolzing A, 2008, MECH AGEING DEV, V129, P163, DOI 10.1016/j.mad.2007.12.002; Tan HP, 2010, MATERIALS, V3, P1746, DOI 10.3390/ma3031746; Teuschl AH, 2013, EUR SURG, V45, P142, DOI 10.1007/s10353-013-0217-9; Tyndall A, 2009, BONE MARROW TRANSPL, V43, P821, DOI 10.1038/bmt.2009.63; Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k; Zhang YB, 2014, CHINESE J POLYM SCI, V32, P1590, DOI 10.1007/s10118-014-1551-5; Zheng ZH, 2008, RHEUMATOLOGY, V47, P22, DOI 10.1093/rheumatology/kem284	50	17	19	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120596	10.1371/journal.pone.0120596	http://dx.doi.org/10.1371/journal.pone.0120596			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774788	Green Published, gold, Green Submitted			2022-12-27	WOS:000351183500185
J	Ng, SSS; Chan, TO; To, KW; Chan, KKP; Ngai, J; Tung, A; Ko, FWS; Hui, DSC				Ng, Susanna S. S.; Chan, Tat-On; To, Kin-Wang; Chan, Ken K. P.; Ngai, Jenny; Tung, Alvin; Ko, Fanny W. S.; Hui, David S. C.			Prevalence of Obstructive Sleep Apnea Syndrome and CPAP Adherence in the Elderly Chinese Population	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; COMMERCIAL BUS DRIVERS; QUALITY-OF-LIFE; APNOEA/HYPOPNOEA SYNDROME; HONG-KONG; OXIDATIVE STRESS; HEART HEALTH; ADULTS; COMMUNITY; SCALE	Background This study assessed the prevalence of obstructive sleep apnea syndrome (OSAS) and CPAP adherence in the elderly Chinese in Hong Kong. Methods We conducted a sleep questionnaire survey among the elders aged >= 60 years in the community centres followed by level 3 home sleep study (Embletta). Subjects with an apnea hypopnea index (AHI) >= 15/hr alone and those with AHI >= 5/hr plus either cardiovascular risk factors or Epworth Sleepiness Score (ESS) >= 10 were offered CPAP treatment. Results Altogether 819 subjects were interviewed with mean (SD) age of 73.9 (7.5) years, BMI 24.2 (3.6) kg/m(2), neck circumference 34.9 (3.4) cm and ESS 6.6 (5.2). Daytime sleepiness was reported by 72.4%, snoring loudly 5.1% and witnessed apnea 4%. Among 234 subjects who underwent home sleep study, 156 (66.7%), 102 (43.6%), 70 (29.9%) and 45 (19.2%) had AHI >= 5, >= 10, >= 15 and >= 20/hr respectively, with the prevalence increasing with age and BMI. In the sample, 149 subjects (63.7%) were classified as having OSAS, as defined by an AHI >= 5/hr with associated symptoms, involving 81 men (74.3%) and 68 women (54.4%). Neck circumference and snoring frequency were the only positive independent factors associated with the AHI and the diagnosis of OSAS. Among 141 subjects who were offered CPAP treatment, 30 accepted CPAP prescription with improvement of ESS and cognitive function over 12 months with CPAP usage of 4.2 (2.2) h/night. Conclusion This study showed a high prevalence of OSAS among the community elders in Hong Kong. Home CPAP acceptance was low but there was significant improvement of subjective sleepiness and cognitive function among those on CPAP treatment.	[Ng, Susanna S. S.; Chan, Tat-On; To, Kin-Wang; Chan, Ken K. P.; Ngai, Jenny; Tung, Alvin; Ko, Fanny W. S.; Hui, David S. C.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Div Resp Med, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital	Hui, DSC (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Div Resp Med, Shatin, Hong Kong, Peoples R China.	dschui@cuhk.edu.hk	Hui, David Shu-Cheong/O-2754-2015; Ng, Susanna SS/G-7431-2017; Ko, Fanny W. S./B-8958-2016; Ng, Susanna/ABI-4965-2020	Hui, David Shu-Cheong/0000-0003-4382-2445; Ng, Susanna SS/0000-0002-4554-7312; Ko, Fanny W. S./0000-0001-8454-0087; 				Allen RP, 2005, ARCH INTERN MED, V165, P1286, DOI 10.1001/archinte.165.11.1286; Aloia M S, 2001, Sleep Breath, V5, P13, DOI 10.1007/s11325-001-0013-9; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS, V2nd; ANCOLIISRAEL S, 1991, SLEEP, V14, P486, DOI 10.1093/sleep/14.6.486; BEARPARK H, 1995, AM J RESP CRIT CARE, V151, P1459, DOI 10.1164/ajrccm.151.5.7735600; Chung KF, 2000, J PSYCHOSOM RES, V49, P367, DOI 10.1016/S0022-3999(00)00186-0; Damjanovic D, 2009, EUR RESPIR J, V33, P804, DOI 10.1183/09031936.00023408; Dingli K, 2003, EUR RESPIR J, V21, P253, DOI 10.1183/09031936.03.00298103; Engleman HM, 2004, THORAX, V59, P618, DOI 10.1136/thx.2003.015867; ENGLEMAN HM, 1994, LANCET, V343, P572, DOI 10.1016/S0140-6736(94)91522-9; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; Flemons WW, 1998, AM J RESP CRIT CARE, V158, P494; FOLEY DJ, 1995, SLEEP, V18, P425, DOI 10.1093/sleep/18.6.425; Gami AS, 2005, NEW ENGL J MED, V352, P1206, DOI 10.1056/NEJMoa041832; Gozal D, 2008, AM J RESP CRIT CARE, V177, P369, DOI 10.1164/rccm.200608-1190PP; Hui DSC, 2006, RESPIROLOGY, V11, P723, DOI 10.1111/j.1440-1843.2006.00932.x; Hui DSC, 2000, CHEST, V117, P1410, DOI 10.1378/chest.117.5.1410; Hui DSC, 2002, INTERN MED J, V32, P149, DOI 10.1046/j.1444-0903.2001.00196.x; Hui DSC, 2001, CHEST, V120, P170, DOI 10.1378/chest.120.1.170; Ip MSM, 2001, CHEST, V119, P62, DOI 10.1378/chest.119.1.62; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Johns MW, 2000, J SLEEP RES, V9, P5, DOI 10.1046/j.1365-2869.2000.00177.x; KUMP K, 1994, AM J RESP CRIT CARE, V150, P735, DOI 10.1164/ajrccm.150.3.8087345; Lavie L, 2009, PROG CARDIOVASC DIS, V51, P303, DOI 10.1016/j.pcad.2008.08.003; Malhotra A, 2009, PROG CARDIOVASC DIS, V51, P279, DOI 10.1016/j.pcad.2008.10.004; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Martinez-Garcia MA, 2012, AM J RESP CRITICAL C; Masa JF, 2000, AM J RESP CRIT CARE, V162, P1407, DOI 10.1164/ajrccm.162.4.9907019; Ng SS, RESPIROLOGY CARLTON, V15, P336, DOI [10.1111/j.1440-1843.2009.01697, DOI 10.1111/J.1440-1843.2009.01697.X]; O'Connor GT, 2003, SLEEP, V26, P74; Parish JM, 2000, SLEEP MED, V1, P209, DOI 10.1016/S1389-9457(00)00011-3; Sforza E, EUR RESP J; Weaver TE, 2007, SLEEP MED REV, V11, P99, DOI 10.1016/j.smrv.2006.08.001; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Young T, 2002, ARCH INTERN MED, V162, P893, DOI 10.1001/archinte.162.8.893	36	15	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119829	10.1371/journal.pone.0119829	http://dx.doi.org/10.1371/journal.pone.0119829			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774657	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500130
J	Sein, H; Varv, S; Kristjuhan, A				Sein, Henel; Varv, Signe; Kristjuhan, Arnold			Distribution and Maintenance of Histone H3 Lysine 36 Trimethylation in Transcribed Locus	PLOS ONE			English	Article							RNA-POLYMERASE-II; DOMAIN-CONTAINING PROTEINS; SACCHAROMYCES-CEREVISIAE; JMJC-DOMAIN; METHYLATION; SET2; DEMETHYLATION; ELONGATION; CHROMATIN; REGIONS	Post-translational modifications of core histones play an important role in the epigenetic regulation of chromatin dynamics and gene expression. In Saccharomyces cerevisiae methylation marks at K4, K36, and K79 of histone H3 are associated with gene transcription. Although Set2-mediated H3K36 methylation is enriched throughout the coding region of active genes and prevents aberrant transcriptional initiation within coding sequences, it is not known if transcription of one locus impacts the methylation pattern of neighbouring areas and for how long H3K36 methylation is maintained after transcription termination. Our results demonstrate that H3K36 methylation is restricted to the transcribed sequence only and the modification does not spread to adjacent loci downstream from transcription termination site. We also show that H3K36 trimethylation mark persists in the locus for at least 60 minutes after transcription inhibition, suggesting a short epigenetic memory for recently occurred transcriptional activity. Our results indicate that both replication-dependent exchange of nucleosomes and the activity of histone demethylases Rph1, Jhd1 and Gis1 contribute to the turnover of H3K36 methylation upon shut-down of transcription.	[Sein, Henel; Varv, Signe; Kristjuhan, Arnold] Univ Tartu, Inst Mol & Cell Biol, Dept Cell Biol, EE-51010 Tartu, Estonia	University of Tartu	Kristjuhan, A (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Dept Cell Biol, Riia 23, EE-51010 Tartu, Estonia.	arnoldk@ut.ee		Kristjuhan, Arnold/0000-0002-5842-4952	Estonian Research Council [ETF9188, IUT20-23]	Estonian Research Council	This work was supported by the Estonian Research Council (grants ETF9188 and IUT20-23). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannister AJ, 2002, CELL, V109, P801, DOI 10.1016/S0092-8674(02)00798-5; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Cairns BR, 2005, CURR OPIN GENET DEV, V15, P185, DOI 10.1016/j.gde.2005.01.003; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Du HN, 2008, GENE DEV, V22, P2786, DOI 10.1101/gad.1700008; Du HN, 2010, J BIOL CHEM, V285, P11704, DOI 10.1074/jbc.M109.085043; Fang J, 2007, MOL CELL BIOL, V27, P5055, DOI 10.1128/MCB.00127-07; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Fuchs SM, 2009, BBA-GENE REGUL MECH, V1789, P26, DOI 10.1016/j.bbagrm.2008.07.008; Kim T, 2007, J BIOL CHEM, V282, P20827, DOI 10.1074/jbc.M703034200; Klose RJ, 2007, MOL CELL BIOL, V27, P3951, DOI 10.1128/MCB.02180-06; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Kristjuhan A, 2004, EMBO J, V23, P4243, DOI 10.1038/sj.emboj.7600433; Kristjuhan A, 2002, MOL CELL, V10, P925, DOI 10.1016/S1097-2765(02)00647-0; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Kwon DW, 2011, BIOCHEM BIOPH RES CO, V410, P614, DOI 10.1016/j.bbrc.2011.06.039; Li B, 2003, J BIOL CHEM, V278, P8897, DOI 10.1074/jbc.M212134200; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Mellor J, 2006, TRENDS GENET, V22, P320, DOI 10.1016/j.tig.2006.03.008; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Psathas JN, 2009, MOL CELL BIOL, V29, P6413, DOI 10.1128/MCB.00876-09; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Tu SJ, 2007, J BIOL CHEM, V282, P14262, DOI 10.1074/jbc.M609900200; Varv S, 2007, BIOCHEM BIOPH RES CO, V358, P666, DOI 10.1016/j.bbrc.2007.05.003; Venkatesh S, 2012, NATURE, V489, P452, DOI 10.1038/nature11326	29	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120200	10.1371/journal.pone.0120200	http://dx.doi.org/10.1371/journal.pone.0120200			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774516	Green Published, gold, Green Submitted			2022-12-27	WOS:000351183500156
J	Yan, SM; Wu, G				Yan, Shaomin; Wu, Guang			Large-Scale Evolutionary Analyses on SecB Subunits of Bacterial Sec System	PLOS ONE			English	Article							CROSS-SPECIES INFECTION; CHAPERONE SECB; ESCHERICHIA-COLI; PROTEIN TRANSLOCATION; ENDOPLASMIC-RETICULUM; BACILLUS-SUBTILIS; SIGNAL PEPTIDE; SUBSTRATE-SPECIFICITY; MOLECULAR CHAPERONE; SECRETORY PATHWAY	Protein secretion systems are extremely important in bacteria because they are involved in many fundamental cellular processes. Of the various secretion systems, the Sec system is composed of seven different subunits in bacteria, and subunit SecB brings secreted preproteins to subunit SecA, which with SecYEG and SecDF forms a complex for the translocation of secreted preproteins through the inner membrane. Because of the wide existence of Sec system across bacteria, eukaryota, and archaea, each subunit of the Sec system has a complicated evolutionary relationship. Until very recently, 5,162 SecB sequences have been documented in UniProtKB, however no phylogenetic study has been conducted on a large sampling of SecBs from bacterial Sec secretion system, and no statistical study has been conducted on such size of SecBs in order to exhaustively investigate their variances of pairwise p-distance along taxonomic lineage from kingdom to phylum, to class, to order, to family, to genus and to organism. To fill in these knowledge gaps, 3,813 bacterial SecB sequences with full taxonomic lineage from kingdom to organism covering 4 phyla, 11 classes, 41 orders, 82 families, 269 genera, and 3,744 organisms were studied. Phylogenetic analysis revealed how the SecBs evolved without compromising their function with examples of 3-D structure comparison of two SecBs from Proteobacteria, and possible factors that affected the SecB evolution were considered. The average pairwise p-distances showed that the variance varied greatly in each taxonomic group. Finally, the variance was further partitioned into inter-and intra-clan variances, which could correspond to vertical and horizontal gene transfers, with relevance for Achromobacter, Brevundimonas, Ochrobactrum, and Pseudoxanthomonas.	[Yan, Shaomin; Wu, Guang] Guangxi Acad Sci, State Key Lab Nonfood Biomass Enzyme Technol, Natl Engn Res Ctr Nonfood Biorefinery, Guangxi Biomass Industrializat Engn Inst,Guangxi, Nanning 530007, Guangxi, Peoples R China		Wu, G (corresponding author), Guangxi Acad Sci, State Key Lab Nonfood Biomass Enzyme Technol, Natl Engn Res Ctr Nonfood Biorefinery, Guangxi Biomass Industrializat Engn Inst,Guangxi, 98 Daling Rd, Nanning 530007, Guangxi, Peoples R China.	hongguanglishibahao@yahoo.com		Wu, Guang/0000-0003-0775-5759; Yan, Shaomin/0000-0001-7642-3972	National Natural Science Foundation of China [31460296]; Guangxi Science Foundation [12237022, 1347004-1, 2013GXNSFDA019007]; Building of Guangxi Talent Highland	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Science Foundation; Building of Guangxi Talent Highland	This study was partly supported by National Natural Science Foundation of China (31460296), Guangxi Science Foundation (12237022, 1347004-1 and 2013GXNSFDA019007) and Building of Guangxi Talent Highland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Baars L, 2006, J BIOL CHEM, V281, P10024, DOI 10.1074/jbc.M509929200; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Bechtluft P, 2010, MOL BIOSYST, V6, P620, DOI 10.1039/b915435c; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Biello D., 2010, SCI AM; Bolhuis A, 2002, MICROBIOL-SGM, V148, P3335, DOI 10.1099/00221287-148-11-3335; BREUKINK E, 1995, J BIOL CHEM, V270, P7902, DOI 10.1074/jbc.270.14.7902; Chatzi KE, 2013, BIOCHEM J, V449, P25, DOI 10.1042/BJ20121227; Crane JM, 2005, J MOL BIOL, V353, P295, DOI 10.1016/j.jmb.2005.08.022; Darwin C., 1872, P458; Debarbieux L, 2001, EMBO J, V20, P4657, DOI 10.1093/emboj/20.17.4657; Dekker C, 2003, J STRUCT BIOL, V144, P313, DOI 10.1016/j.jsb.2003.09.012; Dekker C, 2001, BIOPHYS J, V81, P455, DOI 10.1016/S0006-3495(01)75713-X; Dempsey BR, 2004, BIOCHEMISTRY-US, V43, P9361, DOI 10.1021/bi0493057; Desvaux M, 2006, FEMS MICROBIOL REV, V30, P774, DOI 10.1111/j.1574-6976.2006.00035.x; Desvaux M, 2009, TRENDS MICROBIOL, V17, P139, DOI 10.1016/j.tim.2009.01.004; Diao LY, 2012, APPL ENVIRON MICROB, V78, P651, DOI 10.1128/AEM.07209-11; Driessen AJM, 2001, TRENDS MICROBIOL, V9, P193, DOI 10.1016/S0966-842X(01)01980-1; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Eichler J, 2001, TRENDS MICROBIOL, V9, P130, DOI 10.1016/S0966-842X(01)01954-0; Eichler J, 2000, EUR J BIOCHEM, V267, P3402, DOI 10.1046/j.1432-1327.2000.01396.x; ENGELMAN DM, 1981, CELL, V23, P411, DOI 10.1016/0092-8674(81)90136-7; Fekkes P, 1997, EMBO J, V16, P6105, DOI 10.1093/emboj/16.20.6105; FLOWER AM, 1994, J BACTERIOL, V176, P5607, DOI 10.1128/JB.176.18.5607-5614.1994; Giraudo CG, 2003, MOL BIOL CELL, V14, P3753, DOI 10.1091/mbc.E03-02-0101; Gupta RS, 2011, ANTON LEEUW INT J G, V100, P171, DOI 10.1007/s10482-011-9616-8; Ha SC, 2004, BIOCHEM BIOPH RES CO, V315, P1039, DOI 10.1016/j.bbrc.2004.02.002; HANADA M, 1994, J BIOL CHEM, V269, P23625; HARTL FU, 1990, CELL, V63, P269, DOI 10.1016/0092-8674(90)90160-G; Hugenholtz P, 2009, ENVIRON MICROBIOL, V11, P1327, DOI 10.1111/j.1462-2920.2009.01949.x; JOLY JC, 1993, EMBO J, V12, P255, DOI 10.1002/j.1460-2075.1993.tb05651.x; Jumas-Bilak E, 2009, INT J SYST EVOL MICR, V59, P1028, DOI 10.1099/ijs.0.006718-0; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Kim SW, 2007, J MICROBIOL BIOTECHN, V17, P1316; Knoblauch NTM, 1999, J BIOL CHEM, V274, P34219, DOI 10.1074/jbc.274.48.34219; Krehenbrink M, 2011, MOL MICROBIOL, V82, P164, DOI 10.1111/j.1365-2958.2011.07803.x; Kulothungan SR, 2009, LANGMUIR, V25, P6637, DOI 10.1021/la900198h; KUMAMOTO CA, 1993, J BACTERIOL, V175, P2184, DOI 10.1128/JB.175.8.2184-2188.1993; Kuruma Y, 2005, BIOTECHNOL PROGR, V21, P1243, DOI 10.1021/bp049553u; Kuzuoglu-Ozturk D, 2012, NUCLEIC ACIDS RES, V40, P5651, DOI 10.1093/nar/gks218; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee CN, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-17; Linde D, 2003, FEMS MICROBIOL LETT, V226, P93, DOI 10.1016/S0378-1097(03)00578-0; Mao CF, 2009, J BACTERIOL, V191, P978, DOI 10.1128/JB.01321-08; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; Michener JK, 2014, J BACTERIOL, V196, P2101, DOI 10.1128/JB.00034-14; Miller A, 2002, BIOCHEMISTRY-US, V41, P5325, DOI 10.1021/bi025639p; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Muller JP, 2000, MICROBIOL-SGM, V146, P77, DOI 10.1099/00221287-146-1-77; Muller JP, 2000, BIOCHEM J, V348, P367, DOI 10.1042/0264-6021:3480367; Mykytczuk NCS, 2011, ANTON LEEUW INT J G, V100, P259, DOI 10.1007/s10482-011-9584-z; NAKANO A, 1988, J CELL BIOL, V107, P851, DOI 10.1083/jcb.107.3.851; Nijeholt JALA, 2012, PHILOS T R SOC B, V367, P1016, DOI 10.1098/rstb.2011.0201; NISHIYAMA K, 1994, EMBO J, V13, P3272, DOI 10.1002/j.1460-2075.1994.tb06628.x; Papanikou E, 2007, NAT REV MICROBIOL, V5, P839, DOI 10.1038/nrmicro1771; Patel CN, 2006, PROTEIN SCI, V15, P1379, DOI 10.1110/ps.062141006; Patzelt H, 2001, P NATL ACAD SCI USA, V98, P14244, DOI 10.1073/pnas.261432298; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Pradel N, 2003, BIOCHEM BIOPH RES CO, V306, P786, DOI 10.1016/S0006-291X(03)01043-X; Prinz WA, 1996, EMBO J, V15, P5209, DOI 10.1002/j.1460-2075.1996.tb00906.x; Randall LL, 2005, J MOL BIOL, V348, P479, DOI 10.1016/j.jmb.2005.02.036; Randall LL, 2004, PROTEIN SCI, V13, P1124, DOI 10.1110/ps.03410104; RANDALL LL, 1995, TRENDS BIOCHEM SCI, V20, P65, DOI 10.1016/S0968-0004(00)88959-8; Randall LL, 1997, P NATL ACAD SCI USA, V94, P802, DOI 10.1073/pnas.94.3.802; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Reusch RN, 2012, FEBS J, V279, P894, DOI 10.1111/j.1742-4658.2012.08484.x; Rossanese OW, 1999, J CELL BIOL, V145, P69, DOI 10.1083/jcb.145.1.69; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Sakr S, 2010, J BIOL CHEM, V285, P23504, DOI 10.1074/jbc.M110.133058; Sala A, 2013, CELL STRESS CHAPERON, V18, P129, DOI 10.1007/s12192-012-0396-5; Sandkvist M, 2001, MOL MICROBIOL, V40, P271, DOI 10.1046/j.1365-2958.2001.02403.x; Sapriel G, 2003, J BACTERIOL, V185, P80, DOI 10.1128/JB.185.1.80-88.2003; Sapriel G, 2002, J BIOL CHEM, V277, P6726, DOI 10.1074/jbc.M108632200; Sarkar A, 2014, ENVIRON SCI POLLUT R, V21, P8645, DOI 10.1007/s11356-014-2759-1; Sato M, 1996, J CELL BIOL, V134, P279, DOI 10.1083/jcb.134.2.279; Shapova YA, 2007, ACTA CRYSTALLOGR D, V63, P478, DOI 10.1107/S0907444907005045; Sjostrand J, 2014, SYST BIOL, V63, P409, DOI 10.1093/sysbio/syu007; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; SPSS Inc, 1992, SIGMASTAT WIND VERS; Stathopoulos C, 2000, MICROBES INFECT, V2, P1061, DOI 10.1016/S1286-4579(00)01260-0; Sutcliffe IC, 2010, TRENDS MICROBIOL, V18, P464, DOI 10.1016/j.tim.2010.06.005; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tjalsma H, 2000, MICROBIOL MOL BIOL R, V64, P515, DOI 10.1128/MMBR.64.3.515-547.2000; Topping TB, 2001, J BIOL CHEM, V276, P7437, DOI 10.1074/jbc.M009584200; Ullers RS, 2007, P NATL ACAD SCI USA, V104, P3101, DOI 10.1073/pnas.0608232104; Ullers RS, 2004, P NATL ACAD SCI USA, V101, P7583, DOI 10.1073/pnas.0402398101; van Wely KHM, 2000, MICROBIOL-SGM, V146, P2573, DOI 10.1099/00221287-146-10-2573; van Wely KHM, 2001, FEMS MICROBIOL REV, V25, P437, DOI 10.1016/S0168-6445(01)00062-6; Vorderwulbecke S, 2004, FEBS LETT, V559, P181, DOI 10.1016/S0014-5793(04)00052-3; Wolff N, 2003, J BIOL CHEM, V278, P38247, DOI 10.1074/jbc.M302322200; Woodbury RL, 2000, J BIOL CHEM, V275, P24191, DOI 10.1074/jbc.M002885200; Wu G, 1999, ACTA NEUROL BELG, V99, P182; Xu ZH, 2000, NAT STRUCT BIOL, V7, P1172, DOI 10.1038/82040; Yan S, 2013, TRANSBOUND EMERG DIS, V60, P110, DOI 10.1111/j.1865-1682.2012.01323.x; Yan S, 2010, TRANSBOUND EMERG DIS, V57, P254, DOI 10.1111/j.1865-1682.2010.01143.x; Yan SM, 2009, INTERDISCIP SCI, V1, P303, DOI 10.1007/s12539-009-0068-1; Yan SM, 2014, APPL MICROBIOL BIOT, V98, P5329, DOI 10.1007/s00253-014-5742-3; Yan SM, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-177; Yan SM, 2013, VIRULENCE, V4, P716, DOI 10.4161/viru.26612; Yan SM, 2011, PROTEIN PEPTIDE LETT, V18, P434, DOI 10.2174/092986611794927956; Yan SM, 2010, VIRAL IMMUNOL, V23, P105, DOI 10.1089/vim.2009.0080; Yuan JJ, 2010, CELL MOL LIFE SCI, V67, P179, DOI 10.1007/s00018-009-0160-x	103	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120417	10.1371/journal.pone.0120417	http://dx.doi.org/10.1371/journal.pone.0120417			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775430	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500172
J	Li, YW; Feng, SM; Wu, WP; Li, FX				Li, Yingwei; Feng, Shangming; Wu, Wenping; Li, Faxin			Temperature Dependent Mechanical Property of PZT Film: An Investigation by Nanoindentation	PLOS ONE			English	Article							PIEZORESPONSE FORCE MICROSCOPY; THIN-FILMS; BARIUM-TITANATE; RESIDUAL-STRESS; YOUNGS MODULUS; HARDNESS; DEFORMATION; BEHAVIOR	Load-depth curves of an unpoled Lead Zirconate Titanate (PZT) film composite as a function of temperature were measured by nanoindentation technique. Its reduce modulus and hardness were calculated by the typical Oliver-Pharr method. Then the true modulus and hardness of the PZT film were assessed by decoupling the influence of substrate using methods proposed by Zhou et al. and Korsunsky et al., respectively. Results show that the indentation depth and modulus increase, but the hardness decreases at elevated temperature. The increasing of indentation depth and the decreasing of hardness are thought to be caused by the decreasing of the critical stress needed to excite dislocation initiation at high temperature. The increasing of true modulus is attributed to the reducing of recoverable indentation depth induced by back-switched domains. The influence of residual stress on the indentation behavior of PZT film composite was also investigated by measuring its load-depth curves with pre-load strains.	[Li, Yingwei; Feng, Shangming; Wu, Wenping] Wuhan Univ, Dept Engn Mech, Sch Civil Engn, Wuhan 430072, Peoples R China; [Li, Yingwei] Wuhan Univ, State Key Lab Water Resources & Hydropower Engn S, Wuhan 430072, Peoples R China; [Li, Faxin] Peking Univ, State Key Lab Turbulence & Complex Syst, Coll Engn, Beijing 100871, Peoples R China	Wuhan University; Wuhan University; Peking University	Li, YW (corresponding author), Wuhan Univ, Dept Engn Mech, Sch Civil Engn, Wuhan 430072, Peoples R China.	yingweili@whu.edu.cn; lifaxin@pku.edu.cn	Li, Faxin/B-2286-2008	Li, Faxin/0000-0002-1662-8674	research start-up foundation of Wuhan University	research start-up foundation of Wuhan University	Financial support from the research start-up foundation of Wuhan University is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahr DF, 1999, MAT SCI ENG A-STRUCT, V259, P126, DOI 10.1016/S0921-5093(98)00868-5; Clyne TW, 1993, INTRO METAL MATRIX C, DOI [10.1017/CBO9780511623080, DOI 10.1017/CBO9780511623080]; Delobelle P, 2007, J EUR CERAM SOC, V27, P223, DOI 10.1016/j.jeurceramsoc.2006.05.095; Delobelle P, 2004, APPL PHYS LETT, V85, P5185, DOI 10.1063/1.1827331; Devos A, 2001, PHYS REV LETT, V86, P2669, DOI 10.1103/PhysRevLett.86.2669; Djemia P, 2001, J APPL PHYS, V90, P3771, DOI 10.1063/1.1402667; Doerner MF, 1986, J MATER RES, V1, P601, DOI 10.1557/JMR.1986.0601; Duan ZC, 2009, JOM-US, V61, P32, DOI 10.1007/s11837-009-0177-5; Fett T, 2002, FERROELECTRICS, V274, P67, DOI 10.1080/00150190213958; GAO HJ, 1992, INT J SOLIDS STRUCT, V29, P2471, DOI 10.1016/0020-7683(92)90004-D; Ji DW, 2013, ACTA MATER, V61, P1, DOI 10.1016/j.actamat.2012.08.050; Kalinin SV, 2006, IEEE T ULTRASON FERR, V53, P2226, DOI 10.1109/TUFFC.2006.169; Kim SH, 2002, THIN SOLID FILMS, V416, P264, DOI 10.1016/S0040-6090(02)00726-5; Korsunsky AM, 1998, SURF COAT TECH, V99, P171, DOI 10.1016/S0257-8972(97)00522-7; LEFKI K, 1994, J APPL PHYS, V76, P1764, DOI 10.1063/1.357693; Li YW, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4795330; Li YW, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/17/175501; Lim JE, 2002, APPL PHYS LETT, V81, P3224, DOI 10.1063/1.1516830; Liu D, 2006, ACTA MATER, V54, P4525, DOI 10.1016/j.actamat.2006.05.039; Liu D, 2011, J AM CERAM SOC, V94, P3698, DOI 10.1111/j.1551-2916.2011.04867.x; Luginbuhl P, 1996, SENSOR ACTUAT A-PHYS, V54, P530, DOI 10.1016/S0924-4247(95)01196-X; Marsilius M, 2010, J AM CERAM SOC, V93, P2850, DOI 10.1111/j.1551-2916.2010.03801.x; Muralt P, 2000, J MICROMECH MICROENG, V10, P136, DOI 10.1088/0960-1317/10/2/307; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Saha R, 2002, ACTA MATER, V50, P23, DOI 10.1016/S1359-6454(01)00328-7; Schneider GA, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2830331; Schneider GA, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1920410; Scholz T, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2177364; Scholz T, 2004, APPL PHYS LETT, V84, P3055, DOI 10.1063/1.1711164; Scholz T, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2766846; Schuh CA, 2005, NAT MATER, V4, P617, DOI 10.1038/nmat1429; Schuh CA, 2006, J MATER RES, V21; Scott J.F., 2000, FERROELECTRIC MEMORI; Shepard JF, 1998, SENSOR ACTUAT A-PHYS, V71, P133, DOI 10.1016/S0924-4247(98)00161-7; Suna ZH, 2008, J APPL PHYS, V104; Szuecs F, 1999, J APPL PHYS, V86, P6010, DOI 10.1063/1.371648; Tsui TY, 1996, J MATER RES, V11, P752, DOI 10.1557/JMR.1996.0091; Uchino K., 2000, FERROELECTRIC DEVICE; Webber KG, 2009, ACTA MATER, V57, P4614, DOI 10.1016/j.actamat.2009.06.037; Wheeler JM, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4824710; Wong MF, 2008, PHILOS MAG, V88, P3105, DOI 10.1080/14786430802524330; Yan F, 2002, THIN SOLID FILMS, V406, P282, DOI 10.1016/S0040-6090(01)01745-X; Yao K, 2003, APPL PHYS LETT, V82, P4540, DOI 10.1063/1.1587272; Zheng JH, 1996, J AM CERAM SOC, V79, P3193, DOI 10.1111/j.1151-2916.1996.tb08095.x; Zheng XJ, 2004, ACTA MATER, V52, P3313, DOI 10.1016/j.actamat.2004.02.047; Zheng XJ, 2003, ACTA MATER, V51, P3985, DOI 10.1016/S1359-6454(03)00208-8; Zhou B, 2010, EXP MECH, V50, P793, DOI 10.1007/s11340-009-9309-7; Zhou B, 2010, J MATER RES, V25, P1671, DOI 10.1557/JMR.2010.0228; Zhou H, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4865773	49	4	4	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0116478	10.1371/journal.pone.0116478	http://dx.doi.org/10.1371/journal.pone.0116478			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768957	Green Published, gold, Green Submitted			2022-12-27	WOS:000351277500010
J	Abuduwaili, J; Zhang, ZY; Jiang, FQ				Abuduwaili, Jilili; Zhang, Zhao Yong; Jiang, Feng Qing			Assessment of the Distribution, Sources and Potential Ecological Risk of Heavy Metals in the Dry Surface Sediment of Aibi Lake in Northwest China	PLOS ONE			English	Article							STREET DUSTS; TRACE-METALS; CONTAMINATION; POLLUTION; SPECIATION; CATCHMENT; ACCUMULATION; SOILS	The distribution, sources and potential ecological risk of heavy metals in the sediment of lakes in eastern China and other areas of the world that have undergone rapid economic development have been widely researched by scholars. However, this is not true for heavy metals in the sediment of rump lakes in the arid regions of China and world-wide. Because of this, we chose Aibi Lake to serve as a typical rump lake in an oasis in an arid area in northwest China for our study. Sediment samples were collected from the lake and then the quantities of the heavy metals Pb, Ni, Cd, Cu, Zn, Hg and Cr were measured. Then using a variety of statistical methods, we analyzed the distribution, sources, pollution status and the potential ecological risk of these metals. The results show that: (1) The amounts of the seven heavy metals all fell within the Second Soil National Standard, but the average and maximum values were all higher than the background values of Xinjiang in northwest China. (2) Multivariate statistical analysis determined that the Cd, Pb, Hg and Zn in the sediment were mainly derived from man-sources, and Cu, Ni, and Cr were mainly from the natural geological background. (3) Enrichment factor analysis and the geo-accumulation index evaluation method show that Cd, Hg and Pb in the surface sediment of the Aibi Lake were at low and partial pollution levels, while Zn, Cr, Ni and Cu were at no and low pollution levels. (4) Calculation of the potential ecological hazards index found that, among the seven tested heavy metals, Cd, Hg and Pb were the main potential ecological risk factors, and the contribution of each was 42.6%, 28.6%, and 24.0%, respectively. Cd is the main potential ecological risk factor, followed by Hg and Pb. This work revealed that recent economic development of the Aibi Lake Basin has negatively influenced the accumulation of heavy metals in the sediments of the lake, and, therefore, we should pay increasing attention to this problem and take effective measures to protect the ecology of the Aibi Lake Basin. This work can provide a scientific basis for an early warning of heavy metal pollution and for protection of the environment. Furthermore, it can serve as a reference when creating policies for the economic development in Aibi Lake Basin and environmental protection of rump lakes in arid regions of northwest China and other areas of the world.	[Abuduwaili, Jilili; Zhang, Zhao Yong; Jiang, Feng Qing] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi, Peoples R China; [Zhang, Zhao Yong] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, ZY (corresponding author), Chinese Acad Sci, Xinjiang Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi, Peoples R China.	baiyangdian313@163.com		ji, li li/0000-0001-8483-1554	National Natural Science Foundation of China [41471098]; National Natural Science Foundation of China Xinjiang Joint Fund in China [U1138301]; Knowledge Innovation Program of the Chinese Academy of Sciences [KZCX2-EW-308, KZCX2-YW-GJ04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China Xinjiang Joint Fund in China; Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences)	This study was supported by the National Natural Science Foundation of China (No. 41471098), the National Natural Science Foundation of China Xinjiang Joint Fund in China (Nos. U1138301), and the Knowledge Innovation Program of the Chinese Academy of Sciences (KZCX2-EW-308, KZCX2-YW-GJ04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao Liang, 2014, Huanjing Kexue, V35, P179; Bing HJ, 2011, J ENVIRON SCI-CHINA, V23, P1671, DOI 10.1016/S1001-0742(10)60593-1; Bing Haijian, 2010, Hupo Kexue, V22, P675; Chen Chun-xiao, 2011, China Environmental Science, V31, P1842; Chen J, 2007, HENAN SCI, V25, P303; Chen YZ, 2007, PEDOSPHERE, V17, P284, DOI 10.1016/S1002-0160(07)60035-6; HAKANSON L, 1980, WATER RES, V14, P975, DOI 10.1016/0043-1354(80)90143-8; HORN MK, 1966, GEOCHIM COSMOCHIM AC, V30, P279, DOI 10.1016/0016-7037(66)90003-2; [黄顺生 Huang shunsheng], 2008, [地学前缘, Earth Science Frontiers], V15, P161; Jilili A., 2009, Arid Land Geography, V32, P211; Kankilic GB, 2013, ENVIRON MONIT ASSESS, V185, P6739, DOI 10.1007/s10661-013-3061-2; Kukrer S, 2014, ENVIRON MONIT ASSESS, V186, P3847, DOI 10.1007/s10661-014-3662-4; Lan W H, 2002, ARID ENV MONITORING, V16, P167; Li Bi-cai, 2012, Huanjing Kexue, V33, P2376; Li M, 2014, ECOTOXICOLOGY, V23, P681, DOI 10.1007/s10646-014-1180-3; Li MY, 2009, WATER RESOURCES PROT, V5, P44; [李珊珊 Li Shanshan], 2013, [环境科学学报, Acta Scientiae Circumstantiae], V33, P2277; Li XD, 2001, APPL GEOCHEM, V16, P1361, DOI 10.1016/S0883-2927(01)00045-2; Liu De-hong, 2012, Huanjing Kexue, V33, P253; [刘东伟 Liu Dongwei], 2014, [冰川冻土, Journal of Glaciology and Geocryology], V36, P352; Liu DW, 2011, WATER AIR SOIL POLL, V218, P175, DOI 10.1007/s11270-010-0633-4; Liu Qiang, 2013, China Environmental Science, V33, P2220; Liu WH, 2005, ENVIRON INT, V31, P805, DOI 10.1016/j.envint.2005.05.042; Liu ZK, 2005, JIANG SU ENV SCI TEC, V4, P016; [吕建树 Lu Jianshu], 2012, [地理学报, Acta Geographica Sinica], V67, P971; [吉力力·阿不都外力 JILILI Abuduwaili], 2007, [冰川冻土, Journal of Glaciology and Geocryology], V29, P928; Mamat Z, 2014, SCI TOTAL ENVIRON, V493, P1098, DOI 10.1016/j.scitotenv.2014.03.087; MI Y, 2008, J LAKE SCI, V21, P891; Mi Yan, 2009, Hupo Kexue, V21, P891; Muller G.M.M.G.M.G.M.G.P., 1969, GEOJOURNAL, V2, P108, DOI DOI 10.1055/S-2007-1023171; Munksgaard NC, 2001, MAR CHEM, V75, P165, DOI 10.1016/S0304-4203(01)00033-0; [钱亦兵 Qian Yibing], 2004, [冰川冻土, Journal of Glaciology and Geocryology], V26, P17; [乔敏敏 Qiao Minmin], 2013, [环境科学学报, Acta Scientiae Circumstantiae], V33, P3324; [乔胜英 Qiao Shengying], 2005, [长江流域资源与环境, Resources and Environment in the Yangtze Basin], V14, P353; Ren WX, 2014, LAND USE POLICY, V38, P138, DOI 10.1016/j.landusepol.2013.11.005; SEPA (State Environmental Protection Administration), 2006, GB204232006 STAT ENV; Sutherland RA, 2000, ENVIRON GEOL, V39, P611, DOI 10.1007/s002540050473; Tam NFY, 2000, ENVIRON POLLUT, V110, P195, DOI 10.1016/S0269-7491(99)00310-3; The State Environmental Protection Administration (SEPA), 1990, CHIN SOIL EL BACKGR; Wang L, 2011, J ENV MANAGEMENT COL, V21, P8; Xia JQ, 1995, NATL STANDARD SOIL E; [夏希凡 XIA Xifan], 2006, [新疆地质, Xinjiang Geology], V24, P392; [徐争启 Xu Zhengqi], 2008, [环境科学与技术, Enuivonmental Science and Technology], V31, P112; [杨世琦 Yang Shiqi], 2010, [生态学报, Acta Ecologica Sinica], V30, P6201; Yang ZF, 2009, J HAZARD MATER, V166, P1186, DOI 10.1016/j.jhazmat.2008.12.034; Zeng HA, 2007, QUATERNARY SCI, V27, P128; [张永三 ZHANG Yong-san], 2009, [地球与环境, Earth and Environment], V37, P50; Zhang Zhao-yong, 2012, China Environmental Science, V32, P1799; Zhang ZY, 2013, ANAL LETT, V46, P2122, DOI 10.1080/00032719.2013.784919; Zhao YF, 2007, PEDOSPHERE, V17, P44, DOI 10.1016/S1002-0160(07)60006-X; Zheng SongLin, 2011, Environmental Science & Technology (China), V34, P85; Zhong Xiao-lan, 2010, Huanjing Kexue, V31, P1608; Zhou ChangHai, 2005, Arid Land Geography, V28, P98; Zhu BQ, 2013, J HYDROL, V486, P151, DOI 10.1016/j.jhydrol.2013.01.016; Zhu G.W., 2005, J LAKE SCI, V17, P143, DOI [DOI 10.18307/2005.0209.[, 10.18307/2005.0209, DOI 10.18307/2005.0209]	55	39	44	1	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120001	10.1371/journal.pone.0120001	http://dx.doi.org/10.1371/journal.pone.0120001			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781032	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600117
J	Acuff, NV; Li, X; Kirkland, R; Nagy, T; Watford, WT				Acuff, Nicole V.; Li, Xin; Kirkland, Rebecca; Nagy, Tamas; Watford, Wendy T.			Tumor Progression Locus 2 Differentially Regulates IFN gamma and IL-17 Production by Effector CD4(+) T Cells in a T Cell Transfer Model of Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; TGF-BETA; TH17 CELLS; AUTOIMMUNE-DISEASE; PROTEIN-KINASE; T(H)17 CELLS; ACTIVATE ERK; TPL2 KINASE; ROR-GAMMA; KAPPA-B	Autoimmune diseases are approaching epidemic levels, estimated to affect 5-8% of the population. A number of autoimmune diseases are believed to be driven by autoreactive T cells, specifically by T helper 1 (Th1) cells and T helper 17 (Th17) cells. One molecule gaining interest as a therapeutic target is the serine-threonine kinase, Tpl2, which promotes expression of proinflammatory mediators. We previously demonstrated that Tpl2 regulates Th1 differentiation, secretion of the inflammatory cytokine IFN gamma, and host defense against the intracellular parasite Toxoplasma gondii. The goal of this study was to determine whether Tpl2 also regulates Th1 or Th17 differentiation in vivo in a model of colitis associated with mixed Th1/Th17 pathology. In vitro, Tpl2(-/-) naive CD4 T cells were significantly impaired in IL-17A secretion under traditional Th17 inducing conditions. Reduced IL-17A secretion correlated with increased expression of FoxP3, a transcription factor known to antagonize ROR gamma t function. In a murine T cell transfer model of colitis, transfer of Tpl2(-/-) T cells resulted in reduced proportions of CD4 T cells expressing IFN gamma, but not IL-17A, compared to that induced by wild type T cells. Further studies revealed that IL-17A differentiation induced by IL-6 and IL-23, cytokines implicated in driving Th17 differentiation in vivo, was unaffected by Tpl2 deficiency. Collectively, these results implicate Tpl2 in TGF-beta-induced FoxP3 expression. Additionally, they underscore the contribution of Tpl2 to Th1 immunopathology specifically, which suggests that Tpl2 inhibitors may selectively target Th1-based inflammation.	[Acuff, Nicole V.; Li, Xin; Kirkland, Rebecca; Watford, Wendy T.] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA; [Nagy, Tamas] Univ Georgia, Dept Pathol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Watford, WT (corresponding author), Univ Georgia, Dept Infect Dis, 501 DW Brooks Dr, Athens, GA 30602 USA.	watfordw@uga.edu	Li, Xin V./ABA-4321-2021; Li, Xin/AAH-2983-2019	Li, Xin V./0000-0002-9444-8214; Watford, Wendy/0000-0003-4261-5399	National Institute of Allergy and Infectious Diseases, NIH [R01AI099058]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099058, R56AI099058] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by R01AI099058 (WTW), http://www.niaid.nih.gov/Pages/default.aspx, National Institute of Allergy and Infectious Diseases, NIH.	Azar ST, 1999, CLIN DIAGN LAB IMMUN, V6, P306, DOI 10.1128/CDLI.6.3.306-310.1999; Bandow K, 2012, FEBS LETT, V586, P1540, DOI 10.1016/j.febslet.2012.04.018; Banerjee A, 2006, P NATL ACAD SCI USA, V103, P3274, DOI 10.1073/pnas.0511113103; BELL EB, 1987, J IMMUNOL, V139, P1379; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Das S, 2005, J BIOL CHEM, V280, P23748, DOI 10.1074/jbc.M412837200; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Eliopoulos AG, 2003, EMBO J, V22, P3855, DOI 10.1093/emboj/cdg386; Eliopoulos AG, 2002, EMBO J, V21, P4831, DOI 10.1093/emboj/cdf478; Feng T, 2011, J IMMUNOL, V186, P6313, DOI 10.4049/jimmunol.1001454; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gantke T, 2011, CELL RES, V21, P131, DOI 10.1038/cr.2010.173; George D, 2009, CURR TOP MED CHEM, V9, P611, DOI 10.2174/156802609789007345; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Green N, 2007, J MED CHEM, V50, P4728, DOI 10.1021/jm070436q; Hall JP, 2007, J BIOL CHEM, V282, P33295, DOI 10.1074/jbc.M703694200; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hatziapostolou M, 2008, CANCER RES, V68, P1851, DOI 10.1158/0008-5472.CAN-07-5793; Horwitz DA, 2008, EUR J IMMUNOL, V38, P912, DOI 10.1002/eji.200738109; Kaiser F, 2009, J EXP MED, V206, P1863, DOI 10.1084/jem.20091059; Koliaraki V, 2012, J CLIN INVEST, V122, P4231, DOI 10.1172/JCI63917; Kontoyiannis D, 2002, J EXP MED, V196, P1563, DOI 10.1084/jem.20020281; Kryczek I, 2007, J IMMUNOL, V179, P1423, DOI 10.4049/jimmunol.179.3.1423; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lawrenz M, 2012, MUCOSAL IMMUNOL, V5, P129, DOI 10.1038/mi.2011.57; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Mielke LA, 2009, J IMMUNOL, V183, P7984, DOI 10.4049/jimmunol.0901336; Min B, 2005, J IMMUNOL, V174, P6039, DOI 10.4049/jimmunol.174.10.6039; Miossec P, 2012, NAT REV DRUG DISCOV, V11, P763, DOI 10.1038/nrd3794; Mus AMC, 2010, ARTHRITIS RHEUM-US, V62, P1043, DOI 10.1002/art.27336; Nguyen TLM, 2011, J IMMUNOL, V187, P1745, DOI 10.4049/jimmunol.1004112; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Ostanin DV, 2006, AM J PHYSIOL-GASTR L, V290, pG109, DOI 10.1152/ajpgi.00214.2005; Ostanin DV BJ, 2009, AM J PHYSIOL-GASTR L, V296, P135; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; PATRIOTIS C, 1993, P NATL ACAD SCI USA, V90, P2251, DOI 10.1073/pnas.90.6.2251; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Soria-Castro I, 2010, J BIOL CHEM, V285, P33805, DOI 10.1074/jbc.M110.169409; Sriskantharajah S, 2014, J IMMUNOL; Tsatsanis C, 2008, P NATL ACAD SCI USA, V105, P2987, DOI 10.1073/pnas.0708381104; Watford WT, 2010, J IMMUNOL, V184, P105, DOI 10.4049/jimmunol.0803730; Watford WT, 2008, J EXP MED, V205, P2803, DOI 10.1084/jem.20081461; Wei L, 2007, J BIOL CHEM, V282, P34605, DOI 10.1074/jbc.M705100200; Xiao Y, 2014, J EXP MED; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Zhang N, 2012, NAT IMMUNOL, V13, P667, DOI 10.1038/ni.2319; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	55	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119885	10.1371/journal.pone.0119885	http://dx.doi.org/10.1371/journal.pone.0119885			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781948	Green Published, gold, Green Submitted			2022-12-27	WOS:000351284600104
J	Alanazi, I; Hoffmann, P; Adelson, DL				Alanazi, Ibrahim; Hoffmann, Peter; Adelson, David L.			MicroRNAs Are Part of the Regulatory Network that Controls EGF Induced Apoptosis, Including Elements of the JAK/STAT Pathway, in A431 Cells	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; BREAST-CANCER CELLS; ERBB RECEPTORS; INHIBITION; THERAPY; PROTEIN; OVEREXPRESSION; PROLIFERATION; SUPPRESSION; EXPRESSION	MiRNAs are known to regulate gene expression and in the context of cancer have been shown to regulate metastasis, cell proliferation and cell death. In this report we describe potential miRNA regulatory roles with respect to induction of cell death by pharmacologic dose of Epidermal Growth Factor (EGF). Our previous work suggested that multiple pathways are involved in the induction of apoptosis, including interferon induced genes, cytokines, cytoskeleton and cell adhesion and TP53 regulated genes. Using miRNA time course expression profiling of EGF treated A431 cells and coupling this to our previous gene expression and proteomic data, we have been able to implicate a number of additional miRNAs in the regulation of apoptosis. Specifically we have linked miR-134, miR-145, miR-146b-5p, miR-432 and miR-494 to the regulation of both apoptotic and anti-apoptotic genes expressed as a function of EGF treatment. Whilst additional miRNAs were differentially expressed, these had the largest number of apoptotic and anti-apoptotic targets. We found 5 miRNAs previously implicated in the regulation of apoptosis and our results indicate that an additional 20 miRNAs are likely to be involved based on their correlated expression with targets. Certain targets were linked to multiple miRNAs, including PEG10, BTG1, ID1, IL32 and NCF2. Some miRNAs that target the interferon pathway were found to be down regulated, consistent with a novel layer of regulation of interferon pathway components downstream of JAK/STAT. We have significantly expanded the repertoire of miRNAs that may regulate apoptosis in cancer cells as a result of this work.	[Alanazi, Ibrahim; Hoffmann, Peter; Adelson, David L.] Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia; [Adelson, David L.] Univ Adelaide, Zhendong Australia China Ctr Mol Chinese Med, Adelaide, SA, Australia	University of Adelaide; University of Adelaide	Adelson, DL (corresponding author), Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia.	david.adelson@adelaide.edu.au	Adelson, David L/E-5506-2011; Hoffmann, Peter/U-5996-2017	Adelson, David L/0000-0003-2404-5636; Hoffmann, Peter/0000-0001-8493-2208; Alanazi, Ibrahim O./0000-0002-8479-7875	University of Adelaide	University of Adelaide	This work was supported by The University of Adelaide. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG DK, 1994, CANCER RES, V54, P5280; BARNES DW, 1982, J CELL BIOL, V93, P1, DOI 10.1083/jcb.93.1.1; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Cande C, 2004, ONCOGENE, V23, P1514, DOI 10.1038/sj.onc.1207279; Cerchia L, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/73104; Ciardiello F, 2001, CLIN CANCER RES, V7, P2958; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GILL GN, 1982, J CELL BIOCHEM, V19, P249, DOI 10.1002/jcb.240190306; GILL GN, 1981, NATURE, V293, P305, DOI 10.1038/293305a0; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Gulli LF, 1996, CELL GROWTH DIFFER, V7, P173; Hu HY, 2013, J BIOL CHEM, V288, P10973, DOI 10.1074/jbc.M112.434340; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Janmaat ML, 2003, DRUG TODAY, V39, P61; Kari C, 2003, CANCER RES, V63, P1; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Lima RT, 2011, EUR J CANCER, V47, P163, DOI 10.1016/j.ejca.2010.11.005; Lin CC, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-18; Liu HJ, 2007, INT J DERMATOL, V46, P1171, DOI 10.1111/j.1365-4632.2007.03335.x; Liu XQ, 2011, CARCINOGENESIS, V32, P1798, DOI 10.1093/carcin/bgr213; Mlcochova J., 2013, J CANC RES CLIN ONCO; Nahta R, 2006, MOL CANCER THER, V5, P1593, DOI 10.1158/1535-7163.MCT-06-0133; Normanno N, 2005, CURR DRUG TARGETS, V6, P243, DOI 10.2174/1389450053765879; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Papadopoulou N, 2008, EXP CELL RES, V314, P3162, DOI 10.1016/j.yexcr.2008.07.012; Pinkas-Kramarski R, 1997, J MAMMARY GLAND BIOL, V2, P97, DOI 10.1023/A:1026343528967; Qiu CX, 2010, BMC SYSTEMS BIOLOGY, P4; Rodeck U, 1997, J CELL SCI, V110, P113; Romano G, 2012, P NATL ACAD SCI USA, V109, P16570, DOI 10.1073/pnas.1207917109; Rossi S, 2008, MAMM GENOME, V19, P526, DOI 10.1007/s00335-008-9119-8; Schmidt M, 2002, DRUG RESIST UPDATE, V5, P11, DOI 10.1016/S1368-7646(02)00004-3; Schneeweiss A, 2004, ANTI-CANCER DRUG, V15, P235, DOI 10.1097/00001813-200403000-00007; Solomon B, 2003, INT J RADIAT ONCOL, V55, P713, DOI 10.1016/S0360-3016(02)04357-2; Sun XH, 2008, BMC IMMUNOLOGY, V9; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Walsh B, 2009, REDOX REP, V14, P275, DOI 10.1179/135100009X12525712409652; Weinstein EJ, 1998, ONCOGENE, V17, P2107, DOI 10.1038/sj.onc.1202428; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Woodburn JR, 1999, PHARMACOL THERAPEUT, V82, P241, DOI 10.1016/S0163-7258(98)00045-X; Wu GM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r112; Zhang J, 2013, ONCOGENE, V32, P61, DOI 10.1038/onc.2012.28	43	17	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120337	10.1371/journal.pone.0120337	http://dx.doi.org/10.1371/journal.pone.0120337			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781916	Green Submitted, Green Published, gold			2022-12-27	WOS:000351284600152
J	Hidano, A; Yamamoto, T; Hayama, Y; Muroga, N; Kobayashi, S; Nishida, T; Tsutsui, T				Hidano, Arata; Yamamoto, Takehisa; Hayama, Yoko; Muroga, Norihiko; Kobayashi, Sota; Nishida, Takeshi; Tsutsui, Toshiyuki			Unraveling Antimicrobial Resistance Genes and Phenotype Patterns among Enterococcus faecalis Isolated from Retail Chicken Products in Japan	PLOS ONE			English	Article							TETRACYCLINE RESISTANCE; ANTIBIOTIC-RESISTANCE; ESCHERICHIA-COLI; VANCOMYCIN RESISTANCE; BAYESIAN NETWORKS; FOOD ANIMALS; ERM(B) GENE; FAECIUM; DETERMINANTS; HUMANS	Multidrug-resistant enterococci are considered crucial drivers for the dissemination of antimicrobial resistance determinants within and beyond a genus. These organisms may pass numerous resistance determinants to other harmful pathogens, whose multiple resistances would cause adverse consequences. Therefore, an understanding of the coexistence epidemiology of resistance genes is critical, but such information remains limited. In this study, our first objective was to determine the prevalence of principal resistance phenotypes and genes among Enterococcus faecalis isolated from retail chicken domestic products collected throughout Japan. Subsequent analysis of these data by using an additive Bayesian network (ABN) model revealed the co-appearance patterns of resistance genes and identified the associations between resistance genes and phenotypes. The common phenotypes observed among E. faecalis isolated from the domestic products were the resistances to oxytetracycline (58.4%), dihydrostreptomycin (50.4%), and erythromycin (37.2%), and the gene tet(L) was detected in 46.0% of the isolates. The ABN model identified statistically significant associations between tet(L) and erm(B), tet(L) and ant(6)-Ia, ant(6)-Ia and aph(3')IIIa, and aph(3')-IIIa and erm(B), which indicated that a multiple-resistance profile of tetracycline, erythromycin, streptomycin, and kanamycin is systematic rather than random. Conversely, the presence of tet(O) was only negatively associated with that of erm(B) and tet (M), which suggested that in the presence of tet(O), the aforementioned multiple resistance is unlikely to be observed. Such heterogeneity in linkages among genes that confer the same phenotypic resistance highlights the importance of incorporating genetic information when investigating the risk factors for the spread of resistance. The epidemiological factors that underlie the persistence of systematic multiple-resistance patterns warrant further investigations with appropriate adjustments for ecological and bacteriological factors.	[Hidano, Arata; Yamamoto, Takehisa; Hayama, Yoko; Muroga, Norihiko; Kobayashi, Sota; Tsutsui, Toshiyuki] Natl Inst Anim Hlth, Natl Agr & Food Res Org, Viral Dis & Epidemiol Res Div, Tsukuba, Ibaraki 305, Japan; [Hidano, Arata] Massey Univ, Inst Vet Anim & Biomed Sci, EpiCtr, Palmerston North, New Zealand; [Nishida, Takeshi] Minist Agr Forestry & Fisheries, Food Safety & Consumer Affairs Bur, Anim Prod Safety Div, Chiyoda Ku, Tokyo, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Massey University; Ministry of Agriculture Forestry & Fisheries - Japan	Tsutsui, T (corresponding author), Natl Inst Anim Hlth, Natl Agr & Food Res Org, Viral Dis & Epidemiol Res Div, Tsukuba, Ibaraki 305, Japan.	tsutsui@affrc.go.jp	Hidano, Arata/S-1719-2019	Hidano, Arata/0000-0003-1707-5319	Regulatory Research Projects for Food Safety, Animal Health and Plant Protection - Ministry of Agriculture, Forestry and Fisheries, Japan	Regulatory Research Projects for Food Safety, Animal Health and Plant Protection - Ministry of Agriculture, Forestry and Fisheries, Japan	This study was supported by Regulatory Research Projects for Food Safety, Animal Health and Plant Protection funded by the Ministry of Agriculture, Forestry and Fisheries, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup FM, 2000, DIAGN MICR INFEC DIS, V37, P127, DOI 10.1016/S0732-8893(00)00130-9; Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Aslam M, 2012, INT J FOOD MICROBIOL, V156, P222, DOI 10.1016/j.ijfoodmicro.2012.03.026; Baker-Austin C, 2006, TRENDS MICROBIOL, V14, P176, DOI 10.1016/j.tim.2006.02.006; BENTORCHA F, 1991, ANTIMICROB AGENTS CH, V35, P808, DOI 10.1128/AAC.35.5.808; Blake DP, 2003, J APPL MICROBIOL, V94, P1087, DOI 10.1046/j.1365-2672.2003.01937.x; Cauwerts K, 2007, AVIAN PATHOL, V36, P395, DOI 10.1080/03079450701589167; Clinical and Laboratory Standards Institute, 2009, M07A8 CLSI; Dahl KH, 2007, J ANTIMICROB CHEMOTH, V59, P478, DOI 10.1093/jac/dkl530; De Leener E, 2004, MICROB DRUG RESIST, V10, P341, DOI 10.1089/mdr.2004.10.341; Denwood MJ, 2011, P ROY SOC B-BIOL SCI, V278, P1434, DOI 10.1098/rspb.2010.1719; Di Cesare A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062838; Friedman N, 1999, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, PROCEEDINGS, P196; Frye JG, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00135; Hiroi M, 2012, J FOOD PROTECT, V75, P1774, DOI 10.4315/0362-028X.JFP-11-479; Hollenbeck BL, 2012, VIRULENCE, V3, P421, DOI 10.4161/viru.21282; Hosoi Y, 2014, REV SCI TEC IN PRESS, V33; Huys G, 2004, APPL ENVIRON MICROB, V70, P1555, DOI 10.1128/AEM.70.3.1555-1562.2004; Jackson CR, 2004, J CLIN MICROBIOL, V42, P3558, DOI 10.1128/JCM.42.8.3558-3565.2004; Kehrenberg C, 2006, ANTIMICROB AGENTS CH, V50, P1156, DOI 10.1128/AAC.50.4.1156-1163.2006; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Lewis FI, 2013, EMERG THEMES EPIDEMI, V10, DOI 10.1186/1742-7622-10-4; Lewis FI, 2012, AM J EPIDEMIOL, V176, P1051, DOI 10.1093/aje/kws183; Ludwig A, 2013, PREV VET MED, V110, P64, DOI 10.1016/j.prevetmed.2013.02.005; National Veterinary Assay Laboratory, REP JAP VET ANT RES; Nomura T, 2012, ANTIMICROB AGENTS CH, V56, P6389, DOI 10.1128/AAC.00747-12; PEPPER K, 1987, ANTIMICROB AGENTS CH, V31, P1394, DOI 10.1128/AAC.31.9.1394; Phillips I, 2004, J ANTIMICROB CHEMOTH, V53, P28, DOI 10.1093/jac/dkg483; Portillo A, 2000, ANTIMICROB AGENTS CH, V44, P967, DOI 10.1128/AAC.44.4.967-971.2000; Rice LB, 1998, ANTIMICROB AGENTS CH, V42, P1871, DOI 10.1128/AAC.42.8.1871; Roberts MC, 2005, FEMS MICROBIOL LETT, V245, P195, DOI 10.1016/j.femsle.2005.02.034; Schwaiger K, 2009, VET MICROBIOL, V139, P386, DOI 10.1016/j.vetmic.2009.06.005; Singer RS, 2014, CURR OPIN MICROBIOL, V19, P1, DOI 10.1016/j.mib.2014.05.014; Singer RS, 2006, NAT REV MICROBIOL, V4, P943, DOI 10.1038/nrmicro1553; Summers AO, 2002, CLIN INFECT DIS, V34, pS85, DOI 10.1086/340245; Tremblay CL, 2011, J FOOD PROTECT, V74, P1639, DOI 10.4315/0362-028X.JFP-10-451; Watanabe S, 2009, MICROB DRUG RESIST, V15, P185, DOI 10.1089/mdr.2009.0917; Weigel LM, 2003, SCIENCE, V302, P1569, DOI 10.1126/science.1090956; Werner G, 2001, ANTIMICROB AGENTS CH, V45, P3267, DOI 10.1128/AAC.45.11.3267-3269.2001; Werner G, 2013, INT J MED MICROBIOL, V303, P360, DOI 10.1016/j.ijmm.2013.03.001; Willems RJL, 2005, EMERG INFECT DIS, V11, P821, DOI 10.3201/1106.041204; Wooldridge M, 2012, REV SCI TECH OIE, V31, P231	43	33	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0121189	10.1371/journal.pone.0121189	http://dx.doi.org/10.1371/journal.pone.0121189			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781022	gold, Green Submitted, Green Published			2022-12-27	WOS:000351284600197
J	Kalaska, B; Kaminski, K; Sokolowska, E; Czaplicki, D; Kujdowicz, M; Stalinska, K; Bereta, J; Szczubialka, K; Pawlak, D; Nowakowska, M; Mogielnicki, A				Kalaska, Bartlomiej; Kaminski, Kamil; Sokolowska, Emilia; Czaplicki, Dominik; Kujdowicz, Monika; Stalinska, Krystyna; Bereta, Joanna; Szczubialka, Krzysztof; Pawlak, Dariusz; Nowakowska, Maria; Mogielnicki, Andrzej			Nonclinical Evaluation of Novel Cationically Modified Polysaccharide Antidotes for Unfractionated Heparin	PLOS ONE			English	Article							MOLECULAR-WEIGHT PROTAMINE; ARTERIAL THROMBOSIS; INDUCED THROMBOCYTOPENIA; ANGIOTENSIN-II; HEART-DISEASE; CARDIOPULMONARY; COMPLICATIONS; ANTAGONIST; NEUTRALIZATION; GUIDELINES	Protamine, the only registered antidote of unfractionated heparin (UFH), may produce a number of adverse effects, such as anaphylactic shock or serious hypotension. We aimed to develop an alternative UFH antidote as efficient as protamine, but safer and easier to produce. As a starting material, we have chosen generally non-toxic, biocompatible, widely available, inexpensive, and easy to functionalize polysaccharides. Our approach was to synthesize, purify and characterize cationic derivatives of dextran, hydroxypropylcellulose, pullulan and.-cyclodextrin, then to screen them for potential heparin-reversal activity using an in vitro assay and finally examine efficacy and safety of the most active polymers in Wistar rat and BALB/c mouse models of experimentally induced arterial and venous thrombosis. Efficacy studies included the measurement of thrombus formation, activated partial thromboplastin time, bleeding time, and anti-factor Xa activity; safety studies included the measurement of hemodynamic, hematologic and immunologic parameters. Linear, high molecular weight dextran substituted with glycidyltrimethylammonium chloride groups at a ratio of 0.65 per glucose unit (Dex40-GTMAC3) is the most potent and the safest UFH inhibitor showing activity comparable to that of protamine while possessing lower immunogenicity. Cationic polysaccharides of various structures neutralize UFH. Dex40-GTMAC3 is a promising and potentially better UFH antidote than protamine.	[Kalaska, Bartlomiej; Sokolowska, Emilia; Pawlak, Dariusz; Mogielnicki, Andrzej] Med Univ Bialystok, Dept Pharmacodynam, Bialystok, Poland; [Kaminski, Kamil; Kujdowicz, Monika; Szczubialka, Krzysztof; Nowakowska, Maria] Jagiellonian Univ, Fac Chem, PL-30060 Krakow, Poland; [Czaplicki, Dominik; Stalinska, Krystyna; Bereta, Joanna] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Cell Biochem, Krakow, Poland	Medical University of Bialystok; Jagiellonian University; Jagiellonian University	Mogielnicki, A (corresponding author), Med Univ Bialystok, Dept Pharmacodynam, Bialystok, Poland.	amogiel@umb.edu.pl	Sokolowska, Emilia/Y-5058-2019; Kalaska, Bartlomiej/B-6030-2015; Pawlak, Dariusz/T-3068-2018; Kaminski, Kamil/AAJ-9650-2020; Sokolowska, Emilia/U-2384-2018; Szczubiałka, Krzysztof/D-4728-2016; Mogielnicki, Andrzej/E-9313-2014	Sokolowska, Emilia/0000-0002-8695-5304; Pawlak, Dariusz/0000-0002-3751-0608; Kaminski, Kamil/0000-0002-7421-6758; Sokolowska, Emilia/0000-0002-8695-5304; Szczubiałka, Krzysztof/0000-0001-6612-1102; Mogielnicki, Andrzej/0000-0003-2406-5290; Czaplicki, Dominik/0000-0003-2583-0775; Bereta, Joanna/0000-0001-7930-2770; Kalaska, Bartlomiej/0000-0002-4968-4429	National Science Centre [DEC-2011/03/B/NZ7/ 00755, UMO-2013/09/D/ST5/03864]; Leading National Research Center in Bialystok [31/KNOW/2013]; Foundation for Polish Science Team Programme; EU European Regional Development Fund, PolyMed [TEAM/2008-2/6]	National Science Centre(National Science Centre, Poland); Leading National Research Center in Bialystok; Foundation for Polish Science Team Programme(Foundation for Polish Science); EU European Regional Development Fund, PolyMed	The study was supported by National Science Centre Grant No. DEC-2011/03/B/NZ7/ 00755. BK was supported by funds from Leading National Research Center in Bialystok (31/KNOW/2013). KK was supported by National Science Centre Grant No. UMO-2013/09/D/ST5/03864. KK, KS, and MN acknowledge the financial support of the Foundation for Polish Science Team Programme cofinanced by the EU European Regional Development Fund, PolyMed, TEAM/2008-2/6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON WF, 1992, SCIENCE, V256, P808, DOI 10.1126/science.1589762; [Anonymous], 2008, PROT SULPH INJ USP; Baglin T, 2006, BRIT J HAEMATOL, V133, P19, DOI 10.1111/j.1365-2141.2005.05953.x; Bakchoul T, 2013, BLOOD, V121, P2821, DOI 10.1182/blood-2012-10-460691; Bromfield SM, 2013, CHEM SOC REV, V42, P9184, DOI 10.1039/c3cs60278h; Bull BS, 2009, BLOOD CELL MOL DIS, V43, P256, DOI 10.1016/j.bcmd.2009.07.002; Bulwan M, 2013, MACROMOL BIOSCI, V13, P1610, DOI 10.1002/mabi.201300258; Byun Y, 1999, THROMB RES, V94, P53, DOI 10.1016/S0049-3848(98)00201-1; Chlopicki S, 2007, BRIT J PHARMACOL, V152, P230, DOI 10.1038/sj.bjp.0707383; Chu YQ, 2010, CLIN THER, V32, P1729, DOI 10.1016/j.clinthera.2010.09.010; COLMAN RW, 1995, AM J HEMATOL, V48, P267, DOI 10.1002/ajh.2830480412; Cushing DJ, 2010, EUR J PHARMACOL, V635, P165, DOI 10.1016/j.ejphar.2010.03.016; Diaz JA, 2011, JOVE-J VIS EXP, V53, P27; El-Aneed A, 2004, J CONTROL RELEASE, V94, P1, DOI 10.1016/j.jconrel.2003.09.013; Fazavana J, 2013, J THROMB HAEMOST, V11, P1128, DOI 10.1111/jth.12249; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Guarini S, 1996, J PHARMACOL TOXICOL, V35, P101, DOI 10.1016/1056-8719(96)00006-8; Johansson PI, 2008, VOX SANG, V95, P1, DOI 10.1111/j.1423-0410.2008.01063.x; Kalaska B, 2014, J AGR FOOD CHEM, V62, P2853, DOI 10.1021/jf5008538; Kalaska B, 2012, EUR J PHARMACOL, V686, P81, DOI 10.1016/j.ejphar.2012.04.037; Kaminska M, 2005, J PHYSIOL PHARMACOL, V56, P571; Kaminski K, 2008, BIOMACROMOLECULES, V9, P3127, DOI 10.1021/bm800724q; Kaminski K, 2014, MEDCHEMCOMM, V5, P489, DOI 10.1039/c3md00374d; Kaminski K, 2011, J MED CHEM, V54, P6586, DOI 10.1021/jm200380w; Kaminski K, 2010, J MED CHEM, V53, P4141, DOI 10.1021/jm1001666; Karewicz A, 2015, RSC POLYM CHEM SER, V13, P296; KELTON JG, 1994, BLOOD, V83, P3232; Kikura M, 1996, ANESTH ANALG, V83, P223, DOI 10.1097/00000539-199608000-00004; Kimmel SE, 2002, ANESTH ANALG, V94, P1402, DOI 10.1097/00000539-200206000-00005; Kramkowski K, 2012, ARTERIOSCL THROM VAS, V32, P2149, DOI 10.1161/ATVBAHA.112.253989; Lee LM, 2001, AAPS PHARMSCI, V3, part. no.; LEVY JH, 1989, J THORAC CARDIOV SUR, V98, P200; Liang JF, 2003, BIOCHEMISTRY-MOSCOW+, V68, P116, DOI 10.1023/A:1022109905487; MA XH, 1992, BIOTECHNOL BIOENG, V40, P530, DOI 10.1002/bit.260400412; Mahan CE, 2014, J THROMB THROMBOLYS, V37, P271, DOI 10.1007/s11239-013-0927-7; McDonagh DL, 2014, LANCET NEUROL, V13, P490, DOI 10.1016/S1474-4422(14)70004-3; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; Mogielnicki A, 2007, J PHYSIOL PHARMACOL, V58, P515; Mogielnicki A, 2005, THROMB HAEMOSTASIS, V93, P1069, DOI 10.1160/TH04-10-0701; Nel L, 2011, BRIT J CLIN PHARMACO, V71, P647, DOI 10.1111/j.1365-2125.2011.03913.x; Nybo M, 2008, BASIC CLIN PHARMACOL, V103, P192, DOI 10.1111/j.1742-7843.2008.00274.x; Oney S, 2009, NAT MED, V15, P1224, DOI 10.1038/nm.1990; SCHUMACHER WA, 1993, HAEMOSTASIS, V23, P219; Shi WP, 2011, J PHARM SCI-US, V100, P886, DOI 10.1002/jps.22328; Shigeta O, 1999, J THORAC CARDIOV SUR, V118, P354, DOI 10.1016/S0022-5223(99)70227-8; SINGER RL, 1993, CHEST, V104, P1436, DOI 10.1378/chest.104.5.1436; Stafford-Smith M, 2005, ANESTHESIOLOGY, V103, P229, DOI 10.1097/00000542-200508000-00005; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; VISENTIN GP, 1994, J CLIN INVEST, V93, P81, DOI 10.1172/JCI116987; WEILER JM, 1990, J ALLERGY CLIN IMMUN, V85, P713, DOI 10.1016/0091-6749(90)90189-B; WOODMAN RC, 1990, BLOOD, V76, P1680; WU HF, 1995, BLOOD, V85, P421	52	25	25	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119486	10.1371/journal.pone.0119486	http://dx.doi.org/10.1371/journal.pone.0119486			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781030	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600067
J	Leung, CY; Leung, GM; Schooling, CM				Leung, Cherry Y.; Leung, Gabriel M.; Schooling, C. Mary			Informal Child Care and Adolescent Psychological Well-Being: Hong Kong's "Children of 1997" Birth Cohort	PLOS ONE			English	Article							PATIENT HEALTH QUESTIONNAIRE-9; DEPRESSIVE SYMPTOMS; MATERNAL EMPLOYMENT; ADULT DEPRESSION; SELF-ESTEEM; CHINESE; PREDICTORS; EXPERIENCE; IMPUTATION; DISORDERS	Background Informal child care (child care by untrained family members, relatives or employees in the home) in Western populations is often associated with poorer psychological well-being, which may be confounded by socioeconomic position. We examined the association of informal child care, common in non-Western settings, with adolescent psychological wellbeing, using Hong Kong's Chinese "Children of 1997" birth cohort. Methods Multivariable linear regression was used to examine the adjusted associations of informal child care (at 0.5, 3, 5 and 11 years) with parent-reported Rutter score for child behavior at 11 years, self-reported Culture-Free Self-Esteem Inventories score at 11 years and self-reported Patient Health Questionnaire-9 depressive symptom score at 13 years. Model comparisons were used to identify the best representation of child care, in terms of a critical period of exposure to informal child care (independent variable) at a specific age, combination of exposures to informal child care at several ages or an accumulation of exposures to informal child care. Results Child care was not associated with behavioral problems. A model considering child care at 3 years best represented the association of child care with self-esteem while a model considering child care at 5 years best represented the association of child care with depressive symptoms. Informal child care at 3 years was associated with lower self-esteem (-0.70, 95% confidence interval (CI) -1.26 to -0.14). Informal child care at 5 years was associated with more depressive symptoms (0.45, 95% CI 0.17 to 0.73). Conclusion In a developed non-Western setting, informal child care was associated with lower self-esteem and more depressive symptoms.	[Leung, Cherry Y.; Leung, Gabriel M.; Schooling, C. Mary] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Schooling, C. Mary] CUNY Sch Publ Hlth, New York, NY USA; [Schooling, C. Mary] CUNY Hunter Coll, New York, NY 10021 USA	University of Hong Kong; City University of New York (CUNY) System; City University of New York (CUNY) System; Hunter College (CUNY)	Schooling, CM (corresponding author), Univ Hong Kong, Dept Community Med, Hong Kong, Hong Kong, Peoples R China.	cms1@hkucc.hku.hk		Schooling, Mary/0000-0001-9933-5887; Leung, Gabriel/0000-0002-2503-6283	Health Care and Promotion Fund, Health and Welfare Bureau, Government of the Hong Kong SAR (HCPF) [216106]; Health and Health Services Research Fund (HHSRF) [03040771]; Government of the Hong Kong SAR; Research Fund for the Control of Infectious Diseases (RFCID) [04050172]; Health and Health Services Research Fund [HHSRF] [07080751]; University Research Committee Strategic Research Theme (SRT) of Public Health, The University of Hong Kong	Health Care and Promotion Fund, Health and Welfare Bureau, Government of the Hong Kong SAR (HCPF); Health and Health Services Research Fund (HHSRF); Government of the Hong Kong SAR; Research Fund for the Control of Infectious Diseases (RFCID); Health and Health Services Research Fund [HHSRF]; University Research Committee Strategic Research Theme (SRT) of Public Health, The University of Hong Kong(University of Hong Kong)	This work is a sub-study of the "Children of 1997" birth cohort which was initially supported by the Health Care and Promotion Fund, Health and Welfare Bureau, Government of the Hong Kong SAR (HCPF Grant #216106). Since 2005, the "Children of 1997" birth cohort has been funded by the Health and Health Services Research Fund (HHSRF Grant #03040771), Government of the Hong Kong SAR, the Research Fund for the Control of Infectious Diseases (RFCID Grants #04050172), Government of the Hong Kong SAR, the Health and Health Services Research Fund [HHSRF Grants # 07080751], Government of the Hong Kong SAR and the University Research Committee Strategic Research Theme (SRT) of Public Health, The University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikins JW, 2009, ATTACH HUM DEV, V11, P491, DOI 10.1080/14616730903017019; Allgaier AK, 2012, DEPRESS ANXIETY, V29, P906, DOI 10.1002/da.21971; Battle J., 1992, CULTURE FREE SELF ES; Belfer ML, 2008, J CHILD PSYCHOL PSYC, V49, P226, DOI 10.1111/j.1469-7610.2007.01855.x; Belsky J, 2007, CHILD DEV, V78, P681, DOI 10.1111/j.1467-8624.2007.01021.x; Bhatia SK, 2007, AM FAM PHYSICIAN, V75, P73; Brooks-Gunn J, 2002, CHILD DEV, V73, P1052, DOI 10.1111/1467-8624.00457; Bryson CMB, 2010, ROLE INFORM CHILDCAR; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Chan AHN, 2005, J FAMILY EC ISSUES, V26, P20; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dawson G, 2000, DEV PSYCHOPATHOL, V12, P695, DOI 10.1017/S0954579400004089; Department of Health and Human Services, 2003, ACH PROM TRANSF MENT; DOWNEY G, 1990, PSYCHOL BULL, V108, P50, DOI 10.1037/0033-2909.108.1.50; Elovainio M, 2012, SOC SCI MED, V74, P923, DOI 10.1016/j.socscimed.2011.12.017; Fergusson E, 2008, J CHILD PSYCHOL PSYC, V49, P161, DOI 10.1111/j.1469-7610.2007.01840.x; Gabe M, 2000, Home Care Provid, V5, P117; GREENSTEIN TN, 1993, J FAM ISSUES, V14, P323, DOI 10.1177/019251393014003001; Guarnaccia PJ, 1998, CHILD ADOL PSYCH CL, V7, P537, DOI 10.1016/S1056-4993(18)30228-1; Han WJ, 2001, J MARRIAGE FAM, V63, P336, DOI 10.1111/j.1741-3737.2001.00336.x; Hesketh K, 2004, INT J OBESITY, V28, P1233, DOI 10.1038/sj.ijo.0802624; Huston AC, 2002, EARLY CHILD RES Q, V17, P441, DOI 10.1016/S0885-2006(02)00185-0; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Kolb B, 1998, NEUROSCI BIOBEHAV R, V22, P143, DOI 10.1016/S0149-7634(97)00008-0; Lamb M. E., 1998, HDB CHILD PSYCHOL, V4, P73; Lee W, 2008, THESIS U HONG KONG; Lefebvre P, 2008, CHILDCARE POLICY COG; Leung PWL, 2008, EUR CHILD ADOLES PSY, V17, P452, DOI 10.1007/s00787-008-0687-7; Lin SL, 2011, INT J EPIDEMIOL, V40, P1238, DOI 10.1093/ije/dyr086; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; McClure AC, 2010, ACAD PEDIATR, V10, P238, DOI 10.1016/j.acap.2010.03.007; Mehta KK, 2011, EXPERIENCING GRANDPA; Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009; Pine DS, 1999, AM J PSYCHIAT, V156, P133, DOI 10.1176/ajp.156.1.133; RAKIC P, 1994, PROG BRAIN RES, V102, P227; Richards M, 2011, J GERONTOL B-PSYCHOL, V66, P26, DOI 10.1093/geronb/gbr013; Richardson LP, 2010, PEDIATRICS, V126, P1117, DOI 10.1542/peds.2010-0852; Schooling CM, 2012, INT J EPIDEMIOL, V41, P611, DOI 10.1093/ije/dyq243; Seaman SR, 2012, BIOMETRICS, V68, P129, DOI 10.1111/j.1541-0420.2011.01666.x; Smith PK, 1998, UNDERSTANDING CHILDR; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Steiger AE, 2014, J PERS SOC PSYCHOL, V106, P325, DOI 10.1037/a0035133; Susman-Stillman A., 2008, DEMOGRAPHICS FAMILY; Tin SPP, 2013, THESIS U HONG KONG; U.S. Department of Labor Bureau of Labor Statistics, 2000, EMPL CHAR FAM 1999; Vandell DL, 2010, CHILD DEV, V81, P737, DOI 10.1111/j.1467-8624.2010.01431.x; Vandell DL, 2003, J MARRIAGE FAM, V65, P375, DOI 10.1111/j.1741-3737.2003.00375.x; WONG CK, 1988, ACTA PSYCHIAT SCAND, V77, P724, DOI 10.1111/j.1600-0447.1988.tb05194.x; WONG CK, 1988, ACTA PSYCHIAT SCAND, V78, P11, DOI 10.1111/j.1600-0447.1988.tb06295.x; Yu XN, 2012, COMPR PSYCHIAT, V53, P95, DOI 10.1016/j.comppsych.2010.11.002; Yunus S. Md., 2005, INT J EARLY CHILDHOO, V37, P39, DOI DOI 10.1007/BF03165831; Zachrisson HD, 2013, CHILD DEV, V84, P1152, DOI 10.1111/cdev.12040	52	2	2	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120116	10.1371/journal.pone.0120116	http://dx.doi.org/10.1371/journal.pone.0120116			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7QC	25781484	Green Published, gold			2022-12-27	WOS:000351284600130
J	Meng, Y; Liang, YT; Liu, MM				Meng, Ying; Liang, Yuting; Liu, Mingming			The Value of MRI in the Diagnosis of Primary Biliary Cirrhosis and Assessment of Liver Fibrosis	PLOS ONE			English	Article							TEXTURE	Objectives To evaluate MRI findings in patients with primary biliary cirrhosis (PBC) and to determine the value of MRI in the diagnosis of PBC and assessment of liver fibrosis. Materials and Methods This study reviewed the prevalence of MRI abnormalities seen in 45 PBC patients in the past four years, including 33 patients who underwent liver biopsy. Correlation between the MRI findings and the pathological stage was determined. Results There were 33 patients who underwent liver biopsy. Twenty-five patients (75.8%) had non-homogeneous changes in the liver signal intensity, 25 (75.8%) had a periportal halo sign, and 29 (87.9%) had lymphadenopathy. The short axis of the enlarged lymph nodes was a mean of 1.2 +/- 0.3 cm. A strong positive correlation was observed between histological stage and the inhomogeneity of liver signal intensity (P<0.001). There were significant differences among the four histological stages based on the periportal halo sign (P=0.034), and the grading of the periportal halo sign was found to be significantly correlated with the histological stage (P<0.001). Grading of the periportal halo sign was significantly different at stage II versus III, and stage III versus IV; no significant difference was found between stages I and II. There were also no significant differences among the four histological states in the occurrence and size of enlarged lymph nodes (P=0.674 and P=0.394). Conclusion MRI is valuable in the diagnosis of PBC, and the periportal halo sign and liver signal intensity help to evaluate the degree of liver fibrosis.	[Meng, Ying; Liang, Yuting] Capital Med Univ, Beijing Obstet & Gynecol Hosp, Dept Radiol, Beijing, Peoples R China; [Liu, Mingming] Capital Med Univ, Beijing Friendship Hosp, Dept Radiol, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Liang, YT (corresponding author), Capital Med Univ, Beijing Obstet & Gynecol Hosp, Dept Radiol, Beijing, Peoples R China.	liangyuting688@sina.com						Bartolozzi C, 2011, ABDOM IMAGING, V36, P290, DOI 10.1007/s00261-011-9687-z; Bergasa NV, 2005, J HEPATOL, V43, P1078, DOI 10.1016/j.jhep.2005.09.004; Blachar A, 2001, RADIOLOGY, V220, P329, DOI 10.1148/radiology.220.2.r01au36329; Blumenkrantz G, 2008, OSTEOARTHR CARTILAGE, V16, P584, DOI 10.1016/j.joca.2007.10.019; Bogdanos DP, 2012, DIGEST DIS, V30, P20, DOI 10.1159/000341118; Garrido MC, 1996, J CLIN PATHOL, V49, P556, DOI 10.1136/jcp.49.7.556; Gershwin ME, 2008, HEPATOLOGY, V47, P737, DOI 10.1002/hep.22042; Griffiths L, 2014, SEMIN LIVER DIS, V34, P318, DOI 10.1055/s-0034-1383730; Haliloglu N, 2009, EUR J RADIOL, V69, P523, DOI 10.1016/j.ejrad.2007.11.003; HARALICK RM, 1979, P IEEE, V67, P786, DOI 10.1109/PROC.1979.11328; Hiramatsu Shinsuke, 2012, Nihon Shokakibyo Gakkai Zasshi, V109, P1784; Huet PM, 2000, AM J GASTROENTEROL, V95, P760; Jin E., 2009, APPROACH CLIN APPL M, P227; Kim BH, 2011, J MAGN RESON IMAGING, V34, P1110, DOI 10.1002/jmri.22723; Kobayashi S, 2005, ABDOM IMAGING, V30, P71, DOI 10.1007/s00261-004-0228-x; Kovac JD, 2012, EUR RADIOL, V22, P688, DOI 10.1007/s00330-011-2296-y; Ksiaa Mehdi, 2014, Tunis Med, V92, P123; Lindor KD, 2009, HEPATOLOGY, V50, P291, DOI 10.1002/hep.22906; LUDWIG J, 1978, VIRCHOWS ARCH A, V379, P103, DOI 10.1007/BF00432479; Martinez SM, 2011, HEPATOLOGY, V53, P325, DOI 10.1002/hep.24013; MATSUI O, 1989, RADIOLOGY, V171, P335, DOI 10.1148/radiology.171.2.2704798; Nguyen DL, 2010, BEST PRACT RES CL GA, V24, P647, DOI 10.1016/j.bpg.2010.07.006; Nie K, 2008, ACAD RADIOL, V15, P1513, DOI 10.1016/j.acra.2008.06.005; Qin BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035366; Selmi C, 2011, LANCET, V377, P1600, DOI 10.1016/S0140-6736(10)61965-4; [石喻 SHI Yu], 2010, [中华放射学杂志, Chinese Journal of Radiology], V44, P65; Wenzel JS, 2001, AM J ROENTGENOL, V176, P885, DOI 10.2214/ajr.176.4.1760885; Wong GLH, 2013, WORLD J HEPATOL, V5, P264, DOI 10.4254/wjh.v5.i5.264; Zhang RC, 2013, YIXUE YINGXIANGXUE Z, V23, P237; [张月浪 ZHANG Yue-lang], 2009, [中国医学影像技术, Chinese Journal of Medical Imaging Technology], V25, P1433	30	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120110	10.1371/journal.pone.0120110	http://dx.doi.org/10.1371/journal.pone.0120110			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781184	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600128
J	Tripathi, D; Raikhy, G; Goodin, MM; Dietzgen, RG; Pappu, HR				Tripathi, Diwaker; Raikhy, Gaurav; Goodin, Michael M.; Dietzgen, Ralf G.; Pappu, Hanu R.			In Vivo Localization of Iris yellow spot Tospovirus (Bunyaviridae)-Encoded Proteins and Identification of Interacting Regions of Nucleocapsid and Movement Proteins	PLOS ONE			English	Article							WILT-VIRUS; FLUORESCENCE MICROSCOPY; TRANSIENT EXPRESSION; SELF-ASSOCIATION; PLANT-PROTEINS; NSM PROTEIN; GENE; DOMAINS; SUPPRESSOR; CELLS	Background Localization and interaction studies of viral proteins provide important information about their replication in their host plants. Tospoviruses (Family Bunyaviridae) are economically important viruses affecting numerous field and horticultural crops. Iris yellow spot virus (IYSV), one of the tospoviruses, has recently emerged as an important viral pathogen of Allium spp. in many parts of the world. We studied the in vivo localization and interaction patterns of the IYSV proteins in uninfected and infected Nicotiana benthamiana and identified the interacting partners. Principal Findings Bimolecular fluorescence complementation (BiFC) analysis demonstrated homotypic and heterotypic interactions between IYSV nucleocapsid (N) and movement (NSm) proteins. These interactions were further confirmed by pull-down assays. Additionally, interacting regions of IYSV N and NSm were identified by the yeast-2-hybrid system and beta-galactosidase assay. The N protein self-association was found to be mediated through the N- and C-terminal regions making head to tail interaction. Self-interaction of IYSV NSm was shown to occur through multiple interacting regions. In yeast-2-hybrid assay, the N- and C-terminal regions of IYSV N protein interacted with an N-terminal region of IYSV NSm protein. Conclusion/Significance Our studies provide new insights into localization and interactions of IYSV N and NSm proteins. Molecular basis of these interactions was studied and is discussed in the context of tospovirus assembly, replication, and infection processes.	[Tripathi, Diwaker; Raikhy, Gaurav; Pappu, Hanu R.] Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA; [Goodin, Michael M.] Univ Kentucky, Dept Plant Pathol, Lexington, KY 40546 USA; [Dietzgen, Ralf G.] Univ Queensland, QAAFI, St Lucia, Qld, Australia	Washington State University; University of Kentucky; University of Queensland	Pappu, HR (corresponding author), Washington State Univ, Dept Plant Pathol, POB 646430, Pullman, WA 99164 USA.	hrp@wsu.edu	Tripathi, Diwaker/AAC-9897-2020; Dietzgen, Ralf Georg/A-5565-2010; Raikhy, Gaurav/AAB-3614-2020	Tripathi, Diwaker/0000-0003-3857-2760; Dietzgen, Ralf Georg/0000-0002-7772-2250; Raikhy, Gaurav/0000-0003-4361-3213	Department of Plant Pathology, College of Agricultural, Human and Natural Resource Sciences, Agricultural Research Center [0684]; Hatch Project [WNPO 0545]; Washington State University, Pullman, WA, USA	Department of Plant Pathology, College of Agricultural, Human and Natural Resource Sciences, Agricultural Research Center; Hatch Project(United States Department of Agriculture (USDA)); Washington State University, Pullman, WA, USA	The work was supported by PPNS No. 0684, Department of Plant Pathology, College of Agricultural, Human and Natural Resource Sciences, Agricultural Research Center, Hatch Project # WNPO 0545, Washington State University, Pullman, WA 99164-6430, USA. The authors also acknowledge the support from the Franceschi Microscopy and Imaging Center (FMIC) at the Washington State University, Pullman.	Ausubel F.M., 1993, CURRENT PROTOCOLS MO; Bandyopadhyay A, 2010, VIROLOGY, V402, P61, DOI 10.1016/j.virol.2010.03.013; Bucher E, 2003, J VIROL, V77, P1329, DOI 10.1128/JVI.77.2.1329-1336.2003; Chakrabarty R, 2007, MOL PLANT MICROBE IN, V20, P740, DOI 10.1094/MPMI-20-7-0740; CHIEMSOMBAT P, 2006, CHARACTERIZATION DIA, V3, P1; Cortes I, 1998, PHYTOPATHOLOGY, V88, P1276, DOI 10.1094/PHYTO.1998.88.12.1276; DEHAAN P, 1990, J GEN VIROL, V71, P1001, DOI 10.1099/0022-1317-71-5-1001; Dietzgen RG, 2012, J GEN VIROL, V93, P2490, DOI 10.1099/vir.0.042515-0; Elliot R.M., 1996, BUNYAVIRIDAE; Feng ZK, 2013, NEW PHYTOL, V200, P1212, DOI 10.1111/nph.12447; Geerts-Dimitriadou C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031013; Gent DH, 2006, PLANT DIS, V90, P1468, DOI 10.1094/PD-90-1468; Goodin M, 2005, MOL PLANT MICROBE IN, V18, P703, DOI 10.1094/MPMI-18-0703; Goodin MM, 2007, PLANT PHYSIOL, V145, P1100, DOI 10.1104/pp.107.106641; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; HALL JM, 1993, PLANT DIS, V77, P952, DOI 10.1094/PD-77-0952B; Hapiak M, 2008, VIRUS RES, V138, P119, DOI 10.1016/j.virusres.2008.09.002; Kormelink R, 2011, VIRUS RES, V162, P184, DOI 10.1016/j.virusres.2011.09.028; Lewandowski DJ, 2005, VIROLOGY, V342, P26, DOI 10.1016/j.virol.2005.06.050; Li W, 2009, VIROLOGY, V390, P110, DOI 10.1016/j.virol.2009.04.027; Li YZ, 2002, MOL PLANT MICROBE IN, V15, P1050, DOI 10.1094/MPMI.2002.15.10.1050; Mandal B, 2012, PLANT DIS, V96, P468, DOI 10.1094/PDIS-06-11-0520; Margaria P, 2014, J VIROL, V88, P5788, DOI 10.1128/JVI.00079-14; Martin K, 2009, PLANT J, V59, P150, DOI 10.1111/j.1365-313X.2009.03850.x; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Paape M, 2006, MOL PLANT MICROBE IN, V19, P874, DOI 10.1094/MPMI-19-0874; Pappu HR, 2009, VIRUS RES, V141, P219, DOI 10.1016/j.virusres.2009.01.009; Raikhy G, 2011, VIRUS RES, V159, P69, DOI 10.1016/j.virusres.2011.04.026; Ribeiro D, 2009, VIROLOGY, V383, P121, DOI 10.1016/j.virol.2008.09.028; Ribeiro D, 2008, J GEN VIROL, V89, P1811, DOI 10.1099/vir.0.2008/001164-0; Ribeiro D, 2013, PLANT CELL, V25, P3602, DOI 10.1105/tpc.113.114298; Schwartz HF, 2013, ONION HLTH MANAGEMEN, DOI [10.1002/14651858.CD003826.pub3, DOI 10.1002/14651858.CD003826.PUB3]; Sherwood JL, 2003, PLANT HLTH INSTRUCTO; Silva MS, 2001, ARCH VIROL, V146, P1267, DOI 10.1007/s007050170090; Sin SH, 2005, P NATL ACAD SCI USA, V102, P5168, DOI 10.1073/pnas.0407354102; Snippe M, 2005, ADV VIRUS RES, V65, P63, DOI 10.1016/S0065-3527(05)65003-8; Snippe M, 2005, J VIROL METHODS, V125, P15, DOI 10.1016/j.jviromet.2004.11.028; Snippe M, 2007, VIROLOGY, V357, P115, DOI 10.1016/j.virol.2006.06.037; Soellick TR, 2000, P NATL ACAD SCI USA, V97, P2373, DOI 10.1073/pnas.030548397; Takeda A, 2002, FEBS LETT, V532, P75, DOI 10.1016/S0014-5793(02)03632-3; Turina M, 2012, ADV VIRUS RES, V84, P403, DOI 10.1016/B978-0-12-394314-9.00012-9; Uhrig JF, 1999, P NATL ACAD SCI USA, V96, P55, DOI 10.1073/pnas.96.1.55; Zilian E, 2011, J VIROL METHODS, V174, P158, DOI 10.1016/j.jviromet.2011.03.032	43	16	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0118973	10.1371/journal.pone.0118973	http://dx.doi.org/10.1371/journal.pone.0118973			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781476	Green Published, gold, Green Submitted			2022-12-27	WOS:000351284600040
J	Bassino, E; Fornero, S; Gallo, MP; Gallina, C; Femmino, S; Levi, R; Tota, B; Alloatti, G				Bassino, Eleonora; Fornero, Sara; Gallo, Maria Pia; Gallina, Clara; Femmino, Saveria; Levi, Renzo; Tota, Bruno; Alloatti, Giuseppe			Catestatin Exerts Direct Protective Effects on Rat Cardiomyocytes Undergoing Ischemia/Reperfusion by Stimulating PI3K-Akt-GSK3 beta Pathway and Preserving Mitochondrial Membrane Potential	PLOS ONE			English	Article							CHROMOGRANIN-A; PEPTIDE CATESTATIN; PERMEABILITY TRANSITION; MYOCARDIAL PRODUCTION; EARLY DECLINE; GENETIC RISK; NITRIC-OXIDE; HEART; HUMANS; CARDIOPROTECTION	Catestatin (Cst) is a 21-amino acid peptide deriving from Chromogranin A. Cst exerts an overall protective effect against an excessive sympathetic stimulation of cardiovascular system, being able to antagonize catecholamine secretion and to reduce their positive inotropic effect, by stimulating the release of nitric oxide (NO) from endothelial cells. Moreover, Cst reduces ischemia/reperfusion (I/R) injury, improving post-ischemic cardiac function and cardiomyocyte survival. To define the cardioprotective signaling pathways activated by Cst (5 nM) we used isolated adult rat cardiomyocytes undergoing simulated I/R. We evaluated cell viability rate with propidium iodide labeling and mitochondrial membrane potential (MMP) with the fluorescent probe JC-1. The involvement of Akt, GSK3 beta, eNOS and phospholamban (PLN) cascade was studied by immunofluorescence. The role of PI3K-Akt/NO/ cGMP pathway was also investigated by using the pharmacological blockers wortmannin (Wm), L-NMMA and ODQ. Our experiments revealed that Cst increased cell viability rate by 65% and reduced cell contracture in I/R cardiomyocytes. Wm, L-NMMA and ODQ limited the protective effect of Cst. The protective outcome of Cst was related to its ability to maintain MMP and to increase Akt(Ser473), GSK3 beta(Ser9), PLNThr17 and eNOS(Ser1179) phosphorylation, while treatment with Wm abolished these effects. Thus, the present results show that Cst is able to exert a direct action on cardiomyocytes and give new insights into the molecular mechanisms involved in its protective effect, highlighting the PI3K/NO/cGMP pathway as the trigger and the MMP preservation as the end point of its action.	[Bassino, Eleonora; Fornero, Sara; Gallo, Maria Pia; Gallina, Clara; Levi, Renzo; Alloatti, Giuseppe] Univ Turin, Dept Life Sci & Syst Biol, I-10123 Turin, Italy; [Femmino, Saveria] Univ Turin, Dept Clin & Biol Sci, I-10043 Orbassano, TO, Italy; [Tota, Bruno] Univ Calabria, Dept Cell Biol, I-87030 Cosenza, Italy; [Tota, Bruno; Alloatti, Giuseppe] Natl Inst Cardiovasc Res, I-40126 Bologna, Italy	University of Turin; University of Turin; University of Calabria	Alloatti, G (corresponding author), Univ Turin, Dept Life Sci & Syst Biol, Via Accademia Albertina 13, I-10123 Turin, Italy.	giuseppe.alloatti@unito.it	Bassino, Eleonora/X-1370-2019; Gallo, Mariana C/J-2832-2014; Femmino, Saveria/J-6848-2018	Femmino, Saveria/0000-0003-4644-0784; Gallo, Maria Pia/0000-0002-0382-7607	National Institute of Cardiovascular Research (INRC); PRIN	National Institute of Cardiovascular Research (INRC); PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was supported by National Institute of Cardiovascular Research (INRC); ex-60% (GA, MPG and RL) and PRIN-2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelone T, 2008, ENDOCRINOLOGY, V149, P4780, DOI 10.1210/en.2008-0318; Angelone T, 2012, AM J PHYSIOL-HEART C, V302, pH431, DOI 10.1152/ajpheart.00491.2011; Bassino E, 2011, CARDIOVASC RES, V91, P617, DOI 10.1093/cvr/cvr129; Biswas N, 2010, CELL TISSUE RES, V342, P353, DOI 10.1007/s00441-010-1059-4; Brar BK, 2010, REGUL PEPTIDES, V165, P63, DOI 10.1016/j.regpep.2010.07.153; Catalucci D, 2009, J BIOL CHEM, V284, P28180, DOI 10.1074/jbc.M109.036566; Ceconi C, 2002, EUR HEART J, V23, P967, DOI 10.1053/euhj.2001.2977; Cerra MC, 2008, FASEB J, V22, P3992, DOI 10.1096/fj.08-110239; Cohen MV, 2011, J CARDIOVASC PHARM T, V16, P273, DOI 10.1177/1074248411407071; DeSantiago J, 2004, J MOL CELL CARDIOL, V36, P67, DOI 10.1016/j.yjmcc.2003.10.012; Dev NB, 2010, ENDOCRINOLOGY, V151, P2760, DOI 10.1210/en.2009-1110; Fornero S, 2012, CURR MED CHEM, V19, P4059, DOI 10.2174/092986712802429984; Fung MM, 2010, CLIN EXP HYPERTENS, V32, P278, DOI 10.3109/10641960903265246; Hausenloy DJ, 2011, NAT REV CARDIOL, V8, P619, DOI 10.1038/nrcardio.2011.85; Helle KB, 2007, CELL MOL LIFE SCI, V64, P2863, DOI 10.1007/s00018-007-7254-0; Helle KB, 2010, CARDIOVASC RES, V85, P9, DOI 10.1093/cvr/cvp266; Heusch G, 2008, CIRCULATION, V118, P1915, DOI 10.1161/CIRCULATIONAHA.108.805242; Juhaszova M, 2004, J CLIN INVEST, V113, P1535, DOI 10.1172/JCI200419906; Mahapatra NR, 2005, J CLIN INVEST, V115, P1942, DOI 10.1172/JCI24354; Murphy E, 2008, CIRC RES, V103, P226, DOI 10.1161/CIRCRESAHA.108.181602; O'Connor DT, 2008, CIRCULATION, V118, P247, DOI 10.1161/CIRCULATIONAHA.107.709105; O'Connor DT, 2002, ANN NY ACAD SCI, V971, P533, DOI 10.1111/j.1749-6632.2002.tb04520.x; O'Connor DT, 2002, J HYPERTENS, V20, P1335, DOI 10.1097/00004872-200207000-00020; Penna C, 2010, CELL MOL NEUROBIOL, V30, P1171, DOI 10.1007/s10571-010-9598-5; Perrelli MG, 2013, PFLUG ARCH EUR J PHY, V465, P1031, DOI 10.1007/s00424-013-1217-0; Perrelli MG, 2011, WORLD J CARDIOL, V3, P186, DOI 10.4330/wjc.v3.i6.186; Pieroni M, 2007, EUR HEART J, V28, P1117, DOI 10.1093/eurheartj/ehm022; Ramella R, 2010, J CELL BIOCHEM, V110, P70, DOI 10.1002/jcb.22510; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; Ruiz-Meana M, 2009, AM J PHYSIOL-HEART C, V297, pH1281, DOI 10.1152/ajpheart.00435.2009; Theurl M, 2010, CIRC RES, V107, P1326, DOI 10.1161/CIRCRESAHA.110.219493; Tota B, 2008, CURR MED CHEM, V15, P1444, DOI 10.2174/092986708784567662; Wang PH, 1996, J BIOL CHEM, V271, P29223, DOI 10.1074/jbc.271.46.29223; Willis M, 2011, J NEURAL TRANSM, V118, P727, DOI 10.1007/s00702-011-0648-z; Xie Y, 2005, AM J PHYSIOL-HEART C, V288, pH2594, DOI 10.1152/ajpheart.00926.2004	35	28	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119790	10.1371/journal.pone.0119790	http://dx.doi.org/10.1371/journal.pone.0119790			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774921	gold, Green Published, Green Submitted			2022-12-27	WOS:000351183500123
J	Liu, F; Qi, L; Liu, B; Liu, J; Zhang, H; Che, DH; Cao, JY; Shen, J; Geng, JX; Bi, Y; Ye, LG; Pan, B; Yu, Y				Liu, Fang; Qi, Li; Liu, Bao; Liu, Jie; Zhang, Hua; Che, Dehai; Cao, JingYan; Shen, Jing; Geng, JianXiong; Bi, Yi; Ye, LieGuang; Pan, Bo; Yu, Yan			Fibroblast Activation Protein Overexpression and Clinical Implications in Solid Tumors: A Meta-Analysis	PLOS ONE			English	Article							CARCINOMA-ASSOCIATED FIBROBLASTS; DIFFERENT EXPRESSION PATTERNS; CANCER-ASSOCIATED FIBROBLASTS; TO-MESENCHYMAL TRANSITION; SERINE-PROTEASE; CELL; SEPRASE; STROMA; ALPHA; MICROENVIRONMENT	Objective Fibroblast activation protein (FAP) plays a vital role in tumor invasion and metastasis. Previous studies have reported its prognostic value in different tumors. However, the results of these reports remain controversial. In this study, a meta-analysis was performed to clarify this issue. Methods A search of the PubMed, Embase and CNKI databases was conducted to analyze relevant articles. The outcomes included the relations between FAP expression and histological differentiation, tumor invasion, lymph node metastasis, distant metastasis and overall survival (OS). Sensitivity analysis by FAP expression in different cells and tumor types were further subjected to sensitivity analyses as subgroups. Pooled odds ratios (ORs) and hazard ratios (HRs) were evaluated using the random-effects model. Results The global analysis included 15 studies concerning various solid tumors. For global analysis, FAP overexpression in tumor tissue displayed significant associations with poor OS and tumor progression (OS: HR = 2.18, P = 0.004; tumor invasion: OR = 4.48, P = 0.007; and lymph node metastasis: OR = 3.80, P = 0.004). The subgroup analyses yielded two notable results. First, the relation between FAP overexpression and poor OS and tumor lymph node metastasis was closer in the patients with FAP expression in tumor cells. Second, the pooled analyses of colorectal cancers or pancreatic cancers all indicated that FAP overexpression was associated with a detrimental OS (HR: 1.72, P = 0.009; HR: 3.18, P = 0.005, respectively). The magnitude of this effect was not statistically significant compared with that in patients with non-colorectal cancers or non-pancreatic cancers. These analyses did not display a statistically significant correlation between FAP expression and histological differentiation and distant metastasis in all of the groups. Conclusions FAP expression is associated with worse prognosis in solid tumors, and this association is particularly pronounced if FAP overexpression is found in the tumor cells rather than the stroma.	[Liu, Fang; Liu, Bao; Zhang, Hua; Che, Dehai; Cao, JingYan; Shen, Jing; Geng, JianXiong; Bi, Yi; Ye, LieGuang; Pan, Bo; Yu, Yan] Harbin Med Univ, Dept Internal Med Oncol, Affiliated Hosp 3, Harbin, Peoples R China; [Qi, Li] Harbin Med Univ, Dept Radiat Oncol, Affiliated Hosp 2, Harbin, Peoples R China; [Liu, Jie] Gen Hosp Hegang Min Grp, Digest Dept Internal Med, Hegang, Heilonhjiang Pr, Peoples R China; [Bi, Yi] Heilongjiang Prov Elect Power Hosp, Emergency Dept, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University	Yu, Y (corresponding author), Harbin Med Univ, Dept Internal Med Oncol, Affiliated Hosp 3, Harbin, Peoples R China.	yuyan@hrbmu.edu.cn	Xu, Ping/I-1910-2013	Xu, Ping/0000-0002-1516-4986				Ariga N, 2001, INT J CANCER, V95, P67, DOI 10.1002/1097-0215(20010120)95:1<67::AID-IJC1012>3.0.CO;2-U; Brennen WN, 2012, JNCI-J NATL CANCER I, V104, P1320, DOI 10.1093/jnci/djs336; Brennen WN, 2012, MOL CANCER THER, V11, P257, DOI 10.1158/1535-7163.MCT-11-0340; Canady J, 2013, J INVEST DERMATOL, V133, P647, DOI 10.1038/jid.2012.389; Cohen SJ, 2008, PANCREAS, V37, P154, DOI 10.1097/MPA.0b013e31816618ce; Dohi O, 2009, HISTOPATHOLOGY, V55, P432, DOI 10.1111/j.1365-2559.2009.03399.x; Franco OE, 2010, SEMIN CELL DEV BIOL, V21, P33, DOI 10.1016/j.semcdb.2009.10.010; Goscinski MA, 2008, ULTRASTRUCT PATHOL, V32, P89, DOI 10.1080/01913120802034934; Henry LR, 2007, CLIN CANCER RES, V13, P1736, DOI 10.1158/1078-0432.CCR-06-1746; Herrera M, 2013, CANCER SCI, V104, P437, DOI 10.1111/cas.12096; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huang Y, 2011, CLIN EXP METASTAS, V28, P567, DOI 10.1007/s10585-011-9392-x; Ito M, 2012, CHEST, V142, P151, DOI 10.1378/chest.11-2458; Iwasa S, 2003, CANCER LETT, V199, P91, DOI 10.1016/S0304-3835(03)00315-X; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kidd S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030563; Koperek O, 2007, INT J ONCOL, V31, P59; LeBeau AM, 2009, MOL CANCER THER, V8, P1378, DOI 10.1158/1535-7163.MCT-08-1170; Lee HO, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-245; Liao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007965; Liao YD, 2013, J CANCER RES CLIN, V139, P1523, DOI 10.1007/s00432-013-1471-8; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; [刘蕊 Liu Rui], 2013, [中国肿瘤生物治疗杂志, Chinese Journal of Cancer Biotherapy], V20, P225; Mori Y, 2004, ONCOLOGY-BASEL, V67, P411, DOI 10.1159/000082926; O'Brien P, 2008, BBA-PROTEINS PROTEOM, V1784, P1130, DOI 10.1016/j.bbapap.2008.01.006; Ostman A, 2009, CURR OPIN GENET DEV, V19, P67, DOI 10.1016/j.gde.2009.01.003; Okada K, 2003, ONCOLOGY-BASEL, V65, P363, DOI 10.1159/000074650; Orimo A, 2006, CELL CYCLE, V5, P1597, DOI 10.4161/cc.5.15.3112; Paulette MF, 2013, CANC MICROENVIRONMEN; Paulsson J, 2014, SEMIN CANCER BIOL, V25, P61, DOI 10.1016/j.semcancer.2014.02.006; Potenta S, 2008, BRIT J CANCER, V99, P1375, DOI 10.1038/sj.bjc.6604662; Qin Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079864; Rubin H, 2001, CANCER RES, V61, P799; Saigusa S, 2011, INT J ONCOL, V38, P655, DOI 10.3892/ijo.2011.906; Shi M, 2012, WORLD J GASTROENTERO, V18, P840, DOI 10.3748/wjg.v18.i8.840; Song J, 2011, J HARBIN MED U, V45, P153; Sund M, 2009, CANCER METAST REV, V28, P177, DOI 10.1007/s10555-008-9175-2; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Tse JC, 2007, J CELL BIOCHEM, V101, P816, DOI 10.1002/jcb.21215; Wang HY, 2009, CHIN J GASTROENTEROL, V18, P1102; Wang RF, 2013, EXP MOL PATHOL, V95, P350, DOI 10.1016/j.yexmp.2013.10.008; Wikberg ML, 2013, TUMOR BIOL, V34, P1013, DOI 10.1007/s13277-012-0638-2; Yu DMT, 2010, FEBS J, V277, P1126, DOI 10.1111/j.1742-4658.2009.07526.x; Yuan DT, 2013, J SURG ONCOL, V108, P157, DOI 10.1002/jso.23368; Zeisberg EM, 2007, CANCER RES, V67, P10123, DOI 10.1158/0008-5472.CAN-07-3127; Zhang JP, 2013, FASEB J, V27, P581, DOI 10.1096/fj.12-210377; Zhang L, 2008, CHIN J STOMATOLOGY, V28, P449	48	72	74	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0116683	10.1371/journal.pone.0116683	http://dx.doi.org/10.1371/journal.pone.0116683			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775399	gold, Green Published, Green Submitted			2022-12-27	WOS:000351183500010
J	Pidala, J; Bloom, GC; Eschrich, S; Sarwal, M; Enkemann, S; Betts, BC; Beato, F; Yoder, S; Anasetti, C				Pidala, Joseph; Bloom, Gregory C.; Eschrich, Steven; Sarwal, Minnie; Enkemann, Steve; Betts, Brian C.; Beato, Francisca; Yoder, Sean; Anasetti, Claudio			Tolerance Associated Gene Expression following Allogeneic Hematopoietic Cell Transplantation	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; REGULATORY T-CELLS; PROBE LEVEL DATA; ADAPTER PROTEIN; B-CELLS; IDENTIFICATION; MECHANISMS; RECIPIENTS; PROFILES; GAMMA	Biologic markers of immune tolerance may facilitate tailoring of immune suppression duration after allogeneic hematopoietic cell transplantation (HCT). In a cross-sectional study, peripheral blood samples were obtained from tolerant (n = 15, median 38.5 months post-HCT) and non-tolerant (n = 17, median 39.5 post-HCT) HCT recipients and healthy control subjects (n = 10) for analysis of immune cell subsets and differential gene expression. There were no significant differences in immune subsets across groups. We identified 281 probe sets unique to the tolerant (TOL) group and 122 for non-tolerant (non-TOL). These were enriched for process networks including NK cell cytotoxicity, antigen presentation, lymphocyte proliferation, and cell cycle and apoptosis. Differential gene expression was enriched for CD56, CD66, and CD14 human lineage-specific gene expression. Differential expression of 20 probe sets between groups was sufficient to develop a classifier with > 90% accuracy, correctly classifying 14/15 TOL cases and 15/17 non-TOL cases. These data suggest that differential gene expression can be utilized to accurately classify tolerant patients following HCT. Prospective investigation of immune tolerance biologic markers is warranted.	[Pidala, Joseph; Betts, Brian C.; Beato, Francisca; Anasetti, Claudio] Univ S Florida, H Lee Moffitt Canc Ctr, Blood & Marrow Transplantat, Tampa, FL 33682 USA; [Bloom, Gregory C.; Eschrich, Steven] Univ S Florida, H Lee Moffitt Canc Ctr, Bioinformat, Tampa, FL 33682 USA; [Sarwal, Minnie] UCSF Sch Med, Dept Surg, San Francisco, CA USA; [Enkemann, Steve; Yoder, Sean] Univ S Florida, H Lee Moffitt Canc Ctr, Mol Genom, Tampa, FL 33682 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; University of California System; University of California San Francisco; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Pidala, J (corresponding author), Univ S Florida, H Lee Moffitt Canc Ctr, Blood & Marrow Transplantat, Tampa, FL 33682 USA.	joseph.pidala@moffitt.org	Eschrich, Steven/K-6848-2013	Eschrich, Steven/0000-0002-9833-2788; Betts, Brian/0000-0001-7643-2422	American Society for Blood and Marrow Transplantation; American Cancer Society [MRSG-11-149-01-LIB]; NCI [CA132197]; Moffitt Cancer Center Foundation; NATIONAL CANCER INSTITUTE [P30CA076292] Funding Source: NIH RePORTER	American Society for Blood and Marrow Transplantation; American Cancer Society(American Cancer Society); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Moffitt Cancer Center Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the American Society for Blood and Marrow Transplantation (New Investigator Award, PI: Pidala, J), the American Cancer Society (MRSG-11-149-01-LIB, PI: Pidala, J), NCI (CA132197, PI: Anasetti, C), and the Moffitt Cancer Center Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen IW, 2005, HAEMATOLOGICA, V90, P86; Aliahmad P, 2008, J EXP MED, V205, P245, DOI 10.1084/jem.20071944; Baron C, 2007, PLOS MED, V4, P69, DOI 10.1371/journal.pmed.0040023; Bettini M, 2011, J IMMUNOL, V187, P3493, DOI 10.4049/jimmunol.1100714; Bluestone JA, 2011, IMMUNOL REV, V241, P5, DOI 10.1111/j.1600-065X.2011.01019.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Braud C, 2008, J CELL BIOCHEM, V103, P1681, DOI 10.1002/jcb.21574; Brouard S, 2007, P NATL ACAD SCI USA, V104, P15448, DOI 10.1073/pnas.0705834104; Brown D, 2004, TISSUE ANTIGENS, V64, P215, DOI 10.1111/j.0001-2815.2004.00290.x; Bryceson YT, 2011, J INNATE IMMUN, V3, P216, DOI 10.1159/000325265; Choi J, 2012, BLOOD, V120, P4093, DOI 10.1182/blood-2012-01-403196; Choubey D, 2012, IMMUNOL LETT, V147, P10, DOI 10.1016/j.imlet.2012.07.003; Dobbin KK, 2005, CLIN CANCER RES, V11, P565; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Goldstein DR, 2003, J CLIN INVEST, V111, P1571, DOI 10.1172/JCI200317573; Hu ZD, 2011, J CLIN IMMUNOL, V31, P346, DOI 10.1007/s10875-010-9492-4; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jackson SH, 2004, J IMMUNOL, V172, P2307, DOI 10.4049/jimmunol.172.4.2307; Kawasaki M, 2007, INT SURG, V92, P276; Kochi Y, 2009, J IMMUNOL, V183, P5502, DOI 10.4049/jimmunol.0901982; Koenecke C, 2012, J IMMUNOL, V189, P2890, DOI 10.4049/jimmunol.1200413; Kohrt HE, 2013, CLIN IMMUNOL, V148, P124, DOI 10.1016/j.clim.2013.04.013; Lesley R, 2004, IMMUNITY, V20, P441, DOI 10.1016/S1074-7613(04)00079-2; Liu Y, 2008, J LEUKOCYTE BIOL, V84, P842, DOI 10.1189/jlb.0208087; Lu Y, 2009, BIOL BLOOD MARROW TR, V15, P1347, DOI 10.1016/j.bbmt.2009.07.015; Martinez-Llordella M, 2008, J CLIN INVEST, V118, P2845, DOI 10.1172/JCI35342; McLean S, 2010, BIOCHEM J, V429, P137, DOI 10.1042/BJ20091598; Nagata S, 2009, J IMMUNOL, V182, P7518, DOI 10.4049/jimmunol.0802230; Okamura T, 2009, P NATL ACAD SCI USA, V106, P13974, DOI 10.1073/pnas.0906872106; Peterson KS, 2004, J CLIN INVEST, V113, P1722, DOI 10.1172/JCI200419139; Pidala J, 2011, BIOL BLOOD MARROW TR, V17, P1528, DOI 10.1016/j.bbmt.2011.03.006; Porrett PM, 2008, J IMMUNOL, V181, P1692, DOI 10.4049/jimmunol.181.3.1692; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Sarantopoulos S, 2007, CLIN CANCER RES, V13, P6107, DOI 10.1158/1078-0432.CCR-07-1290; Sarantopoulos S, 2009, BLOOD, V113, P3865, DOI 10.1182/blood-2008-09-177840; Shi YF, 2007, NAT IMMUNOL, V8, P817, DOI 10.1038/ni1489; Skert C, 2009, BONE MARROW TRANSPL, V44, P729, DOI 10.1038/bmt.2009.80; Stewart BL, 2004, BLOOD, V104, P3501, DOI 10.1182/blood-2004-01-0200; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tibshirani R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-106; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; Watkins NA, 2009, BLOOD, V113, pE1, DOI 10.1182/blood-2008-06-162958; Workman CJ, 2005, J IMMUNOL, V174, P688, DOI 10.4049/jimmunol.174.2.688; Zhao Y, 2013, CELL MOL IMMUNOL, V10, P165, DOI 10.1038/cmi.2012.58	47	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0117001	10.1371/journal.pone.0117001	http://dx.doi.org/10.1371/journal.pone.0117001			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774806	Green Submitted, gold, Green Published			2022-12-27	WOS:000351183500014
J	Rathe, J; Andersen, M; Jarbol, DE; Christensen, RD; Hallas, J; Sondergaard, J				Rathe, Jette; Andersen, Morten; Jarbol, Dorte Ejg; Christensen, Rene dePont; Hallas, Jesper; Sondergaard, Jens			Generic Switching and Non-Persistence among Medicine Users: A Combined Population-Based Questionnaire and Register Study	PLOS ONE			English	Article							MEDICATION ADHERENCE; ANTIEPILEPTIC DRUGS; SUBSTITUTION; BELIEFS; PATIENT	Background Generic substitution means that one medicinal product is replaced by another product containing the same active substance. It is strictly regulated with respect to its bioequivalence, and all products must have undergone appropriate studies. Although generic substitution is widely implemented, it still remains to be answered how generic switch influences persistence to long-term treatment, and if it is modified by patients' concerns about medicine and views on generic medicine. This study focuses on users of antidepressants and antiepileptics, and their experience of generic switching. Methods The study was an observational cohort study. By use of a prescription database, we identified patients who had redeemed prescriptions on generically substitutable drugs, and a questionnaire was mailed to them. We analyzed predictors of discontinuation in relation to generic switch and patients' attitudes towards generic medicines and concerns about their medicine. Results Patients who experience their first-time switch of a specific drug were at higher risk of non-persistence, Hazard Ratio 2.98, 95% CI (1.81; 4.89) versus those who have never switched, and 35.7% became non-persistent during the first year of follow-up. Generic switching did not influence persistence considerably in those having previous experience with generic switching of the specific drug. Stratified analyses on users of antidepressants and antiepileptics underpin the results, showing higher risk of non-persistence for first-time switchers for both drug categories. Conclusion In conclusion, patients who are first-time switchers of a specific drug were at higher risk of non-persistence compared to never switchers and those having experienced previous generic switching.	[Rathe, Jette; Jarbol, Dorte Ejg; Christensen, Rene dePont; Sondergaard, Jens] Univ Southern Denmark, Inst Publ Hlth, Res Unit Gen Practice, Odense, Denmark; [Andersen, Morten] Karolinska Inst, Dept Med Solna, Ctr Pharmacoepidemiol, Stockholm, Sweden; [Hallas, Jesper] Univ Southern Denmark, Inst Publ Hlth, Res Unit Clin Pharmacol, Odense, Denmark	University of Southern Denmark; Karolinska Institutet; University of Southern Denmark	Rathe, J (corresponding author), Univ Southern Denmark, Inst Publ Hlth, Res Unit Gen Practice, Odense, Denmark.	jrathe@health.sdu.dk	Andersen, Morten/H-3555-2011; Søndergaard, Jens js/F-3031-2013; Jarbøl, Dorte E/P-8791-2015	Andersen, Morten/0000-0001-7029-2860; Søndergaard, Jens js/0000-0002-1629-1864; Jarbøl, Dorte E/0000-0002-3241-4190	Danish Ministry of Health [2007/S145-180398]; Region of Southern Denmark Research PhD Foundation [11/28042]; Region of Southern Denmark Research Foundation [12/21277]	Danish Ministry of Health; Region of Southern Denmark Research PhD Foundation; Region of Southern Denmark Research Foundation	The study was partly funded through a contract with the Danish Ministry of Health, tender number 2007/S145-180398, the Region of Southern Denmark Research PhD Foundation (j.nr: 11/28042) and the Region of Southern Denmark Research Foundation (j.nr: 12/21277). The funder (The Danish Ministry of Health) initiated this study, but the authors designed the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhewiti Abdullah, 2014, Int J Family Med, V2014, P479596, DOI 10.1155/2014/479596; Andersen M, 2009, GENERIC SUBSTITUTION; Andrade SE, 2006, PHARMACOEPIDEM DR S, V15, P565, DOI 10.1002/pds.1230; Barron TI, 2010, VALUE HEALTH, V13, P796, DOI 10.1111/j.1524-4733.2010.00741.x; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Berg MJ, 2008, EPILEPSY BEHAV, V13, P693, DOI 10.1016/j.yebeh.2008.06.001; Briesacher BA, 2009, AM J MANAG CARE, V15, P450; Dylst P, 2013, EXPERT REV PHARM OUT, V13, P59, DOI [10.1586/ERP.12.83, 10.1586/erp.12.83]; Frank L, 2000, SCIENCE, V287, P2398, DOI 10.1126/science.287.5462.2398; Gaist D, 1997, DAN MED BULL, V44, P445; Hamann J, 2013, EUR NEUROPSYCHOPHARM, V23, P686, DOI 10.1016/j.euroneuro.2012.08.007; Horne R, 1999, PSYCHOL HEALTH, V14, P1, DOI 10.1080/08870449908407311; Horne R, 2000, HDB DRUG RES METHODO; Horne R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080633; Howland RH, 2010, J PSYCHOSOC NURS MEN, V48, P13, DOI 10.3928/02793695-20101105-01; Hunot Vivien M, 2007, Prim Care Companion J Clin Psychiatry, V9, P91; Johnston A, 2011, BRIT J CLIN PHARMACO, V72, P727, DOI 10.1111/j.1365-2125.2011.03987.x; Kesselheim AS, 2013, JAMA INTERN MED, V173, P202, DOI 10.1001/2013.jamainternmed.997; Larsen J, 2002, BRIT J CLIN PHARMACO, V53, P375, DOI 10.1046/j.1365-2125.2002.01563.x; Mardby AC, 2007, PATIENT EDUC COUNS, V69, P158, DOI 10.1016/j.pec.2007.08.011; Moller Pedersen K, 2003, Eur J Health Econ, V4, P60; Nakhutina L, 2011, EPILEPSY BEHAV, V22, P584, DOI 10.1016/j.yebeh.2011.08.007; Olesen C, 2013, PHARMACOEPIDEM DR S, V22, P1093, DOI 10.1002/pds.3497; Ostergaard K, 2012, EUR J CLIN PHARMACOL, V68, P1631, DOI 10.1007/s00228-012-1293-7; Pechlivanoglou P, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-89; Peterson AM, 2007, VALUE HEALTH, V10, P3, DOI 10.1111/j.1524-4733.2006.00139.x; Rathe J, 2014, PHARMACOEPIDEM DR S, V23, P965, DOI 10.1002/pds.3671; Rathe J, 2013, EUR J CLIN PHARMACOL, V69, P1827, DOI 10.1007/s00228-013-1539-z; Sander JW, 2010, EXPERT REV NEUROTHER, V10, P1887, DOI [10.1586/ern.10.163, 10.1586/ERN.10.163]; Shrank WH, 2011, AM J MED, V124, P309, DOI 10.1016/j.amjmed.2010.11.020; Shrank WH, 2009, MED CARE, V47, P319, DOI 10.1097/MLR.0b013e31818af850; Strom O, 2012, OSTEOPOROSIS INT, V23, P2201, DOI 10.1007/s00198-011-1850-4; The Association of Danish Pharmacies, DRUGS IN DENM; Ude M, 2011, J HYPERTENS, V29, P1837, DOI 10.1097/HJH.0b013e32834942be; Van Wijk BLG, 2006, J CLIN EPIDEMIOL, V59, P11, DOI 10.1016/j.jclinepi.2005.05.005; Van Wijk BLG, 2006, ANN PHARMACOTHER, V40, P15, DOI 10.1345/aph.1G163; Verbeeck RK, 2012, J PHARM PHARM SCI, V15, P376, DOI 10.18433/J3VC8J; Vermeire E, 2001, J CLIN PHARM THER, V26, P331, DOI 10.1046/j.1365-2710.2001.00363.x	38	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119688	10.1371/journal.pone.0119688	http://dx.doi.org/10.1371/journal.pone.0119688			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775472	Green Submitted, Green Published, gold			2022-12-27	WOS:000351183500110
J	Shyu, VBH; Hsu, CE; Chen, CH; Chen, CT				Shyu, Victor Bong-Hang; Hsu, Chung-En; Chen, Chih-hao; Chen, Chien-Tzung			3D-Assisted Quantitative Assessment of Orbital Volume Using an Open-Source Software Platform in a Taiwanese Population	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; RECONSTRUCTION; ENOPHTHALMOS; LIVER	Orbital volume evaluation is an important part of pre-operative assessments in orbital trauma and congenital deformity patients. The availability of the affordable, open-source software, OsiriX, as a tool for preoperative planning increased the popularity of radiological assessments by the surgeon. A volume calculation method based on 3D volume rendering-assisted region-of-interest computation was used to determine the normal orbital volume in Taiwanese patients after reorientation to the Frankfurt plane. Method one utilized 3D points for intuitive orbital rim outlining. The mean normal orbital volume for left and right orbits was 24.3 +/- 1.51 ml and 24.7 +/- 1.17 ml in male and 21.0 +/- 1.21 ml and 21.1 +/- 1.30 ml in female subjects. Another method (method two) based on the bilateral orbital lateral rim was also used to calculate orbital volume and compared with method one. The mean normal orbital volume for left and right orbits was 19.0 +/- 1.68 ml and 19.1 +/- 1.45 ml in male and 16.0 +/- 1.01 ml and 16.1 +/- 0.92 ml in female subjects. The inter-rater reliability and intra-rater measurement accuracy between users for both methods was found to be acceptable for orbital volume calculations. 3D-assisted quantification of orbital volume is a feasible technique for orbital volume assessment. The normal orbital volume can be used as controls in cases of unilateral orbital reconstruction with a mean size discrepancy of less than 3.1 +/- 2.03% in females and 2.7 +/- 1.32% in males. The OsiriX software can be used reliably by the individual surgeon as a comprehensive preoperative planning and imaging tool for orbital volume measurement and computed tomography reorientation.	[Shyu, Victor Bong-Hang; Hsu, Chung-En; Chen, Chih-hao] Chang Gung Univ, Chang Gung Mem Hosp Linkou, Dept Plast & Reconstruct Surg, Craniofacial Res Ctr,Coll Med, Taoyuan, Taiwan; [Chen, Chien-Tzung] Chang Gung Univ, Coll Med, Dept Med, Taoyuan, Taiwan; [Chen, Chien-Tzung] Chang Gung Mem Hosp Keelung, Dept Plast & Reconstruct Surg, Keelung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Chen, CT (corresponding author), Chang Gung Univ, Coll Med, Dept Med, Taoyuan, Taiwan.	ctchenap@cgmh.org.tw						Acer N, 2009, J CRANIOFAC SURG, V20, P921, DOI 10.1097/SCS.0b013e3181a1686d; BLAND JM, 1995, INT J EPIDEMIOL, V24, pS7, DOI 10.1093/ije/24.Supplement_1.S7; Chau A, 2004, OPHTHAL PHYSL OPT, V24, P436, DOI 10.1111/j.1475-1313.2004.00217.x; Chen Chien-Tzung, 2006, Chang Gung Med J, V29, P251; Chen Zhe, 2006, Zhonghua Yan Ke Za Zhi, V42, P222; Cooper W C, 1985, Trans Am Ophthalmol Soc, V83, P546; Dello SAWG, 2011, WORLD J SURG, V35, P386, DOI 10.1007/s00268-010-0877-6; Deveci M, 2000, J ORAL MAXIL SURG, V58, P645, DOI 10.1016/S0278-2391(00)90157-5; FORBES G, 1985, AM J NEURORADIOL, V6, P419; Fruhwald J, 2008, J CRANIOFAC SURG, V19, P22, DOI 10.1097/scs.0b013e318052ff1a; Furuta M, 2001, JPN J OPHTHALMOL, V45, P600, DOI 10.1016/S0021-5155(01)00419-1; Gellrich NC, 2002, PLAST RECONSTR SURG, V110, P1417, DOI 10.1097/01.PRS.0000029807.35391.E5; GLASSMAN RD, 1990, PLAST RECONSTR SURG, V86, P1103, DOI 10.1097/00006534-199012000-00009; Ji YR, 2010, J ANAT, V217, P501, DOI 10.1111/j.1469-7580.2010.01286.x; Kim SP, 2012, OPHTHALMIC RES, V47, P98, DOI 10.1159/000329572; Koppel DA, 2003, J CRANIO MAXILL SURG, V31, P88, DOI 10.1016/S1010-5182(02)00170-1; Lagravere MO, 2011, ORAL SURG ORAL MED O, V111, P771, DOI 10.1016/j.tripleo.2011.02.017; Lo LJ, 2007, J PLAST RECONSTR AES, V60, P125, DOI 10.1016/j.bjps.2006.05.021; Lukats O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050333; McGurk M, 1992, Dentomaxillofac Radiol, V21, P70; P'An TH, 1933, J ANAT, V67, P596; PARSONS GS, 1988, ARCH OTOLARYNGOL, V114, P743; Ramieri G, 2000, DENTOMAXILLOFAC RAD, V29, P302, DOI 10.1038/sj.dmfr.4600551; Regensburg NI, 2008, INVEST OPHTH VIS SCI, V49, P1758, DOI 10.1167/iovs.07-1030; Sicurezza E, 2011, ORAL SURG ORAL MED O, V111, P503, DOI 10.1016/j.tripleo.2010.11.022; van der Vorst JR, 2010, WORLD J SURG, V34, P2426, DOI 10.1007/s00268-010-0663-5; WHITEHOUSE RW, 1994, BRIT J OPHTHALMOL, V78, P618, DOI 10.1136/bjo.78.8.618	27	31	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119589	10.1371/journal.pone.0119589	http://dx.doi.org/10.1371/journal.pone.0119589			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774683	gold, Green Submitted, Green Published			2022-12-27	WOS:000351183500103
J	van der Pol, CB; McInnes, MDF; Petrcich, W; Tunis, AS; Hanna, R				van der Pol, Christian B.; McInnes, Matthew D. F.; Petrcich, William; Tunis, Adam S.; Hanna, Ramez			Is Quality and Completeness of Reporting of Systematic Reviews and Meta-Analyses Published in High Impact Radiology Journals Associated with Citation Rates?	PLOS ONE			English	Article							OF-THE-LITERATURE; CONGENITAL DIAPHRAGMATIC-HERNIA; MULTIDETECTOR CT ANGIOGRAPHY; SOLITARY PULMONARY NODULES; COMPUTER-AIDED DETECTION; CORONARY-ARTERY-DISEASE; LYMPH-NODE METASTASES; 64-SECTION SPIRAL CT; COMBINED FDG-PET/CT; DIAGNOSTIC-ACCURACY	Purpose The purpose of this study is to determine whether study quality and completeness of reporting of systematic reviews (SR) and meta-analyses (MA) published in high impact factor (IF) radiology journals is associated with citation rates. Methods All SR and MA published in English between Jan 2007-Dec 2011, in radiology journals with an IF > 2.75, were identified on Ovid MEDLINE. The Assessing the Methodologic Quality of Systematic Reviews (AMSTAR) checklist for study quality, and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist for study completeness, was applied to each SR & MA. Each SR & MA was then searched in Google Scholar to yield a citation rate. Spearman correlation coefficients were used to assess the relationship between AMSTAR and PRISMA results with citation rate. Multivariate analyses were performed to account for the effect of journal IF and journal 5-year IF on correlation with citation rate. Values were reported as medians with interquartile range (IQR) provided. Results 129 studies from 11 journals were included (50 SR and 79 MA). Median AMSTAR result was 8.0/11 (IQR: 5-9) and median PRISMA result was 23.0/27 (IQR: 21-25). The median citation rate for SR & MA was 0.73 citations/month post-publication (IQR: 0.40-1.17). There was a positive correlation between both AMSTAR and PRISMA results and SR & MA citation rate; rho= 0.323 (P=0.0002) and rho=0.327 (P=0.0002) respectively. Positive correlation persisted for AMSTAR and PRISMA results after journal IF was partialed out; rho=0.243 (P=0.006) and rho=0.256 (P=0.004), and after journal 5-year IF was partialed out; rho=0.235 (P=0.008) and rho=0.243 (P=0.006) respectively. Conclusion There is a positive correlation between the quality and the completeness of a reported SR or MA with citation rate which persists when adjusted for journal IF and journal 5-year IF.	[van der Pol, Christian B.; McInnes, Matthew D. F.; Tunis, Adam S.; Hanna, Ramez] Univ Ottawa, Dept Radiol, Ottawa, ON, Canada; [McInnes, Matthew D. F.; Petrcich, William] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	McInnes, MDF (corresponding author), Univ Ottawa, Dept Radiol, Ottawa, ON, Canada.	mmcinnes@toh.on.ca	van der Pol, Christian/AAN-4596-2020; McInnes, Matthew/D-4532-2013; Tunis, Adam Scranton/J-8927-2014	van der Pol, Christian/0000-0002-1718-2619; McInnes, Matthew/0000-0001-8404-4075; Tunis, Adam Scranton/0000-0002-8551-9885	University of Ottawa Department of Radiology	University of Ottawa Department of Radiology	Financial support from the University of Ottawa Department of Radiology for statistical analysis.	Achten E, 2008, EUR J RADIOL, V65, P211, DOI 10.1016/j.ejrad.2007.11.014; Ale-Ebrahim N.A., 2014, MODERN APPL SCI, V8, P63, DOI DOI 10.5539/MAS.V8N5P63; Alomari AI, 2010, AM J NEURORADIOL, V31, P1608, DOI 10.3174/ajnr.A2167; [Anonymous], 2014, J CITATION REPORTS R; Autti T, 2007, NEURORADIOLOGY, V49, P571, DOI 10.1007/s00234-007-0220-6; Aydingoz U, 2010, DIAGN INTERV RADIOL, V16, P255, DOI 10.4261/1305-3825.DIR.4080-10.0; Ba'ath ME, 2007, ULTRASOUND OBST GYN, V30, P897, DOI 10.1002/uog.5164; Berghella V, 2010, ULTRASOUND OBST GYN, V35, P468, DOI 10.1002/uog.7547; Bertot LC, 2011, EUR RADIOL, V21, P2584, DOI 10.1007/s00330-011-2222-3; Bodily KD, 2011, AM J NEURORADIOL, V32, P1232, DOI 10.3174/ajnr.A2478; Bohte AE, 2011, EUR RADIOL, V21, P87, DOI 10.1007/s00330-010-1905-5; Boland GWL, 2011, RADIOLOGY, V259, P117, DOI 10.1148/radiol.11100569; Bouzeghrane F, 2010, AM J NEURORADIOL, V31, P418, DOI 10.3174/ajnr.A1853; Brennan ME, 2011, RADIOLOGY, V260, P119, DOI 10.1148/radiol.11102368; Cahir JG, 2008, EUR J RADIOL, V67, P2, DOI 10.1016/j.ejrad.2008.01.051; Callaham M, 2002, JAMA-J AM MED ASSOC, V287, P2847, DOI 10.1001/jama.287.21.2847; Casadevall A, 2014, MBIO, V5, DOI 10.1128/mBio.00064-14; Chan YY, 2011, ULTRASOUND OBST GYN, V38, P371, DOI 10.1002/uog.10056; Chao AS, 2008, ULTRASOUND OBST GYN, V31, P289, DOI 10.1002/uog.5264; Chlapoutakis K, 2010, EUR J RADIOL, V73, P334, DOI 10.1016/j.ejrad.2008.10.026; Clarke M, 2008, NEURORADIOLOGY, V50, P653, DOI 10.1007/s00234-008-0411-9; Crane JMG, 2008, ULTRASOUND OBST GYN, V31, P579, DOI 10.1002/uog.5323; Cronin P, 2008, EUR RADIOL, V18, P1840, DOI 10.1007/s00330-008-0970-5; Cronin P, 2008, RADIOLOGY, V246, P772, DOI 10.1148/radiol.2463062148; d'Othee BJ, 2008, EUR J RADIOL, V65, P449, DOI 10.1016/j.ejrad.2007.05.003; Dani KA, 2010, AM J NEURORADIOL, V31, P170, DOI 10.3174/ajnr.A1782; Dave M, 2010, RADIOLOGY, V256, P387, DOI 10.1148/radiol.10091953; de Bondt RBJ, 2007, EUR J RADIOL, V64, P266, DOI 10.1016/j.ejrad.2007.02.037; de Haan MC, 2011, EUR RADIOL, V21, P1747, DOI 10.1007/s00330-011-2104-8; de Jesus JO, 2009, AM J ROENTGENOL, V192, P1701, DOI 10.2214/AJR.08.1241; de Zwart IM, 2010, EUR RADIOL, V20, P2609, DOI 10.1007/s00330-010-1850-3; Dimitrov JD, 2010, NATURE, V466, P179, DOI 10.1038/466179b; Dong MJ, 2011, EUR J RADIOL, V80, P834, DOI 10.1016/j.ejrad.2010.11.018; Dorrius MD, 2011, EUR RADIOL, V21, P1600, DOI 10.1007/s00330-011-2091-9; Dym RJ, 2011, RADIOLOGY, V261, P446, DOI 10.1148/radiol.11101344; Ebell MH, 2004, J FAM PRACTICE, V53, P111; Fakhran S, 2008, AM J NEURORADIOL, V29, P159, DOI 10.3174/ajnr.A0750; Falagas ME, 2010, INTERN MED J, V40, P587, DOI 10.1111/j.1445-5994.2010.02247.x; Falagas ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049476; Filion Kristian B, 2008, Epidemiol Perspect Innov, V5, P3, DOI 10.1186/1742-5573-5-3; Floriani I, 2010, J MAGN RESON IMAGING, V31, P19, DOI 10.1002/jmri.22010; Gaitini D E, 2008, Ultraschall Med, V29 Suppl 5, P220, DOI 10.1055/s-2008-1027994; Garfield E, 1999, CAN MED ASSOC J, V161, P979; GARFIELD E, 1955, SCIENCE, V122, P108, DOI 10.1126/science.122.3159.108; Goergen SK, 2010, RADIOLOGY, V254, P261, DOI 10.1148/radiol.09090690; Goodman CS, 2009, AM J ROENTGENOL, V193, P432, DOI 10.2214/AJR.08.1927; Greenberg ED, 2010, AM J NEURORADIOL, V31, P1853, DOI 10.3174/ajnr.A2246; Gu P, 2009, EUR J RADIOL, V71, P164, DOI 10.1016/j.ejrad.2008.02.019; GUYATT GH, 1995, JAMA-J AM MED ASSOC, V274, P1800, DOI 10.1001/jama.274.22.1800; Halligan S, 2007, RADIOLOGY, V243, P13, DOI 10.1148/radiol.2431051823; Hamon M, 2008, RADIOLOGY, V247, P679, DOI 10.1148/radiol.2473071132; Hamon M, 2008, EUR RADIOL, V18, P217, DOI 10.1007/s00330-007-0743-6; Hamon M, 2007, RADIOLOGY, V245, P720, DOI 10.1148/radiol.2453061899; Hamon M, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-29; Harzing AW, 2013, SCIENTOMETRICS, V94, P1057, DOI 10.1007/s11192-012-0777-7; Heijenbrok-Kal MH, 2007, RADIOLOGY, V245, P433, DOI 10.1148/radiol.2451061280; Heijmink SWTPJ, 2007, EUR J RADIOL, V63, P310, DOI 10.1016/j.ejrad.2007.06.027; Heinrich A, 2011, J MAGN RESON IMAGING, V34, P758, DOI 10.1002/jmri.22720; Heinrich MC, 2009, RADIOLOGY, V250, P68, DOI 10.1148/radiol.2501080833; Hillman SC, 2011, ULTRASOUND OBST GYN, V37, P6, DOI 10.1002/uog.7754; Horsthuis K, 2008, RADIOLOGY, V247, P64, DOI 10.1148/radiol.2471070611; Horsthuis K, 2009, EUR RADIOL, V19, P1450, DOI 10.1007/s00330-008-1287-0; Hudelist G, 2011, ULTRASOUND OBST GYN, V37, P257, DOI 10.1002/uog.8858; Jacoby WG, 2000, ELECT STUD, V19, P577, DOI 10.1016/S0261-3794(99)00028-1; Jansen-van der Weide MC, 2010, EUR RADIOL, V20, P2547, DOI 10.1007/s00330-010-1839-y; Jeve Y, 2011, ULTRASOUND OBST GYN, V38, P489, DOI 10.1002/uog.10108; Joshi U, 2007, MOL IMAGING BIOL, V9, P99, DOI 10.1007/s11307-007-0076-5; Kodumuri P, 2014, BONE JOINT J, V96B, P414, DOI 10.1302/0301-620X.96B3.32279; Kok M, 2009, ULTRASOUND OBST GYN, V33, P76, DOI 10.1002/uog.6277; Kranz PG, 2009, AM J NEURORADIOL, V30, P1206, DOI 10.3174/ajnr.A1547; Kressel HY, 2014, RADIOLOGY, V270, P3, DOI 10.1148/radiol.13132314; Krille L, 2010, EUR J RADIOL, V76, P36, DOI 10.1016/j.ejrad.2010.08.025; Krishan S, 2011, AM J ROENTGENOL, V196, P1065, DOI 10.2214/AJR.10.4745; Krug B, 2008, RADIOLOGY, V249, P836, DOI 10.1148/radiol.2493080240; Kulkarni AV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000403; Kulkarni AV, 2009, JAMA-J AM MED ASSOC, V302, P1092, DOI 10.1001/jama.2009.1307; Kunadian V, 2011, EUR J RADIOL, V79, P48, DOI 10.1016/j.ejrad.2009.12.015; Kung Jason, 2010, Open Dent J, V4, P84, DOI 10.2174/1874210601004020084; Kwee RM, 2010, RADIOLOGY, V254, P707, DOI 10.1148/radiol.09091324; Kwee TC, 2007, NEURORADIOLOGY, V49, P703, DOI 10.1007/s00234-007-0266-5; Kwee TC, 2009, EUR RADIOL, V19, P731, DOI 10.1007/s00330-008-1194-4; Lameris W, 2008, EUR RADIOL, V18, P2498, DOI 10.1007/s00330-008-1018-6; Lee KP, 2002, JAMA-J AM MED ASSOC, V287, P2805, DOI 10.1001/jama.287.21.2805; Li YP, 2010, EUR J RADIOL, V74, pE123, DOI 10.1016/j.ejrad.2009.04.069; Lim AC, 2011, ULTRASOUND OBST GYN, V38, P10, DOI 10.1002/uog.9013; Liu JZ, 2007, EUR J RADIOL, V62, P328, DOI 10.1016/j.ejrad.2007.02.040; Lokker C, 2008, BMJ-BRIT MED J, V336, P655, DOI 10.1136/bmj.39482.526713.BE; Maarse W, 2010, ULTRASOUND OBST GYN, V35, P495, DOI 10.1002/uog.7472; Mazhar SM, 2009, J MAGN RESON IMAGING, V30, P1313, DOI 10.1002/jmri.21983; McInnes MDF, 2011, RADIOLOGY, V260, P699, DOI 10.1148/radiol.11110333; Medina LS, 2007, RADIOLOGY, V242, P94, DOI 10.1148/radiol.2421050677; Meho LI, 2007, J AM SOC INF SCI TEC, V58, P2105, DOI 10.1002/asi.20677; Meijer AB, 2008, AM J ROENTGENOL, V191, P1667, DOI 10.2214/AJR.07.4022; Menke J, 2010, RADIOLOGY, V256, P93, DOI 10.1148/radiol.10091938; Menke J, 2009, EUR RADIOL, V19, P2204, DOI 10.1007/s00330-009-1403-9; Mikki S, 2010, SCIENTOMETRICS, V82, P321, DOI 10.1007/s11192-009-0038-6; Miller E, 2009, AM J ROENTGENOL, V192, P1209, DOI 10.2214/AJR.08.2304; Moher D, 2011, EPIDEMIOLOGY, V22, P128, DOI 10.1097/EDE.0b013e3181fe7825; Morris RK, 2011, ULTRASOUND OBST GYN, V37, P629, DOI 10.1002/uog.8981; Morris RK, 2011, ULTRASOUND OBST GYN, V37, P135, DOI 10.1002/uog.7767; Mullassery D, 2010, ULTRASOUND OBST GYN, V35, P609, DOI 10.1002/uog.7586; Naggara ON, 2010, RADIOLOGY, V256, P887, DOI 10.1148/radiol.10091982; Nieder C, 2012, CLIN NEUROL NEUROSUR, V114, P1207, DOI 10.1016/j.clineuro.2012.03.049; Niekel MC, 2010, RADIOLOGY, V257, P674, DOI 10.1148/radiol.10100729; Niemann T, 2009, ULTRASCHALL MED, V30, P150, DOI 10.1055/s-2008-1027856; Niemann T, 2008, AM J ROENTGENOL, V191, P396, DOI 10.2214/AJR.07.3414; Nieminen P, 2006, BMC MED RES METHODOL, P6; Nieminen P, 2007, J CLIN EPIDEMIOL, V60, P939, DOI 10.1016/j.jclinepi.2006.11.014; Oba Y, 2010, RADIOLOGY, V255, P386, DOI 10.1148/radiol.10090946; Okike K, 2011, J CLIN EPIDEMIOL, V64, P331, DOI 10.1016/j.jclinepi.2010.03.019; Pakos EE, 2007, RADIOLOGY, V245, P732, DOI 10.1148/radiol.2452061877; Pakos EE, 2007, RADIOLOGY, V242, P101, DOI 10.1148/radiol.2421052011; Peters NHGM, 2008, RADIOLOGY, V246, P116, DOI 10.1148/radiol.2461061298; Pickhardt PJ, 2011, RADIOLOGY, V259, P393, DOI 10.1148/radiol.11101887; Pinto A, 2011, EUR J RADIOL, V78, P372, DOI 10.1016/j.ejrad.2010.12.028; Provenzale JM, 2008, AM J NEURORADIOL, V29, P1476, DOI 10.3174/ajnr.A1161; Provenzale JM, 2009, AM J ROENTGENOL, V193, P1167, DOI 10.2214/AJR.08.1688; Qu XH, 2011, EUR J RADIOL, V80, P188, DOI 10.1016/j.ejrad.2010.04.003; Roberts D, 2008, ULTRASOUND OBST GYN, V31, P701, DOI 10.1002/uog.5328; Robertson C, 2011, EUR RADIOL, V21, P2484, DOI 10.1007/s00330-011-2226-z; Robinson C, 2008, RADIOLOGY, V246, P426, DOI 10.1148/radiol.2461070121; Royle P, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-74; Salvesen KA, 2011, ULTRASOUND OBST GYN, V38, P267, DOI 10.1002/uog.9055; Sampson FC, 2007, EUR RADIOL, V17, P175, DOI 10.1007/s00330-006-0178-5; Sardanelli F, 2013, AM J ROENTGENOL, V201, pW391, DOI 10.2214/AJR.12.10256; Schlattmann P, 2011, EUR RADIOL, V21, P1904, DOI 10.1007/s00330-011-2142-2; Scholing M, 2009, EUR RADIOL, V19, P2333, DOI 10.1007/s00330-009-1440-4; Semelka RC, 2007, J MAGN RESON IMAGING, V25, P900, DOI 10.1002/jmri.20895; Seror P, 2008, EUR J RADIOL, V67, P146, DOI 10.1016/j.ejrad.2007.06.017; Shah QA, 2008, NEURORADIOLOGY, V50, P963, DOI 10.1007/s00234-008-0449-8; Shanta A, 2013, J MED PHYS, V38, P155, DOI 10.4103/0971-6203.121191; Shapiro M, 2008, AM J NEURORADIOL, V29, P1777, DOI 10.3174/ajnr.A1216; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Smith TO, 2011, EUR RADIOL, V21, P863, DOI 10.1007/s00330-010-1956-7; Guedes BDS, 2011, EUR J RADIOL, V80, P236, DOI 10.1016/j.ejrad.2010.06.007; Sosna J, 2008, AM J ROENTGENOL, V190, P374, DOI 10.2214/AJR.07.2099; Sotiriadis A, 2010, ULTRASOUND OBST GYN, V35, P54, DOI 10.1002/uog.7457; Springer I, 2009, EUR J RADIOL, V71, P275, DOI 10.1016/j.ejrad.2008.04.035; Stringer MJ, 2010, J AM SOC INF SCI TEC, V61, P1377, DOI 10.1002/asi.21335; Stringer MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001683; Sun ZH, 2008, EUR J RADIOL, V67, P78, DOI 10.1016/j.ejrad.2007.07.014; Sun ZH, 2010, EUR J RADIOL, V73, P266, DOI 10.1016/j.ejrad.2008.10.025; Sun ZH, 2009, EUR J RADIOL, V69, P489, DOI 10.1016/j.ejrad.2007.11.030; Sundaram M, 2012, SKELETAL RADIOL, V41, P125, DOI 10.1007/s00256-011-1342-9; Tang SA, 2011, EUR J RADIOL, V78, P142, DOI 10.1016/j.ejrad.2009.09.026; Thayyil S, 2010, EUR J RADIOL, V75, pE142, DOI 10.1016/j.ejrad.2009.10.007; Torloni MR, 2009, ULTRASOUND OBST GYN, V33, P599, DOI 10.1002/uog.6328; Torp-Pedersen S, 2011, ULTRASCHALL MED, V32, P54, DOI 10.1055/s-0029-1245386; Tunis AS, 2013, RADIOLOGY, V269, P413, DOI 10.1148/radiol.13130273; Van Eerde AM, 2007, ULTRASOUND OBST GYN, V29, P463, DOI 10.1002/uog.3975; van Randen A, 2008, RADIOLOGY, V249, P97, DOI 10.1148/radiol.2483071652; Vandenbrouke JP, 2009, J CLIN EPIDEMIOL, V62, P594, DOI 10.1016/j.jclinepi.2008.12.003; Vanhoenacker PK, 2007, RADIOLOGY, V244, P419, DOI 10.1148/radiol.2442061218; Vente MAD, 2009, EUR RADIOL, V19, P951, DOI 10.1007/s00330-008-1211-7; Vinnicombe S, 2009, RADIOLOGY, V251, P347, DOI 10.1148/radiol.2512081235; Visser JJ, 2007, RADIOLOGY, V245, P122, DOI 10.1148/radiol.2451061204; Warren R, 2009, EUR RADIOL, V19, P1629, DOI 10.1007/s00330-009-1341-6; Westerlaan HE, 2011, RADIOLOGY, V258, P134, DOI 10.1148/radiol.10092373; White PM, 2009, AM J NEURORADIOL, V30, P219, DOI 10.3174/ajnr.A1324; Wiesmann M, 2008, EUR RADIOL, V18, P2956, DOI 10.1007/s00330-008-1077-8; Wijers SC, 2011, EUR J RADIOL, V80, pE536, DOI 10.1016/j.ejrad.2011.01.037; Williams GJ, 2007, AM J ROENTGENOL, V188, P798, DOI 10.2214/AJR.06.0355; Willis DL, 2011, BJU INT, V107, P1876, DOI 10.1111/j.1464-410X.2010.10028.x; Wu LM, 2011, J MAGN RESON IMAGING, V34, P128, DOI 10.1002/jmri.22608; Wu LC, 2011, EUR J RADIOL, V80, P582, DOI 10.1016/j.ejrad.2009.11.027; Xia D, 2010, J MAGN RESON IMAGING, V32, P130, DOI 10.1002/jmri.22211; Yang HL, 2011, EUR RADIOL, V21, P2604, DOI 10.1007/s00330-011-2221-4; Yuan Y, 2009, AM J NEURORADIOL, V30, P404, DOI 10.3174/ajnr.A1357; Yuan Y, 2010, AM J ROENTGENOL, V195, P260, DOI 10.2214/AJR.09.3908; Zijta FM, 2010, EUR RADIOL, V20, P1031, DOI 10.1007/s00330-009-1663-4; Zupanc GKH, 2014, J COMP PHYSIOL A, V200, P113, DOI 10.1007/s00359-013-0863-1	172	38	38	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119892	10.1371/journal.pone.0119892	http://dx.doi.org/10.1371/journal.pone.0119892			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD6EY	25775455	Green Submitted, gold, Green Published			2022-12-27	WOS:000351183500137
J	Voldgorn, YI; Adilgereeva, EP; Nekrasov, ED; Lavrov, AV				Voldgorn, Yana I.; Adilgereeva, Elmira P.; Nekrasov, Evgeny D.; Lavrov, Alexander V.			Cultivation and Differentiation Change Nuclear Localization of Chromosome Centromeres in Human Mesenchymal Stem Cells	PLOS ONE			English	Article							NEURONAL DIFFERENTIATION; RNA INTERFERENCE; ORGANIZATION; TERRITORIES; PLURIPOTENCY; MOVEMENTS; CULTURE; GENES	Chromosome arrangement in the interphase nucleus is not accidental. Strong evidences support that nuclear localization is an important mechanism of epigenetic regulation of gene expression. The purpose of this research was to identify differences in the localization of centromeres of chromosomes 6, 12, 18 and X in human mesenchymal stem cells depending on differentiation and cultivating time. We analyzed centromere positions in more than 4000 nuclei in 19 mesenchymal stem cell cultures before and after prolonged cultivation and after differentiation into osteogenic and adipogenic directions. We found a centromere reposition of HSAX at late passages and after differentiation in osteogenic direction as well as of HSA12 and HSA18 after adipogenic differentiation. The observed changes of the nuclear structure are new nuclear characteristics of the studied cells which may reflect regulatory changes of gene expression during the studied processes.	[Voldgorn, Yana I.; Adilgereeva, Elmira P.; Lavrov, Alexander V.] Russian Acad Med Sci, Fed State Budgetary Inst, Med Genet Res Ctr, Moscow 115478, Russia; [Voldgorn, Yana I.; Lavrov, Alexander V.] Minist Hlth Russian Federat, Russian Natl Res Med Univ, State Budgetary Educ Inst Higher Profess Educ, Moscow 117997, Russia; [Nekrasov, Evgeny D.] Moscow Inst Phys & Technol, Dolgoprudnyi 141700, Moscow Region, Russia	Research Centre for Medical Genetics; Russian Academy of Medical Sciences; Ministry of Health of the Russian Federation; Pirogov Russian National Research Medical University; Moscow Institute of Physics & Technology	Lavrov, AV (corresponding author), Russian Acad Med Sci, Fed State Budgetary Inst, Med Genet Res Ctr, Moskvorechie 1, Moscow 115478, Russia.	avlavrov@yandex.ru			Ministry of Education and Science of Russia [02-740-11-0779]; OPTEK [27/2013]	Ministry of Education and Science of Russia(Ministry of Education and Science, Russian Federation); OPTEK	This work was funded by Contract No. 02-740-11-0779 of Ministry of Education and Science of Russia (http://fasi.gov.ru/) - AVL and Grant N<SUP>o</SUP> 27/2013 from OPTEK (http://www.optecgroup.com/) - YIV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartova E, 2008, DEV DYNAM, V237, P3690, DOI 10.1002/dvdy.21773; Bi Y, 2014, INT J BIOCHEM CELL B, V46, P148, DOI 10.1016/j.biocel.2013.11.009; Birbrair A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016816; Boyle S, 2001, HUM MOL GENET, V10, P211, DOI 10.1093/hmg/10.3.211; Clark AT, 2004, STEM CELLS, V22, P169, DOI 10.1634/stemcells.22-2-169; CREMER T, 1993, COLD SPRING HARB SYM, V58, P777, DOI 10.1101/SQB.1993.058.01.085; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; Csink AK, 1998, J CELL BIOL, V143, P13, DOI 10.1083/jcb.143.1.13; Delorme Bruno, 2007, V140, P67; Finch KA, 2008, J CELL SCI, V121, P655, DOI 10.1242/jcs.025205; Foster HA, 2005, J CELL SCI, V118, P1811, DOI 10.1242/jcs.02301; Gadji M, 2011, ADV CANCER RES, V112, P77, DOI 10.1016/B978-0-12-387688-1.00004-1; Galiova G, 2004, BLOOD CELL MOL DIS, V33, P4, DOI 10.1016/j.bcmd.2004.03.006; Gilchrist Susan, 2004, Chromosome Res, V12, P505; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kim SH, 2004, CYTOGENET GENOME RES, V105, P292, DOI 10.1159/000078201; Kuroda M, 2004, J CELL SCI, V117, P5897, DOI 10.1242/jcs.01508; Kurz A, 1996, J CELL BIOL, V135, P1195, DOI 10.1083/jcb.135.5.1195; Li CX, 2010, MOL BIOL REP, V37, P2347, DOI 10.1007/s11033-009-9740-y; Matin MM, 2004, STEM CELLS, V22, P659, DOI 10.1634/stemcells.22-5-659; Mehta IS, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r135; Mora L, 2006, CHROMOSOMA, V115, P367, DOI 10.1007/s00412-006-0064-6; Mudrak OS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052944; Pan QW, 2014, EXP BIOL MED, V239, P105, DOI 10.1177/1535370213506802; Rastegar Farbod, 2010, World J Stem Cells, V2, P67, DOI 10.4252/wjsc.v2.i4.67; Rubtsov NB, 2007, PRIRODA, V8, P3; Tumbar T, 2001, NAT CELL BIOL, V3, P134, DOI 10.1038/35055033; Vorsanova SG, 2010, MOL CYTOGENET, V3, DOI 10.1186/1755-8166-3-1; Wiblin AE, 2005, J CELL SCI, V118, P3861, DOI 10.1242/jcs.02500; Yu Q, 2013, BIOCHEM BIOPH RES CO, V439, P297, DOI 10.1016/j.bbrc.2013.08.030; Zaehres H, 2005, STEM CELLS, V23, P299, DOI 10.1634/stemcells.2004-0252; Zeitz MJ, 2009, J CELL PHYSIOL, V221, P120, DOI 10.1002/jcp.21842	32	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118350	10.1371/journal.pone.0118350	http://dx.doi.org/10.1371/journal.pone.0118350			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775427	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500028
J	Wakasa, Y; Takagi, H; Watanabe, N; Kitamura, N; Fujiwara, Y; Ogo, Y; Hayashi, S; Yang, LJ; Ohta, M; Tin, WWT; Sekikawa, K; Takano, M; Ozawa, K; Hiroi, T; Takaiwa, F				Wakasa, Yuhya; Takagi, Hidenori; Watanabe, Nobumasa; Kitamura, Noriko; Fujiwara, Yoshihiro; Ogo, Yuko; Hayashi, Shimpei; Yang, Lijun; Ohta, Masaru; Tin, Wai Wai Thet; Sekikawa, Kenji; Takano, Makoto; Ozawa, Kenjirou; Hiroi, Takachika; Takaiwa, Fumio			Concentrated Protein Body Product Derived from Rice Endosperm as an Oral Tolerogen for Allergen-Specific Immunotherapy-A New Mucosal Vaccine Formulation against Japanese Cedar Pollen Allergy	PLOS ONE			English	Article							SEED; TOLERANCE; EXPRESSION	The endoplasmic reticulum-derived type-I protein body (PB-I) from rice endosperm cells is an ideal candidate formulation for the oral delivery of bioencapsulated peptides as tolerogens for allergen-specific immunotherapy. In the present study, PBs containing the deconstructed Japanese cedar pollen allergens Cryptomeria japonica 1 (Cry j 1) and Cry j 2 were concentrated by treatment with thermostable a-amylase at 90 degrees C to remove the starch from milled rice powder, which resulted in a 12.5-fold reduction of dry weight compared to the starting material. The modified Cry j 1 and Cry j 2 antigens in this concentrated PB product were more resistant to enzymatic digestion than those in the milled seed powder despite the absence of intact cell wall and starch, and remained stable for at least 10 months at room temperature without detectable loss or degradation. The high resistance of these allergens could be attributed to changes in protein physicochemical properties induced by the high temperature concentration process, as suggested by the decreased solubility of the antigens and seed proteins in PBs in step-wise-extraction experiments. Confocal microscopy showed that the morphology of antigen-containing PB-Is was preserved in the concentrated PB product. The concentrated PB product induced specific immune tolerance against Cry j 1 and Cry j 2 in mice when orally administered, supporting its potential use as a novel oral tolerogen formulation.	[Wakasa, Yuhya; Takagi, Hidenori; Ogo, Yuko; Hayashi, Shimpei; Yang, Lijun; Ohta, Masaru; Tin, Wai Wai Thet; Takano, Makoto; Ozawa, Kenjirou; Takaiwa, Fumio] Natl Inst Agrobiol Sci, Genetically Modified Organism Res Ctr, Tsukuba, Ibaraki, Japan; [Watanabe, Nobumasa; Kitamura, Noriko; Hiroi, Takachika] Tokyo Metropolitan Inst Med Sci, Dept Allergy & Immunol, Setagaya Ku, Tokyo 113, Japan; [Fujiwara, Yoshihiro; Sekikawa, Kenji] PrevenTec Inc, Tsukuba, Ibaraki, Japan	National Institute of Agrobiological Sciences - Japan; Tokyo Metropolitan Institute of Medical Science	Takaiwa, F (corresponding author), Natl Inst Agrobiol Sci, Genetically Modified Organism Res Ctr, Tsukuba, Ibaraki, Japan.	takaiwa@nias.affrc.go.jp		Wakasa, Yuhya/0000-0002-5764-9359	Agri-Health Translational Research Project from the Ministry of Agriculture, Forestry and Fisheries of Japan	Agri-Health Translational Research Project from the Ministry of Agriculture, Forestry and Fisheries of Japan	This work was supported by the Agri-Health Translational Research Project from the Ministry of Agriculture, Forestry and Fisheries of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beier R, 1998, AM J PHYSIOL-GASTR L, V275, pG130, DOI 10.1152/ajpgi.1998.275.1.G130; Crowther J R, 1995, Methods Mol Biol, V42, P1; Derycke V, 2005, CEREAL CHEM, V82, P468, DOI 10.1094/CC-82-0468; KRISHNAN HB, 1986, PLANTA, V169, P471, DOI 10.1007/BF00392095; Kunisawa J, 2012, ADV DRUG DELIVER REV, V64, P523, DOI 10.1016/j.addr.2011.07.003; Lau OS, 2009, BIOTECHNOL ADV, V27, P1015, DOI 10.1016/j.biotechadv.2009.05.005; Mayer L, 2004, NAT REV IMMUNOL, V4, P407, DOI 10.1038/nri1370; Nochi T, 2007, P NATL ACAD SCI USA, V104, P10986, DOI 10.1073/pnas.0703766104; OGAWA M, 1987, PLANT CELL PHYSIOL, V28, P1517; Ou JQ, 2014, PLANT CELL REP, V33, P585, DOI 10.1007/s00299-013-1559-2; Pabst O, 2012, MUCOSAL IMMUNOL, V5, P232, DOI 10.1038/mi.2012.4; Qu LQ, 2004, PLANT BIOTECHNOL J, V2, P113, DOI 10.1111/j.1467-7652.2004.00055.x; Sabalza M, 2013, CURR PHARM DESIGN, V19, P5543, DOI 10.2174/1381612811319310009; Stoger E, 2005, CURR OPIN BIOTECH, V16, P167, DOI 10.1016/j.copbio.2005.01.005; Streatfield SJ, 2006, METHODS, V38, P150, DOI 10.1016/j.ymeth.2005.09.013; Suzuki K, 2011, PLANT BIOTECHNOL J, V9, P982, DOI 10.1111/j.1467-7652.2011.00613.x; Takagi H, 2005, PLANT BIOTECHNOL J, V3, P521, DOI 10.1111/j.1467-7652.2005.00143.x; Takagi H, 2006, J AGR FOOD CHEM, V54, P9901, DOI 10.1021/jf061848v; Takagi H, 2010, PEPTIDES, V31, P1421, DOI 10.1016/j.peptides.2010.04.032; Takaiwa F, 2013, IMMUNOTHERAPY, V5, P1, DOI [10.2217/imt.12.148, DOI 10.2217/IMT.12.148]; Takaiwa F, 2011, HUM VACCINES, V7, P357, DOI 10.4161/hv.7.3.14302; Takemoto Y, 2002, PLANT PHYSIOL, V128, P1212, DOI 10.1104/pp.010624; Tsuji NM, 2008, TRENDS IMMUNOL, V29, P532, DOI 10.1016/j.it.2008.09.002; Wakasa Y, 2006, PLANT BIOTECHNOL J, V4, P499, DOI 10.1111/j.1467-7652.2006.00199.x; Wakasa Y, 2013, BIOTECHNOL J, V8, P1133, DOI 10.1002/biot.201300065; Wakasa Y, 2013, PLANT BIOTECHNOL J, V11, P66, DOI 10.1111/pbi.12007; Wang SY, 2013, PLANT CELL PHYSIOL, V54, P917, DOI 10.1093/pcp/pct043; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Yang LJ, 2007, PLANT BIOTECHNOL J, V5, P815, DOI 10.1111/j.1467-7652.2007.00287.x; Yang LJ, 2012, J EXP BOT, V63, P2947, DOI 10.1093/jxb/ers006; Yasuda H, 2009, PLANT CELL PHYSIOL, V50, P1532, DOI 10.1093/pcp/pcp098	31	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120209	10.1371/journal.pone.0120209	http://dx.doi.org/10.1371/journal.pone.0120209			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774686	Green Submitted, gold, Green Published			2022-12-27	WOS:000351183500157
J	Yamanishi, K; Doe, N; Sumida, M; Watanabe, Y; Yoshida, M; Yamamoto, H; Xu, YF; Li, W; Yamanishi, H; Okamura, H; Matsunaga, H				Yamanishi, Kyosuke; Doe, Nobutaka; Sumida, Miho; Watanabe, Yuko; Yoshida, Momoko; Yamamoto, Hideyuki; Xu, Yunfeng; Li, Wen; Yamanishi, Hiromichi; Okamura, Haruki; Matsunaga, Hisato			Hepatocyte Nuclear Factor 4 Alpha Is a Key Factor Related to Depression and Physiological Homeostasis in the Mouse Brain	PLOS ONE			English	Article							PREFRONTAL CORTEX; STRESS; METAANALYSIS; DISORDER; COAGULATION; EXPRESSION; CYTOKINES; RISK; FIBRINOLYSIS; METABOLISM	Major depressive disorder (MDD) is a common psychiatric disorder that involves marked disabilities in global functioning, anorexia, and severe medical comorbidities. MDD is associated with not only psychological and sociocultural problems, but also pervasive physical dysfunctions such as metabolic, neurobiological and immunological abnormalities. Nevertheless, the mechanisms underlying the interactions between these factors have yet to be determined in detail. The aim of the present study was to identify the molecular mechanisms responsible for the interactions between MDD and dysregulation of physiological homeostasis, including immunological function as well as lipid metabolism, coagulation, and hormonal activity in the brain. We generated depression-like behavior in mice using chronic mild stress (CMS) as a model of depression. We compared the gene expression profiles in the prefrontal cortex (PFC) of CMS and control mice using microarrays. We subsequently categorized genes using two web-based bioinformatics applications: Ingenuity Pathway Analysis and The Database for Annotation, Visualization, and Integrated Discovery. We then confirmed significant group-differences by analyzing mRNA and protein expression levels not only in the PFC, but also in the thalamus and hippocampus. These web tools revealed that hepatocyte nuclear factor 4 alpha (Hnf4a) may exert direct effects on various genes specifically associated with amine synthesis, such as genes involved in serotonin metabolism and related immunological functions. Moreover, these genes may influence lipid metabolism, coagulation, and hormonal activity. We also confirmed the significant effects of Hnf4a on both mRNA and protein expression levels in the brain. These results suggest that Hnf4a may have a critical influence on physiological homeostasis under depressive states, and may be associated with the mechanisms responsible for the interactions between MDD and the dysregulation of physiological homeostasis in humans.	[Yamanishi, Kyosuke; Matsunaga, Hisato] Hyogo Coll Med, Dept Neuropsychiat, Nishinomiya, Hyogo 6638501, Japan; [Yamamoto, Hideyuki; Xu, Yunfeng; Li, Wen; Okamura, Haruki] Hyogo Coll Med, Lab Tumor Immunol & Cell Therapy, Nishinomiya, Hyogo 6638501, Japan; [Doe, Nobutaka] Hyogo Coll Med, Lab Neurogenesis & CNS Repair, Nishinomiya, Hyogo 6638501, Japan; [Doe, Nobutaka; Sumida, Miho] Kouiken Co Ltd, Sect Behav Sci, Akashi, Hyogo, Japan; [Yamanishi, Kyosuke; Watanabe, Yuko; Yoshida, Momoko; Yamanishi, Hiromichi] Hirakata Gen Hosp Dev Disorders, Hirakata, Osaka, Japan	Hyogo College of Medicine; Hyogo College of Medicine; Hyogo College of Medicine	Matsunaga, H (corresponding author), Hyogo Coll Med, Dept Neuropsychiat, Nishinomiya, Hyogo 6638501, Japan.	hisa1311@hyo-med.ac.jp	Yamanishi, Kyosuke/GQH-4743-2022		Department of Neuropsychiatry in Hyogo College of Medicine	Department of Neuropsychiatry in Hyogo College of Medicine	This work was internally supported by the fund of Department of Neuropsychiatry in Hyogo College of Medicine. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery RA, 2000, NEUROPSYCHOPHARMACOL, V23, P240, DOI 10.1016/S0893-133X(00)00111-1; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bonzo JA, 2012, J BIOL CHEM, V287, P7345, DOI 10.1074/jbc.M111.334599; Brown ES, 2010, ALLERGY ASTHMA PROC, V31, P331, DOI 10.2500/aap.2010.31.3338; Bulla GA, 2001, J CELL SCI, V114, P1205; Chien IC, 2013, J PSYCHOSOM RES, V75, P270, DOI 10.1016/j.jpsychores.2013.06.003; Diener C, 2012, NEUROIMAGE, V61, P677, DOI 10.1016/j.neuroimage.2012.04.005; Dong JY, 2012, STROKE, V43, P32, DOI 10.1161/STROKEAHA.111.630871; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Geiser F, 2008, PSYCHOTHER PSYCHOSOM, V77, P377, DOI 10.1159/000151518; Geiser F, 2011, PSYCHIAT CLIN NEUROS, V65, P518, DOI 10.1111/j.1440-1819.2011.02241.x; Gilabert-Juan J, 2013, BRAIN STRUCT FUNCT, V218, P1591, DOI 10.1007/s00429-012-0479-1; Hage MP, 2012, J THROID RES, V2012, DOI 10.1155/2012/590648; Health Statistics Office Vital Health and Social Statistics Division, 2011, PAT SURV; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jagannathan K, 2010, BIOL PSYCHIAT, V68, P657, DOI 10.1016/j.biopsych.2010.06.002; Kahl KG, 2012, EUR ARCH PSY CLIN N, V262, P313, DOI 10.1007/s00406-011-0277-4; Kahn R, 2008, CIRCULATION, V118, P576, DOI 10.1161/CIRCULATIONAHA.108.190186; Kang HJ, 2012, NAT MED, V18, P1413, DOI 10.1038/nm.2886; Keedwell PA, 2005, BIOL PSYCHIAT, V58, P495, DOI 10.1016/j.biopsych.2005.04.035; Kurose Y, 1999, BRAIN RES, V828, P115, DOI 10.1016/S0006-8993(99)01339-6; Laine B, 2000, FEBS LETT, V479, P41, DOI 10.1016/S0014-5793(00)01864-0; Lee Margherita M, 2013, Curr Top Behav Neurosci, V14, P153, DOI 10.1007/7854_2012_226; Light SN, 2011, BIOL PSYCHIAT, V70, P962, DOI 10.1016/j.biopsych.2011.06.031; Ma XC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020955; Mao ZM, 1999, BIOL PSYCHIAT, V46, P1259, DOI 10.1016/S0006-3223(99)00139-0; Marazziti D, 2013, CNS SPECTRUMS, V18, P6, DOI 10.1017/S1092852912000740; McIntyre RS, 2007, CURR OPIN PSYCHIATR, V20, P406, DOI 10.1097/YCO.0b013e3281938102; Mehta D, 2013, BRAIN BEHAV IMMUN, V31, P205, DOI 10.1016/j.bbi.2013.04.004; Ministry of Health Labour and Welfare, 2010, HLTH LAB WELF REP; Naiki T, 2002, J BIOL CHEM, V277, P14011, DOI 10.1074/jbc.M105403200; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Oxenkrug GF, 2010, ISR J PSYCHIATR REL, V47, P56; Paizanis Eleni, 2007, Neural Plasticity, V2007, DOI 10.1155/2007/73754; Radley JJ, 2006, CEREB CORTEX, V16, P313, DOI 10.1093/cercor/bhi104; Raison CL, 2013, JAMA PSYCHIAT, V70, P31, DOI 10.1001/2013.jamapsychiatry.4; Ross DA, 2012, J NEURO-ONCOL, V109, P439, DOI 10.1007/s11060-012-0919-z; Rotella F, 2013, J CLIN PSYCHIAT, V74, P32, DOI 10.4088/JCP.12r07922; Sawyer K, 2012, AGING MENT HEALTH, V16, P753, DOI 10.1080/13607863.2012.678478; Schiepers OJG, 2005, PROG NEURO-PSYCHOPH, V29, P201, DOI 10.1016/j.pnpbp.2004.11.003; Schroeder V, 2007, EUR J CARDIOV PREV R, V14, P782, DOI 10.1097/HJR.0b013e32828622e8; Shao L, 2008, BIOL PSYCHIAT, V64, P89, DOI 10.1016/j.biopsych.2007.11.010; Shelton RC, 2010, PROG NEUROBIOL, V91, P275, DOI 10.1016/j.pneurobio.2010.04.004; Slattery DA, 2004, FUND CLIN PHARMACOL, V18, P1, DOI 10.1111/j.1472-8206.2004.00195.x; Slavich GM, 2014, PSYCHOL BULL, V140, P774, DOI 10.1037/a0035302; Vazquez-Borsetti P, 2011, INT J NEUROPSYCHOPH, V14, P289, DOI 10.1017/S1461145710000349; Wahlqvist ML, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-150; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; You ZL, 2011, BEHAV BRAIN RES, V225, P135, DOI 10.1016/j.bbr.2011.07.006; Young EA, 2002, ENDOCRIN METAB CLIN, V31, P63, DOI 10.1016/S0889-8529(01)00002-0	52	25	26	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119021	10.1371/journal.pone.0119021	http://dx.doi.org/10.1371/journal.pone.0119021			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774879	Green Published, Green Submitted, gold			2022-12-27	WOS:000351183500060
J	Naumenko, AN; Timoshevskiy, VA; Kinney, NA; Kokhanenko, AA; Debruyn, BS; Lovin, DD; Stegniy, VN; Severson, DW; Sharakhov, IV; Sharakhova, MV				Naumenko, Anastasia N.; Timoshevskiy, Vladimir A.; Kinney, Nicholas A.; Kokhanenko, Alina A.; deBruyn, Becky S.; Lovin, Diane D.; Stegniy, Vladimir N.; Severson, David W.; Sharakhov, Igor V.; Sharakhova, Maria V.			Mitotic-Chromosome-Based Physical Mapping of the Culex quinquefasciatus Genome	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; MALARIA PARASITE SUSCEPTIBILITY; TUBULE POLYTENE CHROMOSOMES; AEDES-AEGYPTI; ANOPHELES-GAMBIAE; LINKAGE MAP; MOSQUITO; PIPIENS; DIPTERA; SEQUENCE	The genome assembly of southern house mosquito Cx. quinquefasciatus is represented by a high number of supercontigs with no order or orientation on the chromosomes. Although cytogenetic maps for the polytene chromosomes of this mosquito have been developed, their utilization for the genome mapping remains difficult because of the low number of high-quality spreads in chromosome preparations. Therefore, a simple and robust mitotic-chromosome-based approach for the genome mapping of Cx. quinquefasciatus still needs to be developed. In this study, we performed physical mapping of 37 genomic supercontigs using fluorescent in situ hybridization on mitotic chromosomes from imaginal discs of 4th instar larvae. The genetic linkage map nomenclature was adopted for the chromosome numbering based on the direct positioning of 58 markers that were previously genetically mapped. The smallest, largest, and intermediate chromosomes were numbered as 1, 2, and 3, respectively. For idiogram development, we analyzed and described in detail the morphology and proportions of the mitotic chromosomes. Chromosomes were subdivided into 19 divisions and 72 bands of four different intensities. These idiograms were used for mapping the genomic supercontigs/genetic markers. We also determined the presence of length polymorphism in the q arm of sex-determining chromosome 1 in Cx. quinquefasciatus related to the size of ribosomal locus. Our physical mapping and previous genetic linkage mapping resulted in the chromosomal assignment of 13% of the total genome assembly to the chromosome bands. We provided the first detailed description, nomenclature, and idiograms for the mitotic chromosomes of Cx. quinquefasciatus. Further application of the approach developed in this study will help to improve the quality of the southern house mosquito genome.	[Naumenko, Anastasia N.; Timoshevskiy, Vladimir A.; Sharakhov, Igor V.; Sharakhova, Maria V.] Virginia Tech, Dept Entomol, Blacksburg, VA 24061 USA; [Naumenko, Anastasia N.; Timoshevskiy, Vladimir A.; Sharakhov, Igor V.; Sharakhova, Maria V.] Virginia Tech, Fralin Life Sci Inst, Blacksburg, VA USA; [Kinney, Nicholas A.] Virginia Tech, Dept Genom Bioinformat & Computat Biol, Blacksburg, VA USA; [Kokhanenko, Alina A.; Stegniy, Vladimir N.; Sharakhova, Maria V.] Tomsk State Univ, Inst Biol & Biophys, Tomsk 634050, Russia; [deBruyn, Becky S.; Lovin, Diane D.; Severson, David W.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [deBruyn, Becky S.; Lovin, Diane D.; Severson, David W.] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Tomsk State University; University of Notre Dame; University of Notre Dame	Sharakhova, MV (corresponding author), Virginia Tech, Dept Entomol, Blacksburg, VA 24061 USA.	msharakh@vt.edu	Kinney, Nicholas/I-7168-2016; Kokhanenko, Alina A/F-9438-2017; Sharakhov, Igor/B-1972-2008; Stegniy, Vladimir/N-7656-2014; Stegniy, Vladimir/ABC-6763-2020	Kinney, Nicholas/0000-0002-4563-1813; Sharakhov, Igor/0000-0003-0752-3747; Stegniy, Vladimir/0000-0001-8947-041X	National Institute of Allergy and Infectious Diseases, National Institute of Health [R21-AI101345]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101345] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research was funded by grant R21-AI101345 to MVS from the National Institute of Allergy and Infectious Diseases, National Institute of Health www.niaid.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864; Bachtrog D, 2013, NAT REV GENET, V14, P113, DOI 10.1038/nrg3366; Bartholomay LC, 2010, SCIENCE, V330, P88, DOI 10.1126/science.1193162; Bosio CF, 2000, GENETICS, V156, P687; Brown SE, 1997, INSECT MOL BIOL, V6, P197, DOI 10.1111/j.1365-2583.1997.tb00088.x; Campos J, 2003, MEM I OSWALDO CRUZ, V98, P387, DOI 10.1590/S0074-02762003000300017; Campos J, 2003, MEM I OSWALDO CRUZ, V98, P383, DOI 10.1590/S0074-02762003000300016; Coluzzi M., 1967, Parassitologia, V9, P73; Demin S, 2011, CYTOGENET GENOME RES, V132, P151, DOI 10.1159/000321676; DENNHOFER L, 1968, CHROMOSOMA, V25, P365, DOI 10.1007/BF01183127; DENNHOFER L, 1975, THEOR APPL GENET, V45, P250, DOI 10.1007/BF00831896; George P, 2010, INSECT MOL BIOL, V19, P675, DOI 10.1111/j.1365-2583.2010.01025.x; Gomez-Machorro C, 2004, INSECT MOL BIOL, V13, P637, DOI 10.1111/j.0962-1075.2004.00522.x; Heyse D, 1996, J AM MOSQUITO CONTR, V12, P199; Hickner PV, 2013, J HERED, V104, P649, DOI 10.1093/jhered/est040; Hickner Paul V., 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-358; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Jimenez LV, 2004, INSECT MOL BIOL, V13, P37, DOI 10.1046/j.0962-1075.2004.00456.x; KUMAR A, 1990, HEREDITAS, V113, P277, DOI 10.1111/j.1601-5223.1990.tb00094.x; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Lewin HA, 2009, GENOME RES, V19, P1925, DOI 10.1101/gr.094557.109; McAbee RD, 2007, J MED ENTOMOL, V44, P229, DOI 10.1603/0022-2585(2007)44[229:ADLSGP]2.0.CO;2; MCDONALD PT, 1970, GENETICS, V66, P475; Mori A, 2007, INSECT MOL BIOL, V16, P515, DOI 10.1111/j.1365-2583.2007.00746.x; Mori A, 1999, J HERED, V90, P160, DOI 10.1093/jhered/90.1.160; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; RAI K. S., 1963, ANN ENTOMOL SOC AMER, V56, P160, DOI 10.1093/aesa/56.2.160; Reddy BPN, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-63; Severson David W., 1994, Insect Molecular Biology, V3, P67, DOI 10.1111/j.1365-2583.1994.tb00153.x; SEVERSON DW, 1995, GENETICS, V139, P1711; Severson DW, 2002, INSECT MOL BIOL, V11, P371, DOI 10.1046/j.1365-2583.2002.00347.x; Shaffer LG, 2009, ISCN 2013 INT SYSTEM; Sharakhov IV, 2002, SCIENCE, V298, P182, DOI 10.1126/science.1076803; Sharakhova MV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r5; Sharakhova MV, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001335; Sharakhova MV, 2010, AM J TROP MED HYG, V83, P1023, DOI 10.4269/ajtmh.2010.10-0366; Timoshevskiy VA, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-27; Timoshevskiy VA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002052; Timoshevskiy VA, 2012, JOVE-J VIS EXP, DOI 10.3791/4215; Tolle Michael A, 2009, Curr Probl Pediatr Adolesc Health Care, V39, P97, DOI 10.1016/j.cppeds.2009.01.001; Vinogradova E.B., 2000, CULEX PIPIENS PIPIEN; Zambetaki A, 1998, GENOME, V41, P751, DOI 10.1139/gen-41-6-751; Zhong DB, 2006, GENETICS, V173, P1337, DOI 10.1534/genetics.105.055178	43	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0115737	10.1371/journal.pone.0115737	http://dx.doi.org/10.1371/journal.pone.0115737			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768920	Green Published, gold, Green Submitted			2022-12-27	WOS:000351277500002
J	Abebe, AS; Mikko, S; Johansson, AM				Abebe, Abiye Shenkut; Mikko, Sofia; Johansson, Anna M.			Genetic Diversity of Five Local Swedish Chicken Breeds Detected by Microsatellite Markers	PLOS ONE			English	Article							POPULATION-STRUCTURE; COMPUTER-PROGRAM; MANAGEMENT; SOFTWARE; CLUSTERS; DISTANCE; NUMBER	This study aimed at investigating the genetic diversity, relationship and population structure of 110 local Swedish chickens derived from five breeds (Gotlandshona, Hedemorahona, Olandsk dvarghona, Skansk blommehona, and Bohuslan-Dals svarthona, in the rest of the paper the shorter name Svarthona is used) using 24 microsatellite markers. In total, one hundred thirteen alleles were detected in all populations, with a mean of 4.7 alleles per locus. For the five chicken breeds, the observed and expected heterozygosity ranged from 0.225 to 0.408 and from 0.231 to 0.515, with the lowest scores for the Svarthona and the highest scores for the Skansk blommehona breeds, respectively. Similarly, the average within breed molecular kinship varied from 0.496 to 0.745, showing high coancestry, with Skansk blommehona having the lowest and Svarthona the highest coancestry. Furthermore, all breeds showed significant deviations from Hardy-Weinberg expectations. Across the five breeds, the global heterozygosity deficit (FIT) was 0.545, population differentiation index (F-ST) was 0.440, and the global inbreeding of individuals within breed (F-IS) was 0.187. The phylogenetic relationships of chickens were examined using neighbor-joining trees constructed at the level of breeds and individual samples. The neighbor-joining tree constructed at breed level revealed two main clusters, with Hedemorahona and Olandsk dvarghona breeds in one cluster, and Gotlandshona and Svarthona breeds in the second cluster leaving the Skansk blommehona in the middle. Based on the results of the STRUCTURE analysis, the most likely number of clustering of the five breeds was at K = 4, with Hedemorahona, Gotlandshona and Svarthona breeds forming their own distinct clusters, while Olandsk dvarghona and Skansk blommehona breeds clustered together. Losses in the overall genetic diversity of local Swedish chickens due to breeds extinction varied from -1.46% to -6.723%. The results of the current study can be used as baseline genetic information for genetic conservation program, for instance, to control inbreeding and to implement further genetic studies in local Swedish chickens.	[Abebe, Abiye Shenkut; Mikko, Sofia; Johansson, Anna M.] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden	Swedish University of Agricultural Sciences	Johansson, AM (corresponding author), Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden.	Anna.Johansson@slu.se	Abebe, Abiye/AAZ-9901-2020; Phillips, Andrew N/B-4427-2008; Lodwick, Rebecca/B-7578-2015; Johansson, Anna M/N-2502-2019; Sabin, Caroline/C-2464-2008; Mikko, Sofia/F-1347-2017; Johansson, Anna M/G-4759-2013; Haberer, Jessica/AAH-7976-2019	Phillips, Andrew N/0000-0003-2384-4807; Lodwick, Rebecca/0000-0003-2558-4762; Johansson, Anna M/0000-0002-9762-0497; Sabin, Caroline/0000-0001-5173-2760; Mikko, Sofia/0000-0002-6375-1376; Haberer, Jessica/0000-0001-5845-3190; Nakagawa, Fumiyo/0000-0002-6646-8744; Thirumurthy, Harsha/0000-0002-3308-7603	Erik PhilipSorensen foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924, R01HD074925] Funding Source: NIH RePORTER	Erik PhilipSorensen foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	AMJ received funding for the collection of blood samples and genotyping from the Erik PhilipSorensen foundation (www.epss.se). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anmarkrud JA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-138; [Anonymous], 2000, GENETICS DEMOGRAPHY, DOI [DOI 10.1017/CBO9780511623448, 10.1017/CBO9780511623448.008]; Barker JSF, 2001, CAN J FOREST RES, V31, P588, DOI 10.1139/cjfr-31-4-588; Blackburn HD, 2006, POULTRY SCI, V85, P210, DOI 10.1093/ps/85.2.210; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Caballero A, 2002, CONSERV GENET, V3, P289, DOI 10.1023/A:1019956205473; Chen GH, 2008, ASIAN AUSTRAL J ANIM, V21, P331, DOI 10.5713/ajas.2008.70125; Cuc NTK, 2010, ANIM GENET, V41, P545, DOI 10.1111/j.1365-2052.2010.02039.x; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; Dorshorst B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002412; Englund T, 2014, HEREDITAS, V151, P229, DOI 10.1111/hrd2.00064; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; FAO, 2011, AN PROD HLTH GUID, V9; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Food and Agriculture Organization, 2007, SUB REG REP AN GEN R; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Granevitze Z, 2007, ANIM GENET, V38, P576, DOI 10.1111/j.1365-2052.2007.01650.x; Guo XQ, 1999, HUM HERED, V49, P112, DOI 10.1159/000022855; Gutierrez JP, 2005, J HERED, V96, P718, DOI 10.1093/jhered/esi118; Hillel J, 2003, GENET SEL EVOL, V35, P533, DOI [10.1051/gse:2003038, 10.1186/1297-9686-35-6-533]; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kalinowski ST, 2011, HEREDITY, V106, P625, DOI 10.1038/hdy.2010.95; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kaya M, 2008, BIOCHEM GENET, V46, P480, DOI 10.1007/s10528-008-9164-8; Meuwissen THE, 1997, J ANIM SCI, V75, P934; Muchadeyi FC, 2007, ANIM GENET, V38, P332, DOI 10.1111/j.1365-2052.2007.01606.x; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NEI M, 1974, GENETICS, V76, P379; Nei M., 1987, MOL EVOLUTIONARY GEN; Pritchard JK, 2000, GENETICS, V155, P945; Rajkumar U., 2007, Indian Journal of Animal Sciences, V77, P1194; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rosenberg NA, 2001, GENETICS, V159, P699; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Tadano R, 2008, ANIM GENET, V39, P71, DOI 10.1111/j.1365-2052.2007.01690.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wilkinson S, 2012, ANIM GENET, V43, P552, DOI 10.1111/j.1365-2052.2011.02296.x; Zanetti E, 2010, POULTRY SCI, V89, P420, DOI 10.3382/ps.2009-00324	40	136	159	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0120580	10.1371/journal.pone.0120580	http://dx.doi.org/10.1371/journal.pone.0120580			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25855978	gold, Green Published, Green Submitted			2022-12-27	WOS:000352588500013
J	Rana, Y; Haberer, J; Huang, HJ; Kambugu, A; Mukasa, B; Thirumurthy, H; Wabukala, P; Wagner, GJ; Linnemayr, S				Rana, Yashodhara; Haberer, Jessica; Huang, Haijing; Kambugu, Andrew; Mukasa, Barbara; Thirumurthy, Harsha; Wabukala, Peter; Wagner, Glenn J.; Linnemayr, Sebastian			Short Message Service (SMS)-Based Intervention to Improve Treatment Adherence among HIV-Positive Youth in Uganda: Focus Group Findings	PLOS ONE			English	Article							BEHAVIORAL SKILLS MODEL; ANTIRETROVIRAL THERAPY; ADOLESCENTS; INFORMATION; MOTIVATION	This paper presents one of the first qualitative studies to discuss programmatic barriers to SMS-based interventions for HIV-positive youth and discusses pathways through which youth perceive them to work. We conducted six focus groups with 20 male and 19 female HIV-positive youths in two clinics in Kampala, Uganda. We find that youth commonly use SMS as over 90% of this study's youths knew how to read, write and send messages and almost three-fourths of them had phones. Youth strongly felt that the success of this intervention hinged on ensuring confidentiality about their HIV-positive status. Key programmatic challenges discussed where restrictions on phone use and phone sharing that could exclude some youth. Participants felt that the intervention would improve their adherence by providing them with needed reminders and social support. Youths' suggestions about intervention logistics related to content, frequency, timing and two-way messages will be helpful to practitioners in the field.	[Rana, Yashodhara; Huang, Haijing; Wagner, Glenn J.; Linnemayr, Sebastian] RAND Corp, RAND Hlth, Santa Monica, CA 90401 USA; [Haberer, Jessica] Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA; [Kambugu, Andrew] Infect Dis Inst, Kampala, Uganda; [Mukasa, Barbara; Wabukala, Peter] Mildmay Uganda, Kampala, Uganda; [Thirumurthy, Harsha] Univ N Carolina, Dept Hlth Policy & Management, Chapel Hill, NC USA	RAND Corporation; Harvard University; Massachusetts General Hospital; University of North Carolina; University of North Carolina Chapel Hill	Rana, Y (corresponding author), RAND Corp, RAND Hlth, Santa Monica, CA 90401 USA.	yrana@rand.org	Abebe, Abiye/AAZ-9901-2020; Phillips, Andrew N/B-4427-2008; Lodwick, Rebecca/B-7578-2015; Johansson, Anna M/N-2502-2019; Sabin, Caroline/C-2464-2008; Mikko, Sofia/F-1347-2017; Johansson, Anna M/G-4759-2013; Haberer, Jessica/AAH-7976-2019	Phillips, Andrew N/0000-0003-2384-4807; Lodwick, Rebecca/0000-0003-2558-4762; Johansson, Anna M/0000-0002-9762-0497; Sabin, Caroline/0000-0001-5173-2760; Mikko, Sofia/0000-0002-6375-1376; Haberer, Jessica/0000-0001-5845-3190; Nakagawa, Fumiyo/0000-0002-6646-8744; Thirumurthy, Harsha/0000-0002-3308-7603	National Institute of Child Health and Human Development [R01HD074925]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924, R01HD074925] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was sponsored by Grant R01HD074925 from The National Institute of Child Health and Human Development (PI Sebastian Linnemayr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amico KR, 2005, AIDS CARE, V17, P661, DOI 10.1080/09540120500038058; [Anonymous], PUTT YOUNG PEOPL CTR; Bikaako-Kajura W, 2006, AIDS BEHAV, V10, pS85, DOI 10.1007/s10461-006-9141-3; CRAMER J, 1995, EPILEPSIA, V36, P1111, DOI 10.1111/j.1528-1157.1995.tb00469.x; Curioso Walter H, 2009, AMIA Annu Symp Proc, V2009, P129; DellaVigna S, 2009, J ECON LIT, V47, P315, DOI 10.1257/jel.47.2.315; Dowshen N, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.2015; Ferrer-Roca O, 2004, J TELEMED TELECARE, V10, P282, DOI 10.1258/1357633042026341; Finitsis DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088166; Fisher JD, 2006, HEALTH PSYCHOL, V25, P462, DOI 10.1037/0278-6133.25.4.462; Gray WN, 2011, J HEALTH PSYCHOL, V16, P828, DOI 10.1177/1359105310394230; Katz IT, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18640; Kitara D L, 2012, Afr J Infect Dis, V6, P12; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Mbuagbaw L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046909; Mitchell KJ, 2011, HEALTH EDUC RES, V26, P770, DOI 10.1093/her/cyr022; Mohammed S, 2012, J TELEMED TELECARE, V18, P404, DOI 10.1258/jtt.2012.120311; O'Donoghue T, 1999, AM ECON REV, V89, P103, DOI 10.1257/aer.89.1.103; Pop-Eleches C, 2011, AIDS, V25, P825, DOI 10.1097/QAD.0b013e32834380c1; Rao D, 2007, AIDS CARE, V19, P28, DOI 10.1080/09540120600652303; Simoni JM, 2007, PEDIATRICS, V119, pE1371, DOI 10.1542/peds.2006-1232; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; Steinberg L, 2009, CHILD DEV, V80, P28, DOI 10.1111/j.1467-8624.2008.01244.x; Strandbygaard U, 2010, RESP MED, V104, P166, DOI 10.1016/j.rmed.2009.10.003; Thaler R.H., 2021, NUDGE FINAL EDITION	25	136	159	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0125187	10.1371/journal.pone.0125187	http://dx.doi.org/10.1371/journal.pone.0125187			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1ES	25855978	Green Submitted, Green Published, gold			2022-12-27	WOS:000353016500115
J	Lodwick, RK; Nakagawa, F; van Sighem, A; Sabin, CA; Phillips, AN				Lodwick, Rebecca K.; Nakagawa, Fumiyo; van Sighem, Ard; Sabin, Caroline A.; Phillips, Andrew N.			Use of Surveillance Data on HIV Diagnoses with HIV-Related Symptoms to Estimate the Number of People Living with Undiagnosed HIV in Need of Antiretroviral Therapy	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PROGRESSION; PREVALENCE; INFECTION; DISEASE; SIZE	Background It is important to have methods available to estimate the number of people who have undiagnosed HIV and are in need of antiretroviral therapy (ART). Methods The method uses the concept that a predictable level of occurrence of AIDS or other HIV-related clinical symptoms which lead to presentation for care, and hence diagnosis of HIV, arises in undiagnosed people with a given CD4 count. The method requires surveillance data on numbers of new HIV diagnoses with HIV-related symptoms, and the CD4 count at diagnosis. The CD4 count-specific rate at which HIV-related symptoms develop are estimated from cohort data. 95% confidence intervals can be constructed using a simple simulation method. Results For example, if there were 13 HIV diagnoses with HIV-related symptoms made in one year with CD4 count at diagnosis between 150-199 cells/mm(3), then since the CD4 count-specific rate of HIV-related symptoms is estimated as 0.216 per person-year, the estimated number of person years lived in people with undiagnosed HIV with CD4 count 150-199 cells/mm3 is 13/0.216 = 60 (95% confidence interval: 29-100), which is considered an estimate of the number of people living with undiagnosed HIV in this CD4 count stratum. Conclusions The method is straightforward to implement within a short period once a surveillance system of all new HIV diagnoses, collecting data on HIV-related symptoms at diagnosis, is in place and is most suitable for estimating the number of undiagnosed people with CD4 count <200 cells/mm3 due to the low rate of developing HIV-related symptoms at higher CD4 counts. A potential source of bias is under-diagnosis and under-reporting of diagnoses with HIV-related symptoms. Although this method has limitations as with all approaches, it is important for prompting increased efforts to identify undiagnosed people, particularly those with low CD4 count, and for informing levels of unmet need for ART.	[Lodwick, Rebecca K.] UCL, Res Dept Primary Care & Populat Hlth, London, England; [Nakagawa, Fumiyo; Sabin, Caroline A.; Phillips, Andrew N.] UCL, Res Dept Infect & Populat Hlth, London, England; [van Sighem, Ard] Stichting HIV Monitoring, Amsterdam, Netherlands	University of London; University College London; University of London; University College London	Nakagawa, F (corresponding author), UCL, Res Dept Infect & Populat Hlth, London, England.	f.nakagawa@ucl.ac.uk	Abebe, Abiye/AAZ-9901-2020; Phillips, Andrew N/B-4427-2008; Lodwick, Rebecca/B-7578-2015; Johansson, Anna M/N-2502-2019; Sabin, Caroline/C-2464-2008; Mikko, Sofia/F-1347-2017; Johansson, Anna M/G-4759-2013; Haberer, Jessica/AAH-7976-2019	Phillips, Andrew N/0000-0003-2384-4807; Lodwick, Rebecca/0000-0003-2558-4762; Johansson, Anna M/0000-0002-9762-0497; Sabin, Caroline/0000-0001-5173-2760; Mikko, Sofia/0000-0002-6375-1376; Haberer, Jessica/0000-0001-5845-3190; Nakagawa, Fumiyo/0000-0002-6646-8744; Thirumurthy, Harsha/0000-0002-3308-7603	HIV in Europe; European Centre for Disease Prevention and Control (ECDC) [FWC/ECDC/012/050]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924, R01HD074925] Funding Source: NIH RePORTER	HIV in Europe; European Centre for Disease Prevention and Control (ECDC); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding: The authors acknowledge funding from HIV in Europe and European Centre for Disease Prevention and Control (ECDC) framework contract FWC/ECDC/012/050. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, MMWR-MORBID MORTAL W, V41; Antinori A, 2011, HIV MED, V12, P61, DOI 10.1111/j.1468-1293.2010.00857.x; Babiker A, 2000, LANCET, V355, P1131, DOI 10.1016/S0140-6736(00)02061-4; Beral V, 2004, AIDS, V18, P51, DOI [10.1097/00002030-200401020-00006, 10.1097/01.aids.0000096908.73209.5d]; British HIV Association Audit & Standards Sub-Committee, 2010 11 SURV HIV TES; BROOKMEYER R, 1986, LANCET, V2, P1320; BROOKMEYER R, 1988, J AM STAT ASSOC, V83, P301, DOI 10.2307/2288844; Brown T, 2010, SEX TRANSM INFECT, V86, pI3, DOI 10.1136/sti.2010.044784; European AIDS Clinical Society, 2011, EACS GUID VERS 6 1; FLEGG PJ, 1994, J INFECTION, V29, P311, DOI 10.1016/S0163-4453(94)91266-1; Goubar A, 2008, J R STAT SOC A STAT, V171, P541, DOI 10.1111/j.1467-985X.2007.00537.x; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; LEE CA, 1991, BMJ-BRIT MED J, V303, P1093, DOI 10.1136/bmj.303.6810.1093; Lyerla R, 2006, SEX TRANSM INFECT, V82, pIII41, DOI 10.1136/sti.2006.020198; Morgan D, 2002, BRIT MED J, V324, P193, DOI 10.1136/bmj.324.7331.193; Ndawinz JDA, 2011, AIDS, V25, P1905, DOI 10.1097/QAD.0b013e32834af619; Porter K., 2011, COMMUNICATION; Sommen C, 2009, STAT MED, V28, P1554, DOI 10.1002/sim.3570; Sweeting MJ, 2005, STAT MED, V24, P3991, DOI 10.1002/sim.2432; Van Sighem A, 2014, C RETR OPP INF CROI; Wand H, 2010, HIV MED, V11, P395, DOI 10.1111/j.1468-1293.2009.00804.x; Working Group on Estimation of HIV Prevalence in Europe, 2011, AIDS, V25, P1017, DOI 10.1097/QAD.0b013e3283467087	22	136	159	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0121992	10.1371/journal.pone.0121992	http://dx.doi.org/10.1371/journal.pone.0121992			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25855978	Green Published, gold			2022-12-27	WOS:000351277500146
